<SEC-DOCUMENT>0001596783-21-000110.txt : 20210830
<SEC-HEADER>0001596783-21-000110.hdr.sgml : 20210830
<ACCEPTANCE-DATETIME>20210830092648
ACCESSION NUMBER:		0001596783-21-000110
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210830
DATE AS OF CHANGE:		20210830

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Catalent, Inc.
		CENTRAL INDEX KEY:			0001596783
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208737688
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36587
		FILM NUMBER:		211221356

	BUSINESS ADDRESS:	
		STREET 1:		14 SCHOOLHOUSE ROAD
		CITY:			SOMERSET
		STATE:			NJ
		ZIP:			08873
		BUSINESS PHONE:		(732) 537-6200

	MAIL ADDRESS:	
		STREET 1:		14 SCHOOLHOUSE ROAD
		CITY:			SOMERSET
		STATE:			NJ
		ZIP:			08873

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTS Holdings Corp.
		DATE OF NAME CHANGE:	20140113
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ctlt-20210630.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d,d:dd9cf92bf6a34c78ac936b47262640d7--><html xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ctlt="http://catalent.com/20210630" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ctlt-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV80LTEtMS0xLTA_ab81e7ec-c8ad-49c3-8652-9d5980b49ba0">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV82LTEtMS0xLTEyNzUz_1879c946-9291-40e1-85d4-6af090f6f0e6">2021</ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV84LTEtMS0xLTA_e4103220-adcc-4525-9348-1a90383fa58e">FY</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823" decimals="0" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV8yMC0yLTEtMS0w_83928810-9106-461c-a5b0-631992eadafb">170787238.00</ix:nonFraction><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV8yMS0zLTEtMS0w_08664db8-eb04-44c5-b510-a84f7d37fa8e">08873</ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGV4dHJlZ2lvbjozOGYzNjE5ZjRhYzY0NzQ0OWNkYmRmNTdiNGE2NmNmNV84Ng_f76cc67c-0e7a-4f61-9cd0-8d067a5ea7ab">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGV4dHJlZ2lvbjozOGYzNjE5ZjRhYzY0NzQ0OWNkYmRmNTdiNGE2NmNmNV84Nw_1eae6bbe-508d-4f84-9843-c039479fa8c8">0001596783</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzItMS0xLTEtMA_dbc6e90a-48fc-4861-b768-e07fa79dabd7">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzItMi0xLTEtMA_0c0bbc66-5f17-495e-a360-9c4a810006a1">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzMtMS0xLTEtMA_c7d8c954-f864-4a29-acc7-641550b71a19">1,000,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzMtMi0xLTEtMA_5d466428-9689-4b90-8696-c6d5a28689d8">1,000,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzQtMS0xLTEtMA_e68b720b-8648-4b76-b3f8-b77a9a84d56e">170,549,341</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzQtMi0xLTEtMA_59b2294f-5fa3-49dc-ac02-5622d891197e">162,788,043</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMS0xLTEtMTA0MTY_3de123f6-f6d5-49ce-ade3-ca0c1a6e6a06">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMi0xLTEtMTA0MTY_650093a1-f3c5-4c04-af70-e284c68e9a7c">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMS0xLTEtMA_afe83730-05c7-4a07-b40d-48a191a50df6">100,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMi0xLTEtMA_4c6e6dde-3325-48fb-b8d1-51d099b644d0">100,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzctMS0xLTEtMA_2bde2215-46aa-4740-a451-91b624e7c3b2">384,777</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="0" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzctMi0xLTEtMA_d6e9d86c-012f-41f6-ad5e-8544a136e875">650000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzgtMS0xLTEtMA_90da3d50-1eba-43ba-b3b7-8260ff809864">384,777</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzgtMi0xLTEtMA_374bdc37-3ddc-4800-be62-58b5c90d135c">650000</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-5" name="ctlt:InstallmentPaymentForAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMS0xLTEtMA_ef42241c-e85f-412e-b7c2-8fbeed48a8fe">50.0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-5" name="ctlt:InstallmentPaymentforAcquisitionYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMi0xLTEtMA_ff732e55-5266-4181-b887-76d28c6480f1">50.0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-5" name="ctlt:InstallmentPaymentforAcquisitionYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMy0xLTEtMA_79c8f53c-696a-4d12-8231-9617919c304e">50.0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-5" name="ctlt:InstallmentPaymentforAcquisitionYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItNC0xLTEtMA_517095be-93c4-4adb-ab20-3e65ba6d41d0">50.0</ix:nonFraction><ix:nonNumeric contextRef="i43879f86903647978e93d2adcf449c13_D20200701-20210630" name="ctlt:OperatingLossCarryforwardsCarryForwardPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMxMTQ_40c2bc12-63e0-4386-a398-62f51315a07f">P20Y</ix:nonNumeric><ix:nonNumeric contextRef="id22c9303e1134346b1d14d228108d1e4_D20200701-20210630" name="ctlt:OperatingLossCarryforwardsCarryForwardPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyNTI_21287ddd-d08b-44ee-ae2d-42c777ef2210">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDQvZnJhZzo4MGJhMzk0OThkOWI0ZjAzYWIzYzRmN2U5MWZmNDBjMC90YWJsZTo0Y2ZjNzA0ZmRlNzg0NGM2YTljM2RkYmFhZTQ1MDFmZS90YWJsZXJhbmdlOjRjZmM3MDRmZGU3ODQ0YzZhOWMzZGRiYWFlNDUwMWZlXzAtMC0xLTEtMA_4b248e3e-fa64-4c46-8b17-f14aae481407">us-gaap:OtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDQvZnJhZzo4MGJhMzk0OThkOWI0ZjAzYWIzYzRmN2U5MWZmNDBjMC90YWJsZTo0Y2ZjNzA0ZmRlNzg0NGM2YTljM2RkYmFhZTQ1MDFmZS90YWJsZXJhbmdlOjRjZmM3MDRmZGU3ODQ0YzZhOWMzZGRiYWFlNDUwMWZlXzEtMC0xLTEtMA_ee6545be-ca72-48f6-a1b6-abc593235576">us-gaap:OtherLiabilities</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ctlt-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iaa63168b9f6848698d3cd88bc9a36d76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc35871a5183468aaab7c718b6a42771_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e364a4c60a40d186dee61881303017_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2782505d17674bb49380b553158607bd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86567583f6c54f90bd46551acae65b63_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fcf069e257b4824a1c38afc5b1b50c6_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211bd387923e4c8a8acbce07f918efab_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c291416f38415ea87b555881657be2_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95c6836230814e07a0db1966aafcc2e7_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b17f319169040e68cd6152d58da61f4_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9f0cf3a7646426da02b70234824e7c8_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30cad29fb45d48a2b98661270e7a1647_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib236337c6ce243e4a006557882bad730_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea093bde90c473e96a3747cc21b632d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6562a165cb4a4a09862673671a5213e4_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67f77fb9385943b2aabca06dccddf2d9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4623a02e99844aeb45c994796125655_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia119eac9568e4da69d3502883a5a411c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc274db89144df49cfa6797c23c7a8f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c36070acfe4877985f738b20af4ab6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36a4a8155664853831b16252f0cb6c2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563591751a704301b043dafcbace5b1c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfda33e1a14344bc9edc067079194eba_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0ad825218af4779802948241479fe13_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38c3d72a2b0475e9e8ec4fd255a529e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7e44f48935447b182ae9e7b32b980e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if63d43dbb1eb4d06a5e91cc8f6bb9df5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03ea8538a32e4e6198456232f248d40d_D20140731-20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-07-31</xbrli:startDate><xbrli:endDate>2014-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icca6e1525f554545b89d8494504b8035_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>ctlt:customer</xbrli:measure></xbrli:unit><xbrli:context id="ib5a20ffd9213425fb1e67c81f9224f31_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ctlt:BuildingAndImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i466bfbf6fd7d441db3dfc26c891635e3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ctlt:BuildingAndImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe521655ef544698a6f74f2e8aff928_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ff65157f3540fc804007bced73dae3_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if766739d8f2b4a4889f8d197a5fe2447_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a3c699d9f24539b7342ac1f583ba77_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a2087bb20040eca6de434a5a3a69b4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada4b587fca14301a3db1cee71bb807f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51f38a8412b461597c87ef42543ce85_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i045c4761bada44e6838395223b03d53e_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3da86270c27446129776c8fa261c8181_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b128b8fed0453589f0b1f789d7401d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3b691cfbf74328831c43d672a4f921_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705c4c9f11954b4ea5e99770a3c251a4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b25898ae02243708a9f6f45778360bd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e6d8d7df749456aa44395064bfc68ed_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0aa571359bc437aa855b95942f5960c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39f42b75751f4cb0a931e72af45e2071_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia16a67ca8a3e43959d9b6899ddb210d0_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f0a88b6d220432d822a3a9acc1be96f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60878ec54f754cd685972d131936a863_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093d3096941f487d945682b19471e3df_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66eccdacf8164ed593c34225a88a46d1_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21a0bd7b87e4a03911155430ae8b6ae_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef7d76076a94237a72ee40ceab75b87_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142419c11f5d4f0489522ad07594cdbf_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4927d306a5cd4d059e75f5c9a3d57193_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52cbad2cbd874660845a41e6ce1dd05d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d233789dad44dedabfcbf931339090a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b7f23d170040c08b3f2af50189003e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b4b92b91af444d955bbb9f2174dd7e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884903df67494d87bbab2288ab7a8879_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1254879dc3784a83a23a504c071ed5a3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cfcb80aba194eabb4778da0ffeda957_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ad96da5593486fbc6c6de7f9b3e68f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd4c045f9a3f41bea3c504f692dea648_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a776ebf0a942589e391bead02f211b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7107a7761d40c8904561ccb9c417f6_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bef26a88d4d45d39bca80b0cc08cb49_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:geographicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951ba969a0bc495faf2a70bac7fd4cb8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed9921d6bb04cc7bd39d32cbbc854eb_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf6743117284e278dddc68935f89f38_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60e54ba728a04c0ebb1f97f6fbfd3c64_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:InternationalOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iece8fce5266a4b4a80688042161b0641_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:InternationalOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fb7193cbe7d43bca3a20da21b84f54d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AnagniMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea3ee19783347fcbcdad64f27aae413_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AnagniMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e96532b149d46edb99ca6b0a748f524_D20200210-20200210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-10</xbrli:startDate><xbrli:endDate>2020-02-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a947e3eec134edc93799b574e4dde4a_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8fd61e3e3e4bc587341b5de7823db4_I20200210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd578116a1984512962b999d1a8d51ef_D20201116-20201116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:SkeletalCellTherapySupportSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-16</xbrli:startDate><xbrli:endDate>2020-11-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AcordaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-11</xbrli:startDate><xbrli:endDate>2021-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AcordaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:DelphiGeneticsSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22686bb8eb4342bbb50bc71230a550a9_I20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:DelphiGeneticsSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec05426d8309444b822cb0b7025ea5f5_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:HepaticCellTherapySupportSA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3b7eae092942fba85aaba9e27b78aa_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:KyotoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:BlowFillSealBusinessWoodstockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i180acc781ca7481394028c8cb6e82480_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:BlowFillSealBusinessWoodstockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3271a0d0c6f0478ea7b97b353bd69af2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c2bcc242b14433b4c516133cfacc12_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if22a051247f64fc693ae10ac38acda75_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i654dce15c0874c9fb40648bb53e7594b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2726cb57c9441d90eb8e733906a808_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7061380698a4b9395a2f0cfba0d8aac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab98274d571d4d449f30491cdd65c962_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d420fead59462095697a3993d8f4e5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ebdb26351324dc59f4adf268bf038a1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7814e488a794292a9e3f5a1d348951e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88402b35bd0c42118b8f0b1db0690925_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad48a9578f7b445ab0c1b13ac0a459e2_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i845bd8ba54d74c7fb72abac0310f0e79_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e750947153247c48b42689a9511423f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i111cc1fffc0343ee85c1cfa4409c4152_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c882c4168ec447fba77d5f523c9881f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ee2895bde24a118a0de6982690f442_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief92cbae4c3841df84e37fe359a93709_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i704ca8cefa7742e4aad55ca96150cc8b_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b028860ed64053b94135848c0906f0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93fec8f8cb448208c403c46c07fedc6_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4aea4c64794160b8c6f3912b4dd294_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7344efba23c04c1484bed638331da234_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employees"><xbrli:measure>ctlt:employees</xbrli:measure></xbrli:unit><xbrli:context id="i378811f92e0f4ffeb7fb93c1f1f293eb_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf709e90ec7842118e0f9f686273d1e9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2731c0e309f94c7b87f012c3985d4fc2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff2c23c60004dfab89f35aa1a024575_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8e76f0ec8f455cb11705921585b0c4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i533413c430064ec6b4c844cc3f1acfbe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanFacilityIncrementalDollarTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15fceb629bb441a8a053f8395affd416_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanFacilityIncrementalDollarTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad07736ec7541dcaa87a7b378aa1ebf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684ac58b65d2462d9086fd8d03006003_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i776ba765031f4822ac7631755e4324e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditFacilityTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf427a11407e441c9ae17c2a3bc8d22a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditFacilityTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d7e2c8c43a47c0a933c613e1998a34_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d8daa403fef413dba97b83235c8ea21_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a1e048ba7c4e9691ded7739ee1a189_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6839464700d0468ba36b8a430fd5892f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i796cb7ff80c54ea8a86407355ff7fedb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id16b5a16fdc04b628d9ec759b80705ff_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib061337543284797b3b9d0ef58f9ec80_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d27525d7cf54500bd9efcef6e00f2a5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ac432fc632a4aa4b73cc9827f98414a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508875b781734fda88090125bce65502_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9042a8cb274081acd357a646d69523_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de35b0a15464306a00bc384ef0ae803_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:OtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8095367c62b3442fb4b4cbb5c6ceeaa6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:OtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i801d701548f94353a03e6bbafcc35c85_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d2ad22ca2e9468182fd61677afb1c58_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i324f9e1797a44fa5a5ee426673cb92c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa628a205694eb380b875de3bbacbfa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91ae3a1701e42c4bab269d3f3f05bb4_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanTwoFacilityDollarDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i889429d7ce8e4d9998dd05977d62e04b_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a70d7001a4d41889b95e3278d9d6e76_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditCommitmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i82917b6fc7de420b9f04e1c84874f333_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0282c343e7634e19b53f822bfc4e477f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i076d5ed390e143ec905916749b2b91cd_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51dabd2b047049b4a2d87b4d8f3f5b9c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0408f495c5d4d949488007caa31f4ae_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i814e92c75da3452187f82acd0565e8db_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2277ff43db9c4df8b0dc6f627b3a499a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:FourPointSevenFivePercentSeniorEuroDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic60365c610a94f2a911805e966520b33_I20171018"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf405a2085fd40a8b0117b3a3432c514_D20171001-20171023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b827d728ed040f9aa9a77f9d945ef0d_D20171001-20171023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ctlt:SeniorSecuredCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaffc390ab5942bea52a4be57e7dbde6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c37e0185644986bb65525bb1644ccd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabaebe4c2d684181a51203e58e9005fe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86102d72c35440138d512f3c29d2305f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6671e05a3e2b467a944f21f20d4c3366_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15380ce82624d0e9f2df108f51ffe4b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3db9452ad5e47a1bb0e9ab578f325b3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a6d816c6a3b45b4ac0a46bfbcb69988_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09171d0cebb6430a942aa7517fe61fe9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief6bc672a6674233a298d9a2b454a730_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a171a9b90a84e74bda5120a9f3baca5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6faf7a0fe4914b9f87e7fa0c0d7bd9a2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e1619d8d97442d2b05880b4bab402aa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6dcbdcff43d44a9947d50294da0c59f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8856d25fb8b24759af14435f4b8ba6ca_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-23</xbrli:startDate><xbrli:endDate>2020-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36da9517a14e4528a0349b2cb8978970_I20201123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671c59d76d904023aea5037521cce6c5_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae15435182f490c81d494a5e1ec3b32_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170d00009dcc4cd1ba9ddacd15fdefc1_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc1999796814b39a7ce2ada34826470_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419473081c56497ab865784949c1efce_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1814fd669de945459192151f0faec56c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b3309684564f31b7fd6fb52491e6be_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDenominatedTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbb10789bf7a49039027ed20f163c57d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7abc05af1e54767abafd35e659d3d05_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe887898b5bf481ba802abbfae71dccc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94de709fd06649489f2953db5ca5be8f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7afaad523b4d4aa097e6a26233712228_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33922380dc6b4abe8a22039a9468b7e1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43879f86903647978e93d2adcf449c13_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i125f9fdad01e48d9b2c4c0fac0f4bf10_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id22c9303e1134346b1d14d228108d1e4_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98daa63182c347e2b14fbd8135bcfe10_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ctlt:ForeignNetOperatingLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d70d7b7223b4d6f862421f894246388_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ctlt:ForeignNetOperatingLossEstablishedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e02363e7a2c426689077f3463d3da3f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e85d458dcaf42d481153310021f91c5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife004a47c4ec48ce97f593d352e32a55_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba420f2700c34ea3a4b4416c427c3200_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab053a6427c144d0967665353d78987e_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73585509ea444f569767074a3eb6f0e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40e4763f489e4965b255dfd5a6e6227b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i784893fdb3a544208242b89ecd1ee2d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cee44c9e63c4f489171f4645ccb62f1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice706a08834741238da74ea29809773c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba1dff49d0441b99a14d5a695a48485_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0eab50ed80743d8a5a2731fc313e888_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b5da2a933744c8e97cede443f401e52_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0aa2721ff8ac4556af2c1db97433052f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7641feb3a40c4cc5a431e94405fc50bb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aabee3dc2d143e9831360b8909d220d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c888b0858a407ca4c6882470d3ba57_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec188c749a342bfa2dbee5cfd413b77_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28107f2cb01d42869fd11e36fce2be21_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6731d24e56c6494285a36dd2320f028b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67761642cec34a60aa24257023272899_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i615eba980ba44e7d91f0e6f353950a76_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84be19874184c0ebe7a692cffb1b662_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4219029a0a0f4dbc95510d66f4e4944f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14776c06fd314b2bbd995fa64ee43e49_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf5bb2f93d92431f9720216af1c29f16_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e902584a964a56b042714cd96fd856_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id59d87ec9da544189ca37e884e903023_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic76b7a1a1c50447c8795cfee9b76b6f2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280d65c3f17f458683c59c0a78aeb3f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17dbf7d5602747039f196cf8fed44904_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e5e7182ff24cb9a7f0279131bb4942_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6429ba70c044f03b798cd9e4de2be0b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e0ac7b8ffd4432b71c123c4597bc5f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39f484cfb594508ae46c19f5b6065b4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dbac52f32be4ec29dce953d13e92d44_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d771ace0eb1449fb7f3c12ed9ed1b72_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib594f3bd14cb40f2af014369a711be04_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f6ce956a9a84c788e025d461d2fa55e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9a6629638d4bec8bbeca03f202300b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie042f30541ea42e3925b4408eb1b5efe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616dc17846934bb29e3dfa999602105a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba82bbc9c25342b3ad2b0f7fca13b545_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af23bf32de448b9b29a639e339e12ca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f7205774aa465d8c2c5c62294b0b82_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48b7425856b04051877a7f4af9acb089_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idefe473808f242cfb4d79b76bb4cd1b6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3d162800d3645f09f06e974c9c7b41f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ctlt:DefinedBenefitPlanOtherAssetsAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id478458e161c4187b43283019eb85566_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7d5a90f3e04d0a8cda16af1947057e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f58afe0b33945a38eaa3dbef03f5e38_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9365ffbe0c824e079d7910fb709ae51b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f2ea0ebe25a4a58af6552214e53fb98_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i674ba7cf27b546a4bb3070be9a749b6b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95647ade5004209956c4a57536f85cd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb17a22b64641879d269be22be9f957_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2766d6e8cc8a4999992fa9459d493068_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ddfd65a6674ab581ba4e4d8629a7c1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i338530796387480ebed0b8318b633f47_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c88f034a63243369678cb546a00e1ac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i217e96b6a96a4d41b70da7c1176afaac_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9862365c693c40c5a75f7d109361924b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36fc4fd39be144599048465035ffbf4f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044c92e5d7764b238c02260877d1c6a3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0933365c8e7843c381a38dda5c76730a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i761a3f210f0d4571a49d8aba4bf24cd5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a004bc1607d43e183c8e77e4c139dc5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ad7c55e85245b69bd849dbef9f6339_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i065b118e37ce4fd4b007a6f358dfd1f8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie793845427de4931a83bcaeee475b50b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ctlt:DefinedBenefitPlanOtherAssetsAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925686e50afe4c2ebf90635e12f3836a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:EberbachPensionPromissoryNoteOrLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib73f5a43231945369c1c0f4f80a2d43d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f9023c3b6654d3882840dd7e57a6add_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b03fecf1a824b69b571ab998730a8de_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15d51546be7e4dca88d0b88655adaa62_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7bbc3d33ba64564905716133264e5cf_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c19f2e7fd444db984805e159c3087f7_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-15</xbrli:startDate><xbrli:endDate>2020-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1290537b263472c96221d671edce576_I20200615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-06</xbrli:startDate><xbrli:endDate>2020-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61973bb2144417ab4cb0d8936b28d87_I20200206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f799b0175d45b2b0f741e0b0d836f2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:DesignatedSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7867ffbd357d4690b08c9d4613c293e4_I20190517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-05-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef4a2ddd640405884e26ccb88aec2cc_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec61b66a0ae41bb8d96d423f6b1d627_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a022f50ba3b4184aca687e31673f394_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i221440e603ee468f84a494f340ce58aa_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d58655fb4b4d95a56611db174ed7c0_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5655f5c2bab84586add677e627a148ce_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i821917bb413b4a56aac98433b843532a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b5caf499e0a431a8879e0fccd6f9ece_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2629dad7444ac6a087600fb4eeb17d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f53a97e9a3e45b0b0be1df8cb9a0cb5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i240eab7869244315a4272887642c26a5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if39c138759b140dab2149dee8ac05f30_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib607491522bf4a9cbf1b0e51427ed504_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ebe451150f641eba39d44e90165f2bc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087ba84b22354e09b7931fd608163258_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6065f8b36ce4420b00d99511de9eeb2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef7b19288854132b4c14e7c56376062_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21c601ca07c400c97c3e7ea14464b57_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4b5715f5e247d7b165eac3e63b264b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie772514199484fb3aae9babd28777987_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2b9e16ce3314fc2920a48d1f12d45fd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16adf08f770b46c8aa99e285f1f5c1ac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fabe70416074ebda423b8e2c3b19f93_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226e7ad29001479db3560c191da2d80c_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2bd505327db495a8249c5115973c38f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c12a76e607440788d887a6561e62949_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i696afeb709ea478c8ccf7a35b63793d5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4760a1c73cc4e78b46d8250df062040_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1910093577c14f8a935dd760ba3c5e1d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c79c1d61c8b42c0802484894294b5ab_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be771f1b5b348f8986509afc9283597_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549198ff2e8b45a69be9153279060162_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fcb40d78880478bae00f3e6351a3717_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9521aa39e6a402cbbdddd19532b77db_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab90ce5a26874c06bf75dc201cdc453b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4758e061601246c28a5892fd160aa21b_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8255b75ca674484f85321eed13714758_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd515f3814a4c76bab0cb060aab91ef_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d88dad07c8b4257bc335a79b87e5840_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9126ac8ef8946a0984ee537fe89c5a6_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32780b0807f04e8886a1644091ccd209_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efc8c22dd864f77bfa1a9eeb9bf0b27_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d8aebfe31c4223803b5f24bc0f29f8_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i733c8bb4e1014e9e8cfe80267a047ad9_D20190701-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62be34a4b4e64451b2e516bfcb375e8a_D20180701-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0b3a62ee7424499b7a078665cc2f930_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i651f15c7ca5a4375a12683f4493dd86d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abb0547c47a44e190eab0c56374dc2b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9b2c18f5a64a6084f50a6976406e31_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71b854cd3924d249f25376d9c0ad39a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i971cccffdd7d479f8c71a1f66c16fc3a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa422029d99543199793d9ff01d7b6fa_I20210830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001596783</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:ZenyattaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-30</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTk_f6ab7647-580c-4f54-a153-23d5978f4101" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b" order="4"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8" order="3"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjU_06075297-4751-46c5-a27e-6f29d0b084c2" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjY_d5a34fbe-8aac-4050-91f7-0f104b2d6e4e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329 id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjc_3f28e412-27b7-4462-b4ea-70aa0eee8b9f" order="1"></ix:relationship></ix:resources></ix:header></div><div id="idd9cf92bf6a34c78ac936b47262640d7_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.947%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ZGFkYzk4ODcxZTAxNDAwYWFhYTA5Y2IwZDkwY2Y1YjQvdGFibGVyYW5nZTpkYWRjOTg4NzFlMDE0MDBhYWFhMDljYjBkOTBjZjViNF8wLTEtMS0xLTA_3496981d-402b-4ed9-b2e3-5f86eae87e18">10-K</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-true" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ZjI3ODExNzRmNzk3NDBiNDg2ZTk5Y2FhZWRmMzc2M2IvdGFibGVyYW5nZTpmMjc4MTE3NGY3OTc0MGI0ODZlOTljYWFlZGYzNzYzYl8wLTAtMS0xLTA_3abdb67c-bf68-4b5f-95ea-de8b14265aff">&#253;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgw_3107219b-4a26-469c-bf09-4b00dba01f07">June 30, <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzcz_69c74374-1e39-4195-99eb-9af4c4c9c5fe">2021</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ODBmMjBlZTRhYTZiNGI4ZmFhZTI2ZTdhNDdhNjAwZmMvdGFibGVyYW5nZTo4MGYyMGVlNGFhNmI0YjhmYWFlMjZlN2E0N2E2MDBmY18wLTAtMS0xLTA_c4cedf27-bc54-44cf-b8a7-498ec096b14b">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from to </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgx_81d23cfb-5c60-4bfa-b83c-7485bee6163c">001-36587</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><img src="ctlt-20210630_g1.jpg" alt="ctlt-20210630_g1.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:136px"/></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.385%"><tr><td style="width:1.0%"></td><td style="width:30.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.179%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6NTRmNzIwYWRjZjJiNDg2ZjhhODk5OGU5NzRjODE1YTkvdGFibGVyYW5nZTo1NGY3MjBhZGNmMmI0ODZmOGE4OTk4ZTk3NGM4MTVhOV8wLTEtMS0xLTA_bc7ea5ae-0c04-466c-aa24-fdd09937ca24">CATALENT, INC.</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8wLTAtMS0xLTA_354fb99c-780e-4c44-bce0-2a018c5ce428">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8wLTItMS0xLTA_08e782d5-c3e1-4075-801e-4f92421040b9">20-8737688</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8zLTAtMS0xLTA_e9db74c6-cadc-4315-a4be-3554c12281ee">14 Schoolhouse Road</ix:nonNumeric></span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8zLTItMS0xLTA_08664db8-eb04-44c5-b510-a84f7d37fa8e">08873</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl80LTAtMS0xLTA_0fa96a24-c16f-46cf-ad54-64d73822bb41">Somerset,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl80LTEtMS0xLTA_710bd5ea-3308-495b-8d77-1b2e17e3ff2d">New Jersey</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgy_1d2b51fb-d7cd-45d3-8c08-4bf9d2844e1a">(732)</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzg0_7af64887-6aed-4b30-9d60-2dbc18918fbf">537-6200</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%">____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTAtMS0xLTA_db18c6f1-b284-499b-be29-4b29b836a168">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTEtMS0xLTA_1fcc4f0e-fdfa-4f33-85c8-5948843081e3">CTLT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTItMS0xLTA_fe4a937a-23f6-48bd-be61-40c2e648a0f1">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%">____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________</span></div><div style="margin-bottom:0.3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160; <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc1_c717dc0e-3827-4461-8b94-bf08183871d7">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzg1_e158d32d-f3cb-4f17-8e1e-097946477ff6">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc2_3c700069-d1bd-47fa-a444-ba32f6246595">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc4_b61902f5-b02e-49ad-9a45-a552eeee9f02">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">large accelerated filer,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">accelerated filer,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">smaller reporting company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">emerging growth company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8wLTAtMS0xLTA_16481eee-a0c9-4ccd-a6a7-a1f982fd0a8f">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#253;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8xLTQtMS0xLTA_d5761ed7-a0f2-4b55-b283-118117f41f8c">&#168;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8yLTQtMS0xLTA_ba47403a-d0cf-443e-b7c1-80703d0c4676">&#168;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc5_20e72479-c467-46cb-8ed3-9eed04660b82">&#9746;</ix:nonNumeric></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt:fixed-false" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc3_c7ec0d30-9028-43c1-8ca2-891584e1e647">&#168;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Yes&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;No&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2020, the aggregate market value of the registrant&#8217;s voting and non-voting common equity held by non-affiliates was $<ix:nonFraction unitRef="usd" contextRef="iaa63168b9f6848698d3cd88bc9a36d76_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMDYw_b4d59b6b-9fbd-4420-b703-e8c5683f1f64">17.71</ix:nonFraction> billion. On August&#160;23, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMDgy_83928810-9106-461c-a5b0-631992eadafb">170,787,238</ix:nonFraction> shares of the Registrant&#8217;s Common Stock, par value $0.01 per share, issued and outstanding. </span></div><div style="margin-bottom:0.3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:0.3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the Registrant's Proxy Statement relating to the 2021 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:0.3pt;text-indent:36pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_7"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CATALENT, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Fiscal Year Ended June&#160;30, 2021 </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:7.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_13">Special Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_13">3</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_16">6</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_73">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_73">24</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_76">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_76">39</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_79">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_79">40</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_82">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_82">40</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_85">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_85">40</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_91">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_91">41</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_94">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_94">43</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_97">44</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_142">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_142">63</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_145">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_145">64</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_262">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_262">121</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_265">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_265">121</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_268">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_268">121</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_1544">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_1544">122</a></span></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_274">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_274">122</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_277">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_277">122</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_280">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_280">122</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_283">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_283">122</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_286">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_286">122</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_292">Exhibit and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_292">123</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_304">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_304">127</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_307">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_307">128</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_10"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_13"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to historical information, this Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2021 (this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual Report</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of Catalent, Inc. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) contains </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forward-looking statements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within the meaning of Section 27A of the Securities Act of 1933, as amended (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities Act</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and Section 21E of the Securities Exchange Act of 1934, as amended (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exchange Act</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), which are subject to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">safe harbor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> created by those sections. All statements, other than statements of historical facts, included in this Annual Report are forward-looking statements. In some cases, you can identify these forward-looking statements by the use of words such as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">outlook,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">believes,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expects,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continues,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">should,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seeks,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">predicts,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intends,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plans,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anticipates,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forward,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sustain</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the negative version of these words or other comparable words. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statement is subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the factors that may cause actual results, developments, and business decisions to differ materially from those contemplated by such forward-looking statements include, but are not limited to, those described under the section entitled </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this Annual Report, which are summarized below:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Principal Risk Factors</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any investment, including an investment in our common stock, par value $0.01 (the &#8220;Common Stock&#8221;), involves risk.  The following summary highlights certain risks that an investor in our Common Stock should consider.  The following should be read in conjunction with the complete discussion of risk factors we face, which are set forth in "Item 1A. Risk Factors."</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Business and the Industry in Which We Operate</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-23.98pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.48pt">Our business, financial condition, and operations may be adversely affected by global health epidemics, including the pandemic resulting from the SARS-Co-V-2 strain of coronavirus and its variants (&#8220;COVID-19&#8221;).</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-23.98pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.48pt">The continually evolving nature of the COVID-19 pandemic and the resulting public health response, including the changing demand for various COVID-19 vaccines and treatments from both patients and governments around the world, may affect sales of the COVID-19 products we manufacture.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-23.98pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.48pt">We participate in a highly competitive market, and increased competition may adversely affect our business. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">The demand for our offerings depends in part on our customers&#8217; research and development and the clinical and market success of their products.  </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">We are subject to product and other liability risks that could exceed our anticipated costs or adversely affect our results of operations, financial condition, liquidity, and cash flows.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">We are a part of the highly regulated healthcare industry, subject to stringent regulatory standards and other applicable laws and regulations, which can change unexpectedly and may adversely impact our business.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Any failure to implement fully, monitor, and improve our quality management strategy could lead to quality or safety issues and expose us to significant costs, potential liability and adverse publicity.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">If we cannot keep pace with rapid technological advances, our services may become uncompetitive or obsolete.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Any failure to protect or maintain our intellectual property may adversely affect our competitive edge and result in loss of revenue and reputation.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Future price fluctuations, material shortages of raw materials, or changes in healthcare policies may have an adverse effect on our results of operations and financial conditions.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">We may be unable to attract or retain key personnel.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">We may be unsuccessful in integrating our acquisitions, and we may expend substantial amounts of cash and incur debt in making acquisitions.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Our global operations are subject to economic, and political risks, which could affect the profitability of our operations or require costly changes to our procedures.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">As a global enterprise, fluctuations in the exchange rate of the United States ("U.S.") dollar, our reporting currency, against other currencies could have a material adverse effect on our financial performance and results of operations.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Tax legislative or regulatory initiatives, new interpretations or developments concerning existing tax laws, or challenges to our tax positions could adversely affect our results of operations and financial condition.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">We use advanced information and communication systems to run our operations, compile and analyze financial and operational data, and communicate among our employees, customers, and counter-parties, and the risks generally associated with information and communications systems could adversely affect our results of operations.  We are continuously working to install new, and upgrade existing, systems and provide employee awareness training around phishing, malware, and other cyber security risks to enhance the protections available to us, but such protections may be inadequate to address malicious attacks or inadvertent compromises of data security.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Cell and gene therapies are relatively new modes of treatment and subject to changing public opinion, continuing research, and increased regulatory scrutiny, each of which may affect our customers' ability to conduct their business, or obtain approvals for their therapies, and thereby adversely affect our cell or gene therapy offerings.</span></div><div style="margin-top:6pt;padding-left:12pt;text-align:justify;text-indent:-6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Our Indebtedness</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Our substantial leverage could limit our ability to operate our business and to finance future operations or acquisitions that would enhance our growth.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Our debt agreements contain restrictions that may limit our flexibility in conducting certain current and future operations.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">We may not be able to pay our indebtedness when it becomes due.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Our current and potential future use of derivative financial instruments may expose us to economic losses in the event of price or currency fluctuations.</span></div><div style="margin-top:6pt;padding-left:12pt;text-align:justify;text-indent:-6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risks Relating to Our Series A Preferred Stock</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">The outstanding shares of our Series A Convertible Preferred Stock, par value $0.01 ("Series A Preferred Stock") reduce the relative voting power of holders of our Common Stock, dilute the ownership of those holders, and may adversely affect the market price of our Common Stock.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">The holders of our Series A Preferred Stock have special rights to exercise influence over us and our board of directors.</span></div><div style="margin-top:6pt;padding-left:12pt;text-align:justify;text-indent:-6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risks Relating to Ownership of Our Common Stock</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Our stock price has historically been and may continue to be volatile. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Because we have no plan to pay cash dividends on our Common Stock for the foreseeable future, receiving a return on an investment in our Common Stock may require a sale for a net price greater than was paid for it. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:20.5pt">Provisions in our organizational documents could delay or prevent a change of control.</span></div><div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We caution you that the risks, uncertainties, and other factors referenced above may not contain all of the risks, uncertainties, and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits, or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors&#8217; likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct, or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this report apply only as of the date of this report or as of the date they were made and we undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as required by law.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly, and current reports and other information with and furnish additional information to the U.S. Securities and Exchange Commission (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Our filings with the SEC are available to the public on the SEC&#8217;s website at www.sec.gov. Those filings are also available to the public on, or accessible through, our website (www.catalent.com) for free via the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section as soon as reasonably practicable after we file such material, or furnish it to, the SEC. We also use our website, corporate Facebook page (https://www.facebook.com/CatalentPharmaSolutions), corporate LinkedIn page (https://www.linkedin.com/company/catalent-pharma-solutions/) and corporate Twitter account (@catalentpharma) as channels of distribution of information concerning our activities, our offerings, our various businesses, and other related matters. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, SEC filings, and public conference calls and webcasts. The information we file with or furnish to the SEC (other than the information set forth or incorporated in this Annual Report) or contained on or accessible through our website, our social media channels, or any other website that we may maintain is not a part of this Annual Report.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent References and Fiscal Year</span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, in this Annual Report, the terms &#8220;Catalent,&#8221; &#8220;the company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Catalent, Inc. and its subsidiaries. All references to years in this Annual Report, unless otherwise stated, refer to fiscal years beginning July 1 and ending June 30. All references to quarters, unless otherwise stated, refer to fiscal quarters. Fiscal years are referred to by the calendar year in which they end. For example, &#8220;fiscal 2021&#8221; refers to the fiscal year ended June 30, 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks and Service Marks </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have U.S. or foreign registration in the following marks, among others: Catalent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Clinicopia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, CosmoPod</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Delphi Genetics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Easyburst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, FastChain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, FlexDirect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Follow the Molecule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Galacorin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, GPEx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, GPEx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Boost, GPEx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Lightning,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Graphicaps</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Liqui-Gels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Manufacturing Miracles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, MaSTherCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Micron Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OmegaZero</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OneBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OptiDose</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OptiForm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OptiGel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OptiGel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Bio, OptiGel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> DR, OptiMelt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, OptiShell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Paragon Bioservices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, PEEL-ID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Pharmatek</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, RP Scherer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Savorgel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Scherer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, SMARTag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Softdrop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Staby</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, StabyExpress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, SupplyFlex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Vegicaps</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Zydis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and Zydis Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Annual Report also includes trademarks and trade names owned by other parties, and these trademarks and trade names are the property of their respective owners. We use certain other trademarks and service marks, including, FlexDose&#8482;, OneExpress&#8482; Solution, OptiPact&#8482;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and StartScore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on an unregistered basis in the U.S. and abroad.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solely for convenience, the trademarks, service marks, and trade names identified in this Annual Report may appear without the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and &#8482; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, and trade names.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_16"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;1.&#160;&#160;&#160;&#160;BUSINESS</span><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_19"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products at over fifty facilities across four continents under rigorous quality and operational standards. Our oral, injectable, and respiratory delivery technologies, along with our state-of-the-art protein and cell and gene therapy manufacturing capacity, address a wide and growing range of modalities and therapeutic and other categories across the biopharmaceutical and consumer health industries. Through our extensive capabilities, growth-enabling capacity, and deep expertise in product development, regulatory compliance, and clinical trial supply, we can help our customers take products to market faster, including nearly half of new drug products approved by the U.S. Food and Drug Administration (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in the last decade. Our development and manufacturing platforms, which include those in our Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, our proven formulation, supply, and regulatory expertise, and our broad and deep development and manufacturing know-how enable our customers to advance and then bring to market more products and better treatments for patients and consumers. Our commitment to reliably supply our customers&#8217; and their patients&#8217; needs is the foundation for the value we provide; annually, we produce more than 70 billion doses for nearly 7,000 customer products, or approximately 1 in every 24 doses of such products taken each year by patients and consumers around the world. We believe that, through our investments in state-of-the-art facilities and capacity expansion, including investments in facilities focused on new treatment modalities and other attractive market segments, our continuous improvement activities devoted to operational and quality excellence, the sales of existing and introduction of new customer products, and, in some cases, our innovation activities and patents, we will continue to attract premium opportunities and realize the growth potential from these areas. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in both our product and service offerings and our sales and marketing activities, leading to growth in the number of active development programs for our customers. This has further enhanced our extensive, long-duration relationships and long-term contracts with a broad and diverse range of industry-leading customers. In fiscal 2021, we conducted business with 87 of the top 100 branded drug marketers, 23 of the top 25 generics marketers, 24 of the top 25 biologics marketers, and 17 of the top 25 consumer health marketers globally. Selected key customers include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson &amp; Johnson, Moderna, Pfizer, and Pierre Fabre. We have many long-standing relationships with our customers, particularly those with commercial products, as we provide support and reliable supply through each stage of the products&#8217; lifecycles. A prescription pharmaceutical product relationship with an innovator will often last many years&#8212;in several cases, two decades or more&#8212;extending from pre-clinical development through more mature stages of the product&#8217;s life cycle. We serve customers requiring some combination of innovative product development, superior quality, state-of-the-art manufacturing, and skilled technical services to support their development and marketed product needs. Our broad and diverse range of technologies closely integrates with all aspects of our customers&#8217; final formulations and dose forms, and this generally results in the inclusion of our facilities as manufacturing and testing sites in our customers&#8217; prescription product regulatory filings. Both factors frequently translate to long-duration supply relationships at an individual product level. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our customers value us because our depth of development solutions and state-of-the-art manufacturing technologies, continuous innovations and improvements, consistent and reliable supply, geographic reach, and substantial expertise enable us to create a broad range of business and product solutions that can be customized to fit their individual needs. Today we employ more than 8,000 highly trained direct manufacturing associates, as well as more than 2,500 formulation, analytical development, and process scientists and technicians. We can also bring to bear when helpful to our customers more than 1,300 patents and patent applications in advanced delivery platforms, drug and biologics formulation, and manufacturing. The aim of our offerings is to allow our customers to bring more products to market faster and to develop and market differentiated products that improve patient outcomes. We believe our leading market position and diversity of customers, offerings, regulatory categories, products, and geographies reduce our exposure to potential strategic and product shifts within our industries. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a wide variety of proprietary and non-proprietary, differentiated technologies, products, and service offerings to our customers across our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and manufacturing platforms, which we have advanced and grown over more than 90 years through internal development, strategic alliances, in-licensing, and acquisitions. We initially introduced our softgel capsule technologies in the 1930s and have continuously expanded our range of offerings. In recent years, we have launched more than a dozen internally developed new technology platform offerings. We have also augmented our portfolio through acquisitions. Among the technologies we currently offer are softgel capsules, including both gelatin and non-gelatin formulations, our Zydis orally disintegrating tablets, protein production using advanced mammalian cell lines, adeno-associated virus (&#8220;AAV&#8221;) vectors, and a range of other oral, injectable, and respiratory delivery technologies. The technologies and service offerings within our development solution platforms span the full drug development process, ranging from our OptiForm </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solution Suite for enhancement of bioavailability and other characteristics of early-stage small molecules, Gene Product Expression (&#8220;GPEx&#8221;), GPEx Boost, and GPEx Lightning for protein manufacture, and SMARTag platforms for development of biologics and antibody-drug conjugates (&#8220;ADCs&#8221;), to formulation, analytical services, early-stage clinical development, drug-device combination development and supply, fill and finish operations for injectable products, and clinical trials supply, including our unique FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions. In fiscal 2021, we expanded our recently acquired cell therapy development and manufacturing capabilities, began offering plasmid DNA production services, and signed an agreement to acquire a developer and manufacturer of induced pluripotent stem cells (&#8220;iPSCs&#8221;). We also expanded our spray-dry, liquid nasal, and dry powder inhaler offerings. Our offerings serve a critical need in the development and manufacture of products across a broad range of product types. We focus on serving as an accelerator for new formulation, delivery, and manufacturing technologies, and our expertise enables us to bring advanced products to market at scale, faster.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In large part due to our recent acquisitions and their subseq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uent organic growth, the revenue contribution from our Biologics segment has grown from approximately 17% in fiscal 2016 to 48</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in fiscal 2021. We believe our own internal innovation, supplemented by current and future external partnerships and acquisiti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ons, will continue to strengthen and extend our leadership positions in the development, reliable supply, and delivery of drugs, protein-based biologics, cell and gene therapies, and consumer health products.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">History</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">trace our history to the 1933 founding of the R.P. Scherer Corporation, which developed the first rotary die machine for the manufacture of soft gelatin capsules, and assumed our current form in April 2007. We regularly review our portfolio of offerings and operations in the context of our strategic growth plan, and, as a result, we have sold nine businesses and consolidated operations at six facilities since fiscal 2007, integrating them into the remaining facility network. In fiscal 2021, we sold our facility in Woodstock, Illinois and initiated a plan to close our facility in Bolton, U.K. We have also actively acquired new businesses and facilities. In fiscal 2021 alone, we closed six acquisitions and signed an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of iPSCs. In July 2014, we completed the initial public offering of our  Common Stock, which is listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;CTLT.&#8221; </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company that indirectly owns Catalent Pharma Solutions, Inc. (&#8220;Operating Company&#8221;), which owns, directly or indirectly, all of our operating assets.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_22"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths </span></div><div style="padding-left:24pt"><span><br/></span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available, State-of-the-art Manufacturing Capacity in Attractive Market Segments</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested several billion dollars over the last few years, and plan to continue to invest, to broaden our portfolio of offerings and expand our capacity with state-of-the-art development and manufacturing capabilities that focus on anticipating and meeting the needs of the evolving biopharmaceutical and consumer health industries. In addition, we have hired and trained thousands of new direct manufacturing associates in our rigorous, quality-focused culture of operational excellence. The capacity and capabilities we have built and purchased have enabled, and our further planned expansions will continue to enable, us to secure, along with our operational and quality excellence, attractive new business opportunities in the expanding market for outsourced product development and supply. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vibrant, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patient First</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">-Driven Culture</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the manufacturing line to the executive suite, for all our critical decisions, we ask the question, &#8220;What would the impact be to the patient?&#8221;, and our culture is built on our cornerstone value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient First</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe this mindset, which aligns closely with our customers&#8217; values, enables a pervasive focus on patient safety, impact, and outcomes, and an uncompromising approach to product quality and compliance, by reminding us of those who depend upon our vigilance concerning the safety, quality, reliability, and sustainability of our product supply. Along with other key cultural strengths, including our commitments to diversity and inclusion and to science-based environmental sustainability, we believe our culture brings us both a unique reputation and an operating capability that is difficult to replicate.</span></div><div style="padding-left:24pt"><span><br/></span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversified Operating Platform </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are diversified by virtue of our broad range of product and service offerings, our geographic scope, our large customer portfolio, the extensive range of products we produce, and our ability to provide solutions at every stage of a product&#8217;s lifecycle. In fiscal 2021, we produced nearly 7,000 distinct products across multiple categories. Our fiscal 2021 net </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue was distributed as follows: protein-based biologics and cell and gene therapies 52%, branded drugs 33%, generic prescription drugs 4%, over-the-counter drugs 6%, and consumer health, veterinary products, medical devices, and diagnostics 5% combined). In fiscal 2021, our top 20 products represented approximately 38% of our total net revenue, with no single customer accounting for greater than 10% of net revenue and with no individual product greater than 8%. We serve more than 1,000 customers in approximately 80 countries, with 38% of our fiscal 2021 net revenue coming from outside the U.S. This diversity, combined with long product lifecycles and close customer relationships, has contributed to the stability of our business. It has also allowed us to reduce our exposure to the risks associated with potential strategic, customer, and product shifts as well as to payer-driven pricing pressures experienced by our drug and biologic customers.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Longstanding, Extensive Relationships with a Diverse Customer Portfolio</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have longstanding, extensive relationships with leading pharmaceutical and biotechnology customers. In fiscal 2021, we did business with 87 of the top 100 branded drug marketers, 23 of the top 25 generics marketers, 24 of the top 25 biologics marketers, and 17 of the top 25 consumer health marketers globally, as well as with more than 1,000 other customers, including emerging and specialty biotech and pharmaceutical companies, which are often more reliant on outside partners as a result of their more virtual business models. Regardless of size, our customers seek innovative product development, superior quality, advanced manufacturing, and skilled technical services to support their development and marketed product needs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our customers value us because our broad range of product and service offerings, expanding capacity in state-of-the-art manufacturing facilities, including facilities offering new treatment modalities, reliable supply, geographic reach, commitment to operational and quality excellence, and substantial expertise enable us to create a broad range of tailored solutions, many of which are unavailable from other individual providers.</span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deep, Broad, and Growing Advanced Technology Foundation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r breadth of offerings employing advanced technologies and state-of-the-art manufacturing systems and long track record of innovation substantially differentiate us from other industry participants. Our leading softgel platforms, including Liqui-Gels, OptiShell, and Vegicaps capsules, and our modified release technologies, including the Zydis family of orally disintegrating tablets, our spray drying capabilities, and our OptiPact and OptiMelt technologies, provide formulation expertise to solve complex delivery challenges for our customers. We offer advanced technologies for delivery of small molecules and biologics via oral, respiratory, and injectable routes and also provide advanced biologics formulation options, including GPEx, GPEx Boost, and GPEx Lightning mammalian cell lines for protein production, SMARTag ADC technology, AAV vectors for cell and gene therapies, and plasmid DNA manufacturing. We have a leadership position within respiratory delivery, including metered dose and dry powder inhalers and intra-nasal forms. We have reinforced our leadership position in advanced technologies over the last three years, as we have launched more than a dozen new technology platforms and applications, including the launch of spray-dry dispersion, and recently purchased or expanded our businesses developing and manufacturing protein-based biologic medicines, fill and finish for injectable drugs and biologics, cell and gene therapy offerings, and other new therapeutic and other modalities. Our culture of creativity, problem-solving, and innovation is grounded in our advanced technologies, the substantial expertise and experience of our scientists and engineers, and, in some cases, our patents and proprietary manufacturing processes. Our global product development and innovation teams drive a focused application of resources to opportunities for both new customer product introductions and platform technology development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of June&#160;30, 2021, we had nearly 1,400 product development programs in active development across our businesses. </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Duration Relationships Provide Sustainability </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our broad and diverse range of technologies closely integrates with our customers&#8217; molecules to yield safe and effective final formulations and dose forms, and this generally results in the inclusion of Catalent in our customers&#8217; prescription product regulatory filings. Both factors translate to long-duration supply relationships at an individual product level, to which we apply our expertise in contracting to produce long-duration commercial supply agreements. These agreements typically have initial terms of three to seven years with regular renewals of one to three years (see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual Arrangements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more detail). Approximately three-quarters of our fiscal 2021 net revenue from our product development and delivery offerings and related services (offered through our Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery reporting segments) were covered by such long-term contractual arrangements. We believe this base provides us with a sustainable competitive advantage. </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Recent Growth Investments </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made over time, and expect to continue to make, significant investments in our manufacturing network, which is capable of serving customers and patients worldwide, and today employ approximately 7 million square feet of manufacturing, </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laboratory, and related space across four continents. We have deployed approximately $1.7 billion in the last five fiscal years in gross capital expenditures, not including more than $3.0 billion spent in acquiring new facilities and businesses. Growth-related investments in facilities, capacity, and capabilities across our businesses have positioned us for future growth in areas aligned with anticipated future demand, including in gene and cell therapies and other new treatment modalities and fill and finish for injectable biologics. Through our focus on operational, quality, and regulatory excellence, we drive continuous improvements in safety, productivity, sustainability and reliable supply, which we believe further differentiate us. Our manufacturing network and capabilities allow us the flexibility to reliably supply the changing needs of our customers while consistently meeting their quality, delivery, sustainability, and regulatory compliance expectations. </span></div><div style="padding-left:24pt"><span><br/></span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High Standards of Regulatory Compliance and Operational and Quality Excellence </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our plants in accordance with current good manufacturing practices (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cGMP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or other applicable requirements, following our own high standards that are consistent with those of many of our large global pharmaceutical and biotechnology customers. We have approximately 1,600 employees around the globe focused on quality and regulatory compliance. All of our facilities are registered where required with the FDA or other applicable regulatory agencies, such as the European Medicines Agency (the &#8220;EMA&#8221;). In many cases, our facilities are registered with multiple food, drug, or biologics regulatory agencies around the world. In fiscal 2021, we were subject to 52 regulatory audits, and, over the last five fiscal years, we successfully completed approximately 300 regulatory audits. We also undergo more than 500 customer and internal audits annually. We believe our quality and regulatory track record to be a favorable competitive differentiator.</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong and Experienced Management Team </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive leadership team collectively has approximately 600 years of combined and diverse experience within the pharmaceutical and healthcare industries. With an average of approximately 28 years of functional experience, this team possesses deep knowledge and a wide network of industry relationships.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_25"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategic ambition, guided by and operationalized through our values, is to power the innovation and growth of the life science industry by becoming its leading development and commercial partner in reliable supply, advanced technologies, first-to-scale innovation, integrated solutions, and new therapeutic modalities. To achieve this, we continue to pursue the following key growth initiatives:</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Follow the Molecule</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> by Providing Solutions to our Customers across all Phases of the Product Lifecycle </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to use our development and manufacturing solutions across the entire lifecycle of our customers&#8217; products to drive future growth. Our development solutions span the drug development process, starting with our platforms for early pre-clinical development of small molecules, protein-based biologics, and cell and gene therapies; through formulation and analytical services, development and manufacturing of clinical trial supplies, and fill and finish of injectable products; to regulatory consulting. Once a molecule is ready for clinical trials and subsequent commercialization, we provide our customers with a range of advanced technologies and expert, state-of-the-art manufacturing solutions that allow them to deliver their molecules to the end-users in safe, effective, and, in some cases, attractive dosage forms, and to produce biologics drug substances needed for protein-based biologics and cell and gene therapies. Our relationship with a molecule typically starts with developing and manufacturing the innovator product and can extend throughout the molecule&#8217;s commercial life. For prescription products, we are typically the sole or primary outsourced provider and are frequently reflected in customers&#8217; product approval applications. Our revenues from our development and manufacturing activities are primarily driven by volumes, and, as a result, the loss of an innovator drug&#8217;s market exclusivity may be mitigated if we supply customers offering generic or biosimilar equivalents. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An example of the long and mutually productive relationships we foster can be found in a leading over-the-counter anti-allergy brand, which today uses both our Zydis orally disintegrating tablets and our Liqui-Gels softgel technology. We originally began development of the prescription format of this product for our multinational pharmaceutical company partner in 1992 to address specific patient sub-segment needs. After four years of development, we then commercially supplied the prescription product in our Zydis orally disintegrating tablet format for six years, and we have continued to provide the Zydis form since the switch to over-the-counter status in the U.S. and other markets in the early 2000s. Subsequently, we proactively brought a softgel product concept for the brand to the customer, which the customer elected to develop and launch as well. By following this molecule, we have built a strong, 29-year-long relationship across multiple formats and markets. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customer Product Pipeline </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Continuing to Grow Through New Projects and Product Launches </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to supplement our existing diverse base of commercialized customer products with new development programs. As of June 30, 2021, our product development teams were working on nearly 1,400 active customer development programs. Our base of active development programs has expanded in recent years from growing market demand, as well as from our expanded capabilities and technology platforms. Although there are many complex factors that affect the development and commercialization of pharmaceutical, protein-based biologic, cell and gene therapy, and consumer health products, we expect that a portion of these programs will reach full development and market approval in the future and thereby add to our long-duration commercial revenues under long-term contracts and grow our existing product base. In fiscal 2021, we introduced 139 new products for our customers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent continues to be a leader in providing chemistry, manufacturing, and controls-based product development services to the global pharmaceutical, biotechnology, and consumer health industries, driven by thousands of projects annually. In fiscal 2021, we recognized $1.76 billion of net revenue related to the development of products on behalf of customers in our Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery reporting segments, up 73% from the prior year. In addition, substantially all of the revenue associated with the Clinical Supply Services segment relates to our support of customer products in development.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capabilities &amp; Capacity </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Expanding in Biologics and Other Attractive Markets </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recognizing the strategic importance of protein-based biologics, cell and gene therapies, plasmid DNA, and other newer biopharmaceutical modalities, we began to build a differentiated biologics platform in 2002. Since 2016, we have invested over $3.7 billion in our biologics business, including capital investments and approximately $2.6 billion for acquisitions of biologics-focused businesses and sites. Today, we are a recognized leader in biologics, including AAV vectors for gene therapies; development and supply for cell therapies; advanced cell-line development; formulation and fill-finish into vials, pre-filled syringes, and cartridges; specialized manufacturing of biologic drug substances; and bioanalytical analysis. We have partnered with customers from around the world to develop advanced cell expression for more than 700 cell lines, many using our advanced GPEx and GPEx Boost technologies, and have actively collaborated on developing and scaling up more than 100 cell and gene therapies. We have also invested in a second-generation ADC technology, SMARTag, and we see continued progress in our customers&#8217; SMARTag product-development activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our expansion in biologics, we have invested additional capital in several other existing facilities in order to expand in attractive markets, including a significant expansion of our oral solid controlled release production capacity in Winchester, Kentucky, and the scaling-up of commercial manufacturing capacity for metered-dose inhalers and our next-generation orally disintegrating tablet (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;ODT&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) technology, Zydis Ultra. We have also added specialized new capabilities and capacity in early development over the last several fiscal years. We expanded our capacity for oral and injectable products via our fiscal 2020 acquisition of a facility in Anagni, Italy, and for North American consumer health softgels via our fiscal 2017 acquisition of two facilities in Ontario, Canada.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use Our Proprietary Technologies and Substantial Expertise to Help Our Customers Develop New Products</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have broad and diverse technology platforms that are supported by deep scientific expertise, extensive know-how, and more than 1,300 patents and patent applications in approximately 158 families across advanced delivery, drug and biologics formulation, and manufacturing. For example, we have significant softgel fill and formulation know-how, databases of formulated products, and substantial softgel regulatory approval expertise, and, as a result, approximately 90% of approvals by the FDA over the last 25 years of new chemical entities presented in a softgel format have been developed and supplied by us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to resolving delivery challenges for our customers&#8217; products, for more than two decades we have applied our technology platforms and development expertise to proactively develop proof-of-concept products, whether improved versions of existing drugs, new generic formulations, or innovative consumer health products. In the consumer health area, we file product dossiers with regulators in relevant jurisdictions for self-created products, which help contribute sustainable growth to our consumer health business. We expect to continue to seek proactive development opportunities and other non-traditional relationships to increase demand for and value realized from our technology platforms. These activities have provided us with opportunities to capture an increased share of end-market value through out-licensing, profit-sharing, and other arrangements. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operational Leverage </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Deploy Existing Infrastructure and Operational Discipline to Drive Profitable Growth </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our existing infrastructure, including our global network of operating locations and programs, we promote operational discipline and drive margin expansion. With our active focus on continuous improvement and sustainability enhancement, global procurement function, and conversion cost productivity metrics in place, we have created a culture of </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">functional excellence and cost accountability. Along with the ongoing increase in the share of revenues from higher margin biologics offerings, we expect this discipline to further leverage our operational network for profitable growth. Since fiscal 2016, we have expanded gross margin by 200 basis points and Adjusted EBITDA margin by over 300 basis points. Note that &#8220;Adjusted EBITDA&#8221; is a financial metric that is not prepared in accordance with the accounting principles generally accepted in the U.S. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. GAAP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and that further explanations of this measure and comparisons to the most directly comparable U.S. GAAP measures are set forth below at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Non-GAAP Metrics.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Acquisitions and Licensing </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Build on our Existing Platform</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in the markets for outsourced development solutions and commercial supply, where we estimate current spending at roughly $60.0 billion globally. Our broad platform, global infrastructure, and diversified customer portfolio provide us with a strong foundation from which to consolidate within these markets, to enter new markets, and generate operating leverage through acquisitions. Since fiscal 2013, we have executed 18 transactions, investing more than $3.2 billion, and have demonstrated an ability to efficiently and effectively integrate these acquisitions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are rigorously focused on driving our organic growth, we have in recent years substantially increased our participation in biologics, including protein-based biologics, cell and gene therapies, plasmid DNA production, and drug product fill and finish, via strategy-driven inorganic transactions. We intend to continue opportunistically to source and execute strategic acquisitions within our existing business areas, as well as to undertake transactions that provide us with expansion opportunities within emerging treatment modalities, new geographic markets, or related market segments. We have a dedicated corporate development team in place to identify these opportunities and have a rigorous and financially disciplined process for evaluating, executing, and integrating such acquisitions. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_28"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Reporting Segments </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate in four operating segments, which also constitute our four reporting segments: Biologics, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Softgel and Oral Technologies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Oral and Specialty Delivery, and Clinical Supply Services, as further described below. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biologics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The business has extensive expertise in development, scale up, and commercial manufacturing. Representative customers of Biologics include Moderna, Johnson &amp; Johnson, BMS, AstraZeneca, and Sarepta, along with a broad range of innovative small and mid-tier bio pharmaceutical customers.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growing biologics offering includes cell-line development based on our advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Our development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce cGMP quality biologics drug substance from 250L to 4000L scale using single-use technology to provide maximum efficiency and flexibility. Our Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and our Anagni, Italy facility add substantial capacity for finished-dose biologics drug product manufacturing and packaging. We have continued to expand drug substance production capacity in Madison, bringing on-line fourth and fifth manufacturing suites, have expanded drug product manufacturing and packaging capacity in Bloomington and Anagni, and recently announced a planned expansion of our Anagni facility to permit drug substance development and manufacturing. Our SMARTag next-generation ADC technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our cell and gene therapy centers in Belgium, Maryland and Texas, we develop and manufacture complex biologics including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines. Through continued inorganic investment between November 2020 and June 2021, we acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#8220;Delphi&#8221;), a plasmid DNA business, all located on our Gosselies campus to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production.  Additionally, in August 2021, we acquired RheinCell Therapeutics GmbH (&#8220;RheinCell&#8221;) a company based in Langenfeld, Germany that specializes in &#8220;iPSC&#8221; production.  This portfolio expansion strengthens Catalent&#8217;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances our ability to manufacture next generation cell therapies at scale.  In our gene therapy </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">network across Maryland and Texas, we have further expanded our footprint with our construction of 5 additional commercial gene therapy suites at our Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed our Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Our specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with our expanded capabilities in plasmids, positions us to capitalize on strong and growing industry demand in the cell and gene therapy market. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within our existing network. In addition to primary packaging, our network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. Our Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial and commercial supply of biotherapeutics and cell and gene therapies. Our fill and finish services are largely focused on complex pharmaceuticals and biologics. With our range of technologies, we are able to meet a wide range of specifications, timelines, and budgets. We believe that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide us with a meaningful competitive advantage in the market. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Our OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. We provide a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Biologics segment represented 48%, 33% and 23% of our aggregate net revenue before inter-segment eliminations for fiscal 2021, 2020, and 2019, respectively.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Softgel and Oral Technologies </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Softgel and Oral Technologies segment, we provide formulation, development, and manufacturing services for soft capsules, or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">softgels,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our softgel manufacturing technology was first commercialized by our predecessor in the 1930s, and we have continually enhanced the platform since then. We are the market leader in overall softgel development and manufacturing and hold the leading market position in innovator drug softgels. Our principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. We typically perform encapsulation for a product within one of our softgel facilities, with active ingredients provided by customers or sourced directly by us. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. We also participate in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of our plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, we have extended this platform to pharmaceutical products via our OptiShell capsule offering. Our Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies we have conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our large-scale cGMP manufacturing of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve finished dose packaging or advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site- or time-specific drug release, taste masking, or enhanced bioavailability. We have deep </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#8217;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Representative customers of Softgel and Oral Technologies include Pfizer, Novartis, Bayer, GlaxoSmithKline, and Procter &amp; Gamble.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Softgel and Oral Technologies segment represented 25%, 34%, and 41% of our aggregate net revenue before inter-segment eliminations for fiscal 2021, 2020, and 2019, respectively. </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oral and Specialty Delivery</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including our proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms, including metered dose inhalers, dry powder inhalers, and nasal delivery devices.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral delivery solutions platform provides comprehensive pre-clinical screening, formulation, and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. We have substantial proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. We provide spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#8217;s bioavailability and clinical performance. We offer comprehensive analytical method development and scientific capabilities, including stability testing and global regulatory services to support both fully integrated development programs or standalone fee-for-service work. In recent years, we have expanded our network of early development sites focused on earlier phase compounds (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for our offerings is driven by the need for scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of our supply performance across quality and operational parameters.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched our ODT business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that disintegrates in the mouth, without water, typically in less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). We can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#8217;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. We continue to invest in and develop Zydis ODTs in different ways with our customers as we extend the application of the technology to new therapeutic categories, including immunotherapy, vaccines, and biologic molecule delivery. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.    </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Representative customers of Oral and Specialty Delivery include Johnson &amp; Johnson, Pfizer, Bayer, AbbVie, and Biohaven, along with many small and mid-sized emerging biopharma companies involved in the clinical development space. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Oral and Specialty Delivery segment represented 17%, 22%, and 23% of our aggregate net revenue before inter-segment eliminations for fiscal 2021, 2020, and 2019, respectively.</span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Supply Services </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and protein and cell and gene therapy biologics in clinical trials. We offer customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation and reporting. We support trials in all regions of the world through our facilities and distribution network. In recent years, we have continued to expand and extend our network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. We also continue to develop new solutions for the evolving </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. We are the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies. Representative customers of Clinical Supply Services include Merck KGaA, IQVIA, Eli Lilly, AbbVie, and Incyte Corporation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Clinical Supply Services segment represented 10%, 11%, and 13% of our aggregate net revenue before inter-segment eliminations for fiscal 2021, 2020, and 2019, respectively. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_31"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Integrated Development and Product Supply Chain Solutions </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our proprietary offerings, we are also differentiated in the market by our ability to bring together our development solutions and state-of-the-art product manufacturing to offer integrated development and product supply solutions that can be combined or tailored in many ways to enable our customers to take their drugs, biologics, and consumer health products from laboratory to market, faster. Once a product is on the market, we can provide comprehensive, integrated product supply, from the sourcing or supply of the bulk active ingredient to comprehensive manufacturing and packaging, to the testing required for release, and to cold-chain or ambient temperature distribution. The customer- and product-specific solutions we develop are flexible, scalable, and creative, so that they meet the unique needs of both large and emerging biopharma and consumer health companies and are appropriate for products of all sizes. We believe that our development and product supply solutions, such as OptiForm Solution Suite and OneBio Suite, will continue to contribute to our future growth. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_34"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our target customers include large pharmaceutical and biotechnology companies, mid-size, emerging, and specialty pharmaceutical and biotechnology companies, and consumer health companies, along with companies in other selected healthcare market segments such as animal health and medical devices, and companies in adjacent industries, such as cosmetics. We have longstanding, extensive relationships with leading pharmaceutical and biotechnology customers. In fiscal 2021, we did business with 87 of the top 100 branded drug marketers, 23 of the top 25 generics marketers, 24 of the top 25 biologics marketers, and 17 of the top 25 consumer health marketers globally, as well as with more than 1,000 other customers. Faced with access, pricing, and reimbursement pressures as well as other market challenges, large pharmaceutical and biotechnology companies have increasingly sought partners to enhance the clinical competitiveness of their drugs and biologics and improve the productivity of their research and development activities, while reducing their fixed cost bases. Many mid-size, emerging, and specialty pharmaceutical and biotechnology companies, while facing the same pricing and market pressures, have chosen not to build a full infrastructure, but rather to partner with other companies through licensing agreements or outsourcing to access the critical skills, technologies, and services required to bring their products to market. Consumer health companies require rapidly developed, innovative dose forms and formulations to keep up with the fast-paced over-the-counter medication, dietary supplement, and personal care markets. These market segments are all important to our growth, but require distinct solutions, marketing and sales approaches, and market strategy. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We follow a hybrid demand-generation organization model, with strategic account teams offering the full breadth of Catalent&#8217;s solutions, and technical specialist teams providing the in-depth technical knowledge and practical experience essential for each individual offering. Our sales organization currently consists of approximately 170 full-time, experienced sales professionals, supported by inside sales and sales operations. We also have built a dedicated strategic marketing team, providing strategic market and product planning and management for our offerings. As part of our marketing efforts, we participate in major trade shows relevant to our offerings globally and ensure adequate visibility to our offerings and solutions through a comprehensive print and on-line advertising and publicity program. We believe that Catalent is a strong brand with high overall awareness in our established markets and universe of target customers, and that our brand identity is a competitive advantage for us.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage selected accounts globally due to their substantial current business and growth potential. We recorded approximately 31% of our total revenue in fiscal 2021 from these global accounts. Each global account is assigned a lead business development professional with substantial industry experience. These account leaders, along with other members of the sales and executive leadership teams, are responsible for managing and extending the overall account relationship. Account leaders work closely with the rest of the sales organization as well as operational, quality, and project management personnel to ensure alignment around critical priorities for the accounts. </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging, Specialty, and Virtual Accounts </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging, specialty, and virtual pharmaceutical and biotechnology companies are expected to be critical drivers of industry growth globally and account for more than two-thirds of the active drug and biologic development pipeline. Historically, many of these companies have chosen not to build a full infrastructure, but rather partner with other companies to </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">formulate, develop, analyze, test, and manufacture their products. We expect them to continue to do so in the future, providing a critical source for future integrated solutions demand. We expect to continue to increase our penetration of geographic clusters of emerging companies in North America, Europe, Central and South America, and Asia. We regularly use active pipeline and product screening and customer targeting to identify the optimal candidates for partnering based on product profiles, funding status, and relationships, to ensure that our technical sales specialists and field sales representatives develop custom solutions designed to address the specific needs of these customers. </span></div><div style="text-indent:23.75pt"><span><br/></span></div><div style="text-indent:23.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality; Fluctuations in Operation Results</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our annual financial reporting periods end on June 30. Excluding the impact from COVID-19, in fiscal 2021, as discussed further in "Item 7 &#8212; Management's Discussion and Analysis of Financial Condition and Results of Operations," our revenue and net earnings are generally higher in the third and fourth quarters of each fiscal year, with our first fiscal quarter typically generating our lowest revenue of any quarter, and our last fiscal quarter typically generating our highest revenue. These fluctuations are primarily the result of the timing of our, and our customers&#8217;, annual operational maintenance periods at locations in the U.S. and Europe, the seasonality associated with pharmaceutical and biotechnology budgetary spending decisions, clinical trial and research and development schedules, the timing of new product launches and length of time needed to obtain full market penetration, and, to a lesser extent, the time of the year some of our customers&#8217; products are in higher demand.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Arrangements </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally enter into a broad range of contractual arrangements with our customers, including agreements with respect to feasibility, development, supply, licenses, quality, and confidentiality. The terms of these contracts vary significantly depending on the offering and customer requirements. Some of our agreements may include a variety of revenue arrangements, such as fee-for-service, unit pricing in one or more tiers, minimum volume commitments, royalties, manufacturing preparation services, profit-sharing, and fixed fees. We generally secure pricing and other contract mechanisms in our supply agreements to allow for periodic resetting of pricing terms, and, in some cases, these agreements permit us to raise or renegotiate pricing in the event of certain price increases for the raw materials we use to make products. Our typical supply agreements include indemnification from our customers for product liability and intellectual property matters and caps on our contractual liabilities, subject in each case to negotiated exclusions. The terms of our manufacturing supply agreements range from three to seven years with regular renewals of one to three years, although some of our agreements are terminable upon much shorter notice periods, such as 30 or 90 days. For our development solutions offerings, we may enter into master service agreements, which provide for standardized terms and conditions and make it easier and faster for customers with multiple development needs to access our offerings. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Backlog </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we generally have long-term supply agreements that provide for a revenue stream over a period of years, our backlog represents, as of a point in time, future service revenues from work not yet completed. For our Softgel and Oral Technologies, Biologics, and Oral and Specialty Delivery segments, backlog represents firm orders for manufacturing services and includes minimum volumes, where applicable. For our Clinical Supply Services segment, backlog represents estimated future service revenues from work not yet completed under signed contracts. Using these methods of reporting backlog, as of June&#160;30, 2021, our backlog was $3,767 million compared to $2,282 million as of June&#160;30, 2020, including $501 million and $425 million, respectively, related to our Clinical Supply Services segment. We expect to recognize as revenue approximately 50% of the value of the backlog in existence as of June&#160;30, 2021 by the end of fiscal 2022.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent projects are delayed, the timing of our revenue could be affected. If a customer cancels an order, we may be reimbursed for the costs we have incurred. For orders that are placed inside a contractual firm period or that involve minimum volume commitments, we generally have a contractual right to payment in the event of cancellation. Fluctuations in our reported backlog levels also result from the timing and order pattern of our customers, which often seek to manage their level of inventory on hand. Because of customer ordering patterns, the matters discussed in this paragraph, and other factors, our backlog reported for certain periods may fluctuate and may not be indicative of future results. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing Capabilities </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate manufacturing facilities, development centers, and sales offices throughout the world. As of June&#160;30, 2021, we had 56 facilities (45 geographical locations operate as multiple facilities because they support more than one reporting segment, with one location including both a manufacturing facility and our corporate headquarters) on four continents with approximately 7 million square feet of manufacturing, laboratory, office, and related space. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing capabilities generally include the full suite of competencies relevant to the support of each site&#8217;s activities, including regulatory, quality assurance, and in-house validation.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our manufacturing facilities and development centers in accordance with cGMP or other applicable requirements. All of these sites are registered where required with the FDA or other applicable regulatory agencies, such as the EMA. In some cases, our sites are registered with multiple regulatory agencies. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested $1.37 billion in our manufacturing and development facilities since fiscal 2019 for improvements and expansions, including $686 million in capital expenditures during fiscal 2021. We believe that our sites and equipment are in good condition, are well maintained, and are able to operate at or above present levels for the foreseeable future, in all material respects. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing operations are focused on employee health and safety, regulatory compliance, operational excellence, continuous improvement, and process standardization across the organization. In fiscal 2021, we achieved approximately 96% on-time shipment delivery versus customer request date across our network as a result of this focus. Our manufacturing operations are structured around an enterprise management philosophy and methodology that utilizes principles and tools common to a number of quality management programs, including Lean Six Sigma and Lean Manufacturing. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a broad and diverse range of raw materials in the design, development, and manufacture of our products. This includes, but is not limited to, key materials such as gelatin, starch, and iota carrageenan for our Softgel and Oral Technologies segment; packaging films for our Clinical Supply Services segment; single-use production components for our Biologics segment drug substance production, and glass vials and syringes for Biologics drug product. The raw materials that we use are sourced externally on a global basis. Globally, our supplier relationships could be interrupted due to natural disasters and international supply disruptions, including those caused by pandemics or geopolitical and other issues. For example, commercially usable gelatin is available from a limited number of sources. In addition, much of the gelatin we use is bovine-derived. Past concerns of contamination from Bovine Spongiform Encephalopathy (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSE</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have narrowed the number of possible sources of particular types of gelatin. If there were a future disruption in the supply of gelatin from any one or more key suppliers, there can be no assurance that we could obtain an alternative supply from our other suppliers. Any future restriction that were to emerge on the use of bovine-derived gelatin from certain geographic sources due to concerns of contamination from BSE could hinder our ability to timely supply our customers with products and the use of alternative non-bovine-derived gelatin for specific customer products could be subject to lengthy formulation, testing and regulatory approval periods. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work very closely with our suppliers to assure continuity of supply while maintaining excellence in material quality and reliability. We continually evaluate alternate sources of supply, although we do not frequently pursue regulatory qualification of alternative sources for key raw materials due to the strength of our existing supplier relationships, the reliability of our current supplier base, and the time and expense associated with the regulatory process, since regulators usually must approve changes to prescription product ingredient sources. Although a change in suppliers could require significant effort or investment by us in circumstances where the items supplied are integral to the performance of our products or incorporate specialized material such as gelatin, we do not believe that the loss of any existing supply arrangement would have a material adverse effect on our business. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk Factors&#8212;Risks Relating to Our Business and the Industry in Which We Operate&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our future results of operations are subject to fluctuations in the costs, availability, and suitability of the components of the products we manufacture, including active pharmaceutical ingredients, excipients, purchased components, and raw materials.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In addition, the COVID-19 pandemic may interfere with the operations of certain of our direct or indirect suppliers or with international trade for these supplies, which may either raise our costs or reduce the productivity or slow the timing of our operations."</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_49"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with multiple companies as to each of our offerings and in every region of the globe in which we operate, including with other companies that offer conventional and advanced technologies for the development, supply, and delivery of medicinal products, clinical trials support, outsourced dose form, protein-based biologics or cell or gene therapy manufacturing, or development services to pharmaceutical, biotechnology, and consumer health companies based in North America, Central and South America, Europe, and the Asia-Pacific region. We also compete in some cases with the internal operations of those pharmaceutical, biotechnology, and consumer health customers that also have manufacturing capabilities and choose to source these services internally. Some of our competitors are substantially larger than we are and have access to more substantial resources, which could be deployed to expand their range of offerings or capacity.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Competition is driven by proprietary technologies and know-how (where relevant), capabilities, consistency of operational performance, availability of equipment, quality, price, value, responsiveness, and speed. While we do have competitors that compete with us in our individual offerings, and a few competitors that compete across many of our offerings, we do not believe we have competition from any directly comparable company. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research activities are primarily directed toward the development of new offerings and manufacturing process improvements. Research and development costs amounted to $21&#160;million, $21&#160;million, and $19&#160;million for fiscal 2021, 2020, and 2019, respectively. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_52"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had nearly 17,300&#160;individuals providing services to us at 56 facilities on 4 continents, of which   certain employees at one of our 24 U.S. facilities are represented by a labor union, with their terms and conditions of employment being subject to a collective bargaining agreement. Some combination of national works councils, labor unions, and other labor organizations is active at all 19 of our European facilities consistent with labor environments and laws in European countries. Similar relationships with labor organizations or national works councils exist at our plants in Argentina, Brazil, and Canada. Our management believes that our relations with our workforce are satisfactory. Most of our individual service providers are full-time employees, while slightly more than 1,400 of our workers as of June 30, 2021 are contingent workers who are either self-employed or employed by external services organizations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:50.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.620%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">South America</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate number of workers as of June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,300</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,300</span></td></tr></table></div><div id="idd9cf92bf6a34c78ac936b47262640d7_1397"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees share common goals: to put patients first and to help people around the world live better, healthier lives. Our global workforce is united by our values: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient First</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, commitment to our people, customer dedication, innovation, integrity, and excellence. Together, our values provide the foundation for our culture. We believe that an engaged workforce, empowered by inclusive leaders, will unlock our full potential as a company and as a leader in our sector. Our employees&#8217; success is Catalent&#8217;s success.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We focus on employee development, engagement, and diversity and inclusion (&#8220;D&amp;I&#8221;) to hire, develop, and retain the best talent. As of June 30, 2021, we had nearly 17,300 individuals providing services to us globally, with women representing 44% of our employees and holding 41% of roles at the manager level or higher. In fiscal 2021, ethnically diverse talent represented 31% of our U.S. employees. Our turnover trend is decreasing year-over-year. In fiscal 2021, our total turnover rate was 8.6%, comprising 6.1% voluntary turnover and 2.5% involuntary turnover. We continue to implement and expand several initiatives to develop and engage internal talent at varying levels, which is demonstrated in part by a 10-point increase in our employee engagement score since our last company-wide survey.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aspire to build a company where all employees can develop a fulfilling career with support from our leadership team. We believe that our diverse pool of internal talent and our employees&#8217; passion for excellence make a difference in the way we grow and deliver results. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Acquisition</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established strong human resources processes and practices in order to support our employees through their careers at Catalent. This starts with an aggressive recruiting strategy and a strong employer brand. We attracted more than 5,000 new employees in fiscal 2021, continuously working to reduce the time it takes to fill open positions and reduce our cost per hire, while striving for a best-in-class candidate experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to offering competitive compensation and benefits programs. In addition to offering a comprehensive suite of benefits ranging from medical, dental, and vision coverage to retirement, disability, employee stock purchase, and life insurance programs, we also provide health promotion programs, remote work flexibility, tuition assistance, and employee assistance programs in several countries. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recruitment strategy aims to attract talent representing diverse backgrounds, perspectives, and ideas. This approach includes:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;engaging with potential top talent early in the career path through our college internship program;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;developing future leaders through our Global Organization Leadership Development (&#8220;GOLD&#8221;) program; as discussed further below;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;providing competitive compensation and benefits;</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;continuously improving recruitment processes and platforms; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;working with several recruitment partners to attract diverse profiles and advertise our open positions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent was recognized as a TOP EMPLOYER USA for 2020 and 2021. We differentiate ourselves as a preferred employer to candidates through our reputation as a great place to work, offering a fast-paced work environment and, more recently, providing an opportunity to be part of the solution to the COVID-19 pandemic. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Development</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also committed to the growth, development, and engagement of our people once they have joined our family. Through a strong learning and development culture, we provide opportunities for specialized technical training, leadership development, and high-potential growth opportunities to endow our employees with the knowledge and expertise needed to grow their careers here.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary goal is to develop our people from within, thereby establishing a strong successor bench to help support company growth. In fiscal 2021, over 2,500 employees moved to a new role within the organization, whether as a developmental move or a promotion to a more senior position. Our senior leaders are committed to talent development and dedicate time each fiscal quarter to perform formalized talent reviews to discuss the development of key talent and to update succession plans for critical roles.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strongly believe that the combination of experience (70%), exposure (20%), and education (10%) is the best recipe for personal development and career progression here. We have a library of tools and resources available for our employees within that framework.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer three formal development programs to employees. All three programs provide excellent opportunities to identify internal candidates who can fill critical leadership and other roles with us at different levels. Through these programs, we have created a bench of leaders who model our values and are ready to take on more responsibility.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Entry-level GOLD program. The GOLD program is a two-year rotational program for recent graduates from universities around the world in which the employee participates in three rotations at different sites in our network to learn about us and our varied offerings. GOLD employees receive assignments to perform strategic roles in key business initiatives. We provide them with coaching and opportunities to interact with senior executives, which both develop the skills and experience of our GOLD employees and provide a platform through which they contribute fresh ideas that challenge the status quo. </span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span><br/></span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Manager-level Next Generation Global Leader program. Our Next Generation program for employees at the manager level is a 15-month on-the-job program focused on preparing high-potential managers for director-level roles. In fiscal 2021, we trained 42 employees through this program. </span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span><br/></span></div><div style="padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Senior leader General Manager Excellence Program. Our general managers run our operating sites and have substantial and wide-ranging responsibilities. This program enhances the skills of our general managers by giving them exposure to industry best practices and opportunities to network internally and receive personalized career coaching.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An overarching D&amp;I commitment drives our decisions, policies, and leadership practices. We are committed to workplace diversity and to cultivating, fostering, and advancing a culture of equality and inclusion. Enabling employees to perform at their best while being themselves is fundamental to our continued success. Our commitment to these values starts at the top with a diverse board of directors and an executive management team that represent a broad spectrum of backgrounds and perspectives. In fiscal 2018, we established our Global Office of Diversity &amp; Inclusion (the &#8220;D&amp;I Office&#8221;), which oversees our D&amp;I efforts globally. The D&amp;I Office is supported by regional D&amp;I committees composed of leaders at a variety of levels who oversee the implementation of local programs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our D&amp;I aspirations span the following four focus areas: culture, people, community, and marketplace. We aim to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foster an inclusive culture where every employee feels welcomed, valued, and respected, establishing an environment that supports employees in their careers and in their personal lives;</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prioritize recruitment and promotion strategies that create a strong, representative balance at all levels of the organization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deliver development programs that promote equitable career flows and compensation for all employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">execute rapid scale-up of foundational inclusive leadership and unconscious bias training for all employees, especially our leaders;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enable the recognition and advancement of underserved communities through partnerships with external organizations; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">advance D&amp;I outside of our walls by understanding the needs of our diverse customers, implementing a robust supplier diversity program, and providing philanthropic support to organizations that serve diverse groups.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engagement</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employee-focused practices have had a clear impact on our employee engagement. Through increased engagement, we can grow our business by relying on strong, engaged leaders and professionals willing to ensure we can overcome and thrive during any challenge.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically administer a company-wide engagement survey to garner direct feedback from our employees regarding how we can more deeply and meaningfully engage them, enabling us to focus on improving specific areas where we can support our people. In our most recent engagement survey completed in fiscal 2021, our employee engagement score improved by 10 points overall compared to the immediately prior survey taken two years earlier, with the most important improvements among the senior leadership and manager employee populations, and a notable increase in engagement as a result of our enhanced rewards and recognition programs.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our COVID-19 Response</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adapted our processes and policies during the COVID-19 pandemic in order to support our employees, customers, and our local communities.      </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize that we have a unique responsibility to help respond to the COVID-19 pandemic and are committed to supporting and protecting our employees and their families, ensuring that our supply of COVID-19 related products and our other life-saving and life-enhancing products reach patients, contributing our scientific expertise to the development of COVID-19 treatments and vaccines, and supporting health care providers and the communities in which they serve. We kept our employees safe and feeling protected by using the best-available expertise to modify our process flows and people movement, employing masks, physical barriers, and physical distancing to minimize exposure. We communicated regularly with our leaders and operating personnel regarding our actions and motivations to assure transparency and the incorporation of useful suggestions from every level of the organization. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020 and continuing into fiscal 2021, we implemented new virtual recruitment platforms and streamlined procedures to accelerate onboarding amid rapidly changing local restrictions. We sought to ensure the safety of new hires through training on our COVID-19 protocols and requiring COVID-19 tests for those working on-site, when permissible under local regulations. We continue to provide employees with easy and regular access to information, including details regarding our COVID-19 tracking process, guidance around hygiene measures and travel, and best practices for working from home. We also provided extensive information to support our employees as they made vaccination decisions and provided paid time off for employees to get vaccinated and paid time off if vaccination resulted in side effects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our actions, 92% of employees responding to our COVID-19 survey in fiscal 2021 expressed the view that we are demonstrating care and concern for our employees through our actions and policies.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate Responsibility and our Environmental, Social and Governance (&#8220;ESG&#8221;) Strategy </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission to help people live better, healthier lives drives our culture and inspires us. To us, corporate responsibility (&#8220;CR&#8221;) starts with our nearly 17,300 workers, who live our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient First</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> culture and work to deliver on our responsibility to timely develop and reliably supply products to patients, whether for a potential COVID-19 vaccine or treatment or the more than 70 billion doses we produce every year on behalf of our customers and their patients. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the wake of significant change and uncertainty during the COVID-19 pandemic, we focused on the critical importance of our mission and values to orient us. We prioritized people and patients in our decisions as we adapted rapidly to meet the needs of an ever-evolving pandemic. Our response to the COVID-19 pandemic for our employees and for our customers and global community, coupled with our focus on social justice, have made us stronger and more cohesive. We connected even </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">more deeply with our employees and communities, executed with excellence under stress, and kept our people safe, while accelerating our services, talents, and capabilities to serve our customers and their patients.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CR strategy, which includes our strategy related to ESG matters, is integrated into our company-wide strategic plan, ensuring that we operate in alignment with our values, meet our commitments to all our stakeholders, and contribute to the long-term success of the broader pharmaceutical and biopharmaceutical industries and the communities where we operate. We continue to invest in a corporate culture that understands and prioritizes our impact on people in our daily operations and decision-making strategies.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our approach to ESG focuses on three areas of society relevant to our business, prioritizing our impact on people, the environment, and our communities. We focus on ESG areas that are the most significant to our business, and our strategy is informed by our employees, customers, investors, communities, and other key stakeholders.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We established the Office of Corporate Responsibility in fiscal 2017 and created a formal governance structure through our CR Council, which guides the implementation of our ESG strategy and now reports on a regular cadence to our board of directors. We continuously assess the maturity and performance of our CR programs at each of our operating segments and sites through a scorecard system. Our leaders are held accountable for our CR goals, including those focused on strengthening our environmental and social efforts. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance</span></div><div style="text-align:justify;text-indent:22.3pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to ensuring strong corporate governance practices on behalf of our shareholders and other stakeholders. We believe strong corporate governance and an independent board of directors provide the foundation for financial integrity and shareholder confidence.  More information about our corporate governance features can be found in our Proxy Statement for the 2021 Annual Meeting of Shareholders (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proxy Statement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which will be filed within 120 days after June 30, 2021, the close of our fiscal year covered by this Annual Report.</span></div><div style="text-align:justify;text-indent:22.3pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, as noted above, we have established a CR Council composed of senior leaders from various parts of our business to guide our CR efforts and set our overall CR strategy. Our board of directors regularly reviews aspects of our CR strategy and performance as a full board and through its several committees, including an annual review of our overall CR strategy and performance.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Benefits</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beyond being the right thing to do, our focus on CR strengthens our business by reducing risks, meeting customer and investor expectations, and attracting top talent. CR performance is an important contributor to our business success. It informs our risk management process, protects our reputation, and alerts us to regulatory, environmental, and societal threats to our business. Our CR activities also align with many of our customers&#8217; CR programs and strengthens our relationships with our customers.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our future success depends on our highly skilled and dedicated global workforce, who are passionate about improving health outcomes. We compete for talent in our industry and recognize that our culture and reputation as a responsible company can be a differentiator in attracting candidates and retaining our employees. According to the last two engagement surveys we conducted, D&amp;I and CR are two of the highest-rated engagement elements of our culture. While we are transparent about the progress we still need to make, our commitment energizes our employees and makes them proud. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our customers and our investors regularly ask us to join them in their own ESG commitments, especially in the areas of environmental sustainability and D&amp;I, reflected in the increasing number of business reviews and surveys dedicated to our ESG commitments and progress. We understand that our stakeholders want to know that we share their values. Our ESG strategy drives us to provide concrete evidence of our commitment to our ESG values, which strengthens our relationships with customers and other stakeholders.  </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESG progress in fiscal 2021</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made significant progress in several ESG focus areas in fiscal 2021.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2021, we published our second annual CR report, informed by the requirements of the Sustainability Accounting Standards Board (SASB) for Biotechnology and Pharmaceuticals and covering ESG issues that include: quality, safety, innovation, environmental sustainability and climate change, D&amp;I, and community investment and philanthropy. The CR report, which covers our fiscal year 2020, describes how we extended and deepened our CR commitments as part of our long-term corporate strategy. Some of our highlighted progress includes:</span></div><div><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of our first human rights statement and commencement of a third-party assessment, a critical element of our emerging responsible supply chain initiative that aims to align our 10,000-plus suppliers with our industry&#8217;s standards for responsible, reliable, and sustainable partnership;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our commitment to new targets for waste and water reduction, including our pledge to ensure that none of our sites discharge wastewater with API concentrations above Predicted No Effect Concentrations (PNECs), which standards often exceed current regulatory requirements;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the transition of six more sites to 100% renewable electricity, for a total of 12 sites with 100% renewable electricity, a number that will continue to grow, and as of July 1, 2021, covered 97% of our electricity usage across our global network; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our largest-ever fiscal year philanthropic contribution total, with a substantial portion of our gifts focused on our response to the interconnected COVID-19 and social inequality crises.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past year, we further integrated our employee resource groups (&#8220;ERGs&#8221;) into our diverse talent acquisition and talent development efforts. ERGs are groups of volunteer employees who join together based on shared characteristics or life experiences and serve as a resource for talent development, employee engagement, enhancing a sense of belonging, informing others in the Company regarding their unique challenges, perspectives, and achievements, and fostering a diverse, inclusive workplace aligned with organizational goals. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also deepened the relationships we have with potential sources of talent and other HR providers to continue to enhance our diverse talent recruitment, engagement, and development initiatives.  </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We share our global gender statistics and U.S. ethnicity statistics in our CR report. We are transparent about the progress made and the work still to be done in these areas of focus. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Looking ahead</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leader in a growing industry, we understand the need to demonstrate our shared commitment, sense of urgency, and value in contributing to the responsibility and long-term sustainability of the entire pharmaceutical and biopharmaceutical industries.  We continue to progress against our sustainability, responsible supply chain, human rights, and D&amp;I goals and plan for future progress in these focus areas.</span></div><div style="text-align:justify;text-indent:23.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:23.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This is especially true for environmental sustainability. In fiscal 2021, we achieved our current carbon reduction commitment, and are now setting new, science-based Scope 1 and 2 carbon reduction targets, in alignment with global efforts to mitigate the effects of climate change. Effective July 1, 2021, 97% of our electricity usage across our global network is procured from renewable energy sources such as wind, solar, hydro, and biomass. We will purchase renewable energy certificates (RECs) for all of our sites operating in North America, South America, and Europe, as well as the majority of its sites in Asia.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chair and CEO also recently signed a letter of commitment with the Science-Based Target Initiative, adding us to a growing list of companies setting actionable, science-based, greenhouse gas (&#8220;GHG&#8221;) emission reduction targets to limit global warming. This commitment will include calculating and reducing direct and indirect emissions, even as we continue to evolve and grow. Sourcing the majority of our electricity from renewable sources will contribute to our overall GHG reduction efforts and is a milestone step towards doing our part in the global community and meeting our SBT commitment. We will publicize our new GHG reduction targets in our next, fiscal 2021 CR report. Our Scope 3 targets will take longer to assess and establish.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our emerging &#8220;responsible supplier&#8217; initiative, we will implement recommendations from our current human rights assessment, in line with the United Nations Guiding Principles on Business and Human Rights. We will require our key direct material suppliers to complete a self-assessment that includes questions on ethics and labor, and will rate them for human rights risks based on the quality of the self-assessments, their country of operation, type of business, and information in the public domain. Additionally, select suppliers will be subject to ongoing monitoring for human rights risk violations under our third-party vetting and due diligence program.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, measuring against our baseline D&amp;I statistics, we are progressing on our goal to recruit more diverse talent, especially in leadership roles. Through training, hosting internal forums, and establishing internal performance metrics, we are counter-acting the unconscious bias that too often blinds us from hiring and promoting the diverse talent available to us. Employee surveys tell us that our people are energized and engaged by our CR and D&amp;I initiatives. Therefore, in addition to </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing critical talent gaps, we aim to continue to inspire and motivate our people even more in our journey towards a more diverse and inclusive Catalent.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further information on our CR programs is available on our website at https://www.catalent.com/cr, but our website is not part of our public disclosures and is not incorporated by reference into this Annual Report.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_58"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a combination of know-how, trade secrets, patents, copyrights, trademarks, and other intellectual property, nondisclosure and other contractual provisions, and technical measures to protect certain innovative aspects of our offerings, services, and intangible assets that we have developed. These proprietary rights can be important to aspects of our ongoing operations. Many of our operations and products are covered by intellectual property licenses from third parties, particularly our customers that provide licenses to their proprietary active ingredients or formulations as part of our development or supply agreements with them, and in certain instances we license our technology to third parties. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a long track record of innovation across our lines of business, and, to further encourage active innovation, we have developed incentive compensation systems linked to patent filings and other recognition and reward programs for scientists and non-scientists alike. We have applied in the U.S. and certain other countries for registration of a number of trademarks, service marks, and patents, some of which have been registered and issued, and also hold common law rights in various trademarks and service marks. We hold more than 1,300 patents and patent applications worldwide relating to advanced drug delivery and biologics formulations and technologies, as well as manufacturing and other areas relevant to our business. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold patents and license rights relating to certain aspects of our formulations, pharmaceutical and nutritional dosage forms, mammalian cell engineering, antibody-drug conjugation and plasmid manufacturing. We also hold patents relating to certain processes and products. We have pending patent applications in the U.S. and certain other countries and intend to pursue additional patents as appropriate. We have enforced and will continue to enforce our intellectual property rights in the U.S. and worldwide in appropriate circumstances. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We do not consider any particular patent, trademark, license, franchise, or concession to be material to our overall business. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Matters </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, distribution, and marketing of healthcare products and the provision of certain services for development-stage pharmaceutical and biotechnology products are subject to extensive ongoing regulation by the FDA, other U.S. governmental authorities, and similar regulatory authorities in other countries. Certain of our subsidiaries are required to register for permits or licenses with, and must comply with the operating, cGMP, quality, and security standards of, applicable domestic and foreign healthcare regulators, including the FDA, the U.S. Drug Enforcement Agency (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the U.S. Department of Health and Human Services (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DHHS</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), the equivalent agencies of the European Union (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.U.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its member states, and various state boards of pharmacy, state health departments, and comparable agencies in other jurisdictions, as well as various accrediting bodies, each depending upon the type of operations and the locations of distribution and sale of the products manufactured or services provided by those subsidiaries. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of our subsidiaries are subject to other healthcare laws, including the U.S. Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, the Controlled Substances Act, and comparable state and foreign laws and regulations in certain of their activities.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to various federal, state, local, national, and transnational laws, regulations, and requirements, both in the U.S. and other countries, relating to safe working conditions, laboratory and distribution practices, and the use, transportation, and disposal of hazardous or potentially hazardous substances. In addition, applicable import and export laws and regulations require us to abide by certain standards relating to the cross-border transit of finished goods, raw materials, and supplies and the handling of information. We are also subject to various other laws and regulations concerning the conduct of our non-U.S. operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Anti-Bribery Act, and other anti-bribery laws and laws pertaining to the accuracy of our internal books and records. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The costs associated with complying with the various applicable federal, state, local, national, and transnational regulations could be significant, and the failure to comply with such legal requirements could have an adverse effect on our results of operations and financial condition. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Risk Factors&#8212;Risks Relating to Our Business and the Industry in Which We Operate&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Failure to comply with existing and future regulatory requirements, including changing standards or changing interpretations of existing standards, could adversely affect our results of operations and financial condition or result in claims from customers.  In addition, changes to our procedures or additional procedures, implemented to comply with public health </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">orders or best practice guidelines as a result of the COVID-19 pandemic, may increase our costs or reduce our productivity and thereby affect our business, financial condition, or results of operations,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for additional discussion of the costs associated with complying with the various regulations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we were subject to 52 regulatory audits, and, over the last five fiscal years, we completed approximately 300 regulatory audits. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_64"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality Assurance </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to ensuring and maintaining the highest standard of regulatory compliance while providing high quality products to our customers, supported by our core value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient First</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To meet these commitments, we have developed and implemented a Catalent-wide quality management system. We have employees around the globe focusing on quality and regulatory compliance. Our senior management team is actively involved in setting quality policies, standards, and internal position papers as well as managing internal and external quality performance. Our quality assurance department provides quality leadership and supervises our quality systems programs. An internal audit program monitors compliance with applicable regulations, standards, and internal policies. In addition, our facilities are subject to periodic inspection by the FDA, the DEA, and other equivalent local, state, and foreign regulatory authorities as well as our customers. All FDA, DEA, and other regulatory inspectional observations have been resolved or are on track to be completed at the prescribed timeframe provided in commitments to the applicable agency in all material respects. We believe that our operations are in compliance in all material respects with the regulations under which our facilities are governed. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Health &amp; Safety Matters </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to a variety of environmental, health, and safety laws and regulations, including those of the U.S. Environmental Protection Agency (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the U.S. Occupational Safety &amp; Health Administration (&#8220;OSHA&#8221;),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and equivalent state, local, and national regulatory agencies in each of the jurisdictions in which we operate. These laws and regulations govern, among other things, air emissions, wastewater discharges, the use, handling, and disposal of hazardous substances and wastes, soil and groundwater contamination, and employee health and safety. Our manufacturing facilities use, in varying degrees, hazardous substances in their processes. These substances include, among others, chlorinated solvents, and in the past chlorinated solvents were used at one or more of our facilities, including a number we no longer own or operate. As at our current facilities, contamination at such formerly owned or operated properties can result and has resulted in liability to us, for which we have recorded appropriate reserves as needed. We believe that our operations are in compliance in all material respects with the environment, health, and safety regulations applicable to our facilities.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_70"></div><div style="margin-top:18pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_73"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;1A.&#160;&#160;&#160;&#160;RISK FACTORS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If any of the following risks actually occur, our business, financial condition, operating results, or cash flow could be materially and adversely affected. Additional risks or uncertainties not presently known to us, or that we currently believe are immaterial, may also impair our business operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business and the Industry in Which We Operate</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business, financial condition, and results of operations may be adversely affected by global health epidemics, including the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any public health epidemic, including the COVID-19 pandemic, may affect our operations and those of third parties on which we rely, including our customers and suppliers. Our business, financial condition, and results of operations may be affected by: disruptions in our customers&#8217; abilities to fund, develop, or bring to market products as anticipated; delays in or disruptions to the conduct of clinical trials; cancellations of contracts or confirmed orders from our customers; decreased demand for categories of products in certain affected regions; and inability, difficulty, or additional cost or delays in obtaining key raw materials, components, and other supplies from our existing supply chain; among other factors caused by a public health epidemic, including the COVID-19 pandemic.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the COVID-19 pandemic has not had a material negative effect on our overall business, financial condition or results of operations to date, our customers and suppliers have in some cases experienced negative impacts due to disruptions in supply chains and disruptions to the operations of the FDA and other drug regulatory authorities, which resulted in, among other things, delays of inspections, reviews, and approvals of our customers&#8217; products, as well as the volume and timing of orders from these customers. Such impacts may affect our business in the future. Governmental restrictions related to the COVID-19 pandemic, which continue to evolve, including travel restrictions, quarantines, shelter-in-place orders, business closures, new safety requirements or regulations, or restrictions on the import or export of certain materials, or other operational issues related to the COVID-19 pandemic may have an adverse effect on our business and results of operations. </span></div><div style="text-align:justify;text-indent:23.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:23.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor developments related to the COVID-19 pandemic and its effects on our business, operations, and financial condition.  For purposes of our operational and financial planning, we have made, and update when appropriate, certain assumptions regarding the duration, severity, and global economic impact of the pandemic in different regions, and the need for continued manufacture and supply of COVID-19 vaccines and treatments, each of which remains uncertain. However, despite careful planning, our assumptions may not be accurate, as the extent to which COVID-19 may affect our future results will depend on future developments that are uncertain, including: the duration of the pandemic; emerging information concerning the severity and incidence of the virus and its variants; the emergence of additional virus variants; regional resurgences of the virus globally; the safety, efficacy, and availability of vaccines and treatments for COVID-19 (including its variants); the rate at which the population globally becomes vaccinated against COVID-19; the global economic impact of the pandemic; the actions of governments and regulatory authorities to contain the pandemic or control the supply of vaccines and treatments; and the actions the pharmaceutical industry, competitors, suppliers, customers, patients, and others may take to contain or address the pandemic&#8217;s direct and indirect effects. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have seen revenue increases and the potential for further revenue increases in some of our reporting segments, particularly our Biologics segment, resulting from the testing, manufacturing, and packaging of COVID-19-related products for our customers. While this positive impact is expected to continue through at least the remainder of calendar 2021 and into 2022, the duration and extent of future revenues from such testing, manufacturing, and packaging of COVID-19-related products is uncertain and dependent upon customer demand.  See also "&#8212;Risks Related to Our Business and the Industry in Which We Operate&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The continually evolving nature of the COVID-19 pandemic and the resulting public health response, including the changing demand for various COVID-19 vaccines and treatments from both patients and governments around the world, may affect sales of the COVID-19 products we manufacture."</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the impact of the COVID-19 pandemic or any other public health epidemic could exacerbate other risks we face, including those described elsewhere in "Risk Factors."</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The continually evolving nature of the COVID-19 pandemic and the resulting public health response, including the changing demand for various COVID-19 vaccines and treatments from both patients and governments around the world, may affect sales of the COVID-19 products we manufacture.</span></div><div style="text-align:justify;text-indent:23.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:23.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We manufacture or provide services for a variety of products intended for the prevention or treatment of COVID-19 and its symptoms and effects, including the manufacture of bulk drug substance for one vaccine, fill and finish services for other vaccines, packaging and distribution services, and the manufacture of excipients used in a COVID-19 treatment. No single one </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of these products is material to our business. Several of these products are subject to &#8220;take-or-pay&#8221; provisions that require the customer to either purchase a minimum amount of product or pay any shortfall resulting from purchases not made. Such provisions mitigate risks relating to any future uncertainty in the demand for these products.  </span></div><div style="text-align:justify;text-indent:23.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:23.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the COVID-19-related products we develop and manufacture have yet to receive full regulatory approval from any regulatory authority, although some are being marketed and sold pursuant to an emergency use authorization (EUA) from the FDA or the equivalent authorization from non-U.S. regulatory authorities. Should one or more of these COVID-19-related products be denied an EUA (or equivalent) or be denied full regulatory approval by the FDA or other major non-U.S. regulatory authority, the demand for such product/s could decrease significantly and therefore decrease customer orders for additional development, manufacturing, or packaging of those products, although the financial effect on us may be mitigated by any take-or-pay provision in place with respect to that product. Additionally, the need for continued manufacture and supply of vaccines (including potential &#8220;booster&#8221; doses) and therapies to address the COVID-19 pandemic, including new and developing variants of COVID-19, is highly uncertain and subject to various political, economic, and regulatory factors that are outside of our control. Should the U.S. or other major regions worldwide determine that additional manufacture of COVID-19 vaccines, boosters, or therapies is no longer necessary, it could adversely affect our revenue and financial condition and our ability to grow our business in the near term. In addition, highly-public political and social debate relating to the need for, efficacy of, or side effects related to one or more specific COVID-19 vaccines could contribute to changes in public perception of one or more COVID-19 vaccines manufactured by us, which could decrease demand for a COVID-19 related product we develop, manufacture, or package.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The demand for our offerings depends in part on our customers&#8217; research and development and the clinical and market success of their products. Our business, financial condition, and results of operations may be harmed if our customers spend less on, or are less successful in, these activities. In addition, customer spending may be affected by, among other things, the COVID-19 pandemic or recessionary economic conditions caused in whole or in part by the pandemic.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are engaged in research, development, production, and marketing of pharmaceutical, biotechnology, and consumer health products. The amount of customer spending on research, development, production, and marketing, as well as the outcomes of such research, development, and marketing activities, have a large impact on our sales and profitability, particularly the amount our customers choose to spend on our offerings. Available resources, the need to develop new products, and consolidation in the industries in which our customers operate may have an impact on such spending. Our customers finance their research and development spending from private and public sources. A reduction in spending by our customers, for these reasons or because of the direct or indirect effects of the COVID-19 pandemic, could have a material adverse effect on our business, financial condition, and results of operations. If our customers are not successful in attaining or retaining product sales due to market conditions, reimbursement issues, or other factors, our results of operations may be materially adversely affected.</span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We participate in a highly competitive market, and increased competition may adversely affect our business. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a market that is highly competitive. We compete with multiple companies as to each of our offerings and in every region of the globe in which we operate, including competing with other companies that offer advanced delivery technologies, outsourced dose form or biologics manufacturing, clinical trials support services, or development services to pharmaceutical, biotechnology, and consumer health companies globally. We also compete in some cases with the internal operations of those pharmaceutical, biotechnology, and consumer health customers that also have manufacturing capabilities and choose to source these services internally. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face substantial competition in each of our markets. Competition is driven by proprietary technologies and know-how, capabilities, consistency of operational performance, quality, price, value, responsiveness, and speed. Some competitors have greater financial, research and development, operational, and marketing resources than we do. Competition may also increase as additional companies enter our markets or use their existing resources to compete directly with ours. Expanded competition from companies in low-cost jurisdictions, such as India and China, may in the future adversely affect our results of operations or limit our growth. Greater financial, research and development, operational, and marketing resources may allow our competitors to respond more quickly with strategic acquisitions, or with new, alternative, or emerging technologies. Changes in the nature or extent of our customers&#8217; requirements may render our offerings obsolete or non-competitive and could adversely affect our results of operations and financial condition. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to product and other liability risks that could exceed our anticipated costs or adversely affect our results of operations, financial condition, liquidity, and cash flows. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to potentially significant product liability and other liability risks that are inherent in the design, development, manufacture, and marketing of our offerings. We may be named as a defendant in product liability lawsuits, </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which may allege that our offerings have resulted or could result in an unsafe condition or injury to consumers. Such lawsuits, even those without merit, could be costly to defend and could result in reduced sales, significant liabilities, adverse publicity, and diversion of management&#8217;s time, attention, and resources.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, product liability claims and lawsuits, regardless of their ultimate outcome, could have a material adverse effect on our business operations, financial condition, and reputation and on our ability to attract and retain customers. The availability of product liability insurance for companies in the pharmaceutical industry is generally more limited than insurance available to companies in other industries. We maintain product liability insurance with annual aggregate limits in excess of $25 million. There can be no assurance that a successful product liability or other claim would be adequately covered by our applicable insurance policies or by any applicable contractual indemnity or liability limitations. </span></div><div style="padding-left:24pt"><span><br/></span></div><div style="padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Failure to comply with existing and future regulatory requirements, including changing regulatory standards or changing interpretations of existing standards, could adversely affect our results of operations and financial condition or result in claims from customers. In addition, changes to our procedures or additional procedures, implemented to comply with public health orders or best practice guidelines as a result of the COVID-19 pandemic, may increase our costs or reduce our productivity and thereby affect our business, financial condition, or results of operations.</span></div><div style="padding-left:24pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly regulated. We, and our customers, are subject to various local, state, federal, national, and transnational laws and regulations, which include the operating, quality, and security standards of the FDA, the DEA, various state boards of pharmacy, state health departments, the DHHS, similar bodies of the U.K., the E.U. and its member states, and other comparable agencies around the world, and, in the future, any change to such laws and regulations or the interpretation or application thereof could adversely affect us. Among other rules affecting us, we are subject to laws and regulations concerning cGMP and drug safety. As a result of the COVID-19 pandemic, new public health orders or best practice guidelines may increase our costs to operate or reduce our productivity, thereby affecting our business, financial condition, or results of operations.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure by us or by our customers to comply with the requirements of applicable laws and regulations or requests from regulatory authorities could result in warning letters, product recalls or seizures, monetary sanctions, injunctions to halt manufacture or distribution, restrictions on our operations, civil or criminal sanctions, or withdrawal of existing or denial of pending approvals, permits, or registrations, including those relating to products or facilities. In addition, any such failure relating to the products or services we provide could expose us to contractual or product liability claims as well as claims from our customers, including claims for reimbursement for lost or damaged active pharmaceutical ingredients, which cost could be significant. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any new offering or product classified as a pharmaceutical or medical device must undergo lengthy and rigorous clinical testing and other extensive, costly, and time-consuming procedures mandated by the FDA, the EMA, and other equivalent local, state, federal, national, and transnational regulatory authorities in the jurisdictions that regulate our offerings and products. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we comply in all material respects with applicable laws and regulations, there can be no assurance that a regulatory agency or tribunal would not reach a different conclusion concerning the compliance of our operations with applicable laws and regulations. In addition, there can be no assurance that we will be able to maintain or renew existing permits, licenses, or other regulatory approvals or obtain, without significant delay, future permits, licenses, or other approvals needed for the operation of our businesses. Any noncompliance by us or our customers with applicable law or regulation or the failure to maintain, renew, or obtain necessary permits and licenses could have an adverse effect on our results of operations and financial condition. Furthermore, loss of a permit, license, or other approval in any one portion of our business may have indirect consequences in another portion of our business if regulators or customers adjust their reviews of such other portion as a result or customers cease business with such other portion due to fears that such loss is a sign of broader concerns about our ability to deliver products or services of sufficient quality.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to provide quality offerings to our customers could have an adverse effect on our business, and the market price of our Common Stock and may subject us to regulatory action or costly litigation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results depend on our ability to execute and improve when necessary our quality management strategy and systems, and effectively train and maintain our workforce with respect to quality management. Quality management plays an essential role in determining and meeting customer requirements, preventing defects, and improving our offerings, and, despite our network of quality systems, a quality or safety issue, including with respect to a high-revenue product such as a COVID-19 vaccine or therapy, could have an adverse effect on our business, financial condition, stock price, or results of operations and may subject us to regulatory action, including a product recall, product seizure, injunction to halt manufacture or distribution, or restriction on our operations; monetary fines; or other civil or criminal sanctions. In addition, such an issue could subject us to </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse publicity and costly litigation, including claims from our customers for reimbursement for the cost of lost or damaged active pharmaceutical ingredients or other related losses, the cost of which could be significant. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The services and offerings we provide are highly exacting and complex, and, if we encounter problems providing the services or support required, our business could suffer. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offerings we provide are highly exacting and complex, particularly in our Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, due in part to complex and exacting manufacturing processes and strict regulatory requirements. From time to time, problems may arise in connection with facility operations or during preparation or provision of an offering, in both cases for a variety of reasons including, but not limited to, equipment malfunction, sterility variances or failures, failure to follow specific protocols and procedures, problems with raw materials, environmental factors, and damage to, or loss of, manufacturing operations due to fire, flood, or similar causes. Such problems could affect production of a particular batch or series of batches, require the destruction of or otherwise result in the loss of product or materials used in the production of product, or could halt facility production altogether. This could, among other things, lead to increased costs, lost revenue, damage to customer relations, reimbursement to customers for lost active pharmaceutical ingredients or other related losses, time and expense spent investigating the cause, lost production time, and, depending on the cause, similar losses with respect to other batches or products. Production problems in our drug and biologic manufacturing operations could be particularly significant because the cost of raw materials is often higher than in our other businesses. If problems are not discovered before the product is released to the market, recall and product liability costs may also be incurred. In addition, such risks may be greater at facilities that are new or going through significant expansion or renovation. The risks associated with running a highly complex facility doing exacting work with substantial regulatory oversight are enhanced for our larger sites, like our Bloomington, Indiana, Harmans, Maryland, St. Petersburg, Florida, or Swindon U.K. sites, which generally generate much more revenue.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot keep pace with rapid technological advances, our services may become uncompetitive or obsolete, and our revenue and profitability may decline. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is characterized by rapid technological change. Demand for our offerings may change in ways we may not anticipate because of evolving industry standards as well as a result of evolving customer needs that are increasingly sophisticated and varied and the introduction by others of new offerings and technologies that provide alternatives to our offerings. Several of our higher margin offerings are based on proprietary technologies. To the extent that such technologies are protected by patents, their related offerings may become subject to competition as the patents expire. Without the timely introduction of enhanced or new offerings and technologies, our offerings may become obsolete or uncompetitive over time, in which case our revenue and operating results would suffer. For example, if we are unable to respond to changes in the nature or extent of the technological or other needs of our pharmaceutical customers through enhancing our offerings, our competition may develop offerings that are more competitive than ours and we could find it more difficult to renew or expand existing agreements or obtain new agreements. Potential innovations intended to facilitate enhanced or new offerings generally will require a substantial investment before we can determine their commercial viability, and we may not obtain access to the innovations or have financial resources sufficient to fund all desired innovations. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we succeed in creating or acquiring enhanced or new offerings from these innovations, they may still fail to result in commercially successful offerings or may not produce revenue in excess of the costs of development, and they may be rendered obsolete by changing customer preferences or the introduction by our competitors of offerings embodying new technologies or features. Finally, innovations may not be accepted quickly in the marketplace because of, among other things, entrenched patterns of clinical practice, the need for regulatory clearance, and uncertainty over market access or government or third-party reimbursement. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our customers depend on patents, copyrights, trademarks, know-how, trade secrets, and other forms of intellectual property protections, but these protections may not be adequate. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of know-how, trade secrets, patents, copyrights, trademarks, and other intellectual property laws, nondisclosure and other contractual provisions, and technical measures to protect many of our offerings and intangible assets. These proprietary rights are important to our ongoing operations. There can be no assurance that these protections will provide uniqueness or meaningful competitive differentiation in our offerings or otherwise be commercially valuable or that we will be successful in obtaining additional intellectual property or enforcing our intellectual property rights against unauthorized users. Our exclusive rights under certain of our offerings are protected by patents, some of which will expire in the near term. When patents covering an offering expire, loss of exclusivity may occur, which may force us to compete with third parties, thereby negatively affecting our revenue and profitability. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary rights may be invalidated, circumvented, or challenged. We may in the future be subject to proceedings seeking to oppose or limit the scope of our patent applications or issued patents. In addition, in the future, we may need to take legal actions to enforce our intellectual property rights, to protect our trade secrets, or to determine the validity or scope of the proprietary rights of others. Legal proceedings are inherently uncertain, and the outcome of such proceedings may be unfavorable to us. Any legal action regardless of outcome might result in substantial costs and diversion of resources and management attention.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that our confidentiality agreements will not be breached, our trade secrets will not otherwise become known by competitors, or that we will have adequate remedies in the event of unauthorized use or disclosure of proprietary information. Even if the validity and enforceability of our intellectual property is upheld, an adjudicator might construe our intellectual property not to cover the alleged infringement. In addition, intellectual property enforcement may be unavailable or practically ineffective in some countries. There can be no assurance that our competitors will not independently develop technologies that are substantially equivalent or superior to our technology or that third parties will not design around our intellectual property claims to produce competitive offerings. The use of our technology or similar technology by others could reduce or eliminate any competitive advantage we have developed, cause us to lose sales, or otherwise harm our business. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continue to apply in the U.S. and certain other countries for registration of a number of trademarks, service marks, and patents, and also claim common law rights in various trademarks and service marks, there can be no assurance that third parties will not oppose our applications in the future. In addition, it is possible that in some cases we may be unable to obtain the registrations for trademarks, service marks, and patents for which we have applied, and a failure to obtain trademark and patent registrations in the U.S. or other countries could limit our ability to protect our trademarks and proprietary technologies and impede our marketing efforts in those jurisdictions. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License agreements with third parties control our rights to use certain patents, software, and information technology systems and proprietary technologies owned by third parties, some of which are important to our business. Termination of these license agreements for any reason could result in the loss of our rights to this intellectual property, causing an adverse change in our operations or the inability to commercialize certain offerings. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of our branded pharmaceutical customers rely on patents to protect their products from generic competition. Because incentives exist in some countries, including the U.S., for generic pharmaceutical companies to challenge these patents, pharmaceutical and biotechnology companies are under the ongoing threat of challenges to their patents. If the patents on which our customers rely were successfully challenged and, as a result, the affected products become subject to generic competition, the market for our customers&#8217; products could be significantly adversely affected, which could have an adverse effect on our results of operations and financial condition. We attempt to mitigate these risks by making our offerings available to generic as well as branded manufacturers and distributors, but there can be no assurance that we will be successful in marketing these offerings.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our offerings or our customers&#8217; products may infringe on the intellectual property rights of third parties. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, third parties have asserted intellectual property infringement claims against us and our customers, and there can be no assurance that third parties will not assert infringement claims against either us or our customers in the future. While we believe that our offerings do not infringe in any material respect upon proprietary rights of other parties, and that meritorious defenses would exist with respect to any assertion to the contrary, there can be no assurance that we could successfully avoid being found to infringe on the proprietary rights of others. Patent applications in the United States and certain other countries are generally not publicly disclosed until the patent is issued or published, and we and our customers may not be aware of currently filed patent applications that relate to our or their products, offerings, or processes. If patents later issue on these applications, we or they may be found liable for subsequent infringement. There has been substantial litigation in the pharmaceutical and biotechnology industries with respect to the manufacture, use, and sale of products that are the subject of conflicting patent rights. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any claim that our offerings or processes infringe third-party intellectual property rights (including claims arising through our contractual indemnification of our customers), regardless of the claim&#8217;s merit or resolution, could be costly and may divert the efforts and attention of our management and technical personnel. We may not prevail against any such claim given the complex technical issues and inherent uncertainties in intellectual property matters. If any such claim results in an adverse outcome, we could, among other things, be required to: pay substantial damages (potentially including treble damages in the U.S.); cease the manufacture, use, or sale of the infringing offerings or processes; discontinue the use of the infringing technology; expend significant resources to develop non-infringing technology; license technology from the third party claiming infringement, which license may not be available on commercially reasonable terms or at all; and lose the opportunity </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to license our technology to others or to collect royalty payments based upon successful protection and assertion of our intellectual property against others. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our customers&#8217; products may be subject to claims of intellectual property infringement and such claims could materially affect our business if their products cease to be manufactured or they have to discontinue the use of the infringing technology. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing could affect our ability to compete or have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Events that diminish, tarnish, or otherwise damage our brand may have an adverse effect on our future financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a strong brand in &#8220;Catalent,&#8221; with high overall and generally favorable awareness of the brand in our established markets and with target customers. Our brand identity is a competitive advantage for us in sales and marketing, which is evidenced by our customer mix among top branded drug, generics, biologics, and consumer health marketers. We have spent and continue to spend substantial time, money, and other resources to establish both our brand awareness and a favorable perception of our brand in relevant markets. Among other strategies, we participate in major international trade shows in our established markets and ensure visibility into our offerings through a comprehensive print and on-line advertising and publicity program. It is possible that a single event, or aggregation of several events, may diminish, tarnish, or otherwise damage our brand and adversely affect our future financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, meaningful interruptions to our ability to reliably supply one or more customers with products on time, whether as a result of supply chain disruptions or manufacturing delays or defects, may diminish our customers&#8217; confidence in our ability to timely meet our commitments, thereby damaging our brand. In addition, we are subject to various local, state, federal, national, and transnational laws and regulations, including the operating, quality, and security standards of the FDA, the DEA, and similar bodies of the U.K., the E.U., and other comparable agencies around the world. Highly public or significant negative reports or findings from a regulatory agency with respect to one or more manufacturing or quality defects in our operations, inspections of our facilities, or other routine reviews could cause negative public perception of our operations, negatively impacting our brand, and adversely affecting our financial condition and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many of the other risks we face, including those described elsewhere in "Risk Factors" could diminish, tarnish, or otherwise damage our brand.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future results of operations are subject to fluctuations in the costs, availability, and suitability of the components of the products we manufacture, including active pharmaceutical ingredients, excipients, purchased components, and raw materials. In addition, the COVID-19 pandemic may interfere with the operations of certain of our direct or indirect suppliers or with international trade for these supplies, which may either raise our costs or reduce the productivity or slow the timing of our operations.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on various active pharmaceutical ingredients, components, compounds, raw materials, and energy supplied primarily by third parties for our offerings. Our customers also frequently provide to us their active pharmaceutical or biologic ingredient for formulation or incorporation in the finished product and may supply other raw materials as well. It is possible that any of our or our customers&#8217; supplier relationships could be interrupted due to changing regulatory requirements, import or export restrictions, natural disasters, international supply disruptions, including those caused by public health emergencies such as the COVID-19 pandemic, geopolitical issues, operational or quality issues at the suppliers&#8217; facilities, and other events, or could be terminated in the future.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, gelatin, a critical component for our Softgel and Oral Technologies segment is available from only a limited number of sources. In addition, much of the gelatin we use is bovine-derived. Past concerns of contamination from bovine spongiform encephalopathy, or BSE, have narrowed the number of possible sources of particular types of gelatin. If there were a future disruption in the supply of gelatin, we may not be able to obtain an adequate alternative supply. If future restrictions were to emerge on the use of bovine-derived gelatin, any such restriction could hinder our ability to timely supply our customers with products and the use of alternative material could be subject to lengthy and uncertain formulation, testing, and regulatory approval. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any sustained interruption in our receipt of adequate supplies could have an adverse effect on our business and results of operations. In addition, while we have processes intended to reduce volatility in component and material pricing, we may not be able to successfully manage price fluctuations, and future price fluctuations or shortages may have an adverse effect on our results of operations. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in market access or healthcare reimbursement for, or public sentiment towards our customers&#8217; products in the United States or internationally, or other changes in applicable policies regarding the healthcare industry, could adversely affect our results of operations and financial condition by affecting demand for our offerings. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry has changed significantly over time, and we expect the industry to continue to evolve. Some of these changes, such as ongoing healthcare reform, including with respect to reforming drug pricing, adverse changes in governmental or private funding of healthcare products and services, legislation or regulations governing patient access to care and privacy, or the delivery, pricing, or reimbursement approval of pharmaceuticals and healthcare services or mandated benefits, may cause healthcare industry participants to change the amount of our offerings that they purchase or the price they are willing to pay for these offerings. In particular, it is possible that future legislation in the U.S. may affect or put a cap on future pricing of pharmaceutical and biotechnology products. While we are unable to predict the likelihood of changes to U.S. and other international laws affecting pharmaceutical and biotechnology products, any substantial revision of applicable healthcare legislation could have a material adverse effect on the demand for our customers&#8217; products, which in turn could have a negative impact on our results of operations, financial condition, or business. Changes in the healthcare industry&#8217;s pricing, selling, inventory, distribution, or supply policies or practices, or in public or government sentiment for the industry as a whole, could also significantly reduce our revenue and results of operations. In particular, volatility in individual product demand may result from changes in public or private payer reimbursement or coverage. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated net operating losses (&#8220;NOLs&#8221;) in the past that have been, and continue to be, used to reduce taxable income. Utilization of our NOL carryforwards may be subject to a substantial limitation under Section 382 of the Internal Revenue Code of 1986, as amended (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Internal Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Code</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and comparable provisions of state, local, and foreign tax laws due to changes in ownership of our company that may occur in the future. Under Section 382 of the Internal Revenue Code and comparable provisions of state, local, and foreign tax laws, if a corporation undergoes an </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ownership change,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> generally defined as a greater than 50% change by value in its equity ownership over a three-year period, the corporation&#8217;s ability to carry forward its pre-change NOLs to reduce its post-change income may be limited. In addition, we acquired companies that generated pre-acquisition NOLs for tax purposes that will also be subject to limitation under Section 382 and comparable provisions of state, local, and foreign tax laws. We may experience ownership changes in the future as a result of future changes in our stock ownership. As a result, our ability to use our pre-change NOL carryforwards to reduce U.S. federal, state, local, and foreign taxable income we produce in the future years may be subject to limitations, which could result in increased future tax liability to us.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to the estimated future profitability of the business may require that we establish an additional valuation allowance against all or some portion of our net deferred tax assets.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have deferred tax assets for NOL carryforwards and other temporary differences. We currently maintain a valuation allowance for a portion of our U.S. net deferred tax assets and certain foreign net deferred tax assets. It is possible we may experience a decline in U.S. taxable income resulting from a decline in profitability of our U.S. operations, an increased level of debt in the U.S., or other factors. In assessing our ability to realize our deferred tax assets, we may conclude that it is more likely than not that some additional portion or all our deferred tax assets will not be realized. As a result, we may be required to record an additional valuation allowance against our deferred tax assets, which could adversely affect our effective income tax rate and therefore our financial results.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on key personnel.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on our executive officers and other key personnel, including our technical personnel, to operate and grow our business and to develop new and enhanced offerings and technologies. The loss of any of these officers or other key personnel or a failure to attract and retain suitably skilled technical personnel could adversely affect our operations. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our executive officers, we rely on more than 150 senior employees to lead and direct our business. Our senior leadership team is comprised of our subsidiaries&#8217; executive officers and other vice presidents and directors who hold critical positions and possess specialized talents and capabilities that give us a competitive advantage in the market. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ more than 2,500 scientists and technicians whose areas of expertise and specialization cover subjects such as advanced delivery, biologics and gene and cell therapy formulation and manufacturing. Many of our sites and laboratories are </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">located in competitive labor markets; therefore, global and regional competitors and, in some cases, customers and suppliers compete for the same skills and talent as we do. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire businesses and offerings that complement or expand our business or divest non-strategic businesses or assets. We may not be able to complete desired transactions, and such transactions, if executed, pose significant risks, including risks relating to our ability to successfully and efficiently integrate acquisitions or execute on dispositions and realize anticipated benefits therefrom. The failure to execute or realize the full benefits from any such transaction could have a negative effect on our operations and profitability. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success may depend in part on opportunities to buy or otherwise acquire rights to other businesses or technologies, enter into joint ventures or otherwise enter into strategic arrangements with business partners that could complement, enhance, or expand our current business or offerings and services or that might otherwise offer us growth opportunities, or divest assets or an ongoing business. We face competition from other companies in pursuing acquisitions and similar transactions in the pharmaceutical and biotechnology industry. Our ability to complete transactions may also be limited by applicable antitrust and trade laws and regulations in the U.S. and other jurisdictions in which we or the operations or assets we seek to acquire carry on business. To the extent that we are successful in making acquisitions, we expend substantial amounts of cash, incur debt, or assume loss-making divisions as consideration. We or the purchaser of a divested asset or business may not be able to complete a desired transaction for any number of reasons, including a failure to secure financing. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any acquisition that we are able to identify and complete may involve a number of risks, including, but not limited to, the diversion of management&#8217;s attention to integrate the acquired businesses or joint ventures, the possible adverse effects on our operating results during the integration process, the potential loss of customers or employees in connection with the acquisition, delays or reduction in realizing expected synergies, unexpected liabilities, and our potential inability to achieve our intended objectives for the transaction. In addition, we may be unable to maintain uniform standards, controls, procedures, and policies, which may lead to operational inefficiencies. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we are not successful in completing desired divestitures, we may have to expend cash, incur debt, or continue to absorb the costs of loss-making or under-performing divisions. Any divestiture, whether we complete it or not, may involve numerous risks, including diversion of management&#8217;s attention, a negative impact on our customer relationships, costs associated with maintaining its business during the disposition process, and the costs of closing and disposing of the affected business or transferring remaining portions of the operations of the business to other facilities.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cell and gene therapies are relatively new modes of treatment and subject to changing public opinion, continuing research, and increased regulatory scrutiny, each of which may affect our customers&#8217; abilities to conduct their business or obtain approvals for their therapies, and thereby adversely affect our cell or gene therapy offerings.</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cell and gene therapy remain relatively new means for treating disease and other medical conditions, with only a few cell and gene therapies approved to date in the U.S., the E.U., or elsewhere. Public perception may be influenced by claims that cell or gene therapies are unsafe, and cell or gene therapy may not gain the acceptance of the public or the medical community. In addition, ethical, social, legal, and cost-benefit concerns about cell or gene therapy, genetic testing, and genetic research could result in additional regulations or limitations or even outright prohibitions on certain cell or gene therapies or related products. Various regulatory and legislative bodies have expressed an interest in, or have taken steps towards, further regulation of various biotechnologies, including cell and gene therapies. More restrictive regulations or claims that certain cell or gene therapies are unsafe or pose a hazard could reduce our customers&#8217; use of our services. We can provide no assurance whether legislative changes will be enacted, regulations, policies, or guidance changed, or interpretations of existing strictures by agencies or courts changed, or what the impact of such changes, if any, may be.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to environmental, health, and safety laws and regulations, which could increase our costs or restrict our operations in the future. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject to a variety of environmental, health, and safety laws and regulations, including those of the EPA, OSHA, and equivalent local, state, and national regulatory agencies in the jurisdictions in which we operate. Any failure by us to comply with environmental, health, and safety requirements could result in the limitation or suspension of production or subject us to monetary fines, civil or criminal sanctions, or other future liabilities in excess of our reserves. In particular, we are subject to laws and regulations governing the destruction and disposal of raw materials, byproducts of our manufacturing operations, and non-compliant products, the handling of regulated material included in our offerings, and the disposal of our products or their components at the end of their useful lives. In addition, compliance with environmental, health, and safety requirements could restrict our ability to expand our facilities or require us to acquire costly environmental or safety control equipment, incur other significant expenses, or modify our manufacturing processes. Our manufacturing facilities may use, in varying degrees, hazardous substances in their processes. These substances include, among others, chlorinated solvents, and in </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the past chlorinated solvents were used at one or more of our facilities, including a number we no longer own or operate. As at our current facilities, contamination at such formerly owned or operated properties can result and has resulted in liability to us. In the event of the discovery of new or previously unknown contamination either at our facilities, facilities we acquire in the future, or at third-party locations, including facilities we formerly owned or operated, the issuance of additional requirements with respect to existing contamination, or the imposition of other cleanup obligations for which we are responsible, we may be required to take additional, unplanned remedial measures for which we have not recorded reserves. We are conducting monitoring and cleanup of contamination at certain facilities currently or formerly owned or operated by us, and such activities may result in unanticipated costs or management distraction. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to labor and employment laws and regulations, which could increase our costs and restrict our operations in the future. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have nearly 17,300 individuals providing services for us worldwide, including approximately 10,300 service providers in North America, 5,400 in Europe, 1,000 in South America, and 600 in the Asia-Pacific region. Certain employees at one of our North American facilities are represented by a labor organization, and national works councils or labor organizations are active at our European facilities and certain of our other facilities consistent with local labor environments and laws. Our management believes that our employee relations are satisfactory. However, further organizing activities, collective bargaining, or changes in the regulatory framework for employment may increase our employment-related costs or may result in work stoppages or other labor disruptions. Moreover, as employers are subject to various employment-related claims, such as individual and class actions relating to alleged employment discrimination and wage-hour and labor standards issues, such actions, if brought against us and successful in whole or in part, may affect our ability to compete or have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our pension plans are underfunded, and additional cash contributions we may make to increase the funding level will reduce the cash available for our business, such as the payment of our interest expense. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our current and former employees in the U.S., the U.K., Germany, France, Japan, Belgium, and Switzerland are participants in defined benefit pension plans that we sponsor. As of June 30, 2021, the underfunded amount of our pension plans on a worldwide basis was $54 million, primarily related to our pension plans in the U.K. and Germany. In addition, we have an estimated obligation of $38 million, as of June 30, 2021, related to our withdrawal from a multiemployer pension plan in which we formerly participated. In general, the amount of future contributions to the underfunded plans will depend upon asset returns, applicable actuarial assumptions, prevailing and expected interest rates, and other factors, and, as a result, the amount we may be required to contribute in the future to fund the obligations associated with such plans may vary. Such cash contributions to the plans will reduce the cash available for our business, including the funds available to pursue strategic growth initiatives or the payment of interest expense on our indebtedness.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our global operations are subject to economic and political risks, which could affect the profitability of our operations or require costly changes to our procedures.</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conduct our operations in various regions of the world, including North America, South America, Europe, and the Asia-Pacific region. Global and regional economic and political developments affect businesses such as ours in many ways. Our operations are subject to the effects of global and regional competition. Our global operations are also affected by local economic environments, including inflation and recession. Political changes, some of which may be disruptive, and related hostilities can interfere with our supply chain, our customers, and some or all of our activities in a particular location. While some of these risks can be hedged using derivatives or other financial instruments and some are insurable, such mitigating measures may be unavailable, costly, or unsuccessful. </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">As a global enterprise, fluctuations in the exchange rate of the U.S. dollar, our reporting currency, against other currencies could have a material adverse effect on our financial performance and results of operations.</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a company with significant operations outside of the U.S., certain revenues, costs, assets, and liabilities, including our euro-denominated 2.375% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;), are denominated in currencies other than the U.S. dollar, which is the currency that we use to report our financial results. As a result, changes in the exchange rates of these or any other applicable currency to the U.S. dollar will affect our revenues, earnings, and cash flows. There has been, and may continue to be, volatility in currency exchange rates affecting the various currencies in which we do business. Such volatility and other changes in exchange rates could result in unrealized and realized exchange losses, despite any effort we may undertake to manage or mitigate our exposure to fluctuations in the values of various currencies. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax legislative or regulatory initiatives, new interpretations or developments concerning existing tax laws, or challenges to our tax positions could adversely affect our results of operations and financial condition.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a large multinational enterprise with operations in the U.S. and more than a dozen other countries across North and South America, Europe, and the Asia-Pacific region, and we do business with suppliers and customers in many additional regions. As such, we are subject to the tax laws and regulations of the U.S. federal, state, and local governments and of many jurisdictions outside of the U.S. From time to time, various legislative initiatives may be proposed that could adversely affect our tax positions, and existing legislation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may be subject to additional regulatory changes or new interpretations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There can be no assurance that our effective tax rate or tax payments will not be adversely affected by these initiatives. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, U.S. federal, state, local, and foreign tax laws and regulations are extremely complex and subject to varying interpretations. We are subject to regular examination of our income tax returns by various tax authorities. Examinations or changes in laws, rules, regulations, or interpretations by taxing authorities could result in adverse impacts to tax years open under statute or to our operating structures currently in place. It is possible that the outcomes from these examinations or changes in laws, rules, regulations, or interpretations by taxing authorities will have a material adverse effect on our financial condition or results of operations. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We use advanced information and communication systems to run our operations, compile and analyze financial and operational data, and communicate among our employees, customers, and counter-parties, and the risks generally associated with information and communications systems could adversely affect our results of operations. We are continuously working to install new, and upgrade existing, systems and provide employee awareness training around phishing, malware, and other cyber security risks to enhance the protections available to us, but such protections may be inadequate to address malicious attacks or inadvertent compromises of data security.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information systems in our business to obtain, process, analyze, and manage data to: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">facilitate the manufacture and distribution of thousands of inventory items in, to, and from our facilities; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">receive, process, and ship orders on a timely basis; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">manage the accurate billing and collections for more than one thousand customers; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">create, compile, and retain testing and other product-, manufacturing-, or facility-related data necessary for meeting our and our customers&#8217; regulatory obligations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">manage the accurate accounting and payment for thousands of vendors and our employees; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">schedule and operate our global network of development, manufacturing, and packaging facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">document various aspects of our activities, including the agreements we make with suppliers and customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">compile financial and other operational data into reports necessary to manage our business and comply with various regulatory or contractual obligations, including obligations under our bank loans and other indebtedness, the federal securities laws, the Internal Revenue Code, and other applicable state, local, and ex-U.S. tax laws; and communicate among our nearly 17,300 workers spread across dozens of facilities over four continents.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We face various security threats on a regular basis, including ongoing cyber security threats to and attacks on our information technology infrastructure. We deploy defenses against such threats and attacks and work to secure the integrity of our data systems using techniques, hardware, and software typical of companies of our size and scope. Despite our security measures, however, our information technology and infrastructure may be vulnerable to attacks by increasingly sophisticated intruders or others who try to cause harm to or interfere with our normal use of our systems. They are also susceptible to breach due to employee error, malfeasance, or other disruptions. Our suppliers, contractors, service providers, and other third parties with whom we do business also experience cyber threats and attacks that are similar in frequency and sophistication. In many cases, we have to rely on the controls and safeguards put in place by our suppliers, contractors, service providers, and other third parties to defend against, respond to, and report these attacks. We cannot know the potential impact of future cyber incidents, which vary widely in severity and scale. There can be no assurance that the various procedures and controls we utilize to mitigate these threats will be sufficient to prevent disruptions to our systems, in part because (i) cyber-attack techniques change frequently and, at times, new techniques are not recognized until launched, and (ii) cyber-attacks can originate from a wide variety of sources. Our results of operations could be adversely affected if these systems are interrupted or damaged or fail for any extended period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Indebtedness </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial leverage could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or in our industry or to deploy capital to grow our business, expose us to interest-</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">rate risk to the extent of our variable-rate debt, or prevent us from meeting our obligations under our indebtedness. These risks may be increased in a recessionary environment, particularly as sources of capital may become less available or more expensive. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, we had $3,277 million (U.S. dollar equivalent) of total indebtedness outstanding, consisting of $997 million of secured indebtedness under our senior secured credit facilities and $2,034 million of senior unsecured indebtedness, including $500 million aggregate principal amount of 5.000% U.S. dollar-denominated Senior Notes due 2027 (the &#8220;2027 Notes&#8221;), &#8364;825 million aggregate principal amount of the 2028 Notes, and $550 million aggregate principal amount of U.S. dollar-denominated 3.125% Senior Notes due 2029 (the &#8220;2029 Notes&#8221; and, together with the 2027 Notes and the 2028 Notes, the &#8220;Senior Notes&#8221;).  We also owed $50 million, representing the gross value of the remaining deferred purchase consideration related to the acquisition of Cook Pharmica LLC (now Catalent Indiana, LLC &#8220;Catalent Indiana&#8221;), and $193 million of finance lease obligations. In addition, we had $719 million of unutilized capacity and $6 million of outstanding letters of credit under our $725 million secured revolving credit commitments, which is part of our senior secured credit facilities (the &#8220;Revolving Credit Facility&#8221;).</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our high degree of leverage could have important consequences for us, including: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic, industry, or competitive developments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exposing us to the risk of increased interest rates because certain of our borrowings, including borrowings under our senior secured credit facilities, are at variable rates of interest; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exposing us to the risk of fluctuations in exchange rates because of our euro-denominated notes; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult for us to satisfy our obligations with respect to our indebtedness, and any failure to comply with the obligations of any of our debt instruments, including restrictive covenants and borrowing conditions, could result in one or more events of default under the agreements governing such indebtedness or, through cross-defaults, in agreements governing other indebtedness; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restricting us from making strategic acquisitions or capital investments or causing us to make non-strategic divestitures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to obtain additional financing for working capital, capital expenditures, product development, debt service requirements, acquisitions, and general corporate or other purposes; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for, or reacting to, changes in our business or market conditions and placing us at a competitive disadvantage compared to our competitors who are less highly leveraged and who, therefore, may be able to take advantage of opportunities that our leverage prevents us from exploiting. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total interest expense, net was $110 million, $126 million, and $111 million for fiscal 2021, 2020, and 2019, respectively. After taking into consideration our ratio of fixed-to-floating-rate debt, including as a result of our February 2021 interest-rate swap agreement with Bank of America N.A., and assuming that our Revolving Credit Facility is undrawn and LIBOR is above any applicable minimum floor, each change of 100 basis points in interest rates would result in a change of approximately $5 million in annual interest expense on the indebtedness under our senior secured credit facilities. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Despite our high indebtedness level, we and our subsidiaries are still capable of incurring significant additional debt, which could further exacerbate the risks associated with our substantial indebtedness. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries may be able to incur substantial additional indebtedness in the future. Although the agreements governing our indebtedness contain restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of significant qualifications and exceptions, and, under certain circumstances, the amount of indebtedness that we may incur while remaining in compliance with these restrictions could be substantial. In addition, as of June 30, 2021, we had approximately $719 million available to us for borrowing, subject to certain conditions, under our Revolving Credit Facility. If new debt is added to our subsidiaries&#8217; existing debt levels, the risks associated with debt we currently face would increase.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our debt agreements contain restrictions that limit our flexibility in operating our business. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements governing our outstanding indebtedness contain various covenants that limit our ability to engage in specified types of transactions. These covenants limit the ability of Operating Company and those of its subsidiaries to which these covenants apply (which Operating Company&#8217;s Amended and Restated Credit Agreement, dated as of May 20, 2014 (as amended, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> calls </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricted subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) to, among other things: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness and issue certain preferred stock; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay certain dividends on, repurchase, or make distributions in respect of capital stock or make other restricted payments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay distributions from restricted subsidiaries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue or sell capital stock of restricted subsidiaries; </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">guarantee certain indebtedness; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make certain investments; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell or exchange certain assets; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into transactions with affiliates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create certain liens; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidate, merge, or transfer all or substantially all of our assets and the assets of our subsidiaries on a consolidated basis. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A breach of any of these covenants could result in a default under one or more of these agreements, including as a result of cross-default provisions, and, in the case of our Revolving Credit Facility, permit the lenders to cease making loans to us. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Despite the limitations in our debt agreements, we retain the ability to take certain actions that may interfere with our ability to timely pay our substantial indebtedness. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The covenants in the Credit Agreement and in the several indentures governing our Senior Notes (collectively, the "Indentures") contain various exceptions to the limitations they otherwise impose on our ability and the ability of our restricted subsidiaries to take the various actions described in the prior risk factor. For example, if the Senior Notes have investment-grade ratings and we are not in default under these agreements, certain of these covenants will not apply, including the covenants restricting certain dividends and other payments, the covenants concerning the incurrence of indebtedness, and the covenants limiting guarantees of indebtedness by our restricted subsidiaries. In addition, the covenants restricting dividends and other distributions by us, purchases or redemption of certain equity securities, and prepayment, redemption, or repurchase of any subordinated indebtedness are subject to various exceptions. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are currently using and may in the future use derivative financial instruments to reduce our exposure to market risks from changes in interest rates on our variable-rate indebtedness or changes in currency exchange rates, and any such instrument may expose us to risks related to counterparty credit worthiness or non-performance of these instruments. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have executed and may enter into additional or new interest-rate swap agreements, currency swap agreements, or other hedging transactions in an attempt to limit our exposure to adverse changes in variable interest rates and currency exchange rates. Such instruments may result in economic losses if, for example, prevailing interest rates decline to a point lower than any applicable fixed-rate commitment. Any such swap will expose us to credit-related risks that, if realized, could adversely affect our results of operations or financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Series A Preferred Stock</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares of our Series A Preferred Stock reduces the relative voting power of holders of our Common Stock, dilutes the ownership of such holders, and may adversely affect the market price of our Common Stock. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2019, we filed with the Delaware Secretary of State a certificate of designation of preferences, rights, and limitations (as amended, the &#8220;Certificate of Designation&#8221;) with respect to 1,000,000 shares of our Series A Preferred Stock, and, on May 17, 2019, we completed the sale of 650,000 shares of our Series A Preferred Stock to affiliates (the &#8220;Preferred Stock Investors&#8221;) of Leonard Green &amp; Partners, L.P.  As of August&#160;23, 2021, 384,777 of these shares remained outstanding representing approximately 4.4% of our outstanding Common Stock, on an as-converted basis. Holders of Series A Preferred Stock are entitled to a cumulative dividend at the rate of 5.0% per annum, subject to adjustment and payable quarterly in cash or in-kind through an increase in the stated value of each share of Series A Preferred Stock. Holders of Series A Preferred Stock also receive, on an as-converted basis, whatever holders of Common Stock receive as a result of any declaration of a dividend on the Common Stock.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under various circumstances defined in the Certificate of Designation, shares of our Series A Preferred Stock can be converted into, or redeemed for, shares of our Common Stock.  The number of shares of Common Stock into which Series A Preferred Stock may convert or be redeemed is based in part on the stated value of a share of Series A Preferred Stock, so any increase in the stated value may lead to an increase in the number of deemed shares of Common Stock held by the Preferred Stock Investors on an &#8220;as-converted&#8221; basis. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As holders of our Series A Preferred Stock are entitled to vote, on an as-converted basis, together with holders of our Common Stock, on all matters submitted to a vote of the holders of our Common Stock, the issuance of the Series A Preferred Stock to the Preferred Stock Investors, and any subsequent increase in the stated value of those shares by a payment-in-kind of the dividends payable thereon, effectively reduces the relative voting power of the holders of our Common Stock.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conversion or redemption of the Series A Preferred Stock into or for shares of our Common Stock would dilute the ownership interest of existing holders of our Common Stock, and any sale in the public market of shares of our Common Stock issued upon such conversion or redemption could adversely affect the market prices of our Common Stock. We granted the Preferred Stock Investors customary registration rights in respect of their shares of Series A Preferred Stock and any share of our Common Stock issued upon any conversion or redemption thereof. These registration rights would facilitate the resale of such securities into the public market, and any such resale would increase the number of shares of our Common Stock available for public trading. Sales by the Preferred Stock Investors of a substantial number of shares of our Common Stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the trading price of our Common Stock.  As described in Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements included elsewhere in this Annual Report (the &#8220;Consolidated Financial Statements&#8221;)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on November 23, 2020, the Preferred Stock Investors converted 265,233 shares (approximately 41% of their holdings) and $2 million of unpaid accrued dividends into shares of our Common Stock. The holders received 20.33 shares of Common Stock for each converted preferred share, resulting in the issuance of 5,392,280 shares of our Common Stock.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Preferred Stock Investors may exercise influence over us, including through their ability to designate, and the ability of the holders of Series A Preferred Stock to elect, a member of our board of directors.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August&#160;23, 2021, the outstanding shares of our Series A Preferred Stock represented approximately 4.4% of our outstanding Common Stock, on an as-converted basis. In addition, the terms of the Series A Preferred Stock grant the Preferred Stock Investors consent rights with respect to certain actions by us, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amending our organizational documents in a manner that would have an adverse effect on the Series A Preferred Stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuing securities that are senior to, or equal in priority with, the Series A Preferred Stock; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incurring indebtedness to the extent such incurrence would cause our Total Leverage Ratio for any applicable Test Period to exceed 6:00:1:00, determined on a Pro-Forma Basis (as such terms are defined in our Credit Agreement).</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Preferred Stock Investors have the ability to influence the outcome of certain matters affecting our governance and capitalization. The sponsors of the Preferred Stock Investors are in the business of making or advising on investments in companies, including businesses that may directly or indirectly compete with certain portions of our business, and they may have interests that diverge from, or even conflict with, those of our other shareholders. They may also pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the terms of that certain stockholders&#8217; agreement we entered into with the Preferred Stock Investors (the &#8220;Stockholders&#8217; Agreement&#8221;) and of the Certificate of Designation grant the Preferred Stock Investors certain rights to designate a director to serve on our board of directors, which director is elected by a separate class vote of the holders of shares of the Series A Preferred Stock. For so long as the Preferred Stock Investors beneficially own shares of Series A Preferred Stock (or shares of our Common Stock issued upon conversion of Series A Preferred Stock) that have an aggregate value of $250 million, the Preferred Stock Investors have the right to designate one director for election to our board of directors. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The director designated by the Preferred Stock Investors is entitled to serve on committees of our board of directors, subject to applicable law and stock exchange rules. Notwithstanding the fact that all directors will be subject to fiduciary duties to us and to applicable law, the interests of the director designated by the Preferred Stock Investors may differ from the interests of our security holders as a whole or of our other directors.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Series A Preferred Stock has rights, preferences, and privileges that are not held by, and are preferential to, the rights of holders of our Common Stock, which could adversely affect our liquidity and financial condition, and may result in the interests of the Preferred Stock Investors differing from holders of our Common Stock.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of Series A Preferred Stock have the right under the Certificate of Designation to receive a liquidation preference entitling them to be paid out of our assets available for distribution to stockholders before any payment may be made to holders of any other class or series of capital stock, an amount equal to the greater of (a) the stated value of their preferred shares plus all accrued and unpaid dividends or (b) the amount that such holders would have been entitled to receive upon our liquidation, dissolution, and winding up if all outstanding shares of Series A Preferred Stock had been converted into shares of our Common Stock immediately prior to such liquidation, dissolution, or winding up.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, regular dividends on the Series A Preferred Stock accrue and are cumulative at the rate of 5% per annum, subject to adjustment and payable quarterly in arrears. The dividend on each share of Series A Preferred Stock is to be paid in cash or in-kind through an increase in the stated value of such share.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to redeem all shares of Series A Preferred Stock upon certain change of control events at a value per share equal to the greater of (a) the sum of (1) the product of (A) the applicable Mandatory Redemption Multiplier (as defined in the Certificate of Designation), multiplied by (B) the stated value of each such share, plus (2) all accrued but unpaid dividends on such share, and (b) the consideration holders would have received if they had converted their shares of Series A Preferred Stock into shares of Common Stock immediately prior to the change of control event.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These dividend and share redemption obligations could adversely affect our liquidity and reduce the amount of cash available for working capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes. Our obligations to the holders of Series A Preferred Stock could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The preferential rights could also result in divergent interests between the Preferred Stock Investors and holders of shares of our Common Stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Ownership of Our Common Stock </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price has historically been and may continue to be volatile, and a holder of shares of our Common Stock may not be able to resell such shares at or above the price such stockholder paid, or at all, and could lose all or part of such investment as a result. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Common Stock has been and continues to be volatile. For the three years ended June 30, 2021, our Common Stock price as quoted on the NYSE ranged from $29.84 to $125.27. The trading price of our Common Stock may be adversely affected by any one or more of several factors, such as those listed above in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks Relating to Our Business and Industry in Which We Operate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the following:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of operations that vary from the expectations of securities analysts or investors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of operations that vary from those of our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to our future financial performance, including financial estimates and investment recommendations by securities analysts or investors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">declines in the market prices of stocks generally, or those of pharmaceutical or other healthcare companies; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic actions by us or our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships, or capital commitments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in general economic or market conditions or trends in our industry or markets; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in business or regulatory conditions or regulatory actions taken with respect to our business or the business of any of our competitors or customers; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future sales of our Common Stock or other of our securities; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor perceptions of the investment opportunity associated with our Common Stock relative to other investment alternatives; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any decision by securities analysts to not publish research or reports about our business or to downgrade our stock or our sector;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public response to press releases or other public announcements by us or third parties, including our filings with or information furnished to the SEC; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements relating to or developments in litigation; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">guidance, if any, that we provide to the public, any change in this guidance, or any failure to meet this guidance; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of an active trading market for our Common Stock; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public response to changes in the COVID-19 pandemic and public perceptions as to the need for manufacture of certain COVID-19-related products and our role in the successful manufacture of such products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the accounting principles we use to record our results or our application of these principles to our business; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, including those resulting from natural disasters, hostilities, acts of terrorism, geopolitical activity, public health crises, including pandemics, or responses to these events. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Broad market and industry fluctuations may adversely affect the market price of our Common Stock, regardless of our actual operating performance. In addition, price volatility may be greater if the public float or trading volume of our Common Stock is low, and the amount of public float on any given day can vary depending on the individual actions of our stockholders.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following periods of market volatility, stockholders have been known to institute securities class action litigation in order to recover their resulting losses. If we become involved in securities litigation, it could have a substantial cost and divert resources and the attention of senior management from our business regardless of the outcome of such litigation. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Because we have no plan to pay cash dividends on our Common Stock for the foreseeable future, receiving a return on an investment in our Common Stock may require a sale for a net price greater than what was paid for it. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently intend to retain future earnings, if any, for future operations, expansion, and debt repayment and have no current plan to pay any cash dividend on our Common Stock for the foreseeable future.  Any future decision to pay a dividend in respect of our Common Stock, and the amount and timing of any such dividend, will be at the sole discretion of our board of directors. Our board of directors may take into account, when deciding whether or how to pay a dividend, such factors as they may deem relevant, including general economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, possible future alternative deployments of our cash, our future capital requirements, and contractual, legal, tax, and regulatory restrictions and implications on the payment of dividends by us to our holders of shares of our Common Stock or by our subsidiaries to us. In addition, our ability to pay dividends is limited by covenants in the agreements governing our outstanding indebtedness and may be limited by covenants of any future indebtedness we or our subsidiaries incur. As a result, a holder of a share of our Common Stock may not receive any return on such investment unless it is sold for a price greater than that which was paid for it, taking into account any applicable commission or other costs of acquisition or sale. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales, or the perception of future sales, of our Common Stock, by us or our existing stockholders could cause the market price for our Common Stock to decline. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale of shares of our Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of our Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. In addition, holders of our Series A Preferred Stock may sell shares of our Common Stock resulting from the conversion or redemption of their preferred shares, and holders of restricted stock units or options may sell shares of Common Stock resulting from the vesting of their restricted stock units or the vesting and exercise of their options.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of shares of our Common Stock could drop significantly if the holders of our Common Stock sell their shares or are perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of shares of our equity securities that we wish to issue. In the future, we may also issue our securities in connection with investments or acquisitions. The number of shares of our Common Stock issued or issuable in connection with an investment or acquisition could constitute a material portion of then-outstanding shares of our Common Stock, subject to limitations on issuance of new shares without stockholder approval imposed by the NYSE or to restrictions set forth in the agreements governing our indebtedness, the Certificate of Designation, and the Stockholders&#8217; Agreement. Any issuance of additional securities in connection with investments, acquisitions, or otherwise may result in dilution to the holders of shares of our Common Stock.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our organizational documents could delay or prevent a change of control. </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions of our current certificate of incorporation and bylaws may have an anti-takeover effect and may delay, defer, or prevent a merger, acquisition, tender offer, takeover attempt, or other change of control transaction that may otherwise be in the best interests of our stockholders, including transactions that might otherwise result in the payment of a premium over the market price for the shares held by our stockholders.</span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions provide for, among other things:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the ability of our board of directors to issue one or more series of preferred stock; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">advance notice for nominations of directors by stockholders and for stockholders to include matters to be considered at our annual meetings (though our board of directors has implemented shareholder proxy access);</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">certain limitations on convening special stockholder meetings;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">any amendment of certain provisions of our certificate of incorporation only by the affirmative vote of at least 66-2/3% of the shares of Common Stock entitled to vote generally in the election of directors. </span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions such as those just described, to the extent that they remain in effect, could make it more difficult for a third party to acquire us, even if the third-party&#8217;s offer may be considered beneficial by many of our stockholders. As a result, our stockholders may be limited in their ability to obtain a premium for their shares. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_76"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_79"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:13.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160;&#160;&#160;&#160;PROPERTIES</span><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 14 Schoolhouse Road, Somerset, New Jersey. As of June 30, 2021, we had 56 facilities (5 geographical locations operate as multiple facilities because they support more than one reporting segment, with our Somerset location including both a manufacturing facility and our principal executive offices), comprising manufacturing operations, development centers, and sales offices contained in approximately 7 million square feet of manufacturing, laboratory, office and related space. Our manufacturing capabilities include all required regulatory, quality assurance and in-house validation space. The following table sets forth our facilities containing manufacturing, laboratory, office, and related space by reporting segment and geographic location as of June&#160;30, 2021:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Geographic Region</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56</span></td></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)     Sites that are used by multiple segments are included once for each segment in this table.</span></div><div style="padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)     The facility in Somerset, New Jersey houses both an Oral and Specialty Delivery facility and our principal executive offices.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information with respect to our leases and property, plant, and equipment is contained in Notes 16 and 19, respectively, to our Consolidated Financial Statements.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_82"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be involved in legal proceedings arising in the ordinary course of business, including, without limitation, inquiries and claims concerning environmental contamination as well as litigation and allegations in connection with acquisitions, product liability, manufacturing or packaging defects, and claims for reimbursement for the cost of lost or damaged active pharmaceutical ingredients, the cost of any of which could be significant. We intend to vigorously defend ourselves against any such litigation and do not currently believe that the outcome of any such litigation will have a material adverse effect on our financial statements. In addition, the healthcare industry is highly regulated and government agencies continue to scrutinize certain practices affecting government programs and otherwise.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we receive subpoenas or requests for information relating to the business practices and activities of customers or suppliers from various governmental agencies or private parties, including from state attorneys general, the U.S. Department of Justice, and private parties engaged in patent infringement, antitrust, tort, and other litigation. We generally respond to such subpoenas and requests in a timely and thorough manner, and responses sometimes require considerable time and effort and can result in considerable costs being incurred. We expect to incur costs in future periods in connection with future requests.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_85"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_88"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_91"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;5.&#160;&#160;&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market for trading of our Common Stock is the NYSE. Our Common Stock trades under the symbol </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CTLT.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of August&#160;23, 2021, we had 7 and 4 holders of record of outstanding shares of our Common Stock and Series A Preferred Stock, respectively. This number does not include beneficial owners whose shares were held in street name.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not declare or pay any dividend on our Common Stock in fiscal 2021 or fiscal 2020. We have no current plan to pay any dividend on our Common Stock. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restriction, and other factors that our board of directors may deem relevant. Because we are a holding company and have no direct operations, we will only be able to pay dividends from funds we receive from our subsidiaries. In addition, our ability to pay dividends will be limited by covenants in our existing indebtedness and the Certificate of Designation and may be limited by the agreements governing other indebtedness we or our subsidiaries incur in the future. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Debt and Financing Arrangements&#8212;Debt Covenants.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Equity Securities</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not sell any unregistered equity securities during the period covered by this Annual Report.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2015, our board of directors authorized a share repurchase program, which was terminated by our board of directors in August 2020. There was no purchase by us, on our behalf, or on behalf of any affiliate of our registered equity securities during the period covered by this Annual Report or at any time during the period the share repurchase program was authorized by our board of directors.</span></div><div style="margin-top:4.5pt"><span><br/></span></div><div style="margin-top:4.5pt"><span><br/></span></div><div style="margin-top:4.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is a line graph comparing the cumulative total shareholder return on our Common Stock from June 30, 2016 through June 30, 2021, based on the market price of our Common Stock and assuming reinvestment of dividends, with the cumulative total shareholder return of companies on the S&amp;P 500 Index and S&amp;P 500 Health Care Index. The graph assumes that $100 was invested in our Common Stock and in each index at the market close on June 30, 2016. The stock price performance of the following graph is not necessarily indicative of future stock performance. </span></div><div style="margin-top:9pt;text-align:center;text-indent:24pt"><img src="ctlt-20210630_g2.jpg" alt="ctlt-20210630_g2.jpg" style="height:408px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_94"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;6. &#160;&#160;&#160;&#160;SELECTED FINANCIAL DATA</span><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have omitted the selected financial data previously required by Item 301 of Regulation S-K promulgated under the Exchange Act as we have elected to early adopt the changes to Item 301 contained in SEC Release No. 33-10890.  </span></div><div style="padding-left:9pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_97"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our Consolidated Financial Statements and related notes, which appear elsewhere in this Annual Report. This section of the Annual Report generally discusses the fiscal years ended June 30, 2021 and 2020 and year-to-year comparisons between the fiscal years ended June 30, 2021 and 2020. The discussion of our results of operations for the fiscal year ended June 30, 2019 and a comparison of our results for the fiscal years ended June 30, 2020 and 2019 is included in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the SEC on August 31, 2020 and is incorporated herein by reference. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. You should carefully read </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Special Note Regarding Forward-Looking Statements&#8221; in this Annual Report. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report, particularly in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A. Risk Factors.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_100"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products at over fifty facilities across four continents under rigorous quality and operational standards. Our oral, injectable, and respiratory delivery technologies, along with our state-of-the-art protein and cell and gene therapy manufacturing capacity, address a wide and growing range of modalities and therapeutic and other categories across the biopharmaceutical and consumer health industries. Through our extensive capabilities, growth-enabling capacity, and deep expertise in product development, regulatory compliance, and clinical trial supply, we can help our customers take products to market faster, including nearly half of new drug products approved by the FDA in the last decade. Our development and manufacturing platforms, which include those in our Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, our proven formulation, supply, and regulatory expertise, and our broad and deep development and manufacturing know-how enable our customers to advance and then bring to market more products and better treatments for patients and consumers. Our commitment to reliably supply our customers&#8217; and their patients&#8217; needs is the foundation for the value we provide; annually, we produce more than 70 billion doses for nearly 7,000 customer products, or approximately 1 in every 24 doses of such products taken each year by patients and consumers around the world. We believe that through our investments in state-of-the-art facilities and capacity expansion, including investments in facilities focused on new treatment modalities and other attractive market segments our continuous improvement activities devoted to operational and quality excellence, the sales of existing and introduction of new customer products, and, in some cases, our innovation activities and patents, we will continue to attract premium opportunities and realize the growth potential from these areas. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate in four operating segments, which also constitute our four reporting segments: Biologics, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Softgel and Oral Technologies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Oral and Specialty Delivery, and Clinical Supply Services, as further described in "Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Our Reporting Segments" contained elsewhere in this Annual Report</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The COVID-19 Pandemic</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our response to COVID-19</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the start of the COVID-19 pandemic, we have taken and continue to take steps to protect our employees, ensure the integrity and quality of our products and services, and to maintain business continuity for our customers and their patients who depend on us to manufacture and supply critical products to the market. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o address the multiple dimensions of the pandemic, senior, multi-disciplinary teams reporting directly to our Chief Executive Officer have been continuously monitoring the global situation, executing mitigation activities whenever and wherever required, and implementing a phased and structured return to our facilities as circumstances have permitted for those employees who have been working remotely.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, we implemented measures to avoid or reduce infection or contamination </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in line with guidelines issued by the U.S. Centers for Disease Control and Prevention, the World Health Organization, and local authorities where we operate, re-emphasized good hygiene practices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricted non-employee access to our sites, reorganized our workflows where permitted to maximize physical distancing, limited employee travel, facilitated safer alternatives to travel to and from work, and employed remote-working strategies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed and will continue to analyze our supply chain to identify any risk, delay, or concern that may have an impact on our ability to deliver our services and products. To date, we have not identified any significant risk, delay, or concern that would have a substantial effect on such delivery. We have adopted various procedures to minimize and manage any future disruption to our ongoing operations, including the creation and activation of </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new and existing business continuity plans when needed. Our existing procedures, which are consistent with cGMP and other regulatory standards, are intended to assure the integrity of our supply against any contamination. We have a detailed response plan to manage any impact of the virus on employee health, site operations, and product supply, including immediate assessment of the health of employees reporting symptoms, comprehensive risk assessment of any impact to quality, additional cleaning protocols, and alternative shift patterns to compensate should fewer employees be available.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 on Our Business and Results of Operations</span></div><div style="text-align:justify;text-indent:30.95pt"><span><br/></span></div><div style="text-align:justify;text-indent:30.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout fiscal 2021, we observed some increases in customer delays and cancellations, occasional increases in absenteeism of production employees in our facilities in certain affected regions, disruptions at times in certain clinical trials supported by our Clinical Supply Services segment, and a delay in inspections and product approvals by the FDA and regulatory authorities globally. A portion of our customers reported a reduction in demand, particularly in our consumer health product lines, and a larger percentage reported an increase in demand.</span></div><div style="text-align:justify;text-indent:30.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:30.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also seen increased demand and significant revenue increases and the potential for further revenue increases from COVID-19-related products, particularly in our Biologics segment. As part of our response to the COVID-19 pandemic, we accelerated and enhanced certain of our capital improvement plans to expand capacity for manufacturing drug substance and drug product for protein-based biologics and cell and gene therapies, particularly at our drug product facilities in Bloomington, Indiana, Anagni, Italy, and our commercial-scale viral vector manufacturing facility in Maryland. In order to meet customer demand for developing, manufacturing and packaging COVID-19-related products, we hired approximately 2,200 new employees at our facilities in Indiana, Maryland, and Anagni, Italy, and built and brought online new clean room suites, manufacturing lines and other facilities expansions in those locations ahead of schedule. We have also implemented various strategies to protect our financial condition and results of operations should we experience a reduction in demand for COVID-19 related products, such as ensuring contractual take-or-pay and minimum volume requirements for the manufacture of certain COVID-19 related products.  However, the extent and duration of revenue associated with COVID-19-related products is uncertain and dependent, in important respects, on factors outside our control.</span></div><div style="text-align:justify;text-indent:30.95pt"><span><br/></span></div><div style="text-align:justify;text-indent:30.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19-vaccines we manufacture are still pending approval from the FDA and other non-U.S. regulatory authorities and may not receive approval.  The future duration and extent of the COVID-19 pandemic and the future demand for COVID-19 vaccines and therapies is unknown.  Public opinion of certain COVID-19 vaccines and therapies and the product owners and manufacturers can change quickly and affect the demand for certain products and services, although they should not affect any required minimum payment for a COVID-19 related product subject to a &#8220;take-or-pay&#8221; provision. In addition, any concentration of revenue from certain COVID-19 vaccine products enhances our operational risk with respect to quality, security, regulatory inspections and business disruption resulting from any unforeseen event that affects any of the facilities and communities in which we manufacture COVID-19 vaccines.  We have implemented various mechanisms to protect our customers, their material and product, and our business continuity, such as enhanced security measures at certain facilities and heightened cybersecurity controls.   </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also &#8220;Risk Factors &#8212; Risks Related to Our Business and the Industry in Which We Operate &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our business, financial condition, and results of operations may be adversely affected by global health epidemics, including the COVID-19 pandemic&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;Risk Factors &#8212; Risks Related to Our Business and the Industry in Which We Operate &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The continually evolving nature of the COVID-19 pandemic and the resulting public health response, including the changing demand for various COVID-19 vaccines and treatments from both patients and governments around the world, may affect on sales of the COVID-19 products we manufacture&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elsewhere in this Annual Report. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_103"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Recent Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following disclosure supplements the descriptions of our accounting policies contained in Note&#160;1 to our Consolidated Financial Statements regarding significant areas of judgment. Management made certain estimates and assumptions during the preparation of the Consolidated Financial Statements in accordance with U.S. GAAP. These estimates and assumptions affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities in the Consolidated Financial Statements. These estimates also affect the reported amount of net earnings during the reporting periods. Actual results could differ from those estimates. Because of the size of the financial statement elements to which they relate, some of our accounting policies and estimates have a more significant impact on the Consolidated Financial Statements than others. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has discussed the development and selection of these critical accounting policies and estimates with the audit committee of our board of directors. A discussion of some of our more significant accounting policies and estimates follows.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell products and services directly to our pharmaceutical, biopharmaceutical, and consumer health customers. The majority of our business is conducted through manufacturing and commercial product supply, development services, and clinical supply services. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require judgment. For our manufacturing and commercial product supply revenue, the contract generally includes the terms of the manufacturing services and related product quality assurance procedures to comply with regulatory requirements. Due to the regulated nature of our business, these contract terms are highly interdependent and, therefore, are considered to be a single combined performance obligation. For our development services and clinical supply services revenue, our performance obligations vary per contract and are accounted for as separate performance obligations. If a contract contains a single performance obligation, we allocate the entire transaction price to the single performance obligation. If a contract contains multiple performance obligations, we allocate consideration to each performance obligation using the &#8220;relative standalone selling price&#8221; as defined under Accounting Standards Codification (&#8220;ASC&#8221;) 606, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Generally, we utilize observable standalone selling prices in our allocations of consideration. If observable standalone selling prices are not available, we estimate the applicable standalone selling price using an adjusted market assessment approach, representing the amount that we believe the market is willing to pay for the applicable service. Revenue is recognized over time using an appropriate method of measuring progress towards fulfilling our performance obligation for the respective arrangement. Determining the measure of progress that consistently depicts our satisfaction of performance obligations within each of our revenue streams across similar arrangements requires judgment.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Licensing revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occasionally enter into arrangements with customers that include licensing of functional intellectual property, including drug formulae, or other intangible property (&#8220;out-licensing&#8221;). We do not have any material license arrangement that contains more than one performance obligation. Our out-licensing generally entitles us to nonrefundable, up-front fees or royalties. Nonrefundable, up-front license fees are recognized as revenue when the licensed property is made available for the customer&#8217;s use and benefit, provided there is no unsatisfied performance obligation included in the arrangement. Royalty payments from such arrangements are recognized when subsequent sale or usage of an item subject to the royalty occurs and the performance obligation to which royalty relates is satisfied.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Intangibles - Goodwill and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. We perform an impairment evaluation of goodwill annually during the fourth quarter of our fiscal year or when circumstances otherwise indicate an evaluation should be performed. The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and economic and market conditions. In fiscal 2020, we proceeded immediately to the quantitative assessment, but in fiscal 2019 and 2021 we began with the qualitative assessment. Accordingly, no sensitivity analysis was performed for fiscal 2021. The evaluations performed in fiscal 2019, 2020 and 2021 resulted in no impairment charge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Notes 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Intangibles, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements. </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series A Preferred Stock Dividend Adjustment Feature</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Series A Preferred Stock include a dividend adjustment feature to provide the holders with certain protections against a decline in the trading price of our Common Stock. Because this adjustment feature depends in part on the value of external metrics at future dates, over which we have no control, this feature is accounted for separately from the rest of the Series A Preferred Stock as a derivative instrument, which is measured at fair value, as of the valuation date, using a combination of (i) a Monte Carlo simulation and (ii) a binomial lattice model, which incorporates the terms and conditions of the Series A Preferred Stock and is based on changes in the market prices of shares of our Common Stock over successive periods. Key assumptions used in both models include the current market price of one share of the Common Stock and its historical and expected volatility, risk-neutral interest rates, and the remaining term of the adjustment feature. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the estimated fair value of the derivative liability is highly sensitive to changes in the unobservable inputs, such as the expected volatility and our specific credit spread</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognize the derivative as either an asset or liability in the consolidated balance </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sheets at its fair value and revalue it as of the end of each quarterly reporting period; changes in the fair value are recognized in the consolidated statements of operations.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we account for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and the corresponding financial reporting bases of our assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates in the respective jurisdictions in which we operate. Deferred taxes are not provided on the undistributed earnings of subsidiaries outside of the U.S. when it is expected that these earnings will be permanently reinvested. In fiscal 2018, we recorded a provision for U.S. income taxes and foreign withholding taxes in relation to expected repatriations as a result of the 2017 U.S. Tax Cuts and Jobs Act (the &#8221;2017 Tax Act&#8221;), but we have not made any provision for U.S. income taxes on the remaining undistributed earnings of foreign subsidiaries as those earnings are considered permanently reinvested in the operations of those foreign subsidiaries in post fiscal 2018 years.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Tax Act imposed taxes on so-called &#8220;global intangible low-taxed income&#8221; (&#8220;GILTI&#8221;) earned by certain foreign subsidiaries of a U.S. company. In accordance with ASC 740, we made an accounting policy election to treat taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of deferred tax assets by considering all available evidence, both positive and negative, in assessing the need for a valuation allowance for deferred tax assets. We evaluate four possible sources of taxable income when assessing the realization of deferred tax assets:&#160;</span></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">carrybacks of existing NOLs (if and to the extent permitted by tax law);</span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future reversals of existing taxable temporary differences;&#160;</span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">tax planning strategies; and</span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future taxable income exclusive of reversing temporary differences and carryforwards.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the need to maintain a valuation allowance on deferred tax assets based on management&#8217;s assessment of whether it is more likely than not that we would realize those deferred tax assets as a result of future reversals of existing taxable temporary differences and the ability to generate sufficient taxable income within the carryforward period available under the applicable tax law. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits are generated when there are differences between tax positions taken in a tax return and amounts recognized in the Consolidated Financial Statements. Tax benefits are recognized in the Consolidated Financial Statements when it is more likely than not that a tax position will be sustained upon examination. To the extent we prevail in matters for which liabilities have been established or are required to pay amounts in excess of our liabilities, our effective income tax rate in a given period could be materially affected. An unfavorable income tax settlement may require the use of cash and result in an increase in our effective income tax rate in the year it is resolved. A favorable income tax settlement would be recognized as a reduction in the effective income tax rate in the year of resolution.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting for income taxes involves the application of complex tax regulations in the U.S. and in each of the non-U.S. jurisdictions in which we operate, particularly European tax jurisdictions. The determination of income subject to taxation in each tax-paying jurisdiction requires us to review reported book income and the events occurring during the year in each jurisdiction in which we operate. In addition, the application of deferred tax assets and liabilities will have an effect on the tax expense in each jurisdiction. For those entities engaging in transactions with affiliates, we apply transfer-pricing guidelines relevant in many jurisdictions in which we operate and make certain informed and reasonable assumptions and estimates about the relative value of contributions by affiliates when assessing the allocation of income and deductions between consolidated entities in different jurisdictions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates and assumptions used in these allocations can result in uncertainty in the measured tax benefit. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_106"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting our Performance </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluctuations in Operating Results </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our annual financial reporting periods end on June&#160;30. Our revenue and net earnings are generally higher in the third and fourth quarters of each fiscal year, with our first fiscal quarter typically generating our lowest revenue of any quarter, and our last fiscal quarter typically generating our highest revenue. These fluctuations are primarily the result of the timing of our, and our customers&#8217;, annual operational maintenance periods at locations in Europe and the U.S., the seasonality associated with pharmaceutical and biotechnology budgetary spending decisions, clinical trial and research and development schedules, the </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">timing of new product launches and length of time needed to obtain full market penetration, and, to a lesser extent, the time of the year some of our customers&#8217; products are in higher demand. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition and Related Integration Efforts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth and profitability are affected by the acquisitions we complete and the speed at which we integrate those acquisitions into our existing operating platforms. In fiscal 2019, we completed acquisitions of an early-phase development site in the U.K. and a gene therapy business in the U.S., which have been integrated into our Oral and Specialty Delivery and Biologics segments, respectively. In fiscal 2020, we completed the acquisition of additional gene and cell therapy assets in the U.S. and Belgium, which have been integrated into our Biologics segment. We also completed the acquisition of the Anagni facility in Italy, which has been integrated into our Oral and Specialty Delivery and Biologics segments. In fiscal 2021, we expanded the capacity and capabilities of our Biologics segment through five acquisitions.  First, in September 2020, we purchased a facility in Bloomington, Indiana that was still undergoing qualification at the time of acquisition and is intended to support development and early-phase clinical fill and finish activities. We also completed four additional acquisitions in Gosselies, Belgium: (i) the November 2020 purchase of Skeletal Cell Therapy Support SA (&#8220;Skeletal&#8221;), including its cell therapy manufacturing facility; (ii) the April 2021 purchase of Hepatic Cell Therapy Support SA (&#8220;Hepatic&#8221;), which also included a cell therapy manufacturing facility co-located with Skeletal in a building owned by Soci&#233;t&#233; d&#8217;infrastructures, de services et d&#8217;&#233;nergies SA (&#8220;SISE&#8221;); (iii) the June 2021 purchase of SISE, the owner of the building housing Skeletal and Hepatic's facilities; and (iv) the February 2021 purchase of Delphi. In February 2021, we also acquired a dry powder inhaler and spray dry manufacturing business from Acorda Therapeutics, Inc. (&#8220;Acorda&#8221;), which is included in our Oral and Specialty Delivery segment.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Rates </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating network is global, and, as a result, we have substantial revenues and operating expenses that are denominated in currencies other than the U.S. dollar, the currency in which we report our financial results, and are therefore influenced by changes in currency exchange rates. In fiscal 2021, approximately 38% of our revenue was generated from our operations outside the U.S. Significant foreign currencies for our operations include the British pound, European euro, Brazilian real, Argentine peso, Japanese yen, and the Canadian dollar. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_109"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends Affecting Our Business </span></div><div style="margin-top:9pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in nearly every sector of the global pharmaceutical and biotechnology industry, which has been estimated to generate more than $1 trillion in annual revenue, including, but not limited to, the prescription drug and biologic sectors as well as consumer health, which includes the over-the-counter and vitamins and nutritional supplement sectors. Innovative pharmaceuticals, and biologics in particular, continue to play a critical role in the global market, while the share of revenue due to generic drugs and biosimilars is increasing in both developed and developing markets. Sustained developed market demand and rapid growth in emerging economies is driving consumer health product growth. Payors, both public and private, have sought to limit the economic impact of pharmaceutical and biologics product demand through greater use of generic and biosimilar drugs, access and spending controls, and health technology assessment techniques, favoring products that deliver truly differentiated outcomes. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Molecule Development and R&amp;D Sourcing </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued strengthening in early-stage development pipelines for drugs and biologics, compounded by increasing clinical trial breadth and complexity, support our belief in the attractive growth prospects for development solutions.&#160;Large companies are in many cases reconfiguring their R&amp;D resources, increasingly involving the use of strategic partners for important outsourced functions and new treatment modalities.&#160;Additionally, an increasing portion of compounds in development are from companies that do not have a full research and development infrastructure, and thus are more likely to need strategic development solutions partners. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demographics </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aging population demographics in developed countries, combined with the global COVID-19 pandemic and health care reforms in many global markets that are expanding access to treatments to a greater proportion of the global population, will continue to drive increases in demand for pharmaceuticals, biologics, and consumer health products.&#160;Increasing economic affluence in developing regions will further increase demand for healthcare treatments, and we are taking active steps to allow us to participate effectively in these growth regions and product categories. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we believe the market access and payor pressures our customers face, global supply chain complexity, and the increasing demand for improved and new modality treatments will continue to escalate the need for advanced formulation and manufacturing, product differentiation, improved outcomes, and treatment cost reduction, all of which can often be addressed using our advanced delivery technologies. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_112"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Metrics </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in this section, management uses various financial metrics, including certain metrics that are not based on concepts defined in U.S. GAAP, to measure and assess the performance of our business, to make critical business decisions, and to assess our compliance with certain financial obligations. We therefore believe that presentation of certain of these non-GAAP metrics in this Annual Report will aid investors in understanding our business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA from operations </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures operating performance based on consolidated earnings from operations before interest expense, expense (benefit) for income taxes and depreciation and amortization, adjusted for the income attributable to non-controlling interests (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA from operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). EBITDA from operations is not defined under U.S. GAAP, is not a measure of operating income, operating performance, or liquidity presented in accordance with U.S. GAAP, and is subject to important limitations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the presentation of EBITDA from operations enhances an investor&#8217;s understanding of our financial performance. We believe this measure is a useful financial metric to assess our operating performance across periods and use this measure for business planning purposes. In addition, given the significant investments that we have made in the past in property, plant and equipment, depreciation and amortization expenses represent a meaningful portion of our cost structure. We believe that disclosing EBITDA from operations will provide investors with a useful tool for assessing the comparability between periods of our ability to generate cash from operations sufficient to pay taxes, to service debt, and to undertake capital expenditures without consideration of non-cash depreciation and amortization expense. We present EBITDA from operations in order to provide supplemental information that we consider relevant for the readers of the Consolidated Financial Statements, and such information is not meant to replace or supersede U.S. GAAP measures. Our definition of EBITDA from operations may not be the same as similarly titled measures used by other companies. The most directly comparable measure to EBITDA from operations defined under U.S. GAAP is net earnings. Included in this Management&#8217;s Discussion and Analysis is a reconciliation of net earnings to EBITDA from operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we evaluate the performance of our segments based on segment earnings before non-controlling interest, other (income) expense, impairments, restructuring costs, interest expense, income tax expense (benefit), and depreciation and amortization (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement and in the Indentures, the ability of Operating Company to engage in certain activities, such as incurring certain additional indebtedness, making certain investments and paying certain dividends, is tied to ratios based on Adjusted EBITDA (which is defined as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Credit Agreement and &#8220;EBITDA&#8221; in the Indentures).  Adjusted EBITDA is a covenant compliance measure in our Credit Agreement and Indentures, particularly those covenants governing debt incurrence and restricted payments. Adjusted EBITDA is based on the definitions in the Credit Agreement, is not defined under U.S. GAAP, is not a measure of operating income, operating performance or liquidity presented in accordance with U.S. GAAP, and is subject to important limitations. Because not all companies use identical calculations, our presentation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we use Adjusted EBITDA as a performance metric that guides management in its operation of and planning for the future of the business and drives certain management compensation programs. Management believes that Adjusted EBITDA provides a useful measure of our operating performance from period to period by excluding certain items that are not representative of our core business, including interest expense and non-cash charges like depreciation and amortization.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure under U.S. GAAP most directly comparable to Adjusted EBITDA is net earnings. In calculating Adjusted EBITDA, we add back certain non-cash, non-recurring and other items that are deducted when calculating EBITDA from operations and net earnings, consistent with the requirements of the Credit Agreement. Adjusted EBITDA, among other things:</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">does not include non-cash stock-based employee compensation expense and certain other non-cash charges;</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">does not include cash and non-cash restructuring, severance and relocation costs incurred to realize future cost savings and enhance operations;</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">adds back any non-controlling interest expense, which represents minority investors&#8217; ownership of non-wholly owned consolidated subsidiaries and is, therefore, not available; and</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">includes estimated cost savings that have not yet been fully reflected in our results.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted Net Income and Adjusted Net Income per Share</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted Net Income and Adjusted Net Income per share (which we sometimes refer to as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EPS</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as performance metrics. Adjusted Net Income is not defined under U.S. GAAP, is not a measure of operating income, operating performance, or liquidity presented in accordance with U.S. GAAP, and is subject to important limitations. We believe that providing information concerning Adjusted Net Income and Adjusted Net Income per share enhances an investor&#8217;s understanding of our financial performance. We believe that these measures are useful financial metrics to assess our operating performance from period to period by excluding certain items that we believe are not representative of our core business, and we use these measures for business planning and executive compensation purposes. We define Adjusted Net Income as net earnings adjusted for (1) earnings or loss from discontinued operations, net of tax, (2) amortization attributable to purchase accounting, and (3) income or loss from non-controlling interest in majority-owned operations. We also make adjustments for other cash and non-cash items (as shown above, in &#8220;&#8212;Adjusted EBITDA&#8221;), partially offset by our estimate of the tax effects as a result of such cash and non-cash items. Our definition of Adjusted Net Income may not be the same as similarly titled measures used by other companies. Adjusted Net Income per share is computed by dividing Adjusted Net Income by the weighted average diluted shares outstanding.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Constant Currency </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a constant currency basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to prior periods. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We use results on a constant currency basis as one measure to evaluate our performance. In this Annual Report, we calculate constant currency by calculating current-year results using prior-year foreign currency exchange rates. We generally refer to such amounts calculated on a constant currency basis as excluding the impact of foreign exchange. These results should be considered in addition to, not as a substitute for, results reported in accordance with U.S. GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with U.S. GAAP. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_115"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Two-Year Key Financial Performance Metrics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discussion of the year-over-year changes for the fiscal year ended June 30, 2020 compared to the fiscal year ended June 30, 2019 and the results of operations and cash flows for the fiscal year ended June 30, 2019, is included in Item 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Result of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the SEC on August 31, 2020, and is incorporated herein by reference.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables summarize our results in fiscal 2021 and 2020 with respect to several financial metrics we use to measure performance. Refer to the discussions below regarding performance and the use of key financial metrics and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;&#8212;N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on-GAAP Metrics</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Use of Constant Currency&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> concerning the measurement of revenue at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">constant currency.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><img src="ctlt-20210630_g3.jpg" alt="ctlt-20210630_g3.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:332px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><img src="ctlt-20210630_g4.jpg" alt="ctlt-20210630_g4.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:332px"/></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended June&#160;30, 2021 compared to the Fiscal Year Ended June&#160;30, 2020</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results for the fiscal year ended June&#160;30, 2021 compared to the fiscal year ended June&#160;30, 2020 were as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FX Impact</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency <br/>Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change&#160;$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change&#160;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.921%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Revenue</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="8" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency change</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation impact on reporting</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="8" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total % change</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="8" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue increased by $815 million, or 26%, excluding the impact of foreign exchange, compared to the fiscal year ended June 30, 2020. Net revenue increased 3% as a result of acquisitions, which was partially offset by a 2% decrease in net revenue due to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sale of Catalent USA Woodstock, Inc. (the &#8220;Blow-Fill-Seal Business&#8221;) in March 2021. Among other acquisitions, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we acquired Skeletal in November 2020, and Delphi and Acorda in February 2021. In addition, we divested a facility in Australia in October 2019. Organic net revenue increased 25% on a constant-currency basis, and was primarily driven by robust demand across all our Biologics offerings, in particular demand for our drug product and drug substance offerings for COVID-19-related programs, offset in part by the loss of volume from the voluntary recall of a previously launched product in the respiratory specialty platform in our Oral and Specialty Delivery segment and demand decreases attributable to the COVID-19 pandemic that impacted Softgel and Oral Technologies net revenue.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Margin</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin increased by $336 million, or 34%, in fiscal 2021 compared to fiscal 2020, excluding the impact of foreign exchange, primarily as a result of the strong margin profile for all Biologics segment offerings, including demand across our drug product and drug substance offerings for COVID-19 related programs. Growth was offset in part by the loss in volume from the voluntary recall of a previously launched product in the respiratory specialty platform in our Oral and Specialty Delivery segment and decreased demand for our prescription and consumer health products in our Softgel and Oral Technologies segment. On a constant-currency basis, gross margin, as a percentage of net revenue, increased 200 basis points to 34% in the fiscal year ended June 30, 2021, compared to 32% in the prior year, primarily due to the higher margin profile associated with our Biologics segment.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General, and Administrative Expense</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expense increased by $102 million, or 17%, in fiscal 2021 compared to fiscal 2020, excluding the impact of foreign exchange, driven by $65 million of employee-related cost primarily incurred for wages and bonuses, a $15 million increase in cost for professional and consulting services, and additional selling, general and administrative expenses from acquired companies of $13 million, including $2 million of incremental depreciation and amortization expense and $3 million related to the cost of various transitional services. These increases were partially offset by $12 million in reduced costs associated with health and welfare benefits and $9 million associated with travel and entertainment expenses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-over-year increase in selling, general, and administrative expenses was also due to a $32 million increase in information technology spend associated with headcount increases, additional cyber security initiatives, insurance premium increases, certain market research initiatives, and COVID-19-related spend for personal protective equipment and test kits for our employees.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating Expense</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense for the fiscal years ended June&#160;30, 2021 and 2020 was $19 million and $11 million, respectively. The year-over-year increase was attributable to an increase in impairment charges and an increase in restructuring costs primarily associated with our plan to reduce costs and optimize our infrastructure in Europe by closing our Clinical Supply Services facility in Bolton, U.K.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense, net</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, of $110 million in fiscal 2021 decreased by $16 million, or 13%, compared to fiscal 2020, driven by savings from repayment of our formerly outstanding dollar-denominated term loans, euro-denominated term loans, euro-denominated 4.75% Senior Notes due 2024 (the &#8220;2024 Notes&#8221;), and U.S. dollar-denominated 4.875% Senior Notes due 2026 (the &#8220;2026 Notes&#8221;), partially offset by interest expenses on the 2028 Notes, the new tranche of dollar-denominated term loans, and the 2029 Notes. The savings also includes $6 million of additional capitalized interest costs for the fiscal year ended June 30, 2021 compared to the prior fiscal year due to increased capital expenditures.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information concerning our debt and financing arrangements, including the changing mix of debt and equity in our capital structure, see &#8220;&#8212;Liquidity and Capital Resources&#8212;Debt and Financing Arrangements&#8221; and Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Obligations and Short-Term Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other expense, net of $3 million for fiscal 2021 was primarily driven by an $11 million premium on early redemption of the 2026 Notes, a write-off of $4 million of previously capitalized financing charges related to our repayment of term loans and our redeemed 2026 Notes, $3 million of financing charges related to our outstanding term loans and a net foreign currency translation loss of $5 million.  Those losses were partially offset by a gain of $17 million related to the fair value of the derivative liability associated with the Series A Preferred Stock. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net for fiscal 2020 of $8 million was primarily driven by financing charges of $16 million. The financing charges included a $6 million write-off of previously capitalized financing charges related to our repaid euro-denominated term loan under our senior secured credit facilities and redeemed 2024 Notes, and a $10 million premium on early redemption of the 2024 Notes. The loss was partially offset by a foreign currency gain of $3 million and a derivative gain of $3 million related to the change in the fair value of the derivative liability arising from the dividend adjustment mechanism of our Series A Preferred Stock.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes for the fiscal year ended June 30, 2021 was $130 million relative to earnings before income taxes of $715 million. Our provision for income taxes for the fiscal year ended June 30, 2020 was $39 million relative to earnings before income taxes of $260 million. The increased income tax provision for the fiscal year ended June 30, 2021 over the prior-year was largely the result of an increase in pretax income and a $56 million income tax charge on the divestiture of the Blow-Fill-Seal Business. This increase was partially offset by a $47 million income tax benefit for U.S. foreign tax credits resulting from an amendment to a prior-year return and certain equity compensation deductions. The provision for income taxes was also impacted by the geographic distribution of our pretax income, the tax impact of permanent differences, restructuring, special items, and other discrete tax items that may have unique tax implications depending on the nature of the item.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Review</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below charts depict the percentage of net revenue from each of our four reporting segments for the previous two years. Refer below for discussions regarding the segments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net revenue and EBITDA performance and to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP Metrics</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a discussion of our use of Segment EBITDA, a measure that is not defined under U.S. GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:center;text-indent:24pt"><img src="ctlt-20210630_g5.jpg" alt="ctlt-20210630_g5.jpg" style="height:194px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:9pt;text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results on a segment basis for the fiscal year ended June 30, 2021 compared to the fiscal year ended June 30, 2020 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:45.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FX Impact</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency <br/>Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change&#160;$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change&#160;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inter-segment revenue elimination </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unallocated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combined totals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA from operations </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;padding-left:49.5pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)  Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate-directed costs, and other costs that are not allocated to the segments as follows:</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and gain (loss) on sale of assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on sale of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-allocated corporate costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unallocated costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)     Restructuring and other special items during the fiscal year ended June 30, 2021 include (i) transaction costs for the sale of our Blow-Fill-Seal Business, (ii) transaction and integration costs associated with the acquisition of our facility in Anagni, Italy and the Acorda, Masthercell Global Inc. (&#8220;MaSTherCell&#8221;), Delphi, Hepatic, Skeletal and SISE transactions, and (iii) restructuring costs associated with the closure of our Clinical Supply Services facility in Bolton, U.K. Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Anagni facility, our cell and gene therapy acquisitions, the divestiture of a facility in Australia, and other restructuring initiatives across our network of sites.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)    For the fiscal year ended June 30, 2021, gain on sale of subsidiary is due to the divestiture of our Blow-Fill-Seal Business, which was part of our Oral and Specialty Delivery segment. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is due to the divestiture of the Australian facility that was part of the Softgel and Oral Technologies segment.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of financing charges and foreign currency translation adjustments recorded within Other Expense, net in our Consolidated Financial Statements.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provided below is a reconciliation of net earnings to EBITDA from operations:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biologics segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment EBITDA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency change</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation impact on reporting</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total % change</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue in our Biologics segment increased by $876 million, or 86%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange.  The increase was driven across all segment offerings by robust end-market demand for our global drug product, drug substance, and cell and gene therapy offerings, primarily related to demand for COVID-19-related programs.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biologics Segment EBITDA increased by $360 million, or 151%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. The increase was driven across all segment offerings by robust end-market demand for our global drug product, drug substance, and cell and gene therapy offerings, primarily related to demand for COVID-19-related programs.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several acquisitions contributed to the Biologics inorganic growth in fiscal 2021. Our Anagni, Italy facility, part of which operates within our Biologics segment, and our MaSTherCell acquisition together increased net revenue and Segment EBITDA on an inorganic basis by 6% and 3%, respectively, in the fiscal year ended June 30, 2021, compared to the prior year.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Softgel and Oral Technologies segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment EBITDA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency change</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation impact on reporting</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total % change</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue in our Softgel and Oral Technologies segment decreased by $77 million, or 7%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. The decrease primarily relates to reduced end-market demand for prescription products within North America and Europe, as well as lower demand in consumer health products, particularly in cough, cold, and over-the-counter pain relief products attributable to the effects of the COVID-19 pandemic. The net revenue decrease was partially offset by strong development revenue growth.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Softgel and Oral Technologies Segment EBITDA decreased by $26 million, or 10%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. The decrease, similar to that of net revenue, was primarily driven by a decrease in demand in both the prescription and consumer health portfolio of products, offset in part by the margin generated from strong development revenue growth.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oral and Specialty Delivery segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment EBITDA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation impact on reporting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total % Change</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue in our Oral and Specialty Delivery segment decreased by $11 million, or 2%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. Excluding the effect of acquisitions and divestitures, the loss of volume resulting from the voluntary recall of a previously launched product in our respiratory specialty platform and decreased demand for other non-Zydis orally delivered commercial products were partially offset by increased demand for the segment&#8217;s orally delivered Zydis commercial products and early-phase development programs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oral and Specialty Delivery Segment EBITDA decreased by $50 million, or 25%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. Segment EBITDA without acquisitions and divestitures decreased 24%, primarily driven by the loss of volume and voluntary recall impact of a previously launched product in our respiratory specialty platform, inclusive of charges of $32 million in the aggregate associated with the recall. Increased demand for the segment&#8217;s orally delivered Zydis commercial products and favorable manufacturing efficiencies within our respiratory specialty platform partially offset the decrease.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Anagni and Acorda transactions increased net revenue and Segment EBITDA on an inorganic, constant-currency basis by 7% and 7%, respectively, in the fiscal year ended June 30, 2021 compared to the prior year. We divested the Blow-Fill-Seal Business in March 2021, which decreased net revenue and Segment EBITDA on an inorganic, constant-currency basis by 6% and 8%, respectively, in the fiscal year ended June 30, 2021 compared to the prior year.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Supply Services segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Segment EBITDA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency change</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation impact on reporting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total % Change</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue in our Clinical Supply Services segment increased by $35 million, or 10%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. The increase was driven by strong demand in our manufacturing and packaging and storage and distribution offerings in North America.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Supply Services Segment EBITDA increased by $12 million, or 13%, compared to the fiscal year ended June 30, 2020, excluding the impact of foreign exchange. The increase was driven primarily by strong global demand in our manufacturing and packaging and storage and distribution offerings.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_118"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and use of Cash</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal source of liquidity has been cash flow generated from operations and the net proceeds of capital market activities. The principal uses of cash are to fund operating and capital expenditures, business or asset acquisitions, interest payments on debt, the payment of deferred purchase consideration from the Catalent Indiana acquisition, the payment of the quarterly dividend on the Series A Preferred Stock, and any mandatory or discretionary principal payment on our debt. At the current stated value of the Series A Preferred Stock outstanding as of June&#160;30, 2021, the aggregate amount of each regular quarterly dividend, if paid in cash, is $5 million. As of June&#160;30, 2021, and following the February 2021 execution of Amendment No. 5 (the &#8220;Fifth Amendment&#8221;) to the Credit Agreement, we had available a $725 million Revolving Credit Facility that matures in May 2024, the capacity of which is reduced by the amount of all outstanding letters of credit issued under the senior secured credit facilities and those short-term borrowings referred to as swing-line borrowings. At June 30, 2021, we had $6 million of outstanding letters of credit and no outstanding borrowing under our Revolving Credit Facility.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August 29, 2021, we entered into an agreement to acquire Bettera Holdings, LLC ("Bettera") for $1.00 billion. Bettera is a manufacturer of nutraceuticals specializing in gummy, soft chew, and lozenge delivery systems. The transaction is expected to close before December 31, 2021 and we plan to fund this all-cash acquisition through a combination of additional borrowings under our existing senior secured credit facilities, cash on hand and depending on market conditions, new debt financing. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We nonetheless believe that our cash on hand, cash from operations, and available borrowings under our Revolving Credit Facility will be adequate to meet our future liquidity needs for at least the next twelve months, including with respect to payment of the remaining $50 million installment on the Catalent Indiana deferred purchase consideration, our quarterly regular dividend on the Series A Preferred Stock, if paid in cash, and the amounts expected to become due with respect to our pending capital projects. We have no significant maturity under any of our bank or note debt until the July 2027 maturity of our 2027 Notes.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year Ended June&#160;30, 2021 Compared to the Fiscal Year Ended June&#160;30, 2020 </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our consolidated statements of cash flows for the fiscal year ended June&#160;30, 2021 compared with the fiscal year ended June&#160;30, 2020:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change $&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended June&#160;30, 2021, cash provided by operating activities was $433 million, a decrease of $7 million compared to $440 million for the prior year. Cash flow provided by operating activities for the fiscal year ended June 30, 2021 increased primarily due to an increase in operating earnings, which increased from $394 million in fiscal 2020 to $828 million in fiscal 2021. The increase in cash proceeds from higher operating earnings was partially offset by an unfavorable working capital impact, which included an unfavorable impact from inventory due to an increase of materials on-hand to assure adequate supply during the COVID-19 pandemic, an increase in in-process inventory, and unfavorable timing for the collection of trade accounts receivable.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended June&#160;30, 2021, cash used in investing activities was $649 million, compared to $827 million during fiscal 2020.  The decrease in cash used in investing activities was attributable to a $266 million increase in proceeds from the sale of subsidiaries and a $232 million decrease in payments for acquisitions, which were partially offset by a $206 million increase in cash used in purchases of property, plant, and equipment.  In fiscal 2021, we received $287 million in net proceeds from the divestiture of our Blow-Fill-Seal Business. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we paid $147 million of cash for the Skeletal, Delphi, and Acorda acquisitions. In fiscal 2020, we paid $379 million of cash for the MaSTherCell and Anagni acquisitions, net of cash acquired. </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended June&#160;30, 2021, cash provided by financing activities was $142 million, which decreased $860 million compared to cash provided by financing activities of $1.00 billion during the fiscal year ended June&#160;30, 2020. The decrease in cash provided by financing activities was primarily driven by a $964 million decrease in net proceeds from equity offerings, which was partially offset by a $38 million increase in cash received from the exercise of stock options compared to the prior year. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_124"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Financing Arrangements</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities and Fifth Amendment to the Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we completed the Fifth Amendment to the Credit Agreement. Pursuant to the Fifth Amendment, we refinanced the existing $933 million aggregate principal amount of U.S. dollar-denominated term loans (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term B-2 Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) with the proceeds of an equivalent amount of new U.S. dollar-denominated term loans (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term B-3 Loans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), incurred an additional $67 million aggregate principal amount of Term B-3 Loans, and obtained an additional $175 million of revolving credit commitments (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental Revolving Credit Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the Revolving Credit Facility. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term B-3 Loans constitute a new class of term loans under the Credit Agreement, with an interest rate of one-month LIBOR (subject to a floor of 0.50%) plus 2.00% per annum, a maturity date of February 2028, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly amortization of principal equal to 0.25%, with payments on the last business day of March, June, September, and December. The proceeds of the Term B-3 Loans, after payment of the offering fees and expenses, were used to repay in full the existing Term B-2 Loans under the Credit Agreement, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incremental Revolving Credit Commitments constitute revolving credit commitments under the Revolving Credit Facility.  The applicable rate for all revolving credit commitments under the Revolving Credit Facility is initially LIBOR plus 2.25% and such rate can additionally be reduced to LIBOR plus 2.00% in future periods based on a measure of Operating Company's total leverage ratio.  The maturity date for the Revolving Credit Facility is the earlier of (i) May 17, 2024 and (ii) the 91st day prior to the maturity of the Term B-3 Loans.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, pursuant to the Fifth Amendment, certain modifications were made to the Credit Agreement in order to, among other things, provide for determination of a benchmark replacement interest rate when LIBOR is no longer available.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of capacity under the Revolving Credit Facility is reduced by the aggregate value of all outstanding letters of credit under the Credit Agreement. As of June 30, 2021, we had $719 million of unutilized capacity under the Revolving Credit Facility due to $6 million of outstanding letters of credit.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">5.000% Senior Notes due 2027</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Operating Company completed a private offering of the 2027 Notes. The 2027 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2027 Notes were offered in the U.S. to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S. only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2027 Notes will mature on July 15, 2027 and bear interest at the rate of 5.000% per annum. Interest is payable semi-annually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The proceeds of the 2027 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under Operating Company's then-outstanding term loans under its senior secured credit facilities that would otherwise have matured in May 2024. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2.375% Euro-denominated Senior Notes due 2028</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, Operating Company completed a private offering of the 2028 Notes. The 2028 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2028 Notes were offered in the U.S. to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S. only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2028 Notes will mature on March 1, 2028 and bear interest at the rate of 2.375% per annum. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2020. The proceeds of the 2028 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under Operating Company's euro-denominated term loans under its senior secured credit facilities, that would otherwise have matured in May 2024, and repay in full the 2024 Notes, which would otherwise have matured in December 2024, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">3.125% Senior Notes due 202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">9</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Operating Company completed a private offering of the 2029 Notes. The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2029 Notes will mature on February 15, 2029 and bear interest at the rate of 3.125% per annum payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021. The proceeds of the 2029 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under the 2026 Notes, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Purchase Consideration</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the $950 million aggregate nominal purchase price for the Catalent Indiana </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $200 million was payable in four annual $50 million installments. We made installment payments in October 2018, 2019 and 2020. The balance of the deferred purchase consideration is due in October 2021, with the difference between the remaining nominal amount and the fair value balance recorded at date of acquisition treated as imputed interest.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains covenants that, among other things, restrict, subject to certain exceptions, Operating Company&#8217;s (and Operating Company&#8217;s restricted subsidiaries&#8217;) ability to incur additional indebtedness or issue certain preferred shares; create liens on assets; engage in mergers and consolidations; sell assets; pay dividends and distributions or repurchase capital stock; repay subordinated indebtedness; engage in certain transactions with affiliates; make investments, loans, or advances; make certain acquisitions; enter into sale and leaseback transactions; amend material agreements governing Operating Company&#8217;s subordinated indebtedness; and change Operating Company&#8217;s lines of business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains change-of-control provisions and certain customary affirmative covenants and events of default. The Revolving Credit Facility requires compliance with a net leverage covenant when there is a 30% or more draw outstanding at a period end. As of June&#160;30, 2021, Operating Company was in compliance with all material covenants under the Credit Agreement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, the Credit Agreement permits Operating Company and its restricted subsidiaries to incur certain additional indebtedness, including secured indebtedness. None of Operating Company&#8217;s non-U.S. subsidiaries nor its dormant Puerto Rico subsidiary is a guarantor of the loans.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement, Operating Company&#8217;s ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as &#8220;Consolidated EBITDA&#8221; in the Credit Agreement). Adjusted EBITDA is based on the definitions in the Credit Agreement, is not defined under U.S. GAAP, and is subject to important limitations. See &#8220;&#8212;Non-GAAP Metrics&#8221; for further details on Adjusted EBITDA.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As market conditions warrant, we may from time to time seek to purchase our outstanding debt in privately negotiated or open-market transactions, by tender offer or otherwise. Subject to any limitation contained in the Credit Agreement, any purchase made by us may be funded by the use of cash on hand or the incurrence of new secured or unsecured debt. The amount involved in any such purchase transaction, individually or in the aggregate, may be material. Any such purchase may involve a substantial amount of one particular class or series of debt, with the attendant reduction in the trading liquidity of such class or series. </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Senior Notes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indentures contain certain covenants that, among other things, limit the ability of Operating Company and its restricted subsidiaries to incur or guarantee more debt or issue certain preferred shares; pay dividends on, repurchase, or make distributions in respect of their capital stock or make other restricted payments; make certain investments; sell certain assets; create liens; consolidate, merge, sell; or otherwise dispose of all or substantially all of their assets; enter into certain transactions with their affiliates, and designate their subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of exceptions, limitations, and qualifications as set forth in the Indentures. The Indentures also contain customary events of default including, but not limited to, nonpayment, breach of covenants, and payment or acceleration defaults in certain other indebtedness of Operating Company or certain of its subsidiaries. Upon an event of default, either the holders of at least 30% in principal amount of each of the then-outstanding Senior Notes or the applicable Trustee under the Indentures, may declare the applicable Senior Notes immediately due and payable; or in certain circumstances, the applicable Senior Notes will automatically become immediately due and payable. As of June&#160;30, 2021, Operating Company was in compliance with all material covenants under the Indentures.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity in Foreign Subsidiaries </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and 2020, the amounts of cash and cash equivalents held by foreign subsidiaries were $351 million and $228 million, respectively, out of total consolidated cash and cash equivalents of $896 million and $953 million, respectively. These balances are dispersed across many international locations around the world.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_127"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA and Adjusted Net Income per Share</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below tables summarize our fiscal 2021 and 2020 results with respect to certain financial metrics we use to measure performance throughout the fiscal year. Refer to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP Metrics&#8221; for further details regarding Adjusted EBITDA and Adjusted net income per share.</span></div><div style="margin-top:9pt;text-align:center"><img src="ctlt-20210630_g6.jpg" alt="ctlt-20210630_g6.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:332px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between Adjusted EBITDA and net earnings, the most directly comparable measure under U.S. GAAP, which also shows the adjustments from EBITDA from operations, follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and (gain) loss on sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing-related expenses and other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, integration, and other special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gain) loss (included in other, net) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable (unfavorable) FX impact </span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA - constant currency</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)   Foreign exchange gain of $4 million for the fiscal year ended June&#160;30, 2021 includes: (a) $13 million of unrealized losses related to foreign trade receivables and payables, (b) $3 million of unrealized losses on the unhedged portion of our euro-denominated debt, and (c) $25 million of unrealized gains on inter-company loans. The foreign exchange adjustment was also affected by the exclusion of realized foreign currency exchange rate losses from the settlement of inter-company loans of $5 million. Inter-company loans exist between our subsidiaries and do not reflect the ongoing results of our trade operations. </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange loss of $1 million for the fiscal year ended June&#160;30, 2020 includes: (a) $5 million of unrealized losses related to foreign trade receivables and payables, (b) $6 million of unrealized gains on the unhedged portion of the euro-denominated debt, and (c) $5 million of unrealized losses on inter-company loans. The foreign exchange adjustment was also affected by the exclusion of realized foreign currency exchange rate gains from the </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlement of inter-company loans of $3 million. Inter-company loans exist between our subsidiaries and do not reflect the ongoing results of our trade operations.</span></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)     Primarily represents the gain recorded on the change in the estimated fair value of the derivative liability. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between Adjusted Net Income and net earnings, the most directly comparable measure under U.S. GAAP, follows. The table also provides a calculation of Adjusted Net Income per each basic share and each diluted share. </span></div><div style="margin-top:9pt;text-align:center;text-indent:24pt"><img src="ctlt-20210630_g7.jpg" alt="ctlt-20210630_g7.jpg" style="height:250px;margin-bottom:5pt;vertical-align:text-bottom;width:332px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and (gain) loss on sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing-related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition, integration, and other special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gain) loss (included in other, net) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated tax effect of adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete income tax benefit items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net income (ANI)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANI per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANI per share - basic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANI per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:48pt;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)   Represents the amortization attributable to purchase accounting for previously completed business combinations. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)   Foreign exchange gain of $4 million for the fiscal year ended June&#160;30, 2021 includes: (a) $13 million of unrealized losses related to foreign trade receivables and payables, (b) $3 million of unrealized losses on the unhedged portion of the euro-denominated debt, and (c) $25 million of unrealized gains on inter-company loans. The foreign exchange adjustment was also affected by the exclusion of realized foreign currency exchange rate losses from the settlement of inter-company loans of $5 million. Inter-company loans exist between our subsidiaries and do not reflect the ongoing results of our trade operations. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange loss of $1 million for the fiscal year ended June&#160;30, 2020 includes: (a) $5 million of unrealized losses related to foreign trade receivables and payables, (b) $6 million of unrealized gains on the unhedged portion of the euro-denominated debt, and (c) $5 million of unrealized losses on inter-company loans. The foreign exchange adjustment was also affected by the exclusion of realized foreign currency exchange rate gains from the settlement of inter-company loans of $3 million. Inter-company loans exist between our subsidiaries and do not reflect the ongoing results of our trade operations.  </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Primarily represents the gain recorded on the change in the estimated fair value of the derivative liability.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;We computed the tax effect of adjustments to Adjusted Net Income by applying the statutory tax rate in the relevant jurisdictions to the income or expense items that are adjusted in the period presented. If a valuation allowance exists, the rate applied is zero.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;Discrete period income tax expense (benefit) items are unusual or infrequently occurring items, primarily including: changes in judgment related to the realizability of deferred tax assets in future years, changes in measurement of a prior year tax position, deferred tax impact of changes in tax law, and purchase accounting.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;Represents Adjusted Net Income divided by the weighted average of Common Stock outstanding. For the fiscal year ended June 30, 2021, and 2020, the weighted average was 168 million and 150 million, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;Represents Adjusted Net Income divided by the weighted average sum of (a) the number of shares of Common Stock outstanding, plus (b) the number of shares of Common Stock that would be issued assuming exercise or vesting of all potentially dilutive instruments, plus (c) the number of shares of Common Stock equivalent to the shares of Series A Preferred Stock outstanding under the "if-converted" method. For the fiscal year ended June 30, 2021 and 2020, the weighted average was 180 million and 165 million, respectively.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_130"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk Management</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the debt used to finance our operations is exposed to interest-rate fluctuations. We may use various hedging strategies and derivative financial instruments to create an appropriate mix of fixed-and floating-rate assets and liabilities.  In February 2021, we replaced one interest-rate swap agreement with Bank of America N.A. with another, and each acts or acted as a hedge against the economic effect of a portion of the variable-interest obligation associated with our U.S dollar-denominated term loans under our senior secured credit facilities, so that the interest payable on that portion of the debt becomes fixed at a certain rate, thereby reducing the impact of future interest-rate changes on future interest expense. The applicable rate for the U.S. dollar-denominated term loan under the Credit Agreement was LIBOR (subject to a floor of 0.50%) plus 2.00% as of June 30, 2021; however, as a result of the interest-rate swap agreement, the floating portion of the applicable rate on $500 million of the term loan was effectively fixed at 0.9985% as of February 2021.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currency Risk Management</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to fluctuations in the euro-U.S. dollar exchange rate on our investments in our foreign operations in Europe. While we do not actively hedge against changes in foreign currency, we have mitigated the exposure of our investments in our European operations by denominating a portion of our debt in euros. At June&#160;30, 2021, we had $984 million of euro-denominated debt outstanding that qualifies as a hedge on a net investment in foreign operations. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Consolidated Financial Statements for further discussion of net investment hedge activity in the period. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may use forward currency exchange contracts to manage our exposure to the variability of cash flows primarily related to the foreign exchange rate changes of future foreign currency transaction costs. In addition, we may use foreign currency forward contracts to protect the value of existing foreign currency assets and liabilities. Currently, we do not use foreign currency exchange contracts. We expect to continue to evaluate hedging opportunities for foreign currency in the future.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_142"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to cash flow and earnings fluctuations as a result of certain market risks. These market risks primarily relate to changes in interest rates associated with our long-term debt obligations and foreign exchange rate changes. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically used interest-rate swaps to manage the economic effect of variable-rate interest obligations associated with our floating-rate term loans so that the interest payable on the term loans effectively becomes fixed at a certain rate, thereby reducing the impact of future interest-rate changes on our future interest expense.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we replaced one interest-rate swap agreement with Bank of America N.A. with another, and each acts or acted as a hedge against the economic effect of a portion of the variable-interest obligation associated with our term loans under our senior secured credit facilities, so that the interest payable on that portion of the debt becomes fixed at a certain rate, thereby reducing the impact of future interest-rate changes on future interest expense. The applicable rate for the term loan under our Credit Agreement was LIBOR (subject to a floor of 0.50%) plus 2.00% as of June 30, 2021; however, as a result of the interest-rate swap agreement, the floating portion of the applicable rate on $500 million of the term loan was effectively fixed at 0.9985% as of February 2021. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the nature of our global operations, we are exposed to cash flow and earnings fluctuations resulting from foreign exchange-rate variation. These exposures are transactional and translational in nature. Since we manufacture and sell our products globally, our foreign-currency risk is diversified. Principal drivers of this diversified foreign-exchange exposure include the European euro, British pound, Argentinean peso, and Brazilian real. Our transactional exposure arises from the purchase and sale of goods and services in currencies other than the functional currency of our operational units. We also have exposure related to the translation of financial statements of our foreign divisions into U.S. dollars, our functional currency. The financial statements of our operations outside the U.S. are measured using the local currency as the functional currency, except in Argentina, a hyper-inflationary economy, where our results are measured in U.S. dollars. Adjustments to translate the assets and liabilities of these foreign operations in U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Foreign-currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in other (income) expense, net. Such foreign currency transaction gains and losses include inter-company loans denominated in non-U.S. dollar currencies.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_145"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;8. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_148"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FINANCIAL STATEMENTS </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Statements as of June&#160;30, 2021 and 2020 and for the years ended June&#160;30, 2021, 2020 and 2019.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_151">Reports of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_151">65</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_157">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_157">68</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_163">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_163">69</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_166">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_166">70</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_169">Consolidated Statement of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_169">71</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_172">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_172">72</a></span></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_175">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idd9cf92bf6a34c78ac936b47262640d7_175">73</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_151"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Catalent, Inc. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Catalent, Inc. (the Company) as of June 30, 2021 and 2020, the related consolidated statements of operations, comprehensive income, changes in shareholders&#8217; equity and cash flows for each of the three years in the period ended June 30, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2021, in conformity with U.S. generally accepted accounting principles. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June 30, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated August 30, 2021 expressed an unqualified opinion thereon. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee of the Company&#8217;s Board of Directors and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Measurement of uncertain tax positions</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 11 to the consolidated financial statements, the Company recorded income tax expense related to US and non-US tax paying jurisdictions totaling $130 million for the year ended June 30, 2021 and a liability for unrecognized tax benefits totaling $5 million at June 30, 2021. The Company&#8217;s accounting for income taxes involves the application of complex tax regulations in each of the international tax paying jurisdictions in which it operates. The determination of income subject to income tax in each tax paying jurisdiction requires management to apply transfer pricing guidelines for certain intercompany transactions related to certain European countries and make assumptions and estimates about the value of transactions when allocating income and deductions between consolidated entities in different tax paying jurisdictions. The estimates and assumptions used in these allocations can result in uncertainty in the measured tax benefit. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the completeness and measurement of the liability for recognized tax benefits related to certain intercompany transactions was complex because the assumptions are based on the interpretation of tax laws and legal rulings in multiple tax paying jurisdictions and require significant judgment in determining whether a tax position&#8217;s technical merits are more-likely-than-not to be sustained and measuring the amount of tax benefit that qualifies for recognition.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We tested controls over the process to assess the technical merits of tax positions related to certain intercompany transactions, as well as management&#8217;s process to measure the benefit of those tax positions, including controls over the completeness and accuracy of the underlying data. For example, we tested controls over management&#8217;s review of the evaluation of matters identified by and discussed with various tax authorities.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audit procedures with respect to the calculation of the liability for unrecognized tax benefits involved an assessment of the technical merits of the Company&#8217;s tax positions performed with the assistance of tax subject matter professionals with knowledge of and experience with the application of international and local income tax laws by the relevant income tax authorities. These procedures also included, among others, evaluating third-party advice obtained by the Company and making inquiries of its external tax advisers. We also evaluated the Company&#8217;s significant assumptions and the completeness and accuracy of the data used to determine the amount of tax benefits recognized and tested the accuracy of such calculations. </span></div></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ Ernst&#160;&amp; Young LLP </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2007.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iselin, New Jersey </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;30, 2021 </span></div><div><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_154"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Catalent, Inc. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Catalent, Inc.'s internal control over financial reporting as of June 30, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Catalent, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of June 30, 2021, based on the COSO criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of June 30, 2021 and 2020, the related consolidated statements of  operations, comprehensive income, changes in shareholders&#8217; equity and cash flows for each of the three years in the period ended June 30, 2021, and the related notes and financial statement schedule listed in the Index at Item 15(a)(2) and our report dated August 30, 2021 expressed an unqualified opinion thereon.   </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst&#160;&amp; Young LLP </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iselin, New Jersey </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;30, 2021 </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_157"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in millions, except share and per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMtMS0xLTEtMA_5ed982bc-5912-4b44-9001-acbef8a2131f">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMtMy0xLTEtMA_3333815a-4c17-4cb5-b085-d104220bef96">953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net of allowance for credit losses of $12 and $9, respectively</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQtMS0xLTEtMA_8f73330f-a369-43c7-af8a-427e35453c6c">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQtMy0xLTEtMA_5e5c2875-8325-46f3-9ecb-26f4038995d3">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzUtMS0xLTEtMA_5b81d02d-4597-4dd9-b09d-3e5bfd932ae3">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzUtMy0xLTEtMA_8b254310-4ef7-451e-bf8b-b2f4e46a9fc1">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzYtMS0xLTEtMA_18beac91-5ff7-43d9-b525-5b7a6ff12dea">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzYtMy0xLTEtMA_29079678-896e-4d47-851c-edbbcfc06bdb">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMS0xLTEtNDUzNQ_e3cdb03a-e92c-42bb-aa05-d77a50caf443">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMy0xLTEtNDUzOA_a6785ca0-1a95-487d-a2f0-5bed69ee6511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMS0xLTEtMA_a9c9aea7-2c03-40b4-a1a7-e0a4d1e394db">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMy0xLTEtMA_0776b4d2-2429-4084-b107-89e035bfd813">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzgtMS0xLTEtMA_29801676-cee7-4248-9a79-a51d45e9e48f">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzgtMy0xLTEtMA_d717d579-e475-4615-9b43-5b74120de22d">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEwLTEtMS0xLTA_d7b50507-b0c0-443f-b000-0b3175c3e1ce">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEwLTMtMS0xLTA_fd1da2b6-f963-4547-8839-c9732292d7e0">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzExLTEtMS0xLTA_edee37d7-758f-473f-ba8e-42698e97311a">817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzExLTMtMS0xLTA_b279ece1-d9f7-4727-9a47-9ed8e07471fb">889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEyLTEtMS0xLTA_597077c0-ad80-4827-bb3f-a6306a947723">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEyLTMtMS0xLTA_bc157e23-2c18-46af-ac81-11e8e4f3eabb">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEzLTEtMS0xLTA_b8e2ec16-4f11-45f9-affe-b33d48bb170c">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEzLTMtMS0xLTA_535a0f67-b1c8-4386-9da1-123a5970c97b">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE0LTEtMS0xLTA_53a7d2c7-181e-40ef-a453-1af4a6de1999">9,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE0LTMtMS0xLTA_6bb44d0f-59f0-4aba-8c0f-3e6601035099">7,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other short-term borrowings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE4LTEtMS0xLTA_31056a10-44e4-48e1-aab4-0cab0956668e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE4LTMtMS0xLTA_027a4ea4-d00b-4fa6-8115-2e91c622f23d">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE5LTEtMS0xLTA_0ef3e99d-4695-4192-8ae8-e47881823752">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE5LTMtMS0xLTA_33317954-2b39-4ed5-8e32-6e18cd79d57a">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIwLTEtMS0xLTA_961197b8-8e33-4473-ba87-48c372695abf">736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIwLTMtMS0xLTA_aa279997-2535-410c-8c88-6d2bfd0f8f81">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIxLTEtMS0xLTA_79f7c03a-f7a5-4830-a910-39fdea9abe0d">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIxLTMtMS0xLTA_60a24cf4-db0f-4e4f-a6ca-6174e78d6103">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIyLTEtMS0xLTA_0ab89e8b-729f-43fc-b39b-5e1b759017af">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIyLTMtMS0xLTA_b0b15348-72b1-4ca5-bbec-85129903cd0c">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIzLTEtMS0xLTA_23fa5252-a207-4eb7-aead-6df469201032">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIzLTMtMS0xLTA_44c54e76-6182-4fdc-ab4a-a5d9705c738e">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI0LTEtMS0xLTA_f03c2da6-298b-4699-b07e-13a39715b0e4">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI0LTMtMS0xLTA_47922a0c-68db-4901-b017-19f7057c0a37">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI1LTEtMS0xLTA_042cc530-7367-491e-b420-f7a11cdfbe7a">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI1LTMtMS0xLTA_f2319193-8bd3-4dcc-929a-6d20fd74b6a1">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment and contingencies (see Note 17)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI2LTEtMS0xLTA_8464c523-788d-4d3a-bcb1-638bba9efc9f"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI2LTMtMS0xLTA_ece07847-6212-4953-a133-c1aa28e78d03"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI3LTEtMS0xLTA_1e0cd2fa-80fe-47ec-873d-80ba78bf585e">4,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI3LTMtMS0xLTA_5728eb59-4709-4ded-94f8-121b8c93ceba">4,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred stock, $0.01 par value; 1 million shares authorized at June 30, 2021 and 2020; 384,777 and 650,000 shares issued and outstanding at June 30, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI4LTEtMS0xLTA_17300261-5429-453f-9772-f12912e267e1">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI4LTMtMS0xLTA_6b5b83d3-2888-4025-8df7-bdaa0c8f9d19">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.01 par value; 1 billion shares authorized at June 30, 2021 and 2020; 170.5 million and 162.8 million shares issued and outstanding at June 30, 2021 and 2020, respectively</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMyLTEtMS0xLTA_f17a992e-8865-48d6-ac98-269cf919c308">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMyLTMtMS0xLTA_4a6f32fc-e16c-41f0-b0fb-ad4c73cc0e0b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.01 par value, other than redeemable preferred stock; 99 million shares authorized at June 30, 2021 and 2020; 0 shares issued and outstanding at June 30, 2021 and 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PreferredStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM0LTEtMS0xLTA_7faffefd-5776-42eb-81b8-32df6fa98f3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PreferredStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM0LTMtMS0xLTA_a2b04553-c689-4fc2-863f-ca17796411a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM1LTEtMS0xLTA_47defc1d-1185-4cad-888d-8e2beda4687f">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM1LTMtMS0xLTA_9194dcb4-5c5d-4423-87ad-ae24fda22073">3,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated earnings (deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM2LTEtMS0xLTA_7f0d448e-ec22-437d-9851-0ec9a2c7b69f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM2LTMtMS0xLTA_7361cf34-13c5-4bfc-b20d-e0a4056519d3">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM3LTEtMS0xLTA_24f88586-8e9a-45f5-8155-bb620550a190">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM3LTMtMS0xLTA_5e811735-98b8-40ed-a307-7a8b152ad9c7">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQwLTEtMS0xLTA_65a71657-273e-4316-ae2b-3301727559ec">3,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQwLTMtMS0xLTA_42312a10-3310-4a2f-b7ce-e5f86e78c840">2,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable preferred stock, and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQxLTEtMS0xLTA_bfeee518-15a1-4ab3-86ea-dc2c09bbdb13">9,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQxLTMtMS0xLTA_ffb81fcd-8e98-46a8-8ea7-1469eea067a6">7,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_163"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in millions, except per share data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItMS0xLTEtMA_d5d3238a-56db-4ac3-a483-480ba0e2c171">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItMy0xLTEtMA_416ff419-a8c8-488f-84f3-749310b3fbe2">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItNS0xLTEtMA_500d15d3-f69a-47d2-9374-e4a4fe205d32">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtMS0xLTEtMA_2649e456-6606-493c-95a0-0d74b7bce9ea">2,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtMy0xLTEtMA_2d9eaf1f-8ec7-4f86-9e2a-550933220ca8">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtNS0xLTEtMA_70129d09-8c2c-41c3-98d9-39fa833b8c15">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtMS0xLTEtMA_72952591-ef42-41a5-9732-cb21d6bc1b59">1,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtMy0xLTEtMA_debe294c-514d-40e6-b322-5b2a7f8b4a6a">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtNS0xLTEtMA_999e55cc-816d-469a-8f15-2fb20adaa067">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtMS0xLTEtMA_8dde2b59-1e92-4c55-ab97-34e0972b9521">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtMy0xLTEtMA_bf645687-3c09-4751-9bb6-deb42f2f69b9">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtNS0xLTEtMA_38a723c7-3b82-48e3-a19d-8c745b1261db">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtMS0xLTEtNjM1Nw_b5d5c604-3fa4-4435-a6af-d540efc4e28e">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtMy0xLTEtNjM1Nw_236f57b1-77b8-4c77-9b22-4ed933ea761b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtNS0xLTEtNjM1Nw_5caccbc2-611f-43ac-8caf-b7b2c9e05260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="3" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMS0xLTEtNjM0OQ_eccea6b2-0f64-4710-91a2-8e5504919854">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="3" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMy0xLTEtNjM1Mg_ab3dd5fb-506e-46e2-9305-7e7c7b5c6862">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="3" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktNS0xLTEtNjM1NQ_8ae125f1-18a3-41f7-a95c-8f54e695bc6b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMS0xLTEtMA_36b1142d-ca93-4a93-8b93-a7f0929564b0">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMy0xLTEtMA_a6c42716-2d6a-444f-b295-c716e0eab591">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktNS0xLTEtMA_bc346dfa-5fc3-4ac4-9165-e4950bddc6a8">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTEtMS0xLTA_e5c1071a-2867-4468-adb2-5ea0c6165c64">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTMtMS0xLTA_f54e5255-a00a-4115-a77e-e6fc8ae34164">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTUtMS0xLTA_0ff987ca-7822-4037-98b6-75e14d66511b">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTEtMS0xLTA_7c133a64-527c-43cf-9242-327fb5ce5c82">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTMtMS0xLTA_f02b63d8-463e-4f54-8226-52591ee7177d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTUtMS0xLTA_e72e6b7c-ad51-4e27-97c5-14b51f09e31b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTEtMS0xLTA_99424ffa-bec2-4f80-bb8f-4a1e53f2febc">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTMtMS0xLTA_dea11792-b311-44c4-be93-6cae32c00d63">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTUtMS0xLTA_ae26af82-b84b-4e61-8d03-171b2aea4d1b">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTEtMS0xLTA_8dc63e2e-1333-45dd-a0f4-5fea0d64b0c7">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTMtMS0xLTA_6969e942-2b9a-43e4-84e8-c8953f1af65b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTUtMS0xLTA_7d8d9ab4-9f87-44d6-84cb-e1ba96bc2226">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTEtMS0xLTA_20ad2511-c551-4035-98aa-d0cee59a178a">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTMtMS0xLTA_c4fd6278-5634-469a-88ce-74ab8e2c63bc">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTUtMS0xLTA_f8a71026-7863-49e8-90ed-27c988b7797a">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to preferred shareholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTEtMS0xLTA_e1272089-1562-47ee-abf7-1685e018db63">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTMtMS0xLTA_63a9305e-0e0f-448e-9c80-8db180bff8c1">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTUtMS0xLTA_ed77a160-8510-40ec-9f60-725ab5216d9e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTEtMS0xLTA_f2632dfa-9597-415a-870d-0a21977d3584">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTMtMS0xLTA_4c870e00-582d-4b7f-a801-43f42c872500">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTUtMS0xLTA_234f8d45-a2b9-4702-b159-30ab8611e2dc">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTEtMS0xLTA_96ea0cd2-22b7-41cd-87e9-3764e632c991">3.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTMtMS0xLTA_d1b51ef4-b6cb-4394-bab6-80432ac76835">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTUtMS0xLTA_6469aa4a-869a-40ad-b2d8-6b0271844618">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTEtMS0xLTA_a2b5ad29-bec7-4fd4-a77e-08c00431fa8a">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTMtMS0xLTA_4c40499b-cc6e-4ebe-a06f-96a311b86035">1.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTUtMS0xLTA_fe87e090-ec55-4048-8abe-3673a2be2c1c">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_166"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year ended&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItMS0xLTEtMA_1a79d6e3-63d7-4ec4-8b76-5a9a898091e6">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItMy0xLTEtMA_6c208770-78e3-4aaa-9c2e-471a3e243ba9">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItNS0xLTEtMA_407774af-3cc7-4734-a11e-412bcb077e1d">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMS0xLTEtMA_6f4fa381-2601-4af7-a55e-d115313a0324"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMS0xLTEtMA_d650da5b-cc2c-4d2d-9210-4c997afe3e90">67</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMy0xLTEtMA_5658a72b-25d0-4c3e-8d47-1a6577ac3888">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtNS0xLTEtMA_d3b28fb4-585e-4637-8372-1f65ca34a176">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMS0xLTEtMA_99685733-46fa-438f-af8c-bd67c25837a9"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMS0xLTEtMA_9ba26b85-41ea-47af-8a92-c59194f542df">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMy0xLTEtMA_dcf369e2-3ca5-4669-a130-82bbcf300679">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtNS0xLTEtMA_2068e312-676a-46a5-99ac-0f6a2fb2a40c">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_81b099d4-7acc-4808-92ea-72fada505513"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_8622dedf-b416-4972-98c0-dec8e34dccbd"><ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMy0xLTEtNTA0Mg_294094c2-e198-4ad1-b78d-8c3419594c20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtNS0xLTEtNTA0NA_cc1343ee-71fc-426a-8027-cc6245ccc37f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives and hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMS0xLTEtMA_2e3cd357-055e-4143-bc6e-b2278f860096"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMS0xLTEtMA_90cc32bc-ec3a-4ce0-a044-f1967fe33019">3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMy0xLTEtMA_517d9efd-6125-4672-a11c-a249e469ce1f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctNS0xLTEtMA_5bc30d7e-3c9e-4472-94b3-8df250a44438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktMS0xLTEtMA_c6db2771-aaa5-4f3e-9ccb-e0d12ee2b091">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktMy0xLTEtMA_6e93a492-71dc-4df6-bef5-e4315963c0e4">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktNS0xLTEtMA_a1e8dc24-f76c-415f-9bf9-15482ae733aa">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTEtMS0xLTA_67d2adf9-506e-4019-af67-23c65e0f795f">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTMtMS0xLTA_c4c0f2a6-bc5f-425d-8efb-5cb30fe08f9c">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTUtMS0xLTA_dbf08f0a-c9e5-4824-b43a-3b763d0b55c7">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_169"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statement of Changes in Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in millions, except share data in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.851%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Columns may not foot due to rounding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of Common Stock</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Earnings (Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Preferred Stock</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86567583f6c54f90bd46551acae65b63_I20180630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMS0xLTEtMA_6e80362e-de58-48f8-b9b1-332b692a7d46">133,424</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86567583f6c54f90bd46551acae65b63_I20180630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMy0xLTEtMA_d2ba10d4-7066-452a-a285-819ef9779132">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fcf069e257b4824a1c38afc5b1b50c6_I20180630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtNS0xLTEtMA_e1e7c6e3-5c9b-4638-ae3c-98cbbf0eeed0">2,283</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i211bd387923e4c8a8acbce07f918efab_I20180630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtNy0xLTEtMA_4b9716a7-d2c1-4146-af44-7f3d2bf0a040">872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7c291416f38415ea87b555881657be2_I20180630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtOS0xLTEtMA_a598c42c-ea53-4e62-842d-cf57e7d50a66">326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMTMtMS0xLTA_b376f2e2-be52-4d07-981d-876a06d09511">1,086</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMTUtMS0xLTExNzIz_81d29266-a63b-4115-bd75-647f9f1e92de">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting for ASC 606, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b17f319169040e68cd6152d58da61f4_D20180701-20190630" decimals="-5" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItNy0xLTEtNTExNg_c8512231-c1ed-4588-8411-3d4cd6a3556d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f0cf3a7646426da02b70234824e7c8_D20180701-20190630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMTMtMS0xLTUxMTg_01dec4d6-11b6-407c-9b17-a26bec43bfa6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering, sale of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMS0xLTEtMA_0e98429e-cd41-4f4e-a3f0-577801b0206d">11,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMy0xLTEtNTAwOA_e7d4ab31-67e7-48de-9057-b5801ba7d561">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItNS0xLTEtMA_a1bd1044-3c1f-4c4d-a5a4-88e93311a26f">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMTMtMS0xLTA_a020a447-4fe2-499a-8d39-6f2dcde01e2c">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuances related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMS0xLTEtMA_f3b27527-45c3-462d-a153-bf98d7f3d367">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMy0xLTEtMA_e16f5a8b-3af7-4256-bcdc-879df3986c05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMTMtMS0xLTA_ee3b0a7b-736a-4587-a811-ac3d20ea118f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of redeemable preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtMTUtMS0xLTUxMjU_8328a2cb-734f-409d-bc97-87bfc7c334d3">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzQtNS0xLTEtMA_4ab1c155-0a88-433f-8858-41e85878a837">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzQtMTMtMS0xLTA_713ebd1d-197c-45c7-b44b-7ace12faf20f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid, in lieu of equity, for tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtNS0xLTEtMA_7f531f49-82ae-40eb-8083-ea92fee20688">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtMTMtMS0xLTA_f54c1a1b-ee34-4d87-a150-cc32fc327700">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity issued in lieu of cash consideration for acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630" decimals="-6" sign="-" name="ctlt:EquityIssuedInLieuOfCashConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNS0xLTEtNTEyMQ_8bd63f96-442f-49a2-903d-62367fff2f17">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="ctlt:EquityIssuedInLieuOfCashConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMTMtMS0xLTUxMjM_78e30963-8ee5-4dcb-88fb-a1c738137cd9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividend ($12.50 per share of redeemable preferred stock)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzktNy0xLTEtNTAxMA_9a69bb66-ef71-4ffa-a90d-0fda299682d5">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzktMTMtMS0xLTU2OTU_9a3e3a6b-82c5-40b5-982f-5e71a66fbbf4">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzYtNy0xLTEtMA_fc855854-6ba4-461c-a84c-1b7f8bbaccdf">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzYtMTMtMS0xLTA_f8194b5d-4a74-465f-b0f2-da076d51b547">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30cad29fb45d48a2b98661270e7a1647_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzctOS0xLTEtMA_71f865df-efac-4f58-afa3-dcd63fc6b564">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzctMTMtMS0xLTA_87876c1f-789c-40ba-8a45-373e6ea300a5">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib236337c6ce243e4a006557882bad730_I20190630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMS0xLTEtMA_07f814e6-949b-4b71-9148-2064dfbf1a0a">145,738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib236337c6ce243e4a006557882bad730_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMy0xLTEtMA_6b51f9ee-477f-4b30-a4c8-f59cec2c8da9">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea093bde90c473e96a3747cc21b632d_I20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNS0xLTEtMA_6998e416-2b70-4160-89e2-8f253ebe0bbc">2,757</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6562a165cb4a4a09862673671a5213e4_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNy0xLTEtMA_c73e3494-afc3-4fea-91bf-7304026ab22e">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67f77fb9385943b2aabca06dccddf2d9_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtOS0xLTEtMA_effac47d-6dae-4e5f-b1d1-575ebaaf0e1a">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMTMtMS0xLTA_0607452b-a8eb-4d4c-975f-4127a4adbcb1">1,682</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTE1LTEtMS01MDI1_604874d1-cff3-48cc-8a3a-f00d4dfe6e68">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering, sale of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTEtMS0xLTA_c93c17b1-2b72-4715-abc9-01362636f882">16,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTMtMS0xLTA_9c79b518-6a60-4575-b469-561dcf7fcf10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTUtMS0xLTA_033c6b20-ce54-4e41-829f-81e0ee1f5409">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTEzLTEtMS0w_bf903b8d-0eff-4dde-b1f9-0b6f233fd326">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuances related to stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTEtMS0xLTA_0a6b7e42-b571-4cd2-a16b-9789ef88ec9f">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTMtMS0xLTA_0933a560-96b9-4ff9-a8d5-a749f237e6bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTEzLTEtMS0w_04cb4636-5d35-4454-b826-e5c073d445f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTUtMS0xLTA_6a68b768-a010-417c-9d1a-9d8e86cc8f01">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTEzLTEtMS0w_1793a40a-3797-476c-82bd-edd76234fa1a">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid, in lieu of equity, for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEzLTUtMS0xLTA_747d84cf-e61a-4570-abb5-9e4d9ecba914">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEzLTEzLTEtMS0w_9bb9df94-7bb2-46f7-956d-e9b229771187">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTUtMS0xLTUwMTI_9af7918c-b113-40f9-a6ee-4b30b17d24cb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTEzLTEtMS01Njk3_6786ceb4-9e43-4e02-8fed-ed2caa413dd5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividend ($12.50 per share of redeemable preferred stock)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4623a02e99844aeb45c994796125655_D20190701-20200630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE1LTctMS0xLTA_04c81c39-d3c1-49af-860c-7a05afb38d45">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE1LTEzLTEtMS0w_d9d00cdb-a59c-4f58-8ebd-ebc260e2fb14">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4623a02e99844aeb45c994796125655_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE2LTctMS0xLTA_c6ad9f67-31a6-4637-8aac-8b448db78903">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE2LTEzLTEtMS0w_a1fbfa2b-f2b2-4e8e-ae0f-5dfb6f1d1f48">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia119eac9568e4da69d3502883a5a411c_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTktMS0xLTA_7def25ad-eb2a-46aa-9f69-6063ec187511">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTEzLTEtMS0w_ac006606-b358-498c-98f7-f752839c106a">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTEtMS0xLTA_512a940c-cd38-47ef-8179-83615ed6f51f">162,788</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTMtMS0xLTA_df617707-8dc4-4df4-9bab-8607b60de887">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc274db89144df49cfa6797c23c7a8f_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTUtMS0xLTA_03e0b0ba-7aa2-45b7-a6b8-6bff46f1efe6">3,818</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4c36070acfe4877985f738b20af4ab6_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTctMS0xLTA_ca125f54-2661-4a17-a13d-c3f8b63435de">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia36a4a8155664853831b16252f0cb6c2_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTktMS0xLTA_103252ac-502d-4519-9c55-d3901a7b0773">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTEzLTEtMS0w_8a3d8c71-3c2a-4c63-b71c-3c0dcbfd0317">2,899</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTE1LTEtMS01MDIz_9eec7cda-6538-496f-a108-bba81118d649">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering, sale of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTEtMS0xLTA_9b933749-1ba0-47e9-b8bf-57ac936ab47d">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTMtMS0xLTA_2a216e1f-d4d5-4ed8-bb11-fd00863a5b85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTUtMS0xLTA_b804cd1b-5430-41bc-9546-6d1a47430672">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTEzLTEtMS0w_f5dc7a91-0723-4515-acd6-6d30768551c3">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuances related to stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTEtMS0xLTA_34eff197-e027-43c6-8fa9-e9c378726997">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTMtMS0xLTA_4186d8c9-f759-4b6a-a46b-1d12ceb70979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTEzLTEtMS0w_9e9505ee-bdc6-42db-a603-64aecd499905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of redeemable preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEtMS0xLTMxMjU_3b376d14-d388-46c5-abc5-de2b446a996e">5,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTUtMS0xLTMxMjI_c2f3a8bc-0bae-450b-a87c-734545072eb7">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEzLTEtMS01MDE0_62f2c23e-a243-4ce9-9e1b-c91013824122">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTE1LTEtMS01MDE4_910d004f-383c-4164-9aec-0b993adec8f7">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTUtMS0xLTA_e7424771-0e57-4d9f-8cb3-57821c26d15e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTEzLTEtMS0w_4eb93d94-3b67-4ba6-be7c-36cf4fa7696f">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid, in lieu of equity, for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIyLTUtMS0xLTA_6792a04e-c180-4689-90a1-2bdde644519a">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIyLTEzLTEtMS0w_ffdbd929-3d81-4722-bdfe-1802a4b49d8c">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTUtMS0xLTg1NjE_713f7e7f-ea4a-42f3-a229-b356c2c5c068">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTEzLTEtMS04NTYz_50effdf0-3bd3-4836-877b-6d4155c627a0">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTUtMS0xLTA_3477e63b-184d-4770-83d3-91fa92e7bcc2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEzLTEtMS0w_6cfc632b-6f23-475e-8425-92f5a884c593">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividend ($12.50 per share of redeemable preferred stock)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i563591751a704301b043dafcbace5b1c_D20200701-20210630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI1LTctMS0xLTA_c57c344c-5e99-40cd-99f4-048f0ac75191">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI1LTEzLTEtMS0w_99236016-0897-47b9-804c-2a1e79b2ae6b">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563591751a704301b043dafcbace5b1c_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI2LTctMS0xLTA_587ff629-3a1a-4f3a-80f1-9c70e6165af0">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI2LTEzLTEtMS0w_5f4d9682-4b90-49a1-93ea-c5f5a64f1c61">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfda33e1a14344bc9edc067079194eba_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTktMS0xLTA_66f4d0a9-6509-4106-802b-8d4e2c622c96">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTEzLTEtMS0w_58c935f1-fbef-498d-89a5-d1d8879cf9d8">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0ad825218af4779802948241479fe13_I20210630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTEtMS0xLTA_5ceb66c9-2f94-4dfb-95e1-05c0c5c1331a">170,549</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ad825218af4779802948241479fe13_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTMtMS0xLTA_dad8338a-20a6-481e-a9fd-2dfa6f6286a3">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38c3d72a2b0475e9e8ec4fd255a529e_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTUtMS0xLTA_c2300f34-0e08-4b95-82aa-68105834553e">4,205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e44f48935447b182ae9e7b32b980e6_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTctMS0xLTA_ce0eddd4-3520-4bdf-ae8c-bf80614be7c2">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if63d43dbb1eb4d06a5e91cc8f6bb9df5_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTktMS0xLTA_7562221f-c823-4d82-ae01-792846671433">317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTEzLTEtMS0w_ecd4bba1-a1ee-40e1-9839-97093d448c6a">3,915</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMyLTE1LTEtMS01MDIx_2112c3dd-f5a4-43de-9229-7fc574ab1a7a">359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_172"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtMS0xLTEtMA_5923ca24-8e83-4ed9-a9fb-f86cfc22d017">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtMy0xLTEtMA_ab405469-2e52-46d1-955c-bdb614ac3c72">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtNS0xLTEtMA_4d0a7ec2-cc8c-4659-ab4c-38da70b7b906">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash from operations:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctMS0xLTEtMA_94f3d6c4-48a5-4ab7-9603-862e9e4efcc4">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctMy0xLTEtMA_587f72f2-5b29-4d8a-bffd-f7dcd647b7c3">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctNS0xLTEtMA_008ece6d-4410-42cd-a4dd-f7b208f3bf81">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash foreign currency transaction (gains) losses, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtMS0xLTEtMA_ba49fea5-4943-40ca-9d93-a455cecb481d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtMy0xLTEtMA_0dab8db4-e4e6-4f51-8883-07beb97dc1a0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtNS0xLTEtMA_1730759e-23a7-424e-b33b-a6742838f14e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization and write-off of debt financing costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:AmortizationAndWriteOffOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktMS0xLTEtMA_fb134846-dba3-434a-b726-cb84d40ead51">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:AmortizationAndWriteOffOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktMy0xLTEtMA_f26b8e92-0fad-4689-a9ac-a49a989dc987">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:AmortizationAndWriteOffOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktNS0xLTEtMA_96c4346d-d1dc-46f8-8428-95761777826c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset impairments charges and (gain) loss on sale of assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTEtMS0xLTA_2aa8e8f1-c744-453b-8d65-dc60db9f30e4">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTMtMS0xLTA_a324c84a-f931-4fe8-bfdd-287e2b667313">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTUtMS0xLTA_c3fb0673-e3d3-4a50-87e9-d1769efa0935">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTEtMS0xLTA_1a3894b1-3aca-4513-ab75-3c63433bde13">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTMtMS0xLTA_b8f2fbed-5681-4775-81c1-b9da7358d0d1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTUtMS0xLTA_6f4e1e22-0cf6-4ad1-af6f-834c25f9108a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing related charges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTEtMS0xLTA_25dd9b1a-5c92-4d4f-a838-81c2863eaa50">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTMtMS0xLTA_53711532-8d5c-4494-a442-993c92e1e3b5">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTUtMS0xLTA_8916c085-5355-4fc5-ad83-dc0bbe67ca76">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on derivative instrument</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTEtMS0xLTA_4e47cc83-50f0-4753-b8cd-851140f0374f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTMtMS0xLTA_fc138593-4086-4cef-843b-f579bae5af19">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTUtMS0xLTA_5bd10aff-b3e7-4e29-bc28-8994aedbe3f5">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTEtMS0xLTA_b8aa5ad7-7ef6-4973-8f83-2db07da61164">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTMtMS0xLTA_69dfbcf8-37c1-49f6-9fd5-4e2533dee62a">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTUtMS0xLTA_8726425b-45f3-4901-8552-9a8b5b7b0dd3">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision (benefit) for deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTEtMS0xLTA_2cf81244-fbf1-449b-87ef-33547aa9bda2">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTMtMS0xLTA_b29edccc-3a32-4a97-8926-8ec669e76a16">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTUtMS0xLTA_af28f8b7-eef9-4b66-896f-880345728967">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for bad debts and inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:ProvisionForBadDebtsAndInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTEtMS0xLTA_b4bd9f13-8c1f-435f-a414-dfbbdb7a8efe">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:ProvisionForBadDebtsAndInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTMtMS0xLTA_25a6c0c4-e3de-4958-9484-c061007d2d12">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:ProvisionForBadDebtsAndInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTUtMS0xLTA_cbeae07f-3534-43ff-8392-fa35d4560e23">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in trade receivables</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTEtMS0xLTA_47b9b362-f62d-4cf2-861f-ce5fb4d75bd5">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTMtMS0xLTA_28e0adf9-c94a-47c5-aeda-7807f557d1b8">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTUtMS0xLTA_58f8c145-9a26-4abc-9c8f-e0010b17bfc1">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTEtMS0xLTA_1e92eea3-55e4-482b-b576-ca8b1986be09">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTMtMS0xLTA_1efacf7d-d711-4ef7-b747-b71b612b0901">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTUtMS0xLTA_62ed6b39-a853-4040-aa33-34f0f2e7e9fa">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTEtMS0xLTA_6c0a410a-29c7-402f-a18d-674638740e9d">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTMtMS0xLTA_ffd8e660-1259-41d3-8cb4-eac72d674423">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTUtMS0xLTA_c5ee8e89-805e-467a-b3b6-8dc8fec541be">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets/accrued liabilities, net - current and non-current</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTEtMS0xLTA_76859e4c-ecb3-4eba-9090-2cf85bcf43fd">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTMtMS0xLTA_41800df4-e731-4cf2-873e-64d2eb0a67bc">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTUtMS0xLTA_978fea95-bf35-4c56-8250-7f0bddcd5497">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTEtMS0xLTA_c5e149c2-43c0-4fc9-99a7-b79a9469ea3a">433</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTMtMS0xLTA_604f2c27-f9f0-4222-ae34-db2b11c46dfe">440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTUtMS0xLTA_bf5717f3-ae80-48e0-aad9-15942fde6741">248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of property and equipment and other productive assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTEtMS0xLTA_3783bb83-b50d-43f7-ba14-84cfc53a1767">686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTMtMS0xLTA_5b8c15b0-4939-4b71-bd2a-a824f014f115">466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTUtMS0xLTA_ec169bb4-bde9-407a-8363-eb534410ec94">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTEtMS0xLTQ1OTA_fef596cf-7399-43a8-b128-7841c0429a42">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTMtMS0xLTQ1OTM_730cda77-4921-460a-ba06-bc7936c099f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTUtMS0xLTQ1OTY_9b135a6b-78f8-458c-bdfd-8b6c579f7c48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTEtMS0xLTA_23e7e14e-7f63-4bcb-ae1d-639df07a9219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTMtMS0xLTA_0aa2e32f-b22d-487a-9a5f-4b998d77ea65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTUtMS0xLTA_522505f7-0cec-46c7-9391-e3fb96f3dd5a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTEtMS0xLTA_95be9a56-abdc-4f1f-b8e1-9df9fd6ca07e">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTMtMS0xLTA_577a86fa-c5e3-43e9-b8d2-b1021160884a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTUtMS0xLTA_5bac3fb4-ee2f-4bfd-92f8-962973225e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment for acquisitions, net of cash acquired</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTEtMS0xLTA_0093a0bd-5a86-40a6-9b33-21b968829e2e">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTMtMS0xLTA_ae4657b1-5073-40b0-90c2-0eb780ae2c3e">379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTUtMS0xLTA_65af964f-0af9-4f94-9a2f-8e0dedcd6b1e">1,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment made for investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTEtMS0xLTA_39036523-2769-43f8-b279-4f4e2ead7272">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTMtMS0xLTA_9316a442-69dc-4180-a432-d1abf1890b18">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTUtMS0xLTA_6a6fcf17-d515-4720-aadc-0488c4fb805e">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTEtMS0xLTA_ce002ac2-788a-4449-9c05-1358404d3390">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTMtMS0xLTA_94cb56ff-35c3-421c-bace-a242e110a4a0">827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTUtMS0xLTA_0fc143dc-4785-4d89-87eb-66b3d1882387">1,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change in other borrowings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTEtMS0xLTA_dbe7b003-1da8-4bd5-bff2-e66b0d8a41f2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTMtMS0xLTA_bd843ab8-793d-4d68-961c-c865516f211f">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTUtMS0xLTA_298dc43d-dc05-4945-9ac5-bde9c5d579b6">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowing, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTEtMS0xLTA_f809140d-1a10-4cd0-a9e5-af234780a8a6">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTMtMS0xLTA_51ce669f-f7d1-4d17-b0b1-db775e7672bf">909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTUtMS0xLTA_21570318-5216-4048-aaf9-95c4896a9e3e">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments related to long-term obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTEtMS0xLTA_63d18daf-0393-47b3-a092-f73151c0099a">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTMtMS0xLTA_9937e9bd-bc01-4857-aae3-54133b3d36c8">811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTUtMS0xLTA_a5c0c50b-890f-4357-9019-b294f3f7ad80">1,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing fees paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTEtMS0xLTA_ddb1e324-61db-4c3a-a382-f3351995ec20">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTMtMS0xLTA_fc320ed9-4146-4c91-985d-68e285c092ff">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTUtMS0xLTA_3fd64db4-2ccc-48fc-a6b6-80ba0a67ecd5">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DividendsAndInterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTEtMS0xLTA_4c4e3dc6-b3c6-480e-9184-312991c52eb7">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DividendsAndInterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTMtMS0xLTA_ecdf5a90-dce3-453a-abcc-a0f819a5ea50">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DividendsAndInterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTUtMS0xLTA_c8dade52-ef35-4e23-bd79-7076200fff70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of common stock, net </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTEtMS0xLTA_8da7e0bf-7d54-431f-a997-4707f231323f">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTMtMS0xLTA_b4bfa73c-7f1e-440c-a3a6-61008923159e">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTUtMS0xLTA_d6935306-ec37-44c0-afe9-8660aea2bc3c">445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of preferred stock, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTEtMS0xLTA_09d6336e-5826-472e-b179-7270056dd076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTMtMS0xLTA_f375a9ea-a8b3-44bb-9af4-5169ff408ebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTUtMS0xLTA_67733700-35fa-4a80-9cd5-ac11a6560ec9">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTEtMS0xLTQ1NTQ_a3d27eca-b6b5-4263-8f9f-b9d7cbd4fa08">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTMtMS0xLTQ1NTc_20aa4633-86f0-4c17-9a0b-f94218e288cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTUtMS0xLTQ1NjA_52cff986-23cc-428f-9e90-455fd09f3847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid, in lieu of equity, for tax withholding obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTEtMS0xLTA_ab609412-7216-475d-83aa-377ddd8092e2">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTMtMS0xLTA_cfc1ffba-c4d0-4eb9-b8f3-d9f1704ee8ad">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTUtMS0xLTA_25103fad-cfff-4b2a-86cd-1bf973be1e41">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTEtMS0xLTQ1NzY_75168db8-7dc4-4f22-bc1e-e2fa81793808">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTMtMS0xLTQ1Nzk_6c5c2f5d-0fd2-4fd3-9dc1-30157657e622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTUtMS0xLTQ1ODI_74ea441b-cd41-409b-84d1-ab5a06cc57ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTEtMS0xLTA_b57becb4-1505-4390-83c5-692520fcd62d">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTMtMS0xLTA_1869147a-9525-449d-8c01-34c7594015ca">1,002</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTUtMS0xLTA_187db2de-58ba-43d6-b4b0-e8521f9b866c">1,201</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign currency on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTEtMS0xLTA_8bea2f46-aa24-4428-9f4c-b848a4572a5e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTMtMS0xLTA_225359fe-1b06-48ef-8193-4bef527826d5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTUtMS0xLTA_75931960-b18b-4cd5-b26a-66b10da850e0">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NET (DECREASE) INCREASE  IN CASH AND EQUIVALENTS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTEtMS0xLTA_54ca302c-555f-4519-be37-207e9e4191f0">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTMtMS0xLTA_8dd07942-185c-4eb3-8076-a31116df923d">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTUtMS0xLTA_2dfac1d0-af0b-4925-9680-e4344a338679">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH AND EQUIVALENTS AT BEGINNING OF PERIOD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTEtMS0xLTA_1899a53f-4170-4d52-b11f-eedb14234aa5">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTMtMS0xLTA_6f7f746a-dda7-4b19-88f0-2ae273ce6235">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTUtMS0xLTA_4650a9d9-2a72-45f5-be67-ab2e50051335">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CASH AND EQUIVALENTS AT END OF PERIOD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTEtMS0xLTA_6a26a098-9a39-4126-b92c-b66d48dc7150">896</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTMtMS0xLTA_367d39be-802c-4129-a875-23302858d6c0">953</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTUtMS0xLTA_3e5f3621-63ae-4bcb-8b24-82b2471f1545">345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SUPPLEMENTARY CASH FLOW INFORMATION:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTEtMS0xLTA_01763376-eae4-47ba-a75a-64f1354a52d2">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTMtMS0xLTA_92ea62d0-d0c0-4cef-8efb-359fda628587">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTUtMS0xLTA_3c5a75f7-0038-41a7-bc57-74202153fcab">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTEtMS0xLTA_0161f085-7294-4aa5-ac42-b30e045d0bea">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTMtMS0xLTA_03103e75-7abd-4321-88f5-1befba15b193">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTUtMS0xLTA_0292c875-6832-43b7-8009-b763a3bf6692">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITY:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of Common Stock from partial conversion of redeemable preferred stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTEtMS0xLTEzNTM4_607e3889-af1a-4329-8a6f-bfc60692ff81">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTMtMS0xLTEzNTM4_f91cad0c-7905-4c9c-a679-e600cd1bbc7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="3" format="ixt:fixed-zero" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTUtMS0xLTEzNTM4_4258998b-f867-4c03-9c9d-42427a300689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Note receivable from sale of Blow-Fill-Seal Business</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTEtMS0xLTEzMzc0_3f15c884-a74b-4744-8231-d6bf668aeae1">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="3" format="ixt:fixed-zero" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTMtMS0xLTEzMzc0_9c764804-02fc-468d-a3cb-75a1d37f9d79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="3" format="ixt:fixed-zero" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTUtMS0xLTEzMzc0_2fde397b-0814-498a-82f9-fd3dccdbf6c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_175"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Catalent, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_178"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM0_db6112ff-05fa-4771-a616-0aa3a8f99c39" continuedAt="i4e41041555544786a43cf654011dc341" escape="true">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i4e41041555544786a43cf654011dc341" continuedAt="ie3ab766bee24406aaddf868e1810ceff"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent, Inc. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) directly and wholly owns PTS Intermediate Holdings LLC (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intermediate Holdings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;Intermediate Holdings directly and wholly owns Catalent Pharma Solutions, Inc. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The financial results of Catalent are primarily comprised of the financial results of Operating Company and its subsidiaries on a consolidated basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company commenced an initial public offering (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPO</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of its common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzU3Ng_25277736-6a08-41cf-a7be-7ba84951d436">0.01</ix:nonFraction> (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in which it sold a total of <ix:nonFraction unitRef="shares" contextRef="i03ea8538a32e4e6198456232f248d40d_D20140731-20140731" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzYyOQ_48ac5a49-b389-4549-bd60-4665653f92bf">48.9</ix:nonFraction> million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="icca6e1525f554545b89d8494504b8035_I20140731" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzY1Mw_ff52df7c-7686-4132-9840-11934b9fb4ed">20.50</ix:nonFraction> per share, before underwriting discounts and commissions. The Common Stock began trading on the New York Stock Exchange (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NYSE</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the symbol </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CTLT</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of the IPO. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell, and gene therapies, and consumer health products at over fifty facilities across four continents under rigorous quality and operational standards. Its oral, injectable, and respiratory delivery technologies, along with its state-of-the-art protein and cell and gene therapy manufacturing capacity address a wide and growing range of modalities and therapeutic and other categories across the biopharmaceutical and consumer health industries. Through its extensive capabilities, growth-enabling capacity, and deep expertise in product development, regulatory compliance, and clinical trial supply, it can help its customers take products to market faster, including nearly half of new drug products approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) in the last decade. Its development and manufacturing platforms, which include those in its Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, its proven formulation, supply, and regulatory expertise, and its broad and deep development manufacturing know-how enable its customers to advance and then bring to market more products and better treatments for patients and consumers. Its commitment to reliably supply its customers&#8217; and their patients&#8217; needs is the foundation for the value it provides; annually, it produces more than 70 billion doses for nearly <ix:nonFraction unitRef="customer" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="ctlt:NumberofCustomers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzIwOTE_3b3bc368-e86e-4bdf-981e-ac2d28c7dc0c">7,000</ix:nonFraction> customer products, or approximately 1 in every 24 doses of such products taken each year by patients and consumers around the world. The Company believes that, through its investments in state-of-the-art facilities and capacity expansion, including investments in facilities focused on new treatment modalities and other attractive market segments, its continuous improvement activities devoted to operational and quality excellence, the sales of existing and introduction of new customer products, and, in some cases, its innovation activities and patents, it will continue to attract premium opportunities and realize the growth potential from these areas. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM2_1f0759c7-c5a9-4cf3-bcf0-e3762123f4e8" continuedAt="i60173f0ad837474697377c9eff3166a3" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reporting Segments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the four reporting segments reports through a separate management team and ultimately reports to the Company's Chief Executive Officer, who is designated as the Chief Operating Decision Maker for segment reporting purposes. The Company's operating segments are the same as its reporting segments. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biologics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The segment has extensive expertise in development, scale up, and commercial manufacturing. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s growing biologic offering includes cell-line development based on its advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Its development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce current good manufacturing practices ("cGMP") quality biologics drug substance from 250L to 4,000L scale using single-use technology to provide maximum efficiency and flexibility. Its Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and the Anagni, Italy facility add substantial capacity for finished-dose drug product manufacturing and packaging. The segment has continued to expand production capacity, including the fourth and fifth drug substance manufacturing suites in its Madison, Wisconsin facility, expanded drug product manufacturing and packaging capacity in its Bloomington and Anagni facilities, and recently announced a planned expansion of its Anagni facility to permit drug substance </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie3ab766bee24406aaddf868e1810ceff" continuedAt="i4cb64e7a3e514642a6b575cd3f2d6712"><ix:continuation id="i60173f0ad837474697377c9eff3166a3" continuedAt="i0c7ccb5acb1543b486d113707ec5e687"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and manufacturing. Its SMARTag next-generation antibody-drug conjugate (&#8220;ADC&#8221;) technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s cell and gene therapy centers in Belgium, Maryland, and Texas, it develops and manufactures complex biologics, including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through continued inorganic investment between November 2020 and June 2021, the Company acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#8220;Delphi&#8221;), a plasmid DNA business, to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production. Additionally, in August 2021, it acquired RheinCell Therapeutics GmbH (&#8220;RheinCell&#8221;), a company based in Lagenfeld, Germany that specializes in pluripotent stem cell (&#8220;iPSC&#8221;) production. This portfolio expansion strengthens Catalent&#8217;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances the Company&#8217;s ability to manufacture next generation cell therapies at scale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its gene therapy network across Maryland and Texas, the Company has further expanded its footprint with the construction of 5 additional commercial gene therapy suites at its Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed its Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Its specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with its expanded capabilities in plasmids, positions the Company to capitalize on strong and growing industry demand in the cell and gene therapy market.</span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment's range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within the segment's existing network. In addition to primary packaging, its network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. The Company's Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial supply of biotherapeutics and cell and gene therapies. Its fill and finish services are largely focused on complex pharmaceuticals and biologics. With its range of technologies, the Company is able to meet a wide range of specifications, timelines, and budgets. The Company believes that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide it with a meaningful competitive advantage in the market. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics segment also offers biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Its OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. The Biologics segment provides a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Softgel and Oral Technologies </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its Softgel and Oral Technologies segment, the Company provides formulation, development, and manufacturing services for soft capsules, or &#8220;softgels,&#8221; as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services. Catalent&#8217;s softgel technology was first commercialized by its predecessor in the 1930s, and it has continually enhanced the platform since then. The segment is the market leader in overall softgel development and manufacturing and holds the leading market position in innovator drug softgels. Its principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. The segment typically performs encapsulation for a product within one of its softgel facilities, with active ingredients provided by customers or sourced directly by the Company. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. The segment also participates in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of the Company&#8217;s plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, the segment extended this platform to pharmaceutical products via its OptiShell capsule offering. </span></div></ix:continuation></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4cb64e7a3e514642a6b575cd3f2d6712" continuedAt="id77d3d3a3b9441f4b40f823c8237247d"><ix:continuation id="i0c7ccb5acb1543b486d113707ec5e687" continuedAt="i6fa4e0f6791d4212ae1d0328687b2dfe"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Its Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies the Company has conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Its large-scale manufacturing under cGMP of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site or time-specific drug release, taste masking, or enhanced bioavailability. The Company has deep experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#8217;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Oral and Specialty Delivery</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including its proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms (including metered dose inhalers, dry powder inhalers and nasal delivery devices). </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment provides comprehensive pre-clinical screening, formulation and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. It has substantial, proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. It provides spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#8217;s bioavailability and clinical performance. It offers comprehensive analytical method development and scientific capabilities, including stability testing, and global regulatory services to support both fully integrated development programs and standalone fee-for-service work. In recent years, the segment has expanded its network of clinical development sites focused on earlier phase compounds (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for its offerings is driven by the need for strong scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of its supply performance across quality and operational parameters. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its orally dissolving tablet business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that dissolves in the mouth, without water, in typically less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). The Company can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#8217;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. It continues to invest in and develop Zydis orally dissolving tablets in different ways with its customers as it extends the application of the technology to new therapeutic categories, including immunotherapy, vaccines and biologic molecule delivery.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment&#8217;s respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Clinical Supply Services </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. It offers customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation </span></div></ix:continuation></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id77d3d3a3b9441f4b40f823c8237247d" continuedAt="iba074af73f5747e092a3d37a9a9f3997"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6fa4e0f6791d4212ae1d0328687b2dfe">and reporting. It supports trials in all regions of the world through its facilities and distribution network. In recent years, the segment has continued to expand and extend its network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. The segment continues to develop new solutions for the evolving clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. The Clinical Supply Services segment is the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ1_e9dcfd4a-6931-4404-a039-5aeb957a034f" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements include all of the Company&#8217;s subsidiaries, including those operating outside the United States (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). All significant transactions among the Company&#8217;s subsidiaries and reporting segments have been eliminated, other than as noted.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ5_0889a302-1f20-4739-a851-01b4fb1f340e" continuedAt="ic386d9ed24c64190b3fea890c6298a63" escape="true">Use of Estimates</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic386d9ed24c64190b3fea890c6298a63">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, allowance for credit losses, inventory and long-lived asset valuation, goodwill and other intangible asset valuation and impairment, equity-based compensation, income taxes, derivative valuation, and pension plan asset and liability valuation. Actual amounts may differ from these estimated amounts.</ix:continuation> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:Reclassifications" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjU1_d06f8ad5-3336-45b6-9403-49c4dc4333d8" continuedAt="i17d9598632204c43ace3320110e6405e" escape="true">Reclassification</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i17d9598632204c43ace3320110e6405e">Certain prior-period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows, or notes to the consolidated financial statements.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ2_16135f8d-c5f1-46f5-91b2-07fc583246dd" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s operations outside the U.S. are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of the foreign operations into U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Beginning on July 1, 2018, as a result of the three-year cumulative consumer price index exceeding 100%, the Company has accounted for its Argentine operations as highly inflationary, but this change has not had a material effect on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The currency fluctuation related to certain long-term inter-company loans where settlement is not planned or anticipated in the foreseeable future have been recorded within the cumulative translation adjustment, a component of other comprehensive income. In addition, the currency fluctuation associated with the portion of the Company&#8217;s euro-denominated debt designated as a net investment hedge is included as a component of other comprehensive income. Foreign currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other expense, net.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Such foreign currency transaction gains and losses include inter-company loans that are repayable in the foreseeable future.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM3_8d4ef330-5ff0-41b0-8774-72800e439bda" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All liquid investments purchased with original maturities of three months or less are considered cash equivalents. The carrying value of these cash equivalents approximates fair value.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMx_b599317c-8d1e-44bd-8996-b312a8d3d1a1" continuedAt="ib1d64346e2684da29c235ad67911eb4f" escape="true">Allowance for Credit Losses </ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1d64346e2684da29c235ad67911eb4f">Trade receivables, contract assets, and other amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. The Company determines its allowance methodology by considering various factors, including the Company&#8217;s previous loss history, aging of customer receivable balances, significant aspects of a geographic location's economic conditions, the current and anticipated future condition of the general economy and the industries in which the Company's primary customers operate. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, trade receivables and contract assets are written off against the allowance when the related balances are no longer deemed collectible.</ix:continuation> </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iba074af73f5747e092a3d37a9a9f3997" continuedAt="i7e19b239b27042408a3b6466f35565f7"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUw_378110d7-d906-4b12-b6c8-d5e59dbb2a90" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Major Customers </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers&#8217; financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company&#8217;s expectations. No single customer exceeded 10% of revenue during the fiscal years ended June 30, 2021, 2020, and 2019. As of June 30, 2021, the Company had one customer that represented 15% or $155 million of its net trade receivables balance. No customer exceeded 10% of trade receivables as of June 30, 2020.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM4_653d45cf-df8e-4274-8a2d-de887015ee4e" continuedAt="i18c84f41af664474acf0c9feb92141e6" escape="true">Inventories </ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i18c84f41af664474acf0c9feb92141e6" continuedAt="i4a4f03ee3a044332a696580f81d465a0"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value, using the first-in, first-out (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIFO</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4a4f03ee3a044332a696580f81d465a0">) method. The Company provides for cost adjustments for excess, obsolete, or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory consists of costs associated with raw material, labor, and overhead.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ3_649a3767-bf83-4d05-a83f-bb51a0456624" continuedAt="i9aa278e6d1064fe2a65443fca4e689f1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. The Company performs an impairment evaluation of goodwill annually during the fourth quarter of its fiscal year or when circumstances otherwise indicate an evaluation should be performed. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. Factors considered in a qualitative assessment include, among other things, macroeconomic conditions, industry and market considerations, financial performance of the respective reporting unit and other relevant entity and reporting-unit specific considerations. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and macroeconomic, industry, and market conditions. In fiscal 2019 and 2021, the Company began its impairment evaluation with the qualitative assessment, but in fiscal 2020, the Company proceeded immediately to the quantitative assessment. </span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i9aa278e6d1064fe2a65443fca4e689f1"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its qualitative assessment conducted as of April 1, 2021, the Company determined for each reporting unit with goodwill that it was more likely than not that its respective fair value exceeded its carrying value, indicating there was no impairment. For more information regarding goodwill balances at June 30, 2021, see Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment and Other Definite-Lived Intangible Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUx_19465526-3ec2-4796-b9a1-c4b6f61aa5aa" escape="true">Property and equipment are stated at cost. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including leasehold improvements and finance lease right-of-use assets that are amortized over the shorter of their useful lives or the terms of the respective leases. The Company generally uses the following range of useful lives for its property and equipment categories: buildings and improvements&#8212;<ix:nonNumeric contextRef="ib5a20ffd9213425fb1e67c81f9224f31_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MjQ3_14f8c76d-a14e-46a1-bff5-519f909280ea">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i466bfbf6fd7d441db3dfc26c891635e3_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MjUz_e10165d1-7bd9-44e3-a8f5-662b4ec00a72">50</ix:nonNumeric> years; machinery and equipment&#8212;<ix:nonNumeric contextRef="i5fe521655ef544698a6f74f2e8aff928_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mjg3_7334437d-1685-4231-9fcf-955974838e3e">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i01ff65157f3540fc804007bced73dae3_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mjkz_8f195b58-86a8-4310-b1bc-6194da7376d5">10</ix:nonNumeric> years; and furniture and fixtures&#8212;<ix:nonNumeric contextRef="if766739d8f2b4a4889f8d197a5fe2447_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MzMw_a3d5c7d2-d519-4305-9b29-f63c6eb0ed4f">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ib4a3c699d9f24539b7342ac1f583ba77_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MzM2_0cbdc2a1-f056-40d0-9c16-003c8217e7cd">7</ix:nonNumeric> years. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mzcx_02928f82-6d66-45f0-af80-edec72f91bdd">196</ix:nonFraction> million for the fiscal year ended June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2NDA0_41166567-36d1-45f8-b517-2c5757672814">165</ix:nonFraction> million for the fiscal year ended June&#160;30, 2020, and $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2NDQx_9a702417-536b-429c-9d8e-e7ea85ed8967">141</ix:nonFraction> million for the fiscal year ended June&#160;30, 2019. Depreciation expense includes amortization of assets related to financing leases. The Company charges repairs and maintenance costs to expense as incurred. The amount of capitalized interest for fiscal 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Njgz_fa6980b0-a195-48fa-8b73-215f8258465f">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMxODk_69982df0-f782-41f9-912c-2e5e7d41d7a6">11</ix:nonFraction> million, respectively, and was immaterial for fiscal 2019.</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQy_072ef836-70a8-4521-895c-3f0014b8fe7c" continuedAt="i2924f65ff5ea42dfbb34a4100d22fb9d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, including customer relationships, patents, and trademarks, are amortized over their useful lives. The Company also capitalizes certain computer software and development costs in other intangibles, net, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 5 years. The Company evaluates the recoverability of its other long-lived assets, including amortizing intangible assets, if circumstances indicate impairment may have occurred pursuant to ASC 360,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This analysis is performed by comparing the respective carrying values of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, the carrying value of such assets is reduced to fair value through a charge to the consolidated statements of operations. Fair value is determined based on assumptions the Company believes marketplace participants would utilize and comparable marketplace information in similar arm&#8217;s length transactions. The Company recorded impairment charges related to definite-lived intangible assets and property, </span></ix:nonNumeric></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7e19b239b27042408a3b6466f35565f7" continuedAt="i9fa176576d784f5c9d3a20a4abb50204"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2924f65ff5ea42dfbb34a4100d22fb9d">plant, and equipment of $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTIx_768e72e6-1522-42c5-accb-f178414c260b">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTI1_08e4bd08-fbf6-4ced-839f-97b8f9ff1116">5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTMz_cc13121e-eccd-41a2-93b4-1bb7b17c0672">5</ix:nonFraction> million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUy_5354bee0-f1a6-4b6e-bbee-aef6414b2350" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Retirement and Pension Plans</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement and pension plans, including defined benefit and defined contribution retirement plans.&#160;The measurement of the related benefit obligations and the net periodic benefit costs recorded each year are based upon actuarial computations, which require management&#8217;s judgment as to certain assumptions. These assumptions include the discount rates used in computing the present value of the benefit obligations and the net periodic benefit costs, the expected future rate of salary increases (for pay-related plans) and the expected long-term rate of return on plan assets (for funded plans). The Company uses the corridor approach to amortize actuarial gains and losses. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to utilize an approach to estimate the service and interest components of net periodic benefit cost for benefit plans that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. The expected long-term rate of return on plan assets is based on the target asset allocation and the average expected rate of growth for the asset classes invested. The average expected rate of growth is derived from a combination of historic returns, current market indicators, and the expected risk premium for each asset class. The Company uses a measurement date of June 30 for all its retirement and postretirement benefit plans.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments, Hedging Activities, and Fair Value </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMy_36bb5ffc-54d4-41e2-bb1a-57f5b5b558c2" continuedAt="i683004fb69884fb58c5e127dc465d311" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest-rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments from time to time to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings. The Company does not net any of its derivative positions under master netting arrangements. </span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i683004fb69884fb58c5e127dc465d311" continuedAt="ib693935bd32d4fd8a1d237cbdea9b3e7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily, the Company is exposed to fluctuations in the euro-U.S. dollar exchange rate on its investments in foreign operations in Europe. While the Company does not actively hedge against changes in foreign currency, it has mitigated the exposure of investments in its European operations through a net-investment hedge by denominating a portion of its debt in euros. In addition, a portion of Operating Company's interest payment obligation on its U.S dollar-denominated term loans is exposed to interest rate variability. The Company has mitigated its exposure to this risk by entering into interest-rate swap agreements, which qualify for and are designated as cash-flow hedges. Also, as discussed in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has determined that an aspect of the dividend-rate adjustment feature of the Company&#8217;s convertible Series A Preferred Stock (as defined below, see Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib693935bd32d4fd8a1d237cbdea9b3e7">) should be accounted for as a derivative liability.</ix:continuation>  </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM1_1d2ef732-1bce-405a-a73e-29100bf8c52f" continuedAt="ic0b228d8ced047c0826343cd18507e6a" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. The Company uses fair value extensively, including in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. The Company estimates fair value using an exit price approach, which requires, among other things, that it determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the assets or liability, the Company may use one or all of the following approaches: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Income approach, which is based on the present value of the future stream of net cash flows. </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9fa176576d784f5c9d3a20a4abb50204" continuedAt="i2b30b95f37b147c68debe3cebe7e6119"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="ic0b228d8ced047c0826343cd18507e6a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain investments that are measured at fair value using the net asset value (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NAV</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></ix:continuation></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%;padding-left:17.65pt">&#160;</span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUz_32764cef-646f-4c7a-b19d-19c115519d1b" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its liquid debt investments with original maturities greater than ninety days as marketable securities. The Company invests in highly rated corporate debt securities, with the primary objective of minimizing the potential risk of principal loss. The Company&#8217;s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any single issuer. The Company regularly reviews its investments and utilizes quantitative and qualitative evidence to evaluate potential impairments. For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable securities as available-for-sale, because it may sell certain of its marketable securities prior to the stated maturity for various reasons, including management of liquidity, credit risk, duration, relative return, and asset allocation. The Company determines the fair value of each marketable security in its portfolio at each period end and recognizes gains and losses in the portfolio in other comprehensive income. As of June 30, 2021, the amortized cost basis of marketable securities approximates fair value and all outstanding marketable securities mature within one year.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM5_c35ad6da-189a-4154-9bb3-d125e349a8f5" continuedAt="i2eb26a89c4934ad8877d611a6950ab7a" escape="true">Self-Insurance </ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2eb26a89c4934ad8877d611a6950ab7a">The Company is partially self-insured for certain employee health benefits and partially self-insured for property losses and casualty claims. The Company accrues for losses based upon experience and actuarial assumptions, including provisions for losses incurred but not reported.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQw_64cac38f-7d4f-4a4d-b548-87322ceece9b" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, which is reported in the accompanying consolidated statements of changes in shareholders&#8217; equity, consists of foreign currency translation, net change in marketable securities, and defined benefit pension plan changes.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQz_b5c544df-ffe4-4cd2-862d-a65aadee4de2" continuedAt="i48da04b5b0664884b262801ebbf6897e" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48da04b5b0664884b262801ebbf6897e">The Company expenses research and development costs as incurred.  Research and development costs amounted to $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMxOTg_4905473e-34be-4c4b-ab41-f3e0f048ee66">21</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMyODY_99fc2cb6-0af7-4d79-824a-c31c6da637f8">21</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMzMDM_e13dc6e6-c6da-45cf-9b7f-9e50c9175f70">19</ix:nonFraction> million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.</ix:continuation>  </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjI3_35866b1f-5115-4a1d-9f44-4a1096219af1" continuedAt="i6a210c1a12754531869104ed65e72a8c" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports net earnings per share in accordance with ASC 260,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company computes basic earnings per share for the Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the two-class method by d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Series A Preferred Stock, due to its convertible feature, is participating in nature; accordingly, the outstanding shares of Series A Preferred Stock are included in the two-class method. Diluted earnings per common share measures the performance of the Company over the reporting period while giving effect to all potential shares of Common Stock that were dilutive and outstanding during the period. The denominator includes the weighted average over the measurement period of the sum of the number of shares of Common Stock outstanding and the number of additional such shares that would have been outstanding if </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2b30b95f37b147c68debe3cebe7e6119" continuedAt="ide6a511cd22d43aa834065e42d0eb7d9"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6a210c1a12754531869104ed65e72a8c">the shares of Common Stock that were both potentially issuable and dilutive had been issued, and is calculated using the more dilutive of the two-class, treasury stock, and if-converted methods.</ix:continuation></span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ0_08a04e52-5d17-4a8d-ba2b-d2a784f9505e" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company&#8217;s assets and liabilities. The Company measures deferred tax assets and liabilities using enacted tax rates in the respective jurisdictions in which it operates. In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that the Company will be able to realize some or all of the deferred tax assets. The calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in each of its tax jurisdictions. The number of years with open tax audits varies by tax jurisdiction. A number of years may lapse before a particular matter is audited and finally resolved. The Company applies ASC 740 to determine the accounting for uncertain tax positions. This standard clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before the Company may recognize the position in its financial statements. The standard also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has elected not to reclassify the income tax effects stranded in accumulated other comprehensive income to retained earnings.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjI4_38f9825d-81c4-45d8-b2fa-a5e4ce97bd91" continuedAt="i151945b01d574a1b8298146c40ead952" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 718, companies recognize compensation expense using a fair-value-based method for costs related to share-based payments, including stock options and restricted stock units. The expense is measured based on the grant date fair value of the awards, and the expense is recorded over the applicable requisite service period. Forfeitures are recognized as and when they occur. In the absence of an observable market price for a share-based award, the fair value is based upon a valuation methodology that takes into consideration various factors, including the exercise price of the award, the expected term of the award, the current price of the underlying shares, the expected volatility of the underlying share price, the expected dividends on the underlying shares and the risk-free interest rate. </span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i151945b01d574a1b8298146c40ead952" continuedAt="i915d3ebb53df46a6ac88f37d568e2f65"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Company&#8217;s stock-based compensation plans permit an employee holding vested stock options or restricted stock units to elect to have the Company use a portion of the shares otherwise issuable upon the employee&#8217;s exercise of the option or grant, a so-called </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net settlement transaction,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i915d3ebb53df46a6ac88f37d568e2f65"> as a means of paying the exercise price, meeting tax withholding requirements, or both.</ix:continuation> </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMz_fa7f874f-f015-45a8-bf67-4d1cfd7725c7" continuedAt="i0c9d31ea971947faa26d61d2c31c1425" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Financial Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2018, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirement for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changes the disclosure requirements on fair value measurements in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance eliminates certain disclosure requirements that are no longer considered cost beneficial and adds new disclosure requirements for Level 3 fair value measurements. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial statement disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which introduces a new accounting model known as Credit Expected Credit Losses (&#8220;CECL&#8221;). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for financial assets at the time they are originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaces the multiple existing impairment models in current U.S. GAAP, which generally require that a loss be incurred before it is recognized. The new standard applies to receivables arising from </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ide6a511cd22d43aa834065e42d0eb7d9" continuedAt="i7e88cd68da90421589f0c92abd54c200"><ix:continuation id="i0c9d31ea971947faa26d61d2c31c1425" continuedAt="i149198dc6eda45b6b69205cd1b034652"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue transactions such as contract assets, accounts receivables, available for-sale debt securities and notes receivable arising from divestitures. The Company adopted the amended guidance using a modified retrospective approach on July 1, 2020. The amended guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Standards Not Adopted as of June 30, 2021</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance to ease the potential burden in accounting for the discontinuation of a reference rate such as LIBOR, formerly known as the London Interbank Offered Rate, because of reference rate reform. The expedients and exceptions provided by the guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the incremental approach for intra-period allocation, deferred tax recognition requirement for changes in equity method investments and foreign subsidiaries, and methodology for calculating income taxes in an interim period. The guidance also simplifies certain aspects of the accounting for franchise taxes, the accounting for step-up in the tax basis of goodwill, and accounting for the change in the enacted change in tax laws or rates. The ASU will be effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i7e88cd68da90421589f0c92abd54c200" continuedAt="if4689d94b5d94824b593cd9ffd9a565d"><ix:continuation id="i149198dc6eda45b6b69205cd1b034652" continuedAt="ic0316948e70a4e10983b67cd65a49073"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General (Subtopic 715-20): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Defined Benefit Plan</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if4689d94b5d94824b593cd9ffd9a565d"><ix:continuation id="ic0316948e70a4e10983b67cd65a49073">, which removes certain disclosures and added additional disclosures around weighted-average interest crediting rates for cash balance plans and explanation for significant gains and losses related to change in the benefit obligation for the period. The ASU will be effective for fiscal years beginning after December 15, 2020 with a retrospective application for all periods presented. The adoption of this guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</ix:continuation></ix:continuation> </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_184"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwOTk1MTE2NDMyMTc_4ad94eab-4882-499c-a328-2f34e8b64942" continuedAt="i7cc10a11836545cb9ae4c08d25d0dae8" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><ix:continuation id="i7cc10a11836545cb9ae4c08d25d0dae8" continuedAt="i8f1198b4378c465fbaf97d38bf83e77e"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company generally earns its revenue by supplying goods or providing services under contracts with its customers in three primary revenue streams: manufacturing and commercial product supply, development services, and clinical supply services. The Company measures the revenue from customers based on the consideration specified in its contracts, excluding any sales incentive or amount collected on behalf of a third party. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer contracts generally include provisions entitling the Company to a termination penalty when the customer invokes its contractual right to terminate prior to the contract&#8217;s nominal end date. The termination penalties in the customer contracts vary but are generally considered substantive for accounting purposes and create enforceable rights and obligations throughout the stated duration of the contract. The Company accounts for a contract cancellation as a contract modification in the period in which the customer invokes the termination provision. The determination of the contract termination penalty is based on the terms stated in the relevant customer agreement. As of the modification date, the Company updates its estimate of the transaction price using the expected value method, subject to constraints, and recognizes the amount over the remaining performance period</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally expenses sales commissions as incurred because either the amortization period is one year or less, or the balance with an amortization period greater than one year is not material.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8f1198b4378c465fbaf97d38bf83e77e" continuedAt="ib8ae47759ff4460b9eaa990970dc09eb"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjUz_f1d7ba46-ee09-42e0-821c-67e376935f3d" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a2087bb20040eca6de434a5a3a69b4_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtMS0xLTEtMA_d7741bd2-e439-4673-9216-519c6adbf546">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada4b587fca14301a3db1cee71bb807f_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtMy0xLTEtMA_c857bbd9-83e9-4f8e-990e-47bb80035b44">877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51f38a8412b461597c87ef42543ce85_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtNS0xLTEtMA_2ef47df2-320d-4eee-815b-80e1410ef4ff">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045c4761bada44e6838395223b03d53e_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtNy0xLTEtNDk5NA_af995715-42d9-4f0b-83ae-044635e6920a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3da86270c27446129776c8fa261c8181_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtOS0xLTEtMA_717e9539-728e-41e0-9499-c4cb536d2bf4">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b128b8fed0453589f0b1f789d7401d_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItMS0xLTEtMA_f7c74134-af04-4e26-9912-71905a90d713">1,395</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea3b691cfbf74328831c43d672a4f921_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItMy0xLTEtMA_5a3d67d9-e5f0-4ed0-a4bd-3e44d61317ae">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705c4c9f11954b4ea5e99770a3c251a4_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItNS0xLTEtMA_33e6e1b6-72dd-45fc-a3e2-4d3c949b83da">231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b25898ae02243708a9f6f45778360bd_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItNy0xLTEtNDk5NA_9c490ad8-8575-4137-b8f6-11c5add8bce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6d8d7df749456aa44395064bfc68ed_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItOS0xLTEtMA_3bde8e10-1305-4a3c-9310-0bb32dfe7955">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0aa571359bc437aa855b95942f5960c_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtMS0xLTEtNDk5MQ_f72c59ac-2614-4995-a1b6-c6c2c6a24087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f42b75751f4cb0a931e72af45e2071_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtMy0xLTEtNDk5NA_ff682317-8c16-4008-86db-34a44f345360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16a67ca8a3e43959d9b6899ddb210d0_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtNS0xLTEtNDk5NA_329736e6-3f98-4a00-9075-5d3ea1386e54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0a88b6d220432d822a3a9acc1be96f_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtNy0xLTEtMA_9b1a17e5-76fa-4ab1-b1e2-4ef3e23f401a">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60878ec54f754cd685972d131936a863_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtOS0xLTEtMA_75c768b1-deb6-4653-8616-39ff2e10e230">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtMS0xLTEtMA_87ebbf9f-7273-4935-87e1-3eb8f38b9583">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtMy0xLTEtMA_1178eacf-ee71-48cd-8ac1-144656c6ea9c">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtNS0xLTEtMA_ccc605b3-ab4a-433d-83d0-831215a6ff8d">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtNy0xLTEtMA_ad56be1e-aa1e-4d02-b722-b61738f2cdf8">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093d3096941f487d945682b19471e3df_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtOS0xLTEtMA_4f3ffe5f-f877-4af2-a763-5f98799fd9a2">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationInterSegmentRevenueElimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzUtOS0xLTEtMA_8ef56d82-2af2-4ae7-b90f-501ba1fbba5e">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzYtOS0xLTEtMA_3aa91b7a-6f71-465b-aaf9-90e747833ef9">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.939%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.227%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66eccdacf8164ed593c34225a88a46d1_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtMS0xLTEtMA_2e0c8f26-124d-496d-a100-cb5dccb8b1f4">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21a0bd7b87e4a03911155430ae8b6ae_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtMy0xLTEtMA_c5ed95fb-0ec3-4790-abee-4e3aeb3725d8">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef7d76076a94237a72ee40ceab75b87_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtNS0xLTEtMA_482fd5a3-3104-481d-b5c3-db4b41424dae">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142419c11f5d4f0489522ad07594cdbf_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtNy0xLTEtNDk5OQ_6858c6fa-dd1c-428d-8242-13b6438668f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4927d306a5cd4d059e75f5c9a3d57193_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtOS0xLTEtMA_1e9d386a-b315-48dd-939b-9009db325360">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cbad2cbd874660845a41e6ce1dd05d_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItMS0xLTEtMA_4f5ffd5e-ff54-44bb-9eba-46292c18f990">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d233789dad44dedabfcbf931339090a_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItMy0xLTEtMA_c780d133-007e-4799-a6fa-9f0b45263b28">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b7f23d170040c08b3f2af50189003e_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItNS0xLTEtMA_7e88c0db-401a-4ad3-a560-b25fbd20bec8">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b4b92b91af444d955bbb9f2174dd7e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItNy0xLTEtNDk5OQ_e1a586ca-469d-4f1e-87e6-0eccedcb9996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i884903df67494d87bbab2288ab7a8879_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItOS0xLTEtMA_f6c5e04d-e6fd-4661-bced-7bdab7d3d0ee">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1254879dc3784a83a23a504c071ed5a3_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtMS0xLTEtNDk5OQ_567466a5-3a18-49e5-a316-ff4897f17382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfcb80aba194eabb4778da0ffeda957_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtMy0xLTEtNDk5OQ_3ddb9861-3fb8-45ff-b2d3-79d844079c64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ad96da5593486fbc6c6de7f9b3e68f_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtNS0xLTEtNDk5OQ_6b14b122-2480-44dd-af81-a0bd576f95cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4c045f9a3f41bea3c504f692dea648_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtNy0xLTEtNDk5OQ_3acf983e-e7dc-404d-bd0d-372fa002c83f">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a776ebf0a942589e391bead02f211b_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtOS0xLTEtMA_df0cd2da-28c6-4344-90e4-86f0894d1989">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtMS0xLTEtMA_485ccee2-00c6-4f0b-97e5-731f9ff6eaf3">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtMy0xLTEtMA_46845fc6-7bb3-4d1d-8d32-d208beb63ef6">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtNS0xLTEtMA_72cc8dad-6e05-4406-a933-1c28581df852">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtNy0xLTEtMA_37276f3b-62e3-4b53-abb9-982ece591920">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7107a7761d40c8904561ccb9c417f6_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtOS0xLTEtMA_ecc93dfe-6586-49fe-8a96-7807d7bd4c6b">3,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationInterSegmentRevenueElimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzUtOS0xLTEtMA_3829386f-5a71-4a20-a983-b341bfa996e2">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzYtOS0xLTEtMA_7d329197-0cd9-44c6-85d0-cb6fcb5f0ec5">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i7bef26a88d4d45d39bca80b0cc08cb49_D20200701-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjU5_2d1dbb01-19bb-458f-8907-41c75c587d08" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects revenue by the location where the goods were made or the service performed:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951ba969a0bc495faf2a70bac7fd4cb8_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzItMi0xLTEtNTAwMw_6d37c3c7-247a-41d1-a20a-26bed2c6b80f">2,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed9921d6bb04cc7bd39d32cbbc854eb_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzItNC0xLTEtMA_44cd8094-82dc-4340-8f76-1f79d0d616ef">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtMi0xLTEtNTAwMw_94fda2a1-120e-4889-9794-e257d1515827"><ix:nonFraction unitRef="usd" contextRef="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtMi0xLTEtNTAwMw_cb896e4d-2704-4e51-afb8-94ad9af0894d">1,343</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf6743117284e278dddc68935f89f38_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtNC0xLTEtMA_f030a96a-704d-4a59-9f95-694b5932e51e">976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e54ba728a04c0ebb1f97f6fbfd3c64_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzQtMi0xLTEtNTAwMw_d2dfce39-3b41-4ebb-b3c6-8de44b8024a0">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iece8fce5266a4b4a80688042161b0641_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzQtNC0xLTEtMA_51dcdaa4-8d8d-45e9-bec4-2f579cba1706">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of revenue attributable to multiple locations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="ctlt:Eliminationofrevenueattributabletomultiplelocations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzUtMi0xLTEtNTAwMw_a18887cc-3d4f-4bdf-9030-02107021a71e">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:Eliminationofrevenueattributabletomultiplelocations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzUtNC0xLTEtMA_34e94300-8557-4d21-8d54-7bf4a056ab39">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzYtMi0xLTEtMA_0ddcab6e-66c8-47fc-8598-256ae825d8f0">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzYtNC0xLTEtMA_a382a2a7-8165-4cba-8c54-973591b608e5">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing &amp; Commercial Product Supply Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing and commercial product supply revenue consists of revenue earned by manufacturing products supplied to customers under long-term commercial supply arrangements. In these arrangements, the customer typically owns and supplies the active pharmaceutical ingredient, or API, that is used in the manufacturing process. The contract generally includes the terms of the manufacturing services and related product quality assurance procedures to comply with regulatory requirements. Due to the regulated nature of the Company&#8217;s business, these contract terms are highly interdependent and, therefore, are considered to be a single combined performance obligation. The transaction price is generally stated in the agreement as a fixed price per unit, with no contractual provision for a refund or price concession. Control is transferred to the customer over time, creating a corresponding right to recognize the related revenue, because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. Progress is measured based on the units of product that have successfully completed the contractually required product quality assurance process, as the conclusion of that process generally defines the time when the applicable contract and the related regulatory requirements permit the customer to exercise control over the product&#8217;s disposition. The customer is typically responsible for arranging the shipping and handling of product following completion of the quality assurance process.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days after the goods are shipped as requested by the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development services contracts generally take the form of short-term, fee-for-service arrangements. Performance obligations vary, but frequently include biologic cell-line development, performing formulation, analytical stability, or other services related to product development, and providing manufacturing services for products that are under development or otherwise not intended for commercial sale. The transaction prices for these arrangements are fixed and include amounts stated </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib8ae47759ff4460b9eaa990970dc09eb" continuedAt="i699d17167daa47c580725442920d32d3"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the contracts for each promised service, and each service is generally considered to be a separate performance obligation. The Company recognizes revenue over time because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures progress toward the completion of its performance obligations satisfied over time based on the nature of the services to be performed. For certain types of arrangements, revenue is recognized over time and measured using an output method based on the completion of tasks and activities that are performed to satisfy a performance obligation. For all other types of arrangements, revenue is recognized over time and measured using an input method based on effort expended. Each of these methods provides an appropriate depiction of the Company&#8217;s progress toward fulfilling its performance obligations for its respective arrangement. In certain development services arrangements that require a portion of the contract consideration to be received in advance at the commencement of the contract, such advance payment is initially recorded as a contract liability. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates consideration to each performance obligation using the &#8220;relative standalone selling price&#8221; as defined under ASC 606. Generally, the Company utilizes observable standalone selling prices in its allocations of consideration. If observable standalone selling prices are not available, the Company estimates the applicable standalone selling price using an adjusted market assessment approach, representing the amount that the Company believes the market is willing to pay for the applicable service. Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreemen</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Supply Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical supply services contracts generally take the form of fee-for-service arrangements. Performance obligations for clinical supply services revenue typically include a combination of the following services: the manufacturing, packaging, storage, distribution, destruction, and inventory management of customer clinical trial material. Performance obligations can also include the sourcing of comparator drug products on behalf of customers to be used in clinical trials to compare performance with the drug under clinical investigation. In certain arrangements, the Company recognizes revenue over time when the Company satisfies performance obligations. Satisfaction of the performance obligations is measured using an input method measure of progress based on effort expended by the Company. In other arrangements, revenue is recognized at the point in time when control transfers, which occurs upon either the delivery of the related output of the service to the customer or the completion of quality testing with respect to the product, and the Company has an enforceable right to payment based on the terms of the arrangement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue for comparator sourcing arrangements on a net basis because it is acting as an agent that does not control the product or service before it is transferred to the customer. Payment for comparator sourcing activity is typically received in advance at the commencement of the contract and is initially recorded as a contract liability.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occasionally enters into arrangements with its customers that include licenses of functional intellectual property, including patents, or other intangible property (&#8220;out-licensing&#8221;). Revenue from such arrangements are within the scope of ASC 606. The Company does not have any material license arrangement that contains more than one performance obligation. The terms of such out-licensing arrangements include the license of functional intellectual or intangible property (primarily drug formulae) and typically provide for payment by the licensee of one or more of the following: non-refundable, up-front license fees or royalties on net sales of licensed products. The Company recognizes revenue from nonrefundable, up-front license fees when the licensed intellectual property is made available for the customer&#8217;s use and benefit, which is generally at the inception of the arrangement. Royalty payments from such arrangements are recognized when subsequent sale or usage of an item subject to the royalty occurs and the performance obligation to which royalty relates is satisfied</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i699d17167daa47c580725442920d32d3"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to cash consideration that the Company receives in advance of satisfying the related performance obligations. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ContractualLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjYw_50efcebe-9aa7-4897-8d08-401d1b19da38" continuedAt="i0ca5142316554c7096e56712aa546f53" escape="true">The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><ix:continuation id="i0ca5142316554c7096e56712aa546f53"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzItMi0xLTEtMA_ec95690f-2d41-4399-a774-57bfb0971d0f">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzctMi0xLTEtMA_6f0c558d-9d35-4f5c-85a7-36bbbce22f9f">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzgtMi0xLTEtNTA0Nw_227ffb97-48e0-462a-afe7-16bb122ac7ea">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities that will be recognized within 12 months of June 30, 2021 are accounted for in Other accrued liabilities and those that will be recognized longer than 12 months after June 30, 2021 are accounted for within Other liabilities.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily relate to the Company's conditional right to receive consideration for services that have been performed for the customer as of June&#160;30, 2021 relating to its development services but had not yet been invoiced as of June&#160;30, 2021. Contract assets are transferred to trade receivables, net when the Company&#8217;s right to receive the consideration becomes unconditional. Contract assets totaled $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMDQ2_e3e183b5-22c0-4811-b379-b2e8275fe001">181</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMDUz_5bf307c4-d45e-48fe-badb-28abe2a1de34">61</ix:nonFraction> million as of June&#160;30, 2021 and 2020, respectively. Contract assets are accounted for within prepaid expenses and other in the consolidated balance sheets.</span></div></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_187"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.     <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzExODg2_86fd2a93-7533-4285-8499-9c312aed9488" continuedAt="i22b6fa9c2c794f92b03489f17a864ac9" escape="true">BUSINESS COMBINATIONS AND DIVESTITURES</ix:nonNumeric></span></div><ix:continuation id="i22b6fa9c2c794f92b03489f17a864ac9" continuedAt="i3eaafe5497ca464c9acac28caf15c54e"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anagni Acquisition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company acquired an oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy. The Company paid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i4fb7193cbe7d43bca3a20da21b84f54d_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzYyMDQ_8957f12c-5f27-4180-a20a-603294c905a4">55</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in cash as part of the purchase consideration and as consideration for the provision of certain services to facilitate the transition to Company ownership. At the closing of this acquisition, the seller of the facility also entered into a five-year agreement for continuing supply by the Company of certain products at the Anagni facility. Due to the variety of activities performed at Anagni, the results of the Anagni facility are allocated between the Oral and Specialty Delivery and Biologics segments.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cash consideration was allocated between the facility purchase and the transitional services arrangement, with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:BusinessCombinationTransitionalServiceAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzY4NjA_35998fd9-e276-4170-9875-b55b314e116b">52</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assigned to the purchase consideration and the balance to transitional services. The Company funded the entire amount with cash on hand and allocated the purchase price among the acquired assets, recognizing property, plant, and equipm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ent of $<ix:nonFraction unitRef="usd" contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxMjM_d258c81a-5fb1-497b-a996-ee035395c932">34</ix:nonFraction> million, inventory of $<ix:nonFraction unitRef="usd" contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxNDA_43f10868-401e-49a7-bc3c-51a6489c602b">6</ix:nonFraction> million, and prepaid expenses and other of $<ix:nonFraction unitRef="usd" contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxNzg_71b632c5-d529-4d6d-9f95-c828a1f6a75b">12</ix:nonFraction> million. The purchase price was also allocated to deferred tax assets and certain employee-related liabilities assumed in the a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cquisition. </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MaSTherCell Acquisition </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired 100% of the equity interest in Masthercell Global Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MaSTherCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for an aggregate purchase price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i0e96532b149d46edb99ca6b0a748f524_D20200210-20200210" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzgxMzY_77c708bc-4f91-45c2-9146-b5d0cd4e69af">323</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was funded with the net proceeds of the Company&#8217;s February 2020 equity offering (the &#8220;February 2020 Equity Offering&#8221;) of its Common Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  MaSTherCell is a contract development and manufacturing organization focused on the development and manufacture of autologous and allogeneic cell therapies for third parties, as well as a variety of related analytical services. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the MaSTherCell acquisition using the acquisition method in accordance with ASC 805, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The operating results of MaSTherCell have been included in the Company&#8217;s consolidated financial statements for the period following the acquisition date. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimated fair values at the date of acquisition for the allocation of consideration to the net tangible and intangible assets acquired and liabilities assumed as part of the MaSTherCell acquisition.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3eaafe5497ca464c9acac28caf15c54e" continuedAt="i71867720236944bcb26a5a6ca0d8b026"><ix:nonNumeric contextRef="i1a947e3eec134edc93799b574e4dde4a_D20200701-20210630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzExODg0_000caed4-2f28-4743-b2c9-7c089b55dd28" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation to assets acquired and liabilities assumed in the transaction is (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant, and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzAtMS0xLTEtNTEyNw_524cb993-e46b-47d2-b786-3004dd8f54e1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Identifiable intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzEtMS0xLTEtNTE1NA_feffe566-fc78-437b-8be7-a2fa98d8bc85">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other net assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzItMS0xLTEtNTE1Ng_e05b05c0-2d8f-4282-a58c-6c5ed5224989">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzMtMS0xLTEtNTE2Ng_999c66b0-f8c2-4303-bdcd-10480ceb3d50">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable net assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzQtMS0xLTEtNTE2Ng_4c15b461-0426-41d2-adf2-c0f8ca05438e">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzUtMS0xLTEtNTE2Ng_b2c90999-86b1-4209-a80d-6ef031676c5c">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total assets acquired and liabilities assumed</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzYtMS0xLTEtNTE2Ng_b6a0a3ea-8432-4859-ab03-938f498acdea">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of trade receivables, raw materials inventory, and trade payables, as well as certain other current and non-current assets and liabilities generally represented their fair values at the date of acquisition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment was valued using the cost approach, which is based on the current replacement or reproduction cost of the asset as new, less depreciation attributable to physical, functional, and economic factors. The Company then determined the remaining useful life based on the anticipated life of the asset and Company policy for similar assets.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer-relationship intangible assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8c8fd61e3e3e4bc587341b5de7823db4_I20200210" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5Xzk4NzQ_859c25e5-6403-40df-9273-5587ef594d0e">46</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were valued using the multi-period, excess-earnings method, a method that values the intangible assets using the present value of the after-tax cash flows attributable to the intangible assets only. The assumptions used in developing the valuation included the estimated annual net cash flows (including application of an appropriate margin to forecasted revenue, selling and marketing costs, return on working capital, contributory asset charges, and other factors), the discount rate that appropriately reflects the risk inherent in each future cash flow stream, and an assessment of the assets&#8217; life cycles, as well as other factors. The assumptions used in the financial forecasts were based on historical data, supplemented by current and anticipated growth rates, management plans, and market-comparable information. The customer relationship intangible assets have a weighted average useful life of 13 years. Goodwill is mainly comprised of the growth from an expected increase in capacity utilization, potential new customers, and advanced cell therapy development and manufacturing capabilities. The goodwill arising from the MaSTherCell acquisition has been assigned to the Biologics segment. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Cell Therapy Support SA Acquisition</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the Company acquired 100% of the equity interest in Skeletal Cell Therapy Support SA (&#8220;Skeletal&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="icd578116a1984512962b999d1a8d51ef_D20201116-20201116" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzU0OTc1NTgxNjk1Nzg_02c6f1d8-1766-4447-9337-a6a256dbd904">15</ix:nonFraction> million, subject to customary adjustments, as well as related supply agreements with the seller. Skeletal operates </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a cell therapy manufacturing facility in Gosselies, Belgium. The operations were assigned to the Company&#8217;s Biologics segment, expanding the Company&#8217;s cell therapy capacity for clinical and commercial supply. The acquisition, when combined with the Company's other European-based facilities and capabilities in cell therapy, has created an integrated European center of excellence in cell therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Skeletal acquisition using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price to trade receivables, property, plant, and equipment, deferred tax assets, and other current and non-current assets and liabilities assumed in the acquisition, which resulted in a recognition of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="icd578116a1984512962b999d1a8d51ef_D20201116-20201116" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTU5Nzc_e1a2c135-a32d-48f0-8db8-6a9ff0e4c42b">9</ix:nonFraction> million of goodwill</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Results for the fiscal year ended June 30, 2021 were not material to the Company&#8217;s statement of operations, financial position, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and income taxes are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acorda Therapeutics, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company acquired the manufacturing and packaging operations of Acorda Therapeutics, Inc.'s (&#8220;Acorda&#8221;) dry powder inhaler and spray dry manufacturing business, including its manufacturing facility located near Boston, Massachusetts, for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTU5OTU_7c65665a-67c4-486d-8c7b-5e8bb9c21afe">83</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, subject to customary adjustments. In connection with the purchase, Acorda and the Company entered into a long-term supply agreement, under which the Company will continue the manufacture and packaging of an Acorda product at the facility. The facility and operations became part of the Company&#8217;s Oral and Specialty Delivery segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i71867720236944bcb26a5a6ca0d8b026" continuedAt="i1d7bc7d8ea204441b983962a277c3ad1"><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Acorda transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price among the acquired assets, recognizing property, plant, and equipment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwMTM_3bb028b7-03b8-440c-815d-439951c17caa">79</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, inventory of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwMzA_74cf207f-eb8e-4976-8228-d15139550c7f">2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwNjY_41a1d0f9-be50-4ca7-a707-1d3c069e2967">2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purchase price was also preliminarily allocated to other current and non-current assets and liabilities assumed in the acquisition. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and inventory are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delphi Genetics SA Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company acquired 100% of the equity interest in Delphi for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwODY_7f1b8315-640f-4f43-ae68-c11a43092f9d">50</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, subject to customary adjustments. Delphi is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. The facility and operations acquired became part of the Company&#8217;s Biologics segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Delphi transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price recognizing property, plant, and equipment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMDM_27014ed9-8c62-4d37-ab1a-c59c2aceb306">6</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, intangible assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMjI_8c916c7b-29d9-49b8-b8cb-faa08e191a09">7</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, other current assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMzk_aebe2a20-011d-4eed-afac-f2d3d4961caa">3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, assumed debt of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxNTg_af2b63d9-1479-4491-8cd6-2037e1c1e498">6</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, other current liabilities of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxNzU_af40b4d4-0c8d-4ba6-b6af-392e8b030cfc">5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxOTM_7c91da9d-6df3-4336-9d1c-f54a1d4bf7d3">45</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to intangible assets, inventory, goodwill, and income taxes is preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hepatic Cell Therapy Support SA Asset Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company acquired 100% of the equity interest in Hepatic Cell Therapy Support SA (&#8220;Hepatic&#8221;) for approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iec05426d8309444b822cb0b7025ea5f5_D20210223-20210223" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyMTE_8f730ad9-80dc-4b60-94a4-57ad9b690ab5">15</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of cash acquired and debt assumed. Hepatic operates a manufacturing facility at the same location where Skeletal operates a cell therapy manufacturing facility in Gosselies, Belgium. The facility acquired will expand the C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany&#8217;s cell therapy capacity for clinical and commercial supply in its Biologics segment.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RheinCell Therapeutics GmbH Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into an agreement to acquire 100% of the equity interest in RheinCell for approximately $<ix:nonFraction unitRef="usd" contextRef="i6d3b7eae092942fba85aaba9e27b78aa_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyMzE_5f2f7d31-da41-45b3-bd4e-7f01584f8097">30</ix:nonFraction> million and completed the acquisition in August 2021. RheinCell is a developer and manufacturer of cGMP-grade iPSCs.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations acquired became part of the Company&#8217;s Biologics segment and build upon Catalent&#8217;s existing custom cell therapy process development and manufacturing capabilities with proprietary GMP cell lines for iPSC-based therapies. Due to the date of the closing, a preliminary purchase price allocation has not yet been performed. However, a portion of the purchase price is expected to be allocated to intangible assets and goodwill.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blow</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">-Fill-Seal Divestitur</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company sold 100% of the shares of Catalent USA Woodstock, Inc. and certain related assets (collectively, the &#8220;Blow-Fill-Seal Business&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyNTA_a1bc8e91-efbb-46bf-9347-c33e8c37cb1b">300</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cash, a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyNjg_9779e98d-74e5-4ef4-8e88-39de530a629e">50</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> note receivable (estimated fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzMDI_ffbfbc0d-6da5-4e9c-a1e0-93f1fba997ea">47</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) as well as potential additional contingent consideration (up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzMjA_6000ff1c-9abb-44c3-8bba-39f0b57d0916">50</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) dependent upon the performance of aspects of the Blow-Fill-Seal Business. The Blow-Fill-Seal Business was part of the Oral and Specialty Delivery segment. The carrying value of the net assets sold was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzNDY_637bb7f8-ba74-487a-998e-9c66af26337c">149</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which included goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzNjQ_c4e95476-26ef-447f-b5c9-3ae8fbb732c3">54</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result of the sale, the Company realized a gain from divestiture of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzODM_bbcc9783-6252-48ed-bfec-01b41a9ecf37">182</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of transaction costs, for the fiscal year ended June 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Blow-Fill-Seal Business was classified as held-for-sale. The Company determined that the sale of the business did not meet the criteria to be considered a discontinued operation as the disposal of the Blow-Fill-Seal Business did not represent a strategic shift that has (or will have) a major effect on the Company's financial results upon disposal.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1d7bc7d8ea204441b983962a277c3ad1"><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All consideration received was measured at its divestiture date fair value. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjQ_3f59a9f6-837f-4e78-95e5-338bba93eea3" continuedAt="idc1b9f9b8ce648ec880beb2c9b6cc54f" escape="true">The Company valued the total consideration received from divestiture of the Blow-Fill-Seal Business as follows:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="idc1b9f9b8ce648ec880beb2c9b6cc54f"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fair value of consideration received</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzEtMS0xLTEtNTA1MA_6186abd6-444a-4e1e-9c14-01192913e422">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" name="ctlt:CashAndNoncashDivestitureAmountOfConsiderationReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzUtMS0xLTEtNTA1MA_0a324c6a-1b13-4fb6-aa26-94215c9d90e3">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjU_06075297-4751-46c5-a27e-6f29d0b084c2" continuedAt="i41f56771a8f5498f969d0587e764dce3" footnoteRole="http://www.xbrl.org/2003/role/footnote">The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of </ix:footnote></span><ix:continuation id="i41f56771a8f5498f969d0587e764dce3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquiredReceivablesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0MDE_ffbfbc0d-6da5-4e9c-a1e0-93f1fba997ea">47</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at June 30, 2021, which is the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0NTQ_9779e98d-74e5-4ef4-8e88-39de530a629e">50</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount less a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:BusinessCombinationLoanDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0NzE_6802cf35-d214-4369-9736-5b96f86311f6">3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discount determined using a discounted cash flow model with the market interest rate as a significant input.</span></ix:continuation></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjY_d5a34fbe-8aac-4050-91f7-0f104b2d6e4e" continuedAt="ie2d1a816e63c443dae3446eaf0dc5f2c" footnoteRole="http://www.xbrl.org/2003/role/footnote">The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, </ix:footnote></span><ix:continuation id="ie2d1a816e63c443dae3446eaf0dc5f2c"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjc_3f28e412-27b7-4462-b4ea-70aa0eee8b9f" continuedAt="ib6ef5d3f80034205af183b660b55b1bb" footnoteRole="http://www.xbrl.org/2003/role/footnote">Other includes </ix:footnote></span><ix:continuation id="ib6ef5d3f80034205af183b660b55b1bb"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0ODg_4d1c8f83-59b3-453e-912e-42b880d8571e">8</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of transaction expenses, a working capital adjustment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:BusinessCombinationWorkingCapitalAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY1MDc_3f7062c8-39d0-4b09-b798-3a889afaa91f">6</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY1MzE_d8d4deb3-7aec-405a-8fc2-6563832f7fdc">2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assumption of liabilities resulting in net cash proceed of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:ProceedsFromDivestitureOfBusinessesNetCashProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY2MDc_7cd082fa-c225-4002-a247-b2d0a0624f24">287</ix:nonFraction> million for the fiscal year ended June 30, 2021, with an additional $<ix:nonFraction unitRef="usd" contextRef="i180acc781ca7481394028c8cb6e82480_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNTQ_2d899a23-21c8-4018-8010-ee281a7fcf6f">3</ix:nonFraction>&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.</span></ix:continuation></div></ix:continuation></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_193"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzg0Nw_654d0999-bf36-43e5-859f-28d712b172cc" continuedAt="ibcae6e8f574141099cde6bc39aba6d54" escape="true">GOODWILL</ix:nonNumeric></span></div><ix:continuation id="ibcae6e8f574141099cde6bc39aba6d54" continuedAt="i072d975a5bc24b358d7391797eed3dc9"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzg0NQ_432d4f37-e7f5-48b6-8569-77583bf66b8a" continuedAt="i753ac0569d944d499eca2e7dbea473c5" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes from June&#160;30, 2019 to June&#160;30, 2020 and then to June&#160;30, 2021 in the carrying amount of goodwill in total and by reporting segment:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3271a0d0c6f0478ea7b97b353bd69af2_I20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtMS0xLTEtMA_e31e17b4-97f8-47b6-ba2c-05c76f8d0200">1,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c2bcc242b14433b4c516133cfacc12_I20190630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtNC0xLTEtMA_f0bfb3c1-be16-4cfe-b16b-81cc1e0cd494">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if22a051247f64fc693ae10ac38acda75_I20190630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtNi0xLTEtMA_bda70f9c-dab4-42de-aec9-b93968b9e09d">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i654dce15c0874c9fb40648bb53e7594b_I20190630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtOC0xLTEtMA_89424c17-c32c-4abd-bcd5-ae7097d1ed10">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtMTAtMS0xLTA_3b039108-286a-4df8-9940-77201881020e">2,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItNC0xLTEtMA_7193afb7-b490-4ff5-9879-388c4733b2c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItNi0xLTEtMA_d81e9918-1992-4bf5-9ecc-e605a66cca20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItOC0xLTEtMA_33e03b6d-d1cb-4b99-8809-0179ad3c6e39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-5" sign="-" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtMS0xLTEtMA_ac488c23-e566-4e1f-937e-9847e1407ae9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="3" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtNC0xLTEtMA_879f0127-c6b2-4b62-8431-3de0ee2b0d1b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="3" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtNi0xLTEtMA_bfe92fc1-361f-48ac-b7ee-49cb8c2f28a2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="3" format="ixt:fixed-zero" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtOC0xLTEtMA_6b1c5130-7a8b-4a65-a8c1-1e2bf378e181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="3" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtMTAtMS0xLTA_e68b0b9a-4bd2-4cb3-ac69-affab786e25a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtMS0xLTEtMA_68335b7f-9248-4499-b9bb-98ee84bd78f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtNC0xLTEtMA_4382e8f7-aa2d-469f-bf39-ce6c65074a0c">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtNi0xLTEtMA_67bf76ed-6ba7-4726-a41f-c56d29d8ba66">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtOC0xLTEtMA_53b3a1f5-6c79-4e29-914c-b3cb8613cbde">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtMTAtMS0xLTA_a4004785-776b-44e8-a940-e885dd6d6066">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2726cb57c9441d90eb8e733906a808_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtMS0xLTEtMA_2df4bbad-9ff6-4258-abf3-2d9d99dd3452">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7061380698a4b9395a2f0cfba0d8aac_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtNC0xLTEtMA_ee99cbe3-f070-4b02-bfa6-a68fa03fc347">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtNi0xLTEtMA_462c64a6-a42d-4918-b2f8-fe33533230aa">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab98274d571d4d449f30491cdd65c962_I20200630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtOC0xLTEtMA_7b322eb9-6d52-46d4-a8e0-4923c8427395">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtMTAtMS0xLTA_184bb403-f0da-4591-a250-f37e28d1578d">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNC0xLTEtMA_25bc90be-2749-46b0-9d39-de745eefb38c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctOC0xLTEtMA_b4a1e5f9-b901-4c80-890c-7bb4c03f1a61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMS0xLTEtMjcwNA_83a0654a-4e97-4d1a-8f52-420367b27227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNC0xLTEtMjcyMw_4511990e-71b4-481d-a6b8-9728de355799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtOC0xLTEtMjczOA_2bd19f00-6faa-4672-a288-ee70e359404a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTEtMS0xLTA_5dca7fc9-b46d-42ec-a4d8-2f9a5fc6b076">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTQtMS0xLTA_b1108577-0008-4d4f-b7db-94900e0a67d6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTYtMS0xLTA_ef0167cd-08a3-4ae6-9070-fdea6532edf6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTgtMS0xLTA_73f8c903-637e-4041-bc13-d7cfbbe0b6d7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTEwLTEtMS0w_377a2c6f-150a-4ac6-96df-fb6725840cb6">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d420fead59462095697a3993d8f4e5_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTEtMS0xLTA_89540598-0acb-43c0-b9e7-4e05aedbc5f3">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebdb26351324dc59f4adf268bf038a1_I20210630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTQtMS0xLTA_f8b75c7d-6c6e-48ea-829a-34ecdda0e39f">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7814e488a794292a9e3f5a1d348951e_I20210630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTYtMS0xLTA_cd421907-25a1-4f19-b17a-dcdf80a41f92">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88402b35bd0c42118b8f0b1db0690925_I20210630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTgtMS0xLTA_6d06dde3-4e7d-47d0-aa88-fe4b160728c9">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTEwLTEtMS0w_0bb2a05d-2b56-4dd9-9002-2d3d5ac6a576">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422" continuedAt="icdf5cde7662847b8ae9b2b03c82a3ac6" footnoteRole="http://www.xbrl.org/2003/role/footnote">The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, </ix:footnote></span><ix:continuation id="icdf5cde7662847b8ae9b2b03c82a3ac6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></ix:continuation></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c" footnoteRole="http://www.xbrl.org/2003/role/footnote">The reallocation in fiscal 2020 relates to adjustments to the Company&#8217;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. </ix:footnote></span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b" continuedAt="i4d4eaeb4a9e94c9b80f02ce3db6d1ba1" footnoteRole="http://www.xbrl.org/2003/role/footnote">The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, </ix:footnote></span><ix:continuation id="i4d4eaeb4a9e94c9b80f02ce3db6d1ba1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i072d975a5bc24b358d7391797eed3dc9" continuedAt="i22a3fd3a666c43ada128f51bc7b30f40"><ix:continuation id="i753ac0569d944d499eca2e7dbea473c5">(4) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb" footnoteRole="http://www.xbrl.org/2003/role/footnote">Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.</ix:footnote></ix:continuation></ix:continuation></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i22a3fd3a666c43ada128f51bc7b30f40">The Company recorded no impairment charge to goodwill in fiscal 2021, 2020, or 2019.</ix:continuation> </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_196"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4OQ_bf863b39-a391-4d97-ab36-84892902af3a" continuedAt="i51edbca3b9cc4bb38141d45cf1050265" escape="true">OTHER INTANGIBLES, NET</ix:nonNumeric></span></div><ix:continuation id="i51edbca3b9cc4bb38141d45cf1050265"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4NQ_e691e90d-5377-4a03-95a1-42c463e49459" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of other intangible assets subject to amortization as of June&#160;30, 2021 and June&#160;30, 2020 are as follows (in millions):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iad48a9578f7b445ab0c1b13ac0a459e2_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItMS0xLTEtMA_d12e8402-8c01-4783-9adf-2ae88d8796d4">19</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItMy0xLTEtMA_6b108f39-307c-4083-ad18-01dea2d764fd">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItNS0xLTEtMA_dd4f0fa8-3683-4567-b091-a324a3215b5b">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItNy0xLTEtMA_f3793884-b4a1-410e-bf46-52a030394d64">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i845bd8ba54d74c7fb72abac0310f0e79_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtMS0xLTEtMA_763de78a-2cb4-4787-855b-328b06eeb6a9">14</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e750947153247c48b42689a9511423f_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtMy0xLTEtMA_ceaa0f6e-5218-48a1-a9ea-1c773c0819bf">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e750947153247c48b42689a9511423f_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtNS0xLTEtMA_250c4e14-4c63-4ff8-9cbe-214be9f5444c">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e750947153247c48b42689a9511423f_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtNy0xLTEtMA_12d781ac-09d3-4344-b508-3dd2ac0577a7">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i111cc1fffc0343ee85c1cfa4409c4152_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtMS0xLTEtMA_282cfd92-0265-46fd-bb37-83ebb59c8469">11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtMy0xLTEtMA_6a944c71-36f5-432f-a256-a41b9c4e9714">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtNS0xLTEtMA_824eb597-417b-4d05-a956-9dd06de37673">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtNy0xLTEtMA_246d63b8-a7e3-435c-aa08-92d3c970ab83">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c882c4168ec447fba77d5f523c9881f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtMS0xLTEtMA_fe44493b-f5be-43d6-9c9c-9b2e64b5c6d1">5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ee2895bde24a118a0de6982690f442_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtMy0xLTEtMA_f17d04b2-10e5-4a2e-952f-327cae69b3df">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86ee2895bde24a118a0de6982690f442_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtNS0xLTEtMA_adea48fb-ecd5-43f0-bca6-febf06a56abf">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ee2895bde24a118a0de6982690f442_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtNy0xLTEtMA_cefa1962-b849-4f84-b705-ba42070be742">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtMy0xLTEtMA_23c5cc63-7497-4958-9b7e-05e5c8636b00">1,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtNS0xLTEtMA_56f988d2-5e23-4875-9547-05a03632f85d">645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtNy0xLTEtMA_32f940be-6484-4fed-bc3c-43e0624ad870">817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief92cbae4c3841df84e37fe359a93709_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItMS0xLTEtMA_d0da11b4-09bb-44ae-ad62-d1cfab2a8dd8">19</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItMy0xLTEtMA_bd504f3f-64b0-47be-ad89-6d417954ca85">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItNS0xLTEtMA_0f5e510b-a714-461e-b33e-2f44016554ac">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItNy0xLTEtMA_ebe017c4-d878-4874-997e-1edb49fbc65c">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i704ca8cefa7742e4aad55ca96150cc8b_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtMS0xLTEtMA_ebf423cc-2897-4b2e-b568-f36d0a2c3cf4">14</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b028860ed64053b94135848c0906f0_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtMy0xLTEtMA_2abff124-749f-46ad-8575-234d8ca1ecd4">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26b028860ed64053b94135848c0906f0_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtNS0xLTEtMA_a7a7fa66-618c-4627-892b-90c619984053">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26b028860ed64053b94135848c0906f0_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtNy0xLTEtMA_9f0e8faf-d66d-43b3-92a5-e3a367147c18">773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if93fec8f8cb448208c403c46c07fedc6_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtMS0xLTEtMA_1f20bcf3-cb7e-44fc-8d3d-8cd7f2a382d8">11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtMy0xLTEtMA_03820cb1-ce46-4625-bd67-c900e66428ad">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtNS0xLTEtMA_583ada8e-3c2a-4ddc-8d60-299ea5593556">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtNy0xLTEtMA_40d0ba42-20ff-4822-a2cb-6cbea538e22b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c4aea4c64794160b8c6f3912b4dd294_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtMS0xLTEtMA_500063ab-1b31-4633-acd5-c30091b7e71b">5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7344efba23c04c1484bed638331da234_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtMy0xLTEtMA_80adde64-613f-4e94-8af5-f68f796ad59d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7344efba23c04c1484bed638331da234_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtNS0xLTEtMA_96c57765-2a1e-4810-8120-8626553a3edb">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7344efba23c04c1484bed638331da234_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtNy0xLTEtMA_c294b6e5-f241-4218-9a05-1f3b5eda8590">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtMy0xLTEtMA_865e43f9-5507-4f77-89d7-337ee532a34b">1,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtNS0xLTEtMA_6fe31295-c9b4-4718-889b-7d84cedd7b32">553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtNy0xLTEtMA_1e8ef825-9af1-425b-8be8-66c2e8c281e4">889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ1MQ_19c75992-5b86-460c-b40b-b1636011649b">93</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ1NQ_6587c6e7-7f54-4d85-934e-8b6eca7c0298">89</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ2Mw_d3427ace-7b0b-4696-94e2-69541294e8b3">88</ix:nonFraction> million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4Nw_f94b599d-ea85-4bb5-a2c9-bab2061dd6f9" continuedAt="i498b1141e2b641a9ac876ea653bf8284" escape="true">Future amortization expense for the next five fiscal years is estimated to be:</ix:nonNumeric></span></div><div style="margin-top:9pt"><ix:continuation id="i498b1141e2b641a9ac876ea653bf8284"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtMS0xLTEtMA_ffd7194f-ee25-4d90-af96-86c1f1bee5da">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtMy0xLTEtMA_a4243c14-e69d-48f7-9369-1a30a4ace4f3">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtNS0xLTEtMA_05a1ed95-5c80-4031-8d01-c1904a59f21d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtNy0xLTEtMA_11370430-c50d-426f-9f06-a682a611dd37">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtOS0xLTEtMA_92e5ce6c-3d2b-464b-bf1f-3d279a98ea9a">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_202"></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEzODg_01796e21-9ead-465a-979b-1dc118aff1c4" continuedAt="i7336e7623063482eb620ded028000d3a" escape="true">RESTRUCTURING COSTS</ix:nonNumeric></span></div><ix:continuation id="i7336e7623063482eb620ded028000d3a" continuedAt="iba0ed3c0e2e442e79e27d06a2105624a"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has implemented plans to restructure certain operations, both domestically and internationally. The restructuring plans focused on various aspects of operations, including closing and consolidating certain manufacturing operations, rationalizing headcount and aligning operations in a strategic and more cost-efficient structure. In addition, the Company may incur restructuring charges in the future in cases where a material change in the scope of operation with its business occurs. Employee-related costs consist primarily of severance costs and also include outplacement services provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods. Facility exit and other costs consist of accelerated depreciation, equipment relocation costs, and costs associated with planned facility closures to streamline Company operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2021, the Company adopted a plan to reduce costs and optimize its infrastructure in Europe by closing its Clinical Supply Services facility in Bolton, U.K. In connection with this restructuring plan, the Company expects to reduce its headcount between <ix:nonFraction unitRef="employees" contextRef="i378811f92e0f4ffeb7fb93c1f1f293eb_D20200701-20210630" decimals="0" name="us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0MjI_09c377d3-a278-4d19-abf0-3aa3b6f76045">150</ix:nonFraction> and <ix:nonFraction unitRef="employees" contextRef="icf709e90ec7842118e0f9f686273d1e9_D20200701-20210630" decimals="0" name="us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0Mjg_13b44a24-ef62-41f4-854b-254d4789a2dc">180</ix:nonFraction> employees through December 31, 2021 and estimates that it will incur charges between $<ix:nonFraction unitRef="usd" contextRef="i2731c0e309f94c7b87f012c3985d4fc2_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0NDE_cb60e9ac-d272-4940-9384-ba8ddf7fc3b9">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8ff2c23c60004dfab89f35aa1a024575_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0NTg_28befcb2-902c-40e2-9695-f026962c2692">8</ix:nonFraction> million, primarily associated with employee severance benefits. For the fiscal year ended June 30, 2021, restructuring charges associated with the Bolton facility closure were $<ix:nonFraction unitRef="usd" contextRef="i8e8e76f0ec8f455cb11705921585b0c4_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEwOTk1MTE2MzY2MzE_c097f3fe-a371-4459-aaa0-8668b1f50f1d">7</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2020, no significant restructuring plan was adopted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2019, the Company adopted a plan to restructure its workforce following a temporary suspension of operations at a Softgel and Oral Technology facility. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><ix:continuation id="iba0ed3c0e2e442e79e27d06a2105624a"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEzODU_f7c07225-76eb-48ee-998c-6044a58d82c0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the costs recorded within restructuring costs: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee-related reorganization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtMS0xLTEtMA_48109db2-11c7-47a6-95ce-561094e52ef2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtMy0xLTEtMA_e63c2a51-7d29-4f71-9a62-55b0a154609b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtNS0xLTEtMA_068490a9-c5ac-4cba-a6d2-c7c7f6cc8aa6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facility exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtMS0xLTEtMA_c062582e-961c-4e43-8a63-45d203eb5ed8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtMy0xLTEtMA_3a150b35-725e-4fa6-89d5-1b68532afced">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtNS0xLTEtMA_3727639c-feeb-4d54-81a0-ab78f905e44c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctMS0xLTEtMA_ce350661-9213-4838-91c8-76e15dcd5c6b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctMy0xLTEtMA_95bf33b6-340d-48ce-b496-f38f91cf2c9d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctNS0xLTEtMA_8e83c4e2-5334-4ecf-9433-1843179993f6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_205"></div><div style="padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDE2_036c2ad8-e4da-4aba-ae73-556e20c9a467" continuedAt="i8f2e358cd5d6444daa5bd7ae57859cc5" escape="true">LONG-TERM OBLIGATIONS AND SHORT-TERM BORROWINGS</ix:nonNumeric></span></div><ix:continuation id="i8f2e358cd5d6444daa5bd7ae57859cc5" continuedAt="i3afc0588d4ee4334bc95732827562f40"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDE3_125504bd-42af-4d94-9dc4-1ec4ade63e08" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term obligations and short-term borrowings consist of the following at June&#160;30, 2021 and June&#160;30, 2020:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Maturity as of June 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-2 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533413c430064ec6b4c844cc3f1acfbe_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzItMy0xLTEtMA_35c3d2bb-6c6c-4795-bf81-c1150da4acf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fceb629bb441a8a053f8395affd416_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzItNS0xLTEtMA_e909be16-3d6d-4130-87d6-98c4bac22bab">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad07736ec7541dcaa87a7b378aa1ebf_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzMtMy0xLTEtNjMy_667a07ff-8562-4987-8c01-4fbd4feba9e1">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684ac58b65d2462d9086fd8d03006003_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzMtNS0xLTEtNjM1_2fe4ad7b-b3f2-4b74-b7b0-09259a132b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i776ba765031f4822ac7631755e4324e0_I20210630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzUtMy0xLTEtMA_2f6391cf-8f05-4b0b-b946-f8af1e6228cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf427a11407e441c9ae17c2a3bc8d22a_I20200630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzUtNS0xLTEtMA_2eb6c6f8-6fa6-408e-98d1-6a110ddcd049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% senior notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzctMy0xLTEtMA_04b2316a-e856-4138-8cb2-8a52988099b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d7e2c8c43a47c0a933c613e1998a34_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzctNS0xLTEtMA_cc23af87-7f07-4fec-915b-8e5038fe2de8">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% senior notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8daa403fef413dba97b83235c8ea21_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzgtMy0xLTEtMA_d2e5fd77-4c9d-46c3-9a7c-515626699067">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a1e048ba7c4e9691ded7739ee1a189_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzgtNS0xLTEtMA_85db73c0-8f6a-4878-ac34-fd45a96daab5">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated senior notes due 2028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796cb7ff80c54ea8a86407355ff7fedb_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% senior notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMjMyMA_9c81d95e-bf0c-4c0e-ad43-fd6199fca1d2">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib061337543284797b3b9d0ef58f9ec80_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMjMyMw_aaaa444f-4db6-4f39-bedb-a4fde9132053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred purchase consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d27525d7cf54500bd9efcef6e00f2a5_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEwLTMtMS0xLTA_32299aa3-4269-4a88-9a3f-9feec49a8605">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac432fc632a4aa4b73cc9827f98414a_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEwLTUtMS0xLTA_b7414073-00a0-471c-acb6-cbe144ff23fb">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508875b781734fda88090125bce65502_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEyLTMtMS0xLTA_5af276e1-a426-417d-892f-eb957759d754">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9042a8cb274081acd357a646d69523_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEyLTUtMS0xLTA_1eedf086-5078-4d7f-b235-35aac525bd3b">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de35b0a15464306a00bc384ef0ae803_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEzLTMtMS0xLTA_b2f073b3-a216-4612-ab28-b4acebe9f0f2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8095367c62b3442fb4b4cbb5c6ceeaa6_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEzLTUtMS0xLTA_897c0edd-08db-47e3-9b90-7ca1bce4c605">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTYzOA_06d5b7b5-e0ac-47ef-b6b1-40886220bbb6"><ix:nonFraction unitRef="usd" contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTYzOA_b7e2dc6a-5e00-4abd-97f1-da63c7bf3c6a">36</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTY0MQ_67bc48b1-0174-4a39-9328-c791b43ebbb1"><ix:nonFraction unitRef="usd" contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTY0MQ_f53bae1e-bcd3-43d9-9796-2f87b0cfb09b">37</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE0LTMtMS0xLTA_773f8f9b-afa2-4794-9348-80d38e48e279">3,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE0LTUtMS0xLTA_8ec984fa-f8df-4349-a3db-5e1f2fb68060">3,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term<br/>&#160;&#160;&#160;&#160;&#160;borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTA_0dbe6038-db0e-4942-80bd-e05d09450dd6">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTA_17eb26c2-0656-4536-be47-320e2d7c530c">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE2LTMtMS0xLTA_65b41302-461a-4c7b-b90f-c91f6467b1ae">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE2LTUtMS0xLTA_bddb4a06-6680-4292-9be2-89b4470fd70f">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d" footnoteRole="http://www.xbrl.org/2003/role/footnote">The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</ix:footnote></span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities and Fifth Amendment to the Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Operating Company completed Amendment No. 5 (the "Fifth Amendment") to its Amended and Restated Credit Agreement, dated as of May 20, 2014 (as subsequently amended, the "Credit Agreement"). Pursuant to the Fifth Amendment, Operating Company refinanced the existing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ie91ae3a1701e42c4bab269d3f3f05bb4_I20210228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjI2_7cf8aa7f-d3e6-43d4-9b98-289bf3f4a7c3">933</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount of U.S. dollar-denominated term loans (the "Term B-2 Loans") with the proceeds of an equivalent amount of new U.S. dollar-denominated term loans (the "Term B-3 Loans"), incurred an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i889429d7ce8e4d9998dd05977d62e04b_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseDecreaseOtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjQ2_06037404-ce01-4133-a2ce-c648a2d75503">67</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount of Term B-3 Loans, and obtained an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i8a70d7001a4d41889b95e3278d9d6e76_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseDecreaseOtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEwOTk1MTE2NTUyMzc_2f3ce16b-2fbc-4d74-83fd-fc433399b122">175</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revolving credit commitments (the "Incremental Revolving Credit Commitments") under the Credit Agreement's revolving credit facility (the "Revolving Credit Facility"). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term B-3 Loans constitute a new class of term loans under the Credit Agreement, with an interest rate of one-month LIBOR (subject to a floor of <ix:nonFraction unitRef="number" contextRef="i82917b6fc7de420b9f04e1c84874f333_D20200701-20210630" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjU5_b15bd8f1-5d2a-4dd6-8211-d256f0ab0fed">0.50</ix:nonFraction>%) plus <ix:nonFraction unitRef="number" contextRef="i0282c343e7634e19b53f822bfc4e477f_D20200701-20210630" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjY4_7780d965-b005-4541-b7fb-f40c5c861a52">2.00</ix:nonFraction>% per annum, a maturity date of February 2028 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly amortization of principal equal to <ix:nonFraction unitRef="number" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="ctlt:DebtInstrumentQuarterlyAmortizationRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjc4_cb54d649-4587-4b56-8263-aacd6e952674">0.25</ix:nonFraction>% with payments on the last business day of March, June, September, and December. The proceeds of the Term B-3 Loans, after payment of the offering fees and expenses, were used to repay in full the existing Term B-2 Loans under the Credit Agreement, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3afc0588d4ee4334bc95732827562f40" continuedAt="iac986dd3f55a478cafeda2f1610a7292"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incremental Revolving Credit Commitments constitute revolving credit commitments under the Revolving Credit Facility.  The applicable rate for all revolving credit facility commitments under the Revolving Credit Facility is initially LIBOR plus <ix:nonFraction unitRef="number" contextRef="i076d5ed390e143ec905916749b2b91cd_D20200701-20210630" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjg3_ca974445-21c5-4ec6-85e0-5d96b9f46ad8">2.25</ix:nonFraction>% and such rate can additionally be reduced to LIBOR plus <ix:nonFraction unitRef="number" contextRef="i51dabd2b047049b4a2d87b4d8f3f5b9c_D20200701-20210630" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjk1_f1e52eff-da61-4209-aee1-19b6ede8ddef">2.00</ix:nonFraction>% in future periods based on a measure of Operating Company's total leverage ratio.  The maturity date for the Revolving Credit Facility is the earlier of (i) May 17, 2024 and (ii) the 91st day prior to the maturity of the Term B-3 Loans. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the Fifth Amendment, certain modifications were made to the Credit Agreement in order to, among other things, provide for determination of a benchmark replacement interest rate when LIBOR is no longer available.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of capacity under the Revolving Credit Facility is reduced by the aggregate value of all outstanding letters of credit under the Credit Agreement. As of June&#160;30, 2021, Operating Company had $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzMwMzA_09707abe-7ca4-4411-b03b-76f777df017c">719</ix:nonFraction> million of unutilized capacity under the Revolving Credit Facility due to $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzMxMTU_549913cb-e1e1-4fd4-b61e-034492006731">6</ix:nonFraction> million of outstanding letters of credit. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.000% Senior Notes due 2027</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Operating Company completed a private offering of $<ix:nonFraction unitRef="usd" contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQxNTU_fdebce41-2608-424a-8e7a-1f4dcd666d2d">500</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQxODg_a3bc2dbc-3121-4081-afce-f5e2004d92db">5.000</ix:nonFraction>% Senior Notes due 2027 (the &#8220;2027 Notes&#8221;). The 2027 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2027 Notes were offered in the U.S to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2027 Notes will mature on July 15, 2027 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ3NDY_a3bc2dbc-3121-4081-afce-f5e2004d92db">5.000</ix:nonFraction>% per annum. Interest is payable semi-annually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The proceeds of the 2027 Notes after payment of the offering fees and expenses were used to repay in full the borrowings under Operating Company&#8217;s then-outstanding term loans under its senior secured credit facilities that would otherwise have matured in May 2024.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2.375% Euro-denominated Senior Notes due 2028</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, Operating Company completed a private offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="i814e92c75da3452187f82acd0565e8db_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzMzk5Mzk_3c5c7c34-4906-4dd2-9743-dd71ea01c564">825</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i814e92c75da3452187f82acd0565e8db_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEwOTk1MTE2NDI3NzY_e1989fa5-8bc4-44c0-862a-5a2d96f7bd48">2.375</ix:nonFraction>% Senior Notes due 2028 (the "2028 Notes"). The 2028 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The Euro 2028 Notes were offered in the U.S. to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S. only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2028 Notes will mature on March 1, 2028 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="i814e92c75da3452187f82acd0565e8db_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMDY_e1989fa5-8bc4-44c0-862a-5a2d96f7bd48">2.375</ix:nonFraction>% per annum. Interest is payable semi-annually in arrears on March 1 and September 1 of each year. The proceeds of the 2028 Notes after payment of the offering fees and expenses were used to repay in full the borrowings then outstanding under Operating Company's euro-denominated term loans under its senior secured credit facilities, which would have matured in May 2024, and repay in full Operating Company's euro-denominated <ix:nonFraction unitRef="number" contextRef="i2277ff43db9c4df8b0dc6f627b3a499a_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMTQ_06e8200b-9675-412f-b4a4-68fb3ced285c">4.75</ix:nonFraction>% Senior Notes due 2024 (the &#8220;2024 Notes&#8221;), which would have matured in December 2024, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">3.125% Senior Notes due 2029</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Operating Company completed a private offering of $<ix:nonFraction unitRef="usd" contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzMzk5Nzc_ec97b755-7311-4696-aa48-8c457b696118">550</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwNDE_25a0e80d-17ca-47f0-a724-8745e1508492">3.125</ix:nonFraction>% Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes and the 2028 Notes, the "Senior Notes"). The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2029 Notes will mature on February 15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMzI_25a0e80d-17ca-47f0-a724-8745e1508492">3.125</ix:nonFraction>% per annum payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021. The proceeds of the 2029 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under Operating Company's <ix:nonFraction unitRef="number" contextRef="ic60365c610a94f2a911805e966520b33_I20171018" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMjM_fedc589d-5a97-44ab-ac8b-151a99593a6d">4.875</ix:nonFraction>% Senior Notes due 2026. which would have matured in January 2026 (the "2026 Notes") plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Purchase Consideration</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Cook Pharmica LLC (now Catalent Indiana, LLC) in October 2017, $<ix:nonFraction unitRef="usd" contextRef="ibf405a2085fd40a8b0117b3a3432c514_D20171001-20171023" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzYzNjc_0823772c-9391-49b0-b30a-24710658b975">200</ix:nonFraction> million of the $<ix:nonFraction unitRef="usd" contextRef="i8b827d728ed040f9aa9a77f9d945ef0d_D20171001-20171023" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzYzNzc_e84012ab-6da8-4d4a-b545-cfd53211583c">950</ix:nonFraction> million aggregate nominal purchase price is payable in $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:InstallmentPaymentForAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzY0Mjc_5b27bad1-640a-498e-b622-fe6592fd15e5">50</ix:nonFraction> million installments, on each of the first four anniversaries of the closing date. The Company made installment payments in October 2018, 2019, and 2020. The balance of the deferred purchase consideration was recorded at fair value as of the acquisition date, with the difference between the remaining nominal amount and the fair value as of any relevant period end treated as imputed interest. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iac986dd3f55a478cafeda2f1610a7292" continuedAt="i788ab2edbed543b39c0fcacc07057eed"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term and Other Obligations </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other obligations consist primarily of finance leases for buildings and other loans for business and working capital needs. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDEz_34504090-4dba-4c85-b39e-f4d1e92de4a8" continuedAt="i149cbafaaa3a4c14988be15caf4de46c" escape="true">Maturities of long-term obligations, including finance leases of $<ix:nonFraction unitRef="usd" contextRef="i508875b781734fda88090125bce65502_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzcwMTE_5af276e1-a426-417d-892f-eb957759d754">193</ix:nonFraction> million, and other short-term borrowings for future fiscal years are:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt"><ix:continuation id="i149cbafaaa3a4c14988be15caf4de46c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:35.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of long-term and other obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMS0xLTEtMA_442e5d9d-af27-47e9-861d-216c0838439f">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMi0xLTEtMA_56b46de6-1fbc-4bc7-9799-782e472a809b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMy0xLTEtMA_8f672537-974b-4139-93f1-c5d5f54d34ea">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNC0xLTEtMA_4156afe8-bed3-4a2f-a103-749196db0eba">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNS0xLTEtMA_68f86c88-f962-4cb8-afa6-e8cabdb47092">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNi0xLTEtMA_190f90fd-8f36-4b04-ba51-75b2ffb6b722">3,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNy0xLTEtMA_4237c888-ddb2-4eb7-92fd-a1e535c4f5ee">3,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs associated with the Credit Agreement (other than its Revolving Credit Facility component) and the Senior Notes are presented as a reduction to the carrying value of the related debt, while debt issuance costs associated with the Revolving Credit Facility are capitalized within other long-term assets on the consolidated balance sheet. All debt issuance costs are amortized over the life of the related obligation through charges to interest expense in the consolidated statements of operations. The unamortized total debt issuance costs, including the costs associated with the Revolving Credit Facility capitalized within other long-term assets, were $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc2NzQ_53019b6b-5d60-4662-bb4c-9a69968b93af">38</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc2ODE_a011a7a1-8215-493d-979c-1b8aa3a99e0b">39</ix:nonFraction>&#160;million as of June&#160;30, 2021 and 2020, respectively. Amortization of debt issuance costs totaled $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc3NjE_2eb13d64-f8e6-472b-8fa6-6c59f87931bd">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc3Njg_8e5e9caa-f876-46d2-9117-521ad6addd2f">6</ix:nonFraction> million for the fiscal years ended June&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Security </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the following assets of Operating Company and each guarantor (Operating Company's parent entity, PTS Intermediate, and each of Operating Company's material domestic subsidiaries), subject to certain exceptions: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">a pledge of <ix:nonFraction unitRef="number" contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630" decimals="2" name="ctlt:PledgePercentageOfCapitalStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzgyMjk_3958dd18-d261-4eac-8f45-5c074578ae97">100</ix:nonFraction>% of the capital stock of Operating Company and <ix:nonFraction unitRef="number" contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630" decimals="2" name="ctlt:PledgePercentageOfEquityInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzgyNzg_d53c262d-14f6-4111-b7bc-2dd85aeaa4b3">100</ix:nonFraction>% of the equity interests directly held by Operating Company and each guarantor in any wholly owned material subsidiary of Operating Company or any guarantor (which pledge, in the case of any non-U.S. subsidiary of a U.S. subsidiary, will not include more than <ix:nonFraction unitRef="number" contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630" decimals="2" name="ctlt:MaximumPercentageOfVotingStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzg1NDA_ec582c6f-d9d6-4ded-938e-4fe5e7e76c16">65</ix:nonFraction>% of the voting stock of such non-U.S. subsidiary); and </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">a security interest in, and mortgages on, substantially all tangible and intangible assets of Operating Company and of each guarantor, subject to certain limited exceptions. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Senior Notes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Senior Notes are general, unsecured, and subordinated to all existing and future secured indebtedness of the guarantors to the extent of the value of the assets securing such indebtedness. Each of the Senior Notes is separately guaranteed by all of Operating Company's wholly owned U.S. subsidiaries that guarantee the senior secured credit facilities. None of the Senior Notes is guaranteed by either PTS Intermediate or the Company. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains a number of covenants that, among other things, restrict, subject to certain exceptions, Operating Company&#8217;s (and Operating Company&#8217;s restricted subsidiaries&#8217;) ability to incur additional indebtedness or issue certain preferred shares; create liens on assets; engage in mergers and consolidations; sell assets; pay dividends and distributions or repurchase capital stock; repay subordinated indebtedness; engage in certain transactions with affiliates; make investments, loans or advances; make certain acquisitions; enter into sale and leaseback transactions; amend material agreements governing Operating Company's subordinated indebtedness and change Operating Company's lines of business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains change of control provisions and certain customary affirmative covenants and events of default. The Revolving Credit Facility requires compliance with a net leverage covenant when there is a 30% or more draw outstanding at a period end. As of June&#160;30, 2021, the Company was in compliance with all material covenants under the Credit Agreement. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i788ab2edbed543b39c0fcacc07057eed"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, the Credit Agreement permits Operating Company and its restricted subsidiaries to incur certain additional indebtedness, including secured indebtedness. None of Operating Company&#8217;s non-U.S. subsidiaries nor its dormant Puerto Rico subsidiary is a guarantor of the loans.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement, Operating Company&#8217;s ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Credit Agreement). Adjusted EBITDA is based on the definitions in the Credit Agreement, is not defined under U.S. GAAP, and is subject to important limitations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Senior Notes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various indentures governing the Senior Notes (collectively, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indentures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) contain covenants that, among other things, limit the ability of Operating Company and its restricted subsidiaries to incur or guarantee more debt or issue certain preferred shares; pay dividends on, repurchase, or make distributions in respect of their capital stock or make other restricted payments; make certain investments; sell certain assets; create liens; consolidate, merge, sell; or otherwise dispose of all or substantially all of their assets; enter into certain transactions with their affiliates, and designate their subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of exceptions, limitations, and qualifications as set forth in the Indentures. The Indentures also contain customary events of default, including, but not limited to, nonpayment, breach of covenants, and payment or acceleration defaults in certain other indebtedness of Operating Company or certain of its subsidiaries. Upon an event of default, either the holders of at least 30% in principal amount of each of the then-outstanding Senior Notes or the applicable Trustee under the Indentures may declare the applicable notes immediately due and payable; or in certain circumstances, the applicable notes will automatically become immediately due and payable. As of June&#160;30, 2021, Operating Company was in compliance with all material covenants under the Indentures. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimated Fair Value of Debt Measurements</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair values of the senior secured credit facilities and Senior Notes are classified as Level 2 (see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for a description of the method by which fair value classifications are determined) in the fair value hierarchy and are calculated by using a discounted cash flow model with market interest rate as a significant input. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDA5_b999c210-aae8-4184-9f7a-53c16a54ec2d" continuedAt="i26f720f3ef204ba1996041f18f2fdd52" escape="true">The carrying amounts and the estimated fair values of financial instruments as of June&#160;30, 2021 and June&#160;30, 2020 are as follows:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><ix:continuation id="i26f720f3ef204ba1996041f18f2fdd52"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% Senior Notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtMi0xLTEtMA_04b2316a-e856-4138-8cb2-8a52988099b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaffc390ab5942bea52a4be57e7dbde6_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtNC0xLTEtMA_87f0ac38-d6e7-4890-8450-e735087f7a60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d7e2c8c43a47c0a933c613e1998a34_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtNi0xLTEtMA_cc23af87-7f07-4fec-915b-8e5038fe2de8">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c37e0185644986bb65525bb1644ccd_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtOC0xLTEtMA_ff1e9e67-320e-4c07-b049-9fd6e4ee9eb5">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% Senior Notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8daa403fef413dba97b83235c8ea21_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtMi0xLTEtMA_d2e5fd77-4c9d-46c3-9a7c-515626699067">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabaebe4c2d684181a51203e58e9005fe_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtNC0xLTEtMA_640494c5-495b-49c6-aa6f-db1f71555ca2">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a1e048ba7c4e9691ded7739ee1a189_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtNi0xLTEtMA_85db73c0-8f6a-4878-ac34-fd45a96daab5">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86102d72c35440138d512f3c29d2305f_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtOC0xLTEtMA_063fefc1-ef3b-4eb4-9890-c7750475d546">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated Senior Notes due 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed">984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6671e05a3e2b467a944f21f20d4c3366_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNC0xLTEtMA_4f736a3d-3b80-429c-9eec-a141e9210ff6">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796cb7ff80c54ea8a86407355ff7fedb_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15380ce82624d0e9f2df108f51ffe4b_I20200630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtOC0xLTEtMA_6daf31f9-dd15-483b-af59-e77c2fb8a08d">844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Senior Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtMy0xLTEtMjQ0OA_9c81d95e-bf0c-4c0e-ad43-fd6199fca1d2">550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3db9452ad5e47a1bb0e9ab578f325b3_I20210630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNS0xLTEtMjQ1MQ_94c4e4e3-5430-4f2a-b2d0-a2664a66f136">524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib061337543284797b3b9d0ef58f9ec80_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNy0xLTEtMjQzNA_24e4d6cb-d1c4-42a6-bb5e-9051cd54de1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6d816c6a3b45b4ac0a46bfbcb69988_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtOS0xLTEtMjQzNw_b0d59535-7068-49fe-abac-e27e96b21c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities &amp; other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09171d0cebb6430a942aa7517fe61fe9_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtMi0xLTEtMA_07dd6de1-c684-4c25-84a1-a841fa7e4d9b">1,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief6bc672a6674233a298d9a2b454a730_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNC0xLTEtMA_c5f709e1-734a-4008-acc6-44e67014d6ee">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a171a9b90a84e74bda5120a9f3baca5_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNi0xLTEtMA_c4bb7d70-ae5d-4a25-9000-69d36798b0c5">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6faf7a0fe4914b9f87e7fa0c0d7bd9a2_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtOC0xLTEtMA_5c3c9bef-11dc-48c3-a1e4-907a51c6be8a">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctMi0xLTEtMA_86dfde31-3928-4b88-85c6-0394615f4fb8">3,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e1619d8d97442d2b05880b4bab402aa_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctNC0xLTEtMA_8ce21a05-d64f-4c2b-8757-2508425ba23c">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctNi0xLTEtMA_87652421-47f9-45a2-a834-5debb860ea96">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctOC0xLTEtMA_a33ce110-7584-4190-b380-80fe1eba1a0d">3,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktMy0xLTEtNTcwNg_06d5b7b5-e0ac-47ef-b6b1-40886220bbb6"><ix:nonFraction unitRef="usd" contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktMy0xLTEtNTcwNg_b7e2dc6a-5e00-4abd-97f1-da63c7bf3c6a">36</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dcbdcff43d44a9947d50294da0c59f_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNS0xLTEtNTcwOA_f9f6377c-2869-459d-948a-8d56673d91f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNy0xLTEtNTA2MQ_67bc48b1-0174-4a39-9328-c791b43ebbb1"><ix:nonFraction unitRef="usd" contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630" decimals="-6" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNy0xLTEtNTA2MQ_f53bae1e-bcd3-43d9-9796-2f87b0cfb09b">37</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8856d25fb8b24759af14435f4b8ba6ca_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktOS0xLTEtNTcxMA_3b9ab696-7380-429d-a27f-c86a62d7dd0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTMtMS0xLTUwNjM_e3d6914b-a219-41d7-8cd2-ef6e714dfc25">3,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e1619d8d97442d2b05880b4bab402aa_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTUtMS0xLTUwNjM_cc286f1a-58b0-4f53-9d46-5a2e125f3297">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTctMS0xLTUwNjM_2e0d9d1b-3bb3-4930-bae2-31e78e3bbe16">3,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTktMS0xLTUwNjM_da7eda5f-6d4a-428b-8445-c03e9581420b">3,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_211"></div><div style="padding-left:24pt;text-align:justify;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE4MTM_de5abb6a-bc3c-4d25-820f-e0dc0edcec49" continuedAt="i6cc1bd636e8c455da8d8231aa5f646e5" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span><span style="color:#003366;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:continuation id="i6cc1bd636e8c455da8d8231aa5f646e5" continuedAt="i491227183c2443a58842254a6da7a9d4"> </ix:continuation></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="i491227183c2443a58842254a6da7a9d4" continuedAt="i48783fc24d914ab5a07ba0507daf256d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes earnings per share (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of the Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the two-class method required due to the participating nature of the Series A Preferred Stock (as noted in Note 13,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The weighted-average number of shares outstanding utilized in diluted earnings per share is computed using the weighted-average number of common shares outstanding plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation. The dilutive effect of the securities that are issuable under the Company&#8217;s equity incentive plans (see Note 14, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) are reflected in diluted earnings per share by application of the treasury stock method. The Company applies the if-converted method to compute the potentially dilutive </span></ix:continuation></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i48783fc24d914ab5a07ba0507daf256d"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect of the Series A Preferred Stock. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE4MTQ_3d91c71e-030f-451d-be7d-ff061d46eeae" continuedAt="i180455895e2144a0a2140e4eb1ec6389" escape="true">The reconciliations between basic and diluted earnings per share attributable to Catalent</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i180455895e2144a0a2140e4eb1ec6389" continuedAt="i9b1e8c0da37b4522af1b1fb05f9e1172"> common shareholders for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows: </ix:continuation></span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i9b1e8c0da37b4522af1b1fb05f9e1172"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160; (In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItMS0xLTEtMA_1a79d6e3-63d7-4ec4-8b76-5a9a898091e6">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItMy0xLTEtMA_6c208770-78e3-4aaa-9c2e-471a3e243ba9">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItNS0xLTEtMA_3b8a0bc1-8060-44b7-b861-7fbf8740fc97">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to preferred shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtMS0xLTEtMA_e1272089-1562-47ee-abf7-1685e018db63">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtMy0xLTEtMA_8286ef4e-7b65-49f0-a703-c2d1b94fc4ed">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtNS0xLTEtMA_ddc174b2-b976-49ea-9656-49e6ed404e3d">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtMS0xLTEtMA_4fbf0d88-bf5c-44b9-adcc-69ca0faa4ae6">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtMy0xLTEtMA_839422c6-e698-440a-a53d-5e2fa79e1e03">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtNS0xLTEtMA_c447dfd8-7abb-4e84-8747-482efd7a670e">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtMS0xLTEtMA_35837ed4-2a74-44f1-bc1a-7c970f611653">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtMy0xLTEtMA_8cb8b551-568a-40a8-93df-5f8a0ad609f7">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtNS0xLTEtMA_964393f6-6672-464c-ad69-9339ce13276d">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average dilutive securities issuable - stock plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctMS0xLTEtMA_ad3bf1fd-59a2-4120-85f9-12dca801874b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctMy0xLTEtMA_519cd6f2-a670-47d2-91c5-2fc9ab8ad2e0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctNS0xLTEtMA_2b3bb38a-b8d6-43e1-9a72-9c2bbf3a7866">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtMS0xLTEtMA_e03b5dab-ae88-4d59-ae51-bc6ff464fdcd">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtMy0xLTEtMA_c2a05cbc-9821-42ed-a751-830e5780088b">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtNS0xLTEtMA_b9af67ce-cbc9-4ac4-ba04-0cd9b1cc6eb9">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTEtMS0xLTA_96ea0cd2-22b7-41cd-87e9-3764e632c991">3.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTMtMS0xLTA_d1b51ef4-b6cb-4394-bab6-80432ac76835">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTUtMS0xLTA_6469aa4a-869a-40ad-b2d8-6b0271844618">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTEtMS0xLTA_a2b5ad29-bec7-4fd4-a77e-08c00431fa8a">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTMtMS0xLTA_4c40499b-cc6e-4ebe-a06f-96a311b86035">1.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTUtMS0xLTA_fe87e090-ec55-4048-8abe-3673a2be2c1c">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Series A Preferred Stock is deemed a participating security, meaning that it has the right to participate in undistributed earnings with the Company's Common Stock. On November 23, 2020 (the &#8220;Partial Conversion Date&#8221;), holders of Series A Preferred Stock converted <ix:nonFraction unitRef="shares" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg1NzM_c04e5d78-84ee-47b2-b240-b2fac6cb6740">265,223</ix:nonFraction> shares and $<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg1ODg_36f5a079-2d5a-4621-a158-51b12b0fa54a">2</ix:nonFraction> million of unpaid accrued dividends into shares of Common Stock (the &#8220;Partial Conversion&#8221;). The holders received <ix:nonFraction unitRef="shares" contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg2NDg_a034ab87-5883-4462-9b41-6e23b526c72a">20.33</ix:nonFraction> shares of Common Stock for each converted preferred share, resulting in the issuance of <ix:nonFraction unitRef="shares" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg2NDA_e17c2197-3f56-4849-9d46-e67ba0b48575">5,392,280</ix:nonFraction> shares of Common Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE2NDkyNjc0NDY3MzM_5552de93-df36-4c0a-8256-97070b30fa62" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The diluted weighted average number of shares outstanding for the fiscal years ended June 30, 2021, 2020 and 2019 did not include the weighted average number of shares of Common Stock associated with the Series A Preferred Stock reported below or the weighted average number of shares of Common Stock associated with the following types of outstanding equity grants due to their antidilutive effect:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(share counts in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i671c59d76d904023aea5037521cce6c5_D20200701-20210630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItMS0xLTEtNTA2NQ_ed5362fe-3d8f-49f4-a3bb-f21484e9588a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItMy0xLTEtNTA2Nw_6773d043-4bdd-4881-b8c2-82b4fb804f2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ae15435182f490c81d494a5e1ec3b32_D20180701-20190630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItNS0xLTEtNTA2OQ_1fb46f70-06be-4794-8fb7-273582cce015">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtMS0xLTEtNTA2NQ_76b41dbb-69e4-446a-afff-97dca8219eb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtMy0xLTEtNTA2Nw_8631bf75-54af-46eb-ba42-1f3c15249c78">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtNS0xLTEtNTA2OQ_0f5ac427-6691-4963-b619-0f2add5e1de5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtMS0xLTEtNTA2NQ_3cbe9e8e-fa04-42ff-93fc-be178922faa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i170d00009dcc4cd1ba9ddacd15fdefc1_D20190701-20200630" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtMy0xLTEtNTA2Nw_7c82b24d-f680-45bf-abdd-ce1a24b9adc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bc1999796814b39a7ce2ada34826470_D20180701-20190630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtNS0xLTEtNTA2OQ_a03a0225-0cd8-472a-8aaa-9c76baad12d6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i419473081c56497ab865784949c1efce_D20200701-20210630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtMS0xLTEtNTA2NQ_9cde9cb6-f48f-4d4e-a641-1a0416f0d72b">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1814fd669de945459192151f0faec56c_D20190701-20200630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtMy0xLTEtNTA2Nw_98e9dff8-1b48-45f9-8ff8-26d589051165">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12b3309684564f31b7fd6fb52491e6be_D20180701-20190630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtNS0xLTEtNTA2OQ_d639ca45-6f37-403f-95b9-7aa18c215b4e">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_214"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzU3NDM_0a2ddec7-501e-4263-8a11-bcfe230bfa56" continuedAt="i7bbaa78dfd384924b569f2995286273f" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="i7bbaa78dfd384924b569f2995286273f" continuedAt="i04ffda8db6ee498c92e7cb8cdb995231"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to fluctuations in the currency exchange rates applicable to its investments in foreign operations. While the Company does not actively hedge against changes in foreign currency, the Company has mitigated the exposure arising from its investments in its European operations by denominating a portion of its Senior Notes in euros. At June&#160;30, 2021, the Company had euro-denominated debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzUxNg_009e287b-5966-4eca-a57b-f95754e12597">984</ix:nonFraction> million (U.S. dollar equivalent), which qualifies as a hedge of a net investment in foreign operations. For non-derivatives designated and qualifying as net investment hedges, the effective portion of the translation gains or losses are reported in accumulated other comprehensive income (loss) as part of the cumulative translation adjustment. The unhedged portions of the translation gains or losses are reported in the consolidated statements of operations. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzU3MzU_2547f6ea-2751-4723-8bfd-cdf42c176d59" continuedAt="ibbcaba96df68471abd96f6500e6ae402" escape="true">The following table includes net investment hedge activity during the fiscal years ended June&#160;30, 2021 and 2020, respectively:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><ix:continuation id="ibbcaba96df68471abd96f6500e6ae402"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within Other Comprehensive Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzEtMS0xLTEtMA_9dd4fd36-4384-4b42-9456-376e63fe5fb9">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzEtMy0xLTEtMA_e21e2eaf-5c8d-42b6-86e1-9fce390cfa91">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within the Consolidated Statements of Operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzItMS0xLTEtMA_d572997d-311d-4bd1-937d-a5a818b66265">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzItMy0xLTEtMA_2222b4e7-7757-4958-bc49-c8d066aaefc9">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net accumulated gain of this net investment within accumulated other comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEwOTk1MTE2NDMwNDE_2795e08d-333c-4654-b7a5-4a4e608f9030">6</ix:nonFraction> million as of June&#160;30, 2021. Amounts are reclassified out of accumulated other comprehensive loss into earnings when the entity in which the gains and losses reside is either sold or substantially liquidated. </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock Derivative Liability </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 13, Equity, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Preferred Stock and Accumulated Other Comprehensive Loss, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in May 2019, the Company issued shares of Series A Preferred Stock in exchange for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzE1OTY_becddaad-feb8-4311-8692-6dedd63c11ad">646</ix:nonFraction> million after taking into account the $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzE2Mjk_ae2b1322-eb27-47f9-ad51-bcfe65c35d40">4</ix:nonFraction> million issuance cost.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dividend rate used to determine the amount of the quarterly dividend payable on shares of the Series A Preferred Stock is subject to adjustment so as to provide holders of shares of Series A Preferred Stock with certain protections against a decline in the trading price of shares of Common Stock. The Company determined that this feature should be accounted for as a derivative liability, since the feature fluctuates inversely to changes in the trading price and is also linked to the performance of the S&amp;P 500 stock index. Accordingly, the Company bifurcated the adjustable dividend feature from the remainder of the Series A Preferred Stock and accounted for this feature as a derivative liability at fair value. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzMxNDk_5af9799a-756c-4275-bba2-3fc0591ea46b">17</ix:nonFraction> million on the change in the estimated fair value of the derivative liability for the fiscal year ended June 30, 2021, which is reflected as other expense, net in the consolidated statements of operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the derivative liability was settled on the Partial Conversion Date due to the Partial Conversion. The fair value of the derivative liability as of the Partial Conversion Date was $<ix:nonFraction unitRef="usd" contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwMDM_b1c6376e-373a-4675-ae72-7c941c688aad">9</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwNDc_31b7f59c-063f-4ca5-902f-32fff0947f49">4</ix:nonFraction> million was related to the converted portion of the outstanding shares of Series A Preferred Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of the Partial Conversion.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest-Rate Swap </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its interest rate and risk management strategy, in April 2020, the Company entered into an interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its U.S dollar-denominated term loans under its senior secured credit facilities, so that the interest payable on that portion of the debt becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, in connection with the Fifth Amendment to the Credit Agreement, the Company settled the interest-rate swap agreement with Bank of America N.A. The Company paid $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:CashPaidToSettleInterestRateSwapAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwNjQ_8eff8c7c-44be-46a6-be88-81f1d462f182">2</ix:nonFraction> million in cash to Bank of America N.A to settle the interest-rate swap agreement. This loss is deferred in stockholders&#8217; equity, net of income taxes, as a component of accumulated other comprehensive loss, and amortized as an adjustment to interest expense, net over the original term of the Term B-2 Loans. The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is not material.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a new interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its Term B-3 Loans, so that the </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i04ffda8db6ee498c92e7cb8cdb995231"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest payable on that portion of the Term B-3 Loans becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense. As a result of entering into the interest-rate swap agreement, the floating portion of the applicable rate on $<ix:nonFraction unitRef="usd" contextRef="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:TotalDebtUSDenominatedTermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwODM_d5ab8bbc-247a-4ede-86a6-188d66bc5420">500</ix:nonFraction> million of the Term B-3 Loans is now effectively fixed at <ix:nonFraction unitRef="number" contextRef="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwOTk_5ef099c4-ec9f-4f6b-9a4c-535c1f5e88e5">0.9985</ix:nonFraction>%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new interest-rate swap agreement qualifies for and is designated as a cash-flow hedge. The Company evaluates hedge effectiveness at the inception of the hedge and on an ongoing basis. The cash flows associated with the interest-rate swap are reported in net cash provided by operating activities in the consolidated statements of cash flows. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_2ff40c16-7a1b-4c09-90ff-19c722f4e5bf" escape="true"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_cf75d7dd-b4bb-4204-90f9-c72343dfc2d0" escape="true"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_dde010e9-27b3-42ee-b30d-9259997fd1e2" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTplZGJlMjU1OThjM2Y0NDA5YTVlYWE1NTVjYjAyOTUxOC90YWJsZXJhbmdlOmVkYmUyNTU5OGMzZjQ0MDlhNWVhYTU1NWNiMDI5NTE4XzItNC0xLTEtNTA3NA_7daed9eb-87cb-44f1-8c8a-d278601eabb9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTplZGJlMjU1OThjM2Y0NDA5YTVlYWE1NTVjYjAyOTUxOC90YWJsZXJhbmdlOmVkYmUyNTU5OGMzZjQ0MDlhNWVhYTU1NWNiMDI5NTE4XzItOC0xLTEtNTA3Ng_2480659d-4e2c-4684-a74f-44ce2316a380">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_1416"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM1OTU4_eeb2238b-9e7e-497c-b400-3d7741585940" continuedAt="i2052c17eb2f646a58f9af6e8346ed972" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i2052c17eb2f646a58f9af6e8346ed972" continuedAt="i08b70dea091e4944b932a58b0dafafd8"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, defines fair value as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. To measure fair value, the Company uses the following fair value hierarchy based on three levels of inputs, of which Level 1 and Level 2 are considered observable and Level 3 is considered unobservable:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Quoted prices in active markets for identical assets or liabilities.                      </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.                      </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Value is determined using pricing models, discounted cash flow methodologies, or similar techniques and also includes instruments for which the determination of fair value requires significant judgment or estimation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses of the Company approximate fair value based on the short maturities of these instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level of classification as of the end of each reporting period. <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM2MDY3_c43fa72c-9cc9-4f7a-a7d8-30ebdbcb220f" continuedAt="ibe4a32daaff242bba1fcd7e6f24d116a" escape="true">The following table sets forth the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis and the fair value measurement for such assets and liabilities at June 30, 2021 and June 30, 2020, respectively:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i08b70dea091e4944b932a58b0dafafd8"><div style="padding-left:9pt;text-align:justify"><ix:continuation id="ibe4a32daaff242bba1fcd7e6f24d116a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Basis of Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTItMS0xLTUwNzg_50cee40f-0927-469d-af8a-c37bfd020983">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630" decimals="-6" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTQtMS0xLTUwNzg_2524bf4a-5fc7-4c7e-b4d2-9c816734c0ce">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTYtMS0xLTUwNzg_367b7a09-ae17-436e-b948-fd4612074491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:MarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTgtMS0xLTUwNzg_aad16228-a9bf-42b3-9e65-64e1de7384a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTItMS0xLTUwNzg_c3743952-1002-4d60-a08b-d34704ee396c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTQtMS0xLTUwNzg_8e4af942-035d-4140-810b-2478d2d2c4d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTYtMS0xLTUwNzg_e877522a-7546-46a0-9bdb-59aa5a394399">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTgtMS0xLTUwNzg_17e6375f-0fd2-402d-ad56-ab85b153383b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTItMS0xLTUwNzg_a95ef7f9-b048-4d71-951e-945c898abca3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630" decimals="-6" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTQtMS0xLTUwNzg_6dd2a584-0610-49f9-bae9-0db8446b9631">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTYtMS0xLTUwNzg_0fc0b684-7f8c-49f9-8068-483f5146b225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTgtMS0xLTUwNzg_87a72100-bedb-4922-b7e5-c7fedbc6b316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTItMS0xLTUwODA_66fa85e0-5e3d-407b-b2bf-dc5115101f95">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTQtMS0xLTUwODA_9984747b-8f81-4182-a151-ebfd91bfe2aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTYtMS0xLTUwODA_e880f53d-c7ca-4a99-ad5d-dc51f6c4b6b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTgtMS0xLTUwODA_1d29df7f-f05f-4140-ba87-c6f55ba0b4c3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC0yLTEtMS01MDgy_863b9f7e-8566-42fa-91ec-979c29c32ddd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630" decimals="-6" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC00LTEtMS01MDgy_e6fd1d9d-b54b-401f-b73d-8cd9dad9aed5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC02LTEtMS01MDgy_64fc7c91-28d2-4e39-bfb0-d4afb8f7f53e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:TradingSecuritiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC04LTEtMS01MDgy_374ad867-f7a9-4f68-9364-ed886899cb4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy0yLTEtMS01MDg0_bb440e7f-bd01-4a81-945a-5b7b8b58d09f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy00LTEtMS01MDg0_c0e99d0f-f3d1-4690-aead-386620c03a0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy02LTEtMS01MDg0_2756d050-2955-4102-b920-6bd404d90eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630" decimals="-6" name="ctlt:SeriesAPreferredStockDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy04LTEtMS01MDg0_c768be15-ddcd-419c-8292-0b98fa5b77e4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC0yLTEtMS01MDg0_8d96161a-9072-4537-b797-0b9484e8660d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC00LTEtMS01MDg0_c426fc42-2eb3-4b9d-aad3-34d6ef4c3902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC02LTEtMS01MDg0_52800fcc-686d-48bd-a91c-645d9eeeac20">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC04LTEtMS01MDg0_80db4db9-1294-46ec-b378-b21d80c3933f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the interest-rate swap agreement is determined at the end of each reporting period based on valuation models that use interest-rate yield curves and discount rates as inputs. The discount rates are based on U.S. deposit or U.S. Treasury rates. The significant inputs used in the valuation models are readily available in public markets or can be derived from observable market transactions, and the valuation is therefore classified as Level 2 in the fair-value hierarchy.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Series A Preferred Stock derivative is determined using an option pricing methodology, specifically both a Monte Carlo simulation and a binomial lattice model. The methodology incorporates the terms and conditions of the preferred stock arrangement, historical stock price volatility, the risk-free interest rate, a credit spread based on the yield indexes of high-yield bonds, and the trading price of shares of the Common Stock. The calculation of the estimated fair value of the derivative liability is highly sensitive to changes in unobservable inputs, such as the expected volatility and the Company&#8217;s credit spread. The estimated fair value of the Series A Preferred Stock derivative liability is classified as Level 3 in the fair-value hierarchy due to the significant management judgment required to make the assumptions underlying the calculation of value.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM2MDY2_13840978-a833-4784-95f9-1c6f277f018b" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of changes in the estimated fair value of the Series A Preferred Stock derivative liability from June 30, 2020 to June 30, 2021:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.877%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement of<br/>Series A Preferred Stock<br/>Derivative Liability<br/>Using Significant<br/>Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8xLTEtMS0xLTUwODY_76328e66-ceeb-4ad9-a165-376cfb0e042f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value of Series A Preferred Stock derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8yLTEtMS0xLTUwODY_0f03689f-fb6d-4867-ae1b-49ece1b961b1">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of derivative liability upon Partial Conversion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8zLTEtMS0xLTUwODY_026f7518-9656-44c9-a0dd-c388e9c1a45a">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF80LTEtMS0xLTUwODY_0c4069c6-e647-4984-b5a3-71f29939f89c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, goodwill, and other intangible assets are subject to non-recurring fair value measurement for the evaluation of potential impairment. Other than the fair value estimates disclosed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there was no non-recurring fair value measurement during the fiscal years ended June 30, 2021 and 2020.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_217"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDI_01f0fee9-fa0a-4afd-838c-1018334a4d83" continuedAt="icbff319033f14b1f8af33df90008b279" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="icbff319033f14b1f8af33df90008b279" continuedAt="i8886529fea4a471fbec0a58a5611681c"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTQ_1d6227ef-828a-457a-ac40-4d2b20b3dde9" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes are as follows for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItMS0xLTEtMA_d1548fdb-5830-494f-be99-1cb3ee6b7cdd">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItMy0xLTEtMA_6b671b32-873a-4134-9207-e68da87f7b3d">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItNS0xLTEtMA_3a405c8a-2cba-4a57-b8a2-09264984929e">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtMS0xLTEtMA_c5c9c791-daae-47be-8b81-0721f91ea57b">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtMy0xLTEtMA_08117b26-cbb0-478a-9de1-a48c6c57eb67">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtNS0xLTEtMA_b6be044a-cdeb-42ff-881a-4ea5f782fc68">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtMS0xLTEtMA_bd884e0c-5c64-4b62-bcb1-8224cf4c2803">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtMy0xLTEtMA_446ca5f3-9326-4c5b-b1fe-85c628ce03e9">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtNS0xLTEtMA_8b30e64c-1f89-43cd-b26d-234772aab60f">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyODg_ed191553-3c7f-451d-8ac4-a6f738af4568" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtMS0xLTEtMA_43bdfee6-41a8-4d1f-a68c-ac315fb9c249">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtMy0xLTEtMA_f560701d-6b75-4a86-88b6-ac39d90260d9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtNS0xLTEtMA_24a5ec3b-2d4e-40fb-9a07-105cab5a8a0c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtMS0xLTEtMA_f124c0db-657e-4254-8cba-873c4f8241ab">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtMy0xLTEtMA_36723cc3-dc68-4bf7-9ae2-fc02e43be351">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtNS0xLTEtMA_3e96d1fe-ecb4-4387-ac6c-2cdefe1696e6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtMS0xLTEtMA_1aceffe9-550f-48c0-b6b1-14f7f4215a9d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtMy0xLTEtMA_182d0b4a-066a-474c-aad3-b6375a0d0a4a">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtNS0xLTEtMA_50d4309c-f26e-4cab-b758-39a9e6b71b20">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtMS0xLTEtMA_065344ae-3537-4be8-a993-77e6a831edf5">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtMy0xLTEtMA_2da45a20-6b15-479c-8084-1bd75be8bb42">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtNS0xLTEtMA_57b89138-53e9-4b96-a1c2-c394b209d7b7">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtMS0xLTEtMA_bdb78ac8-8652-407a-8a51-61057637d520">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtMy0xLTEtMA_142b2c01-9c82-439a-86f9-e407cff2882f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtNS0xLTEtMA_2a0c4cf3-9126-4c26-90e4-a71e4a4b30ff">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktMS0xLTEtMA_d96cfc6e-0321-4cbe-b1c8-07e03cd7b082">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktMy0xLTEtMA_b4cf35a4-ff26-4286-8634-3f453c708eea">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktNS0xLTEtMA_26db35f0-d5a5-4da2-8b5a-bfb3040d7131">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTEtMS0xLTA_38f8c645-8ae6-43ef-aeb8-5bf812f32ba6">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTMtMS0xLTA_68270f0e-c04a-418a-b22d-0a48a3746016">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTUtMS0xLTA_7d0efc6e-be9d-4f4c-bbca-b91e4c5b90cc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTEtMS0xLTA_93e569d6-64cc-4946-98f0-8c47dadc4847">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTMtMS0xLTA_f2400096-47d0-44ce-9392-677faf91ca40">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTUtMS0xLTA_f95a66ce-44c7-4dfd-b559-ddccfb362cec">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTEtMS0xLTA_66e484d0-5658-4be6-9a79-c82e5fb190d5">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTMtMS0xLTA_bb844f8d-8426-49b5-9dd7-228ab517c2ca">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTUtMS0xLTA_8405b9ec-ea9f-4097-9a72-d5c1120c8101">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDM_41328708-cfee-4333-ad7e-f6e0047ad516" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision starting from the tax computed at the federal statutory income tax rate to the tax computed at the Company&#8217;s effective income tax rate is as follows for the fiscal years ended 2021, 2020, and 2019:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision at U.S. federal statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItMS0xLTEtMA_3ca4cfb4-6e3d-4024-a94b-54f6f8ad1763">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItMy0xLTEtMA_645e44c1-fcc7-432f-8d83-a6db6f130922">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItNS0xLTEtMA_9abd345b-97f3-4c66-9e2f-b456476c1028">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtMS0xLTEtMA_aec56c65-21bf-4a8b-a6fa-137102c95ab5">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtMy0xLTEtMA_a053e3e4-c27c-4d5f-9727-9fe45f23c3bd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtNS0xLTEtMA_726bc59b-14ca-4d12-908e-2ce770d379ad">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtMS0xLTEtMA_c92f2c07-4daf-4d96-ac42-041ac3faafa9">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtMy0xLTEtMA_111379df-0eb3-4b15-a8f4-22b8f7baf50a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtNS0xLTEtMA_f3ad92cc-9aad-42f0-b9be-130990261fb4">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low tax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtMS0xLTEtMA_9964b464-81ed-495a-8739-a5d53767ca80">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtMy0xLTEtMA_4b2fb0c3-dcab-46f9-bb81-cf82dfdfcb6b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtNS0xLTEtMA_b4ad2514-166b-4b25-bb30-440263ba5e22">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtMS0xLTEtMA_17181542-af4d-4b91-8525-117b94204dca">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtMy0xLTEtMA_d3bacc92-2b39-40cc-9df4-945a741f0c86">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtNS0xLTEtMA_560cf443-4ad6-4665-a625-ad4e97a58529">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctMS0xLTEtMA_cd091ede-8b97-40f9-91b9-9977797c4b71">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctMy0xLTEtMA_ab6558f5-1e4b-4bd9-9aa0-81397175e497">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctNS0xLTEtMA_c5893d26-a423-4140-be7f-28d263499f3c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtMS0xLTEtMA_745eb40d-ca55-47df-b70c-4c81b54976a3">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtMy0xLTEtMA_0d78d91a-e651-47c2-a438-838297b4a2d2">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtNS0xLTEtMA_0cc86cac-ade6-44a9-ada5-189b94cf2050">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="3" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktMS0xLTEtMA_4557d66e-ea45-457a-ad27-f09a7892ac8a">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="3" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktMy0xLTEtMA_a708ddec-5c5f-4503-9eb8-4610789e1033">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="3" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktNS0xLTEtMA_cc791f73-55a7-4c64-8fbb-b3978790affd">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax and other foreign taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTEtMS0xLTA_cac1f87c-dc11-43b0-9307-90d0ad4dc676">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTMtMS0xLTA_f20a3e3d-1fa1-40d1-8bb7-a42a0c8230c3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTUtMS0xLTA_4391c1bf-83f4-435c-a809-6d27a58cf09e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTEtMS0xLTA_223ad6ae-9040-4f36-8836-1fe618157718">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTMtMS0xLTA_d8a124c3-baeb-4ab3-b59b-42a0b2213199">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTUtMS0xLTA_3ca46f48-e540-4e51-9036-6879904104b9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTEtMS0xLTA_a412cbbc-55a4-4056-95b9-6fbc3798035e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTMtMS0xLTA_e4d4e5c1-a6cc-4ece-ae37-b8e1704b0539">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTUtMS0xLTA_94239aed-6f52-4884-92b0-4d688fa0d46a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTEtMS0xLTA_25dc1b3d-ffcc-4600-8d97-55a9d19a464c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTMtMS0xLTA_1ffa38e3-72bf-4544-a38a-0cf7bb1e4c9e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTUtMS0xLTA_57bff55f-e3ca-4b3a-a667-58349c0a59d4">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTEtMS0xLTA_4f878f8b-bb0a-43d9-8fdc-81fcf888802b">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTMtMS0xLTA_0cd11be7-92fb-4fb7-88e1-946ec43c33d0">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTUtMS0xLTA_a40fbb54-d76e-4eb0-91df-4c7bbfd2655c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for the fiscal year ended June 30, 2021 is not comparable to the provision in the prior year due to changes in the geographic mix of pretax income, changes in the tax impact of permanent differences and credits, and the tax impact of discrete items. The effective tax rate for the fiscal year ended June 30, 2021 reflects a tax expense for the sale of the </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8886529fea4a471fbec0a58a5611681c" continuedAt="i8c173b61e88645caa0ff9f08ffc15d04"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blow-Fill-Seal Business and an increase to state taxes, offset by an increase to the U.S. foreign tax credits as a result of amended prior year returns, as well as a reduction to the foreign valuation allowance. The effective tax rate for the fiscal year ended June 30, 2020 reflects a reduction to the federal and foreign valuation allowance partially offset by permanent items, and an increase in state tax.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to repatriate foreign earnings taxed in prior fiscal years as a result of the changes imposed by the 2017 U.S. Tax Cuts and Jobs Act. In addition to these foreign earnings previously taxed, as of June 30, 2021, for purposes of ASC 740-10-25-3, the Company had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzE1MTE_4b1ba73c-8018-47db-ac75-9181989df2a0">142</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of undistributed earnings from non-U.S. subsidiaries that it intends to reinvest permanently in its non-U.S. operations. As these ASC 740-10-25-3 earnings are considered permanently reinvested, no tax provision has been accrued. It is not feasible to estimate the amount of tax that might be payable on the eventual remittance of such earnings.</span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTk_4472fa42-4fd6-47bf-a511-a6fd28903b11" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the Company's deferred income tax assets and liabilities are as follows at June&#160;30, 2021 and 2020:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMtMS0xLTEtMA_05ba7403-1e60-4a8c-98ad-fcd55bf78264">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMtMy0xLTEtMA_740fb93f-f91a-41f4-aa55-4f35515f2e86">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzQtMS0xLTEtMA_a99336f3-7f0a-44b2-918d-0a69eb0307ce">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzQtMy0xLTEtMA_d4084d70-76c7-4843-acfb-74190e6326d1">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzUtMS0xLTEtMA_17f58603-8540-4440-8e74-080ec38e9efa">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzUtMy0xLTEtMA_44157c75-f671-4a81-8235-37d6156cbc38">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzYtMS0xLTEtMA_09a9a268-09c4-4c73-8314-4cfd41a50158">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzYtMy0xLTEtMA_c80d2e10-cf0e-4e9a-add6-7d2b9668ad11">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzctMS0xLTEtMA_2d67d916-9ffd-4e89-a540-e3f4e8ed33c5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzctMy0xLTEtMA_698d9408-dd64-4137-b728-fd9ee1ef5fef">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzgtMS0xLTEtMA_db3636b1-7c19-4ef8-a204-24c7796a5d14">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzgtMy0xLTEtMA_b117c411-3c21-4dd1-8938-d6c598940d62">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzktMS0xLTEtMA_022e32d6-4cf2-4755-bf14-5299084d5406">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzktMy0xLTEtMA_ec420d69-bc0b-4868-8287-2bec48e2803b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" sign="-" name="ctlt:DeferredIncomeTaxOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzExLTEtMS0xLTA_867bcbe3-385b-4f57-a25b-bee0f0968dd5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" sign="-" name="ctlt:DeferredIncomeTaxOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzExLTMtMS0xLTA_9888761b-8a4b-4ae8-bcc9-f8ad5b4fd2ea">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEyLTEtMS0xLTA_db69f549-2ba5-4a5e-bdc6-bf81c88f61c6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsOtherComprehensiveLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEyLTMtMS0xLTA_981cdf62-593f-4614-bf7b-898b9f690557">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEzLTEtMS0xLTA_22560352-827e-4cc1-90eb-3ac602801c84">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEzLTMtMS0xLTA_c70f8d49-87c4-4a6b-8e19-2355b10f0bf8">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE0LTEtMS0xLTA_807a1c40-7a59-41c8-a854-a0706a0b2f49">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE0LTMtMS0xLTA_d6bd84a9-7ef3-4e31-9fff-55a1cacc95fd">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE1LTEtMS0xLTA_0fdc26eb-baee-4424-87ba-0c799841cc43">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE1LTMtMS0xLTA_8a763e78-83db-4e62-adb9-19e9769ab86a">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzIzLTEtMS0xLTA_d4c00027-0cd2-45f1-aef6-7ffc411f5b8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzIzLTMtMS0xLTA_83bc0742-ac7e-44e8-8942-f4c178d92306">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI0LTEtMS0xLTA_e89201d7-e7cc-432d-90e6-735a2791ca7a">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI0LTMtMS0xLTA_9d084ef7-20b0-4ccd-8d3b-0d94b92d00f2">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI1LTEtMS0xLTA_15c07ad7-69c6-4682-931e-785c3d790aca">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI1LTMtMS0xLTA_2ca6b9e9-077f-4e60-b4b0-a5c075b637f6">192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" sign="-" name="ctlt:DeferredIncomeTaxRightOfUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI2LTEtMS0xLTA_9237e7cb-3b40-474d-bad3-3a69742f6bce">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" sign="-" name="ctlt:DeferredIncomeTaxRightOfUse" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI2LTMtMS0xLTA_3c0e3620-ecb7-41f2-b4ba-23e60be5b0b3">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI3LTEtMS0xLTA_c930687b-9301-4b63-9b87-06b115359d29">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI3LTMtMS0xLTA_87be0d39-2bea-4006-98d3-148e809d5267">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI5LTEtMS0xLTA_d15677c1-fc7e-465c-9027-06eb6728845a">389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI5LTMtMS0xLTA_1cf1a9ac-3633-46fc-a4fc-35eef980461a">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMxLTEtMS0xLTA_2d3ca1ac-72ef-4dbc-9b99-1de194a45e2f">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMxLTMtMS0xLTA_194e99cd-843d-4725-86d7-209052cf3024">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8c173b61e88645caa0ff9f08ffc15d04" continuedAt="i8eda61da9fc742e084f5a63d18a1a3b0"><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:DeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTE_2b5be1a3-75ad-46e2-bf04-922c7fce2e64" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities in the preceding table are in the following captions in the consolidated balance sheets at June&#160;30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzItMS0xLTEtMA_597077c0-ad80-4827-bb3f-a6306a947723">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzItMy0xLTEtMA_bc157e23-2c18-46af-ac81-11e8e4f3eabb">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzMtMS0xLTEtMA_f03c2da6-298b-4699-b07e-13a39715b0e4">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzMtMy0xLTEtMA_47922a0c-68db-4901-b017-19f7057c0a37">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzQtMS0xLTEtMA_9031eb88-341d-4988-a26a-bf031114c887">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzQtMy0xLTEtMA_e3b17268-4f4c-4cd1-bc4b-fe40d2fdec2a">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company had federal net operating loss (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOL</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzIzODU_854897dc-8b99-4b10-8dfc-9794cd66e57f">512</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzIzODk_f1fb795a-88d2-4762-ba4e-78e805f6e473">229</ix:nonFraction> million of which are subject to limitations under Section 382 of the Internal Revenue Code of 1986, as amended (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal Revenue Code</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  The majority of the $<ix:nonFraction unitRef="usd" contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI1NDc_f1fb795a-88d2-4762-ba4e-78e805f6e473">229</ix:nonFraction> million federal NOL carryforwards subject to Section 382 of the Internal Revenue Code are attributed to the Company's acquisitions of Pharmatek Laboratories, Inc., Juniper Pharmaceuticals, Inc., Paragon Bioservices, Inc., and MaSTherCell. As of June 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:OperatingLossCarryforwardsIndefiniteLife" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI3NDM_c9f184eb-0a78-4bfe-8c69-9b9260858fa4">432</ix:nonFraction> million of the Company's federal NOL carryforwards have an indefinite life and the remaining NOL carryforwards will expire in fiscal years 2023 through 2037.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company had state tax NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i33922380dc6b4abe8a22039a9468b7e1_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI5NTA_7a3c196e-308f-4ac2-b60f-00cecb4e99bb">441</ix:nonFraction> million. Substantially all state NOL carryforwards have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMxMTQ_40c2bc12-63e0-4386-a398-62f51315a07f">twenty</span>-year carryforward period. At June&#160;30, 2021, the Company had non-U.S. tax NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i125f9fdad01e48d9b2c4c0fac0f4bf10_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyMDA_4a512b1b-40a1-4828-be00-94de5a91becd">161</ix:nonFraction> million, a majority of which, are available for at least <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyNTI_21287ddd-d08b-44ee-ae2d-42c777ef2210">three</span> years or have an indefinite carryforward period.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMzNDQ_807a1c40-7a59-41c8-a854-a0706a0b2f49">65</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMzNTE_d6bd84a9-7ef3-4e31-9fff-55a1cacc95fd">53</ix:nonFraction> million as of June&#160;30, 2021 and 2020, respectively, against its deferred tax assets. The Company considered all available evidence, both positive and negative, in assessing the need for a valuation allowance against tax assets. Four possible sources of taxable income were evaluated when assessing the realization of deferred tax assets:</span></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">carrybacks of existing NOLs (if and to the extent permitted under the tax law);</span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future reversals of existing taxable temporary differences; </span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">tax planning strategies; and </span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future taxable income exclusive of reversing temporary differences and carryforwards. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the valuation allowance related to certain U.S. combined states was released during the fiscal year ended June 30, 2019, there remained as of June 30, 2021 a valuation allowance for the NOLs and deductible temporary differences in the remaining combined and separate states of $<ix:nonFraction unitRef="usd" contextRef="i33922380dc6b4abe8a22039a9468b7e1_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzQyMTQ_3f8f6eea-7165-44b1-b0d9-27c9d5f3bc36">39</ix:nonFraction> million. The state valuation allowance as of June 30, 2021 is due to the Company&#8217;s history of tax losses and anticipated loss utilization rates in separate filing status states as well as the difference in the rules related to allocated and apportioned income for separate filing status states versus combined filing status states.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the need to maintain a valuation allowance on deferred tax assets based on management&#8217;s assessment of whether it is more likely than not that the Company would realize the value of its deferred tax assets based on future reversals of existing taxable temporary differences and the ability to generate sufficient taxable income within the carryforward period available under the applicable tax laws. During the fiscal year ended June 30, 2021, the Company released $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUwMjg_b667b210-b65e-4346-b6e7-4937df5ed32f">17</ix:nonFraction> million of its valuation allowances. The amount released is related to $<ix:nonFraction unitRef="usd" contextRef="i98daa63182c347e2b14fbd8135bcfe10_D20200701-20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUxMzI_932aec58-331c-42e8-a366-d24f5ba4c51b">17</ix:nonFraction> million of NOLs and temporary differences for certain Italian operations. The $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUyMDU_b667b210-b65e-4346-b6e7-4937df5ed32f">17</ix:nonFraction> million release of the Company&#8217;s valuation allowance was partially offset by establishing a $<ix:nonFraction unitRef="usd" contextRef="i9d70d7b7223b4d6f862421f894246388_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUyOTI_9d9b37fa-2d07-4c65-97b2-b5114b96dd2d">2</ix:nonFraction> million valuation allowance on NOLs and temporary differences related to certain Canadian operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company's income taxes are subject to audits by federal, state, and foreign tax authorities, some of which are ongoing and may result in proposed assessments. Germany and the U.K. are among the jurisdictions where the Company has substantial tax positions. The Company is no longer subject to examinations by the relevant tax authorities for years prior to fiscal 2009. The Company&#8217;s estimate for the potential outcome for any uncertain tax issue is highly judgmental. The Company assesses its income tax positions and records benefits for all years subject to examination based upon management&#8217;s evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions for which it is more likely than not that a tax benefit will be sustained, the Company records the amount that has a greater than 50% likelihood of being realized upon resolution with the taxing authority that has full knowledge of all relevant information based on the technical merit. Interest and penalties are accrued, where applicable.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8eda61da9fc742e084f5a63d18a1a3b0"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company had a total of $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzY1MTM_64acb880-6c0f-4b0c-b591-5e14f36dabce">5</ix:nonFraction> million of unrecognized tax benefits.&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDQ_b2bd2aa8-aa00-4538-8f6e-bad3c1e18935" continuedAt="idca74434044541f0a1676b4ed2e6e8b3" escape="true">A reconciliation of unrecognized tax benefits, excluding accrued interest, as of June&#160;30, 2021, 2020, and 2019 is as follows:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><ix:continuation id="idca74434044541f0a1676b4ed2e6e8b3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEtMS0xLTEtMA_1d9d8236-007d-4df9-917b-f93645333467">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzMtMS0xLTEtMA_97668d15-041c-454b-8011-b1291fc4903b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzYtMS0xLTEtMA_ca35cef1-d104-4752-bc4c-ce13bf8392b1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzctMS0xLTEtMA_f5e2ae3a-68e8-4f89-9406-19ba99c4f8f4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzktMS0xLTEtMA_ff23dd7d-c682-4410-829d-22fcb1be2f07">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEyLTEtMS0xLTA_2c5a4fa9-12f6-4985-bce6-d8103a0e9ecc">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEzLTEtMS0xLTA_9aacdd8e-82ab-4f1b-a0d7-1f1d0c78cca0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE0LTEtMS0xLTA_04fdcaf8-11d6-4150-b41a-9b4326f6f77d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE1LTEtMS0xLTA_7d05f31a-bfff-4bf5-a6ff-0f3d6287b4ea">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE3LTEtMS0xLTA_ce6fc1ec-f654-479a-817c-3b37c756e528">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE5LTEtMS0xLTA_64acb880-6c0f-4b0c-b591-5e14f36dabce">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the unrecognized tax benefits as of June 30, 2021 and 2020 would, if subsequently recognized, favorably affect the effective income tax rate.  </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.&#160;As of June&#160;30, 2021, the Company has $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzY5NDI_bcad0957-8c71-4413-ab37-7234544a4cc0">1</ix:nonFraction> million of accrued interest related to uncertain tax positions, consistent with the prior year, as a result of an increase to certain tax positions taken in the fiscal year ended June 30, 2021, offset by a reduction to prior-year positions due to lapses in the statute of limitations. The Company had $<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcxODU_8ca6628c-9a13-4e0f-a65d-c9c353aae81a">1</ix:nonFraction> million of accrued interest related to uncertain tax positions as of both June 30, 2020 and 2019.</span></div></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_220"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTk_7c18940f-60e0-4634-ab9a-61d335a3e315" continuedAt="i2daba346715647d39b1277d5eb2e22c1" escape="true">EMPLOYEE RETIREMENT BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="i2daba346715647d39b1277d5eb2e22c1" continuedAt="ia4d048636420441696c630f43d9aca84"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement plans, including defined benefit pension plans and defined contribution plans. Substantially all of the Company&#8217;s domestic non-union employees are&#160;eligible to participate in employer-sponsored retirement savings plans, which include plans created under Section&#160;401(k) of the Internal Revenue Code that provide for the Company to match a portion of contributions by participating U.S. employees. The Company&#8217;s contributions to the plans are discretionary but are subject to certain minimum requirements as specified in the plans. The Company uses a measurement date of June&#160;30 for all of its retirement and postretirement benefit plans. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records obligations related to its withdrawal from one multi-employer pension plan that covered former employees at three former sites. This withdrawal was classified as a mass withdrawal under the Multiemployer Pension Plan Amendments Act of 1980, as amended, and the Pension Protection Act of 2006 and resulted in the recognition of liabilities associated with the Company&#8217;s long-term obligations in prior years not presented, which were primarily recorded as an expense within discontinued operations. The estimated discounted value of the projected contributions related to these plans is $<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzEzMzY_dd7b8d30-36b4-4955-981e-2bc557a718ba">38</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzEzNDM_73759093-ebad-42ba-ae89-df6e8b014d9b">39</ix:nonFraction> million as of June&#160;30, 2021 and 2020, respectively. The annual cash impact associated with the Company&#8217;s long-term obligation arising from this plan is $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:MultiemployerPlansEstimatedAnnualCashContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzE0Nzk_818c9c34-7e7a-487b-802e-ce6c7dc056c4">2</ix:nonFraction> million per year. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NzI_e00982c7-1a51-4d4c-bd29-08629369b18c" continuedAt="i569b355c91664ea9a188d4a66c6da43f" escape="true">The following table provides a reconciliation of the change in projected benefit obligation and fair value of plan assets for the defined benefit retirement and other retirement plans, excluding the multi-employer pension plan liability:</ix:nonNumeric></span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia4d048636420441696c630f43d9aca84" continuedAt="i3421de9958954e84b2955a0ba943aeea"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><ix:continuation id="i569b355c91664ea9a188d4a66c6da43f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtMS0xLTEtMA_353314a5-4c5f-4733-a244-a86d6074fb21">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtMy0xLTEtMA_d537efbc-543b-4a2e-833a-f95eeb0fc613">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtNS0xLTEtMA_a46afc02-0481-4b5e-bdb4-27a583f0a4fa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtNy0xLTEtMA_44c214fc-8937-4676-a588-bdfd2952264e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtMS0xLTEtMA_b2adc2dd-37d7-45c8-9eae-a4ae2b39126c">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife004a47c4ec48ce97f593d352e32a55_I20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtMy0xLTEtMA_45b97a6e-e9a6-491f-839a-3f0388d099f6">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtNS0xLTEtMA_1a3a5909-690f-4435-a4da-7873b1ba5483">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba420f2700c34ea3a4b4416c427c3200_I20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtNy0xLTEtMA_39520583-b635-41d9-a190-154cc4790eb9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctMS0xLTEtMA_73fb7814-a660-47aa-9fc5-80ef6583d33a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctMy0xLTEtMA_d9cf0617-fd44-41d2-a4d6-17286d4895a5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctNS0xLTEtMA_6d3c4c7f-a105-4914-8f0d-a387ea940f42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctNy0xLTEtMA_6409ca32-a01e-4239-bdd0-bd1507fdcddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtMS0xLTEtMA_0f6d2ea0-69c3-4b80-a19d-82ee67155960">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtMy0xLTEtMA_f3ff0888-da44-472c-a270-08dd69eb7f8d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtNS0xLTEtMA_1e87c129-48ac-41d5-bfd8-4bd0c67c2aa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtNy0xLTEtMA_c8dc2d0b-f407-469a-8a95-597a1b21a6f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTEtMS0xLTA_1646606e-0024-457d-a778-a0d002c1117c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTMtMS0xLTA_aa53c693-0bd5-4a50-ab83-661da6c152c9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTUtMS0xLTA_a52644e9-5023-4b5c-b3dd-d3b157f9364c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTctMS0xLTA_ec6afff7-5a83-4172-80ce-ff46f6b53306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTEtMS0xLTA_6f2111c1-e4c5-41eb-b43a-b791005195c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTMtMS0xLTA_5e3fa859-3eeb-4936-9277-6d06e977000d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTUtMS0xLTA_803f7755-15a0-4a5a-b4b6-cbeabf52374e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTctMS0xLTA_4fd8f404-07f0-46d0-a41f-e7f01156e0d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTEtMS0xLTA_baf24f4c-e6cd-4ad3-b754-72df2e1f8b37">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTMtMS0xLTA_9b0d3c77-599c-4ad5-a6b7-c8e5a5dfb4f9">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTUtMS0xLTA_d35b2c9a-8412-449e-9515-5dbc869f9ee7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTctMS0xLTA_fe2768f7-bb63-476b-8f86-062f2244b1fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTEtMS0xLTA_fb4055fb-602f-46f6-be76-ea031e518bdc">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTMtMS0xLTA_6333c9ad-3175-44d5-bfda-88cbd8251866">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTUtMS0xLTA_7984767f-a26f-4045-8922-c2c6072d6e89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTctMS0xLTA_71330c05-1f25-4c79-b54e-a1af5d0422f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTEtMS0xLTA_90338dae-310c-45e2-b5d1-6ed34d8671df">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTMtMS0xLTA_1eb2c488-669a-4e40-a30b-97850c7b301a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTUtMS0xLTA_b11bb95f-54aa-4f6e-a253-7ab1e322a8ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTctMS0xLTA_c8862b84-f970-4525-a8b9-9dc76c3e3ba9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTEtMS0xLTA_2c9797d5-4c2d-4011-84c9-acf4cc8f9a3d">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTMtMS0xLTA_32cf863c-6617-408b-a6e0-8a5f36b86c27">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTUtMS0xLTA_877de718-3190-4b6d-8d3b-64d4a16afa50">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTctMS0xLTA_6c5e4802-6e88-459e-b13e-537ba01bc744">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTEtMS0xLTA_54e25a77-0dd1-432c-af64-b73e5f843037">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife004a47c4ec48ce97f593d352e32a55_I20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTMtMS0xLTA_56cf91de-1946-4d72-acc3-929b51d90ceb">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTUtMS0xLTA_74d5259f-8b17-4a58-9b84-4af94f6f2fd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba420f2700c34ea3a4b4416c427c3200_I20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTctMS0xLTA_0d87fc3a-8e39-4216-b58c-522e6ab62eee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTEtMS0xLTA_b850ecb6-0613-4838-a925-c2984df1c8ec">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTMtMS0xLTA_7034afa5-f7cb-4b6a-9e8f-4de625f1c5da">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTUtMS0xLTA_40cfe8a0-4618-4230-9020-f3b3eca7a762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTctMS0xLTA_12ed5398-702c-483e-a3f4-8895265201f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTEtMS0xLTA_fea1d14b-f406-4a33-8eeb-62db699da382">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTMtMS0xLTA_9f01e52d-7604-4025-bf91-666ce26f7a15">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTUtMS0xLTA_0c3a4b6d-ef6f-484a-94fd-5183c61cdd88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTctMS0xLTA_a4d464b5-fe23-4c89-b741-a335ffbce5be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTEtMS0xLTA_f264c785-3805-4560-96a8-16d708214793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTMtMS0xLTA_b3fc7c53-c4f8-44cf-a4a6-d304f6a81cc2">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTUtMS0xLTA_ebe08cc9-61ba-4ef7-8db1-b2f501ec961e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTctMS0xLTA_7c165542-40e4-4687-a9ca-1ec680d03480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTEtMS0xLTA_e5dca4ec-ab0f-449e-9584-845e2b0a1d59">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTMtMS0xLTA_95477984-5efc-4ae1-931f-1f8502bdccdd">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTUtMS0xLTA_d40b4968-a5db-41c4-ba7e-7533ad941873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTctMS0xLTA_303f6cbb-69e5-4da7-a884-2e9b886cb9b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTEtMS0xLTA_8221664c-02f4-40d7-b7f0-e42e1d7e9127">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTMtMS0xLTA_206c8a07-a2c8-4ef8-a37b-9a3988f69c30">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTUtMS0xLTA_56e7a702-a14d-417a-888e-0712e09ceb47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTctMS0xLTA_d069764d-aa69-4802-a661-b0c0271bfa77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTEtMS0xLTA_0fc44fd9-1a96-478d-9cbe-7c14fa9c97ab">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTMtMS0xLTA_78057b72-e37e-4bdf-adf0-7b7a6bb005ce">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTUtMS0xLTA_dd137b86-4718-4925-9152-7833431423ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTctMS0xLTA_4dcc7347-dc1b-4f07-8ac5-ef717eebb428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTEtMS0xLTA_9d041fd6-e2fa-4bbd-8ad7-0c84a01ee1a0">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTMtMS0xLTA_ab49c9f3-47d0-46d7-b6f8-a9bc77714b0a">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTUtMS0xLTA_126bc802-0d33-41a2-b629-5e46b3c14f9f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTctMS0xLTA_a9ec1b40-1a9a-43f1-89cd-056c27c3e909">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTEtMS0xLTA_c84c889d-156a-474b-b095-8210a775bff0">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTMtMS0xLTA_cf410428-5d3a-41f8-80ee-8960db137807">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTUtMS0xLTA_9772968e-b213-4d34-9b79-a24cc0ea3fcb">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTctMS0xLTA_a70d8728-7943-4e72-8865-2f69868ad4be">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NjA_ec8c2411-eb19-43c5-9716-7f871d7dea7b" continuedAt="i50606631ef6d4d0b9afbf6810011cf56" escape="true">The following table provides a reconciliation of the net amount recognized in the consolidated balance sheets: </ix:nonNumeric></span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><ix:continuation id="i3421de9958954e84b2955a0ba943aeea" continuedAt="i8f01425438e849b08b4ea7d7056f8648"><ix:continuation id="i50606631ef6d4d0b9afbf6810011cf56" continuedAt="ia506f751ad074a32a0b2dada88aa5c4f"><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Statement of Financial Position</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtMS0xLTEtMA_3fbb4132-e197-448a-b3d5-e0dc6fddf9f2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtMy0xLTEtMA_fc48c5d9-df29-4a80-a8ac-2c7f4a9ef99a">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtNS0xLTEtMA_f816577f-4c3e-4913-a86b-659ac1232765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtNy0xLTEtMA_27c60929-9307-494f-810b-967b179781df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtMS0xLTEtMA_53aac8fb-f2c2-410d-9fac-4a4ceff41a26">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtMy0xLTEtMA_e7608941-a1e4-4869-b7f9-65a81829cb9c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtNS0xLTEtMA_a84307af-6e85-498e-bc2b-61fa2c1f4fbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtNy0xLTEtMA_65142cf4-d69a-447c-93e2-624156a9ce91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtMS0xLTEtMA_efbbd69a-c356-41ba-8b62-2300cd007b09">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtMy0xLTEtMA_02a4bee9-fbe0-4c6c-b229-5a6b8159fd43">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtNS0xLTEtMA_a8ef54c0-342b-4722-856b-2f6847b7ec6c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtNy0xLTEtMA_543e3948-1145-44b6-94a4-d3cad95fbafc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctMS0xLTEtMA_2c493e38-462a-4a29-9d8e-2ecf9e53545d">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctMy0xLTEtMA_bf77ad82-80ed-45f4-b65c-9a9f1c7b4436">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctNS0xLTEtMA_305b61a5-7c42-4633-ab49-70cc0a71ed8f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctNy0xLTEtMA_a8c1232b-fb6b-4a45-b5ff-905848fdc9b9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTEtMS0xLTA_013ccb55-3743-4265-834a-5fcdbd99cb2b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTMtMS0xLTA_593cf810-e27b-43a5-82a8-b4da7b90fe8b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTUtMS0xLTA_226cab9d-e745-4253-a347-e07ae376286d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTctMS0xLTA_42f6cdce-61ab-4b6c-959b-753434bb1fdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTEtMS0xLTA_165c88a6-c08c-4651-8f45-7f7b4d240c4b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTMtMS0xLTA_5d0cb46d-c6ea-4ee4-83eb-eeeb7834ab31">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTUtMS0xLTA_8ffeaf88-c6c9-48a7-9c41-3d3337187cf7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTctMS0xLTA_731ec339-326e-455d-8167-e2b8e34fd3cd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive loss (income) at the end of the fiscal year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTEtMS0xLTA_e4dc0e4b-c88b-4538-a771-6751309b11b4">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTMtMS0xLTA_cb076a92-9f6c-45b4-aa4f-18a2da09c5e3">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTUtMS0xLTA_66ddb42e-610e-468d-bb9e-6d257d8a00e0">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTctMS0xLTA_2c9aa663-d3d7-46f5-a632-7d5f788f997c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Information for Plan with ABO or PBO in Excess of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTEtMS0xLTA_58c5424f-d443-488f-97ca-afe62c4a6ece">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTMtMS0xLTA_02eb32f8-c81e-44f5-94da-a67a5d8030f5">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTUtMS0xLTA_5e4d33bc-5e90-4468-8376-0b4789efceec">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTctMS0xLTA_c9a43e3f-cece-4d26-9b90-271971500855">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTEtMS0xLTA_5ef2ce9d-85ee-44d0-95c2-cdee096140be">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTMtMS0xLTA_ba2d22f2-d4d2-48b4-bd94-10a3d9f38c38">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTUtMS0xLTA_5d05515e-ef39-4b7f-981d-a78651f9f07f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTctMS0xLTA_2375f076-93f2-4696-97ca-fdde0e011e44">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTEtMS0xLTA_122875e0-7de5-40a0-97a5-c66d290db98d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTMtMS0xLTA_720364b0-ee2b-4a8e-b886-6a65623860b1">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTUtMS0xLTA_3d6a53dd-6d1e-4a78-a584-6c94c8b80d4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTctMS0xLTA_d377868f-603e-435c-a898-f87d7340a6d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTEtMS0xLTA_cf2a0250-e094-4fc9-b646-643d477eb2bb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTMtMS0xLTA_2d15d2af-ca73-4af3-8a13-2063160ea34b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTUtMS0xLTA_37c46c0c-02a2-488d-8b89-be5ea0280e74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTctMS0xLTA_506e12a2-7bc4-4f71-be6f-8d85a869c7d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTEtMS0xLTA_aac8c6c3-8818-4577-a752-bf8776e3a477">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTMtMS0xLTA_341793f1-3898-44fe-8121-341884084b05">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTUtMS0xLTA_24a9bf21-fa35-4b7f-89cf-f44fb9ec3160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTctMS0xLTA_6a72790a-e3e7-404a-a714-7a48e6a20fa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTEtMS0xLTA_38f31982-d209-47e8-931a-b7f7e721e263">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTMtMS0xLTA_1fecd08a-dbb8-44d3-8e88-1577115e9c14">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTUtMS0xLTA_02322edc-98cf-4df4-9148-0dbc9848ec79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTctMS0xLTA_ecd7465c-8c62-44db-8f30-6b11a833b065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTEtMS0xLTA_46e64683-e458-4a44-a6b4-8a8467974cb2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTMtMS0xLTA_b360b75c-59db-428d-b5e1-7661bfac8ac8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTUtMS0xLTA_0d66df68-fd0d-461d-af2e-caa38f2fd9d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTctMS0xLTA_e52765e3-3f02-4ecb-8188-d830b0579796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTEtMS0xLTA_f676746d-62d0-4473-a5ee-f846247ba492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTMtMS0xLTA_ad362033-c54a-47ef-ae64-a5843c6101da">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTUtMS0xLTA_21204f73-1199-4de2-b36d-14c6e22025b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTctMS0xLTA_f0ba5021-cbdd-4c72-8a29-5a8f6f8cbc27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="i8f01425438e849b08b4ea7d7056f8648" continuedAt="i27efe681205446ca95636af377020da7"><ix:continuation id="ia506f751ad074a32a0b2dada88aa5c4f" continuedAt="i2db12619e57f4da99abf5bf12a6d9c29"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain) loss arising during the year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtMS0xLTEtMA_200a42e7-b554-4ab5-b5d3-0931c9fd64ae">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtMy0xLTEtMA_76450a1d-1472-413d-80b8-367cd07bb108">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtNS0xLTEtMA_df106c1c-3361-44bb-887c-2557f30f3a37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtNy0xLTEtMA_f131b023-eacc-427e-9437-54015b6d020f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtMS0xLTEtMA_2293450e-56de-484d-9840-086d5cbfc325">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtMy0xLTEtMA_34be9207-4085-4c2f-9d04-eed9f7354b78">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtNS0xLTEtMA_b0914fd3-1a50-4d72-be31-cd169108fbcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtNy0xLTEtMA_75f7a1d5-5bc9-4c1f-a47a-0df43325325d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTEtMS0xLTA_03023b05-0bc6-4b9f-b2c1-8da14d2f64f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTMtMS0xLTA_1a9bbd51-a3e6-48e0-8571-9f6cbbf61d05">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTUtMS0xLTA_e2011344-99cf-41a4-b287-e67c9069a6eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTctMS0xLTA_3280eada-1203-4fe4-b202-55cbe9363b4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTEtMS0xLTA_14154d14-a73f-4cb9-abd5-648a62dd13aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTMtMS0xLTA_0632262f-58f0-45af-afc0-80aed5ee7d49">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTUtMS0xLTA_2d052201-6f90-489b-8bf3-424ef29c6126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTctMS0xLTA_aa49ba29-0538-4288-b513-e0b58e4cb3fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTEtMS0xLTA_fb20b43e-45f9-4b0c-a219-46adec953173">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTMtMS0xLTA_425a5ad2-c775-4d28-8fe0-54741e568816">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTUtMS0xLTA_b0f36f64-9f47-4b6b-8b6f-2a3df5300e7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTctMS0xLTA_038a5264-8b23-4b81-a688-ac183d774fa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTEtMS0xLTA_ced30e1f-4142-44b4-82d1-aaa85736e2b1">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTMtMS0xLTA_9a4872d5-0528-420c-a075-64dae39aba85">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTUtMS0xLTA_3d094626-18eb-474a-8f40-d6f2e02e6530">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTctMS0xLTA_c9c63e12-3e51-4e7d-9829-fb7d1e0db1d9">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIwLTEtMS0xLTA_beb607bf-2a70-4f1d-9380-a52e4e5aaf5f">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIwLTMtMS0xLTA_03462529-7d01-4ba6-8204-9bd5bc9d1910">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTEtMS0xLTA_d14f6976-a898-4731-8c8a-9758adce07ed">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTMtMS0xLTA_7f8c4c43-fa77-4661-8e1f-ec54a99d94cc">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTUtMS0xLTA_d4e633dd-315e-4596-a425-a9dc378a4e3f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTctMS0xLTUwODg_33a604cc-b071-4df9-8d07-05f516499f9e">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIzLTEtMS0xLTA_d67e8999-67f7-448e-9056-2ad3266e4f34">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIzLTMtMS0xLTA_ad0a8c39-3732-40a6-b1fb-42f45c2f5944">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI0LTEtMS0xLTA_6042dc33-8664-47cd-8d77-7f16bd000c1a">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI0LTMtMS0xLTA_04fe7de9-d369-4080-859b-acc1b2b066ee">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTEtMS0xLTA_4db9ebc7-722c-4970-a380-3aa85e6420f4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTMtMS0xLTA_7aa08bad-e23d-4a2e-85b5-48fa375cfbc2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTUtMS0xLTA_8a54a82a-2134-49cc-861a-fe94cadc6f08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTctMS0xLTA_25c77b08-4c26-4fa0-a6a8-850206b05fc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i27efe681205446ca95636af377020da7" continuedAt="i03da3162c12e4f69962659f2ab4ea6f0"><div style="text-align:center"><ix:continuation id="i2db12619e57f4da99abf5bf12a6d9c29"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtMS0xLTEtMA_3b23bde6-9e69-4785-92c1-0b1ee5d35119">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtMy0xLTEtMA_13070bab-7194-408d-919d-fe346effdb6f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtNS0xLTEtMA_509c044e-54e5-4ba1-b488-cea2b9c392eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtNy0xLTEtMA_680abac7-ed73-4ab7-9693-f96a5f30cc62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtMS0xLTEtMA_6e8de67e-3f1a-4894-83b1-438473f469c4">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtMy0xLTEtMA_0a5a04d3-5bab-4406-a9a0-100c2409b14c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtNS0xLTEtMA_8e4538eb-c79d-4bfe-847a-6bcf625b85b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtNy0xLTEtMA_c784f4ba-9822-4518-8da7-0f9edbff6eba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctMS0xLTEtMA_f4516a4c-5beb-4c5b-a0d6-a87978871123">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctMy0xLTEtMA_97764e43-f2ed-4f87-8f47-d8e2021f9c42">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctNS0xLTEtMA_00d23f20-371f-40ee-a270-174685e6073e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctNy0xLTEtMA_e0fc0618-57be-4282-b8d8-cdd63ae9784e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtMS0xLTEtMA_b53bba15-4573-49a7-b754-f5d816956111">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtMy0xLTEtMA_3ace11bd-10e8-4e86-a008-26368f77909e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtNS0xLTEtMA_c63aa7cb-98d1-409c-8486-c5ed5d0a49f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtNy0xLTEtMA_f53c8657-2b0b-41ed-b89f-b52a3f151f58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktMS0xLTEtMA_e5b222f1-a7cd-4f85-9f48-22ac387ec8fb">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktMy0xLTEtMA_62d6e9ef-b2a0-4c16-aa68-2a011ce9c480">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktNS0xLTEtMA_7af98ed5-123d-46c2-a8b8-34bf1169faca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktNy0xLTEtMA_b6f3e954-2b88-459a-9b86-8c83f643952f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTEtMS0xLTA_dd3a671f-ed73-4818-8f9b-102e249a33fe">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTMtMS0xLTA_2799fb57-d721-4521-a436-d1f317552dec">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTUtMS0xLTA_29997273-dee2-411b-b3a2-e488ff9780b8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTctMS0xLTA_3b2ac667-e2e2-4233-a5c5-e2906dcfb61a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTEtMS0xLTA_cc4334e7-1bbc-46cc-8cb2-9e9dadae49a0">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTMtMS0xLTA_337c1570-7f88-493a-b2ea-6f2faaac9b24">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTUtMS0xLTA_20dfec78-a6ed-4061-ab6b-ac8d1fcfe381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTctMS0xLTA_6dfec4d7-7145-412c-92ad-b5b21882ce67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTEtMS0xLTA_aec9a262-76f3-48ae-889f-5311be6b6c46">30.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTMtMS0xLTA_cc7cc422-4a2e-4792-905d-6258ad805ecc">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice706a08834741238da74ea29809773c_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTUtMS0xLTA_de394db6-df40-4bb8-a9ec-34fabf956384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTctMS0xLTA_25676a5a-9cd4-418c-ab9c-70687c294af8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTEtMS0xLTA_61675bd0-7269-4f00-9913-7d6c073b781c">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTMtMS0xLTA_a14cdb3e-a2e2-41a8-bd70-2fad4a61b70c">24.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTUtMS0xLTA_4f829068-af8f-436f-975d-0e1c609957bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTctMS0xLTA_f9e883e3-d112-49d9-b284-d384aa92862c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTEtMS0xLTA_ed5f05a2-5309-46bd-9f90-f688bc362e1a">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTMtMS0xLTA_96412499-a958-4aa3-89f3-53bc7c452877">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTUtMS0xLTA_b740a394-c8b5-4aa0-af56-8aa1fdabf454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTctMS0xLTA_024399f4-9c76-41d5-98b7-be6d7dd82af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTEtMS0xLTA_acbff6d6-ed72-40a5-ba12-070ae567451c">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTMtMS0xLTA_38354b67-0e05-4229-8524-6a840e6ff9a8">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67761642cec34a60aa24257023272899_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTUtMS0xLTA_e60d90dc-6c5c-4e41-b6fa-a9afecd886c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTctMS0xLTA_19c74819-fcae-4ef8-95a6-0efd364c1a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTEtMS0xLTA_8c6d48d1-81e5-4c71-8aa1-3d0ec7322e70">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTMtMS0xLTA_219cfaed-8ac1-4d82-a5c3-2019e7a04848">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTUtMS0xLTA_3fe78aa5-dd5b-4890-a180-012e53863f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTctMS0xLTA_992d0748-06bc-4b8e-ad11-e22e9ec98441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTEtMS0xLTA_78e75b4a-7ecc-4e3a-8730-ed2759554ab2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTMtMS0xLTA_1ef76915-f560-4bee-9ad9-96c2f5c941b7">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTUtMS0xLTA_f71d29d0-af4c-4b9e-9993-3bd7c1b029cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTctMS0xLTA_211a4d0c-793c-4eeb-8acb-aa23efba932a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (Amount)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTEtMS0xLTA_6a21b6f4-b4b9-4c47-a3b0-d34351322325">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTMtMS0xLTA_ffd281cf-88d9-44e7-9815-1289d95d9a80">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTUtMS0xLTA_e4e3fc34-6ecc-41ff-b9ef-ddbd3adf0e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTctMS0xLTA_898597f7-efc5-4d76-83bc-971c8ac4357c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTEtMS0xLTA_f02b5bf4-c9e8-44f6-972f-e3366175507d">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTMtMS0xLTA_b4be7578-2d34-41e9-8b11-15114c242b74">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice706a08834741238da74ea29809773c_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTUtMS0xLTA_efb169f3-fea1-4570-8f6f-da4c6ec49bff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTctMS0xLTA_3690b653-7a8a-4ab2-90f0-a92d7e9e3ed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTEtMS0xLTA_c32d60b7-5573-494d-a4ef-15a2320c5635">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTMtMS0xLTA_61764979-4ab6-4245-877e-066257b49e4a">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTUtMS0xLTA_f303d72e-6c6c-41e4-9e9c-d7dbd41f3061">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTctMS0xLTA_5b6e5d6c-7769-40cc-b120-85be131ef147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTEtMS0xLTA_668ca035-e135-4458-ae86-bea52d936f68">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTMtMS0xLTA_b6521090-7b24-4a32-a516-c8672253a6f8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTUtMS0xLTA_5c337001-6959-45c1-9786-2dc659a23412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTctMS0xLTA_9b6244e2-5545-4d28-9581-156768729bbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTEtMS0xLTA_4ccfcd78-0c81-43d9-83be-9f905d3ae772">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTMtMS0xLTA_01a10526-f1f5-4234-8e6f-7743bfdb4ebd">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67761642cec34a60aa24257023272899_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTUtMS0xLTA_54a8f337-c717-43ed-ae04-a3bbdd9dc0ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTctMS0xLTA_3794e17d-13c8-4bd9-b9b9-7e6cebe2c082">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTEtMS0xLTA_308e42e1-3005-49e1-900b-7882d502ad30">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTMtMS0xLTA_89a11efd-18d4-4b30-9cdd-3a85ab097575">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTUtMS0xLTA_6e9461e7-271d-4c19-9312-3af33a837382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTctMS0xLTA_a34f7cef-a9c2-46fa-a208-bfb86d5238ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTEtMS0xLTA_0143d76a-41f6-443f-8f3e-d4e0ee382ff3">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="-6" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTMtMS0xLTA_ed6a64e3-7256-44ab-9edf-92d305fa5f3d">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTUtMS0xLTA_2c41e2e4-6e9b-4288-8086-0971add50f5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="-6" format="ixt:fixed-zero" name="ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTctMS0xLTA_aa35a44d-1e75-4842-8d37-3364a41663b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTEtMS0xLTA_18abd976-dbc2-4836-b36d-55c37c996c29">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTMtMS0xLTA_3a2a0220-d38b-40cb-b140-25e214fa767f">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTUtMS0xLTA_5ba33554-72e4-41b4-8e1a-3dadbf3c50eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTctMS0xLTA_27c8f6b0-8012-4fc6-b04c-efe0258a4e2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTEtMS0xLTA_99e4a501-f610-4677-8554-c8cfa0064ad1">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTMtMS0xLTA_d6866693-a5b7-4cc9-8bd2-d7a66bec4119">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice706a08834741238da74ea29809773c_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTUtMS0xLTA_d9521326-dffa-4245-ac26-84a2b12ab2fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTctMS0xLTA_4e20c9ca-e06d-4b1c-a694-057a0c02310e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTEtMS0xLTA_351caa37-13d4-4956-b01a-45960dd8b22e">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTMtMS0xLTA_99cada45-084b-462e-98ed-3799e3287fef">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTUtMS0xLTA_293bf227-a7f9-438f-9fa7-8304fb205eff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTctMS0xLTA_5ee89c37-07f5-44d2-ac75-cbacd6973584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTEtMS0xLTA_79f232e8-30d0-4306-9969-6c504f33c62e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTMtMS0xLTA_9506744e-5b25-484c-95a2-afe34bcd9a97">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTUtMS0xLTA_2bce002b-516e-4e2f-81fd-4dc7dbd7054e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTctMS0xLTA_28d9d3d1-4c5a-4882-bc27-2f8219092380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTEtMS0xLTA_88772a0f-868b-465b-91e1-27c5e6ee49e5">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTMtMS0xLTA_d3f1c4b0-cc71-4c1d-aa5d-d319dda4e498">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67761642cec34a60aa24257023272899_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTUtMS0xLTA_aa6383f2-3ae2-405d-a64e-169f41bed55f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTctMS0xLTA_27a3e142-d876-42d4-955f-9bad5ebeaa14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTEtMS0xLTA_d936553d-d49e-4da3-9c41-e78eb5b94b99">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTMtMS0xLTA_01948fc2-52a6-4bcc-96d8-e4278643e125">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTUtMS0xLTA_0f74d287-a069-4508-8220-89224255d3de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTctMS0xLTA_e571eab7-8506-4052-8a0d-1b43a6cf3b14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTEtMS0xLTA_3896537f-5733-4819-acff-6be267228cf1">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTMtMS0xLTA_59da4ede-e6f2-45e8-9aef-eb91c95b1141">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTUtMS0xLTA_d42b80d3-ed31-48c8-9ec2-272eef0aa0b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTctMS0xLTA_88f636df-76df-4b6f-80b2-f3adc1583cbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Investment Committee employs a building-block approach in determining the long-term rate of return for plan assets, with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed income are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long run. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data are reviewed to check for reasonability and appropriateness. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets are recognized and measured at fair value in accordance with the accounting standards regarding fair value measurements. The following are valuation techniques used to determine the fair value of each major category of assets: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Short-term investments, equity securities, fixed-income securities, and real estate are valued using quoted market prices or other valuation methods, and thus are classified within Level 1 or Level 2.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i03da3162c12e4f69962659f2ab4ea6f0" continuedAt="i411795b9a75644729b4d3f5984c41d9b"><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Insurance contracts and other types of investments include investments with some observable and unobservable prices that are adjusted by cash contributions and distributions, and thus are classified within Level 2 or Level 3. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTM_1595a5b1-c9b3-49eb-bf96-48b873c01a29" escape="true"><div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of plan assets that are measured at fair value as of June&#160;30, 2021 and 2020, aggregated by the level in the fair value hierarchy within which those measurements fall:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.178%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></td></tr><tr style="height:15pt"><td colspan="30" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e902584a964a56b042714cd96fd856_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItMS0xLTEtMA_b4a5968e-3dc2-467d-99da-40f94a00f84a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59d87ec9da544189ca37e884e903023_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItMy0xLTEtMA_7a4f1c2e-a2ce-4a69-a142-a9813aed29b8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76b7a1a1c50447c8795cfee9b76b6f2_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItNS0xLTEtMA_dec3ba10-4014-42bf-bf62-b22b69264ea9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280d65c3f17f458683c59c0a78aeb3f5_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItNy0xLTEtMA_94b4574d-42cc-421c-869c-d030209f7919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17dbf7d5602747039f196cf8fed44904_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItOS0xLTEtMA_aa256855-1652-4e53-9b22-8f2d025d7472">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78e5e7182ff24cb9a7f0279131bb4942_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtMS0xLTEtMA_591b5d1d-92ae-4615-8386-812f518e6d8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6429ba70c044f03b798cd9e4de2be0b_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtMy0xLTEtMA_cdb2f4fb-648a-4d4e-97f8-7dc861503f2c">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e0ac7b8ffd4432b71c123c4597bc5f_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtNS0xLTEtMA_0a06099d-9925-4891-a917-f55efe6e9762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39f484cfb594508ae46c19f5b6065b4_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtNy0xLTEtMA_d302ad70-8811-4121-88a9-0481fa115c2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dbac52f32be4ec29dce953d13e92d44_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtOS0xLTEtMA_c9a81c7c-644d-4071-bd4f-02b2d1295962">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d771ace0eb1449fb7f3c12ed9ed1b72_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtMS0xLTEtMA_09208a73-289d-4748-b33f-fa082dac9df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib594f3bd14cb40f2af014369a711be04_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtMy0xLTEtMA_abac4d4f-09f1-4246-be21-6bd7b0723789">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6ce956a9a84c788e025d461d2fa55e_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtNS0xLTEtMA_43bfe666-204b-46b2-8218-7bf54ebee0a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9a6629638d4bec8bbeca03f202300b_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtNy0xLTEtMA_4acb686a-3b24-4f55-97df-c1835493d1bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie042f30541ea42e3925b4408eb1b5efe_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtOS0xLTEtMA_5ffac322-7b6e-4a6d-9ad8-200781d87fe8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616dc17846934bb29e3dfa999602105a_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtMS0xLTEtMA_cd4a161d-39bc-4628-b4b0-7a765c2f36cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba82bbc9c25342b3ad2b0f7fca13b545_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtMy0xLTEtMA_d6de63f3-fea5-4580-8184-a3c2c06de327">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2af23bf32de448b9b29a639e339e12ca_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtNS0xLTEtMA_a5b61bda-058d-44d5-9730-25dcfaa8b7d1">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f7205774aa465d8c2c5c62294b0b82_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtNy0xLTEtMA_44fc0b90-ac3b-4138-a62e-99fbd6ac5c37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48b7425856b04051877a7f4af9acb089_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtOS0xLTEtMA_71de675f-8d61-48ef-9bf6-a4fed789be1f">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtMS0xLTEtMA_b5648112-0e1b-44db-8f31-c2c30b524353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtMy0xLTEtMA_b659079c-5fb4-45ae-89b4-350e5057c1fa">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtNS0xLTEtMA_7090ce52-08a5-4442-9c6a-7e16c8676862">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idefe473808f242cfb4d79b76bb4cd1b6_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtNy0xLTEtMA_a0076e8d-cd94-41c5-b663-6c86ac0cd9b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtOS0xLTEtMA_d40a96e4-c9ae-4b56-9f65-e21c1064e389">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other as of June&#160;30, 2021, included $<ix:nonFraction unitRef="usd" contextRef="id3d162800d3645f09f06e974c9c7b41f_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzI3NDg3NzkwNzUzMTI_c9f145a6-3293-4bb0-ba66-fed5b687f5ed">62</ix:nonFraction> million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><ix:nonNumeric contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" name="ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTU_32ce8404-64ef-47ed-a373-70c7d86e4109" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.178%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></div></td></tr><tr style="height:14pt"><td colspan="30" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id478458e161c4187b43283019eb85566_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItMS0xLTEtMA_40262f4d-b1ec-4be5-8fcc-253be80a4e54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7d5a90f3e04d0a8cda16af1947057e_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItMy0xLTEtMA_723c693a-50d9-4f9a-93fb-3bde0db7f843">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f58afe0b33945a38eaa3dbef03f5e38_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItNS0xLTEtMA_32b83951-d5c1-428b-b621-be87c68b2dd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9365ffbe0c824e079d7910fb709ae51b_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItNy0xLTEtMA_5e7a767a-23bf-4ad1-8452-311932de2383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2ea0ebe25a4a58af6552214e53fb98_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItOS0xLTEtMA_bbdbab5b-176e-468e-b357-06b26915f17b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674ba7cf27b546a4bb3070be9a749b6b_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtMS0xLTEtMA_5b581752-d836-449f-8dc7-2aba0e34f8bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if95647ade5004209956c4a57536f85cd_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtMy0xLTEtMA_a9fd76ad-2bb0-4dbe-909e-2e631a4bef67">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb17a22b64641879d269be22be9f957_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtNS0xLTEtMA_ce8f6c11-685b-4252-983c-dbe6b46e40c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2766d6e8cc8a4999992fa9459d493068_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtNy0xLTEtMA_47a948bf-14d5-4775-b7b3-17b6abb3949b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ddfd65a6674ab581ba4e4d8629a7c1_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtOS0xLTEtMA_d71658a2-ddee-4986-9eb8-6e6c7eecae40">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338530796387480ebed0b8318b633f47_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtMS0xLTEtMA_385f0d4f-0a18-49c8-b995-702680466bfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c88f034a63243369678cb546a00e1ac_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtMy0xLTEtMA_51f669dd-8453-4192-8324-a7c6050aea5d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217e96b6a96a4d41b70da7c1176afaac_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtNS0xLTEtMA_a7f194c8-3e8d-42f1-9ce1-40dcc06ffa6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9862365c693c40c5a75f7d109361924b_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtNy0xLTEtMA_9ebb18da-11ab-481a-822e-b5f14e4d987d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36fc4fd39be144599048465035ffbf4f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtOS0xLTEtMA_d195fe81-920c-40b5-8951-54ee8496f2c7">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044c92e5d7764b238c02260877d1c6a3_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtMS0xLTEtMA_69ef09ff-7b1f-4051-8dff-82fdf76c5bbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0933365c8e7843c381a38dda5c76730a_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtMy0xLTEtMA_0d79ab29-29ae-4c92-8221-1031eec3485b">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761a3f210f0d4571a49d8aba4bf24cd5_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtNS0xLTEtMA_442d3969-0fa0-4472-ba2d-d4b72498b845">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a004bc1607d43e183c8e77e4c139dc5_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtNy0xLTEtMA_a001f3e8-a69c-4837-a723-3fa7f5238b85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ad7c55e85245b69bd849dbef9f6339_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtOS0xLTEtMA_5a1777eb-8fb2-4d72-b0fe-1ecd6957a5cf">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtMS0xLTEtMA_1578b7c9-0ecb-4556-a801-ba65b1256a61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtMy0xLTEtMA_b8c73733-8307-4875-8f81-7246f3663d26">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtNS0xLTEtMA_ba8d3452-e244-4dde-9b27-f2efbe181786">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i065b118e37ce4fd4b007a6f358dfd1f8_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtNy0xLTEtMA_2c96cd52-0296-42ae-b6b0-b14df3dbdc78">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtOS0xLTEtMA_3a2e186c-be56-4010-bc7f-e8b5e495b73e">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other as of June 30, 2020, included $<ix:nonFraction unitRef="usd" contextRef="ie793845427de4931a83bcaeee475b50b_I20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzI3NDg3NzkwNzU0Nzk_6f0006bd-4bfc-42d4-a4af-71e5850348b9">31</ix:nonFraction> million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 other assets as of June 30, 2021 and 2020 consist of an insurance contract in the U.K. to fulfill the benefit obligations for a portion of the participant benefits. The value of this commitment is determined using the same assumptions and methods used to value the pension liability of the associated plan. Level 3 other assets for the same periods also include the partial funding of a pension liability relating to current and former employees of the Company&#8217;s Eberbach, Germany facility through a Company promissory note with an annual rate of interest of <ix:nonFraction unitRef="number" contextRef="i925686e50afe4c2ebf90635e12f3836a_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzQwNTY_442ae9d6-436d-4f4c-9e7f-74d49f3f58f2">5</ix:nonFraction>%. The value of this commitment fluctuates due to contributions and benefit payments in addition to loan interest. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTc_7a9b4960-dbeb-44b6-a80f-2a06505d5f3a" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of Level 3 assets as well as the changes during the period attributable to assets held and those purchases, sales, settlements, contributions, and benefits that were paid:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.617%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Insurance Contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Other</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtMS0xLTEtMA_c7b82690-c03b-4f3f-b42f-ee7aa5440b59">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73f5a43231945369c1c0f4f80a2d43d_I20200630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtMy0xLTEtMA_612cd9c1-bb22-43ed-abf9-d28aa5ea417a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9023c3b6654d3882840dd7e57a6add_I20200630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtNS0xLTEtMA_d3cdb419-3cde-4b4e-a555-ea4e1f1725ce">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at the reporting date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630" decimals="-6" name="ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtMS0xLTEtMA_dba784bd-4f46-48d4-b382-eb22cc94b198">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtMy0xLTEtMA_ba580126-9b75-4a3e-91cf-e0f26f65a1f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630" decimals="-6" name="ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtNS0xLTEtMA_677514e5-69d7-4bcb-b8d3-be3edd0fe634">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales, settlements, contributions and benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctMS0xLTEtMA_54ed3828-af08-4405-a6b2-8abec94970d6">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctMy0xLTEtMA_e30353d6-628b-43ff-bcbe-fc2b5e08b923">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctNS0xLTEtMA_7074f9a7-3947-462f-9690-c1fc56b9208c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in or out of Level 3, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtMS0xLTEtMA_3cd13479-065f-4c80-9eb5-a13285140d1b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtMy0xLTEtMA_41f3a180-8bed-440c-96d2-29c7084deb93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtNS0xLTEtMA_6c6f3fc3-ac39-4c8b-a09c-9a2606b9779b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktMS0xLTEtMA_6bfdeaa5-07b2-4796-9e38-faaeec9e163d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b03fecf1a824b69b571ab998730a8de_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktMy0xLTEtMA_52a6d504-997d-4387-b31f-32fd73eb7aa9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d51546be7e4dca88d0b88655adaa62_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktNS0xLTEtMA_90bd4686-ea84-4ca9-b309-fef3c28bb3e9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment policy reflects the long-term nature of the plans&#8217; funding obligations. The assets are invested to provide the opportunity for both income and growth of principal. This objective is pursued as a long-term goal designed to provide required benefits for participants without undue risk. It is expected that this objective can be achieved through a well-diversified asset portfolio. All equity investments are made within the guidelines of quality, marketability, and diversification mandated by the Employee Retirement Income Security Act of 1974, as amended (for plans subject to the act) and other </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i411795b9a75644729b4d3f5984c41d9b"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relevant legal requirements. Investment managers are directed to maintain equity portfolios at a risk level approximately equivalent to that of the specific benchmark established for that portfolio. Assets invested in fixed income securities and pooled fixed-income portfolios are managed actively to pursue opportunities presented by changes in interest rates, credit ratings, or maturity premiums. </span></div><div style="margin-top:9pt;text-align:justify"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTg_2fedab74-dfa3-4654-b2ee-15cc50bb9d7c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumed Healthcare Cost Trend Rates at the Balance Sheet Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; initial (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630" decimals="4" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzYtMS0xLTEtMA_2dab37b1-a0ba-4d58-a213-2938d9dfe0bf">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630" decimals="4" sign="-" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzYtMy0xLTEtMA_4f3a2082-61d9-4570-9ca5-8e4e91d29578">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; ultimate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzktMS0xLTEtMA_6621e662-7c81-42c7-a1a5-03a0dc23d343">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630" decimals="4" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzktMy0xLTEtMA_24306a0e-d08d-4ed2-8f9e-81df533cab1a">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year in which ultimate rates are reached</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie7bbc3d33ba64564905716133264e5cf_D20200701-20210630" name="us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzEyLTEtMS0xLTA_6c04b61f-f5be-4c33-8886-22447a47bc12">2035</ix:nonNumeric>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c19f2e7fd444db984805e159c3087f7_D20190701-20200630" name="us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzEyLTMtMS0xLTA_c81f4439-052a-4c98-8cc9-bd82db9ecf7c">2032</ix:nonNumeric>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:24pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_223"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ0NTg_2f59cdeb-0cda-46e7-b78b-b34c7a103892" continuedAt="i42082269ac2743318aa466f393850311" escape="true">EQUITY, REDEEMABLE PREFERRED STOCK AND ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span><span style="color:#026dce;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:continuation id="i42082269ac2743318aa466f393850311" continuedAt="ie4fcb92ce9d54cbe961a14441387968a"> </ix:continuation></span></div><ix:continuation id="ie4fcb92ce9d54cbe961a14441387968a" continuedAt="ia48919d47eb543b299d89dbff1a0acb3"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Capital Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEzMQ_00e49571-3c4a-4177-b4bf-a833652af615">1,000,000,000</ix:nonFraction> shares of its Common Stock and <ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEyNjQ0MzgzNzMyOTc4_afe83730-05c7-4a07-b40d-48a191a50df6">100,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzIwNQ_0b7e8939-8328-4121-8af9-7926ea4a5d5d"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzIwNQ_de854692-8dcd-40ab-8d48-c7e6c3ee8d40">0.01</ix:nonFraction></ix:nonFraction> per share. In accordance with the Company&#8217;s amended and restated certificate of incorporation, each share of Common Stock has one vote, and the Common Stock votes together as a single class. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offerings of Common Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2020, the Company completed a public offering of its Common Stock (the &#8220;June 2020 Equity Offering&#8221;), in which the Company sold <ix:nonFraction unitRef="shares" contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzU0MA_909013c5-1849-49ee-a2fb-87ba3b4312dd">7.7</ix:nonFraction> million shares of Common Stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic1290537b263472c96221d671edce576_I20200615" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzU4MA_07b60c2a-60c2-4cc3-9f3a-ed08025439f1">70.72</ix:nonFraction> per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the June 2020 Equity Offering of $<ix:nonFraction unitRef="usd" contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzcxOQ_76e0d94a-9695-4e07-b692-92a2bcf8228d">548</ix:nonFraction> million after the payment of associated offering expenses. The net proceeds of the June 2020 Equity Offering were used to repay $<ix:nonFraction unitRef="usd" contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzg0Mg_f2e56138-7aa0-4661-968e-76aa2ad24486">200</ix:nonFraction> million of prophylactic borrowings from the third quarter of fiscal 2020 under Operating Company's Revolving Credit Facility, with the remainder available for general corporate purposes. On July 10, 2020, the underwriter for the June 2020 Equity Offering exercised its over-allotment option on <ix:nonFraction unitRef="number" contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615" decimals="-5" format="ixt:num-dot-decimal" name="ctlt:StcokIssuedDuringPeriodSharesOverAllotmentOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzExMzE_aa810c8d-7931-4810-aff6-dd604d78f996">1.2</ix:nonFraction> million additional shares, resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:StockIssuedDuringPeriodValueOverAllotmentOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzExODI_888e8a6b-49b7-4fb6-aeef-f59977ac0d2b">82</ix:nonFraction> million from the June 2020 Equity Offering, which was recorded in the fiscal year ended June 30, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2020, the Company completed the February 2020 Equity Offering, in which the Company sold <ix:nonFraction unitRef="shares" contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEzODU_019b6959-12e1-4ac9-8120-4251b74b381d">8.4</ix:nonFraction> million shares of Common Stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic61973bb2144417ab4cb0d8936b28d87_I20200206" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE0MjU_6892460e-ef66-4ef0-93f5-286637b654c9">58.58</ix:nonFraction> per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the February 2020 Equity Offering of $<ix:nonFraction unitRef="usd" contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE1Njg_48d1844c-e716-49a2-b55f-e742a1d8c760">494</ix:nonFraction> million. The net proceeds of the February 2020 Equity Offering were used to repay $<ix:nonFraction unitRef="usd" contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE2NDU_cc380c60-01dd-49f2-a02a-5baea2b27b72">100</ix:nonFraction> million of borrowings earlier in the quarter under Operating Company's Revolving Credit Facility and the consideration for the MaSTherCell acquisition due at its closing, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Restricted Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares outstanding of Common Stock include shares of unvested restricted stock. Unvested restricted stock included in reportable shares outstanding as of June 30, 2021 was not material. Shares of unvested restricted stock are excluded from the calculation of basic weighted average shares outstanding, but their dilutive impact is added back in the calculation of diluted weighted average shares outstanding.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Preferred Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Company designated <ix:nonFraction unitRef="shares" contextRef="i47f799b0175d45b2b0f741e0b0d836f2_I20190630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4ODk3MTI_60670215-af81-4a2b-a693-0aa60e0fdbef">1,000,000</ix:nonFraction> shares of its preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4ODk3NTc_9e180431-23dc-40d3-99a6-b631e7ae80bf">0.01</ix:nonFraction>, as its &#8220;Series A Convertible Preferred Stock&#8221; (the &#8220;Series A Preferred Stock&#8221;), pursuant to a certificate of designation of preferences, rights, and limitations (as amended, the &#8220;Certificate of Designation&#8221;) filed with the Delaware Secretary of State, and issued and sold <ix:nonFraction unitRef="shares" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAwMzQ_99414299-7213-4e40-b41f-f2e11affb860">650,000</ix:nonFraction> shares of the Series A Preferred Stock for an aggregate purchase price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:PreferredStockIssuanceValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAxMTI_007aff17-dca1-4739-a085-b16f770b9b20">650</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to affiliates of Leonard Green </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia48919d47eb543b299d89dbff1a0acb3" continuedAt="i7e8998e7503f4517bf23f673d3655b1a"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&amp; Partners, L.P., each share having an initial stated value of $<ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAyMzg_6db4bdf1-836b-480a-8abb-75be20bb89af">1,000</ix:nonFraction> (as such value may be adjusted in accordance with the terms of the Certificate of Designation). The Series A Preferred Stock ranks senior to the Company&#8217;s Common Stock with respect to dividend rights and rights upon the voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the offering of the Series A Preferred Stock, net of stock issuance costs, were $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:PreferredStockIssuanceValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTA2Nzk_c4ba2591-111d-41e1-ae4f-cf92f8d7c958">646</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i7867ffbd357d4690b08c9d4613c293e4_I20190517" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTA4MjM_e37ddcd1-8f63-47c6-9ad8-68f157feffca">40</ix:nonFraction> million was allocated to the dividend-adjustment feature at its issuance and separately accounted for as a derivative liability.  Any change in the fair value of derivative liability during a fiscal quarter is recorded as a non-operating expense in the consolidated statement of operations. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail concerning the change in fair value during the fiscal year ended June 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Partial Conversion Date, holders of Series A Preferred Stock converted <ix:nonFraction unitRef="shares" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4MTE_c04e5d78-84ee-47b2-b240-b2fac6cb6740">265,223</ix:nonFraction> shares (approximately 41% of their holdings) and $<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4MzA_36f5a079-2d5a-4621-a158-51b12b0fa54a">2</ix:nonFraction> million of unpaid accrued dividends into shares of Common Stock. The holders received <ix:nonFraction unitRef="shares" contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NDI_a034ab87-5883-4462-9b41-6e23b526c72a">20.33</ix:nonFraction> shares of Common Stock for each converted preferred share, resulting in the issuance of <ix:nonFraction unitRef="shares" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NTQ_e17c2197-3f56-4849-9d46-e67ba0b48575">5,392,280</ix:nonFraction> shares of Common Stock. There was no gain or loss recognized upon the Partial Conversion as it occurred in accordance with the terms of the Certificate of Designation. The Company has <ix:nonFraction unitRef="shares" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NjQ_5cb3f38f-3836-44a1-9cac-8de848da877c">384,777</ix:nonFraction> shares of Series A Preferred Stock that remain outstanding at June 30, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Partial Conversion, additional paid in capital increased $<ix:nonFraction unitRef="usd" contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4Nzk_27fc9003-6ea4-4142-8d19-264f214754e1">253</ix:nonFraction> million, which includes $<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4OTY_50bacd1f-1cfc-4bd7-bbda-a21ecc18ac09">4</ix:nonFraction> million related to the fair value of the portion of the derivative liability that was settled upon the Partial Conversion and $<ix:nonFraction unitRef="usd" contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc5MTc_eb817beb-4aee-4466-ac6e-245c14e64c01">2</ix:nonFraction> million related to an unpaid accrued dividend. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail concerning the change in fair value during the fiscal year ended June 30, 2021. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ0Njk_b365b05b-649e-43c7-94ed-06ede9f05c8f" continuedAt="i4fed25a946414f4cbe57245777db0b99" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the changes in the cumulative translation adjustment, derivatives and hedges, minimum pension liability, and marketable securities for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consists of:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:59.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtMS0xLTEtMA_fd850335-8201-4d6c-b85c-88f13b7ee55a">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtMy0xLTEtMA_3f28fdfc-9593-45c4-875a-6d77cb18c637">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtNS0xLTEtMA_6111aef2-96b9-4f2e-bded-6a9bf10f323c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term inter-company loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtMS0xLTEtMA_9afe1f70-25dc-4683-9577-ce591c0c8a42">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtMy0xLTEtMA_9b9d45b2-2f3e-40a3-8e74-aa5c302443c9">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtNS0xLTEtMA_a9a7c335-b3d3-4b5f-a1af-a12d20d8970b">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtMS0xLTEtMA_0c2e356f-c363-4311-b947-a85642fd11d5">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtMy0xLTEtMA_fa438ef4-3c06-45e9-8b5f-b1dc2d1d7e42">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtNS0xLTEtMA_cd4a6de2-fae2-4063-a614-dd6296242755">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, pretax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtMS0xLTEtMA_866cc24a-5d86-4502-9856-d841380246ed">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtMy0xLTEtMA_69061225-adc9-4818-b7e0-470362765fc8">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtNS0xLTEtMA_21284fbd-d316-4aa3-b9f4-3ec2abd194e9">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctMS0xLTEtMA_f441fc41-dbdc-4547-80f9-44494eee7cd5">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctMy0xLTEtMA_61011f03-ec04-40a6-83b9-b337aeaf34cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctNS0xLTEtMA_9ea0aa81-45da-495c-870a-4825d9b04347">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMS0xLTEtMA_6f4fa381-2601-4af7-a55e-d115313a0324"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMS0xLTEtMA_d650da5b-cc2c-4d2d-9210-4c997afe3e90">67</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMy0xLTEtMA_8ffe0386-3303-4e56-8a7b-0a67a31207df">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtNS0xLTEtMA_5e59bc11-8f2f-4d6d-a71d-7a0305ee41f5">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTEtMS0xLTA_f3aa80cd-b2ed-4c2f-aa57-adc31ba5e5cf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTMtMS0xLTA_4438e0ee-5981-4e30-a421-69be4816f3ad">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTUtMS0xLTA_3adf60da-271b-42b1-9b74-5d7296c24c66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTEtMS0xLTA_d9b4d234-0e9a-4fe2-ab53-99107fc32778">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTMtMS0xLTA_aa0fcd51-73e4-4dbc-8de7-01630bc70122">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTUtMS0xLTA_6013ff85-b96a-433d-8b18-fca263fa6af2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges, net of tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTEtMS0xLTA_2e3cd357-055e-4143-bc6e-b2278f860096"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTEtMS0xLTA_90cc32bc-ec3a-4ce0-a044-f1967fe33019">3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTMtMS0xLTA_9591aeb1-4789-4457-b392-cadd01bce960">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTUtMS0xLTA_b6e6139d-36f3-4009-a6bf-9b04b907be3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTEtMS0xLTA_a16eaf0a-f9ec-4254-a6b9-b47cafed2052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTMtMS0xLTA_32cd0922-01ed-484f-978c-ed0382af711f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTUtMS0xLTA_41b1baf8-38af-4cc9-840e-373117a4b692">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTEtMS0xLTA_5f055d4f-b67d-43cd-9209-1d9f2680b27f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTMtMS0xLTA_12689245-e134-407d-a5ef-c7ec00adb2ef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTUtMS0xLTA_d16c72ea-7817-4c10-955a-e702a9044db8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTEtMS0xLTA_99685733-46fa-438f-af8c-bd67c25837a9"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTEtMS0xLTA_9ba26b85-41ea-47af-8a92-c59194f542df">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTMtMS0xLTA_1f5d240f-4b65-44ef-951a-e169021835af">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTUtMS0xLTA_b8fbc437-bea8-418c-9047-ec0daa8dc3b3">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTEtMS0xLTA_6b481b86-fa99-46ab-bbaf-ca590630ea76">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTMtMS0xLTA_9b5ddd8c-1bdf-4a1a-a3e3-5d22090556c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTUtMS0xLTA_b3f85d1d-4e53-4941-b10a-d5fb22b9b3a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTEtMS0xLTA_8ba473ec-dfdf-4e5f-8f61-9e5dd2dde15d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTMtMS0xLTA_e4cb6765-2364-447b-a77f-3739f9dc72bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTUtMS0xLTA_0101654d-6bfd-4600-97c6-d8e857060ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_81b099d4-7acc-4808-92ea-72fada505513"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_8622dedf-b416-4972-98c0-dec8e34dccbd"><ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTMtMS0xLTA_761890dd-4fa3-4e6f-8ab1-759b3b28209c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTUtMS0xLTA_9ae49af7-3e45-45fc-833f-e41cd3580791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><ix:continuation id="i7e8998e7503f4517bf23f673d3655b1a"><ix:continuation id="i4fed25a946414f4cbe57245777db0b99"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEwOTk1MTE2NDExODU_e32b762c-5743-4ee0-8e59-f21b0729f671" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign&#160;Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Liability Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives and Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef4a2ddd640405884e26ccb88aec2cc_I20180630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMS0xLTEtNTA5MA_dda4ac51-14a2-4cff-8d03-8ae3dfc8e056">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifec61b66a0ae41bb8d96d423f6b1d627_I20180630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMy0xLTEtNTA5MA_f00daa25-3bdf-498a-a821-6d809fbddd70">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a022f50ba3b4184aca687e31673f394_I20180630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctNS0xLTEtNTA5MA_7bc63b78-32f4-4437-8dcd-b277689dc59e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i221440e603ee468f84a494f340ce58aa_I20180630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctNy0xLTEtNTA5MA_d5589bc2-c535-4bde-b2a1-e1f9fce8e657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50d58655fb4b4d95a56611db174ed7c0_I20180630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctOS0xLTEtNTA5MA_5386ad20-ad15-430c-8e8f-9d62f8d5abb1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMTEtMS0xLTUwOTA_b0e29b48-b7a1-4da7-b106-fc2bb794a831">326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMS0xLTEtNTA5MA_db38f36f-60db-4dc2-8f00-90f3b9b02787">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMy0xLTEtNTA5MA_3dbab112-7e81-4929-8321-bb8ef544e921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5655f5c2bab84586add677e627a148ce_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtNS0xLTEtNTA5MA_70577b62-b3b6-4107-8d18-5968b04f47a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtNy0xLTEtNTA5MA_826f6ad5-f553-4cdc-94fb-cce5189ea280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtOS0xLTEtNTA5MA_0e00fa74-02ea-4ce1-9637-ea2705824371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMTEtMS0xLTUwOTA_78b79cf5-6ce8-4f4f-8602-f4ef32f8e55e">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMS0xLTEtNTA5MA_83762249-c8be-4a73-a4f1-04a65fd6321e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMy0xLTEtNTA5MA_3eb9d600-5840-4b50-8303-c6d06caebf8f">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5655f5c2bab84586add677e627a148ce_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktNS0xLTEtNTA5MA_4f2f6dc5-760c-4e52-b37f-78bf848b8049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktNy0xLTEtNTA5MA_09ec7f51-9e6e-48cf-9090-7b834a483836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktOS0xLTEtNTA5MA_721f847f-8a2a-46b5-bc46-8d906dbacdc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMTEtMS0xLTUwOTA_e1a38828-0248-422e-9c01-b4304617fa4e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i821917bb413b4a56aac98433b843532a_I20190630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTEtMS0xLTUwOTI_cc83b973-1dea-4b78-8d89-6c2397f868ee">304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5caf499e0a431a8879e0fccd6f9ece_I20190630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTMtMS0xLTUwOTI_657e4136-02ed-4ce0-82ce-b13afff90c7b">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2629dad7444ac6a087600fb4eeb17d_I20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTUtMS0xLTUwOTI_ec09edb4-37d4-49cc-9275-92e4f1527965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f53a97e9a3e45b0b0be1df8cb9a0cb5_I20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTctMS0xLTUwOTI_d699d4c5-6097-4369-be2f-b127c7f597c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i240eab7869244315a4272887642c26a5_I20190630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTktMS0xLTUwOTI_1845d146-fee4-4d51-9d53-371ecec59d38">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTExLTEtMS01MDky_58f69434-cae7-4712-a113-b38d6164a96b">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTEtMS0xLTUwOTQ_93e36e68-0501-4c88-805c-1b267d6a2d35">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTMtMS0xLTUwOTQ_9564d480-3127-4bcb-b5be-e916fc7bf37d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTUtMS0xLTUwOTQ_80be04d7-bb83-4ce9-bfc3-c5120c7e3229">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTctMS0xLTUwOTQ_974c931d-89bd-40f8-92ad-7ffc0dbdda1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39c138759b140dab2149dee8ac05f30_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTktMS0xLTUwOTQ_356c7bf2-89d4-4901-bc26-6db6bd2dda24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTExLTEtMS01MDk0_93581bd0-a95b-4834-b25d-5f772e9607a8">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTEtMS0xLTUwOTQ_c22a1ada-4aa8-4853-bf1c-c9ff9d3bff0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTMtMS0xLTUwOTQ_d081f622-b3dc-4527-8713-0425a7668331">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTUtMS0xLTUwOTQ_f0f49017-b66a-4f6d-94c7-f67ee62b0c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTctMS0xLTUwOTQ_353d5043-8de7-4149-ad6f-a50982315177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39c138759b140dab2149dee8ac05f30_D20190701-20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTktMS0xLTUwOTQ_630b3f7d-4cca-43fb-8087-ad66451081bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTExLTEtMS01MDk0_ce9964f4-c35e-4fa6-bc54-4aef34549916">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib607491522bf4a9cbf1b0e51427ed504_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTEtMS0xLTUwOTY_ae79c586-5587-4200-8ad4-fd75b4166b64">335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ebe451150f641eba39d44e90165f2bc_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTMtMS0xLTUwOTY_a5b3418a-fcd2-4e85-8397-99301402f0a2">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i087ba84b22354e09b7931fd608163258_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTUtMS0xLTUwOTY_0ea8f2a1-9cb1-45b8-83f5-2ef1d3d4ccc2">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6065f8b36ce4420b00d99511de9eeb2_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTctMS0xLTUwOTY_4b0f0a60-98f2-4d6e-9924-743a6b5eb434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef7b19288854132b4c14e7c56376062_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTktMS0xLTUwOTY_aa8fb7e3-f23f-456c-b074-86f791255789">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTExLTEtMS01MDk2_8037ce50-054a-4c0a-bbbd-296a714f7723">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTEtMS0xLTUwOTk_6f4fa381-2601-4af7-a55e-d115313a0324"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTEtMS0xLTUwOTk_d650da5b-cc2c-4d2d-9210-4c997afe3e90">67</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTMtMS0xLTUwOTk_aabf3331-c614-45ed-929a-4f5868df38c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTUtMS0xLTUwOTk_2e3cd357-055e-4143-bc6e-b2278f860096"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTUtMS0xLTUwOTk_90cc32bc-ec3a-4ce0-a044-f1967fe33019">3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_81b099d4-7acc-4808-92ea-72fada505513"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_8622dedf-b416-4972-98c0-dec8e34dccbd"><ix:nonFraction unitRef="usd" contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21c601ca07c400c97c3e7ea14464b57_D20200701-20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTktMS0xLTUwOTk_9b627365-dac5-4558-b6fc-44a4d23759ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTExLTEtMS01MDk5_a75c1eb8-1784-430c-9b4a-7faff266bc0c">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf4b5715f5e247d7b165eac3e63b264b_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTEtMS0xLTUwOTg_bf34b67f-893f-4f23-8f49-d84a7a02d2e0">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie772514199484fb3aae9babd28777987_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTMtMS0xLTUwOTg_690b35f1-b443-4fb7-9a51-9ff810b5d0b2">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2b9e16ce3314fc2920a48d1f12d45fd_I20210630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTUtMS0xLTUwOTg_3abf5338-6c2d-4466-afbe-1caf50c01cc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16adf08f770b46c8aa99e285f1f5c1ac_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTctMS0xLTUwOTg_73f09cd7-bcd8-407c-b5c0-4bb5018810d8">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fabe70416074ebda423b8e2c3b19f93_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTktMS0xLTUwOTg_ac05242d-5098-471e-8e92-a721c82c2795">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTExLTEtMS01MDk4_c4c03530-d4b0-4404-b78f-8490674f471f">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_232"></div><div style="padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">14.   <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDM2_c9b3ec5b-d5a4-428a-b8bf-7c03533e422c" continuedAt="ia4783b94a66f462c81561ba2ebc68d16" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:continuation id="ia4783b94a66f462c81561ba2ebc68d16" continuedAt="i07f15bae261c455fb13dd0e9de14af3f"> </ix:continuation></span></div><ix:continuation id="i07f15bae261c455fb13dd0e9de14af3f" continuedAt="i74c23e60f0e446a68e7d07e9ec200198"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation is comprised of stock options, restricted stock units, performance-based restricted stock units, and restricted stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 and 2018 Omnibus Incentive Plans</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s board of directors adopted, and the holder of a majority of the shares approved, the 2014 Omnibus Incentive Plan effective July 31, 2014 (the &#8220;2014 Plan&#8221;). The 2014 Plan provided certain members of management, employees, and directors of the Company and its subsidiaries with the opportunity to obtain various incentives, including grants of stock options, restricted stock units (defined below), and restricted stock. In October 2018, the Company&#8217;s shareholders approved the 2018 Omnibus Incentive Plan (the &#8220;2018 Plan&#8221;), and, as a result, new awards may no longer be issued under the 2014 Plan, although it remains in effect as to any previously granted award. The 2018 Plan is substantially similar to the 2014 Plan, except that (a) a total of <ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNTY_ff6b888d-df18-4458-a7e8-5dda23079594">15,600,000</ix:nonFraction> shares of Common Stock (subject to adjustment) may be issued under the 2018 Plan, (b) each share of Common Stock issuable under the 2018 Plan pursuant to a restricted stock or restricted stock unit award will reduce the number of reserved shares by <ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDI4_ea316afe-ebf8-494a-ab61-5e34ad16cf84">2.25</ix:nonFraction> shares, and (c) the 2018 Plan imposes a limit on the aggregate value of awards that may be made in a single year to a non-employee director. Both the 2014 Plan and the 2018 Plan permit &#8220;net settlement&#8221; of vested awards, pursuant to which the award holder forfeits a portion of the vested award to satisfy the purchase price (in the case of options), the holder&#8217;s withholding tax obligation, if any (in all cases), or both. Where the holder net-settles the tax obligation, the Company pays the amount of the withholding tax to the U.S. government in cash, which is accounted for as an adjustment to Additional Paid in Capital.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock compensation expense recognized in the consolidated statements of operations was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNTQ_b978c74d-cf4a-4dda-9f48-74d97fa3f7bf">51</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNTg_6e136a50-5685-48eb-87ab-8af66d11981f">48</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNjY_35e176d1-f2d4-4251-bbbb-06d7dd323f33">33</ix:nonFraction> million in fiscal 2021, 2020, and 2019, respectively. Stock compensation expense is classified in selling, general, and administrative expenses as well as cost of sales. The Company has elected to account for forfeitures as they occur. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i74c23e60f0e446a68e7d07e9ec200198" continuedAt="i8a5fcd54231641258de52dac785eeb81"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted under the 2014 Plan or 2018 Plan, as applicable, during fiscal 2021, 2020, and 2019 had an intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxMzM_4f6c99cf-b2af-47bd-a882-9906de465e41">5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxMzc_24d17f3a-55f6-4dcc-889a-35d7de65932f">6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i226e7ad29001479db3560c191da2d80c_D20180701-20190630" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxNDU_5d3368ee-7eb4-456f-8376-23d09fcd68d2">24</ix:nonFraction> million, respectively, which represents approximately <ix:nonFraction unitRef="shares" contextRef="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxOTQ_b76ba68e-f5cf-4c7b-89f5-e3df4d0f622d">231,000</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxOTg_a2d55259-f7d5-48d8-9e32-098df18932a8">329,000</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i226e7ad29001479db3560c191da2d80c_D20180701-20190630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQyMDY_2550ab85-f51d-41c7-a404-0b80f140995b">1,179,000</ix:nonFraction> shares of Common Stock, respectively. Each stock option granted under the 2014 Plan or 2018 Plan vests in equal annual installments over a four-year period from the date of grant, contingent upon the participant&#8217;s continued employment with the Company, except for a small number of grants that vest based on the achievement of operating performance targets set forth in the award documents.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Methodology and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding stock options have an exercise price per share equal to the fair market value of one share of Common Stock on the date of grant. All outstanding stock options have a contractual term of <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:duryear" name="ctlt:StockOptionGrantedContractualTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQ4MzE_13988ff7-8a1e-4dbd-9328-723934a0f205">10</ix:nonNumeric>&#160;years, subject to forfeiture under certain conditions upon separation of employment. The grant-date fair value is recognized as expense on a graded-vesting basis over the vesting period. The fair value of stock options is determined using the Black-Scholes-Merton option pricing model for service and performance-based awards, and an adaptation of the Black-Scholes-Merton option valuation model, which takes into consideration the internal rate of return thresholds, for market-based awards. This model adaptation is essentially equivalent to the use of a path dependent-lattice model. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQ0_0b006c4c-d8e6-4b82-95b2-46c57d22f19a" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average of assumptions used in estimating the fair value of stock options granted during each year were as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2bd505327db495a8249c5115973c38f_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItMS0xLTEtMA_5907c3ab-1285-4227-89b0-443e9bd6bad6">27</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItNS0xLTEtMA_71caabe8-5b3e-47f6-a4f0-0efb2d76579f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItNy0xLTEtMA_a2d833f6-6f4e-4a15-8329-897c14bce21f">24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c12a76e607440788d887a6561e62949_D20180701-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItOS0xLTEtMA_70628cf6-2d6b-41a5-8e05-c3bf04a495ea">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItMTEtMS0xLTA_4717feee-79cb-4836-96c0-2f0eaecbe1fe">24</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtMS0xLTEtMA_b04b0daa-851a-4ff5-8c2f-c53888b3fb75">6.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtNS0xLTEtMA_35bd0e86-b3d4-4327-85b4-f1c0dac9cfe8">6.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtOS0xLTEtMA_090a39c9-aca7-4f6d-b282-c2001494f097">6.25</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib2bd505327db495a8249c5115973c38f_D20200701-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtMS0xLTEtMA_1d4984f5-ca32-477f-90b2-1702ba60a97e">0.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtNS0xLTEtMA_bf14cce4-fc97-4683-a806-aada038a6832">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtNy0xLTEtMA_6da4e320-5206-413b-a589-2347faedea82">1.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c12a76e607440788d887a6561e62949_D20180701-20190630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtOS0xLTEtMA_b30da5c5-aef9-481f-9d15-89853b7ead87">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtMTEtMS0xLTA_a9fe75cc-dbfa-4e69-83fa-34b86fdede91">2.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630" decimals="0" format="ixt-sec:numwordsen" name="ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtMS0xLTEtMA_61b4fafb-3bce-4604-93f9-9931afe615f5">None</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630" decimals="0" format="ixt-sec:numwordsen" name="ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtNS0xLTEtMA_c7fe7117-0be0-4d2e-8399-4a426f82d2de">None</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630" decimals="0" format="ixt-sec:numwordsen" name="ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtOS0xLTEtMA_7441a120-9036-4bfd-803e-3289c96a08b8">None</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public trading of the Common Stock commenced only in July 2014, and, as a result, there is only available limited relevant historical volatility experience; therefore, the expected volatility assumption is based on the historical volatility of the closing share prices of a comparable peer group. The Company selected peer companies from the pharmaceutical industry with similar characteristics, including market capitalization, number of employees and product focus.&#160;In addition, since the Company does not have a pattern of exercise behavior of option holders, the Company used the simplified method to determine the expected life of each option, which is the mid-point between the vesting date and the end of the contractual term. The risk-free interest-rate for the expected life of the option is based on the comparable U.S.&#160;Treasury yield curve in effect at the time of grant. The weighted-average grant-date fair value of stock options in fiscal 2021, 2020, and 2019 was $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1MjU_a20fa09f-a745-4a8e-86cf-1a02d5fcf0e2">24.36</ix:nonFraction> per share, $<ix:nonFraction unitRef="usdPerShare" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1Mzk_efe944f0-feb2-40e3-9087-929b2ea57c3c">15.22</ix:nonFraction> per share, and $<ix:nonFraction unitRef="usdPerShare" contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1NTc_5972be3a-999e-401e-936a-56c316bd3dfc">9.49</ix:nonFraction> per share, respectively.</span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDM5_b281ec97-4817-4d7a-bf17-5ba0112f71da" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity and shares subject to outstanding options for the fiscal year ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMS0xLTEtMA_be29843a-75a1-4d20-9f0b-41d560309baa">35.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i696afeb709ea478c8ccf7a35b63793d5_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMi0xLTEtMA_beabe15a-c692-4876-b3bd-07f14fa049a7">1,997,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id4760a1c73cc4e78b46d8250df062040_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMy0xLTEtMA_546dafb0-f63b-4095-9464-50c2a3c3ead9">8.63</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i696afeb709ea478c8ccf7a35b63793d5_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNC0xLTEtMA_992071b4-70e1-4bfd-b13c-802962c1940c">76,229,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNS0xLTEtMA_7ab7a9c8-55a2-4345-8d3d-fa8b028f685c">85,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1910093577c14f8a935dd760ba3c5e1d_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNi0xLTEtMA_b2031bb6-f5c1-48ed-a433-b905b005b263">5.01</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNy0xLTEtMA_86e86620-7400-4b95-835e-bed570965b82">2,453,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTEtMS0xLTA_78b80bbf-a855-46a0-8a10-d67a066cdc5c">88.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTItMS0xLTA_21410c6b-6586-4ced-b53d-94d49d8b721b">231,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTUtMS0xLTA_a174ca1b-9f55-47fb-8bdc-0f2746021d22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTEtMS0xLTA_fe7856df-007d-422d-8216-40ae0a5d8818">26.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTItMS0xLTA_bca11769-d253-41b1-b1f1-ed47c438bf2a">870,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTQtMS0xLTA_ad609b46-d613-42bb-aa6c-0eb634e8a82a">63,527,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTUtMS0xLTA_3c61aee7-9cd5-4bd7-a515-9904830fa5d6">2,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTctMS0xLTA_97bba896-ccd6-4f41-b7dd-2f5fc9898b81">222,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTEtMS0xLTA_7b0a9a24-bad9-461a-80dd-29c50309f6ac">48.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTItMS0xLTA_d42be68a-ec1e-41d5-9dd3-0a8c9ecab4ed">73,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTUtMS0xLTA_43e340ca-4436-480f-98e0-8356b5f21593">82,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired / Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTEtMS0xLTA_4bfae6dd-1d10-485b-9af4-0f0d0d837ac0">41.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTItMS0xLTA_361abf2a-1b0e-4598-a325-cd6fba9cfacf">5,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTUtMS0xLTA_8e03a8cf-a51a-4822-9187-368ff3f5e255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTEtMS0xLTA_9b9882bb-f0b0-437e-9ff1-b4ef5f7bf677">49.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTItMS0xLTA_3222cfa5-40d6-4019-96cb-372d749144f6"><ix:nonFraction unitRef="shares" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTItMS0xLTA_92fa9489-3a68-4d8c-a8de-5028790cb029">1,280,174</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTMtMS0xLTA_5d3d963b-c4c1-4b29-b4c7-c09f40db047b">4.92</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTQtMS0xLTA_c952409e-e3a7-4b94-9de7-964988244ec8">74,696,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTYtMS0xLTA_03ed959a-3dd3-4c95-86d9-dd7c331b9a68">0.00</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTctMS0xLTA_0c1c7322-2892-472e-ba95-38b7e05ef754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vest and expected to vest as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTEtMS0xLTA_d96b9c25-7be3-4182-b436-09ce5dcb1b92">49.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTItMS0xLTA_7d4caefb-3dfc-4316-9dca-7829254bd3aa">1,280,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" format="ixt-sec:duryear" name="ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTMtMS0xLTA_591e83f5-c280-4a0f-99b4-4b0e4b9521bd">4.92</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTQtMS0xLTA_9967c788-1c26-4e7f-9789-edeb5ee22286">74,696,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTUtMS0xLTA_1b7c1e77-5e3c-410d-aadf-ef392d610950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" format="ixt-sec:duryear" name="ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTYtMS0xLTA_477ff6c6-377d-458b-824e-05a5ac312abc">0.00</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTctMS0xLTA_17cd9477-12b3-4314-9260-dab40f9fcdba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and exercisable as of June 30, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTEtMS0xLTA_8f112b03-c6fc-4d30-85c6-7da917a04751">38.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTItMS0xLTA_1d83ecd7-e929-4d55-aae3-61290eba6268">480,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTMtMS0xLTA_271ef1fb-c907-4e39-b694-f78e5b4886f8">6.69</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTQtMS0xLTA_94a7285b-df78-4185-8252-ff95aabad1a5">33,607,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTUtMS0xLTA_9cc0502f-3650-4382-b351-33a7bb98545e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTYtMS0xLTA_8b2d224d-bab1-4945-831f-89db55f550b8">0.00</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630" decimals="0" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTctMS0xLTA_b04d5a59-98e1-429b-920b-472a14324e98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, participants exercised options to purchase approximately <ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY3ODQ_42ea0aba-27d0-4e4c-a08a-f6e04f0dbbfa">726,000</ix:nonFraction> net settled shares, resulting in $<ix:nonFraction unitRef="usd" contextRef="i671c59d76d904023aea5037521cce6c5_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY4MjA_fee0e9c3-71f6-4e57-a645-7cfb7cea13bb">27</ix:nonFraction> million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2021 was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY5NDc_2c746d67-f5d1-49c4-a3fa-7af0aded36ea">64</ix:nonFraction> million. The total fair value of options vested during the period was $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcwMTI_0446cc17-df4b-44b6-be27-b3a7ef20f744">7</ix:nonFraction> million. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8a5fcd54231641258de52dac785eeb81" continuedAt="iee43ade2664e443382b41dc7d026d334"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, participants exercised options to purchase approximately <ix:nonFraction unitRef="shares" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcwODg_f4e1d759-223b-42d2-b86e-5352848a0957">166,000</ix:nonFraction>&#160;net settled shares, resulting in $<ix:nonFraction unitRef="usd" contextRef="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcxMjQ_c54cacf5-c321-4710-91b9-77bf6901c4d3">7</ix:nonFraction> million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2020 was $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcyNTE_0f7adc66-4240-4dfa-af58-065cd5dfd381">18</ix:nonFraction> million. The total fair value of options vested during the period was $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzczMTY_3b9e09fa-78be-4e6e-98c0-14d4e626e06b">4</ix:nonFraction> million. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzc1NDU_96baf624-1c31-4fc7-891f-69b183a23f13">2</ix:nonFraction> million of unrecognized compensation cost related to granted and not forfeited stock options is expected to be recognized as expense over a weighted-average period of approximately <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzc3MjE_f63a4b04-6f32-40c4-9ff5-631a33e16655">1.8</ix:nonNumeric> years. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may grant to employees and members of its board of directors under the 2018 Plan (and formerly granted under the 2014 Plan) shares of restricted stock and units each representing the right to one share of Common Stock (&#8220;restricted stock units&#8221;). Since the IPO, the Company has granted to employees and directors restricted stock units and restricted stock that vest over specified periods as well as restricted stock units and restricted stock that have certain performance-related vesting requirements (&#8220;performance stock units&#8221; and &#8220;performance stock,&#8221; respectively). The restricted stock and restricted stock units granted during fiscal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2021 and 2020 had grant date fair values aggregating $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg0NzI_2b10a08f-d39d-4cd4-8059-04e198358b87">47</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg0Nzk_d9237148-4185-43d2-a1e1-9eb334b524ce">43</ix:nonFraction> million, respectively, which represent approximately <ix:nonFraction unitRef="shares" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg1Mjc_ee26b7ac-3ac7-4898-b707-0713cd97ff6c">502,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg1MzQ_373a4cfc-0014-4503-90dd-e3c97a78fdda">748,000</ix:nonFraction> shares of Common Stock, respectively. Under the 2014 Plan or 2018 Plan, as appropriate, the performance stock and performance stock units vest upon achieving Company financial performance metrics established at the outset of the three-year performance period associated with each grant. The metrics for the fiscal 2019, 2020, and 2021 performance stock and performance stock unit grants were based on performance against a mix of adjusted EPS targets and relative total shareholder return (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RTSR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) targets. Note that adjusted EPS is calculated as a quotient of tax-effected Adjusted EBITDA by the weighted average number of fully diluted shares, a financial measure that is not defined under U.S. GAAP and is subject to important limitations. The performance stock and performance stock units vest following the end of their respective three-year performance periods upon a determination of achievement relative to the targets. Each quarter during the period in which the performance stock and performance stock units are outstanding, the Company estimates the likelihood of such achievement by the end of the performance period in order to determine the probability of vesting. The number of shares actually earned at the end of the three-year period for the fiscal 2019, 2020 and 2021 grants will vary, based only on actual performance, from 0% to 200%, or from 0% to 150%, of the target number of performance stock or performance stock units specified on the date of grant, in the case of adjusted EPS and RTSR grants, respectively. Time-based restricted stock units and restricted stock generally vest on the second or third anniversary of the date of grant, subject to the participant&#8217;s continued employment with the Company.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Methodology and Assumptions - Expense Recognition and Grant Date Fair Value</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of (a) time-based restricted stock units and restricted stock are recognized as expense on a cliff-vesting schedule over the applicable vesting period and (b) performance shares and performance share units are re-assessed quarterly as discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair values of both time-based and performance-based shares and units are determined based on the number of shares subject to the grants and the fair value of the Common Stock on the dates of the grants, as determined by the closing market prices. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iee43ade2664e443382b41dc7d026d334" continuedAt="i72f0c15dd9024f1b969d7f524127f058"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-Based Restricted Stock Units and Restricted Stock</span></div><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQw_8c647e43-6b46-4dba-8678-2ee5cc62afed" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested time-based restricted stock units and restricted stock for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6be771f1b5b348f8986509afc9283597_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzUtMS0xLTEtMA_ea68eb0c-d30c-45c7-ad94-6045c9f220b1">1,081,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6be771f1b5b348f8986509afc9283597_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzUtMy0xLTEtMA_edba076d-3f7c-4c21-a5fc-75ab9067e674">47.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzYtMS0xLTEtMA_ea2369a5-7566-4962-9f34-3be1c4ddf024">283,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzYtMy0xLTEtMA_6d8a40a3-b568-4c86-b545-11bc7f5ecc95">93.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzctMS0xLTEtMA_dad9a4a0-ff8b-4f9f-9be7-06bb18e725af">492,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzctMy0xLTEtMA_546453d1-fd1c-437e-9dea-db5ac76af5c4">43.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzgtMS0xLTEtMA_006ad979-2b11-49f0-967f-4fe23d00d3fa">108,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzgtMy0xLTEtMA_71fec20d-6a74-445a-9669-b89c3c6be00a">57.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i549198ff2e8b45a69be9153279060162_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzktMS0xLTEtMA_f89404a4-ed36-437f-a893-e6182ad853f2">764,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i549198ff2e8b45a69be9153279060162_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzktMy0xLTEtMA_15b04191-bc70-4e95-9d05-451efe5e1343">65.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:24pt"><span><br/></span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDMw_3dec8c6c-2cfa-4da9-90c9-0aed2724abcf" escape="true"><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EPS and RTSR-Based Performance Share Units and Performance Shares</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Performance-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fcb40d78880478bae00f3e6351a3717_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzUtMS0xLTEtMA_16219ba6-4f29-407b-b0a5-b4c6e89a65f7">516,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6fcb40d78880478bae00f3e6351a3717_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzUtMy0xLTEtMA_3b61e632-792d-44e2-bb8e-9668c8bf24d7">43.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzYtMS0xLTEtMA_3af9ce61-b2b3-406b-8d5b-18653c2dcb9c">113,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzYtMy0xLTEtMA_4cccc69c-7d5c-4930-be5d-e8cb959455d4">88.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzctMS0xLTEtMA_a1132cc9-82ba-440a-8fed-90672df3c0e7">259,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzctMy0xLTEtMA_298696ac-e962-4336-923c-31f07f9746c9">36.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="0" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzgtMS0xLTEtMA_37810197-d880-4d80-9ede-027da8c2222c">22,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzgtMy0xLTEtMA_2289c37e-d296-4464-ba64-7c8a1b3785ea">47.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzktMS0xLTEtMA_d0b0be03-8c01-4518-85de-535b443b110e">392,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzktMy0xLTEtMA_0b2d9803-72bd-452c-bef4-f78a88fc4f3c">58.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQx_cadc6eac-5451-49c6-933f-1bb189db5cf0" continuedAt="ib1404816823645efa73f64ab8a4a28b3" escape="true"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of RTSR Performance Shares and Performance Share Units</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RTSR performance share unit and performance share is determined using the Monte Carlo pricing model because the number of shares to be awarded is subject to a market condition. The Monte Carlo simulation is a generally accepted statistical technique used to simulate a range of possible future outcomes. Because the valuation model considers a range of possible outcomes, compensation cost is recognized regardless of whether the market condition is actually satisfied.</span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i72f0c15dd9024f1b969d7f524127f058" continuedAt="i013016418a86437896f7c681ea0ae98c"><div style="margin-top:9pt;text-indent:24pt"><ix:continuation id="ib1404816823645efa73f64ab8a4a28b3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units and performance shares granted during each year were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItMS0xLTEtMA_5175e919-5aad-493b-826e-f484f44a3a82">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItMy0xLTEtMA_79de8c3d-c13c-4895-a385-029fb74660b8">42</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItNS0xLTEtMA_e5352635-3c20-40fa-8835-7eabf80cb378">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItNy0xLTEtMA_e76af2c5-b0b2-46c6-b11a-09ef5035a5a6">31</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtMS0xLTEtMA_f23515af-d17e-4923-9b15-f4307a08ae43">2.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtMy0xLTEtMA_4a1fcda0-a2e4-4a70-adf5-898a44d5c701">2.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtNS0xLTEtMA_6127874c-be1f-413d-a229-a41e46f9dcba">2.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtNy0xLTEtMA_02583bff-721d-4c5e-91ce-24e7a52f0754">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtMS0xLTEtMA_cb7cf9f1-99b9-4cad-ad2e-81aceb128371">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtMy0xLTEtMA_041c5b25-bd3f-418b-8aac-6651eb7a761d">0.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtNS0xLTEtMA_037d2105-447c-455a-922e-15496a58f01d">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtNy0xLTEtMA_52f9768c-5ce4-40e0-a891-604e2f3bcb04">1.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630" decimals="2" format="ixt-sec:numwordsen" name="ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzUtMS0xLTEtMA_7434bba8-184a-4851-b43b-d03c0b862ab4">None</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630" decimals="2" format="ixt-sec:numwordsen" name="ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzUtNS0xLTEtMA_a37b58fb-72a5-47b1-8067-d6fa5cb20333">None</ix:nonFraction></span></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDMy_73d5dfc7-0dcd-4d49-8ade-1a4edadcd213" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested RTSR performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">RTSR Units and Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzUtMS0xLTEtMA_30646461-632e-43f7-94a7-f214fe2876e5">427,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzUtMy0xLTEtMA_260b125d-9d0a-44d3-b084-b098699988ca">49.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzYtMS0xLTEtMA_25319c5d-03d5-430a-81d2-6bfa1a837758">105,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzYtMy0xLTEtMA_3f51576c-48ac-46cf-ba09-6ca075144e3f">101.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzctMS0xLTEtMA_d5bbfed3-9885-4d53-bac0-c29b0e6b8012">202,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzctMy0xLTEtMA_8a8ae6c7-05aa-4372-9fc3-a9f58db8f388">38.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzgtMS0xLTEtMA_2324c384-b9dd-4ed8-b65d-8f277ddead7b">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzgtMy0xLTEtMA_6ffed89f-b766-4c70-a922-1e9e7820a8d7">56.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9521aa39e6a402cbbdddd19532b77db_I20210630" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzktMS0xLTEtMA_85e14841-f301-495c-86dc-ba431ecd013f">327,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id9521aa39e6a402cbbdddd19532b77db_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzktMy0xLTEtMA_0cca288c-f520-4798-9bc7-0ccd7a504bf4">68.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, participants vested and settled <ix:nonFraction unitRef="shares" contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNjUx_b184a7ee-9f64-43ae-a86f-947a580d173a">671,000</ix:nonFraction> net settled shares, resulting in $<ix:nonFraction unitRef="usd" contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNjg3_3ac705d1-2d7a-484e-8e6a-97295fd2b9d7">31</ix:nonFraction> million of cash paid on behalf of participants for withholding taxes. In fiscal 2020, participants vested and settled <ix:nonFraction unitRef="shares" contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNzk4_5d33c8c9-6ba9-482c-b020-1fa3584b37c0">734,000</ix:nonFraction> net settled shares, resulting in $<ix:nonFraction unitRef="usd" contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyODM0_cbf6294d-e0ef-4cd7-86f3-723dbe71cd7a">24</ix:nonFraction> million of cash paid on behalf of participants for withholding taxes.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i013016418a86437896f7c681ea0ae98c">As of June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="iab90ce5a26874c06bf75dc201cdc453b_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyOTA5_718397b9-fc89-4771-9d3b-0d19e29a2be9">54</ix:nonFraction> million of unrecognized compensation cost related to restricted stock and restricted stock units (including performance shares and performance share units, respectively) is expected to be recognized as expense over a weighted-average period of approximately <ix:nonNumeric contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMTYy_467cab5f-a604-4e44-9d16-bc911577258b">1.9</ix:nonNumeric>&#160;years. The weighted-average grant-date fair value of restricted stock and restricted stock units in fiscal 2021, 2020, and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" decimals="2" format="ixt:num-dot-decimal" name="ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMjkx_d93ed318-12b0-4448-98c5-cbcbbe3744d0">94.19</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630" decimals="2" format="ixt:num-dot-decimal" name="ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMjk1_008110d6-6b91-4708-aed6-1664d929fd6c">57.17</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630" decimals="2" format="ixt:num-dot-decimal" name="ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMzAz_31ddffe8-c202-4c93-80c5-e0ddbf9a94b7">44.65</ix:nonFraction>, respectively. The fair value of restricted stock units vested in fiscal 2021, 2020, and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMzk4_f6532229-ef39-4e6e-87cd-b868ae427ef3">39</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDAy_08142995-b746-499b-b279-205a900c006e">35</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDEw_e77901c1-ee4e-4570-985b-e9a4ed6bd879">13</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_238"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMDk_a82c64c1-2acb-430b-ae5f-32ae44c4cde6" continuedAt="i42122a9d58ad48db8fa1018cb84802ed" escape="true">OTHER EXPENSE, NET</ix:nonNumeric></span></div><ix:continuation id="i42122a9d58ad48db8fa1018cb84802ed" continuedAt="i2b58ff6a907044c7a6d93eaa543ac299"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTU_b6ebc903-5311-4484-a284-e3c513b1fc38" continuedAt="i38af7225dd3940d0bbb17ebe04973df4" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other expense, net for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt refinancing costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (gains) and losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktNS0xLTEtMA_37239cc0-b91a-4ce1-bd42-e142869274d5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktNy0xLTEtMA_eaf0f4d6-98fb-444b-9cc1-9b8c35d7d3a7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktOS0xLTEtMA_0597521b-8d28-4730-8d41-d4ecebce9976">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)    <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03" continuedAt="i1dc1733d611a4fd2996ef91e0fa9c9f7" footnoteRole="http://www.xbrl.org/2003/role/footnote">Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwMTQ_d52b983c-45de-49dd-a568-48d210ac5936">4</ix:nonFraction> million of previously capitalized financing charges related to the Company&#8217;s repaid Term B-2 Loans and the 2026 Notes, (b) $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwMzE_7797d350-b302-484e-8944-f13339717cbc">3</ix:nonFraction> million of financing charges related to the Company&#8217;s Term B-3 Loans, and (c) an $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EarlyRepaymentOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwNDk_57af6860-9fbb-4402-9e0e-a5072c904a4d">11</ix:nonFraction> million premium on early redemption of the 2026 Notes.</ix:footnote></span></div><ix:continuation id="i1dc1733d611a4fd2996ef91e0fa9c9f7"><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzE4OA_e022dc83-cc22-4e48-b17e-e192c42861ff">6</ix:nonFraction> million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EarlyRepaymentOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQwOA_94a4e93d-9f63-44b4-999d-0d711190abc5">10</ix:nonFraction> million premium on early redemption of the 2024 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2019 includes $<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c">16</ix:nonFraction> million of financing charges related to the offering of the 2028 Notes. </span></div></ix:continuation><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)    <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f" footnoteRole="http://www.xbrl.org/2003/role/footnote">Foreign currency (gains) and losses include both cash and non-cash transactions.</ix:footnote> </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b58ff6a907044c7a6d93eaa543ac299"><ix:continuation id="i38af7225dd3940d0bbb17ebe04973df4">(3)    <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593" footnoteRole="http://www.xbrl.org/2003/role/footnote">Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkxOTE_0a9804f2-63fd-476b-826f-d02b029a0eeb">17</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEyNjQ0MzgzNzIzOTc3_a10106dc-5e99-4b08-96dc-5103e5404caa">3</ix:nonFraction> million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.</ix:footnote></ix:continuation></ix:continuation> </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_241"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:LeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NTc_eef74991-e5eb-410c-8b6a-c81f6bad090d" continuedAt="i7a52baef16a74f76b3cbd1813e1dadce" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i7a52baef16a74f76b3cbd1813e1dadce" continuedAt="i7333ea76ff1e497a8e89cccb2f3e1f4d"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain manufacturing and office facilities, land, vehicles, and equipment. The terms of these leases vary widely, although most have terms between 3 and 10 years. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes a &#8220;right-of-use&#8221; asset and related lease liability at the commencement date of each lease based on the present value of the fixed lease payments over the expected lease term. The lease term for this purpose will include any renewal period where the Company determines that it is reasonably certain that it will exercise the option to renew. While certain leases also permit the Company to terminate the lease in advance of the nominal term upon payment of an associated penalty, the Company generally does not take into account potential early termination dates in its determination of the lease term as it is reasonably certain not to exercise an early-termination option as of the lease commencement date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its incremental borrowing rate, which represents the interest rate the Company would expect to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms, in order to calculate the present value of a lease, when the implicit discount rate for its leases is not readily determinable.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed lease payments are recognized on straight-line basis over the lease term, while variable payments are recognized in the period incurred. As permitted by ASC 842, the Company has elected not to separate those components of a lease agreement not related to the leasing of an asset from those components that are related.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not record leases with an initial lease term of 12 months or less on its consolidated balance sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. </span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7333ea76ff1e497a8e89cccb2f3e1f4d" continuedAt="i5e923175ae204d8797ee766a9f09d2b0"><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NTg_8eb9010a-5e01-46dc-85cf-b6b8d98690ac" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information concerning the leases recorded in the Company's consolidated balance sheet as of June&#160;30, 2021 is detailed in the following table:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Line item in the consolidated balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance at <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzItMi0xLTEtMA_cdfe5463-afed-42aa-b1e6-7073915cd062">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzMtMi0xLTEtMA_03645225-b73f-49e9-abb2-14b63d4a4f21">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other       short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzYtMi0xLTEtMA_8a658523-ba41-4082-be42-cd11f81e32ab">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzctMi0xLTEtMA_63c1f3de-5508-492e-a044-0fad99ade9c7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzEwLTItMS0xLTA_4a157271-9ce5-48ba-aa05-a46c3fd1d0d7">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzExLTItMS0xLTA_b7758115-f97a-43d8-aa9e-a3ba58ae35bb">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjA_69d8f6ad-37e2-4f58-8c3e-e2cf0bc372ee" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net lease costs for the fiscal year ended June&#160;30, 2021 reflected in the Company's consolidated statement of operations were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzItMi0xLTEtMA_5b53c311-994c-49c7-a367-e4c285c5d47b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzMtMi0xLTEtMA_fbd9f622-fabd-4d60-8c1e-c0a33f37198f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:FinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzQtMi0xLTEtMA_3429538b-139a-42ab-b5a7-c71b8136a4ca">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzYtMi0xLTEtMA_41a1201c-7787-42d4-afe0-f108e0f3746b">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzctMi0xLTEtMA_489b6680-87c5-460d-ac2c-c2c626ec355c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzgtMi0xLTEtMA_59102bdd-cd64-462d-a6a8-764435f7094b">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term lease cost amounted to $<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:ShortTermLeaseCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzIxOTU_e01ceff5-89d6-462b-8695-547cf5943df8">4</ix:nonFraction> million during the fiscal year ended June&#160;30, 2021.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate related to the Company's right-of-use assets and lease liabilities as of June&#160;30, 2021 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzEtMS0xLTEtMA_dfc69862-84b0-4d80-a797-95234f8b20c5">12.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzItMS0xLTEtMA_6e3950ad-57dd-45d1-908f-fe4936522826">11.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzQtMS0xLTEtMA_6da0bc3c-d540-422f-8a8a-75a9fcf5334c">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzUtMS0xLTEtMA_ed855a1e-a5ef-4cbc-ae67-03aa70a06f3d">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjE_d8eb48d1-6496-426b-8010-157d87d893cc" continuedAt="id49963e771f341618ff23297eedd244e" escape="true">Supplemental information concerning the cash-flow impact arising from the Company's leases for the fiscal year ended June&#160;30, 2021 recorded in the Company's unaudited consolidated statement of cash flows is detailed in the following table (in </ix:nonNumeric></span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5e923175ae204d8797ee766a9f09d2b0"><div style="margin-top:9pt"><ix:continuation id="id49963e771f341618ff23297eedd244e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.771%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for amounts included in lease liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows used for finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzItMy0xLTEtMA_8b54654d-34d5-4a47-acd6-cbc1ce8ebc1b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzMtMy0xLTEtMA_541dd33b-82b6-4278-97d9-db82bfdba1ed">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzQtMy0xLTEtMA_4bf3af44-b237-4551-88e4-8b08d6c6ce48">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-cash transactions:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzctMy0xLTEtMA_22e7424c-ffcb-47b0-b2fd-10c0199833c8">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzgtMy0xLTEtMA_e27e29be-a4e2-4c1c-a2e0-26339f4fab87">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjI_738d5932-bffa-44ae-8d7c-cab8af78a0d0" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company expects that its future minimum lease payments will become due and payable as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtMS0xLTEtMA_a52ad4da-f4b8-4766-8bab-ea904c8316c0">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtMy0xLTEtMA_e489498c-4d6a-4bc5-9cfe-6e766e560645">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtNS0xLTEtMA_77c0bcd8-4346-4750-b313-b45df1a450de">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItMS0xLTEtMA_d90c5f39-dedf-4452-a214-63b9f6f71416">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItMy0xLTEtMA_97a91670-b631-41e9-9986-964a9d9aceb8">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItNS0xLTEtMA_ef158506-9117-424d-84ee-bcbce8991cdd">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtMS0xLTEtMA_8bad36be-3f8c-4abf-a91e-1391355ef277">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtMy0xLTEtMA_96571199-472d-44bb-8779-72f0a54c8cb9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtNS0xLTEtMA_35ddc456-81f9-4bd4-96d7-7045c8eba61f">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtMS0xLTEtMA_523e22ee-1a09-4f9f-8d60-bf7a9e09f065">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtMy0xLTEtMA_c0aef192-8a88-4698-9b88-6d1eb146fa4a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtNS0xLTEtMA_d8809504-0b38-4797-88ad-6258c6838071">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtMS0xLTEtMA_6743c23e-6899-4e95-af3e-9f69bddbebdd">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtMy0xLTEtMA_07c20d36-5be7-4bf4-b89d-f9bad6c4477d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtNS0xLTEtMA_91c5c8eb-922f-4d20-9200-af4ee28e2db6">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtMS0xLTEtMA_cb33289a-b0f4-4f13-9d59-7c1a0c8f00a7">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtMy0xLTEtMA_a8918fcf-41d7-495c-97a7-c861877d0054">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtNS0xLTEtMA_aa7a1cb1-38c8-4dd1-99cb-4c90276cb560">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctMS0xLTEtMA_eedc73f9-6e4e-4bd1-8536-4174f201c9f6">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctMy0xLTEtMA_95cd3224-5d29-4ce4-bb56-f4588cd6e13e">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctNS0xLTEtMA_e873a85c-a72a-4056-85ea-59a8a88c72fb">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtMS0xLTEtMA_24e84c34-121d-4b6f-aa5f-89b7664074d6">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtMy0xLTEtMA_5981fe65-181a-4901-8cba-639ed29e591c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtNS0xLTEtMA_a81f623e-783d-46c1-a0f2-9c4feb8dfbec">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktMS0xLTEtMA_f7462ace-07ed-43ef-a9be-c61e716d906b">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktMy0xLTEtMA_1e68e10a-be76-4064-a5ef-1adb8e4dd905">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:TotalLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktNS0xLTEtMA_93e4512b-ea5c-4b2a-a285-7540dbbbf069">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_247"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDcvZnJhZzoxZGQ0OWZiNTMwMjI0OTY3YmYyMTM3M2E2NmE0Yjg2Yy90ZXh0cmVnaW9uOjFkZDQ5ZmI1MzAyMjQ5NjdiZjIxMzczYTY2YTRiODZjXzE1ODg_0d43ccb4-474b-47c7-ab14-25c490e7256d" continuedAt="idde78375c20a4224bc9c62d5a1a2846a" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="idde78375c20a4224bc9c62d5a1a2846a"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Losses</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal proceedings arising in the ordinary course of business, including, without limitation, inquiries and claims concerning environmental contamination as well as litigation and allegations in connection with acquisitions, product liability, manufacturing or packaging defects, and claims for reimbursement for the cost of lost or damaged active pharmaceutical ingredients, the cost of any of which could be significant. The Company intends to vigorously defend itself against any such litigation and does not currently believe that the outcome of any such litigation will have a material adverse effect on the Company&#8217;s financial statements. In addition, the healthcare industry is highly regulated and government agencies continue to scrutinize certain practices affecting government programs and otherwise.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information relating to the business practices and activities of customers or suppliers from various governmental agencies or private parties, including from state attorneys general, the U.S. Department of Justice, and private parties engaged in patent infringement, antitrust, tort, and other litigation. The Company generally responds to such subpoenas and requests in a timely and thorough manner, which responses sometimes require considerable time and effort and can result in considerable costs being incurred. The Company expects to incur costs in future periods in connection with future requests.</span></div></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_253"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.   <ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40" continuedAt="ib9a97eaf04a04a4c942465f9e5ce3ca9" escape="true">SEGMENT AND GEOGRAPHIC INFORMATION</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><ix:continuation id="ib9a97eaf04a04a4c942465f9e5ce3ca9" continuedAt="ia58cb4015b9f4984b493adbd99939214"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company conducts its business within the following segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Company evaluates the performance of its segments based on segment revenue and segment earnings before non-controlling interest, other (income) expense, impairments, restructuring costs, interest expense, income tax (benefit) expense, and depreciation and amortization (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Company considers its reporting segments results in the context of a similar Company-wide measure: EBITDA from operations, which the Company defines as consolidated earnings from operations before interest expense, income tax (benefit) expense, depreciation and amortization, adjusted for the income or loss attributable to non-controlling interest. Neither Segment EBITDA nor EBITDA from operations is defined under U.S. </span></ix:continuation></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia58cb4015b9f4984b493adbd99939214" continuedAt="i81d020ae5679497a941a0c4aea9a65ba"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP, and neither is a measure of operating income, operating performance, or liquidity presented in accordance with U.S. GAAP. Each of these non-GAAP measures is subject to important limitations. These consolidated financial statements include information concerning Segment EBITDA and EBITDA from operations (a) because Segment EBITDA and EBITDA from operations are operational measures used by management in the assessment of the operating segments, the allocation of resources to the segments, and the setting of strategic goals and annual goals for the segments, and (b) in order to provide supplemental information that the Company considers relevant for the readers of the consolidated financial statements, but such information is not meant to replace or supersede U.S. GAAP measures. The Company&#8217;s presentation of Segment EBITDA and EBITDA from operations may not be comparable to similarly titled measures used by other companies. The most directly comparable U.S. GAAP measure to EBITDA from operations is net earnings. Included in this Note is a reconciliation of net earnings to EBITDA from operations. </span></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f" continuedAt="i280d770ae5a64071890407e752810c32" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include net revenue and Segment EBITDA for each of the Company's current reporting segments during the fiscal years ended June&#160;30, 2021, 2020, and 2019:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtMS0xLTEtMA_b78bdfaf-5c4c-48b8-a4d3-897704a0e901">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtMy0xLTEtMA_628169c3-05a7-4781-a1c3-903412d7be4b">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtNS0xLTEtMA_c82b9fab-a55f-4b2c-861f-400498b53325">573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtMS0xLTEtMA_697a891b-3515-4764-8a13-9ee5771f9ef3">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtMy0xLTEtMA_3f91e120-3954-4c02-b675-0e526b327c75">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtNS0xLTEtMA_fc1f300b-8ea2-4f1c-9cb4-6209e25d94a5">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtMS0xLTEtMA_dee04950-925a-4af2-8269-d64d14da0267">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtMy0xLTEtMA_a3e80105-aaa8-4a80-836c-925d02b23410">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtNS0xLTEtMA_745a835d-ff9d-4294-929c-c4072f06798a">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtMS0xLTEtMA_73c35975-78d1-4d63-84f2-4257526dfc3e">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtMy0xLTEtMA_434b8e48-ee6c-428d-8726-4206a04b7e7a">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtNS0xLTEtMA_56e0188d-7c80-401a-b171-f65e2e316f3f">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationInterSegmentRevenueElimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctMS0xLTEtMA_8c368462-168e-4ba3-8cb0-152e30584671">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationInterSegmentRevenueElimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctMy0xLTEtMA_40fbf22e-1a7b-47c8-9784-eeb68754fb3e">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationInterSegmentRevenueElimination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctNS0xLTEtMA_2c05fb1b-0ee1-4b59-9fc6-a904b100f34c">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtMS0xLTEtMA_3f1ccd72-43dd-4019-b357-845871c7b151">3,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtMy0xLTEtMA_bfdfaab8-2717-425c-a4d0-417ee05996fb">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtNS0xLTEtMA_48ab64f7-70a3-4641-a8a5-4c31b5814d48">2,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA reconciled to net earnings:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtMS0xLTEtMA_6010e54a-aeae-4ad3-8154-6d97e32803cc">608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtMy0xLTEtMA_de646374-64be-47b5-bc31-d92edfb6a314">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtNS0xLTEtMA_581a3042-6a4b-4b5d-8f07-49cda3758217">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtMS0xLTEtMA_234b16d6-a96f-4e1e-a864-51f20b37cd36">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtMy0xLTEtMA_2b945f9a-bfab-43f5-9c29-2cc64d2e05c3">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtNS0xLTEtMA_fe3a49db-21e6-4331-ab70-c1243a973c44">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtMS0xLTEtMA_2e39d7c4-1e06-4e03-bdfd-aa8259145015">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtMy0xLTEtMA_20154d36-37af-443a-9785-7a0f9f8b9dbf">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtNS0xLTEtMA_53ef3271-a87e-45b5-bb1b-6ed1cae5b0ce">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtMS0xLTEtMA_c6940e4e-89f5-4317-b2b8-984e30f115f8">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtMy0xLTEtMA_b824e9b3-3c8d-468a-a6c3-77c8c529f51c">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtNS0xLTEtMA_36689440-a7af-44cf-915b-b5cf667a8329">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd515f3814a4c76bab0cb060aab91ef_D20200701-20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctMS0xLTEtMA_fb8118b2-9781-4165-b034-50f904aa4ce0">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d88dad07c8b4257bc335a79b87e5840_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctMy0xLTEtMA_c866367a-2dbe-4172-9f41-a55086dd5a8c">786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9126ac8ef8946a0984ee537fe89c5a6_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctNS0xLTEtMA_432e9b4a-b9fd-4264-959f-47b44488ad9e">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktMS0xLTEtMA_08be16a0-eb59-4ade-817c-e302bcc1f8b8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktMy0xLTEtMA_fc7016cd-4c5a-447c-9fdd-94d91beb3525">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktNS0xLTEtMA_b044a391-528f-4f02-8218-432338e84444">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTEtMS0xLTA_480f62d4-6c81-4470-8ee1-59a359e90e83">289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTMtMS0xLTA_61031c6b-c0ae-400c-94b1-e5eaa672cb01">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTUtMS0xLTA_4429bb66-9c4f-4bee-8154-9fbb9e95c344">229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTEtMS0xLTA_c0402fc3-a03d-49f8-b7a0-9a5530e3cf00">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTMtMS0xLTA_a1d3017a-089b-4fac-9e3c-d3221cbdd3f8">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTUtMS0xLTA_1eee9496-4f6f-4a1a-a8b3-6e73fe347092">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTEtMS0xLTA_8f1e5ced-5c3f-4201-be62-60256ba6b443">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTMtMS0xLTA_0458cdd8-27f6-4f1a-8b35-c427b850a1c2">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTUtMS0xLTA_5445cee7-8b68-447b-894b-9bc2768444f2">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTEtMS0xLTA_f9cd8cd8-2620-43f6-a7ca-d62638c2d27a">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTMtMS0xLTA_5d139d54-e786-44f6-94d5-fe13ca54f837">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTUtMS0xLTA_d2059b2f-6c64-4ccc-9c48-989de01575ea">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTk_f6ab7647-580c-4f54-a153-23d5978f4101" footnoteRole="http://www.xbrl.org/2003/role/footnote">Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:</ix:footnote></span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i81d020ae5679497a941a0c4aea9a65ba" continuedAt="i86f6c4b923164f9ca0cf55351f3bdeb2"><ix:continuation id="i280d770ae5a64071890407e752810c32"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and gain (loss) on sale of assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItMS0xLTEtMA_94c9cf7e-8513-4535-9166-76877bfb41ea">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItMy0xLTEtMA_c026a663-f664-4426-b142-724a98a737c2">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItNS0xLTEtMA_1195b58f-1666-47bc-88ec-ca3effa0aaf9">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtMS0xLTEtMA_a050b05e-a6aa-4ff5-86ed-a5ddb3cce614">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtMy0xLTEtMA_feecf005-88a6-44a8-93db-48130ad4cb23">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtNS0xLTEtMA_dc2a4d5b-dde5-4114-9688-dea64c8fc0f7">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:RestructuringAndOtherSpecialItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:RestructuringAndOtherSpecialItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:RestructuringAndOtherSpecialItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on sale of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-allocated corporate costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="ctlt:NonAllocatedCorporateCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktMS0xLTEtMA_a9142283-5106-48a7-a28e-4442c5e85a63">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:NonAllocatedCorporateCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktMy0xLTEtMA_ea2167c5-08b8-4b41-84a6-b23806ac65ea">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:NonAllocatedCorporateCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktNS0xLTEtMA_e9642bf5-8901-4e32-b38a-b0291212a088">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unallocated costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" sign="-" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTEtMS0xLTA_8aa5bc24-dad0-486d-be85-e801e8eefdb9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTMtMS0xLTA_d9c355b1-0761-4e96-8435-09b4f4f06dd4">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="ctlt:SegmentReportingInformationUnallocatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTUtMS0xLTA_ec2a859b-bfda-4c20-bad9-991224cd1f15">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b" continuedAt="i6cc214013a2e4e91a1b78aeee2b460d2" footnoteRole="http://www.xbrl.org/2003/role/footnote">Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. </ix:footnote></span></div><ix:continuation id="i6cc214013a2e4e91a1b78aeee2b460d2"><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#8217;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </span></div></ix:continuation><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)    <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8" footnoteRole="http://www.xbrl.org/2003/role/footnote">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</ix:footnote></span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)     <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14" continuedAt="i1f026c12c0804961926f59a32b3b861e" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to Note 15, </ix:footnote></span><ix:continuation id="i1f026c12c0804961926f59a32b3b861e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></ix:continuation></div></ix:continuation></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i86f6c4b923164f9ca0cf55351f3bdeb2"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNjA_ec132e38-a88f-4aad-bc38-c3f17f2d422f" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes total assets for each segment, as well as reconciling items necessary to total the amounts reported in the consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Assets </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d420fead59462095697a3993d8f4e5_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzEtMS0xLTEtMA_ee227c73-fca0-4938-b254-d683632ace4c">4,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2726cb57c9441d90eb8e733906a808_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzEtMy0xLTEtMA_b72362e6-0ac4-4dc7-9a33-a687b97dced6">3,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebdb26351324dc59f4adf268bf038a1_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzItMS0xLTEtMA_a6ebb868-6abe-46e0-a019-9676caef86e5">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7061380698a4b9395a2f0cfba0d8aac_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzItMy0xLTEtMA_1218af07-1013-4137-80c2-06d7fdbe3e67">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7814e488a794292a9e3f5a1d348951e_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzMtMS0xLTEtMA_ddfb0cab-68de-4c25-8955-193a5e3a45f4">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzMtMy0xLTEtMA_1c9587ef-d0b7-42ac-8d46-938c5df40c58">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88402b35bd0c42118b8f0b1db0690925_I20210630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzQtMS0xLTEtMA_be1b240b-b89c-4ce7-82b5-5782ba5b906b">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab98274d571d4d449f30491cdd65c962_I20200630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzQtMy0xLTEtMA_c92878ff-e72d-41d7-a2d8-e15d1758ef30">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and eliminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32780b0807f04e8886a1644091ccd209_I20210630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzUtMS0xLTEtMA_8885cc27-c277-451b-9e5f-fa90554fb963">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2efc8c22dd864f77bfa1a9eeb9bf0b27_I20200630" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzUtMy0xLTEtMA_a6c521ff-d1e2-4700-b65b-ae9cfade2183">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzYtMS0xLTEtMA_98bcdeb5-a6b6-4ae3-84da-f63ab9aa0b14">9,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzYtMy0xLTEtMA_94b1a72b-8aea-41ee-b51a-592856962ec9">7,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTY_35e66337-7888-422a-a822-deb1f0071a57" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Expenditures </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMS0xLTEtNjMyMQ_7433332e-1525-4637-bb16-17f5148ed3fe">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMy0xLTEtNjMyMQ_ed1dd3e0-ae24-40a2-b130-ed784e38c4dc">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItNS0xLTEtNjMyMQ_9172a329-8e17-40a6-871c-31fdecc9a7dc">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMS0xLTEtMA_988d1dca-7f39-4353-b209-52783bd5c4c7">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMy0xLTEtMA_c731a624-d178-4673-990a-f3b148a619a2">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItNS0xLTEtMA_033e39da-cb0b-4719-8c91-41b88aabe3ea">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtMS0xLTEtMA_65be1e50-0928-4f4a-b6fa-1fe82f1a36d9">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtMy0xLTEtMA_6228c795-61ec-4c48-8844-9d9ec8fdeee8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtNS0xLTEtMA_c99b15a9-1c60-4684-b844-d05024bc2ddd">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtMS0xLTEtMA_965e76ee-6c15-4240-9652-b54d6deaaf9b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtMy0xLTEtMA_6b1b4ce9-faab-4704-b4a2-903674244bd6">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtNS0xLTEtMA_e4b57264-aa33-4e86-b2b6-bacbae94e665">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d8aebfe31c4223803b5f24bc0f29f8_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtMS0xLTEtMA_6ca22022-720c-4463-a5f3-6c3e6315808a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i733c8bb4e1014e9e8cfe80267a047ad9_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtMy0xLTEtMA_b7abf8ac-e0cc-44ba-a99d-21e434e49168">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62be34a4b4e64451b2e516bfcb375e8a_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtNS0xLTEtMA_6d5b82bd-400f-4d66-879d-8641e212b481">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctMS0xLTEtMA_76f03209-bbf6-4aad-b678-c77a5d22799a">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctMy0xLTEtMA_e4dd79b8-efb4-46ba-a080-dc58aca21b4b">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctNS0xLTEtMA_cf7e49ea-d827-4fd9-8f75-504deb51e31c">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTE_41a46ef2-081b-41da-b1b7-da14c35f8554" escape="true"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by geographic area: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.908%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Long-Lived Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0b3a62ee7424499b7a078665cc2f930_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i651f15c7ca5a4375a12683f4493dd86d_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abb0547c47a44e190eab0c56374dc2b_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07">541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9b2c18f5a64a6084f50a6976406e31_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71b854cd3924d249f25376d9c0ad39a_I20210630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i971cccffdd7d479f8c71a1f66c16fc3a_I20200630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030" footnoteRole="http://www.xbrl.org/2003/role/footnote">Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</ix:footnote></span></div></ix:nonNumeric></ix:continuation><div id="idd9cf92bf6a34c78ac936b47262640d7_256"></div><div style="margin-top:9pt;padding-left:24pt;text-indent:-24pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcxNQ_407c4400-6839-489e-8a08-de6db5930eef" continuedAt="i3382b6c7f1904325924769e6b06bc5be" escape="true">SUPPLEMENTAL BALANCE SHEET INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i3382b6c7f1904325924769e6b06bc5be" continuedAt="i25213a7d8a704eabb547941f45d9da11"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information at June&#160;30, 2021 and June&#160;30, 2020 is detailed in the following tables.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyNg_364b57d6-c25d-4e67-b8a9-f638d84447c4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process and inventories include raw materials, labor, and overhead. Total inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzEtMS0xLTEtMA_6732150d-d341-4c3e-a6ab-a1f93e72804c">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzEtMy0xLTEtMA_d0510a30-75a7-4ecc-9c54-f7db32966208">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzItMS0xLTEtMA_7baab436-5d1f-439f-ba30-779307d51c35">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzItMy0xLTEtMA_dc1a6c22-51a3-41ae-a47e-2406741afc1d">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzQtMS0xLTEtMA_bbb87577-3c87-4d34-b6d8-3426d8c4434c">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzQtMy0xLTEtMA_c3e6c090-d96f-45bb-9edf-e63b72d6604d">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory cost adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzUtMS0xLTEtMA_3d3bbaf6-ae7e-411f-a46d-81e9cfe2ea8f">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzUtMy0xLTEtMA_aa8a9005-7184-4a0d-b268-5255a6d0284a">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzYtMS0xLTEtMA_f31e3532-f742-4cb4-9e0c-bcadfc633bd9">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzYtMy0xLTEtMA_9445d7a9-0683-47cd-8da8-087a07314122">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i25213a7d8a704eabb547941f45d9da11" continuedAt="ic0ebc03fdbe546a491dc5e49e0223305"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcxNw_abf363e9-2335-4965-8e0d-860b05376865" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEtMS0xLTEtMA_cd3950f1-4b76-494a-a0eb-b0ea24092def">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEtMy0xLTEtMA_5fbe6de3-df9f-4fab-8c07-63815caabb08">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" decimals="-6" name="us-gaap:ContractWithCustomerAssetPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzItMS0xLTEtMA_e3e183b5-22c0-4811-b379-b2e8275fe001">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630" decimals="-6" name="us-gaap:ContractWithCustomerAssetPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzItMy0xLTEtMA_5bf307c4-d45e-48fe-badb-28abe2a1de34">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:SpareParts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzMtMS0xLTEtMA_6208e15e-4aa0-4a3b-a473-17f2bf529920">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="ctlt:SpareParts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzMtMy0xLTEtMA_92d8f760-7657-40df-8a5c-11802a4b5a6b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzQtMS0xLTEtMA_c3593790-2d6e-439a-b5d1-0221b9d91f55">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzQtMy0xLTEtMA_73262589-4feb-44d0-a9c7-ce764d6929ed">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. value-added tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:ValueAddedTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzUtMS0xLTEtMA_2ccdf257-c004-4f63-93fb-a41bb24b8aac">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:ValueAddedTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzUtMy0xLTEtMA_bf8a3ef2-fc69-4d6d-b98e-96eb65e44562">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzktMS0xLTEtMA_a48352dc-3f84-421d-bfca-357d10ee8677">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzktMy0xLTEtMA_d6e3472e-f835-4084-a2f7-58baff8f3546">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEwLTEtMS0xLTA_fd08b1ef-c757-4b9b-8efd-200b33fd9ffd">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEwLTMtMS0xLTA_618d9372-214f-4f3c-b097-5121c5b68234">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant, and equipment, net</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyMw_74dc7547-31f7-4e11-ac67-4d197bd02caf" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment, net consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings, and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:LandBuildingsAndImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzEtMS0xLTEtMA_379c34df-315f-4154-abd3-de13612c3b03">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="ctlt:LandBuildingsAndImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzEtMy0xLTEtMA_9fb40c64-5375-4f69-9940-cb5f326456b4">1,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzItMS0xLTEtMA_a880765c-c814-42e8-b155-ba9d8e72a5ca">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzItMy0xLTEtMA_0729a913-2fa5-4c25-803d-0152b9c86477">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzMtMS0xLTEtMA_4b25e064-6975-4524-b139-d04452fdedea">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzMtMy0xLTEtMA_d73c03cf-2100-4714-a64c-6fb7af9607c8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzQtMS0xLTEtMA_9ee79cb4-46a3-4f8b-a4fb-953e30e3c9c5">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzQtMy0xLTEtMA_5fd33dbb-b9fd-4fb0-bbad-c51e60644ec4">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, at cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzUtMS0xLTEtMA_4108905e-6684-4527-b37d-e098cc02727d">3,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzUtMy0xLTEtMA_963f2603-ec78-4b4f-bc69-5d12f98253a4">2,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzYtMS0xLTEtMA_339b1afc-758a-4da4-95c9-7c75f2940d01">1,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzYtMy0xLTEtMA_1e08c50b-f921-409e-9c1d-52ff1b822adf">1,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzctMS0xLTEtMA_c2fb245a-e740-43c2-b6b9-4f9c5293eb5d">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzctMy0xLTEtMA_39bf0a74-18a6-4699-bc52-55bda3a811ee">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term assets</span></div><div style="margin-top:9pt;text-indent:24pt"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyNA_254eb1c6-3e27-4230-80ba-49f1adb25bfe" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzEtMS0xLTEtMTgyNA_5541053e-3267-409c-9d70-1ad92172f3ff">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzEtMy0xLTEtNTEwNg_3c1c26e3-e98f-4b5b-ae69-8c3a4916881a">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:LoansAndLeasesReceivableGrossCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzItMS0xLTEtNTEwOA_cb3f7909-89b9-4f10-99d5-04b7d7b0343e">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LoansAndLeasesReceivableGrossCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzItMy0xLTEtNTEwNg_29039eb3-177a-4e2a-bf96-6adcb79a418c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:PensionAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzMtMS0xLTEtMA_12f57e20-1be3-48ae-a4ff-45572821fb58">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzMtMy0xLTEtMA_e3ccdde0-3568-4153-9f36-1149ea837a38">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate-owned life insurance policies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzUtMS0xLTEtNTExMA_18976838-446c-4817-bb83-3ba874367cf5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzUtMy0xLTEtNTEwNg_7568d424-6a19-4433-b65b-af6426f543fb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venture capital investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMS0xLTEtNTEzNQ_c47bda3a-d0cd-40dc-8c3f-2fb827f44eb1">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:AlternativeInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMy0xLTEtNTEzNw_a3882efd-b5aa-4ddc-b7b5-548f64eb3a11">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzgtMS0xLTEtNTExMg_110d859b-0ec0-4224-8d91-0605c7988f88">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzgtMy0xLTEtNTExMg_701b5432-a2a3-49e3-b076-74480f96dd93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzYtMS0xLTEtMA_c82039b7-28c3-48b3-bb20-44a8d59a5431">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzYtMy0xLTEtMA_c40cb797-026b-4ed4-837d-a8ad074a66af">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMS0xLTEtMA_4354b178-f05c-45e9-8d90-548537317be5">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMy0xLTEtMA_2c9548c2-c9a6-49b3-84ec-5a378b798247">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other accrued liabilities</span></div></ix:continuation><div style="margin-top:9pt;text-indent:24pt"><ix:continuation id="ic0ebc03fdbe546a491dc5e49e0223305"><ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="ctlt:OtherAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyOA_a20bbe53-aa03-4a66-8129-a79b9e136862" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMS0xLTEtMTg5Mg_68ffb821-428d-4be2-bd7f-ab930142f785">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMy0xLTEtMTg4OQ_7ec0e48c-8784-43da-97ba-189407218b28">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMS0xLTEtMA_179084f4-dd04-4aab-a39d-cf8ffad84872">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMy0xLTEtMA_374cdd28-b1ca-4326-94b9-a1e5ddc4886f">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMS0xLTEtODEzMQ_a0c52042-052b-4716-b38a-e9644dba899a">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMy0xLTEtODEzNQ_830e52f0-58aa-470f-a9a0-9891f7fe857e">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:AccruedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMS0xLTEtNTExNA_2fa7e00b-9b2f-4c7f-bf71-7a9a839fc7af">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="ctlt:AccruedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMy0xLTEtNTExNA_06ba8009-f59b-4bf9-a8bd-ac257888224c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="ctlt:AccruedRestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzItMS0xLTEtMA_f59717af-2999-4aa1-8553-5a5d71c7b6df">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="ctlt:AccruedRestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzItMy0xLTEtMA_dfb9bc11-9907-4feb-86aa-2b46ecc9f7f6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzQtMS0xLTEtMA_cf038c28-d830-40fa-9659-c25b75bc6954">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzQtMy0xLTEtMA_a7e4eb9a-71c8-4c81-bcdf-c0c89010b563">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzctMS0xLTEtMA_6a4ab9c5-ab23-4456-8ab7-6db8f6606eda">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzctMy0xLTEtMA_53a1ae05-b6ab-43b5-9955-073ae95ae18d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzktMS0xLTEtMA_ef5ad15c-b176-4a42-a960-ec8261d93215">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e364a4c60a40d186dee61881303017_I20200630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzktMy0xLTEtMA_314396c9-a05b-4a24-8cf3-80906d7a33ba">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_1502"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTAyL2ZyYWc6ZWFjMzdhOWYzM2Y2NDZlY2E2ZmFjOGE3MDk3YzZkNDQvdGV4dHJlZ2lvbjplYWMzN2E5ZjMzZjY0NmVjYTZmYWM4YTcwOTdjNmQ0NF8xMDk5NTExNjMxNzgy_63ca1bad-3ea9-40d8-9f80-5208977af7e1" continuedAt="ie8b974fb8352499caabe3ec69dba55b1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="ie8b974fb8352499caabe3ec69dba55b1"><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bettera Holdings, LLC Purchase Agreement</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company entered into an agreement to acquire Bettera Holdings, LLC ("Bettera") for $<ix:nonFraction unitRef="usd" contextRef="iaa422029d99543199793d9ff01d7b6fa_I20210830" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTAyL2ZyYWc6ZWFjMzdhOWYzM2Y2NDZlY2E2ZmFjOGE3MDk3YzZkNDQvdGV4dHJlZ2lvbjplYWMzN2E5ZjMzZjY0NmVjYTZmYWM4YTcwOTdjNmQ0NF8xMDk5NTExNjM0MjYx_627e3a16-c6f6-4060-a8d1-8c3159f33948">1.00</ix:nonFraction> billion, subject to customary adjustments. Bettera is a manufacturer of nutraceuticals and nutritional supplements in gummy, soft chew, and lozenge delivery formats.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing, Bettera&#8217;s operations and facilities, will become part of the Company&#8217;s Softgel and Oral Technologies segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement is subject to customary closing conditions and is expected to close before December 31, 2021.</span></div></ix:continuation><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_262"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_265"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, and our Senior Vice President and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our Chief Executive Officer, and our Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Annual Report. Based upon that evaluation, our Chief Executive Officer and our Senior Vice President and Chief Financial Officer concluded that, as of June 30, 2021, our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Our internal control over financial reporting is designed to provide reasonable assurances regarding the reliability of financial reporting and the preparation of our consolidated financial statements in accordance with U.S. GAAP.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because either conditions change or the degree of compliance with our policies and procedures may deteriorate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has assessed the effectiveness of our internal control over financial reporting as of&#160;June&#160;30, 2021. In making this assessment, management used the framework set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Based on this assessment, our management concluded that our internal control over financial reporting was effective as of&#160;June&#160;30, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of June&#160;30, 2021 has been audited by Ernst &amp; Young LLP, an independent registered public accounting firm, as stated in its report, which is included in Item 8. Financial Statements and Supplementary Data in this Annual Report.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting (as such term is defined in Rules&#160;13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_268"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_1544"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_271"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_274"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning our Directors and Executive Officers, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 16(a) Beneficial Ownership Reporting Compliance,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> definitive shareholder communications with our board of directors, and corporate governance may be found in our Proxy Statement, which will be filed within 120 days after June&#160;30, 2021, the close of our fiscal year covered by this Annual Report. Such information is incorporated by reference.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_277"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning executive compensation may be found in the Proxy Statement, which will be filed within 120 days after June&#160;30, 2021, the close of our fiscal year covered by this Annual Report. Such information is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_280"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding security ownership of certain beneficial owners and management may be found in the Proxy Statement, which will be filed within 120 days after June&#160;30, 2021, the close of our fiscal year covered by this Annual Report. Such information is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_283"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding certain relationships and related-party transactions and director independence may be found in the Proxy Statement, which will be filed within 120 days after June&#160;30, 2021, the close of our fiscal year covered by this Annual Report. Such information is incorporated herein by reference.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_286"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fees paid to and services performed by our independent accountants may be found in the Proxy Statement, which will be filed within 120 days after June&#160;30, 2021, the close of our fiscal year covered by this Annual Report. Such information is incorporated herein by reference.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_289"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV </span></div><div><span><br/></span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_292"></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM&#160;15.&#160;&#160;&#160;&#160;EXHIBIT AND FINANCIAL STATEMENT SCHEDULES</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_295"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1)&#160;&#160;&#160;&#160;Financial Statements. The Financial Statements listed in the Index to Financial Statements are filed under Item 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements and Supplementary Data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report.</span></div><div id="idd9cf92bf6a34c78ac936b47262640d7_298"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2)&#160;&#160;&#160;&#160;Financial Statements Schedule. The valuation allowance for credit losses is not material to the Company's consolidated balance sheets.  </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Tax Assets - Valuation Allowance</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Period (Charge) Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ending Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ended June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ended June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="idd9cf92bf6a34c78ac936b47262640d7_301"></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves and you should not rely on them for that purpose. In particular, any representation or warranty made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312520022221/d881893dex21.htm">2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Purchase Agreement, dated as of February 2, 2020, among Catalent Pharma Solutions, Inc., Orgenesis Inc. and GPP-II Masthercell, LLC (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 5, 2020).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678318000162/catalent-2018930xex31.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amended and Restated Certificate of Incorporation of Catalent, Inc., as filed with the Secretary of State of the State of Delaware on October 31, 2018 (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the Commission on November 6, 2018).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519154128/d751728dex31.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, Par Value $0.01 Per Share, of Catalent, Inc. (incorporated by reference to exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 22, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519244410/d800808dex31.htm">3.2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, Par Value $0.01 Per Share, of Catalent, Inc. (incorporated by reference to exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on September 13, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678318000162/catalent-2018930xex32.htm">3.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws of Catalent, Inc., effective October 31, 2018 (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed with the Commission on November 6, 2018).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519184346/d701449dex41.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated June 27, 2019, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on June 27, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519184346/d701449dex41.htm">4.1.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 5.00% Senior Notes due 2027 (included as part of Exhibit 4.1 above).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312520060465/d865747dex41.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated March 2, 2020, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, Deutsche Trustee Company Limited, as trustee, Deutsche Bank AG, London Branch, as principal paying agent, and Deutsche Bank Luxembourg S.A., as transfer agent and registrar (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on March 3, 2020). </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312520060465/d865747dex41.htm">4.2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2.375% Senior Notes due 2028 (included as part of Exhibit 4.2 above).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312521050792/d126765dex41.htm">4.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated February 22, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on February 21, 2021).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312521050792/d126765dex41.htm">4.3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.125% Senior Notes due 2029 (included as part of Exhibit 4.3 above).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000183/catalent-2019630xex47.htm">4.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of the Company&#8217;s Common Stock, par value $0.01 (incorporated by reference to Exhibit 4.7 to the Company&#8217;s Annual Report on Form 10-K filed on August 27, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514296041/d767327dex103.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catalent, Inc. 2014 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2014).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678318000162/catalent-2018930xex101.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catalent, Inc. 2018 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 6, 2018). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678317000170/catalent-2017930xex101.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Catalent Pharma Solutions, Inc. Deferred Compensation Plan as amended and restated effective January 1, 2016 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 6, 2017).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678317000148/catalent-2017630xex1041.htm">10.4.1</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to the Catalent Pharma Solutions, Inc. Deferred Compensation Plan effective January 1, 2017 (incorporated by reference to Exhibit 10.41 to the Company&#8217;s Annual Report on Form 10-K filed on August 28, 2017). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678317000170/catalent-2017930xex102.htm">10.4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2 to the Catalent Pharma Solutions, Inc. Deferred Compensation Plan effective October 16, 2017 (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 6, 2017).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514296041/d767327dex104.htm">10.5.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement for U.S. Employees (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2014).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514296041/d767327dex107.htm">10.5.1.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement for Non-U.S. Employees (incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2014).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514296041/d767327dex105.htm">10.5.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement for U.S. Employees (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2014).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514296041/d767327dex108.htm">10.5.2.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement for Non-U.S. Employees (incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on August 5, 2014).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678320000155/catalent-20200630xex102.htm">10.5.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (incorporated by reference to Exhibit 10.5.4 to the Company&#8217;s Annual Report on Form 10-K filed on August 31, 2020). &#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678317000146/catalent2017630-ex102.htm">10.5.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Agreement for U.S. Employees (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on August 28, 2017).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678318000101/catalent-2018630xex1046.htm">10.5.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (incorporated by reference to Exhibit 10.46 to the Company's Annual Report on Form 10-K filed on August 28, 2018). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678318000101/catalent-2018630xex1047.htm">10.5.5.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (incorporated by reference to Exhibit 10.47 to the Company's Annual Report on Form 10-K filed on August 28, 2018). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001596783/000159678319000040/catalent-2019331xex1040.htm">10.5.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for U.S. Employees (incorporated by reference to exhibit 10.40 to the Company's Quarterly Report on Form 10-Q filed on May 7, 2019). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000040/catalent-2019331xex1041.htm">10.5.6.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for non-U.S. Employees (incorporated by reference to exhibit 10.41 to the Company's Quarterly Report on Form 10-Q filed on May 7, 2019). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000040/catalent-2019331xex1044.htm">10.5.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2018 Omnibus Incentive Plan Option Agreement for U.S. Employees (incorporated by reference to exhibit 10.44 to the Company's Quarterly Report on Form 10-Q filed on May 7, 2019). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000040/catalent-2019331xex1045.htm">10.5.7.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2018 Omnibus Incentive Plan Option Agreement for non-U.S. Employees (incorporated by reference to exhibit 10.45 to the Company's Quarterly Report on Form 10-Q filed on May 7, 2019). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1596783/000159678319000205/catalent-2019930xex101.htm">10.5.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of the Performance Share Unit Agreement for U.S. Employees (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 5, 2019).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1596783/000159678319000205/catalent-2019930xex102.htm">10.5.8.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of the Performance Share Unit Agreement for Non-U.S. Employees (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 5, 2019).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678320000224/catalent-2020930xex101.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary of Management Incentive Plan for the fiscal year ended June 30, 2021 (incorporated by reference to exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on November 3, 2020). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1416083/000119312514213106/d733044dex101.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Credit Agreement, dated as of May 20, 2014, relating to the Credit Agreement, dated as of April 10, 2007, as amended, among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc., as the administrative agent, collateral agent and swing line lender and other lenders as parties thereto (incorporated by reference to Exhibit 10.1 to Catalent Pharma Solutions, Inc.&#8217;s Current Report on Form 8-K filed on May 27, 2014).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678314000017/debtrefiex101-20141201.htm">10.7.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1, dated December 1, 2014 to Amended and Restated Credit Agreement, dated as of May 20, 2014 among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc., as the administrative agent, collateral agent and swing line lender and other lenders as parties thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on December 2, 2014).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312516790237/d304648dex101.htm">10.7.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2 to Amended and Restated Credit Agreement, dated as of December 9, 2016, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc. as administrative agent, collateral agent and swing line lender and the lenders party thereto, which amends that certain Amended and Restated Credit Agreement, dated as of May 20, 2014 (as amended), by and among Catalent Pharma Solutions, Inc. PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc. and JP Morgan Chase Bank, N.A. as L/C Issuers, the other lenders party thereto and the other agents party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on December 12, 2016).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312517312653/d477822dex101.htm">10.7.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 3 to Amended and Restated Credit Agreement, dated as of October 18, 2017, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc., as administrative agent, collateral agent and swing line lender and the lenders party thereto, which amends that certain Amended and Restated Credit Agreement, dated as of May 20, 2014 (as amended), by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A., as L/C Issuers, the other lenders party thereto and the other agents party thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 18, 2017).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519154128/d751728dex104.htm">10.7.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 4 to Amended and Restated Credit Agreement, dated as of May 17, 2019, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc., as administrative agent, collateral agent and swing line lender and the lenders party thereto, which amends that certain Amended and Restated Credit Agreement, dated as of May 20, 2014 (as amended), by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A., as L/C Issuers, the other lenders party thereto and the other agents party thereto (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on May 22, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312521050792/d126765dex101.htm">10.7.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 5 to Amended and Restated Credit Agreement, dated as of February 22, 2021, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JP Morgan Chase Bank, N.A., as the administrative agent, collateral agent, swing line lender, and letter of credit issuer, and the lenders and other parties thereto, which amends that certain Amended and Restated Credit Agreement, dated as of May 20, 2014 (as amended), by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JP Morgan Chase Bank, N.A., as the successor administrative agent, collateral agent, swing line lender, and letter of credit issuer, and the lenders and other parties thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 22, 2021).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1416078/000119312507260555/dex1021.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property Security Agreement, dated as of April 10, 2007, among PTS Acquisition Corp., Cardinal Health 409, Inc., PTS Intermediate Holdings LLC, Certain Subsidiaries of Holdings Identified Therein and Morgan Stanley Senior Funding, Inc. (incorporated by reference to Exhibit 10.21 to Catalent Pharma Solutions, Inc.&#8217;s Registration Statement on Form S-4 filed on December 6, 2007).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1416083/000119312508203179/dex1028.htm">10.8.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property Security Agreement Supplement, dated as of July 1, 2008, to the Intellectual Property Security Agreement, dated as of April 10, 2007, among PTS Acquisition Corp., Cardinal Health 409, Inc., PTS Intermediate Holdings LLC, Certain Subsidiaries of Holdings Identified Therein and Morgan Stanley Senior Funding, Inc. (incorporated by reference to Exhibit 10.28 to Catalent Pharma Solutions, Inc.&#8217;s Annual Report on Form 10-K filed on September 29, 2008).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519154128/d751728dex101.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A LLC and LGP Associates VII-B LLC (incorporated by reference to exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 22, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312519154128/d751728dex102.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Rights Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A LLC and LGP Associates VII-B LLC (incorporated by reference to exhibit 10.2 to the Company's Current Report on Form 8-K filed on May 22, 2019).</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1416083/000119312510212161/dex103.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Severance Agreement between named executive officers and Catalent Pharma Solutions, Inc. (incorporated by reference to Exhibit 10.3 to Catalent Pharma Solutions, Inc.&#8217;s Annual Report on Form 10-K filed on September 17, 2010).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312514381560/d809630dex101.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated October 22, 2014 by and among Catalent, Inc. and John R. Chiminski (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 24, 2014). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678317000146/catalent2017630-ex101.htm">10.12.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Employment Agreement, dated August 23, 2017, by and between Catalent, Inc. and John R. Chiminski (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on August 28, 2017). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678320000155/catalent-20200630xex101.htm">10.12.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Second Amendment to Employment Agreement, dated August 11, 2020, by and between Catalent, Inc. and John R. Chiminski</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">(incorporated by reference to Exhibit 10.12.2 to the Company&#8217;s Annual Report on Form 10-K filed on August 31, 2020). &#8224;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000183/catalent-2019630xex1052.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer letter, dated March 13, 2018, between Steven Fasman and Catalent Pharma Solutions Inc. (incorporated by reference to Exhibit 10.52 to the Company&#8217;s Annual Report on Form 10-K filed on August 27, 2019) &#8224; *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678320000155/catalent-20200630xex10.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer letter, dated November 20, 2019, between Karen Flynn and Catalent Pharma Solutions Inc. &#8224; *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000183/catalent-2019630xex1041.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terms and Conditions of Employment Statement, dated February 1, 2018, between Alessandro Maselli and Catalent Pharma Solutions (incorporated by reference to Exhibit 10.41 to the Company's Annual Report on Form 10-K filed on August 27, 2019). &#8224; </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000159678319000183/catalent-2019630xex1040.htm">10.15.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer letter, dated January 31, 2019, between Alessandro Maselli and Catalent Pharma Solutions (incorporated by reference to Exhibit 10.40 to the Company's Annual Report on Form 10-K filed on August 27, 2019). &#8224; </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1596783/000119312521156992/d482423dex101.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer letter, dated May 10, 2021, between Thomas Castellano and Catalent Pharma Solutions, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 11, 2021). &#8224;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-2021630xex211.htm">21.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of the Registrant. *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-2021630xex231.htm">23.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Ernst &amp; Young LLP. *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-20210630xex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-20210630xex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-20210630xex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="catalent-20210630xex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials are formatted in inline XBRL (inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statement of Changes in Shareholders&#8217; Equity, (v) the Consolidated Statements of Cash Flows and (vi) Notes to Consolidated Financial Statements. *</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page of this Annual Report on Form 10-K, formatted as Inline XBRL and contained in Exhibit 101.1.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*   Filed herewith</span></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Furnished herewith&#160;&#160;&#160;&#160;</span></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;   Represents a management contract, compensatory plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_304"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#016ba9;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. We elect not to include such summary information.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><div id="idd9cf92bf6a34c78ac936b47262640d7_307"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:4.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.035%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.057%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CATALENT, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RICKY HOPSON</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ricky Hopson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer </span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.499%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOHN R. CHIMINSKI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer (Principal Executive Officer) and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John R. Chiminski</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MADHAVAN BALACHANDRAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Madhavan Balachandran</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MICHAEL J. BARBER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Michael J. Barber</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ J. MARTIN CARROLL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">J. Martin Carroll</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ROLF CLASSON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rolf Classon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ROSEMARY A. CRANE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rosemary A. Crane</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOHN J. GREISCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John J. Greisch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTA KREUZBURG</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christa Kreuzburg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GREGORY T. LUCIER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gregory T. Lucier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DONALD E. MOREL, JR.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Donald E. Morel, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JACK STAHL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jack Stahl</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PETER ZIPPELIUS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Peter Zippelius</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ THOMAS CASTELLANO </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President &amp; Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/30/2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Castellano</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>catalent-2021630xex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5e172432fcb94ba69074b6edfc188f1e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 21.1</font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Attachment A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CATALENT, INC. SUBSIDIARIES</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">As of June 30, 2021</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NAME (STATE&#47;COUNTRY OF ORGANIZATION)</font></div><div style="margin-bottom:17pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHOLLY OWNED SUBSIDIARIES OF CATALENT, INC. (UNLESS OTHERWISE INDICATED)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.923%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Anagni S.r.l. (ITALY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Argentina S.A.I.C. (ARGENTINA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Belgium Holding S.A. (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Belgium S.A. (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Brasil Ltda (BRAZIL)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent China Holdings Limited (CAYMAN ISLANDS) </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Cosmetics AG (SWITZERLAND)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS (Edinburgh) Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS (Kansas City), LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS (Singapore) Pvt Ltd (SINGAPORE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS (Wales) Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS UK Holding Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent CTS, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent France Beinheim S.A. (FRANCE) (99.85%)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent France Limoges Holding S.A.S. (FRANCE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent France Limoges S.A.S. (FRANCE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Germany Eberbach GmbH (GERMANY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Germany Holding II GmbH (GERMANY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Germany Holding III GmbH (GERMANY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Germany Schorndorf GmbH (GERMANY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Gosselies SA (f&#47;k&#47;a MaSTherCell S.A.) (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Gosselies PS SA (f&#47;k&#47;a Delphi Genetics SA) (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Harmans Road, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Holdco II, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Holdco III, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Holdco IV, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Houston, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Indiana Holdings, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Indiana, LLC (INDIANA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Italy Holding Srl (ITALY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Italy S.p.A. (ITALY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Japan K.K. (JAPAN)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent JNP, Inc. (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Maryland (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Massachusetts, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Micron Technologies Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Micron Technologies, Inc. (PENNSYLVANIA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent MSTC, Inc. (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #bfbfbf;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #bfbfbf;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent MTI Pharma Solutions Limited (UNITED KINGDOM)</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 21.1</font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.923%"><tr><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent MTI Pharma Solutions, Inc. (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Netherlands Holding B.V. (NETHERLANDS)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Nottingham Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Ontario Limited (CANADA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Pharma Solutions GmbH (SWITZERLAND)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Pharma Solutions Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Pharma Solutions, Inc. (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Pharma Solutions, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Pharmaceutical Technology (Shanghai) Co., Ltd. (CHINA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent PR Humacao, Inc. (PUERTO RICO)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent San Diego Inc. (CALIFORNIA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent (Shanghai) Clinical Trial Supplies Co Ltd. (CHINA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Shiga K.K. (JAPAN)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Singapore Holdings Pte. Ltd. (SINGAPORE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent U.K. Packaging Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent U.K. Swindon Holding II Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent U.K. Swindon Zydis Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent UK Supply Chain Limited (UNITED KINGDOM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">58</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent Uruguay S.A. (URUGUAY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">59</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent US Holding I, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Catalent USA Packaging, LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">61</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cell Therapy Holding S.A. (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Columbia Laboratories (Bermuda) Ltd. (BERMUDA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">63</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hepatic Cell Therapy Support S.A. (BELGIUM) </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">64</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PTS Intermediate Holdings LLC (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">R.P. Scherer Technologies, LLC (NEVADA)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Raritan Valley Insurance Company (NEW JERSEY)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Redwood Bioscience Inc. (DELAWARE)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Skeletal Cell Therapy Support S.A. (BELGIUM)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">69</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #bfbfbf;border-right:1pt solid #bfbfbf;border-top:1pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Soci&#233;t&#233; d&#8217;Infrastructures de Services et d&#8217;Energies S.A. (BELGIUM)</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #bfbfbf;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>catalent-2021630xex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib1369ba060984b5daac8e411c0bf7856_33"></div><div style="min-height:72pt;width:100%"><div style="padding-left:396pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;       </font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)   Registration Statement (Form S-8 No. 333-197726) pertaining to the Catalent, Inc. 2014 Omnibus Incentive Plan,</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)   Registration Statement (Form S-8 No. 333-228438) pertaining to the Catalent, Inc. 2018 Omnibus Incentive Plan and the Catalent, Inc. 2019 Employee Stock Purchase Plan, and</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)   Registration Statement (Form S-3 No. 333-233756) of Catalent, Inc. and in the related Prospectus&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated August 30, 2021, with respect to the consolidated financial statements of Catalent, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of Catalent, Inc. and subsidiaries included in this Annual Report (Form 10-K) of Catalent, Inc. and subsidiaries for the year ended June 30, 2021.</font></div><div style="margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Ernst&#160;&#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Iselin, New Jersey</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">August 30, 2021</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>catalent-20210630xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1c5aca01f2154d51802913433deeb6f5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">CERTIFICATION PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John R. Chiminski, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K for the period ended June&#160;30, 2021 of Catalent, Inc.&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;  </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  </font></div><div style="margin-top:9pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt"><font><br></font></div><div style="margin-top:9pt"><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;30, 2021</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.368%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JOHN R. CHIMINSKI</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John R. Chiminski</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>catalent-20210630xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iff4a5597f0764b3196e92d153177f04e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">CERTIFICATION PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas Castellano, certify that&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K for the period ended June&#160;30, 2021 of Catalent, Inc.&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;  </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  </font></div><div style="margin-top:5pt;padding-left:31.5pt;text-indent:31.5pt"><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;30, 2021</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.368%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THOMAS CASTELLANO</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Castellano</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>catalent-20210630xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3780ac58144040cda55f41c6385e5488_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="margin-bottom:2pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of the Chief Executive Officer </font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, </font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Catalent, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended June&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John R. Chiminski, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;30, 2021</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.368%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JOHN R. CHIMINSKI</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John R. Chiminski</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>catalent-20210630xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia14731231c7147409a8c8106849deb8b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-bottom:2pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of the Chief Financial Officer </font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, </font></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 </font></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Catalent, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended June&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Thomas Castellano, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;30, 2021 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.368%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THOMAS CASTELLANO</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thomas Castellano</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ctlt-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ctlt="http://catalent.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://catalent.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctlt-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctlt-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctlt-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ctlt-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://catalent.com/role/DocumentandEntityInformation">
        <link:definition>000010001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://catalent.com/role/ConsolidatedStatementsofOperations">
        <link:definition>100010002 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income / (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://catalent.com/role/ConsolidatedBalanceSheets">
        <link:definition>100030004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofChangesinShareholdersEquity" roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity">
        <link:definition>100050006 - Statement - Consolidated Statement of Changes in Shareholder's Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock" roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock">
        <link:definition>100060007 - Statement - Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://catalent.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100070008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>240034001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails">
        <link:definition>240044002 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Concentrations of Credit Risk and Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails">
        <link:definition>240054003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails">
        <link:definition>240064004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails" roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails">
        <link:definition>240074005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://catalent.com/role/RevenueRecognition">
        <link:definition>210081002 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractwithCustomerPolicies" roleURI="http://catalent.com/role/RevenuefromContractwithCustomerPolicies">
        <link:definition>220092002 - Disclosure - Revenue from Contract with Customer (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://catalent.com/role/RevenueRecognitionTables">
        <link:definition>230103001 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails" roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails">
        <link:definition>240114006 - Disclosure - Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenuebyGeographyDetails" roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails">
        <link:definition>240124007 - Disclosure - Revenue Recognition Disaggregation of Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionContractualLiabilitiesDetails" roleURI="http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails">
        <link:definition>240134008 - Disclosure - Revenue Recognition Contractual Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionContractualAssetsDetails" roleURI="http://catalent.com/role/RevenueRecognitionContractualAssetsDetails">
        <link:definition>240144009 - Disclosure - Revenue Recognition Contractual Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://catalent.com/role/BusinessCombinations">
        <link:definition>210151003 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://catalent.com/role/BusinessCombinationsTables">
        <link:definition>230163002 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchaseAgreementDetails" roleURI="http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails">
        <link:definition>240174010 - Disclosure - Business Combinations Purchase Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNetAssetsAcquiredDetails" roleURI="http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails">
        <link:definition>240184011 - Disclosure - Business Combinations Net Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsProFormaResultsDetails" roleURI="http://catalent.com/role/BusinessCombinationsProFormaResultsDetails">
        <link:definition>240194012 - Disclosure - Business Combinations Pro Forma Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsDivestituresDetails" roleURI="http://catalent.com/role/BusinessCombinationsDivestituresDetails">
        <link:definition>240204013 - Disclosure - Business Combinations, Divestitures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://catalent.com/role/Goodwill">
        <link:definition>210211004 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://catalent.com/role/GoodwillTables">
        <link:definition>230223003 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillCarryingAmountofGoodwillDetail" roleURI="http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail">
        <link:definition>240234014 - Disclosure - Goodwill - Carrying Amount of Goodwill (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefiniteLivedLongLivedAssets" roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssets">
        <link:definition>210241005 - Disclosure - Definite Lived Long-Lived Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefiniteLivedLongLivedAssetsTables" roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsTables">
        <link:definition>230253004 - Disclosure - Definite Lived Long-Lived Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail">
        <link:definition>240264015 - Disclosure - Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefiniteLivedLongLivedAssetsAdditionalInformationDetail" roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail">
        <link:definition>240274016 - Disclosure - Definite Lived Long-Lived Assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail" roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail">
        <link:definition>240284017 - Disclosure - Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCosts" roleURI="http://catalent.com/role/RestructuringandOtherCosts">
        <link:definition>210291006 - Disclosure - Restructuring and Other Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCostsTables" roleURI="http://catalent.com/role/RestructuringandOtherCostsTables">
        <link:definition>230303005 - Disclosure - Restructuring and Other Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCostsDetails" roleURI="http://catalent.com/role/RestructuringandOtherCostsDetails">
        <link:definition>240314018 - Disclosure - Restructuring and Other Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowings" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings">
        <link:definition>210321007 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsTables" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables">
        <link:definition>230333006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail">
        <link:definition>240344019 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails">
        <link:definition>240354020 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails">
        <link:definition>240364021 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails" roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails">
        <link:definition>240374022 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://catalent.com/role/EarningsPerShare">
        <link:definition>210381008 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareCalculationTables" roleURI="http://catalent.com/role/EarningsPerShareCalculationTables">
        <link:definition>230393007 - Disclosure - Earnings Per Share Calculation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareCalculationsofEarningsPerShareDetails" roleURI="http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails">
        <link:definition>240404023 - Disclosure - Earnings Per Share Calculations of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareEarningsPerShareAdditionalDetailsDetails" roleURI="http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails">
        <link:definition>240414024 - Disclosure - Earnings Per Share Earnings Per Share - Additional Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivities" roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivities">
        <link:definition>210421009 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>230433008 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
        <link:definition>240444025 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosures" roleURI="http://catalent.com/role/FairValueMeasuresandDisclosures">
        <link:definition>210451010 - Disclosure - Fair Value Measures and Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresTables" roleURI="http://catalent.com/role/FairValueMeasuresandDisclosuresTables">
        <link:definition>230463009 - Disclosure - Fair Value Measures and Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresDetails" roleURI="http://catalent.com/role/FairValueMeasuresandDisclosuresDetails">
        <link:definition>240474026 - Disclosure - Fair Value Measures and Disclosures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://catalent.com/role/IncomeTaxes">
        <link:definition>210481011 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://catalent.com/role/IncomeTaxesTables">
        <link:definition>230493010 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://catalent.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>240504027 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails" roleURI="http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails">
        <link:definition>240514028 - Disclosure - Income Taxes Schedule of Income before Tax Domestic and Foreign (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseDetails" roleURI="http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails">
        <link:definition>240524029 - Disclosure - Income Taxes-Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxReconciliationDetails" roleURI="http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails">
        <link:definition>240534030 - Disclosure - Income Taxes-Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsDetails" roleURI="http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails">
        <link:definition>240544031 - Disclosure - Income Taxes-Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesBalanceSheetDetails" roleURI="http://catalent.com/role/IncomeTaxesBalanceSheetDetails">
        <link:definition>240554032 - Disclosure - Income Taxes-Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>240564033 - Disclosure - Income Taxes-Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlans" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlans">
        <link:definition>210571012 - Disclosure - Employee Retirement Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansTables" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansTables">
        <link:definition>230583011 - Disclosure - Employee Retirement Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansAdditionalInformationDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails">
        <link:definition>240594034 - Disclosure - Employee Retirement Benefit Plans-Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails">
        <link:definition>240604035 - Disclosure - Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansBalanceSheetDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails">
        <link:definition>240614036 - Disclosure - Employee Retirement Benefit Plans-Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansAOCIDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails">
        <link:definition>240624037 - Disclosure - Employee Retirement Benefit Plans-AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansFiscalYearMaturityDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails">
        <link:definition>240634038 - Disclosure - Employee Retirement Benefit Plans-Fiscal Year Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansFairValueDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails">
        <link:definition>240644039 - Disclosure - Employee Retirement Benefit Plans-Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansLevel3Details" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details">
        <link:definition>240654040 - Disclosure - Employee Retirement Benefit Plans-Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails" roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails">
        <link:definition>240664041 - Disclosure - Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandAccumulatedOtherComprehensiveIncomeLoss" roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>210671013 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandAccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>230683012 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails" roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails">
        <link:definition>240694042 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails" roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails">
        <link:definition>240704043 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails" roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails">
        <link:definition>240714044 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemablePreferredStockSeriesAPreferred" roleURI="http://catalent.com/role/RedeemablePreferredStockSeriesAPreferred">
        <link:definition>210721014 - Disclosure - Redeemable Preferred Stock - Series A Preferred</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://catalent.com/role/EquityTables">
        <link:definition>230733013 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetails" roleURI="http://catalent.com/role/EquityDetails">
        <link:definition>240744045 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityBasedCompensation" roleURI="http://catalent.com/role/EquityBasedCompensation">
        <link:definition>210751015 - Disclosure - Equity Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityBasedCompensationTables" roleURI="http://catalent.com/role/EquityBasedCompensationTables">
        <link:definition>230763014 - Disclosure - Equity Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityBasedCompensationAdditionalDetails" roleURI="http://catalent.com/role/EquityBasedCompensationAdditionalDetails">
        <link:definition>240774046 - Disclosure - Equity Based Compensation (Additional) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityBasedCompensationOptionActivityDetails" roleURI="http://catalent.com/role/EquityBasedCompensationOptionActivityDetails">
        <link:definition>240784047 - Disclosure - Equity Based Compensation (Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityBasedCompensationRSUActivityDetails" roleURI="http://catalent.com/role/EquityBasedCompensationRSUActivityDetails">
        <link:definition>240794048 - Disclosure - Equity Based Compensation (RSU Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpense" roleURI="http://catalent.com/role/OtherIncomeExpense">
        <link:definition>210801016 - Disclosure - Other Income / Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpenseTables" roleURI="http://catalent.com/role/OtherIncomeExpenseTables">
        <link:definition>230813015 - Disclosure - Other Income / Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeExpenseDetails" roleURI="http://catalent.com/role/OtherIncomeExpenseDetails">
        <link:definition>240824049 - Disclosure - Other Income / Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://catalent.com/role/Leases">
        <link:definition>210831017 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://catalent.com/role/LeasesTables">
        <link:definition>230843016 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails" roleURI="http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails">
        <link:definition>240854050 - Disclosure - Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCostDetails" roleURI="http://catalent.com/role/LeasesCostDetails">
        <link:definition>240864051 - Disclosure - Leases - Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofSupplementalCashFlowInformationDetails" roleURI="http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails">
        <link:definition>240874052 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails" roleURI="http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails">
        <link:definition>240884053 - Disclosure - Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://catalent.com/role/CommitmentsandContingencies">
        <link:definition>210891018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://catalent.com/role/CommitmentsandContingenciesTables">
        <link:definition>230903017 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFuturePaymentsDetails" roleURI="http://catalent.com/role/CommitmentsandContingenciesFuturePaymentsDetails">
        <link:definition>240914054 - Disclosure - Commitments and Contingencies-Future Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://catalent.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>240924055 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsandContingenciesClaimsDetails" roleURI="http://catalent.com/role/CommitmentsandContingenciesCommitmentsandContingenciesClaimsDetails">
        <link:definition>240934056 - Disclosure - Commitments and Contingencies Commitments and Contingencies - Claims (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://catalent.com/role/SegmentInformation">
        <link:definition>210941019 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://catalent.com/role/SegmentInformationTables">
        <link:definition>230953018 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNetRevenueandSegmentEbitdaDetail" roleURI="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail">
        <link:definition>240964057 - Disclosure - Segment Information - Net Revenue and Segment Ebitda (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail" roleURI="http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail">
        <link:definition>240974058 - Disclosure - Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTotalAssetsDetails" roleURI="http://catalent.com/role/SegmentInformationTotalAssetsDetails">
        <link:definition>240984059 - Disclosure - Segment Information Total Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDepreciationandAmortizationDetails" roleURI="http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails">
        <link:definition>240994060 - Disclosure - Segment Information Depreciation and Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationCapitalExpendituresDetails" roleURI="http://catalent.com/role/SegmentInformationCapitalExpendituresDetails">
        <link:definition>241004061 - Disclosure - Segment Information Capital Expenditures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsandRevenuesDetail" roleURI="http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail">
        <link:definition>241014062 - Disclosure - Segment Information - Assets and Revenues (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformation">
        <link:definition>211021020 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>231033019 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail">
        <link:definition>241044063 - Disclosure - Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail">
        <link:definition>241054064 - Disclosure - Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationPropertyandEquipmentDetail" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail">
        <link:definition>241064065 - Disclosure - Supplemental Balance Sheet Information - Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail">
        <link:definition>241074066 - Disclosure - Supplemental Balance Sheet Information - Other Assets Non Current (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail">
        <link:definition>241084067 - Disclosure - Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails" roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails">
        <link:definition>241094068 - Disclosure - Supplemental Balance Sheet Information- Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNotes" roleURI="http://catalent.com/role/SubsequentEventsNotes">
        <link:definition>211101021 - Disclosure - Subsequent Events (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://catalent.com/role/SubsequentEventsDetails">
        <link:definition>241114069 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ctlt_InstallmentPaymentforAcquisitionYearThree" abstract="false" name="InstallmentPaymentforAcquisitionYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueYearOne" abstract="false" name="TotalLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" abstract="true" name="FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ProFormaResultsAbstract" abstract="true" name="ProFormaResultsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_RedeemablePreferredStockLineItems" abstract="true" name="RedeemablePreferredStockLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="TotalLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_BusinessCombinationLoanDiscount" abstract="false" name="BusinessCombinationLoanDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_geographicalMember" abstract="true" name="geographicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_SpareParts" abstract="false" name="SpareParts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DefinedBenefitPlanOtherAssetsAxis" abstract="true" name="DefinedBenefitPlanOtherAssetsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_SkeletalCellTherapySupportSAMember" abstract="true" name="SkeletalCellTherapySupportSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ForeignNetOperatingLossMember" abstract="true" name="ForeignNetOperatingLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ParagonMember" abstract="true" name="ParagonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_OralDrugDeliveryMember" abstract="true" name="OralDrugDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_PreferredStockIssuanceValue" abstract="false" name="PreferredStockIssuanceValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" abstract="false" name="AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_LandBuildingsAndImprovements" abstract="false" name="LandBuildingsAndImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" abstract="false" name="ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" abstract="false" name="RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" abstract="false" name="ImpairmentChargesAndGainLossOnSaleOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" abstract="false" name="DefinedBenefitPlanActualPlanAssetsAllocationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" abstract="false" name="WeightedAverageGrantDateFairValueOfRestrictedStockUnit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DocumentDocumentAndEntityInformationAbstract" abstract="true" name="DocumentDocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_MultiemployerPlansEstimatedAnnualCashContribution" abstract="false" name="MultiemployerPlansEstimatedAnnualCashContribution" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_AccruedRestructuringReserve" abstract="false" name="AccruedRestructuringReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_AcordaTherapeuticsIncMember" abstract="true" name="AcordaTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" abstract="true" name="ExcludingSharesGrantedInConsiderationForAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ProductRightsLineItems" abstract="true" name="ProductRightsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" abstract="false" name="EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_ContractualLiabilitiesTableTextBlock" abstract="false" name="ContractualLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_SeniorSecuredCreditFacilityMember" abstract="true" name="SeniorSecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" abstract="false" name="DeferredIncomeTaxOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" abstract="true" name="FairValueMeasurementsOfFinancialInstrumentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_PostretirementBenefitsByAgeGroupDomain" abstract="true" name="PostretirementBenefitsByAgeGroupDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_SegmentReportingInformationInterSegmentRevenueElimination" abstract="false" name="SegmentReportingInformationInterSegmentRevenueElimination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfRedeemablePreferredStockTable" abstract="true" name="ScheduleOfRedeemablePreferredStockTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_U.S.Dollardenominated4.875SeniorNotesMember" abstract="true" name="U.S.Dollardenominated4.875SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" abstract="true" name="TotalCatalentbeforeintersegmentrevenueeliminationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_AcceleratedAmortizationOfIntangibleAssets" abstract="false" name="AcceleratedAmortizationOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfDebtTable" abstract="true" name="ScheduleOfDebtTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_EberbachPensionPromissoryNoteOrLoanMember" abstract="true" name="EberbachPensionPromissoryNoteOrLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TaxCutsandJobsActTaxEffect" abstract="false" name="TaxCutsandJobsActTaxEffect" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_A3125SeniorUSDenominatedNotesMember" abstract="true" name="A3125SeniorUSDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_DeferredIncomeTaxRightOfUse" abstract="false" name="DeferredIncomeTaxRightOfUse" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_BusinessCombinationWorkingCapitalAdjustments" abstract="false" name="BusinessCombinationWorkingCapitalAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" abstract="false" name="SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_NonAllocatedCorporateCostsNet" abstract="false" name="NonAllocatedCorporateCostsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_RevolvingCreditCommitmentsMember" abstract="true" name="RevolvingCreditCommitmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DevelopmentServicesMember" abstract="true" name="DevelopmentServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalFixedRate" abstract="false" name="TotalFixedRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ctlt_HepaticCellTherapySupportSA" abstract="false" name="HepaticCellTherapySupportSA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" abstract="false" name="OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OtherAccruedLiabilitiesTableTextBlock" abstract="false" name="OtherAccruedLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_PledgePercentageOfEquityInterest" abstract="false" name="PledgePercentageOfEquityInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ctlt_ManufacturingCommercialProductSupplyMember" abstract="true" name="ManufacturingCommercialProductSupplyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ProductRelationshipsMember" abstract="true" name="ProductRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ClinicalSupplyServicesMember" abstract="true" name="ClinicalSupplyServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ForeignNetOperatingLossEstablishedMember" abstract="true" name="ForeignNetOperatingLossEstablishedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_InstallmentPaymentForAcquisition" abstract="false" name="InstallmentPaymentForAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_Eliminationofrevenueattributabletomultiplelocations" abstract="false" name="Eliminationofrevenueattributabletomultiplelocations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ShortTermLeaseCosts" abstract="false" name="ShortTermLeaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_PerformanceMember" abstract="false" name="PerformanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" abstract="false" name="DeferredTaxAssetsAndLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_PreferredStockIssuanceValueNet" abstract="false" name="PreferredStockIssuanceValueNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_InstallmentPaymentforAcquisitionYearFour" abstract="false" name="InstallmentPaymentforAcquisitionYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DefinedBenefitPlanOtherAssetsDomain" abstract="true" name="DefinedBenefitPlanOtherAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" abstract="false" name="ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_DesignatedSharesMember" abstract="true" name="DesignatedSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_SoftgelTechnologiesMember" abstract="true" name="SoftgelTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_SeniorSecuredCreditFacilitiesOtherMember" abstract="true" name="SeniorSecuredCreditFacilitiesOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_BuildingAndImprovementsMember" abstract="true" name="BuildingAndImprovementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_SeniorUnsecuredTermLoanFacilityMember" abstract="true" name="SeniorUnsecuredTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_InternationalOtherMember" abstract="true" name="InternationalOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" abstract="false" name="OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TermLoanThreeFacilityDollarDenominatedMember" abstract="true" name="TermLoanThreeFacilityDollarDenominatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_BoltonCSMember" abstract="true" name="BoltonCSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="ctlt_LongTermAndShortTermDebtAbstract" abstract="true" name="LongTermAndShortTermDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_AccruedOperatingLeaseLiabilities" abstract="false" name="AccruedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_EmployeeStockOptionsandRSUsMember" abstract="true" name="EmployeeStockOptionsandRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_OperatingLossCarryforwardsIndefiniteLife" abstract="false" name="OperatingLossCarryforwardsIndefiniteLife" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_InsuranceContractsMember" abstract="true" name="InsuranceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_InstallmentPaymentforAcquisitionYearTwo" abstract="false" name="InstallmentPaymentforAcquisitionYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OtherObligationsMember" abstract="true" name="OtherObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_USDenominatedTermLoanMember" abstract="true" name="USDenominatedTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" abstract="true" name="FairValueMeasurementsOfFinancialInstrumentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" abstract="false" name="OperatingLossCarryforwardsSubjectToLimitationsSection382" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_DebtInstrumentQuarterlyAmortizationRate" abstract="false" name="DebtInstrumentQuarterlyAmortizationRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ctlt_OralAndSpecialtyDeliveryMember" abstract="true" name="OralAndSpecialtyDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalLeaseLiability" abstract="false" name="TotalLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" abstract="false" name="TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_NumberofDoses" abstract="false" name="NumberofDoses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ctlt_DebtIssuanceCostsMember" abstract="true" name="DebtIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_PensionAsset" abstract="false" name="PensionAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_BiologicsMember" abstract="true" name="BiologicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_Post65Member" abstract="true" name="Post65Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" abstract="false" name="ProceedsFromDivestitureOfBusinessesNetCashProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_A2375SeniorEuroDenominatedNotesMember" abstract="true" name="A2375SeniorEuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_MarketMember" abstract="false" name="MarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_CashPaidToSettleInterestRateSwapAgreement" abstract="false" name="CashPaidToSettleInterestRateSwapAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" abstract="false" name="ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_RTSRPerformanceShareUnitsMember" abstract="true" name="RTSRPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_DebtRefinancingCostsAxis" abstract="true" name="DebtRefinancingCostsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueYearFive" abstract="false" name="TotalLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" abstract="false" name="AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_AnagniMember" abstract="true" name="AnagniMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TermLoanFacilityIncrementalDollarTermB2Member" abstract="true" name="TermLoanFacilityIncrementalDollarTermB2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ConcentrationRiskNumberofCustomers" abstract="false" name="ConcentrationRiskNumberofCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ctlt_StockCompensationPlanOmnibusMember" abstract="true" name="StockCompensationPlanOmnibusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalCatalentSubTotalOfSegmentReportingMember" abstract="true" name="TotalCatalentSubTotalOfSegmentReportingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" abstract="false" name="ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" abstract="false" name="EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_KyotoMember" abstract="true" name="KyotoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ScheduleOfDebtLineItems" abstract="true" name="ScheduleOfDebtLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_AccumulatedDeferredCompensationMember" abstract="true" name="AccumulatedDeferredCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_CoreTechnologyMember" abstract="true" name="CoreTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" abstract="false" name="ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ctlt_NetAssetsAcquiredLineItems" abstract="true" name="NetAssetsAcquiredLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_SeriesAPreferredStockDerivativeLiability" abstract="false" name="SeriesAPreferredStockDerivativeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueYearThree" abstract="false" name="TotalLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" abstract="true" name="ACOIAccumulatedGainLossMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_RecentFinancialAccountingStandardsAbstract" abstract="true" name="RecentFinancialAccountingStandardsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" abstract="false" name="CashAndNoncashDivestitureAmountOfConsiderationReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TimeBasedRestrictedStockUnitsMember" abstract="true" name="TimeBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ZenyattaMember" abstract="true" name="ZenyattaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_MaximumPercentageOfVotingStock" abstract="false" name="MaximumPercentageOfVotingStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" abstract="false" name="PrepaidExpenseAndOtherAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" abstract="true" name="ConcentrationsofCreditRiskandMajorCustomersAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_FinanceLeaseExpense" abstract="false" name="FinanceLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_StockOptionGrantedContractualTerm" abstract="false" name="StockOptionGrantedContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ctlt_RestructuringAndOtherSpecialItems" abstract="false" name="RestructuringAndOtherSpecialItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_PledgePercentageOfCapitalStock" abstract="false" name="PledgePercentageOfCapitalStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="ctlt_TradingSecuritiesAtFairValue" abstract="false" name="TradingSecuritiesAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" abstract="false" name="NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_EquityIssuedInLieuOfCashConsideration" abstract="false" name="EquityIssuedInLieuOfCashConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_SegmentReportingInformationUnallocatedExpense" abstract="false" name="SegmentReportingInformationUnallocatedExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_MaSTherCellMember" abstract="true" name="MaSTherCellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" abstract="false" name="StockIssuedDuringPeriodValueOverAllotmentOption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDue" abstract="false" name="TotalLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" abstract="false" name="ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_AmortizationAndWriteOffOfFinancingCosts" abstract="false" name="AmortizationAndWriteOffOfFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_PropertyandEquipmentAbstract" abstract="true" name="PropertyandEquipmentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_DebtRefinancingCostsDomain" abstract="true" name="DebtRefinancingCostsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueYearFour" abstract="false" name="TotalLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_BusinessCombinationTransitionalServiceAgreement" abstract="false" name="BusinessCombinationTransitionalServiceAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_TermLoanTwoFacilityDollarDenominatedMember" abstract="true" name="TermLoanTwoFacilityDollarDenominatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalDebtUSDenominatedTermLoan" abstract="false" name="TotalDebtUSDenominatedTermLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" abstract="false" name="SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" abstract="false" name="StcokIssuedDuringPeriodSharesOverAllotmentOption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" abstract="false" name="SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="ctlt_USDollarDenominated500SeniorNotesMember" abstract="true" name="USDollarDenominated500SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_PostretirementBenefitsByAgeGroupAxis" abstract="true" name="PostretirementBenefitsByAgeGroupAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_AdditionalInformationAbstract" abstract="true" name="AdditionalInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_RevolvingCreditFacilityTwoMember" abstract="true" name="RevolvingCreditFacilityTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_OperatingLossCarryforwardsCarryForwardPeriod" abstract="false" name="OperatingLossCarryforwardsCarryForwardPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ctlt_DelphiGeneticsSAMember" abstract="true" name="DelphiGeneticsSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_FinitelivedintangibleassetsdisclosureAbstract" abstract="true" name="FinitelivedintangibleassetsdisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ctlt_TimeMember" abstract="false" name="TimeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_NumberofCustomers" abstract="false" name="NumberofCustomers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ctlt_SoftgelAndOralTechnologiesMember" abstract="true" name="SoftgelAndOralTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_ProvisionForBadDebtsAndInventory" abstract="false" name="ProvisionForBadDebtsAndInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ctlt_OtherUnobservableAssetsMember" abstract="true" name="OtherUnobservableAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_BlowFillSealBusinessWoodstockMember" abstract="true" name="BlowFillSealBusinessWoodstockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="TotalLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>ctlt-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_defd8e50-c6d2-4e44-8a36-e733555a2cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_81f8e3a3-20c8-4bad-bba2-0d0b01dfb921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_defd8e50-c6d2-4e44-8a36-e733555a2cb4" xlink:to="loc_us-gaap_NetIncomeLoss_81f8e3a3-20c8-4bad-bba2-0d0b01dfb921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_f6d8732f-23d7-46b9-871c-0c2ab9787526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_defd8e50-c6d2-4e44-8a36-e733555a2cb4" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_f6d8732f-23d7-46b9-871c-0c2ab9787526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fe9f2580-1ee8-4eaf-8569-f97997f17164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_486d3f25-ab94-4298-9354-b9f1aaf6cb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fe9f2580-1ee8-4eaf-8569-f97997f17164" xlink:to="loc_us-gaap_Revenues_486d3f25-ab94-4298-9354-b9f1aaf6cb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_727cbfcf-e303-46c6-a876-550e2406b7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_fe9f2580-1ee8-4eaf-8569-f97997f17164" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_727cbfcf-e303-46c6-a876-550e2406b7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_26127c8e-e309-4527-9834-cefba6e7f268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_311f8fc3-8d7b-425c-952e-7f0afbb132a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_26127c8e-e309-4527-9834-cefba6e7f268" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_311f8fc3-8d7b-425c-952e-7f0afbb132a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c504f292-5adf-478f-a9da-3293624c64fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_26127c8e-e309-4527-9834-cefba6e7f268" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c504f292-5adf-478f-a9da-3293624c64fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a4b2c2fa-f1fb-463c-bbaf-72617d88f694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7665806d-24a8-4360-a72b-4c08cbf2139b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a4b2c2fa-f1fb-463c-bbaf-72617d88f694" xlink:to="loc_us-gaap_OperatingIncomeLoss_7665806d-24a8-4360-a72b-4c08cbf2139b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_255e8f94-ff96-4447-b4f5-bd81561610c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a4b2c2fa-f1fb-463c-bbaf-72617d88f694" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_255e8f94-ff96-4447-b4f5-bd81561610c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dfee5a3c-38f1-4ef1-94f9-f9ab4b66a16f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a4b2c2fa-f1fb-463c-bbaf-72617d88f694" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dfee5a3c-38f1-4ef1-94f9-f9ab4b66a16f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_74eb69c1-b5c6-49b3-a23b-78c27714744a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_735b1bce-e211-4b62-99b8-c3cfc124c46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_74eb69c1-b5c6-49b3-a23b-78c27714744a" xlink:to="loc_us-gaap_GrossProfit_735b1bce-e211-4b62-99b8-c3cfc124c46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13376379-8ee3-4aa0-92db-6d577e708545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_74eb69c1-b5c6-49b3-a23b-78c27714744a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_13376379-8ee3-4aa0-92db-6d577e708545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_a3dcdf8b-537f-4e8c-9970-81a6be24d024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_74eb69c1-b5c6-49b3-a23b-78c27714744a" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_a3dcdf8b-537f-4e8c-9970-81a6be24d024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8b790db7-d03e-469d-b106-b5d30a70d9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_74eb69c1-b5c6-49b3-a23b-78c27714744a" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8b790db7-d03e-469d-b106-b5d30a70d9ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c80f520-259c-4eb3-a596-86a2ef5a7461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_875260aa-f541-4b80-a58c-0c671dd1c7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c80f520-259c-4eb3-a596-86a2ef5a7461" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_875260aa-f541-4b80-a58c-0c671dd1c7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7174305c-c414-4f99-b5b5-e3a5b4a50a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7c80f520-259c-4eb3-a596-86a2ef5a7461" xlink:to="loc_us-gaap_ProfitLoss_7174305c-c414-4f99-b5b5-e3a5b4a50a1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bb4050f3-02f6-4dc4-9f25-e659e5dc1651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_fc80635b-f72a-4ccd-b4f9-1bc70c0be7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bb4050f3-02f6-4dc4-9f25-e659e5dc1651" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_fc80635b-f72a-4ccd-b4f9-1bc70c0be7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0de65a38-5670-4867-93eb-144d96ca793c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bb4050f3-02f6-4dc4-9f25-e659e5dc1651" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0de65a38-5670-4867-93eb-144d96ca793c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_5e57577f-5dd6-4128-9450-7b5b71af571d" xlink:href="ctlt-20210630.xsd#ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bb4050f3-02f6-4dc4-9f25-e659e5dc1651" xlink:to="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_5e57577f-5dd6-4128-9450-7b5b71af571d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_639425ac-8f6f-4ef3-9401-90072810c3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bb4050f3-02f6-4dc4-9f25-e659e5dc1651" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_639425ac-8f6f-4ef3-9401-90072810c3b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://catalent.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_1a21f605-4221-427f-b708-357ba2705f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_1a21f605-4221-427f-b708-357ba2705f1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7ff416e-7e7d-49b0-b406-61da08f9154f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7ff416e-7e7d-49b0-b406-61da08f9154f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_1667da4c-854b-4843-9404-b45ad56a7cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:to="loc_us-gaap_CommonStockValueOutstanding_1667da4c-854b-4843-9404-b45ad56a7cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d864b38c-7275-4315-8ad2-18f52c727416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d864b38c-7275-4315-8ad2-18f52c727416" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8c25dd8c-503c-4635-82ff-2885bee69e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_53de5817-c3f3-45d9-8f7b-c4f6b257e7be" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8c25dd8c-503c-4635-82ff-2885bee69e4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e38183bc-c6fb-44bf-ac7a-d179acbd79e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_8a575322-716d-412a-a936-8a5d6b4957cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e38183bc-c6fb-44bf-ac7a-d179acbd79e1" xlink:to="loc_us-gaap_DebtCurrent_8a575322-716d-412a-a936-8a5d6b4957cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_07c9737b-f3bf-47cc-9565-618b24a07f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e38183bc-c6fb-44bf-ac7a-d179acbd79e1" xlink:to="loc_us-gaap_AccountsPayableCurrent_07c9737b-f3bf-47cc-9565-618b24a07f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ff9075c-1430-4a13-b1e0-cd4364335250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e38183bc-c6fb-44bf-ac7a-d179acbd79e1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ff9075c-1430-4a13-b1e0-cd4364335250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2300f856-24ce-4fb9-b5e7-573e00cff286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_LiabilitiesCurrent_2300f856-24ce-4fb9-b5e7-573e00cff286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3ce15261-98d8-419d-a255-34dd18ce312a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_3ce15261-98d8-419d-a255-34dd18ce312a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e1fdc647-9154-4071-95ec-c013950a5b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e1fdc647-9154-4071-95ec-c013950a5b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_39b89b9c-2629-4cd5-ba69-2a08e67b8956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_39b89b9c-2629-4cd5-ba69-2a08e67b8956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9a948dcd-3c5b-44e3-89af-a9e05d3f8832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9a948dcd-3c5b-44e3-89af-a9e05d3f8832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2cfab319-0dd6-4b74-8a64-78aec3fa0805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2cfab319-0dd6-4b74-8a64-78aec3fa0805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_361cb1ba-da26-471e-a7cc-2a0ea456765a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_361cb1ba-da26-471e-a7cc-2a0ea456765a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fb54837f-3291-4ae6-bed0-b51e8f82f8fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_bcba4910-c4e8-41c9-b389-b392cd94aa07" xlink:to="loc_us-gaap_StockholdersEquity_fb54837f-3291-4ae6-bed0-b51e8f82f8fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6cebe3d0-ad51-4220-8d63-dc9f3d9345ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_AssetsCurrent_6cebe3d0-ad51-4220-8d63-dc9f3d9345ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_24687c03-c437-4be3-9673-663f665b9ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_24687c03-c437-4be3-9673-663f665b9ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e063a3f-1746-41ca-b9c3-28acc4ec6892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_Goodwill_7e063a3f-1746-41ca-b9c3-28acc4ec6892" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_82f236b1-d5c6-480f-b755-bca985b2bc73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_82f236b1-d5c6-480f-b755-bca985b2bc73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e38c3457-b5c7-49b4-bf22-a7059435f277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e38c3457-b5c7-49b4-bf22-a7059435f277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ecf4dfaf-c929-447b-bd5a-c5a3019e5872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_630d3ec3-1616-4be6-a8ea-ff03b7855f81" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ecf4dfaf-c929-447b-bd5a-c5a3019e5872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f34334e8-b995-4b6d-991f-d6e8effd206e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f34334e8-b995-4b6d-991f-d6e8effd206e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1e9b0625-7610-490f-a3fb-89b12b8c05a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1e9b0625-7610-490f-a3fb-89b12b8c05a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9847bca3-d7a2-498d-a9a2-83507e4b9f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:to="loc_us-gaap_InventoryNet_9847bca3-d7a2-498d-a9a2-83507e4b9f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_858e91e1-723c-403e-97d1-31bf3b3f99fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_858e91e1-723c-403e-97d1-31bf3b3f99fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_53bbeaf6-4ec3-4061-8c76-d58c34fbfff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc02a8ae-cea8-467f-b303-8505f3270851" xlink:to="loc_us-gaap_MarketableSecurities_53bbeaf6-4ec3-4061-8c76-d58c34fbfff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_51ef7d6c-af6d-49c8-b1a4-7882b88fa949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_51ef7d6c-af6d-49c8-b1a4-7882b88fa949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7f11d61f-94be-44fb-8397-837198c67f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7f11d61f-94be-44fb-8397-837198c67f77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4f8e82e5-3b52-47e7-b3d3-506a6afd7ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_LiabilitiesCurrent_4f8e82e5-3b52-47e7-b3d3-506a6afd7ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_28d9abe0-6f06-4109-8d8e-9fe6d55a68fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_28d9abe0-6f06-4109-8d8e-9fe6d55a68fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_ebb55266-857e-4d97-8b23-5cecf9c61c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_ebb55266-857e-4d97-8b23-5cecf9c61c4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4867738c-a71e-4c83-8564-d989be3cee07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7c3d0da1-adce-4b0b-a6fd-d62086f3cf87" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4867738c-a71e-4c83-8564-d989be3cee07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc2560d6-08d1-465c-840e-f38af4f6ac9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d816f4aa-3d44-4993-860f-084f55fd4337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc2560d6-08d1-465c-840e-f38af4f6ac9f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d816f4aa-3d44-4993-860f-084f55fd4337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17ffde7c-0e6c-4f00-b02f-cc09bee439d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc2560d6-08d1-465c-840e-f38af4f6ac9f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17ffde7c-0e6c-4f00-b02f-cc09bee439d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7d4e6e7c-0621-4146-a329-392b93bad16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc2560d6-08d1-465c-840e-f38af4f6ac9f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7d4e6e7c-0621-4146-a329-392b93bad16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c785358d-0bd8-488a-96e9-eeb71237a425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc2560d6-08d1-465c-840e-f38af4f6ac9f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c785358d-0bd8-488a-96e9-eeb71237a425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_140a2069-8c08-41f8-ac1a-a3f8b8eac139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_140a2069-8c08-41f8-ac1a-a3f8b8eac139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333b149e-b674-4a39-af79-06f8ba98a699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_333b149e-b674-4a39-af79-06f8ba98a699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7c28e5fc-aa47-4690-a0aa-cbf5e3819ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7c28e5fc-aa47-4690-a0aa-cbf5e3819ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAndInterestPaid_e2cf8e6f-25e3-44c8-b6d1-303210c684b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAndInterestPaid"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_DividendsAndInterestPaid_e2cf8e6f-25e3-44c8-b6d1-303210c684b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a691a163-e261-497d-a79e-1d7b002e671e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a691a163-e261-497d-a79e-1d7b002e671e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_9a5c37b2-023e-43c9-9a9c-dbafef1f181f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_9a5c37b2-023e-43c9-9a9c-dbafef1f181f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e6808e1d-426d-4a76-867c-1e2cace2e21d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e6808e1d-426d-4a76-867c-1e2cace2e21d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c668ce3f-31cc-4461-8017-fe184dd91718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c668ce3f-31cc-4461-8017-fe184dd91718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3da01e1a-9eb3-454c-8baf-b27ef418eda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3da01e1a-9eb3-454c-8baf-b27ef418eda9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_61743e57-6ae4-465a-85a7-296d5de9af3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_61743e57-6ae4-465a-85a7-296d5de9af3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_39ea88e0-9860-4356-b4ef-f915bad1bc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_231ed812-bc09-4475-9d3e-0ac8a2b03658" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_39ea88e0-9860-4356-b4ef-f915bad1bc16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f4c382c9-2643-4100-9b28-a82b1173e2a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_ProfitLoss_f4c382c9-2643-4100-9b28-a82b1173e2a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_366e7e8a-6046-46d1-9d6b-25126e718bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_366e7e8a-6046-46d1-9d6b-25126e718bd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_87b765a7-d91b-411b-85de-92cfdc9cf30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_87b765a7-d91b-411b-85de-92cfdc9cf30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts_a58a1d23-9750-45ef-afb9-32ab73f6c0f2" xlink:href="ctlt-20210630.xsd#ctlt_AmortizationAndWriteOffOfFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts_a58a1d23-9750-45ef-afb9-32ab73f6c0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9d5f3987-9cf4-44f8-9488-8fdf4dedadda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9d5f3987-9cf4-44f8-9488-8fdf4dedadda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a13bd998-4a36-4271-a086-f80c4ed7f75d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_a13bd998-4a36-4271-a086-f80c4ed7f75d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_ab41afd9-fb34-407c-be8e-bf6f8e818a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_ab41afd9-fb34-407c-be8e-bf6f8e818a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea5251b-1cf8-42e9-a543-fd39c97f8621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5ea5251b-1cf8-42e9-a543-fd39c97f8621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f16047f4-a0d1-4211-ba95-c8d9ccc8c3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_ShareBasedCompensation_f16047f4-a0d1-4211-ba95-c8d9ccc8c3ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b093708f-9fb0-4fd7-b931-7945f85326ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b093708f-9fb0-4fd7-b931-7945f85326ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProvisionForBadDebtsAndInventory_a3171c71-ff76-4a52-a648-c81e1ae15e15" xlink:href="ctlt-20210630.xsd#ctlt_ProvisionForBadDebtsAndInventory"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_ctlt_ProvisionForBadDebtsAndInventory_a3171c71-ff76-4a52-a648-c81e1ae15e15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d4162390-8e28-44ff-af31-72e1d7073375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d4162390-8e28-44ff-af31-72e1d7073375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8738cb48-3139-41b7-9ffe-b4c01f05b4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8738cb48-3139-41b7-9ffe-b4c01f05b4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d0f831e2-5173-445f-9ef2-b6c0a2e11fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d0f831e2-5173-445f-9ef2-b6c0a2e11fe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c7af0bf2-77b0-412b-a8ca-515e83842ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1f669ed7-4c9d-4e4f-9a4f-381df1c7de1f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c7af0bf2-77b0-412b-a8ca-515e83842ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4ad22c6d-a52c-4a91-9491-4ffe58116326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4ad22c6d-a52c-4a91-9491-4ffe58116326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_dbdca988-7533-461d-86d7-74912ff68935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_dbdca988-7533-461d-86d7-74912ff68935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b5880b20-eb2d-4e35-a93e-d0ddee8e59a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b5880b20-eb2d-4e35-a93e-d0ddee8e59a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_5a1699f3-3252-43eb-939f-fa063d21c73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_5a1699f3-3252-43eb-939f-fa063d21c73f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cb5d9df3-e4b9-490d-a795-1a0bbd5a6b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cb5d9df3-e4b9-490d-a795-1a0bbd5a6b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_486c1d3a-050b-4002-a193-50221c61ecd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_09e4a0ed-fa5b-427f-aeed-718a30b7c71f" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_486c1d3a-050b-4002-a193-50221c61ecd2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"/>
  <link:calculationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_795f4d7f-aa4c-4297-b17d-ef08b5d726b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_132aa531-53b2-4724-9c58-c836421dd6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_795f4d7f-aa4c-4297-b17d-ef08b5d726b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_132aa531-53b2-4724-9c58-c836421dd6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_996e525b-98e6-48b5-8d62-13d258685418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_795f4d7f-aa4c-4297-b17d-ef08b5d726b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_996e525b-98e6-48b5-8d62-13d258685418" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RestructuringandOtherCostsDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_51452dca-eb94-43b9-860d-af646b22ee6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_76df4a3b-bf81-4993-a1c0-d86fadd0a5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_51452dca-eb94-43b9-860d-af646b22ee6a" xlink:to="loc_us-gaap_SeveranceCosts1_76df4a3b-bf81-4993-a1c0-d86fadd0a5a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_59b207c1-38f9-4b0c-a190-838672d06e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_51452dca-eb94-43b9-860d-af646b22ee6a" xlink:to="loc_us-gaap_BusinessExitCosts1_59b207c1-38f9-4b0c-a190-838672d06e19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_294a3901-61c0-4ec7-91af-cac11b7b1560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d819e54a-17c3-4380-989c-ba7e6fcbb182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_294a3901-61c0-4ec7-91af-cac11b7b1560" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_d819e54a-17c3-4380-989c-ba7e6fcbb182" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_32cc3fba-c1a3-4092-bc79-d8d94ee88f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_294a3901-61c0-4ec7-91af-cac11b7b1560" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_32cc3fba-c1a3-4092-bc79-d8d94ee88f21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d8ee413-118d-47b9-ad1f-530a55647936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4896a14d-3178-4d13-8aff-a0729349cfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d8ee413-118d-47b9-ad1f-530a55647936" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4896a14d-3178-4d13-8aff-a0729349cfa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_74dcc012-e2dc-4681-a395-33ae9b5225f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d8ee413-118d-47b9-ad1f-530a55647936" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_74dcc012-e2dc-4681-a395-33ae9b5225f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d7b5e074-0126-4f42-bc19-b96647e16bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6d8ee413-118d-47b9-ad1f-530a55647936" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d7b5e074-0126-4f42-bc19-b96647e16bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47e2ffcd-e7ac-4edc-a16e-af0e677959a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8fc896a6-6095-49b0-a6b9-97c9907347d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_47e2ffcd-e7ac-4edc-a16e-af0e677959a8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8fc896a6-6095-49b0-a6b9-97c9907347d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76622b90-fccc-4065-94e5-c7a88604d94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_47e2ffcd-e7ac-4edc-a16e-af0e677959a8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_76622b90-fccc-4065-94e5-c7a88604d94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa9724de-4338-4d1c-add8-2afb1fe681d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b06b8679-576a-429c-84ba-ecaf1b5e8726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa9724de-4338-4d1c-add8-2afb1fe681d8" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b06b8679-576a-429c-84ba-ecaf1b5e8726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fbc06e15-8621-4290-8189-f801506efc66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa9724de-4338-4d1c-add8-2afb1fe681d8" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fbc06e15-8621-4290-8189-f801506efc66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4614ea62-39d0-4edd-aaad-fd626ea3a4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fa9724de-4338-4d1c-add8-2afb1fe681d8" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4614ea62-39d0-4edd-aaad-fd626ea3a4f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_85c5e8e9-3a62-4acd-b4a7-d4f5052812c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_85c5e8e9-3a62-4acd-b4a7-d4f5052812c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_67495865-894c-4613-a58a-9ebc71dd7bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_67495865-894c-4613-a58a-9ebc71dd7bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_7163a47c-cc63-479e-a9a2-4bf2b1ee289f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_7163a47c-cc63-479e-a9a2-4bf2b1ee289f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_39da145c-7ff1-44d6-8be9-02d39d28ffec" xlink:href="ctlt-20210630.xsd#ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_39da145c-7ff1-44d6-8be9-02d39d28ffec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_31254b6e-ac3a-4d88-a5b2-0c103f5c8566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_31254b6e-ac3a-4d88-a5b2-0c103f5c8566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4833a0d6-06e7-4709-867a-0db98a8270ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_4833a0d6-06e7-4709-867a-0db98a8270ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5b3ffc3b-0df5-486c-b20a-9b3fb76a830d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5b3ffc3b-0df5-486c-b20a-9b3fb76a830d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_9b10fb70-edae-427a-97b6-dbb0a0e5bd6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_9b10fb70-edae-427a-97b6-dbb0a0e5bd6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2c234ef0-508d-4e06-957d-38153bd75078" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_2c234ef0-508d-4e06-957d-38153bd75078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_bf5bf8ff-e5f5-4727-9181-0e5d726be414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_bf5bf8ff-e5f5-4727-9181-0e5d726be414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_83fab9b7-28de-456e-b405-dacb4a9492a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_83fab9b7-28de-456e-b405-dacb4a9492a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TaxCutsandJobsActTaxEffect_773ae436-019f-46a5-b5c6-0a54a04fa18b" xlink:href="ctlt-20210630.xsd#ctlt_TaxCutsandJobsActTaxEffect"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_ctlt_TaxCutsandJobsActTaxEffect_773ae436-019f-46a5-b5c6-0a54a04fa18b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_2e4ca15b-9cee-4ace-b8f6-ed8b99f61d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ac130090-f4ed-4f7c-9664-90bb8a256490" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_2e4ca15b-9cee-4ace-b8f6-ed8b99f61d7b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_38ba8c77-6070-4c93-bfae-648bab1622b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_38ba8c77-6070-4c93-bfae-648bab1622b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_afb5dbcc-d46b-413e-85d1-f6e9aea05788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_afb5dbcc-d46b-413e-85d1-f6e9aea05788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_34e36a3e-5584-44c9-9f97-c2cb9908a772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_34e36a3e-5584-44c9-9f97-c2cb9908a772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxRightOfUse_560be0ac-3621-4524-b6b7-8dbf13454a12" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxRightOfUse"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:to="loc_ctlt_DeferredIncomeTaxRightOfUse_560be0ac-3621-4524-b6b7-8dbf13454a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_5d5e980d-681b-4eb0-84f6-65f497160544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_241c3f90-ff64-4596-971d-8d8c770c7c77" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_5d5e980d-681b-4eb0-84f6-65f497160544" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f7629923-f9e4-468d-80f1-02b4a3d8bccf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_52ea1619-45e2-49ff-bd75-9f63e25fedca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f7629923-f9e4-468d-80f1-02b4a3d8bccf" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_52ea1619-45e2-49ff-bd75-9f63e25fedca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7426a754-6d28-4637-b155-063c4eb30fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f7629923-f9e4-468d-80f1-02b4a3d8bccf" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7426a754-6d28-4637-b155-063c4eb30fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8c5ef32-96fd-49b6-867c-e10e0c0462ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8c5ef32-96fd-49b6-867c-e10e0c0462ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4efbf3a1-bd24-4330-87e7-c6bb2a83a4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4efbf3a1-bd24-4330-87e7-c6bb2a83a4ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e562b295-efe1-4cc6-b4af-77fe14774c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e562b295-efe1-4cc6-b4af-77fe14774c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_01b34200-2419-4d2c-9d38-baf6486de960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_01b34200-2419-4d2c-9d38-baf6486de960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_8953407c-a543-4615-918a-112133893768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_8953407c-a543-4615-918a-112133893768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_87901ed8-e196-40b9-8fa2-241a2ca1956f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_87901ed8-e196-40b9-8fa2-241a2ca1956f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_ccc5b570-97d1-4be5-a262-eb18e24d1f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_ccc5b570-97d1-4be5-a262-eb18e24d1f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_2d69dce6-cd9b-4869-9f0a-3847785d8acf" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxOperatingLeaseLiabilities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_2d69dce6-cd9b-4869-9f0a-3847785d8acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_3278258b-d196-4f44-a301-f3bffa06af96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f4588e30-c14f-4520-a904-39a4869ebc50" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_3278258b-d196-4f44-a301-f3bffa06af96" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_092e6290-f193-41c0-83e2-0e94b2c24af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_092e6290-f193-41c0-83e2-0e94b2c24af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c42f8d18-a4d9-448b-bea5-05fa4e9ec7b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c42f8d18-a4d9-448b-bea5-05fa4e9ec7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fcbeea71-b286-4178-971f-3b3226fdc450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fcbeea71-b286-4178-971f-3b3226fdc450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_c20622c8-2f06-4cd1-8a5a-f7861c370d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_c20622c8-2f06-4cd1-8a5a-f7861c370d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_172275c2-9f8d-416f-91d8-ac859fe2d822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_172275c2-9f8d-416f-91d8-ac859fe2d822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0e8c2c9e-a7f0-4d3a-8c2a-0a43a4ace018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0f2635c2-abea-47e1-84e1-9bc1bcfc590e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0e8c2c9e-a7f0-4d3a-8c2a-0a43a4ace018" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAOCIDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d602b235-926e-4e2e-a0c6-f086376575b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d602b235-926e-4e2e-a0c6-f086376575b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_79095df4-68a2-4451-9686-95d9d20111c6" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_79095df4-68a2-4451-9686-95d9d20111c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_5b0a8e4f-6e25-4ea4-99ad-ee22e362ba7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_5b0a8e4f-6e25-4ea4-99ad-ee22e362ba7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_d3970821-ff53-4a72-be2a-b6ed86c21704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_d3970821-ff53-4a72-be2a-b6ed86c21704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_cd74106f-67d1-4da5-a3e2-bb2b1521426c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_56362a0a-2017-41d6-89cf-c2cbcc502e7b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_cd74106f-67d1-4da5-a3e2-bb2b1521426c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"/>
  <link:calculationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5749f627-c57f-4406-a73a-b449a36d57b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d744a50a-426e-4cf5-a9d7-a39e6fc06cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5749f627-c57f-4406-a73a-b449a36d57b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_d744a50a-426e-4cf5-a9d7-a39e6fc06cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7abef4c6-0ebd-4879-8f0a-76f7543db1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5749f627-c57f-4406-a73a-b449a36d57b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7abef4c6-0ebd-4879-8f0a-76f7543db1ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_0814d273-90fe-48d7-a9fc-0e09df6a63f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_45616cfc-3f23-45e8-8dee-9989add06d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_0814d273-90fe-48d7-a9fc-0e09df6a63f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_45616cfc-3f23-45e8-8dee-9989add06d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_f2eb0e0b-d369-45a4-9c15-c484074ed8cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_0814d273-90fe-48d7-a9fc-0e09df6a63f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_f2eb0e0b-d369-45a4-9c15-c484074ed8cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_b9970a65-4cb4-4862-821e-e01320b27fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_fdf9e646-7798-4fd0-bdea-0a31db3258b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_b9970a65-4cb4-4862-821e-e01320b27fe9" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_fdf9e646-7798-4fd0-bdea-0a31db3258b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_38f2fda6-3324-4498-b811-2d9e2c341c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_b9970a65-4cb4-4862-821e-e01320b27fe9" xlink:to="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_38f2fda6-3324-4498-b811-2d9e2c341c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_534540ee-15a1-4e00-a523-430802a43edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_b9970a65-4cb4-4862-821e-e01320b27fe9" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_534540ee-15a1-4e00-a523-430802a43edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a697055c-7a72-4872-b78c-8bb7243e98dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_6fa92374-765a-434f-b489-6a324024e4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a697055c-7a72-4872-b78c-8bb7243e98dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_6fa92374-765a-434f-b489-6a324024e4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_ac3297af-731b-4eb1-bf9c-a6906e28a233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a697055c-7a72-4872-b78c-8bb7243e98dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_ac3297af-731b-4eb1-bf9c-a6906e28a233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_9340a023-798c-41eb-a650-748aa0902537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_a697055c-7a72-4872-b78c-8bb7243e98dc" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_9340a023-798c-41eb-a650-748aa0902537" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationNetRevenueandSegmentEbitdaDetail"/>
  <link:calculationLink xlink:role="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationUnallocatedExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_54b9dbba-49ee-4e10-92e0-32b6d246e5ff" xlink:href="ctlt-20210630.xsd#ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_54b9dbba-49ee-4e10-92e0-32b6d246e5ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d2ca3e-9790-4b9e-b445-e8ec97c3d09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_45d2ca3e-9790-4b9e-b445-e8ec97c3d09b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestructuringAndOtherSpecialItems_59ce85aa-66e9-4f2f-aeef-fce2f95acc57" xlink:href="ctlt-20210630.xsd#ctlt_RestructuringAndOtherSpecialItems"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_ctlt_RestructuringAndOtherSpecialItems_59ce85aa-66e9-4f2f-aeef-fce2f95acc57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eafdeb53-7d1c-41a4-889e-4fd239afe71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eafdeb53-7d1c-41a4-889e-4fd239afe71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_f62b8ff4-aa5f-4caf-a9f1-7635f7a0cc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_f62b8ff4-aa5f-4caf-a9f1-7635f7a0cc9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NonAllocatedCorporateCostsNet_968458c8-1726-4838-9e5d-ff14b94f27df" xlink:href="ctlt-20210630.xsd#ctlt_NonAllocatedCorporateCostsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense_0529c007-1dfd-4cbd-a636-41baeccd4b23" xlink:to="loc_ctlt_NonAllocatedCorporateCostsNet_968458c8-1726-4838-9e5d-ff14b94f27df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"/>
  <link:calculationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_22485fae-c84e-467c-9e8e-10508bcc93e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_1b2e68bb-35bd-4e6b-acc3-c3b7faca924e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_22485fae-c84e-467c-9e8e-10508bcc93e1" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_1b2e68bb-35bd-4e6b-acc3-c3b7faca924e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_6feecb6a-e17e-4680-821e-a9d1e61ba718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_22485fae-c84e-467c-9e8e-10508bcc93e1" xlink:to="loc_us-gaap_InventoryWorkInProcess_6feecb6a-e17e-4680-821e-a9d1e61ba718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e6e8e339-f703-484f-8ac7-715a6c7ecd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_b00b0768-ff41-4e9d-8aa0-07107f11f619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e6e8e339-f703-484f-8ac7-715a6c7ecd0d" xlink:to="loc_us-gaap_InventoryGross_b00b0768-ff41-4e9d-8aa0-07107f11f619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_e439c82f-f2bd-4ff8-8479-f91de268d9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_e6e8e339-f703-484f-8ac7-715a6c7ecd0d" xlink:to="loc_us-gaap_InventoryValuationReserves_e439c82f-f2bd-4ff8-8479-f91de268d9bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationPropertyandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_20ad00d9-6ddf-41de-a6bf-e1777a10d87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_LandBuildingsAndImprovements_fb86bd5a-12a4-48fa-9e1b-15486cef0843" xlink:href="ctlt-20210630.xsd#ctlt_LandBuildingsAndImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_20ad00d9-6ddf-41de-a6bf-e1777a10d87a" xlink:to="loc_ctlt_LandBuildingsAndImprovements_fb86bd5a-12a4-48fa-9e1b-15486cef0843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_25fd12cc-3570-4c8e-8946-43e8b287d6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_20ad00d9-6ddf-41de-a6bf-e1777a10d87a" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_25fd12cc-3570-4c8e-8946-43e8b287d6fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_395da8b1-e07d-46c3-8514-f277f0fbc7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_20ad00d9-6ddf-41de-a6bf-e1777a10d87a" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_395da8b1-e07d-46c3-8514-f277f0fbc7d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_65510540-d4b6-4868-87e1-a4bba13c60c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_20ad00d9-6ddf-41de-a6bf-e1777a10d87a" xlink:to="loc_us-gaap_ConstructionInProgressGross_65510540-d4b6-4868-87e1-a4bba13c60c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1aeab2f0-0d82-435f-949a-219430f9fda3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9e664efe-2a63-4de2-a1c7-ee440637b2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1aeab2f0-0d82-435f-949a-219430f9fda3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9e664efe-2a63-4de2-a1c7-ee440637b2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_af139291-7bc8-48de-8f59-1123fb7043f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1aeab2f0-0d82-435f-949a-219430f9fda3" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_af139291-7bc8-48de-8f59-1123fb7043f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_70afbcd7-26d2-4f96-ac23-b480524a6b51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_DeferredRevenueCurrent_70afbcd7-26d2-4f96-ac23-b480524a6b51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2482c77a-a789-4f88-be96-17a8a4bfe79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2482c77a-a789-4f88-be96-17a8a4bfe79c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_80a2d3b6-7a1b-4fbc-8313-3ef44ae2bcb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_80a2d3b6-7a1b-4fbc-8313-3ef44ae2bcb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedOperatingLeaseLiabilities_1334e675-6e13-45c8-b629-3f98e7d39326" xlink:href="ctlt-20210630.xsd#ctlt_AccruedOperatingLeaseLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_ctlt_AccruedOperatingLeaseLiabilities_1334e675-6e13-45c8-b629-3f98e7d39326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedRestructuringReserve_3fa0e525-a43a-4484-b93e-25cf650f7dca" xlink:href="ctlt-20210630.xsd#ctlt_AccruedRestructuringReserve"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_ctlt_AccruedRestructuringReserve_3fa0e525-a43a-4484-b93e-25cf650f7dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_389dd2c4-1f93-4c57-9516-7669a1af64c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_389dd2c4-1f93-4c57-9516-7669a1af64c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_4feb7c7c-b4f9-42d7-9e69-32da2b7ee4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_InterestPayableCurrent_4feb7c7c-b4f9-42d7-9e69-32da2b7ee4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4c21f2aa-76f7-450c-a133-d4f61bd6039c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_38b5305c-fa8e-4bb8-83e5-fb078600c4ef" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4c21f2aa-76f7-450c-a133-d4f61bd6039c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>ctlt-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i25d1a9eb01b34f6ba2315420eb41de91_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6090caf9-ded6-4568-b486-e92619f76d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_ProfitLoss_6090caf9-ded6-4568-b486-e92619f76d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_726fd133-7b61-4e98-83a9-5659052396a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_726fd133-7b61-4e98-83a9-5659052396a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3996f010-23b6-4068-8a30-48d07a9980e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3996f010-23b6-4068-8a30-48d07a9980e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0071b53d-5851-4404-ab5b-35f1e18aa0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0071b53d-5851-4404-ab5b-35f1e18aa0c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_88e1f9a6-51bf-4c2f-a6ba-5827941d0221" xlink:href="ctlt-20210630.xsd#ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_88e1f9a6-51bf-4c2f-a6ba-5827941d0221" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4cc1fe5f-d505-4ac5-a10f-5486968e7fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4cc1fe5f-d505-4ac5-a10f-5486968e7fc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbad3413-eada-4515-8c23-7be1f085c304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbad3413-eada-4515-8c23-7be1f085c304" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:to="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a18cf5f8-6f88-468b-904f-d974066b0386_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a18cf5f8-6f88-468b-904f-d974066b0386_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a49601d4-3f4f-478f-8635-37e3e1191be0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a49601d4-3f4f-478f-8635-37e3e1191be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4aaf2e32-391f-4b1c-87be-97318375d03a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:to="loc_us-gaap_ClassOfStockDomain_4aaf2e32-391f-4b1c-87be-97318375d03a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8361d29c-e79a-45f6-b8c1-0b43d672ff48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:to="loc_us-gaap_ClassOfStockDomain_8361d29c-e79a-45f6-b8c1-0b43d672ff48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_894ef63b-8216-4132-9403-1b1f9e1dedb1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:to="loc_us-gaap_EquityComponentDomain_894ef63b-8216-4132-9403-1b1f9e1dedb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:to="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_23821907-85c4-4721-b359-52ba7a7c8581" xlink:href="ctlt-20210630.xsd#ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:to="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_23821907-85c4-4721-b359-52ba7a7c8581" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementofChangesinShareholdersEquity"/>
  <link:definitionLink xlink:role="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="extended" id="i2f6b3fea46a74b178529ab700de34ada_ConsolidatedStatementofChangesinShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caf15f82-d1c9-4ae6-b7f6-af243616daa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caf15f82-d1c9-4ae6-b7f6-af243616daa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_90e76009-3192-4d71-8645-f799ad0e2f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockholdersEquityOther_90e76009-3192-4d71-8645-f799ad0e2f15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12e67295-861e-4974-94f6-54c2d943aae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12e67295-861e-4974-94f6-54c2d943aae3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb4cd253-4a27-4866-acb7-60f64e635e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb4cd253-4a27-4866-acb7-60f64e635e2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_95af356c-fb17-46a4-bff5-bd1fcea13f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_95af356c-fb17-46a4-bff5-bd1fcea13f0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e5bbf17d-cf7f-4549-9f76-735189243684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e5bbf17d-cf7f-4549-9f76-735189243684" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f3b4e9a-9a21-4259-a419-cc2974add74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f3b4e9a-9a21-4259-a419-cc2974add74e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c8d86ab5-7c94-4db7-af8c-2eab1b0a986a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c8d86ab5-7c94-4db7-af8c-2eab1b0a986a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EquityIssuedInLieuOfCashConsideration_29b886e0-d667-4b52-bf82-9da3b2014c1f" xlink:href="ctlt-20210630.xsd#ctlt_EquityIssuedInLieuOfCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_ctlt_EquityIssuedInLieuOfCashConsideration_29b886e0-d667-4b52-bf82-9da3b2014c1f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_484690f5-32dc-4ea1-af2e-18433a0a6e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_484690f5-32dc-4ea1-af2e-18433a0a6e67" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_24acfb33-7f87-4639-8560-678393d966a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_DividendsPreferredStock_24acfb33-7f87-4639-8560-678393d966a2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_136b424d-4160-4f9e-88ec-5d1f85c9b6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_NetIncomeLoss_136b424d-4160-4f9e-88ec-5d1f85c9b6ba" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58e827a3-d340-44b2-a261-a30804a82dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58e827a3-d340-44b2-a261-a30804a82dbf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_47936dcc-1abd-4ab2-8c0c-6b6074a4aab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_494bd8c4-2816-4c1e-9067-24008015f24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_494bd8c4-2816-4c1e-9067-24008015f24d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_1e570691-d578-40f2-92d1-899be95ff191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_1e570691-d578-40f2-92d1-899be95ff191" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1f5a270b-ac3e-4fed-9444-9e59e75fe689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1f5a270b-ac3e-4fed-9444-9e59e75fe689" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:to="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8bdd7d93-920e-4ba0-adec-52a4c02a28df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:to="loc_us-gaap_EquityComponentDomain_8bdd7d93-920e-4ba0-adec-52a4c02a28df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:to="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e1e5e8dc-9b7a-4365-9584-49ea39539f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_CommonStockMember_e1e5e8dc-9b7a-4365-9584-49ea39539f9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d30a3f4a-0692-42f9-b49f-62584aa5a747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d30a3f4a-0692-42f9-b49f-62584aa5a747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c3ead6ab-a245-46b7-aa0c-c8e8363bc087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_RetainedEarningsMember_c3ead6ab-a245-46b7-aa0c-c8e8363bc087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_32318431-b2ff-46b3-b9c9-63662bbdd9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_32318431-b2ff-46b3-b9c9-63662bbdd9e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a8754e50-fa49-4375-88ee-c2cb0128c1f4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a8754e50-fa49-4375-88ee-c2cb0128c1f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f50435e0-a908-4df3-bca0-557eb1c3ba2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f50435e0-a908-4df3-bca0-557eb1c3ba2c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock"/>
  <link:definitionLink xlink:role="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock" xlink:type="extended" id="i12a3a6822e5c4f54a48284dc4fcaad86_ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c386dd38-2968-4022-a6ba-b5b732001808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c386dd38-2968-4022-a6ba-b5b732001808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9fe9b79-2150-4d29-bb6b-8c86b0b4d713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9fe9b79-2150-4d29-bb6b-8c86b0b4d713" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_72983900-8c00-46f9-b45b-16754a8837c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_72983900-8c00-46f9-b45b-16754a8837c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ad56b1c4-47a5-4fca-8a1d-6cd087b39eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ad56b1c4-47a5-4fca-8a1d-6cd087b39eb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7df0fb86-fa2f-40fc-878a-a0b00f03d609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:to="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1b9232b4-4b41-4497-9795-ae6345218aac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:to="loc_us-gaap_EquityComponentDomain_1b9232b4-4b41-4497-9795-ae6345218aac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:to="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4bf5a6a-59ce-416a-998b-6f28a25ac7a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:to="loc_us-gaap_CommonStockMember_b4bf5a6a-59ce-416a-998b-6f28a25ac7a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i078ba90ad2554b7d8c3946c6a5431871_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c578b357-075e-49c8-8764-930aab50a74b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c578b357-075e-49c8-8764-930aab50a74b" xlink:to="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c0955717-dbfa-476f-96d8-291f9c3b56fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:to="loc_us-gaap_EquityComponentDomain_c0955717-dbfa-476f-96d8-291f9c3b56fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:to="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_55b016a4-86d7-4e0d-bab2-6c25462ec564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_55b016a4-86d7-4e0d-bab2-6c25462ec564" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:to="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b47828f0-fe59-4e1b-baf6-44c0fce31b05_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b47828f0-fe59-4e1b-baf6-44c0fce31b05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c502ffbe-1ec3-4b92-ad98-1cae0e6523ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c502ffbe-1ec3-4b92-ad98-1cae0e6523ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="ic457c9ab87ef49e89c3ef839eff64e57_BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bf862bfb-92ce-4519-b45a-265ea1e9fe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bf862bfb-92ce-4519-b45a-265ea1e9fe3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_781295e7-307b-4040-ae44-8630cf5544af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_781295e7-307b-4040-ae44-8630cf5544af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c203264-b84b-41fa-a9c6-b323a53652cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c203264-b84b-41fa-a9c6-b323a53652cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_2dc8f55e-5261-4442-b294-afa7ada5e4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_SharePrice_2dc8f55e-5261-4442-b294-afa7ada5e4f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofDoses_6d1b0ab5-8bad-4918-afe3-6fb87d136915" xlink:href="ctlt-20210630.xsd#ctlt_NumberofDoses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_ctlt_NumberofDoses_6d1b0ab5-8bad-4918-afe3-6fb87d136915" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofCustomers_7b7f2448-816a-4c99-bc3b-6e5bf9127dfe" xlink:href="ctlt-20210630.xsd#ctlt_NumberofCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_ctlt_NumberofCustomers_7b7f2448-816a-4c99-bc3b-6e5bf9127dfe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6314170b-619b-4bf3-8722-3c984b231d4e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:to="loc_us-gaap_RelatedPartyDomain_6314170b-619b-4bf3-8722-3c984b231d4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8a634d02-5488-4cdb-baa1-ae12456174d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:to="loc_us-gaap_RelatedPartyDomain_8a634d02-5488-4cdb-baa1-ae12456174d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails" xlink:type="extended" id="i458fd65c8f58402db2ea8ebf3b61c6a6_BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ConcentrationRiskNumberofCustomers_60eb2525-4ecc-4be8-9791-db8f4ab19b02" xlink:href="ctlt-20210630.xsd#ctlt_ConcentrationRiskNumberofCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:to="loc_ctlt_ConcentrationRiskNumberofCustomers_60eb2525-4ecc-4be8-9791-db8f4ab19b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:to="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_37102988-b1f6-4ffc-9d5a-59f9a800bc6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_37102988-b1f6-4ffc-9d5a-59f9a800bc6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5d3760ef-7a03-45e6-8508-c9f80c2d2dea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5d3760ef-7a03-45e6-8508-c9f80c2d2dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6808d45f-fcb8-4d9e-84bf-0c2623335492_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6808d45f-fcb8-4d9e-84bf-0c2623335492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_6ebc1ca5-016e-4468-aa5d-c3b64ed6e5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:to="loc_us-gaap_SalesMember_6ebc1ca5-016e-4468-aa5d-c3b64ed6e5c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="i3d245524abe944d79e035896eefbea8e_BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b649076c-042a-455a-b6be-8dd55d734ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b649076c-042a-455a-b6be-8dd55d734ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_87cc57a8-e2a2-4410-adf3-5ba64c1f1803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_Depreciation_87cc57a8-e2a2-4410-adf3-5ba64c1f1803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4dc00092-6f58-48b2-9096-c3bd0c25f1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_InterestCostsCapitalized_4dc00092-6f58-48b2-9096-c3bd0c25f1c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6c05c537-7c60-41a8-955a-4a5c239c91e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6c05c537-7c60-41a8-955a-4a5c239c91e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_25a63030-9c0e-4853-aa34-3cf3de5826cb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_25a63030-9c0e-4853-aa34-3cf3de5826cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BuildingAndImprovementsMember_23c47f09-644d-444a-bb2e-c99c0a35c594" xlink:href="ctlt-20210630.xsd#ctlt_BuildingAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_ctlt_BuildingAndImprovementsMember_23c47f09-644d-444a-bb2e-c99c0a35c594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_875a7bf8-3f1d-4e79-9a0d-71514176c713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_875a7bf8-3f1d-4e79-9a0d-71514176c713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_eee4ad03-09a3-42ca-b9ed-a3b351758800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_eee4ad03-09a3-42ca-b9ed-a3b351758800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:to="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e5de09c0-5a4e-418b-9804-c8772ac5a67b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:to="loc_srt_RangeMember_e5de09c0-5a4e-418b-9804-c8772ac5a67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:to="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fb52775-3277-4afa-af36-8febf0fd6f3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:to="loc_srt_MinimumMember_0fb52775-3277-4afa-af36-8febf0fd6f3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_94d9e585-03b8-409f-ae60-891f60573365" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:to="loc_srt_MaximumMember_94d9e585-03b8-409f-ae60-891f60573365" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails" xlink:type="extended" id="i1275f00367384523b7e064f4beaed0d8_BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6ee15d64-d108-433a-b83d-1d2f7592e290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6ee15d64-d108-433a-b83d-1d2f7592e290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:to="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c6883dde-ca00-4437-be83-2b788956feee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c6883dde-ca00-4437-be83-2b788956feee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7ae26907-a3cb-4695-800e-ca16c0f39607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7ae26907-a3cb-4695-800e-ca16c0f39607" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b513f618-f429-4110-a3f1-f231f469c1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:to="loc_us-gaap_CostOfSalesMember_b513f618-f429-4110-a3f1-f231f469c1c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails" xlink:type="extended" id="i25d7c2dff6bb46a4a223f8f0ddfcc1ad_BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6d408e74-2652-4169-933c-a1bcdab2e89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:to="loc_us-gaap_OperatingLeaseLiability_6d408e74-2652-4169-933c-a1bcdab2e89e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_7e00da17-5353-4fb3-a4e8-361bf960f63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_7e00da17-5353-4fb3-a4e8-361bf960f63e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_0180486e-9514-4802-8bf5-ca03117e84c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_0180486e-9514-4802-8bf5-ca03117e84c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_737e19ed-85c5-4fb7-b7f6-2eb0a36f34e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_737e19ed-85c5-4fb7-b7f6-2eb0a36f34e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f6c9b03b-4927-4201-8d34-f05b19472712_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:to="loc_us-gaap_EquityComponentDomain_f6c9b03b-4927-4201-8d34-f05b19472712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:to="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0fd82b79-17b6-4f6a-8d0b-e1aa6f08167b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:to="loc_us-gaap_RetainedEarningsMember_0fd82b79-17b6-4f6a-8d0b-e1aa6f08167b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_20acb1f1-d5d4-4273-a769-5ee95210bdb8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:to="loc_srt_RestatementDomain_20acb1f1-d5d4-4273-a769-5ee95210bdb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:to="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_256bc3d6-ff27-4095-93db-7605121c2ec2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_256bc3d6-ff27-4095-93db-7605121c2ec2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionTables"/>
  <link:definitionLink xlink:role="http://catalent.com/role/RevenueRecognitionTables" xlink:type="extended" id="i72a694f1277e44c0a3ebe019fa9439b5_RevenueRecognitionTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50126320-8cf7-493f-b3ef-b54d507b67ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50126320-8cf7-493f-b3ef-b54d507b67ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:to="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4ff46689-f6b3-4784-b0df-94171d277893_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:to="loc_srt_ProductsAndServicesDomain_4ff46689-f6b3-4784-b0df-94171d277893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:to="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_9d4c89c2-dcc3-4ad8-91f1-3f8b52a88f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_9d4c89c2-dcc3-4ad8-91f1-3f8b52a88f67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:to="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:to="loc_srt_SegmentGeographicalDomain_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:to="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_geographicalMember_857cbc85-8063-4f53-be4b-a51db8ba2dad" xlink:href="ctlt-20210630.xsd#ctlt_geographicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:to="loc_ctlt_geographicalMember_857cbc85-8063-4f53-be4b-a51db8ba2dad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails" xlink:type="extended" id="i157e00d4bcde48fda7b4673e6f748b2c_RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_027421a1-bb7b-4485-a2a4-87a490876c0c" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationInterSegmentRevenueElimination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:to="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_027421a1-bb7b-4485-a2a4-87a490876c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e1337a32-762a-4d43-836d-c3706404dcc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:to="loc_us-gaap_Revenues_e1337a32-762a-4d43-836d-c3706404dcc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7057bf4b-28e6-4100-8ffa-549e5865c6c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:to="loc_us-gaap_SegmentDomain_7057bf4b-28e6-4100-8ffa-549e5865c6c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:to="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_99ad2f51-9162-436e-9f33-f2db4b399090" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_99ad2f51-9162-436e-9f33-f2db4b399090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_fed6aff8-f188-4450-9cc1-5fb8ff7e04d8" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_BiologicsMember_fed6aff8-f188-4450-9cc1-5fb8ff7e04d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_a8a37d89-ff50-4f58-aa85-37aac7476dec" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_a8a37d89-ff50-4f58-aa85-37aac7476dec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_06d67e49-96de-4f9e-a78c-248e6b4a90f6" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_06d67e49-96de-4f9e-a78c-248e6b4a90f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_2cd67b89-0c73-4d6d-b799-6841ed668d11" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_2cd67b89-0c73-4d6d-b799-6841ed668d11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:to="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_415f7256-3c3e-4c10-b87c-51d91f4beb17_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:to="loc_srt_ProductsAndServicesDomain_415f7256-3c3e-4c10-b87c-51d91f4beb17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:to="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ManufacturingCommercialProductSupplyMember_104272e3-40f7-446a-b763-d55efcf9f03d" xlink:href="ctlt-20210630.xsd#ctlt_ManufacturingCommercialProductSupplyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_ManufacturingCommercialProductSupplyMember_104272e3-40f7-446a-b763-d55efcf9f03d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DevelopmentServicesMember_07f0073d-3b2a-43c6-9ba3-3a46a5ca0701" xlink:href="ctlt-20210630.xsd#ctlt_DevelopmentServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_DevelopmentServicesMember_07f0073d-3b2a-43c6-9ba3-3a46a5ca0701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_42bdea67-a0a4-4d4a-a105-2cc182410a12" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_42bdea67-a0a4-4d4a-a105-2cc182410a12" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionDisaggregationofRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails" xlink:type="extended" id="i78d79e5eafad42378e0b9cd139b3343d_RevenueRecognitionDisaggregationofRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations_a948129f-9857-41cd-817d-f6249beeeaa5" xlink:href="ctlt-20210630.xsd#ctlt_Eliminationofrevenueattributabletomultiplelocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:to="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations_a948129f-9857-41cd-817d-f6249beeeaa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e63972b-3b18-4c0f-a341-30062a5b9c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:to="loc_us-gaap_Revenues_2e63972b-3b18-4c0f-a341-30062a5b9c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:to="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7478c275-2daa-4389-8421-f689e41d9d9f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:to="loc_srt_SegmentGeographicalDomain_7478c275-2daa-4389-8421-f689e41d9d9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:to="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_d57f36c7-9a8f-4998-8ab0-d016da17a8d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_srt_NorthAmericaMember_d57f36c7-9a8f-4998-8ab0-d016da17a8d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_748880b3-8f45-45a6-85d6-5ca4bc116c92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_srt_EuropeMember_748880b3-8f45-45a6-85d6-5ca4bc116c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InternationalOtherMember_342ce9ca-6277-4cee-b813-0a603a590486" xlink:href="ctlt-20210630.xsd#ctlt_InternationalOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_ctlt_InternationalOtherMember_342ce9ca-6277-4cee-b813-0a603a590486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_25ad2688-8cbb-4052-9d28-a3e4c1e813a6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_country_US_25ad2688-8cbb-4052-9d28-a3e4c1e813a6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BusinessCombinationsTables" xlink:type="extended" id="ie8849e309aa6428292df21c37fe6504d_BusinessCombinationsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ab267ca9-9848-4cd9-9809-693b548ab199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ab267ca9-9848-4cd9-9809-693b548ab199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9171936d-c21b-467b-a394-959204b8c364_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9171936d-c21b-467b-a394-959204b8c364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_1212830b-4a02-48dd-a12e-59ed7b039fdc" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:to="loc_ctlt_ParagonMember_1212830b-4a02-48dd-a12e-59ed7b039fdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_9a010337-d3e3-4b2f-8cf9-2c2e29efa9b9" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:to="loc_ctlt_MaSTherCellMember_9a010337-d3e3-4b2f-8cf9-2c2e29efa9b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsPurchaseAgreementDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails" xlink:type="extended" id="ifb1393a666cd47a1a6dd21f1c5a089e6_BusinessCombinationsPurchaseAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b41a66ee-8a1c-4e1d-b01d-b40547a9cf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b41a66ee-8a1c-4e1d-b01d-b40547a9cf10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_770c5108-3b2c-40fa-8f26-889b7256f737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_770c5108-3b2c-40fa-8f26-889b7256f737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0c213e5a-cf45-4c60-83cc-3529223e883f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0c213e5a-cf45-4c60-83cc-3529223e883f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_f031cb20-dc8d-4682-a8d4-b08efeaa4352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_f031cb20-dc8d-4682-a8d4-b08efeaa4352" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3d2067-d235-41af-8935-16c69d2013f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3d2067-d235-41af-8935-16c69d2013f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32cf27ad-0010-42b0-97f6-65a9efbc1c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32cf27ad-0010-42b0-97f6-65a9efbc1c17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c2941a60-8e93-495d-b957-62786c205ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c2941a60-8e93-495d-b957-62786c205ba6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_202cfebc-724a-4eab-9330-49631cf6da66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_202cfebc-724a-4eab-9330-49631cf6da66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7566b19b-69e6-424c-8143-e5062cbe0e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7566b19b-69e6-424c-8143-e5062cbe0e5a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_8c35f048-50c2-424b-a9b9-e39abc793162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_8c35f048-50c2-424b-a9b9-e39abc793162" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9a792955-94d1-4582-bf3f-5c38f5053e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9a792955-94d1-4582-bf3f-5c38f5053e18" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b62aeebc-a229-49d6-8574-19877cea4380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b62aeebc-a229-49d6-8574-19877cea4380" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d028ecc1-670f-4923-b19a-db8823692aa5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d028ecc1-670f-4923-b19a-db8823692aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_2120b301-b929-44a5-8d2e-df451013057d" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_ParagonMember_2120b301-b929-44a5-8d2e-df451013057d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AnagniMember_14877586-c8d1-4ea5-910b-ca966cfef146" xlink:href="ctlt-20210630.xsd#ctlt_AnagniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_AnagniMember_14877586-c8d1-4ea5-910b-ca966cfef146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_3a9babe4-d6d8-4116-9cb7-12406332d5ef" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_MaSTherCellMember_3a9babe4-d6d8-4116-9cb7-12406332d5ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SkeletalCellTherapySupportSAMember_7b424f02-2680-41f8-9d6c-7a6d32e2983d" xlink:href="ctlt-20210630.xsd#ctlt_SkeletalCellTherapySupportSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_SkeletalCellTherapySupportSAMember_7b424f02-2680-41f8-9d6c-7a6d32e2983d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_HepaticCellTherapySupportSA_862e91e8-b83c-410c-85ae-f202dfb0a046" xlink:href="ctlt-20210630.xsd#ctlt_HepaticCellTherapySupportSA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_HepaticCellTherapySupportSA_862e91e8-b83c-410c-85ae-f202dfb0a046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_KyotoMember_4c35eefd-5b25-4ab2-ad75-0c08cb9e6dff" xlink:href="ctlt-20210630.xsd#ctlt_KyotoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_KyotoMember_4c35eefd-5b25-4ab2-ad75-0c08cb9e6dff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AcordaTherapeuticsIncMember_71af5f2c-1e31-43ee-9370-77d8dedece85" xlink:href="ctlt-20210630.xsd#ctlt_AcordaTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_AcordaTherapeuticsIncMember_71af5f2c-1e31-43ee-9370-77d8dedece85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_4ebcbdb2-8bc6-4dd8-9925-eb92410b4b8a" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_DelphiGeneticsSAMember_4ebcbdb2-8bc6-4dd8-9925-eb92410b4b8a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsNetAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails" xlink:type="extended" id="id802ce618be440a2800ec466cdc9f727_BusinessCombinationsNetAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:href="ctlt-20210630.xsd#ctlt_NetAssetsAcquiredLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2264669d-85f3-4be9-adaf-b53fbd30caeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2264669d-85f3-4be9-adaf-b53fbd30caeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_704b666b-cd10-4c13-96b0-7fbf5adbd188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_704b666b-cd10-4c13-96b0-7fbf5adbd188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_537d2b4e-ac25-4dbb-9ad6-0074c810c648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_537d2b4e-ac25-4dbb-9ad6-0074c810c648" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4de56af5-9847-4501-bda1-b1c0356bb832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4de56af5-9847-4501-bda1-b1c0356bb832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationTransitionalServiceAgreement_daaeceaf-6ab8-4fb4-b06f-84156442d14b" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationTransitionalServiceAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_ctlt_BusinessCombinationTransitionalServiceAgreement_daaeceaf-6ab8-4fb4-b06f-84156442d14b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_829b10a2-c546-412f-9b17-c4b79d3f82e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_829b10a2-c546-412f-9b17-c4b79d3f82e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0ef5269a-29d6-4d65-bffd-4a94072ebe34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0ef5269a-29d6-4d65-bffd-4a94072ebe34" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_129db59d-6ccf-48c2-8055-c2fb9f26561f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_129db59d-6ccf-48c2-8055-c2fb9f26561f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_07758091-676f-462f-b78a-f64e31f3dd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_07758091-676f-462f-b78a-f64e31f3dd83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_ec3e0405-61fd-4e68-9638-f63f142a8f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_ec3e0405-61fd-4e68-9638-f63f142a8f4a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa27bf3d-7e76-4aa3-a160-9b74f0a3d340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa27bf3d-7e76-4aa3-a160-9b74f0a3d340" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e3f52df-c24f-4b0d-a860-142e1b4a1ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e3f52df-c24f-4b0d-a860-142e1b4a1ad4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cced575-cfd7-403a-be74-0f9e3b5be88c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cced575-cfd7-403a-be74-0f9e3b5be88c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6ec441a0-a323-49a3-ace2-991a21803250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6ec441a0-a323-49a3-ace2-991a21803250" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRelationshipsMember_04e76c96-e7e1-449d-822e-f1604e41e8d6" xlink:href="ctlt-20210630.xsd#ctlt_ProductRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_ctlt_ProductRelationshipsMember_04e76c96-e7e1-449d-822e-f1604e41e8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_0265643e-b03f-4c98-80d5-3ac4eb1874cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_0265643e-b03f-4c98-80d5-3ac4eb1874cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea116dd7-6cbc-4e53-acb9-aa4e2311a215_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea116dd7-6cbc-4e53-acb9-aa4e2311a215_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_10d1fa3d-4640-4714-ad69-c95685ae8fa8" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_ParagonMember_10d1fa3d-4640-4714-ad69-c95685ae8fa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AnagniMember_132b59af-c183-4095-91db-5c3de1be427a" xlink:href="ctlt-20210630.xsd#ctlt_AnagniMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_AnagniMember_132b59af-c183-4095-91db-5c3de1be427a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_00a80251-7e30-4bf2-a74b-3038e09b5b5d" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_MaSTherCellMember_00a80251-7e30-4bf2-a74b-3038e09b5b5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_c3b538f8-9e2e-4cca-85c3-b176939542b6" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_DelphiGeneticsSAMember_c3b538f8-9e2e-4cca-85c3-b176939542b6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsDivestituresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsDivestituresDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/BusinessCombinationsDivestituresDetails" xlink:type="extended" id="i003074d7c7164de094b846463c26e202_BusinessCombinationsDivestituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_734f3475-856c-4696-a330-d317b490c2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_734f3475-856c-4696-a330-d317b490c2fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_de707f68-3a93-4a38-87df-88ee08bb326e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_de707f68-3a93-4a38-87df-88ee08bb326e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_e681f2c4-2143-4fd2-8a4c-a9b33b1730ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_e681f2c4-2143-4fd2-8a4c-a9b33b1730ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_54814c0d-b563-46f8-ae2d-b4fcb6b4f386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_54814c0d-b563-46f8-ae2d-b4fcb6b4f386" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c5edddd3-51a6-4093-8734-da68d4d4204e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c5edddd3-51a6-4093-8734-da68d4d4204e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d42aa24d-771d-40a7-9584-97f8432040c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d42aa24d-771d-40a7-9584-97f8432040c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_098e2719-ee3b-47e7-8c2d-76b62cd95fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_098e2719-ee3b-47e7-8c2d-76b62cd95fed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationLoanDiscount_5b4a6cf1-e1a2-4193-8794-d8ef146cac2d" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationLoanDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_BusinessCombinationLoanDiscount_5b4a6cf1-e1a2-4193-8794-d8ef146cac2d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4d42e133-7755-493d-b3f5-97f1a2b1fb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4d42e133-7755-493d-b3f5-97f1a2b1fb67" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments_eec7d4eb-2664-43c8-8e0a-f0c5ceb04abc" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationWorkingCapitalAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments_eec7d4eb-2664-43c8-8e0a-f0c5ceb04abc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9d8aa5d2-d1ce-4dbf-aead-9f3ba9bcff22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9d8aa5d2-d1ce-4dbf-aead-9f3ba9bcff22" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_30deda38-6384-4110-afe9-22fbf6f06541" xlink:href="ctlt-20210630.xsd#ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_30deda38-6384-4110-afe9-22fbf6f06541" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_d6caf820-e20e-43be-8295-0dac77d7cf5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_d6caf820-e20e-43be-8295-0dac77d7cf5a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_eea49b1a-5187-41ab-95e6-50706198f887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_eea49b1a-5187-41ab-95e6-50706198f887" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_206e25f8-1959-4d68-8ed9-dbe5183142c6" xlink:href="ctlt-20210630.xsd#ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_206e25f8-1959-4d68-8ed9-dbe5183142c6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_76f6cb8d-7efc-4ce7-b219-7bba829c0732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_76f6cb8d-7efc-4ce7-b219-7bba829c0732" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BlowFillSealBusinessWoodstockMember_8613c223-6796-41b0-86f9-63bf070ff60c" xlink:href="ctlt-20210630.xsd#ctlt_BlowFillSealBusinessWoodstockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:to="loc_ctlt_BlowFillSealBusinessWoodstockMember_8613c223-6796-41b0-86f9-63bf070ff60c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_99ebfd45-65a5-442f-be51-37f29d61186a" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:to="loc_ctlt_DelphiGeneticsSAMember_99ebfd45-65a5-442f-be51-37f29d61186a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_aab7195a-4a00-44b3-9e28-002dff103a54_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_aab7195a-4a00-44b3-9e28-002dff103a54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1dd70386-2f01-4e6b-8233-a34c1aa2f28f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1dd70386-2f01-4e6b-8233-a34c1aa2f28f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:to="loc_srt_OwnershipDomain_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_215d9fe0-fd57-458e-8c99-771669f0b0b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:to="loc_srt_OwnershipDomain_215d9fe0-fd57-458e-8c99-771669f0b0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0d384f22-a141-4bab-8d79-b9c1800b5e7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:to="loc_us-gaap_ClassOfStockDomain_0d384f22-a141-4bab-8d79-b9c1800b5e7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0435d27-b9c3-4189-a6f1-994b2a97059c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:to="loc_us-gaap_ClassOfStockDomain_a0435d27-b9c3-4189-a6f1-994b2a97059c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#GoodwillCarryingAmountofGoodwillDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail" xlink:type="extended" id="i79fb60be46c94e3c9270307caac7ff08_GoodwillCarryingAmountofGoodwillDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:to="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_751d2fcd-0f9e-4d9d-9d76-f8c158588bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_Goodwill_751d2fcd-0f9e-4d9d-9d76-f8c158588bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_19e8ad7e-597c-44e9-b43d-196acd72623c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_19e8ad7e-597c-44e9-b43d-196acd72623c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7af05da7-640d-41c5-ac88-5ee6ca36e6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillTransfers_7af05da7-640d-41c5-ac88-5ee6ca36e6bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_36fc18f1-3715-499a-ae22-15ad119f84e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_36fc18f1-3715-499a-ae22-15ad119f84e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_83cb99bd-5a41-44a9-a38d-8b7160bbb2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_83cb99bd-5a41-44a9-a38d-8b7160bbb2c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_263232ac-dec3-48d9-a432-b27afecf7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_62dfe99f-ddeb-4d73-84b3-292a47ec24e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_62dfe99f-ddeb-4d73-84b3-292a47ec24e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4d45254-fcc4-498f-aead-e8d90476aa6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:to="loc_us-gaap_SegmentDomain_a4d45254-fcc4-498f-aead-e8d90476aa6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:to="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_353a6f2e-9f2a-4820-80eb-e79ea0726056" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_353a6f2e-9f2a-4820-80eb-e79ea0726056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_2333ca4f-931a-4c25-b6ad-43a9d75cab68" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_BiologicsMember_2333ca4f-931a-4c25-b6ad-43a9d75cab68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_cca4f8d0-4329-4966-aad6-11d62e4580e9" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_cca4f8d0-4329-4966-aad6-11d62e4580e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_7d080136-86a2-4b88-8793-2fcd2b5eb10c" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_7d080136-86a2-4b88-8793-2fcd2b5eb10c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelTechnologiesMember_7a0ae9d7-7e12-444d-8fa4-06d6b5ae67c8" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_SoftgelTechnologiesMember_7a0ae9d7-7e12-444d-8fa4-06d6b5ae67c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralDrugDeliveryMember_625a3d59-6d35-4263-8914-57a8045a5994" xlink:href="ctlt-20210630.xsd#ctlt_OralDrugDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_OralDrugDeliveryMember_625a3d59-6d35-4263-8914-57a8045a5994" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="extended" id="idf493a5772a740a3b0307df93c46793e_DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:href="ctlt-20210630.xsd#ctlt_ProductRightsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aaabb96e-ce08-4ddd-85f9-5caef35b1608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aaabb96e-ce08-4ddd-85f9-5caef35b1608" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dd93391-d85a-415f-b5c9-309fb7ed088f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dd93391-d85a-415f-b5c9-309fb7ed088f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d264738-22e9-463a-b077-6de92da074e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d264738-22e9-463a-b077-6de92da074e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_430b9b15-5fbd-495a-a289-2640f18d617e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_430b9b15-5fbd-495a-a289-2640f18d617e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1648f4a0-07d1-41cc-8192-d9e61252108b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1648f4a0-07d1-41cc-8192-d9e61252108b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CoreTechnologyMember_4f693baf-4050-4dd1-b9a2-537ab1b000f6" xlink:href="ctlt-20210630.xsd#ctlt_CoreTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_ctlt_CoreTechnologyMember_4f693baf-4050-4dd1-b9a2-537ab1b000f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8ca8f69d-f9fc-4dc1-a33f-85c27fbe04e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8ca8f69d-f9fc-4dc1-a33f-85c27fbe04e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRelationshipsMember_1aa60f25-85b3-46e3-a27c-ffd78436ca89" xlink:href="ctlt-20210630.xsd#ctlt_ProductRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_ctlt_ProductRelationshipsMember_1aa60f25-85b3-46e3-a27c-ffd78436ca89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ce81ef9d-bb32-4487-87d1-cad843246614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ce81ef9d-bb32-4487-87d1-cad843246614" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RestructuringandOtherCostsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="extended" id="i3c93c16cc1504f13950f85a26b13dd0e_RestructuringandOtherCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_495126b9-c444-4047-952f-9e62e705398f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_495126b9-c444-4047-952f-9e62e705398f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5ebacdd7-eb46-42c6-ad18-4988ca97f7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5ebacdd7-eb46-42c6-ad18-4988ca97f7d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0be69687-d505-4581-86e7-2382d4bf4da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_SeveranceCosts1_0be69687-d505-4581-86e7-2382d4bf4da1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_294e71ec-3ea5-4cc6-8af5-6d7f4918656d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_BusinessExitCosts1_294e71ec-3ea5-4cc6-8af5-6d7f4918656d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3f2a6be4-ce0f-49f6-b5d9-80b82c0d2fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringCharges_3f2a6be4-ce0f-49f6-b5d9-80b82c0d2fce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_57dadcc4-bcf7-4a14-b6fc-8e5a0605c428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_57dadcc4-bcf7-4a14-b6fc-8e5a0605c428" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_37d420fc-c0e0-4e6a-bf9d-cb12023e50ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_37d420fc-c0e0-4e6a-bf9d-cb12023e50ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:to="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_03b14a04-3367-4dfa-999a-56eb8b9642b6_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:to="loc_dei_EntityDomain_03b14a04-3367-4dfa-999a-56eb8b9642b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:to="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BoltonCSMember_c29e8ed9-40a6-4114-8320-3c378fbb195b" xlink:href="ctlt-20210630.xsd#ctlt_BoltonCSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:to="loc_ctlt_BoltonCSMember_c29e8ed9-40a6-4114-8320-3c378fbb195b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:to="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ee807e5-8172-47c9-9b91-12cebabda9cd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:to="loc_srt_RangeMember_6ee807e5-8172-47c9-9b91-12cebabda9cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:to="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f7d78eb0-6519-4e1c-bdca-fb3504cf4195" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:to="loc_srt_MinimumMember_f7d78eb0-6519-4e1c-bdca-fb3504cf4195" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b85f483-0f5a-4cb7-ae9e-41e1998e5515" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:to="loc_srt_MaximumMember_8b85f483-0f5a-4cb7-ae9e-41e1998e5515" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail" xlink:type="extended" id="i3eb694725e6748d680625505d2d6f457_LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_cd61e316-d8c2-4728-8ee3-6473845516df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_cd61e316-d8c2-4728-8ee3-6473845516df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8d3d59be-ddea-4dfb-8158-4ce6fab693a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8d3d59be-ddea-4dfb-8158-4ce6fab693a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_f74eee26-d357-4e44-b5dc-823f5710f2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtCurrent_f74eee26-d357-4e44-b5dc-823f5710f2ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e710d50e-dd7a-4cad-9477-74fe999e44d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e710d50e-dd7a-4cad-9477-74fe999e44d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred_5d6afa35-2e15-4170-a3e0-1075df14d499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_InterestCostsIncurred_5d6afa35-2e15-4170-a3e0-1075df14d499" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a96d0ab6-44df-49c7-b23b-6ad30f62afa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a96d0ab6-44df-49c7-b23b-6ad30f62afa4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_2c71a869-c00a-4e3d-81a5-6ab8a64355eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_2c71a869-c00a-4e3d-81a5-6ab8a64355eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_491b688e-eeb4-47ea-a294-5ffbeebe9452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_491b688e-eeb4-47ea-a294-5ffbeebe9452" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c6bd6449-1ffc-4d84-8344-a116f99745db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c6bd6449-1ffc-4d84-8344-a116f99745db" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentForAcquisition_b991ddec-ff43-4315-b04a-a36795e4dc47" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentForAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentForAcquisition_b991ddec-ff43-4315-b04a-a36795e4dc47" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo_fd9da3f2-bc5b-424a-8aa4-b74cf841716f" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo_fd9da3f2-bc5b-424a-8aa4-b74cf841716f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearThree_661c807f-3dd6-48cb-bde7-fab708d0cdd2" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearThree_661c807f-3dd6-48cb-bde7-fab708d0cdd2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearFour_bc5c7c2a-cc89-44d0-866e-13f7be0e842b" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearFour_bc5c7c2a-cc89-44d0-866e-13f7be0e842b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_16c69076-3481-4805-b188-19f9024c9013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_16c69076-3481-4805-b188-19f9024c9013" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_121665e4-6592-43f7-a42b-f750e690e8de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_121665e4-6592-43f7-a42b-f750e690e8de" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfCapitalStock_5650befe-0bf5-471d-ab69-93b60190acfd" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfCapitalStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_PledgePercentageOfCapitalStock_5650befe-0bf5-471d-ab69-93b60190acfd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfEquityInterest_1a022dcc-3883-4d8f-bc1e-e5feda5146ff" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_PledgePercentageOfEquityInterest_1a022dcc-3883-4d8f-bc1e-e5feda5146ff" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaximumPercentageOfVotingStock_88afb7c4-ecec-4642-bc15-96bf15031a29" xlink:href="ctlt-20210630.xsd#ctlt_MaximumPercentageOfVotingStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_MaximumPercentageOfVotingStock_88afb7c4-ecec-4642-bc15-96bf15031a29" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate_8e825605-cf89-4a74-b760-aee102a5cdba" xlink:href="ctlt-20210630.xsd#ctlt_DebtInstrumentQuarterlyAmortizationRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate_8e825605-cf89-4a74-b760-aee102a5cdba" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_3820243f-a6ea-4b87-959c-59b549fbe51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_3820243f-a6ea-4b87-959c-59b549fbe51a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9c9955d2-2257-415f-b3ed-1bb9c56dd051_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9c9955d2-2257-415f-b3ed-1bb9c56dd051_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_892bbe5c-3278-4dd9-ab16-ee707d19ceef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_892bbe5c-3278-4dd9-ab16-ee707d19ceef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4b4955e5-e1dd-471d-88ff-22ad140ca18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4b4955e5-e1dd-471d-88ff-22ad140ca18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1c726fd0-450b-433c-a677-eccddf547e33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1c726fd0-450b-433c-a677-eccddf547e33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_38a8ba2e-bc54-4ae2-85be-33ff351d882b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_38a8ba2e-bc54-4ae2-85be-33ff351d882b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_eed90b59-b709-4507-9c91-8edf67f8d1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_eed90b59-b709-4507-9c91-8edf67f8d1b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_79fe47a9-e319-42e7-9211-9657ba24c2ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_79fe47a9-e319-42e7-9211-9657ba24c2ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_5f8d1de2-6f94-4fe0-808a-5ab4f93914cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_5f8d1de2-6f94-4fe0-808a-5ab4f93914cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsDomain_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c_default" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:to="loc_ctlt_DebtRefinancingCostsDomain_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsDomain_b134ff04-f97a-482c-9af8-cc5984b8d3a8" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:to="loc_ctlt_DebtRefinancingCostsDomain_b134ff04-f97a-482c-9af8-cc5984b8d3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7021722c-abde-4f3a-a1de-bd4f021e086b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7021722c-abde-4f3a-a1de-bd4f021e086b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_3113817d-4f22-4b30-91cc-ff7e944c854b" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanFacilityIncrementalDollarTermB2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_3113817d-4f22-4b30-91cc-ff7e944c854b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_31dc0d8c-ce38-4208-9c51-d08ca5ac6a96" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_31dc0d8c-ce38-4208-9c51-d08ca5ac6a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditCommitmentsMember_9c5524d9-c75b-4697-be1c-9f0ab98968cc" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditCommitmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_RevolvingCreditCommitmentsMember_9c5524d9-c75b-4697-be1c-9f0ab98968cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_3335aeb3-0455-4a5c-ba84-99e3fa4ecda0" xlink:href="ctlt-20210630.xsd#ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_3335aeb3-0455-4a5c-ba84-99e3fa4ecda0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_d6c77df4-386c-4601-ac84-602f1d634cea" xlink:href="ctlt-20210630.xsd#ctlt_U.S.Dollardenominated4.875SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_d6c77df4-386c-4601-ac84-602f1d634cea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDollarDenominated500SeniorNotesMember_5c955f23-9d0b-4527-90db-af56a4502ee6" xlink:href="ctlt-20210630.xsd#ctlt_USDollarDenominated500SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_USDollarDenominated500SeniorNotesMember_5c955f23-9d0b-4527-90db-af56a4502ee6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_8a021294-1c96-4f4c-8062-962f854a8bd5" xlink:href="ctlt-20210630.xsd#ctlt_A2375SeniorEuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_8a021294-1c96-4f4c-8062-962f854a8bd5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_236e7fa7-7d42-4671-bf60-01cc586a7b27" xlink:href="ctlt-20210630.xsd#ctlt_SeniorUnsecuredTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_236e7fa7-7d42-4671-bf60-01cc586a7b27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_0aef9118-60aa-4bff-ad1f-bcf4c244dfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_0aef9118-60aa-4bff-ad1f-bcf4c244dfcf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherObligationsMember_3e010f17-4ce6-4ed5-88cf-d3f04a050adf" xlink:href="ctlt-20210630.xsd#ctlt_OtherObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_OtherObligationsMember_3e010f17-4ce6-4ed5-88cf-d3f04a050adf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A3125SeniorUSDenominatedNotesMember_aa789c71-3a5b-454e-a881-639ca9ac4d91" xlink:href="ctlt-20210630.xsd#ctlt_A3125SeniorUSDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_A3125SeniorUSDenominatedNotesMember_aa789c71-3a5b-454e-a881-639ca9ac4d91" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_b1436bba-2bce-4a3a-8e60-78ef3d63bb83" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanThreeFacilityDollarDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_b1436bba-2bce-4a3a-8e60-78ef3d63bb83" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtIssuanceCostsMember_1f28fd5d-39c2-4413-b987-a25c0209f905" xlink:href="ctlt-20210630.xsd#ctlt_DebtIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_DebtIssuanceCostsMember_1f28fd5d-39c2-4413-b987-a25c0209f905" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_dd28f75a-9705-4150-b618-eba28d85dca1" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanTwoFacilityDollarDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_dd28f75a-9705-4150-b618-eba28d85dca1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0c67809f-0c7c-4605-ac11-86a42968a548_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:to="loc_us-gaap_CreditFacilityDomain_0c67809f-0c7c-4605-ac11-86a42968a548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:to="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilityMember_693fce1b-7fa6-4bf0-9391-26a06a89642e" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:to="loc_ctlt_SeniorSecuredCreditFacilityMember_693fce1b-7fa6-4bf0-9391-26a06a89642e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails" xlink:type="extended" id="iaadf15c239dc4f599098c2b9a953d5ef_LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_df16a48b-8eba-4fb7-9982-f038cee99c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_df16a48b-8eba-4fb7-9982-f038cee99c49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_1dba48ac-b3a9-40d2-8ce2-2d9c78245a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_1dba48ac-b3a9-40d2-8ce2-2d9c78245a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:to="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_20805979-9dde-4c3a-820e-1f23562f78de" xlink:href="ctlt-20210630.xsd#ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_20805979-9dde-4c3a-820e-1f23562f78de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_bc3dcc4d-0b11-47f5-8676-185edebe4dfb" xlink:href="ctlt-20210630.xsd#ctlt_U.S.Dollardenominated4.875SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_bc3dcc4d-0b11-47f5-8676-185edebe4dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDollarDenominated500SeniorNotesMember_a17953cc-5cb1-4cc1-8350-42c99ca4055c" xlink:href="ctlt-20210630.xsd#ctlt_USDollarDenominated500SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_USDollarDenominated500SeniorNotesMember_a17953cc-5cb1-4cc1-8350-42c99ca4055c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_437bfada-a39b-4725-881d-334e7c83db7f" xlink:href="ctlt-20210630.xsd#ctlt_A2375SeniorEuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_437bfada-a39b-4725-881d-334e7c83db7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A3125SeniorUSDenominatedNotesMember_27c354f3-7829-4a24-a488-93feaf5a5050" xlink:href="ctlt-20210630.xsd#ctlt_A3125SeniorUSDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_A3125SeniorUSDenominatedNotesMember_27c354f3-7829-4a24-a488-93feaf5a5050" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember_380879a7-227d-4b61-89cb-93e829411f52" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilitiesOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember_380879a7-227d-4b61-89cb-93e829411f52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtIssuanceCostsMember_23bd3399-8a79-440f-acb6-dc14cf24bebe" xlink:href="ctlt-20210630.xsd#ctlt_DebtIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_DebtIssuanceCostsMember_23bd3399-8a79-440f-acb6-dc14cf24bebe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4e1ef5d1-4cba-43c6-888d-e0be280dba3b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4e1ef5d1-4cba-43c6-888d-e0be280dba3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_626880b4-f63f-44ee-8e1b-e20228b3a17d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_626880b4-f63f-44ee-8e1b-e20228b3a17d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_43e23e66-c5f8-4252-92f1-1b881a01f8fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_43e23e66-c5f8-4252-92f1-1b881a01f8fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0a5df28c-7a39-4151-aa54-268823cb2c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0a5df28c-7a39-4151-aa54-268823cb2c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6e89c250-44d4-465b-b15f-a22f9996cf3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6e89c250-44d4-465b-b15f-a22f9996cf3f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails" xlink:type="extended" id="idd075cc428b243c28dacb37bdffcc772_LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f26d4087-fc98-4983-913b-3281a29d5dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f26d4087-fc98-4983-913b-3281a29d5dc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_5a10ae07-81a1-49a7-b7e3-378415136227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_5a10ae07-81a1-49a7-b7e3-378415136227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:to="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f1688022-66b1-4c09-8d3c-680c42e8fa49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f1688022-66b1-4c09-8d3c-680c42e8fa49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d00483bb-6955-4971-9463-430d7106ee76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d00483bb-6955-4971-9463-430d7106ee76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bb4647dd-3af2-4822-ade4-80e8fab6c727_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bb4647dd-3af2-4822-ade4-80e8fab6c727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_bfa31239-e462-4d00-8996-22e0ba36a15d" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanThreeFacilityDollarDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_bfa31239-e462-4d00-8996-22e0ba36a15d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_a25d573f-c906-47a2-b568-7261439bcb2d" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_a25d573f-c906-47a2-b568-7261439bcb2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_cad8c7e2-f274-4188-b483-65c53f83d011" xlink:href="ctlt-20210630.xsd#ctlt_SeniorUnsecuredTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_cad8c7e2-f274-4188-b483-65c53f83d011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6409b6e5-29aa-45c5-9f67-b686ef7b6684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6409b6e5-29aa-45c5-9f67-b686ef7b6684" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_d0396ae5-67ce-43b6-bae6-95a91a59b186" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanTwoFacilityDollarDenominatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_d0396ae5-67ce-43b6-bae6-95a91a59b186" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3556548b-cd9a-4411-b7a4-6509d063e659_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:to="loc_us-gaap_VariableRateDomain_3556548b-cd9a-4411-b7a4-6509d063e659_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:to="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_96bc7f6a-2025-4394-9840-7f3ea314c997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_96bc7f6a-2025-4394-9840-7f3ea314c997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_497352dd-b358-4eec-aaea-9568acd0f68a" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_497352dd-b358-4eec-aaea-9568acd0f68a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6e71a7da-b5da-44eb-b19f-a39ac4153334_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6e71a7da-b5da-44eb-b19f-a39ac4153334_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6658973e-78ca-4913-8eb6-4dc4f26d7b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6658973e-78ca-4913-8eb6-4dc4f26d7b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_904c4cfd-8667-46ce-858d-afbe5f912e6a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:to="loc_srt_RangeMember_904c4cfd-8667-46ce-858d-afbe5f912e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:to="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b94dbd69-ad35-4ff8-9194-e7a8d3bbe876" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:to="loc_srt_MinimumMember_b94dbd69-ad35-4ff8-9194-e7a8d3bbe876" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EarningsPerShareEarningsPerShareAdditionalDetailsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails" xlink:type="extended" id="ic6ee985fd4194e5686391761410c1036_EarningsPerShareEarningsPerShareAdditionalDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a8bf7259-c3fb-4509-a2f9-456be79e02f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a8bf7259-c3fb-4509-a2f9-456be79e02f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_fb0ed3d9-0177-49c4-a450-6a370736f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_fb0ed3d9-0177-49c4-a450-6a370736f8a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7dee68-3302-4fee-8937-c2f83ed387a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d7dee68-3302-4fee-8937-c2f83ed387a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_25e3a016-ffe4-44e8-b39c-29ea5a61a328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:to="loc_us-gaap_StockCompensationPlanMember_25e3a016-ffe4-44e8-b39c-29ea5a61a328" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmployeeStockOptionsandRSUsMember_d36f8060-686f-4e7f-9b77-3ea86f7bacc2" xlink:href="ctlt-20210630.xsd#ctlt_EmployeeStockOptionsandRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:to="loc_ctlt_EmployeeStockOptionsandRSUsMember_d36f8060-686f-4e7f-9b77-3ea86f7bacc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d39181f-707b-4294-97e6-6d43cf57669b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d39181f-707b-4294-97e6-6d43cf57669b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd570423-1562-4aae-a595-98bc12439b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd570423-1562-4aae-a595-98bc12439b27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0625e2c7-9e2e-407f-b8a0-2c0c19f5dd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0625e2c7-9e2e-407f-b8a0-2c0c19f5dd4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ebdeea84-28f3-4800-8085-08b93da57738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_PerformanceSharesMember_ebdeea84-28f3-4800-8085-08b93da57738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9c68e52d-7a60-4109-b871-d9b0ebb8daf2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:to="loc_us-gaap_ClassOfStockDomain_9c68e52d-7a60-4109-b871-d9b0ebb8daf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:to="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_42dbd49c-bba3-4c47-9435-5dbd50a4c24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_42dbd49c-bba3-4c47-9435-5dbd50a4c24a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended" id="id6dd48a4041640f38bf5ac8107f9e36f_DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_90d06254-699b-44fa-abcd-f3a9b27f1110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_90d06254-699b-44fa-abcd-f3a9b27f1110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_32c880ca-634b-485a-9400-981d741cc71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_32c880ca-634b-485a-9400-981d741cc71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_85c9e26c-4cb8-4c27-8222-da8cdb33b858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_85c9e26c-4cb8-4c27-8222-da8cdb33b858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_51d75787-fb04-4a06-9cab-d6b292f487ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_51d75787-fb04-4a06-9cab-d6b292f487ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_5695e35d-da90-4509-8656-d159618dec3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_5695e35d-da90-4509-8656-d159618dec3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_095ab335-ae7b-4e08-825e-6bd06c05f2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_095ab335-ae7b-4e08-825e-6bd06c05f2a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_358cd29c-6a23-4437-ab43-80df65806a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_358cd29c-6a23-4437-ab43-80df65806a2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_87187e0b-3bd2-4f9f-b71f-0fcee13b6579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_87187e0b-3bd2-4f9f-b71f-0fcee13b6579" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1f256bd9-abf7-4444-ab43-44bedc1a1b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeLiabilities_1f256bd9-abf7-4444-ab43-44bedc1a1b2d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_873a99ec-c392-4b92-a5f0-353f3796c30c" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_873a99ec-c392-4b92-a5f0-353f3796c30c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3d17de4b-f6be-4029-8550-9999d7ef551e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_1bda63d2-db21-4577-a69d-43be60ce1350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_35606831-54e3-405a-862d-05bf6fd73017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_35606831-54e3-405a-862d-05bf6fd73017" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalFixedRate_cedc53fc-d400-4958-8d35-b3717442c044" xlink:href="ctlt-20210630.xsd#ctlt_TotalFixedRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_TotalFixedRate_cedc53fc-d400-4958-8d35-b3717442c044" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalDebtUSDenominatedTermLoan_9680eaa3-e143-4a25-96b7-6df6dcff9a6a" xlink:href="ctlt-20210630.xsd#ctlt_TotalDebtUSDenominatedTermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_TotalDebtUSDenominatedTermLoan_9680eaa3-e143-4a25-96b7-6df6dcff9a6a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement_567446db-44e8-4fea-a629-83152212ab09" xlink:href="ctlt-20210630.xsd#ctlt_CashPaidToSettleInterestRateSwapAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement_567446db-44e8-4fea-a629-83152212ab09" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_62446927-7f1e-4bdb-96bb-0450f6336316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_62446927-7f1e-4bdb-96bb-0450f6336316" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:to="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_441e7ac5-b276-40f1-a611-ee270665ca24_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_441e7ac5-b276-40f1-a611-ee270665ca24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDenominatedTermLoanMember_8545e802-7685-4239-a530-efe50a3b2393" xlink:href="ctlt-20210630.xsd#ctlt_USDenominatedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:to="loc_ctlt_USDenominatedTermLoanMember_8545e802-7685-4239-a530-efe50a3b2393" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended" id="i9e2d9b695064423abf98fd69fe7b6669_FairValueMeasuresandDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_9b4438cb-86b8-454e-9806-14a635249e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_MarketableSecurities_9b4438cb-86b8-454e-9806-14a635249e3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_e4335081-2a5a-43e9-af69-ae61431064de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_e4335081-2a5a-43e9-af69-ae61431064de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableFairValueDisclosure_cc1b763c-2889-4e70-8856-4aa47917f7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_PremiumsReceivableFairValueDisclosure_cc1b763c-2889-4e70-8856-4aa47917f7b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_22ca9390-fff9-415c-8d76-522641e3c4ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_22ca9390-fff9-415c-8d76-522641e3c4ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TradingSecuritiesAtFairValue_a4c9ee0f-686e-4520-b8b9-cd390c157070" xlink:href="ctlt-20210630.xsd#ctlt_TradingSecuritiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_ctlt_TradingSecuritiesAtFairValue_a4c9ee0f-686e-4520-b8b9-cd390c157070" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeriesAPreferredStockDerivativeLiability_5647638e-2cce-43a6-93dc-735f7dd3c2c1" xlink:href="ctlt-20210630.xsd#ctlt_SeriesAPreferredStockDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_ctlt_SeriesAPreferredStockDerivativeLiability_5647638e-2cce-43a6-93dc-735f7dd3c2c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_d1a727b1-5565-4143-bac3-07a330364b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_d1a727b1-5565-4143-bac3-07a330364b32" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e0cdf48-70dd-42a1-b3f6-4477378d99a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e0cdf48-70dd-42a1-b3f6-4477378d99a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc8fd80a-d244-423f-8404-72c3d9cfed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc8fd80a-d244-423f-8404-72c3d9cfed54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bb252674-1ffc-479f-a1e7-2b473f78b095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bb252674-1ffc-479f-a1e7-2b473f78b095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b095ead7-a233-460b-9b1c-1c215b92cf6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b095ead7-a233-460b-9b1c-1c215b92cf6c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="ib57e6ca25ca54a998f1374adfe3bba2a_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_407fd266-4036-46b2-9e13-2c7c123b1cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_OperatingLossCarryforwards_407fd266-4036-46b2-9e13-2c7c123b1cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_902d335f-e6b6-474b-b288-8612c2aa7a33" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_902d335f-e6b6-474b-b288-8612c2aa7a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife_da8ba8d9-087d-462b-93c6-1da5339cbf1c" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsIndefiniteLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife_da8ba8d9-087d-462b-93c6-1da5339cbf1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_ab3be139-7f76-4979-80db-68b7005e9ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_ab3be139-7f76-4979-80db-68b7005e9ae2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_33aa2ece-7d1d-4480-b309-4e987377251f" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsCarryForwardPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_33aa2ece-7d1d-4480-b309-4e987377251f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_978739c2-9586-42d7-b281-015d27492189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_978739c2-9586-42d7-b281-015d27492189" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bc420d2a-f491-4ba5-a9ca-f0ff80bad842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bc420d2a-f491-4ba5-a9ca-f0ff80bad842" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a7cbad9d-6088-4c81-acb3-251873082173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a7cbad9d-6088-4c81-acb3-251873082173" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_f2e94539-8c58-482d-b20c-2448a66bb09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_f2e94539-8c58-482d-b20c-2448a66bb09b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b980d137-a4a2-4bd5-8851-3dfc6f487597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_DomesticCountryMember_b980d137-a4a2-4bd5-8851-3dfc6f487597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_44c1184d-9b01-4291-be87-606a58e62e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_44c1184d-9b01-4291-be87-606a58e62e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_32cc4c6b-1ffe-4073-a876-17d95e2a69d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_ForeignCountryMember_32cc4c6b-1ffe-4073-a876-17d95e2a69d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_510e36fb-b09a-443f-b3db-593f475f3e37_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_510e36fb-b09a-443f-b3db-593f475f3e37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b61dad25-e9be-4821-93a0-1e282703a1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_us-gaap_DomesticCountryMember_b61dad25-e9be-4821-93a0-1e282703a1e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossMember_0ebd2ab4-2a70-4113-a4b5-746c182f0d03" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_ctlt_ForeignNetOperatingLossMember_0ebd2ab4-2a70-4113-a4b5-746c182f0d03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossEstablishedMember_bbc53967-470c-4845-9abc-cff15ecdec75" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossEstablishedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_ctlt_ForeignNetOperatingLossEstablishedMember_bbc53967-470c-4845-9abc-cff15ecdec75" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails" xlink:type="extended" id="i9d4310a1f6eb4693a44d2c09c559262b_EmployeeRetirementBenefitPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_0c2146cf-26ac-4567-bc37-31924c928505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_0c2146cf-26ac-4567-bc37-31924c928505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9342648e-95e4-4565-85d3-efdb61863ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9342648e-95e4-4565-85d3-efdb61863ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_358dac3f-d402-4a23-b23a-cdd2bfdf9039" xlink:href="ctlt-20210630.xsd#ctlt_MultiemployerPlansEstimatedAnnualCashContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_358dac3f-d402-4a23-b23a-cdd2bfdf9039" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_607e97e8-c609-4e9e-a0ce-400d238b0fb5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_607e97e8-c609-4e9e-a0ce-400d238b0fb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a16b79-8ada-42fd-9910-f00522c6e58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a16b79-8ada-42fd-9910-f00522c6e58e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:to="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0e943a0a-b8c8-40a1-98b9-d25ef8700191_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0e943a0a-b8c8-40a1-98b9-d25ef8700191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember_897f3810-1f5e-404f-b841-35535f462e1d" xlink:href="ctlt-20210630.xsd#ctlt_EberbachPensionPromissoryNoteOrLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:to="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember_897f3810-1f5e-404f-b841-35535f462e1d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails" xlink:type="extended" id="i1b1ceb7b0d2945d0b22efbc5799f4841_EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_98ac47d2-634f-4928-849b-2160eacaaecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_98ac47d2-634f-4928-849b-2160eacaaecc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6463e84-4882-46f1-a00a-b5e63ac14938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6463e84-4882-46f1-a00a-b5e63ac14938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a0298656-eccf-49ff-863d-8b2fab58ffd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a0298656-eccf-49ff-863d-8b2fab58ffd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_02abe664-4b28-46b5-a1bc-1db4cfc9e057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_02abe664-4b28-46b5-a1bc-1db4cfc9e057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a1337215-594f-460c-9d7b-f3fa8f85994f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a1337215-594f-460c-9d7b-f3fa8f85994f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7fedae51-0fd8-47e0-b62d-0f12c619ece5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7fedae51-0fd8-47e0-b62d-0f12c619ece5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_423f4ede-ff92-4ee1-b213-76242e227bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_423f4ede-ff92-4ee1-b213-76242e227bca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_829b7b9e-1c38-4e3f-bbae-2a15839e05f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_829b7b9e-1c38-4e3f-bbae-2a15839e05f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6c64bc35-d1c3-41c4-b885-8eddae222344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6c64bc35-d1c3-41c4-b885-8eddae222344" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_ec672a59-6c0e-42a3-b7bb-c2f9d0ba9ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSpecialTerminationBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_ec672a59-6c0e-42a3-b7bb-c2f9d0ba9ced" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_64e5372b-133b-4af5-89db-88df8d70a50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_64e5372b-133b-4af5-89db-88df8d70a50e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_13fbb5ac-06d2-4f60-8eb3-8218243d571a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_13fbb5ac-06d2-4f60-8eb3-8218243d571a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d146ede6-5f18-44a0-a506-de17cefd3b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d146ede6-5f18-44a0-a506-de17cefd3b0d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e3bf74f3-96a5-43cd-b9c4-6cc0c4cc3604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e3bf74f3-96a5-43cd-b9c4-6cc0c4cc3604" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8990aad4-a725-4fb5-a407-bf45d14e2d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8990aad4-a725-4fb5-a407-bf45d14e2d3f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7ae2fa2b-79c4-467b-9586-9bc9b4181718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a1ee389-53a8-4491-835a-88b98df708c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a1ee389-53a8-4491-835a-88b98df708c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_878fb6b5-d840-4a2a-840f-895f3e8b8c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_878fb6b5-d840-4a2a-840f-895f3e8b8c6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_124e7919-6ca6-4b44-a5bd-486a51c170cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_124e7919-6ca6-4b44-a5bd-486a51c170cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5d75cd1c-9f8e-4828-b143-67f2dc0968b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5d75cd1c-9f8e-4828-b143-67f2dc0968b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_7de2bbc8-5ec5-4d32-8a7b-06127fc32058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_7de2bbc8-5ec5-4d32-8a7b-06127fc32058" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_4262de01-d0f5-4680-b5e6-d8052a3a6ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSpecialTerminationBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_b647ebe4-61bf-4389-b9d9-75a6ad5bc0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_b647ebe4-61bf-4389-b9d9-75a6ad5bc0d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_72a23b60-0df0-4034-afac-f7469bc7ec94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_72a23b60-0df0-4034-afac-f7469bc7ec94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2a8a5b09-0fa9-4324-b238-c6ccaba1dab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2a8a5b09-0fa9-4324-b238-c6ccaba1dab2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_36112dde-1e59-4b5c-82ad-aee77962db86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_36112dde-1e59-4b5c-82ad-aee77962db86" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e53911f-4d20-4430-ac33-a338c3318cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ba3b3959-4705-4ba7-a78f-0158916dbe78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ba3b3959-4705-4ba7-a78f-0158916dbe78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_36b635df-ab23-448a-92e2-e336e110a354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_02b61b01-8924-4823-812c-061d4907674c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d9f6387c-ddf9-4755-b538-3899910968ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d9f6387c-ddf9-4755-b538-3899910968ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_635e2004-2085-4ef5-b5ad-16c74f725ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_635e2004-2085-4ef5-b5ad-16c74f725ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_78fdc0e1-6d52-4f88-92e7-6eeb962d5377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_78fdc0e1-6d52-4f88-92e7-6eeb962d5377" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="extended" id="i10b82c69189143e3949628c7933ef323_EmployeeRetirementBenefitPlansBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_44119424-5bdb-46c6-b452-53f0ff107068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_44119424-5bdb-46c6-b452-53f0ff107068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0317dc2f-e28d-40ab-ab27-80b93a528d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0317dc2f-e28d-40ab-ab27-80b93a528d44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eca02553-b1d9-4cab-acf5-e397581ce196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eca02553-b1d9-4cab-acf5-e397581ce196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_28a1a928-3117-46f5-9391-d7f885ad862d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_28a1a928-3117-46f5-9391-d7f885ad862d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_6db2d0e0-413b-4ccb-b0e5-79c7e1ed8385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_6db2d0e0-413b-4ccb-b0e5-79c7e1ed8385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_cb5e3d73-31ea-4dae-82e8-410a81c750c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_cb5e3d73-31ea-4dae-82e8-410a81c750c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_1ca85d8a-7c4b-4e38-8d4b-9834d4758884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_1ca85d8a-7c4b-4e38-8d4b-9834d4758884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30268d46-75c6-4007-9084-80a9406f18f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30268d46-75c6-4007-9084-80a9406f18f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_aa21d46b-39e4-4ce1-b919-a0fb16d417ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_aa21d46b-39e4-4ce1-b919-a0fb16d417ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_49a6c9c4-da6a-4f09-aa05-e012b740b6d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_49a6c9c4-da6a-4f09-aa05-e012b740b6d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5f26b70c-bd63-448a-930c-4cf11d434e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5f26b70c-bd63-448a-930c-4cf11d434e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_62e5873e-f396-4a71-ac7c-fd83580c14d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_62e5873e-f396-4a71-ac7c-fd83580c14d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_82ac5f3a-6656-46de-9a3b-14f9af98f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_82ac5f3a-6656-46de-9a3b-14f9af98f9f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_016547be-12ba-493a-b391-5aba07db74cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_016547be-12ba-493a-b391-5aba07db74cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_97c03a70-ffd4-49c6-9af5-784bdeb6a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_97c03a70-ffd4-49c6-9af5-784bdeb6a8d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7a81d11-8eb4-41e1-8b12-9d4e5eff2077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7a81d11-8eb4-41e1-8b12-9d4e5eff2077" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3ae1e939-4cca-48f5-99fd-ec8ef8c46af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3ae1e939-4cca-48f5-99fd-ec8ef8c46af4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a531bbb-a774-4d59-b07c-f5893d2d02dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a531bbb-a774-4d59-b07c-f5893d2d02dc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c271e981-23e7-4ac8-aaba-a90b34bd4367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c271e981-23e7-4ac8-aaba-a90b34bd4367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c92b26c-b4e8-42b5-b00f-7861d971da4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c92b26c-b4e8-42b5-b00f-7861d971da4f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAOCIDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="extended" id="i2c72892c7a0e48fc8e57170067a28737_EmployeeRetirementBenefitPlansAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_cf2b2e16-3056-4867-922e-ef9c207cd6a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_cf2b2e16-3056-4867-922e-ef9c207cd6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_db4a87d1-b57b-4609-be27-844af1298fe8" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_db4a87d1-b57b-4609-be27-844af1298fe8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_0d8a01b1-f680-475b-968b-100f9c98e04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_0d8a01b1-f680-475b-968b-100f9c98e04a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_13690c50-b484-4c7e-8adf-987da8dd47ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_13690c50-b484-4c7e-8adf-987da8dd47ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_ffab20e7-7bdd-4c04-995b-b0fb038024ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_ffab20e7-7bdd-4c04-995b-b0fb038024ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_7fac3f41-36a8-4932-b03f-edc146e9e486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_7fac3f41-36a8-4932-b03f-edc146e9e486" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7ad005ca-5bad-46ec-a82a-e554ac2f32f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7ad005ca-5bad-46ec-a82a-e554ac2f32f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_b7d65418-e52b-40e6-bbc4-6213f036879a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_b7d65418-e52b-40e6-bbc4-6213f036879a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_40a1336a-9f64-4034-ac4f-a73298b0c8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_40a1336a-9f64-4034-ac4f-a73298b0c8f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_f54198f9-4cd2-4559-9e2a-faa7f6296a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_f54198f9-4cd2-4559-9e2a-faa7f6296a73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b7c40657-3cfb-4ab4-a2bd-999eb0eb2cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b7c40657-3cfb-4ab4-a2bd-999eb0eb2cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_74d54cf7-53df-45c8-93a1-db3b0dbacb97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_74d54cf7-53df-45c8-93a1-db3b0dbacb97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_569dc1c4-ffb1-4299-8b21-30b58d97176c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_569dc1c4-ffb1-4299-8b21-30b58d97176c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_49829d0c-811b-4132-ae33-2d78ef383dab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_49829d0c-811b-4132-ae33-2d78ef383dab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3f9163f6-32c9-4a46-862a-2b2412b340cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3f9163f6-32c9-4a46-862a-2b2412b340cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_94b14e87-59aa-4be4-81d8-c3b08987a536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_94b14e87-59aa-4be4-81d8-c3b08987a536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c03cf396-f083-43bb-a435-4fb435dd5002_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c03cf396-f083-43bb-a435-4fb435dd5002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a37aa3c0-930a-4a65-b616-9c12cab70688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a37aa3c0-930a-4a65-b616-9c12cab70688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5f8719af-dc1c-4d5d-87ec-0a79848ab735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5f8719af-dc1c-4d5d-87ec-0a79848ab735" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails" xlink:type="extended" id="i1b6de939aa244c19a87f0db9edecb449_EmployeeRetirementBenefitPlansFiscalYearMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_cff17bcd-eff2-4608-95c1-82d9775f8482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_cff17bcd-eff2-4608-95c1-82d9775f8482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2bd5ceb4-f94e-4f55-a757-736aca8e3c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2bd5ceb4-f94e-4f55-a757-736aca8e3c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad25d7f0-826f-4654-a4fb-d2020ca2185f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad25d7f0-826f-4654-a4fb-d2020ca2185f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_adaa9df4-1c1e-4489-a5d5-55038cb0a7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_adaa9df4-1c1e-4489-a5d5-55038cb0a7bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_86ec89e4-9c4e-461f-bd72-5302fb4fb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_86ec89e4-9c4e-461f-bd72-5302fb4fb50a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_b0032776-ee10-41f7-ac7c-a4aa4429307d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_b0032776-ee10-41f7-ac7c-a4aa4429307d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_cdc5add6-0293-4ac0-b03a-88d37ca79a88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_cdc5add6-0293-4ac0-b03a-88d37ca79a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_80e4598e-8639-430d-b3a4-4c53c9c6170c" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_80e4598e-8639-430d-b3a4-4c53c9c6170c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_22ef1262-f227-4c35-8f90-d361d8a79ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_22ef1262-f227-4c35-8f90-d361d8a79ac0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d73d6baf-885e-46e1-ba5e-ab1c9448268d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d73d6baf-885e-46e1-ba5e-ab1c9448268d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93aadc24-959f-4c0e-b65a-0359aab99661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93aadc24-959f-4c0e-b65a-0359aab99661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d1a69bee-59b9-4ff4-b313-4b3001cda22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d1a69bee-59b9-4ff4-b313-4b3001cda22b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7c2e9a09-1f82-445d-857a-251660c52157_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7c2e9a09-1f82-445d-857a-251660c52157_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_57561cf1-4683-4447-a56b-dc3db3ab53f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_EquitySecuritiesMember_57561cf1-4683-4447-a56b-dc3db3ab53f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_394cf86f-4ea3-4076-a595-07a027897c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_394cf86f-4ea3-4076-a595-07a027897c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_05e83bc6-c5ea-4204-998d-ee784b689c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_05e83bc6-c5ea-4204-998d-ee784b689c7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_56b9995f-2fa8-4a9e-b21f-efd189af0492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_RealEstateMember_56b9995f-2fa8-4a9e-b21f-efd189af0492" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_d80936e6-fc4f-478f-bd9c-0b31e0eef236" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_ctlt_InsuranceContractsMember_d80936e6-fc4f-478f-bd9c-0b31e0eef236" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_cb89938a-3d5f-453c-bfcb-05c822870a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_OtherAssetsMember_cb89938a-3d5f-453c-bfcb-05c822870a6f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansFairValueDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails" xlink:type="extended" id="ie71490f24530445fa00b361ca3da9614_EmployeeRetirementBenefitPlansFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4914dbd8-99ec-4d72-94e1-b930e6d0b39e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4914dbd8-99ec-4d72-94e1-b930e6d0b39e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_b5c128ba-b28a-4757-aa22-8e6e1f0ba051_default" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:to="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_b5c128ba-b28a-4757-aa22-8e6e1f0ba051_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:to="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_b4d15c5b-cf99-4f62-b887-473d38785bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:to="loc_us-gaap_HedgeFundsMember_b4d15c5b-cf99-4f62-b887-473d38785bd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_57d8b727-c4c3-47cd-9155-0eb6cc966ae7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_57d8b727-c4c3-47cd-9155-0eb6cc966ae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_017ef5e5-afa4-4d39-a140-451471a30b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_EquitySecuritiesMember_017ef5e5-afa4-4d39-a140-451471a30b61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6d0b7cb7-30b3-4548-b27d-18c6097501c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_DebtSecuritiesMember_6d0b7cb7-30b3-4548-b27d-18c6097501c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_ae83c9a4-bdc0-404a-89f9-4fa3ea08d846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_RealEstateMember_ae83c9a4-bdc0-404a-89f9-4fa3ea08d846" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_17e5fd0a-54b4-4d46-badd-4e5f30760eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_OtherAssetsMember_17e5fd0a-54b4-4d46-badd-4e5f30760eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_431d522c-725b-488e-8246-d2b389375720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_HedgeFundsMember_431d522c-725b-488e-8246-d2b389375720" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9371d007-033d-4f77-be60-08a4a8a75c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9371d007-033d-4f77-be60-08a4a8a75c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2d0ad42a-954e-4c28-8442-8c1d22aa24d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2d0ad42a-954e-4c28-8442-8c1d22aa24d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e368f3c4-d06c-43c7-8c16-ff711bc93986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e368f3c4-d06c-43c7-8c16-ff711bc93986" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_e26b0ae0-7e59-4122-b8f3-c3d01c8d161c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_e26b0ae0-7e59-4122-b8f3-c3d01c8d161c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansLevel3Details"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details" xlink:type="extended" id="i632b4979eaae43e99cb45fb1d380436a_EmployeeRetirementBenefitPlansLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_fbfb8821-e100-4cb1-8dd5-fe6b1c2caf45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_fbfb8821-e100-4cb1-8dd5-fe6b1c2caf45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_324f4377-ecae-4580-baf6-dd68c6be52c7" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_324f4377-ecae-4580-baf6-dd68c6be52c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c0da381b-daba-4e96-ad4e-e88057e5acb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c0da381b-daba-4e96-ad4e-e88057e5acb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_a4ab3f23-5002-4cd7-9187-8b93e4417bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_a4ab3f23-5002-4cd7-9187-8b93e4417bb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9d6c029-0a3c-48fd-90c4-2e0211ae51a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9d6c029-0a3c-48fd-90c4-2e0211ae51a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b7e3f403-9029-4c4d-872b-9fac95312762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10fec4db-2abc-4ad7-b8aa-319f90346ec9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10fec4db-2abc-4ad7-b8aa-319f90346ec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_58ee9e36-549a-45cd-8304-6404c6a87a98" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:to="loc_ctlt_InsuranceContractsMember_58ee9e36-549a-45cd-8304-6404c6a87a98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherUnobservableAssetsMember_9c320499-36f5-4662-be55-07a18f57b959" xlink:href="ctlt-20210630.xsd#ctlt_OtherUnobservableAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:to="loc_ctlt_OtherUnobservableAssetsMember_9c320499-36f5-4662-be55-07a18f57b959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3be2c12a-77cc-4c63-a0b7-123f4570415f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3be2c12a-77cc-4c63-a0b7-123f4570415f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bd6e9a10-5c16-4154-9682-867be258da89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bd6e9a10-5c16-4154-9682-867be258da89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_7cb21e1b-e1c2-4bc3-a36d-5ab7755a6637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cb21e1b-e1c2-4bc3-a36d-5ab7755a6637_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_681090d0-4dc8-4c68-b1ab-b8f53f334015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_bbe74416-4053-4330-8db8-32bfffafefbc" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherUnobservableAssetsMember_a09e2c03-2fc7-4553-80e0-5a17ce16cea3" xlink:href="ctlt-20210630.xsd#ctlt_OtherUnobservableAssetsMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails" xlink:type="extended" id="ic7ed54361e8c4f49a21dd7426e509265_EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_1756dc5a-605c-43f9-8439-ba373198bac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_1756dc5a-605c-43f9-8439-ba373198bac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_e272b3b6-f9db-4a32-8335-32de7c13f43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_e272b3b6-f9db-4a32-8335-32de7c13f43e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_23158f52-271b-4f85-b7ed-a5b2f7f5d151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_23158f52-271b-4f85-b7ed-a5b2f7f5d151" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_d18ce6c5-a4c6-4d66-81dd-8cfd2c2ab449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_d18ce6c5-a4c6-4d66-81dd-8cfd2c2ab449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_f45fbbad-d865-4e6a-94ab-8dc226d4cd3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_f45fbbad-d865-4e6a-94ab-8dc226d4cd3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_2fbba757-ecba-4076-807b-7f78113e7681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_2fbba757-ecba-4076-807b-7f78113e7681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_b5551587-9324-432f-9316-09c7ccc51fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_b5551587-9324-432f-9316-09c7ccc51fc3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d6749d74-1549-4a08-9419-55ec31850073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d6749d74-1549-4a08-9419-55ec31850073" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e22897e6-f5fa-41db-86c3-2e35d5384701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e22897e6-f5fa-41db-86c3-2e35d5384701" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2a50f2fd-e13a-41ef-8491-f782566fbe46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2a50f2fd-e13a-41ef-8491-f782566fbe46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:to="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_e725cbbb-dc00-4223-9165-253ae7190020_default" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:to="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_e725cbbb-dc00-4223-9165-253ae7190020_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:to="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Post65Member_0f767a4a-784e-4211-a938-e5d523a48d9f" xlink:href="ctlt-20210630.xsd#ctlt_Post65Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:to="loc_ctlt_Post65Member_0f767a4a-784e-4211-a938-e5d523a48d9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_78ac9154-adc6-48e9-86c9-45bbf737fd30_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_78ac9154-adc6-48e9-86c9-45bbf737fd30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d2a2571-30b3-4b8f-8417-a44915847692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d2a2571-30b3-4b8f-8417-a44915847692" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails" xlink:type="extended" id="i350527780fc3482e89656c7866521668_EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f69d41fa-721c-4847-91d2-1dfc61a61a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f69d41fa-721c-4847-91d2-1dfc61a61a9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16fb5ea-2cc0-4157-9253-d8c690335e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16fb5ea-2cc0-4157-9253-d8c690335e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2f5aef3c-c71e-4fc5-a580-6cc84202c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2f5aef3c-c71e-4fc5-a580-6cc84202c9e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValue_e439afed-c347-4327-87a6-9ca69071b648" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_PreferredStockIssuanceValue_e439afed-c347-4327-87a6-9ca69071b648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9a5daac7-6284-4544-8241-52bb82281697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockValue_9a5daac7-6284-4544-8241-52bb82281697" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValueNet_862226ca-e3a8-472c-886f-0e1a6c31ba55" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_PreferredStockIssuanceValueNet_862226ca-e3a8-472c-886f-0e1a6c31ba55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_607aa8f5-1569-4fd1-afd8-45db81e7d400" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_607aa8f5-1569-4fd1-afd8-45db81e7d400" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_3c1d13cc-02ad-4fc6-b7df-4d3df3ca5f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_3c1d13cc-02ad-4fc6-b7df-4d3df3ca5f3d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_e3b67b78-4c21-4d3b-b5a1-e9b2aa967fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_DividendsPreferredStockStock_e3b67b78-4c21-4d3b-b5a1-e9b2aa967fad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_ccd3c30e-f89e-4b44-b3b6-e66540b3c0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_ccd3c30e-f89e-4b44-b3b6-e66540b3c0cf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e202c3b8-6127-48a9-a832-d8dd9df66431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e202c3b8-6127-48a9-a832-d8dd9df66431" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_a54b145b-8de6-4557-a0e0-5fd2790a0e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_a54b145b-8de6-4557-a0e0-5fd2790a0e0a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3442ac59-a090-4105-abdb-fec0b912fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3442ac59-a090-4105-abdb-fec0b912fb3f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_e6d974c3-b485-4441-831e-ce701522841c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_e6d974c3-b485-4441-831e-ce701522841c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:to="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DesignatedSharesMember_2a86cf78-94ee-423c-ab82-8b7e56e309cc" xlink:href="ctlt-20210630.xsd#ctlt_DesignatedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:to="loc_ctlt_DesignatedSharesMember_2a86cf78-94ee-423c-ab82-8b7e56e309cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee400f98-a86a-4c78-9a66-6dda7257cedd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:to="loc_us-gaap_EquityComponentDomain_ee400f98-a86a-4c78-9a66-6dda7257cedd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:to="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_688733ac-4dd4-4f8f-8926-45f13c137dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_688733ac-4dd4-4f8f-8926-45f13c137dc0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails" xlink:type="extended" id="i2d3074a17908440eb640453bd1f82fa0_EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ac31b6d6-0697-4a95-9953-cee9340850f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ac31b6d6-0697-4a95-9953-cee9340850f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ccff3b2f-0d9c-43f6-a414-84ff80ba77e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ccff3b2f-0d9c-43f6-a414-84ff80ba77e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba9c169c-efff-4679-b483-172768d4a415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba9c169c-efff-4679-b483-172768d4a415" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76a6754a-a76b-48ed-a1f7-e73f9638950a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76a6754a-a76b-48ed-a1f7-e73f9638950a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4f681b35-b555-4214-82a1-4581a10ae54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4f681b35-b555-4214-82a1-4581a10ae54b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2cddc10f-d8b5-447d-951c-431ddbd3ff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2cddc10f-d8b5-447d-951c-431ddbd3ff5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3a11ba15-c7cc-4286-8951-30509079a910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3a11ba15-c7cc-4286-8951-30509079a910" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e4693a40-4287-421d-b9b3-dc449fdd98ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e4693a40-4287-421d-b9b3-dc449fdd98ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e404bb06-5664-4e85-aa41-66755aa6eb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e404bb06-5664-4e85-aa41-66755aa6eb4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6195bfad-b4a3-4e7e-aaba-319461b127c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:to="loc_us-gaap_EquityComponentDomain_6195bfad-b4a3-4e7e-aaba-319461b127c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:to="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_824234a7-d9bb-4d05-9ff8-06a6f8262a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_824234a7-d9bb-4d05-9ff8-06a6f8262a67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_461a8b4a-31d3-4767-99a8-e8d9f60ac6e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_461a8b4a-31d3-4767-99a8-e8d9f60ac6e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccumulatedDeferredCompensationMember_ccfd3f0a-591a-4ece-a482-a275c73b5dfb" xlink:href="ctlt-20210630.xsd#ctlt_AccumulatedDeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_ctlt_AccumulatedDeferredCompensationMember_ccfd3f0a-591a-4ece-a482-a275c73b5dfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_51816e97-a0e4-47ed-b8af-fb4c1a7d7306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_51816e97-a0e4-47ed-b8af-fb4c1a7d7306" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_81d3c0ff-138b-4e8e-8c56-1d2a52a4580e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_81d3c0ff-138b-4e8e-8c56-1d2a52a4580e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_b0c626f0-9873-4a50-8398-f4cbee8926b5" xlink:href="ctlt-20210630.xsd#ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_b0c626f0-9873-4a50-8398-f4cbee8926b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_120772c9-3a9a-47df-a0cc-2a9faa48ea2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_120772c9-3a9a-47df-a0cc-2a9faa48ea2f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityDetails" xlink:type="extended" id="i518f6b80df6848f2adcba0ba2fd0c541_EquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:href="ctlt-20210630.xsd#ctlt_RedeemablePreferredStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_78fd2ef6-5bc4-4710-a56f-f2ad8a130403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_78fd2ef6-5bc4-4710-a56f-f2ad8a130403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aeabcda8-96d0-4018-842e-bc6eef1df733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aeabcda8-96d0-4018-842e-bc6eef1df733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_04795453-54ae-4501-98e6-ecc351190c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_04795453-54ae-4501-98e6-ecc351190c9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValue_a097c380-4356-4036-b276-ed7e92926a12" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_PreferredStockIssuanceValue_a097c380-4356-4036-b276-ed7e92926a12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b7419db1-3d91-4464-8b9a-5c0316165351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockValue_b7419db1-3d91-4464-8b9a-5c0316165351" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_428f60c3-500a-4d91-a369-c7d3eafe5d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_428f60c3-500a-4d91-a369-c7d3eafe5d65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_05400bf6-f1c7-4408-9918-86d867742e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_05400bf6-f1c7-4408-9918-86d867742e64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValueNet_b96cf0c8-2067-498b-b773-cd28a2cb209a" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_PreferredStockIssuanceValueNet_b96cf0c8-2067-498b-b773-cd28a2cb209a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ecef3217-02bf-42b7-af64-c9372eea4e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_506998b7-2e61-41d3-9348-e3b44f744a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_506998b7-2e61-41d3-9348-e3b44f744a86" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_a1473d10-4797-4750-a52d-135b922948cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_466650db-10a4-49eb-b4b6-11ce24962fc0" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_466650db-10a4-49eb-b4b6-11ce24962fc0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_33dd3f46-0c85-4773-9fef-424ad5564c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_33dd3f46-0c85-4773-9fef-424ad5564c62" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfRedeemablePreferredStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:to="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_6a30ca46-2bbe-4966-81f1-b61e613c362a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_6a30ca46-2bbe-4966-81f1-b61e613c362a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DesignatedSharesMember_68d8307c-db61-40ab-a270-c19e29602327" xlink:href="ctlt-20210630.xsd#ctlt_DesignatedSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:to="loc_ctlt_DesignatedSharesMember_68d8307c-db61-40ab-a270-c19e29602327" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationAdditionalDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationAdditionalDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityBasedCompensationAdditionalDetails" xlink:type="extended" id="i25cc32cf27be495ab27076867befa66d_EquityBasedCompensationAdditionalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_157e40e9-76f6-4c25-889e-896c4a51de04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_157e40e9-76f6-4c25-889e-896c4a51de04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_c8d3aa53-a6c5-4872-95f2-ba6793e47def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_c8d3aa53-a6c5-4872-95f2-ba6793e47def" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_534917de-668c-4379-86a5-e0b9c8bf5596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_534917de-668c-4379-86a5-e0b9c8bf5596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_e3a44db2-0621-4ca3-b6d8-2e022574fe3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_e3a44db2-0621-4ca3-b6d8-2e022574fe3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0d5518f0-70b8-4fe1-80c6-f72e58733472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0d5518f0-70b8-4fe1-80c6-f72e58733472" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_727cd62e-078e-46d6-a6cc-d799871ccaba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_727cd62e-078e-46d6-a6cc-d799871ccaba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_9267b919-a94f-4ef8-8015-f4a15df2a532" xlink:href="ctlt-20210630.xsd#ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_9267b919-a94f-4ef8-8015-f4a15df2a532" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fc7d9c59-af63-49f1-a625-eacfa2ac04f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fc7d9c59-af63-49f1-a625-eacfa2ac04f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockOptionGrantedContractualTerm_c7911c7b-2488-4160-803c-31a1197c8c02" xlink:href="ctlt-20210630.xsd#ctlt_StockOptionGrantedContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_StockOptionGrantedContractualTerm_c7911c7b-2488-4160-803c-31a1197c8c02" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_53030ef0-a994-4a2f-8c29-6f66bababa7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_53030ef0-a994-4a2f-8c29-6f66bababa7d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6d05ce0e-3955-4a55-990d-f4e5c3f63fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6d05ce0e-3955-4a55-990d-f4e5c3f63fde" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220c18c5-0fbb-46c7-83ea-b32e088fe188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220c18c5-0fbb-46c7-83ea-b32e088fe188" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_68c8e32a-132f-4f23-b2da-70b7b8494888" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_68c8e32a-132f-4f23-b2da-70b7b8494888" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_84e88858-e967-4c3a-8912-189d8860aa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_84e88858-e967-4c3a-8912-189d8860aa41" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_924bb881-61ec-4d61-8a9d-6bcf534858bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_924bb881-61ec-4d61-8a9d-6bcf534858bd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:to="loc_us-gaap_TypeOfAdoptionMember_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3a79cd54-3a8f-408f-9f86-91f7fb71e22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3a79cd54-3a8f-408f-9f86-91f7fb71e22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ed2e5e7-4c5f-4427-9448-41ee24dcac72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:to="loc_us-gaap_PlanNameDomain_5ed2e5e7-4c5f-4427-9448-41ee24dcac72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:to="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockCompensationPlanOmnibusMember_37c81daf-5234-4d9b-8553-0e7bed933309" xlink:href="ctlt-20210630.xsd#ctlt_StockCompensationPlanOmnibusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:to="loc_ctlt_StockCompensationPlanOmnibusMember_37c81daf-5234-4d9b-8553-0e7bed933309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_3192a511-3189-4816-8f02-ff75c01e5191_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:to="loc_us-gaap_AwardDateDomain_3192a511-3189-4816-8f02-ff75c01e5191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_573a72cc-4578-4c54-9cbc-c6e2b8b3be03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:to="loc_us-gaap_AwardDateDomain_573a72cc-4578-4c54-9cbc-c6e2b8b3be03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1e9c057-4a01-428a-8363-23d14badc2c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d1e9c057-4a01-428a-8363-23d14badc2c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_30868b33-79e8-46b3-ad72-26f7c6ba42e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_30868b33-79e8-46b3-ad72-26f7c6ba42e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9485254d-8ca0-460c-aac7-2f744595af40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9485254d-8ca0-460c-aac7-2f744595af40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_94dd8d50-e6c1-4372-ac6f-5e2b9ca78087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_PerformanceSharesMember_94dd8d50-e6c1-4372-ac6f-5e2b9ca78087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_40a3e642-775b-4ac1-869a-2c49440cd4e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:to="loc_us-gaap_ClassOfStockDomain_40a3e642-775b-4ac1-869a-2c49440cd4e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe103111-541b-493f-b7f8-bd0e588c1a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:to="loc_us-gaap_ClassOfStockDomain_fe103111-541b-493f-b7f8-bd0e588c1a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3060130c-503f-4d82-b568-4d02e5eb8560_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:to="loc_srt_RangeMember_3060130c-503f-4d82-b568-4d02e5eb8560_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:to="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66d8509a-9c82-4679-90ac-5d6da0a88b4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:to="loc_srt_MinimumMember_66d8509a-9c82-4679-90ac-5d6da0a88b4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf4dba16-9db5-4da1-9ed8-f9874830e273" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:to="loc_srt_MaximumMember_cf4dba16-9db5-4da1-9ed8-f9874830e273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_c0f5c5a0-963a-479c-9c33-aa279e03f894_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:to="loc_us-gaap_VestingDomain_c0f5c5a0-963a-479c-9c33-aa279e03f894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_934fcf01-9623-4654-a6d4-ea1db8f2ec08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:to="loc_us-gaap_VestingDomain_934fcf01-9623-4654-a6d4-ea1db8f2ec08" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationOptionActivityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityBasedCompensationOptionActivityDetails" xlink:type="extended" id="i69064b983b94422d822f7813f56e6d5c_EquityBasedCompensationOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_ef34bd46-2dcf-4a58-a998-9a1c501c4ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_ef34bd46-2dcf-4a58-a998-9a1c501c4ead" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4607e0c4-bba2-482a-8cdc-8e8b128bdcc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4607e0c4-bba2-482a-8cdc-8e8b128bdcc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_33734f4f-6de8-4326-8dc0-867d1700ae73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_33734f4f-6de8-4326-8dc0-867d1700ae73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_84d13f08-4b8c-4c3f-8779-fa1c2aa629b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_84d13f08-4b8c-4c3f-8779-fa1c2aa629b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ef40bc28-b328-4b08-a93a-1962c86095a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ef40bc28-b328-4b08-a93a-1962c86095a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7280cef6-d8a3-4639-a523-10b5f5c67bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7280cef6-d8a3-4639-a523-10b5f5c67bc7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_77489914-68bc-4839-9b17-7af161a4d550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_77489914-68bc-4839-9b17-7af161a4d550" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4fb6e978-3a72-46d9-80a8-ae70ee39b1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4fb6e978-3a72-46d9-80a8-ae70ee39b1c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_07850019-b99b-4787-805b-ca6181c80753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_07850019-b99b-4787-805b-ca6181c80753" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4005ba8e-34a1-4b0c-bb98-d76fb2345efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4005ba8e-34a1-4b0c-bb98-d76fb2345efd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b29d5348-fddb-4335-8edb-cae4c4270ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b29d5348-fddb-4335-8edb-cae4c4270ab0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0b809269-df9f-49ed-ba2e-2d99c850abe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0b809269-df9f-49ed-ba2e-2d99c850abe3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d51e8a4-30d5-43d4-8913-e4f401e38fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d51e8a4-30d5-43d4-8913-e4f401e38fc4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_033f2426-483d-4068-a492-ee2336c6e318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_033f2426-483d-4068-a492-ee2336c6e318" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_627b3a3d-2385-4b98-a9ba-33f14bf5e43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_627b3a3d-2385-4b98-a9ba-33f14bf5e43f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_019e7f42-d146-4a4c-b3a8-59d04c8f05ef" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_019e7f42-d146-4a4c-b3a8-59d04c8f05ef" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_79ef5c4b-1e2f-45d6-9344-36b0ae2db566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_79ef5c4b-1e2f-45d6-9344-36b0ae2db566" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_14e76f13-d999-47f4-aff5-508755c7e5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_14e76f13-d999-47f4-aff5-508755c7e5cc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dda8dbbb-c2ee-4b9c-a465-4013158358a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dda8dbbb-c2ee-4b9c-a465-4013158358a3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b0586ae7-639b-46f2-8813-430b8a055970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b0586ae7-639b-46f2-8813-430b8a055970" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_f0550dba-5004-45bc-97d4-0e5c617ab559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_f0550dba-5004-45bc-97d4-0e5c617ab559" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_470f54e0-c854-4b3d-8918-23c09adde20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_470f54e0-c854-4b3d-8918-23c09adde20a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_29311961-66e4-445b-b293-dc1a679b0926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_29311961-66e4-445b-b293-dc1a679b0926" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e44d846f-6e20-42d1-a098-173327a1d470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e44d846f-6e20-42d1-a098-173327a1d470" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3eff0a83-77d3-4554-8e7f-e2137ae2107b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3eff0a83-77d3-4554-8e7f-e2137ae2107b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:to="loc_us-gaap_PlanNameDomain_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_76ff03e4-7f39-47bc-9e18-f81533a141fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:to="loc_us-gaap_PlanNameDomain_76ff03e4-7f39-47bc-9e18-f81533a141fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:to="loc_us-gaap_AwardDateDomain_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_037c4600-a969-43e3-b83d-b8d9c2992db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:to="loc_us-gaap_AwardDateDomain_037c4600-a969-43e3-b83d-b8d9c2992db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8fa3f2d-4b00-40ee-8463-f3db3d7898db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b8fa3f2d-4b00-40ee-8463-f3db3d7898db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0847ad12-a514-49cb-a551-6ff5289d110d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0847ad12-a514-49cb-a551-6ff5289d110d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeMember_5a06581d-d4bd-40ed-b040-c7cacad3d9af" xlink:href="ctlt-20210630.xsd#ctlt_TimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_TimeMember_5a06581d-d4bd-40ed-b040-c7cacad3d9af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PerformanceMember_dfc838b8-5636-4375-b73e-c6305c86e603" xlink:href="ctlt-20210630.xsd#ctlt_PerformanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_PerformanceMember_dfc838b8-5636-4375-b73e-c6305c86e603" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MarketMember_17505994-67d9-46a6-b14f-3bd48ed4692b" xlink:href="ctlt-20210630.xsd#ctlt_MarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_MarketMember_17505994-67d9-46a6-b14f-3bd48ed4692b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_b00fb991-d11c-447e-b1de-1dd467c8d04c" xlink:href="ctlt-20210630.xsd#ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_b00fb991-d11c-447e-b1de-1dd467c8d04c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:to="loc_us-gaap_ClassOfStockDomain_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9a276c29-98cc-48bf-9fa5-6bc18387e1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:to="loc_us-gaap_ClassOfStockDomain_9a276c29-98cc-48bf-9fa5-6bc18387e1e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2853b0de-be06-41da-82ce-a4f61bb96394_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:to="loc_srt_RangeMember_2853b0de-be06-41da-82ce-a4f61bb96394_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c816960-0780-4ccc-9337-0ed6d256e546" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:to="loc_srt_RangeMember_2c816960-0780-4ccc-9337-0ed6d256e546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_e319d33b-037c-48dc-b6ee-2d5cc4460677_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:to="loc_us-gaap_VestingDomain_e319d33b-037c-48dc-b6ee-2d5cc4460677_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_8273d1fd-9364-46ee-b29d-dc84c7dc3806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:to="loc_us-gaap_VestingDomain_8273d1fd-9364-46ee-b29d-dc84c7dc3806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_807b2d6b-28ce-4e9f-a921-3bc59223a63c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_807b2d6b-28ce-4e9f-a921-3bc59223a63c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_381442a3-a0ad-4da1-9191-57a191b46845" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:to="loc_ctlt_ParagonMember_381442a3-a0ad-4da1-9191-57a191b46845" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationRSUActivityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/EquityBasedCompensationRSUActivityDetails" xlink:type="extended" id="ia0f8c9f6129b48ec9bb127ffafbab1f3_EquityBasedCompensationRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8befc985-4394-4708-9c02-0aefdc9eccad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8befc985-4394-4708-9c02-0aefdc9eccad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_56bb39bf-08f7-497e-8a2a-2c7925621613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_56bb39bf-08f7-497e-8a2a-2c7925621613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c05e64e8-3170-492c-91cf-ee188e99db00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c05e64e8-3170-492c-91cf-ee188e99db00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_7180151f-b66f-447e-891d-53164a0a467a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_7180151f-b66f-447e-891d-53164a0a467a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12efa499-f610-4cac-bb7e-eb1e543b3a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12efa499-f610-4cac-bb7e-eb1e543b3a60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_918d3404-4bc3-4570-aa43-70cca6efe178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_918d3404-4bc3-4570-aa43-70cca6efe178" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8ee1924c-41dc-40d2-a123-ee7e63993af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8ee1924c-41dc-40d2-a123-ee7e63993af2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5a2bb52b-eace-442f-a672-1cd168b336f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5a2bb52b-eace-442f-a672-1cd168b336f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2f1cb290-a2a6-4693-9626-36c5505f6cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2f1cb290-a2a6-4693-9626-36c5505f6cf1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56bfca32-3f0d-4d3c-8bc6-9adb88e126f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56bfca32-3f0d-4d3c-8bc6-9adb88e126f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_8bcac33a-dfac-49f5-a6cc-e65c71084e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_8bcac33a-dfac-49f5-a6cc-e65c71084e0c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_901590a0-bbe5-4de1-9e5a-56fb8abc14b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_901590a0-bbe5-4de1-9e5a-56fb8abc14b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_c61ee03f-02d8-4b71-a04e-e2d91008b094" xlink:href="ctlt-20210630.xsd#ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_c61ee03f-02d8-4b71-a04e-e2d91008b094" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c2cfb550-eb46-4923-8667-ec295d944b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c2cfb550-eb46-4923-8667-ec295d944b61" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:to="loc_us-gaap_PlanNameDomain_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f9d78240-a18b-455e-ad0b-16ff5d2748af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:to="loc_us-gaap_PlanNameDomain_f9d78240-a18b-455e-ad0b-16ff5d2748af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:to="loc_us-gaap_AwardDateDomain_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_d8abcc4a-4e67-4c51-bceb-4da4bfab5ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:to="loc_us-gaap_AwardDateDomain_d8abcc4a-4e67-4c51-bceb-4da4bfab5ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc4d401d-2557-4cf2-8805-feab1902386e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc4d401d-2557-4cf2-8805-feab1902386e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeBasedRestrictedStockUnitsMember_f85717ad-0bd8-4ac4-8e85-d812718140ef" xlink:href="ctlt-20210630.xsd#ctlt_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_ctlt_TimeBasedRestrictedStockUnitsMember_f85717ad-0bd8-4ac4-8e85-d812718140ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_78c7d5d4-d947-4b97-828d-b64065c8f4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_us-gaap_PerformanceSharesMember_78c7d5d4-d947-4b97-828d-b64065c8f4a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RTSRPerformanceShareUnitsMember_d23d8c36-13ec-4257-ae54-8270275149c9" xlink:href="ctlt-20210630.xsd#ctlt_RTSRPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_ctlt_RTSRPerformanceShareUnitsMember_d23d8c36-13ec-4257-ae54-8270275149c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_00d5365d-794e-4860-9c95-f7d26b7ee537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_00d5365d-794e-4860-9c95-f7d26b7ee537" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0a722696-6ec2-41ff-ba3e-d45f4ece1439_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:to="loc_us-gaap_ClassOfStockDomain_0a722696-6ec2-41ff-ba3e-d45f4ece1439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_11714b93-7e7b-4e5e-8d72-5b9585bb8d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:to="loc_us-gaap_ClassOfStockDomain_11714b93-7e7b-4e5e-8d72-5b9585bb8d07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30424792-bd90-4b70-973c-bab90f7cdb21_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:to="loc_srt_RangeMember_30424792-bd90-4b70-973c-bab90f7cdb21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:to="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ebc0f9f1-dd6e-4dd6-86f1-a87c932302ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:to="loc_srt_MinimumMember_ebc0f9f1-dd6e-4dd6-86f1-a87c932302ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3e07b239-8aaa-41df-82d6-907d965707b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:to="loc_srt_MaximumMember_3e07b239-8aaa-41df-82d6-907d965707b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_1a7a0624-7a64-427a-99ea-de8f28f0fe06_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:to="loc_us-gaap_VestingDomain_1a7a0624-7a64-427a-99ea-de8f28f0fe06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_b42bb60b-632d-43c4-a84c-0f43a01203b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:to="loc_us-gaap_VestingDomain_b42bb60b-632d-43c4-a84c-0f43a01203b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationNetRevenueandSegmentEbitdaDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="extended" id="ib09b1f3df01d4778aca018d28942b3ed_SegmentInformationNetRevenueandSegmentEbitdaDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e8534e28-aa06-4188-a64b-c42b9519a8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_Revenues_e8534e28-aa06-4188-a64b-c42b9519a8bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_02cb9e88-cfd6-40a4-80e3-b205501b2701" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_02cb9e88-cfd6-40a4-80e3-b205501b2701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_b33e8a2d-f9b1-4bc9-8fc4-3485e45ee984" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationInterSegmentRevenueElimination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_b33e8a2d-f9b1-4bc9-8fc4-3485e45ee984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_cd9f5cb4-8589-4aca-adaf-1a3326640031" xlink:href="ctlt-20210630.xsd#ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_cd9f5cb4-8589-4aca-adaf-1a3326640031" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0066aacb-2a65-4281-924d-0969110835fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0066aacb-2a65-4281-924d-0969110835fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestructuringAndOtherSpecialItems_cea05b2d-5bfc-414b-a31e-8fe7c92cb7ea" xlink:href="ctlt-20210630.xsd#ctlt_RestructuringAndOtherSpecialItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_RestructuringAndOtherSpecialItems_cea05b2d-5bfc-414b-a31e-8fe7c92cb7ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dcf9dbe7-ace0-4cd0-a3ce-bf8f466488b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dcf9dbe7-ace0-4cd0-a3ce-bf8f466488b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_7b13767e-e29c-4d93-8a7c-f180362d5f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_7b13767e-e29c-4d93-8a7c-f180362d5f86" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NonAllocatedCorporateCostsNet_a6ec3c47-2357-4176-8b3d-6b40463642cd" xlink:href="ctlt-20210630.xsd#ctlt_NonAllocatedCorporateCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_NonAllocatedCorporateCostsNet_a6ec3c47-2357-4176-8b3d-6b40463642cd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationUnallocatedExpense_4c2434ad-fbed-4595-aa9b-9b59f9df285f" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationUnallocatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationUnallocatedExpense_4c2434ad-fbed-4595-aa9b-9b59f9df285f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_705f187a-777a-47f7-812e-b382c5a19d29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:to="loc_us-gaap_SegmentDomain_705f187a-777a-47f7-812e-b382c5a19d29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:to="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_e9c58ea6-0d2d-460d-806f-b99842eef388" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_e9c58ea6-0d2d-460d-806f-b99842eef388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_ca460601-a79d-47fc-b387-9c04e458e302" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_BiologicsMember_ca460601-a79d-47fc-b387-9c04e458e302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_830ae8f6-4aa8-4476-b169-06d5861c7d3b" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_830ae8f6-4aa8-4476-b169-06d5861c7d3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_7cbed37f-3ca8-4af8-b203-2467049ed6fe" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_7cbed37f-3ca8-4af8-b203-2467049ed6fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_cbfe4575-fab9-48e4-85f2-ecb6faad9834" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentSubTotalOfSegmentReportingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_cbfe4575-fab9-48e4-85f2-ecb6faad9834" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationTotalAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationTotalAssetsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SegmentInformationTotalAssetsDetails" xlink:type="extended" id="i9abfdead8e7b4ba29cace15fecca5f13_SegmentInformationTotalAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c3208b2a-cfa0-4e77-b800-3fcad52ec3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:to="loc_us-gaap_Assets_c3208b2a-cfa0-4e77-b800-3fcad52ec3ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:to="loc_us-gaap_SegmentDomain_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:to="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_7d6e2771-d211-4f6a-a17c-8c4953068735" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_7d6e2771-d211-4f6a-a17c-8c4953068735" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_74556c4c-2d9a-42c4-9995-3ded8f1bb012" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_BiologicsMember_74556c4c-2d9a-42c4-9995-3ded8f1bb012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_2b611fd6-f669-48e3-b38f-682a34b611ed" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_2b611fd6-f669-48e3-b38f-682a34b611ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_f60bf3ca-c8b0-4abd-8651-e2013c446d4b" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_f60bf3ca-c8b0-4abd-8651-e2013c446d4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CorporateAndEliminationsMember_8dd83e99-c18f-477c-8e3d-5e67592325ff" xlink:href="ctlt-20210630.xsd#ctlt_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_CorporateAndEliminationsMember_8dd83e99-c18f-477c-8e3d-5e67592325ff" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationDepreciationandAmortizationDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails" xlink:type="extended" id="i6882cd7cf7d14ecaafbafe5847e6f5a7_SegmentInformationDepreciationandAmortizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_106729f2-1faf-4f8a-8e98-c5ab56aec6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_106729f2-1faf-4f8a-8e98-c5ab56aec6c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_941a990c-bc8c-4696-8653-e1ee09adca7c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:to="loc_us-gaap_SegmentDomain_941a990c-bc8c-4696-8653-e1ee09adca7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:to="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_b99372bf-8880-45c3-9ad7-8d3163a56eb6" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_b99372bf-8880-45c3-9ad7-8d3163a56eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_141dc380-9223-468b-a24b-77e3eab42f60" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_BiologicsMember_141dc380-9223-468b-a24b-77e3eab42f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_9c9030d3-5968-4896-b5f2-44e513ef407c" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_9c9030d3-5968-4896-b5f2-44e513ef407c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_22b78ae5-4b72-4e8d-927b-02b5ef2971a9" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_22b78ae5-4b72-4e8d-927b-02b5ef2971a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_ac03b302-2607-4764-a02e-3eb14a2a575a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_us-gaap_CorporateMember_ac03b302-2607-4764-a02e-3eb14a2a575a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationCapitalExpendituresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationCapitalExpendituresDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SegmentInformationCapitalExpendituresDetails" xlink:type="extended" id="i3798461b2d5d45f3b3a9291ad1bc37b4_SegmentInformationCapitalExpendituresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6f957b84-6086-43c6-8aa9-b94e5c20ca17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6f957b84-6086-43c6-8aa9-b94e5c20ca17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e119f740-6b57-4254-be5b-7b68ccffd55e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:to="loc_us-gaap_SegmentDomain_e119f740-6b57-4254-be5b-7b68ccffd55e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:to="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_c5676a15-b9e6-499e-a05e-cf7549f2f22d" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_c5676a15-b9e6-499e-a05e-cf7549f2f22d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_8e9678e5-f8b0-4cf5-be35-2268ff3fba09" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_BiologicsMember_8e9678e5-f8b0-4cf5-be35-2268ff3fba09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_7ab557aa-489c-42cf-8131-96d680e3ce40" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_7ab557aa-489c-42cf-8131-96d680e3ce40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_cbc4d203-3f67-4738-8dcb-0c75a79b1f5b" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_cbc4d203-3f67-4738-8dcb-0c75a79b1f5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_63a7f826-d2a1-4688-932d-659c5b561e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_us-gaap_CorporateMember_63a7f826-d2a1-4688-932d-659c5b561e9b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationAssetsandRevenuesDetail"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail" xlink:type="extended" id="id63947d1e9f348d19cabf5531e63180e_SegmentInformationAssetsandRevenuesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1ce5ec5-a159-47ff-87c1-be8c158c3a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1ce5ec5-a159-47ff-87c1-be8c158c3a25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:to="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:to="loc_srt_SegmentGeographicalDomain_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:to="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_574a118e-433a-4cf6-b2ec-9c3e5e3ea0d4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_country_US_574a118e-433a-4cf6-b2ec-9c3e5e3ea0d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b5cc3ab2-8adc-485b-946d-98d939364047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_srt_EuropeMember_b5cc3ab2-8adc-485b-946d-98d939364047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestofWorldMember_6392f7f3-1387-44aa-aa21-4489fdee9e9f" xlink:href="ctlt-20210630.xsd#ctlt_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_ctlt_RestofWorldMember_6392f7f3-1387-44aa-aa21-4489fdee9e9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_781e7229-dadf-4ff4-a853-f1d82f9d2578" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_srt_ConsolidationEliminationsMember_781e7229-dadf-4ff4-a853-f1d82f9d2578" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://catalent.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://catalent.com/role/SubsequentEventsDetails" xlink:type="extended" id="i1bc05397fe844f91abfe2644cfc556a3_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_63200a93-43da-437e-8e67-29d93c0abd07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_63200a93-43da-437e-8e67-29d93c0abd07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:to="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3dc61630-454b-4e73-ba97-5b766acd4cd6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3dc61630-454b-4e73-ba97-5b766acd4cd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ZenyattaMember_b2c31b21-9fa3-4208-bde3-2c3ba6fd0896" xlink:href="ctlt-20210630.xsd#ctlt_ZenyattaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:to="loc_ctlt_ZenyattaMember_b2c31b21-9fa3-4208-bde3-2c3ba6fd0896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_47675abf-e362-4c13-b44c-e2ce625a6dde_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_47675abf-e362-4c13-b44c-e2ce625a6dde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6c59831f-e489-4c6f-aa2d-2e00cfb6d0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:to="loc_us-gaap_SubsequentEventMember_6c59831f-e489-4c6f-aa2d-2e00cfb6d0c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>ctlt-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24a0b3a3-f6d6-486b-b079-4f7497a9632d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_25207ee8-93af-4b95-a3db-8728f0ab7a61_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TradingSecuritiesAtFairValue_fe7020d8-afc3-4c0d-bdb9-5f52e3b32efc_terseLabel_en-US" xlink:label="lab_ctlt_TradingSecuritiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities at Fair Value</link:label>
    <link:label id="lab_ctlt_TradingSecuritiesAtFairValue_label_en-US" xlink:label="lab_ctlt_TradingSecuritiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities at Fair Value</link:label>
    <link:label id="lab_ctlt_TradingSecuritiesAtFairValue_documentation_en-US" xlink:label="lab_ctlt_TradingSecuritiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">participant-directed stock and bond mutual funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TradingSecuritiesAtFairValue" xlink:href="ctlt-20210630.xsd#ctlt_TradingSecuritiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TradingSecuritiesAtFairValue" xlink:to="lab_ctlt_TradingSecuritiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_edb06e1f-37c0-4936-8094-54324900d540_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_b4bd8e34-45f1-4a65-9a0e-1392c12d13be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Asset Allocation (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9c7a8b26-1190-483c-9f61-72672810d75b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_5fc62b94-7f30-4ae5-92ab-56d600e77d8a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year 2020 Expected Future Contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_d02cf842-44ac-4893-9a02-14e399ee7bc8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b301dd76-c66a-4829-a9d3-d205589de7ed_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_6fc4878c-8494-42c8-a209-0e2bd53bc29e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BlowFillSealBusinessWoodstockMember_e445a7b7-f027-4165-bc5d-11112d8a220f_terseLabel_en-US" xlink:label="lab_ctlt_BlowFillSealBusinessWoodstockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blow-Fill-Seal Business, Woodstock</link:label>
    <link:label id="lab_ctlt_BlowFillSealBusinessWoodstockMember_label_en-US" xlink:label="lab_ctlt_BlowFillSealBusinessWoodstockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blow-Fill-Seal Business, Woodstock [Member]</link:label>
    <link:label id="lab_ctlt_BlowFillSealBusinessWoodstockMember_documentation_en-US" xlink:label="lab_ctlt_BlowFillSealBusinessWoodstockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blow-Fill-Seal Business, Woodstock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BlowFillSealBusinessWoodstockMember" xlink:href="ctlt-20210630.xsd#ctlt_BlowFillSealBusinessWoodstockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BlowFillSealBusinessWoodstockMember" xlink:to="lab_ctlt_BlowFillSealBusinessWoodstockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fe67511a-d0f8-42a2-82e1-07e71f9ed5f9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b9ace5ee-a4fb-4f98-bbe0-25e498ae9a24_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions between measurement date and reporting date</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_e8468437-2809-46b5-b54e-df710a52aa0e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1d5c1e48-b4f8-4e74-9e1b-e95a435ae273_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_664b8844-7e1e-4f68-859e-8e05ae878dbe_terseLabel_en-US" xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Axis]</link:label>
    <link:label id="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_label_en-US" xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable" xlink:to="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_5f0fed21-6c4a-4e7b-97f4-4060d1b016d9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred long term debt financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_16dbc953-f440-41b4-b1b5-b2588d7546fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_02ecd344-0cd1-4bb6-bfed-d527f126df09_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase (Decrease), Other, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase (Decrease), Other, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:to="lab_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_2d479e53-f070-40bd-a8d5-3e96a00e821d_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_676806c4-c21a-4965-8f1e-4d64a7338eff_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_da806ff8-f54a-4179-8001-e045bb3544b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_67ee97b1-2ea6-4ebd-b325-f7abe5fcdf2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree_205b10d6-dd35-4a81-aa35-c90af8aa2b96_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_dd458f18-57b9-47e6-9baf-711720a597d5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dbf285e4-9f50-4fc7-ac83-df5503834a7a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_cd7c7d61-8218-4704-9d58-fb5c47073f6e_terseLabel_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Asset Allocation</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_label_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actual Plan Assets Allocation, Amount</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_documentation_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actual Plan Assets Allocation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:to="lab_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f6b9559f-216f-4740-a34a-5a12e6aa8d27_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_838d1e4c-c31a-4f7d-b07e-df647b4f71a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_60f11f5a-0c28-4d74-8dee-eaac831d431f_terseLabel_en-US" xlink:label="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding shares granted in consideration for acquisition [Member]</link:label>
    <link:label id="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_label_en-US" xlink:label="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding shares granted in consideration for acquisition [Member]</link:label>
    <link:label id="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_documentation_en-US" xlink:label="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding shares granted in consideration for acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:href="ctlt-20210630.xsd#ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:to="lab_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f5461bd7-8f2d-4edd-829b-f704e9e70182_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_cd21db05-48b4-49a6-8ed5-f87cca6e5ba1_terseLabel_en-US" xlink:label="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Estimated Annual Cash Contribution</link:label>
    <link:label id="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_label_en-US" xlink:label="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Estimated Annual Cash Contribution</link:label>
    <link:label id="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_documentation_en-US" xlink:label="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Estimated Annual Cash Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:href="ctlt-20210630.xsd#ctlt_MultiemployerPlansEstimatedAnnualCashContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:to="lab_ctlt_MultiemployerPlansEstimatedAnnualCashContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9a1f770a-d63f-4e01-80d8-ebc54f4850ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9b61e593-6353-4864-9606-acb0ff1beffc_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a144cdbe-3278-42fa-9f44-a8c7716cc906_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_67dbe650-605e-4c19-9a92-2ef04c8092d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BiologicsMember_1b14a939-3285-49f8-9d9e-d77a8d9c6571_terseLabel_en-US" xlink:label="lab_ctlt_BiologicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics [Member]</link:label>
    <link:label id="lab_ctlt_BiologicsMember_label_en-US" xlink:label="lab_ctlt_BiologicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics [Member]</link:label>
    <link:label id="lab_ctlt_BiologicsMember_documentation_en-US" xlink:label="lab_ctlt_BiologicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biologics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BiologicsMember" xlink:to="lab_ctlt_BiologicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_29f84a2a-c276-4e25-84c4-e00f9c371517_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_9122597c-e4d8-410d-bf77-e36f4b67da63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_03fa4e56-0b3a-4121-8f05-c1345214c366_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_b8fad617-25d7-4cb9-908d-e8f9f598b5bb_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ccd0b3a7-576d-4ac7-bcee-90606f613d60_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7977f9ca-de94-4fde-a688-dd51ee362aa3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_d954d23c-1aaf-41f4-a0ff-203f4bb38b54_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_fa7e1ecc-c3d1-4267-978b-54fc99dec543_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_0b90cc6c-27d3-4b55-8ce6-6773250b3b6b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TaxCutsandJobsActTaxEffect_bd2dd30b-328f-4799-b3de-ac2b5c80de8a_negatedTerseLabel_en-US" xlink:label="lab_ctlt_TaxCutsandJobsActTaxEffect" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Tax Effect</link:label>
    <link:label id="lab_ctlt_TaxCutsandJobsActTaxEffect_label_en-US" xlink:label="lab_ctlt_TaxCutsandJobsActTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Tax Effect</link:label>
    <link:label id="lab_ctlt_TaxCutsandJobsActTaxEffect_documentation_en-US" xlink:label="lab_ctlt_TaxCutsandJobsActTaxEffect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Tax Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TaxCutsandJobsActTaxEffect" xlink:href="ctlt-20210630.xsd#ctlt_TaxCutsandJobsActTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TaxCutsandJobsActTaxEffect" xlink:to="lab_ctlt_TaxCutsandJobsActTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f01bd99d-7900-447e-b7ed-0662969819a6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_08b87b1d-41a3-401d-8b0e-5a705baefd8b_terseLabel_en-US" xlink:label="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Senior Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_label_en-US" xlink:label="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Senior Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Senior Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:href="ctlt-20210630.xsd#ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:to="lab_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3612699c-0d96-4868-a371-bd9635f04bf7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock_e839f5a6-ce7f-4743-a7d4-b8d9287d6125_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures by Segment</link:label>
    <link:label id="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, Capital Expenditures by Segment [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, Capital Expenditures by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:to="lab_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_57e0cc06-f5c4-46ea-b26f-025bafbf3770_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_A3125SeniorUSDenominatedNotesMember_269ed2ed-6eaf-4269-99d6-312b0853718f_terseLabel_en-US" xlink:label="lab_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Senior US Denominated Notes</link:label>
    <link:label id="lab_ctlt_A3125SeniorUSDenominatedNotesMember_label_en-US" xlink:label="lab_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Senior US Denominated Notes [Member]</link:label>
    <link:label id="lab_ctlt_A3125SeniorUSDenominatedNotesMember_documentation_en-US" xlink:label="lab_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Senior US Denominated Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:href="ctlt-20210630.xsd#ctlt_A3125SeniorUSDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:to="lab_ctlt_A3125SeniorUSDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DebtRefinancingCostsAxis_23dbb996-31a2-4044-b835-5d6e692fcc5b_terseLabel_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Costs [Axis]</link:label>
    <link:label id="lab_ctlt_DebtRefinancingCostsAxis_label_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Costs [Axis]</link:label>
    <link:label id="lab_ctlt_DebtRefinancingCostsAxis_documentation_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Costs [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsAxis" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DebtRefinancingCostsAxis" xlink:to="lab_ctlt_DebtRefinancingCostsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_298b62a6-ac2b-4a8c-8f6a-3645c6bb1942_negatedTerseLabel_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit) during the year</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_label_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During the Year, before Tax</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_documentation_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During the Year, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:to="lab_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_3c5d538b-c6aa-4e2f-b812-423fe2999ff4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_51e0ac91-08a5-42fa-b03b-b3650554d33c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_7417773f-52d0-4b51-8ec8-519591ed1e6e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BusinessCombinationTransitionalServiceAgreement_3108aa1e-780c-44f3-80e1-de2ae782f687_terseLabel_en-US" xlink:label="lab_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Consideration</link:label>
    <link:label id="lab_ctlt_BusinessCombinationTransitionalServiceAgreement_label_en-US" xlink:label="lab_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, transitional service agreement</link:label>
    <link:label id="lab_ctlt_BusinessCombinationTransitionalServiceAgreement_documentation_en-US" xlink:label="lab_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, transitional service agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationTransitionalServiceAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:to="lab_ctlt_BusinessCombinationTransitionalServiceAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SoftgelTechnologiesMember_e67cdb67-ed2e-437e-a46d-a37844eaceb3_terseLabel_en-US" xlink:label="lab_ctlt_SoftgelTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel Technologies</link:label>
    <link:label id="lab_ctlt_SoftgelTechnologiesMember_label_en-US" xlink:label="lab_ctlt_SoftgelTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel Technologies [Member]</link:label>
    <link:label id="lab_ctlt_SoftgelTechnologiesMember_documentation_en-US" xlink:label="lab_ctlt_SoftgelTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelTechnologiesMember" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SoftgelTechnologiesMember" xlink:to="lab_ctlt_SoftgelTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7d4db15-aced-4b07-a508-afd7a3979caf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_82691399-0876-4359-86cd-6f7fe3ff7c4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f3b26147-0f54-4e1b-95f4-94dd7d0fb777_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b680a489-bba2-47c9-b2a9-3a2c8d2f88ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7edb6324-81ac-4923-9624-1dff35c0cf29_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d82c55b-b500-4e21-9cca-917a44360daa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Finance Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e7e1a346-2c6b-49ec-9b53-600781864055_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fd50765b-2138-4159-b580-b8ce2683b053_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d797a22a-352d-4f74-ad34-0d14ff47b314_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ee179d45-5013-4fbf-9b21-5ec40f130d96_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6c0f16dd-bf16-4504-bceb-c9bd6890374f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_6829fc6b-9709-4945-9b1b-9c92289b92de_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_39aba944-d845-4c40-afa8-2901a3f40f36_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d191b9a0-3d4f-44f1-a410-ded22f7cd6f6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_7eafc027-dacb-467a-9453-d555f07bdfed_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_f93152d6-0bc9-429e-b9de-652a0b2daed5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AlternativeInvestment_c29ac82c-9ac4-4c37-a209-4e196e89e6b2_terseLabel_en-US" xlink:label="lab_us-gaap_AlternativeInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investment</link:label>
    <link:label id="lab_us-gaap_AlternativeInvestment_label_en-US" xlink:label="lab_us-gaap_AlternativeInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AlternativeInvestment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AlternativeInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AlternativeInvestment" xlink:to="lab_us-gaap_AlternativeInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_a4918d74-0b8e-4a74-b130-640dfa99be84_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:to="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_34e47046-c32f-4715-87e9-37d3f8b644e5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3c2bdc6f-9934-4973-97c8-8a86cd5b3028_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9913a1d1-942d-419a-b235-320b8e2a3687_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_aec0fd48-3bea-4e9a-ade9-083523d55b9f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition (asset)/obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RecentFinancialAccountingStandardsAbstract_label_en-US" xlink:label="lab_ctlt_RecentFinancialAccountingStandardsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Financial Accounting Standards [Abstract]</link:label>
    <link:label id="lab_ctlt_RecentFinancialAccountingStandardsAbstract_documentation_en-US" xlink:label="lab_ctlt_RecentFinancialAccountingStandardsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RecentFinancialAccountingStandardsAbstract" xlink:href="ctlt-20210630.xsd#ctlt_RecentFinancialAccountingStandardsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RecentFinancialAccountingStandardsAbstract" xlink:to="lab_ctlt_RecentFinancialAccountingStandardsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_99419d74-e6ee-49a0-acf5-fea798763998_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_085b6cae-8d11-4500-ad4e-f39d577d460e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ProductRightsLineItems_3e18598f-7772-44e4-b747-8ec002432c3d_terseLabel_en-US" xlink:label="lab_ctlt_ProductRightsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles [Line Items]</link:label>
    <link:label id="lab_ctlt_ProductRightsLineItems_label_en-US" xlink:label="lab_ctlt_ProductRightsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Line Items]</link:label>
    <link:label id="lab_ctlt_ProductRightsLineItems_documentation_en-US" xlink:label="lab_ctlt_ProductRightsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Rights [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRightsLineItems" xlink:href="ctlt-20210630.xsd#ctlt_ProductRightsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ProductRightsLineItems" xlink:to="lab_ctlt_ProductRightsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a44ece16-834c-4271-bf99-60de9329c849_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a395e05d-b83b-4a70-8876-d080597aeba4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9ce32f06-617f-46aa-8d17-0fe393447f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_9b7eaf5c-7cc8-48b6-a4b4-45b5c59e41e1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_702a2723-d7e7-4403-b43b-826040fb02a9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_d4c2ccc7-89f3-4ab9-a446-aafd2bcdd023_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1f9a085b-0e1f-409d-9a23-1221bbe210b6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_d1612e33-6150-42c7-b4ca-9e8db939d100_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f2ed0642-2b24-4e5a-af13-74a7d22e484f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_39309bc8-8ee4-448b-94ec-f8e2ea0eaf34_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BoltonCSMember_33ff3533-7ad8-4664-8333-6e2235a5dd86_terseLabel_en-US" xlink:label="lab_ctlt_BoltonCSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolton CS [Member]</link:label>
    <link:label id="lab_ctlt_BoltonCSMember_label_en-US" xlink:label="lab_ctlt_BoltonCSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolton CS [Member]</link:label>
    <link:label id="lab_ctlt_BoltonCSMember_documentation_en-US" xlink:label="lab_ctlt_BoltonCSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolton CS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BoltonCSMember" xlink:href="ctlt-20210630.xsd#ctlt_BoltonCSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BoltonCSMember" xlink:to="lab_ctlt_BoltonCSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_7c5f3be9-eb4e-49d9-b9a6-f0b4164ad0d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock_73119e17-989e-4c6b-9457-32fe5acb7df4_terseLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue and Segment EBITDA</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock_label_en-US" xlink:label="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Net Revenue And Ebitda Table [Text Block]</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment reporting information net revenue and EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:to="lab_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_7dd0dfbe-1f88-4d79-b38e-e191729f445f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_99bfd6c2-7f0f-41dd-ba61-9fa2222ac5e1_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_5bc2f4d8-0881-4208-8e40-232d9e515ffe_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term inter-company loans</link:label>
    <link:label id="lab_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_label_en-US" xlink:label="lab_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for Long-term Intercompany Transactions, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:to="lab_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DebtIssuanceCostsMember_cbbcd7f5-724a-40ce-a39e-f1267fef9463_terseLabel_en-US" xlink:label="lab_ctlt_DebtIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_ctlt_DebtIssuanceCostsMember_label_en-US" xlink:label="lab_ctlt_DebtIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs [Member]</link:label>
    <link:label id="lab_ctlt_DebtIssuanceCostsMember_documentation_en-US" xlink:label="lab_ctlt_DebtIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtIssuanceCostsMember" xlink:href="ctlt-20210630.xsd#ctlt_DebtIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DebtIssuanceCostsMember" xlink:to="lab_ctlt_DebtIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df3e1385-43f4-4271-88ea-71d14e8b29de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_e8eb51aa-3461-4a82-9c0f-baa4458dba22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_50487131-3b08-4874-a99e-cfda465a2cf0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_69b81037-9bf7-4176-8bdb-935343b38e2f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain/(loss) recognized during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9710f6e0-8a7a-4569-955d-8c12f555afeb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_ae8d86f6-d530-468a-92dd-9730ef783f78_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d30cd0f-1a72-4a33-8fb2-64ec586023f2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember_29be0645-2e3b-4321-af0a-74738feae6c6_terseLabel_en-US" xlink:label="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Two Facility Dollar Denominated [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember_label_en-US" xlink:label="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Two Facility Dollar Denominated [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember_documentation_en-US" xlink:label="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Two Facility Dollar Denominated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanTwoFacilityDollarDenominatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:to="lab_ctlt_TermLoanTwoFacilityDollarDenominatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_ac96653d-4357-4cd3-bf09-f054eb37f167_terseLabel_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Operating Lease, Liabilities</link:label>
    <link:label id="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_label_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Operating Lease, Liabilities</link:label>
    <link:label id="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Operating Lease, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:to="lab_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_e4c978bc-aa9b-413b-9798-1064da0c1caf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_bdad8eed-ccb7-47d4-b0a8-6a1f76e55af9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DeferredIncomeTaxRightOfUse_b0b7d928-2cb8-4e5c-bf5a-2ce46f9c9413_terseLabel_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxRightOfUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Right-of-Use Asset</link:label>
    <link:label id="lab_ctlt_DeferredIncomeTaxRightOfUse_label_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxRightOfUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Right-of-Use</link:label>
    <link:label id="lab_ctlt_DeferredIncomeTaxRightOfUse_documentation_en-US" xlink:label="lab_ctlt_DeferredIncomeTaxRightOfUse" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax, Right-of-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxRightOfUse" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxRightOfUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DeferredIncomeTaxRightOfUse" xlink:to="lab_ctlt_DeferredIncomeTaxRightOfUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_19c41f10-1e9f-4873-962e-e8827d7004f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_32537d30-7cda-4be8-a0d6-395d996adee8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4459e3da-e52e-4ae7-996d-cca26fec8cf2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations_02dc59ed-cd74-421b-90a9-f9db3c880d02_terseLabel_en-US" xlink:label="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of revenue attributable to multiple locations</link:label>
    <link:label id="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations_label_en-US" xlink:label="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of revenue attributable to multiple locations</link:label>
    <link:label id="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations_documentation_en-US" xlink:label="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of revenue attributable to multiple locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:href="ctlt-20210630.xsd#ctlt_Eliminationofrevenueattributabletomultiplelocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:to="lab_ctlt_Eliminationofrevenueattributabletomultiplelocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3955c404-ccad-4fb1-b9dc-aa67999e020c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_cf9545ff-21d6-4c01-97a7-99294d5dfc7b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of 1% increase on total service and interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_89f233b6-1062-4ed7-a12e-4113df4a4622_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_69a2c256-7408-4546-a03f-a82f6e54dfa5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_a00e44f6-a1a2-4fc3-968d-5a4579aec51a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_f7d5e1f8-2cf4-4874-b9fa-dcf392cb222a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_da34ff9d-712d-4211-92af-7a286bbb8964_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_655f8699-e930-4e51-bcc8-59c94fd631ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_d483cdc5-8f4d-413c-a71c-6687e8fd96cf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ClinicalSupplyServicesMember_fc175aec-c1ab-4aa0-9404-217dd0eaaf15_terseLabel_en-US" xlink:label="lab_ctlt_ClinicalSupplyServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Supply Services [Member]</link:label>
    <link:label id="lab_ctlt_ClinicalSupplyServicesMember_label_en-US" xlink:label="lab_ctlt_ClinicalSupplyServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Supply Services [Member]</link:label>
    <link:label id="lab_ctlt_ClinicalSupplyServicesMember_documentation_en-US" xlink:label="lab_ctlt_ClinicalSupplyServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Supply Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ClinicalSupplyServicesMember" xlink:to="lab_ctlt_ClinicalSupplyServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_cdba845c-5d5c-47ce-80e6-ba62c91533d6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_LandBuildingsAndImprovements_0b555f41-7e9c-4eab-83af-1659ebece494_terseLabel_en-US" xlink:label="lab_ctlt_LandBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, buildings, and improvements</link:label>
    <link:label id="lab_ctlt_LandBuildingsAndImprovements_label_en-US" xlink:label="lab_ctlt_LandBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Buildings And Improvements</link:label>
    <link:label id="lab_ctlt_LandBuildingsAndImprovements_documentation_en-US" xlink:label="lab_ctlt_LandBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, buildings and improvements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_LandBuildingsAndImprovements" xlink:href="ctlt-20210630.xsd#ctlt_LandBuildingsAndImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_LandBuildingsAndImprovements" xlink:to="lab_ctlt_LandBuildingsAndImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_a5a30e58-a9df-4c18-bc60-c60005954873_terseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember_423427d2-80aa-43eb-8e63-49be3272ecbb_terseLabel_en-US" xlink:label="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eberbach Pension Promissory Note or Loan [Member]</link:label>
    <link:label id="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember_label_en-US" xlink:label="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eberbach Pension Promissory Note or Loan [Member]</link:label>
    <link:label id="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember_documentation_en-US" xlink:label="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eberbach Pension Promissory Note or Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:href="ctlt-20210630.xsd#ctlt_EberbachPensionPromissoryNoteOrLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:to="lab_ctlt_EberbachPensionPromissoryNoteOrLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8feb4827-0269-4cc4-b57f-d554c28ebade_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57005c57-d9a4-4c0c-a6f9-1948870bc425_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_56888797-a8a8-4e05-86b2-c03dcfe4e306_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PledgePercentageOfEquityInterest_60f0656f-6196-44a2-91c6-fde2bb1e2ef6_terseLabel_en-US" xlink:label="lab_ctlt_PledgePercentageOfEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge Percentage Of Equity Interest</link:label>
    <link:label id="lab_ctlt_PledgePercentageOfEquityInterest_label_en-US" xlink:label="lab_ctlt_PledgePercentageOfEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge Percentage Of Equity Interest</link:label>
    <link:label id="lab_ctlt_PledgePercentageOfEquityInterest_documentation_en-US" xlink:label="lab_ctlt_PledgePercentageOfEquityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge percentage of equity interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfEquityInterest" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PledgePercentageOfEquityInterest" xlink:to="lab_ctlt_PledgePercentageOfEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5bfa5110-f29e-4b40-aa6b-6498bcb51d27_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_d8f02b99-b244-4afa-a2b5-43c765c6e685_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_db7fbda3-8c8f-4357-9109-dd2e197bc9f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_13aed988-8f02-48bf-861e-e6f19b2bba6a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_fa4567db-414e-463f-b940-11b6157c475d_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b0b0f32e-25ad-4f7a-87f4-ed3c09f9aac2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c12a8d1c-9cb7-4320-a674-15c7e777b717_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_ca9c84cb-116a-44bd-a1a8-9f6651593869_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_2eca2643-0aa7-4b01-87dd-2fac70fe2d4c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_5f4380cb-929e-452e-b7d7-94741422780d_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_90c7a13e-c2a3-4a68-8d5b-36c3227d2c99_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_49244146-92e4-4089-a04b-68046be72adc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_aa936404-47b9-435d-88c3-1811ab3c751e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_0f80ea98-8281-404f-87b1-437f44a1be39_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DelphiGeneticsSAMember_1db043b1-b4fb-4f59-9b9b-39f2a7a66ea3_terseLabel_en-US" xlink:label="lab_ctlt_DelphiGeneticsSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delphi Genetics SA</link:label>
    <link:label id="lab_ctlt_DelphiGeneticsSAMember_label_en-US" xlink:label="lab_ctlt_DelphiGeneticsSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delphi Genetics SA [Member]</link:label>
    <link:label id="lab_ctlt_DelphiGeneticsSAMember_documentation_en-US" xlink:label="lab_ctlt_DelphiGeneticsSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delphi Genetics SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DelphiGeneticsSAMember" xlink:to="lab_ctlt_DelphiGeneticsSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_88735451-bb4c-4cc0-a627-b00d3c8274bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_12dd50f1-3446-4645-9463-d82da1b1fbdb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_d27e85c5-6e93-4512-80d6-daa6edd78669_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3f373222-67c4-4583-b311-9668786bf2d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_109c5431-cab9-413e-92e9-8e77b0443feb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock_7c15916f-9282-493a-a8c3-19205bd38fb9_terseLabel_en-US" xlink:label="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Representation of depreciation and amortization expense and capital expenditure by segment</link:label>
    <link:label id="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock_label_en-US" xlink:label="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Representation Of Depreciation And Amortization Expense And Capital Expenditure In Consolidated Financial Statements Table [Text Block]</link:label>
    <link:label id="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Representation Of Depreciation And Amortization Expense And Capital Expenditure In Consolidated Financial Statements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:to="lab_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_87317a2e-62a2-4458-9dd6-12233f530a5f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_38849685-312d-4131-a8ea-82f1c9cbd86c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_28d3bee6-3a06-45bc-ad86-7b875d41d1a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_b0357a79-3592-4993-bd87-e85d29073f1f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_18788f88-b08e-498c-8131-785af274de22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues_b8cc45f2-bf05-4b69-8ef6-f87e8fc8b4fc_terseLabel_en-US" xlink:label="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues</link:label>
    <link:label id="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues_label_en-US" xlink:label="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues</link:label>
    <link:label id="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues_documentation_en-US" xlink:label="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:href="ctlt-20210630.xsd#ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:to="lab_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FinitelivedintangibleassetsdisclosureAbstract_label_en-US" xlink:label="lab_ctlt_FinitelivedintangibleassetsdisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived intangible assets disclosure [Abstract]</link:label>
    <link:label id="lab_ctlt_FinitelivedintangibleassetsdisclosureAbstract_documentation_en-US" xlink:label="lab_ctlt_FinitelivedintangibleassetsdisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived intangible assets disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract" xlink:to="lab_ctlt_FinitelivedintangibleassetsdisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_8fce13d2-cb7b-45a8-bf9e-274787d1927a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ProductRelationshipsMember_bb015534-bbc9-477d-820f-0eb5e2f9a5a7_terseLabel_en-US" xlink:label="lab_ctlt_ProductRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product relationships [Member]</link:label>
    <link:label id="lab_ctlt_ProductRelationshipsMember_label_en-US" xlink:label="lab_ctlt_ProductRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Relationships [Member]</link:label>
    <link:label id="lab_ctlt_ProductRelationshipsMember_documentation_en-US" xlink:label="lab_ctlt_ProductRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product relationships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRelationshipsMember" xlink:href="ctlt-20210630.xsd#ctlt_ProductRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ProductRelationshipsMember" xlink:to="lab_ctlt_ProductRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_4d7d236e-e689-4146-b275-b9dc74032f4e_totalLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total foreign currency translation adjustments, net of tax</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_60e40a16-c93b-4bc3-9e5e-cc5cff528508_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Future Benefit Payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7b74cb59-498b-4e76-939f-68b51df51fbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7247618c-d837-4bd5-a31c-13649f87c7dc_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_1ce2a4d4-7de9-42f6-a4dc-4205a166f642_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6de07abb-5069-4cc4-b10d-cec8e05a6068_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_17ad5c9d-6a01-4e6e-b408-f44cec86ebad_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_7decd313-20d4-42c7-9eec-581568ca8d8b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_a6791a0d-382f-4ebc-8b4c-36a9e90a8521_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_75c87410-d5da-4acd-b445-48ff0c3e7b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Major Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo_feac555c-2674-417d-bc7c-e678d1b974a3_terseLabel_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Two</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo_label_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Two</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo_documentation_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:to="lab_ctlt_InstallmentPaymentforAcquisitionYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_geographicalMember_3365554b-518c-41ad-ad8e-5530ca06d064_terseLabel_en-US" xlink:label="lab_ctlt_geographicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">geographical [Member]</link:label>
    <link:label id="lab_ctlt_geographicalMember_label_en-US" xlink:label="lab_ctlt_geographicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">geographical [Member]</link:label>
    <link:label id="lab_ctlt_geographicalMember_documentation_en-US" xlink:label="lab_ctlt_geographicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">geographical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_geographicalMember" xlink:href="ctlt-20210630.xsd#ctlt_geographicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_geographicalMember" xlink:to="lab_ctlt_geographicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_2254d188-64fd-46a6-954e-98f90d67ab72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_26162ae4-bef8-488c-8624-bc8091d25fea_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_63f839dc-54b9-4fc4-96e5-b36780e7172d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SegmentReportingInformationUnallocatedExpense_9feafe61-a569-4ce7-8af5-8449530297c8_negatedTotalLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unallocated costs</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationUnallocatedExpense_42a8cf98-587f-4768-ab6a-297af9558f84_terseLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unallocated costs</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationUnallocatedExpense_label_en-US" xlink:label="lab_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Unallocated Expense</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationUnallocatedExpense_documentation_en-US" xlink:label="lab_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Unallocated Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationUnallocatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:to="lab_ctlt_SegmentReportingInformationUnallocatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_05873c50-5b58-41a6-af10-958fbfce8d51_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_bd3e2c5c-b6c3-48b1-9e99-bc239e1f335f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_7a8c8dcb-4a5b-409b-8961-8e59fd433ff3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9395a65a-c04b-4a95-b407-20d02148bccc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_e0069c38-0b2c-41d0-b6e4-0824d06d7b84_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_e1db1e04-c722-49b3-8bf6-e4b05ad1104d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a308adbe-8b6a-495a-874a-22e24374043f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_f6686b84-c856-4f3f-b893-6d7d5008b436_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_138d4238-a8b0-43a0-b841-2220ca59efe0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_c7eb4b74-d796-45de-a59c-e4665662ffbe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets/accrued liabilities, net - current and non-current</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfDebtTable_de5ca0fe-086c-4de8-b220-4e733efd7b0f_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Table]</link:label>
    <link:label id="lab_ctlt_ScheduleOfDebtTable_label_en-US" xlink:label="lab_ctlt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Table]</link:label>
    <link:label id="lab_ctlt_ScheduleOfDebtTable_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtTable" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfDebtTable" xlink:to="lab_ctlt_ScheduleOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_36222879-d572-4a94-a50b-3f1fd8552d6a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bd9b74f7-b05c-4d9e-9a9a-820b6f633a95_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_685032d5-3458-4d97-a39e-0ef6aa2ed6f9_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_e0dcc14a-83d3-4c64-a69c-7f34e86881a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_687ea65c-fe5b-4865-b47f-8c0a2453f263_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory, gross</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_8fa84c3d-0cac-43c5-b2b2-258d721c3476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_5a328c91-163f-4d74-abfe-8a0ecfa796d7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_268b0c4b-a300-47a7-a514-c2d546aa04f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_e7b1ca95-c94f-40e2-8f87-e35f5a8b6e15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6b958600-5b30-43c6-a476-b68221e9e0ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_fa61c12d-508d-4188-9df8-98c63f777022_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RedeemablePreferredStockLineItems_64ae52f2-7196-4f37-9f37-f63fe3a88f3d_terseLabel_en-US" xlink:label="lab_ctlt_RedeemablePreferredStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Line Items]</link:label>
    <link:label id="lab_ctlt_RedeemablePreferredStockLineItems_label_en-US" xlink:label="lab_ctlt_RedeemablePreferredStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Line Items]</link:label>
    <link:label id="lab_ctlt_RedeemablePreferredStockLineItems_documentation_en-US" xlink:label="lab_ctlt_RedeemablePreferredStockLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RedeemablePreferredStockLineItems" xlink:href="ctlt-20210630.xsd#ctlt_RedeemablePreferredStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems" xlink:to="lab_ctlt_RedeemablePreferredStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_a14c7485-8ab7-4952-817a-4d43f7bda93a_terseLabel_en-US" xlink:label="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent before inter-segment revenue elimination [Member]</link:label>
    <link:label id="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_label_en-US" xlink:label="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent before inter-segment revenue elimination [Member]</link:label>
    <link:label id="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_documentation_en-US" xlink:label="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent before inter-segment revenue elimination [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:to="lab_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ManufacturingCommercialProductSupplyMember_66236f48-efa5-49db-a747-cf57ac33aeb1_terseLabel_en-US" xlink:label="lab_ctlt_ManufacturingCommercialProductSupplyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing &amp; Commercial Product Supply [Member]</link:label>
    <link:label id="lab_ctlt_ManufacturingCommercialProductSupplyMember_label_en-US" xlink:label="lab_ctlt_ManufacturingCommercialProductSupplyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing &amp; Commercial Product Supply [Member]</link:label>
    <link:label id="lab_ctlt_ManufacturingCommercialProductSupplyMember_documentation_en-US" xlink:label="lab_ctlt_ManufacturingCommercialProductSupplyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing &amp; Commercial Product Supply [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ManufacturingCommercialProductSupplyMember" xlink:href="ctlt-20210630.xsd#ctlt_ManufacturingCommercialProductSupplyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ManufacturingCommercialProductSupplyMember" xlink:to="lab_ctlt_ManufacturingCommercialProductSupplyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_18b29e58-fc70-4f4f-82de-83e14f1cac9f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9a5aa0bf-00fe-4c18-98ee-a537cb1e5ef0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2afbd32c-40b6-46f9-8088-b9d50b653b16_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance - Common Stock Outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a7baa272-e423-4320-96d4-f211f904da15_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance - Common Stock Outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_4b5ec466-e562-46d0-8914-e94faa4e6e16_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_2acf8faf-2f8c-4d7a-aa9a-64ce2dc82f76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_b83010e1-d3c6-46d6-8340-32a4d1344079_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ContractualLiabilitiesTableTextBlock_6660876a-61f9-4839-8011-eadee2e4ad6f_terseLabel_en-US" xlink:label="lab_ctlt_ContractualLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Liabilities</link:label>
    <link:label id="lab_ctlt_ContractualLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_ctlt_ContractualLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Liabilities [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ContractualLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ContractualLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Contractual Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ContractualLiabilitiesTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ContractualLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ContractualLiabilitiesTableTextBlock" xlink:to="lab_ctlt_ContractualLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_6173355e-ee77-47c7-81d2-445bd245ba06_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_62109776-bc8b-4a67-a65d-a9625c068513_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a37f7ebe-7912-4a84-ac09-adacb003d8a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1aab2e73-a20c-4c95-9f52-a3d7a6629be5_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_416161f5-3756-4f3d-976d-99b600b30342_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1ace22c8-3cbb-4e3a-bb9c-a1c4bcb1585a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_3597cac1-c412-49cf-9a34-85a8ca6a2753_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_311f45ff-43ae-4a56-865c-cfeda588939c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special termination benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_42bac430-c318-48be-bb74-647e16dedebc_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special company contributions to fund termination benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSpecialTerminationBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:to="lab_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_2634d6e0-c988-4d1a-bb20-4da386498029_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_404876bd-307b-4414-9a59-801e8fdeb026_netLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pension assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_cdc67c6c-9689-45a3-9229-f0257bc79d5a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b61d2f1d-ff3f-4479-a568-a7dabecd1e10_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss)/Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2c9e5dc4-4bc0-446c-920c-d421978815e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EquityIssuedInLieuOfCashConsideration_c3990964-244d-41e9-bd21-dc941890f919_negatedTerseLabel_en-US" xlink:label="lab_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issued in lieu of cash consideration</link:label>
    <link:label id="lab_ctlt_EquityIssuedInLieuOfCashConsideration_label_en-US" xlink:label="lab_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issued in lieu of cash consideration</link:label>
    <link:label id="lab_ctlt_EquityIssuedInLieuOfCashConsideration_documentation_en-US" xlink:label="lab_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity issued in lieu of cash consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:href="ctlt-20210630.xsd#ctlt_EquityIssuedInLieuOfCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:to="lab_ctlt_EquityIssuedInLieuOfCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_d13100f5-b69b-4909-9784-a50e254dd695_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_798992cd-a700-463d-b8b8-7d79cca2ebd9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AccumulatedDeferredCompensationMember_78f30984-cc92-453a-9d32-79364e885f9c_terseLabel_en-US" xlink:label="lab_ctlt_AccumulatedDeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Cash Flow Hedge [Member]</link:label>
    <link:label id="lab_ctlt_AccumulatedDeferredCompensationMember_label_en-US" xlink:label="lab_ctlt_AccumulatedDeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deferred Compensation [Member]</link:label>
    <link:label id="lab_ctlt_AccumulatedDeferredCompensationMember_documentation_en-US" xlink:label="lab_ctlt_AccumulatedDeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deferred Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccumulatedDeferredCompensationMember" xlink:href="ctlt-20210630.xsd#ctlt_AccumulatedDeferredCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AccumulatedDeferredCompensationMember" xlink:to="lab_ctlt_AccumulatedDeferredCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DebtRefinancingCostsDomain_6dc495c4-ff01-4074-84de-2428b666becc_terseLabel_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Costs [Domain]</link:label>
    <link:label id="lab_ctlt_DebtRefinancingCostsDomain_label_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Refinancing Costs [Domain]</link:label>
    <link:label id="lab_ctlt_DebtRefinancingCostsDomain_documentation_en-US" xlink:label="lab_ctlt_DebtRefinancingCostsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Refinancing Costs [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsDomain" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DebtRefinancingCostsDomain" xlink:to="lab_ctlt_DebtRefinancingCostsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_02a426ee-a869-4a38-8360-5696378c4725_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_88dbc502-cf32-413a-ba10-7031b382f1ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_57111a9f-6244-4e64-9745-3295cfabf2dd_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_592825ff-5011-4bd7-b5bc-1c85eb8eae65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d61e7f13-86b6-4af6-be34-6af9051cc2b4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_9f5272b0-be95-49c1-b120-5c92fb81eb33_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding Tax and other foreign taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_ac1d332a-f2fb-40ca-9523-fd07041e6d07_terseLabel_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing fees paid</link:label>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RestructuringAndOtherSpecialItems_eac3d4b8-90eb-4311-8366-47c922ba5296_negatedTerseLabel_en-US" xlink:label="lab_ctlt_RestructuringAndOtherSpecialItems" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and other special items</link:label>
    <link:label id="lab_ctlt_RestructuringAndOtherSpecialItems_label_en-US" xlink:label="lab_ctlt_RestructuringAndOtherSpecialItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Other Special Items</link:label>
    <link:label id="lab_ctlt_RestructuringAndOtherSpecialItems_documentation_en-US" xlink:label="lab_ctlt_RestructuringAndOtherSpecialItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and other special items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestructuringAndOtherSpecialItems" xlink:href="ctlt-20210630.xsd#ctlt_RestructuringAndOtherSpecialItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RestructuringAndOtherSpecialItems" xlink:to="lab_ctlt_RestructuringAndOtherSpecialItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_90e76953-14c9-4596-956e-80a51dad7f88_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_c00c46f1-cd28-4d20-8eed-5cb6e2a5bfbb_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_89b41dd2-5687-4e0e-9452-2c2541447d1e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Asset Allocation (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1683424a-5ab8-48f3-a2f3-e30676dd799a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_d1e61934-ef7d-435c-a686-06b4dc23e731_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_19261ea6-84eb-4a4c-ba95-fa3f2d73e373_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b932d6a8-f8f3-4fd2-aa71-21f303486c7a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_b97f00e3-dee9-4321-9e3f-532a42d30e83_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_a7c93734-60a5-417e-8759-19f0b785b8b8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_d283ea88-3b21-4128-a043-8c888f6fccf3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_USDollarDenominated500SeniorNotesMember_f75dd3a3-d7ce-46c7-94e0-ef13d45b07be_terseLabel_en-US" xlink:label="lab_ctlt_USDollarDenominated500SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Dollar-denominated 5.00% Senior Notes [Member]</link:label>
    <link:label id="lab_ctlt_USDollarDenominated500SeniorNotesMember_label_en-US" xlink:label="lab_ctlt_USDollarDenominated500SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Dollar-denominated 5.00% Senior Notes [Member]</link:label>
    <link:label id="lab_ctlt_USDollarDenominated500SeniorNotesMember_documentation_en-US" xlink:label="lab_ctlt_USDollarDenominated500SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S Dollar-denominated 5.00% Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDollarDenominated500SeniorNotesMember" xlink:href="ctlt-20210630.xsd#ctlt_USDollarDenominated500SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_USDollarDenominated500SeniorNotesMember" xlink:to="lab_ctlt_USDollarDenominated500SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_13b46620-c60e-4b9d-9332-42a5232ea10c_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_92ac3a79-e8d9-4b6b-8574-491f65f5887d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Related to Tax Withholding for Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_210d4cec-63c9-4715-a4d4-f2b98a147da8_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Related to Tax Withholding for Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OralDrugDeliveryMember_ac73dc3c-f586-4af1-9c70-a81393484fe0_terseLabel_en-US" xlink:label="lab_ctlt_OralDrugDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Drug Delivery</link:label>
    <link:label id="lab_ctlt_OralDrugDeliveryMember_label_en-US" xlink:label="lab_ctlt_OralDrugDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Drug Delivery [Member]</link:label>
    <link:label id="lab_ctlt_OralDrugDeliveryMember_documentation_en-US" xlink:label="lab_ctlt_OralDrugDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Drug Delivery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralDrugDeliveryMember" xlink:href="ctlt-20210630.xsd#ctlt_OralDrugDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OralDrugDeliveryMember" xlink:to="lab_ctlt_OralDrugDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne_3acf62aa-509b-4a81-900b-eb71c1552a6b_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year One</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year One</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_04731ec4-2a6c-419c-ba19-5e8bfe1135e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Other Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f0329c80-5f33-413d-8668-2c422caa425c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9557dfcc-1a1f-45a8-beee-52a8dc36efcf_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite Lived Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3c430ad5-f0bf-4f57-a4b9-70b1d2ba5427_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_754f1a41-ed70-4520-af38-0fe7adf11c20_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock_7ab5d84b-c761-4f35-bbc5-c13870972314_terseLabel_en-US" xlink:label="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and Other Assets</link:label>
    <link:label id="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense And Other Assets Table [Text Block]</link:label>
    <link:label id="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expense and other assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:to="lab_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_56b46a2e-6e4a-4a76-995a-d1cc348fda3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of 1% decrease on APBO at balance sheet date</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_817d38d2-7b6d-4d46-95d7-3596dec96742_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Reclassifications_3dd5a365-1596-4960-9961-fc2fb33e812b_terseLabel_en-US" xlink:label="lab_us-gaap_Reclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_Reclassifications_label_en-US" xlink:label="lab_us-gaap_Reclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Reclassifications" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Reclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Reclassifications" xlink:to="lab_us-gaap_Reclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_a131437b-047b-4c9b-8091-56613a05c010_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_879cc2e6-fc1e-4d91-b5e1-f153303862cc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_88826605-c6f5-420a-9c4b-dcc0f5840e98_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare cost trend rate-ulitimate (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_70a125f7-3f26-4c16-bc8d-b99572d822b8_terseLabel_en-US" xlink:label="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</link:label>
    <link:label id="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_label_en-US" xlink:label="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</link:label>
    <link:label id="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_documentation_en-US" xlink:label="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:href="ctlt-20210630.xsd#ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:to="lab_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3daae3b5-0432-4ab7-9ddc-f4778ea473d7_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2c74f871-4724-415b-bd51-4318a30c1f23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5181c56-aa80-4f5a-8bab-ea6aea268f48_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_A2375SeniorEuroDenominatedNotesMember_dfee8121-3b09-4f02-aec8-af2ae84da940_terseLabel_en-US" xlink:label="lab_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% Senior Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_ctlt_A2375SeniorEuroDenominatedNotesMember_label_en-US" xlink:label="lab_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% Senior Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_ctlt_A2375SeniorEuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.375% Senior Euro Denominated Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:href="ctlt-20210630.xsd#ctlt_A2375SeniorEuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:to="lab_ctlt_A2375SeniorEuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d53fc09a-3b96-4e2b-adda-a57c89102b07_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_CoreTechnologyMember_0bfc7ba2-bc6d-47ca-8164-4068f9e48284_terseLabel_en-US" xlink:label="lab_ctlt_CoreTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core technology [Member]</link:label>
    <link:label id="lab_ctlt_CoreTechnologyMember_label_en-US" xlink:label="lab_ctlt_CoreTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technology [Member]</link:label>
    <link:label id="lab_ctlt_CoreTechnologyMember_documentation_en-US" xlink:label="lab_ctlt_CoreTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CoreTechnologyMember" xlink:href="ctlt-20210630.xsd#ctlt_CoreTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_CoreTechnologyMember" xlink:to="lab_ctlt_CoreTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_NonAllocatedCorporateCostsNet_952eaef6-a843-45c4-b4e3-f8870b95f0bf_negatedTerseLabel_en-US" xlink:label="lab_ctlt_NonAllocatedCorporateCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-allocated corporate costs, net</link:label>
    <link:label id="lab_ctlt_NonAllocatedCorporateCostsNet_label_en-US" xlink:label="lab_ctlt_NonAllocatedCorporateCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Allocated Corporate Costs Net</link:label>
    <link:label id="lab_ctlt_NonAllocatedCorporateCostsNet_documentation_en-US" xlink:label="lab_ctlt_NonAllocatedCorporateCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-allocated corporate costs, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NonAllocatedCorporateCostsNet" xlink:href="ctlt-20210630.xsd#ctlt_NonAllocatedCorporateCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_NonAllocatedCorporateCostsNet" xlink:to="lab_ctlt_NonAllocatedCorporateCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_eb464b5c-904f-4a21-9f0b-5a14739b407e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales, settlements, contributions and benefits paid</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a34f8175-b440-4d8e-aa65-68d82079ce0c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_60eceaca-7ae7-4476-9e04-ace82ed4c3f9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2e37c539-b1ab-40ed-9823-a7e7750e1065_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_d1d77a42-01a6-4c9f-bbb4-956ee96a1cbf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_787e12c8-4975-430c-92a6-f6583d8b7616_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1989329b-e936-4f29-985b-205a2210ac18_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_38af0caa-5289-4258-a140-413820024cca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_dcad82fb-c7b9-44cc-b99e-73ae4bc74949_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupDomain_1f2a6b04-559b-4541-af0a-5787e6205804_terseLabel_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, by Age Group [Domain]</link:label>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupDomain_label_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, by Age Group [Domain]</link:label>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupDomain_documentation_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Postretirement Benefits, by Age Group [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:to="lab_ctlt_PostretirementBenefitsByAgeGroupDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a945e406-26b6-4f3d-bbad-b9340f6abf8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_52f09140-d19f-4802-bcca-4412a7839389_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total foreign currency translation adjustments, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5d3d11c0-a44c-4928-9c98-a0e826de0d7f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_7876646f-5c5a-43a5-9121-163dae71d177_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_aef71a6c-1eac-494d-9949-c3bfe9e10ae1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_67f8cbdb-4217-4314-ad22-214125edf9c7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_41bfb3f7-d02a-4d5c-a1c3-3ef9b835f5bb_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_82a82b50-59ef-4021-8ac7-84fb245308f4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_12c3e7ff-213a-466b-9f13-45ba0ac77f9d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8b30a98f-63cf-4561-ae4c-4007e1ce10c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_4489a3d1-7d8d-47c4-ae54-843a6f1165b3_terseLabel_en-US" xlink:label="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value of Restricted Stock Unit</link:label>
    <link:label id="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_label_en-US" xlink:label="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value of Restricted Stock Unit</link:label>
    <link:label id="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_documentation_en-US" xlink:label="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of restricted stock unit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:href="ctlt-20210630.xsd#ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:to="lab_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_3ee2b80b-4b06-4425-9d87-153584c407fc_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_a2ce8a8c-e10a-4711-afbb-de7fc25676bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_3d668f90-19c3-42cd-90d6-a49c42b007a5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_label_en-US" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:to="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RestofWorldMember_56533194-3a98-49c3-8152-e76b3aeb1dc8_terseLabel_en-US" xlink:label="lab_ctlt_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Other [Member]</link:label>
    <link:label id="lab_ctlt_RestofWorldMember_label_en-US" xlink:label="lab_ctlt_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_ctlt_RestofWorldMember_documentation_en-US" xlink:label="lab_ctlt_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestofWorldMember" xlink:href="ctlt-20210630.xsd#ctlt_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RestofWorldMember" xlink:to="lab_ctlt_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ConcentrationRiskNumberofCustomers_73b68164-7f58-4e92-a0d2-623e70b9616c_terseLabel_en-US" xlink:label="lab_ctlt_ConcentrationRiskNumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:label id="lab_ctlt_ConcentrationRiskNumberofCustomers_label_en-US" xlink:label="lab_ctlt_ConcentrationRiskNumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:label id="lab_ctlt_ConcentrationRiskNumberofCustomers_documentation_en-US" xlink:label="lab_ctlt_ConcentrationRiskNumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Number of Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ConcentrationRiskNumberofCustomers" xlink:href="ctlt-20210630.xsd#ctlt_ConcentrationRiskNumberofCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ConcentrationRiskNumberofCustomers" xlink:to="lab_ctlt_ConcentrationRiskNumberofCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_4e63e46d-08cc-47fe-a62a-7463875b8a2e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_938aaa59-1d5c-4e03-9662-cedd676a5e5d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_ec0b33b2-6b55-4457-a9b4-deca2442707f_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_899374c2-332f-4cfc-970e-9a7ac49bc819_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ca186d3f-c252-40e6-a197-3b548b64924e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife_467e3496-f386-4a40-b7a3-535af0803c47_terseLabel_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Indefinite Life</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife_label_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Indefinite Life</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife_documentation_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Indefinite Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsIndefiniteLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:to="lab_ctlt_OperatingLossCarryforwardsIndefiniteLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_985c96c9-8098-449e-93b2-88e062d1036b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_9a9c1ab8-e2c6-422e-84aa-fb91cd6aa7a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_5371f40d-50ec-4cab-a143-236eb6e388e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6d0902bc-c189-4ad7-a5ab-635f2803e2cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ec737c61-13e2-43f3-be5c-f081b01fff3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_33483c96-d177-4fa2-a99a-dfc6f73cbc74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_3c15fe70-89ca-4ba6-b425-1b4c1f9aaa33_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING ACTIVITY:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1cf50e60-e05f-451f-b60a-aae2e9462014_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_19224440-39a1-4664-9843-f384a8b55ab5_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_495d759f-52e7-4aa7-98fa-0912de503632_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd3b3504-5152-48e8-acde-64db04dce3ac_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d30810b2-9f73-4c2c-94a0-98ae70a7129f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_936e53e5-4d38-402b-bebd-3550d290fe3b_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Pension, Significant, Future Employer Contribution, Amount</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Pension, Significant, Future Employer Contribution, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" xlink:to="lab_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_fdadfcbb-eefe-4b83-8514-29edc5049c02_terseLabel_en-US" xlink:label="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:label id="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_label_en-US" xlink:label="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:label id="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_documentation_en-US" xlink:label="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Noncash Divestiture, Amount of Consideration Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:href="ctlt-20210630.xsd#ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:to="lab_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_1b37aaf1-100e-4e00-9c57-4b544325494c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_e0d2d5fc-26d0-4bb7-9628-612369d373f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_cde91d92-dc0e-4aa4-8791-1b17ba95060b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by/(used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_23561831-1b5b-444c-b0d1-4025562aa6e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PensionAsset_45baf40a-d1e6-4722-be91-0c21a03e1766_terseLabel_en-US" xlink:label="lab_ctlt_PensionAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Asset</link:label>
    <link:label id="lab_ctlt_PensionAsset_label_en-US" xlink:label="lab_ctlt_PensionAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Asset</link:label>
    <link:label id="lab_ctlt_PensionAsset_documentation_en-US" xlink:label="lab_ctlt_PensionAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PensionAsset" xlink:href="ctlt-20210630.xsd#ctlt_PensionAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PensionAsset" xlink:to="lab_ctlt_PensionAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_825dd6b1-f3b1-4531-8d34-d8c8c2c7ff71_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ca43842e-8dac-45a9-9350-3ed755e1422a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c5f3051f-3c8d-45aa-a312-63c1f82f7def_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3342bf9f-efc5-4fe4-8c3b-001804de2dd8_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount_312bd84c-c1f3-4fcb-a067-35c1be15ea6a_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d44a3360-b8c2-490e-95eb-be472b414f54_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fdb00d1d-a37e-4047-9e41-1176736760a5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_6151d311-a561-412d-8906-0ea4e45035b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_56a427df-36e9-42b3-91a0-096c30e5ed8b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PledgePercentageOfCapitalStock_66684977-0b31-42ad-a1b4-bc97dc9a30f4_terseLabel_en-US" xlink:label="lab_ctlt_PledgePercentageOfCapitalStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge Percentage Of Capital Stock</link:label>
    <link:label id="lab_ctlt_PledgePercentageOfCapitalStock_label_en-US" xlink:label="lab_ctlt_PledgePercentageOfCapitalStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge Percentage Of Capital Stock</link:label>
    <link:label id="lab_ctlt_PledgePercentageOfCapitalStock_documentation_en-US" xlink:label="lab_ctlt_PledgePercentageOfCapitalStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledge percentage of capital stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfCapitalStock" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfCapitalStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PledgePercentageOfCapitalStock" xlink:to="lab_ctlt_PledgePercentageOfCapitalStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_6c24b0ff-9eea-42ec-86d9-992dd699dc22_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_c4772022-b841-41a0-a707-c7a7bf634cef_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_d3211e90-2b95-41b5-b199-6f8ffbeae6a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a8cd40e0-8f76-442d-9970-caf9f3b0203d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax_38bd9542-c324-445c-8f32-e6715af2b489_terseLabel_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative and Hedge, (Income) Loss</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax_label_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Derivative and Hedge, after Reclassification Adjustment, Tax</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax_documentation_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Derivative and Hedge, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:to="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_70e0a57a-01f2-4fef-8486-8594ca90e36e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition (asset)/obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Transition Asset (Obligation)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_d3a664b8-a22f-4ab5-9907-59692b5beb1a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_348f9d88-262e-4826-aaea-2971e17bfffb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_cba510ab-473d-4ba9-9336-735acc7ee892_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_d196ffc0-bf7d-4c0a-be06-357cf095e3ec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InstallmentPaymentForAcquisition_a6dd94c2-d9ac-488f-a851-0b3921a857d8_terseLabel_en-US" xlink:label="lab_ctlt_InstallmentPaymentForAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Next Twelve Months</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentForAcquisition_label_en-US" xlink:label="lab_ctlt_InstallmentPaymentForAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentForAcquisition_documentation_en-US" xlink:label="lab_ctlt_InstallmentPaymentForAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentForAcquisition" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentForAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InstallmentPaymentForAcquisition" xlink:to="lab_ctlt_InstallmentPaymentForAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86718cf6-22af-4d55-b63b-02d3e88bf0fb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange_462294f1-771a-42d4-9e5e-f59d4db1525a_terseLabel_en-US" xlink:label="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign exchange</link:label>
    <link:label id="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange_label_en-US" xlink:label="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Receivable, Impact Of Foreign Exchange</link:label>
    <link:label id="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange_documentation_en-US" xlink:label="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts receivable impact of foreign exchange.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:href="ctlt-20210630.xsd#ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:to="lab_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_4096141d-5ca8-4208-837a-69558ebaa8c1_terseLabel_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Line Items]</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_label_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Line Items]</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_documentation_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:to="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_47ebfaf0-2963-44d5-912c-5a3b584217f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7ad9e605-8fc3-4c4d-925a-832a3871b3fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_14ff5ad6-65aa-4d63-98d7-a953b957899b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND EQUIVALENTS AT BEGINNING OF PERIOD</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e25b1de5-c9df-4655-b13e-b7b1afe4f044_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND EQUIVALENTS AT END OF PERIOD</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fac2a37f-36cb-48e7-bb1a-2c565d8cfa61_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_c52d906a-6dc6-45b2-b73d-2674899b1de1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TimeBasedRestrictedStockUnitsMember_cf713de9-a63c-4b4c-9f7a-7bde8949b0f5_terseLabel_en-US" xlink:label="lab_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_ctlt_TimeBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_ctlt_TimeBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:href="ctlt-20210630.xsd#ctlt_TimeBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:to="lab_ctlt_TimeBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b215328f-e2ef-4a5a-b857-46198793d5e5_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_574c234b-21ae-46ba-b4e7-a7f0f74c0059_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition asset/(obligation) recognized during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a0a4bdca-833d-45c8-8ec5-b21bb0cc40b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a86ef864-433d-4350-90c0-09eedb5d1969_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock Outstandings</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_af620ab9-c0c3-433c-ae88-598d7ade0797_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RevolvingCreditCommitmentsMember_0313529b-7a1c-4729-8d41-215ef2a77cf6_terseLabel_en-US" xlink:label="lab_ctlt_RevolvingCreditCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Commitments [Member]</link:label>
    <link:label id="lab_ctlt_RevolvingCreditCommitmentsMember_label_en-US" xlink:label="lab_ctlt_RevolvingCreditCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Commitments [Member]</link:label>
    <link:label id="lab_ctlt_RevolvingCreditCommitmentsMember_documentation_en-US" xlink:label="lab_ctlt_RevolvingCreditCommitmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditCommitmentsMember" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditCommitmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RevolvingCreditCommitmentsMember" xlink:to="lab_ctlt_RevolvingCreditCommitmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_cc89f172-e572-4bb9-8448-52b17e758479_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3393ca91-462e-46b7-83f2-33d6baa11c74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ForeignNetOperatingLossEstablishedMember_3c5626f0-9621-45a2-8a3b-3ff1a25cf4ef_terseLabel_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss Established [Member]</link:label>
    <link:label id="lab_ctlt_ForeignNetOperatingLossEstablishedMember_label_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss Established [Member]</link:label>
    <link:label id="lab_ctlt_ForeignNetOperatingLossEstablishedMember_documentation_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss Established</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossEstablishedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:to="lab_ctlt_ForeignNetOperatingLossEstablishedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilityMember_f3e90240-f863-47dd-ace0-a91e97160a43_terseLabel_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility [Member]</link:label>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilityMember_label_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility [Member]</link:label>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilityMember_documentation_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilityMember" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SeniorSecuredCreditFacilityMember" xlink:to="lab_ctlt_SeniorSecuredCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_dfdb75cc-bdae-4cee-8a89-8ce1f900b6d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_75726648-1f7f-473d-be1e-3d210b93b7a5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee-related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_4053e335-5620-4bdc-891c-7f37b8a48b70_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_53732de6-f80e-4f6e-9dca-af1b6c0f9b5f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8dbaf9f9-bc30-4d58-a51b-436cd6e52fb7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AcordaTherapeuticsIncMember_e5dbbde3-bfd8-4d6e-b804-7a3806b08c79_terseLabel_en-US" xlink:label="lab_ctlt_AcordaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acorda Therapeutics, Inc</link:label>
    <link:label id="lab_ctlt_AcordaTherapeuticsIncMember_label_en-US" xlink:label="lab_ctlt_AcordaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acorda Therapeutics, Inc [Member]</link:label>
    <link:label id="lab_ctlt_AcordaTherapeuticsIncMember_documentation_en-US" xlink:label="lab_ctlt_AcordaTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acorda Therapeutics, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AcordaTherapeuticsIncMember" xlink:href="ctlt-20210630.xsd#ctlt_AcordaTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AcordaTherapeuticsIncMember" xlink:to="lab_ctlt_AcordaTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax_b34276e1-659f-4dfa-a397-b39038e4b4b7_terseLabel_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Derivative and Hedge (gain)/loss arising during the year</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative and Hedge, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax_documentation_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative and Hedge, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_d7faa55a-5454-447a-9bc2-96888a1be548_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare cost trend rate-initial (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_b36210f8-5d87-4a52-8bac-cac07c4d740a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_16aa80cf-59f8-4a6b-94e8-719b40335764_terseLabel_en-US" xlink:label="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Estimate of Embedded Derivative Liability</link:label>
    <link:label id="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_label_en-US" xlink:label="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Estimate of Embedded Derivative Liability</link:label>
    <link:label id="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_documentation_en-US" xlink:label="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Estimate of Embedded Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:to="lab_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2fd612b0-0b2d-4443-8657-4cc9e2b4a491_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_6cf7b1a1-6438-492a-b74f-5c707caf9b6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_f7b59465-7158-4a6a-a46c-ae82ad3413b2_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_16c615f4-0f45-43fb-927c-15c76cc2ac84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed (Earnings) Loss, Basic</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_f9ad553f-b03a-4770-9dcc-a5905c61bbf1_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustments</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive_62229072-8357-45ab-aa40-52c56d09e988_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_38865ede-d2b6-48ff-b0a5-c14e5f0a4dd4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_aabe58c8-fdce-44c8-94a6-c7a301127371_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis_f2160439-db58-4889-9739-79749fa33c0d_terseLabel_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets [Axis]</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis_label_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets [Axis]</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis_documentation_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:to="lab_ctlt_DefinedBenefitPlanOtherAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_59640001-3808-4b06-b889-fe6bb9fc00dd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate gain/(loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7ca5427d-da50-4187-80db-2b4f643b80e4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fb21f508-ab6c-4dcf-b349-1ee6417f9092_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_247be99e-812b-46e3-a5fa-9720d91608ad_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_4faa6966-d620-454f-97ac-5c59212723fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition (asset)/obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Transition Asset (Obligation), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_ef3668cc-e980-4e1e-bc06-52c069f29d1e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b8a0c5c5-268d-4ccc-83c0-9221c02bdbbd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities and expenses</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_7b542a70-c757-4662-90df-0cb7ff521187_terseLabel_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent</link:label>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_label_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:to="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_320f3994-87f5-48d7-a629-d0032756df44_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income /(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4eadcd82-012f-46bd-a630-58564ebea860_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income /(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_5bfba1c5-8390-4321-bad4-bfc601f499b1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a7b28302-5325-4b17-ab73-9ddaa2fc44b0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_308604c4-9964-48c4-a5fd-7231fe938557_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_dec3bf4d-a26a-4085-af24-ff2593c32243_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_17a77bb4-a98a-447d-baaa-3889d0200520_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d64ce367-5540-49f7-9e2c-6a0083c64508_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e9f9f713-78a8-4fcb-a456-20b4eae182ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of the deferred income tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BusinessCombinationLoanDiscount_ca379e9d-65bb-4d55-9690-556e21c6bb57_terseLabel_en-US" xlink:label="lab_ctlt_BusinessCombinationLoanDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Loan Discount</link:label>
    <link:label id="lab_ctlt_BusinessCombinationLoanDiscount_label_en-US" xlink:label="lab_ctlt_BusinessCombinationLoanDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Loan Discount</link:label>
    <link:label id="lab_ctlt_BusinessCombinationLoanDiscount_documentation_en-US" xlink:label="lab_ctlt_BusinessCombinationLoanDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Loan Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationLoanDiscount" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationLoanDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BusinessCombinationLoanDiscount" xlink:to="lab_ctlt_BusinessCombinationLoanDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_97520685-234f-4ac5-94df-da6e0261fa80_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_bbf7aabb-9d05-468a-81b8-1edeade1096b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss recognized during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_30c4186e-279e-4d72-8cf8-158f45cbd054_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_452d1b65-9cfb-480e-b26f-da25bf52bdef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_835c3500-1c4a-48b5-a696-32a3575f781a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_507089df-1d60-4baa-b22f-911d6a049d58_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b77686b4-67c9-4c6b-82d0-edc3c375d7e2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d6fa8eef-05eb-4d6e-98e5-6023c1d2c71b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_1ccb77ef-66d2-4fe1-8af8-5a061fa05200_terseLabel_en-US" xlink:label="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relating to assets still held at the reporting date</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_label_en-US" xlink:label="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconcilation, Recurring Basis, Assets Held at Reporting Date</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_documentation_en-US" xlink:label="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconcilation, Recurring Basis, Assets Held at Reporting Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:to="lab_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_65303880-a5a2-48c3-870b-20ebced42229_terseLabel_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Limitations, Section 382</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_label_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Limitations, Section 382</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_documentation_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Limitations, Section 382</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:to="lab_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_4a9e7ca7-62c3-44e9-95dc-16b3f34b1e59_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_0d785dd2-9ca6-4321-bf87-28218416e676_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Deferred Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_36ac8f34-dc1c-44e7-a2eb-8e384dd392c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_6fa1aacb-539e-4f6d-9d3b-d5956e553c6f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_85449877-313f-4d78-882c-bd5ee57f6bb4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain" xlink:to="lab_us-gaap_DeferredTaxAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_99221be5-4ecf-41b2-9921-ca93d1d7d57a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_90de96ac-7167-4b2b-9ba3-7e2196c85a22_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_2c98b527-1579-4b33-b5d2-a1557a90f121_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_fa35ef25-cae3-4936-a47f-eaa2129336c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Translation Adjustment [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0f9f9883-7b11-47ba-a9b5-a382a2f1f602_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3dc282ff-dc10-4a19-81c8-a6323ba20bd8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2191146f-6bbe-4595-a0c5-080f68648736_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_StockOptionGrantedContractualTerm_f0e22256-501b-47d7-8314-8812d8e9ac22_terseLabel_en-US" xlink:label="lab_ctlt_StockOptionGrantedContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Granted Contractual Term</link:label>
    <link:label id="lab_ctlt_StockOptionGrantedContractualTerm_label_en-US" xlink:label="lab_ctlt_StockOptionGrantedContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Granted Contractual Term</link:label>
    <link:label id="lab_ctlt_StockOptionGrantedContractualTerm_documentation_en-US" xlink:label="lab_ctlt_StockOptionGrantedContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option granted contractual term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockOptionGrantedContractualTerm" xlink:href="ctlt-20210630.xsd#ctlt_StockOptionGrantedContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_StockOptionGrantedContractualTerm" xlink:to="lab_ctlt_StockOptionGrantedContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfDebtLineItems_ed2eed0d-edc0-4f79-a528-1f50bd172277_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Line Items]</link:label>
    <link:label id="lab_ctlt_ScheduleOfDebtLineItems_label_en-US" xlink:label="lab_ctlt_ScheduleOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Line Items]</link:label>
    <link:label id="lab_ctlt_ScheduleOfDebtLineItems_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtLineItems" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfDebtLineItems" xlink:to="lab_ctlt_ScheduleOfDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_77686584-060f-41e4-b04b-f08e4da5281a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in Statement of Financial Position</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_MaximumPercentageOfVotingStock_4a3b3c14-db29-468b-87c3-223e43273907_terseLabel_en-US" xlink:label="lab_ctlt_MaximumPercentageOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Percentage Of Voting Stock from non US subsidiary</link:label>
    <link:label id="lab_ctlt_MaximumPercentageOfVotingStock_label_en-US" xlink:label="lab_ctlt_MaximumPercentageOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Percentage Of Voting Stock</link:label>
    <link:label id="lab_ctlt_MaximumPercentageOfVotingStock_documentation_en-US" xlink:label="lab_ctlt_MaximumPercentageOfVotingStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of voting stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaximumPercentageOfVotingStock" xlink:href="ctlt-20210630.xsd#ctlt_MaximumPercentageOfVotingStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_MaximumPercentageOfVotingStock" xlink:to="lab_ctlt_MaximumPercentageOfVotingStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_e58163a5-cbf8-48cd-b12b-8ef1bbe24dce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed healthcare cost trend rates</link:label>
    <link:label id="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Health Care Cost Trend Rates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_c7f21e4f-7c95-4078-97f9-1fde5c1168e3_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_2d51ffcd-9b63-4281-aa12-b9e792dd7d49_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_4e750eca-ac0c-49b2-8494-4a4969da67d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_da1c92ab-eb64-46ec-ae58-a4b75c45e972_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_f9447ffa-7af0-445c-922e-8ccd1be8d1da_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_f156df6a-75ab-48d0-b3ba-ca62a393988f_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service[Member]</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_913bd15f-e2bb-49ec-89d2-ad9eaf32e317_negatedLabel_en-US" xlink:label="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges and gain/(loss) on sale of assets</link:label>
    <link:label id="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_label_en-US" xlink:label="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charges And Gain Loss On Sale Of Assets</link:label>
    <link:label id="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_documentation_en-US" xlink:label="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges and (gain)/loss on sale of assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:href="ctlt-20210630.xsd#ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:to="lab_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_eaae5e0d-c5c3-4078-8f3b-7d22a7413346_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ac4bcfe6-9c26-4b5f-a876-51a0ba84511a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1623afca-8df5-4db6-a35d-412b47f09305_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_2a3f8467-dd0a-425e-9fdb-d1c36dce4fd5_terseLabel_en-US" xlink:label="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar-denominated 4.875% Senior Notes [Member]</link:label>
    <link:label id="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_label_en-US" xlink:label="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar-denominated 4.875% Senior Notes [Member]</link:label>
    <link:label id="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_documentation_en-US" xlink:label="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar-denominated 4.875% Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:href="ctlt-20210630.xsd#ctlt_U.S.Dollardenominated4.875SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:to="lab_ctlt_U.S.Dollardenominated4.875SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_7f8dfd31-f708-4a21-9eb4-4d01e09b7478_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7ec27d65-26f2-4fa7-b957-32e9a0d063bf_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_40268f92-eab5-4ba6-bc82-a4a2e3b34094_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStock_4778d48f-5a19-4699-bebd-4dbc16dde31d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStock" xlink:to="lab_us-gaap_DividendsPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_b3120f1b-3375-425b-b4dc-e527529a4a55_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7c46bc05-f2a3-47ad-b04f-f6c8b882fead_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e3fd4d98-09c1-4a46-a5ae-1a6d545cd2f0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_8c0245a9-6d9e-4bba-b0f0-9f91b827dd2b_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TimeMember_303f2c6d-d33b-4c31-b030-ce321f88ce0c_terseLabel_en-US" xlink:label="lab_ctlt_TimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time [Member]</link:label>
    <link:label id="lab_ctlt_TimeMember_label_en-US" xlink:label="lab_ctlt_TimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time [Member]</link:label>
    <link:label id="lab_ctlt_TimeMember_documentation_en-US" xlink:label="lab_ctlt_TimeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeMember" xlink:href="ctlt-20210630.xsd#ctlt_TimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TimeMember" xlink:to="lab_ctlt_TimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_982550b0-acf0-4ff6-afc1-f38011e2449e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1e00af7e-146e-4d46-9917-1c7a99934f4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d366b50f-b318-4e40-8e99-7dd5bf514074_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5edcd1c2-bd8f-45db-8e6d-c75cbeea5606_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d5033989-9103-4928-be33-fdcd8a9de678_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6d3ab248-ac8d-4329-a507-7d3c9d7e2f67_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_9958ce78-f438-4a05-a33c-5420474783dc_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_c19d3190-6cda-49f8-b690-ecd0a8872809_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock_70a882f2-c20b-4f29-ad23-4e527098c20a_terseLabel_en-US" xlink:label="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables allowance for doubtful accounts</link:label>
    <link:label id="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock_label_en-US" xlink:label="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables Allowance For Doubtful Accounts Table [Text Block]</link:label>
    <link:label id="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables allowance for doubtful accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:to="lab_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_NumberofDoses_49ba133b-dccb-40cd-b956-fde3aca0d941_terseLabel_en-US" xlink:label="lab_ctlt_NumberofDoses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Doses</link:label>
    <link:label id="lab_ctlt_NumberofDoses_label_en-US" xlink:label="lab_ctlt_NumberofDoses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Doses</link:label>
    <link:label id="lab_ctlt_NumberofDoses_documentation_en-US" xlink:label="lab_ctlt_NumberofDoses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Doses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofDoses" xlink:href="ctlt-20210630.xsd#ctlt_NumberofDoses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_NumberofDoses" xlink:to="lab_ctlt_NumberofDoses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_f4300f49-5b62-4e31-8a42-0e0c4d952d29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_59c050a1-eea4-4df5-a9ef-e7bfefcb3923_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_11ab1737-f91d-4c73-899e-19230aab95c4_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock_4e0581ea-8299-40e9-b9fd-cdfeb634a554_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:to="lab_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c724c0e9-3871-4f97-9d01-8854bb2150ed_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_65f452c6-6f36-4e55-9249-7c518762d0b4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationEliminationsMember_e1422304-3206-4a6e-acdb-2a1675dff643_terseLabel_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Eliminations [Member]</link:label>
    <link:label id="lab_srt_ConsolidationEliminationsMember_label_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationEliminationsMember" xlink:to="lab_srt_ConsolidationEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f1ac7b93-72a7-4467-9ca7-3812740cb367_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f1f97c9c-7464-4f8e-9663-58e108cde877_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_fb8100db-3b6f-4a47-b75e-303d7874f838_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock_0eb41a71-73d0-4db5-b53b-269047c1cf47_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Financing Leases Presented in Balance Sheet</link:label>
    <link:label id="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Financing Leases Presented in Balance Sheet [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Financing Leases Presented in Balance Sheet</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:to="lab_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ec2d981e-1cc4-44a1-af70-4a1de42d5df2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c7fc6c2d-bbd7-45f1-aa82-799b11c01e13_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_cddf3836-6aef-4e20-b3bf-a84ff8b8312c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivable_74c61d34-b70f-4cdd-90e5-c86dc53fc638_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Receivable</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivable_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValueAddedTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivable" xlink:to="lab_us-gaap_ValueAddedTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherObligationsMember_f5ca822b-9e53-4e11-a9df-32fdaa5d6c00_terseLabel_en-US" xlink:label="lab_ctlt_OtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Obligations [Member]</link:label>
    <link:label id="lab_ctlt_OtherObligationsMember_label_en-US" xlink:label="lab_ctlt_OtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Obligations [Member]</link:label>
    <link:label id="lab_ctlt_OtherObligationsMember_documentation_en-US" xlink:label="lab_ctlt_OtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherObligationsMember" xlink:href="ctlt-20210630.xsd#ctlt_OtherObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherObligationsMember" xlink:to="lab_ctlt_OtherObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_Post65Member_4b7b9f47-76aa-4433-83f6-293103449d68_terseLabel_en-US" xlink:label="lab_ctlt_Post65Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 65 [Member]</link:label>
    <link:label id="lab_ctlt_Post65Member_label_en-US" xlink:label="lab_ctlt_Post65Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 65 [Member]</link:label>
    <link:label id="lab_ctlt_Post65Member_documentation_en-US" xlink:label="lab_ctlt_Post65Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 65 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Post65Member" xlink:href="ctlt-20210630.xsd#ctlt_Post65Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_Post65Member" xlink:to="lab_ctlt_Post65Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d810328-c90c-41d4-b1fa-f1c925623f45_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ed1adb3a-6860-439f-82d0-3011de678b23_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_4adbbfb3-34a6-4381-bdb6-059290cbf75d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6f53dc7b-1e31-4050-8777-0fb9f8f11994_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_65bd8a1f-845d-4e07-832b-9d60a020316f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_e41e9e47-bbad-4f3e-9c58-850acb63a3bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_eb007165-1cb5-40a4-89e9-2ba743d11b58_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc965e22-3c5b-4047-8f5c-7e3d36816b70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_59d424c9-febb-4423-b1bb-8b3c380214e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/(credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DocumentDocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_ctlt_DocumentDocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_ctlt_DocumentDocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_ctlt_DocumentDocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DocumentDocumentAndEntityInformationAbstract" xlink:href="ctlt-20210630.xsd#ctlt_DocumentDocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract" xlink:to="lab_ctlt_DocumentDocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_b4cf987a-e55f-4bed-891c-a63ed5172329_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_9f333d28-5b8d-4a43-990c-a9b0e7142b8f_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5937a54b-fdf5-4491-bf6d-85c8bb316033_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Post-Retirement Benefits [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1bd2060a-20da-48ba-af50-83efb7758a8a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_0c36917a-df67-4e7a-af3e-f5f4baba65cf_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate_2c33dac3-8eac-4beb-b2f1-7fac082fd81d_terseLabel_en-US" xlink:label="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Quarterly Amortization Rate</link:label>
    <link:label id="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate_label_en-US" xlink:label="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Quarterly Amortization Rate</link:label>
    <link:label id="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate_documentation_en-US" xlink:label="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Quarterly Amortization Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:href="ctlt-20210630.xsd#ctlt_DebtInstrumentQuarterlyAmortizationRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:to="lab_ctlt_DebtInstrumentQuarterlyAmortizationRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7e5cd460-1607-4a34-82cf-5492882dbdc6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EmployeeStockOptionsandRSUsMember_a06d10ae-9a87-402c-96b9-c97d88df5d96_terseLabel_en-US" xlink:label="lab_ctlt_EmployeeStockOptionsandRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and RSUs [Member]</link:label>
    <link:label id="lab_ctlt_EmployeeStockOptionsandRSUsMember_label_en-US" xlink:label="lab_ctlt_EmployeeStockOptionsandRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and RSUs [Member]</link:label>
    <link:label id="lab_ctlt_EmployeeStockOptionsandRSUsMember_documentation_en-US" xlink:label="lab_ctlt_EmployeeStockOptionsandRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and RSUs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmployeeStockOptionsandRSUsMember" xlink:href="ctlt-20210630.xsd#ctlt_EmployeeStockOptionsandRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EmployeeStockOptionsandRSUsMember" xlink:to="lab_ctlt_EmployeeStockOptionsandRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_607eac3a-2117-40d9-ab81-aea3137015da_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_8cd4ec0d-0c27-4efa-bab0-13275cd7d583_terseLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment EBITDA</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_5d8299e6-da54-47ab-9855-e63bd5d295ae_verboseLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA from continuing operations</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_label_en-US" xlink:label="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Earning Before Interest Tax Depreciation And Amortization</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_documentation_en-US" xlink:label="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment reporting information earning before interest tax depreciation and amortization.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:to="lab_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2dbf94b8-ed4d-4d00-b80d-cd044ddad89d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8497751f-e5be-48ad-977d-7cbb51643464_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c042a63a-833a-4848-a77b-3f9b7c4df9b3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9e78b193-45dd-4282-bd6f-a9ed4e3065c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4222e095-8a07-4323-b120-18688041d370_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_50090533-8b19-480d-8f91-2cad88ad74e8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b9716bbb-ab93-4a10-a941-f3ceed8e7d24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_d770218e-6c79-40ee-84dc-ba6066986e42_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_28f86517-0e2a-42ec-8f9a-ab17965bf8a5_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_0b1ff34c-f0b6-491f-8222-73d200c81110_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_45b8cb48-fc59-496a-a472-83e8f9308b20_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_c13d1090-0e4b-499d-a7c5-21f5fb0ed35b_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_4f7c5464-6e0e-42cc-b6dd-2e58b07d15b1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_KyotoMember_eae33846-3fce-4ef0-b2b8-794659117e12_terseLabel_en-US" xlink:label="lab_ctlt_KyotoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyoto</link:label>
    <link:label id="lab_ctlt_KyotoMember_label_en-US" xlink:label="lab_ctlt_KyotoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyoto [Member]</link:label>
    <link:label id="lab_ctlt_KyotoMember_documentation_en-US" xlink:label="lab_ctlt_KyotoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyoto</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_KyotoMember" xlink:href="ctlt-20210630.xsd#ctlt_KyotoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_KyotoMember" xlink:to="lab_ctlt_KyotoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b5ee4d2d-2151-48b3-937c-1f22e20825b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsIncurred_794d5b74-54ea-4d88-a107-289cfdac2674_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Incurred</link:label>
    <link:label id="lab_us-gaap_InterestCostsIncurred_label_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsIncurred" xlink:to="lab_us-gaap_InterestCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PreferredStockIssuanceValueNet_905bae3d-4f20-4516-b1d6-d3a4a75a7def_terseLabel_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value, Net</link:label>
    <link:label id="lab_ctlt_PreferredStockIssuanceValueNet_label_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value, Net</link:label>
    <link:label id="lab_ctlt_PreferredStockIssuanceValueNet_documentation_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValueNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValueNet" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PreferredStockIssuanceValueNet" xlink:to="lab_ctlt_PreferredStockIssuanceValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SkeletalCellTherapySupportSAMember_df26bb1b-3378-42a8-9546-221915c62319_terseLabel_en-US" xlink:label="lab_ctlt_SkeletalCellTherapySupportSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Cell Therapy Support SA</link:label>
    <link:label id="lab_ctlt_SkeletalCellTherapySupportSAMember_label_en-US" xlink:label="lab_ctlt_SkeletalCellTherapySupportSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Cell Therapy Support SA [Member]</link:label>
    <link:label id="lab_ctlt_SkeletalCellTherapySupportSAMember_documentation_en-US" xlink:label="lab_ctlt_SkeletalCellTherapySupportSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Cell Therapy Support SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SkeletalCellTherapySupportSAMember" xlink:href="ctlt-20210630.xsd#ctlt_SkeletalCellTherapySupportSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SkeletalCellTherapySupportSAMember" xlink:to="lab_ctlt_SkeletalCellTherapySupportSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_abf7a1c1-5b80-46ec-895c-f788f16f08bd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7ca7e923-c91c-4529-964b-f46d6eb695a2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retirement Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3deea419-f330-4e6c-bac5-7f596aee5cd1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fd89da69-0441-4c80-b265-e572ed14df60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2a918329-7705-44ff-813f-5c4dcb44af03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption_2886ae77-31d1-4cd6-9fd5-586c22e40f2b_terseLabel_en-US" xlink:label="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Over-allotment Option</link:label>
    <link:label id="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption_label_en-US" xlink:label="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Over-allotment Option</link:label>
    <link:label id="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption_documentation_en-US" xlink:label="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Over-allotment Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:href="ctlt-20210630.xsd#ctlt_StockIssuedDuringPeriodValueOverAllotmentOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:to="lab_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_be02b427-56de-488b-9033-a4cdbe899768_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_0912cbe8-2af9-4595-bd28-a25a7345cc3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax positions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_06101734-aeac-4a0a-b34d-a625f39d42ec_terseLabel_en-US" xlink:label="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACOI, Accumulated Gain (Loss), Marketable Securities</link:label>
    <link:label id="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_label_en-US" xlink:label="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACOI, Accumulated Gain (Loss), Marketable Securities [Member]</link:label>
    <link:label id="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACOI, Accumulated Gain (Loss), Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:href="ctlt-20210630.xsd#ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:to="lab_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_a664f19a-ff16-4b73-9bca-1b9ba94aa032_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_414c06cf-0baa-4a58-9fbc-e0e096af3781_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Retirement and Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_d4e0e264-22f6-4509-8052-82a960e8802e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c6fbc43b-4644-4b5c-acf5-198c640e708f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember_2bfc94c3-dfae-444f-81dc-81199368bb2a_terseLabel_en-US" xlink:label="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facility [Member]</link:label>
    <link:label id="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember_label_en-US" xlink:label="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facility [Member]</link:label>
    <link:label id="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember_documentation_en-US" xlink:label="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:href="ctlt-20210630.xsd#ctlt_SeniorUnsecuredTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:to="lab_ctlt_SeniorUnsecuredTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_31a6f9a2-0175-4c21-887e-643daed79d02_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_258eb03f-94ca-4a7f-911a-8344aa99b2f0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_43a986a9-7d48-47a1-8d81-037e7c8b03f1_terseLabel_en-US" xlink:label="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility Incremental Dollar Term B-2 [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_label_en-US" xlink:label="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility Incremental Dollar Term B-2 [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_documentation_en-US" xlink:label="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility Incremental Dollar Term B-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanFacilityIncrementalDollarTermB2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:to="lab_ctlt_TermLoanFacilityIncrementalDollarTermB2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_7695d088-0a0a-42e3-82c8-2424cf86122d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue and fees</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_75f55ce5-5167-4f89-99ed-751af4e898fe_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_4f8fafbd-da8e-4ec5-bfe0-53f863b7abac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_62a6a6c9-b9f0-4984-bf2b-acff485ec105_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_1b67a10a-5532-4e2a-8496-a358ef2fa271_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_b3810dca-86ea-4768-87c0-daff02d13933_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related reorganization</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RTSRPerformanceShareUnitsMember_b7247114-fb79-4f55-8fb4-d85b69335b0f_terseLabel_en-US" xlink:label="lab_ctlt_RTSRPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_ctlt_RTSRPerformanceShareUnitsMember_label_en-US" xlink:label="lab_ctlt_RTSRPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RTSR Performance Share Units [Member]</link:label>
    <link:label id="lab_ctlt_RTSRPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_ctlt_RTSRPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RTSR Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RTSRPerformanceShareUnitsMember" xlink:href="ctlt-20210630.xsd#ctlt_RTSRPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RTSRPerformanceShareUnitsMember" xlink:to="lab_ctlt_RTSRPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ff7cb843-831e-405a-bac4-2cfc1ff0c238_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d26f79e6-2a29-4707-b15a-649a3a957540_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_a595fc32-fce6-4563-8e06-c4a1593c42eb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and contingencies (see Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a489ee00-94a6-4661-9690-984c255a2e51_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_5f260f1f-ed98-4f18-a874-c171eceb5a29_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_a2ae3628-f021-4a1b-ae58-61947b4f074c_terseLabel_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Carry Forward Period</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_label_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Carry Forward Period</link:label>
    <link:label id="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_documentation_en-US" xlink:label="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Carry Forward Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsCarryForwardPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:to="lab_ctlt_OperatingLossCarryforwardsCarryForwardPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ProFormaResultsAbstract_label_en-US" xlink:label="lab_ctlt_ProFormaResultsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Results [Abstract]</link:label>
    <link:label id="lab_ctlt_ProFormaResultsAbstract_documentation_en-US" xlink:label="lab_ctlt_ProFormaResultsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Results [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProFormaResultsAbstract" xlink:href="ctlt-20210630.xsd#ctlt_ProFormaResultsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ProFormaResultsAbstract" xlink:to="lab_ctlt_ProFormaResultsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_670f8496-2087-48e4-bd8d-bedc901f0154_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_93723f63-a8ee-4de0-8b21-c02daf8096c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1f22f0ce-b9c1-4de3-aba7-db5945cc7e4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision at U.S. federal statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember_3b404d67-1fa4-44fd-8a3b-02b757c9e2f8_terseLabel_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities &amp; Other [Member]</link:label>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember_label_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities &amp; Other [Member]</link:label>
    <link:label id="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember_documentation_en-US" xlink:label="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities &amp; Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilitiesOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:to="lab_ctlt_SeniorSecuredCreditFacilitiesOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7c913378-cd4e-436a-b855-694369505c60_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_10d31c0b-0f4d-4b24-ba13-adb13ea67664_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_b4eeedd0-81c9-45f4-84c8-c62e94a347ea_terseLabel_en-US" xlink:label="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global intangible low tax income</link:label>
    <link:label id="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_label_en-US" xlink:label="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Global intangible low tax income</link:label>
    <link:label id="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_documentation_en-US" xlink:label="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the income earned by foreign affiliates of US companies from intangible assets such as patents, trademarks, and copyrights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:href="ctlt-20210630.xsd#ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:to="lab_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock_ec740626-99a3-45b6-a461-9d45f1c48592_terseLabel_en-US" xlink:label="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities</link:label>
    <link:label id="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:label id="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_04abf841-5f47-4ea9-86bb-cb2f4c1a17c4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_658aa2f4-3078-4323-bacb-2307e7189f09_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_MaSTherCellMember_fb51e043-9373-4d45-8e1f-8a0457fa3b38_terseLabel_en-US" xlink:label="lab_ctlt_MaSTherCellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MaSTherCell [Member]</link:label>
    <link:label id="lab_ctlt_MaSTherCellMember_label_en-US" xlink:label="lab_ctlt_MaSTherCellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MaSTherCell [Member]</link:label>
    <link:label id="lab_ctlt_MaSTherCellMember_documentation_en-US" xlink:label="lab_ctlt_MaSTherCellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MaSTherCell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_MaSTherCellMember" xlink:to="lab_ctlt_MaSTherCellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1323a6f8-2105-42c0-9d27-aecf22c694cb_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8d9c4bdd-2172-44a2-b007-4e0abe482abd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-related</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock_98a7061d-7de3-4a4b-80a0-ef3578dd5200_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Lease Liabilities [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:to="lab_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ddc7e660-3abd-42dc-9de9-6b2cf434519d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of beginning and ending balances of level 3 assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_128051fc-07b1-4b35-8070-cd7d997e7401_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2d65ebdc-5b07-4284-a486-d7b8f248909d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_f327dd03-e86d-4da4-8766-cd8a389b2b1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfRedeemablePreferredStockTable_aa792935-5e95-40eb-bb36-86b49216d83e_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Redeemable Preferred Stock [Table]</link:label>
    <link:label id="lab_ctlt_ScheduleOfRedeemablePreferredStockTable_label_en-US" xlink:label="lab_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Redeemable Preferred Stock [Table]</link:label>
    <link:label id="lab_ctlt_ScheduleOfRedeemablePreferredStockTable_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Redeemable Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfRedeemablePreferredStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:to="lab_ctlt_ScheduleOfRedeemablePreferredStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_b9ea84e0-76b3-48e9-a0c4-2354843a81d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_4faa023c-09f5-4c88-81f3-edcac8b3a11e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_b14d877b-e486-4b48-ab26-34033a46f83b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_ad7eefc5-3d57-4911-bc79-d5c13dcc792a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Future Contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_RevolvingCreditFacilityTwoMember_ed5eb81e-0989-440c-b4fc-62bd09ed8cac_terseLabel_en-US" xlink:label="lab_ctlt_RevolvingCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility - Two [Member]</link:label>
    <link:label id="lab_ctlt_RevolvingCreditFacilityTwoMember_label_en-US" xlink:label="lab_ctlt_RevolvingCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility - Two [Member]</link:label>
    <link:label id="lab_ctlt_RevolvingCreditFacilityTwoMember_documentation_en-US" xlink:label="lab_ctlt_RevolvingCreditFacilityTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_RevolvingCreditFacilityTwoMember" xlink:to="lab_ctlt_RevolvingCreditFacilityTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_7b2c167d-0c0b-4502-a3b5-2a7634c270e7_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InternationalOtherMember_02981b5c-2037-4023-b253-16d839d4d510_terseLabel_en-US" xlink:label="lab_ctlt_InternationalOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Other</link:label>
    <link:label id="lab_ctlt_InternationalOtherMember_label_en-US" xlink:label="lab_ctlt_InternationalOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Other [Member]</link:label>
    <link:label id="lab_ctlt_InternationalOtherMember_documentation_en-US" xlink:label="lab_ctlt_InternationalOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InternationalOtherMember" xlink:href="ctlt-20210630.xsd#ctlt_InternationalOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InternationalOtherMember" xlink:to="lab_ctlt_InternationalOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a08c84f9-c338-4c6b-b2ad-7852818314b8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableFairValueDisclosure_ec1ba88e-94c1-4b36-a84e-fbc3b452ed05_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableFairValueDisclosure" xlink:to="lab_us-gaap_PremiumsReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_dadddcd1-0f9e-46c7-88e2-74a4159f7cbc_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Untied States</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_67c6db26-9005-491f-979a-4e606c61e7bb_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_7200a110-7555-43f8-9ce4-b3fa90bde51f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Healthcare Cost Trend Rates at the Balance Sheet Date</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d875ef93-3b91-45b9-9147-a976028c4794_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_ac104c07-8b2e-417e-8eb1-988650c12d84_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_3248530d-2503-462c-a0f6-76f10f464bcb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_e5d93436-dc61-47bd-b8de-c9d1afc8819c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_5a45256f-f024-431c-85ab-dffd635e961f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_fca8c8bf-633f-48f8-bc71-06392678f5ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e66ad636-fcf2-4269-8a0e-9f22e3135510_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_ece6dcac-1a17-4e0c-b9f7-8621c9050ab6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision/(benefit) for deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ee0edcaa-6ecc-408f-ae7e-23d79c4e94eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_a9b108f7-f661-43ff-aedb-0a0a48b91971_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_784c09ad-0991-4d28-92d2-3f6345e12a29_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_49ad47b9-010f-4f94-8401-155834bcdf36_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2ce196fe-1a93-4560-929c-1f879f9e682d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_1a03734e-136c-467d-aea8-c8e87283c254_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_0141a297-b777-4f50-875c-ea1a07b00672_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4127cf21-c973-4b40-a18b-3b372c026262_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember_98f55969-3ca1-4a8c-a10e-09ae7842a5ae_terseLabel_en-US" xlink:label="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Three Facility Dollar Denominated [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember_label_en-US" xlink:label="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Three Facility Dollar Denominated [Member]</link:label>
    <link:label id="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember_documentation_en-US" xlink:label="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Three Facility Dollar Denominated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanThreeFacilityDollarDenominatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:to="lab_ctlt_TermLoanThreeFacilityDollarDenominatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_b299340a-6d11-472e-bf06-887125c143b8_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_63786e36-64a3-4a8b-8b62-80cefcc0f36c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock_86443251-0355-4407-b01a-a47a4ea51a44_terseLabel_en-US" xlink:label="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of plan assets that are measured in fair value</link:label>
    <link:label id="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock_label_en-US" xlink:label="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Plan Assets Measured In Fair Value Table [Text Block]</link:label>
    <link:label id="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of plan assets that are measured in fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:to="lab_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_26976f37-e992-4a10-91b7-06a8863ebab1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OralAndSpecialtyDeliveryMember_32aca9c2-2d90-43b3-a1b5-fce145a3c734_terseLabel_en-US" xlink:label="lab_ctlt_OralAndSpecialtyDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral and Specialty Drug Delivery [Member]</link:label>
    <link:label id="lab_ctlt_OralAndSpecialtyDeliveryMember_label_en-US" xlink:label="lab_ctlt_OralAndSpecialtyDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral and Specialty Delivery [Member]</link:label>
    <link:label id="lab_ctlt_OralAndSpecialtyDeliveryMember_documentation_en-US" xlink:label="lab_ctlt_OralAndSpecialtyDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral and Specialty Delivery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OralAndSpecialtyDeliveryMember" xlink:to="lab_ctlt_OralAndSpecialtyDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDue_57afa13e-85a3-4a89-ae31-6afad9a0200f_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_f8c15080-7de3-45a7-b151-ea3ef16b63d1_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_38ecb310-7e85-4bef-a2cf-86bde38a6f8f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5cdbeea8-d2c2-4c5c-a502-1a7b267ac606_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_e0575a15-ea4d-4512-bed2-1b34fbb6b1c2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_50c11b26-382f-4774-9046-07b4b4bc2afb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_4740ce03-2622-4af0-bec7-b172fc4a9494_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e47bd712-3dc2-49e7-abe3-e6b6e1b92494_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AdditionalInformationAbstract_label_en-US" xlink:label="lab_ctlt_AdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information [Abstract]</link:label>
    <link:label id="lab_ctlt_AdditionalInformationAbstract_documentation_en-US" xlink:label="lab_ctlt_AdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AdditionalInformationAbstract" xlink:href="ctlt-20210630.xsd#ctlt_AdditionalInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AdditionalInformationAbstract" xlink:to="lab_ctlt_AdditionalInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_851c944c-4acd-4a56-b877-0d3e0938df01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateMember_37885371-8dfa-4264-8368-b2f5cc62abe1_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Member]</link:label>
    <link:label id="lab_us-gaap_RealEstateMember_label_en-US" xlink:label="lab_us-gaap_RealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateMember" xlink:to="lab_us-gaap_RealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearFour_8a8e2491-004c-49fb-8067-13d4c2c691c6_terseLabel_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Four</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearFour_label_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Four</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearFour_documentation_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:to="lab_ctlt_InstallmentPaymentforAcquisitionYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure_c72ca344-ee8e-48bc-9dc5-fa698b53954a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_494ed097-84dd-4e33-9024-c842c2909563_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_ce917dd3-ca3b-4f96-b12e-70026df52068_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2b28217a-5de3-4fa4-8f98-825320541095_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_4cbf416e-3ac4-43b1-af58-4d1339c9cab2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1fdbe889-f20e-4256-b115-9cff0e05fac9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c38920ee-bcc9-482f-8778-84cd782fd9c2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cd3c04f7-08a8-4df5-882d-228c1e1477f6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_e1e50292-b3c7-48c7-8d1e-a4174734dcf2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included In Measurement Of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:href="ctlt-20210630.xsd#ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c160155c-e2f9-4611-8d77-c684440cb08a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_76077e72-3635-4c7f-ab6e-f4db6bddc172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_dad4ce92-2dc5-42a5-bb5b-d1a6aed3392a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d1e36412-4b46-4847-99a5-7731e46315d3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ece1ffa2-ab6f-45b3-928a-341b9e5c8ede_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract_71b0d511-3164-4ece-ae47-0b504b96f9f0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour_b0b8772c-92c6-4cea-a026-4d3c899ce192_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a2ebb75d-0e64-43be-a777-be6470a507a5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_de2ad98c-7a62-4496-b390-e00d55d03d26_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4f9a01b0-649c-4a0a-a5ad-413c953fc5ec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_70eb2db8-0d81-4db6-97c3-5a04b888fa93_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_aac0a63b-5010-4464-beb6-d7ed5c1225c3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_395d6d9d-f64c-49cf-8019-5bc59afaf66b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f35ffc89-19a8-4f09-adf9-1b92d100507b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_948d024b-743d-4fc6-8123-a0cd1ff5bb11_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum pension liability, pretax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_f1218310-9071-4253-b5e0-0ba910e0450d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables and Allowance dor Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_f7ad8f35-c1ea-4195-9718-38b90fe1d31e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_fe6eeda9-2ffe-4d5c-b9e0-bb0c6e95d949_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivables, Gross Contractual Amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivables, Gross Contractual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_35e7e30b-da23-43d5-be14-abedb6f98dd4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_07612b53-3bc3-4bd3-bf59-1db3db80f678_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_e0d4a0cd-6bdb-46b1-8720-3280d67d36ed_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Four</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2645784d-7a04-458b-8591-b38a5c99e512_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Two</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_b96de05f-32e8-486a-818f-dfba50f627b2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Tax Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_109250cb-a8c1-457e-85c9-c9ffdb97e68d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo_55a85bcd-1a24-4232-8db0-afa931eb3e49_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_8dd8b208-b75a-40e3-ae97-d2a178191f6e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_9cd0ae66-786f-48ed-acbd-816c4ae509f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption_6014c0e0-88c7-485a-b477-6d00eeeacf49_terseLabel_en-US" xlink:label="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stcok Issued During Period, Shares, Over-allotment Option</link:label>
    <link:label id="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption_label_en-US" xlink:label="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stcok Issued During Period, Shares, Over-allotment Option</link:label>
    <link:label id="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption_documentation_en-US" xlink:label="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stcok Issued During Period, Shares, Over-allotment Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:href="ctlt-20210630.xsd#ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:to="lab_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_8b1d3082-5d03-4892-a534-e21a73e6e242_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax_89977bfb-6bbf-49ff-852f-290caeba9d4a_terseLabel_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative and Hedge,Total, before Tax</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax_label_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative and Hedge,Total, before Tax</link:label>
    <link:label id="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax_documentation_en-US" xlink:label="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative and Hedge,Total, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:to="lab_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_83af03bb-672e-44af-afcd-8aee79d058f6_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_be98cff2-f815-44ed-89b4-687f9ee1378e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_2dfbe7b7-a340-42ed-8bc4-89c63efffe4e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a1b0df13-110f-453f-96be-15c646989d7b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a07be03e-733c-4c22-9d2c-cc02f9236ed0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_2a8b24d3-86fa-4989-8379-52f193ce9246_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility exit and other costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_e72db097-7317-403f-8d9a-c63406f2fd0f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income tax</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_6200f6a4-3a77-4163-a539-322fe5d4c98d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_35c20be1-9c28-4d7b-b403-b9fccada8d1c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accumulated gain related to investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FinanceLeaseExpense_f234bee8-20af-4439-b2be-63a3be39854b_terseLabel_en-US" xlink:label="lab_ctlt_FinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Expense</link:label>
    <link:label id="lab_ctlt_FinanceLeaseExpense_label_en-US" xlink:label="lab_ctlt_FinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Expense</link:label>
    <link:label id="lab_ctlt_FinanceLeaseExpense_documentation_en-US" xlink:label="lab_ctlt_FinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinanceLeaseExpense" xlink:href="ctlt-20210630.xsd#ctlt_FinanceLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FinanceLeaseExpense" xlink:to="lab_ctlt_FinanceLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments_9d2014ae-78b0-40ef-92c5-9a1cbda50381_terseLabel_en-US" xlink:label="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustments</link:label>
    <link:label id="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments_label_en-US" xlink:label="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustments</link:label>
    <link:label id="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments_documentation_en-US" xlink:label="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Working Capital Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationWorkingCapitalAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:to="lab_ctlt_BusinessCombinationWorkingCapitalAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_b80b3c5a-0621-4d25-abe1-7be0a3ff5979_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_f27d25ac-730c-459f-886b-752802d35c7d_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_99e6d2bd-9fd9-43d8-b141-92bc1f2a23e1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_3c4f8552-31cd-45ec-ad61-946e9996f030_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_af1c79bc-0989-46c1-adee-780dff74f723_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f9535068-b903-4586-a130-b0b8fc512f5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision/ (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PropertyandEquipmentAbstract_label_en-US" xlink:label="lab_ctlt_PropertyandEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment [Abstract]</link:label>
    <link:label id="lab_ctlt_PropertyandEquipmentAbstract_documentation_en-US" xlink:label="lab_ctlt_PropertyandEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PropertyandEquipmentAbstract" xlink:href="ctlt-20210630.xsd#ctlt_PropertyandEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PropertyandEquipmentAbstract" xlink:to="lab_ctlt_PropertyandEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_66e5833e-89da-4c35-ab24-ddfb0e58a18b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_66abc589-21e9-4401-98cc-330396e0faca_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_777877cd-514b-4636-97c5-90d7142f2ab7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c1978412-12eb-4311-914b-c6ab0bd33df2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e0f880d5-d20d-4aa8-bf68-e9bac1f8fd24_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3ed5cef4-8bb0-4bd1-bf9a-fdcac0005a69_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6a04ddad-5b14-4a24-b100-bc9373878382_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_ba2fdf66-8aaf-42e7-8d34-28b951394d3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_65361ca5-c267-4ff7-aabf-66ece34545ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_696cfae5-6e02-4cf7-94ef-ce44a2ffd6c6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Debt</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other Comprehensive Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:to="lab_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SeriesAPreferredStockDerivativeLiability_41c27434-2d46-4944-9751-e1453cc254dd_terseLabel_en-US" xlink:label="lab_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock derivative liability</link:label>
    <link:label id="lab_ctlt_SeriesAPreferredStockDerivativeLiability_label_en-US" xlink:label="lab_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock derivative liability</link:label>
    <link:label id="lab_ctlt_SeriesAPreferredStockDerivativeLiability_documentation_en-US" xlink:label="lab_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock derivative liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:href="ctlt-20210630.xsd#ctlt_SeriesAPreferredStockDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:to="lab_ctlt_SeriesAPreferredStockDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5baa2088-691a-49d8-847c-afdb96ca0b78_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AnagniMember_b32a9c83-6dc5-4311-9a36-02d71844ed23_terseLabel_en-US" xlink:label="lab_ctlt_AnagniMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anagni [Member]</link:label>
    <link:label id="lab_ctlt_AnagniMember_label_en-US" xlink:label="lab_ctlt_AnagniMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anagni [Member]</link:label>
    <link:label id="lab_ctlt_AnagniMember_documentation_en-US" xlink:label="lab_ctlt_AnagniMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anagni</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AnagniMember" xlink:href="ctlt-20210630.xsd#ctlt_AnagniMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AnagniMember" xlink:to="lab_ctlt_AnagniMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1f30829c-9c75-4906-9c43-32afea9734df_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_79dc1194-ecd3-4134-b437-53da2f6850c3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_627a721a-3818-4e27-a50f-1929897bc0a7_terseLabel_en-US" xlink:label="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Businesses, Net Cash Proceeds</link:label>
    <link:label id="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_label_en-US" xlink:label="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Businesses, Net Cash Proceeds</link:label>
    <link:label id="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_documentation_en-US" xlink:label="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Divestiture Of Businesses, Net Cash Proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:href="ctlt-20210630.xsd#ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:to="lab_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_679f35a0-223a-4162-8606-77c492d36ffd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_05e5fd56-9294-4783-bc0a-7d80794bdcbd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile earnings from continued operations to net cash from operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PreferredStockIssuanceValue_d3ca843c-e555-4364-823d-593284bb714d_terseLabel_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value</link:label>
    <link:label id="lab_ctlt_PreferredStockIssuanceValue_label_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value</link:label>
    <link:label id="lab_ctlt_PreferredStockIssuanceValue_documentation_en-US" xlink:label="lab_ctlt_PreferredStockIssuanceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Issuance Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValue" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PreferredStockIssuanceValue" xlink:to="lab_ctlt_PreferredStockIssuanceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_618d4fac-c7cd-44a9-9c19-8e247cf5ba5c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d05cffec-bd85-4297-a700-768605d60f7b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_12eeb7ed-5422-4b1b-8743-e8c5c48d64e4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_e3df6b62-b298-4ccd-8134-1e4660efe92d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_90f626e6-d7d9-483e-ad9d-f611df72839b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_324b5554-e3a8-404a-bd7a-d953ad76c245_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_648e15e0-51e2-4171-b897-f06b156dd119_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_cb45d8d3-d2f6-4d35-b559-e0e4d39363ca_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure</link:label>
    <link:label id="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_4d7d871f-338f-483e-9d47-f5ce5d3a9245_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsAndInterestPaid_462ab8e8-0bb9-4ddb-9c85-b56316bf6eb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsAndInterestPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends and Interest Paid</link:label>
    <link:label id="lab_us-gaap_DividendsAndInterestPaid_label_en-US" xlink:label="lab_us-gaap_DividendsAndInterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends and Interest Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAndInterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAndInterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAndInterestPaid" xlink:to="lab_us-gaap_DividendsAndInterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_4ea57fd4-560e-4bc7-bee2-536154e331b1_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_fe8b8b4b-a9fe-481c-8f44-7ed500d55b94_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ProvisionForBadDebtsAndInventory_c2ed3bf9-9e6a-4a44-9b22-8c631e22b893_terseLabel_en-US" xlink:label="lab_ctlt_ProvisionForBadDebtsAndInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for bad debts and inventory</link:label>
    <link:label id="lab_ctlt_ProvisionForBadDebtsAndInventory_label_en-US" xlink:label="lab_ctlt_ProvisionForBadDebtsAndInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Bad Debts And Inventory</link:label>
    <link:label id="lab_ctlt_ProvisionForBadDebtsAndInventory_documentation_en-US" xlink:label="lab_ctlt_ProvisionForBadDebtsAndInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for bad debts and inventory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProvisionForBadDebtsAndInventory" xlink:href="ctlt-20210630.xsd#ctlt_ProvisionForBadDebtsAndInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ProvisionForBadDebtsAndInventory" xlink:to="lab_ctlt_ProvisionForBadDebtsAndInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ecc0b2db-eaa4-4ea1-be77-9f74111ffc0b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_947f6fdd-52c5-4544-a90a-7c10ec7bf085_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_8f8e731e-a453-4d58-b34f-4586d836cc26_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c50a844e-81be-4d0e-a03b-c63413bac386_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in minimum pension liability, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_105ccf0e-0024-4e85-a944-fc74e8bd918e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_BuildingAndImprovementsMember_224f10f0-55d3-4d45-aa7c-4dfe7da3d603_terseLabel_en-US" xlink:label="lab_ctlt_BuildingAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Improvements [Member]</link:label>
    <link:label id="lab_ctlt_BuildingAndImprovementsMember_label_en-US" xlink:label="lab_ctlt_BuildingAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Improvements [Member]</link:label>
    <link:label id="lab_ctlt_BuildingAndImprovementsMember_documentation_en-US" xlink:label="lab_ctlt_BuildingAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BuildingAndImprovementsMember" xlink:href="ctlt-20210630.xsd#ctlt_BuildingAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_BuildingAndImprovementsMember" xlink:to="lab_ctlt_BuildingAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9968a5e0-d8c7-4430-80db-bdbf4b12eb0b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_73260c92-7166-498d-8186-5a39fcae20c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ec02b87c-506c-464a-b19a-6624d02c92ac_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_3bb1dbe3-ba87-4805-ad89-b33ea510af4f_terseLabel_en-US" xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Line Items]</link:label>
    <link:label id="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_label_en-US" xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems" xlink:to="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_abb45b06-1656-46dc-bd66-5823ba73d561_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_aba51294-173b-4e60-b3ea-a44059e7f618_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the provision/(benefit) based on the federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupAxis_69ff94d7-4040-4d63-8d0c-6d5ef6ff5444_terseLabel_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, by Age Group [Axis]</link:label>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupAxis_label_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, by Age Group [Axis]</link:label>
    <link:label id="lab_ctlt_PostretirementBenefitsByAgeGroupAxis_documentation_en-US" xlink:label="lab_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefits, by Age Group [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:to="lab_ctlt_PostretirementBenefitsByAgeGroupAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_ce04601b-d548-42aa-a071-83012d74390d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increases (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_2dfd7873-dce3-47a0-96b9-c053f24bd6da_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2ef99fdb-e5b8-4f7e-9a17-32a8b6fa8b35_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_9d26e286-cbb6-4975-8bf2-bc90f8d5def4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d6517d3e-2418-433d-9cd6-994d9d7c67d9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ea16a6f2-279f-4857-9255-4867f5b78c58_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information for Plan with ABO in Excess of Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DesignatedSharesMember_d49fa450-5ecd-49eb-8039-4758452309eb_terseLabel_en-US" xlink:label="lab_ctlt_DesignatedSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated shares [Member]</link:label>
    <link:label id="lab_ctlt_DesignatedSharesMember_label_en-US" xlink:label="lab_ctlt_DesignatedSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated shares [Member]</link:label>
    <link:label id="lab_ctlt_DesignatedSharesMember_documentation_en-US" xlink:label="lab_ctlt_DesignatedSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DesignatedSharesMember" xlink:href="ctlt-20210630.xsd#ctlt_DesignatedSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DesignatedSharesMember" xlink:to="lab_ctlt_DesignatedSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_da8b3b38-58ca-4817-8b6c-4c78f65a4026_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_45e23c52-b0a8-4579-9560-64efa2dd846c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalDebtUSDenominatedTermLoan_428381df-a94b-430a-8928-4416a5a92bda_terseLabel_en-US" xlink:label="lab_ctlt_TotalDebtUSDenominatedTermLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Debt, U.S Denominated Term Loan</link:label>
    <link:label id="lab_ctlt_TotalDebtUSDenominatedTermLoan_label_en-US" xlink:label="lab_ctlt_TotalDebtUSDenominatedTermLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Debt, U.S Denominated Term Loan</link:label>
    <link:label id="lab_ctlt_TotalDebtUSDenominatedTermLoan_documentation_en-US" xlink:label="lab_ctlt_TotalDebtUSDenominatedTermLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Debt, U.S Denominated Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalDebtUSDenominatedTermLoan" xlink:href="ctlt-20210630.xsd#ctlt_TotalDebtUSDenominatedTermLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalDebtUSDenominatedTermLoan" xlink:to="lab_ctlt_TotalDebtUSDenominatedTermLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_9a607c61-c27e-470c-b30e-7fa42e3e6bd9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2fc727a7-7f6a-4842-b3f4-619edd43c334_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_2322af0e-169c-4655-b868-b1ff27c895aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relating to assets sold during the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SoftgelAndOralTechnologiesMember_f9efcd37-4d16-4776-9884-cf74cdf47abf_terseLabel_en-US" xlink:label="lab_ctlt_SoftgelAndOralTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel and Oral Technologies [Member]</link:label>
    <link:label id="lab_ctlt_SoftgelAndOralTechnologiesMember_label_en-US" xlink:label="lab_ctlt_SoftgelAndOralTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel and Oral Technologies [Member]</link:label>
    <link:label id="lab_ctlt_SoftgelAndOralTechnologiesMember_documentation_en-US" xlink:label="lab_ctlt_SoftgelAndOralTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Softgel and Oral Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SoftgelAndOralTechnologiesMember" xlink:to="lab_ctlt_SoftgelAndOralTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalFixedRate_b8dbe873-3327-4f98-b5cc-39694a855a01_terseLabel_en-US" xlink:label="lab_ctlt_TotalFixedRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fixed Rate</link:label>
    <link:label id="lab_ctlt_TotalFixedRate_label_en-US" xlink:label="lab_ctlt_TotalFixedRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fixed Rate</link:label>
    <link:label id="lab_ctlt_TotalFixedRate_documentation_en-US" xlink:label="lab_ctlt_TotalFixedRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fixed Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalFixedRate" xlink:href="ctlt-20210630.xsd#ctlt_TotalFixedRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalFixedRate" xlink:to="lab_ctlt_TotalFixedRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0dba9c09-dd17-434c-a9c2-478f7118b7d9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_59498411-e29d-4964-9f69-139cfa82a517_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_PerformanceMember_f12d4aec-3124-4f22-a1fb-d7f3c9b7ac06_terseLabel_en-US" xlink:label="lab_ctlt_PerformanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance [Member]</link:label>
    <link:label id="lab_ctlt_PerformanceMember_label_en-US" xlink:label="lab_ctlt_PerformanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance [Member]</link:label>
    <link:label id="lab_ctlt_PerformanceMember_documentation_en-US" xlink:label="lab_ctlt_PerformanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PerformanceMember" xlink:href="ctlt-20210630.xsd#ctlt_PerformanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_PerformanceMember" xlink:to="lab_ctlt_PerformanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9f3b178b-1373-41da-b2ea-459177494232_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in other borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AccruedRestructuringReserve_326298a6-6582-4b77-9bc4-7922322fa718_terseLabel_en-US" xlink:label="lab_ctlt_AccruedRestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring accrual</link:label>
    <link:label id="lab_ctlt_AccruedRestructuringReserve_label_en-US" xlink:label="lab_ctlt_AccruedRestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Restructuring Reserve</link:label>
    <link:label id="lab_ctlt_AccruedRestructuringReserve_documentation_en-US" xlink:label="lab_ctlt_AccruedRestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring reserve.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedRestructuringReserve" xlink:href="ctlt-20210630.xsd#ctlt_AccruedRestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AccruedRestructuringReserve" xlink:to="lab_ctlt_AccruedRestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_USDenominatedTermLoanMember_6dbd08f6-24b8-4c4c-a82a-c9469b755989_terseLabel_en-US" xlink:label="lab_ctlt_USDenominatedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Denominated Term Loan [Member]</link:label>
    <link:label id="lab_ctlt_USDenominatedTermLoanMember_label_en-US" xlink:label="lab_ctlt_USDenominatedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Denominated Term Loan [Member]</link:label>
    <link:label id="lab_ctlt_USDenominatedTermLoanMember_documentation_en-US" xlink:label="lab_ctlt_USDenominatedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Denominated Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDenominatedTermLoanMember" xlink:href="ctlt-20210630.xsd#ctlt_USDenominatedTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_USDenominatedTermLoanMember" xlink:to="lab_ctlt_USDenominatedTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_38d2de16-232f-4756-ade5-8fc3a9be9b4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property-related</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4687e2cb-6236-423e-903c-aff3ae04fb29_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_65ae682b-74f7-40f2-ab2b-205b5234c0a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_d3161348-9b5a-45dc-b061-1709e8f404fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_NetAssetsAcquiredLineItems_85f67444-9e4f-4bb7-a88a-816ebadbeb16_terseLabel_en-US" xlink:label="lab_ctlt_NetAssetsAcquiredLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets Acquired from Business Combinations</link:label>
    <link:label id="lab_ctlt_NetAssetsAcquiredLineItems_label_en-US" xlink:label="lab_ctlt_NetAssetsAcquiredLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets Acquired [Line Items]</link:label>
    <link:label id="lab_ctlt_NetAssetsAcquiredLineItems_documentation_en-US" xlink:label="lab_ctlt_NetAssetsAcquiredLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NetAssetsAcquiredLineItems" xlink:href="ctlt-20210630.xsd#ctlt_NetAssetsAcquiredLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems" xlink:to="lab_ctlt_NetAssetsAcquiredLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_9dd22fc1-95bd-461f-9289-377c1ceba73d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(loss) from continuing operations before income taxes and discontinued operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_a76c111c-6a45-4219-8c6f-1d4e5c3458a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_5e7b6828-5afb-43e5-9f1b-883c410bd454_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of 1% decrease on total service and interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_e635bfbf-8d1d-4718-8111-c3d7a9a312b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_5d13398e-e642-4fa4-a233-9759a69ba826_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_75d000af-04d1-4b4d-a731-af78ebbf0555_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_5a24bd7b-7376-4607-adbe-470d0700c6c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_2dc1c786-1312-4c09-9c62-55ea78cf3475_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_07260ba1-657f-44e6-824c-1acffc2dadde_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiability_115f4580-d9e9-4890-bbc8-d4480a8ddb49_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiability_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiability_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiability" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiability" xlink:to="lab_ctlt_TotalLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a1f146a9-a1a1-4ea2-aa14-b3012dbb3482_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_a4129bd1-cd71-493b-b6c7-144ff447055a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6e9fdd68-57ef-4f63-9821-733596b87e7b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock_b9a7dba9-3ce1-42f5-8a8f-901b0a17f341_terseLabel_en-US" xlink:label="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Accumulated Other Comprehensive Income Disclosure [Text Block]</link:label>
    <link:label id="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock_label_en-US" xlink:label="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Accumulated Other Comprehensive Income Disclosure [Text Block]</link:label>
    <link:label id="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock_documentation_en-US" xlink:label="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Accumulated Other Comprehensive Income Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:to="lab_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_425bc915-0b28-4981-9fc3-090f94998bea_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fdbf1129-3717-46ea-b9b5-6b63c290d1e4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_ecdfe0f0-3633-4d9b-8a95-2a38d848a144_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_d37c685e-6a8c-44b6-a6d9-372bae47085b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_0c59cf0c-d543-4671-b261-edd44afaaab8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4559f2e9-8cd1-47de-8652-d4e345785a82_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_45adbc09-96a9-458a-90b2-6516eeb552e9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_8763e125-8eb1-4b4f-857f-adf219551c0a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_65fd48a3-15c3-4053-b7a2-2cb68c0c1e41_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7aec74f4-5180-498b-8b15-d81d693cec4d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_b148e59c-3ffb-4bbb-9ed6-ec860eb49c6b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_27eb356e-4fb8-4e96-896f-c7a3a3d6b43a_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_0ec0c6eb-9fe6-4ce3-9086-b83f1fbab663_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InsuranceContractsMember_ce0bf78c-9cb6-4295-9e6f-a2f272d4271d_terseLabel_en-US" xlink:label="lab_ctlt_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts [Member]</link:label>
    <link:label id="lab_ctlt_InsuranceContractsMember_label_en-US" xlink:label="lab_ctlt_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts [Member]</link:label>
    <link:label id="lab_ctlt_InsuranceContractsMember_documentation_en-US" xlink:label="lab_ctlt_InsuranceContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InsuranceContractsMember" xlink:to="lab_ctlt_InsuranceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_2dde4389-d43f-4862-8669-2c5db00ebea2_terseLabel_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</link:label>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_label_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</link:label>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_documentation_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:to="lab_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_c665a4d2-1ee5-4c3c-a058-deaa8ebe9e2b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets_85eac565-aedc-4985-ba28-df22bf80ea35_terseLabel_en-US" xlink:label="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Amortization Of Intangible Assets</link:label>
    <link:label id="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Amortization Of Intangible Assets</link:label>
    <link:label id="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets_documentation_en-US" xlink:label="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Amortization Of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:href="ctlt-20210630.xsd#ctlt_AcceleratedAmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:to="lab_ctlt_AcceleratedAmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b2737a00-6000-4dcf-b75a-23d9ab5d4310_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_HepaticCellTherapySupportSA_c99b8956-5af9-4a9f-b564-fa8975accebb_terseLabel_en-US" xlink:label="lab_ctlt_HepaticCellTherapySupportSA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hepatic Cell Therapy Support SA</link:label>
    <link:label id="lab_ctlt_HepaticCellTherapySupportSA_label_en-US" xlink:label="lab_ctlt_HepaticCellTherapySupportSA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hepatic Cell Therapy Support SA</link:label>
    <link:label id="lab_ctlt_HepaticCellTherapySupportSA_documentation_en-US" xlink:label="lab_ctlt_HepaticCellTherapySupportSA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hepatic Cell Therapy Support SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_HepaticCellTherapySupportSA" xlink:href="ctlt-20210630.xsd#ctlt_HepaticCellTherapySupportSA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_HepaticCellTherapySupportSA" xlink:to="lab_ctlt_HepaticCellTherapySupportSA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_084f3455-f667-4fea-9ec8-11f4590a823a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_20b2773e-8fd0-4460-ac3a-e9cf15064bcd_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_a3e9b1b7-3fe8-4031-b274-84a241435801_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the net amount recognized in the Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_94c0a451-1db5-4abf-bdd8-ef0a706ededa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c94b14a-9098-467f-982a-28ad1b6f9700_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_708deaed-ad2b-4159-9e0a-dc468e76cbd1_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States [Member]</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41617326-4235-4def-89f9-785c240f397e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4548c449-f758-4121-94fb-0d06b86d8335_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ab37a27e-95b2-47f9-9f82-22a2fd685094_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5fe04116-df34-4917-a2f9-cfd28a946422_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_8d2a02a6-ea8e-458d-9f87-a61fa2ff2779_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain_eb7e7ac8-bcbf-4bba-ba94-f8dab0f77e2a_terseLabel_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets [Domain]</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain_label_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets [Domain]</link:label>
    <link:label id="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain_documentation_en-US" xlink:label="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:to="lab_ctlt_DefinedBenefitPlanOtherAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_def6a1ec-5402-4c93-bc2a-c8d891673dd3_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_673a3b98-1a80-40d5-8308-93be59c78889_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_d05cc78b-a96e-47f4-baac-71b9037b632e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers in and/or out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_1ac0c951-cb6a-4ce5-aae6-86889c00208d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets Subject to Amortization</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_928d1fcf-c2d2-428b-92ef-86324423a9f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_784e145a-11fb-4c0f-8d2c-5f1daa6d1791_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_f95d0b2c-c6c3-45e8-9dc3-9046cf550b74_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c6e6f48a-316f-43e9-8572-fcc2ab506aa3_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_63235d52-0242-44aa-ac6e-05e81c47a78d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_aa14ef0a-5366-43b5-a994-251e299239f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ZenyattaMember_e2bc3b64-46d9-42f9-bebf-a233d38b32bd_terseLabel_en-US" xlink:label="lab_ctlt_ZenyattaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zenyatta</link:label>
    <link:label id="lab_ctlt_ZenyattaMember_label_en-US" xlink:label="lab_ctlt_ZenyattaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zenyatta [Member]</link:label>
    <link:label id="lab_ctlt_ZenyattaMember_documentation_en-US" xlink:label="lab_ctlt_ZenyattaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zenyatta</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ZenyattaMember" xlink:href="ctlt-20210630.xsd#ctlt_ZenyattaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ZenyattaMember" xlink:to="lab_ctlt_ZenyattaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b00b0807-75c5-4bf8-bd66-bc8f98e70de5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_4fcc72dc-e6e2-4186-9fad-1ab1b9c95956_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7ceeeef2-3b89-469f-a49b-7b9700ec11c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_b0ddd761-c0d0-4b77-b1fa-4d20f841213c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (gain)/loss arising during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a5fdba79-d28d-4df3-8a72-7150f18d2de4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain/(loss) arising during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_34276ba1-6fa8-46a0-af6f-f43a3b9cdb76_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_29dd70ba-14c7-4aa1-8bee-a7b4cee077ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_28793deb-5bb4-471f-825b-a00b1a3d6b51_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_28d724cc-421f-47d2-adbd-02f99a430d18_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive income at the end of the year</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d5715eb3-0477-4a03-9319-6c9b209d96d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_3875b477-1fe8-45c4-b861-33693f7feedf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement_193579e2-6514-4278-8e16-eb4e7eb933c4_terseLabel_en-US" xlink:label="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid to Settle, Interest Rate Swap Agreement</link:label>
    <link:label id="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement_label_en-US" xlink:label="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid to Settle, Interest Rate Swap Agreement</link:label>
    <link:label id="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement_documentation_en-US" xlink:label="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid to Settle, Interest Rate Swap Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:href="ctlt-20210630.xsd#ctlt_CashPaidToSettleInterestRateSwapAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:to="lab_ctlt_CashPaidToSettleInterestRateSwapAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract_label_en-US" xlink:label="lab_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Major Customers [Abstract]</link:label>
    <link:label id="lab_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract_documentation_en-US" xlink:label="lab_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Major Customers [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" xlink:href="ctlt-20210630.xsd#ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" xlink:to="lab_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_b155dd58-5b53-4fc1-85e2-e18195600745_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_7fa6eeb6-c537-451b-893b-e94bd4f13904_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_df5997fa-b22a-4ad6-b8c0-faf7a9edd53f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_5039d7de-2248-452f-a28f-bf78dfcd0600_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation and Transaction of Foreign Currencies</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_c4857b70-b6ac-4b98-a5c9-4fbf3d8f2d97_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_79408a51-d437-4172-b195-688e2f4cba72_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Three</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock_1b60d329-9b05-4d93-b353-6ff6ed6183ec_terseLabel_en-US" xlink:label="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities Table [Text Block]</link:label>
    <link:label id="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_OtherAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:to="lab_ctlt_OtherAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_7f9eb4ca-1a1b-4675-b35a-a58eba924132_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetPurchase_c529cd67-bf81-4b8d-a96a-ad93adde220b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetPurchase_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetPurchase" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetPurchase" xlink:to="lab_us-gaap_ContractWithCustomerAssetPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ecf68e91-315a-4a84-9ed2-36ec671cf524_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_74d9ee76-8163-478b-8a4c-908ed47a281a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_f03c6b78-fcf7-475e-8040-7e571f6db3fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_694534ba-1cbb-430d-8e97-462d5d616a80_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4496f27a-1dc4-4992-93a9-ea9112ec7740_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_ace7025f-8d9c-4059-8856-9dc56c4c3dbb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_0b3f95a6-4940-47e4-b7d1-312927e890f1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_41cb32a9-58d5-4426-9302-abaf24ab9570_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_635058c9-276b-47a3-ae9f-a5387a4e8b5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_1d41961d-8181-474e-ab65-2e3612e8f1cf_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_f58f41a7-1ae0-4917-9827-e272bf5532ce_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_66367ce8-073f-4f9f-8ea3-8b343a2df457_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_3955d872-745c-43d5-b766-bf1221b57956_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SpareParts_f9cc1924-c851-464a-acdf-c6a016b2e192_terseLabel_en-US" xlink:label="lab_ctlt_SpareParts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare Parts</link:label>
    <link:label id="lab_ctlt_SpareParts_label_en-US" xlink:label="lab_ctlt_SpareParts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare Parts</link:label>
    <link:label id="lab_ctlt_SpareParts_documentation_en-US" xlink:label="lab_ctlt_SpareParts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SpareParts" xlink:href="ctlt-20210630.xsd#ctlt_SpareParts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SpareParts" xlink:to="lab_ctlt_SpareParts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_d6ba1271-9206-4add-956d-b591fac18c83_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_fc296162-a078-4fdd-8290-3bd8bdaacfae_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AccruedOperatingLeaseLiabilities_7ded5a7c-2f15-4bb7-aecc-929b515a6bb3_terseLabel_en-US" xlink:label="lab_ctlt_AccruedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Operating Lease, Liabilities</link:label>
    <link:label id="lab_ctlt_AccruedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_ctlt_AccruedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Operating Lease, Liabilities</link:label>
    <link:label id="lab_ctlt_AccruedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_ctlt_AccruedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Operating Lease, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedOperatingLeaseLiabilities" xlink:href="ctlt-20210630.xsd#ctlt_AccruedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AccruedOperatingLeaseLiabilities" xlink:to="lab_ctlt_AccruedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b5f3dd25-f01e-4e75-aeec-6c14de492ae5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_4ae08ecb-c0dc-48a0-bf03-45d0470de35c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3b70b2e9-3fa7-4041-b088-2e05c6f097eb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_StockCompensationPlanOmnibusMember_51080640-3bbf-4d2c-971e-54d5b3870889_terseLabel_en-US" xlink:label="lab_ctlt_StockCompensationPlanOmnibusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan - Omnibus [Member]</link:label>
    <link:label id="lab_ctlt_StockCompensationPlanOmnibusMember_label_en-US" xlink:label="lab_ctlt_StockCompensationPlanOmnibusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan - Omnibus [Member]</link:label>
    <link:label id="lab_ctlt_StockCompensationPlanOmnibusMember_documentation_en-US" xlink:label="lab_ctlt_StockCompensationPlanOmnibusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan - Omnibus [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockCompensationPlanOmnibusMember" xlink:href="ctlt-20210630.xsd#ctlt_StockCompensationPlanOmnibusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_StockCompensationPlanOmnibusMember" xlink:to="lab_ctlt_StockCompensationPlanOmnibusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb2e2b50-17ab-4231-9383-6607155fac0f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_5a3116db-7dd4-4c00-b0a8-044396130c17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a0666722-055a-46e9-a6f6-34c3c7246be6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_6055d9ac-fe33-4377-a535-0b2d1dd10bee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_24e27396-9857-4c5d-846b-76dcf22d5b29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6ce82ae2-a00d-4364-b50f-8bd36a605592_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_0fd8ce3e-a585-41ea-8686-b63e1258b451_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increases (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive_b46703c2-0ea1-4654-aa3a-ff431e7afa6b_terseLabel_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_ec534e35-6f7f-402c-9372-fccf0f871397_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized tax benefit, excluding accrued interest</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_28388c14-1214-4b7c-955f-13cae0fb7e6a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b111e7a2-70d5-4ef5-9876-989b22cc009c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_21f8a149-1061-4f88-960a-9bf3c4519086_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_fad98b46-06a6-4a81-bece-d8fbf43985db_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory cost adjustment</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b0ef2e58-d143-415f-bde8-87690059ec33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_33964423-d08b-43b8-a361-6b25657c5f65_negatedLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ShortTermLeaseCosts_f5b9db44-2f7d-4c7d-a88f-e0bbd83b75f4_terseLabel_en-US" xlink:label="lab_ctlt_ShortTermLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease Costs</link:label>
    <link:label id="lab_ctlt_ShortTermLeaseCosts_label_en-US" xlink:label="lab_ctlt_ShortTermLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease Costs</link:label>
    <link:label id="lab_ctlt_ShortTermLeaseCosts_documentation_en-US" xlink:label="lab_ctlt_ShortTermLeaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShortTermLeaseCosts" xlink:href="ctlt-20210630.xsd#ctlt_ShortTermLeaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ShortTermLeaseCosts" xlink:to="lab_ctlt_ShortTermLeaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f71ef378-5cf1-4f65-b76f-b8c883447ed8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_19f3da80-112e-4f67-84c1-50e412aef139_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8ae08d0a-80f3-4c9b-b77d-6a2c58f07a29_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_c4b8b613-5283-4aa5-bd0a-c2dc747ad584_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_a003387d-8d89-4b16-9deb-1188e13db0a3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_40856754-7efc-4bb1-aae6-448504f3c336_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearThree_73a8e11a-784a-4f36-a710-f2fd3b846e3e_terseLabel_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Three</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearThree_label_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Three</link:label>
    <link:label id="lab_ctlt_InstallmentPaymentforAcquisitionYearThree_documentation_en-US" xlink:label="lab_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Installment Payment for Acquisition, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:to="lab_ctlt_InstallmentPaymentforAcquisitionYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_CorporateAndEliminationsMember_9f8b18ed-be96-46c2-a347-d86c7207e83e_terseLabel_en-US" xlink:label="lab_ctlt_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations [Member]</link:label>
    <link:label id="lab_ctlt_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_ctlt_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:label id="lab_ctlt_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_ctlt_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and eliminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CorporateAndEliminationsMember" xlink:href="ctlt-20210630.xsd#ctlt_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_CorporateAndEliminationsMember" xlink:to="lab_ctlt_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_54552194-15be-4ecf-a4aa-e94c85c0cd53_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_cb81fd37-ff8b-41cd-b3ec-6f308166836b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_17f79b82-e74e-4402-8d61-6069686d5c36_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f3a6b72-4e37-4094-ba86-a02a64f861f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b3ddb096-9d22-442f-b9ae-ef88fef32d33_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_29f8ee2d-9cb1-48ab-b4ac-f17d4aa86001_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_c9b05441-4903-4b43-b6a5-2e0fac057ec3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_907ae45c-2af8-4f2e-8d87-35cccfdbcef6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b0f59324-153a-45dc-b682-2ea6ea3d3414_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase)/decrease in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_d05d8a30-007f-4700-8019-eed825c17fda_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Liability at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_4ddfc8e3-eb05-45e5-b746-2e5f449f8516_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_df567163-fbe1-4f85-8ccc-1406d053adaf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_bd77b277-680b-49b9-9ff9-e78451691b13_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1c928fc0-c7a1-431b-ab52-ff9fafbf89ff_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable preferred stock, and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5b79587d-c84d-419e-93f6-d86e3a96fce0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f901ad7f-ad6c-4aa7-b915-5195220a4a92_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_847e7ffd-c9e8-4c4c-8198-eba33ee89db6_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bdab7ef6-5ecd-4844-9d14-0862451550c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad5326a2-7ac8-4b9e-976c-3d97c0ef570d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6fd19b81-a9a6-40ea-bc17-431fba14330b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_582ad1f7-bec9-4ae9-814b-93e1a11442e3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_f25e396e-bd73-4d03-8a20-cacfc1fb4695_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f5eeeed5-ccf5-4ee5-b4d7-740df11e4514_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_OtherUnobservableAssetsMember_e231ab99-5a68-4f02-aea7-59732589e36b_terseLabel_en-US" xlink:label="lab_ctlt_OtherUnobservableAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Unobservable Assets [Member]</link:label>
    <link:label id="lab_ctlt_OtherUnobservableAssetsMember_label_en-US" xlink:label="lab_ctlt_OtherUnobservableAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Unobservable Assets [Member]</link:label>
    <link:label id="lab_ctlt_OtherUnobservableAssetsMember_documentation_en-US" xlink:label="lab_ctlt_OtherUnobservableAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Unobservable Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherUnobservableAssetsMember" xlink:href="ctlt-20210630.xsd#ctlt_OtherUnobservableAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_OtherUnobservableAssetsMember" xlink:to="lab_ctlt_OtherUnobservableAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_855d8b20-d7b3-47a4-b8d8-0603e7144a40_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8cb32a50-b855-4ba9-898b-5f06130c212c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_9cd1fec6-5113-49cf-9e66-511f8ec20de9_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_6a75a084-51fc-401f-8f91-f5e86adddeb8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9eb9ae90-8495-4a44-a6b1-67da1fbfea6b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_11c07ac2-1e28-4efb-aa27-ca644462ee66_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a8f0add5-633d-4175-b831-d17c84318e2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_7bbaaf57-ebd4-46ce-a18c-95cada67ee6e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of 1% increase on APBO at balance sheet date</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_20dcdb26-282c-4a2c-a033-0b06ed69d028_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e2a577de-8b68-4655-a970-8083e5be1f27_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a90de3bb-6e1b-41a0-bead-2a5896e06290_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_af09bd64-6b5d-49e7-b6cd-f47cd7716b41_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e1a17501-591f-49c2-87bf-866c0c5018b5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_1d33edc8-1ca1-49b2-8f98-b1a60f32319b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate gain/(loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a89a172c-6c9b-48e4-9c48-659178a55581_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_97cb6e80-a920-4f31-9c82-405b785231fd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_8c2fd04e-6caf-4d28-8343-7ddd2b2dc6c1_verboseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_68118e05-8b39-46f9-9689-e7152c92e193_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Catalent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f08352c7-0547-4690-9191-9997c9c0b889_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5f1c3f96-1f77-427d-8948-bb28b2660df7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_efe51b7c-3ca4-4796-a182-414a9fad0d46_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_f82cfaf0-fa36-412c-8b3b-269de05b268f_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_MarketMember_063c46d9-f892-43c0-a605-670a49385bad_terseLabel_en-US" xlink:label="lab_ctlt_MarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market [Member]</link:label>
    <link:label id="lab_ctlt_MarketMember_label_en-US" xlink:label="lab_ctlt_MarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market [Member]</link:label>
    <link:label id="lab_ctlt_MarketMember_documentation_en-US" xlink:label="lab_ctlt_MarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MarketMember" xlink:href="ctlt-20210630.xsd#ctlt_MarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_MarketMember" xlink:to="lab_ctlt_MarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3c1ed903-7ecb-4d8d-8a9c-b4c06c3c4be3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_14185da7-94a4-486c-ae98-a898c987e93f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_9b38366c-fd3e-454e-b3a9-add5f79251a0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt and Capital Lease Obligations Repayments of Principal After Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d28d054c-d8a9-4507-a5ac-a434e8271998_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Net Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_506315f5-cc76-495f-adea-5d626b49e44c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet_b98dea50-1349-44a9-949a-0953fcbd14a5_negatedTerseLabel_en-US" xlink:label="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net</link:label>
    <link:label id="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet_label_en-US" xlink:label="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net</link:label>
    <link:label id="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet_documentation_en-US" xlink:label="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:href="ctlt-20210630.xsd#ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:to="lab_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_d44f3257-b3ba-4fd3-a428-cdf6215da1e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring (Income) Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_d57e1012-4b77-4c24-b4fc-dc91f099ffcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_63456e57-0744-4ebd-9470-9e33986c937b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_773fb5f2-f694-4d82-9564-51dc69c004e2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTARY CASH FLOW INFORMATION:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8cea1d17-3c53-418c-9e93-381fa6164525_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_90c8b702-1197-4d10-ad99-39ddb2b0728f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2dc22030-e7e0-417c-9825-cc0022f90573_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ForeignNetOperatingLossMember_f06da8bb-d629-4d5f-a4f7-357b22fa9d53_terseLabel_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss [Member]</link:label>
    <link:label id="lab_ctlt_ForeignNetOperatingLossMember_label_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss [Member]</link:label>
    <link:label id="lab_ctlt_ForeignNetOperatingLossMember_documentation_en-US" xlink:label="lab_ctlt_ForeignNetOperatingLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Net Operating Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossMember" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ForeignNetOperatingLossMember" xlink:to="lab_ctlt_ForeignNetOperatingLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e4d1017b-c78a-4015-9872-5e381bb79aa7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount_0f5bef31-b094-4e79-9f56-34a1234f6564_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Gross</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansAndLeasesReceivableGrossCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount" xlink:to="lab_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_DevelopmentServicesMember_bf7eb4d6-820b-4fc3-b7fa-48303c172ffc_terseLabel_en-US" xlink:label="lab_ctlt_DevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Services [Member]</link:label>
    <link:label id="lab_ctlt_DevelopmentServicesMember_label_en-US" xlink:label="lab_ctlt_DevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Services [Member]</link:label>
    <link:label id="lab_ctlt_DevelopmentServicesMember_documentation_en-US" xlink:label="lab_ctlt_DevelopmentServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DevelopmentServicesMember" xlink:href="ctlt-20210630.xsd#ctlt_DevelopmentServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_DevelopmentServicesMember" xlink:to="lab_ctlt_DevelopmentServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ea2e20d7-3d03-4843-89a3-0061a499f8c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_50085f16-6094-40b8-b267-245b81a89c46_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ce8ee9ae-9d58-4cfd-8b68-10826ec9d6c4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_e5875332-5bd8-45fb-af17-c29596110935_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_6dcf4054-0897-449e-8216-06518b233e03_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_0f0f12f3-d6ba-4c92-abea-5e9f8696b009_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_6e61c982-7e30-467d-99f9-8395d31383b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_19e38edf-5564-43e7-b551-318dc946ac09_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_ae6a5555-20c9-4cfb-b638-9cbf834f79bf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_aaf6e047-e760-4999-9ce2-9ebd9ae73f81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_b867a5e2-9370-457d-af38-c1829f7499c9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_NumberofCustomers_2c494e25-45d3-4801-a2f2-c905b905ff08_terseLabel_en-US" xlink:label="lab_ctlt_NumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Customers</link:label>
    <link:label id="lab_ctlt_NumberofCustomers_label_en-US" xlink:label="lab_ctlt_NumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Customers</link:label>
    <link:label id="lab_ctlt_NumberofCustomers_documentation_en-US" xlink:label="lab_ctlt_NumberofCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofCustomers" xlink:href="ctlt-20210630.xsd#ctlt_NumberofCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_NumberofCustomers" xlink:to="lab_ctlt_NumberofCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aa230b0f-334b-421d-8c4b-c4fd19129127_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_a34123b1-7636-4620-a954-bd42de1fc2c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6ad31b-64cf-4fd9-a4a2-6665d4695e31_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0718da13-e44a-473e-b586-7dce3c2ffeb4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_860a041b-2d78-4afb-ae16-b44e5f356934_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9c80c0ce-a937-4de6-be8b-71880fcf8841_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_586530ba-4d18-4ac6-94f7-5b6af839a7ff_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_129865f0-427e-49a1-9a52-66dd0b01c614_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b35971ae-2e51-4e81-85a8-798365ac0b44_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d3c909c7-4f1f-4443-bd15-28a6eedd7388_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_768bbee2-4b61-49a9-a543-43258e038a48_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_77587357-94e3-4325-bd35-c53618eae859_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_87dbf319-85d5-4932-8f1f-2cb96593cfbb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock_defe477e-5d47-4293-bb10-d0ec0a50020d_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Carrying And Fair Value Of Financial Instruments Table</link:label>
    <link:label id="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Carrying And Fair Value Of Financial Instruments Table [Table Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying and fair value of financial instruments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:to="lab_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_8eaa6580-a723-4c65-b839-a5a1e9bab7d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_88321b5a-cd9d-424d-9789-8dbb5fff354e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_28efde45-8496-4b5b-ac5c-1089a333ab0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_e7ac5e7e-12be-4ec1-8608-368851c914ee_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1f278fb9-796b-44ad-bfd8-da58e46d41e2_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_86801aff-a05b-4bdc-9aed-d10fb5967f9f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_538139cc-1b87-47b7-82de-0ef11cc349ed_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year in which ultimate rates are reached</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:to="lab_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_df31b395-b40c-4cf4-8ac6-802ea918c4c2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1f46b3f2-555b-4a1f-a2c4-3ebb8478c29b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of long-term obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock_5840d555-a0dc-4421-8d5b-6c965b4babc3_terseLabel_en-US" xlink:label="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Presentation of revenue and long-lived assets by geographic area</link:label>
    <link:label id="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock_label_en-US" xlink:label="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue And Long Lived Assets By Geographic Area Table [Text Block]</link:label>
    <link:label id="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock_documentation_en-US" xlink:label="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and long-lived assets by geographic area.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:to="lab_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_92e0d079-6658-4c4e-a0cf-3244ce50f2ec_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_946bf682-5df7-4bc4-90c1-52665e548601_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_89cf5408-3a75-481a-baee-c558000a3b3f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_9fd9c61c-b66a-4de3-9766-dc10484a99ca_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_32528c97-4fe7-47e5-a9f6-1928f3717125_terseLabel_en-US" xlink:label="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent sub-total of Segment Reporting [Member]</link:label>
    <link:label id="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_label_en-US" xlink:label="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent sub-total of Segment Reporting [Member]</link:label>
    <link:label id="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_documentation_en-US" xlink:label="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Catalent sub-total of Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentSubTotalOfSegmentReportingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:to="lab_ctlt_TotalCatalentSubTotalOfSegmentReportingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_ece7e1c7-6de8-48fd-b55e-78acee4be9b9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets for Each Segment and Reconciling in Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_864c1a2a-0389-4dc8-8266-9e0e172c69eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f90614a7-eabf-4410-bf36-c651e37ee98d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_a21b5b52-0716-4320-bcfe-f81db1259f13_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for Sale Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a7df8b4c-4103-479f-aedb-c94857eff847_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_2a04e57f-10f4-4521-aa2a-9492511ef7ae_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5f6b42fc-865b-44b8-b84a-f929140cf198_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7ef7603f-938f-4a5a-99f5-5a2b16fa5b02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_cd4ca930-51d7-4ac4-8a8f-54772fedfa98_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_ed955c92-4e90-4a43-a215-783c4ad12dff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_92065386-8fe2-4912-bdb7-20e27b61310c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_39f87e61-326b-445e-9d1e-6819d2f9f8f0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_40d54d2e-60d4-409a-90ca-e5f056af119c_terseLabel_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Table]</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_label_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Table]</link:label>
    <link:label id="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_documentation_en-US" xlink:label="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements Of Financial Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:to="lab_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_93f7b294-4b7f-45c4-92da-cfe5aa9d7e34_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of 1% Change in Healthcare Cost Trend Rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_37b9cd0c-ff54-4dad-83a8-076f4556b87e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_3fefcfc4-af7f-4821-bf27-678ed3370ca0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_f1462443-aa7b-4ee7-b598-1c658143e744_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_877350b2-669e-4237-9f52-7f2c7fcbf351_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_353ea7e8-5c30-4110-9f99-a93efea97558_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4c1778d1-6e80-4a74-874a-b8cd48598d15_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued &amp; Outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_7b26048b-4181-476d-8f2f-4e8549c94038_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_23b6c642-9ae4-454e-8426-bdcfcedd6a0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation and fair value of plan assets for the defined benefit retirement and postretirement plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_34776090-80cb-481b-aa99-a37e312c785e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_97a2c6fb-73f2-4202-8a12-5a2d0cdf9104_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee5106ed-6dbd-49ba-b8d9-de958d0d355e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_8dd756a5-cf7a-444f-88b5-0f559cc3fecf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_cf1cbcc7-6110-47c0-8bf0-7029b64c65ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Non Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_dd12ca0d-fa93-4e47-8609-b11464dc754c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_LongTermAndShortTermDebtAbstract_label_en-US" xlink:label="lab_ctlt_LongTermAndShortTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term and Short-term Debt [Abstract]</link:label>
    <link:label id="lab_ctlt_LongTermAndShortTermDebtAbstract_documentation_en-US" xlink:label="lab_ctlt_LongTermAndShortTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term and Short-term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_LongTermAndShortTermDebtAbstract" xlink:href="ctlt-20210630.xsd#ctlt_LongTermAndShortTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract" xlink:to="lab_ctlt_LongTermAndShortTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_36a60836-15a2-42d4-957f-e6c4adcfa5c2_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts_dfc4dc6f-1c8f-45b8-8dc6-adba529740dd_terseLabel_en-US" xlink:label="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and write-off of debt financing costs</link:label>
    <link:label id="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts_label_en-US" xlink:label="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization And Write Off Of Financing Costs</link:label>
    <link:label id="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts_documentation_en-US" xlink:label="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization And Write Off Of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:href="ctlt-20210630.xsd#ctlt_AmortizationAndWriteOffOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:to="lab_ctlt_AmortizationAndWriteOffOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_d4f08dda-adc1-4d5a-8d99-3cab0a513b9f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_04c58aa8-6603-4feb-9429-eb07eb7799db_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_2bab745b-1c8a-46cc-86f3-24cdbf758547_terseLabel_en-US" xlink:label="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inter-segment revenue elimination</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_label_en-US" xlink:label="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Inter Segment Revenue Elimination</link:label>
    <link:label id="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_documentation_en-US" xlink:label="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment reporting information inter segment revenue elimination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationInterSegmentRevenueElimination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:to="lab_ctlt_SegmentReportingInformationInterSegmentRevenueElimination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_898a33f5-b1ba-4b5c-9c96-8b33b81841f7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_df0c53ed-ffd3-4b7b-a236-14c2c3d38a80_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a07a5880-ebed-46b7-980d-48da6c7e860c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ParagonMember_7ffb2f6a-7d0d-441c-85c6-1c45bae96da2_terseLabel_en-US" xlink:label="lab_ctlt_ParagonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paragon [Member]</link:label>
    <link:label id="lab_ctlt_ParagonMember_label_en-US" xlink:label="lab_ctlt_ParagonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paragon [Member]</link:label>
    <link:label id="lab_ctlt_ParagonMember_documentation_en-US" xlink:label="lab_ctlt_ParagonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paragon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ParagonMember" xlink:to="lab_ctlt_ParagonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_4ab03d84-fa89-4559-92a1-8f2b12961c0a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_64382f69-9a18-4318-a9ed-390f717b7760_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_c75fa5aa-b400-4247-a8e0-fb6da87c57b2_terseLabel_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share</link:label>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_label_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share</link:label>
    <link:label id="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_documentation_en-US" xlink:label="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The estimated amount of dividends per share to be paid to holders of the underlying shares (expected dividends per share) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:to="lab_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>ctlt-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3705feb3-dff9-4f6e-bde0-737999dd0e1f,g:3ff68315-97ea-4210-babd-b5a10e6ce01d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://catalent.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:href="ctlt-20210630.xsd#ctlt_DocumentDocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_35791f32-6c7c-4fd6-9355-9822eb961251" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentType_35791f32-6c7c-4fd6-9355-9822eb961251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fe2d8197-60c9-4145-8681-6ba1a467b0e7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentAnnualReport_fe2d8197-60c9-4145-8681-6ba1a467b0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a79737cb-4778-49ae-b4f0-21a9d9afb10c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentTransitionReport_a79737cb-4778-49ae-b4f0-21a9d9afb10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0dd8fdb9-e3a1-4e69-aea0-7b2ca91a9114" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentFiscalYearFocus_0dd8fdb9-e3a1-4e69-aea0-7b2ca91a9114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0e1d43c5-1973-4b27-ab58-351481b720ff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0e1d43c5-1973-4b27-ab58-351481b720ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7447251e-f070-4c29-8986-c191c560ad70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_AmendmentFlag_7447251e-f070-4c29-8986-c191c560ad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90df76ac-5fe0-40ac-883d-d284816dcb79" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_DocumentPeriodEndDate_90df76ac-5fe0-40ac-883d-d284816dcb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_679bb743-5cd1-4f70-9f41-305985262613" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityFileNumber_679bb743-5cd1-4f70-9f41-305985262613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d82b10b1-3640-4123-bb13-bf0d39c1d3a3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d82b10b1-3640-4123-bb13-bf0d39c1d3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e11fbcff-8f53-460c-bfab-3c7acb0f3aaf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityTaxIdentificationNumber_e11fbcff-8f53-460c-bfab-3c7acb0f3aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f4e83637-544b-40c8-b38b-ae83c5012dee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityAddressAddressLine1_f4e83637-544b-40c8-b38b-ae83c5012dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_455a6975-52a5-4ff4-867d-ea4387f528e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityAddressCityOrTown_455a6975-52a5-4ff4-867d-ea4387f528e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_56066758-2c02-49ac-9e50-59af409a5470" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityAddressStateOrProvince_56066758-2c02-49ac-9e50-59af409a5470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a44d9622-9f68-4086-bdf1-df7ccfe1ee29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityAddressPostalZipCode_a44d9622-9f68-4086-bdf1-df7ccfe1ee29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ad3e6ca5-7c2b-463e-b81f-2ae80b7a102b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_CityAreaCode_ad3e6ca5-7c2b-463e-b81f-2ae80b7a102b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_986ad03a-be7e-400a-9049-e097d658043c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_LocalPhoneNumber_986ad03a-be7e-400a-9049-e097d658043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_24606487-b941-46d2-89d9-c3c17df4424f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_TradingSymbol_24606487-b941-46d2-89d9-c3c17df4424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2b75eebe-22da-4507-a6ce-32df74bf7022" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityRegistrantName_2b75eebe-22da-4507-a6ce-32df74bf7022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_28863ac3-a70f-4aad-9b35-741d6d49c114" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityCentralIndexKey_28863ac3-a70f-4aad-9b35-741d6d49c114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c6f2c3a4-2d34-44bf-b347-873fcd405877" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_CurrentFiscalYearEndDate_c6f2c3a4-2d34-44bf-b347-873fcd405877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_24a985a4-0931-441b-bedd-f12ad2eb0a38" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_24a985a4-0931-441b-bedd-f12ad2eb0a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_17049e54-a595-47b2-9708-a7e7695de194" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityCurrentReportingStatus_17049e54-a595-47b2-9708-a7e7695de194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_2a130f3f-d05a-4c16-acc5-537ba2bc5d59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityVoluntaryFilers_2a130f3f-d05a-4c16-acc5-537ba2bc5d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_060e5b30-3ff3-4ba4-9d0c-c227252666df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityFilerCategory_060e5b30-3ff3-4ba4-9d0c-c227252666df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_198b30e2-d064-4a79-ae62-487104bfaa3f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityEmergingGrowthCompany_198b30e2-d064-4a79-ae62-487104bfaa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_319054e2-cd4a-4289-854f-f56bd3b652e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntitySmallBusiness_319054e2-cd4a-4289-854f-f56bd3b652e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_09df7069-4507-43ae-9e48-d2d4d3b081ac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityShellCompany_09df7069-4507-43ae-9e48-d2d4d3b081ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_705d5358-3974-4686-8b40-a07ebec00096" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_705d5358-3974-4686-8b40-a07ebec00096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7f176205-3e36-48bc-98ea-6a73dbafb7d8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityInteractiveDataCurrent_7f176205-3e36-48bc-98ea-6a73dbafb7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8616564c-6fcb-4459-ba36-ab044038b29d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_SecurityExchangeName_8616564c-6fcb-4459-ba36-ab044038b29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b394ba92-f3ff-4964-ab57-9107cb7a6dfb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_Security12bTitle_b394ba92-f3ff-4964-ab57-9107cb7a6dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_31486781-5c62-415e-ab5e-acd78c3ba3a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_31486781-5c62-415e-ab5e-acd78c3ba3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_7759152b-ff64-420a-9d10-1bc76905ab7d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_IcfrAuditorAttestationFlag_7759152b-ff64-420a-9d10-1bc76905ab7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_a4f1f469-36e2-4401-835d-6ddf7174ec49" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DocumentDocumentAndEntityInformationAbstract_256d735b-2b85-4d0e-afd8-55b38f09cab2" xlink:to="loc_dei_EntityPublicFloat_a4f1f469-36e2-4401-835d-6ddf7174ec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fab631ec-5e68-4eea-a698-b75b34085281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_Revenues_fab631ec-5e68-4eea-a698-b75b34085281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0069a921-7612-4f2b-8535-51ce90e2fa86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0069a921-7612-4f2b-8535-51ce90e2fa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d7fa58e7-584d-47f8-a703-f5b06d1d29db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_GrossProfit_d7fa58e7-584d-47f8-a703-f5b06d1d29db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_34034f07-4c32-46f4-a70e-d7861a2ff4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_34034f07-4c32-46f4-a70e-d7861a2ff4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_16a701f1-eccf-4223-ae39-15e092dcc333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_16a701f1-eccf-4223-ae39-15e092dcc333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_93e1d06f-f64a-4daa-841d-034e686a0a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_93e1d06f-f64a-4daa-841d-034e686a0a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_aa698f2b-c711-4d28-be27-6bbb04798ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_OperatingIncomeLoss_aa698f2b-c711-4d28-be27-6bbb04798ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4d0add22-ef91-4e88-823d-472b500314eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4d0add22-ef91-4e88-823d-472b500314eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e5c601a4-9854-4095-8d29-e1ae338e1cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e5c601a4-9854-4095-8d29-e1ae338e1cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0e21f474-e503-4fd9-8a49-4282ea9646cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0e21f474-e503-4fd9-8a49-4282ea9646cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_51c44ce2-2db1-4222-8fb8-3b4cf3c9b2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_51c44ce2-2db1-4222-8fb8-3b4cf3c9b2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cbdb8766-5825-46cf-9dca-9b62f376f30e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_NetIncomeLoss_cbdb8766-5825-46cf-9dca-9b62f376f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_aec0874d-342e-42af-a2ec-1ddfa0216db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_aec0874d-342e-42af-a2ec-1ddfa0216db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e52593cb-70b0-436c-88fd-1983943a7fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e52593cb-70b0-436c-88fd-1983943a7fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_87abc24a-4ea1-430b-92ec-664f3195d743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_EarningsPerShareBasic_87abc24a-4ea1-430b-92ec-664f3195d743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cf1dd57e-d7da-4505-b668-8b9453210868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e424287b-6865-43bb-8115-e234f177cf32" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cf1dd57e-d7da-4505-b668-8b9453210868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_31db8b6f-1d2c-47f0-b166-8e6769b27d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_31db8b6f-1d2c-47f0-b166-8e6769b27d5c" xlink:to="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a49601d4-3f4f-478f-8635-37e3e1191be0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a18cf5f8-6f88-468b-904f-d974066b0386" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a49601d4-3f4f-478f-8635-37e3e1191be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8361d29c-e79a-45f6-b8c1-0b43d672ff48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4aaf2e32-391f-4b1c-87be-97318375d03a" xlink:to="loc_us-gaap_ClassOfStockDomain_8361d29c-e79a-45f6-b8c1-0b43d672ff48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_894ef63b-8216-4132-9403-1b1f9e1dedb1" xlink:to="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_23821907-85c4-4721-b359-52ba7a7c8581" xlink:href="ctlt-20210630.xsd#ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4ac3e6f2-34b9-4e2e-bd6e-4dda7ab19764" xlink:to="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_23821907-85c4-4721-b359-52ba7a7c8581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6188993d-5926-4010-9215-a5b581487d05" xlink:to="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78830466-ebc3-47f7-b6b0-fde39f16ca3e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6090caf9-ded6-4568-b486-e92619f76d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_ProfitLoss_6090caf9-ded6-4568-b486-e92619f76d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_726fd133-7b61-4e98-83a9-5659052396a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_726fd133-7b61-4e98-83a9-5659052396a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3996f010-23b6-4068-8a30-48d07a9980e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3996f010-23b6-4068-8a30-48d07a9980e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0071b53d-5851-4404-ab5b-35f1e18aa0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0071b53d-5851-4404-ab5b-35f1e18aa0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_88e1f9a6-51bf-4c2f-a6ba-5827941d0221" xlink:href="ctlt-20210630.xsd#ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_88e1f9a6-51bf-4c2f-a6ba-5827941d0221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4cc1fe5f-d505-4ac5-a10f-5486968e7fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4cc1fe5f-d505-4ac5-a10f-5486968e7fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbad3413-eada-4515-8c23-7be1f085c304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8936b05d-6a21-4d22-82b5-08d8682feddd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bbad3413-eada-4515-8c23-7be1f085c304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4c7013c6-8abd-4a69-a92f-e637f2aa75c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_bc2fa07e-2f18-4ed0-89ec-f5551c747979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4c7013c6-8abd-4a69-a92f-e637f2aa75c9" xlink:to="loc_us-gaap_AssetsAbstract_bc2fa07e-2f18-4ed0-89ec-f5551c747979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bc2fa07e-2f18-4ed0-89ec-f5551c747979" xlink:to="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34551d43-757f-4bdd-8a22-7a11ac18d0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_34551d43-757f-4bdd-8a22-7a11ac18d0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_416065ca-6830-43dc-b443-e1f5bbf5f5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_416065ca-6830-43dc-b443-e1f5bbf5f5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ca9868c9-6084-4821-8f56-7d861a8bcbec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_InventoryNet_ca9868c9-6084-4821-8f56-7d861a8bcbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2338deb2-3536-4f29-befc-d202919d82fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2338deb2-3536-4f29-befc-d202919d82fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_d427ca35-ccb2-45c2-8ad1-7dc5f51a64b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_MarketableSecurities_d427ca35-ccb2-45c2-8ad1-7dc5f51a64b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_19bc6acf-57b7-4ea1-831e-7a741da52686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_AssetsCurrent_19bc6acf-57b7-4ea1-831e-7a741da52686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1380775f-6cf1-4edf-bbaf-afa35ced869f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_49db36d8-c64e-4bf2-9e29-77a4a6891aba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1380775f-6cf1-4edf-bbaf-afa35ced869f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bc2fa07e-2f18-4ed0-89ec-f5551c747979" xlink:to="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9df4bd1d-19d9-4e8d-ba4e-ef1a17ae300c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:to="loc_us-gaap_Goodwill_9df4bd1d-19d9-4e8d-ba4e-ef1a17ae300c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd3ab924-80c9-4a83-8177-2415c6d924d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cd3ab924-80c9-4a83-8177-2415c6d924d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_31524fa0-931f-4a78-aa2f-6bb8f357a250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_31524fa0-931f-4a78-aa2f-6bb8f357a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_06a3cbec-b42c-44cc-b1aa-6f32ce296c90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bac670de-7ab6-4b6c-8acc-b607725b91f8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_06a3cbec-b42c-44cc-b1aa-6f32ce296c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_226446f2-2063-4878-a5f0-2db4d43129ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bc2fa07e-2f18-4ed0-89ec-f5551c747979" xlink:to="loc_us-gaap_Assets_226446f2-2063-4878-a5f0-2db4d43129ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4c7013c6-8abd-4a69-a92f-e637f2aa75c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_8b2e1557-92a4-4324-b1dd-0fa4ce23b573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:to="loc_us-gaap_DebtCurrent_8b2e1557-92a4-4324-b1dd-0fa4ce23b573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_849a5eb1-4f78-432d-829f-3c02aea0bbaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:to="loc_us-gaap_AccountsPayableCurrent_849a5eb1-4f78-432d-829f-3c02aea0bbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_0e98adfd-946c-46fe-9892-721d0b49a358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_0e98adfd-946c-46fe-9892-721d0b49a358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b952897a-e9a6-4f75-8b0c-9058dbe693b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_30bc070d-bdee-49cc-90c4-d60ac77b1e36" xlink:to="loc_us-gaap_LiabilitiesCurrent_b952897a-e9a6-4f75-8b0c-9058dbe693b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5812b23b-ad39-4d87-bd6a-0b3657c1c754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5812b23b-ad39-4d87-bd6a-0b3657c1c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_a6e8b8e0-26e7-4039-991d-fbbf2e5f5454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_a6e8b8e0-26e7-4039-991d-fbbf2e5f5454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_cdfa263d-0b18-4798-9e9b-e5d24443c9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_cdfa263d-0b18-4798-9e9b-e5d24443c9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e8b109aa-cf5c-4128-92de-10d6d85af6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e8b109aa-cf5c-4128-92de-10d6d85af6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8906f49b-369d-4151-bd62-f99740532b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8906f49b-369d-4151-bd62-f99740532b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e0553419-c225-4804-b52c-047e0b830faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_Liabilities_e0553419-c225-4804-b52c-047e0b830faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9ba2a008-5650-43f0-9d15-31d440fbf51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_9ba2a008-5650-43f0-9d15-31d440fbf51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_568de532-b815-49de-8fe5-27b401d5264e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_CommonStockValueOutstanding_568de532-b815-49de-8fe5-27b401d5264e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_18885ecd-a62b-4933-8b67-cb9d4933d383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_18885ecd-a62b-4933-8b67-cb9d4933d383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e55847b3-6ec3-405f-852c-0625b94ed6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e55847b3-6ec3-405f-852c-0625b94ed6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33f7b3bd-8eaa-4ac0-84a5-b950092e4c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33f7b3bd-8eaa-4ac0-84a5-b950092e4c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3660d115-9232-4e63-9417-238cab3622fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3660d115-9232-4e63-9417-238cab3622fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ef19e274-7c81-481e-854b-c41f9baaf40f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_StockholdersEquity_ef19e274-7c81-481e-854b-c41f9baaf40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_284ac32e-410d-4376-b530-70448d6e8201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9376d177-71fc-4c00-8fdf-5335736efead" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_284ac32e-410d-4376-b530-70448d6e8201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f46e8e2d-7383-4511-b8bf-485899482219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f46e8e2d-7383-4511-b8bf-485899482219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e8cfacae-672a-4ab3-8f5b-d524178fa996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e8cfacae-672a-4ab3-8f5b-d524178fa996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3e7c8298-55c9-434d-8946-905a634c4c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_CommonStockSharesIssued_3e7c8298-55c9-434d-8946-905a634c4c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_31e35afe-04aa-4475-8b7b-bbff625f8f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_31e35afe-04aa-4475-8b7b-bbff625f8f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2aa138a9-03c9-48aa-8de8-ff0acfde8e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2aa138a9-03c9-48aa-8de8-ff0acfde8e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c1cc0dee-fbcf-4a08-becf-f275b03255d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c1cc0dee-fbcf-4a08-becf-f275b03255d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_0bce88d8-3556-4e3a-87e0-3dd7f923c6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78ebb86c-3ddc-46af-b63e-b566441b8497" xlink:to="loc_us-gaap_PreferredStockSharesIssued_0bce88d8-3556-4e3a-87e0-3dd7f923c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementofChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1782d2f-371b-4e37-a405-424478c0238e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1782d2f-371b-4e37-a405-424478c0238e" xlink:to="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8bdd7d93-920e-4ba0-adec-52a4c02a28df" xlink:to="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e1e5e8dc-9b7a-4365-9584-49ea39539f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_CommonStockMember_e1e5e8dc-9b7a-4365-9584-49ea39539f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d30a3f4a-0692-42f9-b49f-62584aa5a747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d30a3f4a-0692-42f9-b49f-62584aa5a747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c3ead6ab-a245-46b7-aa0c-c8e8363bc087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_RetainedEarningsMember_c3ead6ab-a245-46b7-aa0c-c8e8363bc087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_32318431-b2ff-46b3-b9c9-63662bbdd9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b305a8d2-d085-4bda-acf8-9f7cd4cab1e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_32318431-b2ff-46b3-b9c9-63662bbdd9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a8754e50-fa49-4375-88ee-c2cb0128c1f4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f50435e0-a908-4df3-bca0-557eb1c3ba2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6f92a7fb-8a2c-4e65-8b4f-c0395a0f62b7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f50435e0-a908-4df3-bca0-557eb1c3ba2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e8726076-853b-4a9f-a7fc-2cf2f246721f" xlink:to="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6ae4d49a-198b-4ba2-bef5-5b35701a7c0e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caf15f82-d1c9-4ae6-b7f6-af243616daa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caf15f82-d1c9-4ae6-b7f6-af243616daa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_90e76009-3192-4d71-8645-f799ad0e2f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockholdersEquityOther_90e76009-3192-4d71-8645-f799ad0e2f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12e67295-861e-4974-94f6-54c2d943aae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_12e67295-861e-4974-94f6-54c2d943aae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb4cd253-4a27-4866-acb7-60f64e635e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fb4cd253-4a27-4866-acb7-60f64e635e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_95af356c-fb17-46a4-bff5-bd1fcea13f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_95af356c-fb17-46a4-bff5-bd1fcea13f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e5bbf17d-cf7f-4549-9f76-735189243684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e5bbf17d-cf7f-4549-9f76-735189243684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f3b4e9a-9a21-4259-a419-cc2974add74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1f3b4e9a-9a21-4259-a419-cc2974add74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c8d86ab5-7c94-4db7-af8c-2eab1b0a986a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c8d86ab5-7c94-4db7-af8c-2eab1b0a986a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EquityIssuedInLieuOfCashConsideration_29b886e0-d667-4b52-bf82-9da3b2014c1f" xlink:href="ctlt-20210630.xsd#ctlt_EquityIssuedInLieuOfCashConsideration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_ctlt_EquityIssuedInLieuOfCashConsideration_29b886e0-d667-4b52-bf82-9da3b2014c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_484690f5-32dc-4ea1-af2e-18433a0a6e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_484690f5-32dc-4ea1-af2e-18433a0a6e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStock_24acfb33-7f87-4639-8560-678393d966a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_DividendsPreferredStock_24acfb33-7f87-4639-8560-678393d966a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_136b424d-4160-4f9e-88ec-5d1f85c9b6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_NetIncomeLoss_136b424d-4160-4f9e-88ec-5d1f85c9b6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58e827a3-d340-44b2-a261-a30804a82dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_58e827a3-d340-44b2-a261-a30804a82dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_47936dcc-1abd-4ab2-8c0c-6b6074a4aab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_47936dcc-1abd-4ab2-8c0c-6b6074a4aab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_494bd8c4-2816-4c1e-9067-24008015f24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_494bd8c4-2816-4c1e-9067-24008015f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_1e570691-d578-40f2-92d1-899be95ff191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_1e570691-d578-40f2-92d1-899be95ff191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1f5a270b-ac3e-4fed-9444-9e59e75fe689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_55108aa2-1dec-4890-99de-18e0ad129415" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1f5a270b-ac3e-4fed-9444-9e59e75fe689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e6441255-90b3-4ab4-888c-1a6ac72a31f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e6441255-90b3-4ab4-888c-1a6ac72a31f8" xlink:to="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1b9232b4-4b41-4497-9795-ae6345218aac" xlink:to="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4bf5a6a-59ce-416a-998b-6f28a25ac7a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ac7c3d7-7e98-4a49-a82b-9364dce2f355" xlink:to="loc_us-gaap_CommonStockMember_b4bf5a6a-59ce-416a-998b-6f28a25ac7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6493d58a-e896-4af1-a98a-14d44a28b1e4" xlink:to="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8019fac-f966-4ea1-a3ab-b8302aff69d8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c386dd38-2968-4022-a6ba-b5b732001808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c386dd38-2968-4022-a6ba-b5b732001808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9fe9b79-2150-4d29-bb6b-8c86b0b4d713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f9fe9b79-2150-4d29-bb6b-8c86b0b4d713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_72983900-8c00-46f9-b45b-16754a8837c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_72983900-8c00-46f9-b45b-16754a8837c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ad56b1c4-47a5-4fca-8a1d-6cd087b39eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ad56b1c4-47a5-4fca-8a1d-6cd087b39eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7df0fb86-fa2f-40fc-878a-a0b00f03d609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_56556e0f-5dfc-4ea6-b1c9-7ec5b4ebd884" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7df0fb86-fa2f-40fc-878a-a0b00f03d609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ctlt-20210630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://catalent.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c0955717-dbfa-476f-96d8-291f9c3b56fe" xlink:to="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_55b016a4-86d7-4e0d-bab2-6c25462ec564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f86551f-c10f-4ea1-9393-29fbda7c104f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_55b016a4-86d7-4e0d-bab2-6c25462ec564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:to="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c502ffbe-1ec3-4b92-ad98-1cae0e6523ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b47828f0-fe59-4e1b-baf6-44c0fce31b05" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c502ffbe-1ec3-4b92-ad98-1cae0e6523ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c578b357-075e-49c8-8764-930aab50a74b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cab707a-14e1-4578-8b25-ac60c97061c1" xlink:to="loc_us-gaap_StatementLineItems_c578b357-075e-49c8-8764-930aab50a74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5978f9b4-d80d-4fb2-abc0-f7578d6b6318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5978f9b4-d80d-4fb2-abc0-f7578d6b6318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ac42d06a-039d-40a8-8350-e1e06b970b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5978f9b4-d80d-4fb2-abc0-f7578d6b6318" xlink:to="loc_us-gaap_ProfitLoss_ac42d06a-039d-40a8-8350-e1e06b970b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5978f9b4-d80d-4fb2-abc0-f7578d6b6318" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3271001e-9192-4add-994f-b0ff29c6d427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3271001e-9192-4add-994f-b0ff29c6d427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_26ee52a7-df99-4195-b52d-a5a48dffba11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_26ee52a7-df99-4195-b52d-a5a48dffba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts_22e7ca70-67ba-4c2c-b27a-4d2fec3c9dc7" xlink:href="ctlt-20210630.xsd#ctlt_AmortizationAndWriteOffOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_ctlt_AmortizationAndWriteOffOfFinancingCosts_22e7ca70-67ba-4c2c-b27a-4d2fec3c9dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9af1fe16-6b91-465f-8966-9bd20a7b3784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9af1fe16-6b91-465f-8966-9bd20a7b3784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1b3c9744-5f84-422e-b8d3-38fdd5027f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1b3c9744-5f84-422e-b8d3-38fdd5027f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_ea419655-03fc-4262-8903-2c1ce7d0dc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_ea419655-03fc-4262-8903-2c1ce7d0dc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_19aba68d-89e4-4dae-bf37-06f9b1b58194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_19aba68d-89e4-4dae-bf37-06f9b1b58194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0ad91a6a-901d-428c-9dd5-156467086c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_ShareBasedCompensation_0ad91a6a-901d-428c-9dd5-156467086c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_44767764-a1eb-4544-8214-ae4230269601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_44767764-a1eb-4544-8214-ae4230269601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProvisionForBadDebtsAndInventory_2c8d23ba-e42a-411c-bdcd-28f62e127039" xlink:href="ctlt-20210630.xsd#ctlt_ProvisionForBadDebtsAndInventory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3ed52c9c-f2b3-47eb-830e-a908d23b233b" xlink:to="loc_ctlt_ProvisionForBadDebtsAndInventory_2c8d23ba-e42a-411c-bdcd-28f62e127039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5978f9b4-d80d-4fb2-abc0-f7578d6b6318" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4b7530e6-1f0f-4363-92f5-ac2f200dc195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4b7530e6-1f0f-4363-92f5-ac2f200dc195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_e962aedc-9327-4c9f-b733-03d4401ac54c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_e962aedc-9327-4c9f-b733-03d4401ac54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_753e7c25-daae-46f5-b211-809648427547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_753e7c25-daae-46f5-b211-809648427547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ff52cccd-9cd5-4b2b-bb95-eb2561dccff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ff52cccd-9cd5-4b2b-bb95-eb2561dccff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f602dd9f-da9f-40de-9b04-565f771e99be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f14727-33aa-4998-b93d-a4699141a35f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f602dd9f-da9f-40de-9b04-565f771e99be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f17d2868-b32d-4cfc-8b42-f879f9fbb18a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f17d2868-b32d-4cfc-8b42-f879f9fbb18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_825a6ee5-c7f8-45d6-a824-15e9989eec63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_825a6ee5-c7f8-45d6-a824-15e9989eec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c8c4bd16-98cc-422b-9f24-0a30041ef4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c8c4bd16-98cc-422b-9f24-0a30041ef4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_43b8d987-7275-4f05-96b9-79dd4ad33724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries_43b8d987-7275-4f05-96b9-79dd4ad33724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b01ca302-c847-4fee-8756-4b372ddd1517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b01ca302-c847-4fee-8756-4b372ddd1517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_da883f1c-7398-4cfd-b6c8-a9989b02867f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_da883f1c-7398-4cfd-b6c8-a9989b02867f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaac44f0-9104-407f-95df-a99b7e5d6392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f4069bf-58bb-4fd2-8532-981e598d3e79" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaac44f0-9104-407f-95df-a99b7e5d6392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0e73ba27-3ece-48f3-a8e5-2ac3732d0b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0e73ba27-3ece-48f3-a8e5-2ac3732d0b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_f991874b-db54-475a-a564-3301679b6df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_f991874b-db54-475a-a564-3301679b6df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1edf0ded-ff1f-40af-ac8c-1e2cfc89df79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1edf0ded-ff1f-40af-ac8c-1e2cfc89df79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_40c262c0-58d6-4bbc-b98b-668b6d718da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_40c262c0-58d6-4bbc-b98b-668b6d718da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAndInterestPaid_c59a5133-1a2d-415f-95b9-508b8861525f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAndInterestPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_DividendsAndInterestPaid_c59a5133-1a2d-415f-95b9-508b8861525f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6029744a-b72d-4db1-ac96-0177dd63d193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6029744a-b72d-4db1-ac96-0177dd63d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_bbd3a6c8-be4e-47da-ad5f-d9ddfd08be8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_bbd3a6c8-be4e-47da-ad5f-d9ddfd08be8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_aea8828f-5622-42a4-9cdf-702bf7c7272a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_aea8828f-5622-42a4-9cdf-702bf7c7272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1df0e99f-6854-4651-aa65-e7244957411c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1df0e99f-6854-4651-aa65-e7244957411c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_54f35210-da39-481c-a957-267de63a5d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_54f35210-da39-481c-a957-267de63a5d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64750e20-15b4-4e59-87bb-af059925c246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b3fd9ed4-c755-44fb-8cec-987215c3fb94" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_64750e20-15b4-4e59-87bb-af059925c246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_c987e019-6e1e-4e94-a2d6-e2d15f36a3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_c987e019-6e1e-4e94-a2d6-e2d15f36a3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f451cdd7-4865-44c0-ae6e-e309a670abc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f451cdd7-4865-44c0-ae6e-e309a670abc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8bec7a7e-1430-41d7-9ea9-e4f72cd81e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8bec7a7e-1430-41d7-9ea9-e4f72cd81e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b00b238-972a-45ad-9274-8d3e99dc6023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b00b238-972a-45ad-9274-8d3e99dc6023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d88a0361-5cf9-4a3c-a9c7-cec88fd9c8b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d88a0361-5cf9-4a3c-a9c7-cec88fd9c8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_dc4339f7-cb59-44b1-aa9e-728ba0c00417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d88a0361-5cf9-4a3c-a9c7-cec88fd9c8b9" xlink:to="loc_us-gaap_InterestPaidNet_dc4339f7-cb59-44b1-aa9e-728ba0c00417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_2d6ad8c0-746e-4609-b12b-f830538fb8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d88a0361-5cf9-4a3c-a9c7-cec88fd9c8b9" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_2d6ad8c0-746e-4609-b12b-f830538fb8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36fb571e-16b7-44f1-b3f7-6dc78cad496b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8fa77c4a-b865-4dc6-a5c7-1385f56efa1f" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36fb571e-16b7-44f1-b3f7-6dc78cad496b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_a476becf-1ccc-4956-ba45-8ec8b6ea383c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36fb571e-16b7-44f1-b3f7-6dc78cad496b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_a476becf-1ccc-4956-ba45-8ec8b6ea383c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_cbce5620-065f-42ca-bfd1-066bc5410764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36fb571e-16b7-44f1-b3f7-6dc78cad496b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_cbce5620-065f-42ca-bfd1-066bc5410764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d16ebdc1-70c2-4260-982e-743389ab3cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d1c5e2b4-cf79-47cd-83b5-ba698b63cb5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d16ebdc1-70c2-4260-982e-743389ab3cb6" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d1c5e2b4-cf79-47cd-83b5-ba698b63cb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9863addb-8bbc-4005-b86f-2b4c5a9ada6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9863addb-8bbc-4005-b86f-2b4c5a9ada6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d76e5318-6f97-4caa-be77-dbc17907163d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d76e5318-6f97-4caa-be77-dbc17907163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e7b1b6ea-d5cc-4814-ae63-00b69ae8f6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_UseOfEstimates_e7b1b6ea-d5cc-4814-ae63-00b69ae8f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Reclassifications_9e2b0f6f-be35-461d-91b9-a08a139feb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Reclassifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_Reclassifications_9e2b0f6f-be35-461d-91b9-a08a139feb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_81ec5dc4-4830-4f17-beb3-bbb3b094d645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_81ec5dc4-4830-4f17-beb3-bbb3b094d645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a4e45d78-6a9e-40d1-92f1-2562eccd328b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a4e45d78-6a9e-40d1-92f1-2562eccd328b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_608d50cd-0c49-427e-a5ad-130d4e480107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_608d50cd-0c49-427e-a5ad-130d4e480107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_b5eed2f8-9993-4138-9f05-b4efc86a6113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_b5eed2f8-9993-4138-9f05-b4efc86a6113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d7c71f97-0cb3-48d4-9a46-9c26a2f0bebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d7c71f97-0cb3-48d4-9a46-9c26a2f0bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_9506701c-4caa-4172-85bf-fa29a68deb60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_9506701c-4caa-4172-85bf-fa29a68deb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_28e081d4-199a-4300-9871-cbd91dd09f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_28e081d4-199a-4300-9871-cbd91dd09f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7b2f4db3-5c82-4e79-8a39-6c34a26c94c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7b2f4db3-5c82-4e79-8a39-6c34a26c94c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_31fef5e0-edb9-4c7f-ab9b-589cd3979ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_31fef5e0-edb9-4c7f-ab9b-589cd3979ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_16c494fa-b74a-4e62-82ea-abda1c4ce442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_16c494fa-b74a-4e62-82ea-abda1c4ce442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_49ca9cff-9c99-4cdd-a805-a444b23d9696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_49ca9cff-9c99-4cdd-a805-a444b23d9696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_94075fd0-db55-4ca6-b411-43cc604fdcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_94075fd0-db55-4ca6-b411-43cc604fdcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_0e514a9a-8eff-41e1-a1b0-ea3a441e542f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_0e514a9a-8eff-41e1-a1b0-ea3a441e542f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_6bb23f9c-a78b-4f75-b27b-ca91ec627a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_6bb23f9c-a78b-4f75-b27b-ca91ec627a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1dff7d27-fbc0-4de6-a133-f5038d456eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1dff7d27-fbc0-4de6-a133-f5038d456eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_02c59bc4-395a-49cd-a300-8e78aa26bef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_02c59bc4-395a-49cd-a300-8e78aa26bef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_4365ce4a-8e15-4959-ae72-8fe82aed3f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_4365ce4a-8e15-4959-ae72-8fe82aed3f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_023ce428-7fe3-46df-8889-6b73c6f8ea4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_023ce428-7fe3-46df-8889-6b73c6f8ea4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c1f56c19-cdbc-469d-811d-174f88b1ec5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dd8f786-cc66-4178-bebf-16ea2932d06b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c1f56c19-cdbc-469d-811d-174f88b1ec5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AdditionalInformationAbstract_842923fd-af28-48e7-9681-695217a6bde2" xlink:href="ctlt-20210630.xsd#ctlt_AdditionalInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_AdditionalInformationAbstract_842923fd-af28-48e7-9681-695217a6bde2" xlink:to="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8a634d02-5488-4cdb-baa1-ae12456174d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6314170b-619b-4bf3-8722-3c984b231d4e" xlink:to="loc_us-gaap_RelatedPartyDomain_8a634d02-5488-4cdb-baa1-ae12456174d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a11f636-d156-4204-9742-800052fbfd40" xlink:to="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bf862bfb-92ce-4519-b45a-265ea1e9fe3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bf862bfb-92ce-4519-b45a-265ea1e9fe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_781295e7-307b-4040-ae44-8630cf5544af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_781295e7-307b-4040-ae44-8630cf5544af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c203264-b84b-41fa-a9c6-b323a53652cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c203264-b84b-41fa-a9c6-b323a53652cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_2dc8f55e-5261-4442-b294-afa7ada5e4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_us-gaap_SharePrice_2dc8f55e-5261-4442-b294-afa7ada5e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofDoses_6d1b0ab5-8bad-4918-afe3-6fb87d136915" xlink:href="ctlt-20210630.xsd#ctlt_NumberofDoses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_ctlt_NumberofDoses_6d1b0ab5-8bad-4918-afe3-6fb87d136915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NumberofCustomers_7b7f2448-816a-4c99-bc3b-6e5bf9127dfe" xlink:href="ctlt-20210630.xsd#ctlt_NumberofCustomers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3484a7cd-81d0-45cd-86ed-118f99e4648d" xlink:to="loc_ctlt_NumberofCustomers_7b7f2448-816a-4c99-bc3b-6e5bf9127dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract_5f52194d-c2f4-4de8-8950-bcc52a5be68c" xlink:href="ctlt-20210630.xsd#ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract_5f52194d-c2f4-4de8-8950-bcc52a5be68c" xlink:to="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_37102988-b1f6-4ffc-9d5a-59f9a800bc6c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5d3760ef-7a03-45e6-8508-c9f80c2d2dea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_d75a4149-87cd-482e-8d00-21c2a14ad1af" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5d3760ef-7a03-45e6-8508-c9f80c2d2dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6808d45f-fcb8-4d9e-84bf-0c2623335492" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_6ebc1ca5-016e-4468-aa5d-c3b64ed6e5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_366f0047-64e5-4e9f-ba23-cea3669158a5" xlink:to="loc_us-gaap_SalesMember_6ebc1ca5-016e-4468-aa5d-c3b64ed6e5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d6e70754-360d-40b0-af10-444717f10511" xlink:to="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ConcentrationRiskNumberofCustomers_60eb2525-4ecc-4be8-9791-db8f4ab19b02" xlink:href="ctlt-20210630.xsd#ctlt_ConcentrationRiskNumberofCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ff4201e0-0f5b-485c-9500-06e05aeaf1aa" xlink:to="loc_ctlt_ConcentrationRiskNumberofCustomers_60eb2525-4ecc-4be8-9791-db8f4ab19b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PropertyandEquipmentAbstract_31245fb2-1a34-4006-af0f-56b60a127b59" xlink:href="ctlt-20210630.xsd#ctlt_PropertyandEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_PropertyandEquipmentAbstract_31245fb2-1a34-4006-af0f-56b60a127b59" xlink:to="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_25a63030-9c0e-4853-aa34-3cf3de5826cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BuildingAndImprovementsMember_23c47f09-644d-444a-bb2e-c99c0a35c594" xlink:href="ctlt-20210630.xsd#ctlt_BuildingAndImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_ctlt_BuildingAndImprovementsMember_23c47f09-644d-444a-bb2e-c99c0a35c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_875a7bf8-3f1d-4e79-9a0d-71514176c713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_875a7bf8-3f1d-4e79-9a0d-71514176c713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_eee4ad03-09a3-42ca-b9ed-a3b351758800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_29889449-aafc-4353-8679-aaa6c8043cca" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_eee4ad03-09a3-42ca-b9ed-a3b351758800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:to="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e5de09c0-5a4e-418b-9804-c8772ac5a67b" xlink:to="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fb52775-3277-4afa-af36-8febf0fd6f3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:to="loc_srt_MinimumMember_0fb52775-3277-4afa-af36-8febf0fd6f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_94d9e585-03b8-409f-ae60-891f60573365" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d2f3172c-7b2a-4690-b989-752402590aa3" xlink:to="loc_srt_MaximumMember_94d9e585-03b8-409f-ae60-891f60573365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e17b0cb9-146a-46aa-9df8-0e65f41a45ca" xlink:to="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b649076c-042a-455a-b6be-8dd55d734ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b649076c-042a-455a-b6be-8dd55d734ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_87cc57a8-e2a2-4410-adf3-5ba64c1f1803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_Depreciation_87cc57a8-e2a2-4410-adf3-5ba64c1f1803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_4dc00092-6f58-48b2-9096-c3bd0c25f1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_InterestCostsCapitalized_4dc00092-6f58-48b2-9096-c3bd0c25f1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6c05c537-7c60-41a8-955a-4a5c239c91e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b79410e7-9e03-4700-be8f-9da6ac31ca25" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6c05c537-7c60-41a8-955a-4a5c239c91e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract_8b95299b-b81f-49ec-9e1c-0e1d57d8ff63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract_8b95299b-b81f-49ec-9e1c-0e1d57d8ff63" xlink:to="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c6883dde-ca00-4437-be83-2b788956feee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7ae26907-a3cb-4695-800e-ca16c0f39607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7ae26907-a3cb-4695-800e-ca16c0f39607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b513f618-f429-4110-a3f1-f231f469c1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdae97bb-f7e8-4411-9d67-3537311d4db8" xlink:to="loc_us-gaap_CostOfSalesMember_b513f618-f429-4110-a3f1-f231f469c1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7dbc2a2e-494b-42c0-8cdb-a8f6ae21a2aa" xlink:to="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6ee15d64-d108-433a-b83d-1d2f7592e290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8c8904f8-766c-4e27-865c-061058ee8dfc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6ee15d64-d108-433a-b83d-1d2f7592e290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RecentFinancialAccountingStandardsAbstract_47d4dfbf-8a99-414e-83e4-f385d25ee64e" xlink:href="ctlt-20210630.xsd#ctlt_RecentFinancialAccountingStandardsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RecentFinancialAccountingStandardsAbstract_47d4dfbf-8a99-414e-83e4-f385d25ee64e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0180486e-9514-4802-8bf5-ca03117e84c8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_737e19ed-85c5-4fb7-b7f6-2eb0a36f34e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8c9a464e-7b41-4d96-95df-48067b3c7f75" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_737e19ed-85c5-4fb7-b7f6-2eb0a36f34e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f6c9b03b-4927-4201-8d34-f05b19472712" xlink:to="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0fd82b79-17b6-4f6a-8d0b-e1aa6f08167b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4616bce6-83ba-4af5-8993-d2c2e57fb185" xlink:to="loc_us-gaap_RetainedEarningsMember_0fd82b79-17b6-4f6a-8d0b-e1aa6f08167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_20acb1f1-d5d4-4273-a769-5ee95210bdb8" xlink:to="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_256bc3d6-ff27-4095-93db-7605121c2ec2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_85fe19e0-5c47-4543-a36b-a8b76af13296" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_256bc3d6-ff27-4095-93db-7605121c2ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0e4223a1-8b11-4851-ab37-a49e1f231fc6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6d408e74-2652-4169-933c-a1bcdab2e89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:to="loc_us-gaap_OperatingLeaseLiability_6d408e74-2652-4169-933c-a1bcdab2e89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_7e00da17-5353-4fb3-a4e8-361bf960f63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2a2f8e2b-73dc-427b-8995-3ee1d4149e39" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_7e00da17-5353-4fb3-a4e8-361bf960f63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognition" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b2779fc-922b-4a52-b765-8d621294c914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0eb04703-0e9f-4810-8fce-989ee453b458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b2779fc-922b-4a52-b765-8d621294c914" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0eb04703-0e9f-4810-8fce-989ee453b458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenuefromContractwithCustomerPolicies"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenuefromContractwithCustomerPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_be95eac4-ab79-4135-8ef5-a46fb7cb55cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_8d598fbb-960f-4c75-9198-34c5dfa34e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_be95eac4-ab79-4135-8ef5-a46fb7cb55cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_8d598fbb-960f-4c75-9198-34c5dfa34e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_fa2cdf97-da8b-4459-8803-55db24d58eab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_fa2cdf97-da8b-4459-8803-55db24d58eab" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:to="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4ff46689-f6b3-4784-b0df-94171d277893" xlink:to="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_9d4c89c2-dcc3-4ad8-91f1-3f8b52a88f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0bb0598d-f5f5-4060-b425-40c3a7711464" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_9d4c89c2-dcc3-4ad8-91f1-3f8b52a88f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:to="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a8dc1f38-c6d5-4f3b-b4c2-5f37450034ee" xlink:to="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_geographicalMember_857cbc85-8063-4f53-be4b-a51db8ba2dad" xlink:href="ctlt-20210630.xsd#ctlt_geographicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b5603a23-09c5-42df-83e8-526970f963ec" xlink:to="loc_ctlt_geographicalMember_857cbc85-8063-4f53-be4b-a51db8ba2dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d58d8ba8-9149-4824-b02e-27f1020c5c99" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50126320-8cf7-493f-b3ef-b54d507b67ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f7e28fb7-eba6-4fee-a9b5-f6b51289e57c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_50126320-8cf7-493f-b3ef-b54d507b67ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_0c8d0dcb-e3e2-42ca-95b6-bf3843003612" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ContractualLiabilitiesTableTextBlock_8de705c0-2c45-4684-a8ec-ac596a8227c8" xlink:href="ctlt-20210630.xsd#ctlt_ContractualLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_0c8d0dcb-e3e2-42ca-95b6-bf3843003612" xlink:to="loc_ctlt_ContractualLiabilitiesTableTextBlock_8de705c0-2c45-4684-a8ec-ac596a8227c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4fba5730-53fd-46db-a4f6-61eb55bf718c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4fba5730-53fd-46db-a4f6-61eb55bf718c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7057bf4b-28e6-4100-8ffa-549e5865c6c0" xlink:to="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_99ad2f51-9162-436e-9f33-f2db4b399090" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_99ad2f51-9162-436e-9f33-f2db4b399090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_fed6aff8-f188-4450-9cc1-5fb8ff7e04d8" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_BiologicsMember_fed6aff8-f188-4450-9cc1-5fb8ff7e04d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_a8a37d89-ff50-4f58-aa85-37aac7476dec" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_a8a37d89-ff50-4f58-aa85-37aac7476dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_06d67e49-96de-4f9e-a78c-248e6b4a90f6" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_06d67e49-96de-4f9e-a78c-248e6b4a90f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_2cd67b89-0c73-4d6d-b799-6841ed668d11" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3e3b7-c86c-44e1-a1fa-4a031b78d4db" xlink:to="loc_ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember_2cd67b89-0c73-4d6d-b799-6841ed668d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:to="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_415f7256-3c3e-4c10-b87c-51d91f4beb17" xlink:to="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ManufacturingCommercialProductSupplyMember_104272e3-40f7-446a-b763-d55efcf9f03d" xlink:href="ctlt-20210630.xsd#ctlt_ManufacturingCommercialProductSupplyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_ManufacturingCommercialProductSupplyMember_104272e3-40f7-446a-b763-d55efcf9f03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DevelopmentServicesMember_07f0073d-3b2a-43c6-9ba3-3a46a5ca0701" xlink:href="ctlt-20210630.xsd#ctlt_DevelopmentServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_DevelopmentServicesMember_07f0073d-3b2a-43c6-9ba3-3a46a5ca0701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_42bdea67-a0a4-4d4a-a105-2cc182410a12" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_39e55897-07f6-4ce7-9f7a-3c76b52da268" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_42bdea67-a0a4-4d4a-a105-2cc182410a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5616f23-62d6-450d-8ef7-8129694ddf2b" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_027421a1-bb7b-4485-a2a4-87a490876c0c" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationInterSegmentRevenueElimination"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:to="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_027421a1-bb7b-4485-a2a4-87a490876c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e1337a32-762a-4d43-836d-c3706404dcc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6fc47a84-3cc3-4c28-a4dd-97b65b0d8476" xlink:to="loc_us-gaap_Revenues_e1337a32-762a-4d43-836d-c3706404dcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionDisaggregationofRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_435ecbe8-339d-461d-a5ce-2665b3bd058b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_435ecbe8-339d-461d-a5ce-2665b3bd058b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:to="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7478c275-2daa-4389-8421-f689e41d9d9f" xlink:to="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_d57f36c7-9a8f-4998-8ab0-d016da17a8d2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_srt_NorthAmericaMember_d57f36c7-9a8f-4998-8ab0-d016da17a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_748880b3-8f45-45a6-85d6-5ca4bc116c92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_srt_EuropeMember_748880b3-8f45-45a6-85d6-5ca4bc116c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InternationalOtherMember_342ce9ca-6277-4cee-b813-0a603a590486" xlink:href="ctlt-20210630.xsd#ctlt_InternationalOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_ctlt_InternationalOtherMember_342ce9ca-6277-4cee-b813-0a603a590486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_25ad2688-8cbb-4052-9d28-a3e4c1e813a6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e8fdbcc4-12b6-40fb-a359-6abf8e418228" xlink:to="loc_country_US_25ad2688-8cbb-4052-9d28-a3e4c1e813a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_92e28d6b-fe8b-49c1-8751-8589c13e01cb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations_a948129f-9857-41cd-817d-f6249beeeaa5" xlink:href="ctlt-20210630.xsd#ctlt_Eliminationofrevenueattributabletomultiplelocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:to="loc_ctlt_Eliminationofrevenueattributabletomultiplelocations_a948129f-9857-41cd-817d-f6249beeeaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e63972b-3b18-4c0f-a341-30062a5b9c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71bdf084-876f-4e7f-b048-2d17f4abaa62" xlink:to="loc_us-gaap_Revenues_2e63972b-3b18-4c0f-a341-30062a5b9c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionContractualLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_c641508a-b8ed-40c2-abc2-03c3720e29ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionAndDeferredRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7e01516b-7717-4fd5-9930-90708e92c5e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_c641508a-b8ed-40c2-abc2-03c3720e29ec" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7e01516b-7717-4fd5-9930-90708e92c5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7efa72e1-22a4-4ade-8a94-9a7f5ea877da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_c641508a-b8ed-40c2-abc2-03c3720e29ec" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7efa72e1-22a4-4ade-8a94-9a7f5ea877da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_e494dc13-0fd8-44fd-a6b1-fea485d436e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract_c641508a-b8ed-40c2-abc2-03c3720e29ec" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_e494dc13-0fd8-44fd-a6b1-fea485d436e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RevenueRecognitionContractualAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RevenueRecognitionContractualAssetsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RevenueRecognitionContractualAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_3653a30c-dca1-4008-b102-296e9d7210ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetPurchase_57f0175b-cab5-4c40-9aba-af5657f5aa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_3653a30c-dca1-4008-b102-296e9d7210ec" xlink:to="loc_us-gaap_ContractWithCustomerAssetPurchase_57f0175b-cab5-4c40-9aba-af5657f5aa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinations" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_566421ac-b53c-4fc2-a021-01ac4c3254d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0b4a9ed7-b697-4991-ab90-23f050acf40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_566421ac-b53c-4fc2-a021-01ac4c3254d0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_0b4a9ed7-b697-4991-ab90-23f050acf40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_83f97d27-695d-4dee-8ff6-e0dfaca22bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_83f97d27-695d-4dee-8ff6-e0dfaca22bfc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9171936d-c21b-467b-a394-959204b8c364" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_1212830b-4a02-48dd-a12e-59ed7b039fdc" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:to="loc_ctlt_ParagonMember_1212830b-4a02-48dd-a12e-59ed7b039fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_9a010337-d3e3-4b2f-8cf9-2c2e29efa9b9" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_366ffdf0-c760-4203-b56f-a582c5f9bb4e" xlink:to="loc_ctlt_MaSTherCellMember_9a010337-d3e3-4b2f-8cf9-2c2e29efa9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0ae39b33-eda9-4d8e-83b0-8c727cff80ae" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ab267ca9-9848-4cd9-9809-693b548ab199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_20ebec59-05d7-438b-b1bb-5b06651d4047" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ab267ca9-9848-4cd9-9809-693b548ab199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_69d50f7b-b33c-4144-9b7a-56d2e7a7d83a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_83f97d27-695d-4dee-8ff6-e0dfaca22bfc" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_69d50f7b-b33c-4144-9b7a-56d2e7a7d83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsPurchaseAgreementDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_29d94c29-964a-4a60-8e6c-b90d5e690fc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_29d94c29-964a-4a60-8e6c-b90d5e690fc8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d028ecc1-670f-4923-b19a-db8823692aa5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_2120b301-b929-44a5-8d2e-df451013057d" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_ParagonMember_2120b301-b929-44a5-8d2e-df451013057d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AnagniMember_14877586-c8d1-4ea5-910b-ca966cfef146" xlink:href="ctlt-20210630.xsd#ctlt_AnagniMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_AnagniMember_14877586-c8d1-4ea5-910b-ca966cfef146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_3a9babe4-d6d8-4116-9cb7-12406332d5ef" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_MaSTherCellMember_3a9babe4-d6d8-4116-9cb7-12406332d5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SkeletalCellTherapySupportSAMember_7b424f02-2680-41f8-9d6c-7a6d32e2983d" xlink:href="ctlt-20210630.xsd#ctlt_SkeletalCellTherapySupportSAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_SkeletalCellTherapySupportSAMember_7b424f02-2680-41f8-9d6c-7a6d32e2983d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_HepaticCellTherapySupportSA_862e91e8-b83c-410c-85ae-f202dfb0a046" xlink:href="ctlt-20210630.xsd#ctlt_HepaticCellTherapySupportSA"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_HepaticCellTherapySupportSA_862e91e8-b83c-410c-85ae-f202dfb0a046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_KyotoMember_4c35eefd-5b25-4ab2-ad75-0c08cb9e6dff" xlink:href="ctlt-20210630.xsd#ctlt_KyotoMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_KyotoMember_4c35eefd-5b25-4ab2-ad75-0c08cb9e6dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AcordaTherapeuticsIncMember_71af5f2c-1e31-43ee-9370-77d8dedece85" xlink:href="ctlt-20210630.xsd#ctlt_AcordaTherapeuticsIncMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_AcordaTherapeuticsIncMember_71af5f2c-1e31-43ee-9370-77d8dedece85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_4ebcbdb2-8bc6-4dd8-9925-eb92410b4b8a" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cba817a-0ca9-4315-add0-aad265839aa7" xlink:to="loc_ctlt_DelphiGeneticsSAMember_4ebcbdb2-8bc6-4dd8-9925-eb92410b4b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a4dc23ed-14ef-45aa-874d-a07e939bfa62" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b41a66ee-8a1c-4e1d-b01d-b40547a9cf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b41a66ee-8a1c-4e1d-b01d-b40547a9cf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_770c5108-3b2c-40fa-8f26-889b7256f737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_770c5108-3b2c-40fa-8f26-889b7256f737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0c213e5a-cf45-4c60-83cc-3529223e883f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0c213e5a-cf45-4c60-83cc-3529223e883f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_f031cb20-dc8d-4682-a8d4-b08efeaa4352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_f031cb20-dc8d-4682-a8d4-b08efeaa4352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3d2067-d235-41af-8935-16c69d2013f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f3d2067-d235-41af-8935-16c69d2013f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32cf27ad-0010-42b0-97f6-65a9efbc1c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32cf27ad-0010-42b0-97f6-65a9efbc1c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c2941a60-8e93-495d-b957-62786c205ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c2941a60-8e93-495d-b957-62786c205ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_202cfebc-724a-4eab-9330-49631cf6da66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_202cfebc-724a-4eab-9330-49631cf6da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7566b19b-69e6-424c-8143-e5062cbe0e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7566b19b-69e6-424c-8143-e5062cbe0e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_8c35f048-50c2-424b-a9b9-e39abc793162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_8c35f048-50c2-424b-a9b9-e39abc793162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9a792955-94d1-4582-bf3f-5c38f5053e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9a792955-94d1-4582-bf3f-5c38f5053e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b62aeebc-a229-49d6-8574-19877cea4380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_025fef9f-d509-458a-8c3a-1dcd05af67b3" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b62aeebc-a229-49d6-8574-19877cea4380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsNetAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b0783f71-7fca-480d-b6e5-0666e17b6949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0783f71-7fca-480d-b6e5-0666e17b6949" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cced575-cfd7-403a-be74-0f9e3b5be88c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6ec441a0-a323-49a3-ace2-991a21803250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6ec441a0-a323-49a3-ace2-991a21803250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRelationshipsMember_04e76c96-e7e1-449d-822e-f1604e41e8d6" xlink:href="ctlt-20210630.xsd#ctlt_ProductRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_ctlt_ProductRelationshipsMember_04e76c96-e7e1-449d-822e-f1604e41e8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_0265643e-b03f-4c98-80d5-3ac4eb1874cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_33b86c43-5f16-4e90-ae1e-cec97baae23a" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_0265643e-b03f-4c98-80d5-3ac4eb1874cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea116dd7-6cbc-4e53-acb9-aa4e2311a215" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_10d1fa3d-4640-4714-ad69-c95685ae8fa8" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_ParagonMember_10d1fa3d-4640-4714-ad69-c95685ae8fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AnagniMember_132b59af-c183-4095-91db-5c3de1be427a" xlink:href="ctlt-20210630.xsd#ctlt_AnagniMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_AnagniMember_132b59af-c183-4095-91db-5c3de1be427a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaSTherCellMember_00a80251-7e30-4bf2-a74b-3038e09b5b5d" xlink:href="ctlt-20210630.xsd#ctlt_MaSTherCellMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_MaSTherCellMember_00a80251-7e30-4bf2-a74b-3038e09b5b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_c3b538f8-9e2e-4cca-85c3-b176939542b6" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b3c534-a414-4516-8336-828a5da861d2" xlink:to="loc_ctlt_DelphiGeneticsSAMember_c3b538f8-9e2e-4cca-85c3-b176939542b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:href="ctlt-20210630.xsd#ctlt_NetAssetsAcquiredLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb6058c1-f6ba-4e7b-88fd-ec0bdcd30cd5" xlink:to="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2264669d-85f3-4be9-adaf-b53fbd30caeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2264669d-85f3-4be9-adaf-b53fbd30caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_704b666b-cd10-4c13-96b0-7fbf5adbd188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_704b666b-cd10-4c13-96b0-7fbf5adbd188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_537d2b4e-ac25-4dbb-9ad6-0074c810c648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_537d2b4e-ac25-4dbb-9ad6-0074c810c648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4de56af5-9847-4501-bda1-b1c0356bb832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_4de56af5-9847-4501-bda1-b1c0356bb832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationTransitionalServiceAgreement_daaeceaf-6ab8-4fb4-b06f-84156442d14b" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationTransitionalServiceAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_ctlt_BusinessCombinationTransitionalServiceAgreement_daaeceaf-6ab8-4fb4-b06f-84156442d14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_829b10a2-c546-412f-9b17-c4b79d3f82e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_829b10a2-c546-412f-9b17-c4b79d3f82e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0ef5269a-29d6-4d65-bffd-4a94072ebe34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0ef5269a-29d6-4d65-bffd-4a94072ebe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_129db59d-6ccf-48c2-8055-c2fb9f26561f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_129db59d-6ccf-48c2-8055-c2fb9f26561f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_07758091-676f-462f-b78a-f64e31f3dd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_07758091-676f-462f-b78a-f64e31f3dd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_ec3e0405-61fd-4e68-9638-f63f142a8f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_ec3e0405-61fd-4e68-9638-f63f142a8f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa27bf3d-7e76-4aa3-a160-9b74f0a3d340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa27bf3d-7e76-4aa3-a160-9b74f0a3d340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e3f52df-c24f-4b0d-a860-142e1b4a1ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_NetAssetsAcquiredLineItems_f5d90c3b-c930-4034-ace0-6abcb59bdcdd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2e3f52df-c24f-4b0d-a860-142e1b4a1ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsProFormaResultsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsProFormaResultsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinationsProFormaResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProFormaResultsAbstract_ca045e91-c56e-4030-b536-4b850365a85d" xlink:href="ctlt-20210630.xsd#ctlt_ProFormaResultsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d709d071-7931-43a0-8e7a-b7fdca626f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProFormaResultsAbstract_ca045e91-c56e-4030-b536-4b850365a85d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d709d071-7931-43a0-8e7a-b7fdca626f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_25e0726d-5df9-4394-96cf-2828ae59f3af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProFormaResultsAbstract_ca045e91-c56e-4030-b536-4b850365a85d" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_25e0726d-5df9-4394-96cf-2828ae59f3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/BusinessCombinationsDivestituresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#BusinessCombinationsDivestituresDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/BusinessCombinationsDivestituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6d72ca08-242e-4164-98a4-92e3af56149d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6d72ca08-242e-4164-98a4-92e3af56149d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c2ee73d-4f17-4ee3-9c23-d1c7300355b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BlowFillSealBusinessWoodstockMember_8613c223-6796-41b0-86f9-63bf070ff60c" xlink:href="ctlt-20210630.xsd#ctlt_BlowFillSealBusinessWoodstockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:to="loc_ctlt_BlowFillSealBusinessWoodstockMember_8613c223-6796-41b0-86f9-63bf070ff60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DelphiGeneticsSAMember_99ebfd45-65a5-442f-be51-37f29d61186a" xlink:href="ctlt-20210630.xsd#ctlt_DelphiGeneticsSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_614a4877-c11d-4060-bbcf-ceb958bba3e4" xlink:to="loc_ctlt_DelphiGeneticsSAMember_99ebfd45-65a5-442f-be51-37f29d61186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1dd70386-2f01-4e6b-8233-a34c1aa2f28f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aab7195a-4a00-44b3-9e28-002dff103a54" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1dd70386-2f01-4e6b-8233-a34c1aa2f28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_215d9fe0-fd57-458e-8c99-771669f0b0b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_dd26eb20-adc3-4f3d-9ebe-4091e36bea2c" xlink:to="loc_srt_OwnershipDomain_215d9fe0-fd57-458e-8c99-771669f0b0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0435d27-b9c3-4189-a6f1-994b2a97059c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0d384f22-a141-4bab-8d79-b9c1800b5e7e" xlink:to="loc_us-gaap_ClassOfStockDomain_a0435d27-b9c3-4189-a6f1-994b2a97059c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_271b9d72-e7d3-403b-a9f3-cf60af5b01fc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_734f3475-856c-4696-a330-d317b490c2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_734f3475-856c-4696-a330-d317b490c2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_de707f68-3a93-4a38-87df-88ee08bb326e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_de707f68-3a93-4a38-87df-88ee08bb326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_e681f2c4-2143-4fd2-8a4c-a9b33b1730ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesFairValue_e681f2c4-2143-4fd2-8a4c-a9b33b1730ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_54814c0d-b563-46f8-ae2d-b4fcb6b4f386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_54814c0d-b563-46f8-ae2d-b4fcb6b4f386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c5edddd3-51a6-4093-8734-da68d4d4204e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c5edddd3-51a6-4093-8734-da68d4d4204e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d42aa24d-771d-40a7-9584-97f8432040c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d42aa24d-771d-40a7-9584-97f8432040c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_098e2719-ee3b-47e7-8c2d-76b62cd95fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_098e2719-ee3b-47e7-8c2d-76b62cd95fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationLoanDiscount_5b4a6cf1-e1a2-4193-8794-d8ef146cac2d" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationLoanDiscount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_BusinessCombinationLoanDiscount_5b4a6cf1-e1a2-4193-8794-d8ef146cac2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4d42e133-7755-493d-b3f5-97f1a2b1fb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_4d42e133-7755-493d-b3f5-97f1a2b1fb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments_eec7d4eb-2664-43c8-8e0a-f0c5ceb04abc" xlink:href="ctlt-20210630.xsd#ctlt_BusinessCombinationWorkingCapitalAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_BusinessCombinationWorkingCapitalAdjustments_eec7d4eb-2664-43c8-8e0a-f0c5ceb04abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9d8aa5d2-d1ce-4dbf-aead-9f3ba9bcff22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9d8aa5d2-d1ce-4dbf-aead-9f3ba9bcff22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_30deda38-6384-4110-afe9-22fbf6f06541" xlink:href="ctlt-20210630.xsd#ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds_30deda38-6384-4110-afe9-22fbf6f06541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_d6caf820-e20e-43be-8295-0dac77d7cf5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_d6caf820-e20e-43be-8295-0dac77d7cf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_eea49b1a-5187-41ab-95e6-50706198f887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_eea49b1a-5187-41ab-95e6-50706198f887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_206e25f8-1959-4d68-8ed9-dbe5183142c6" xlink:href="ctlt-20210630.xsd#ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived_206e25f8-1959-4d68-8ed9-dbe5183142c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_76f6cb8d-7efc-4ce7-b219-7bba829c0732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e8a83144-c632-46fa-85ee-f38afcf35fb2" xlink:to="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_76f6cb8d-7efc-4ce7-b219-7bba829c0732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/Goodwill" xlink:type="simple" xlink:href="ctlt-20210630.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://catalent.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9434f45-cbb4-411f-aab0-c5437afe4c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_d00793fe-0ea5-427c-820a-c5c4db170966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9434f45-cbb4-411f-aab0-c5437afe4c0d" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_d00793fe-0ea5-427c-820a-c5c4db170966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/GoodwillTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_79cf480b-dfd4-4f27-a9fd-64827793b54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_e2a5391f-10f2-4dec-b4d5-550cbfdadd5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_79cf480b-dfd4-4f27-a9fd-64827793b54f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_e2a5391f-10f2-4dec-b4d5-550cbfdadd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#GoodwillCarryingAmountofGoodwillDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_996b6618-9b4a-43bd-a2e1-c4f9da309541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_996b6618-9b4a-43bd-a2e1-c4f9da309541" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a4d45254-fcc4-498f-aead-e8d90476aa6a" xlink:to="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_353a6f2e-9f2a-4820-80eb-e79ea0726056" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_353a6f2e-9f2a-4820-80eb-e79ea0726056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_2333ca4f-931a-4c25-b6ad-43a9d75cab68" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_BiologicsMember_2333ca4f-931a-4c25-b6ad-43a9d75cab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_cca4f8d0-4329-4966-aad6-11d62e4580e9" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_cca4f8d0-4329-4966-aad6-11d62e4580e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_7d080136-86a2-4b88-8793-2fcd2b5eb10c" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_7d080136-86a2-4b88-8793-2fcd2b5eb10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelTechnologiesMember_7a0ae9d7-7e12-444d-8fa4-06d6b5ae67c8" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelTechnologiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_SoftgelTechnologiesMember_7a0ae9d7-7e12-444d-8fa4-06d6b5ae67c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralDrugDeliveryMember_625a3d59-6d35-4263-8914-57a8045a5994" xlink:href="ctlt-20210630.xsd#ctlt_OralDrugDeliveryMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f55eb520-9975-4cda-9800-e357961c3cb0" xlink:to="loc_ctlt_OralDrugDeliveryMember_625a3d59-6d35-4263-8914-57a8045a5994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d565652-9b9a-49ff-8d46-d63bfd4d485c" xlink:to="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:to="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_751d2fcd-0f9e-4d9d-9d76-f8c158588bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_Goodwill_751d2fcd-0f9e-4d9d-9d76-f8c158588bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_19e8ad7e-597c-44e9-b43d-196acd72623c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_19e8ad7e-597c-44e9-b43d-196acd72623c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_7af05da7-640d-41c5-ac88-5ee6ca36e6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillTransfers_7af05da7-640d-41c5-ac88-5ee6ca36e6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_36fc18f1-3715-499a-ae22-15ad119f84e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_36fc18f1-3715-499a-ae22-15ad119f84e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_83cb99bd-5a41-44a9-a38d-8b7160bbb2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_83cb99bd-5a41-44a9-a38d-8b7160bbb2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_263232ac-dec3-48d9-a432-b27afecf7a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_34cdbe8b-8982-4297-9f09-f5b92ffadcbb" xlink:to="loc_us-gaap_Goodwill_263232ac-dec3-48d9-a432-b27afecf7a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_62dfe99f-ddeb-4d73-84b3-292a47ec24e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a8c4a076-f22b-4339-98e1-f67ef8d326ce" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_62dfe99f-ddeb-4d73-84b3-292a47ec24e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssets" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssets"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_ddb10235-f31a-424d-bb55-4071d099bc60" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4073137b-654f-441b-abd3-e8c1bbfd3f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_ddb10235-f31a-424d-bb55-4071d099bc60" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4073137b-654f-441b-abd3-e8c1bbfd3f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_e393c3c8-18b8-473b-846f-fd541ce64e54" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_cafed225-385c-40d9-b295-2284767fa2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_e393c3c8-18b8-473b-846f-fd541ce64e54" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_cafed225-385c-40d9-b295-2284767fa2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8f1d9e78-1a93-4b66-99bc-ee1717327d10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_e393c3c8-18b8-473b-846f-fd541ce64e54" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8f1d9e78-1a93-4b66-99bc-ee1717327d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_8023f4d6-0133-45c8-8450-d6dd6538c550" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_8023f4d6-0133-45c8-8450-d6dd6538c550" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1648f4a0-07d1-41cc-8192-d9e61252108b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CoreTechnologyMember_4f693baf-4050-4dd1-b9a2-537ab1b000f6" xlink:href="ctlt-20210630.xsd#ctlt_CoreTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_ctlt_CoreTechnologyMember_4f693baf-4050-4dd1-b9a2-537ab1b000f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8ca8f69d-f9fc-4dc1-a33f-85c27fbe04e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8ca8f69d-f9fc-4dc1-a33f-85c27fbe04e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRelationshipsMember_1aa60f25-85b3-46e3-a27c-ffd78436ca89" xlink:href="ctlt-20210630.xsd#ctlt_ProductRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_ctlt_ProductRelationshipsMember_1aa60f25-85b3-46e3-a27c-ffd78436ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_ce81ef9d-bb32-4487-87d1-cad843246614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cc8d8b5-ea6f-4fe1-b212-58ac094f109c" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_ce81ef9d-bb32-4487-87d1-cad843246614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:href="ctlt-20210630.xsd#ctlt_ProductRightsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_746bf5b8-8717-4b44-aa4c-4c64d9537e78" xlink:to="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aaabb96e-ce08-4ddd-85f9-5caef35b1608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aaabb96e-ce08-4ddd-85f9-5caef35b1608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dd93391-d85a-415f-b5c9-309fb7ed088f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5dd93391-d85a-415f-b5c9-309fb7ed088f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d264738-22e9-463a-b077-6de92da074e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d264738-22e9-463a-b077-6de92da074e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_430b9b15-5fbd-495a-a289-2640f18d617e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ProductRightsLineItems_bdd9aba8-a586-436b-8512-c287d834ecfa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_430b9b15-5fbd-495a-a289-2640f18d617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_f6717e77-f38b-4312-bca5-0211dc7d4b4f" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_710d7d5d-dc85-45bc-98bb-065b40923985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_f6717e77-f38b-4312-bca5-0211dc7d4b4f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_710d7d5d-dc85-45bc-98bb-065b40923985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3158e2e3-010b-43ba-a484-21e2e93f515b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_f6717e77-f38b-4312-bca5-0211dc7d4b4f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3158e2e3-010b-43ba-a484-21e2e93f515b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AcceleratedAmortizationOfIntangibleAssets_418897af-4251-432d-b392-0d15110accd9" xlink:href="ctlt-20210630.xsd#ctlt_AcceleratedAmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_f6717e77-f38b-4312-bca5-0211dc7d4b4f" xlink:to="loc_ctlt_AcceleratedAmortizationOfIntangibleAssets_418897af-4251-432d-b392-0d15110accd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:href="ctlt-20210630.xsd#ctlt_FinitelivedintangibleassetsdisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_96092d8f-dd21-4b78-bc9b-59fb5d2cb372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_96092d8f-dd21-4b78-bc9b-59fb5d2cb372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4babd432-1c6b-4a78-9ce6-4eecedec81af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4babd432-1c6b-4a78-9ce6-4eecedec81af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_73265f5d-06d5-4813-86f7-397a64037450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_73265f5d-06d5-4813-86f7-397a64037450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_403df8cd-08e8-48bc-89b5-223f544fae0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_403df8cd-08e8-48bc-89b5-223f544fae0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_760b872a-e24a-46ae-862a-b4c7fdfd6173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FinitelivedintangibleassetsdisclosureAbstract_2448ba51-badb-4ceb-9238-2a1389591add" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_760b872a-e24a-46ae-862a-b4c7fdfd6173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RestructuringandOtherCosts" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RestructuringandOtherCosts"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RestructuringandOtherCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b7996cb1-2c5f-4920-bf63-0ebf1f77cde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_95baedc3-b53d-4c98-a13c-9dcca66b37f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_b7996cb1-2c5f-4920-bf63-0ebf1f77cde2" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_95baedc3-b53d-4c98-a13c-9dcca66b37f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RestructuringandOtherCostsTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RestructuringandOtherCostsTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RestructuringandOtherCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0955379d-1d03-49e0-99da-3685c54fe395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8d5e4325-ebfe-4203-a7f7-143479b19d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0955379d-1d03-49e0-99da-3685c54fe395" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_8d5e4325-ebfe-4203-a7f7-143479b19d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RestructuringandOtherCostsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RestructuringandOtherCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_239ade90-3931-42c3-99af-36edde86ffdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_239ade90-3931-42c3-99af-36edde86ffdc" xlink:to="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:to="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_03b14a04-3367-4dfa-999a-56eb8b9642b6" xlink:to="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BoltonCSMember_c29e8ed9-40a6-4114-8320-3c378fbb195b" xlink:href="ctlt-20210630.xsd#ctlt_BoltonCSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_27d7429d-5d7b-48e9-8b12-6fdc86f0b372" xlink:to="loc_ctlt_BoltonCSMember_c29e8ed9-40a6-4114-8320-3c378fbb195b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:to="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6ee807e5-8172-47c9-9b91-12cebabda9cd" xlink:to="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f7d78eb0-6519-4e1c-bdca-fb3504cf4195" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:to="loc_srt_MinimumMember_f7d78eb0-6519-4e1c-bdca-fb3504cf4195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8b85f483-0f5a-4cb7-ae9e-41e1998e5515" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dd33c8b7-9acb-43c5-9058-a42de40d8f85" xlink:to="loc_srt_MaximumMember_8b85f483-0f5a-4cb7-ae9e-41e1998e5515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_2076e4a6-09f3-410f-973e-4633e8262edb" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_495126b9-c444-4047-952f-9e62e705398f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_495126b9-c444-4047-952f-9e62e705398f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5ebacdd7-eb46-42c6-ad18-4988ca97f7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5ebacdd7-eb46-42c6-ad18-4988ca97f7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0be69687-d505-4581-86e7-2382d4bf4da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_SeveranceCosts1_0be69687-d505-4581-86e7-2382d4bf4da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_294e71ec-3ea5-4cc6-8af5-6d7f4918656d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_BusinessExitCosts1_294e71ec-3ea5-4cc6-8af5-6d7f4918656d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3f2a6be4-ce0f-49f6-b5d9-80b82c0d2fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringCharges_3f2a6be4-ce0f-49f6-b5d9-80b82c0d2fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_57dadcc4-bcf7-4a14-b6fc-8e5a0605c428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_57dadcc4-bcf7-4a14-b6fc-8e5a0605c428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_37d420fc-c0e0-4e6a-bf9d-cb12023e50ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5f251551-1431-41b5-af82-35536ef3a508" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_37d420fc-c0e0-4e6a-bf9d-cb12023e50ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowings"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d69f51ea-fa54-4e2b-a627-5def156ea8b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_c4c260b8-2ecf-4f82-9b7c-b89b333f00da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d69f51ea-fa54-4e2b-a627-5def156ea8b1" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_c4c260b8-2ecf-4f82-9b7c-b89b333f00da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4d7fa811-ac45-43bd-a6e0-d1dbb9dede86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_1d9b1290-ba60-45fa-aafc-664178cf5290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4d7fa811-ac45-43bd-a6e0-d1dbb9dede86" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_1d9b1290-ba60-45fa-aafc-664178cf5290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5f7957fb-11a8-45af-a1dc-059b44055fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4d7fa811-ac45-43bd-a6e0-d1dbb9dede86" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5f7957fb-11a8-45af-a1dc-059b44055fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d3892704-5a75-4bf2-a0e0-547e77811829" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock_90db56bc-65a9-46ca-8ddd-4bdb7d3a6a1f" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d3892704-5a75-4bf2-a0e0-547e77811829" xlink:to="loc_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock_90db56bc-65a9-46ca-8ddd-4bdb7d3a6a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9fa3bbd5-b53e-47b1-b3b9-8f453ab5589a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9fa3bbd5-b53e-47b1-b3b9-8f453ab5589a" xlink:to="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9c9955d2-2257-415f-b3ed-1bb9c56dd051" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_892bbe5c-3278-4dd9-ab16-ee707d19ceef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_892bbe5c-3278-4dd9-ab16-ee707d19ceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4b4955e5-e1dd-471d-88ff-22ad140ca18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f55394a5-e893-4d63-bafb-6966349abfd9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4b4955e5-e1dd-471d-88ff-22ad140ca18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1c726fd0-450b-433c-a677-eccddf547e33" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_38a8ba2e-bc54-4ae2-85be-33ff351d882b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_38a8ba2e-bc54-4ae2-85be-33ff351d882b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_eed90b59-b709-4507-9c91-8edf67f8d1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0777b7a5-273d-4bfe-9539-ee21d9abf6da" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_eed90b59-b709-4507-9c91-8edf67f8d1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_79fe47a9-e319-42e7-9211-9657ba24c2ca" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_5f8d1de2-6f94-4fe0-808a-5ab4f93914cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ff6ebdd-f493-44af-a5f2-09847f966d3b" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_5f8d1de2-6f94-4fe0-808a-5ab4f93914cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtRefinancingCostsDomain_b134ff04-f97a-482c-9af8-cc5984b8d3a8" xlink:href="ctlt-20210630.xsd#ctlt_DebtRefinancingCostsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DebtRefinancingCostsAxis_e2c7ef76-6b00-48b3-8566-ee3dfe720b6c" xlink:to="loc_ctlt_DebtRefinancingCostsDomain_b134ff04-f97a-482c-9af8-cc5984b8d3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7021722c-abde-4f3a-a1de-bd4f021e086b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_3113817d-4f22-4b30-91cc-ff7e944c854b" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanFacilityIncrementalDollarTermB2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanFacilityIncrementalDollarTermB2Member_3113817d-4f22-4b30-91cc-ff7e944c854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_31dc0d8c-ce38-4208-9c51-d08ca5ac6a96" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_31dc0d8c-ce38-4208-9c51-d08ca5ac6a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditCommitmentsMember_9c5524d9-c75b-4697-be1c-9f0ab98968cc" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditCommitmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_RevolvingCreditCommitmentsMember_9c5524d9-c75b-4697-be1c-9f0ab98968cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_3335aeb3-0455-4a5c-ba84-99e3fa4ecda0" xlink:href="ctlt-20210630.xsd#ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_3335aeb3-0455-4a5c-ba84-99e3fa4ecda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_d6c77df4-386c-4601-ac84-602f1d634cea" xlink:href="ctlt-20210630.xsd#ctlt_U.S.Dollardenominated4.875SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_d6c77df4-386c-4601-ac84-602f1d634cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDollarDenominated500SeniorNotesMember_5c955f23-9d0b-4527-90db-af56a4502ee6" xlink:href="ctlt-20210630.xsd#ctlt_USDollarDenominated500SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_USDollarDenominated500SeniorNotesMember_5c955f23-9d0b-4527-90db-af56a4502ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_8a021294-1c96-4f4c-8062-962f854a8bd5" xlink:href="ctlt-20210630.xsd#ctlt_A2375SeniorEuroDenominatedNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_8a021294-1c96-4f4c-8062-962f854a8bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_236e7fa7-7d42-4671-bf60-01cc586a7b27" xlink:href="ctlt-20210630.xsd#ctlt_SeniorUnsecuredTermLoanFacilityMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_236e7fa7-7d42-4671-bf60-01cc586a7b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_0aef9118-60aa-4bff-ad1f-bcf4c244dfcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_0aef9118-60aa-4bff-ad1f-bcf4c244dfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherObligationsMember_3e010f17-4ce6-4ed5-88cf-d3f04a050adf" xlink:href="ctlt-20210630.xsd#ctlt_OtherObligationsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_OtherObligationsMember_3e010f17-4ce6-4ed5-88cf-d3f04a050adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A3125SeniorUSDenominatedNotesMember_aa789c71-3a5b-454e-a881-639ca9ac4d91" xlink:href="ctlt-20210630.xsd#ctlt_A3125SeniorUSDenominatedNotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_A3125SeniorUSDenominatedNotesMember_aa789c71-3a5b-454e-a881-639ca9ac4d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_b1436bba-2bce-4a3a-8e60-78ef3d63bb83" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanThreeFacilityDollarDenominatedMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_b1436bba-2bce-4a3a-8e60-78ef3d63bb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtIssuanceCostsMember_1f28fd5d-39c2-4413-b987-a25c0209f905" xlink:href="ctlt-20210630.xsd#ctlt_DebtIssuanceCostsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_DebtIssuanceCostsMember_1f28fd5d-39c2-4413-b987-a25c0209f905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_dd28f75a-9705-4150-b618-eba28d85dca1" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanTwoFacilityDollarDenominatedMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3ac9fb49-8f54-44af-955f-baac19854aa0" xlink:to="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_dd28f75a-9705-4150-b618-eba28d85dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0c67809f-0c7c-4605-ac11-86a42968a548" xlink:to="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilityMember_693fce1b-7fa6-4bf0-9391-26a06a89642e" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fb423063-5a2b-4e79-ad41-5509f3a70269" xlink:to="loc_ctlt_SeniorSecuredCreditFacilityMember_693fce1b-7fa6-4bf0-9391-26a06a89642e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfDebtLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtTable_91021369-69db-4640-9ca8-a1e76fcdcc85" xlink:to="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_cd61e316-d8c2-4728-8ee3-6473845516df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_cd61e316-d8c2-4728-8ee3-6473845516df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8d3d59be-ddea-4dfb-8158-4ce6fab693a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8d3d59be-ddea-4dfb-8158-4ce6fab693a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_f74eee26-d357-4e44-b5dc-823f5710f2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtCurrent_f74eee26-d357-4e44-b5dc-823f5710f2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e710d50e-dd7a-4cad-9477-74fe999e44d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e710d50e-dd7a-4cad-9477-74fe999e44d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred_5d6afa35-2e15-4170-a3e0-1075df14d499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_InterestCostsIncurred_5d6afa35-2e15-4170-a3e0-1075df14d499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a96d0ab6-44df-49c7-b23b-6ad30f62afa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a96d0ab6-44df-49c7-b23b-6ad30f62afa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_2c71a869-c00a-4e3d-81a5-6ab8a64355eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_2c71a869-c00a-4e3d-81a5-6ab8a64355eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_491b688e-eeb4-47ea-a294-5ffbeebe9452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_491b688e-eeb4-47ea-a294-5ffbeebe9452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c6bd6449-1ffc-4d84-8344-a116f99745db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c6bd6449-1ffc-4d84-8344-a116f99745db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentForAcquisition_b991ddec-ff43-4315-b04a-a36795e4dc47" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentForAcquisition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentForAcquisition_b991ddec-ff43-4315-b04a-a36795e4dc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo_fd9da3f2-bc5b-424a-8aa4-b74cf841716f" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearTwo_fd9da3f2-bc5b-424a-8aa4-b74cf841716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearThree_661c807f-3dd6-48cb-bde7-fab708d0cdd2" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearThree_661c807f-3dd6-48cb-bde7-fab708d0cdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InstallmentPaymentforAcquisitionYearFour_bc5c7c2a-cc89-44d0-866e-13f7be0e842b" xlink:href="ctlt-20210630.xsd#ctlt_InstallmentPaymentforAcquisitionYearFour"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_InstallmentPaymentforAcquisitionYearFour_bc5c7c2a-cc89-44d0-866e-13f7be0e842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_16c69076-3481-4805-b188-19f9024c9013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_16c69076-3481-4805-b188-19f9024c9013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_121665e4-6592-43f7-a42b-f750e690e8de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_121665e4-6592-43f7-a42b-f750e690e8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfCapitalStock_5650befe-0bf5-471d-ab69-93b60190acfd" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfCapitalStock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_PledgePercentageOfCapitalStock_5650befe-0bf5-471d-ab69-93b60190acfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PledgePercentageOfEquityInterest_1a022dcc-3883-4d8f-bc1e-e5feda5146ff" xlink:href="ctlt-20210630.xsd#ctlt_PledgePercentageOfEquityInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_PledgePercentageOfEquityInterest_1a022dcc-3883-4d8f-bc1e-e5feda5146ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MaximumPercentageOfVotingStock_88afb7c4-ecec-4642-bc15-96bf15031a29" xlink:href="ctlt-20210630.xsd#ctlt_MaximumPercentageOfVotingStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_MaximumPercentageOfVotingStock_88afb7c4-ecec-4642-bc15-96bf15031a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate_8e825605-cf89-4a74-b760-aee102a5cdba" xlink:href="ctlt-20210630.xsd#ctlt_DebtInstrumentQuarterlyAmortizationRate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_ctlt_DebtInstrumentQuarterlyAmortizationRate_8e825605-cf89-4a74-b760-aee102a5cdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_3820243f-a6ea-4b87-959c-59b549fbe51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseDecreaseOtherNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfDebtLineItems_45e5d783-a0a2-4c61-98e6-2633ef2c9cea" xlink:to="loc_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet_3820243f-a6ea-4b87-959c-59b549fbe51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:href="ctlt-20210630.xsd#ctlt_LongTermAndShortTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_25cb3322-8452-48f8-9e38-3ee97bb562b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_25cb3322-8452-48f8-9e38-3ee97bb562b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_311f99f8-6a49-40fb-bc64-8bbc6997a04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_311f99f8-6a49-40fb-bc64-8bbc6997a04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_d322df95-2663-44b8-ae2b-4329f22807d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_d322df95-2663-44b8-ae2b-4329f22807d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_e5572856-f400-44f2-9918-540f424a6b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_e5572856-f400-44f2-9918-540f424a6b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_516c54f7-c7b2-4516-a910-b09c07cbc96d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_516c54f7-c7b2-4516-a910-b09c07cbc96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_da9fd829-1e5d-44e1-8419-bc1c2d774a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_da9fd829-1e5d-44e1-8419-bc1c2d774a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3df645aa-93c9-4dde-8e28-03aed14dcd16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_LongTermAndShortTermDebtAbstract_1f05f79b-4f40-42d9-a963-247bb696830a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3df645aa-93c9-4dde-8e28-03aed14dcd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eb78cccc-6659-412c-b40f-17adad7b6c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb78cccc-6659-412c-b40f-17adad7b6c4f" xlink:to="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4fbbd1a-2ac8-4301-bd79-49e4c19397a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_20805979-9dde-4c3a-820e-1f23562f78de" xlink:href="ctlt-20210630.xsd#ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember_20805979-9dde-4c3a-820e-1f23562f78de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_bc3dcc4d-0b11-47f5-8676-185edebe4dfb" xlink:href="ctlt-20210630.xsd#ctlt_U.S.Dollardenominated4.875SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_U.S.Dollardenominated4.875SeniorNotesMember_bc3dcc4d-0b11-47f5-8676-185edebe4dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDollarDenominated500SeniorNotesMember_a17953cc-5cb1-4cc1-8350-42c99ca4055c" xlink:href="ctlt-20210630.xsd#ctlt_USDollarDenominated500SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_USDollarDenominated500SeniorNotesMember_a17953cc-5cb1-4cc1-8350-42c99ca4055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_437bfada-a39b-4725-881d-334e7c83db7f" xlink:href="ctlt-20210630.xsd#ctlt_A2375SeniorEuroDenominatedNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_A2375SeniorEuroDenominatedNotesMember_437bfada-a39b-4725-881d-334e7c83db7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_A3125SeniorUSDenominatedNotesMember_27c354f3-7829-4a24-a488-93feaf5a5050" xlink:href="ctlt-20210630.xsd#ctlt_A3125SeniorUSDenominatedNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_A3125SeniorUSDenominatedNotesMember_27c354f3-7829-4a24-a488-93feaf5a5050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember_380879a7-227d-4b61-89cb-93e829411f52" xlink:href="ctlt-20210630.xsd#ctlt_SeniorSecuredCreditFacilitiesOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_SeniorSecuredCreditFacilitiesOtherMember_380879a7-227d-4b61-89cb-93e829411f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DebtIssuanceCostsMember_23bd3399-8a79-440f-acb6-dc14cf24bebe" xlink:href="ctlt-20210630.xsd#ctlt_DebtIssuanceCostsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_32a29772-8b4e-4995-9b1c-cc42a6a9c4f9" xlink:to="loc_ctlt_DebtIssuanceCostsMember_23bd3399-8a79-440f-acb6-dc14cf24bebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4e1ef5d1-4cba-43c6-888d-e0be280dba3b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_626880b4-f63f-44ee-8e1b-e20228b3a17d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1664ab7b-19b6-41ad-a7b3-5454f791921a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_626880b4-f63f-44ee-8e1b-e20228b3a17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_43e23e66-c5f8-4252-92f1-1b881a01f8fd" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4e68df46-7dd5-48e2-9e36-1bcb38e53b6c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0a5df28c-7a39-4151-aa54-268823cb2c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0a5df28c-7a39-4151-aa54-268823cb2c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6e89c250-44d4-465b-b15f-a22f9996cf3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a77ddfb0-96e8-4ab3-8a84-ed9a6ed4be92" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_6e89c250-44d4-465b-b15f-a22f9996cf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsTable_13059d4e-c654-46f3-bce7-0624b00366f2" xlink:to="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_df16a48b-8eba-4fb7-9982-f038cee99c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_df16a48b-8eba-4fb7-9982-f038cee99c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_1dba48ac-b3a9-40d2-8ce2-2d9c78245a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems_bc8e3f88-3dc6-41dc-b889-43656f97ca0b" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_1dba48ac-b3a9-40d2-8ce2-2d9c78245a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_382b5ba9-7d7d-4b06-bbc6-5c80553ecce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_382b5ba9-7d7d-4b06-bbc6-5c80553ecce9" xlink:to="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d00483bb-6955-4971-9463-430d7106ee76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1688022-66b1-4c09-8d3c-680c42e8fa49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d00483bb-6955-4971-9463-430d7106ee76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bb4647dd-3af2-4822-ade4-80e8fab6c727" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_bfa31239-e462-4d00-8996-22e0ba36a15d" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanThreeFacilityDollarDenominatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_TermLoanThreeFacilityDollarDenominatedMember_bfa31239-e462-4d00-8996-22e0ba36a15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_a25d573f-c906-47a2-b568-7261439bcb2d" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_a25d573f-c906-47a2-b568-7261439bcb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_cad8c7e2-f274-4188-b483-65c53f83d011" xlink:href="ctlt-20210630.xsd#ctlt_SeniorUnsecuredTermLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_SeniorUnsecuredTermLoanFacilityMember_cad8c7e2-f274-4188-b483-65c53f83d011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6409b6e5-29aa-45c5-9f67-b686ef7b6684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6409b6e5-29aa-45c5-9f67-b686ef7b6684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_d0396ae5-67ce-43b6-bae6-95a91a59b186" xlink:href="ctlt-20210630.xsd#ctlt_TermLoanTwoFacilityDollarDenominatedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f16cdff2-f4af-40dc-8935-dd8e9cb60514" xlink:to="loc_ctlt_TermLoanTwoFacilityDollarDenominatedMember_d0396ae5-67ce-43b6-bae6-95a91a59b186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_3556548b-cd9a-4411-b7a4-6509d063e659" xlink:to="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_96bc7f6a-2025-4394-9840-7f3ea314c997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_96bc7f6a-2025-4394-9840-7f3ea314c997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RevolvingCreditFacilityTwoMember_497352dd-b358-4eec-aaea-9568acd0f68a" xlink:href="ctlt-20210630.xsd#ctlt_RevolvingCreditFacilityTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3269cedf-217d-4c35-9df2-6f037add684c" xlink:to="loc_ctlt_RevolvingCreditFacilityTwoMember_497352dd-b358-4eec-aaea-9568acd0f68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6658973e-78ca-4913-8eb6-4dc4f26d7b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e71a7da-b5da-44eb-b19f-a39ac4153334" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6658973e-78ca-4913-8eb6-4dc4f26d7b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_904c4cfd-8667-46ce-858d-afbe5f912e6a" xlink:to="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b94dbd69-ad35-4ff8-9194-e7a8d3bbe876" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_294b2762-a4b4-4ab6-8d00-ebf96999f2bb" xlink:to="loc_srt_MinimumMember_b94dbd69-ad35-4ff8-9194-e7a8d3bbe876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b59d0f3-33df-4f74-9cbc-3787df00527c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f26d4087-fc98-4983-913b-3281a29d5dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f26d4087-fc98-4983-913b-3281a29d5dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_5a10ae07-81a1-49a7-b7e3-378415136227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c4e66d0-bd5d-4a5c-9770-7f11592027ba" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_5a10ae07-81a1-49a7-b7e3-378415136227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EarningsPerShare" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cd246ba2-28cb-4152-96bd-6fa13795a1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5c07066a-21a2-4bc6-9557-87e54a38b42f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd246ba2-28cb-4152-96bd-6fa13795a1bf" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5c07066a-21a2-4bc6-9557-87e54a38b42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EarningsPerShareCalculationTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EarningsPerShareCalculationTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EarningsPerShareCalculationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6033773d-892f-4ef4-8499-025945a6cc5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_73ca72eb-c031-4956-a0c5-2ce8df29792c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6033773d-892f-4ef4-8499-025945a6cc5c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_73ca72eb-c031-4956-a0c5-2ce8df29792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5c33065b-6ca4-4595-98fe-db97cbf1c9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6033773d-892f-4ef4-8499-025945a6cc5c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5c33065b-6ca4-4595-98fe-db97cbf1c9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EarningsPerShareCalculationsofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e05c831e-e2f3-425e-bcc6-2143b3bd689a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_ProfitLoss_e05c831e-e2f3-425e-bcc6-2143b3bd689a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_8b385726-7fcb-49e1-bde9-350fa0ac811e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_8b385726-7fcb-49e1-bde9-350fa0ac811e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_532a9524-b3b7-4c4a-b92e-ca99b6280d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_532a9524-b3b7-4c4a-b92e-ca99b6280d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a140d19-9255-404d-a7dc-7e4ea9720e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8a140d19-9255-404d-a7dc-7e4ea9720e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_884a0416-dec3-4228-b889-f8c42095fcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_884a0416-dec3-4228-b889-f8c42095fcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc62ec01-d94b-403c-9eeb-59c2c22f2ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cc62ec01-d94b-403c-9eeb-59c2c22f2ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_256fdb3c-851e-4a98-869f-3d0bf2452a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_EarningsPerShareBasic_256fdb3c-851e-4a98-869f-3d0bf2452a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bcf21497-86b9-436e-9fee-91d4aa7c4419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ba0eb7-0e76-4d2b-9624-3633a3772a03" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bcf21497-86b9-436e-9fee-91d4aa7c4419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_2267f6f0-adfb-4bba-8174-84ac3b79cdde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EarningsPerShareEarningsPerShareAdditionalDetailsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a6fcd310-ea68-4618-ba0d-b4d9b74b8353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a6fcd310-ea68-4618-ba0d-b4d9b74b8353" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d7dee68-3302-4fee-8937-c2f83ed387a0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_25e3a016-ffe4-44e8-b39c-29ea5a61a328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:to="loc_us-gaap_StockCompensationPlanMember_25e3a016-ffe4-44e8-b39c-29ea5a61a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmployeeStockOptionsandRSUsMember_d36f8060-686f-4e7f-9b77-3ea86f7bacc2" xlink:href="ctlt-20210630.xsd#ctlt_EmployeeStockOptionsandRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_35398683-3f5d-4dee-be64-2b2edd74c75d" xlink:to="loc_ctlt_EmployeeStockOptionsandRSUsMember_d36f8060-686f-4e7f-9b77-3ea86f7bacc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3d39181f-707b-4294-97e6-6d43cf57669b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd570423-1562-4aae-a595-98bc12439b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd570423-1562-4aae-a595-98bc12439b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0625e2c7-9e2e-407f-b8a0-2c0c19f5dd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0625e2c7-9e2e-407f-b8a0-2c0c19f5dd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ebdeea84-28f3-4800-8085-08b93da57738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2374307f-fdf4-4a6c-a05d-9d500e75cf04" xlink:to="loc_us-gaap_PerformanceSharesMember_ebdeea84-28f3-4800-8085-08b93da57738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9c68e52d-7a60-4109-b871-d9b0ebb8daf2" xlink:to="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_42dbd49c-bba3-4c47-9435-5dbd50a4c24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d9c84b64-bcab-4651-8a56-0e9bdb878e93" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_42dbd49c-bba3-4c47-9435-5dbd50a4c24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_03a0c577-a7eb-4555-8f1c-a03d7e4bc350" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a8bf7259-c3fb-4509-a2f9-456be79e02f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a8bf7259-c3fb-4509-a2f9-456be79e02f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_fb0ed3d9-0177-49c4-a450-6a370736f8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ee9f03bd-6418-4e2a-a1da-885b119a99dc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_fb0ed3d9-0177-49c4-a450-6a370736f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c6ed7d0b-613a-437c-b8ba-d02c0a34767e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_87a052c5-846d-4f2d-8deb-10d325e80391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c6ed7d0b-613a-437c-b8ba-d02c0a34767e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_87a052c5-846d-4f2d-8deb-10d325e80391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9181b397-5c4f-4c00-9586-689338bfe62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock_ec6e49cf-1da9-4185-8500-09b929671dfe" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9181b397-5c4f-4c00-9586-689338bfe62b" xlink:to="loc_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock_ec6e49cf-1da9-4185-8500-09b929671dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_23359169-71a1-4201-a623-2ba4b243e628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9181b397-5c4f-4c00-9586-689338bfe62b" xlink:to="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_23359169-71a1-4201-a623-2ba4b243e628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd027e90-65e1-4a85-bb5c-c978f8e69de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fd027e90-65e1-4a85-bb5c-c978f8e69de9" xlink:to="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:to="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_441e7ac5-b276-40f1-a611-ee270665ca24" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_USDenominatedTermLoanMember_8545e802-7685-4239-a530-efe50a3b2393" xlink:href="ctlt-20210630.xsd#ctlt_USDenominatedTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e362adb2-fa7c-44f2-9425-3a24550021a1" xlink:to="loc_ctlt_USDenominatedTermLoanMember_8545e802-7685-4239-a530-efe50a3b2393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d4a8572a-a821-4b0f-8219-b017e438dc19" xlink:to="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_90d06254-699b-44fa-abcd-f3a9b27f1110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_90d06254-699b-44fa-abcd-f3a9b27f1110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_32c880ca-634b-485a-9400-981d741cc71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_32c880ca-634b-485a-9400-981d741cc71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_85c9e26c-4cb8-4c27-8222-da8cdb33b858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_85c9e26c-4cb8-4c27-8222-da8cdb33b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_51d75787-fb04-4a06-9cab-d6b292f487ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_51d75787-fb04-4a06-9cab-d6b292f487ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_5695e35d-da90-4509-8656-d159618dec3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock_5695e35d-da90-4509-8656-d159618dec3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_095ab335-ae7b-4e08-825e-6bd06c05f2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_095ab335-ae7b-4e08-825e-6bd06c05f2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_358cd29c-6a23-4437-ab43-80df65806a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_358cd29c-6a23-4437-ab43-80df65806a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_87187e0b-3bd2-4f9f-b71f-0fcee13b6579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_87187e0b-3bd2-4f9f-b71f-0fcee13b6579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1f256bd9-abf7-4444-ab43-44bedc1a1b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DerivativeLiabilities_1f256bd9-abf7-4444-ab43-44bedc1a1b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_873a99ec-c392-4b92-a5f0-353f3796c30c" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_873a99ec-c392-4b92-a5f0-353f3796c30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3d17de4b-f6be-4029-8550-9999d7ef551e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_1bda63d2-db21-4577-a69d-43be60ce1350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_35606831-54e3-405a-862d-05bf6fd73017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_35606831-54e3-405a-862d-05bf6fd73017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalFixedRate_cedc53fc-d400-4958-8d35-b3717442c044" xlink:href="ctlt-20210630.xsd#ctlt_TotalFixedRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_TotalFixedRate_cedc53fc-d400-4958-8d35-b3717442c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalDebtUSDenominatedTermLoan_9680eaa3-e143-4a25-96b7-6df6dcff9a6a" xlink:href="ctlt-20210630.xsd#ctlt_TotalDebtUSDenominatedTermLoan"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_TotalDebtUSDenominatedTermLoan_9680eaa3-e143-4a25-96b7-6df6dcff9a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement_567446db-44e8-4fea-a629-83152212ab09" xlink:href="ctlt-20210630.xsd#ctlt_CashPaidToSettleInterestRateSwapAgreement"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_ctlt_CashPaidToSettleInterestRateSwapAgreement_567446db-44e8-4fea-a629-83152212ab09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_62446927-7f1e-4bdb-96bb-0450f6336316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8440d02e-b587-464d-b25e-38bda53d46d3" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_62446927-7f1e-4bdb-96bb-0450f6336316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/FairValueMeasuresandDisclosures" xlink:type="simple" xlink:href="ctlt-20210630.xsd#FairValueMeasuresandDisclosures"/>
  <link:presentationLink xlink:role="http://catalent.com/role/FairValueMeasuresandDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c31ea4af-46b0-4ee1-8e34-bccebd09428e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c7a0485f-f499-4361-9b67-a2428c78ba3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c31ea4af-46b0-4ee1-8e34-bccebd09428e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c7a0485f-f499-4361-9b67-a2428c78ba3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fa93f8ed-c5b1-4f63-95cc-de29f7941105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4db22c4b-c855-4d91-8968-cdc433a6118d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fa93f8ed-c5b1-4f63-95cc-de29f7941105" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4db22c4b-c855-4d91-8968-cdc433a6118d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_93cb32c8-4b6f-4fbb-be57-308d5b6a1512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fa93f8ed-c5b1-4f63-95cc-de29f7941105" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_93cb32c8-4b6f-4fbb-be57-308d5b6a1512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_341f0122-44ed-494a-928a-4c56e287226c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_341f0122-44ed-494a-928a-4c56e287226c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e0cdf48-70dd-42a1-b3f6-4477378d99a6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc8fd80a-d244-423f-8404-72c3d9cfed54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc8fd80a-d244-423f-8404-72c3d9cfed54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bb252674-1ffc-479f-a1e7-2b473f78b095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bb252674-1ffc-479f-a1e7-2b473f78b095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b095ead7-a233-460b-9b1c-1c215b92cf6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_177cfb27-d32e-42fb-a47a-83278909ced1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b095ead7-a233-460b-9b1c-1c215b92cf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2b2cc4ef-fa41-46f1-8a27-9cf614b01479" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_9b4438cb-86b8-454e-9806-14a635249e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_MarketableSecurities_9b4438cb-86b8-454e-9806-14a635249e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_e4335081-2a5a-43e9-af69-ae61431064de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_e4335081-2a5a-43e9-af69-ae61431064de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableFairValueDisclosure_cc1b763c-2889-4e70-8856-4aa47917f7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_PremiumsReceivableFairValueDisclosure_cc1b763c-2889-4e70-8856-4aa47917f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_22ca9390-fff9-415c-8d76-522641e3c4ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_22ca9390-fff9-415c-8d76-522641e3c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TradingSecuritiesAtFairValue_a4c9ee0f-686e-4520-b8b9-cd390c157070" xlink:href="ctlt-20210630.xsd#ctlt_TradingSecuritiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_ctlt_TradingSecuritiesAtFairValue_a4c9ee0f-686e-4520-b8b9-cd390c157070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SeriesAPreferredStockDerivativeLiability_5647638e-2cce-43a6-93dc-735f7dd3c2c1" xlink:href="ctlt-20210630.xsd#ctlt_SeriesAPreferredStockDerivativeLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_ctlt_SeriesAPreferredStockDerivativeLiability_5647638e-2cce-43a6-93dc-735f7dd3c2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_d1a727b1-5565-4143-bac3-07a330364b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85fd17a3-c96c-4ee5-a4ff-8cad891d8e4b" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue_d1a727b1-5565-4143-bac3-07a330364b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_84c86fbb-3e5d-4f33-915e-843c915ec0a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f4e39dc8-585f-4b24-88ff-b8e1bee1e067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_84c86fbb-3e5d-4f33-915e-843c915ec0a2" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f4e39dc8-585f-4b24-88ff-b8e1bee1e067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f700e1d8-fa2a-441f-8e15-eefc126a642b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f700e1d8-fa2a-441f-8e15-eefc126a642b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cfd8b5c8-70cc-488a-b63c-0e433f79640f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cfd8b5c8-70cc-488a-b63c-0e433f79640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ca4d9666-0daa-410d-8b23-11b126ccaba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ca4d9666-0daa-410d-8b23-11b126ccaba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5588c48e-e1ba-4d1b-896b-d6dffd5bef52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5588c48e-e1ba-4d1b-896b-d6dffd5bef52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock_6d6c7083-5ba0-412c-b4a7-7a88238fa1ed" xlink:href="ctlt-20210630.xsd#ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock_6d6c7083-5ba0-412c-b4a7-7a88238fa1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_5bbe15c8-378c-4766-801d-1d28288a537f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4208ed6-12d9-405c-8efb-1b359177ecc4" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_5bbe15c8-378c-4766-801d-1d28288a537f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_58726381-a568-4808-8be4-413a01862065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_58726381-a568-4808-8be4-413a01862065" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b95f8237-18cb-4bc0-a52d-6a2ffd7cda33" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b980d137-a4a2-4bd5-8851-3dfc6f487597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_DomesticCountryMember_b980d137-a4a2-4bd5-8851-3dfc6f487597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_44c1184d-9b01-4291-be87-606a58e62e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_44c1184d-9b01-4291-be87-606a58e62e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_32cc4c6b-1ffe-4073-a876-17d95e2a69d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_fcf7e224-6b15-4d2f-8b73-3446a74bd524" xlink:to="loc_us-gaap_ForeignCountryMember_32cc4c6b-1ffe-4073-a876-17d95e2a69d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_510e36fb-b09a-443f-b3db-593f475f3e37" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b61dad25-e9be-4821-93a0-1e282703a1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_us-gaap_DomesticCountryMember_b61dad25-e9be-4821-93a0-1e282703a1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossMember_0ebd2ab4-2a70-4113-a4b5-746c182f0d03" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_ctlt_ForeignNetOperatingLossMember_0ebd2ab4-2a70-4113-a4b5-746c182f0d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ForeignNetOperatingLossEstablishedMember_bbc53967-470c-4845-9abc-cff15ecdec75" xlink:href="ctlt-20210630.xsd#ctlt_ForeignNetOperatingLossEstablishedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_f2b0f56f-7972-4d5c-8cdc-a9a6a072c65a" xlink:to="loc_ctlt_ForeignNetOperatingLossEstablishedMember_bbc53967-470c-4845-9abc-cff15ecdec75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_d58087b5-67b3-4aeb-8875-a128feb81df5" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_407fd266-4036-46b2-9e13-2c7c123b1cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_OperatingLossCarryforwards_407fd266-4036-46b2-9e13-2c7c123b1cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_902d335f-e6b6-474b-b288-8612c2aa7a33" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382_902d335f-e6b6-474b-b288-8612c2aa7a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife_da8ba8d9-087d-462b-93c6-1da5339cbf1c" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsIndefiniteLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsIndefiniteLife_da8ba8d9-087d-462b-93c6-1da5339cbf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_ab3be139-7f76-4979-80db-68b7005e9ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_ab3be139-7f76-4979-80db-68b7005e9ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_33aa2ece-7d1d-4480-b309-4e987377251f" xlink:href="ctlt-20210630.xsd#ctlt_OperatingLossCarryforwardsCarryForwardPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_ctlt_OperatingLossCarryforwardsCarryForwardPeriod_33aa2ece-7d1d-4480-b309-4e987377251f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_978739c2-9586-42d7-b281-015d27492189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_978739c2-9586-42d7-b281-015d27492189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bc420d2a-f491-4ba5-a9ca-f0ff80bad842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bc420d2a-f491-4ba5-a9ca-f0ff80bad842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a7cbad9d-6088-4c81-acb3-251873082173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a7cbad9d-6088-4c81-acb3-251873082173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_f2e94539-8c58-482d-b20c-2448a66bb09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_44d3d13a-89bc-4d76-bb93-5fd1553c65db" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_f2e94539-8c58-482d-b20c-2448a66bb09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6e2b8237-a049-4f41-a8aa-56badf087ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2655b125-99f0-435b-a205-8852194c1329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6e2b8237-a049-4f41-a8aa-56badf087ca5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2655b125-99f0-435b-a205-8852194c1329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_42daa9be-ed46-4ce9-8e67-165829383131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6e2b8237-a049-4f41-a8aa-56badf087ca5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_42daa9be-ed46-4ce9-8e67-165829383131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2471f440-6cc6-4eca-8878-ffddbe2cb7a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6e2b8237-a049-4f41-a8aa-56badf087ca5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2471f440-6cc6-4eca-8878-ffddbe2cb7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_54e1d776-2148-4ea8-8916-b6592fc4f6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_54e1d776-2148-4ea8-8916-b6592fc4f6b5" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f6b5ad31-4f45-4d07-b678-805b9f103bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f6b5ad31-4f45-4d07-b678-805b9f103bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7dcc3f90-27eb-4ad3-b54d-ba684bc40e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7dcc3f90-27eb-4ad3-b54d-ba684bc40e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fb1a7b31-1469-433b-8bd4-055a3f1edc99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_fb1a7b31-1469-433b-8bd4-055a3f1edc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f8adfea-7fb8-499c-8122-56f627210bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b462c528-3cee-4704-959b-c1af60c4c105" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f8adfea-7fb8-499c-8122-56f627210bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_54e1d776-2148-4ea8-8916-b6592fc4f6b5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7cf15720-9458-4b99-bbac-2cdeaa9a4f35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7cf15720-9458-4b99-bbac-2cdeaa9a4f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_358f117d-cc54-44c9-8b58-edc8bb38e61a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_358f117d-cc54-44c9-8b58-edc8bb38e61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_491c12fd-35ea-48aa-ab57-a964deaacce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_491c12fd-35ea-48aa-ab57-a964deaacce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1115c09-24ef-433b-8912-841918865320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3a75ad4c-83dc-41f7-a472-ff6c8522c3e5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e1115c09-24ef-433b-8912-841918865320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_873f3224-faba-4775-b8fc-75937f287166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_54e1d776-2148-4ea8-8916-b6592fc4f6b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_873f3224-faba-4775-b8fc-75937f287166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7115aef3-ae41-48ba-8a3b-90f29c34b07c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7115aef3-ae41-48ba-8a3b-90f29c34b07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0ec247e8-4d20-41b0-8581-81f77c25f22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0ec247e8-4d20-41b0-8581-81f77c25f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_701435e1-0ccd-4fcb-9acc-eae3d9437002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_701435e1-0ccd-4fcb-9acc-eae3d9437002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_b456491e-1ed7-4d41-94c2-7e4ee6dc5a45" xlink:href="ctlt-20210630.xsd#ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome_b456491e-1ed7-4d41-94c2-7e4ee6dc5a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_433352f0-0e60-4653-b686-2f8d102edb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_433352f0-0e60-4653-b686-2f8d102edb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b7223302-aac9-4ade-ab03-959f4a0f6776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b7223302-aac9-4ade-ab03-959f4a0f6776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_eb1cb9d0-423e-44d2-a6c2-dda18548abbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_eb1cb9d0-423e-44d2-a6c2-dda18548abbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_f5abc012-9089-45e3-b774-d180ddb8f6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_f5abc012-9089-45e3-b774-d180ddb8f6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7df0896c-f5e4-466c-971f-a4f0048c7121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7df0896c-f5e4-466c-971f-a4f0048c7121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_14c7e5d4-a78f-4c5d-a9cc-2ffdb0e5932b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_14c7e5d4-a78f-4c5d-a9cc-2ffdb0e5932b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ce274f3e-d4a1-4c35-99fa-94e0c0d44c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ce274f3e-d4a1-4c35-99fa-94e0c0d44c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TaxCutsandJobsActTaxEffect_a55f2976-5cfb-4877-9151-cda97cd6eec9" xlink:href="ctlt-20210630.xsd#ctlt_TaxCutsandJobsActTaxEffect"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_ctlt_TaxCutsandJobsActTaxEffect_a55f2976-5cfb-4877-9151-cda97cd6eec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_34b158bb-0ec3-40cb-a966-2d94cee30bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_34b158bb-0ec3-40cb-a966-2d94cee30bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bbb54ca0-4c64-4773-a951-a4a6b175af81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_12dd480e-e303-40c5-8a95-44a1a4968969" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bbb54ca0-4c64-4773-a951-a4a6b175af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb87ea1a-0bbb-4502-97b7-a8435342be8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb87ea1a-0bbb-4502-97b7-a8435342be8e" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_7d90a6d1-63ea-41c1-a0e9-94f6a06b305c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_7d90a6d1-63ea-41c1-a0e9-94f6a06b305c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_05d6ebc8-4405-49d3-b934-5ac0013e7d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_05d6ebc8-4405-49d3-b934-5ac0013e7d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d2451a98-43fd-4ee4-9161-82230940f3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d2451a98-43fd-4ee4-9161-82230940f3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_fa88160c-7b17-4995-b1e9-ecfe347edd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_fa88160c-7b17-4995-b1e9-ecfe347edd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_92ef838b-1128-41c6-b0b3-4220d5b851cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_92ef838b-1128-41c6-b0b3-4220d5b851cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_7081bac9-ddbf-400a-8d28-fb77e441ad8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_7081bac9-ddbf-400a-8d28-fb77e441ad8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2d86fac1-7373-4a22-b41c-4ed1226e3e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2d86fac1-7373-4a22-b41c-4ed1226e3e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_e061b057-9bfe-46f2-b074-015950f06e44" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxOperatingLeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities_e061b057-9bfe-46f2-b074-015950f06e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_0d62c270-e331-4968-97f5-f5bb880e42ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss_0d62c270-e331-4968-97f5-f5bb880e42ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_29fcbf41-0959-4afe-b4e8-a43914c617f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_29fcbf41-0959-4afe-b4e8-a43914c617f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9acb51c5-857e-4532-a36d-77d453c7081b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9acb51c5-857e-4532-a36d-77d453c7081b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_254e7e42-d3b1-4a94-a3b8-8a9d54fe3a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_dd9b33c0-254b-4696-a865-181a83cf2812" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_254e7e42-d3b1-4a94-a3b8-8a9d54fe3a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb87ea1a-0bbb-4502-97b7-a8435342be8e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_bc0f4eac-8e3f-4549-8464-a472234d07a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_bc0f4eac-8e3f-4549-8464-a472234d07a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d9b128d5-68d8-4712-9abd-00910a62a413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d9b128d5-68d8-4712-9abd-00910a62a413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_7a09e471-1d4a-4bb0-b569-e05844280954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_7a09e471-1d4a-4bb0-b569-e05844280954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DeferredIncomeTaxRightOfUse_fcb8ffac-e46f-4088-aa70-c1baa898f7b7" xlink:href="ctlt-20210630.xsd#ctlt_DeferredIncomeTaxRightOfUse"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_ctlt_DeferredIncomeTaxRightOfUse_fcb8ffac-e46f-4088-aa70-c1baa898f7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_6bb372c8-c86e-4b7c-ae99-ab01c3cd7053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_6bb372c8-c86e-4b7c-ae99-ab01c3cd7053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a7f1e6bb-b6ac-4547-905e-2fa6974eb445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a7f1e6bb-b6ac-4547-905e-2fa6974eb445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_902584b6-88c9-4b99-8574-70ec011770b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_3b1e6123-3f97-4b1c-9944-9a4e37f97609" xlink:to="loc_us-gaap_DeferredTaxLiabilities_902584b6-88c9-4b99-8574-70ec011770b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesBalanceSheetDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0edceeda-7de9-464c-be4f-0799480bf16a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2b49ac2a-dfac-4e3a-9224-ab821a48aa40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0edceeda-7de9-464c-be4f-0799480bf16a" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2b49ac2a-dfac-4e3a-9224-ab821a48aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_1de268bf-5b4c-47aa-8429-cfe4454d6b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0edceeda-7de9-464c-be4f-0799480bf16a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_1de268bf-5b4c-47aa-8429-cfe4454d6b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_7a6acf08-9fc0-42d8-929e-c8fe6014c0e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0edceeda-7de9-464c-be4f-0799480bf16a" xlink:to="loc_us-gaap_DeferredTaxLiabilities_7a6acf08-9fc0-42d8-929e-c8fe6014c0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c38325ba-6cff-47c5-91c9-47e99be6d8af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0edceeda-7de9-464c-be4f-0799480bf16a" xlink:to="loc_us-gaap_MarketableSecurities_c38325ba-6cff-47c5-91c9-47e99be6d8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e31ea9b8-40f3-48b1-8426-dd293d874d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e31ea9b8-40f3-48b1-8426-dd293d874d85" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7dd630e8-ad8f-4c57-87b9-89a781bd8c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7dd630e8-ad8f-4c57-87b9-89a781bd8c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9a3174be-823b-4dc7-8bbf-726a92d146f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_9a3174be-823b-4dc7-8bbf-726a92d146f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d56812c4-aa1d-4f5b-bcc0-e077e66aa31f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d56812c4-aa1d-4f5b-bcc0-e077e66aa31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f29a1d4-8d8f-4bb1-ae7c-6b60ffe04778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_7f29a1d4-8d8f-4bb1-ae7c-6b60ffe04778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_d2e716f2-9099-490a-b306-96a324161e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_d2e716f2-9099-490a-b306-96a324161e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6e901040-0e06-444c-b1cf-80d9547c439a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_6e901040-0e06-444c-b1cf-80d9547c439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_255e3ad2-adb6-482d-8cec-d8ff681e4b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3af97bfe-5eaf-4bef-804f-9a96c3703d31" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_255e3ad2-adb6-482d-8cec-d8ff681e4b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlans" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlans"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_56caa912-031c-4f47-9b55-531ff14f7d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_eb97f027-d3db-44e7-bfe0-d41cfffea383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_56caa912-031c-4f47-9b55-531ff14f7d01" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_eb97f027-d3db-44e7-bfe0-d41cfffea383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7a0ee91c-eb68-4f06-99f8-99c8864aeb1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_7a0ee91c-eb68-4f06-99f8-99c8864aeb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_cf5ccb86-153d-4a63-9e25-c85a2a396651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_cf5ccb86-153d-4a63-9e25-c85a2a396651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock_2d73ad36-3218-444f-83f8-d0082cbc2499" xlink:href="ctlt-20210630.xsd#ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:to="loc_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock_2d73ad36-3218-444f-83f8-d0082cbc2499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d803aa18-831f-4ee4-91f8-3a73f36e2dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d803aa18-831f-4ee4-91f8-3a73f36e2dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_fbcf36e1-6bd0-4dad-8ae3-acab948ed6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6749c240-1e70-4cc1-b62b-0c56853f79bc" xlink:to="loc_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock_fbcf36e1-6bd0-4dad-8ae3-acab948ed6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_636ee754-3438-4909-95f8-0aa1c4edbf62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_636ee754-3438-4909-95f8-0aa1c4edbf62" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_607e97e8-c609-4e9e-a0ce-400d238b0fb5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a16b79-8ada-42fd-9910-f00522c6e58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_41b10e45-e1ff-40d8-9e66-c4ac9a6122d1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a4a16b79-8ada-42fd-9910-f00522c6e58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:to="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0e943a0a-b8c8-40a1-98b9-d25ef8700191" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember_897f3810-1f5e-404f-b841-35535f462e1d" xlink:href="ctlt-20210630.xsd#ctlt_EberbachPensionPromissoryNoteOrLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f8801cdc-a4eb-4fec-922f-2890b0c09aad" xlink:to="loc_ctlt_EberbachPensionPromissoryNoteOrLoanMember_897f3810-1f5e-404f-b841-35535f462e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e35fab72-9c6e-42a0-a6f7-061c21fb34b2" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_0c2146cf-26ac-4567-bc37-31924c928505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount_0c2146cf-26ac-4567-bc37-31924c928505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9342648e-95e4-4565-85d3-efdb61863ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9342648e-95e4-4565-85d3-efdb61863ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_358dac3f-d402-4a23-b23a-cdd2bfdf9039" xlink:href="ctlt-20210630.xsd#ctlt_MultiemployerPlansEstimatedAnnualCashContribution"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_f1cc0a4f-2dda-4462-b36e-86a9403c93d5" xlink:to="loc_ctlt_MultiemployerPlansEstimatedAnnualCashContribution_358dac3f-d402-4a23-b23a-cdd2bfdf9039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_582dce82-6c8e-4449-9a54-94cc4ca1211a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_582dce82-6c8e-4449-9a54-94cc4ca1211a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d9f6387c-ddf9-4755-b538-3899910968ee" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_635e2004-2085-4ef5-b5ad-16c74f725ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_635e2004-2085-4ef5-b5ad-16c74f725ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_78fdc0e1-6d52-4f88-92e7-6eeb962d5377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ef41552-da0c-44e3-8c0c-d415c74a02e0" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_78fdc0e1-6d52-4f88-92e7-6eeb962d5377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c1dd91f7-ca56-40c3-bea0-ac4dfaecfafd" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_98ac47d2-634f-4928-849b-2160eacaaecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_98ac47d2-634f-4928-849b-2160eacaaecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6463e84-4882-46f1-a00a-b5e63ac14938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_d6463e84-4882-46f1-a00a-b5e63ac14938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a0298656-eccf-49ff-863d-8b2fab58ffd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a0298656-eccf-49ff-863d-8b2fab58ffd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_02abe664-4b28-46b5-a1bc-1db4cfc9e057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_02abe664-4b28-46b5-a1bc-1db4cfc9e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a1337215-594f-460c-9d7b-f3fa8f85994f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a1337215-594f-460c-9d7b-f3fa8f85994f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7fedae51-0fd8-47e0-b62d-0f12c619ece5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7fedae51-0fd8-47e0-b62d-0f12c619ece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_423f4ede-ff92-4ee1-b213-76242e227bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_423f4ede-ff92-4ee1-b213-76242e227bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_829b7b9e-1c38-4e3f-bbae-2a15839e05f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_829b7b9e-1c38-4e3f-bbae-2a15839e05f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6c64bc35-d1c3-41c4-b885-8eddae222344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_6c64bc35-d1c3-41c4-b885-8eddae222344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_ec672a59-6c0e-42a3-b7bb-c2f9d0ba9ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSpecialTerminationBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_ec672a59-6c0e-42a3-b7bb-c2f9d0ba9ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_64e5372b-133b-4af5-89db-88df8d70a50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_64e5372b-133b-4af5-89db-88df8d70a50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_13fbb5ac-06d2-4f60-8eb3-8218243d571a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_13fbb5ac-06d2-4f60-8eb3-8218243d571a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d146ede6-5f18-44a0-a506-de17cefd3b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_d146ede6-5f18-44a0-a506-de17cefd3b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e3bf74f3-96a5-43cd-b9c4-6cc0c4cc3604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_e3bf74f3-96a5-43cd-b9c4-6cc0c4cc3604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8990aad4-a725-4fb5-a407-bf45d14e2d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8990aad4-a725-4fb5-a407-bf45d14e2d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7ae2fa2b-79c4-467b-9586-9bc9b4181718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_0c887092-f5ce-4449-91d6-333262a38272" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_7ae2fa2b-79c4-467b-9586-9bc9b4181718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a1ee389-53a8-4491-835a-88b98df708c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8a1ee389-53a8-4491-835a-88b98df708c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_878fb6b5-d840-4a2a-840f-895f3e8b8c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_878fb6b5-d840-4a2a-840f-895f3e8b8c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_124e7919-6ca6-4b44-a5bd-486a51c170cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_124e7919-6ca6-4b44-a5bd-486a51c170cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5d75cd1c-9f8e-4828-b143-67f2dc0968b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5d75cd1c-9f8e-4828-b143-67f2dc0968b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_7de2bbc8-5ec5-4d32-8a7b-06127fc32058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_7de2bbc8-5ec5-4d32-8a7b-06127fc32058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_4262de01-d0f5-4680-b5e6-d8052a3a6ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanSpecialTerminationBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanSpecialTerminationBenefits_4262de01-d0f5-4680-b5e6-d8052a3a6ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_b647ebe4-61bf-4389-b9d9-75a6ad5bc0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_b647ebe4-61bf-4389-b9d9-75a6ad5bc0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_72a23b60-0df0-4034-afac-f7469bc7ec94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets_72a23b60-0df0-4034-afac-f7469bc7ec94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2a8a5b09-0fa9-4324-b238-c6ccaba1dab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_2a8a5b09-0fa9-4324-b238-c6ccaba1dab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_36112dde-1e59-4b5c-82ad-aee77962db86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_36112dde-1e59-4b5c-82ad-aee77962db86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e53911f-4d20-4430-ac33-a338c3318cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7ca0a547-1e3e-4f46-85eb-8c79451c16dd" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e53911f-4d20-4430-ac33-a338c3318cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ba3b3959-4705-4ba7-a78f-0158916dbe78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ba3b3959-4705-4ba7-a78f-0158916dbe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_36b635df-ab23-448a-92e2-e336e110a354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_36b635df-ab23-448a-92e2-e336e110a354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_02b61b01-8924-4823-812c-061d4907674c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18079f06-1225-419f-9e03-52d10c6728bb" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_02b61b01-8924-4823-812c-061d4907674c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c46863f6-4fff-4457-b33c-a187f85fbe34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c46863f6-4fff-4457-b33c-a187f85fbe34" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_dc7f15a9-7607-4ff9-9f38-734fe83e2cfa" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c271e981-23e7-4ac8-aaba-a90b34bd4367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c271e981-23e7-4ac8-aaba-a90b34bd4367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c92b26c-b4e8-42b5-b00f-7861d971da4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_367e0f13-a968-44da-8027-ae56d2dca94f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c92b26c-b4e8-42b5-b00f-7861d971da4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_512a492f-4454-4365-88a5-9d50f3436f13" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_44119424-5bdb-46c6-b452-53f0ff107068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_44119424-5bdb-46c6-b452-53f0ff107068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0317dc2f-e28d-40ab-ab27-80b93a528d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0317dc2f-e28d-40ab-ab27-80b93a528d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eca02553-b1d9-4cab-acf5-e397581ce196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_eca02553-b1d9-4cab-acf5-e397581ce196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_28a1a928-3117-46f5-9391-d7f885ad862d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_bd2d37a8-2125-432f-8841-857bbdf7f84f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_28a1a928-3117-46f5-9391-d7f885ad862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_6db2d0e0-413b-4ccb-b0e5-79c7e1ed8385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax_6db2d0e0-413b-4ccb-b0e5-79c7e1ed8385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_cb5e3d73-31ea-4dae-82e8-410a81c750c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax_cb5e3d73-31ea-4dae-82e8-410a81c750c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_1ca85d8a-7c4b-4e38-8d4b-9834d4758884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax_1ca85d8a-7c4b-4e38-8d4b-9834d4758884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30268d46-75c6-4007-9084-80a9406f18f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_91b2672f-db06-4150-89f3-a06333155bd7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30268d46-75c6-4007-9084-80a9406f18f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_aa21d46b-39e4-4ce1-b919-a0fb16d417ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_aa21d46b-39e4-4ce1-b919-a0fb16d417ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_49a6c9c4-da6a-4f09-aa05-e012b740b6d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_49a6c9c4-da6a-4f09-aa05-e012b740b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5f26b70c-bd63-448a-930c-4cf11d434e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract_ac51f48a-deeb-4644-9876-57e68e823293" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5f26b70c-bd63-448a-930c-4cf11d434e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_56869448-25ab-46ea-a3a0-b1b2fc810535" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_62e5873e-f396-4a71-ac7c-fd83580c14d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_62e5873e-f396-4a71-ac7c-fd83580c14d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_82ac5f3a-6656-46de-9a3b-14f9af98f9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_82ac5f3a-6656-46de-9a3b-14f9af98f9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_016547be-12ba-493a-b391-5aba07db74cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_016547be-12ba-493a-b391-5aba07db74cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_97c03a70-ffd4-49c6-9af5-784bdeb6a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation_97c03a70-ffd4-49c6-9af5-784bdeb6a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7a81d11-8eb4-41e1-8b12-9d4e5eff2077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a7a81d11-8eb4-41e1-8b12-9d4e5eff2077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3ae1e939-4cca-48f5-99fd-ec8ef8c46af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3ae1e939-4cca-48f5-99fd-ec8ef8c46af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a531bbb-a774-4d59-b07c-f5893d2d02dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7a55aab5-455b-4dcd-913c-3652e1f4e1ce" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3a531bbb-a774-4d59-b07c-f5893d2d02dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAOCIDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_956ea951-ee72-4820-94f3-daf3897040d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_956ea951-ee72-4820-94f3-daf3897040d2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c03cf396-f083-43bb-a435-4fb435dd5002" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a37aa3c0-930a-4a65-b616-9c12cab70688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a37aa3c0-930a-4a65-b616-9c12cab70688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5f8719af-dc1c-4d5d-87ec-0a79848ab735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71f57652-7bca-4503-a202-83f123b16899" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5f8719af-dc1c-4d5d-87ec-0a79848ab735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_31b3b218-0a83-4eed-86fd-e6db065aba8d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_cf2b2e16-3056-4867-922e-ef9c207cd6a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_cf2b2e16-3056-4867-922e-ef9c207cd6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_db4a87d1-b57b-4609-be27-844af1298fe8" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax_db4a87d1-b57b-4609-be27-844af1298fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_0d8a01b1-f680-475b-968b-100f9c98e04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax_0d8a01b1-f680-475b-968b-100f9c98e04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_13690c50-b484-4c7e-8adf-987da8dd47ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_13690c50-b484-4c7e-8adf-987da8dd47ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_ffab20e7-7bdd-4c04-995b-b0fb038024ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_ffab20e7-7bdd-4c04-995b-b0fb038024ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_7fac3f41-36a8-4932-b03f-edc146e9e486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract_ddd086ff-70a2-4e30-8ecd-acd975aefa83" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_7fac3f41-36a8-4932-b03f-edc146e9e486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7ad005ca-5bad-46ec-a82a-e554ac2f32f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7ad005ca-5bad-46ec-a82a-e554ac2f32f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_b7d65418-e52b-40e6-bbc4-6213f036879a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear_b7d65418-e52b-40e6-bbc4-6213f036879a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_40a1336a-9f64-4034-ac4f-a73298b0c8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_40a1336a-9f64-4034-ac4f-a73298b0c8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_f54198f9-4cd2-4559-9e2a-faa7f6296a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract_2d2cf342-7b7f-4089-b42b-628666134c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_f54198f9-4cd2-4559-9e2a-faa7f6296a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b7c40657-3cfb-4ab4-a2bd-999eb0eb2cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b7c40657-3cfb-4ab4-a2bd-999eb0eb2cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_74d54cf7-53df-45c8-93a1-db3b0dbacb97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e3cd8da1-d05c-40dd-9211-7a9e78233b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_74d54cf7-53df-45c8-93a1-db3b0dbacb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_569dc1c4-ffb1-4299-8b21-30b58d97176c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_569dc1c4-ffb1-4299-8b21-30b58d97176c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_49829d0c-811b-4132-ae33-2d78ef383dab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_49829d0c-811b-4132-ae33-2d78ef383dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3f9163f6-32c9-4a46-862a-2b2412b340cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_787a24d9-5037-4299-9e11-6d5de889daa3" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3f9163f6-32c9-4a46-862a-2b2412b340cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b2206ae7-c82f-4bb4-a4d2-865798ae863b" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_94b14e87-59aa-4be4-81d8-c3b08987a536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract_82740bf9-d92f-4ed0-adce-ebf3927dfaec" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_94b14e87-59aa-4be4-81d8-c3b08987a536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c442e837-384a-446e-86b2-5a2798fc280f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c442e837-384a-446e-86b2-5a2798fc280f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d73d6baf-885e-46e1-ba5e-ab1c9448268d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_93aadc24-959f-4c0e-b65a-0359aab99661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_93aadc24-959f-4c0e-b65a-0359aab99661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d1a69bee-59b9-4ff4-b313-4b3001cda22b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9510daa7-33ad-4df2-b6ca-4d5e1db904fa" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_d1a69bee-59b9-4ff4-b313-4b3001cda22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7c2e9a09-1f82-445d-857a-251660c52157" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_57561cf1-4683-4447-a56b-dc3db3ab53f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_EquitySecuritiesMember_57561cf1-4683-4447-a56b-dc3db3ab53f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_394cf86f-4ea3-4076-a595-07a027897c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_394cf86f-4ea3-4076-a595-07a027897c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_05e83bc6-c5ea-4204-998d-ee784b689c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_05e83bc6-c5ea-4204-998d-ee784b689c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_56b9995f-2fa8-4a9e-b21f-efd189af0492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_RealEstateMember_56b9995f-2fa8-4a9e-b21f-efd189af0492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_d80936e6-fc4f-478f-bd9c-0b31e0eef236" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_ctlt_InsuranceContractsMember_d80936e6-fc4f-478f-bd9c-0b31e0eef236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_cb89938a-3d5f-453c-bfcb-05c822870a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_293d22e9-2665-49e6-8191-aa164b99e9d0" xlink:to="loc_us-gaap_OtherAssetsMember_cb89938a-3d5f-453c-bfcb-05c822870a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8b8ec0cc-4751-4be6-a292-131766ea5056" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_cff17bcd-eff2-4608-95c1-82d9775f8482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_cff17bcd-eff2-4608-95c1-82d9775f8482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2bd5ceb4-f94e-4f55-a757-736aca8e3c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2bd5ceb4-f94e-4f55-a757-736aca8e3c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad25d7f0-826f-4654-a4fb-d2020ca2185f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad25d7f0-826f-4654-a4fb-d2020ca2185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_adaa9df4-1c1e-4489-a5d5-55038cb0a7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_adaa9df4-1c1e-4489-a5d5-55038cb0a7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_86ec89e4-9c4e-461f-bd72-5302fb4fb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_86ec89e4-9c4e-461f-bd72-5302fb4fb50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_b0032776-ee10-41f7-ac7c-a4aa4429307d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_fc201dba-94bf-4ec4-a543-f42767924b84" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_b0032776-ee10-41f7-ac7c-a4aa4429307d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_cdc5add6-0293-4ac0-b03a-88d37ca79a88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_cdc5add6-0293-4ac0-b03a-88d37ca79a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_80e4598e-8639-430d-b3a4-4c53c9c6170c" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount_80e4598e-8639-430d-b3a4-4c53c9c6170c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_22ef1262-f227-4c35-8f90-d361d8a79ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_82008933-ec0d-47b8-bd80-902a02c8254b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_22ef1262-f227-4c35-8f90-d361d8a79ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansFairValueDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_565df269-6562-4e55-b406-7e390923df40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_565df269-6562-4e55-b406-7e390923df40" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:href="ctlt-20210630.xsd#ctlt_DefinedBenefitPlanOtherAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsAxis_b5c128ba-b28a-4757-aa22-8e6e1f0ba051" xlink:to="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_b4d15c5b-cf99-4f62-b887-473d38785bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_DefinedBenefitPlanOtherAssetsDomain_acc48e54-b72d-4196-a131-a268ed68db83" xlink:to="loc_us-gaap_HedgeFundsMember_b4d15c5b-cf99-4f62-b887-473d38785bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57d8b727-c4c3-47cd-9155-0eb6cc966ae7" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_017ef5e5-afa4-4d39-a140-451471a30b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_EquitySecuritiesMember_017ef5e5-afa4-4d39-a140-451471a30b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_6d0b7cb7-30b3-4548-b27d-18c6097501c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_DebtSecuritiesMember_6d0b7cb7-30b3-4548-b27d-18c6097501c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateMember_ae83c9a4-bdc0-404a-89f9-4fa3ea08d846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_RealEstateMember_ae83c9a4-bdc0-404a-89f9-4fa3ea08d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_17e5fd0a-54b4-4d46-badd-4e5f30760eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_OtherAssetsMember_17e5fd0a-54b4-4d46-badd-4e5f30760eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_431d522c-725b-488e-8246-d2b389375720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_dd736b21-98fa-4513-bae4-32120693a246" xlink:to="loc_us-gaap_HedgeFundsMember_431d522c-725b-488e-8246-d2b389375720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec882a2-5af1-46d9-989d-1c6ae8dbcd10" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9371d007-033d-4f77-be60-08a4a8a75c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9371d007-033d-4f77-be60-08a4a8a75c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2d0ad42a-954e-4c28-8442-8c1d22aa24d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2d0ad42a-954e-4c28-8442-8c1d22aa24d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e368f3c4-d06c-43c7-8c16-ff711bc93986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e368f3c4-d06c-43c7-8c16-ff711bc93986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_e26b0ae0-7e59-4122-b8f3-c3d01c8d161c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cc9e3743-bd94-44f4-aef4-ccfe62c10ae1" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_e26b0ae0-7e59-4122-b8f3-c3d01c8d161c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_02654272-c564-4323-8c7d-57f02024d072" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4914dbd8-99ec-4d72-94e1-b930e6d0b39e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_572cce32-4f18-4d78-8d84-e7966ece7243" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4914dbd8-99ec-4d72-94e1-b930e6d0b39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansLevel3Details"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ae08848e-957d-416e-a52e-b096765b84a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ae08848e-957d-416e-a52e-b096765b84a4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_10fec4db-2abc-4ad7-b8aa-319f90346ec9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_58ee9e36-549a-45cd-8304-6404c6a87a98" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:to="loc_ctlt_InsuranceContractsMember_58ee9e36-549a-45cd-8304-6404c6a87a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherUnobservableAssetsMember_9c320499-36f5-4662-be55-07a18f57b959" xlink:href="ctlt-20210630.xsd#ctlt_OtherUnobservableAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27e300e9-f98f-452c-a141-849f4c552100" xlink:to="loc_ctlt_OtherUnobservableAssetsMember_9c320499-36f5-4662-be55-07a18f57b959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3be2c12a-77cc-4c63-a0b7-123f4570415f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bd6e9a10-5c16-4154-9682-867be258da89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_675bf6e5-5dd8-4786-9179-e7c5b99f2884" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bd6e9a10-5c16-4154-9682-867be258da89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_7cb21e1b-e1c2-4bc3-a36d-5ab7755a6637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_681090d0-4dc8-4c68-b1ab-b8f53f334015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_InsuranceContractsMember_bbe74416-4053-4330-8db8-32bfffafefbc" xlink:href="ctlt-20210630.xsd#ctlt_InsuranceContractsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherUnobservableAssetsMember_a09e2c03-2fc7-4553-80e0-5a17ce16cea3" xlink:href="ctlt-20210630.xsd#ctlt_OtherUnobservableAssetsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_53cc3020-a798-40c2-995f-2facdaf40743" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18cc8fda-03a6-4b9b-85fd-9d7dd3fa0494" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_fbfb8821-e100-4cb1-8dd5-fe6b1c2caf45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_fbfb8821-e100-4cb1-8dd5-fe6b1c2caf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_324f4377-ecae-4580-baf6-dd68c6be52c7" xlink:href="ctlt-20210630.xsd#ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate_324f4377-ecae-4580-baf6-dd68c6be52c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c0da381b-daba-4e96-ad4e-e88057e5acb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c0da381b-daba-4e96-ad4e-e88057e5acb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_a4ab3f23-5002-4cd7-9187-8b93e4417bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_a4ab3f23-5002-4cd7-9187-8b93e4417bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9d6c029-0a3c-48fd-90c4-2e0211ae51a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9d6c029-0a3c-48fd-90c4-2e0211ae51a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b7e3f403-9029-4c4d-872b-9fac95312762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_64bd94f2-56ab-4a06-abf5-4602379fdcfe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b7e3f403-9029-4c4d-872b-9fac95312762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_824247d9-221c-4303-a7de-9c521332f1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_824247d9-221c-4303-a7de-9c521332f1f5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:to="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:href="ctlt-20210630.xsd#ctlt_PostretirementBenefitsByAgeGroupDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupAxis_e725cbbb-dc00-4223-9165-253ae7190020" xlink:to="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_Post65Member_0f767a4a-784e-4211-a938-e5d523a48d9f" xlink:href="ctlt-20210630.xsd#ctlt_Post65Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_PostretirementBenefitsByAgeGroupDomain_7536b019-fce0-4b52-b71e-d897fe126c22" xlink:to="loc_ctlt_Post65Member_0f767a4a-784e-4211-a938-e5d523a48d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_78ac9154-adc6-48e9-86c9-45bbf737fd30" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d2a2571-30b3-4b8f-8417-a44915847692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_86db592d-6b8f-4fd7-b0f6-69d6191433dc" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_3d2a2571-30b3-4b8f-8417-a44915847692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ee4c43b4-c53a-4c2e-907d-882cf6db590f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_1756dc5a-605c-43f9-8439-ba373198bac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_1756dc5a-605c-43f9-8439-ba373198bac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_e272b3b6-f9db-4a32-8335-32de7c13f43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_e272b3b6-f9db-4a32-8335-32de7c13f43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_23158f52-271b-4f85-b7ed-a5b2f7f5d151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract_da61850c-73f8-4b2b-aaa0-9b590a17b1c4" xlink:to="loc_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_23158f52-271b-4f85-b7ed-a5b2f7f5d151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_d18ce6c5-a4c6-4d66-81dd-8cfd2c2ab449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_d18ce6c5-a4c6-4d66-81dd-8cfd2c2ab449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_f45fbbad-d865-4e6a-94ab-8dc226d4cd3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents_f45fbbad-d865-4e6a-94ab-8dc226d4cd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_2fbba757-ecba-4076-807b-7f78113e7681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1_2fbba757-ecba-4076-807b-7f78113e7681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_b5551587-9324-432f-9316-09c7ccc51fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract_f29f1103-1bfb-430c-b752-d252d0edb094" xlink:to="loc_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1_b5551587-9324-432f-9316-09c7ccc51fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d6749d74-1549-4a08-9419-55ec31850073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_d6749d74-1549-4a08-9419-55ec31850073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e22897e6-f5fa-41db-86c3-2e35d5384701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e22897e6-f5fa-41db-86c3-2e35d5384701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2a50f2fd-e13a-41ef-8491-f782566fbe46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_aa184bb1-6bd5-40c9-b5b7-0c5a205df73f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2a50f2fd-e13a-41ef-8491-f782566fbe46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_19b9c195-886d-417a-bcc2-234c8bf815ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f9c3af70-8764-4846-b346-4e2b96bb4380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19b9c195-886d-417a-bcc2-234c8bf815ba" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f9c3af70-8764-4846-b346-4e2b96bb4380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b258dbcb-8825-47a9-9757-1542b3832aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock_c216c670-28ff-4b64-abc7-ec23c00aac39" xlink:href="ctlt-20210630.xsd#ctlt_EquityandAccumulatedOtherComprehensiveIncomeDisclosureTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_18f894b9-26d1-4e2f-9049-a5ae0ad63073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4931ece5-0485-44f8-ba41-bb5c025386de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7ed2b6b0-1ee9-455a-9573-f28158511a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4931ece5-0485-44f8-ba41-bb5c025386de" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7ed2b6b0-1ee9-455a-9573-f28158511a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7c29ee95-506f-4389-8936-7363751834fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4931ece5-0485-44f8-ba41-bb5c025386de" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7c29ee95-506f-4389-8936-7363751834fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_587dd808-c81f-41e9-a8d6-b0fa28aaaad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_587dd808-c81f-41e9-a8d6-b0fa28aaaad8" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:to="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_58a1cf66-5cf2-41ef-97ac-9de4cfdd676f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DesignatedSharesMember_2a86cf78-94ee-423c-ab82-8b7e56e309cc" xlink:href="ctlt-20210630.xsd#ctlt_DesignatedSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1e501857-d9f4-4d14-8381-9581829e0e22" xlink:to="loc_ctlt_DesignatedSharesMember_2a86cf78-94ee-423c-ab82-8b7e56e309cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee400f98-a86a-4c78-9a66-6dda7257cedd" xlink:to="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_688733ac-4dd4-4f8f-8926-45f13c137dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee1e7fb4-0fa2-4fda-bf52-8f024519ee9f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_688733ac-4dd4-4f8f-8926-45f13c137dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable_6cb9c2e8-b8d8-496c-98e4-6973a3d0d468" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f69d41fa-721c-4847-91d2-1dfc61a61a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f69d41fa-721c-4847-91d2-1dfc61a61a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16fb5ea-2cc0-4157-9253-d8c690335e93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16fb5ea-2cc0-4157-9253-d8c690335e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2f5aef3c-c71e-4fc5-a580-6cc84202c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2f5aef3c-c71e-4fc5-a580-6cc84202c9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValue_e439afed-c347-4327-87a6-9ca69071b648" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_PreferredStockIssuanceValue_e439afed-c347-4327-87a6-9ca69071b648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9a5daac7-6284-4544-8241-52bb82281697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockValue_9a5daac7-6284-4544-8241-52bb82281697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValueNet_862226ca-e3a8-472c-886f-0e1a6c31ba55" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValueNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_PreferredStockIssuanceValueNet_862226ca-e3a8-472c-886f-0e1a6c31ba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_607aa8f5-1569-4fd1-afd8-45db81e7d400" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_607aa8f5-1569-4fd1-afd8-45db81e7d400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_3c1d13cc-02ad-4fc6-b7df-4d3df3ca5f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_3c1d13cc-02ad-4fc6-b7df-4d3df3ca5f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_e3b67b78-4c21-4d3b-b5a1-e9b2aa967fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_DividendsPreferredStockStock_e3b67b78-4c21-4d3b-b5a1-e9b2aa967fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_ccd3c30e-f89e-4b44-b3b6-e66540b3c0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_ccd3c30e-f89e-4b44-b3b6-e66540b3c0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e202c3b8-6127-48a9-a832-d8dd9df66431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e202c3b8-6127-48a9-a832-d8dd9df66431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_a54b145b-8de6-4557-a0e0-5fd2790a0e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_a54b145b-8de6-4557-a0e0-5fd2790a0e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3442ac59-a090-4105-abdb-fec0b912fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3442ac59-a090-4105-abdb-fec0b912fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_e6d974c3-b485-4441-831e-ce701522841c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems_b8a84c54-91d5-46aa-91b9-f4625a8dfe08" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements_e6d974c3-b485-4441-831e-ce701522841c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_26410d0e-710e-4517-9dc0-764e230a981c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_26410d0e-710e-4517-9dc0-764e230a981c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0cdf758b-e540-4724-a7ac-0711fa99fcf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0cdf758b-e540-4724-a7ac-0711fa99fcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a381eb5b-cf8e-4034-8cd9-8fd0d4d7343e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a381eb5b-cf8e-4034-8cd9-8fd0d4d7343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e5aeb078-c904-4c36-91d7-30dcc809bbb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e5aeb078-c904-4c36-91d7-30dcc809bbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b0128a22-ec67-400e-ae1d-a629fa2148f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b0128a22-ec67-400e-ae1d-a629fa2148f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_023c45ff-9666-479d-be66-c0604ce13306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_023c45ff-9666-479d-be66-c0604ce13306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_0b49f3ca-e238-4238-9f7c-1b08522abbe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_0b49f3ca-e238-4238-9f7c-1b08522abbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3c33eced-f5c6-4dfe-a2e5-9dc7372e69d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_3c33eced-f5c6-4dfe-a2e5-9dc7372e69d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues_20502bd1-153b-4e36-9e86-cdd0ba264ed7" xlink:href="ctlt-20210630.xsd#ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues_20502bd1-153b-4e36-9e86-cdd0ba264ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption_16bdf3a6-caa9-4923-89fc-ce1972b142eb" xlink:href="ctlt-20210630.xsd#ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption_16bdf3a6-caa9-4923-89fc-ce1972b142eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption_f159861d-e902-4f09-966d-f01c90dd87f5" xlink:href="ctlt-20210630.xsd#ctlt_StockIssuedDuringPeriodValueOverAllotmentOption"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1e3740c4-cbe8-4e3a-b5d5-588502f7dda4" xlink:to="loc_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption_f159861d-e902-4f09-966d-f01c90dd87f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_42c00d9f-09f1-40e7-a69b-ca13739ec94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_42c00d9f-09f1-40e7-a69b-ca13739ec94d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e404bb06-5664-4e85-aa41-66755aa6eb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e4693a40-4287-421d-b9b3-dc449fdd98ac" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e404bb06-5664-4e85-aa41-66755aa6eb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6195bfad-b4a3-4e7e-aaba-319461b127c8" xlink:to="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_824234a7-d9bb-4d05-9ff8-06a6f8262a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_824234a7-d9bb-4d05-9ff8-06a6f8262a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_461a8b4a-31d3-4767-99a8-e8d9f60ac6e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_461a8b4a-31d3-4767-99a8-e8d9f60ac6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccumulatedDeferredCompensationMember_ccfd3f0a-591a-4ece-a482-a275c73b5dfb" xlink:href="ctlt-20210630.xsd#ctlt_AccumulatedDeferredCompensationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_ctlt_AccumulatedDeferredCompensationMember_ccfd3f0a-591a-4ece-a482-a275c73b5dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_51816e97-a0e4-47ed-b8af-fb4c1a7d7306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_51816e97-a0e4-47ed-b8af-fb4c1a7d7306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_81d3c0ff-138b-4e8e-8c56-1d2a52a4580e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_81d3c0ff-138b-4e8e-8c56-1d2a52a4580e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_b0c626f0-9873-4a50-8398-f4cbee8926b5" xlink:href="ctlt-20210630.xsd#ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember_b0c626f0-9873-4a50-8398-f4cbee8926b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_120772c9-3a9a-47df-a0cc-2a9faa48ea2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70e56c2b-4b72-4a5f-85ce-21167937a778" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_120772c9-3a9a-47df-a0cc-2a9faa48ea2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_bcefe943-c107-4753-98fe-c1c757d6e9fd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ac31b6d6-0697-4a95-9953-cee9340850f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ac31b6d6-0697-4a95-9953-cee9340850f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ccff3b2f-0d9c-43f6-a414-84ff80ba77e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ccff3b2f-0d9c-43f6-a414-84ff80ba77e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba9c169c-efff-4679-b483-172768d4a415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba9c169c-efff-4679-b483-172768d4a415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76a6754a-a76b-48ed-a1f7-e73f9638950a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_76a6754a-a76b-48ed-a1f7-e73f9638950a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4f681b35-b555-4214-82a1-4581a10ae54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4f681b35-b555-4214-82a1-4581a10ae54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2cddc10f-d8b5-447d-951c-431ddbd3ff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2cddc10f-d8b5-447d-951c-431ddbd3ff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3a11ba15-c7cc-4286-8951-30509079a910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d12defd8-f9c8-4a9c-8020-ed586f6695ea" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3a11ba15-c7cc-4286-8951-30509079a910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_818af392-8384-441e-b402-1d9675a596e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_818af392-8384-441e-b402-1d9675a596e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_dc52caae-1871-4191-8c28-a7a3bc13cd22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_dc52caae-1871-4191-8c28-a7a3bc13cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_7d69393e-1588-416b-a718-16a10993528b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_7d69393e-1588-416b-a718-16a10993528b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_a4c2c908-f0cc-4e76-97a2-ab91503e3d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_a4c2c908-f0cc-4e76-97a2-ab91503e3d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_72354b84-a9d3-4f08-9c9c-c2f4438e2517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_72354b84-a9d3-4f08-9c9c-c2f4438e2517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_dcde3220-8364-4c39-989b-c8e1616b87bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_dcde3220-8364-4c39-989b-c8e1616b87bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax_a0fac358-f443-451f-9e4c-104eed9fc5e5" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax_a0fac358-f443-451f-9e4c-104eed9fc5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax_62e0256d-0bc5-4a2a-a2b9-7c5bdd329e80" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax_62e0256d-0bc5-4a2a-a2b9-7c5bdd329e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax_04a4b923-8807-4193-825a-ac531d17e5ab" xlink:href="ctlt-20210630.xsd#ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax_04a4b923-8807-4193-825a-ac531d17e5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_719ebe58-ff30-4647-8c2e-d080d67568c8" xlink:href="ctlt-20210630.xsd#ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax_719ebe58-ff30-4647-8c2e-d080d67568c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a6f516bf-d0ca-4f98-b51d-46acd9c07bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_a6f516bf-d0ca-4f98-b51d-46acd9c07bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2bd2dff1-c67d-48db-a55d-2babcc1333f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2bd2dff1-c67d-48db-a55d-2babcc1333f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_9f76e8ca-0c1d-40f1-aaa2-4ab2133b8fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax_9f76e8ca-0c1d-40f1-aaa2-4ab2133b8fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c6b2e1cc-6158-46f7-b194-e18d59e8e7d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c6b2e1cc-6158-46f7-b194-e18d59e8e7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7c11aee5-7d96-4213-b0de-bf87f50073e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7c11aee5-7d96-4213-b0de-bf87f50073e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3eed2270-971d-428e-83a5-5b9b954f3a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3eed2270-971d-428e-83a5-5b9b954f3a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_8a82810c-d854-42cd-a5c9-69c68f503987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_8a82810c-d854-42cd-a5c9-69c68f503987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6e254830-66bf-4bc9-b7ce-16909e33d69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6e254830-66bf-4bc9-b7ce-16909e33d69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_84f035eb-852d-411f-9d40-96456dc89052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_84f035eb-852d-411f-9d40-96456dc89052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_900170a5-2bdc-488a-8fb4-1cffbf1f10cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_900170a5-2bdc-488a-8fb4-1cffbf1f10cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c48de261-4a36-4eb4-84a2-2a524676153d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a7fe7b0e-d4ac-49ae-a997-ac52dddb0dfa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c48de261-4a36-4eb4-84a2-2a524676153d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/RedeemablePreferredStockSeriesAPreferred" xlink:type="simple" xlink:href="ctlt-20210630.xsd#RedeemablePreferredStockSeriesAPreferred"/>
  <link:presentationLink xlink:role="http://catalent.com/role/RedeemablePreferredStockSeriesAPreferred" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1a7929e3-24a2-4d3d-8125-d8ed2b399268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_2811946c-3bd1-4375-95e3-570d93d22160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1a7929e3-24a2-4d3d-8125-d8ed2b399268" xlink:to="loc_us-gaap_PreferredStockTextBlock_2811946c-3bd1-4375-95e3-570d93d22160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1883f101-d607-4be9-bf90-826a629a1326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_beb74738-374d-4066-a060-0ecb0e67801c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfRedeemablePreferredStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_beb74738-374d-4066-a060-0ecb0e67801c" xlink:to="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:to="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_41a1e5ec-63f4-4127-9ae3-fa5d8c520fa7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_6a30ca46-2bbe-4966-81f1-b61e613c362a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_6a30ca46-2bbe-4966-81f1-b61e613c362a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_DesignatedSharesMember_68d8307c-db61-40ab-a270-c19e29602327" xlink:href="ctlt-20210630.xsd#ctlt_DesignatedSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1762ab77-2af6-4394-8d99-436cd2c5ca66" xlink:to="loc_ctlt_DesignatedSharesMember_68d8307c-db61-40ab-a270-c19e29602327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:href="ctlt-20210630.xsd#ctlt_RedeemablePreferredStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_ScheduleOfRedeemablePreferredStockTable_21847436-f5c9-456f-b49c-6cfd7e73ad4e" xlink:to="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_78fd2ef6-5bc4-4710-a56f-f2ad8a130403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_78fd2ef6-5bc4-4710-a56f-f2ad8a130403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aeabcda8-96d0-4018-842e-bc6eef1df733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aeabcda8-96d0-4018-842e-bc6eef1df733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_04795453-54ae-4501-98e6-ecc351190c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_04795453-54ae-4501-98e6-ecc351190c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValue_a097c380-4356-4036-b276-ed7e92926a12" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_PreferredStockIssuanceValue_a097c380-4356-4036-b276-ed7e92926a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b7419db1-3d91-4464-8b9a-5c0316165351" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockValue_b7419db1-3d91-4464-8b9a-5c0316165351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_428f60c3-500a-4d91-a369-c7d3eafe5d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_428f60c3-500a-4d91-a369-c7d3eafe5d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_05400bf6-f1c7-4408-9918-86d867742e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_05400bf6-f1c7-4408-9918-86d867742e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PreferredStockIssuanceValueNet_b96cf0c8-2067-498b-b773-cd28a2cb209a" xlink:href="ctlt-20210630.xsd#ctlt_PreferredStockIssuanceValueNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_PreferredStockIssuanceValueNet_b96cf0c8-2067-498b-b773-cd28a2cb209a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ecef3217-02bf-42b7-af64-c9372eea4e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_506998b7-2e61-41d3-9348-e3b44f744a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_506998b7-2e61-41d3-9348-e3b44f744a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_a1473d10-4797-4750-a52d-135b922948cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_466650db-10a4-49eb-b4b6-11ce24962fc0" xlink:href="ctlt-20210630.xsd#ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability_466650db-10a4-49eb-b4b6-11ce24962fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_33dd3f46-0c85-4773-9fef-424ad5564c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_RedeemablePreferredStockLineItems_a7ca229a-5681-4569-9d15-ad681dff86c0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_33dd3f46-0c85-4773-9fef-424ad5564c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensation" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensation"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f861f23e-d0cb-44c3-8af0-6732079280b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5caeb498-f681-4e69-86fd-09ecc263c93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f861f23e-d0cb-44c3-8af0-6732079280b7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5caeb498-f681-4e69-86fd-09ecc263c93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_f20a2270-ed89-4121-8041-17bbbbac4756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f861f23e-d0cb-44c3-8af0-6732079280b7" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_f20a2270-ed89-4121-8041-17bbbbac4756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_33f06779-271e-4fe0-9867-f51493ced71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_33f06779-271e-4fe0-9867-f51493ced71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_be1b74b5-eefb-4f0c-88f4-176dd8207ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_be1b74b5-eefb-4f0c-88f4-176dd8207ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8ffc276c-e36a-4c4d-b5b9-bdbe780fc2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_8ffc276c-e36a-4c4d-b5b9-bdbe780fc2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_edd30f43-6172-449c-9e63-da435e7fa653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_edd30f43-6172-449c-9e63-da435e7fa653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_a1a5da01-d262-455c-8f8f-46e073cab623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_a1a5da01-d262-455c-8f8f-46e073cab623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_0a72508d-5af7-4407-bb12-c87a0bd7f18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_0a72508d-5af7-4407-bb12-c87a0bd7f18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_0847af2c-2560-4a66-bb93-65e1cec022c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48395231-f437-4f54-ad75-ac4ca76cfc13" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_0847af2c-2560-4a66-bb93-65e1cec022c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationAdditionalDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationAdditionalDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityBasedCompensationAdditionalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67610cf1-1870-404f-bd98-16fe17712202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67610cf1-1870-404f-bd98-16fe17712202" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3a79cd54-3a8f-408f-9f86-91f7fb71e22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_77e5bd8b-18f6-40dd-8ef0-2eb3b75a3c14" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3a79cd54-3a8f-408f-9f86-91f7fb71e22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5ed2e5e7-4c5f-4427-9448-41ee24dcac72" xlink:to="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockCompensationPlanOmnibusMember_37c81daf-5234-4d9b-8553-0e7bed933309" xlink:href="ctlt-20210630.xsd#ctlt_StockCompensationPlanOmnibusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_acf2a1a3-c287-4386-99d4-f89b5398b4e5" xlink:to="loc_ctlt_StockCompensationPlanOmnibusMember_37c81daf-5234-4d9b-8553-0e7bed933309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_573a72cc-4578-4c54-9cbc-c6e2b8b3be03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_3192a511-3189-4816-8f02-ff75c01e5191" xlink:to="loc_us-gaap_AwardDateDomain_573a72cc-4578-4c54-9cbc-c6e2b8b3be03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d1e9c057-4a01-428a-8363-23d14badc2c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_30868b33-79e8-46b3-ad72-26f7c6ba42e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_30868b33-79e8-46b3-ad72-26f7c6ba42e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9485254d-8ca0-460c-aac7-2f744595af40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9485254d-8ca0-460c-aac7-2f744595af40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_94dd8d50-e6c1-4372-ac6f-5e2b9ca78087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58787073-c9ac-4557-a193-fbf915c62806" xlink:to="loc_us-gaap_PerformanceSharesMember_94dd8d50-e6c1-4372-ac6f-5e2b9ca78087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe103111-541b-493f-b7f8-bd0e588c1a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_40a3e642-775b-4ac1-869a-2c49440cd4e1" xlink:to="loc_us-gaap_ClassOfStockDomain_fe103111-541b-493f-b7f8-bd0e588c1a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3060130c-503f-4d82-b568-4d02e5eb8560" xlink:to="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66d8509a-9c82-4679-90ac-5d6da0a88b4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:to="loc_srt_MinimumMember_66d8509a-9c82-4679-90ac-5d6da0a88b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf4dba16-9db5-4da1-9ed8-f9874830e273" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7f77a0e9-3e4d-4853-8456-1ac3899396f0" xlink:to="loc_srt_MaximumMember_cf4dba16-9db5-4da1-9ed8-f9874830e273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_934fcf01-9623-4654-a6d4-ea1db8f2ec08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_c0f5c5a0-963a-479c-9c33-aa279e03f894" xlink:to="loc_us-gaap_VestingDomain_934fcf01-9623-4654-a6d4-ea1db8f2ec08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_05ed7e19-a588-46f5-95c7-77cbef753786" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_157e40e9-76f6-4c25-889e-896c4a51de04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_157e40e9-76f6-4c25-889e-896c4a51de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_c8d3aa53-a6c5-4872-95f2-ba6793e47def" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_c8d3aa53-a6c5-4872-95f2-ba6793e47def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_534917de-668c-4379-86a5-e0b9c8bf5596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_534917de-668c-4379-86a5-e0b9c8bf5596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_e3a44db2-0621-4ca3-b6d8-2e022574fe3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_e3a44db2-0621-4ca3-b6d8-2e022574fe3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0d5518f0-70b8-4fe1-80c6-f72e58733472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0d5518f0-70b8-4fe1-80c6-f72e58733472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_727cd62e-078e-46d6-a6cc-d799871ccaba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_727cd62e-078e-46d6-a6cc-d799871ccaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_9267b919-a94f-4ef8-8015-f4a15df2a532" xlink:href="ctlt-20210630.xsd#ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_9267b919-a94f-4ef8-8015-f4a15df2a532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fc7d9c59-af63-49f1-a625-eacfa2ac04f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fc7d9c59-af63-49f1-a625-eacfa2ac04f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_StockOptionGrantedContractualTerm_c7911c7b-2488-4160-803c-31a1197c8c02" xlink:href="ctlt-20210630.xsd#ctlt_StockOptionGrantedContractualTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_StockOptionGrantedContractualTerm_c7911c7b-2488-4160-803c-31a1197c8c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_53030ef0-a994-4a2f-8c29-6f66bababa7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_53030ef0-a994-4a2f-8c29-6f66bababa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6d05ce0e-3955-4a55-990d-f4e5c3f63fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6d05ce0e-3955-4a55-990d-f4e5c3f63fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220c18c5-0fbb-46c7-83ea-b32e088fe188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_220c18c5-0fbb-46c7-83ea-b32e088fe188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_68c8e32a-132f-4f23-b2da-70b7b8494888" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare_68c8e32a-132f-4f23-b2da-70b7b8494888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_84e88858-e967-4c3a-8912-189d8860aa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_84e88858-e967-4c3a-8912-189d8860aa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_924bb881-61ec-4d61-8a9d-6bcf534858bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a815531-08de-4f5e-a5c7-5c455901316e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_924bb881-61ec-4d61-8a9d-6bcf534858bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationOptionActivityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityBasedCompensationOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c787c098-c14d-4c72-b474-ea8cfc1f2270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c787c098-c14d-4c72-b474-ea8cfc1f2270" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_76ff03e4-7f39-47bc-9e18-f81533a141fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6b9ae2f1-d313-4bad-b50c-9ad7b986a94d" xlink:to="loc_us-gaap_PlanNameDomain_76ff03e4-7f39-47bc-9e18-f81533a141fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_037c4600-a969-43e3-b83d-b8d9c2992db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_dbba0cfc-99ba-4bfd-ae48-617e2d040fd1" xlink:to="loc_us-gaap_AwardDateDomain_037c4600-a969-43e3-b83d-b8d9c2992db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b8fa3f2d-4b00-40ee-8463-f3db3d7898db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0847ad12-a514-49cb-a551-6ff5289d110d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0847ad12-a514-49cb-a551-6ff5289d110d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeMember_5a06581d-d4bd-40ed-b040-c7cacad3d9af" xlink:href="ctlt-20210630.xsd#ctlt_TimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_TimeMember_5a06581d-d4bd-40ed-b040-c7cacad3d9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PerformanceMember_dfc838b8-5636-4375-b73e-c6305c86e603" xlink:href="ctlt-20210630.xsd#ctlt_PerformanceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_PerformanceMember_dfc838b8-5636-4375-b73e-c6305c86e603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_MarketMember_17505994-67d9-46a6-b14f-3bd48ed4692b" xlink:href="ctlt-20210630.xsd#ctlt_MarketMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_MarketMember_17505994-67d9-46a6-b14f-3bd48ed4692b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_b00fb991-d11c-447e-b1de-1dd467c8d04c" xlink:href="ctlt-20210630.xsd#ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43cd07e1-8b6b-4af3-bd18-31aff0fcfdd2" xlink:to="loc_ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember_b00fb991-d11c-447e-b1de-1dd467c8d04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9a276c29-98cc-48bf-9fa5-6bc18387e1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82d3e6f4-aa8b-4dec-bca4-c6fa36aafb79" xlink:to="loc_us-gaap_ClassOfStockDomain_9a276c29-98cc-48bf-9fa5-6bc18387e1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c816960-0780-4ccc-9337-0ed6d256e546" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2853b0de-be06-41da-82ce-a4f61bb96394" xlink:to="loc_srt_RangeMember_2c816960-0780-4ccc-9337-0ed6d256e546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_8273d1fd-9364-46ee-b29d-dc84c7dc3806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_e319d33b-037c-48dc-b6ee-2d5cc4460677" xlink:to="loc_us-gaap_VestingDomain_8273d1fd-9364-46ee-b29d-dc84c7dc3806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_807b2d6b-28ce-4e9f-a921-3bc59223a63c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ParagonMember_381442a3-a0ad-4da1-9191-57a191b46845" xlink:href="ctlt-20210630.xsd#ctlt_ParagonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b63e7cec-d161-4d38-b6e1-8ad147576dca" xlink:to="loc_ctlt_ParagonMember_381442a3-a0ad-4da1-9191-57a191b46845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c267c95-164a-43e6-9b33-2837ccdfc753" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_ef34bd46-2dcf-4a58-a998-9a1c501c4ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_ef34bd46-2dcf-4a58-a998-9a1c501c4ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4607e0c4-bba2-482a-8cdc-8e8b128bdcc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4607e0c4-bba2-482a-8cdc-8e8b128bdcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_33734f4f-6de8-4326-8dc0-867d1700ae73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_33734f4f-6de8-4326-8dc0-867d1700ae73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_84d13f08-4b8c-4c3f-8779-fa1c2aa629b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_84d13f08-4b8c-4c3f-8779-fa1c2aa629b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ef40bc28-b328-4b08-a93a-1962c86095a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ef40bc28-b328-4b08-a93a-1962c86095a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7280cef6-d8a3-4639-a523-10b5f5c67bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7280cef6-d8a3-4639-a523-10b5f5c67bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_77489914-68bc-4839-9b17-7af161a4d550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_77489914-68bc-4839-9b17-7af161a4d550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4fb6e978-3a72-46d9-80a8-ae70ee39b1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4fb6e978-3a72-46d9-80a8-ae70ee39b1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_07850019-b99b-4787-805b-ca6181c80753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_07850019-b99b-4787-805b-ca6181c80753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4005ba8e-34a1-4b0c-bb98-d76fb2345efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4005ba8e-34a1-4b0c-bb98-d76fb2345efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b29d5348-fddb-4335-8edb-cae4c4270ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b29d5348-fddb-4335-8edb-cae4c4270ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0b809269-df9f-49ed-ba2e-2d99c850abe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0b809269-df9f-49ed-ba2e-2d99c850abe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d51e8a4-30d5-43d4-8913-e4f401e38fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d51e8a4-30d5-43d4-8913-e4f401e38fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_033f2426-483d-4068-a492-ee2336c6e318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_033f2426-483d-4068-a492-ee2336c6e318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_627b3a3d-2385-4b98-a9ba-33f14bf5e43f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_627b3a3d-2385-4b98-a9ba-33f14bf5e43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_019e7f42-d146-4a4c-b3a8-59d04c8f05ef" xlink:href="ctlt-20210630.xsd#ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration_019e7f42-d146-4a4c-b3a8-59d04c8f05ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_79ef5c4b-1e2f-45d6-9344-36b0ae2db566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_79ef5c4b-1e2f-45d6-9344-36b0ae2db566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_14e76f13-d999-47f4-aff5-508755c7e5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_14e76f13-d999-47f4-aff5-508755c7e5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dda8dbbb-c2ee-4b9c-a465-4013158358a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dda8dbbb-c2ee-4b9c-a465-4013158358a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b0586ae7-639b-46f2-8813-430b8a055970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b0586ae7-639b-46f2-8813-430b8a055970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_f0550dba-5004-45bc-97d4-0e5c617ab559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_f0550dba-5004-45bc-97d4-0e5c617ab559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_470f54e0-c854-4b3d-8918-23c09adde20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_470f54e0-c854-4b3d-8918-23c09adde20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_29311961-66e4-445b-b293-dc1a679b0926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_29311961-66e4-445b-b293-dc1a679b0926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e44d846f-6e20-42d1-a098-173327a1d470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e44d846f-6e20-42d1-a098-173327a1d470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3eff0a83-77d3-4554-8e7f-e2137ae2107b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_267de292-78e4-4100-b994-9c5da564d5c5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3eff0a83-77d3-4554-8e7f-e2137ae2107b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/EquityBasedCompensationRSUActivityDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#EquityBasedCompensationRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/EquityBasedCompensationRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4771a02-6027-4e32-9d27-7f8f022d70fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4771a02-6027-4e32-9d27-7f8f022d70fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f9d78240-a18b-455e-ad0b-16ff5d2748af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ebe612dd-91bd-4ad5-8562-00e44cf0b0d8" xlink:to="loc_us-gaap_PlanNameDomain_f9d78240-a18b-455e-ad0b-16ff5d2748af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_d8abcc4a-4e67-4c51-bceb-4da4bfab5ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_a5dd64c4-f854-4afb-8b07-0660cdf2a9c8" xlink:to="loc_us-gaap_AwardDateDomain_d8abcc4a-4e67-4c51-bceb-4da4bfab5ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dc4d401d-2557-4cf2-8805-feab1902386e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TimeBasedRestrictedStockUnitsMember_f85717ad-0bd8-4ac4-8e85-d812718140ef" xlink:href="ctlt-20210630.xsd#ctlt_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_ctlt_TimeBasedRestrictedStockUnitsMember_f85717ad-0bd8-4ac4-8e85-d812718140ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_78c7d5d4-d947-4b97-828d-b64065c8f4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_us-gaap_PerformanceSharesMember_78c7d5d4-d947-4b97-828d-b64065c8f4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RTSRPerformanceShareUnitsMember_d23d8c36-13ec-4257-ae54-8270275149c9" xlink:href="ctlt-20210630.xsd#ctlt_RTSRPerformanceShareUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_ctlt_RTSRPerformanceShareUnitsMember_d23d8c36-13ec-4257-ae54-8270275149c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_00d5365d-794e-4860-9c95-f7d26b7ee537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_90230b88-aa33-4669-be61-752c8b047fb0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_00d5365d-794e-4860-9c95-f7d26b7ee537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_11714b93-7e7b-4e5e-8d72-5b9585bb8d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a722696-6ec2-41ff-ba3e-d45f4ece1439" xlink:to="loc_us-gaap_ClassOfStockDomain_11714b93-7e7b-4e5e-8d72-5b9585bb8d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_30424792-bd90-4b70-973c-bab90f7cdb21" xlink:to="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ebc0f9f1-dd6e-4dd6-86f1-a87c932302ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:to="loc_srt_MinimumMember_ebc0f9f1-dd6e-4dd6-86f1-a87c932302ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3e07b239-8aaa-41df-82d6-907d965707b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c4ab16d-d211-4e70-8ead-61dc958741cf" xlink:to="loc_srt_MaximumMember_3e07b239-8aaa-41df-82d6-907d965707b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_b42bb60b-632d-43c4-a84c-0f43a01203b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_1a7a0624-7a64-427a-99ea-de8f28f0fe06" xlink:to="loc_us-gaap_VestingDomain_b42bb60b-632d-43c4-a84c-0f43a01203b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad3dc00a-d686-4fd8-b593-d8204e3cdda1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8befc985-4394-4708-9c02-0aefdc9eccad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8befc985-4394-4708-9c02-0aefdc9eccad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_56bb39bf-08f7-497e-8a2a-2c7925621613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_56bb39bf-08f7-497e-8a2a-2c7925621613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c05e64e8-3170-492c-91cf-ee188e99db00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c05e64e8-3170-492c-91cf-ee188e99db00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_7180151f-b66f-447e-891d-53164a0a467a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_7180151f-b66f-447e-891d-53164a0a467a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12efa499-f610-4cac-bb7e-eb1e543b3a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_12efa499-f610-4cac-bb7e-eb1e543b3a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_918d3404-4bc3-4570-aa43-70cca6efe178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_918d3404-4bc3-4570-aa43-70cca6efe178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8ee1924c-41dc-40d2-a123-ee7e63993af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8ee1924c-41dc-40d2-a123-ee7e63993af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5a2bb52b-eace-442f-a672-1cd168b336f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5a2bb52b-eace-442f-a672-1cd168b336f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2f1cb290-a2a6-4693-9626-36c5505f6cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2f1cb290-a2a6-4693-9626-36c5505f6cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56bfca32-3f0d-4d3c-8bc6-9adb88e126f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_56bfca32-3f0d-4d3c-8bc6-9adb88e126f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_8bcac33a-dfac-49f5-a6cc-e65c71084e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_8bcac33a-dfac-49f5-a6cc-e65c71084e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_901590a0-bbe5-4de1-9e5a-56fb8abc14b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_901590a0-bbe5-4de1-9e5a-56fb8abc14b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_c61ee03f-02d8-4b71-a04e-e2d91008b094" xlink:href="ctlt-20210630.xsd#ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit_c61ee03f-02d8-4b71-a04e-e2d91008b094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c2cfb550-eb46-4923-8667-ec295d944b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b115560a-a5e9-4b5c-95bd-eb7b40b1c687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_c2cfb550-eb46-4923-8667-ec295d944b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/OtherIncomeExpense" xlink:type="simple" xlink:href="ctlt-20210630.xsd#OtherIncomeExpense"/>
  <link:presentationLink xlink:role="http://catalent.com/role/OtherIncomeExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_fb1103c7-4cc7-4502-8ac2-92fab4d6999b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_c16e7099-d049-4b8c-8a93-d304025161d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_fb1103c7-4cc7-4502-8ac2-92fab4d6999b" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_c16e7099-d049-4b8c-8a93-d304025161d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/OtherIncomeExpenseTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#OtherIncomeExpenseTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/OtherIncomeExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ac5abd2-e562-41ae-893f-7d6482d4e72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_bda28db8-e1ea-4f2e-b11c-e4b5efe1ac4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ac5abd2-e562-41ae-893f-7d6482d4e72c" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_bda28db8-e1ea-4f2e-b11c-e4b5efe1ac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/OtherIncomeExpenseDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#OtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/OtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_a8f5e199-0839-41e7-b2f6-a6644fc01b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_OtherNonoperatingExpense_a8f5e199-0839-41e7-b2f6-a6644fc01b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_e8b3064c-ca78-43c3-9bac-0ed29661f8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_e8b3064c-ca78-43c3-9bac-0ed29661f8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fd8c95ae-41bb-4147-bb41-9329ea0f5e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fd8c95ae-41bb-4147-bb41-9329ea0f5e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dc13959d-c788-4ab1-a7e3-a0c75a582718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dc13959d-c788-4ab1-a7e3-a0c75a582718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_dfc96722-2eb6-4c71-9d49-5105b6ccac33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityFee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityFee_dfc96722-2eb6-4c71-9d49-5105b6ccac33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c38cf9db-8d9f-49d5-a418-185a128eae7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c38cf9db-8d9f-49d5-a418-185a128eae7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_9fa4bfd4-bdb7-402e-9c0f-491b1b4f77a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_9fa4bfd4-bdb7-402e-9c0f-491b1b4f77a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_e7c6cea2-e711-4fa0-9b11-929a25b04917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_e7c6cea2-e711-4fa0-9b11-929a25b04917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_af87b85d-4a92-47db-917a-d55164950cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_efbd72b3-5f05-46ab-a2a6-6c9695db8549" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_af87b85d-4a92-47db-917a-d55164950cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/Leases" xlink:type="simple" xlink:href="ctlt-20210630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://catalent.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e8af7b65-ff8e-4a9b-b6fc-fbb3ca84b073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_c8127ce8-a141-4e3d-b97e-1e9a0c1bc678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e8af7b65-ff8e-4a9b-b6fc-fbb3ca84b073" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_c8127ce8-a141-4e3d-b97e-1e9a0c1bc678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LeasesTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_98dab137-322d-4037-ab07-f6761eacb957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock_75dadfa7-37fd-4965-b221-a11380b18fe8" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_98dab137-322d-4037-ab07-f6761eacb957" xlink:to="loc_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock_75dadfa7-37fd-4965-b221-a11380b18fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_9dc22390-8116-4a4e-a06a-8cc241a59a82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_98dab137-322d-4037-ab07-f6761eacb957" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_9dc22390-8116-4a4e-a06a-8cc241a59a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6dd4979c-cfc0-4ad0-861d-bfe4a0be66e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_98dab137-322d-4037-ab07-f6761eacb957" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6dd4979c-cfc0-4ad0-861d-bfe4a0be66e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock_a5a5fa3f-82ef-40b8-b2bf-73973e76cd22" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_98dab137-322d-4037-ab07-f6761eacb957" xlink:to="loc_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock_a5a5fa3f-82ef-40b8-b2bf-73973e76cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_a6f78b3f-85f9-49ad-beeb-a36af8e207e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_a6f78b3f-85f9-49ad-beeb-a36af8e207e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_96909836-3107-4fac-b665-fd37241d4c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_96909836-3107-4fac-b665-fd37241d4c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b6159b44-b1be-4633-81a4-0731e2587cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b6159b44-b1be-4633-81a4-0731e2587cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_74a67139-73de-4595-b4dd-e20c1bddc92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_74a67139-73de-4595-b4dd-e20c1bddc92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a4389d22-6003-455e-927e-ecf6acb9cb11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a4389d22-6003-455e-927e-ecf6acb9cb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b09197d-a3b7-495c-8c78-76a115da6bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAndLiabilitiesLesseeAbstract_81a9cc71-04d5-4037-a18f-cae242f6ff46" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2b09197d-a3b7-495c-8c78-76a115da6bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LeasesCostDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LeasesCostDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LeasesCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_776d3c14-8525-4974-b358-b63857ce6f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_776d3c14-8525-4974-b358-b63857ce6f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_61cca01c-a970-4042-8b7f-82ae60991a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_61cca01c-a970-4042-8b7f-82ae60991a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_FinanceLeaseExpense_ac5be927-cd2a-4e13-ab34-9778082cf589" xlink:href="ctlt-20210630.xsd#ctlt_FinanceLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_ctlt_FinanceLeaseExpense_ac5be927-cd2a-4e13-ab34-9778082cf589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_cef621b5-561a-4acc-812b-a4a3f5c3a76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_OperatingLeaseExpense_cef621b5-561a-4acc-812b-a4a3f5c3a76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_bda7f1cb-9ccb-4da5-bc13-55fe5714b118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_VariableLeaseCost_bda7f1cb-9ccb-4da5-bc13-55fe5714b118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e817b7ed-062d-4de9-b743-8358de65bfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_LeaseCost_e817b7ed-062d-4de9-b743-8358de65bfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ShortTermLeaseCosts_4c939ad4-024d-4a1d-81f9-87630b569bd8" xlink:href="ctlt-20210630.xsd#ctlt_ShortTermLeaseCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_ctlt_ShortTermLeaseCosts_4c939ad4-024d-4a1d-81f9-87630b569bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_02e81304-6a44-4bbd-80a5-74cce587401e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_02e81304-6a44-4bbd-80a5-74cce587401e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92410b02-6d5d-430d-ac2b-b58679cc0a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_92410b02-6d5d-430d-ac2b-b58679cc0a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf91c044-4aa4-414e-ae9c-549b65a5161c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_cf91c044-4aa4-414e-ae9c-549b65a5161c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3e08326d-cd49-479c-ad78-44698d2fa5a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2afeaa06-4f70-4f8d-b385-df06b0a1a7dc" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3e08326d-cd49-479c-ad78-44698d2fa5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LeasesScheduleofSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:href="ctlt-20210630.xsd#ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_eb37eb20-b32a-4115-a623-739911ebe8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_eb37eb20-b32a-4115-a623-739911ebe8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d2a80ea7-181e-49d0-9831-8f65604f05bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d2a80ea7-181e-49d0-9831-8f65604f05bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_004327e4-858b-4154-9e69-9b740bbdae9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:to="loc_us-gaap_OperatingLeasePayments_004327e4-858b-4154-9e69-9b740bbdae9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_e29fc82b-17d0-4709-a260-8651afeb5b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_e29fc82b-17d0-4709-a260-8651afeb5b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf283e87-e3d6-4b4e-bd2c-eb624abe0d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_44adaf80-b4ee-44a6-8955-d7ad1469de14" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf283e87-e3d6-4b4e-bd2c-eb624abe0d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dbb1e3fa-e114-4564-8de4-cc368d70d4a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dbb1e3fa-e114-4564-8de4-cc368d70d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_aa6f3f98-ce3b-49a7-9e8d-37588924b453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_aa6f3f98-ce3b-49a7-9e8d-37588924b453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_04a53cc3-1354-4071-b830-ba0631ee7c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_04a53cc3-1354-4071-b830-ba0631ee7c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c583b9b9-a889-405a-94f2-d013fd925ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c583b9b9-a889-405a-94f2-d013fd925ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_984df0a4-b0f8-4b36-ae7d-eb2580715b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_984df0a4-b0f8-4b36-ae7d-eb2580715b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_229694dd-41a6-4559-8719-0ab6c4a617e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_229694dd-41a6-4559-8719-0ab6c4a617e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e830a65b-e927-4878-bd46-ad6ce7fc2328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e830a65b-e927-4878-bd46-ad6ce7fc2328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_30a673e4-2e27-4fda-8723-c47f31bb4a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_30a673e4-2e27-4fda-8723-c47f31bb4a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_dc0ce575-43e8-4c8b-a22d-5b81466ccb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiability_dc0ce575-43e8-4c8b-a22d-5b81466ccb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2416dd58-24da-4997-a84a-adafeb042afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2416dd58-24da-4997-a84a-adafeb042afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9f6b1b9a-079b-422e-aad6-314faef6d5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9f6b1b9a-079b-422e-aad6-314faef6d5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07e7b244-2a30-444b-a03c-222ba6b80906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07e7b244-2a30-444b-a03c-222ba6b80906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_460bb80a-4756-49ba-930b-fdff311ad41d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_460bb80a-4756-49ba-930b-fdff311ad41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8e43916c-36ac-45d0-9090-882cd6480ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8e43916c-36ac-45d0-9090-882cd6480ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9da4c01a-6094-4c7d-9331-5d06dfd66c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9da4c01a-6094-4c7d-9331-5d06dfd66c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cda949af-f161-4cd3-83c5-32e932566e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cda949af-f161-4cd3-83c5-32e932566e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5632930b-b251-4a2c-a15c-01b78efe292c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5632930b-b251-4a2c-a15c-01b78efe292c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_debdf71a-5454-4411-8fac-496b85e73c35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_OperatingLeaseLiability_debdf71a-5454-4411-8fac-496b85e73c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearOne_67ea66de-9b2b-49f5-a492-352674e5d2e1" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearOne_67ea66de-9b2b-49f5-a492-352674e5d2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo_91591726-851c-494a-b9a9-24fbedf56b21" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo_91591726-851c-494a-b9a9-24fbedf56b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearThree_272b0a15-27bf-456b-8feb-c8e435db528a" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearThree_272b0a15-27bf-456b-8feb-c8e435db528a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFour_18d13d59-2f3b-45ac-b2e1-003c591a2acf" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFour_18d13d59-2f3b-45ac-b2e1-003c591a2acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFive_c3fa4af8-3afd-4bd2-a920-de2a1668eed2" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueYearFive_c3fa4af8-3afd-4bd2-a920-de2a1668eed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive_60c058fb-0083-4d04-ad5b-bbb3ecbd2781" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive_60c058fb-0083-4d04-ad5b-bbb3ecbd2781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityPaymentsDue_f4f53121-d680-4c65-90ac-e06eea82a0a8" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityPaymentsDue_f4f53121-d680-4c65-90ac-e06eea82a0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount_e5127be6-9405-45d9-9789-2c3cd9d5081d" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount_e5127be6-9405-45d9-9789-2c3cd9d5081d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bea85b64-a636-416a-9fb1-8f7a176212ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_57ba70be-a016-4fca-8c68-7bbfd0880795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalLeaseLiability_c3859a47-ebfc-42e0-939a-d5c150057ce3" xlink:href="ctlt-20210630.xsd#ctlt_TotalLeaseLiability"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_ctlt_TotalLeaseLiability_c3859a47-ebfc-42e0-939a-d5c150057ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_5a0e29ca-4bfd-4862-80c0-afe04e7f563e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_5a0e29ca-4bfd-4862-80c0-afe04e7f563e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1e682895-aa43-4a55-9d99-893f1dfbe245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_03472182-4042-4011-9e58-066b1a15b6fd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1e682895-aa43-4a55-9d99-893f1dfbe245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ctlt-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://catalent.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61c93e99-1bc7-415c-b5e5-8fca9a6639b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85b54c84-7aec-45a3-88af-fedbbd8df2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61c93e99-1bc7-415c-b5e5-8fca9a6639b1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_85b54c84-7aec-45a3-88af-fedbbd8df2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ffb2b3b3-9425-4b21-8e1a-607364aaa746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/CommitmentsandContingenciesFuturePaymentsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#CommitmentsandContingenciesFuturePaymentsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/CommitmentsandContingenciesFuturePaymentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://catalent.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_810235d6-b5a6-4b5f-9901-698b732d26da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/CommitmentsandContingenciesCommitmentsandContingenciesClaimsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#CommitmentsandContingenciesCommitmentsandContingenciesClaimsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/CommitmentsandContingenciesCommitmentsandContingenciesClaimsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b81c4da7-2968-4a9f-b7a4-1e5340e35930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformation" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a804a1ef-274b-4d6e-adc7-52ea5ba6f6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b2aa41a4-ff76-4d46-a79e-3c7974abf67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a804a1ef-274b-4d6e-adc7-52ea5ba6f6e5" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b2aa41a4-ff76-4d46-a79e-3c7974abf67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock_64272dc3-9511-4f2d-a7bb-811ecd76583a" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:to="loc_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock_64272dc3-9511-4f2d-a7bb-811ecd76583a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_adffcada-79eb-4b49-9624-84c7bc145b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_adffcada-79eb-4b49-9624-84c7bc145b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock_4f6b678f-d33a-4864-82c3-09d0eda5be1a" xlink:href="ctlt-20210630.xsd#ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:to="loc_ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock_4f6b678f-d33a-4864-82c3-09d0eda5be1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock_70af5d13-8e4c-490b-9689-7f6abd664946" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:to="loc_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock_70af5d13-8e4c-490b-9689-7f6abd664946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock_de9bc0ab-3c36-487c-9e1e-56ea12012b24" xlink:href="ctlt-20210630.xsd#ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ee913f6c-fbda-414e-af74-0a2ef9269207" xlink:to="loc_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock_de9bc0ab-3c36-487c-9e1e-56ea12012b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationNetRevenueandSegmentEbitdaDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a0bc5011-4a86-4005-9cb8-3401b47e30ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a0bc5011-4a86-4005-9cb8-3401b47e30ad" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_705f187a-777a-47f7-812e-b382c5a19d29" xlink:to="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_e9c58ea6-0d2d-460d-806f-b99842eef388" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_e9c58ea6-0d2d-460d-806f-b99842eef388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_ca460601-a79d-47fc-b387-9c04e458e302" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_BiologicsMember_ca460601-a79d-47fc-b387-9c04e458e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_830ae8f6-4aa8-4476-b169-06d5861c7d3b" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_830ae8f6-4aa8-4476-b169-06d5861c7d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_7cbed37f-3ca8-4af8-b203-2467049ed6fe" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_7cbed37f-3ca8-4af8-b203-2467049ed6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_cbfe4575-fab9-48e4-85f2-ecb6faad9834" xlink:href="ctlt-20210630.xsd#ctlt_TotalCatalentSubTotalOfSegmentReportingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_efcf06bd-880a-4e9d-8314-8d7940261522" xlink:to="loc_ctlt_TotalCatalentSubTotalOfSegmentReportingMember_cbfe4575-fab9-48e4-85f2-ecb6faad9834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c5b86147-e44b-4dd0-87d9-f59fc22647b1" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e8534e28-aa06-4188-a64b-c42b9519a8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_Revenues_e8534e28-aa06-4188-a64b-c42b9519a8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_02cb9e88-cfd6-40a4-80e3-b205501b2701" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_02cb9e88-cfd6-40a4-80e3-b205501b2701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_b33e8a2d-f9b1-4bc9-8fc4-3485e45ee984" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationInterSegmentRevenueElimination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationInterSegmentRevenueElimination_b33e8a2d-f9b1-4bc9-8fc4-3485e45ee984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_cd9f5cb4-8589-4aca-adaf-1a3326640031" xlink:href="ctlt-20210630.xsd#ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets_cd9f5cb4-8589-4aca-adaf-1a3326640031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0066aacb-2a65-4281-924d-0969110835fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0066aacb-2a65-4281-924d-0969110835fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestructuringAndOtherSpecialItems_cea05b2d-5bfc-414b-a31e-8fe7c92cb7ea" xlink:href="ctlt-20210630.xsd#ctlt_RestructuringAndOtherSpecialItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_RestructuringAndOtherSpecialItems_cea05b2d-5bfc-414b-a31e-8fe7c92cb7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dcf9dbe7-ace0-4cd0-a3ce-bf8f466488b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dcf9dbe7-ace0-4cd0-a3ce-bf8f466488b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_7b13767e-e29c-4d93-8a7c-f180362d5f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_7b13767e-e29c-4d93-8a7c-f180362d5f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_NonAllocatedCorporateCostsNet_a6ec3c47-2357-4176-8b3d-6b40463642cd" xlink:href="ctlt-20210630.xsd#ctlt_NonAllocatedCorporateCostsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_NonAllocatedCorporateCostsNet_a6ec3c47-2357-4176-8b3d-6b40463642cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationUnallocatedExpense_4c2434ad-fbed-4595-aa9b-9b59f9df285f" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationUnallocatedExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_951f648b-2b02-4211-aa7b-c5dedff11f35" xlink:to="loc_ctlt_SegmentReportingInformationUnallocatedExpense_4c2434ad-fbed-4595-aa9b-9b59f9df285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_03d57804-f96b-49c5-9f9b-84048a4e2af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_03d57804-f96b-49c5-9f9b-84048a4e2af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationUnallocatedExpense_c118afc1-d65a-4295-b5e1-62f8a37998f0" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationUnallocatedExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_ctlt_SegmentReportingInformationUnallocatedExpense_c118afc1-d65a-4295-b5e1-62f8a37998f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_07589a81-56c3-44cc-a55c-07b378d9b88e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_us-gaap_DepreciationAndAmortization_07589a81-56c3-44cc-a55c-07b378d9b88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_d1878320-8c65-45ad-a57d-6387a60b1d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_d1878320-8c65-45ad-a57d-6387a60b1d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_759e2454-4add-45f3-9cff-50d3534b1a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_759e2454-4add-45f3-9cff-50d3534b1a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_7ba90631-40fb-4307-82d2-d4e892594350" xlink:href="ctlt-20210630.xsd#ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7ea3ed9-4bda-4c1e-8b23-cbe530ad73a9" xlink:to="loc_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization_7ba90631-40fb-4307-82d2-d4e892594350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationTotalAssetsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationTotalAssetsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationTotalAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bad7681e-13d0-471a-ae19-15be3103b1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bad7681e-13d0-471a-ae19-15be3103b1cb" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_099ec4e3-a24f-452c-8e9d-fb8c2e585f5c" xlink:to="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_7d6e2771-d211-4f6a-a17c-8c4953068735" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_7d6e2771-d211-4f6a-a17c-8c4953068735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_74556c4c-2d9a-42c4-9995-3ded8f1bb012" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_BiologicsMember_74556c4c-2d9a-42c4-9995-3ded8f1bb012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_2b611fd6-f669-48e3-b38f-682a34b611ed" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_2b611fd6-f669-48e3-b38f-682a34b611ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_f60bf3ca-c8b0-4abd-8651-e2013c446d4b" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_f60bf3ca-c8b0-4abd-8651-e2013c446d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_CorporateAndEliminationsMember_8dd83e99-c18f-477c-8e3d-5e67592325ff" xlink:href="ctlt-20210630.xsd#ctlt_CorporateAndEliminationsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c97b92ba-c858-42e2-af8a-9b48c4a020fa" xlink:to="loc_ctlt_CorporateAndEliminationsMember_8dd83e99-c18f-477c-8e3d-5e67592325ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_ae23bae3-c65a-420d-9299-2d78675e220e" xlink:to="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c3208b2a-cfa0-4e77-b800-3fcad52ec3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_4887afb0-d880-4d92-9339-93a16595aa20" xlink:to="loc_us-gaap_Assets_c3208b2a-cfa0-4e77-b800-3fcad52ec3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationDepreciationandAmortizationDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3411b0a5-d379-4d7b-a1bf-3a20f3947e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3411b0a5-d379-4d7b-a1bf-3a20f3947e80" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_941a990c-bc8c-4696-8653-e1ee09adca7c" xlink:to="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_b99372bf-8880-45c3-9ad7-8d3163a56eb6" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_b99372bf-8880-45c3-9ad7-8d3163a56eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_141dc380-9223-468b-a24b-77e3eab42f60" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_BiologicsMember_141dc380-9223-468b-a24b-77e3eab42f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_9c9030d3-5968-4896-b5f2-44e513ef407c" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_9c9030d3-5968-4896-b5f2-44e513ef407c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_22b78ae5-4b72-4e8d-927b-02b5ef2971a9" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_22b78ae5-4b72-4e8d-927b-02b5ef2971a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_ac03b302-2607-4764-a02e-3eb14a2a575a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c111efeb-7d1f-4ea4-9265-45b2982b45a8" xlink:to="loc_us-gaap_CorporateMember_ac03b302-2607-4764-a02e-3eb14a2a575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12ede2f9-f644-4953-b7e7-0652245f3840" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_106729f2-1faf-4f8a-8e98-c5ab56aec6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_79d373a7-9433-4b48-9a46-c819c025b9bb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_106729f2-1faf-4f8a-8e98-c5ab56aec6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationCapitalExpendituresDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationCapitalExpendituresDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationCapitalExpendituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c3e6c371-a18d-4385-b6ff-5835c06af0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c3e6c371-a18d-4385-b6ff-5835c06af0cf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e119f740-6b57-4254-be5b-7b68ccffd55e" xlink:to="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SoftgelAndOralTechnologiesMember_c5676a15-b9e6-499e-a05e-cf7549f2f22d" xlink:href="ctlt-20210630.xsd#ctlt_SoftgelAndOralTechnologiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_SoftgelAndOralTechnologiesMember_c5676a15-b9e6-499e-a05e-cf7549f2f22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_BiologicsMember_8e9678e5-f8b0-4cf5-be35-2268ff3fba09" xlink:href="ctlt-20210630.xsd#ctlt_BiologicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_BiologicsMember_8e9678e5-f8b0-4cf5-be35-2268ff3fba09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OralAndSpecialtyDeliveryMember_7ab557aa-489c-42cf-8131-96d680e3ce40" xlink:href="ctlt-20210630.xsd#ctlt_OralAndSpecialtyDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_OralAndSpecialtyDeliveryMember_7ab557aa-489c-42cf-8131-96d680e3ce40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ClinicalSupplyServicesMember_cbc4d203-3f67-4738-8dcb-0c75a79b1f5b" xlink:href="ctlt-20210630.xsd#ctlt_ClinicalSupplyServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_ctlt_ClinicalSupplyServicesMember_cbc4d203-3f67-4738-8dcb-0c75a79b1f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_63a7f826-d2a1-4688-932d-659c5b561e9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0444574c-e8df-447e-b191-bb7716ebf62c" xlink:to="loc_us-gaap_CorporateMember_63a7f826-d2a1-4688-932d-659c5b561e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73985fb3-2fff-4092-b0f7-d6ca39b94b22" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6f957b84-6086-43c6-8aa9-b94e5c20ca17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5da92492-8d82-489a-9639-469a3126607d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6f957b84-6086-43c6-8aa9-b94e5c20ca17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SegmentInformationAssetsandRevenuesDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_847169cf-e18a-40bb-aede-bdb60529e79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_847169cf-e18a-40bb-aede-bdb60529e79c" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:to="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1a2ce752-88b4-42ff-b770-d8ca4b66e5cd" xlink:to="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_574a118e-433a-4cf6-b2ec-9c3e5e3ea0d4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_country_US_574a118e-433a-4cf6-b2ec-9c3e5e3ea0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b5cc3ab2-8adc-485b-946d-98d939364047" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_srt_EuropeMember_b5cc3ab2-8adc-485b-946d-98d939364047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_RestofWorldMember_6392f7f3-1387-44aa-aa21-4489fdee9e9f" xlink:href="ctlt-20210630.xsd#ctlt_RestofWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_ctlt_RestofWorldMember_6392f7f3-1387-44aa-aa21-4489fdee9e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_781e7229-dadf-4ff4-a853-f1d82f9d2578" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69130b82-58ed-4177-a451-ab855fe88e50" xlink:to="loc_srt_ConsolidationEliminationsMember_781e7229-dadf-4ff4-a853-f1d82f9d2578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_8c13893f-ac95-4a9f-8879-6dd1d2daaf57" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1ce5ec5-a159-47ff-87c1-be8c158c3a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_af5543b0-6668-4d74-b9e1-e3d07275f6bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1ce5ec5-a159-47ff-87c1-be8c158c3a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_423666b5-5fd1-4a64-9b8c-19bb1a38a1f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_c09ae884-6aa4-49e9-a247-e9491810e169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_423666b5-5fd1-4a64-9b8c-19bb1a38a1f3" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_c09ae884-6aa4-49e9-a247-e9491810e169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5491baa5-378f-47ea-b0d7-c1d347102205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5491baa5-378f-47ea-b0d7-c1d347102205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock_eb7a82f4-9a29-4491-8882-46f512425150" xlink:href="ctlt-20210630.xsd#ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock_eb7a82f4-9a29-4491-8882-46f512425150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ca826cba-0d94-4fb8-857a-46a429deec9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ca826cba-0d94-4fb8-857a-46a429deec9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_74bb0ba1-e04a-492f-a885-b005d0996c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_74bb0ba1-e04a-492f-a885-b005d0996c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_OtherAccruedLiabilitiesTableTextBlock_ba9b4f59-40c0-41ef-814b-0c6603b9d63f" xlink:href="ctlt-20210630.xsd#ctlt_OtherAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_ctlt_OtherAccruedLiabilitiesTableTextBlock_ba9b4f59-40c0-41ef-814b-0c6603b9d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock_f4fa383c-8c30-4d0b-964e-64de4cda6a97" xlink:href="ctlt-20210630.xsd#ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_994bcfe7-ee3f-41f7-b21d-0701b255e29a" xlink:to="loc_ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock_f4fa383c-8c30-4d0b-964e-64de4cda6a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_8ca88bdd-ac00-40f8-97a3-029aff67fe2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_8ca88bdd-ac00-40f8-97a3-029aff67fe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_b77306a3-106f-414d-8469-41a01914c9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:to="loc_us-gaap_InventoryWorkInProcess_b77306a3-106f-414d-8469-41a01914c9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_3be1e5e5-a753-4b76-8f20-f1d961f25772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:to="loc_us-gaap_InventoryGross_3be1e5e5-a753-4b76-8f20-f1d961f25772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_71806ab1-cbb2-41c1-807c-64f5e538179e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:to="loc_us-gaap_InventoryValuationReserves_71806ab1-cbb2-41c1-807c-64f5e538179e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_35c31f74-9d1b-43bd-9a82-55071e245323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6a14154a-e754-4fae-a30f-6f051f4b2921" xlink:to="loc_us-gaap_InventoryNet_35c31f74-9d1b-43bd-9a82-55071e245323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_591f5052-2867-4a4e-9a3c-608e3b5b5e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_591f5052-2867-4a4e-9a3c-608e3b5b5e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetPurchase_59ca2f49-2ce2-4050-b8c3-8c0d752fde0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetPurchase"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_ContractWithCustomerAssetPurchase_59ca2f49-2ce2-4050-b8c3-8c0d752fde0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_SpareParts_a53768bb-35ea-4d82-945e-078fdc029945" xlink:href="ctlt-20210630.xsd#ctlt_SpareParts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_ctlt_SpareParts_a53768bb-35ea-4d82-945e-078fdc029945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_1c2564c4-25b2-484a-8e48-be2c8d1e12aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_PrepaidTaxes_1c2564c4-25b2-484a-8e48-be2c8d1e12aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivable_2e182242-907c-4473-8a50-27e2a36a37ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValueAddedTaxReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_ValueAddedTaxReceivable_2e182242-907c-4473-8a50-27e2a36a37ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_100808ae-5105-44d9-a592-d63d062cd0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_OtherAssetsCurrent_100808ae-5105-44d9-a592-d63d062cd0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3c19196a-d82e-4811-88ba-71e5016790a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1d426fd4-6fb2-4d23-9b16-3be2628a6f4d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3c19196a-d82e-4811-88ba-71e5016790a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationPropertyandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_LandBuildingsAndImprovements_a5524222-e875-4c90-a4f1-4b99fe242e2c" xlink:href="ctlt-20210630.xsd#ctlt_LandBuildingsAndImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_ctlt_LandBuildingsAndImprovements_a5524222-e875-4c90-a4f1-4b99fe242e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_0e9aa587-3f21-4cdd-a5ae-67520bd449a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_0e9aa587-3f21-4cdd-a5ae-67520bd449a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_f8e5c28d-208a-49ba-9003-af88057d2a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_f8e5c28d-208a-49ba-9003-af88057d2a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_7399bb64-63aa-4c0f-9949-78558e4bb76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_ConstructionInProgressGross_7399bb64-63aa-4c0f-9949-78558e4bb76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3501b9ed-aea7-48a2-a5c2-ba5e72969a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3501b9ed-aea7-48a2-a5c2-ba5e72969a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_318b6224-fd15-4944-9223-28fa740f7ce5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_318b6224-fd15-4944-9223-28fa740f7ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4581b307-3dc3-4fa3-8089-cd23a64d93fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_13dad09f-ddae-4fc2-b717-4118beef8889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4581b307-3dc3-4fa3-8089-cd23a64d93fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_d3e7f950-8d2a-43fc-9efd-b24dc48a5a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_d3e7f950-8d2a-43fc-9efd-b24dc48a5a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_PensionAsset_66956f16-00ce-4727-9961-32d2096b5b7e" xlink:href="ctlt-20210630.xsd#ctlt_PensionAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_ctlt_PensionAsset_66956f16-00ce-4727-9961-32d2096b5b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ed662136-ad33-4ed1-b7e3-db48f530da66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ed662136-ad33-4ed1-b7e3-db48f530da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AlternativeInvestment_9c82f688-9697-4cab-a068-7cd8632e8b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AlternativeInvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_AlternativeInvestment_9c82f688-9697-4cab-a068-7cd8632e8b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8d5665cf-a819-4dda-882e-2395d2f07a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8d5665cf-a819-4dda-882e-2395d2f07a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_a31d90a0-d49f-45b1-a9d9-3fc1c323e3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_a31d90a0-d49f-45b1-a9d9-3fc1c323e3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0fc7daa0-085d-466c-b014-71458a313c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0fc7daa0-085d-466c-b014-71458a313c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_db807588-b393-4b4a-966c-e21c98088e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_db807588-b393-4b4a-966c-e21c98088e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount_a1203365-55a2-4f99-a962-91f14199ed9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansAndLeasesReceivableGrossCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount_a1203365-55a2-4f99-a962-91f14199ed9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_0fda3eca-b255-431b-a9d7-617604d7affb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_0fda3eca-b255-431b-a9d7-617604d7affb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_9bdcb742-b321-4840-9e86-90eefa406cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f1460be6-e33f-4716-9488-602a108c17e8" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_9bdcb742-b321-4840-9e86-90eefa406cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b1c3c328-25ec-499d-a827-a8acf1cc5798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b1c3c328-25ec-499d-a827-a8acf1cc5798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedRestructuringReserve_596236e8-4f22-40ac-a76c-5f4c11c7e391" xlink:href="ctlt-20210630.xsd#ctlt_AccruedRestructuringReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_ctlt_AccruedRestructuringReserve_596236e8-4f22-40ac-a76c-5f4c11c7e391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_90636341-ece2-4f90-a197-d26359f57241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_90636341-ece2-4f90-a197-d26359f57241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_16f1ae44-291b-4e9b-9378-a0fe65e7e4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_InterestPayableCurrent_16f1ae44-291b-4e9b-9378-a0fe65e7e4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_18c29d92-b82a-4c20-a94d-7c231f3d37fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_DeferredRevenueCurrent_18c29d92-b82a-4c20-a94d-7c231f3d37fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_b7fc36f0-4083-48f7-b03e-6196614bf7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_b7fc36f0-4083-48f7-b03e-6196614bf7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1d9fcc14-4316-4e3a-a591-5e4ac81b2278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1d9fcc14-4316-4e3a-a591-5e4ac81b2278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c8a3559d-f105-46e4-bfd4-f16ee5536676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c8a3559d-f105-46e4-bfd4-f16ee5536676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AccruedOperatingLeaseLiabilities_47d48f2f-322b-4e36-9b02-9a161a013849" xlink:href="ctlt-20210630.xsd#ctlt_AccruedOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b75298fc-cad7-49da-a4e6-8b1cbcdb4b44" xlink:to="loc_ctlt_AccruedOperatingLeaseLiabilities_47d48f2f-322b-4e36-9b02-9a161a013849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cb080321-4031-4870-99e5-a9a34b43bcea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_cb080321-4031-4870-99e5-a9a34b43bcea" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cefad510-9d6d-4e17-8883-64661ada88f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_cefad510-9d6d-4e17-8883-64661ada88f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_cd10cdbd-5246-43b0-a25a-1f2fca0af4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_cd10cdbd-5246-43b0-a25a-1f2fca0af4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet_26a7e85f-4d77-4ce5-ad74-180b21ee9711" xlink:href="ctlt-20210630.xsd#ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:to="loc_ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet_26a7e85f-4d77-4ce5-ad74-180b21ee9711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange_d565cce0-d706-4bfa-ac31-8ea83cadf85d" xlink:href="ctlt-20210630.xsd#ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:to="loc_ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange_d565cce0-d706-4bfa-ac31-8ea83cadf85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_91f41103-2f89-40e2-8492-933e9d35884a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_79c5df94-e852-454b-b270-d91ec874960e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_91f41103-2f89-40e2-8492-933e9d35884a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SubsequentEventsNotes" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SubsequentEventsNotes"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SubsequentEventsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_adc61ca0-54bc-4478-b30f-1ab99ef1b902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_318c949d-ee5b-4f1f-9a22-0dd5954a62b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_adc61ca0-54bc-4478-b30f-1ab99ef1b902" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_318c949d-ee5b-4f1f-9a22-0dd5954a62b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://catalent.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="ctlt-20210630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://catalent.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_c20ccb96-1686-4c0f-b6f5-81c42ac9983c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_c20ccb96-1686-4c0f-b6f5-81c42ac9983c" xlink:to="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3dc61630-454b-4e73-ba97-5b766acd4cd6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ctlt_ZenyattaMember_b2c31b21-9fa3-4208-bde3-2c3ba6fd0896" xlink:href="ctlt-20210630.xsd#ctlt_ZenyattaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_54284e32-3026-4c3d-9093-3e4850ef56c2" xlink:to="loc_ctlt_ZenyattaMember_b2c31b21-9fa3-4208-bde3-2c3ba6fd0896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_47675abf-e362-4c13-b44c-e2ce625a6dde" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6c59831f-e489-4c6f-aa2d-2e00cfb6d0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_648f04fd-e250-4e71-81f8-853b646a6bf7" xlink:to="loc_us-gaap_SubsequentEventMember_6c59831f-e489-4c6f-aa2d-2e00cfb6d0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d6099ae5-783c-4c37-a780-59b1092fae90" xlink:to="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_63200a93-43da-437e-8e67-29d93c0abd07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_cf464fea-f470-4918-9f22-3dbe2e145e39" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_63200a93-43da-437e-8e67-29d93c0abd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ctlt-20210630_g1.jpg
<TEXT>
begin 644 ctlt-20210630_g1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-   G(P  8<L  (?5  "PT?_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@!)@+8 P$1
M  (1 0,1 ?_$ 2\  0 " @,! 0$            ("0<*! 4& P(! 0$  P$!
M 0$!            !@<(!00# 0(0   & 0(#!@<! 0$! 0     " P0%!@$U
M!Q! "" P,Q0T-Q$Q$A,5%C87D& A)!$  @(! 00%!08/#04$"P   0(#! 41
M "$2!A Q01,446$B,G4@0E(CLQ4P0'&!8G(S=+2%E;7%AK:1H8+20U-C)#34
M-39V<X/3)1:0DZ,'8+&B1%1DA*1%9282  $" @$.# 0& @(# 0    $" P 1
M$"$Q05%A<8&1H;'!T1($($#A(C)R@K(3(S-S,%*2PO#Q0F(4)$,%D*)@XF,5
M$P$  0,# @8#  (# 0     !$0 A,1!!46%Q,/"!D:&Q($#!4/%@T>&0_]H
M# ,!  (1 Q$   &_P
M
M
M
M
M
M
M                                                           Z
M/T>:,TLB.(^WPN%_?S]_S>I)&*RS)W)[
M             '3??SU97!3-<UHU3Y[U>4 ?K\_990R;6^TC>N;X_(@    /
M%^_GQ_DL8][S>EG>.R4     #$W9XF#)%&Y-1*8>R\/O          &/^ER\
M!R2,Y;XO<S#P^\           !Y;V>*A+1V:8ZRB*?3\_911"92(B\JY_P _
MIA;O1^)4UA'0>GRW%4;?-BU7VJ    !5?<-,57W#3%LM,7;9W4EP@     :[
MNG<L8!DL8V(LPZGS]&Y.          *<+SH6NZSZKNDH;0,_*VLT
M   "C?0F<X3SZO<B\OJWE9ZT;)&+2P >4]GBJZMZFYA0>>2NALU     JON&
MF*K[AIBV6F+ML[J2X0     -=W3N6, R6,;$68=3Y^C<G          %.%YT
M+7=9]5W24-H&?E;6:           (P2Z':_VE,Q<K^/[V$LS:CD)&90
M   !5?<-,57W#3%LM,7;9W4EP@     :[NG<L8!DL8V(LPZGS]&Y.
M   *<+SH6NZSZKNDH;0,_*VLT           4RWM0-?-F5?.&OK%N_S]HD
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M2ZXVC+YUW=/98  FE K O.SUHX          :MVOL;<#Z?+8/S/J&2,5EH
M  A;/*_XG]_.8,(G?>>?TC$_9XFNOJ#*WG_3Y=C?+>KLT\&057W#3%5]PTQ;
M+3%VV=U)<($,IW .K^WQF)!IYWOG](Q7V.+KKZ?RMYOU^38NR]JO.4>D>N[I
MW+& 9+&-B+,.I\_1N3TTWK0=>MFU;8)6EH7+T3?GU_/ZZ;[^>@O2&9HV2N)7
M?9^T3.*OK%J:N>DJQ+;IX35@-@V^4C>N3^3V(Z2B*:^&F,O?'^OYV6\HZYR+
MR^K3A>="UW6?5=TE#:!GY6UF@          ?/]_-6/8.,AL39@U3GJ.24
M    :_NE,Q1AET.OXS;IJ5$/FE5]PTQ5?<-,6RTQ=MG=27"   !0%I/,<7)?
M#;^,VZ:E1#YIKNZ=RQ@&2QC8BS#J?,?#[^LCK/('S_?S9AR?KKUGC]P$,9W
M*+=#YPFA [ O0SSHZIJYZ2K$MNGIPU]8MWN?M$?I^@:W>I\G8C[?"V-\MZNS
M3P9!3A>="UW6?5=TE#:!GY6UF@          #5XUUCGIO1Y]@#->G901&8@
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MZ1S+%>8PN_C-NFI40^::[NG<L8!DL8V(LPZG\QZ_'0)I/,DEXG+M@G-.H
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MM^OQ\E[?#Z'R^OOO/Z>!]/EUWU^7H/-Z@
M
M
M
M
M
M
M
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MHK83JQQL,I"47.%-(\-VVG2*T!#TBDUB+/Q);NA2Y6A'0V1=(A ?*25SK7,
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M-MA04FY3YBP5VDU3R88\)/,W:U;OG1GAUM9 !2#B_..FC&(=4DS'-[B:)BO
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M.N4;#R2E=VI0X[;<EB'+\3=^W]E#]].GXSW7H9ZG%V_;TFA?O'NIXU_':/\
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MY_\ 0Y*FB@NV5KR"IK^&ERPIL9">2C90"57(YK+F$2SQ,LJR'-&PX"E=HU*
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M["8_8/N.@8XV=W0E(N4N]GN)H:[7?51N_;^RA^^G32O>5]% _ PPI]XS<4:
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MQHXF.\F3AK#O-3\+78/C<#AL>X.H:CBZ51@?*#! A!^C!<CCJ-\ : 7:E>T
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M18LJ5Y>ILD"P-G)&BN7<UZ L^\@J8*56HBT1 $!IM5E1.X3$,40 T\9P:=+
MY=%[H4Y5?9'Q<I@&4;_B5Q #2O17?5T*1*!3=# #EH+-F+9HFL=4/F'HC$E2
M*_ (*RZH3G1&9[*2(3^N?N6.P0.2D248UP2$\FJ!?@G*6H(] C;]&*!4 ;7
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MJ&Q6>?U"A$P((+;TBX?16 !XD7[&?"YY+%CEI^ OD,OP1+&D,??[Y].&X/\
M'JV^?+':2.19AGPF<_0F/Q^S5C8BXFD9D35W@6-%\"AP=(!4HFA1ZS(HB3!<
M.6U?21M4W6^2].5<=N/%YY97G'>!8(0 -VQLW*;0/ Q"O*\_7CP^>2Q8N%"[
M(N$D9M-U( ^8B$@="-QI9 8\!T>A4%<8XL'.09#!N?DJQ*D9N="($(')_B5;
M?/ECL^R:TY.R &@L)=*![+L(P*LC4CO!Y)(Z79A8E>J!IB'+Z4K.I_P)'[&
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M'T:,7/8">S4O>\WCV#_[+__:  P# 0 "$0,1   0
M
M
M
M
M
M
M
M                      %AZX
M       O9)*(      #      &*           ]H            L).?!@
M   )(      18          "(            !)P &<     !)      "+
M         1            !)@         )(      18          "(
M        9(    #22E8=,:!):2X"+ WV+ %87'6K!+(          '/
M!6S(Y))0Y.],818Q)H.@!'PI#))+           !(    "Y 1,!) %" ;("+
M$,XO, )^%9 1            A,        18)(    )818?8 Q !K &("(
M          Y0     1RJ+!)  Z5R+"+IS;9/ )  ) 1            #+
M  1+;18)( O.@181:/)))0!( !("(            1     [O@"+!) Z0 "+
M"+Y8    )  ) 1            &I0   Z*  18)('-  181;O(  0!( !("(
M            !*> U^9 &3+%, AH'4+"+%-X $ )  ) I@ R          &)
M\F)SCV198Q:5Q9'9818@*MA !( !($)-$Q          E))JJ!1IP.',/QA*
M?.!( ]I/K')  YP?)\@P           #"  #7    L( I      &3X
M %>#0
M
M
M
M
M
M
M                                           '_]H " $! P$_$/\
M[.L/:&YG2HA!# U/(H&%#=D"'"1-X_W11DE<))OL+%91'S,<L$D#*2+Z%AD4
MHE,,K*:)ST\8RX=9&&S#;_BA_F4Q@8:ZCRB >!V";D40+)EIY5#$V&$>"
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MS0%9 DL*#04LC17R9G"TB01$DHB4"GUL8(0H6#:DOJ+2@("OCJ-H5F85)_\
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MJ#FLA28+S@+\DI';*<;F9+U54R_@WPNP1.$2E&;0T<DC%90)-IB3 LC\.]S
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M/4K>>1)8<!8JP9CQ>%=&R2T ?"$S3J;7X$6[Z% ?*,Z4<G T)INLCP:3WLM
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M4+;#JF*00:CGF3T(CE3^6I!:-TU!K'<\$*@4 JL,F#A32$8  &I4DJ&*IZ@
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MQ'AS %' )5Z!1P33@/8-Z=[1QN2=O3,.I)Z5&#\9''/J4&=ZAI4PI^XL]<T
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MQ,FF;126N5!AI5 CAX% 5<,E#+8LD"#,B&@4%[!.O:=#>9_&&0)O?UQ'-_%
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M2 =I<(9R"5&%YO9V0D<+1(2%I3+7^#H#!90:N.N:04W<$3>;I<_JC%S-,>!
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MDGM .W4>&P+I 5!PAB.P%#,&3$9WE5'-TC(+9$ ?BG9T3:B(D)(<F$'<"*&
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M9'W7.O84N[#]WHC/1@=:DU^<+GCTJ6FT5.Q3D!]E Z!%($5,JY7PVVP'#E4
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M D20%#*""X$#D\' WD7+3R+AI\#^YLYI!(6= CSH.UE+I#CNN N(0B=**F,
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M+FD9=P$]M#'4^%V18-V2U FE$CR-2?[[4JLSV$P$JK"G?P$0H04,EB!3&$Y
MDQN$#L,8_8"@6W0<=)MQ4M#LG:(Q88O$3>9EI:4WGSD=,=*6!7>W-T"O59=W
M\G;_ )8NX(^U%GQ*8Y7-@^2A(HR*,]W>#T,RGV"4JRJM-P5&+#>;01>_?51G
M@)NX(^U'4S<CE[!=N2*.@#(H#S+I\80/$ =&=ZDYLD&>H ]0U%-V93FUY&]B
J_0XH (+!^B;%L OL$TM."^$&'!-C93LNF<GC%W!'U*=2']D7GK_]E__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ctlt-20210630_g2.jpg
<TEXT>
begin 644 ctlt-20210630_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1"<17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0>.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI;7-E+"!-
M;VYA;&D   'J'  '   (#   "&H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BK_P  1" &8 GP# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M@_[\:?\ _(M'_"+ZO_T/?B#_ +\:?_\ (M=)10!S?_"+ZO\ ]#WX@_[\:?\
M_(M'_"+ZO_T/?B#_ +\:?_\ (M=)10!S?_"+ZO\ ]#WX@_[\:?\ _(M'_"+Z
MO_T/?B#_ +\:?_\ (M=)10!S?_"+ZO\ ]#WX@_[\:?\ _(M'_"+ZO_T/?B#_
M +\:?_\ (M=)10!S?_"+ZO\ ]#WX@_[\:?\ _(M'_"+ZO_T/?B#_ +\:?_\
M(M=)10!S?_"+ZO\ ]#WX@_[\:?\ _(M'_"+ZO_T/?B#_ +\:?_\ (M=)10!S
M?_"+ZO\ ]#WX@_[\:?\ _(M'_"+ZO_T/?B#_ +\:?_\ (M=)10!S?_"+ZO\
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M_P#(M-3PIJL<:HGCKQ %48 \C3^!_P" M=-10!S?_"+ZO_T/?B#_ +\:?_\
M(M'_  B^K_\ 0]^(/^_&G_\ R+7244 <W_PB^K_]#WX@_P"_&G__ "+1_P (
MOJ__ $/?B#_OQI__ ,BUTE% '-_\(OJ__0]^(/\ OQI__P BT?\ "+ZO_P!#
MWX@_[\:?_P#(M=)10!S?_"+ZO_T/?B#_ +\:?_\ (M-3PIJL<:HGCKQ %48
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M4 <W_P (OJ__ $/?B#_OQI__ ,BTU/"FJQQJB>.O$ 51@#R-/X'_ ("UTU%
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M#G_DEGA3_L#6?_HA*Z2N;^'/_)+/"G_8&L__ $0E=)0 4444 %%%% !1110
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MRKRP4$G (SCJ*Z>L[7K'4-1T::WT?4_[,O&P8[@P+,HP>59&ZJ1D'!!YX(H
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M/_X 1?\ Q-'_  A?A;_H6M'_ / "+_XFBT>_]?>'O&W16)_PA?A;_H6M'_\
M "+_ .)H_P"$+\+?]"UH_P#X 1?_ !-%H]_Z^\/>-NBL3_A"_"W_ $+6C_\
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M /@!%_\ $T6CW_K[P]XVZ*Q/^$+\+?\ 0M:/_P" $7_Q-'_"%^%O^A:T?_P
MB_\ B:+1[_U]X>\;=%8G_"%^%O\ H6M'_P# "+_XFC_A"_"W_0M:/_X 1?\
MQ-%H]_Z^\/>-NBL3_A"_"W_0M:/_ . $7_Q-'_"%^%O^A:T?_P  (O\ XFBT
M>_\ 7WA[QMT5B?\ "%^%O^A:T?\ \ (O_B:/^$+\+?\ 0M:/_P" $7_Q-%H]
M_P"OO#WC;HK$_P"$+\+?]"UH_P#X 1?_ !-'_"%^%O\ H6M'_P# "+_XFBT>
M_P#7WA[QMT5B?\(7X6_Z%K1__ "+_P")H_X0OPM_T+6C_P#@!%_\31:/?^OO
M#WC;HK$_X0OPM_T+6C_^ $7_ ,31_P (7X6_Z%K1_P#P B_^)HM'O_7WA[QM
MT5B?\(7X6_Z%K1__   B_P#B:/\ A"_"W_0M:/\ ^ $7_P 31:/?^OO#WC;H
MK$_X0OPM_P!"UH__ ( 1?_$T?\(7X6_Z%K1__ "+_P")HM'O_7WA[QMT5B?\
M(7X6_P"A:T?_ , (O_B:/^$+\+?]"UH__@!%_P#$T6CW_K[P]XVZ*Q/^$+\+
M?]"UH_\ X 1?_$T?\(7X6_Z%K1__   B_P#B:+1[_P!?>'O&W16)_P (7X6_
MZ%K1_P#P B_^)H_X0OPM_P!"UH__ ( 1?_$T6CW_ *^\/>-NBL3_ (0OPM_T
M+6C_ /@!%_\ $T?\(7X6_P"A:T?_ , (O_B:+1[_ -?>'O&W16)_PA?A;_H6
MM'_\ (O_ (FC_A"_"W_0M:/_ . $7_Q-%H]_Z^\/>-NBL3_A"_"W_0M:/_X
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M10 5R_AN-G\2>,BLSQC^V8^%"_\ 0/M/4&NHKF_"_P#R,7C+_L,Q_P#IOM*
M#X<_\DL\*?\ 8&L__1"5TE<W\.?^26>%/^P-9_\ HA*Z2@ HHHH *Y[QSXKC
M\%^$[C698!/Y<D<2JTGEH&=P@+O@[5!;).#QVKH:Q_%5C?:EX:N[/3+?3;J>
M50IM]4C+P3+GYE;'3(S@X(!QP: ,#3O'UQ!\*$\7>*],&GS"V65;>&42"Z+*
M#'Y6,D>86 "MR"<'(&XXJ_&A9-%AU6+0P;6#3;;4M5S>8:TBFD**(QY?[U@
MS$'8,8P23@9_@[X-7MC\/+'3]5U6ZTZ^M[F2_AM;26.6*WE> 1[6\V-PV/F;
M(&%9VVDX#&M:_!G7K3PTVC?VC93IJFE6NFZG-)*P:V$,I;= %C D&QBH#[2"
MH))R: .PNOB7';^*'LETY9-*AU2#2)]0^TX=;F5 R[8MF"@+(I;>""3@$#-=
MU7FMY\-=0F\43"&:T&AW.N6VMRNTK_:$>&,#R0FW:RLR*=V\$ D8) ->E4 8
MGA/_ ) L_P#V$[__ -+)JVZY[PO:1RZ3<.S3 G4[_P"[.ZC_ (^YNP.*V/L$
M/]^X_P# F3_XJJG\3)C\*+-%5OL$/]^X_P# F3_XJC[!#_?N/_ F3_XJI*+-
M%5OL$/\ ?N/_  )D_P#BJ/L$/]^X_P# F3_XJ@"S15;[!#_?N/\ P)D_^*H^
MP0_W[C_P)D_^*H LT56^P0_W[C_P)D_^*H^P0_W[C_P)D_\ BJ +-%5OL$/]
M^X_\"9/_ (JC[!#_ '[C_P "9/\ XJ@"S15;[!#_ '[C_P "9/\ XJC[!#_?
MN/\ P)D_^*H LT56^P0_W[C_ ,"9/_BJ/L$/]^X_\"9/_BJ +-%5OL$/]^X_
M\"9/_BJ/L$/]^X_\"9/_ (J@"S15;[!#_?N/_ F3_P"*H^P0_P!^X_\  F3_
M .*H LT56^P0_P!^X_\  F3_ .*H^P0_W[C_ ,"9/_BJ +-%5OL$/]^X_P#
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M (J@"S15;[!#_?N/_ F3_P"*H^P0_P!^X_\  F3_ .*H LT56^P0_P!^X_\
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M;YQ7"0@]5B7^$>_)/<FI+#P_8:;;F*T6= S;G;[3(6D8]68[LDGU-6?L$/\
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M)/&06%Y!_;,?*E?^@?:>I%=17-^%_P#D8O&7_89C_P#3?:4 'PY_Y)9X4_[
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MQ^%%FBJWV"'^_<?^!,G_ ,51]@A_OW'_ ($R?_%5)19HJM]@A_OW'_@3)_\
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M[!#_ '[C_P "9/\ XJ@"S15;[!#_ '[C_P "9/\ XJC[!#_?N/\ P)D_^*H
MLT56^P0_W[C_ ,"9/_BJ/L$/]^X_\"9/_BJ +-%5OL$/]^X_\"9/_BJ/L$/]
M^X_\"9/_ (J@"S6)XT_Y$'Q!_P!@RY_]%-6E]@A_OW'_ ($R?_%5B^,K*)/
MFO,&GR--N",W#D?ZINQ-5#XD3+X6='1114E!1110 4444 %<OX;F6/Q)XR#!
MR?[9C/RQLW_,/M/05U%<WX7_ .1B\9?]AF/_ --]I0 ?#G_DEGA3_L#6?_HA
M*Z2N;^'/_)+/"G_8&L__ $0E=)0 4444 %%%% !1110 4444 8GA/_D"S_\
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MW*;P@QH?]F( (/K@GWK;    & .@HHJ6V]QI);!1112&%%%% !1110 4444
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M LT56^RS?\_UQ_WS'_\ $T?99O\ G^N/^^8__B: +-%5OLLW_/\ 7'_?,?\
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M"3X<_P#)+/"G_8&L_P#T0E=)7-_#G_DEGA3_ + UG_Z(2NDH **** "BBB@
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M*21\ DX56). "?H* -NBBB@ HHHH **** "B@D 9)P*@>]M8O]9<PI_O2 4
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MFL)"D ^S3QY?.-N7RF&(.X'@XKVWQ5IVL0>%=0D\/3:AJ&K>45M8?M*1Y<G
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M_?AO_BZ +-%5ME]_S\6__?AO_BZ-E]_S\6__ 'X;_P"+H LT56V7W_/Q;_\
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M>&TMHK>UB2&"% D<4:A510,!0!P !QBI*** "BBB@#$\)_\ (%G_ .PG?_\
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M-_\ H7O#_P#X/I__ )#H Z2BN;^W>-_^A>\/_P#@^G_^0Z/MWC?_ *%[P_\
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MMWC?_H7O#_\ X/I__D.@#I**YO[=XW_Z%[P__P"#Z?\ ^0Z/MWC?_H7O#_\
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M_D.C[=XW_P"A>\/_ /@^G_\ D.@#I**YO[=XW_Z%[P__ .#Z?_Y#H^W>-_\
MH7O#_P#X/I__ )#H Z2BN;^W>-_^A>\/_P#@^G_^0Z/MWC?_ *%[P_\ ^#Z?
M_P"0Z .DHKF_MWC?_H7O#_\ X/I__D.C[=XW_P"A>\/_ /@^G_\ D.@#I*Q/
M&G_(@^(/^P9<_P#HIJK?;O&__0O>'_\ P?3_ /R'6)XTU+QA#X"U^2\T#0TM
MTTRY:5HM;F=U01-DJIM0"<= 2,^HZU47:28I:IG?T445(PHHHH **** "N;\
M+_\ (Q>,O^PS'_Z;[2NDKE_#<\,7B3QDLLJ(?[9C.&8#_F'VE $GPY_Y)9X4
M_P"P-9_^B$KI*YOX<_\ )+/"G_8&L_\ T0E=)0 4444 %%%% !5:^^Q16_VO
M4A L-GFX\Z<#$.U3E\G[N%+<^A-6:YKXBZ1>Z_\ #?7M+TI=]Y=64B0INV[V
MQ]W)X&>G/'/- $NG^.O#VJ:;J5]:WSK!I47G7HN+66!X(RGF!RDBJVTIR"!@
MXXS1IWCKP[JNO?V/8Z@7O<RA%:WE1)6B($BI(RA'9=PW*I)'<<&O/]$MM=OK
M+5=/AM];;0;V[TV"!-82?SH^$:]_UPWB/8-O/R;B=O?.EK"W_B;XAZ>VD:1J
M5E-;V]]9ZA-J=HRPQQ%-L;0R'*99RIS$=Q4?/PH  .IT[QWX5O+2_FL-05;>
MP@>]G<V\D:M#ERTR%E'FIE7^=-P)[\UH3^)M'MO$5EH,U]&NJW\336]I@^8T
M:@DL1CY1P<;L9((&2#7C&B^'M<O+CPY:'2-0MX[#1+;1-3-Q:R1KN-W&TRJ2
M,.OE0R?.I*_,G)SBNO\ %7@\-\6M U+1=,:.6^M]3_M#4(XV(61K>*.+S'&=
MHPN%' ^]@9)H [#1?&F@>(=2FL-(OC-<Q1>=M:"2,21;RGF1LZ@2)N!&Y"1[
M\BMVO(OA'I^OZ3J=EI\D.LVVG6>AI!J4.I^;Y2WRRD+]G,GRE=@;)B.PC9GG
M%>NT %%%% !1110 4444 84_C30+?Q)'H4U\5OY)1 J^1(8Q*4,@C,NWRPY0
M9"%@Q!''(JMJWQ$\+Z'=SVNI:DR36[,)DCM9I3&%1'9FV(<(!*F7/R@DC.00
M//[31O$>D?$FY&GIK"W5[XI-Y+(#*=/DTQX?GW?\LO,!&T9^?(3'&*T-:>?_
M (5K=:;>Z%KDU_K<=Y?PM;6;R(MPTA>&"95Y7AHQME7RRJ$,3@B@#MM0\8^&
M].UBVM;V^074J)Y<B0O(L:2L%3?*JE8P[* -Q 8@8SBK&H^+-#TC3=3U#4M1
MCMK32I/*NY9 P"/L5]HX^<X=>%SDG'4$5Y%XC\->))5\1:==:?<2:AXEL=%C
M@EL[9FMXI8'Q.&=1MB"_>&X@$=,GBNA\2>%/[<^"VJ3W^CRW>L2QWU_;6[PL
MTL<LQ<H!'C.]495 (R,>M '7:M\0?#VB+')J<M_%#*(_+N%TJZ>%O,QL D6,
MKDY QG.>.M=-7GDFF7VJ^,/!-C>6-R-+TG3FU&9GA/E&Z54CB5B1@.NYV Z]
M^U>AT %%%% !1110 4444 9>N^)-+\-V\4VKSR1B9BL:0V\D\CD*6;"1JS$!
M5))Q@ <U5OO&WAS3=#MM8O=4BCT^Z@-Q#.%9A)& #D8!/< #J20!R0*Y+XH:
M-=7/BCPYJ_EZQ)I]G!?0SG1C-Y\<DD:F)L0_O-I9,$CC.W=\I-/T*Y\16%O9
MZQXKTK4+^^TGP_"LJ6D(>66:>3,P5<@.ZK#$6"G/) !)Q0!TA\;^&KK0;B_D
MNF>T6X^PS026<OG><Q"^2;<IYA8[A\NW)!SC%7]/\2Z1JL&GRV%X)DU$2&VQ
M&P+;/O@@C*E2,$-@@\'GBO*!HVJJL>JVNF7XT.Q\81ZE#')92_;98#$8Y96C
M*^=(1(_&\%]H/\(45J?#GPQ>7%SJ7_"0Z;<0V-Q#>/#'<(\3%+VZD9T(X*MY
M<,1(X*^8 <'( !VA^(7A8Z==WT6K)/;VE\NG2-;Q/*7N6VXBC5%)D8[A]P-W
M]#C6T;6=/\0:3#J6CW*W-I-G9(%*\@D$%2 5(((((!!&#7B[^&;_ $G3]5@L
M-!O+2Q@\<17,4EE9NTMI;+$@%Q;Q 'S "-OW77!;*M@X]%^%EE=:?X$B@O;*
M2S;[5<.@G5EEF1I6*RR*W*NX.XK@8)X"CY0 =C1110 4444 %%%% #)IHK:W
MDGN)$BAB4O))(P544#)))Z #O6%I?CKP]K%CJ%Y97SB+38A/=BXM98'AC9"Z
MN4D56VE02"!@X.*3Q]I%YKWP\U[2M+ :\O+&6*%2P7>Q4X7)X&>G/'->>:':
M:[>Z7JNFP6VN/H5\VF6J1:RD_FQEBOVT@2C>(_+X_N;L[>,T >AZ=X\\-ZKK
MHT>QU$R7K-(J*UO*B2-& 9$21E",R[AN522.<C@TS3O'/A>__M&6POUVVD+7
M=S(UO)&LD2Y4S(S*!*@\LC>FX< 9Y%<QK!O?$?Q(TI]*T?4[2>R2]M;Z?4K1
MA!' 8R%>&0Y3<[E.8CO*C#C"X'%Z1X<UR['AW3CH]_"NG:/'HNIFXM9(T_>7
M<?FA&(Q(OE1R'>I*\KS\PH ]IF\4:-;Z[IVBS7\:ZGJ4;2VMK@^8Z*I8L1CY
M1@'EL9(('(J'0?&>@>)KJ6WT6_\ M$L4?FX,,D8DCW%?,C+J!(FY2-Z97/?D
M5R7B;PC ?C%X9U>PTB1OMGV\ZK>0QL<_Z(L48=^BC"X49 R6(Y))R/AKX>U.
M'QAIMP5U&/2]%T:;3XUU'3&LY4W3*4C8EF69@J$F2/Y/NX&2: /8**** "BB
MB@ HHHH *PKKQIH%GXCBT.YOBE_+,D"KY$AC$KH76)I0NQ7*C<$+!B,<<BMV
MO&4T;Q'I/Q,NCIJ:PMU?>)X[QI4,IL)--:#$N_\ Y9;QM*@-\^0FWB@#T'6/
MB'X8T&ZGMM3U%DFMRPFCBM9IC&%1)&9@B'"A9$);[HS@G-2ZCXR\-:9JEK#>
MWT8N)HT:.5(7D2..5PJ,\BJ5C5V"@%B Q'&<5QFL/*OP[U"PU+0M;GO-=6]O
M(VL[.215E+DP0RJO(^7RQB1?+(4ASC(KFO$OAGQ-+9Z[IUYIT\FI>(]%TFUA
M>RMF:WBN(GQ.&=!MB5<[@6(!'3)&* /7-2\9Z%I32)>7<GFQW8LO)@MI9I'F
M,8DV(B*6<[&#':#COBJ@^(WA0K8LFK*Z7T4<L4B02,B)(^Q#*P7$.7^4>85^
M8$=017*:[K/B;PW\-S/H.C7L^O:[J$[[ULI9A8K)(Q661$4M\D6P ;2<@<'&
M#PK^!;O2_#>N:!H-KK%[%K^FV-M87<VG3Q$S)<N9VF#*# -SF3Y\94\%NX!]
M&4444 %%%% !1110 5FZWXATWP[;13:K,Z":3RXHX8))I)&P6(6.-69L*I)P
M. "3Q6E7G?Q-T:>\\1>%=5D35I-+T^6Z6]_L<S?:$\R'$;*(?WF-RX)7LW/!
M- '37/CCPY9^'[37+C58DTV\B,T%QM8JZ!"Y/ R/E4\'!SA?O$"H1XX\,WF@
MW=])=LUI!,+2XAFLY5E$CX"Q&!D\PLVX87;SGC-<MX;G\36>F:5JOBW3-1U"
M_P!&\/F2:*VB#2SRS2?=4$@/*L< RH.?GZ989P+G1M5G:[U/3M,OQH=IXLL=
M5@2:SE%[/$J@7#E'7SI ';*A@6VKA> HH ]3M?%NAWEE:7<%^OD7;RI&SHR;
M6C5FD#A@#&5"-G?C!&#R0*J:9\0?#&KVES=6NJ"."UMENY7NX)+8"!L[91YJ
MKN0[3\PR/>N+\ :;J5CK^LZQJ6FW\=FLVHZG:1/;NLCK=7&54(1GS-EOG9]X
M>:,@;JS?#&C2>/;G7_$7CS2+T:K=6^RSTBZTRXBBLH(F8QIO= LKECN(!/)S
MCLH!Z]I&K66NZ/:ZII4WGV5W&)89=C+O4]#A@"/Q%7*Y3X7V=SI_PL\.VE_;
MRVMS#81I+#,A1T8#D%3R#]:ZN@ HHHH *YOPO_R,7C+_ +#,?_IOM*Z2N;\+
M_P#(Q>,O^PS'_P"F^TH /AS_ ,DL\*?]@:S_ /1"5TE<W\.?^26>%/\ L#6?
M_HA*Z2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N7\-P0R^)/&32Q(Y_MF,990?^8?:5
MU%<WX7_Y&+QE_P!AF/\ ]-]I0 ?#G_DEGA3_ + UG_Z(2NDKF_AS_P DL\*?
M]@:S_P#1"5TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ%O?B3[.S[HFVNDD31LIQD95@#T]JY:W\*:E'MAW6\5M)+%+<".X<N[JREI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ!_W_P!/_P#DJC_A*-7_ .A$\0?]_P#3_P#Y*HHH /\ A*-7_P"A$\0?]_\
M3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2J** #_ (2C5_\ H1/$'_?_ $__ .2J
M/^$HU?\ Z$3Q!_W_ -/_ /DJBB@ _P"$HU?_ *$3Q!_W_P!/_P#DJC_A*-7_
M .A$\0?]_P#3_P#Y*HHH /\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'
M_?\ T_\ ^2J** #_ (2C5_\ H1/$'_?_ $__ .2J/^$HU?\ Z$3Q!_W_ -/_
M /DJBB@ _P"$HU?_ *$3Q!_W_P!/_P#DJC_A*-7_ .A$\0?]_P#3_P#Y*HHH
M /\ A*-7_P"A$\0?]_\ 3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2J** #_ (2C
M5_\ H1/$'_?_ $__ .2J:GBO59(U=/ OB JPR#Y^G\C_ ,"J** '?\)1J_\
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M$3Q!_P!_]/\ _DJC_A*-7_Z$3Q!_W_T__P"2J** #_A*-7_Z$3Q!_P!_]/\
M_DJFIXKU62-73P+X@*L,@^?I_(_\"J** '?\)1J__0B>(/\ O_I__P E4?\
M"4:O_P!")X@_[_Z?_P#)5%% !_PE&K_]")X@_P"_^G__ "51_P )1J__ $(G
MB#_O_I__ ,E444 '_"4:O_T(GB#_ +_Z?_\ )5'_  E&K_\ 0B>(/^_^G_\
MR5110 ?\)1J__0B>(/\ O_I__P E4U/%>JR1JZ>!?$!5AD'S]/Y'_@5110 [
M_A*-7_Z$3Q!_W_T__P"2J/\ A*-7_P"A$\0?]_\ 3_\ Y*HHH /^$HU?_H1/
M$'_?_3__ )*H_P"$HU?_ *$3Q!_W_P!/_P#DJBB@ _X2C5_^A$\0?]_]/_\
MDJC_ (2C5_\ H1/$'_?_ $__ .2J** #_A*-7_Z$3Q!_W_T__P"2J:GBO59(
MU=/ OB JPR#Y^G\C_P "J** '?\ "4:O_P!")X@_[_Z?_P#)51^%(M5%[XAO
A[W2)=.&HZFMQ#!=SQF38MI;Q9/E,ZCYHF_BS[444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ctlt-20210630_g3.jpg
<TEXT>
begin 644 ctlt-20210630_g3.jpg
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M\?\ 21C_ ,G-5_\ CM'_ !#T_M\?])&/_)S5?_CM?K]17E?ZS9M_-'_P&/\
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M/_)S5?\ X[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\
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M_P# 8_Y!_8N [/\ \"?^9^0/_$/3^WQ_TD8_\G-5_P#CM'_$/3^WQ_TD8_\
M)S5?_CM?K]11_K-FW\T?_ 8_Y!_8N [/_P "?^9^0/\ Q#T_M\?])&/_ "<U
M7_X[1_Q#T_M\?])&/_)S5?\ X[7Z_44?ZS9M_-'_ ,!C_D']BX#L_P#P)_YG
MY _\0]/[?'_21C_R<U7_ ..T?\0]/[?'_21C_P G-5_^.U^OU%'^LV;?S1_\
M!C_D']BX#L__  )_YGY _P#$/3^WQ_TD8_\ )S5?_CM'_$/3^WQ_TD8_\G-5
M_P#CM?K]11_K-FW\T?\ P&/^0?V+@.S_ / G_F?D#_Q#T_M\?])&/_)S5?\
MX[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\  G_F?D#_
M ,0]/[?'_21C_P G-5_^.T?\0]/[?'_21C_R<U7_ ..U^OU%'^LV;?S1_P#
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M:_Y('\*_^QPO?_2445^@9!7GC\LC6K).3;Z);,^3S6E'"XV5.FVDK=7V./\
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MD\ ?MA^*/'NC_#CPEJUKIO@/61ILVNZ@T0M]2EWS+N@V,QV;8@^6VG$J<=:
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M'WPZT+X9:EK'P,\43W'Q%:U\V.S=6@TKSQ$ZPF=E43W*Q7$,C0H/D\P!F4D
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M(X )"#*.?N&%I'A1YHMCE063=G:>XSWH =1110 4444 %%%% !1110 4444
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M[2ZL'\/V)@OI#)>PFT39<.<99QC#DX')STJY###;0I;V\2QQQJ%1$7 4#@
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M^H7TVCZ/- 8H;NXTL7+I]DMYIH9#&3!%9;#"%E=3NC8'FOK7X]_!GX/^!?\
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MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$\/Z#%K#^(8]$LUOY$V27RVR"9EX^4OC<1P.,]J^7O#7[/W[8?[3<&L_"_\
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MJG:V&7.&"L"!TDUM;W!1IX$<QOOC+J#L;!&1GH<$\^]/H _.3]M+08?VU_\
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M]<OG)9YYW  QEFVHH"H&.!DL2 >E4444 %%%% !1110 4444 %%%% !1110
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M0F\R:3?O?:!G#L!P!CH!15P\Z,;NP4ZT:CLC4HHHKG-@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /RQ_X.FO\ D@?PK_['"]_])111_P '
M37_) _A7_P!CA>_^DHHK]9X4_P"1)#UE^;/@L]_Y&4O1?D<?_P &]/\ R?Q^
MT9_VV_\ 3K+7Z_5^0/\ P;T_\G\?M&?]MO\ TZRU^OU?"\2_\C:7^&/_ *2C
MZ?)?]P7K+\V%%%%> >L%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!^!O_!:K_E)G\2_^X-_Z9K&OEFOJ;_@M5_RDS^)?_<&_P#3-8U\LU^X93_R
M*L/_ ((?^DH_)\Q_Y&%;_'+\V?4W_!%7_E)G\-/^XS_Z9KZOWRK\#?\ @BK_
M ,I,_AI_W&?_ $S7U?OE7Y_QM_R-8?X%_P"E2/LN%?\ D7R_QO\ *)\G?\%(
M-2^+WQA\8>"?V*_V>?B+JOACQ)XDM-3\1:QK>B:C);3V5A8VSK;H[QLK".>\
MDAC.#_RS/2O2OV&_VC8?CS^QWX5^,WC#45MM0MM':V\727KA#;7UGNANVEW?
MZO+Q-)ST5P:^>_@YX4_:8_:K_:H^*W[87P&^.6A^$=*M]7/@3PW-K/@W^UC=
MZ?IY4S20L;B+RXI+IG?H=Q]-M<[\,OAM\9?A3XK_ &EO^">WBGQ=9:SKWQ,\
M ZEXT\%:CIVF?V?;7EW?02VMXB0F1Q#F<Q+M#G 1FX!P/CSZ8^@_A[_P46\-
M_$[5M)U/PG^S;\4I_!&O:Q'IND_$0>'(_P"S9WDF$*3E!*;A+9I"%$S1 #(R
M ,D<'\(_V]?CGXD_;>^(WPBUW]GCXC7GAVPDT&VTC2HM&TU7\.^<LJS7EVXG
M#-#,0LJ_-(0D9PJG@V/V+?\ @H)^R_HW[/7PO^!>H>)+JT\>6&EZ5X4OO 46
MCW#:G;:C"D=K*'A"92-65I&D8A0F23N!6H/"WQI^&?P!_P""IOQ>T;XQ^*(O
M#\WQ T'PBO@TWT3A=6>..:V9(2 0S>=(JX]F[*: /H7X6?M&>#OBU\6?B%\'
MO#^D:G!J/PWU&RL]9N+R*,0W#W-OYZ&$J[,0%!!W!3GIFL'P3^V7X \>_#7Q
MY\3O#W@CQ7=6_P /_&>H>&=0TNQT<75]?WMI)'&WV6&!W,BNTJ!<E3U+!0":
M\!\!_M$?"']CK]O3]H>Q_:/\5?\ ",CQA<:#K7A.:ZLYG76+:.Q,,@M_+1C+
M(LIV>6!N+9"@X..!^!WQ[^+GPB_X)^_M$?'?X0^$;ZP\0?\ "^]<NX[;5](,
MMSHT%S/8^=/-:C.9((I&9D.0K(2V55A0!]1> OVZ].USXQ^'_@E\5?V>_'OP
MZU3Q?#<OX1N/%EI:?9]3:"/S)(=]M<2^5,(_FV/CTSDJ#R/['G_*0S]J_P#[
M"OA#_P!-,E>":AXV^'7C;]L/]GBY\ ?MG^+_ (R2P^,YWU>]OX+,Z5ILLNGS
M%%1K6SA6&:38Y\AI'94C.0."?>_V/ 1_P4,_:OR/^8KX0_\ 33)0!]34444
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M7QI^._\ P1\TWXS?&/1Y)]2LO%NG7^H:C::0]L;[2[;5U5-2^S8W1+)"%E(
M P2X 4@#U/\ ;!_;FLKGX/\ @GQ[^S9\;;/3?!?B3X@PZ%XQ^*.G:8+U/#]J
M8RSLJS(8T9F*)YKJR(3TW$8 /4_@5^V3HGQ>^+.J? /Q=\(_%O@'QKIFB)K(
MT'Q7;V^;S3FE$7VF"6WFE215D(1N003CG#8X";_@J=X U6#Q+-\-/V<_BAXO
M_P"$+U:_LO%[Z#H,#QZ6+25XW=I'G5)&<(TB1(6?9RP3(SY3^RMXB\$>*?\
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M-W^QP?VV(_#VM#PT/#+ZW_9IAA^W>2N<IM\SR]^1_?Q[UC_&_P#X* _!_P"
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MVE_AC_Z2CZ?)?]P7K+\V%%%%> >L%%%% !1110 4444 %%%% !1110 4444
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MSU K+_X5UX-_Z __ ),2?_%5MT5<9SBK)M$N$9/5&)_PKKP;_P! ?_R8D_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y8_\
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M_P!5\]_Y\_\ DT?_ )(/[?RC_G[^$O\ (_4.BOR\_P"(E72?^C.;G_PO5_\
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M .%ZO_R#1_JOGO\ SY_\FC_\D']OY1_S]_"7^1^H=%?EY_Q$JZ3_ -&<W/\
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M^H=%?EY_Q$JZ3_T9S<_^%ZO_ ,@T?\1*ND_]&<W/_A>K_P#(-'^J^>_\^?\
MR:/_ ,D']OY1_P _?PE_D?J'17Y>?\1*ND_]&<W/_A>K_P#(-'_$2KI/_1G-
MS_X7J_\ R#1_JOGO_/G_ ,FC_P#)!_;^4?\ /W\)?Y'ZAT5^7G_$2KI/_1G-
MS_X7J_\ R#1_Q$JZ3_T9S<_^%ZO_ ,@T?ZKY[_SY_P#)H_\ R0?V_E'_ #]_
M"7^1^H=%?EY_Q$JZ3_T9S<_^%ZO_ ,@T?\1*ND_]&<W/_A>K_P#(-'^J^>_\
M^?\ R:/_ ,D']OY1_P _?PE_D?IEXN=X_#5Y)&Y5A"<,IP15O3R6L("3DF%<
MD_05\ ?LP?\ !<#3OVO_ (W:1^SK!^S7-X??Q%!>XU=_%HNA!Y%G-=?ZH6J;
MMWD[?O#&[/.,'[_T[_D'P?\ 7%?Y"O,QN Q>7553Q$>635]T]-5T;['?A<9A
ML;3<Z,KI.VS6OS]2:BBBN,Z0HHHH _+'_@Z:_P"2!_"O_L<+W_TE%%'_  =-
M?\D#^%?_ &.%[_Z2BBOUGA3_ )$D/67YL^"SW_D92]%^1Q__  ;T_P#)_'[1
MG_;;_P!.LM?K]7Y _P#!O3_R?Q^T9_VV_P#3K+7Z_5\+Q+_R-I?X8_\ I*/I
M\E_W!>LOS84445X!ZP4444 %%%% !1110 4444 %%%% !7DO[=W_ ":'X\_[
M A_]&)7K5>2_MW?\FA^//^P(?_1B4 ?S@T445_0!^-A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1175?!CX-
M?$'X\_$/3?AO\-_"VIZI?7]W%%(NF:=)<FVC9U5IW6,$K&F[+,<  <D5,YQI
MQ<I.R148RG)1BKMG*T5ZE^U_^RMXW_9!^..J_!SQ7'?7<-E,%TS7)]&ELX=5
MCV(QE@$F=Z!FVY5F&1UHO/V(OVPM/\"/\3+_ /9D\<0Z%%;FXDU&7PU<*J0@
M;C*04W"/;SO(VXYSBL8XO#2IQJ<ZM+;6U_O-'AZ\9RARN\=^MCRVBBN[^$'[
M+_[17Q^M;J_^"WP4\2^)K:R?9=W>CZ3+-#$^,[&D VA\'.W.<<XK6I4ITH\T
MVDN[T,X0G4ERQ5WY'"45KZ_\/_'?A7QE+\.O$W@O5=/\0072VTVAWNGR17:3
M-C;&864/N.1@8R<C'6NQ^(_['O[5'P?\'K\0/BC^SUXOT#1&*AM3U309H88B
MQ 42,R_NB20 'P23CK4NM1BXIR7O;:K7T[E*E5:;47IOIMZGF]%=Q\'_ -FC
M]H+]H#[2WP4^#7B/Q/'9,%O+C1]*DFB@8C(5Y -JL1R 3D]JP_B'\,_B)\(_
M%$W@GXI>!M6\.ZO;J&FTW6;"2VF53T;8X!*GLW0]C35:DZCIJ2YETOK]PG2J
M*'.XNW>VA[O_ ,$AO^4AG@'_ *X:U_Z9KZOW_P!._P"0?!_UQ7^0K\ /^"0W
M_*0SP#_UPUK_ -,U]7[_ .G?\@^#_KBO\A7YGQM_R-8?X%_Z5(^[X5_Y%\O\
M;_*)-1117QY],%%%% 'Y8_\ !TU_R0/X5_\ 8X7O_I***/\ @Z:_Y('\*_\
ML<+W_P!)117ZSPI_R)(>LOS9\%GO_(REZ+\CC_\ @WI_Y/X_:,_[;?\ IUEK
M]?J_('_@WI_Y/X_:,_[;?^G66OU^KX7B7_D;2_PQ_P#24?3Y+_N"]9?FPHHH
MKP#U@HHHH **** "BBB@ HHHH **** "O)?V[O\ DT/QY_V!#_Z,2O6J\E_;
MN_Y-#\>?]@0_^C$H _G!HHHK^@#\;"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$AO^4AG@'_KAK7_IFOJ_?_3O^0?!_P!<5_D*\#C;_D:P_P "_P#2I'K\*_\
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M"!_B<H#)^TS8!L?,!X5<@'Z_:*7_ (<'^)?^CF['_P )1_\ Y)K]I_M[*?\
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M  E'_P#DFC^WLI_Y^?A+_(/[(S'_ )]_BO\ ,_/>BOT(_P"'!_B7_HYNQ_\
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M7_HYNQ_\)1__ ))H_P"'!_B7_HYNQ_\ "4?_ .2:/[>RG_GY^$O\@_LC,?\
MGW^*_P S\]Z*_0C_ (<'^)?^CF['_P )1_\ Y)H_X<'^)?\ HYNQ_P#"4?\
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M1_PX/\2_]'-V/_A*/_\ )-3'.\GC>U1+Y/\ R*>4YG+>'XK_ #/SWHK]"/\
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M U<T[_D'P?\ 7%?Y"J?C'_D6+W_K@:N:=_R#X/\ KBO\A7GG834444 %%%%
M'Y8_\'37_) _A7_V.%[_ .DHHH_X.FO^2!_"O_L<+W_TE%%?K/"G_(DAZR_-
MGP6>_P#(REZ+\CC_ /@WI_Y/X_:,_P"VW_IUEK]?J_('_@WI_P"3^/VC/^VW
M_IUEK]?J^%XE_P"1M+_#'_TE'T^2_P"X+UE^;"BBBO /6"BBB@ HHHH ****
M "BBB@ HHHH *\E_;N_Y-#\>?]@0_P#HQ*]:KR7]N[_DT/QY_P!@0_\ HQ*
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MQ]J%GXFUY/&&HQ>;J$$]C$TL829OF0-)"S. ?G\UMV1P/I?]CS]B#X^?$_\
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M_P#H(6?_ 'V__P 31_PJ37_^@A9_]]O_ /$T?6*/\P>QJ]CE:*ZK_A4FO_\
M00L_^^W_ /B:/^%2:_\ ]!"S_P"^W_\ B:/K%'^8/8U>QRM%=5_PJ37_ /H(
M6?\ WV__ ,31_P *DU__ *"%G_WV_P#\31]8H_S![&KV.5HKJO\ A4FO_P#0
M0L_^^W_^)H_X5)K_ /T$+/\ [[?_ .)H^L4?Y@]C5['*T5U7_"I-?_Z"%G_W
MV_\ \31_PJ37_P#H(6?_ 'V__P 31]8H_P P>QJ]CE:*ZK_A4FO_ /00L_\
MOM__ (FC_A4FO_\ 00L_^^W_ /B:/K%'^8/8U>QRM%=5_P *DU__ *"%G_WV
M_P#\35;2OAQK&KVS75O>6RJLK1D.S9RIP>BT?6*/\P>QJ]CGJ*ZK_A4FO_\
M00L_^^W_ /B:/^%2:_\ ]!"S_P"^W_\ B:/K%'^8/8U>QRM%=5_PJ37_ /H(
M6?\ WV__ ,31_P *DU__ *"%G_WV_P#\31]8H_S![&KV.5HKJO\ A4FO_P#0
M0L_^^W_^)H_X5)K_ /T$+/\ [[?_ .)H^L4?Y@]C5['*T5U7_"I-?_Z"%G_W
MV_\ \31_PJ37_P#H(6?_ 'V__P 31]8H_P P>QJ]CE:*ZK_A4FO_ /00L_\
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MEBE0,KJ1@J0>"".,5UO_  J37_\ H(6?_?;_ /Q-'_"I-?\ ^@A9_P#?;_\
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M8/8U>QRM>V5Y[_PJ37_^@A9_]]O_ /$UZ%7%C*D*G+RN^YTX:$H7NC-\8_\
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MH **** "BBB@ HHHH **** "L?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_9O\
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MO_0C?$O_ ,$5C_\ )M?BO11_J?DW:7WA_K-F?=?<?M1_Q$/_ +#O_0C?$O\
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M0_\ L._]"-\2_P#P16/_ ,FU^*]%'^I^3=I?>'^LV9]U]Q^U'_$0_P#L._\
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MBB@#\L?^#IK_ )('\*_^QPO?_2444?\ !TU_R0/X5_\ 8X7O_I***_6>%/\
MD20]9?FSX+/?^1E+T7Y''_\ !O3_ ,G\?M&?]MO_ $ZRU^OU?D#_ ,&]/_)_
M'[1G_;;_ -.LM?K]7PO$O_(VE_AC_P"DH^GR7_<%ZR_-A1117@'K!1110 44
M44 %%%% !1110 4444 %>2_MW?\ )H?CS_L"'_T8E>M5Y+^W=_R:'X\_[ A_
M]&)0!_.#1117] 'XV%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\
M(L7O_7 U<T[_ )!\'_7%?Y"@":BBB@ HHHH _+'_ (.FO^2!_"O_ +'"]_\
M2444?\'37_) _A7_ -CA>_\ I***_6>%/^1)#UE^;/@L]_Y&4O1?D<?_ ,&]
M/_)_'[1G_;;_ -.LM?K]7Y _\&]/_)_'[1G_ &V_].LM?K]7PO$O_(VE_AC_
M .DH^GR7_<%ZR_-A1117@'K!1110 4444 %%%% !1110 4444 %>2_MW?\FA
M^//^P(?_ $8E>M5Y+^W=_P FA^//^P(?_1B4 ?S@T445_0!^-A1110 4444
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M44 %8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\ H5 &Q1110 4444 %%%%
M!1110 4444 %%%% !1110!CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S6Q0
M4444 %%%% !1110 4444 %%%% !1110 5CV7_([WO_7E%_,UL5CV7_([WO\
MUY1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1110!F^,?\ D6+W_K@:
MN:=_R#X/^N*_R%4_&/\ R+%[_P!<#5S3O^0?!_UQ7^0H FHHHH **** /RQ_
MX.FO^2!_"O\ ['"]_P#2444?\'37_) _A7_V.%[_ .DHHK]9X4_Y$D/67YL^
M"SW_ )&4O1?D<?\ \&]/_)_'[1G_ &V_].LM?K]7Y _\&]/_ "?Q^T9_VV_]
M.LM?K]7PO$O_ "-I?X8_^DH^GR7_ '!>LOS84445X!ZP4444 %%%% !1110
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MS-;%8]E_R.][_P!>47\S0!L4444 %%%% !1110 4444 %%%% !1110 4444
M9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\ (L7O_7 U<T[_ )!\'_7%?Y"@
M":BBB@ HHHH _+'_ (.FO^2!_"O_ +'"]_\ 2444?\'37_) _A7_ -CA>_\
MI***_6>%/^1)#UE^;/@L]_Y&4O1?D<?_ ,&]/_)_'[1G_;;_ -.LM?K]7Y _
M\&]/_)_'[1G_ &V_].LM?K]7PO$O_(VE_AC_ .DH^GR7_<%ZR_-A1117@'K!
M1110 4444 %%%% !1110 4444 %87Q,^'?ASXL^ ]3^'/BY)FTW5K;R+Q;>7
M8Y3(/#=CD"MVB@"KH>CV7A[1;/0-.#"WL;6.W@#MDA$4*N3W. *M444 %%%%
M !1110 4444 %%%% !1110 4444 %5].TVUTJ!K>T#!6D9SN.>2<FK%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!7CTVUBU&35$#>;+&$<YXP.G%6
M*** "BBB@ HHHH **** "BBB@ HHHH **** "J\>FVL6HR:H@;S98PCG/&!T
MXJQ10 4444 %%%% !1110 4444 %%%% !1110 4444 0W]C!J5G)870)CE7:
MX4X.*DBC6&)84^ZB@#/H*=10 4444 %%%% 'Y8_\'37_ "0/X5_]CA>_^DHH
MH_X.FO\ D@?PK_['"]_])117ZSPI_P B2'K+\V?!9[_R,I>B_(X__@WI_P"3
M^/VC/^VW_IUEK]?J_('_ (-Z?^3^/VC/^VW_ *=9:_7ZOA>)?^1M+_#'_P!)
M1]/DO^X+UE^;"BBBO /6"BBB@ HHHH **** "BBB@ HHHH **\?_ &V/VF=6
M_9<^$MAXH\*^%;76?$'B/Q38>&_#5EJ-V8+3[=>.5C>XD )2)0K,V.3@#*YW
M#COV6/A%^W!\(OB_XAUSXT:Q\.M?T'QYK,NL:]<^'I+^"ZTB\%K%#%#;QW!9
M)+;$"+@E7!=F)(X !](T5\MS?'S]L']I7XO^/O"/[(M[X%\.^&/AOK;:!?:]
MXRTVZO9=9UF-%>X@C2&1!!#$65&8[F)((ZX'H/[#_P"TUKO[4'PBOM=\=>%K
M;0_%WA;Q/?>&O&FD64I>"VU.T<++Y18EO+961@"21N*Y;;N(!['1110 4444
M %%%% !1110 445\9_&SQE^T]^W;X]^(?[./[.]SX,\,>&?AOXGTRWUG6?$\
MEY)?:IJ-O+%?+''';,HAMO,B5&9B6=02I&2% /LRBO/+'Q]\;/!G[/Q\;_%?
MX5PZOXWLH)!>>&/A_<-<17LWV@Q1?9GN?+*HZ&.1C)CRPS9)V<^9_L3?M-?M
M$?&OXU_&#X6?M#>"?#OAZ\\!7>BBPTG0+E[DVR7UK+<&*:X8[9Y%41@LB(N[
M?C(P: /H^BJVM:QIOAW1[OQ!K-VMO9V-M)<7<[_=CB12S,?8 $_A7QMI?[4/
M_!1#XI_ 34?VVOA3X>^'=CX*@MKS5-!\ :U87<FJZGI-NSYDDNDE"17$B1N\
M:*A7E <YH ^TJ*^7O'_[=?C+Q_X<^#GAC]D[PYI,_B_XU:8^J:=+XG:1[/P_
MI\-NLMU-<+"5:5T+>4B J&=6YX -SX.?M'?M#?#_ /:C_P"&2OVNY/"FH76L
M>%)=?\'^,O"UI-9P7<<#[;FUG@F=]DJ#,@96V[!SR> #Z5HKXT\-?M-?\% ?
MVA_A-K/[6W[.>E_#S3_ UM)?3>$/"?B/3;R;4_$-E:.Z-+)/'*BV\DIBD\M
MN!\NXD?,?I']F7XZZ#^TS\ _"OQW\-V3VMMXETE+HV;ON-M-DI+#NP-VR573
M=@9VYP,XH [JBBB@ HHHH **** "BOF?]JSXX?''QO\ '<?L%?LV67AJPUW6
M_AU<Z]X@\5>+)KCRK#3I)FL@MK% 0\MSO)8,6V+@$AN0.T_9;\+_ +3WPB^
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M86=VNJV>CSLA5UO&DV/<K'(CN&C"##<9&* /M:BOF[XQ_M3_ !=\=?&OPO\
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M_:\Q&7;U)('.1GT'X'?LZ^)]$_:?^)?[5GQ.6UBUCQ.\.B>&K"RF\Q;/0[0
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M(_N.%;:W<(:^5+J[M8_ H_:1S'_PATG_  4*7Q NI;OW+Z8LAA^W;ON[/,!
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M_":_\.:]X5TZZ\3Z?I5]_P (-K-]<SVYTC498=L4PEMR)%02+$SJ,AA&,JV
M* /'?A+XH^/W[+7[<OAC]CCQ7\?M0^*/A#QEX6OM2TRX\2PQMK7AUK4$@W%Q
M& ;B*3:4#R $L<#;M._3_;S_ &0=6^._P[\7_$S3_P!KOQ7IVCQZ7_:8\)7-
M_!)X8E6T@#&*>.-$D>&1H=S[I6 9F;! "CT_]E7]B_X(_LJ^'X;GP1X&LXO%
M-YI-O;^)?$SW$]U=ZA*J)YA\^X9I!&TB[O+!51A?E&!CE_$'_!+7]BGQ)K%[
MJ-_\--2BL]2OFO-2T"R\6ZE!IEU.S;R[VD=P(N6Y*A0I].M &_\ L2_M!6?Q
MB_8V\ _&OQCH^E>$_P"UM(2%M/B9;:TA>.5[95A5S\D;^4&C3)PK* 3C)\Y^
M#=U!X;_X*Y?&;0-:98;KQ+\.O#VIZ(LAPT]M;AK>9DSU E.#CT_+M/VI_P!E
M6Z^/6D_#CX"Z!HNF:3\-]$\0V^I^*(K;;$RVM@@-II]M$HPJ22$!F&W8D1 R
M6 KJ_C]^R#\ _P!I>_TK7?BIX2N)-7T,.-'UW2-6N=/OK17^^BSVTB.4//R$
ME>20 3F@#XJ_;3T6_P#BA\9_VNM4\"P_:H?#?P.TC3=6GMOF"W*S?;GCR.K"
M")]P[;<'TKW7]JKXG>";S_@C]K?CF#5;<:;K7PDMH-.='!#RW-M%##$O/WO,
M=5V]00?2O=?@I^S=\%/V>? MQ\.?A-X$MM.TN^N)+C4TFE>YEU":08DEN)9F
M=YW8<$NQXXX  KSKPK_P3'_8N\&^+[+Q;HOPIG*Z7J9U'2=#N_$%]/I5C=[B
MWG164DS0(P8D@;,*3P!@8 /&?V1/#^J?"+_@H?IO@#Q](]OJ6H_LN^'8K!+G
MY3+)9-'#<1*3U=71V*]< G&!FNX\'F+Q;_P69\7>(= =9K7PI\ [+1-=DB.1
M#?7.J_:XHW.<!C I8#TKV3]H']DWX$_M.II,WQ<\(RW-]H,[RZ'K.FZG<6-]
M8,X ?RKBW=)%5@!E<[3@'&0"+OP%_9M^#/[,_ANZ\+_!SP>NF1:A>-=ZI=3W
M<MU=7]P>LL]Q.SR2MZ;F(&3@"@#NJ*** "BBB@ HHHH YGXP>"OA=\2_AYJ/
MPT^,EA87GA[Q#&-/O;'49Q&ER9& 1%;((DW %"I#!@"N" :^0OB3X8^+O_!,
MKQE\-'^$/[1.O^+/A_XK\>V'A:7X8>-I4OKFVBN25633[G E580N!$?E&5R3
M7U[\7O@U\+_CWX$N_AG\8/!EIKVA7K(UQI]X&"EE.Y75E(9&!Y#*01ZUXC^Q
MG_P3?^$/[.%M9^.O&?@[3-8^(%I?Z@UKXADU*\OQ86DEU,;:&V^UL?**6S11
MLZJK$A\LV=Q //->^*WQ?\._MU^*_C/\2_V+?BOXIL_#%H?#WPO;POHEM<6=
MM:-AKR_#RW$>9[EPJAE7Y84"$G)Q/_P0]^*#W_[ V@>$=9\!:YHUAX6AOY1X
MIU>&*+3-4274[^5VMI?,+,(<%9"ZH%;ID<U]H5X1\4_V4?\ A$OV)]1_8Y_9
M+T"RT33=7LY]$B_M._FGCTRPO[AS?S[I6:29Q'/<,B;OO,HR . #A?VF]9TO
M2_\ @I)^S#X^NKZW?1=6L/%&FV.II,&A-S/8QM  XR"9<A4P?F)XIW[6"+XS
M_P""E?[-O@SP]*DFHZ#IOB[6-6*'+6-G-IZ6\4K <A7F!0'U6O7-?_8S_9[\
M9?L]>'_V8_'/@A=7\+^&+"SM]&2XN9([FV>VB$<5PD\122.; .70@G<P/!(J
M7X"?L>_ +]FS5M2\3?##PE<C6M8B6+5/$&LZO<ZC?W$2D%8C/<R.ZQC"_(I"
MDJ"02 : /&_^"/'BC0?#O_!-_P .Z=K]]!I\O@F\URR\4+/(%&GS1:C=3R"7
M)^0B.1'.<8#9Z5\O_LJ:9?>"M._8L^*_BGS;'1-1^(/CA(3=+L6-]3WQV*G/
M ,AC8KZA\BOMOXA_\$U_V//B=X[U7X@^)_AK=I=:_<BX\1V6F>([ZRLM7F!S
MYES;03)%*Q/+$K\Q)+9).?0/BE^S?\#_ (S_  F3X&_$7X<:??>%88H4L])B
M5H$LQ"-L)@:(JT#(O"F,J0,CH2* /"_VV6B\4?MQ?LP_#_17$NJ6WBG5];N8
MXSEK>QM[(;Y'P?E5F^4$]6! Z$5]5UY7\!OV+_V>_P!G#Q%?>-/AMX2NVU[4
MK5;6[\0:YK5UJ5ZUNI!$"S74CM''D [$P"0"<X&/5* /RQ_X.FO^2!_"O_L<
M+W_TE%%'_!TU_P D#^%?_8X7O_I***_6>%/^1)#UE^;/@L]_Y&4O1?D<?_P;
MT_\ )_'[1G_;;_TZRU^OU?D#_P &]/\ R?Q^T9_VV_\ 3K+7Z_5\+Q+_ ,C:
M7^&/_I*/I\E_W!>LOS84445X!ZP4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^6/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /RQ_X.FO\ D@?PK_['"]_])111_P '37_) _A7_P!CA>_^DHHK
M]9X4_P"1)#UE^;/@L]_Y&4O1?D<?_P &]/\ R?Q^T9_VV_\ 3K+7Z_5^0/\
MP;T_\G\?M&?]MO\ TZRU^OU?"\2_\C:7^&/_ *2CZ?)?]P7K+\V%%%%> >L%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?EC_P=-?\D#^%?_8X7O\ Z2BBC_@Z:_Y(
M'\*_^QPO?_2445^L\*?\B2'K+\V?!9[_ ,C*7HOR./\ ^#>G_D_C]HS_ +;?
M^G66OU^K\@?^#>G_ )/X_:,_[;?^G66OU^KX7B7_ )&TO\,?_24?3Y+_ +@O
M67YL****\ ]8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _+'_ (.FO^2!_"O_ +'"
M]_\ 2444?\'37_) _A7_ -CA>_\ I***_6>%/^1)#UE^;/@L]_Y&4O1?D?DK
M\6O'7C;P-^T)X]N_!/C'5='EG\6ZDD\NE:A+;M(HNY" QC8$C/8UE?\ #0GQ
M\_Z+AXP_\*6Z_P#CE%%>Y3ITY4XMI;(\R<Y*;2?4/^&A/CY_T7#QA_X4MU_\
M<H_X:$^/G_1</&'_ (4MU_\ '***OV5+^5?<3SS[L/\ AH3X^?\ 1</&'_A2
MW7_QRC_AH3X^?]%P\8?^%+=?_'***/94OY5]P<\^[#_AH3X^?]%P\8?^%+=?
M_'*/^&A/CY_T7#QA_P"%+=?_ !RBBCV5+^5?<'//NP_X:$^/G_1</&'_ (4M
MU_\ '*/^&A/CY_T7#QA_X4MU_P#'***/94OY5]P<\^[#_AH3X^?]%P\8?^%+
M=?\ QRC_ (:$^/G_ $7#QA_X4MU_\<HHH]E2_E7W!SS[L/\ AH3X^?\ 1</&
M'_A2W7_QRC_AH3X^?]%P\8?^%+=?_'***/94OY5]P<\^[#_AH3X^?]%P\8?^
M%+=?_'*/^&A/CY_T7#QA_P"%+=?_ !RBBCV5+^5?<'//NP_X:$^/G_1</&'_
M (4MU_\ '*/^&A/CY_T7#QA_X4MU_P#'***/94OY5]P<\^[#_AH3X^?]%P\8
M?^%+=?\ QRC_ (:$^/G_ $7#QA_X4MU_\<HHH]E2_E7W!SS[L/\ AH3X^?\
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MX^?]%P\8?^%+=?\ QRC_ (:$^/G_ $7#QA_X4MU_\<HHH]E2_E7W!SS[L/\
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1,0#CN****M1459(3;;NS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ctlt-20210630_g4.jpg
<TEXT>
begin 644 ctlt-20210630_g4.jpg
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M\?\ 21C_ ,G-5_\ CM'_ !#T_M\?])&/_)S5?_CM?K]17E?ZS9M_-'_P&/\
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M/_)S5?\ X[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\
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M_P# 8_Y!_8N [/\ \"?^9^0/_$/3^WQ_TD8_\G-5_P#CM'_$/3^WQ_TD8_\
M)S5?_CM?K]11_K-FW\T?_ 8_Y!_8N [/_P "?^9^0/\ Q#T_M\?])&/_ "<U
M7_X[1_Q#T_M\?])&/_)S5?\ X[7Z_44?ZS9M_-'_ ,!C_D']BX#L_P#P)_YG
MY _\0]/[?'_21C_R<U7_ ..T?\0]/[?'_21C_P G-5_^.U^OU%'^LV;?S1_\
M!C_D']BX#L__  )_YGY _P#$/3^WQ_TD8_\ )S5?_CM'_$/3^WQ_TD8_\G-5
M_P#CM?K]11_K-FW\T?\ P&/^0?V+@.S_ / G_F?D#_Q#T_M\?])&/_)S5?\
MX[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\  G_F?D#_
M ,0]/[?'_21C_P G-5_^.T?\0]/[?'_21C_R<U7_ ..U^OU%'^LV;?S1_P#
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M:_Y('\*_^QPO?_2445^@9!7GC\LC6K).3;Z);,^3S6E'"XV5.FVDK=7V./\
M^#>G_D_C]HS_ +;?^G66OU^K\@?^#>G_ )/X_:,_[;?^G66OU^K\_P")?^1M
M+_#'_P!)1]7DO^X+UE^;"BBBO /6"BBB@ HHHH **** "BBB@ HHHH ****
M"JFN:]H?AC2+CQ!XEUFTTZPM(S)=7M]<+##"@ZL[N0JCW)JW7Y7Z!XT\4_\
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MG^)'D^,=14B*W2X>2TAA>=^ I$,EV0S'HK'^&KGQX^%6K_M__P#!13X?^&/
MNEY^$_P)=+C7?$$"8LKG4_,BE;3K=A\LQ @M8W"']V!*#@A0WWGJ>E:9K5D^
MFZSIT%W;2X\RWN85D1\'(RK @\BGV=G::?:QV-A:QP01*%BAA0*J*.@ ' %
M'Y=?\%$-+^'_ ,<] T?_ (*7?L<_$%=(^*'A7Q9'H5]HFG7:R7^I3QWAL[?9
M"OSO/C8=FTB6VDY!5 #[S^VMX*^!_P"W5X2U+]D3XP>(=(\'?$SPGX1T_P 4
M:5J%W?QQ16U[<1S?:(EW$;X%,:B7DX6:-\94&OL)/#/AN/4(=6C\/V*W5O$(
MK>Y%H@DB3&-BMC*KCC XI=4\->'-;B,&LZ!97:-*)62ZM4D!<  -A@>0 !GK
M@4 ?-_\ P2"\7?&WQO\ L+^%];^.\5T^HQR3VNCZAJ /VB^TN-\6TLA;EN"Z
MJQ^\BJV3NW'QS_@N1KVL?%6_^#G[#?@^_,>H_$/QK%/>F,9,,",MO$SC/*;[
MB23T_P!&)XQ7Z   # & .@HH _,'Q1\#?!'[0?\ P5U\$?LH>&[61O ?P&\%
MP2ZE;I)DSRJ%N':1Q]YY9[FU24]6*R=#DC5_X)9^+?\ A<7[?/[0G[35UX6U
M&[U6XO)M+T2%+)ECL;!)'VQS2, J.4M;*%4&7)WG:$1B/TIID-O;V^X6\")O
M<N^Q0-S'J3CJ3ZT ?BU^S;^U5J7@7]@;]I3XB)::C=?%+QEXC,7BG5I-.E6.
MPLKLI LKSE=@E,UW>*D(;>""^W:A->G?$[QMX<^ W_! SP_X!\$BY^U^.+JR
MT^6^-N4^V7%W(=1NO+SS(J(CVI?&TE" 3@$_J8WA?PR]C<Z8_AVQ-M>RF6\M
MS:)LG<D$LZXPQ) Y.3Q5R***")8((U1$4*B(,!0.@ ["@#QW]F_X0>'OV3_V
M0=!\.>)=%-U<^%_"8O->:TLQ+/+<):#SUC'WG(5?)09SL1$R<5^='[)GB/\
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MT^/WC7]G'_@GE\/;'4-$T[Q!J,-_>6-S ([BQTV,?9+:8Q')4K;K>2;'PR[
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MOHT4F@Z3IB)O32;6)WCDFDD!V(L:6*QL^?GDNCM!W''/?L'ZS%XU\1_M,_\
M!7#Q!I\]])I#:L/!=I)$653% UPN1W*0_9(AG@!G)Y (_46QTC2=,FN+C3=+
MM[>2[E\RZD@@5&F?^\Y ^8^YYJ=E5E*LH((P01UH _*C]BB_\4?"C_@C%\8O
MB[X"LM5E\4^(DOKZ_P!?^S,I4/+]C=(W/S.\,2RW)D4%5-P/FW*P3R'XF?&'
M15_X)/?!_P#9G^%D=SIVF>*_%SIXX\17^GRP03WJ7+3/"K,!YZQ&2W=Y%RH$
M<2JS,LBI^V2V5FMI_9ZVD0@\OR_($8V;,8VXZ8QQBJW_  C/APVEK8'P_8^1
M8R+)90_9$V6[K]UD&,(1G@C&* ,CX/:?X=T?X4^'-#\(:/>6&CZ?HMM::1::
MA;F&9+6*-8X=T9Y0F-5.U@& (#*K J/@G]LKX\_LQ_"W_@K3X<^(/BCQS-X&
M\5>"O!Y@O->\0^'KG4M)U/[3!*L,*0VI65&6.[D)N=^P% A0X+5^C$JN\;)'
M)L8J0K 9P?6OCOX5?L?>*]'^'6K_  X_;(_9FTKXV:]<:M=3I\0Y=2L[B?4H
MI)&:$.;YXY[#RT;8(X"Z( =GWCD B_98^#_P._9?^%_Q4_X*'Z9\?;/XI^(/
M$FE:EK.M^+[&-(;/;$'N7M((4DD,69 JE&<L-D:@+C!P/^"$WP3ELOV4+_XY
M^.X%OM1^(&OWUS&UW"&_T991%(V&'WI9H6+=F6*'CY<GU_\ X)K?L4:G^Q)\
M(M=\)ZWJMNUWXE\4W&L-I.GW<D]KI,3JD<5K'+(JM,RQHH:4JNX\8PH)^BZ
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MTL/A_0;;5I->M]$LX[Z6/9+>I;()77CY2X&2.!QGL* +<<:1(L42!54 *JC
M ]!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y8_P#!TU_R0/X5
M_P#8X7O_ *2BBC_@Z:_Y('\*_P#L<+W_ -)117ZSPI_R)(>LOS9\%GO_ ",I
M>B_(X_\ X-Z?^3^/VC/^VW_IUEK]?J_('_@WI_Y/X_:,_P"VW_IUEK]?J^%X
ME_Y&TO\ #'_TE'T^2_[@O67YL****\ ]8**** "BBB@ HHHH **** "BBB@
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MJ/\ :"T?]EKX&ZY\=O$7A>_U?3]!A26\M-.FA278SJ@8&9T!^9E& 2QR, T
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MKWQV^''P^O\ QEX-\-^(X=$O?$<.HQV=M?WCMAX[#>&:[\OJSX2,_P #N 2
M#ZKHJEX:UR#Q/X<T_P 2VMI<6\6HV45S'!=Q;)8UD0.%=?X6 .".Q!J[0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?EC_P=-?\D#^%?_8X7O\ Z2BBC_@Z:_Y('\*_^QPO?_2445^L\*?\
MB2'K+\V?!9[_ ,C*7HOR./\ ^#>G_D_C]HS_ +;?^G66OU^K\@?^#>G_ )/X
M_:,_[;?^G66OU^KX7B7_ )&TO\,?_24?3Y+_ +@O67YL****\ ]8**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BOKZ
MSTRRFU+4+E(;>WB:6>:1L*B*,LQ/8  FOR,_9J\90WO@;]J/_@K=XHED6]FN
MK_2?A^)L@6MW=82%QGDM&MS9Q+Z+YG?D?KQ10!^+'Q%^&EQ^S#_P1A\*:?9:
M?<?\)!\=_%UK=ZQ<M&Q2+3EW3VT*D#C>(+67&,MO?J$4#U[_ (*KWFE_#G]F
MO]F/X!7&EZMI7PS;5HXO$DEU8/%-+;6*VL,4DD2Y=6EAFN+@1,!)DC<BNK*O
MZC36]O<A1<0)($<.@=0=K Y!&>A'K46H:5I>K)%'JNFV]RL,RS0K<0JXCD7[
MKKD<,,\$<B@#\S-7^+>F?M%_\%LO!EIXB\.:A9Z!\.?#4,OA#PT=+=+JYDFM
MUF@E:!@# Q^U0W!#[/*BMU\SRV1U7K?@/HX_:P_X+8?%3XHWS"Y\._"K3+?1
M[>)EWH;R%T2.-L\ +=0W4X(Y#PI[U^@T>D:5%J<FM1:9;K>2Q".6[6%1*Z#H
MI;&2!Z9JQ0!\"?\ !9+Q?^SAX7^(OP1T3XI75]X;U+3/%,^NZ3XLCT9[S3-.
MBCEAEN$N;6+$EWYTL<(*1LC+G>7Q\K]I^R?\%/@-^TQ^U;J/_!0^/]J+2/B;
MK]C;+8Z#I7A_3VL;3PW"T+1*KP2RR3F0HTI!DV M+(P7.TKT+_LS_$FW_: ^
M(GBG]H+X1:=\:_"'BRZBE\))>W=K-+X<ME4AK%;+4&2"-,D'S87W.5#.,_=A
M_88_X)_6W[,_[0WQ&_:"TSPW:>$-)\7P067A[P#INHM=)IMNFQI)9I/N^8\J
M%ECC+)$KLH=@<* ?/?\ P2E^*_A7X@_M6?M$?MD>-OM)NKV^N%1OLY_XDVC1
M&6=WN&; 0;(+2)5SO8Q.0I5'9.,_8@O-6T?]F;]I+_@JWXELKB3Q/KEUJR>%
M8RI<64T@)-R@]%ENUBW#!2.&51@,:_5O3])TK21*NE:9;VPGF::<6\*IYDC=
M7; Y8]R>34TL44\303QJZ.I5T<9# ]01W% 'QM_P0K\':/X._85TUM-TF\6X
MUK5;G5=5U&>U,<-Q<2.8UCB+8:01P0VX9P-F]V569E<+S'_!?/XHS6/[/?@_
M]G'2-6M[6^^)'C""*9[J<1Q"SMF1V9V) 51/+:L6/ "FOO&...&-8HD"JH 5
M5&  .@ KXF^-O[,_[3'QQ_X*<?#_ /:+\6?!@2_#'P#;M:V=F^NV+74TQ2=O
MMAA,NT#SY(3MW;C';@XW';0!Q_[7'P)TO]L;XP?!S]@?X(1+?^!/A/!;W7Q%
M\0VP#VEA;QPQ0V]CY@RIN7@1_P!V"2//1B,*Y'FQ^)?AJU_X++?%G6?VH_CM
M?_#.2Q\/RZ7X,UID@1H;0B!8UMI+F*6.%I(#)(KA<DRR[2&:OU*TK1])T*R7
M3=$TNVL[="2EO:P+&BD\G"J !4=]X;\.ZGJ,&L:EH%E<7=K_ ,>UU/:H\D7.
M?E8C*\^E 'Y]?M_77P4_9:_X)2Z[X,_9V\#ZGH5AX_\ $EOI=G>ZO%*M_KCR
ML)Y[Z7SCY[^;%;RH&E"DJ1M4(4S])_";X&>)OV:?V (_ _@71EG\<:+\/;BX
MM7AMPTSZW_9Y50F<DE6"0)DY\N-%).*]_HH _-__ ((N_M/_ +-O@K]DNZ^"
M?BW6FG\>7OBK4)=8\(_V9-=:AK$LP15*Q!6\T&-51BV%38QD*J"U8O[?/C6P
MT3_@KE\'K'XX^*YO ?P^\.>&DN?#>JRVD+6NGW9CN&$RAUDA5UN$MHR<,J"*
M,GY>:_2ZR\/:!INH7&KZ=H=G;W=V<W5U!;(DDW?YV RWXTFL^'/#WB...'Q#
MH-E?I"^^);VU24(WJ P.#[T ?(>J^*_V=OV6_P!D[XR_M6_ J;6M;U74-(>:
MX^*?B!M\WB34YLPVWDS,J!X8YI(0/(C2W^8"/<5<+\@77@'_ (9"_P""&4OC
M2&UN/^$E^-^N6T%W=["3:6,SO*D:G^%)+:SRQ_B-P <[4Q^Q  4!5   X IE
MQ;6]W'Y5U;I(NX-MD0$9!R#SW! - 'Y=?\%!M;A^"?\ P2 ^%'[-_@O3KK3[
M?Q-?Z=IUY>:E;FUCN8X5-W/<D-S&DMWLE7> 2F6(Q3/^"G^L^#O!?AK]D_X$
MWL.H0?!^SU>W76KE]/DQJ%K92VEKYPB4%WS;//*@P6D6X# $FOU#U+2-)UB.
M.'5],M[I(IEEB2Y@5PDB_=<!@<,.QZBB^TK2]4:%M3TVWN#;3":W,\*OY4@Z
M.N1\K#U'- 'YI>%OBQ'^T?\ \%S;77/&OA_4K>R^'OA=(?!_A]]/?[2S2Q1[
M9)8F \IE%_+<OOVF)8 IRR &#5/VE/V9?AA_P4W^,OCOP[\:X_A5XHO=*;PO
M>7?C?PE<ZE:W=\IB$E];?9WC%LBFVB8"9F6;=O\ D! /Z*?%+P-K7BCP!XHT
MOX<:Y#X;\4:WH-Q9Z=XFAM%:6TN&A9(9B<9?RV(8#/&.*^5;/]B=_%'[-$7P
M:^/W[$>A>+_'=OI3VL_C]O$5K(-2O2A7^T)=1E9=00N0KL/*<K]T JH% 'G_
M ,6OV8O#_P"Q!_P2.^)FJ?LO?$.[\;ZEXTM[:[\0^.K219#J%G-/'%/+$(F<
M"$023<[G($LCECCAG[ WA7]BKXR? ?X-^"]4\=ZM\2-7\,6<%Y;?#"T@C^PZ
M%J;LSW5[=PQQ1@[)'F(EO)61@<1*S2!7^LOV#?V6[S]C[]E?PY\ -<\4)K=[
MIJW$NHW<2L(#-/,\SQQ*W/EJ7*C(!;!8A2V!ZOHWA[0/#D#6OA[0[.PB=]SQ
MV=LD2LWJ0H&3[T 7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#\L?\ @Z:_Y('\*_\ L<+W_P!)111_
MP=-?\D#^%?\ V.%[_P"DHHK]9X4_Y$D/67YL^"SW_D92]%^1Q_\ P;T_\G\?
MM&?]MO\ TZRU^OU?D#_P;T_\G\?M&?\ ;;_TZRU^OU?"\2_\C:7^&/\ Z2CZ
M?)?]P7K+\V%%%%> >L%%%% !1110 4444 %%%% !1110 5ROQN\6:QX&^%.M
M^+?#\J)>6-IYENTD890VY1R#UZUU5<'^T[_R03Q/_P!@_P#]G6@#K?"NH7.K
M>%]-U6\8&:YL(992HP"S(">.W)J_63X"_P"1%T7_ +!-M_Z*6M:@ HHHH **
M** "BBB@ HHHH SO#.I76JZ>]S=E2RW,B#:,< X%:-8_@?\ Y!$O_7[-_P"A
M5L4 %%%% !1110 4444 %%%% &=X9U*ZU73WN;LJ66YD0;1C@' K1K'\#_\
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M7_L$VW_HI:UJ "BBB@ HHHH **** "BBB@#'\#_\@B7_ *_9O_0JV*Q_ _\
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M **** "BBB@ HHHH *X/]IW_ )()XG_[!_\ [.M=Y7!_M._\D$\3_P#8/_\
M9UH _/[P]_P<;_#O1- L=&?]ES6I&M+.* R#Q-" Q1 N<>3QTJY_Q$E_#C_H
MU;6__"GA_P#C-?DQ17Z]_JID?_/M_P#@4O\ ,_-O]8LV_G_!?Y'ZS_\ $27\
M./\ HU;6_P#PIX?_ (S1_P 1)?PX_P"C5M;_ /"GA_\ C-?DQ11_JID?_/M_
M^!2_S#_6+-OY_P %_D?K/_Q$E_#C_HU;6_\ PIX?_C-'_$27\./^C5M;_P#"
MGA_^,U^3%%'^JF1_\^W_ .!2_P P_P!8LV_G_!?Y'ZS_ /$27\./^C5M;_\
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MB2_AQ_T:MK?_ (4\/_QFOR8HH_U4R/\ Y]O_ ,"E_F'^L6;?S_@O\C]6H/\
M@XU^'<.O3ZP?V7-:(F@2,1_\)+#D8[Y\FKO_ !$E_#C_ *-6UO\ \*>'_P",
MU^3%%'^JF1_\^W_X%+_,/]8LV_G_  7^1^L__$27\./^C5M;_P#"GA_^,T?\
M1)?PX_Z-6UO_ ,*>'_XS7Y,44?ZJ9'_S[?\ X%+_ ##_ %BS;^?\%_D?K/\
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M]U7P%X)NEWK<16>TPQ,XC$4<MT@+ ;3&DC!3D U]-_\ !7[PO\#A^R3^SO\
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M(7[$EO\ #!?@;^Q]\3[+Q!:^%;5;C6)D\TW,TLS,7N[AW1=\DCAB2.F   H
M'S]\2/V]OV.]6_X*6_#;XN:=^T#H$WAK2?AYK-CJ6L),_DV]Q+(ICC8[<Y8
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M2'QI\;/AW^U/X5^+'P^B\4^'/A?IVD36_C2.XF-CJC6^-0GCCA@>/>\CR#S
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M6?[,.M.H<J2+VTZCJ/\ 75+_ ,.E/^"BW_1K>M_^!MG_ /'J_?7P/_R")?\
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M*+?]&MZW_P"!MG_\>K]]? __ "")?^OV;_T*MBC_ %VS+_GW#\?\P_U5P/\
M/+\/\C^?+_ATI_P46_Z-;UO_ ,#;/_X]1_PZ4_X*+?\ 1K>M_P#@;9__ !ZO
MZ#:*/]=LR_Y]P_'_ ##_ %5P/\\OP_R/Y\O^'2G_  46_P"C6];_ / VS_\
MCU'_  Z4_P""BW_1K>M_^!MG_P#'J_H-HH_UVS+_ )]P_'_,/]5<#_/+\/\
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M6_Z-;UO_ ,#;/_X]7]!M%'^NV9?\^X?C_F'^JN!_GE^'^1_/E_PZ4_X*+?\
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M7T?_ *_3_P"@FMBC_7;,O^?</Q_S#_57 _SR_#_(_GR_X=*?\%%O^C6];_\
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MKO*X/]IW_D@GB?\ [!__ +.M '3> O\ D1=%_P"P3;?^BEK6K)\!?\B+HO\
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M\G\?M&?]MO\ TZRU^OU?"\2_\C:7^&/_ *2CZ?)?]P7K+\V%%%%> >L%%%%
M!1110 4444 %%%% !1110 5P?[3O_)!/$_\ V#__ &=:[RN#_:=_Y()XG_[!
M_P#[.M '3> O^1%T7_L$VW_HI:UJR? 7_(BZ+_V";;_T4M:U !1110 4444
M%%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !11
M10 4444 %%%% &/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444
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M>LOS84445X!ZP4444 %%%% !1110 4444 %%%% !7!_M._\ )!/$_P#V#_\
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M %%%% !7!_M._P#)!/$__8/_ /9UKO*X/]IW_D@GB?\ [!__ +.M '3> O\
MD1=%_P"P3;?^BEK6K)\!?\B+HO\ V";;_P!%+6M0 4444 %%%% !1110 444
M4 8_@?\ Y!$O_7[-_P"A5L5C^!_^01+_ -?LW_H5;% !1110 4444 %%%% !
M1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A5L4 %%%% !1110 444
M4 %%%% &/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,UL4 %%%% !1110 4444
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M "/TQHK\SO\ B)+^''_1JVM_^%/#_P#&:/\ B)+^''_1JVM_^%/#_P#&:/\
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ML]_Y&4O1?D<?_P &]/\ R?Q^T9_VV_\ 3K+7Z_5^0/\ P;T_\G\?M&?]MO\
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MW_KRB_F:V*Q[+_D=[W_KRB_F:V*_'S]+"BBB@ HHHH **** "BBB@#'\2_\
M(7T?_K]/_H)K8K'\2_\ (7T?_K]/_H)K8H **** "BBB@ HHHH **** ,WQC
M_P BQ>_]<#5S3O\ D'P?]<5_D*I^,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%%
M !1110!^6/\ P=-?\D#^%?\ V.%[_P"DHHH_X.FO^2!_"O\ ['"]_P#2445^
ML\*?\B2'K+\V?!9[_P C*7HOR./_ .#>G_D_C]HS_MM_Z=9:_7ZOR!_X-Z?^
M3^/VC/\ MM_Z=9:_7ZOA>)?^1M+_  Q_])1]/DO^X+UE^;"BBBO /6"BBB@#
MY>_X*EWVO'P?\'_"6D_$?Q!X7M/$_P >-#T;7=1\-:[+IURUA/;WHEC\Z-@0
MORJW.1E%..!6QX7_ &)O VG>$?%_ASX??M5_%+4+_P 1>&IM,BOM4^)UUJ#:
M5(Y5H[N$!P8Y4=%^8$97<O1B*YS_ (*L^%/#GCK0_@1X+\8:-!J.DZM^T?X=
MM-2L+I-T=Q!);WRO&P[JRD@CWKVSX.?LI_LX_L]ZI>:U\$O@UH/AB[U"!8+V
MXTBR$3S1AMP5B.H!YH ^/7_;,^-_CO\ 8WT7]E#3]9N;']H+6/&,GPTU6>.=
MA<V,EM@W>L[@0Y066V0S+@^9*64_+7TI\2/V*+;XJ:=X<\*>(_VB_B99^'?#
MGAV'3ETC0_%4EG)J<Z#!O+VY7,US(5"_*S;0P+8):O+_  ?\/O!47_!;+Q;X
MJC\-VHU ?!*SO1=>7\PN7O%MFF_WS!&D>[KM&.YS)_P4K_;UT_X"ZWHG[+GA
M'XBV'@_Q5XUL/M-]XWUF)S:^&=)9Y(FNT5 3/<LT4B11KT9=S%1C(!R/[)_[
M1/Q'^!GP4_::/B#XA:KX\\._!77]1M_!&N^)+PW-S=&&WD<V,MQUE\N18E+=
M1YIQA=JC,\1?LX_&'1/V$W_;CC_:H^([?%VT\$KXVN;YO%,ITLD0"]DL/[/_
M ./?[.(=T80+@D ]/EKL? FF_LA?&C]@CX@?L9?L)_$BR\2W=IX'O4?89/M%
MW?SQR%+BYDD1 TDTZ\MT'0 *H X?7/V^?@]XS_X)KG]G/0=0N[SXNZQ\/!X&
M;X;)I\_]K+JSVGV"96A*Y55)>7>Q VCKN^6@#[6^ WQ*'QE^!_@[XNBV2 ^*
M/"VGZLT$9R(FN+>.4H/]TN1^%=97&?LY?#:Z^#?[/O@;X27\JR7/ACPCIVEW
M,B-E7E@MHXG8'T+*3^-=G0 5P?[3O_)!/$__ &#_ /V=:[RN#_:=_P"2">)_
M^P?_ .SK0!_-'1117] 'XV%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?H;_P2(^ /@75_V8/B
M5^U!X3^"&C?$WXL>$M9CA\)^$M<D5H;9%CAE2X6-C@R,S3%2?F)M=J%6)->8
M_M ?$MOVZ_VNOAM\+OC9^RS8_"?QKJWC:WTOQSJ=A;36EQJ<-W<6T,;2P3H&
M66-1)AV9B_F < "J'_!/_P#9+_;;^('A>7]H+]ASXR:7INNV&JR:=J>A6OB8
M6>H+$J12+)+$X\J6W8N0 Y(+(>#CCZ)_X*Y>-+W6/@5\$?A;\5O&WAB]_:-L
M=?@;5]3\-W2(=-B*NI\QXP/(+3-:OT5=\4C( HKY&<XT\[E:2G*3:5F^:G[O
M6.SAI?IJ[ZGTD(N>5*\7&,;-Z+EG[W1[J73TTT/19O%/P$T7_@HS#_P2W?\
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M+/B-J&D7^H0>'_#,NI3V&E0"6ZN4@B>4Q0H2 \C!2JKD98@9%?DK^W+\6/\
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M'_D6+W_K@:N:=_R#X/\ KBO\A5/QC_R+%[_UP-7-._Y!\'_7%?Y"@":BBB@
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M/4?\.E/^"BW_ $:WK?\ X&V?_P >H_M/+?\ G]#_ ,"7^8?4,=_SZE_X"_\
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M4K^(-?ETE=!DUR\:Q1MR637+F)3ZA,X!_"O?_P#ATI_P46_Z-;UO_P #;/\
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M@^#_ *XK_(53\8_\BQ>_]<#5S3O^0?!_UQ7^0H FHHHH **** /RQ_X.FO\
MD@?PK_['"]_])111_P '37_) _A7_P!CA>_^DHHK]9X4_P"1)#UE^;/@L]_Y
M&4O1?D<?_P &]/\ R?Q^T9_VV_\ 3K+7Z_5^0/\ P;T_\G\?M&?]MO\ TZRU
M^OU?"\2_\C:7^&/_ *2CZ?)?]P7K+\V%%%%> >L%%%% !1110 4444 %%%%
M!1110 5P?[3O_)!/$_\ V#__ &=:[RN#_:=_Y()XG_[!_P#[.M '3> O^1%T
M7_L$VW_HI:UJR? 7_(BZ+_V";;_T4M:U !1110 4444 %%%% !1110!C^!_^
M01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%% &/X
M'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444 %%%% !1110 4444
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M-;% !1110 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\
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M]>47\S6Q6/9?\CO>_P#7E%_,UL4 %%%% !1110 4444 %%%% &/9?\CO>_\
M7E%_,UL5CV7_ ".][_UY1?S-;% !1110 4444 %%%% !1110!C^)?^0OH_\
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M $ZRU^OU?"\2_P#(VE_AC_Z2CZ?)?]P7K+\V%%%%> >L%%%% !1110 4444
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MA+P4/&.F>*O"UM-!:ZIH:LT<\CP2N[12Q2*5(#$-S@#;N8 ^F:*^*8_VH_\
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M:C%)HL%I#,L+632EXY>9F,@;;O/*E1Q0!]145\S?\%#OVM/VD?V<?AYK^O?
M/X(6U[#X=T./4]:\:>*)]FF6R/-Y:VT$,;"6ZN#U(^2.,%2S-NVU]"^"-9N_
M$?@O2/$-^J+/?Z7;W$RQ A0[QJQP"3@9/K0!J45X)^W7\>_CC\&U^&WA/]G]
M?#*:[X^\?P^'Q=^*[.>>UMT>WFDW[8)$;.Z-><GC/'.1U'P!TS]M&PUR_?\
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M7O\ Z2BBC_@Z:_Y('\*_^QPO?_2445^L\*?\B2'K+\V?!9[_ ,C*7HOR./\
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MZOVJO@+KOQ"U3QY8?#'QG9Z?X>\7ZK()KR[LX+^TN)X9YE&)I(%C;<YY^;G
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MR%^S_P#LRW.IZK\)?!#6VJZUM_MC7=2U&XO[^]"_=5[BY=Y-HX^0$+P#C/-
M'BW_  1QU_1O#'_!._1O#WB+4(+*Z\#ZOKUAXJ-Q(%^Q3QZC<SR>:3C;MBE1
MCGH.:T?^".VG7</[#>C>()K%[:WU[Q'K6IZ=%(FUOLTNH3>6V.P(7(]B#WKK
M?B/_ ,$V?V/OBGXXU7Q_XH^&UW'=^()Q-XDM=)\1WUC9ZQ(#G?<V]O,D<K$Y
M))7+$DMG->U^'] T/PIH5GX8\,Z1;:?IVG6L=M86-G"(XK>%%"I&BK@*JJ
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M^PE\(OV5/".CZTOA"PN_B&_AVVM/%?C![NXO)[RY$:^?Y4MRQ>.%I 2$0("
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MEK]HSQ9I7CGXN_#>XU#5M$TS^SM*O++Q)J-@UO;;F;RU%I<1#&6;D@G!QG
MJ3X5_L._LR_!>+6[?X?^ [Z&+Q'I+Z9K4&I^*M3U".YM7R&C*7=S*JY!()4
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M>%/^1)#UE^;/@L]_Y&4O1?D<?_P;T_\ )_'[1G_;;_TZRU^OU?D#_P &]/\
MR?Q^T9_VV_\ 3K+7Z_5\+Q+_ ,C:7^&/_I*/I\E_W!>LOS84445X!ZP4444
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MS_HN'C#_ ,*6Z_\ CE'_  T)\?/^BX>,/_"ENO\ XY111[*E_*ON#GGW8?\
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M11[*E_*ON#GGW8?\-"?'S_HN'C#_ ,*6Z_\ CE'_  T)\?/^BX>,/_"ENO\
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MS_HN'C#_ ,*6Z_\ CE'_  T)\?/^BX>,/_"ENO\ XY111[*E_*ON#GGW8?\
M#0GQ\_Z+AXP_\*6Z_P#CE'_#0GQ\_P"BX>,/_"ENO_CE%%'LJ7\J^X.>?=F7
MXI^)7Q&\<V\5IXV\?ZWK$4#EX(M5U6:X6-B,$J)&(!QW%%%%6HJ*LD)MMW9_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ctlt-20210630_g5.jpg
<TEXT>
begin 644 ctlt-20210630_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %F!.L# 2(  A$! Q$!_\0
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ME^-DF/A;6+V6)X]5"#)PL;%X"5Y'F!2<<5?+*]DM?\[V^^STWT?8FZMS=/\
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M5+K^T[OR88FVDQG_ $7)8;>.,<U^B%%2HJ,7%;/_ #B_SBBN9\REU7Z*2_\
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M=B(SL&920%R.N3S7WG13C[K@U]G;_P "4_\ TI?IL-Z\WG;\(\OY?Y[GS?\
M#OX#^._#/[7'C3XH:G-X</AOQ!IEMIZVMI=7#7D1A0!6(:((<G.?FX&*S?VG
M_P!F/QS\</B5H^KZ1XBTJT\.6F@:GICZ=J1E)2ZN8)(5G150J2!(>200,XKZ
MBHJ)14HQ@]DFOONG_P"E,<6XMR6[M^%K?^DH^$F_8I^*=EX1_9^TFRU#P=--
M\,YIKBYDN+R[5;QG/RJF(#@8SG..:SK;_@GQX]U+X2^/O#^JZ_X;LO$&J>,F
M\9:/<V,MQ-;1S$J?(G#Q*=GRCYE#'VK[^HK9RDY.?5N_SO&5_OA'[B4E91Z)
M6MY>\K?^32^\^6/AK^SQ\3-(_:YU3XP^*+SPJ;'5]!BTJYT_2KBY>2WD14YC
M+PJ'4LG5B#@].U>J?$?P)XUU'Q]I'BKPEJ^FQ#3]-NK.71=65Q;Z@TKQ,N^1
M58QA?+/S*K'G&,$UZG14/:*6G+>WSO?_ -*86U;?6U_DDE^2/S*_;(^"\GP3
M_9;^(.K:[>Z'IWB#QMXJL=2ETG1F*:?:LFU2L'F!6D)"[V8J#ECQ7O7A/]F'
M6/BU\2?%7Q)\;ZYX>OM+\0>%&\-Z,OA>=[A#:RQ!6NGD9%!=E.0J[E&>&-?5
MFKZ!IGB"%(=4TVTU*)3N6.\@650?4!@>:LV=G;Z?:Q6UK!';6T*A(X84"(BC
M@  < >PI*,>1PDM.GDN10^^RM?LRW)WBT]M_-\RE^:1\<?LS_L+R?!N^T^S\
M1>%?AWJ\&C3226'BRUMYFUF53G8)$:((C ,?G5R> ,=ZZKX#_LX_$?\ 9Z\;
M^,]-\/Z[H%_\-O$6L2:VDE\9O[5L9I0#(BH(_+D4D8&7&,9ZDU]1T5HI-2YO
M*WKM_DON,N16:\[^F_\ F_O]#X5U[]C'XOZO8_'6VM/$/A72?^%AZS!J4$EO
M=W9*0I,ID@F_<CY7BW [<\G'0YI5_8?^(]AX=^/^G6FK>%)7^),5G':&26XB
M2S\H,'#A83Q@\8S[U]TT5BHI0]GTMR_*R5O_ "5?TV;<TN?VE];\WSO>_P!_
M]:(^.-#_ &2/B'H/Q,^#?CA=9\-PWOA#PM_PC.JP*\\B;%+[9[?,8WMM;E7V
MC/>MGP-X1\&?&;]JUOC#X'\0M?Z9;Z9+I.MV\"R1)-?02A(UF1U4Y3:&&1U4
M$9KZNJGI^CV&DB46-E;V0F<R2?9XECWL>K-@<GW-;<\O:*?9R?SE>_RU?](Q
MY$H."ZJ*^4=OR1QGQX\,>)O&WPI\0>'O"::2VK:I;/9AM:GEAMT1U*LV8D=B
M1D8&,'UKY*\(_L2_&$_LUZ;\!]>\1>$-'\'QRL;[6]%EN;J_N8FE:0Q"*6%$
M3.[&[?VZ5]Z45DHI.3>M[7^3NOQ^_KH:N3:C;2U[?/1_@?'GQZ_8)L_%]Q\+
MK_P7:Z!=CP+:+I<?A[Q8)&T^^LP,;9'C1W#CJ&VGGFF_%[]C?Q!XH^!^A>#O
M VB^ O!E['X@MM>U&ULS/!9*T.2$C9(2TA/&6=5X[5]BT56O?[7-\[J7YJY%
MEI;HN7Y6:_)M'S/\*?@#X^\,_M/>._B/XA?PPVA>*-+M;%K33KJYDN(6AC"Y
MP\*J0Q+=^@''6M?]F#]F*Y_9]O?&\5QK$>J:+J6JW%QH=E'N"Z=9RR&1H2",
M9WL3Q7T#10K)6\G'Y-W_ #"WYI_-1Y5^!\-?"S_@GDOPU\<:O#>>&_A_XR\)
M7>J'4;/6-<MY7UFP!.XQB/RC'( 0,$R#')]J]7^&_P !_&7@C]J[XB?$R_F\
M/MX3\1V%M:06]K/.;V 6Z84LAB"<Y;(#'  Q7T=241;CRVZ*WX6^^W7[]0DE
M)RO]IW?W\WYZ_EH?*7@#PCX-^,7[5DWQC\#^('O])CTM]+UFW@62))[Z";RT
M69'53NC" C(_A!''-?5U5-/TBPTA95L;*WLEE<R2"WB6,.QZL<#D^]6Z%=0C
M#HOU=W^+^[0;UG*??\DK+\$%%%% !1110 4444 %%%% !1110 4444 %>2_M
M0?L\Z5^TY\)-1\%ZE=MIDTCK<V6HI'YAM;A,[)-N1N'/(R,UZU142BIJS*C)
MP?,CYW^'-K^T)H'A'2?!NL:-X/+6, L/^$SAUB:21HD&V.<Z>;=<N5 ROG@9
MSS7(>//@'\3=3_:DU3XAZ9I^@WVAS^#Y_#<?VK5I(+AY9 ")606[ #< ,;CP
M<YXQ7UO15U+U'S2WUU_Q)Q?X-DP_=KEAHM/P::_%+[O4_.O3OV,?C18_##X*
M>&_[-\*M=^ ?$%SJ]Q)_;LP6Z1Y ZJO^B_*>6!Z]!Z\6+G]C'XPWGP@^/'AA
MK#PO'J/Q#\1'6+1AK4ICMHVE#LKG[-DD#T'/M7Z&44Y>]?SO?Y\O_P A$J,G
M%J2>WZ.3_.<CXWM/V>?BU\._CMH'Q8\)6?AW5[V]\,1:#XB\.:GJ\L$431["
MCVURMNQ;E<_-&. 1WR,?]J']F/XW_''Q5?2QWOAG4?#U[X5DTN+3[R\F@BT^
M^D<L\R1^6XD(78HD)!XR N<5]P44I_O$E+I?\>:Z_P#)GY_<33_=_#Y?A:W_
M *2D?$WAG]F7XK:;\0OV=-:NM+\-K9?#O1!H^I^7K4K/-F+RC)$/LPSA?FVD
MC)XR.M?2'QE\)^,?$3>&KOP=?V%M<:7?M=7EGJ0<P:A 8)4-NVWH&+K\Q!VX
MSM;&*])HJYR<]7O=OYMW]+7Z??<F,5&WHH_):??Y_=8^+V_8W\0>-)/C#XAO
M=&\._#G6O&GA]=!M]$T"]>\LPR@G[5-)Y4(+ME5VK& H3.26-8'PT_9?^+_A
MWXP?!/Q?XFL_"EGHWP_\--X>NUL]8EDDDC$+Q^>-UNHS@AMIQCD;N]?=]175
MK#?6TMO<PQW%O,ACDBE4,CJ1@J0>"".QK+5*T.VG;:2_*<OOTV1<O?34NM[_
M #Y5_P"V1^[S9^4W[,_PE\8_M(?L[_\ "#:,_AZ+PE%\0)=5U359=09KZ".)
MPWEI;K&02YQAS(N #P<UV,.D>*_%7[5'[4W@[P!%X=U&[UC2],TPKK.J&W\E
M1;;/-0+'(92@SN3 Y(RPK]#/"?P\\*^ _M7_  C/AG1_#OVHJ;C^R;"*U\XC
M."_EJ-V,G&?4U%IOPQ\':+XCE\0:?X3T.QUZ7=YFJ6VFPQW3[L;LRJH8YP,\
M\XJI*,KQ?PN+3\VU&/W6C;OUWU+]I+FE-;MW7E[_ #_G_5M#Y)M_V5?%_P *
M_'GP%UFP?1;OP?\ ##0Y+35M0O-0DAGEWQL)Y4B$+C"Y9@N[G&..M=C^SO\
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M9R5W][7XVN3\-2I#HG^B?ZA1112*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "J^H&Z6QN#8K"][Y;>0MPQ6,OCY0Q ) SC. 35BBD]58
M:T=SXC^$O[8GQD^,?Q2\>^!=)\(^ =.U'P;(T=]=ZCK-ZMO+A]N8RMN3C_>
MJ3XY?MB_&GX$?".V\;ZU\+_#\D<.HOINI0PZG<,L1P#%/&WE?/$ZG[W8@BO
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M6WN94(\A3N^56D/E@\D*V<CK7IO[1?[-NO>!?!?P]M_ >B+XU\->'C<W>N>
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M)7Z3J-QXS\8>$-8U1]6T/X<ZC<QZ+;R1;1'/([QR3=3R5+?+VSUK[%_:N^)
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MFO5Z*(^ZVXZ7!^\DGT/GCXC?L _ OXM>,-0\4>+?!T^M:[?L&GNYM:OP3@8
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M=%%%8F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%-9UC4LS!5]2<"@!U%9MQXAL;?CSO,/I&,_KTK.F\8
M+_RRMR?=VQ^@K14Y/H0YQ74Z.BN1D\67C?=6)!]"?ZU7;Q%J#?\ +?;]$7_"
MK]C(CVL3MJ*Y+3=7O)_M6^=FVV[NO X('!K\TH?VO?B_;_=\;71_W[:W?^<9
MKMPV7U,4Y*#6EOQ.:OC(8>SDGJ?JU17YBZ9^W5\7-/QY^LV.HX_Y^M.A&?\
MOV%KN/#_ /P4<\6VFT:SX6T?4E'4V<DMJQ_$F0?I71+)\5':S^?^=C&.9X>6
M]U\C] J*^4?"?_!1+P/JK+'KNB:MH,C=9(PEU"OU(*M^2&O</!/QY^'WQ%9(
M] \6:=>7+XVVLDGDSGZ12!6/X"O.J82O1^.#1V4\31J?!)'?4445R'2%%%%
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M&?9SN4;WVY'E%=E/]Y37.OO.:?N3?(_N/K3X<_\ !0SQ7HGDVWB_2;7Q';#
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M=%%-CD61%=&#HPR&4Y!'J*=7RY[X4444 %%%% !1110 4444 %%%% !1110
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M@@X(KJ-#\0>=MM[IOWG19#_%['WKYBI2MK$]Z%2^C.@HHHKF-PHHHH ****
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M'G!K[9K\1.G(K]"/V,_VI#XZM;?P+XJNL^(K>/&GWTK<WT:C[C$]95 SG^(
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MECGP(KVRW9>UG ^9#[=P>X(]P.^KX"<)4Y.$E9H^RC)3BI1V84445!04444
M%%%% !1110 4444 -9Q&I9CM51DD]JX[6]:;4I/+C)6W4\#^][FK'B/63<2-
M:PM^Z4_.P_B/I]*PJ[*5.WO,YJD[Z(****Z3 ***DM[:6[F6*)"[GL* (ZT;
M+0YKJ/SI66VM^IDDX_(5:\NST%1YH6[OO^>?\*?6LN^U*XU"3=-(6'91PH^@
MK%S;^$Z84;ZR-$W^GZ7Q:0_:IA_RVFZ#Z"J-YK-W?9$DS!#_  )PO_U_QJE1
M46ZLZE%1V"BBBF4%:OAG_D,1?1OY&LJM7PS_ ,AB+Z-_(U,MF)['R[J'_(0N
M?^NK?S-5ZLWS!=2N&*AP)F)5LX/S=.*Z/QHUM')X:NHM.M8$ETV.:2VA0I&Y
M\Z488@[CPH!8MN..N>:]SFM9'0<G3HI7AD62-VCD4Y5E."#Z@UZ'JLVE6?B;
M3;BXM;&P2YT2.5/]%#6\=P\1*NT85MPR?[K=CSBK?C+PC;0Z?J<FE)9B2662
MYDC:,K(D<80M'$"N$P7W,,J>B ?*PK/VJNDUN+F,32/BWKEE:M8ZBT/B#3)!
MMEL]403*ZYY!)Y/XY'M7'>*/V>OA5\6UDET&63X=>(Y.5MV/F6$K^@!QM[#Y
M2O\ NFHZ*UC%TWS4WROR_P MC"MAJ5=6J1N?,WQ6^ OC/X-7GE^(M*9;)FVP
MZG:DRVLWT<#@_P"RP!]JK_!7X3:E\:/B!8>&]./E1O\ OKRZ(R+:W4C?)[GD
M #NS*.,YK[.\._$2[TK3I='U2VA\0>';A#'/I>H*)(V0]ER#@<=.1[9YKTKX
M->"? WA?0M=F^'EH;6;4IUFO;>9RT\"[<+$N>=@^8CD\LW/8=<\RJ4Z34H^]
MT?3Y]CYZIE/)433O'\3H+/2=,\*Z'IWAS0K=;31=+B$%O$O?'5B>Y)R23R22
M3UI:""#@C!HKP3M"BBB@#I_#VN&8K:W#9?I&Y[^QKH:\W!*D$<&NP\/ZQ]OB
M\F4_Z0@Z_P!X>OUKDJT[>\CIISOHS8HHHKE-PHHHH **** "BBB@ HHI"0H)
M/ H JZIJ":;:M*W+=$7U-<+-,\\K2.=SL<DU<UK4CJ5XS _ND^5![>OXU0KO
MIPY5YG'4ES,****V,PI\,+W$BQQJ7=N HHAA>XD6.-2SL< "MF>XC\/0>1!M
M>^<?O)>NSV%1*7+ZFD(.;!C;^'5 (6XU#&?]F.L6YNI;R8RS.9'/<U&S%V+,
M2S$Y)/4TE8^;.^,5%604444R@HHHH **?'#),VV-&D/HH)JW'H=_)TM7'^]A
M?YT70'/_ !%_Y)/JG_7S%_Z$E>%:*(CJD)FNH;)%W,)KB#SHPP4E0R8.06 !
MX/7.#TKZ,\:>$]5U;X>W^FVMKYM[+/&Z1>8@R RDG)..Q[UXC=?"GQ;9J6DT
M.Y8#_GEMD/Y*37;AIPY&F^I<6K%_5M4TW4M0TR0:M9+?VMF4EO'L7>R=@V$C
M6%HSM 0GI'C=SC)S5AO&%G;^+8[V'4?W LX?MTB0%EO)XP"!$CK^[Y"A6PFW
M!(QP#PM]IEYIK[+RTGM'Z;9XV0_J*K5U>SBUN7RH[SQ5XFTGQ!X:CD*VPU-E
M@588K8I)"RF029?;S&5\L*NXXP.!@UP=%%:1BH*R&E8*M:7JEWHM]%>6-Q):
MW,1RLD9P1_B/8\&JM%5OHQG0^//A[X7_ &GK14U P^&OB%$FRVU6-<0WV!\J
M2COZ>H[9'RU\1^._ FM_#;Q/>:!X@LGL=2M6PR-RKKV=&Z,I[$5]=ABI!!P1
MT-=5KWA_1/VC/#,7A;Q5*MIXFMU(T7Q#MRX;M%+_ '@>.O7V;!.V'Q$L*[/6
M'Y>GEY?<>#C\N59.I2TE^9^?5%;WCGP/K/PY\47_ (?UZT:SU*S?8Z'E6'9U
M/\2D<@]P:P:^DC)22:V/CFG%V85;TG5KS0=4M-2TZYDL[^TE6>"XA;#QNIRK
M ^H(JI13WT8'ZN_LT?'JS^.G@.*ZD>.+Q'8*L.J6BC&'QQ*H_N/@D>A##MD^
MO5^1G[/_ ,8+OX*?$K3]>B+R:<Y^SZC;*?\ 76[$;N/[R\,/=1V)K]:=+U2T
MUO3;34+"=+JRNXEG@GC.5DC8 JP]B"*^!S+!_5:MX_"]O\C[# XGZQ3M+XD6
MJ***\@](**** "BBB@ HHHH *;)(L4;.YVJHR2>PIU<YXIU/ %G&>>LA'Z"K
MC'F=B92Y5<Q]6U)]3NBYXC7A%]!_C5*BBO1225D<3=]6%%%%,05L6>GPV$ N
M]0'!_P!7!W;ZBEL+.+3;<7]XN?\ GC#W8^M95[>RW]PTTS98]!V ]!6,I<VB
M.FG3OJR74M4FU*3+G;&OW8UZ+5.BBIV.P**** "BBI(;>6X;;%&\A_V5)H C
MHK5A\,W\P!,:QC_;8?TJTO@^X_BGC'TR:GF7<5T>-?M"?\CE8_\ 8.C_ /0Y
M*\_U#Q!JFKPQQ7VI7E[%&<HEQ.\BJ<8R 3Q7OOQ.^$-_XXUNWO[2^M[<16JV
MYCF#<D,QSD _WJ\_O_V?/%%I&6A>QO3V2&8JW_CZ@?K7HT:U+DBF]4:QDK(\
M[CU"ZBCA1+F9$@D\V)5D($;\?,HSP>!R/05)#K6H6ZW:Q7US&MYQ<A)F FZ_
M?Y^;J>OJ:T=8\"^(-!5GO](NX(E^]+Y9:,?\"&1^M85=BY9*ZU- HHHJP"I[
M&^N--NXKJTF>WN(FW)+&Q#*?8U!12 Z?QAX,\,?M,:3]@UU8-%\?1QB.PUZ-
M JW)'W8Y@.H/IVS\N/NGX=\>> ];^&OB>\T#Q!9/8ZC;-RK<JZ]G1NC*>Q%?
M7==7KOAO2?VCO"2^%/$DL=KXIM$)T37G&7W8_P!5(>K ]_7K]X G;#XAX5V>
ML/R]/+R/"Q^7JLG4I*TOS/SYHK:\9>#M7\ >)K_0-<M&LM3LI#'+$W3V93W4
MC!!'!!%8M?2)J2NMCXUIIV85-8WMQIMY;W=K,]O=6\BRQ31G:R.IRK ]B" :
MAHI@?JG^RW\?(?CGX#$EXT<7B;3=L.I0)QO)'RS*.RO@\=B&'3&?:*_(KX!?
M%Z\^"OQ)T[7X2\E@Q^SZA;*?]=;L1N&/4<,/=1[U^M6DZM9Z[I=IJ6GW"7=C
M=Q+/!/&<K)&P!5A[$$5\%F6#^JU;Q7NRV_R/L,#B?K%.TOB7]7+=%%%>.>D%
M%%% !1110 4444 %%%-DD6-&=CM51DD]A0!0UO5!IMJ2I!F?A!_6N)9BS%F.
M23DDU:U2^;4;QY3]WHH]!52O0IPY5YG'.7,PHHHK4S"I;6UEO)EBB7<Y_3W-
M);V\EW,L42[G8\"M6\NDT6 V=HV;AO\ 73CJ/8?Y_6HE+ET6YI"#FQTUU!H,
M9@M=LMZ>'FQD)["L.21YI&=V+NQR68Y)IM%8VZGH1BHJR"BBBF,**** "BK=
MOI5W=8\JW=@?XB,#\S5^+PG>O]YHH_JV3^@I<R07(_#G_'U<?]<'_I7R[IFI
M7&CZA;WMHRQW,#B2-V17"L.APP(R/I7USI?AV6PFD=YE;=&R84'OWKQJX_9O
MUA5/DZK8R-V$@=1^@-=&'JTXN7,]RHR6MSS]?&VK1ZK!J4;VL-]"7*S0V$"$
MEQABP" ,?<YQDXZU ?%6H"\2ZB-M:W"1M&LEK9PP$!A@D;$'.#PW4=B*ZC4_
M@;XMTY2R645\HZFUF4G\FP3^ KC-2T>^T:?R;^SGLY?[L\90GZ9ZUZ,72E\-
MC56>Q.WB34&T5=*,Z_85P-@B0,0&+A2^-Q7<S-M)QDYQ6;116J26PPHHHI@=
M'X.\=:CX-N'$!6YT^;BYL)^8IE(P01V.._YY'%>5?'K]E^RU#2;OQ[\,(FN-
M(&9=2\/H,S6!ZLT:]2G4[1T'(ROW>RK7\+^*M0\'ZM'?Z=-Y<B\/&W*2+W5A
MW'_ZQS2C*=&7M*6_X/U_S.+%82GBH<LM^Y\&T5]7_M0? O3=;T.3XH^!+/R;
M-FSKNCPK_P >DAZS*!_ 3][ P/O="V/E"OHZ%>.(ASQ^?DSX6O0GAYN$PHHH
MKH.8]6_9N^.%W\#?B';ZD6>30[S;;ZI:KSOASPX']]"=P_$?Q&OU;TO5+36M
M-M=0L+B.[LKJ)9H)XCE9$8 JP/H017XG5]T?L ?' WEK<?#?5[C=+ &NM(>1
MB2R=98!_N\N/8OZ"OF\WP?/'ZQ!:K?T_X![N6XGEE[&6SV]3[3HHHKXX^F"B
MBB@ HHHH **** "L?Q%JAL;?RHSB:0?DOK6G<7"6L#RR'"(,FN#OKQ[ZZ>9^
MK'@>@["MZ4.9W>QE4ERJQ!1117<<@445/8V<E_<+#$/F/4]@/6C;4!UAI\NH
MSB.(>[,>BCU-:%WJ4.F0FTT\Y8\27'<_3_/^--U.^BL;<Z?9'Y?^6THZN?3Z
M5BUSM\WH=U.GRZO<"23D\FBBB@W"BBB@ HI54LP !)/0"M&W\.WUS@B'RU/>
M0X_3K2;2W S:U?#/_(8B^C?R-78O!TA_UERJ_P"ZI/\ A6AIOAM-.NEG$[2,
MH(QMP.142FK6);1\A7DABU2=U"DK,Q&Y0PX;N#P?QJ_J/B_4M6%H+K[&XM"I
MA"V$"!0"2%^5!E,DG:?E.>E>QWW[-]I<RRR1:Y-$SL6^>W# 9.?[PKG]2_9Q
MUBW4M9:G9W>/X9 T1/TZC]:]58BC*UV;\T3S^[\:ZM?7=E<RR6WGV6WR'2R@
M0H%&%'RH,@=@>!VJ"/Q3JD6FW-B+LF"X9VD+(K2'>5+X<C< VU<@'!QSFK^O
M?#CQ)X;W->Z5.(EZS0CS$^I9<X_&N;KIBH27NV*TZ!1116@PKM_A'X?U;6O%
M,<^FW<FG0VF'N;R/'R)_=YX);!X.1P3CBN=\+^&;WQ=K5OIMC'NED.6<CY8U
M'5V/8#_ =37T1;Z?8^%-'BT/2AB"/F>;^*>3N2?\] .@KCQ%7E7(MV1)]#<N
M([/Q!)+]F/E7:]-W E'K6!)&T,C(ZE74X*GM3(Y&B=71BK*<AAU%;H\OQ':D
M\)J,2\]A(*\Z,N71['#4I]48=%#*58@C!'!!HK<XPJ2WN'M9DEC.UU.14=%
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M_I7AK5+_ %G2+%4U"=-JQ_P1?WBB]B?3VXQSGTJ>-?+:2U-54[G/>&/#5O\
M#K0?L$+++J]P U[<IV_V%/H,_P SWX?3I&9I&9R2Y.23US3:PU;N]Q!3X)GM
MYDEC8JZG((IE% &YJ,*:I:?VC;KM<<3QCL?6L:K>CZA_9]V"_,#C9(OJ/6G:
MM8?V?>,B\Q-\T;>HJX.WNLXJL.5W12HHHK4YPKM?#^H&^L5W',L?R-[^AKBJ
MU/#M]]CU!58XCE^0_7L?\^M958\T32G+E9VE%%%>>=@4444 %%%% &7XBN_L
MNF. </(=@_'K^E<76YXLNO,O$@!XC7)^I_\ K8K#KOI1M$Y*CO(****V,A\,
M33RI&@R[' %:6O3+;K#I\)_=P %\?Q-_G^=.T%5MUN;^096W3Y<]V/3_ #[U
MCR2-+(SN=S,<D^I-82=Y6['91CIS#:***1TA3XHGFD6.-2SL<!13*ZWPQI(M
MX1=R#][(/D!_A7U_&IE+E5Q-V+FBZ.FEP@L UPP^9O3V%:5%?G5_P\6^)'_0
M$\+?^ ES_P#)%7A\)6QG,Z?0X<1BJ>'M[3J?HK17YU?\/%OB1_T!/"W_ ("7
M/_R11_P\6^)'_0$\+?\ @)<__)%=O]CXKLOO.3^TL/W?W'Z*T5^=7_#Q;XD?
M] 3PM_X"7/\ \D5^BM<.)P=7"6]KU.NAB:>(O[/H%%%%<1U!1110 4444 <G
M\0OA[8^/-+,4H6&_B!^SW6.4/H?53Z5\L:UHUYX?U.XT^^A,%U"VUE/Z$'N#
MU!K[3KS3XU?#U?%&C-JEG&/[5L4+?*.9HADE?<CDC\1WKT,+7Y'R2V-82MHS
MYJHHHKVSH"NU^'%Q8:TNI^#-=7SM \10-:2QL<;)",(R^C9X!'.=I[5Q5.CD
M>&171F1U.Y64X((Z$&HE'F5B914DXL^0OB!X+OOAUXTUGPUJ2XO--N6@9L8#
MJ.5<>S*58>S"N?KZV_;8\+IXE\.^#_B;:P@37D?]E:JR+@><@)C8CWVR#Z!*
M^2:^CPM;V])3>_7U6Y^=XFB\/5E3[!11174<I^D_[!?Q$_X2_P"#9T.XEWWW
MAVX-L03SY#Y>(_\ H:CV2OI2OS2_8-\;OX7^.4&E/+LL]>M9+1U/W?,4>9&?
MK\C*/]^OTMKX#-*/L<3*VSU_KYGV6 J^UH*^ZT"BBBO)/1"BBB@ I&8(I9CA
M0,DTM9OB&X^SZ5+CK)\@_'K^F:<5S.PF[*YR%]=&\NY9C_&V1].WZ5!117J;
M:' %%%/@A:XFCB7[SL%'XT :VG?\2O2YKX\32?NX?ZG_ #Z5ADDG)Y-:_B*<
M?:8[2/B*V4*/KCD_RK(KF6NIZ4(\L;!1113+"MSP]H?VUA<3C]PI^5?[Y_PJ
MAI.G-J5XL71!\SMZ"N\CC6&-410J*, #M64Y6T1+9R_Q/^(FF?"7P+J7BK5X
M+JXT[3_*\V*Q16E.^5(EVAF4=7&<D<9^E>!_\/%OAO\ ] 3Q3_X"6W_R17;_
M +:G_)LOC+_MS_\ 2V"ORSKW<MP%'%47.IO>WX(^?QV,JX>HHPVM_F?HK_P\
M6^&__0$\4_\ @);?_)%'_#Q;X;_] 3Q3_P" EM_\D5^=5%>M_8^%[/[SSO[2
MQ'=?<?K1\#_VB_#?Q^_MK_A'K+5;/^R?(\_^TXHX]WF^9MV[)'S_ *ILYQU'
M6O4Z^&_^";\[VMG\39H[>2[DCCT]UMX2H>4@71"J6*KD]!N('/)'6O5_!/[:
MEE\0-+?5-(^%7C^72H];;P[-?,ND[(;\2"+RF4:@6 \QD7S-NS+#YL<U\ECJ
M4*&)E1I]+?C;]6E\UW1]%A:LJF'C5GUO^OZ+\&?1M%>!_#[]L/0OB7\*_&OC
MG1_!?BW[/X3O9=/OM%N([%=2>>+;YJ1Q"[(W)N^Z[*S8P@<X!U?CA^U1X;_9
M_P#"FEZYXH\/^*)OM<*W-U8:1IHO9M+ARH>6[:-S%$B,X4MYAW'(3?@UP2:B
MKOR_'5?*VMSM2<M%Y_AN>ST5X[XQ_:K\#>#GTYFDO=6L;C2(O$-W?Z;$CPZ9
MI<C!([VXWNK"-F; 6,/)A6.S:I(I^(?VO/ WACXT:#\-[ZWUQ;O6IQ96?B!=
M-;^QGO"H86HNB0'E(9>$#!2P#$'BJUYE'JW;YWM^>GKIN3S*SET2O\M_RU]-
M=CVZBO-/"GQVTWQ1\9O%'PS;0=:TG7] LHM1DGOEMC;75M(Y2.2%HIW;DJ3A
MU1@.H'2O2Z6Z4NC_ .&_-#ZM=O\ A_R."^*7PQ@\=:?]HM@L.LP+^ZE/ D']
MQO;T/;\Z^8+JUELKF6WGC:*>)BCQL,%6!P0:^W*\4^/GP_62#_A);&+$B86]
M51]X=%D^HZ'\/2O2PE?E?LY;&U.71GA5%%%>R;A7:>#]-L_B-X6\0_#G5V7[
M'K5NSV4CC/V>Z4;E<<>P;_@&/XC7%U8T^_GTN_M[RV?R[BWD66-O1@<BHDG)
M:;]/4B<54BXRV9\5:YHMYX;UJ_TG4(6M[^QG>VGB;JDB,58?F#5&OIG]N3P;
M;P^,-!\=Z=!Y5AXJLEDF"CA;J,*'!QP"5*?4JQ]:^9J^EP];V]*-3O\ TS\Y
MKTG1J2IOH%%%%=!@?IM^PY\1?^$W^"-GIT\N^_\ #\ITZ0$\^5C="WTVG8/^
MN9KZ%K\YO^"?'C,Z'\8;W09)-MOKE@ZK'G[TT/[Q3^">=^=?HS7Y]F5'V.)D
MEL]?O_X)]G@:OM:$6]UH%%%%>6>@%%%% !1110!D^)KK[/IK(#\TIV#Z=_\
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M04G)Z^G^1\M+-*T9-)+\?\S]3/\ AM3X,_\ 0Y?^4N]_^,T?\-J?!G_H<O\
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M!5G3?^0C:YZ>:O\ ,56J2WD\FXC?^ZP;\C0!Z/1117$9!1110 4444 %%%%
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M_)K_ .PK6-.<U>**46]CTNBO-/\ A<W_ %!__)K_ .PH_P"%S?\ 4'_\FO\
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MEUX.M-:2;Q!;.\3P>1*(FE1 \D*3E?*DF1&5GB1RZ*064"NTK\WOAGI6N?\
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MM)T'Q5:Z]K,1N=/CMI;2/<LEL4NKB/S'=6^Z5V$$Y8=*[+_A&=8_Z!-]_P"
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MJ#C#8\N+W)[_ .?>L?.>3R:J&KN<E:7V0HHHK8Y0KJO"-OLM)IB.7? ^@_\
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M@HHHIB-F\7^U])CNEYN+8;)?4KZ_Y]ZPZT-)U#^S[L.W,3?+(OJ*36--^P7
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M "-9%Y9RV,[0S+M<?D1ZBL-4[,]",E)71#1113+"I(+B6UD#Q.T;^JG%1T4
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M:RWU_=2+#!;P*6>1R<  5^GG[*_[.,'P+\*O<:@([GQ9J2 WLZ?,L"=1 A]
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MLS.V6)8^I.:?)+JR'7[(U_,TG3_]7$]])_>DX7\O_K55OM:N;[Y6?RXNT<?
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M%J^BO@;^Q;XM^*36VIZXLGA;PV^&\ZYC_P!)N%_Z91'H"/XVP.X#5]<_!O\
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M36--O<Q]*\+B,B6\PQ[1#I^/K70@!0 !@4M%<4I.3NSIC%1V"BBBI*"BBB@
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1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ctlt-20210630_g6.jpg
<TEXT>
begin 644 ctlt-20210630_g6.jpg
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M\?\ 21C_ ,G-5_\ CM'_ !#T_M\?])&/_)S5?_CM?K]17E?ZS9M_-'_P&/\
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M/_)S5?\ X[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\
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M_P# 8_Y!_8N [/\ \"?^9^0/_$/3^WQ_TD8_\G-5_P#CM'_$/3^WQ_TD8_\
M)S5?_CM?K]11_K-FW\T?_ 8_Y!_8N [/_P "?^9^0/\ Q#T_M\?])&/_ "<U
M7_X[1_Q#T_M\?])&/_)S5?\ X[7Z_44?ZS9M_-'_ ,!C_D']BX#L_P#P)_YG
MY _\0]/[?'_21C_R<U7_ ..T?\0]/[?'_21C_P G-5_^.U^OU%'^LV;?S1_\
M!C_D']BX#L__  )_YGY _P#$/3^WQ_TD8_\ )S5?_CM'_$/3^WQ_TD8_\G-5
M_P#CM?K]11_K-FW\T?\ P&/^0?V+@.S_ / G_F?D#_Q#T_M\?])&/_)S5?\
MX[1_Q#T_M\?])&/_ "<U7_X[7Z_44?ZS9M_-'_P&/^0?V+@.S_\  G_F?D#_
M ,0]/[?'_21C_P G-5_^.T?\0]/[?'_21C_R<U7_ ..U^OU%'^LV;?S1_P#
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M:_Y('\*_^QPO?_2445^@9!7GC\LC6K).3;Z);,^3S6E'"XV5.FVDK=7V./\
M^#>G_D_C]HS_ +;?^G66OU^K\@?^#>G_ )/X_:,_[;?^G66OU^K\_P")?^1M
M+_#'_P!)1]7DO^X+UE^;"BBBO /6"BBB@ HHHH **** "BBB@ HHHH ****
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M[8+= <O*W0 X#;3CY!\%:GKW[8W_  6YCU;Q5X4&G6?P-\(RPW=DET+B#^T
MSH&27:I<&6[WH2J$BV!*J<K0!^BM%%>(?MH?M!^,/AK\//$?A3X(_9Y?&=IX
M0OM;N;ZXCWV_A[3H(97:^G'0NQC:."(_ZV0,2/+BE*@'KF@^,O"GBC4=5TGP
MYX@M;VYT*_%EK$-M,'-G<F*.;RI,?=?RY8VQUPXJ[J6I:=H^GSZOJ]_#:VEK
M"TUS=7,H2.&-02SLS$!5 !))X %?#G_!OS=ZSK?['?BOQ=XDU*XOM0UKXJ:C
M>7E]>.7EN)&L[ ,[.Q)<E@Q)/<FO0?BU_P %+] LOA]\5/'OP.\!W/B3P_\
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M07BQ$]F,3MM/L<5TM?EE_P %:=;_ .&1?^"C?PH_:*^!Y71]>UNU0^)8-/\
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M(A22)T!5E(P5(/!&.,56/AWP^8[2$Z'9[-/(-@GV5,6Q P#&,?)@<<8H J>
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M_'[1G_;;_P!.LM?K]7Y _P#!O3_R?Q^T9_VV_P#3K+7Z_5\+Q+_R-I?X8_\
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M&5A[$$'\: +-%%% !1110!Y5X[_Y&V]_ZZC_ -!%9%:_CO\ Y&V]_P"NH_\
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M_P#X-Z?^3^/VC/\ MM_Z=9:_7ZOR!_X-Z?\ D_C]HS_MM_Z=9:_7ZOA>)?\
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M8HVY-RYVGU'H:=10 V6&*=/+FB5UR#M9<C(Y%.HHH *:88FE69HE+J"%<KR
M>N#3J* &R11S1F*:-71AAE89!'TI5554*J@ #  '2EHH **** "BBB@#*O\
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M67YL^"SW_D92]%^1Q_\ P;T_\G\?M&?]MO\ TZRU^OU?D#_P;T_\G\?M&?\
M;;_TZRU^OU?"\2_\C:7^&/\ Z2CZ?)?]P7K+\V%%%%> >L%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ?EC_P=-?\ ) _A7_V.%[_Z2BBC_@Z:_P"2!_"O_L<+W_TE
M%%?K/"G_ ")(>LOS9\%GO_(REZ+\CC_^#>G_ )/X_:,_[;?^G66OU^K\@?\
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M7G_$2KI/_1G-S_X7J_\ R#1_Q$JZ3_T9S<_^%ZO_ ,@T?ZKY[_SY_P#)H_\
MR0?V_E'_ #]_"7^1^EGB.21-5TE4D8!KPA@#U&T]:UZ_*_4_^#C_ $G4;RSN
MA^R!<)]DF,FW_A.E.[C&/^/+BKO_ !$JZ3_T9S<_^%ZO_P @T?ZKY[_SY_\
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M !1110 4444 %%%% !1110 5Y+^W=_R:'X\_[ A_]&)7K5>2_MW?\FA^//\
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M(.*^;)OV=_&/[5?_  4<\3? GP2A6ZUSXF:NES=[-R65JM[,\]P_LD89L=R
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MAGF]>CB(4I0GS.SZ6M[SLK7T[)=D?O1_P15_Y1F?#3_N,_\ IYOJ^IJ^6?\
M@BK_ ,HS/AI_W&?_ $\WU?4U?F.;?\C7$?XY_P#I3/O,N_Y%]'_!'\D%%%%>
M>=H4444 %%%% !1110!^6/\ P=-?\D#^%?\ V.%[_P"DHHH_X.FO^2!_"O\
M['"]_P#2445^L\*?\B2'K+\V?!9[_P C*7HOR./_ .#>G_D_C]HS_MM_Z=9:
M_7ZOR!_X-Z?^3^/VC/\ MM_Z=9:_7ZOA>)?^1M+_  Q_])1]/DO^X+UE^;"B
MBBO /6"BBB@#C?BW^T/\"?@+;6]U\:?B_P"'/"ZWA/V-=;U>*W>XQUV([!G
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M_P"$H_\ \DT?V]E/_/S\)?Y!_9&8_P#/O\5_F?GO17Z$?\.#_$O_ $<W8_\
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M^>]%?H.?^"!_B?(V_M-6'OGPJ_\ \D4O_#@_Q+_T<W8_^$H__P DT?V]E/\
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M/_/O\5_F?GO17Z$?\.#_ !+_ -'-V/\ X2C_ /R31_PX/\2_]'-V/_A*/_\
M)-']O93_ ,_/PE_D']D9C_S[_%?YGY[T5^A'_#@_Q+_T<W8_^$H__P DT?\
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M #[_ !7^9^>]%?H1_P .#_$O_1S=C_X2C_\ R31_PX/\2_\ 1S=C_P"$H_\
M\DT?V]E/_/S\)?Y!_9&8_P#/O\5_F?GO17Z$?\.#_$O_ $<W8_\ A*/_ /)-
M'_#@_P 2_P#1S=C_ .$H_P#\DT?V]E/_ #\_"7^0?V1F/_/O\5_F?GO6IK?C
M?QIXET;2_#OB/Q?JFH:?H<#PZ+87VH22PZ?&[;G2!&8K$K-\Q"@ GDU]Z?\
M#@_Q+_T<W8_^$H__ ,DT?\.#_$O_ $<W8_\ A*/_ /)-)YYE#:;J;>3_ ,AK
M*<R2TA^*_P S\]ZT_!?C/Q1\._%NG>._!.LRZ=J^D7B76FW\&-]O,AW)(N01
MD$ CW%?>O_#@_P 2_P#1S=C_ .$H_P#\DT?\.#_$O_1S=C_X2C__ "30\\RB
M2LZFGH_\@64YDG=0_%?YGP-XH\4>(O&WB.^\8>+];N=2U34[N2ZU#4+V8R2W
M$SL6>1V/+,222:H5^@Y_X('^)\C;^TU8>^?"K_\ R15_1_\ @WE^)'B;S/\
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MV[O^30_'G_8$/_HQ* ,VBM[P[\/]6\2^'[#Q'97=ND.H6<5S"DK,&59$# '
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M .^W_P#B:/\ A4FO_P#00L_^^W_^)H^L4?Y@]C5['*T5U7_"I-?_ .@A9_\
M?;__ !-'_"I-?_Z"%G_WV_\ \31]8H_S![&KV.5HKJO^%2:__P!!"S_[[?\
M^)H_X5)K_P#T$+/_ +[?_P")H^L4?Y@]C5['*T5U7_"I-?\ ^@A9_P#?;_\
MQ-'_  J37_\ H(6?_?;_ /Q-'UBC_,'L:O8Y6BNJ_P"%2:__ -!"S_[[?_XF
MJVE?#C6-7MFNK>\ME596C(=FSE3@]%H^L4?Y@]C5['/45U7_  J37_\ H(6?
M_?;_ /Q-'_"I-?\ ^@A9_P#?;_\ Q-'UBC_,'L:O8Y6BNJ_X5)K_ /T$+/\
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M>BC_ %/R;M+[P_UFS/NON/VH_P"(A_\ 8=_Z$;XE_P#@BL?_ )-H_P"(A_\
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MW:7WA_K-F?=?<?M1_P 1#_[#O_0C?$O_ ,$5C_\ )M'_ !$/_L._]"-\2_\
MP16/_P FU^*]%'^I^3=I?>'^LV9]U]Q_2Y^S+^T1X&_:N^"&B?'WX;V.IVVB
MZ_\ :?L4&L0)%<KY%S+;/O6-W4?/"Q&&/!!X/ [ROEG_ ((J_P#*,SX:?]QG
M_P!/-]7U-7YGCZ,,/CJM*&T922]$VC[O!U95\)3J2WE%-_-7"BBBN0Z0K-\8
M_P#(L7O_ %P-:59OC'_D6+W_ *X&@"YIW_(/@_ZXK_(5-4.G?\@^#_KBO\A4
MU !1110 4444 %%%% !1110 4444 8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\
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M^J7P'\:_L]_\%/;OXQ_LKZG^R=X!\)1^&M$NKOX=:WX9T1+2]M%AF:&-Y)%
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M=KM*RM%66EWYMZ]3BQ>+IUX0ITX\L8WM=W=V[O6R/WR_X(J_\HS/AI_W&?\
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MVG^%?%6K>$;.VOO'FKQ2&U\.Z5%&;9KU%52TUR[02+%&!PPW,5&,@%#]D_\
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M_K)F7E]P?V%@//[S\EO^'(?[8O\ T'? _P#X.KC_ .1J/^'(?[8O_0=\#_\
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M44 8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/_P!?I_\ 036Q0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"C$H =I'@SQ%KNDVNN:78B2VO+=)[>0RJNZ-U#*<$@C((X/-6?^%;^,/\
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M $"U_P# A/\ &O3Z*/KM7L@^JT_,\P_X5OXP_P"@6O\ X$)_C1_PK?QA_P!
MM?\ P(3_ !KT^BCZ[5[(/JM/S/,/^%;^,/\ H%K_ .!"?XT?\*W\8?\ 0+7_
M ,"$_P :]/HH^NU>R#ZK3\SS#_A6_C#_ *!:_P#@0G^-'_"M_&'_ $"U_P#
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MU_R0/X5_]CA>_P#I***/^#IK_D@?PK_['"]_])117ZSPI_R)(>LOS9\%GO\
MR,I>B_(X_P#X-Z?^3^/VC/\ MM_Z=9:_7ZOR!_X-Z?\ D_C]HS_MM_Z=9:_7
MZOA>)?\ D;2_PQ_])1]/DO\ N"]9?FPHHHKP#U@HHHH **** "BBB@ HHHH
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M-I\,_@=9V7A-/'>CZ#J_C#Q9-G^TFO)$W)I]M$X8JBL0T\I"[@RJC%=U?5M
M!17S]^TC^T3\;%_:#\-_L?\ [+=AX>3Q=J_AV?Q%X@\0>*8)I[/1-)CE\A)!
M#"RM++)-E%!8*,#((;*X_P &?VN_BMX&^+'Q _9W_;*C\/+K7@?P6/&-EXG\
M*V\L-KJVA*66:9H)G9HI(G&T@-M8DXQMRP!],T5\4/\ M2_\%&-6_9QF_;PT
M+PO\.H/!4>F2:];_  XNK2[;5)M"3,AF:]638MP8 90!'LVD<$_+7??%']M#
MQ_X^U?X6?"G]C[2]%F\2_%/PO_PDZ:QXKCEDL]!T01(_GRPPLKRRLT@C1 P
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M'PU\+VFBZ'I%N(-.TVQBV1PIDDX[DDDL6.2S$DDDDT ;5%%% !1110 4444
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MQ/BK_@F/^Q?XR\8ZCXQUGX5W"_VSJ7]H:UHUGXAOK?2]1NMV[SIK**98'8L
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M9Z7J.H6-T=7DA!BMS]FN9H&N%W'Y$<0^9UP-QQP*\[_X)SV]Y\?_ !_\1_\
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MD/V,_P!A+X1?LJ>$='UI?"%A=_$-_#MM:>*_&#W=Q>3WER(U\_RI;EB\<+2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_#0GQ\_Z+AXP_P#"ENO_ (Y111[*E_*ON#GGW8?\-"?'S_HN'C#_ ,*6Z_\
MCE'_  T)\?/^BX>,/_"ENO\ XY111[*E_*ON#GGW8?\ #0GQ\_Z+AXP_\*6Z
M_P#CE'_#0GQ\_P"BX>,/_"ENO_CE%%'LJ7\J^X.>?=A_PT)\?/\ HN'C#_PI
M;K_XY1_PT)\?/^BX>,/_  I;K_XY111[*E_*ON#GGW8?\-"?'S_HN'C#_P *
M6Z_^.4?\-"?'S_HN'C#_ ,*6Z_\ CE%%'LJ7\J^X.>?=A_PT)\?/^BX>,/\
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99KA8V(P2HD8@''<4445:BHJR0FVW=G__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ctlt-20210630_g7.jpg
<TEXT>
begin 644 ctlt-20210630_g7.jpg
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MOG?]>^(OYX_^"X?Y'U/_ !#CA;^2?_@R?_R1^4O_  X;_;A_Z/\ O_)O4_\
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M */^_P#)O4__ (Y7ZM44?Z]\1?SQ_P#!</\ (/\ B''"W\D__!D__DC\I?\
MAPW^W#_T?]_Y-ZG_ /'*/^'#?[</_1_W_DWJ?_QROU:HH_U[XB_GC_X+A_D'
M_$..%OY)_P#@R?\ \D?E+_PX;_;A_P"C_O\ R;U/_P".4?\ #AO]N'_H_P"_
M\F]3_P#CE?JU11_KWQ%_/'_P7#_(/^(<<+?R3_\ !D__ )(_*7_APW^W#_T?
M]_Y-ZG_\<H_X<-_MP_\ 1_W_ )-ZG_\ '*_5JBC_ %[XB_GC_P""X?Y!_P 0
MXX6_DG_X,G_\D?E+_P .&_VX?^C_ +_R;U/_ ..4?\.&_P!N'_H_[_R;U/\
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M_P .&_VX?^C_ +_R;U/_ ..5^K5%'^O?$7\\?_!</\@_XAQPM_)/_P &3_\
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M_APW^W#_ -'_ '_DWJ?_ ,<K]6J*/]>^(OYX_P#@N'^0?\0XX6_DG_X,G_\
M)'Y2_P##AO\ ;A_Z/^_\F]3_ /CE'_#AO]N'_H_[_P F]3_^.5^K5%'^O?$7
M\\?_  7#_(/^(<<+?R3_ /!D_P#Y(_*7_APW^W#_ -'_ '_DWJ?_ ,<H_P"'
M#?[</_1_W_DWJ?\ \<K]6J*/]>^(OYX_^"X?Y!_Q#CA;^2?_ (,G_P#)'Y2_
M\.&_VX?^C_O_ ";U/_XY1_PX;_;A_P"C_O\ R;U/_P".5^K5%'^O?$7\\?\
MP7#_ "#_ (AQPM_)/_P9/_Y(_*7_ (<-_MP_]'_?^3>I_P#QRC_APW^W#_T?
M]_Y-ZG_\<K]6J*/]>^(OYX_^"X?Y!_Q#CA;^2?\ X,G_ /)'Y2_\.&_VX?\
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M%DY)5/9V=KN^S3T6O;IW..&8SIU53Q"2;ASW5].Z?IW_  /N_P (?M<_LO\
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MCWX@_&7XW_M-_&#XJ^,9O$&O:IK6A)=ZO,-OG%6U0?*@)$<858U1 =J*H4<
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M5\4?^2SK^D/_ $A'*?\ !!O_ )/A^/\ _P!M?_3G+7ZM5^4O_!!O_D^'X_\
M_;7_ -.<M?JU7Y'QW_R44_\ #3_](1^W>&__ "2T/\=3_P!+D%%%%?''W@44
M44 %%%% !1110 4444 %%%% !1110 4444 %(S*BEW8  9))X I:* /R#_X*
M>_''X,?M6_\ !7OX(_ '6OBYX9A^'_P]EBO_ !1K-_KMO%IT<[2?;+N%YW<1
M@M!:6T7+9WR%>O%'_!0OQEJO_!23_@I1\'M"_P""?/VG7I?A[+&VM_$_P_ [
M:?8,UXDQ8WBC8\<"1LP(8AWG9$W,2#^OE%?0TL]A05+V=+6G!Q5Y75Y7YI-<
MJO>^USQJF4SJNISU-)R4G9:V5K).^EK;V/RQ_:T^,-I8_P#!PA\/;/XV:)K-
M[H7@[P>&\ Z)INFRW3ZCJ-Q:3M&\,2#&]KEMGF,516M4+NJH6',?\$Q?VEM+
MU']I[]K/_@H5\6M(GU'Q%IVFWTD>GZ:C&.PTFRCFG>-YW4*@9;.QMHA@R.RD
MB,JDA3];)-'TF;4XM;FTNV>]AB:.&[:!3+&AZJKXR >X!Q3+3P]H%A!<6MCH
M=G#%=3--=1Q6R*LTC?>=P!\S' R3R<4O[:H/">Q]EKR1A?FZ*7,^GVNH_P"R
MZJQ/M?:?:<K6ZM677IT/RI\7?!S3O@[_ ,%0_@U^UK_P3D^(%IK7ASX^ZTS>
M-?"&F72S1I82/%)J5Q)&I.VW\N5I2''[BXCP.JHNSX>\>Z5\>O\ @XVUS6O%
M%E>W4?PI\,+H_A+2XK8O++<&..*64JV%2*,W]].9&( 6-,99D4_IY8>'/#VE
MZC<ZOIF@V5M=WA!N[J"U1))R.F]@,M^-20:+H]KJ<^M6VDVT=Y=*JW5W' HE
MF"C"AF RP Z9/%)YW>+YH7?LW33OK9OKIK9>[W?<%E5FK2LN=3M;2Z7372[U
M/RK_ &#OVJ/A?\ _^"JG[4VJ?MN>,4\*^+]>\0):^%)]<BD ETZ&ZN EO"VT
ME@T T\Q*/]8B KG KZC_ &UO^"H_PF_X)]?#SP+X]U#]G?Q/<:9\0M;O2(;?
M3H]->UBC9&DNIHY!D33+(LL<,@21P'\SRV1E'U;<^&O#E[K$/B&\\/V4NH6Z
M[;>^EM$::)>>%<C<HY/0]Z\]^/\ ^S-H7[3&K:#HOQ8O[6]\%Z%JMMK!\+?V
M8I;4-2MW9H6GG9C_ *.N5;R41"[##R-&6C:)X_ 8O&0JUZ;44DI+FT?+&RY;
M+3H]7\T7#"8O#8:5.E-7NVG;N[N]WKVV^1Z7#=P3V:7ROMB>,2!I!MPI&<G/
M3CUK\;?^"NOQ^^"7[67_  51^"_[.NJ_%KP\/A[X,OK3_A+-;N-6A&GPS7-R
MDMY&\^[RQ_H\%O'N+85W93C!K]EJ*Y<KQ\,NQ#K.',[-+6UFU:^SZ&^/PDL;
M15/FLKIO2][:VW1^>'_!3SXZ>-?^"@GP^A_8/_X)Y:5)XX_X2K4+9O'/C_2]
MQ\/:1812K*(FU  PR.\B(Q$3.=D;( S/M'B'_!6?X*>%?V)_V"_@+_P37\"^
M(3;VGB[QJ;CQ-XIN8BD=S+"8_M$\O7:AGO8Y F252W1<G;D_K]5;4-%T?5WM
MY=5TFVNFM)Q-:M<0*YAD'1TR#M8>HYKKPF=+".E"%/\ =P;E:^LI6LFW;II9
M6_S.?$98\0JDI3]^24;VT4;W:2OUZZGY3?\ !5?Q)X$^(?[3/[)7[$D^AZEH
M?@*R-MK5]I=_ILGG7.GI,+6U@6! S^<UO9SHD.WS,W:*R*_R"S_P5N^*.F?$
MS_@J3^S/\#?B'X8UZ/P_H%O;^*+_ $.UTIKR[O;J>X9Q8B&WWB61CI\<&Y6,
M:F=R7"AG'ZH7.BZ/>:C;ZQ=Z3;2W=H&%K=20*TD(88;8Q&5R.#CK2RZ1I,VI
MQ:U-I=N]Y#&T<-VT"F6-&ZJK8R >X!YJJ.=4Z+I?NW[D9KXOM3O>6WGYDU<K
MG4]I[_Q.+VZ1MIOY'Y.?LT^-O$O[0?\ P<&^*?'GQKLKR?5/ &C2Z9X9\/:?
M;F==*D\M+=XR_""&!;F^D>=BHDD(,:EI8XZZ3]ACQWH?QZ_X+I_'GXV>+%N)
M]1\+R/X2\)Z,D):6%(I#:27FTX\J%(K&4N[8 :]5.7E16_3ZVT;2++4+C5K/
M2K:*ZO-OVNYB@59)]HPN]@,M@<#/2BRT71M.O+G4-/TFV@N+QP]Y/# JO.P&
M 78#+$#C)HJYU3J1DHT[7IJFM=DFF^FS^_S"GE<X.+<[VFYO3>^W7I_2/Q;_
M ."=OCKX.>//BE^T;IW[</[1WB#P%XU\<^+/L?B3PU8(L6I:W:^9<"3387^S
MRW.-[>48+79*RK&H^4 5W?\ P6!C^%_PEOOV1_V>C\,;_P #? Q/%']I:]X<
M_LR1V$,=W:JZRQ1&1Y)Q;S7#E<O,QNGW OD5^L:^%?#":Z?%">'+ :FR;6U$
M6:>>5QC'F8W8QQUJ>_TC2=5:!M4TRWN3;3B:V-Q K^5(.CKD?*PR<$<UK+/X
M/'QQ"INR^SS:)\O*FO=TMT;N^BL1'*)+".BYJ[ZVUMS<VNO7K:Q^5OPZ^+S_
M +4'_!P7_P )1\1?#>JVEM\-_""6W@CPQ-IK?:D:>&("2>(X$+(FH7%S(7VF
M/REC^9U0-^EG[0'BKQ5X%^ _C;QOX$L&N]<T;PCJ5]HUJD6\S7<-K))"@7!W
M$NJC'?-=+!HVCVVISZU;:5;1WERBI<W:0*)957[H9@,L!V!/%6:\W&XZGBJE
M)QA90C&-KWVWZ=7?[SNPN$GAX5$Y7<FW>UM_\C\!OAU^T]9_#3_@A]X]\+_#
MZUU.\\6?$'XCR6?Q&\37EC,(X%N C);BY==MQ--!;R$JI;8KS,Y1GB$GT)_P
M4"\6:;\+_P#@C7\#_P!BOX*V]U)>?$6_TO2+4R6Y@&L+#Y=U=7,*-\YBDU"6
M#:S*-ZON&Y&1F_6,^#?"!TC_ (1\^%---@9?--E]AC\GS-V[?LQMW;N<XSGF
MM(  8 KU:G$-&=>-14=JCJ6YMW:R^S]GIY:>9YT,FJ1I.#J;P4-ME>[Z]>OG
MKY'X_P#_  4<^#G@/X7?&#]D;_@F-8V6H77A/16@UGQ5+!I\ES/K[B1+=L(@
M9I)FCM;F-4&0HN(UX10!UO[?/QAM(?\ @NA\![#X]Z!KL?A#PMX8CU/P[H5E
MI<E[-<:O,EV\/E16^_S)3>16<)*Y4&W4E@H+C]3WM;62X2[DMHVEB4B.5D!9
M <9 /49P,_2HY](TFZU&#5[G3+>2[M59;6ZD@4R0AAA@K$97(ZXZUA3SQ)04
MZ=[1G&]];SO>2TT?3J:SRF[ERSM>47:VEH[1WU1^7G_!)[X@W7[0W_!67]H3
M]HKXEV-P_BB*X;PYI&F6L!ECTFPCE=&>20X1%1;"U@##YY'G8A,&0K^@/[57
M[67P3_8W^$]]\7/C;XNM["T@B8:?I_GH+K5+@ ;;>VC8@R2,2H_NJ#N<JH+#
MT&PT;1]*EN)M+TJVMGNYC-=O;P*AFD/5W('S-[GFK-<.-QU'&8R-5P:@E%<J
M?2*M9.VGW,Z\+A:F%PSIJ=Y-MWMU;OJKZ_>?+P^!6@6^@ZC^V;^T3^T]K>@:
MYK&AQRZSJ7A/QA%;:/IFG(7E@L+25DQ)#&'.9,@SREI2J[E1?B#_ (-M/&I\
M._!#]H+4_#MQ;W_BR*&UU&PT(2*UQ=>3;790B,'<RF5PF0,98#J:_8"BMJ>;
M.."JX><;\_+ULDHNZ5K?+<SEER>*IUHRMR\W35N2M>]_T/P,_9__ &JY_AS_
M ,$@?CU=^&H]7OOB3X_\=&V\?^)[JPE$=O97BPQ!7N"H22:;??XC#%EWS.VW
M]V']_P#VMO'7AW]GG_@WT^'_ ,"?AI%=FX\=2:7HZ3BU,9U&68_VI?SP _/)
M"9P]N'(&\-E049&;]8+[PGX?;0;S1K/PMI<D5RSS/93VB""><G=ND4*026 )
M;!/&>37Q;>?L9_M??MM?'3X-_%+]N[P]X1\-:1\(;F]U2[\/>%;IIH-<U5KH
M-:^6C22[;9(;>U9VE<.S^:@B56W5[-/.<+BJ_M9PY(QG[1WE=MJ/NI*RO9JW
M9)Z]SS)Y9B,/2]G"7,W#D6EDDY>\V[O=._G;Y'SG_P %F_#Q_9G_ .">'[-W
M[ T5Q)IUMJE_:0^(M3M[5YD#6-O$MP2D8+.7N+TSA%!9C%\H-8/[6'C!OB[_
M ,%5_P!G'X!>)O"6MZ7\/_ NBV&I^%/ S:6WVZ2*(22V\4L':>Y6QM4*N46%
M)%67RF28C]B+_2-)U62WEU/2[>Y>TG$UJT\"N89!P'0D?*PR>1SS2/HVCR:L
MFO2:5;-?1PF&.],"F58R<E ^,A<\XSBN"AGRHT8QE3O)>TUO]J?VMMTM/\CK
MK90ZE1M3M%\FEND.F_4_.C_@K;X#_9H_;M\$?$ZSTGXA:?X6^+7[-TC76FWM
MUJ:0R7]H=/M[YTQD,8V=GA1AEH[BWSD"0AO&O^"EOQY^/_BW_@D1^SW\+?CV
MTFD^,OBKK=M_PE6IZQ'Y :UM"?)FNB<!'D62QG<MC[C\#''ZZWWA/PMJDT-Q
MJ?AK3[B2WG,]O)/9H[12DY+J2/E;(!R.:GU+1M'UD0C6-)MKL6\ZS6XN8%D\
MJ5>CKN!VL,G!'(S48;.H8>-&+I\RIRYE=ZIVM9.VSE[UN^GF77RN59U)*=G-
M6=EH]>JOO;W;GY*_\%B]9\/>'=6_9%^$^H/J?A_X$:;J5LMWJ-[I3>5Y-I-;
M6R32PLIR%LU:5$9=QCG?*YRH^G_#Z_L]V?A;XQ_MG?LP^(->^+?Q*M?AMJTT
M'Q8U%$NK=9[>T=[;2K%HHXK<?.H)CM(CC;B9][H'^R=:T'0_$EB=,\0Z-:7]
MLS!FM[VW66,D=#M8$9%3VEI:6%K'8V-K'!#"@2*&% JHHX  '  ]*RGFT9X6
MG24&G&]]=))RYG?2^NSUL[)VZ%PRYQQ$ZG,O>M;35-*VFMOPOOJ?@-X2_:9M
M/AG_ ,$,/$W@;X:66JS>(?'OQ+DLOB3XFN;"98HFG!DCM5N'&)Y9K:SRP0L(
MT>3>4:6/?^S7_!/SPGX4\ _L8_#KP+X(MKC^S-'\+VMI!>W%J81J+J@\Z\C1
ML-Y<TIDD5F WJP8 JRL?4CX/\(G2!X?/A;3C8"7S19&QC\G?NW;MF-N=W.<9
MSS6C3S/-X8^DX1I\MYN;UO>Z271;;+R^\6 RZ>#J*4I\UHJ*TMMKW>_7S/G7
MXL_'KX+^._VX_AE^S"/BCH;:KX?74_%NIZ2-3BWF[AB%A9V;+NYE9K^XN%B^
M^/L0?  &?$?^#@O]CVY^/G[(L?QZ\#V+GQ7\*+A]4BEM@1-)I;[?M:@KSF/9
M'< Y^40/CEJ^^*;+%%/$T$\:NCJ5='7(8'J".XKEPV8/!XJC6I*SAY[ZN_16
MNG;J=%?!K$T*E*H_C\MM%;KTM<_.+_@I#H7QX^ 7_!#!/#-O-J%UXEUJ.QF^
M*.IQ)B82ZE<M>:I(Y4#"O=S&)N -DI7 !Q5O]@3P9^P=\:_ _P #AI'Q%UOX
MMZ]X#\.:>=#\%PV\0TWP7=F-&N;VZ@BBBCCF64.WF7<DLCN/W 9BHK]$;BW@
MNX'M;J!)8I4*21R*&5U(P00>"".U5M$\.^'_  S9G3O#>A6>GVY<L8+&U2)-
MQZG:H S[UT+-G]3E2Y6I.4I73M\2M9Z7^YK1M&+RY?654O>*BHV:OL[Z:V^]
M/74_,/\ 8%\>:#\?_P#@N-\??CGXJ-Q/J7AR9_"GA/1UMRTL,,<AM7O,<>5$
MD5@V]VP-UZJ<O(BG]2*K66BZ-IMW<W^G:3;6\]ZX>\F@@5'G8# +D#+$#N<U
M9KES#&1QM:,HQY5&,8I7OLK=EZG1@\,\+3<92NVVV[6W=PHHHK@.L**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#\T/^#EO_ )(?\,_^QKO/_284
M4?\ !RW_ ,D/^&?_ &-=Y_Z3"BOZ-\._^25H^L__ $IG\J^*/_)9U_2'_I".
M4_X(-_\ )\/Q_P#^VO\ Z<Y:_5JORE_X(-_\GP_'_P#[:_\ ISEK]6J_(^._
M^2BG_AI_^D(_;O#?_DEH?XZG_I<@HHHKXX^\"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S?XF?MB_LH?!?Q
M"?"7Q>_:/\$^%]4";O[/U_Q+;6DQ7U"2NI(]Z[CPMXK\->.- MO%7@_7;74]
M-O$WVE]93"2*9<XW*PX8<=17Y2?M^6]K^W)_P7F^%'[*J6R7N@_#RWM)_$5N
MRAHV*JVJ72N>FUX5MH2/[Q(ZG%?97[2?_!3[P7^S?^V%X0_8[UKX3ZM=:EXJ
MM8=0;Q%+JMK!I]EII:7S[Q_F>0+"EO<.P=$SY1P<$-7MU\I<:5%4DW4G#G:N
MM(].W34\NEF*=2JZEE",N5/75_\ #Z'U#17R[^RU_P %1O 7[5/[8/C3]D;P
M[\&/%V@WG@_16U(ZMXCM!;&YC66",A[9@);<M]IC=!)\Q7.Y8V&VNB\>?\%!
M?AWIGC3QYX'^%^BCQ(?A9H\VI?$OQ'<7S6FC>'5CC>1K:6XCBFDENML;GR88
M9-NQ@[(PVUPSR[&PJ^SE!WLG\GMY:W7STW.J.-PLH<ZEI=KYK?[CZ HKYP@_
MX*B?LV:;^Q'X;_;F\?2:KH.A>*82NC>'[BU$FJ7MX)9(OLEO"I_?.SQ.58$*
M4PY*KDANF?\ !1#3]!_:U\'?L??'+X0WG@_Q%\0?#(UGPG*NL1WJ8Q,3:7@5
M$^S7(\B080S1E@ )"31_9V-][W'[O-?_ +=^+UMUM>P?7<+I[V]K?]O;>E^E
MSZ1HKY.UO_@K%X T+]M[7OV*KWX,>(TO/"FGO>:_KHN()E$;01/;+;6]N99+
MB2>2YM(8XODD+W"@J"-M<-\//^"[_P #?'G[-_C[]HI_@EXOM(O!>K&RM-!3
MRI[G4DVJQG+(=EO'&7C$K.2L9EB4,[RHC:QRC,I14E3;3Y7T^U\/7K_P7H9O
M,L#&33GJK]_L[_<?=5%>+_!3]N+X3?$W]BW2/VXO';'P/X5OM&DU"_&O3@FQ
M1)GA(+(/WFYT^3:-TF] %W,%KS*[_P""KGART^,'P9^'\WP \20Z/\<IY5\'
M:K=7D*7J0*T2QWD]B 6BMY1*LB,T@?RPS,BE=M8PR_&3G*,8:Q;3VWBFVO-I
M)O0UEC,-&,9.6DK->CT7WMGUK15?5[Z?3-)NM1M=-EO);>W>2.T@D1'F95)"
M*TC*@)Q@%F"C/) YKX(\._\ !>30O&_[/GCG]I3P)^QAX]U/PWX(U2WL[R]2
M^M5A DP'DEEY5 I>$;8O.;]Z&8(F')A<!B\8FZ,;V:3U2U>BW:W"OB\/AFE4
ME:]WL^F^W8^_Z*\*T[_@HC^S8G[&&A_MS>-/$DOA_P (:[IT<UI!?1;[Q[EF
M9/L4<4>3-/YD<BA4R#L+9"@L.6\(?\%(VUK]L_0/V,?%G[.FOZ%K'B?P.WB?
M39I]4MIY[.#;.RV]]!'\MK,5@;Y1+( TD8)^;@CE^,DI-0?NWOT^'XO6W6VP
M/&89.*YOBM;Y[??TN?3U%? _B3_@O=\)/#GP\\?_ !#N/V>?%93P9XK7P]I^
MG"^MY)]4ND<K=R,8?,CM[>#=; S;W#/>0H.7!/W=H6J?VYHEGK7V*:V^V6L<
M_P!FN5VR1;U#;&'9AG!'J*6)P&+P:3K1LGMMT2?3U04,7A\2VJ4KV_X/^3+5
M<A\9/V@?@;^SSH,/B?XZ?%SP[X1L+F1H[6X\0:M%:BX<#)2(.P,C <[5!..U
M?.OAW_@JSIGQ0\(_%CXG_ ;X$WGB_P -?"#4I[+7A#XBAM]6O?*1F>YMK)HR
M&ML(Y#R2H["-]L;,I2O%O^#@;Q;?_$[2O@C^PQI%['9:C\2_'L-UJTGF@K96
ML&V#?(QP!&'NFD+' Q:L3@ UV83*:U3'0H5URIWOJKI)<STUM9:ZG/B<QIPP
MDJM)\S5K;V;;LOQ['Z(>#?%_AKX@^$=+\>>#-7CU#2-:T^&^TJ_A!V7-O*@>
M.5<@':RL&'L16E7R5^SM_P %-?@Y\0/VQS_P3W^'/P7\4Z7;Z!X66?2-?U*U
M%O!-:PP1/$5MW E2!X71HY6P7!7Y &!KM?BE^W_X0\,?'+6?V=?A-X%N_''B
M7PCX<EU_QZ;+4([6S\/6$:!]DL[AM]W(I'EVZCG.7>-<L.:IEV+A6Y.1K3F5
M[?"]FWLO\]#:&-P\J?-S+>VE]^J1] 45\J?!+_@JS\/?CE^R3\1OVS_#7P9\
M3Q^$?A]>W<.R2>U6YU6.V@2:::)9)$55"R+P6+$Y !8;:YGX1?\ !9[X=?%O
MQO\ !OX=:;\"?$L.J_%V:X*1).DR:';JTOD/<2!0K2211K<&)3F."5)"2&4-
M?]DYA[W[OX79ZK2RYGU[?Y;D_P!H8/W??^+;?76WYGVC17S3\<O^"F7PS^',
M?Q*@^%'A&X\=S_"+1)-0\?WMKJ,=GINER*#ML#=.&\V\?:P$,:. 5979&&T^
MK_LL_'[1_P!J;]GKPG^T)H'AF_T:S\5Z4M[!IFI@>= "S*02O# E258?>4JV
M!G%<]3!XFC156<;1;M\VKK3?5:^AM#$T*E5TXRN]_P ;;[;Z'?T445S&X444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?FA_P<M_\ )#_AG_V-=Y_Z3"BC_@Y;_P"2'_#/_L:[S_TF%%?T;X=_
M\DK1]9_^E,_E7Q1_Y+.OZ0_](1RG_!!O_D^'X_\ _;7_ -.<M?JU7Y2_\$&_
M^3X?C_\ ]M?_ $YRU^K5?D?'?_)13_PT_P#TA'[=X;_\DM#_ !U/_2Y!1117
MQQ]X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8GQ#^)'@'X3>$;SQ[\3/&&G:%HVGPM+=ZEJEVL,4:JI8_,Q&3@'
M ')QP#6W13CRWUV$[VT/R*_X(+>(O#_[3'_!0+X]?ME>+M<LH]<U:21- TBZ
MNT^T^1?7<D[F.,G<5ABM88MPSA7QGK74_LU^']"_;B_X+;?&?]JCQ7YM]X2^
M!]NFE:+;PH9(Y;J$/;1XQ]]-]O?3A1U9DZC@_J917O5\\]I7JU84^5S@H+6_
M*E:]M%>Z7E:YY-+*N2C3IRG?EDY/3XGK;KT;^=C\H_\ @B#XI\7?%=?VF?VP
M=%\,ZC>^/O'&J:C-IDC6>8+"2-&NH+;S'PK-+-=*HC3=M6Q^;8"F^?\ X(-?
MM<?LU?#/]F+Q1\&?BUXHF'Q-U;X@ZA<ZUX6NM)N+O5M;DEAA0!(51WN"3'(C
M+C*L'+A0VX_JC;6MK9Q^3:6T<2%BVR- HR3DG [DDD_6JMIX9\-Z?JT^OV'A
M^Q@O[H8NKV&T19IAQPS@;FZ#J>U&(SFCBE64J32GRVM+;D5DOAU7R0J.65:'
MLG&I=QYKW6_,[M[Z/[S\T_V\?#-WX[_X+1_LN?#[XH:2OA[X9Z5X>_M;1+34
M3%#8PZC;"[NI+<E6,(D#6EA$8U8C'E@$AQGH?@W\,_$G[;'_  5EUG_@H]XA
MM);'X0?";1Y-%^'^M7RE(M?EABF22Z@S]^U22XNYA./E;]T 6^?;^ANM^'?#
M_B6V2S\1Z%9ZA#'()(XKVU255<=& 8$ \GGWJVB)&H1%"JHP !@ 5F\YDL/&
M$(6:@X7OT;;DTN\EI]_?3198G6<Y2NG)3M;JDDD_);_\-K^*7[+'CJ&\^%O[
M7/\ P6;\733+J5Y>ZCHGPY6;@6EW>;8X9 #RS1+=V42D=%$O?D<7\5OA9<_L
ME_\ !"OP3H-EIMP/$G[0WC2UU#7+EHV*1:8@-Q:P @<;Q!9RXQEBS_>"*!^\
M5,GMK>Y"BY@20(X= Z@[6'((ST(]:[5Q):LI>RTYHNW-TA&T8[='[U^KZ'*\
MDO3Y?::\K5[=9.\I;]5I;L?D=_P6?@?X;_L9?LN_ S3]+UO1?A+'JT=GXJNK
MG37AE\FRBMH;66:+[RM- ]Y<B*0"3*C>BR*57['_ &4O"O[&OQ1^/S?M#_"O
MQOJWQ@\6V>B_8(OB)<QPOIGAJS"D)I]GY,4%K S!W'EP(\RJ6\YE$F7^I-6T
M?2=>L'TK7-+MKVUEQYEM=P+)&^#D95@0>:?I^G:?I%E'INE6$-K;0KMAM[>(
M(B#T"C  ^E>?5S7VN!C146I+FU3WYG=WTOY;V=E<ZZ>7>SQ3JMII\NEMN565
MM;>>VG0\$_X*G?'W_AFO]@/XF_$RUO1!J#>'9-+T=PV'%Y>D6D3KZLAF\SZ1
MD] :^ ?#GAN71/\ @BG\._V#/V<HK;Q5\4_CT\>HW.F:-<I,;"TFO$N9[V[*
M$BWBB@B@MG:3&&W=T8+],_\ !:3]E_\ :\_;<\&>$_@'\!OAE'<^%[#Q%'K'
MBK5+OQ':69NRD;1QV\*,Y8X$LK,7"C<(\!L9'V5X"\+^&?#N@V[^'_ -OX=:
M>UB\_3TMX$EBPH CD:%F1V4?+D,P]"1S75A\71R_+:35I3<^=JZTY5:"EUM=
MMV^1A6P]7&8ZHG>,5'E3MOS.\K=-K(_(?]OCX=Z9^R1^TW^QU^RY\5_&]QHW
MPG\ >'[2ZG\6/8^99R:V+N0W5RT;JR-MDCMG*N&")<'(*EL_97@3Q#^R=\"O
MAI\9?VZ_@YK.M?$#7XO"5WJ.N?&+Q"4F7698(6:'3K28)%"8@T<2[+6)8 1&
MA8LFU?KW7/#GA[Q/:#3_ !+H-EJ,"N'6"^M4F0,,@-AP1GD\^]6X88K>)8((
ME1$4*B(N H'   Z"L*^<?6*%.$XNZOS6=E*\N9WTOJ]];7L[&M++?8UIRC)6
M>VFL;+E76VGI?I<^!?\ @WM_9Y'A#]AB/XR>-K5;O5/B+K-Y?K]KB#%;2.<Q
M*6#9R\DD32%_XU$&?]6M?9WQ]^+^B_L__!#Q=\<?$5E)=67A+PY>:M/:0N%>
MX$$+2")2> SE0@)XRPKKJ9/;P741@N8$D0D$I(H(.#D<'WKAQF,>-QTL146D
MG>U^G:_II>QUX;#+"X2-&#V5K^?>WKJ?E)>?!&P^ G_!5SX1_M&?\$[?B%9:
M[X-^/M]//XS\*Z1<K<06^G,T4E_<.BD[;8K,9E# >5-&4& 52MVV\':?_P %
M _\ @O\ ^(K_ %V1[KP;\!/#$=DT .8;N[4%&MI!TVM<W=UN4Y#I:E&X.*_3
M33O#?AW2+ZYU/2=!LK6YO&W7=Q;VJ(\Y]790"QY[U=KT99Y-^]R^_P"S<%)O
M75[O35J/NK;OY'$LJCMS>[SJ;5M-%LM=$WK^!^6/_!(/QM/\<?V_?VFOVPKS
MPGJFI:[J&I7&EZ#"MDP6PT^.1V6*:5\*KLMM80I&I,C%7;:$1F'S1^RY^V%J
M/P__ .":W[4?Q(AM-2OOBYX\\6&'QCK4NF3+%8:?>^5 LSW!78)FGO+]8X0W
MF*<R;=J$U^\-O:VMJ'%K;1QB20O)Y: ;F/5CCJ3ZU3;PEX4?3[K2'\,Z>;2^
MF::]M391^7<2$@EW7&'8D DG).!6ZSZ@ZLY2H^Z_9V7-LJ?3;5/Y:]S)Y155
M.*C5U7/K;=SZ[[K^K'Y#?&3QWX9_9X_X-R_"GPQ^'Z7?VWX@7EAILE\;5HS?
MW-Y(=4O##GYI414>S+XVDH54D8)^\O"GP3\7_L>?\$Q[OPC\,="%]X_\)_"N
M\N;&2VME>>37%TQ@#%P6;:RI%&O+&.*./)P*^E8HHX(UAAC5$10J(HP% Z #
MM3JXL3FSKPY>3[<IN[OS-VT>BT27SOT.JAERHRYN;["@M+6MUWZGXS_\$H-,
M_8L^+G[%T/P6^.7QH\2:_K6K^.;K5/$7P4T$ 7/B6]61/LSSB*(75S#LBA<D
MSQVR,&:4C:6'[&>'=)TK0/#]CH6AZ'#I=E96<4%GIMM$D<=I$B!4B54^554
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MB@ HHHH ***BDOK**[CL);R)9YE9HH6D =PN-Q ZD#(SCIF@"6BBB@ HHHH
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M(K_5]5O_  59S7VIZG=O<7%S(5Y>21R6=CZDDUX)\8? 'B#]IC_@L!K/[/\
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MPM\)O[)A?Q#=W%O)(LN8Q+Y20JB"9IFD"+%(C$Y8+7F/Q?M[>X_X*2_L>M/
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M_P#DA_PS_P"QKO/_ $F%%'_!RW_R0_X9_P#8UWG_ *3"BOZ-\._^25H^L_\
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MVTZ[DD0JZYQD$8-/HH Q/^%=>#?^@/\ ^3$G_P 51_PKKP;_ - ?_P F)/\
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M''&H55 Z  =!3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#\T/\ @Y;_ .2'_#/_ +&N\_\ 2844?\'+?_)#_AG_ -C7>?\
MI,**_HWP[_Y)6CZS_P#2F?RKXH_\EG7](?\ I".4_P""#?\ R?#\?_\ MK_Z
M<Y:_5JORE_X(-_\ )\/Q_P#^VO\ Z<Y:_5JOR/CO_DHI_P"&G_Z0C]N\-_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*** "BBB@ HHHH **** "BBJD.JQS:Q-HXB8-#$LA?/!![4 6Z*** "BBB@
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M+\/\CX7_ %KQ?_/N/XG]%O\ P\@_8,_Z.V\"?^#^+_&C_AY!^P9_T=MX$_\
M!_%_C7\Z5%'^I&!_Y^R_#_(/]:\7_P ^X_B?T6_\/(/V#/\ H[;P)_X/XO\
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M5\GG^54LHQD:-.3:<4]?5K]#Z+)\PJ9EA75FDFG;3T3_ %"BBBO#/6"BBB@
MHHHH **** "BBB@ K-\8_P#(L7O_ %P-:59OC'_D6+W_ *X&@"YIW_(/@_ZX
MK_(5-4.G?\@^#_KBO\A4U !1110 4444 %%%% !1110 4444 ?FA_P '+?\
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MQ!X.\)?&3PEXJ^(FD?VAX?TSQ-87>NV'EA_M-G'<1O-%M/#;HPRX/7-?K?\
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MF_4OVW/%EO$WCCQYJ;>$_A!9W,0W10F4)>:IL.>% *J<=4VG*S@U6_X."_\
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MZCBU.<>1WAK+R6_]=^A7UK#<L9<RM+;S/HNBBBN4Z KYS_X*W?\ *.CXI?\
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M?:5%']L9G_S]8?V9@/\ GVCXM_X<6_LF_P#11OB)_P"#6P_^0J/^'%O[)O\
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M[!7A'XZ_'_Q.-,T_2?AUI%QJUQ<<S37!LH?W*)UDF>0[50<LQQ7B\7_!,/\
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MX?TJVL;&S^#7B&&TLK.!8HH(UEC"HB* %4#@ # KW#]GSX7_ +5G@&^U6?\
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M_G]A_P"_@H^WV/\ S^P_]_!0'++L2T5%]OL?^?V'_OX*/M]C_P _L/\ W\%
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M!.R QDR+(")F..H<Q53!UL/2H\Z3CS:Q4N7;2Z:O=L,/2Q=*M.KR-WMNU?\
M#2R1YY_P6Q^'_@72_P!AOQW\1-.\'Z9!K^J7NBP:CK4=D@NKF*.]A"1O+C<R
M+V4G ]*]+U7X2>)OCQ_P3%L/@YX,N;.'5?$?PBTZQL)=0E9(%D>QA +LJL0O
MN%/TKE?VZ_V"?B]^VEJ5YHD'[;DWA?P1?6UJLW@H>$(KV$S0MO\ .,WVJ)R2
MX5L8XV]2*T/AK^QM^T/X$_9L\0_ ;4O^"@.KWVH74>FQ>#O%-GX;BLIO#<5H
MZ-Y2(EPQG218UC8,XRA8<[CF8U:*P5**JKGC+FVEI?E7:VEM?+8IT:[Q<Y>R
M?*XVZ:[OOUO_ )G@%]^TU^WS_P $L-(^&'P[_:9\+?#GQ'\-G2U\/07_ (1D
MN_MMK%!&B L\P0-*(QOQY15]A 9"<U^CE?$EI_P3$^+OQB^*/AOQM^W+^VU<
M?$C2?"%Z+K2/#-IH,-A!-(&5@9BC;2#L4,-A9ER-X'7[8AN;:XD$-O<([GHJ
M."3^ K#,JF&J<CA9SUYG%-)ZZ;VU[Z&N"I8F'-SIJ.G*G9M::[?@>J?#K_D3
M;/\ [:?^C&K;K%^'BLG@^S5U((\S((_Z:-6U7R%7^++U9]%3_AKT"BBBLRPH
MHHH **** "BBB@ K-\8_\BQ>_P#7 UI5F^,?^18O?^N!H N:=_R#X/\ KBO\
MA4U0Z=_R#X/^N*_R%34 %%%% !1110 4444 %%%% !1110!^:'_!RW_R0_X9
M_P#8UWG_ *3"BC_@Y;_Y(?\ #/\ [&N\_P#2845_1OAW_P DK1]9_P#I3/Y5
M\4?^2SK^D/\ TA'*?\$&_P#D^'X__P#;7_TYRU^K5?E+_P $&_\ D^'X_P#_
M &U_].<M?JU7Y'QW_P E%/\ PT__ $A'[=X;_P#)+0_QU/\ TN04445\<?>!
M1110 4444 %%%% !1110 4444 %?.?\ P5N_Y1T?%+_L"P?^ED%?1E?.?_!6
M[_E'1\4O^P+!_P"ED% 'PO1117Z0?H 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445D^/=8U
M?P]X%UK7_#]A]KO['2;FXL;7:3YTR1,R)@<G+ #CUII7=B9S5.#D]EJ%]XZ\
M)Z9XPL? -]K,<>L:G;R3V-B48M+'']]L@8 'N16M7Q7^S]X<B_:0,7Q%UG]K
M76=-^)*2S1VUF)T7[-&6.$CA8KYD;#YBL9"_-@CCGW_]HGP%8^+)-.F\:?M&
MWO@K0HH'BEM['4XK WUP>=QE=L$!1]S!]>*[*N%A2JJFY:]='^&FI\_@<ZQ&
M-P4\5&E[NG)[T=4_YG=\K6[7FDKNYZK17S3^P1XE\?:CXF\;^&I_&>I>)/".
ME7_DZ#K6I.[^:1(ZCRW8G(:,*Q4' ^4X&[GZ \=#QHWA&_3X=FQ&MM!MTYM3
MW>0LA(&Y]O. ,G [BL:U%T:WL[]OQ/0R[,HYAEZQ48-;Z;O1M:6T=[:/J:U%
M?,?[*]]\4=-_:U\<^!/B1\3+_P 0S:?HJ/+)+*RV_FLT#$QPYVQ@;RHP!QV&
M<5H_MZ-\>-+\"ZGXO\,_$*/1/#&EP6N+73&=+V^N))UC8/(,;(U# @*?F(((
MZ$:_5/\ :%2YEK;7U.%9\O[*J8WV,O<<DXZ77*W=MWLDK:ZORN?1=>N_L(_\
MG6>%?^W[_P!(;BOG?X$7U[JGP/\ !NIZG>2W%S<>%-.EN+B>0N\KM;1EF9CR
MQ))))Y)-?1'["/\ R=9X5_[?O_2&XKS,?'EPM5=E+\F>G5JJMETJB7Q0;^]'
MZ+T445^?'Q@4444 %%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_(L7O_7
MT 7-._Y!\'_7%?Y"IJAT[_D'P?\ 7%?Y"IJ "BBB@ HHHH **** "BBB@ HH
MHH _-#_@Y;_Y(?\ #/\ [&N\_P#2844?\'+?_)#_ (9_]C7>?^DPHK^C?#O_
M ))6CZS_ /2F?RKXH_\ )9U_2'_I".4_X(-_\GP_'_\ [:_^G.6OU:K\I?\
M@@W_ ,GP_'__ +:_^G.6OU:K\CX[_P"2BG_AI_\ I"/V[PW_ .26A_CJ?^ER
M"BBBOCC[P**** "BBB@ HHHH **** "BBB@ KYS_ ."MW_*.CXI?]@6#_P!+
M(*^C*^<_^"MW_*.CXI?]@6#_ -+(* /A>BOI'X:_\$Z=?^(_PYT#XAV_Q1L[
M6/7M$M=12U?2W<PB>%90A8.,D;L9P,XK;_X=;>)?^BP6/_@H?_XY7V_]K9?_
M #_@_P#(^Q_M/ _S_@_\CY3HKZL_X=;>)?\ HL%C_P""A_\ XY1_PZV\2_\
M18+'_P %#_\ QRC^ULO_ )_P?^0?VG@?Y_P?^1\IT5]6?\.MO$O_ $6"Q_\
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M%%% !1110 4444 %%%% !1110 4444 8]E_R.][_ ->47\S6Q6/9?\CO>_\
M7E%_,UL4 %%%% !1110 4444 %%%% !1110 5F^,?^18O?\ K@:TJS?&/_(L
M7O\ UP- %S3O^0?!_P!<5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@ H
MHHH **** /S0_P"#EO\ Y(?\,_\ L:[S_P!)A11_P<M_\D/^&?\ V-=Y_P"D
MPHK^C?#O_DE:/K/_ -*9_*OBC_R6=?TA_P"D(Y3_ ((-_P#)\/Q__P"VO_IS
MEK]6J_*7_@@W_P GP_'_ /[:_P#ISEK]6J_(^._^2BG_ (:?_I"/V[PW_P"2
M6A_CJ?\ I<@HHHKXX^\"BBB@ HHHH **** "BBB@ HHHH *^<_\ @K=_RCH^
M*7_8%@_]+(*^C*^<_P#@K=_RCH^*7_8%@_\ 2R"@#\=/#O\ P50_X* >$_#]
MCX5\._M*ZM:Z?IEG%:6-LEA9D0PQH$1 3"20% ')SQ5S_A[A_P %&/\ HZ/6
M?_!?9?\ QBOG*BOW/^S,M_Y\P_\  5_D?DOU_'?\_9?^!/\ S/HW_A[A_P %
M&/\ HZ/6?_!?9?\ QBC_ (>X?\%&/^CH]9_\%]E_\8KYRHH_LS+?^?,/_ 5_
MD'U_'?\ /V7_ ($_\SZ-_P"'N'_!1C_HZ/6?_!?9?_&*/^'N'_!1C_HZ/6?_
M  7V7_QBOG*BC^S,M_Y\P_\  5_D'U_'?\_9?^!/_,^C?^'N'_!1C_HZ/6?_
M  7V7_QBC_A[A_P48_Z.CUG_ ,%]E_\ &*^<J*/[,RW_ )\P_P# 5_D'U_'?
M\_9?^!/_ #/HW_A[A_P48_Z.CUG_ ,%]E_\ &*/^'N'_  48_P"CH]9_\%]E
M_P#&*^<J*/[,RW_GS#_P%?Y!]?QW_/V7_@3_ ,SZ-_X>X?\ !1C_ *.CUG_P
M7V7_ ,8H_P"'N'_!1C_HZ/6?_!?9?_&*^<J*/[,RW_GS#_P%?Y!]?QW_ #]E
M_P"!/_,^C?\ A[A_P48_Z.CUG_P7V7_QBHD_X*Q?\%#H[Q[]/VG=8$TB!7?[
M!9Y('0?ZFOG>BC^S,M_Y\P_\!7^0?7\=_P _9?\ @3_S/HW_ (>X?\%&/^CH
M]9_\%]E_\8H_X>X?\%&/^CH]9_\ !?9?_&*^<J*/[,RW_GS#_P !7^0?7\=_
MS]E_X$_\SZ-_X>X?\%&/^CH]9_\ !?9?_&*/^'N'_!1C_HZ/6?\ P7V7_P 8
MKYRHH_LS+?\ GS#_ ,!7^0?7\=_S]E_X$_\ ,^C?^'N'_!1C_HZ/6?\ P7V7
M_P 8H_X>X?\ !1C_ *.CUG_P7V7_ ,8KYRHH_LS+?^?,/_ 5_D'U_'?\_9?^
M!/\ S/HW_A[A_P %&/\ HZ/6?_!?9?\ QBC_ (>X?\%&/^CH]9_\%]E_\8KL
M/^">7[%_PB\;_!_Q3^W9^TMXVU>P\"?#76X(VTKPY9)-=ZC=1F"4HV\,%BS/
M I&/F\QLM&%W'%_X* ^*OV+?VAOCOI/QL_9\^*6NVC>-]:=?&NE>(="6!?#Z
M+]FBCGB\H!'C9#(=@=F'E')&X5YT5E,\:Z$,.FE>\E!63LG;;M^BW9W-YC'"
MJM*NTWLN9W:VOOW_ %?0R?\ A[A_P48_Z.CUG_P7V7_QBC_A[A_P48_Z.CUG
M_P %]E_\8KZ<_9Q_X)\_\$E/VO=4U[X$_L__ !W^(NH>,=%TE[[_ (2*[MTB
MMKA%D2)IHXG@4/$LDL8*$HY#C#'EA^=?COPE?> /'&L^!-3GBEN=$U6XL+B6
M Y1Y(96C8J>X)4D>U/"+)L95G3CAU&4;74H).SV>J)Q+S/#4XSE6;4KV:FWJ
MMUN>\?\ #W#_ (*,?]'1ZS_X+[+_ .,4?\/</^"C'_1T>L_^"^R_^,5Z#_P3
M*_X)Y?LY?M4ZCI5Y\?/VA8+.[U^:\A\/> /#5RIU6X^S(SRW%PS(XMH@%8KE
M?WF.&!X/SSK'P/TF]_:QU3]GG0O&&GZ+I\7CF[T6UUSQ/?+%;V<$=T\0FN90
M  %1<LP 'L*J$,DJ8BI15&-X*[]Q6Z[::[/84Y9K"C"HZLK2=E[S\O/3?J>A
M77_!6;_@HA?6[VEU^T]K#QR##J=/L^1_WYIT?_!6W_@HM$@CC_:BU@*H  _L
M^RX'_?BO3?VX_P#@GQ^RW^SS^PAX+_:5^ _Q>UCQK?:[XS31[G7W*1:?>H(;
M_P YX(/+#H!-9[5)D<%=QRP92/B:KP=')\=2=2E1C9-K6"3NM]&B<35S+"5%
M"I5E>R>DF]_F?T*_\$L/BY\1OCM^P=X$^*OQ:\4S:UX@U7^U/[0U.XC1'F\K
M5+N&/(1548CC1> /N^M?0=?+/_!%7_E&9\-/^XS_ .GF^KZFK\ES2,89G7C%
M62G*R_[>9^C9?*4\!2E)W;C'\D%%%%<)UA1110 4444 %%%% !1110!CV7_(
M[WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% !
M6;XQ_P"18O?^N!K2K-\8_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_U
MQ7^0J:@ HHHH **** "BBB@ HHHH **** /S0_X.6_\ DA_PS_[&N\_])A11
M_P '+?\ R0_X9_\ 8UWG_I,**_HWP[_Y)6CZS_\ 2F?RKXH_\EG7](?^D(Y3
M_@@W_P GP_'_ /[:_P#ISEK]6J_*7_@@W_R?#\?_ /MK_P"G.6OU:K\CX[_Y
M**?^&G_Z0C]N\-_^26A_CJ?^ER"BBBOCC[P**** "BBB@ HHHH **** "BBB
M@ KYS_X*W?\ *.CXI?\ 8%@_]+(*^C*^<_\ @K=_RCH^*7_8%@_]+(* /Y\Z
M*^B(_P#@E#^W](@D7X . P!&[Q-I8/X@W612_P##I[]O_P#Z("W_ (5&E?\
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M ##ZEC/^?<ON?^1\[45]$_\ #I[]O_\ Z("W_A4:5_\ )5'_  Z>_;__ .B
MM_X5&E?_ "51_:.7_P#/Z/\ X$O\P^I8S_GW+[G_ )'SM17T3_PZ>_;_ /\
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MZ7!K/QV^,GAKPC;W;%;-M?UB*V:Y(QD1J[!I",C(4''>OD+]KG]C/X#>"?\
M@C/J&B^#_AUI&G:CX+^'%GKNC:]9V$<5]#J-K%%<-=K.H$@ED97W-G)\QAT-
M?1GPZ^'OP/\ C;\,?!'[5'QM^&7AC4_$5U\-M/EN]?U_389OL=M);K=2JK3
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M7]J/]I7]AGQ7\9=<UKQ/<7GB+Q-)X7BU'2= T_RT98Q).&2.1=SYX3;$L0#
M"O7CE,7B:T+MJFTM+7;>V^BV/.EF,E0I2LDYJ^M[*WIJ?L9X=\1^'_%^@V?B
MGPIKEIJ>F:A;I<6&H6%RLT%S$PRLB.A*NI!!!!(->A_!W_F(_P#;'_V>O!?V
M3OB)\%_BI^SMX4\;_L\Z<MEX.NM,$>BZ<ML(39)$S1-;L@)"M&Z,A )&5."1
M@GWKX._\Q'_MC_[/7SV/@Z<)Q:M9]=]^I[.$ESRC+O\ Y';4445XAZ@4444
M%%%% !1110 4444 9OC'_D6+W_K@:N:=_P @^#_KBO\ (53\8_\ (L7O_7 U
M<T[_ )!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** ,>R_P"1WO?^
MO*+^9K8K'LO^1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ K-\8_\
M(L7O_7 UI5F^,?\ D6+W_K@: +FG?\@^#_KBO\A4U0Z=_P @^#_KBO\ (5-0
M 4444 %%%% !1110 4444 %%%% 'YH?\'+?_ "0_X9_]C7>?^DPHH_X.6_\
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M_7 U<T[_ )!\'_7%?Y"J?C'_ )%B]_ZX&KFG?\@^#_KBO\A0!-1110 4444
M%%%% !1110 4444 %%%% &/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S-;% !
M1110 4444 %%%% !1110 4444 %9OC'_ )%B]_ZX&M*LWQC_ ,BQ>_\ 7 T
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M* "BBB@#-\8_\BQ>_P#7 U<T[_D'P?\ 7%?Y"J?C'_D6+W_K@:N:=_R#X/\
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MY:_5JORE_P""#?\ R?#\?_\ MK_Z<Y:_5JOR/CO_ )**?^&G_P"D(_;O#?\
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MY"@":BBB@ HHHH **** "BBB@ HHHH **** ,>R_Y'>]_P"O*+^9K8K'LO\
MD=[W_KRB_F:V* "BBB@ HHHH **** "BBB@ HHHH *S?&/\ R+%[_P!<#6E6
M;XQ_Y%B]_P"N!H N:=_R#X/^N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !1
M110 4444 %%%% 'YH?\ !RW_ ,D/^&?_ &-=Y_Z3"BC_ (.6_P#DA_PS_P"Q
MKO/_ $F%%?T;X=_\DK1]9_\ I3/Y5\4?^2SK^D/_ $A'*?\ !!O_ )/A^/\
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M'_)[/[7?_91](_\ 3:*^O*^?/AE_P2V_8C^#GQ!M_BG\.?AEKFGZ[;ZC%?\
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M*/\ @Y;_ .2'_#/_ +&N\_\ 2845_1OAW_R2M'UG_P"E,_E7Q1_Y+.OZ0_\
M2$<I_P $&_\ D^'X_P#_ &U_].<M?JU7Y2_\$&_^3X?C_P#]M?\ TYRU^K5?
MD?'?_)13_P -/_TA'[=X;_\ )+0_QU/_ $N04445\<?>!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'YH?\'+?_)#_ (9_]C7>?^DPHH_X.6_^2'_#/_L:[S_TF%%?
MT;X=_P#)*T?6?_I3/Y5\4?\ DLZ_I#_TA'*?\$&_^3X?C_\ ]M?_ $YRU^K5
M?E+_ ,$&_P#D^'X__P#;7_TYRU^K5?D?'?\ R44_\-/_ -(1^W>&_P#R2T/\
M=3_TN04445\<?>!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YH?\ !RW_ ,D/^&?_
M &-=Y_Z3"BC_ (.6_P#DA_PS_P"QKO/_ $F%%?T;X=_\DK1]9_\ I3/Y5\4?
M^2SK^D/_ $A'*?\ !!O_ )/A^/\ _P!M?_3G+7ZM5^4O_!!O_D^'X_\ _;7_
M -.<M?JU7Y'QW_R44_\ #3_](1^W>&__ "2T/\=3_P!+D%%%%?''W@4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!^:'_!RW_R0_P"&?_8UWG_I,**/^#EO_DA_PS_[
M&N\_])A17]&^'?\ R2M'UG_Z4S^5?%'_ )+.OZ0_](1^7'Q2\:>,?!?QW\;W
M7@[Q9J>DRS^*-02:33+^2!I%%U(0&*$9&>QK,_X7O\</^BR^*_\ PHKG_P"+
MHHKZVC1HSH0<HINRZ>1\37KUZ>(FHR:5WLWW#_A>_P </^BR^*__  HKG_XN
MC_A>_P </^BR^*__  HKG_XNBBM/J^'_ )%]R,OK6*_G?WL/^%[_ !P_Z++X
MK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_
M !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G
M?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7
MW(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ*
M*/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\
M"BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_
MZ++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/
M^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\
M"BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_
MZ++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/
M^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K
M6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^
M'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?
M_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++X
MK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_
M !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?
M_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++X
MK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_
M !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G
M?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7
MW(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ*
M*/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\
M"BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_
MZ++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/
M^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\
M"BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_
MZ++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/
M^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K
M6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^
M'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?
M_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++X
MK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_
M !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?
M_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++X
MK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_
M !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G
M?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7
MW(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ*
M*/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\
M"BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/^%[_ !P_
MZ++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\ "BN?_BZ/
M^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_Z++XK_\
M"BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WL/^%[_ !P_
MZ++XK_\ "BN?_BZ/^%[_ !P_Z++XK_\ "BN?_BZ**/J^'_D7W(/K6*_G?WLS
M/$WQ#\?^-((K7QCXYUC5HH'+PQZGJ<LZQL1@E0['!QW%%%%:1C&"M%61E.<Z
'DKR=WYG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ctlt-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:ctlt="http://catalent.com/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ctlt-20210630.xsd" xlink:type="simple"/>
    <context id="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa63168b9f6848698d3cd88bc9a36d76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2021-08-23</instant>
        </period>
    </context>
    <context id="ifc35871a5183468aaab7c718b6a42771_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i33e364a4c60a40d186dee61881303017_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2782505d17674bb49380b553158607bd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i86567583f6c54f90bd46551acae65b63_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i0fcf069e257b4824a1c38afc5b1b50c6_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i211bd387923e4c8a8acbce07f918efab_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="ia7c291416f38415ea87b555881657be2_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i95c6836230814e07a0db1966aafcc2e7_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i5b17f319169040e68cd6152d58da61f4_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia9f0cf3a7646426da02b70234824e7c8_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i30cad29fb45d48a2b98661270e7a1647_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib236337c6ce243e4a006557882bad730_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7ea093bde90c473e96a3747cc21b632d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i6562a165cb4a4a09862673671a5213e4_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i67f77fb9385943b2aabca06dccddf2d9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib7738cb71ee1402fa2cb64c881b42e46_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id4623a02e99844aeb45c994796125655_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia119eac9568e4da69d3502883a5a411c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iabc274db89144df49cfa6797c23c7a8f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic4c36070acfe4877985f738b20af4ab6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia36a4a8155664853831b16252f0cb6c2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i563591751a704301b043dafcbace5b1c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icfda33e1a14344bc9edc067079194eba_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0ad825218af4779802948241479fe13_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie38c3d72a2b0475e9e8ec4fd255a529e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib7e44f48935447b182ae9e7b32b980e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if63d43dbb1eb4d06a5e91cc8f6bb9df5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i03ea8538a32e4e6198456232f248d40d_D20140731-20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2014-07-31</startDate>
            <endDate>2014-07-31</endDate>
        </period>
    </context>
    <context id="icca6e1525f554545b89d8494504b8035_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="ib5a20ffd9213425fb1e67c81f9224f31_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ctlt:BuildingAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i466bfbf6fd7d441db3dfc26c891635e3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ctlt:BuildingAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5fe521655ef544698a6f74f2e8aff928_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i01ff65157f3540fc804007bced73dae3_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if766739d8f2b4a4889f8d197a5fe2447_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib4a3c699d9f24539b7342ac1f583ba77_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i07a2087bb20040eca6de434a5a3a69b4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iada4b587fca14301a3db1cee71bb807f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib51f38a8412b461597c87ef42543ce85_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i045c4761bada44e6838395223b03d53e_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3da86270c27446129776c8fa261c8181_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97b128b8fed0453589f0b1f789d7401d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iea3b691cfbf74328831c43d672a4f921_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i705c4c9f11954b4ea5e99770a3c251a4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8b25898ae02243708a9f6f45778360bd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3e6d8d7df749456aa44395064bfc68ed_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0aa571359bc437aa855b95942f5960c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39f42b75751f4cb0a931e72af45e2071_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia16a67ca8a3e43959d9b6899ddb210d0_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7f0a88b6d220432d822a3a9acc1be96f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i60878ec54f754cd685972d131936a863_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i093d3096941f487d945682b19471e3df_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i66eccdacf8164ed593c34225a88a46d1_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie21a0bd7b87e4a03911155430ae8b6ae_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaef7d76076a94237a72ee40ceab75b87_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i142419c11f5d4f0489522ad07594cdbf_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4927d306a5cd4d059e75f5c9a3d57193_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ManufacturingCommercialProductSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i52cbad2cbd874660845a41e6ce1dd05d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0d233789dad44dedabfcbf931339090a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if9b7f23d170040c08b3f2af50189003e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i09b4b92b91af444d955bbb9f2174dd7e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i884903df67494d87bbab2288ab7a8879_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:DevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1254879dc3784a83a23a504c071ed5a3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5cfcb80aba194eabb4778da0ffeda957_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i20ad96da5593486fbc6c6de7f9b3e68f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icd4c045f9a3f41bea3c504f692dea648_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i59a776ebf0a942589e391bead02f211b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9b7107a7761d40c8904561ccb9c417f6_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentbeforeintersegmentrevenueeliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7bef26a88d4d45d39bca80b0cc08cb49_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:geographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i951ba969a0bc495faf2a70bac7fd4cb8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0ed9921d6bb04cc7bd39d32cbbc854eb_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6cf6743117284e278dddc68935f89f38_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i60e54ba728a04c0ebb1f97f6fbfd3c64_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:InternationalOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iece8fce5266a4b4a80688042161b0641_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:InternationalOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4fb7193cbe7d43bca3a20da21b84f54d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AnagniMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ea3ee19783347fcbcdad64f27aae413_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AnagniMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i0e96532b149d46edb99ca6b0a748f524_D20200210-20200210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-10</startDate>
            <endDate>2020-02-10</endDate>
        </period>
    </context>
    <context id="i1a947e3eec134edc93799b574e4dde4a_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c8fd61e3e3e4bc587341b5de7823db4_I20200210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:MaSTherCellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-10</instant>
        </period>
    </context>
    <context id="icd578116a1984512962b999d1a8d51ef_D20201116-20201116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:SkeletalCellTherapySupportSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-16</startDate>
            <endDate>2020-11-16</endDate>
        </period>
    </context>
    <context id="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AcordaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-11</startDate>
            <endDate>2021-02-11</endDate>
        </period>
    </context>
    <context id="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:AcordaTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-11</instant>
        </period>
    </context>
    <context id="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:DelphiGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="i22686bb8eb4342bbb50bc71230a550a9_I20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:DelphiGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-23</instant>
        </period>
    </context>
    <context id="iec05426d8309444b822cb0b7025ea5f5_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:HepaticCellTherapySupportSA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="i6d3b7eae092942fba85aaba9e27b78aa_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:KyotoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:BlowFillSealBusinessWoodstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i180acc781ca7481394028c8cb6e82480_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:BlowFillSealBusinessWoodstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3271a0d0c6f0478ea7b97b353bd69af2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib4c2bcc242b14433b4c516133cfacc12_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if22a051247f64fc693ae10ac38acda75_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i654dce15c0874c9fb40648bb53e7594b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibe2726cb57c9441d90eb8e733906a808_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7061380698a4b9395a2f0cfba0d8aac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iab98274d571d4d449f30491cdd65c962_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia0d420fead59462095697a3993d8f4e5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5ebdb26351324dc59f4adf268bf038a1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7814e488a794292a9e3f5a1d348951e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i88402b35bd0c42118b8f0b1db0690925_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iad48a9578f7b445ab0c1b13ac0a459e2_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i845bd8ba54d74c7fb72abac0310f0e79_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e750947153247c48b42689a9511423f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i111cc1fffc0343ee85c1cfa4409c4152_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4c882c4168ec447fba77d5f523c9881f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i86ee2895bde24a118a0de6982690f442_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ief92cbae4c3841df84e37fe359a93709_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:CoreTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i704ca8cefa7742e4aad55ca96150cc8b_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i26b028860ed64053b94135848c0906f0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if93fec8f8cb448208c403c46c07fedc6_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ctlt:ProductRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4c4aea4c64794160b8c6f3912b4dd294_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7344efba23c04c1484bed638331da234_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i378811f92e0f4ffeb7fb93c1f1f293eb_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf709e90ec7842118e0f9f686273d1e9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2731c0e309f94c7b87f012c3985d4fc2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8ff2c23c60004dfab89f35aa1a024575_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8e8e76f0ec8f455cb11705921585b0c4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ctlt:BoltonCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i533413c430064ec6b4c844cc3f1acfbe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanFacilityIncrementalDollarTermB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i15fceb629bb441a8a053f8395affd416_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanFacilityIncrementalDollarTermB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icad07736ec7541dcaa87a7b378aa1ebf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i684ac58b65d2462d9086fd8d03006003_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i776ba765031f4822ac7631755e4324e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditFacilityTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icf427a11407e441c9ae17c2a3bc8d22a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditFacilityTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i93d7e2c8c43a47c0a933c613e1998a34_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d8daa403fef413dba97b83235c8ea21_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i13a1e048ba7c4e9691ded7739ee1a189_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6839464700d0468ba36b8a430fd5892f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i796cb7ff80c54ea8a86407355ff7fedb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id16b5a16fdc04b628d9ec759b80705ff_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib061337543284797b3b9d0ef58f9ec80_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4d27525d7cf54500bd9efcef6e00f2a5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0ac432fc632a4aa4b73cc9827f98414a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorUnsecuredTermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i508875b781734fda88090125bce65502_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2a9042a8cb274081acd357a646d69523_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9de35b0a15464306a00bc384ef0ae803_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:OtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8095367c62b3442fb4b4cbb5c6ceeaa6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:OtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i801d701548f94353a03e6bbafcc35c85_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2d2ad22ca2e9468182fd61677afb1c58_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i324f9e1797a44fa5a5ee426673cb92c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iafa628a205694eb380b875de3bbacbfa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie91ae3a1701e42c4bab269d3f3f05bb4_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanTwoFacilityDollarDenominatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i889429d7ce8e4d9998dd05977d62e04b_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8a70d7001a4d41889b95e3278d9d6e76_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:RevolvingCreditCommitmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i82917b6fc7de420b9f04e1c84874f333_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0282c343e7634e19b53f822bfc4e477f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:TermLoanThreeFacilityDollarDenominatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i076d5ed390e143ec905916749b2b91cd_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i51dabd2b047049b4a2d87b4d8f3f5b9c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0408f495c5d4d949488007caa31f4ae_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i814e92c75da3452187f82acd0565e8db_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2277ff43db9c4df8b0dc6f627b3a499a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:FourPointSevenFivePercentSeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic60365c610a94f2a911805e966520b33_I20171018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-18</instant>
        </period>
    </context>
    <context id="ibf405a2085fd40a8b0117b3a3432c514_D20171001-20171023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-23</endDate>
        </period>
    </context>
    <context id="i8b827d728ed040f9aa9a77f9d945ef0d_D20171001-20171023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-23</endDate>
        </period>
    </context>
    <context id="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ctlt:SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibaffc390ab5942bea52a4be57e7dbde6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i05c37e0185644986bb65525bb1644ccd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:U.S.Dollardenominated4.875SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iabaebe4c2d684181a51203e58e9005fe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i86102d72c35440138d512f3c29d2305f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDollarDenominated500SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6671e05a3e2b467a944f21f20d4c3366_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie15380ce82624d0e9f2df108f51ffe4b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A2375SeniorEuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia3db9452ad5e47a1bb0e9ab578f325b3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5a6d816c6a3b45b4ac0a46bfbcb69988_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:A3125SeniorUSDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i09171d0cebb6430a942aa7517fe61fe9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ief6bc672a6674233a298d9a2b454a730_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1a171a9b90a84e74bda5120a9f3baca5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6faf7a0fe4914b9f87e7fa0c0d7bd9a2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:SeniorSecuredCreditFacilitiesOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2e1619d8d97442d2b05880b4bab402aa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if6dcbdcff43d44a9947d50294da0c59f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8856d25fb8b24759af14435f4b8ba6ca_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:DebtIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2020-11-23</startDate>
            <endDate>2020-11-23</endDate>
        </period>
    </context>
    <context id="i36da9517a14e4528a0349b2cb8978970_I20201123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2020-11-23</instant>
        </period>
    </context>
    <context id="i671c59d76d904023aea5037521cce6c5_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3ae15435182f490c81d494a5e1ec3b32_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i170d00009dcc4cd1ba9ddacd15fdefc1_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9bc1999796814b39a7ce2ada34826470_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i419473081c56497ab865784949c1efce_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1814fd669de945459192151f0faec56c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i12b3309684564f31b7fd6fb52491e6be_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:USDenominatedTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifbb10789bf7a49039027ed20f163c57d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if7abc05af1e54767abafd35e659d3d05_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibe887898b5bf481ba802abbfae71dccc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i94de709fd06649489f2953db5ca5be8f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7afaad523b4d4aa097e6a26233712228_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i33922380dc6b4abe8a22039a9468b7e1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i43879f86903647978e93d2adcf449c13_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i125f9fdad01e48d9b2c4c0fac0f4bf10_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id22c9303e1134346b1d14d228108d1e4_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i98daa63182c347e2b14fbd8135bcfe10_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ctlt:ForeignNetOperatingLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d70d7b7223b4d6f862421f894246388_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ctlt:ForeignNetOperatingLossEstablishedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1e02363e7a2c426689077f3463d3da3f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8e85d458dcaf42d481153310021f91c5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ife004a47c4ec48ce97f593d352e32a55_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iba420f2700c34ea3a4b4416c427c3200_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iab053a6427c144d0967665353d78987e_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i73585509ea444f569767074a3eb6f0e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i40e4763f489e4965b255dfd5a6e6227b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i784893fdb3a544208242b89ecd1ee2d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2cee44c9e63c4f489171f4645ccb62f1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ice706a08834741238da74ea29809773c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3ba1dff49d0441b99a14d5a695a48485_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib0eab50ed80743d8a5a2731fc313e888_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0b5da2a933744c8e97cede443f401e52_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0aa2721ff8ac4556af2c1db97433052f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7641feb3a40c4cc5a431e94405fc50bb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6aabee3dc2d143e9831360b8909d220d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i55c888b0858a407ca4c6882470d3ba57_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4ec188c749a342bfa2dbee5cfd413b77_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i28107f2cb01d42869fd11e36fce2be21_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6731d24e56c6494285a36dd2320f028b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i67761642cec34a60aa24257023272899_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i615eba980ba44e7d91f0e6f353950a76_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if84be19874184c0ebe7a692cffb1b662_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4219029a0a0f4dbc95510d66f4e4944f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i14776c06fd314b2bbd995fa64ee43e49_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icf5bb2f93d92431f9720216af1c29f16_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i91e902584a964a56b042714cd96fd856_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id59d87ec9da544189ca37e884e903023_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic76b7a1a1c50447c8795cfee9b76b6f2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i280d65c3f17f458683c59c0a78aeb3f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17dbf7d5602747039f196cf8fed44904_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i78e5e7182ff24cb9a7f0279131bb4942_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib6429ba70c044f03b798cd9e4de2be0b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i87e0ac7b8ffd4432b71c123c4597bc5f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if39f484cfb594508ae46c19f5b6065b4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3dbac52f32be4ec29dce953d13e92d44_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d771ace0eb1449fb7f3c12ed9ed1b72_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib594f3bd14cb40f2af014369a711be04_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1f6ce956a9a84c788e025d461d2fa55e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icb9a6629638d4bec8bbeca03f202300b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie042f30541ea42e3925b4408eb1b5efe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i616dc17846934bb29e3dfa999602105a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iba82bbc9c25342b3ad2b0f7fca13b545_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2af23bf32de448b9b29a639e339e12ca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i42f7205774aa465d8c2c5c62294b0b82_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48b7425856b04051877a7f4af9acb089_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idefe473808f242cfb4d79b76bb4cd1b6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id3d162800d3645f09f06e974c9c7b41f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:DefinedBenefitPlanOtherAssetsAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id478458e161c4187b43283019eb85566_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3d7d5a90f3e04d0a8cda16af1947057e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5f58afe0b33945a38eaa3dbef03f5e38_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9365ffbe0c824e079d7910fb709ae51b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9f2ea0ebe25a4a58af6552214e53fb98_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i674ba7cf27b546a4bb3070be9a749b6b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if95647ade5004209956c4a57536f85cd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ideb17a22b64641879d269be22be9f957_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2766d6e8cc8a4999992fa9459d493068_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib8ddfd65a6674ab581ba4e4d8629a7c1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i338530796387480ebed0b8318b633f47_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6c88f034a63243369678cb546a00e1ac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i217e96b6a96a4d41b70da7c1176afaac_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9862365c693c40c5a75f7d109361924b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i36fc4fd39be144599048465035ffbf4f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i044c92e5d7764b238c02260877d1c6a3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0933365c8e7843c381a38dda5c76730a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i761a3f210f0d4571a49d8aba4bf24cd5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3a004bc1607d43e183c8e77e4c139dc5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia9ad7c55e85245b69bd849dbef9f6339_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i065b118e37ce4fd4b007a6f358dfd1f8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie793845427de4931a83bcaeee475b50b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:DefinedBenefitPlanOtherAssetsAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i925686e50afe4c2ebf90635e12f3836a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ctlt:EberbachPensionPromissoryNoteOrLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib73f5a43231945369c1c0f4f80a2d43d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7f9023c3b6654d3882840dd7e57a6add_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b03fecf1a824b69b571ab998730a8de_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:InsuranceContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i15d51546be7e4dca88d0b88655adaa62_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ctlt:OtherUnobservableAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie7bbc3d33ba64564905716133264e5cf_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0c19f2e7fd444db984805e159c3087f7_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ctlt:PostretirementBenefitsByAgeGroupAxis">ctlt:Post65Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9d1f082bc83040aea156051c060c4587_D20200615-20200615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2020-06-15</startDate>
            <endDate>2020-06-15</endDate>
        </period>
    </context>
    <context id="ic1290537b263472c96221d671edce576_I20200615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2020-06-15</instant>
        </period>
    </context>
    <context id="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <startDate>2020-02-06</startDate>
            <endDate>2020-02-06</endDate>
        </period>
    </context>
    <context id="ic61973bb2144417ab4cb0d8936b28d87_I20200206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2020-02-06</instant>
        </period>
    </context>
    <context id="i47f799b0175d45b2b0f741e0b0d836f2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:DesignatedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7867ffbd357d4690b08c9d4613c293e4_I20190517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
        </entity>
        <period>
            <instant>2019-05-17</instant>
        </period>
    </context>
    <context id="i6ef4a2ddd640405884e26ccb88aec2cc_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="ifec61b66a0ae41bb8d96d423f6b1d627_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i2a022f50ba3b4184aca687e31673f394_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i221440e603ee468f84a494f340ce58aa_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i50d58655fb4b4d95a56611db174ed7c0_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5655f5c2bab84586add677e627a148ce_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i821917bb413b4a56aac98433b843532a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9b5caf499e0a431a8879e0fccd6f9ece_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibf2629dad7444ac6a087600fb4eeb17d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9f53a97e9a3e45b0b0be1df8cb9a0cb5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i240eab7869244315a4272887642c26a5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if39c138759b140dab2149dee8ac05f30_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib607491522bf4a9cbf1b0e51427ed504_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4ebe451150f641eba39d44e90165f2bc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i087ba84b22354e09b7931fd608163258_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib6065f8b36ce4420b00d99511de9eeb2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ieef7b19288854132b4c14e7c56376062_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id21c601ca07c400c97c3e7ea14464b57_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf4b5715f5e247d7b165eac3e63b264b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie772514199484fb3aae9babd28777987_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie2b9e16ce3314fc2920a48d1f12d45fd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i16adf08f770b46c8aa99e285f1f5c1ac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ctlt:ACOIAccumulatedGainLossMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1fabe70416074ebda423b8e2c3b19f93_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i226e7ad29001479db3560c191da2d80c_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ctlt:StockCompensationPlanOmnibusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib2bd505327db495a8249c5115973c38f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4c12a76e607440788d887a6561e62949_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i696afeb709ea478c8ccf7a35b63793d5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id4760a1c73cc4e78b46d8250df062040_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1910093577c14f8a935dd760ba3c5e1d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iedbb1269e11a4079b292052a9060792f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7c79c1d61c8b42c0802484894294b5ab_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:PerformanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6be771f1b5b348f8986509afc9283597_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i549198ff2e8b45a69be9153279060162_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6fcb40d78880478bae00f3e6351a3717_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9521aa39e6a402cbbdddd19532b77db_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ctlt:RTSRPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iab90ce5a26874c06bf75dc201cdc453b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4758e061601246c28a5892fd160aa21b_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:BiologicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:SoftgelAndOralTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8255b75ca674484f85321eed13714758_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:OralAndSpecialtyDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:ClinicalSupplyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2bd515f3814a4c76bab0cb060aab91ef_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2d88dad07c8b4257bc335a79b87e5840_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia9126ac8ef8946a0984ee537fe89c5a6_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:TotalCatalentSubTotalOfSegmentReportingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i32780b0807f04e8886a1644091ccd209_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2efc8c22dd864f77bfa1a9eeb9bf0b27_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ctlt:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i56d8aebfe31c4223803b5f24bc0f29f8_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i733c8bb4e1014e9e8cfe80267a047ad9_D20190701-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i62be34a4b4e64451b2e516bfcb375e8a_D20180701-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie0b3a62ee7424499b7a078665cc2f930_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i651f15c7ca5a4375a12683f4493dd86d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7abb0547c47a44e190eab0c56374dc2b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icb9b2c18f5a64a6084f50a6976406e31_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic71b854cd3924d249f25376d9c0ad39a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i971cccffdd7d479f8c71a1f66c16fc3a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ctlt:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaa422029d99543199793d9ff01d7b6fa_I20210830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001596783</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ctlt:ZenyattaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-30</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="customer">
        <measure>ctlt:customer</measure>
    </unit>
    <unit id="employees">
        <measure>ctlt:employees</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV80LTEtMS0xLTA_ab81e7ec-c8ad-49c3-8652-9d5980b49ba0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV82LTEtMS0xLTEyNzUz_1879c946-9291-40e1-85d4-6af090f6f0e6">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV84LTEtMS0xLTA_e4103220-adcc-4525-9348-1a90383fa58e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV8yMC0yLTEtMS0w_83928810-9106-461c-a5b0-631992eadafb"
      unitRef="shares">170787238.00</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityAddressPostalZipCode
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGFibGU6ODlmZTJiOGFhNzMwNDRmMGI5NTc4ZTAyNjM2YTZjNGUvdGFibGVyYW5nZTo4OWZlMmI4YWE3MzA0NGYwYjk1NzhlMDI2MzZhNmM0ZV8yMS0zLTEtMS0w_08664db8-eb04-44c5-b510-a84f7d37fa8e">08873</dei:EntityAddressPostalZipCode>
    <dei:CurrentFiscalYearEndDate
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGV4dHJlZ2lvbjozOGYzNjE5ZjRhYzY0NzQ0OWNkYmRmNTdiNGE2NmNmNV84Ng_f76cc67c-0e7a-4f61-9cd0-8d067a5ea7ab">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN180L2ZyYWc6MzhmMzYxOWY0YWM2NDc0NDljZGJkZjU3YjRhNjZjZjUvdGV4dHJlZ2lvbjozOGYzNjE5ZjRhYzY0NzQ0OWNkYmRmNTdiNGE2NmNmNV84Nw_1eae6bbe-508d-4f84-9843-c039479fa8c8">0001596783</dei:EntityCentralIndexKey>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzItMS0xLTEtMA_dbc6e90a-48fc-4861-b768-e07fa79dabd7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzItMi0xLTEtMA_0c0bbc66-5f17-495e-a360-9c4a810006a1"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzMtMS0xLTEtMA_c7d8c954-f864-4a29-acc7-641550b71a19"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzMtMi0xLTEtMA_5d466428-9689-4b90-8696-c6d5a28689d8"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzQtMS0xLTEtMA_e68b720b-8648-4b76-b3f8-b77a9a84d56e"
      unitRef="shares">170549341</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzQtMi0xLTEtMA_59b2294f-5fa3-49dc-ac02-5622d891197e"
      unitRef="shares">162788043</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMS0xLTEtMTA0MTY_3de123f6-f6d5-49ce-ade3-ca0c1a6e6a06"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMi0xLTEtMTA0MTY_650093a1-f3c5-4c04-af70-e284c68e9a7c"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMS0xLTEtMA_afe83730-05c7-4a07-b40d-48a191a50df6"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzYtMi0xLTEtMA_4c6e6dde-3325-48fb-b8d1-51d099b644d0"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzctMS0xLTEtMA_2bde2215-46aa-4740-a451-91b624e7c3b2"
      unitRef="shares">384777</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzctMi0xLTEtMA_d6e9d86c-012f-41f6-ad5e-8544a136e875"
      unitRef="shares">650000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzgtMS0xLTEtMA_90da3d50-1eba-43ba-b3b7-8260ff809864"
      unitRef="shares">384777</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjAvZnJhZzpmY2FmMDQ4NmUyOGE0ZjNlYTNjOWQxMTRmYjZmM2NjNS90YWJsZTpiZGZlMGM3OTQ5Mjg0ODRhOGMxOTJkZDI5NGZkNWEwYy90YWJsZXJhbmdlOmJkZmUwYzc5NDkyODQ4NGE4YzE5MmRkMjk0ZmQ1YTBjXzgtMi0xLTEtMA_374bdc37-3ddc-4800-be62-58b5c90d135c"
      unitRef="shares">650000</us-gaap:PreferredStockSharesOutstanding>
    <ctlt:InstallmentPaymentForAcquisition
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMS0xLTEtMA_ef42241c-e85f-412e-b7c2-8fbeed48a8fe"
      unitRef="usd">50000000.0</ctlt:InstallmentPaymentForAcquisition>
    <ctlt:InstallmentPaymentforAcquisitionYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMi0xLTEtMA_ff732e55-5266-4181-b887-76d28c6480f1"
      unitRef="usd">50000000.0</ctlt:InstallmentPaymentforAcquisitionYearTwo>
    <ctlt:InstallmentPaymentforAcquisitionYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItMy0xLTEtMA_79c8f53c-696a-4d12-8231-9617919c304e"
      unitRef="usd">50000000.0</ctlt:InstallmentPaymentforAcquisitionYearThree>
    <ctlt:InstallmentPaymentforAcquisitionYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTAvZnJhZzo3NDMzNTcxYzM1NGE0NmQ5OTE1OWQwNGVmZjNhNjY1OS90YWJsZToyODU2YmU3NDM4YmU0ZjVmYTljN2RkMGRmYmEzNjI5MS90YWJsZXJhbmdlOjI4NTZiZTc0MzhiZTRmNWZhOWM3ZGQwZGZiYTM2MjkxXzItNC0xLTEtMA_517095be-93c4-4adb-ab20-3e65ba6d41d0"
      unitRef="usd">50000000.0</ctlt:InstallmentPaymentforAcquisitionYearFour>
    <ctlt:OperatingLossCarryforwardsCarryForwardPeriod
      contextRef="i43879f86903647978e93d2adcf449c13_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMxMTQ_40c2bc12-63e0-4386-a398-62f51315a07f">P20Y</ctlt:OperatingLossCarryforwardsCarryForwardPeriod>
    <ctlt:OperatingLossCarryforwardsCarryForwardPeriod
      contextRef="id22c9303e1134346b1d14d228108d1e4_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyNTI_21287ddd-d08b-44ee-ae2d-42c777ef2210">P3Y</ctlt:OperatingLossCarryforwardsCarryForwardPeriod>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDQvZnJhZzo4MGJhMzk0OThkOWI0ZjAzYWIzYzRmN2U5MWZmNDBjMC90YWJsZTo0Y2ZjNzA0ZmRlNzg0NGM2YTljM2RkYmFhZTQ1MDFmZS90YWJsZXJhbmdlOjRjZmM3MDRmZGU3ODQ0YzZhOWMzZGRiYWFlNDUwMWZlXzAtMC0xLTEtMA_4b248e3e-fa64-4c46-8b17-f14aae481407">us-gaap:OtherLiabilities</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDQvZnJhZzo4MGJhMzk0OThkOWI0ZjAzYWIzYzRmN2U5MWZmNDBjMC90YWJsZTo0Y2ZjNzA0ZmRlNzg0NGM2YTljM2RkYmFhZTQ1MDFmZS90YWJsZXJhbmdlOjRjZmM3MDRmZGU3ODQ0YzZhOWMzZGRiYWFlNDUwMWZlXzEtMC0xLTEtMA_ee6545be-ca72-48f6-a1b6-abc593235576">us-gaap:OtherLiabilities</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ZGFkYzk4ODcxZTAxNDAwYWFhYTA5Y2IwZDkwY2Y1YjQvdGFibGVyYW5nZTpkYWRjOTg4NzFlMDE0MDBhYWFhMDljYjBkOTBjZjViNF8wLTEtMS0xLTA_3496981d-402b-4ed9-b2e3-5f86eae87e18">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ZjI3ODExNzRmNzk3NDBiNDg2ZTk5Y2FhZWRmMzc2M2IvdGFibGVyYW5nZTpmMjc4MTE3NGY3OTc0MGI0ODZlOTljYWFlZGYzNzYzYl8wLTAtMS0xLTA_3abdb67c-bf68-4b5f-95ea-de8b14265aff">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgw_3107219b-4a26-469c-bf09-4b00dba01f07">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzcz_69c74374-1e39-4195-99eb-9af4c4c9c5fe">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6ODBmMjBlZTRhYTZiNGI4ZmFhZTI2ZTdhNDdhNjAwZmMvdGFibGVyYW5nZTo4MGYyMGVlNGFhNmI0YjhmYWFlMjZlN2E0N2E2MDBmY18wLTAtMS0xLTA_c4cedf27-bc54-44cf-b8a7-498ec096b14b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgx_81d23cfb-5c60-4bfa-b83c-7485bee6163c">001-36587</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6NTRmNzIwYWRjZjJiNDg2ZjhhODk5OGU5NzRjODE1YTkvdGFibGVyYW5nZTo1NGY3MjBhZGNmMmI0ODZmOGE4OTk4ZTk3NGM4MTVhOV8wLTEtMS0xLTA_bc7ea5ae-0c04-466c-aa24-fdd09937ca24">CATALENT, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8wLTAtMS0xLTA_354fb99c-780e-4c44-bce0-2a018c5ce428">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8wLTItMS0xLTA_08e782d5-c3e1-4075-801e-4f92421040b9">20-8737688</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8zLTAtMS0xLTA_e9db74c6-cadc-4315-a4be-3554c12281ee">14 Schoolhouse Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl8zLTItMS0xLTA_08664db8-eb04-44c5-b510-a84f7d37fa8e">08873</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl80LTAtMS0xLTA_0fa96a24-c16f-46cf-ad54-64d73822bb41">Somerset,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6YTYwZTk5MTQ4MmRkNDgwMGIzNjQ1ZDI2YjM5OGZlMTIvdGFibGVyYW5nZTphNjBlOTkxNDgyZGQ0ODAwYjM2NDVkMjZiMzk4ZmUxMl80LTEtMS0xLTA_710bd5ea-3308-495b-8d77-1b2e17e3ff2d">NJ</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzgy_1d2b51fb-d7cd-45d3-8c08-4bf9d2844e1a">(732)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzg0_7af64887-6aed-4b30-9d60-2dbc18918fbf">537-6200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTAtMS0xLTA_db18c6f1-b284-499b-be29-4b29b836a168">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTEtMS0xLTA_1fcc4f0e-fdfa-4f33-85c8-5948843081e3">CTLT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6Y2M1ZDViYmI4YTY3NGNlYTk1ZmMwMjI2NjA2ODg5MjkvdGFibGVyYW5nZTpjYzVkNWJiYjhhNjc0Y2VhOTVmYzAyMjY2MDY4ODkyOV8xLTItMS0xLTA_fe4a937a-23f6-48bd-be61-40c2e648a0f1">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc1_c717dc0e-3827-4461-8b94-bf08183871d7">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzg1_e158d32d-f3cb-4f17-8e1e-097946477ff6">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc2_3c700069-d1bd-47fa-a444-ba32f6246595">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc4_b61902f5-b02e-49ad-9a45-a552eeee9f02">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8wLTAtMS0xLTA_16481eee-a0c9-4ccd-a6a7-a1f982fd0a8f">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8xLTQtMS0xLTA_d5761ed7-a0f2-4b55-b283-118117f41f8c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGFibGU6MjlhOTNmNzA1MjE5NDJiZTk5NDBhMGU5OTA3MjE1ZjUvdGFibGVyYW5nZToyOWE5M2Y3MDUyMTk0MmJlOTk0MGEwZTk5MDcyMTVmNV8yLTQtMS0xLTA_ba47403a-d0cf-443e-b7c1-80703d0c4676">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc5_20e72479-c467-46cb-8ed3-9eed04660b82">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMzc3_c7ec0d30-9028-43c1-8ca2-891584e1e647">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="iaa63168b9f6848698d3cd88bc9a36d76_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMDYw_b4d59b6b-9fbd-4420-b703-e8c5683f1f64"
      unitRef="usd">17710000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i54ea012ef14a44f6a436d3d6c4a25d0a_I20210823"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xL2ZyYWc6ODYxODM1NGQ5Zjg5NDIyMTg0MDZlM2M2NTVkMTMzODEvdGV4dHJlZ2lvbjo4NjE4MzU0ZDlmODk0MjIxODQwNmUzYzY1NWQxMzM4MV8zMDgy_83928810-9106-461c-a5b0-631992eadafb"
      unitRef="shares">170787238</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMtMS0xLTEtMA_5ed982bc-5912-4b44-9001-acbef8a2131f"
      unitRef="usd">896000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMtMy0xLTEtMA_3333815a-4c17-4cb5-b085-d104220bef96"
      unitRef="usd">953000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQtMS0xLTEtMA_8f73330f-a369-43c7-af8a-427e35453c6c"
      unitRef="usd">1012000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQtMy0xLTEtMA_5e5c2875-8325-46f3-9ecb-26f4038995d3"
      unitRef="usd">838000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzUtMS0xLTEtMA_5b81d02d-4597-4dd9-b09d-3e5bfd932ae3"
      unitRef="usd">563000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzUtMy0xLTEtMA_8b254310-4ef7-451e-bf8b-b2f4e46a9fc1"
      unitRef="usd">324000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzYtMS0xLTEtMA_18beac91-5ff7-43d9-b525-5b7a6ff12dea"
      unitRef="usd">376000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzYtMy0xLTEtMA_29079678-896e-4d47-851c-edbbcfc06bdb"
      unitRef="usd">178000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:MarketableSecurities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMS0xLTEtNDUzNQ_e3cdb03a-e92c-42bb-aa05-d77a50caf443"
      unitRef="usd">71000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMy0xLTEtNDUzOA_a6785ca0-1a95-487d-a2f0-5bed69ee6511"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:AssetsCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMS0xLTEtMA_a9c9aea7-2c03-40b4-a1a7-e0a4d1e394db"
      unitRef="usd">2918000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzctMy0xLTEtMA_0776b4d2-2429-4084-b107-89e035bfd813"
      unitRef="usd">2293000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzgtMS0xLTEtMA_29801676-cee7-4248-9a79-a51d45e9e48f"
      unitRef="usd">2524000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzgtMy0xLTEtMA_d717d579-e475-4615-9b43-5b74120de22d"
      unitRef="usd">1901000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEwLTEtMS0xLTA_d7b50507-b0c0-443f-b000-0b3175c3e1ce"
      unitRef="usd">2519000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEwLTMtMS0xLTA_fd1da2b6-f963-4547-8839-c9732292d7e0"
      unitRef="usd">2471000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzExLTEtMS0xLTA_edee37d7-758f-473f-ba8e-42698e97311a"
      unitRef="usd">817000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzExLTMtMS0xLTA_b279ece1-d9f7-4727-9a47-9ed8e07471fb"
      unitRef="usd">889000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEyLTEtMS0xLTA_597077c0-ad80-4827-bb3f-a6306a947723"
      unitRef="usd">66000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEyLTMtMS0xLTA_bc157e23-2c18-46af-ac81-11e8e4f3eabb"
      unitRef="usd">49000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEzLTEtMS0xLTA_b8e2ec16-4f11-45f9-affe-b33d48bb170c"
      unitRef="usd">268000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzEzLTMtMS0xLTA_535a0f67-b1c8-4386-9da1-123a5970c97b"
      unitRef="usd">174000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE0LTEtMS0xLTA_53a7d2c7-181e-40ef-a453-1af4a6de1999"
      unitRef="usd">9112000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE0LTMtMS0xLTA_6bb44d0f-59f0-4aba-8c0f-3e6601035099"
      unitRef="usd">7777000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE4LTEtMS0xLTA_31056a10-44e4-48e1-aab4-0cab0956668e"
      unitRef="usd">75000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE4LTMtMS0xLTA_027a4ea4-d00b-4fa6-8115-2e91c622f23d"
      unitRef="usd">73000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE5LTEtMS0xLTA_0ef3e99d-4695-4192-8ae8-e47881823752"
      unitRef="usd">385000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzE5LTMtMS0xLTA_33317954-2b39-4ed5-8e32-6e18cd79d57a"
      unitRef="usd">321000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIwLTEtMS0xLTA_961197b8-8e33-4473-ba87-48c372695abf"
      unitRef="usd">736000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIwLTMtMS0xLTA_aa279997-2535-410c-8c88-6d2bfd0f8f81"
      unitRef="usd">499000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIxLTEtMS0xLTA_79f7c03a-f7a5-4830-a910-39fdea9abe0d"
      unitRef="usd">1196000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIxLTMtMS0xLTA_60a24cf4-db0f-4e4f-a6ca-6174e78d6103"
      unitRef="usd">893000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIyLTEtMS0xLTA_0ab89e8b-729f-43fc-b39b-5e1b759017af"
      unitRef="usd">3166000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIyLTMtMS0xLTA_b0b15348-72b1-4ca5-bbec-85129903cd0c"
      unitRef="usd">2945000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIzLTEtMS0xLTA_23fa5252-a207-4eb7-aead-6df469201032"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzIzLTMtMS0xLTA_44c54e76-6182-4fdc-ab4a-a5d9705c738e"
      unitRef="usd">135000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI0LTEtMS0xLTA_f03c2da6-298b-4699-b07e-13a39715b0e4"
      unitRef="usd">164000000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI0LTMtMS0xLTA_47922a0c-68db-4901-b017-19f7057c0a37"
      unitRef="usd">94000000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI1LTEtMS0xLTA_042cc530-7367-491e-b420-f7a11cdfbe7a"
      unitRef="usd">175000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI1LTMtMS0xLTA_f2319193-8bd3-4dcc-929a-6d20fd74b6a1"
      unitRef="usd">204000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI2LTEtMS0xLTA_8464c523-788d-4d3a-bcb1-638bba9efc9f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI2LTMtMS0xLTA_ece07847-6212-4953-a133-c1aa28e78d03"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI3LTEtMS0xLTA_1e0cd2fa-80fe-47ec-873d-80ba78bf585e"
      unitRef="usd">4838000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI3LTMtMS0xLTA_5728eb59-4709-4ded-94f8-121b8c93ceba"
      unitRef="usd">4271000000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI4LTEtMS0xLTA_17300261-5429-453f-9772-f12912e267e1"
      unitRef="usd">359000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzI4LTMtMS0xLTA_6b5b83d3-2888-4025-8df7-bdaa0c8f9d19"
      unitRef="usd">607000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMyLTEtMS0xLTA_f17a992e-8865-48d6-ac98-269cf919c308"
      unitRef="usd">2000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzMyLTMtMS0xLTA_4a6f32fc-e16c-41f0-b0fb-ad4c73cc0e0b"
      unitRef="usd">2000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM0LTEtMS0xLTA_7faffefd-5776-42eb-81b8-32df6fa98f3b"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM0LTMtMS0xLTA_a2b04553-c689-4fc2-863f-ca17796411a0"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM1LTEtMS0xLTA_47defc1d-1185-4cad-888d-8e2beda4687f"
      unitRef="usd">4205000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM1LTMtMS0xLTA_9194dcb4-5c5d-4423-87ad-ae24fda22073"
      unitRef="usd">3818000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM2LTEtMS0xLTA_7f0d448e-ec22-437d-9851-0ec9a2c7b69f"
      unitRef="usd">25000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM2LTMtMS0xLTA_7361cf34-13c5-4bfc-b20d-e0a4056519d3"
      unitRef="usd">-535000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM3LTEtMS0xLTA_24f88586-8e9a-45f5-8155-bb620550a190"
      unitRef="usd">-317000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzM3LTMtMS0xLTA_5e811735-98b8-40ed-a307-7a8b152ad9c7"
      unitRef="usd">-386000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQwLTEtMS0xLTA_65a71657-273e-4316-ae2b-3301727559ec"
      unitRef="usd">3915000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQwLTMtMS0xLTA_42312a10-3310-4a2f-b7ce-e5f86e78c840"
      unitRef="usd">2899000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQxLTEtMS0xLTA_bfeee518-15a1-4ab3-86ea-dc2c09bbdb13"
      unitRef="usd">9112000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTcvZnJhZzowMjAyMTM3Y2ZjZGE0ZDRiYTA1NTYwYTVmOTg3MWIyOC90YWJsZTo4YzljNmIxMjQ5Mzc0Njc3YWZmMDA2NzAxNmVlNDcyZC90YWJsZXJhbmdlOjhjOWM2YjEyNDkzNzQ2NzdhZmYwMDY3MDE2ZWU0NzJkXzQxLTMtMS0xLTA_ffb81fcd-8e98-46a8-8ea7-1469eea067a6"
      unitRef="usd">7777000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItMS0xLTEtMA_d5d3238a-56db-4ac3-a483-480ba0e2c171"
      unitRef="usd">3998000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItMy0xLTEtMA_416ff419-a8c8-488f-84f3-749310b3fbe2"
      unitRef="usd">3094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzItNS0xLTEtMA_500d15d3-f69a-47d2-9374-e4a4fe205d32"
      unitRef="usd">2518000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtMS0xLTEtMA_2649e456-6606-493c-95a0-0d74b7bce9ea"
      unitRef="usd">2646000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtMy0xLTEtMA_2d9eaf1f-8ec7-4f86-9e2a-550933220ca8"
      unitRef="usd">2111000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMtNS0xLTEtMA_70129d09-8c2c-41c3-98d9-39fa833b8c15"
      unitRef="usd">1713000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtMS0xLTEtMA_72952591-ef42-41a5-9732-cb21d6bc1b59"
      unitRef="usd">1352000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtMy0xLTEtMA_debe294c-514d-40e6-b322-5b2a7f8b4a6a"
      unitRef="usd">983000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzQtNS0xLTEtMA_999e55cc-816d-469a-8f15-2fb20adaa067"
      unitRef="usd">805000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtMS0xLTEtMA_8dde2b59-1e92-4c55-ab97-34e0972b9521"
      unitRef="usd">687000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtMy0xLTEtMA_bf645687-3c09-4751-9bb6-deb42f2f69b9"
      unitRef="usd">577000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzUtNS0xLTEtMA_38a723c7-3b82-48e3-a19d-8c745b1261db"
      unitRef="usd">512000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtMS0xLTEtNjM1Nw_b5d5c604-3fa4-4435-a6af-d540efc4e28e"
      unitRef="usd">182000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtMy0xLTEtNjM1Nw_236f57b1-77b8-4c77-9b22-4ed933ea761b"
      unitRef="usd">-1000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzgtNS0xLTEtNjM1Nw_5caccbc2-611f-43ac-8caf-b7b2c9e05260"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMS0xLTEtNjM0OQ_eccea6b2-0f64-4710-91a2-8e5504919854"
      unitRef="usd">19000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMy0xLTEtNjM1Mg_ab3dd5fb-506e-46e2-9305-7e7c7b5c6862"
      unitRef="usd">11000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktNS0xLTEtNjM1NQ_8ae125f1-18a3-41f7-a95c-8f54e695bc6b"
      unitRef="usd">19000000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMS0xLTEtMA_36b1142d-ca93-4a93-8b93-a7f0929564b0"
      unitRef="usd">828000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktMy0xLTEtMA_a6c42716-2d6a-444f-b295-c716e0eab591"
      unitRef="usd">394000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzktNS0xLTEtMA_bc346dfa-5fc3-4ac4-9165-e4950bddc6a8"
      unitRef="usd">274000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTEtMS0xLTA_e5c1071a-2867-4468-adb2-5ea0c6165c64"
      unitRef="usd">-110000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTMtMS0xLTA_f54e5255-a00a-4115-a77e-e6fc8ae34164"
      unitRef="usd">-126000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEwLTUtMS0xLTA_0ff987ca-7822-4037-98b6-75e14d66511b"
      unitRef="usd">-111000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTEtMS0xLTA_7c133a64-527c-43cf-9242-327fb5ce5c82"
      unitRef="usd">-3000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTMtMS0xLTA_f02b63d8-463e-4f54-8226-52591ee7177d"
      unitRef="usd">-8000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzExLTUtMS0xLTA_e72e6b7c-ad51-4e27-97c5-14b51f09e31b"
      unitRef="usd">-3000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTEtMS0xLTA_99424ffa-bec2-4f80-bb8f-4a1e53f2febc"
      unitRef="usd">715000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTMtMS0xLTA_dea11792-b311-44c4-be93-6cae32c00d63"
      unitRef="usd">260000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEyLTUtMS0xLTA_ae26af82-b84b-4e61-8d03-171b2aea4d1b"
      unitRef="usd">160000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTEtMS0xLTA_8dc63e2e-1333-45dd-a0f4-5fea0d64b0c7"
      unitRef="usd">130000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTMtMS0xLTA_6969e942-2b9a-43e4-84e8-c8953f1af65b"
      unitRef="usd">39000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzEzLTUtMS0xLTA_7d8d9ab4-9f87-44d6-84cb-e1ba96bc2226"
      unitRef="usd">23000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTEtMS0xLTA_20ad2511-c551-4035-98aa-d0cee59a178a"
      unitRef="usd">585000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTMtMS0xLTA_c4fd6278-5634-469a-88ce-74ab8e2c63bc"
      unitRef="usd">221000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE4LTUtMS0xLTA_f8a71026-7863-49e8-90ed-27c988b7797a"
      unitRef="usd">137000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTEtMS0xLTA_e1272089-1562-47ee-abf7-1685e018db63"
      unitRef="usd">56000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTMtMS0xLTA_63a9305e-0e0f-448e-9c80-8db180bff8c1"
      unitRef="usd">48000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzE5LTUtMS0xLTA_ed77a160-8510-40ec-9f60-725ab5216d9e"
      unitRef="usd">5000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTEtMS0xLTA_f2632dfa-9597-415a-870d-0a21977d3584"
      unitRef="usd">529000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTMtMS0xLTA_4c870e00-582d-4b7f-a801-43f42c872500"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzIwLTUtMS0xLTA_234f8d45-a2b9-4702-b159-30ab8611e2dc"
      unitRef="usd">132000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTEtMS0xLTA_96ea0cd2-22b7-41cd-87e9-3764e632c991"
      unitRef="usdPerShare">3.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTMtMS0xLTA_d1b51ef4-b6cb-4394-bab6-80432ac76835"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzI5LTUtMS0xLTA_6469aa4a-869a-40ad-b2d8-6b0271844618"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTEtMS0xLTA_a2b5ad29-bec7-4fd4-a77e-08c00431fa8a"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTMtMS0xLTA_4c40499b-cc6e-4ebe-a06f-96a311b86035"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjMvZnJhZzphMDMyZDI3NmVkMWQ0YjdmOTg5MDljNmE3NWVkMDU3NC90YWJsZTo5YmZlYzAzMTYzOTE0YWI2YjY1ZDJkODM5ZjRlMDMyMy90YWJsZXJhbmdlOjliZmVjMDMxNjM5MTRhYjZiNjVkMmQ4MzlmNGUwMzIzXzMyLTUtMS0xLTA_fe87e090-ec55-4048-8abe-3673a2be2c1c"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItMS0xLTEtMA_1a79d6e3-63d7-4ec4-8b76-5a9a898091e6"
      unitRef="usd">585000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItMy0xLTEtMA_6c208770-78e3-4aaa-9c2e-471a3e243ba9"
      unitRef="usd">221000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzItNS0xLTEtMA_407774af-3cc7-4734-a11e-412bcb077e1d"
      unitRef="usd">137000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMS0xLTEtMA_6f4fa381-2601-4af7-a55e-d115313a0324"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMS0xLTEtMA_d650da5b-cc2c-4d2d-9210-4c997afe3e90"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtMy0xLTEtMA_5658a72b-25d0-4c3e-8d47-1a6577ac3888"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzQtNS0xLTEtMA_d3b28fb4-585e-4637-8372-1f65ca34a176"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMS0xLTEtMA_99685733-46fa-438f-af8c-bd67c25837a9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMS0xLTEtMA_9ba26b85-41ea-47af-8a92-c59194f542df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtMy0xLTEtMA_dcf369e2-3ca5-4669-a130-82bbcf300679"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzUtNS0xLTEtMA_2068e312-676a-46a5-99ac-0f6a2fb2a40c"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_81b099d4-7acc-4808-92ea-72fada505513"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_8622dedf-b416-4972-98c0-dec8e34dccbd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMS0xLTEtNTAyNw_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtMy0xLTEtNTA0Mg_294094c2-e198-4ad1-b78d-8c3419594c20"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzYtNS0xLTEtNTA0NA_cc1343ee-71fc-426a-8027-cc6245ccc37f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMS0xLTEtMA_2e3cd357-055e-4143-bc6e-b2278f860096"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMS0xLTEtMA_90cc32bc-ec3a-4ce0-a044-f1967fe33019"
      unitRef="usd">3000000</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctMy0xLTEtMA_517d9efd-6125-4672-a11c-a249e469ce1f"
      unitRef="usd">-3000000</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzctNS0xLTEtMA_5bc30d7e-3c9e-4472-94b3-8df250a44438"
      unitRef="usd">0</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktMS0xLTEtMA_c6db2771-aaa5-4f3e-9ccb-e0d12ee2b091"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktMy0xLTEtMA_6e93a492-71dc-4df6-bef5-e4315963c0e4"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzktNS0xLTEtMA_a1e8dc24-f76c-415f-9bf9-15482ae733aa"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTEtMS0xLTA_67d2adf9-506e-4019-af67-23c65e0f795f"
      unitRef="usd">654000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTMtMS0xLTA_c4c0f2a6-bc5f-425d-8efb-5cb30fe08f9c"
      unitRef="usd">189000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjYvZnJhZzo3MTllMGZiZjYxOWI0NzhmODAwYzI3OTQwMzY2OTljMC90YWJsZTozNWI2OWI2YWRlNTM0M2NlYjBhYzZmNzNmYTM1N2I5My90YWJsZXJhbmdlOjM1YjY5YjZhZGU1MzQzY2ViMGFjNmY3M2ZhMzU3YjkzXzEwLTUtMS0xLTA_dbf08f0a-c9e5-4824-b43a-3b763d0b55c7"
      unitRef="usd">109000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i86567583f6c54f90bd46551acae65b63_I20180630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMS0xLTEtMA_6e80362e-de58-48f8-b9b1-332b692a7d46"
      unitRef="shares">133424000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86567583f6c54f90bd46551acae65b63_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMy0xLTEtMA_d2ba10d4-7066-452a-a285-819ef9779132"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0fcf069e257b4824a1c38afc5b1b50c6_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtNS0xLTEtMA_e1e7c6e3-5c9b-4638-ae3c-98cbbf0eeed0"
      unitRef="usd">2283000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i211bd387923e4c8a8acbce07f918efab_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtNy0xLTEtMA_4b9716a7-d2c1-4146-af44-7f3d2bf0a040"
      unitRef="usd">-872000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7c291416f38415ea87b555881657be2_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtOS0xLTEtMA_a598c42c-ea53-4e62-842d-cf57e7d50a66"
      unitRef="usd">-326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMTMtMS0xLTA_b376f2e2-be52-4d07-981d-876a06d09511"
      unitRef="usd">1086000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEtMTUtMS0xLTExNzIz_81d29266-a63b-4115-bd75-647f9f1e92de"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockholdersEquityOther
      contextRef="i5b17f319169040e68cd6152d58da61f4_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItNy0xLTEtNTExNg_c8512231-c1ed-4588-8411-3d4cd6a3556d"
      unitRef="usd">15000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ia9f0cf3a7646426da02b70234824e7c8_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMTMtMS0xLTUxMTg_01dec4d6-11b6-407c-9b17-a26bec43bfa6"
      unitRef="usd">15000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMS0xLTEtMA_0e98429e-cd41-4f4e-a3f0-577801b0206d"
      unitRef="shares">11431000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMy0xLTEtNTAwOA_e7d4ab31-67e7-48de-9057-b5801ba7d561"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItNS0xLTEtMA_a1bd1044-3c1f-4c4d-a5a4-88e93311a26f"
      unitRef="usd">446000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzItMTMtMS0xLTA_a020a447-4fe2-499a-8d39-6f2dcde01e2c"
      unitRef="usd">447000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMS0xLTEtMA_f3b27527-45c3-462d-a153-bf98d7f3d367"
      unitRef="shares">883000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibb3696c831cb4cfdbcd1be74e1a29c64_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMy0xLTEtMA_e16f5a8b-3af7-4256-bcdc-879df3986c05"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMtMTMtMS0xLTA_ee3b0a7b-736a-4587-a811-ac3d20ea118f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtMTUtMS0xLTUxMjU_8328a2cb-734f-409d-bc97-87bfc7c334d3"
      unitRef="usd">607000000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzQtNS0xLTEtMA_4ab1c155-0a88-433f-8858-41e85878a837"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzQtMTMtMS0xLTA_713ebd1d-197c-45c7-b44b-7ace12faf20f"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtNS0xLTEtMA_7f531f49-82ae-40eb-8083-ea92fee20688"
      unitRef="usd">15000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzUtMTMtMS0xLTA_f54c1a1b-ee34-4d87-a150-cc32fc327700"
      unitRef="usd">15000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <ctlt:EquityIssuedInLieuOfCashConsideration
      contextRef="i2dd0a2548d52438ea0f8ef417dc26a4b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNS0xLTEtNTEyMQ_8bd63f96-442f-49a2-903d-62367fff2f17"
      unitRef="usd">-10000000</ctlt:EquityIssuedInLieuOfCashConsideration>
    <ctlt:EquityIssuedInLieuOfCashConsideration
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMTMtMS0xLTUxMjM_78e30963-8ee5-4dcb-88fb-a1c738137cd9"
      unitRef="usd">-10000000</ctlt:EquityIssuedInLieuOfCashConsideration>
    <us-gaap:DividendsPreferredStock
      contextRef="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzktNy0xLTEtNTAxMA_9a69bb66-ef71-4ffa-a90d-0fda299682d5"
      unitRef="usd">3000000</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzktMTMtMS0xLTU2OTU_9a3e3a6b-82c5-40b5-982f-5e71a66fbbf4"
      unitRef="usd">3000000</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="i4e86b4f7968b47adaac3c1f0ff389b56_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzYtNy0xLTEtMA_fc855854-6ba4-461c-a84c-1b7f8bbaccdf"
      unitRef="usd">137000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzYtMTMtMS0xLTA_f8194b5d-4a74-465f-b0f2-da076d51b547"
      unitRef="usd">137000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i30cad29fb45d48a2b98661270e7a1647_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzctOS0xLTEtMA_71f865df-efac-4f58-afa3-dcd63fc6b564"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzctMTMtMS0xLTA_87876c1f-789c-40ba-8a45-373e6ea300a5"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib236337c6ce243e4a006557882bad730_I20190630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMS0xLTEtMA_07f814e6-949b-4b71-9148-2064dfbf1a0a"
      unitRef="shares">145738000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib236337c6ce243e4a006557882bad730_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMy0xLTEtMA_6b51f9ee-477f-4b30-a4c8-f59cec2c8da9"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ea093bde90c473e96a3747cc21b632d_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNS0xLTEtMA_6998e416-2b70-4160-89e2-8f253ebe0bbc"
      unitRef="usd">2757000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6562a165cb4a4a09862673671a5213e4_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtNy0xLTEtMA_c73e3494-afc3-4fea-91bf-7304026ab22e"
      unitRef="usd">-723000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67f77fb9385943b2aabca06dccddf2d9_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtOS0xLTEtMA_effac47d-6dae-4e5f-b1d1-575ebaaf0e1a"
      unitRef="usd">-354000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzgtMTMtMS0xLTA_0607452b-a8eb-4d4c-975f-4127a4adbcb1"
      unitRef="usd">1682000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTE1LTEtMS01MDI1_604874d1-cff3-48cc-8a3a-f00d4dfe6e68"
      unitRef="usd">607000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTEtMS0xLTA_c93c17b1-2b72-4715-abc9-01362636f882"
      unitRef="shares">16196000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTMtMS0xLTA_9c79b518-6a60-4575-b469-561dcf7fcf10"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTUtMS0xLTA_033c6b20-ce54-4e41-829f-81e0ee1f5409"
      unitRef="usd">1042000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEwLTEzLTEtMS0w_bf903b8d-0eff-4dde-b1f9-0b6f233fd326"
      unitRef="usd">1042000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTEtMS0xLTA_0a6b7e42-b571-4cd2-a16b-9789ef88ec9f"
      unitRef="shares">854000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i876d3dde87e64fd39b953a618913e3db_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTMtMS0xLTA_0933a560-96b9-4ff9-a8d5-a749f237e6bb"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzExLTEzLTEtMS0w_04cb4636-5d35-4454-b826-e5c073d445f5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTUtMS0xLTA_6a68b768-a010-417c-9d1a-9d8e86cc8f01"
      unitRef="usd">48000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEyLTEzLTEtMS0w_1793a40a-3797-476c-82bd-edd76234fa1a"
      unitRef="usd">48000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEzLTUtMS0xLTA_747d84cf-e61a-4570-abb5-9e4d9ecba914"
      unitRef="usd">32000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzEzLTEzLTEtMS0w_9bb9df94-7bb2-46f7-956d-e9b229771187"
      unitRef="usd">32000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i7bb196d701dd45648308a97fb5608a9e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTUtMS0xLTUwMTI_9af7918c-b113-40f9-a6ee-4b30b17d24cb"
      unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTEzLTEtMS01Njk3_6786ceb4-9e43-4e02-8fed-ed2caa413dd5"
      unitRef="usd">3000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:DividendsPreferredStock
      contextRef="id4623a02e99844aeb45c994796125655_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE1LTctMS0xLTA_04c81c39-d3c1-49af-860c-7a05afb38d45"
      unitRef="usd">33000000</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE1LTEzLTEtMS0w_d9d00cdb-a59c-4f58-8ebd-ebc260e2fb14"
      unitRef="usd">33000000</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="id4623a02e99844aeb45c994796125655_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE2LTctMS0xLTA_c6ad9f67-31a6-4637-8aac-8b448db78903"
      unitRef="usd">221000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE2LTEzLTEtMS0w_a1fbfa2b-f2b2-4e8e-ae0f-5dfb6f1d1f48"
      unitRef="usd">221000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia119eac9568e4da69d3502883a5a411c_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTktMS0xLTA_7def25ad-eb2a-46aa-9f69-6063ec187511"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE3LTEzLTEtMS0w_ac006606-b358-498c-98f7-f752839c106a"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTEtMS0xLTA_512a940c-cd38-47ef-8179-83615ed6f51f"
      unitRef="shares">162788000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibdd4f23dc6dd41fc910df940ee08ebe4_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTMtMS0xLTA_df617707-8dc4-4df4-9bab-8607b60de887"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabc274db89144df49cfa6797c23c7a8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTUtMS0xLTA_03e0b0ba-7aa2-45b7-a6b8-6bff46f1efe6"
      unitRef="usd">3818000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4c36070acfe4877985f738b20af4ab6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTctMS0xLTA_ca125f54-2661-4a17-a13d-c3f8b63435de"
      unitRef="usd">-535000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia36a4a8155664853831b16252f0cb6c2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTktMS0xLTA_103252ac-502d-4519-9c55-d3901a7b0773"
      unitRef="usd">-386000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE4LTEzLTEtMS0w_8a3d8c71-3c2a-4c63-b71c-3c0dcbfd0317"
      unitRef="usd">2899000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTE1LTEtMS01MDIz_9eec7cda-6538-496f-a108-bba81118d649"
      unitRef="usd">607000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTEtMS0xLTA_9b933749-1ba0-47e9-b8bf-57ac936ab47d"
      unitRef="shares">1163000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTMtMS0xLTA_2a216e1f-d4d5-4ed8-bb11-fd00863a5b85"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTUtMS0xLTA_b804cd1b-5430-41bc-9546-6d1a47430672"
      unitRef="usd">82000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzE5LTEzLTEtMS0w_f5dc7a91-0723-4515-acd6-6d30768551c3"
      unitRef="usd">82000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTEtMS0xLTA_34eff197-e027-43c6-8fa9-e9c378726997"
      unitRef="shares">1206000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTMtMS0xLTA_4186d8c9-f759-4b6a-a46b-1d12ceb70979"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIwLTEzLTEtMS0w_9e9505ee-bdc6-42db-a603-64aecd499905"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="id5a43680a9c8438c97eb4126f264fd81_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEtMS0xLTMxMjU_3b376d14-d388-46c5-abc5-de2b446a996e"
      unitRef="shares">5392000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTUtMS0xLTMxMjI_c2f3a8bc-0bae-450b-a87c-734545072eb7"
      unitRef="usd">253000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEzLTEtMS01MDE0_62f2c23e-a243-4ce9-9e1b-c91013824122"
      unitRef="usd">253000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTE1LTEtMS01MDE4_910d004f-383c-4164-9aec-0b993adec8f7"
      unitRef="usd">-248000000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTUtMS0xLTA_e7424771-0e57-4d9f-8cb3-57821c26d15e"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIxLTEzLTEtMS0w_4eb93d94-3b67-4ba6-be7c-36cf4fa7696f"
      unitRef="usd">51000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIyLTUtMS0xLTA_6792a04e-c180-4689-90a1-2bdde644519a"
      unitRef="usd">46000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzIyLTEzLTEtMS0w_ffdbd929-3d81-4722-bdfe-1802a4b49d8c"
      unitRef="usd">46000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTUtMS0xLTg1NjE_713f7e7f-ea4a-42f3-a229-b356c2c5c068"
      unitRef="usd">38000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTEzLTEtMS04NTYz_50effdf0-3bd3-4836-877b-6d4155c627a0"
      unitRef="usd">38000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTUtMS0xLTA_3477e63b-184d-4770-83d3-91fa92e7bcc2"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI0LTEzLTEtMS0w_6cfc632b-6f23-475e-8425-92f5a884c593"
      unitRef="usd">9000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:DividendsPreferredStock
      contextRef="i563591751a704301b043dafcbace5b1c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI1LTctMS0xLTA_c57c344c-5e99-40cd-99f4-048f0ac75191"
      unitRef="usd">25000000</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI1LTEzLTEtMS0w_99236016-0897-47b9-804c-2a1e79b2ae6b"
      unitRef="usd">25000000</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="i563591751a704301b043dafcbace5b1c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI2LTctMS0xLTA_587ff629-3a1a-4f3a-80f1-9c70e6165af0"
      unitRef="usd">585000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI2LTEzLTEtMS0w_5f4d9682-4b90-49a1-93ea-c5f5a64f1c61"
      unitRef="usd">585000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfda33e1a14344bc9edc067079194eba_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTktMS0xLTA_66f4d0a9-6509-4106-802b-8d4e2c622c96"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI3LTEzLTEtMS0w_58c935f1-fbef-498d-89a5-d1d8879cf9d8"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if0ad825218af4779802948241479fe13_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTEtMS0xLTA_5ceb66c9-2f94-4dfb-95e1-05c0c5c1331a"
      unitRef="shares">170549000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0ad825218af4779802948241479fe13_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTMtMS0xLTA_dad8338a-20a6-481e-a9fd-2dfa6f6286a3"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie38c3d72a2b0475e9e8ec4fd255a529e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTUtMS0xLTA_c2300f34-0e08-4b95-82aa-68105834553e"
      unitRef="usd">4205000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7e44f48935447b182ae9e7b32b980e6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTctMS0xLTA_ce0eddd4-3520-4bdf-ae8c-bf80614be7c2"
      unitRef="usd">25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if63d43dbb1eb4d06a5e91cc8f6bb9df5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTktMS0xLTA_7562221f-c823-4d82-ae01-792846671433"
      unitRef="usd">-317000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzI4LTEzLTEtMS0w_ecd4bba1-a1ee-40e1-9839-97093d448c6a"
      unitRef="usd">3915000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNjkvZnJhZzplMTA1MzNjMmMwNTc0MDA3ODhjZjQ0NmNjNjRlMThiZi90YWJsZTo2ZGIzZGRjM2Y1YjA0ZmQzYjVhNTI5ZGMxY2FiMDcxMi90YWJsZXJhbmdlOjZkYjNkZGMzZjViMDRmZDNiNWE1MjlkYzFjYWIwNzEyXzMyLTE1LTEtMS01MDIx_2112c3dd-f5a4-43de-9229-7fc574ab1a7a"
      unitRef="usd">359000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:ProfitLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtMS0xLTEtMA_5923ca24-8e83-4ed9-a9fb-f86cfc22d017"
      unitRef="usd">585000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtMy0xLTEtMA_ab405469-2e52-46d1-955c-bdb614ac3c72"
      unitRef="usd">221000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMtNS0xLTEtMA_4d0a7ec2-cc8c-4659-ab4c-38da70b7b906"
      unitRef="usd">137000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctMS0xLTEtMA_94f3d6c4-48a5-4ab7-9603-862e9e4efcc4"
      unitRef="usd">289000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctMy0xLTEtMA_587f72f2-5b29-4d8a-bffd-f7dcd647b7c3"
      unitRef="usd">254000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzctNS0xLTEtMA_008ece6d-4410-42cd-a4dd-f7b208f3bf81"
      unitRef="usd">229000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtMS0xLTEtMA_ba49fea5-4943-40ca-9d93-a455cecb481d"
      unitRef="usd">4000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtMy0xLTEtMA_0dab8db4-e4e6-4f51-8883-07beb97dc1a0"
      unitRef="usd">-2000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzgtNS0xLTEtMA_1730759e-23a7-424e-b33b-a6742838f14e"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <ctlt:AmortizationAndWriteOffOfFinancingCosts
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktMS0xLTEtMA_fb134846-dba3-434a-b726-cb84d40ead51"
      unitRef="usd">11000000</ctlt:AmortizationAndWriteOffOfFinancingCosts>
    <ctlt:AmortizationAndWriteOffOfFinancingCosts
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktMy0xLTEtMA_f26b8e92-0fad-4689-a9ac-a49a989dc987"
      unitRef="usd">12000000</ctlt:AmortizationAndWriteOffOfFinancingCosts>
    <ctlt:AmortizationAndWriteOffOfFinancingCosts
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzktNS0xLTEtMA_96c4346d-d1dc-46f8-8428-95761777826c"
      unitRef="usd">14000000</ctlt:AmortizationAndWriteOffOfFinancingCosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTEtMS0xLTA_2aa8e8f1-c744-453b-8d65-dc60db9f30e4"
      unitRef="usd">-9000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTMtMS0xLTA_a324c84a-f931-4fe8-bfdd-287e2b667313"
      unitRef="usd">-5000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzExLTUtMS0xLTA_c3fb0673-e3d3-4a50-87e9-d1769efa0935"
      unitRef="usd">-5000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTEtMS0xLTA_1a3894b1-3aca-4513-ab75-3c63433bde13"
      unitRef="usd">182000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTMtMS0xLTA_b8f2fbed-5681-4775-81c1-b9da7358d0d1"
      unitRef="usd">-1000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEyLTUtMS0xLTA_6f4e1e22-0cf6-4ad1-af6f-834c25f9108a"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTEtMS0xLTA_25dd9b1a-5c92-4d4f-a838-81c2863eaa50"
      unitRef="usd">18000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTMtMS0xLTA_53711532-8d5c-4494-a442-993c92e1e3b5"
      unitRef="usd">10000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzEzLTUtMS0xLTA_8916c085-5355-4fc5-ad83-dc0bbe67ca76"
      unitRef="usd">5000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTEtMS0xLTA_4e47cc83-50f0-4753-b8cd-851140f0374f"
      unitRef="usd">17000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTMtMS0xLTA_fc138593-4086-4cef-843b-f579bae5af19"
      unitRef="usd">3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE0LTUtMS0xLTA_5bd10aff-b3e7-4e29-bc28-8994aedbe3f5"
      unitRef="usd">13000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ShareBasedCompensation
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTEtMS0xLTA_b8aa5ad7-7ef6-4973-8f83-2db07da61164"
      unitRef="usd">51000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTMtMS0xLTA_69dfbcf8-37c1-49f6-9fd5-4e2533dee62a"
      unitRef="usd">48000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE1LTUtMS0xLTA_8726425b-45f3-4901-8552-9a8b5b7b0dd3"
      unitRef="usd">33000000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTEtMS0xLTA_2cf81244-fbf1-449b-87ef-33547aa9bda2"
      unitRef="usd">-64000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTMtMS0xLTA_b29edccc-3a32-4a97-8926-8ec669e76a16"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE2LTUtMS0xLTA_af28f8b7-eef9-4b66-896f-880345728967"
      unitRef="usd">15000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <ctlt:ProvisionForBadDebtsAndInventory
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTEtMS0xLTA_b4bd9f13-8c1f-435f-a414-dfbbdb7a8efe"
      unitRef="usd">41000000</ctlt:ProvisionForBadDebtsAndInventory>
    <ctlt:ProvisionForBadDebtsAndInventory
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTMtMS0xLTA_25a6c0c4-e3de-4958-9484-c061007d2d12"
      unitRef="usd">10000000</ctlt:ProvisionForBadDebtsAndInventory>
    <ctlt:ProvisionForBadDebtsAndInventory
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE3LTUtMS0xLTA_cbeae07f-3534-43ff-8392-fa35d4560e23"
      unitRef="usd">13000000</ctlt:ProvisionForBadDebtsAndInventory>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTEtMS0xLTA_47b9b362-f62d-4cf2-861f-ce5fb4d75bd5"
      unitRef="usd">186000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTMtMS0xLTA_28e0adf9-c94a-47c5-aeda-7807f557d1b8"
      unitRef="usd">151000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzE5LTUtMS0xLTA_58f8c145-9a26-4abc-9c8f-e0010b17bfc1"
      unitRef="usd">119000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTEtMS0xLTA_1e92eea3-55e4-482b-b576-ca8b1986be09"
      unitRef="usd">260000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTMtMS0xLTA_1efacf7d-d711-4ef7-b747-b71b612b0901"
      unitRef="usd">76000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIwLTUtMS0xLTA_62ed6b39-a853-4040-aa33-34f0f2e7e9fa"
      unitRef="usd">34000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTEtMS0xLTA_6c0a410a-29c7-402f-a18d-674638740e9d"
      unitRef="usd">50000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTMtMS0xLTA_ffd8e660-1259-41d3-8cb4-eac72d674423"
      unitRef="usd">72000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIxLTUtMS0xLTA_c5ee8e89-805e-467a-b3b6-8dc8fec541be"
      unitRef="usd">36000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTEtMS0xLTA_76859e4c-ecb3-4eba-9090-2cf85bcf43fd"
      unitRef="usd">36000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTMtMS0xLTA_41800df4-e731-4cf2-873e-64d2eb0a67bc"
      unitRef="usd">-33000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzIyLTUtMS0xLTA_978fea95-bf35-4c56-8250-7f0bddcd5497"
      unitRef="usd">43000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTEtMS0xLTA_c5e149c2-43c0-4fc9-99a7-b79a9469ea3a"
      unitRef="usd">433000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTMtMS0xLTA_604f2c27-f9f0-4222-ae34-db2b11c46dfe"
      unitRef="usd">440000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI1LTUtMS0xLTA_bf5717f3-ae80-48e0-aad9-15942fde6741"
      unitRef="usd">248000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTEtMS0xLTA_3783bb83-b50d-43f7-ba14-84cfc53a1767"
      unitRef="usd">686000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTMtMS0xLTA_5b8c15b0-4939-4b71-bd2a-a824f014f115"
      unitRef="usd">466000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI3LTUtMS0xLTA_ec169bb4-bde9-407a-8363-eb534410ec94"
      unitRef="usd">218000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTEtMS0xLTQ1OTA_fef596cf-7399-43a8-b128-7841c0429a42"
      unitRef="usd">72000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTMtMS0xLTQ1OTM_730cda77-4921-460a-ba06-bc7936c099f3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTUtMS0xLTQ1OTY_9b135a6b-78f8-458c-bdfd-8b6c579f7c48"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTEtMS0xLTA_23e7e14e-7f63-4bcb-ae1d-639df07a9219"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTMtMS0xLTA_0aa2e32f-b22d-487a-9a5f-4b998d77ea65"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI4LTUtMS0xLTA_522505f7-0cec-46c7-9391-e3fb96f3dd5a"
      unitRef="usd">1000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTEtMS0xLTA_95be9a56-abdc-4f1f-b8e1-9df9fd6ca07e"
      unitRef="usd">287000000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTMtMS0xLTA_577a86fa-c5e3-43e9-b8d2-b1021160884a"
      unitRef="usd">21000000</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzI5LTUtMS0xLTA_5bac3fb4-ee2f-4bfd-92f8-962973225e46"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTEtMS0xLTA_0093a0bd-5a86-40a6-9b33-21b968829e2e"
      unitRef="usd">147000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTMtMS0xLTA_ae4657b1-5073-40b0-90c2-0eb780ae2c3e"
      unitRef="usd">379000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMwLTUtMS0xLTA_65af964f-0af9-4f94-9a2f-8e0dedcd6b1e"
      unitRef="usd">1291000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTEtMS0xLTA_39036523-2769-43f8-b279-4f4e2ead7272"
      unitRef="usd">31000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTMtMS0xLTA_9316a442-69dc-4180-a432-d1abf1890b18"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzMxLTUtMS0xLTA_6a6fcf17-d515-4720-aadc-0488c4fb805e"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTEtMS0xLTA_ce002ac2-788a-4449-9c05-1358404d3390"
      unitRef="usd">-649000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTMtMS0xLTA_94cb56ff-35c3-421c-bace-a242e110a4a0"
      unitRef="usd">-827000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM0LTUtMS0xLTA_0fc143dc-4785-4d89-87eb-66b3d1882387"
      unitRef="usd">-1510000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTEtMS0xLTA_dbe7b003-1da8-4bd5-bff2-e66b0d8a41f2"
      unitRef="usd">2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTMtMS0xLTA_bd843ab8-793d-4d68-961c-c865516f211f"
      unitRef="usd">-49000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM2LTUtMS0xLTA_298dc43d-dc05-4945-9ac5-bde9c5d579b6"
      unitRef="usd">-8000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTEtMS0xLTA_f809140d-1a10-4cd0-a9e5-af234780a8a6"
      unitRef="usd">164000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTMtMS0xLTA_51ce669f-f7d1-4d17-b0b1-db775e7672bf"
      unitRef="usd">909000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM3LTUtMS0xLTA_21570318-5216-4048-aaf9-95c4896a9e3e"
      unitRef="usd">1448000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTEtMS0xLTA_63d18daf-0393-47b3-a092-f73151c0099a"
      unitRef="usd">67000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTMtMS0xLTA_9937e9bd-bc01-4857-aae3-54133b3d36c8"
      unitRef="usd">811000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzM4LTUtMS0xLTA_a5c0c50b-890f-4357-9019-b294f3f7ad80"
      unitRef="usd">1290000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTEtMS0xLTA_ddb1e324-61db-4c3a-a382-f3351995ec20"
      unitRef="usd">19000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTMtMS0xLTA_fc320ed9-4146-4c91-985d-68e285c092ff"
      unitRef="usd">25000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQwLTUtMS0xLTA_3fd64db4-2ccc-48fc-a6b6-80ba0a67ecd5"
      unitRef="usd">25000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:DividendsAndInterestPaid
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTEtMS0xLTA_4c4e3dc6-b3c6-480e-9184-312991c52eb7"
      unitRef="usd">22000000</us-gaap:DividendsAndInterestPaid>
    <us-gaap:DividendsAndInterestPaid
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTMtMS0xLTA_ecdf5a90-dce3-453a-abcc-a0f819a5ea50"
      unitRef="usd">36000000</us-gaap:DividendsAndInterestPaid>
    <us-gaap:DividendsAndInterestPaid
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQxLTUtMS0xLTA_c8dade52-ef35-4e23-bd79-7076200fff70"
      unitRef="usd">0</us-gaap:DividendsAndInterestPaid>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTEtMS0xLTA_8da7e0bf-7d54-431f-a997-4707f231323f"
      unitRef="usd">82000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTMtMS0xLTA_b4bfa73c-7f1e-440c-a3a6-61008923159e"
      unitRef="usd">1046000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQzLTUtMS0xLTA_d6935306-ec37-44c0-afe9-8660aea2bc3c"
      unitRef="usd">445000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTEtMS0xLTA_09d6336e-5826-472e-b179-7270056dd076"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTMtMS0xLTA_f375a9ea-a8b3-44bb-9af4-5169ff408ebe"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ0LTUtMS0xLTA_67733700-35fa-4a80-9cd5-ac11a6560ec9"
      unitRef="usd">646000000</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTEtMS0xLTQ1NTQ_a3d27eca-b6b5-4263-8f9f-b9d7cbd4fa08"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTMtMS0xLTQ1NTc_20aa4633-86f0-4c17-9a0b-f94218e288cf"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ2LTUtMS0xLTQ1NjA_52cff986-23cc-428f-9e90-455fd09f3847"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTEtMS0xLTA_ab609412-7216-475d-83aa-377ddd8092e2"
      unitRef="usd">46000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTMtMS0xLTA_cfc1ffba-c4d0-4eb9-b8f3-d9f1704ee8ad"
      unitRef="usd">32000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ1LTUtMS0xLTA_25103fad-cfff-4b2a-86cd-1bf973be1e41"
      unitRef="usd">15000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTEtMS0xLTQ1NzY_75168db8-7dc4-4f22-bc1e-e2fa81793808"
      unitRef="usd">10000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTMtMS0xLTQ1Nzk_6c5c2f5d-0fd2-4fd3-9dc1-30157657e622"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTUtMS0xLTQ1ODI_74ea441b-cd41-409b-84d1-ab5a06cc57ab"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTEtMS0xLTA_b57becb4-1505-4390-83c5-692520fcd62d"
      unitRef="usd">142000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTMtMS0xLTA_1869147a-9525-449d-8c01-34c7594015ca"
      unitRef="usd">1002000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzQ4LTUtMS0xLTA_187db2de-58ba-43d6-b4b0-e8521f9b866c"
      unitRef="usd">1201000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTEtMS0xLTA_8bea2f46-aa24-4428-9f4c-b848a4572a5e"
      unitRef="usd">17000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTMtMS0xLTA_225359fe-1b06-48ef-8193-4bef527826d5"
      unitRef="usd">-7000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUwLTUtMS0xLTA_75931960-b18b-4cd5-b26a-66b10da850e0"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTEtMS0xLTA_54ca302c-555f-4519-be37-207e9e4191f0"
      unitRef="usd">-57000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTMtMS0xLTA_8dd07942-185c-4eb3-8076-a31116df923d"
      unitRef="usd">608000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUxLTUtMS0xLTA_2dfac1d0-af0b-4925-9680-e4344a338679"
      unitRef="usd">-65000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTEtMS0xLTA_1899a53f-4170-4d52-b11f-eedb14234aa5"
      unitRef="usd">953000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTMtMS0xLTA_6f7f746a-dda7-4b19-88f0-2ae273ce6235"
      unitRef="usd">345000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUyLTUtMS0xLTA_4650a9d9-2a72-45f5-be67-ab2e50051335"
      unitRef="usd">410000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTEtMS0xLTA_6a26a098-9a39-4126-b92c-b66d48dc7150"
      unitRef="usd">896000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTMtMS0xLTA_367d39be-802c-4129-a875-23302858d6c0"
      unitRef="usd">953000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzUzLTUtMS0xLTA_3e5f3621-63ae-4bcb-8b24-82b2471f1545"
      unitRef="usd">345000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTEtMS0xLTA_01763376-eae4-47ba-a75a-64f1354a52d2"
      unitRef="usd">105000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTMtMS0xLTA_92ea62d0-d0c0-4cef-8efb-359fda628587"
      unitRef="usd">98000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU1LTUtMS0xLTA_3c5a75f7-0038-41a7-bc57-74202153fcab"
      unitRef="usd">103000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTEtMS0xLTA_0161f085-7294-4aa5-ac42-b30e045d0bea"
      unitRef="usd">47000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTMtMS0xLTA_03103e75-7abd-4321-88f5-1befba15b193"
      unitRef="usd">43000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzU2LTUtMS0xLTA_0292c875-6832-43b7-8009-b763a3bf6692"
      unitRef="usd">42000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTEtMS0xLTEzNTM4_607e3889-af1a-4329-8a6f-bfc60692ff81"
      unitRef="usd">253000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTMtMS0xLTEzNTM4_f91cad0c-7905-4c9c-a679-e600cd1bbc7a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTUtMS0xLTEzNTM4_4258998b-f867-4c03-9c9d-42427a300689"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTEtMS0xLTEzMzc0_3f15c884-a74b-4744-8231-d6bf668aeae1"
      unitRef="usd">47000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTMtMS0xLTEzMzc0_9c764804-02fc-468d-a3cb-75a1d37f9d79"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzIvZnJhZzpkZGRjZDUyOTg3Y2U0MGY5OTg1YWEzYjVhODk2Mzk4Yi90YWJsZTpmOTM2YWQzMDdlMjk0YjBiYWM1ZDhjNTY5N2NjMWRmZi90YWJsZXJhbmdlOmY5MzZhZDMwN2UyOTRiMGJhYzVkOGM1Njk3Y2MxZGZmXzYxLTUtMS0xLTEzMzc0_2fde397b-0814-498a-82f9-fd3dccdbf6c5"
      unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM0_db6112ff-05fa-4771-a616-0aa3a8f99c39">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Catalent, Inc. (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Catalent&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) directly and wholly owns PTS Intermediate Holdings LLC (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intermediate Holdings&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&#160;Intermediate Holdings directly and wholly owns Catalent Pharma Solutions, Inc. (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The financial results of Catalent are primarily comprised of the financial results of Operating Company and its subsidiaries on a consolidated basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, the Company commenced an initial public offering (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPO&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) of its common stock, par value $0.01 (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), in which it sold a total of 48.9 million shares at a price of $20.50 per share, before underwriting discounts and commissions. The Common Stock began trading on the New York Stock Exchange (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NYSE&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) under the symbol &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CTLT&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as of the IPO. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell, and gene therapies, and consumer health products at over fifty facilities across four continents under rigorous quality and operational standards. Its oral, injectable, and respiratory delivery technologies, along with its state-of-the-art protein and cell and gene therapy manufacturing capacity address a wide and growing range of modalities and therapeutic and other categories across the biopharmaceutical and consumer health industries. Through its extensive capabilities, growth-enabling capacity, and deep expertise in product development, regulatory compliance, and clinical trial supply, it can help its customers take products to market faster, including nearly half of new drug products approved by the U.S. Food and Drug Administration (the &#x201c;FDA&#x201d;) in the last decade. Its development and manufacturing platforms, which include those in its Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, its proven formulation, supply, and regulatory expertise, and its broad and deep development manufacturing know-how enable its customers to advance and then bring to market more products and better treatments for patients and consumers. Its commitment to reliably supply its customers&#x2019; and their patients&#x2019; needs is the foundation for the value it provides; annually, it produces more than 70 billion doses for nearly 7,000 customer products, or approximately 1 in every 24 doses of such products taken each year by patients and consumers around the world. The Company believes that, through its investments in state-of-the-art facilities and capacity expansion, including investments in facilities focused on new treatment modalities and other attractive market segments, its continuous improvement activities devoted to operational and quality excellence, the sales of existing and introduction of new customer products, and, in some cases, its innovation activities and patents, it will continue to attract premium opportunities and realize the growth potential from these areas. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reporting Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the four reporting segments reports through a separate management team and ultimately reports to the Company's Chief Executive Officer, who is designated as the Chief Operating Decision Maker for segment reporting purposes. The Company's operating segments are the same as its reporting segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:24pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Biologics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The segment has extensive expertise in development, scale up, and commercial manufacturing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s growing biologic offering includes cell-line development based on its advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Its development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce current good manufacturing practices ("cGMP") quality biologics drug substance from 250L to 4,000L scale using single-use technology to provide maximum efficiency and flexibility. Its Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and the Anagni, Italy facility add substantial capacity for finished-dose drug product manufacturing and packaging. The segment has continued to expand production capacity, including the fourth and fifth drug substance manufacturing suites in its Madison, Wisconsin facility, expanded drug product manufacturing and packaging capacity in its Bloomington and Anagni facilities, and recently announced a planned expansion of its Anagni facility to permit drug substance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;development and manufacturing. Its SMARTag next-generation antibody-drug conjugate (&#x201c;ADC&#x201d;) technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the Company&#x2019;s cell and gene therapy centers in Belgium, Maryland, and Texas, it develops and manufactures complex biologics, including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through continued inorganic investment between November 2020 and June 2021, the Company acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#x201c;Delphi&#x201d;), a plasmid DNA business, to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production. Additionally, in August 2021, it acquired RheinCell Therapeutics GmbH (&#x201c;RheinCell&#x201d;), a company based in Lagenfeld, Germany that specializes in pluripotent stem cell (&#x201c;iPSC&#x201d;) production. This portfolio expansion strengthens Catalent&#x2019;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances the Company&#x2019;s ability to manufacture next generation cell therapies at scale.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its gene therapy network across Maryland and Texas, the Company has further expanded its footprint with the construction of 5 additional commercial gene therapy suites at its Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed its Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Its specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with its expanded capabilities in plasmids, positions the Company to capitalize on strong and growing industry demand in the cell and gene therapy market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment's range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within the segment's existing network. In addition to primary packaging, its network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. The Company's Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial supply of biotherapeutics and cell and gene therapies. Its fill and finish services are largely focused on complex pharmaceuticals and biologics. With its range of technologies, the Company is able to meet a wide range of specifications, timelines, and budgets. The Company believes that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide it with a meaningful competitive advantage in the market. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Biologics segment also offers biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Its OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. The Biologics segment provides a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:24pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Softgel and Oral Technologies &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through its Softgel and Oral Technologies segment, the Company provides formulation, development, and manufacturing services for soft capsules, or &#x201c;softgels,&#x201d; as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services. Catalent&#x2019;s softgel technology was first commercialized by its predecessor in the 1930s, and it has continually enhanced the platform since then. The segment is the market leader in overall softgel development and manufacturing and holds the leading market position in innovator drug softgels. Its principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. The segment typically performs encapsulation for a product within one of its softgel facilities, with active ingredients provided by customers or sourced directly by the Company. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. The segment also participates in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of the Company&#x2019;s plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, the segment extended this platform to pharmaceutical products via its OptiShell capsule offering. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Its Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies the Company has conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Its large-scale manufacturing under cGMP of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site or time-specific drug release, taste masking, or enhanced bioavailability. The Company has deep experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#x2019;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including its proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms (including metered dose inhalers, dry powder inhalers and nasal delivery devices). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment provides comprehensive pre-clinical screening, formulation and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. It has substantial, proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. It provides spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#x2019;s bioavailability and clinical performance. It offers comprehensive analytical method development and scientific capabilities, including stability testing, and global regulatory services to support both fully integrated development programs and standalone fee-for-service work. In recent years, the segment has expanded its network of clinical development sites focused on earlier phase compounds (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;i.e&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for its offerings is driven by the need for strong scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of its supply performance across quality and operational parameters. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched its orally dissolving tablet business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that dissolves in the mouth, without water, in typically less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). The Company can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#x2019;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. It continues to invest in and develop Zydis orally dissolving tablets in different ways with its customers as it extends the application of the technology to new therapeutic categories, including immunotherapy, vaccines and biologic molecule delivery.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment&#x2019;s respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Clinical Supply Services &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. It offers customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and reporting. It supports trials in all regions of the world through its facilities and distribution network. In recent years, the segment has continued to expand and extend its network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. The segment continues to develop new solutions for the evolving clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. The Clinical Supply Services segment is the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These financial statements include all of the Company&#x2019;s subsidiaries, including those operating outside the United States (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and are prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). All significant transactions among the Company&#x2019;s subsidiaries and reporting segments have been eliminated, other than as noted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, allowance for credit losses, inventory and long-lived asset valuation, goodwill and other intangible asset valuation and impairment, equity-based compensation, income taxes, derivative valuation, and pension plan asset and liability valuation. Actual amounts may differ from these estimated amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior-period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows, or notes to the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s operations outside the U.S. are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of the foreign operations into U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Beginning on July 1, 2018, as a result of the three-year cumulative consumer price index exceeding 100%, the Company has accounted for its Argentine operations as highly inflationary, but this change has not had a material effect on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The currency fluctuation related to certain long-term inter-company loans where settlement is not planned or anticipated in the foreseeable future have been recorded within the cumulative translation adjustment, a component of other comprehensive income. In addition, the currency fluctuation associated with the portion of the Company&#x2019;s euro-denominated debt designated as a net investment hedge is included as a component of other comprehensive income. Foreign currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other expense, net.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Such foreign currency transaction gains and losses include inter-company loans that are repayable in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All liquid investments purchased with original maturities of three months or less are considered cash equivalents. The carrying value of these cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade receivables, contract assets, and other amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. The Company determines its allowance methodology by considering various factors, including the Company&#x2019;s previous loss history, aging of customer receivable balances, significant aspects of a geographic location's economic conditions, the current and anticipated future condition of the general economy and the industries in which the Company's primary customers operate. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, trade receivables and contract assets are written off against the allowance when the related balances are no longer deemed collectible. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Major Customers &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers&#x2019; financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company&#x2019;s expectations. No single customer exceeded 10% of revenue during the fiscal years ended June 30, 2021, 2020, and 2019. As of June 30, 2021, the Company had one customer that represented 15% or $155 million of its net trade receivables balance. No customer exceeded 10% of trade receivables as of June 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost or net realizable value, using the first-in, first-out (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FIFO&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) method. The Company provides for cost adjustments for excess, obsolete, or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory consists of costs associated with raw material, labor, and overhead. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. The Company performs an impairment evaluation of goodwill annually during the fourth quarter of its fiscal year or when circumstances otherwise indicate an evaluation should be performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. Factors considered in a qualitative assessment include, among other things, macroeconomic conditions, industry and market considerations, financial performance of the respective reporting unit and other relevant entity and reporting-unit specific considerations. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and macroeconomic, industry, and market conditions. In fiscal 2019 and 2021, the Company began its impairment evaluation with the qualitative assessment, but in fiscal 2020, the Company proceeded immediately to the quantitative assessment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its qualitative assessment conducted as of April 1, 2021, the Company determined for each reporting unit with goodwill that it was more likely than not that its respective fair value exceeded its carrying value, indicating there was no impairment. For more information regarding goodwill balances at June 30, 2021, see Note 4, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment and Other Definite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including leasehold improvements and finance lease right-of-use assets that are amortized over the shorter of their useful lives or the terms of the respective leases. The Company generally uses the following range of useful lives for its property and equipment categories: buildings and improvements&#x2014;5 to 50 years; machinery and equipment&#x2014;3 to 10 years; and furniture and fixtures&#x2014;3 to 7 years. Depreciation expense was $196 million for the fiscal year ended June&#160;30, 2021, $165 million for the fiscal year ended June&#160;30, 2020, and $141 million for the fiscal year ended June&#160;30, 2019. Depreciation expense includes amortization of assets related to financing leases. The Company charges repairs and maintenance costs to expense as incurred. The amount of capitalized interest for fiscal 2021 and 2020 was $17 million and $11 million, respectively, and was immaterial for fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, including customer relationships, patents, and trademarks, are amortized over their useful lives. The Company also capitalizes certain computer software and development costs in other intangibles, net, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 5 years. The Company evaluates the recoverability of its other long-lived assets, including amortizing intangible assets, if circumstances indicate impairment may have occurred pursuant to ASC 360,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This analysis is performed by comparing the respective carrying values of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, the carrying value of such assets is reduced to fair value through a charge to the consolidated statements of operations. Fair value is determined based on assumptions the Company believes marketplace participants would utilize and comparable marketplace information in similar arm&#x2019;s length transactions. The Company recorded impairment charges related to definite-lived intangible assets and property, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plant, and equipment of $9 million, $5 million, and $5 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Post-Retirement and Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various retirement and pension plans, including defined benefit and defined contribution retirement plans.&#160;The measurement of the related benefit obligations and the net periodic benefit costs recorded each year are based upon actuarial computations, which require management&#x2019;s judgment as to certain assumptions. These assumptions include the discount rates used in computing the present value of the benefit obligations and the net periodic benefit costs, the expected future rate of salary increases (for pay-related plans) and the expected long-term rate of return on plan assets (for funded plans). The Company uses the corridor approach to amortize actuarial gains and losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to utilize an approach to estimate the service and interest components of net periodic benefit cost for benefit plans that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. The expected long-term rate of return on plan assets is based on the target asset allocation and the average expected rate of growth for the asset classes invested. The average expected rate of growth is derived from a combination of historic returns, current market indicators, and the expected risk premium for each asset class. The Company uses a measurement date of June 30 for all its retirement and postretirement benefit plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments, Hedging Activities, and Fair Value &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest-rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments from time to time to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company&#x2019;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#x2019;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#x2019;s borrowings. The Company does not net any of its derivative positions under master netting arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Primarily, the Company is exposed to fluctuations in the euro-U.S. dollar exchange rate on its investments in foreign operations in Europe. While the Company does not actively hedge against changes in foreign currency, it has mitigated the exposure of investments in its European operations through a net-investment hedge by denominating a portion of its debt in euros. In addition, a portion of Operating Company's interest payment obligation on its U.S dollar-denominated term loans is exposed to interest rate variability. The Company has mitigated its exposure to this risk by entering into interest-rate swap agreements, which qualify for and are designated as cash-flow hedges. Also, as discussed in Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company has determined that an aspect of the dividend-rate adjustment feature of the Company&#x2019;s convertible Series A Preferred Stock (as defined below, see Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) should be accounted for as a derivative liability.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. The Company uses fair value extensively, including in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. The Company estimates fair value using an exit price approach, which requires, among other things, that it determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the assets or liability, the Company may use one or all of the following approaches: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Income approach, which is based on the present value of the future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain investments that are measured at fair value using the net asset value (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;NAV&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%;padding-left:17.65pt"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its liquid debt investments with original maturities greater than ninety days as marketable securities. The Company invests in highly rated corporate debt securities, with the primary objective of minimizing the potential risk of principal loss. The Company&#x2019;s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any single issuer. The Company regularly reviews its investments and utilizes quantitative and qualitative evidence to evaluate potential impairments. For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its marketable securities as available-for-sale, because it may sell certain of its marketable securities prior to the stated maturity for various reasons, including management of liquidity, credit risk, duration, relative return, and asset allocation. The Company determines the fair value of each marketable security in its portfolio at each period end and recognizes gains and losses in the portfolio in other comprehensive income. As of June 30, 2021, the amortized cost basis of marketable securities approximates fair value and all outstanding marketable securities mature within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is partially self-insured for certain employee health benefits and partially self-insured for property losses and casualty claims. The Company accrues for losses based upon experience and actuarial assumptions, including provisions for losses incurred but not reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, which is reported in the accompanying consolidated statements of changes in shareholders&#x2019; equity, consists of foreign currency translation, net change in marketable securities, and defined benefit pension plan changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses research and development costs as incurred.  Research and development costs amounted to $21 million, $21 million, and $19 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports net earnings per share in accordance with ASC 260,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company computes basic earnings per share for the Common Stock &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;using the two-class method by d&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Series A Preferred Stock, due to its convertible feature, is participating in nature; accordingly, the outstanding shares of Series A Preferred Stock are included in the two-class method. Diluted earnings per common share measures the performance of the Company over the reporting period while giving effect to all potential shares of Common Stock that were dilutive and outstanding during the period. The denominator includes the weighted average over the measurement period of the sum of the number of shares of Common Stock outstanding and the number of additional such shares that would have been outstanding if &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the shares of Common Stock that were both potentially issuable and dilutive had been issued, and is calculated using the more dilutive of the two-class, treasury stock, and if-converted methods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company&#x2019;s assets and liabilities. The Company measures deferred tax assets and liabilities using enacted tax rates in the respective jurisdictions in which it operates. In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that the Company will be able to realize some or all of the deferred tax assets. The calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in each of its tax jurisdictions. The number of years with open tax audits varies by tax jurisdiction. A number of years may lapse before a particular matter is audited and finally resolved. The Company applies ASC 740 to determine the accounting for uncertain tax positions. This standard clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before the Company may recognize the position in its financial statements. The standard also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has elected not to reclassify the income tax effects stranded in accumulated other comprehensive income to retained earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation&#x2014;Stock Compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 718, companies recognize compensation expense using a fair-value-based method for costs related to share-based payments, including stock options and restricted stock units. The expense is measured based on the grant date fair value of the awards, and the expense is recorded over the applicable requisite service period. Forfeitures are recognized as and when they occur. In the absence of an observable market price for a share-based award, the fair value is based upon a valuation methodology that takes into consideration various factors, including the exercise price of the award, the expected term of the award, the current price of the underlying shares, the expected volatility of the underlying share price, the expected dividends on the underlying shares and the risk-free interest rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the Company&#x2019;s stock-based compensation plans permit an employee holding vested stock options or restricted stock units to elect to have the Company use a portion of the shares otherwise issuable upon the employee&#x2019;s exercise of the option or grant, a so-called &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net settlement transaction,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as a means of paying the exercise price, meeting tax withholding requirements, or both. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2018, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#x2019;s financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework&#x2014;Changes to the Disclosure Requirement for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which changes the disclosure requirements on fair value measurements in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance eliminates certain disclosure requirements that are no longer considered cost beneficial and adds new disclosure requirements for Level 3 fair value measurements. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which introduces a new accounting model known as Credit Expected Credit Losses (&#x201c;CECL&#x201d;). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for financial assets at the time they are originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaces the multiple existing impairment models in current U.S. GAAP, which generally require that a loss be incurred before it is recognized. The new standard applies to receivables arising from &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revenue transactions such as contract assets, accounts receivables, available for-sale debt securities and notes receivable arising from divestitures. The Company adopted the amended guidance using a modified retrospective approach on July 1, 2020. The amended guidance did not have a material impact on the Company&#x2019;s financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Standards Not Adopted as of June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance to ease the potential burden in accounting for the discontinuation of a reference rate such as LIBOR, formerly known as the London Interbank Offered Rate, because of reference rate reform. The expedients and exceptions provided by the guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the incremental approach for intra-period allocation, deferred tax recognition requirement for changes in equity method investments and foreign subsidiaries, and methodology for calculating income taxes in an interim period. The guidance also simplifies certain aspects of the accounting for franchise taxes, the accounting for step-up in the tax basis of goodwill, and accounting for the change in the enacted change in tax laws or rates. The ASU will be effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#x2014;Retirement Benefits&#x2014;Defined Benefit Plans&#x2014;General (Subtopic 715-20): Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Defined Benefit Plan&lt;/span&gt;, which removes certain disclosures and added additional disclosures around weighted-average interest crediting rates for cash balance plans and explanation for significant gains and losses related to change in the benefit obligation for the period. The ASU will be effective for fiscal years beginning after December 15, 2020 with a retrospective application for all periods presented. The adoption of this guidance is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzU3Ng_25277736-6a08-41cf-a7be-7ba84951d436"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i03ea8538a32e4e6198456232f248d40d_D20140731-20140731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzYyOQ_48ac5a49-b389-4549-bd60-4665653f92bf"
      unitRef="shares">48900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="icca6e1525f554545b89d8494504b8035_I20140731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzY1Mw_ff52df7c-7686-4132-9840-11934b9fb4ed"
      unitRef="usdPerShare">20.5</us-gaap:SharesIssuedPricePerShare>
    <ctlt:NumberofCustomers
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzIwOTE_3b3bc368-e86e-4bdf-981e-ac2d28c7dc0c"
      unitRef="customer">7000</ctlt:NumberofCustomers>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM2_1f0759c7-c5a9-4cf3-bcf0-e3762123f4e8">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reporting Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the four reporting segments reports through a separate management team and ultimately reports to the Company's Chief Executive Officer, who is designated as the Chief Operating Decision Maker for segment reporting purposes. The Company's operating segments are the same as its reporting segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:24pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Biologics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The segment has extensive expertise in development, scale up, and commercial manufacturing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s growing biologic offering includes cell-line development based on its advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Its development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce current good manufacturing practices ("cGMP") quality biologics drug substance from 250L to 4,000L scale using single-use technology to provide maximum efficiency and flexibility. Its Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and the Anagni, Italy facility add substantial capacity for finished-dose drug product manufacturing and packaging. The segment has continued to expand production capacity, including the fourth and fifth drug substance manufacturing suites in its Madison, Wisconsin facility, expanded drug product manufacturing and packaging capacity in its Bloomington and Anagni facilities, and recently announced a planned expansion of its Anagni facility to permit drug substance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;development and manufacturing. Its SMARTag next-generation antibody-drug conjugate (&#x201c;ADC&#x201d;) technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the Company&#x2019;s cell and gene therapy centers in Belgium, Maryland, and Texas, it develops and manufactures complex biologics, including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through continued inorganic investment between November 2020 and June 2021, the Company acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#x201c;Delphi&#x201d;), a plasmid DNA business, to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production. Additionally, in August 2021, it acquired RheinCell Therapeutics GmbH (&#x201c;RheinCell&#x201d;), a company based in Lagenfeld, Germany that specializes in pluripotent stem cell (&#x201c;iPSC&#x201d;) production. This portfolio expansion strengthens Catalent&#x2019;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances the Company&#x2019;s ability to manufacture next generation cell therapies at scale.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its gene therapy network across Maryland and Texas, the Company has further expanded its footprint with the construction of 5 additional commercial gene therapy suites at its Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed its Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Its specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with its expanded capabilities in plasmids, positions the Company to capitalize on strong and growing industry demand in the cell and gene therapy market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment's range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within the segment's existing network. In addition to primary packaging, its network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. The Company's Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial supply of biotherapeutics and cell and gene therapies. Its fill and finish services are largely focused on complex pharmaceuticals and biologics. With its range of technologies, the Company is able to meet a wide range of specifications, timelines, and budgets. The Company believes that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide it with a meaningful competitive advantage in the market. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Biologics segment also offers biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Its OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. The Biologics segment provides a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:24pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Softgel and Oral Technologies &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through its Softgel and Oral Technologies segment, the Company provides formulation, development, and manufacturing services for soft capsules, or &#x201c;softgels,&#x201d; as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services. Catalent&#x2019;s softgel technology was first commercialized by its predecessor in the 1930s, and it has continually enhanced the platform since then. The segment is the market leader in overall softgel development and manufacturing and holds the leading market position in innovator drug softgels. Its principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. The segment typically performs encapsulation for a product within one of its softgel facilities, with active ingredients provided by customers or sourced directly by the Company. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. The segment also participates in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of the Company&#x2019;s plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, the segment extended this platform to pharmaceutical products via its OptiShell capsule offering. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Its Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies the Company has conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Its large-scale manufacturing under cGMP of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site or time-specific drug release, taste masking, or enhanced bioavailability. The Company has deep experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#x2019;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including its proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms (including metered dose inhalers, dry powder inhalers and nasal delivery devices). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment provides comprehensive pre-clinical screening, formulation and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. It has substantial, proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. It provides spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#x2019;s bioavailability and clinical performance. It offers comprehensive analytical method development and scientific capabilities, including stability testing, and global regulatory services to support both fully integrated development programs and standalone fee-for-service work. In recent years, the segment has expanded its network of clinical development sites focused on earlier phase compounds (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;i.e&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for its offerings is driven by the need for strong scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of its supply performance across quality and operational parameters. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched its orally dissolving tablet business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that dissolves in the mouth, without water, in typically less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). The Company can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#x2019;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. It continues to invest in and develop Zydis orally dissolving tablets in different ways with its customers as it extends the application of the technology to new therapeutic categories, including immunotherapy, vaccines and biologic molecule delivery.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The segment&#x2019;s respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Clinical Supply Services &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. It offers customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation &lt;/span&gt;&lt;/div&gt;and reporting. It supports trials in all regions of the world through its facilities and distribution network. In recent years, the segment has continued to expand and extend its network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. The segment continues to develop new solutions for the evolving clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. The Clinical Supply Services segment is the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ1_e9dcfd4a-6931-4404-a039-5aeb957a034f">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These financial statements include all of the Company&#x2019;s subsidiaries, including those operating outside the United States (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and are prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). All significant transactions among the Company&#x2019;s subsidiaries and reporting segments have been eliminated, other than as noted.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ5_0889a302-1f20-4739-a851-01b4fb1f340e">Use of EstimatesThe preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, allowance for credit losses, inventory and long-lived asset valuation, goodwill and other intangible asset valuation and impairment, equity-based compensation, income taxes, derivative valuation, and pension plan asset and liability valuation. Actual amounts may differ from these estimated amounts.</us-gaap:UseOfEstimates>
    <us-gaap:Reclassifications
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjU1_d06f8ad5-3336-45b6-9403-49c4dc4333d8">ReclassificationCertain prior-period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows, or notes to the consolidated financial statements.</us-gaap:Reclassifications>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ2_16135f8d-c5f1-46f5-91b2-07fc583246dd">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s operations outside the U.S. are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of the foreign operations into U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Beginning on July 1, 2018, as a result of the three-year cumulative consumer price index exceeding 100%, the Company has accounted for its Argentine operations as highly inflationary, but this change has not had a material effect on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The currency fluctuation related to certain long-term inter-company loans where settlement is not planned or anticipated in the foreseeable future have been recorded within the cumulative translation adjustment, a component of other comprehensive income. In addition, the currency fluctuation associated with the portion of the Company&#x2019;s euro-denominated debt designated as a net investment hedge is included as a component of other comprehensive income. Foreign currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other expense, net.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Such foreign currency transaction gains and losses include inter-company loans that are repayable in the foreseeable future.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM3_8d4ef330-5ff0-41b0-8774-72800e439bda">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All liquid investments purchased with original maturities of three months or less are considered cash equivalents. The carrying value of these cash equivalents approximates fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMx_b599317c-8d1e-44bd-8996-b312a8d3d1a1">Allowance for Credit Losses Trade receivables, contract assets, and other amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. The Company determines its allowance methodology by considering various factors, including the Company&#x2019;s previous loss history, aging of customer receivable balances, significant aspects of a geographic location's economic conditions, the current and anticipated future condition of the general economy and the industries in which the Company's primary customers operate. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, trade receivables and contract assets are written off against the allowance when the related balances are no longer deemed collectible.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUw_378110d7-d906-4b12-b6c8-d5e59dbb2a90">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Major Customers &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers&#x2019; financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company&#x2019;s expectations. No single customer exceeded 10% of revenue during the fiscal years ended June 30, 2021, 2020, and 2019. As of June 30, 2021, the Company had one customer that represented 15% or $155 million of its net trade receivables balance. No customer exceeded 10% of trade receivables as of June 30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM4_653d45cf-df8e-4274-8a2d-de887015ee4e">Inventories &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost or net realizable value, using the first-in, first-out (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FIFO&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;) method. The Company provides for cost adjustments for excess, obsolete, or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory consists of costs associated with raw material, labor, and overhead.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ3_649a3767-bf83-4d05-a83f-bb51a0456624">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. The Company performs an impairment evaluation of goodwill annually during the fourth quarter of its fiscal year or when circumstances otherwise indicate an evaluation should be performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. Factors considered in a qualitative assessment include, among other things, macroeconomic conditions, industry and market considerations, financial performance of the respective reporting unit and other relevant entity and reporting-unit specific considerations. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and macroeconomic, industry, and market conditions. In fiscal 2019 and 2021, the Company began its impairment evaluation with the qualitative assessment, but in fiscal 2020, the Company proceeded immediately to the quantitative assessment. &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its qualitative assessment conducted as of April 1, 2021, the Company determined for each reporting unit with goodwill that it was more likely than not that its respective fair value exceeded its carrying value, indicating there was no impairment. For more information regarding goodwill balances at June 30, 2021, see Note 4, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUx_19465526-3ec2-4796-b9a1-c4b6f61aa5aa">Property and equipment are stated at cost. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including leasehold improvements and finance lease right-of-use assets that are amortized over the shorter of their useful lives or the terms of the respective leases. The Company generally uses the following range of useful lives for its property and equipment categories: buildings and improvements&#x2014;5 to 50 years; machinery and equipment&#x2014;3 to 10 years; and furniture and fixtures&#x2014;3 to 7 years. Depreciation expense was $196 million for the fiscal year ended June&#160;30, 2021, $165 million for the fiscal year ended June&#160;30, 2020, and $141 million for the fiscal year ended June&#160;30, 2019. Depreciation expense includes amortization of assets related to financing leases. The Company charges repairs and maintenance costs to expense as incurred. The amount of capitalized interest for fiscal 2021 and 2020 was $17 million and $11 million, respectively, and was immaterial for fiscal 2019.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib5a20ffd9213425fb1e67c81f9224f31_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MjQ3_14f8c76d-a14e-46a1-bff5-519f909280ea">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i466bfbf6fd7d441db3dfc26c891635e3_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MjUz_e10165d1-7bd9-44e3-a8f5-662b4ec00a72">P50Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5fe521655ef544698a6f74f2e8aff928_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mjg3_7334437d-1685-4231-9fcf-955974838e3e">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i01ff65157f3540fc804007bced73dae3_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mjkz_8f195b58-86a8-4310-b1bc-6194da7376d5">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if766739d8f2b4a4889f8d197a5fe2447_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MzMw_a3d5c7d2-d519-4305-9b29-f63c6eb0ed4f">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib4a3c699d9f24539b7342ac1f583ba77_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2MzM2_0cbdc2a1-f056-40d0-9c16-003c8217e7cd">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Mzcx_02928f82-6d66-45f0-af80-edec72f91bdd"
      unitRef="usd">196000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2NDA0_41166567-36d1-45f8-b517-2c5757672814"
      unitRef="usd">165000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2NDQx_9a702417-536b-429c-9d8e-e7ea85ed8967"
      unitRef="usd">141000000</us-gaap:Depreciation>
    <us-gaap:InterestCostsCapitalized
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI2Njgz_fa6980b0-a195-48fa-8b73-215f8258465f"
      unitRef="usd">17000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMxODk_69982df0-f782-41f9-912c-2e5e7d41d7a6"
      unitRef="usd">11000000</us-gaap:InterestCostsCapitalized>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQy_072ef836-70a8-4521-895c-3f0014b8fe7c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives, including customer relationships, patents, and trademarks, are amortized over their useful lives. The Company also capitalizes certain computer software and development costs in other intangibles, net, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 5 years. The Company evaluates the recoverability of its other long-lived assets, including amortizing intangible assets, if circumstances indicate impairment may have occurred pursuant to ASC 360,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This analysis is performed by comparing the respective carrying values of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, the carrying value of such assets is reduced to fair value through a charge to the consolidated statements of operations. Fair value is determined based on assumptions the Company believes marketplace participants would utilize and comparable marketplace information in similar arm&#x2019;s length transactions. The Company recorded impairment charges related to definite-lived intangible assets and property, &lt;/span&gt;plant, and equipment of $9 million, $5 million, and $5 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTIx_768e72e6-1522-42c5-accb-f178414c260b"
      unitRef="usd">-9000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTI1_08e4bd08-fbf6-4ced-839f-97b8f9ff1116"
      unitRef="usd">-5000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzI4MTMz_cc13121e-eccd-41a2-93b4-1bb7b17c0672"
      unitRef="usd">-5000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUy_5354bee0-f1a6-4b6e-bbee-aef6414b2350">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Post-Retirement and Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various retirement and pension plans, including defined benefit and defined contribution retirement plans.&#160;The measurement of the related benefit obligations and the net periodic benefit costs recorded each year are based upon actuarial computations, which require management&#x2019;s judgment as to certain assumptions. These assumptions include the discount rates used in computing the present value of the benefit obligations and the net periodic benefit costs, the expected future rate of salary increases (for pay-related plans) and the expected long-term rate of return on plan assets (for funded plans). The Company uses the corridor approach to amortize actuarial gains and losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to utilize an approach to estimate the service and interest components of net periodic benefit cost for benefit plans that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. The expected long-term rate of return on plan assets is based on the target asset allocation and the average expected rate of growth for the asset classes invested. The average expected rate of growth is derived from a combination of historic returns, current market indicators, and the expected risk premium for each asset class. The Company uses a measurement date of June 30 for all its retirement and postretirement benefit plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMy_36bb5ffc-54d4-41e2-bb1a-57f5b5b558c2">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest-rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments from time to time to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company&#x2019;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#x2019;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#x2019;s borrowings. The Company does not net any of its derivative positions under master netting arrangements. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Primarily, the Company is exposed to fluctuations in the euro-U.S. dollar exchange rate on its investments in foreign operations in Europe. While the Company does not actively hedge against changes in foreign currency, it has mitigated the exposure of investments in its European operations through a net-investment hedge by denominating a portion of its debt in euros. In addition, a portion of Operating Company's interest payment obligation on its U.S dollar-denominated term loans is exposed to interest rate variability. The Company has mitigated its exposure to this risk by entering into interest-rate swap agreements, which qualify for and are designated as cash-flow hedges. Also, as discussed in Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company has determined that an aspect of the dividend-rate adjustment feature of the Company&#x2019;s convertible Series A Preferred Stock (as defined below, see Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss&lt;/span&gt;) should be accounted for as a derivative liability.</us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM1_1d2ef732-1bce-405a-a73e-29100bf8c52f">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. The Company uses fair value extensively, including in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. The Company estimates fair value using an exit price approach, which requires, among other things, that it determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the assets or liability, the Company may use one or all of the following approaches: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Income approach, which is based on the present value of the future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain investments that are measured at fair value using the net asset value (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;NAV&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjUz_32764cef-646f-4c7a-b19d-19c115519d1b">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its liquid debt investments with original maturities greater than ninety days as marketable securities. The Company invests in highly rated corporate debt securities, with the primary objective of minimizing the potential risk of principal loss. The Company&#x2019;s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any single issuer. The Company regularly reviews its investments and utilizes quantitative and qualitative evidence to evaluate potential impairments. For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its marketable securities as available-for-sale, because it may sell certain of its marketable securities prior to the stated maturity for various reasons, including management of liquidity, credit risk, duration, relative return, and asset allocation. The Company determines the fair value of each marketable security in its portfolio at each period end and recognizes gains and losses in the portfolio in other comprehensive income. As of June 30, 2021, the amortized cost basis of marketable securities approximates fair value and all outstanding marketable securities mature within one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:SelfInsuranceReservePolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjM5_c35ad6da-189a-4154-9bb3-d125e349a8f5">Self-Insurance The Company is partially self-insured for certain employee health benefits and partially self-insured for property losses and casualty claims. The Company accrues for losses based upon experience and actuarial assumptions, including provisions for losses incurred but not reported.</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQw_64cac38f-7d4f-4a4d-b548-87322ceece9b">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss, which is reported in the accompanying consolidated statements of changes in shareholders&#x2019; equity, consists of foreign currency translation, net change in marketable securities, and defined benefit pension plan changes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQz_b5c544df-ffe4-4cd2-862d-a65aadee4de2">Research and Development CostsThe Company expenses research and development costs as incurred.  Research and development costs amounted to $21 million, $21 million, and $19 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMxOTg_4905473e-34be-4c4b-ab41-f3e0f048ee66"
      unitRef="usd">21000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMyODY_99fc2cb6-0af7-4d79-824a-c31c6da637f8"
      unitRef="usd">21000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzEwOTk1MTE3NTMzMDM_e13dc6e6-c6da-45cf-9b7f-9e50c9175f70"
      unitRef="usd">19000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjI3_35866b1f-5115-4a1d-9f44-4a1096219af1">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports net earnings per share in accordance with ASC 260,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company computes basic earnings per share for the Common Stock &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;using the two-class method by d&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Series A Preferred Stock, due to its convertible feature, is participating in nature; accordingly, the outstanding shares of Series A Preferred Stock are included in the two-class method. Diluted earnings per common share measures the performance of the Company over the reporting period while giving effect to all potential shares of Common Stock that were dilutive and outstanding during the period. The denominator includes the weighted average over the measurement period of the sum of the number of shares of Common Stock outstanding and the number of additional such shares that would have been outstanding if &lt;/span&gt;&lt;/div&gt;the shares of Common Stock that were both potentially issuable and dilutive had been issued, and is calculated using the more dilutive of the two-class, treasury stock, and if-converted methods.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjQ0_08a04e52-5d17-4a8d-ba2b-d2a784f9505e">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company&#x2019;s assets and liabilities. The Company measures deferred tax assets and liabilities using enacted tax rates in the respective jurisdictions in which it operates. In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that the Company will be able to realize some or all of the deferred tax assets. The calculation of the Company&#x2019;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in each of its tax jurisdictions. The number of years with open tax audits varies by tax jurisdiction. A number of years may lapse before a particular matter is audited and finally resolved. The Company applies ASC 740 to determine the accounting for uncertain tax positions. This standard clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before the Company may recognize the position in its financial statements. The standard also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has elected not to reclassify the income tax effects stranded in accumulated other comprehensive income to retained earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjI4_38f9825d-81c4-45d8-b2fa-a5e4ce97bd91">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation&#x2014;Stock Compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 718, companies recognize compensation expense using a fair-value-based method for costs related to share-based payments, including stock options and restricted stock units. The expense is measured based on the grant date fair value of the awards, and the expense is recorded over the applicable requisite service period. Forfeitures are recognized as and when they occur. In the absence of an observable market price for a share-based award, the fair value is based upon a valuation methodology that takes into consideration various factors, including the exercise price of the award, the expected term of the award, the current price of the underlying shares, the expected volatility of the underlying share price, the expected dividends on the underlying shares and the risk-free interest rate. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the Company&#x2019;s stock-based compensation plans permit an employee holding vested stock options or restricted stock units to elect to have the Company use a portion of the shares otherwise issuable upon the employee&#x2019;s exercise of the option or grant, a so-called &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net settlement transaction,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt; as a means of paying the exercise price, meeting tax withholding requirements, or both.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNzgvZnJhZzoyYTMzN2ViNTAzYmY0M2YzYTVhMGJkZjAwNDM5YWJkZi90ZXh0cmVnaW9uOjJhMzM3ZWI1MDNiZjQzZjNhNWEwYmRmMDA0MzlhYmRmXzQ2MjMz_fa7f874f-f015-45a8-bf67-4d1cfd7725c7">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2018, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#x2019;s financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosure Framework&#x2014;Changes to the Disclosure Requirement for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which changes the disclosure requirements on fair value measurements in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance eliminates certain disclosure requirements that are no longer considered cost beneficial and adds new disclosure requirements for Level 3 fair value measurements. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which introduces a new accounting model known as Credit Expected Credit Losses (&#x201c;CECL&#x201d;). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for financial assets at the time they are originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaces the multiple existing impairment models in current U.S. GAAP, which generally require that a loss be incurred before it is recognized. The new standard applies to receivables arising from &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revenue transactions such as contract assets, accounts receivables, available for-sale debt securities and notes receivable arising from divestitures. The Company adopted the amended guidance using a modified retrospective approach on July 1, 2020. The amended guidance did not have a material impact on the Company&#x2019;s financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Standards Not Adopted as of June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which provides optional guidance to ease the potential burden in accounting for the discontinuation of a reference rate such as LIBOR, formerly known as the London Interbank Offered Rate, because of reference rate reform. The expedients and exceptions provided by the guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the incremental approach for intra-period allocation, deferred tax recognition requirement for changes in equity method investments and foreign subsidiaries, and methodology for calculating income taxes in an interim period. The guidance also simplifies certain aspects of the accounting for franchise taxes, the accounting for step-up in the tax basis of goodwill, and accounting for the change in the enacted change in tax laws or rates. The ASU will be effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation&#x2014;Retirement Benefits&#x2014;Defined Benefit Plans&#x2014;General (Subtopic 715-20): Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Defined Benefit Plan&lt;/span&gt;, which removes certain disclosures and added additional disclosures around weighted-average interest crediting rates for cash balance plans and explanation for significant gains and losses related to change in the benefit obligation for the period. The ASU will be effective for fiscal years beginning after December 15, 2020 with a retrospective application for all periods presented. The adoption of this guidance is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwOTk1MTE2NDMyMTc_4ad94eab-4882-499c-a328-2f34e8b64942">REVENUE RECOGNITION&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company generally earns its revenue by supplying goods or providing services under contracts with its customers in three primary revenue streams: manufacturing and commercial product supply, development services, and clinical supply services. The Company measures the revenue from customers based on the consideration specified in its contracts, excluding any sales incentive or amount collected on behalf of a third party. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer contracts generally include provisions entitling the Company to a termination penalty when the customer invokes its contractual right to terminate prior to the contract&#x2019;s nominal end date. The termination penalties in the customer contracts vary but are generally considered substantive for accounting purposes and create enforceable rights and obligations throughout the stated duration of the contract. The Company accounts for a contract cancellation as a contract modification in the period in which the customer invokes the termination provision. The determination of the contract termination penalty is based on the terms stated in the relevant customer agreement. As of the modification date, the Company updates its estimate of the transaction price using the expected value method, subject to constraints, and recognizes the amount over the remaining performance period&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally expenses sales commissions as incurred because either the amortization period is one year or less, or the balance with an amortization period greater than one year is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing &amp;amp; commercial product supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical supply services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing &amp;amp; commercial product supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical supply services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects revenue by the location where the goods were made or the service performed:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of revenue attributable to multiple locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Manufacturing &amp;amp; Commercial Product Supply Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturing and commercial product supply revenue consists of revenue earned by manufacturing products supplied to customers under long-term commercial supply arrangements. In these arrangements, the customer typically owns and supplies the active pharmaceutical ingredient, or API, that is used in the manufacturing process. The contract generally includes the terms of the manufacturing services and related product quality assurance procedures to comply with regulatory requirements. Due to the regulated nature of the Company&#x2019;s business, these contract terms are highly interdependent and, therefore, are considered to be a single combined performance obligation. The transaction price is generally stated in the agreement as a fixed price per unit, with no contractual provision for a refund or price concession. Control is transferred to the customer over time, creating a corresponding right to recognize the related revenue, because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. Progress is measured based on the units of product that have successfully completed the contractually required product quality assurance process, as the conclusion of that process generally defines the time when the applicable contract and the related regulatory requirements permit the customer to exercise control over the product&#x2019;s disposition. The customer is typically responsible for arranging the shipping and handling of product following completion of the quality assurance process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment is typically due 30 to 90 days after the goods are shipped as requested by the customer, based on the payment terms set forth in the applicable customer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Development Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Development services contracts generally take the form of short-term, fee-for-service arrangements. Performance obligations vary, but frequently include biologic cell-line development, performing formulation, analytical stability, or other services related to product development, and providing manufacturing services for products that are under development or otherwise not intended for commercial sale. The transaction prices for these arrangements are fixed and include amounts stated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the contracts for each promised service, and each service is generally considered to be a separate performance obligation. The Company recognizes revenue over time because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures progress toward the completion of its performance obligations satisfied over time based on the nature of the services to be performed. For certain types of arrangements, revenue is recognized over time and measured using an output method based on the completion of tasks and activities that are performed to satisfy a performance obligation. For all other types of arrangements, revenue is recognized over time and measured using an input method based on effort expended. Each of these methods provides an appropriate depiction of the Company&#x2019;s progress toward fulfilling its performance obligations for its respective arrangement. In certain development services arrangements that require a portion of the contract consideration to be received in advance at the commencement of the contract, such advance payment is initially recorded as a contract liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocates consideration to each performance obligation using the &#x201c;relative standalone selling price&#x201d; as defined under ASC 606. Generally, the Company utilizes observable standalone selling prices in its allocations of consideration. If observable standalone selling prices are not available, the Company estimates the applicable standalone selling price using an adjusted market assessment approach, representing the amount that the Company believes the market is willing to pay for the applicable service. Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreemen&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Clinical Supply Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical supply services contracts generally take the form of fee-for-service arrangements. Performance obligations for clinical supply services revenue typically include a combination of the following services: the manufacturing, packaging, storage, distribution, destruction, and inventory management of customer clinical trial material. Performance obligations can also include the sourcing of comparator drug products on behalf of customers to be used in clinical trials to compare performance with the drug under clinical investigation. In certain arrangements, the Company recognizes revenue over time when the Company satisfies performance obligations. Satisfaction of the performance obligations is measured using an input method measure of progress based on effort expended by the Company. In other arrangements, revenue is recognized at the point in time when control transfers, which occurs upon either the delivery of the related output of the service to the customer or the completion of quality testing with respect to the product, and the Company has an enforceable right to payment based on the terms of the arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue for comparator sourcing arrangements on a net basis because it is acting as an agent that does not control the product or service before it is transferred to the customer. Payment for comparator sourcing activity is typically received in advance at the commencement of the contract and is initially recorded as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company occasionally enters into arrangements with its customers that include licenses of functional intellectual property, including patents, or other intangible property (&#x201c;out-licensing&#x201d;). Revenue from such arrangements are within the scope of ASC 606. The Company does not have any material license arrangement that contains more than one performance obligation. The terms of such out-licensing arrangements include the license of functional intellectual or intangible property (primarily drug formulae) and typically provide for payment by the licensee of one or more of the following: non-refundable, up-front license fees or royalties on net sales of licensed products. The Company recognizes revenue from nonrefundable, up-front license fees when the licensed intellectual property is made available for the customer&#x2019;s use and benefit, which is generally at the inception of the arrangement. Royalty payments from such arrangements are recognized when subsequent sale or usage of an item subject to the royalty occurs and the performance obligation to which royalty relates is satisfied&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities relate to cash consideration that the Company receives in advance of satisfying the related performance obligations. The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:91.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities that will be recognized within 12 months of June 30, 2021 are accounted for in Other accrued liabilities and those that will be recognized longer than 12 months after June 30, 2021 are accounted for within Other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets primarily relate to the Company's conditional right to receive consideration for services that have been performed for the customer as of June&#160;30, 2021 relating to its development services but had not yet been invoiced as of June&#160;30, 2021. Contract assets are transferred to trade receivables, net when the Company&#x2019;s right to receive the consideration becomes unconditional. Contract assets totaled $181 million and $61 million as of June&#160;30, 2021 and 2020, respectively. Contract assets are accounted for within prepaid expenses and other in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjUz_f1d7ba46-ee09-42e0-821c-67e376935f3d">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing &amp;amp; commercial product supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical supply services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing &amp;amp; commercial product supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical supply services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i07a2087bb20040eca6de434a5a3a69b4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtMS0xLTEtMA_d7741bd2-e439-4673-9216-519c6adbf546"
      unitRef="usd">533000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iada4b587fca14301a3db1cee71bb807f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtMy0xLTEtMA_c857bbd9-83e9-4f8e-990e-47bb80035b44"
      unitRef="usd">877000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib51f38a8412b461597c87ef42543ce85_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtNS0xLTEtMA_2ef47df2-320d-4eee-815b-80e1410ef4ff"
      unitRef="usd">455000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i045c4761bada44e6838395223b03d53e_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtNy0xLTEtNDk5NA_af995715-42d9-4f0b-83ae-044635e6920a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3da86270c27446129776c8fa261c8181_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzEtOS0xLTEtMA_717e9539-728e-41e0-9499-c4cb536d2bf4"
      unitRef="usd">1865000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97b128b8fed0453589f0b1f789d7401d_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItMS0xLTEtMA_f7c74134-af04-4e26-9912-71905a90d713"
      unitRef="usd">1395000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea3b691cfbf74328831c43d672a4f921_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItMy0xLTEtMA_5a3d67d9-e5f0-4ed0-a4bd-3e44d61317ae"
      unitRef="usd">135000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i705c4c9f11954b4ea5e99770a3c251a4_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItNS0xLTEtMA_33e6e1b6-72dd-45fc-a3e2-4d3c949b83da"
      unitRef="usd">231000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8b25898ae02243708a9f6f45778360bd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItNy0xLTEtNDk5NA_9c490ad8-8575-4137-b8f6-11c5add8bce7"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e6d8d7df749456aa44395064bfc68ed_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzItOS0xLTEtMA_3bde8e10-1305-4a3c-9310-0bb32dfe7955"
      unitRef="usd">1761000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0aa571359bc437aa855b95942f5960c_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtMS0xLTEtNDk5MQ_f72c59ac-2614-4995-a1b6-c6c2c6a24087"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39f42b75751f4cb0a931e72af45e2071_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtMy0xLTEtNDk5NA_ff682317-8c16-4008-86db-34a44f345360"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia16a67ca8a3e43959d9b6899ddb210d0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtNS0xLTEtNDk5NA_329736e6-3f98-4a00-9075-5d3ea1386e54"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f0a88b6d220432d822a3a9acc1be96f_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtNy0xLTEtMA_9b1a17e5-76fa-4ab1-b1e2-4ef3e23f401a"
      unitRef="usd">391000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60878ec54f754cd685972d131936a863_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzMtOS0xLTEtMA_75c768b1-deb6-4653-8616-39ff2e10e230"
      unitRef="usd">391000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtMS0xLTEtMA_87ebbf9f-7273-4935-87e1-3eb8f38b9583"
      unitRef="usd">1928000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtMy0xLTEtMA_1178eacf-ee71-48cd-8ac1-144656c6ea9c"
      unitRef="usd">1012000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtNS0xLTEtMA_ccc605b3-ab4a-433d-83d0-831215a6ff8d"
      unitRef="usd">686000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtNy0xLTEtMA_ad56be1e-aa1e-4d02-b722-b61738f2cdf8"
      unitRef="usd">391000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i093d3096941f487d945682b19471e3df_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzQtOS0xLTEtMA_4f3ffe5f-f877-4af2-a763-5f98799fd9a2"
      unitRef="usd">4017000000</us-gaap:Revenues>
    <ctlt:SegmentReportingInformationInterSegmentRevenueElimination
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzUtOS0xLTEtMA_8ef56d82-2af2-4ae7-b90f-501ba1fbba5e"
      unitRef="usd">-19000000</ctlt:SegmentReportingInformationInterSegmentRevenueElimination>
    <us-gaap:Revenues
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0MWUzMDk4YzI3Mzk0Mjg2OWNjYjdjMmMyY2RjY2Y2My90YWJsZXJhbmdlOjQxZTMwOThjMjczOTQyODY5Y2NiN2MyYzJjZGNjZjYzXzYtOS0xLTEtMA_3aa91b7a-6f71-465b-aaf9-90e747833ef9"
      unitRef="usd">3998000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i66eccdacf8164ed593c34225a88a46d1_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtMS0xLTEtMA_2e0c8f26-124d-496d-a100-cb5dccb8b1f4"
      unitRef="usd">332000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie21a0bd7b87e4a03911155430ae8b6ae_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtMy0xLTEtMA_c5ed95fb-0ec3-4790-abee-4e3aeb3725d8"
      unitRef="usd">955000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaef7d76076a94237a72ee40ceab75b87_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtNS0xLTEtMA_482fd5a3-3104-481d-b5c3-db4b41424dae"
      unitRef="usd">450000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i142419c11f5d4f0489522ad07594cdbf_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtNy0xLTEtNDk5OQ_6858c6fa-dd1c-428d-8242-13b6438668f2"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4927d306a5cd4d059e75f5c9a3d57193_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzEtOS0xLTEtMA_1e9d386a-b315-48dd-939b-9009db325360"
      unitRef="usd">1737000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52cbad2cbd874660845a41e6ce1dd05d_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItMS0xLTEtMA_4f5ffd5e-ff54-44bb-9eba-46292c18f990"
      unitRef="usd">689000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d233789dad44dedabfcbf931339090a_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItMy0xLTEtMA_c780d133-007e-4799-a6fa-9f0b45263b28"
      unitRef="usd">107000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if9b7f23d170040c08b3f2af50189003e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItNS0xLTEtMA_7e88c0db-401a-4ad3-a560-b25fbd20bec8"
      unitRef="usd">226000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09b4b92b91af444d955bbb9f2174dd7e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItNy0xLTEtNDk5OQ_e1a586ca-469d-4f1e-87e6-0eccedcb9996"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i884903df67494d87bbab2288ab7a8879_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzItOS0xLTEtMA_f6c5e04d-e6fd-4661-bced-7bdab7d3d0ee"
      unitRef="usd">1022000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1254879dc3784a83a23a504c071ed5a3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtMS0xLTEtNDk5OQ_567466a5-3a18-49e5-a316-ff4897f17382"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cfcb80aba194eabb4778da0ffeda957_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtMy0xLTEtNDk5OQ_3ddb9861-3fb8-45ff-b2d3-79d844079c64"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i20ad96da5593486fbc6c6de7f9b3e68f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtNS0xLTEtNDk5OQ_6b14b122-2480-44dd-af81-a0bd576f95cb"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd4c045f9a3f41bea3c504f692dea648_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtNy0xLTEtNDk5OQ_3acf983e-e7dc-404d-bd0d-372fa002c83f"
      unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i59a776ebf0a942589e391bead02f211b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzMtOS0xLTEtMA_df0cd2da-28c6-4344-90e4-86f0894d1989"
      unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtMS0xLTEtMA_485ccee2-00c6-4f0b-97e5-731f9ff6eaf3"
      unitRef="usd">1021000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtMy0xLTEtMA_46845fc6-7bb3-4d1d-8d32-d208beb63ef6"
      unitRef="usd">1062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtNS0xLTEtMA_72cc8dad-6e05-4406-a933-1c28581df852"
      unitRef="usd">676000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtNy0xLTEtMA_37276f3b-62e3-4b53-abb9-982ece591920"
      unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b7107a7761d40c8904561ccb9c417f6_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzQtOS0xLTEtMA_ecc93dfe-6586-49fe-8a96-7807d7bd4c6b"
      unitRef="usd">3104000000</us-gaap:Revenues>
    <ctlt:SegmentReportingInformationInterSegmentRevenueElimination
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzUtOS0xLTEtMA_3829386f-5a71-4a20-a983-b341bfa996e2"
      unitRef="usd">-10000000</ctlt:SegmentReportingInformationInterSegmentRevenueElimination>
    <us-gaap:Revenues
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpkYzczMjA0NzRjODk0NTA2YTc3OGYzOGFmMWRkZGNkZC90YWJsZXJhbmdlOmRjNzMyMDQ3NGM4OTQ1MDZhNzc4ZjM4YWYxZGRkY2RkXzYtOS0xLTEtMA_7d329197-0cd9-44c6-85d0-cb6fcb5f0ec5"
      unitRef="usd">3094000000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i7bef26a88d4d45d39bca80b0cc08cb49_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjU5_2d1dbb01-19bb-458f-8907-41c75c587d08">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reflects revenue by the location where the goods were made or the service performed:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of revenue attributable to multiple locations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i951ba969a0bc495faf2a70bac7fd4cb8_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzItMi0xLTEtNTAwMw_6d37c3c7-247a-41d1-a20a-26bed2c6b80f"
      unitRef="usd">2462000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ed9921d6bb04cc7bd39d32cbbc854eb_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzItNC0xLTEtMA_44cd8094-82dc-4340-8f76-1f79d0d616ef"
      unitRef="usd">1822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtMi0xLTEtNTAwMw_94fda2a1-120e-4889-9794-e257d1515827"
      unitRef="usd">1343000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9056d45f9c5d454ba4d5fc46692cb16b_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtMi0xLTEtNTAwMw_cb896e4d-2704-4e51-afb8-94ad9af0894d"
      unitRef="usd">1343000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6cf6743117284e278dddc68935f89f38_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzMtNC0xLTEtMA_f030a96a-704d-4a59-9f95-694b5932e51e"
      unitRef="usd">976000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60e54ba728a04c0ebb1f97f6fbfd3c64_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzQtMi0xLTEtNTAwMw_d2dfce39-3b41-4ebb-b3c6-8de44b8024a0"
      unitRef="usd">288000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iece8fce5266a4b4a80688042161b0641_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzQtNC0xLTEtMA_51dcdaa4-8d8d-45e9-bec4-2f579cba1706"
      unitRef="usd">376000000</us-gaap:Revenues>
    <ctlt:Eliminationofrevenueattributabletomultiplelocations
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzUtMi0xLTEtNTAwMw_a18887cc-3d4f-4bdf-9030-02107021a71e"
      unitRef="usd">-95000000</ctlt:Eliminationofrevenueattributabletomultiplelocations>
    <ctlt:Eliminationofrevenueattributabletomultiplelocations
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzUtNC0xLTEtMA_34e94300-8557-4d21-8d54-7bf4a056ab39"
      unitRef="usd">-80000000</ctlt:Eliminationofrevenueattributabletomultiplelocations>
    <us-gaap:Revenues
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzYtMi0xLTEtMA_0ddcab6e-66c8-47fc-8598-256ae825d8f0"
      unitRef="usd">3998000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTpjNjQyNGI5YjU0YTE0ZmU3OGI0ODMwNGY1ZjQ3NDIxYS90YWJsZXJhbmdlOmM2NDI0YjliNTRhMTRmZTc4YjQ4MzA0ZjVmNDc0MjFhXzYtNC0xLTEtMA_a382a2a7-8165-4cba-8c54-973591b608e5"
      unitRef="usd">3094000000</us-gaap:Revenues>
    <ctlt:ContractualLiabilitiesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMjYw_50efcebe-9aa7-4897-8d08-401d1b19da38">The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:91.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:ContractualLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzItMi0xLTEtMA_ec95690f-2d41-4399-a774-57bfb0971d0f"
      unitRef="usd">218000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzctMi0xLTEtMA_6f0c558d-9d35-4f5c-85a7-36bbbce22f9f"
      unitRef="usd">321000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90YWJsZTo0NTMzNjI1NmFlYmQ0YTczYmQ2NDNmZjRhZmI5YTQzNy90YWJsZXJhbmdlOjQ1MzM2MjU2YWViZDRhNzNiZDY0M2ZmNGFmYjlhNDM3XzgtMi0xLTEtNTA0Nw_227ffb97-48e0-462a-afe7-16bb122ac7ea"
      unitRef="usd">196000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMDQ2_e3e183b5-22c0-4811-b379-b2e8275fe001"
      unitRef="usd">181000000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODQvZnJhZzowN2RlMDkyNjUxMjk0OTgyOGE2NzAyY2Y0ZWI5MzJkMC90ZXh0cmVnaW9uOjA3ZGUwOTI2NTEyOTQ5ODI4YTY3MDJjZjRlYjkzMmQwXzEwMDUz_5bf307c4-d45e-48fe-badb-28abe2a1de34"
      unitRef="usd">61000000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzExODg2_86fd2a93-7533-4285-8499-9c312aed9488">BUSINESS COMBINATIONS AND DIVESTITURES&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Anagni Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the Company acquired an oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy. The Company paid &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$55 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in cash as part of the purchase consideration and as consideration for the provision of certain services to facilitate the transition to Company ownership. At the closing of this acquisition, the seller of the facility also entered into a five-year agreement for continuing supply by the Company of certain products at the Anagni facility. Due to the variety of activities performed at Anagni, the results of the Anagni facility are allocated between the Oral and Specialty Delivery and Biologics segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total cash consideration was allocated between the facility purchase and the transitional services arrangement, with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$52 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; assigned to the purchase consideration and the balance to transitional services. The Company funded the entire amount with cash on hand and allocated the purchase price among the acquired assets, recognizing property, plant, and equipm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ent of $34 million, inventory of $6 million, and prepaid expenses and other of $12 million. The purchase price was also allocated to deferred tax assets and certain employee-related liabilities assumed in the a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MaSTherCell Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company acquired 100% of the equity interest in Masthercell Global Inc. (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MaSTherCell&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) for an aggregate purchase price of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$323 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which was funded with the net proceeds of the Company&#x2019;s February 2020 equity offering (the &#x201c;February 2020 Equity Offering&#x201d;) of its Common Stock. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  MaSTherCell is a contract development and manufacturing organization focused on the development and manufacture of autologous and allogeneic cell therapies for third parties, as well as a variety of related analytical services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the MaSTherCell acquisition using the acquisition method in accordance with ASC 805, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The operating results of MaSTherCell have been included in the Company&#x2019;s consolidated financial statements for the period following the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimated fair values at the date of acquisition for the allocation of consideration to the net tangible and intangible assets acquired and liabilities assumed as part of the MaSTherCell acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation to assets acquired and liabilities assumed in the transaction is (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Identifiable intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of trade receivables, raw materials inventory, and trade payables, as well as certain other current and non-current assets and liabilities generally represented their fair values at the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment was valued using the cost approach, which is based on the current replacement or reproduction cost of the asset as new, less depreciation attributable to physical, functional, and economic factors. The Company then determined the remaining useful life based on the anticipated life of the asset and Company policy for similar assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer-relationship intangible assets of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$46 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were valued using the multi-period, excess-earnings method, a method that values the intangible assets using the present value of the after-tax cash flows attributable to the intangible assets only. The assumptions used in developing the valuation included the estimated annual net cash flows (including application of an appropriate margin to forecasted revenue, selling and marketing costs, return on working capital, contributory asset charges, and other factors), the discount rate that appropriately reflects the risk inherent in each future cash flow stream, and an assessment of the assets&#x2019; life cycles, as well as other factors. The assumptions used in the financial forecasts were based on historical data, supplemented by current and anticipated growth rates, management plans, and market-comparable information. The customer relationship intangible assets have a weighted average useful life of 13 years. Goodwill is mainly comprised of the growth from an expected increase in capacity utilization, potential new customers, and advanced cell therapy development and manufacturing capabilities. The goodwill arising from the MaSTherCell acquisition has been assigned to the Biologics segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Skeletal Cell Therapy Support SA Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the Company acquired 100% of the equity interest in Skeletal Cell Therapy Support SA (&#x201c;Skeletal&#x201d;) for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$15 million, subject to customary adjustments, as well as related supply agreements with the seller. Skeletal operates &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a cell therapy manufacturing facility in Gosselies, Belgium. The operations were assigned to the Company&#x2019;s Biologics segment, expanding the Company&#x2019;s cell therapy capacity for clinical and commercial supply. The acquisition, when combined with the Company's other European-based facilities and capabilities in cell therapy, has created an integrated European center of excellence in cell therapy.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Skeletal acquisition using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price to trade receivables, property, plant, and equipment, deferred tax assets, and other current and non-current assets and liabilities assumed in the acquisition, which resulted in a recognition of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$9 million of goodwill&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Results for the fiscal year ended June 30, 2021 were not material to the Company&#x2019;s statement of operations, financial position, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and income taxes are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acorda Therapeutics, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company acquired the manufacturing and packaging operations of Acorda Therapeutics, Inc.'s (&#x201c;Acorda&#x201d;) dry powder inhaler and spray dry manufacturing business, including its manufacturing facility located near Boston, Massachusetts, for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$83 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, subject to customary adjustments. In connection with the purchase, Acorda and the Company entered into a long-term supply agreement, under which the Company will continue the manufacture and packaging of an Acorda product at the facility. The facility and operations became part of the Company&#x2019;s Oral and Specialty Delivery segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Acorda transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price among the acquired assets, recognizing property, plant, and equipment of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$79 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, inventory of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and goodwill of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purchase price was also preliminarily allocated to other current and non-current assets and liabilities assumed in the acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and inventory are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Delphi Genetics SA Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company acquired 100% of the equity interest in Delphi for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, subject to customary adjustments. Delphi is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. The facility and operations acquired became part of the Company&#x2019;s Biologics segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Delphi transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price recognizing property, plant, and equipment of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, intangible assets of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, other current assets of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, assumed debt of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, other current liabilities of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and goodwill of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$45 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to intangible assets, inventory, goodwill, and income taxes is preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hepatic Cell Therapy Support SA Asset Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company acquired 100% of the equity interest in Hepatic Cell Therapy Support SA (&#x201c;Hepatic&#x201d;) for approximately &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$15 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of cash acquired and debt assumed. Hepatic operates a manufacturing facility at the same location where Skeletal operates a cell therapy manufacturing facility in Gosselies, Belgium. The facility acquired will expand the C&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ompany&#x2019;s cell therapy capacity for clinical and commercial supply in its Biologics segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RheinCell Therapeutics GmbH Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company entered into an agreement to acquire 100% of the equity interest in RheinCell for approximately $30 million and completed the acquisition in August 2021. RheinCell is a developer and manufacturer of cGMP-grade iPSCs.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operations acquired became part of the Company&#x2019;s Biologics segment and build upon Catalent&#x2019;s existing custom cell therapy process development and manufacturing capabilities with proprietary GMP cell lines for iPSC-based therapies. Due to the date of the closing, a preliminary purchase price allocation has not yet been performed. However, a portion of the purchase price is expected to be allocated to intangible assets and goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blow&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;-Fill-Seal Divestitur&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company sold 100% of the shares of Catalent USA Woodstock, Inc. and certain related assets (collectively, the &#x201c;Blow-Fill-Seal Business&#x201d;) for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$300 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cash, a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; note receivable (estimated fair value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$47 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) as well as potential additional contingent consideration (up to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) dependent upon the performance of aspects of the Blow-Fill-Seal Business. The Blow-Fill-Seal Business was part of the Oral and Specialty Delivery segment. The carrying value of the net assets sold was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$149 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which included goodwill of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$54 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As a result of the sale, the Company realized a gain from divestiture of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$182 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, net of transaction costs, for the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the Blow-Fill-Seal Business was classified as held-for-sale. The Company determined that the sale of the business did not meet the criteria to be considered a discontinued operation as the disposal of the Blow-Fill-Seal Business did not represent a strategic shift that has (or will have) a major effect on the Company's financial results upon disposal.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All consideration received was measured at its divestiture date fair value. The Company valued the total consideration received from divestiture of the Blow-Fill-Seal Business as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fair value of consideration received&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$47 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; at June 30, 2021, which is the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aggregate principal amount less a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; discount determined using a discounted cash flow model with the market interest rate as a significant input.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) &#160;&#160;&#160;&#160;The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) &#160;&#160;&#160;&#160;Other includes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of transaction expenses, a working capital adjustment of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; assumption of liabilities resulting in net cash proceed of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4fb7193cbe7d43bca3a20da21b84f54d_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzYyMDQ_8957f12c-5f27-4180-a20a-603294c905a4"
      unitRef="usd">55000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <ctlt:BusinessCombinationTransitionalServiceAgreement
      contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzY4NjA_35998fd9-e276-4170-9875-b55b314e116b"
      unitRef="usd">52000000</ctlt:BusinessCombinationTransitionalServiceAgreement>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxMjM_d258c81a-5fb1-497b-a996-ee035395c932"
      unitRef="usd">34000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxNDA_43f10868-401e-49a7-bc3c-51a6489c602b"
      unitRef="usd">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i1ea3ee19783347fcbcdad64f27aae413_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzcxNzg_71b632c5-d529-4d6d-9f95-c828a1f6a75b"
      unitRef="usd">12000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0e96532b149d46edb99ca6b0a748f524_D20200210-20200210"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzgxMzY_77c708bc-4f91-45c2-9146-b5d0cd4e69af"
      unitRef="usd">323000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i1a947e3eec134edc93799b574e4dde4a_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzExODg0_000caed4-2f28-4743-b2c9-7c089b55dd28">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation to assets acquired and liabilities assumed in the transaction is (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Identifiable intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzAtMS0xLTEtNTEyNw_524cb993-e46b-47d2-b786-3004dd8f54e1"
      unitRef="usd">26000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzEtMS0xLTEtNTE1NA_feffe566-fc78-437b-8be7-a2fa98d8bc85"
      unitRef="usd">51000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzItMS0xLTEtNTE1Ng_e05b05c0-2d8f-4282-a58c-6c5ed5224989"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzMtMS0xLTEtNTE2Ng_999c66b0-f8c2-4303-bdcd-10480ceb3d50"
      unitRef="usd">8000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzQtMS0xLTEtNTE2Ng_4c15b461-0426-41d2-adf2-c0f8ca05438e"
      unitRef="usd">70000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzUtMS0xLTEtNTE2Ng_b2c90999-86b1-4209-a80d-6ef031676c5c"
      unitRef="usd">253000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6014f686d33241c3ab6ba3c6c271a3ab_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo2YmI1OThiZDlmMmY0NjdhOGFkODE1YzVkZDA5MGVkMi90YWJsZXJhbmdlOjZiYjU5OGJkOWYyZjQ2N2E4YWQ4MTVjNWRkMDkwZWQyXzYtMS0xLTEtNTE2Ng_b6a0a3ea-8432-4859-ab03-938f498acdea"
      unitRef="usd">323000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8c8fd61e3e3e4bc587341b5de7823db4_I20200210"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5Xzk4NzQ_859c25e5-6403-40df-9273-5587ef594d0e"
      unitRef="usd">46000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icd578116a1984512962b999d1a8d51ef_D20201116-20201116"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzU0OTc1NTgxNjk1Nzg_02c6f1d8-1766-4447-9337-a6a256dbd904"
      unitRef="usd">15000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icd578116a1984512962b999d1a8d51ef_D20201116-20201116"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTU5Nzc_e1a2c135-a32d-48f0-8db8-6a9ff0e4c42b"
      unitRef="usd">9000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTU5OTU_7c65665a-67c4-486d-8c7b-5e8bb9c21afe"
      unitRef="usd">83000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwMTM_3bb028b7-03b8-440c-815d-439951c17caa"
      unitRef="usd">79000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="if0b9e45fbfaa47cb8e10c5022765a0fe_I20210211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwMzA_74cf207f-eb8e-4976-8228-d15139550c7f"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iad9244208fb94deebb616d62ae613a7f_D20210211-20210211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwNjY_41a1d0f9-be50-4ca7-a707-1d3c069e2967"
      unitRef="usd">2000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYwODY_7f1b8315-640f-4f43-ae68-c11a43092f9d"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMDM_27014ed9-8c62-4d37-ab1a-c59c2aceb306"
      unitRef="usd">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMjI_8c916c7b-29d9-49b8-b8cb-faa08e191a09"
      unitRef="usd">7000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxMzk_aebe2a20-011d-4eed-afac-f2d3d4961caa"
      unitRef="usd">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxNTg_af2b63d9-1479-4491-8cd6-2037e1c1e498"
      unitRef="usd">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i22686bb8eb4342bbb50bc71230a550a9_I20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxNzU_af40b4d4-0c8d-4ba6-b6af-392e8b030cfc"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1eccd2ec91d34dd2943b2b8ca0a454ef_D20210223-20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYxOTM_7c91da9d-6df3-4336-9d1c-f54a1d4bf7d3"
      unitRef="usd">45000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iec05426d8309444b822cb0b7025ea5f5_D20210223-20210223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyMTE_8f730ad9-80dc-4b60-94a4-57ad9b690ab5"
      unitRef="usd">15000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6d3b7eae092942fba85aaba9e27b78aa_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyMzE_5f2f7d31-da41-45b3-bd4e-7f01584f8097"
      unitRef="usd">30000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyNTA_a1bc8e91-efbb-46bf-9347-c33e8c37cb1b"
      unitRef="usd">300000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYyNjg_9779e98d-74e5-4ef4-8e88-39de530a629e"
      unitRef="usd">50000000</us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzMDI_ffbfbc0d-6da5-4e9c-a1e0-93f1fba997ea"
      unitRef="usd">47000000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzMjA_6000ff1c-9abb-44c3-8bba-39f0b57d0916"
      unitRef="usd">50000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzNDY_637bb7f8-ba74-487a-998e-9c66af26337c"
      unitRef="usd">149000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzNjQ_c4e95476-26ef-447f-b5c9-3ae8fbb732c3"
      unitRef="usd">54000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTYzODM_bbcc9783-6252-48ed-bfec-01b41a9ecf37"
      unitRef="usd">182000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjQ_3f59a9f6-837f-4e78-95e5-338bba93eea3">The Company valued the total consideration received from divestiture of the Blow-Fill-Seal Business as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fair value of consideration received&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$47 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; at June 30, 2021, which is the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aggregate principal amount less a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; discount determined using a discounted cash flow model with the market interest rate as a significant input.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) &#160;&#160;&#160;&#160;The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) &#160;&#160;&#160;&#160;Other includes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of transaction expenses, a working capital adjustment of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; assumption of liabilities resulting in net cash proceed of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzEtMS0xLTEtNTA1MA_6186abd6-444a-4e1e-9c14-01192913e422"
      unitRef="usd">300000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10"
      unitRef="usd">47000000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9"
      unitRef="usd">16000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <ctlt:CashAndNoncashDivestitureAmountOfConsiderationReceived
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzUtMS0xLTEtNTA1MA_0a324c6a-1b13-4fb6-aa26-94215c9d90e3"
      unitRef="usd">331000000</ctlt:CashAndNoncashDivestitureAmountOfConsiderationReceived>
    <us-gaap:BusinessCombinationAcquiredReceivablesFairValue
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0MDE_ffbfbc0d-6da5-4e9c-a1e0-93f1fba997ea"
      unitRef="usd">47000000</us-gaap:BusinessCombinationAcquiredReceivablesFairValue>
    <us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0NTQ_9779e98d-74e5-4ef4-8e88-39de530a629e"
      unitRef="usd">50000000</us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount>
    <ctlt:BusinessCombinationLoanDiscount
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0NzE_6802cf35-d214-4369-9736-5b96f86311f6"
      unitRef="usd">3000000</ctlt:BusinessCombinationLoanDiscount>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY0ODg_4d1c8f83-59b3-453e-912e-42b880d8571e"
      unitRef="usd">8000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <ctlt:BusinessCombinationWorkingCapitalAdjustments
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY1MDc_3f7062c8-39d0-4b09-b798-3a889afaa91f"
      unitRef="usd">6000000</ctlt:BusinessCombinationWorkingCapitalAdjustments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY1MzE_d8d4deb3-7aec-405a-8fc2-6563832f7fdc"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <ctlt:ProceedsFromDivestitureOfBusinessesNetCashProceeds
      contextRef="i68464b9bc71941688262bd571d7a7c49_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzQ5NDc4MDIzNTY2MDc_7cd082fa-c225-4002-a247-b2d0a0624f24"
      unitRef="usd">287000000</ctlt:ProceedsFromDivestitureOfBusinessesNetCashProceeds>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i180acc781ca7481394028c8cb6e82480_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNTQ_2d899a23-21c8-4018-8010-ee281a7fcf6f"
      unitRef="usd">3000000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzg0Nw_654d0999-bf36-43e5-859f-28d712b172cc">GOODWILL&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes from June&#160;30, 2019 to June&#160;30, 2020 and then to June&#160;30, 2021 in the carrying amount of goodwill in total and by reporting segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) The reallocation in fiscal 2020 relates to adjustments to the Company&#x2019;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;(4) Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.The Company recorded no impairment charge to goodwill in fiscal 2021, 2020, or 2019.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzg0NQ_432d4f37-e7f5-48b6-8569-77583bf66b8a">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes from June&#160;30, 2019 to June&#160;30, 2020 and then to June&#160;30, 2021 in the carrying amount of goodwill in total and by reporting segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reallocation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) The reallocation in fiscal 2020 relates to adjustments to the Company&#x2019;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;(4) Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3271a0d0c6f0478ea7b97b353bd69af2_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtMS0xLTEtMA_e31e17b4-97f8-47b6-ba2c-05c76f8d0200"
      unitRef="usd">1320000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib4c2bcc242b14433b4c516133cfacc12_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtNC0xLTEtMA_f0bfb3c1-be16-4cfe-b16b-81cc1e0cd494"
      unitRef="usd">409000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if22a051247f64fc693ae10ac38acda75_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtNi0xLTEtMA_bda70f9c-dab4-42de-aec9-b93968b9e09d"
      unitRef="usd">340000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i654dce15c0874c9fb40648bb53e7594b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtOC0xLTEtMA_89424c17-c32c-4abd-bcd5-ae7097d1ed10"
      unitRef="usd">152000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEtMTAtMS0xLTA_3b039108-286a-4df8-9940-77201881020e"
      unitRef="usd">2221000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab"
      unitRef="usd">264000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItNC0xLTEtMA_7193afb7-b490-4ff5-9879-388c4733b2c3"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItNi0xLTEtMA_d81e9918-1992-4bf5-9ecc-e605a66cca20"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItOC0xLTEtMA_33e03b6d-d1cb-4b99-8809-0179ad3c6e39"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84"
      unitRef="usd">264000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTransfers
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329"
      unitRef="usd">-124000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359"
      unitRef="usd">108000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77"
      unitRef="usd">16000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtMS0xLTEtMA_ac488c23-e566-4e1f-937e-9847e1407ae9"
      unitRef="usd">-3000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtNC0xLTEtMA_879f0127-c6b2-4b62-8431-3de0ee2b0d1b"
      unitRef="usd">-2000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtNi0xLTEtMA_bfe92fc1-361f-48ac-b7ee-49cb8c2f28a2"
      unitRef="usd">2000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtOC0xLTEtMA_6b1c5130-7a8b-4a65-a8c1-1e2bf378e181"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzQtMTAtMS0xLTA_e68b0b9a-4bd2-4cb3-ac69-affab786e25a"
      unitRef="usd">3000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtMS0xLTEtMA_68335b7f-9248-4499-b9bb-98ee84bd78f3"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtNC0xLTEtMA_4382e8f7-aa2d-469f-bf39-ce6c65074a0c"
      unitRef="usd">-10000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtNi0xLTEtMA_67bf76ed-6ba7-4726-a41f-c56d29d8ba66"
      unitRef="usd">-3000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtOC0xLTEtMA_53b3a1f5-6c79-4e29-914c-b3cb8613cbde"
      unitRef="usd">-4000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzUtMTAtMS0xLTA_a4004785-776b-44e8-a940-e885dd6d6066"
      unitRef="usd">-17000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ibe2726cb57c9441d90eb8e733906a808_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtMS0xLTEtMA_2df4bbad-9ff6-4258-abf3-2d9d99dd3452"
      unitRef="usd">1463000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id7061380698a4b9395a2f0cfba0d8aac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtNC0xLTEtMA_ee99cbe3-f070-4b02-bfa6-a68fa03fc347"
      unitRef="usd">505000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtNi0xLTEtMA_462c64a6-a42d-4918-b2f8-fe33533230aa"
      unitRef="usd">355000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iab98274d571d4d449f30491cdd65c962_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtOC0xLTEtMA_7b322eb9-6d52-46d4-a8e0-4923c8427395"
      unitRef="usd">148000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzYtMTAtMS0xLTA_184bb403-f0da-4591-a250-f37e28d1578d"
      unitRef="usd">2471000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09"
      unitRef="usd">54000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNC0xLTEtMA_25bc90be-2749-46b0-9d39-de745eefb38c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b"
      unitRef="usd">2000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctOC0xLTEtMA_b4a1e5f9-b901-4c80-890c-7bb4c03f1a61"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282"
      unitRef="usd">56000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMS0xLTEtMjcwNA_83a0654a-4e97-4d1a-8f52-420367b27227"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNC0xLTEtMjcyMw_4511990e-71b4-481d-a6b8-9728de355799"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b"
      unitRef="usd">54000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtOC0xLTEtMjczOA_2bd19f00-6faa-4672-a288-ee70e359404a"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe"
      unitRef="usd">54000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTEtMS0xLTA_5dca7fc9-b46d-42ec-a4d8-2f9a5fc6b076"
      unitRef="usd">14000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTQtMS0xLTA_b1108577-0008-4d4f-b7db-94900e0a67d6"
      unitRef="usd">11000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTYtMS0xLTA_ef0167cd-08a3-4ae6-9070-fdea6532edf6"
      unitRef="usd">13000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTgtMS0xLTA_73f8c903-637e-4041-bc13-d7cfbbe0b6d7"
      unitRef="usd">8000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzEwLTEwLTEtMS0w_377a2c6f-150a-4ac6-96df-fb6725840cb6"
      unitRef="usd">46000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ia0d420fead59462095697a3993d8f4e5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTEtMS0xLTA_89540598-0acb-43c0-b9e7-4e05aedbc5f3"
      unitRef="usd">1531000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5ebdb26351324dc59f4adf268bf038a1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTQtMS0xLTA_f8b75c7d-6c6e-48ea-829a-34ecdda0e39f"
      unitRef="usd">516000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia7814e488a794292a9e3f5a1d348951e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTYtMS0xLTA_cd421907-25a1-4f19-b17a-dcdf80a41f92"
      unitRef="usd">316000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i88402b35bd0c42118b8f0b1db0690925_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTgtMS0xLTA_6d06dde3-4e7d-47d0-aa88-fe4b160728c9"
      unitRef="usd">156000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzExLTEwLTEtMS0w_0bb2a05d-2b56-4dd9-9002-2d3d5ac6a576"
      unitRef="usd">2519000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4OQ_bf863b39-a391-4d97-ab36-84892902af3a">OTHER INTANGIBLES, NET&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The details of other intangible assets subject to amortization as of June&#160;30, 2021 and June&#160;30, 2020 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $93 million, $89 million, and $88 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively. Future amortization expense for the next five fiscal years is estimated to be:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4NQ_e691e90d-5377-4a03-95a1-42c463e49459">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The details of other intangible assets subject to amortization as of June&#160;30, 2021 and June&#160;30, 2020 are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Core technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iad48a9578f7b445ab0c1b13ac0a459e2_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItMS0xLTEtMA_d12e8402-8c01-4783-9adf-2ae88d8796d4">P19Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItMy0xLTEtMA_6b108f39-307c-4083-ad18-01dea2d764fd"
      unitRef="usd">140000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItNS0xLTEtMA_dd4f0fa8-3683-4567-b091-a324a3215b5b"
      unitRef="usd">94000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2c45190de9b244b99a1de76a3f9b9f5d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzItNy0xLTEtMA_f3793884-b4a1-410e-bf46-52a030394d64"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i845bd8ba54d74c7fb72abac0310f0e79_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtMS0xLTEtMA_763de78a-2cb4-4787-855b-328b06eeb6a9">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e750947153247c48b42689a9511423f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtMy0xLTEtMA_ceaa0f6e-5218-48a1-a9ea-1c773c0819bf"
      unitRef="usd">1024000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e750947153247c48b42689a9511423f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtNS0xLTEtMA_250c4e14-4c63-4ff8-9cbe-214be9f5444c"
      unitRef="usd">306000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e750947153247c48b42689a9511423f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzMtNy0xLTEtMA_12d781ac-09d3-4344-b508-3dd2ac0577a7"
      unitRef="usd">718000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i111cc1fffc0343ee85c1cfa4409c4152_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtMS0xLTEtMA_282cfd92-0265-46fd-bb37-83ebb59c8469">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtMy0xLTEtMA_6a944c71-36f5-432f-a256-a41b9c4e9714"
      unitRef="usd">281000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtNS0xLTEtMA_824eb597-417b-4d05-a956-9dd06de37673"
      unitRef="usd">237000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1a58e652f5474f6e9ed3ba76bde9e344_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzQtNy0xLTEtMA_246d63b8-a7e3-435c-aa08-92d3c970ab83"
      unitRef="usd">44000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4c882c4168ec447fba77d5f523c9881f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtMS0xLTEtMA_fe44493b-f5be-43d6-9c9c-9b2e64b5c6d1">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i86ee2895bde24a118a0de6982690f442_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtMy0xLTEtMA_f17d04b2-10e5-4a2e-952f-327cae69b3df"
      unitRef="usd">17000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i86ee2895bde24a118a0de6982690f442_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtNS0xLTEtMA_adea48fb-ecd5-43f0-bca6-febf06a56abf"
      unitRef="usd">8000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i86ee2895bde24a118a0de6982690f442_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzUtNy0xLTEtMA_cefa1962-b849-4f84-b705-ba42070be742"
      unitRef="usd">9000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtMy0xLTEtMA_23c5cc63-7497-4958-9b7e-05e5c8636b00"
      unitRef="usd">1462000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtNS0xLTEtMA_56f988d2-5e23-4875-9547-05a03632f85d"
      unitRef="usd">645000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo1MzU2MjM3NjNjZDk0ZDg4YTllNmQxZDY5YzUyNjQyOS90YWJsZXJhbmdlOjUzNTYyMzc2M2NkOTRkODhhOWU2ZDFkNjljNTI2NDI5XzYtNy0xLTEtMA_32f940be-6484-4fed-bc3c-43e0624ad870"
      unitRef="usd">817000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ief92cbae4c3841df84e37fe359a93709_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItMS0xLTEtMA_d0da11b4-09bb-44ae-ad62-d1cfab2a8dd8">P19Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItMy0xLTEtMA_bd504f3f-64b0-47be-ad89-6d417954ca85"
      unitRef="usd">135000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItNS0xLTEtMA_0f5e510b-a714-461e-b33e-2f44016554ac"
      unitRef="usd">83000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2e34a16cd0fb4f35a31d4911daae4de7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzItNy0xLTEtMA_ebe017c4-d878-4874-997e-1edb49fbc65c"
      unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i704ca8cefa7742e4aad55ca96150cc8b_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtMS0xLTEtMA_ebf423cc-2897-4b2e-b568-f36d0a2c3cf4">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i26b028860ed64053b94135848c0906f0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtMy0xLTEtMA_2abff124-749f-46ad-8575-234d8ca1ecd4"
      unitRef="usd">1021000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i26b028860ed64053b94135848c0906f0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtNS0xLTEtMA_a7a7fa66-618c-4627-892b-90c619984053"
      unitRef="usd">248000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i26b028860ed64053b94135848c0906f0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzMtNy0xLTEtMA_9f0e8faf-d66d-43b3-92a5-e3a367147c18"
      unitRef="usd">773000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if93fec8f8cb448208c403c46c07fedc6_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtMS0xLTEtMA_1f20bcf3-cb7e-44fc-8d3d-8cd7f2a382d8">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtMy0xLTEtMA_03820cb1-ce46-4625-bd67-c900e66428ad"
      unitRef="usd">270000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtNS0xLTEtMA_583ada8e-3c2a-4ddc-8d60-299ea5593556"
      unitRef="usd">217000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i70f8516a268c4ee4b2e752e5dc8c67b9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzQtNy0xLTEtMA_40d0ba42-20ff-4822-a2cb-6cbea538e22b"
      unitRef="usd">53000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4c4aea4c64794160b8c6f3912b4dd294_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtMS0xLTEtMA_500063ab-1b31-4633-acd5-c30091b7e71b">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7344efba23c04c1484bed638331da234_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtMy0xLTEtMA_80adde64-613f-4e94-8af5-f68f796ad59d"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7344efba23c04c1484bed638331da234_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtNS0xLTEtMA_96c57765-2a1e-4810-8120-8626553a3edb"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7344efba23c04c1484bed638331da234_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzUtNy0xLTEtMA_c294b6e5-f241-4218-9a05-1f3b5eda8590"
      unitRef="usd">11000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtMy0xLTEtMA_865e43f9-5507-4f77-89d7-337ee532a34b"
      unitRef="usd">1442000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtNS0xLTEtMA_6fe31295-c9b4-4718-889b-7d84cedd7b32"
      unitRef="usd">553000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTo4NzEyMzdhMjNmM2Y0Y2I3YmZjZTc2ZjZhYmE1NDQ0Zi90YWJsZXJhbmdlOjg3MTIzN2EyM2YzZjRjYjdiZmNlNzZmNmFiYTU0NDRmXzYtNy0xLTEtMA_1e8ef825-9af1-425b-8be8-66c2e8c281e4"
      unitRef="usd">889000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ1MQ_19c75992-5b86-460c-b40b-b1636011649b"
      unitRef="usd">93000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ1NQ_6587c6e7-7f54-4d85-934e-8b6eca7c0298"
      unitRef="usd">89000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0XzQ2Mw_d3427ace-7b0b-4696-94e2-69541294e8b3"
      unitRef="usd">88000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90ZXh0cmVnaW9uOjUxMTdhNzYyZDBjMTRhN2E5MjE3MjJhNWNlODQxY2Y0Xzg4Nw_f94b599d-ea85-4bb5-a2c9-bab2061dd6f9">Future amortization expense for the next five fiscal years is estimated to be:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtMS0xLTEtMA_ffd7194f-ee25-4d90-af96-86c1f1bee5da"
      unitRef="usd">93000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtMy0xLTEtMA_a4243c14-e69d-48f7-9369-1a30a4ace4f3"
      unitRef="usd">92000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtNS0xLTEtMA_05a1ed95-5c80-4031-8d01-c1904a59f21d"
      unitRef="usd">91000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtNy0xLTEtMA_11370430-c50d-426f-9f06-a682a611dd37"
      unitRef="usd">90000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTYvZnJhZzo1MTE3YTc2MmQwYzE0YTdhOTIxNzIyYTVjZTg0MWNmNC90YWJsZTozN2I3YjA3NGFiZmQ0ZWVhOWE3YTQ0N2YzYjNmMjM0ZC90YWJsZXJhbmdlOjM3YjdiMDc0YWJmZDRlZWE5YTdhNDQ3ZjNiM2YyMzRkXzEtOS0xLTEtMA_92e5ce6c-3d2b-464b-bf1f-3d279a98ea9a"
      unitRef="usd">83000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEzODg_01796e21-9ead-465a-979b-1dc118aff1c4">RESTRUCTURING COSTS&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has implemented plans to restructure certain operations, both domestically and internationally. The restructuring plans focused on various aspects of operations, including closing and consolidating certain manufacturing operations, rationalizing headcount and aligning operations in a strategic and more cost-efficient structure. In addition, the Company may incur restructuring charges in the future in cases where a material change in the scope of operation with its business occurs. Employee-related costs consist primarily of severance costs and also include outplacement services provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods. Facility exit and other costs consist of accelerated depreciation, equipment relocation costs, and costs associated with planned facility closures to streamline Company operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended June 30, 2021, the Company adopted a plan to reduce costs and optimize its infrastructure in Europe by closing its Clinical Supply Services facility in Bolton, U.K. In connection with this restructuring plan, the Company expects to reduce its headcount between 150 and 180 employees through December 31, 2021 and estimates that it will incur charges between $7 million and $8 million, primarily associated with employee severance benefits. For the fiscal year ended June 30, 2021, restructuring charges associated with the Bolton facility closure were $7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the fiscal year ended June 30, 2020, no significant restructuring plan was adopted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the fiscal year ended June 30, 2019, the Company adopted a plan to restructure its workforce following a temporary suspension of operations at a Softgel and Oral Technology facility. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the costs recorded within restructuring costs: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee-related reorganization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facility exit and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
      contextRef="i378811f92e0f4ffeb7fb93c1f1f293eb_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0MjI_09c377d3-a278-4d19-abf0-3aa3b6f76045"
      unitRef="employees">150</us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
      contextRef="icf709e90ec7842118e0f9f686273d1e9_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0Mjg_13b44a24-ef62-41f4-854b-254d4789a2dc"
      unitRef="employees">180</us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i2731c0e309f94c7b87f012c3985d4fc2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0NDE_cb60e9ac-d272-4940-9384-ba8ddf7fc3b9"
      unitRef="usd">7000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i8ff2c23c60004dfab89f35aa1a024575_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzQ5NDc4MDIzMzE0NTg_28befcb2-902c-40e2-9695-f026962c2692"
      unitRef="usd">8000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i8e8e76f0ec8f455cb11705921585b0c4_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEwOTk1MTE2MzY2MzE_c097f3fe-a371-4459-aaa0-8668b1f50f1d"
      unitRef="usd">7000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90ZXh0cmVnaW9uOmFiOTA1YjQyMmFlYzQ4YjhhMjE4OThhNWM4YmVmYmUzXzEzODU_f7c07225-76eb-48ee-998c-6044a58d82c0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the costs recorded within restructuring costs: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee-related reorganization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facility exit and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtMS0xLTEtMA_48109db2-11c7-47a6-95ce-561094e52ef2"
      unitRef="usd">8000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtMy0xLTEtMA_e63c2a51-7d29-4f71-9a62-55b0a154609b"
      unitRef="usd">6000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzUtNS0xLTEtMA_068490a9-c5ac-4cba-a6d2-c7c7f6cc8aa6"
      unitRef="usd">14000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtMS0xLTEtMA_c062582e-961c-4e43-8a63-45d203eb5ed8"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtMy0xLTEtMA_3a150b35-725e-4fa6-89d5-1b68532afced"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzYtNS0xLTEtMA_3727639c-feeb-4d54-81a0-ab78f905e44c"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctMS0xLTEtMA_ce350661-9213-4838-91c8-76e15dcd5c6b"
      unitRef="usd">10000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctMy0xLTEtMA_95bf33b6-340d-48ce-b496-f38f91cf2c9d"
      unitRef="usd">6000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDIvZnJhZzphYjkwNWI0MjJhZWM0OGI4YTIxODk4YTVjOGJlZmJlMy90YWJsZTo4MTBlM2ZlNmY2ZWM0Y2M2YTRhZTJiZDIyMjc1ZjAyNS90YWJsZXJhbmdlOjgxMGUzZmU2ZjZlYzRjYzZhNGFlMmJkMjIyNzVmMDI1XzctNS0xLTEtMA_8e83c4e2-5334-4ecf-9433-1843179993f6"
      unitRef="usd">14000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDE2_036c2ad8-e4da-4aba-ae73-556e20c9a467">LONG-TERM OBLIGATIONS AND SHORT-TERM BORROWINGS&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term obligations and short-term borrowings consist of the following at June&#160;30, 2021 and June&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Maturity as of June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior secured credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility B-2 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility B-3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit facility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Euro-denominated senior notes due 2028&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term obligations, less current portion &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Secured Credit Facilities and Fifth Amendment to the Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, Operating Company completed Amendment No. 5 (the "Fifth Amendment") to its Amended and Restated Credit Agreement, dated as of May 20, 2014 (as subsequently amended, the "Credit Agreement"). Pursuant to the Fifth Amendment, Operating Company refinanced the existing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$933 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aggregate principal amount of U.S. dollar-denominated term loans (the "Term B-2 Loans") with the proceeds of an equivalent amount of new U.S. dollar-denominated term loans (the "Term B-3 Loans"), incurred an additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$67 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aggregate principal amount of Term B-3 Loans, and obtained an additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$175 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of revolving credit commitments (the "Incremental Revolving Credit Commitments") under the Credit Agreement's revolving credit facility (the "Revolving Credit Facility"). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term B-3 Loans constitute a new class of term loans under the Credit Agreement, with an interest rate of one-month LIBOR (subject to a floor of 0.50%) plus 2.00% per annum, a maturity date of February 2028 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;quarterly amortization of principal equal to 0.25% with payments on the last business day of March, June, September, and December. The proceeds of the Term B-3 Loans, after payment of the offering fees and expenses, were used to repay in full the existing Term B-2 Loans under the Credit Agreement, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Incremental Revolving Credit Commitments constitute revolving credit commitments under the Revolving Credit Facility.  The applicable rate for all revolving credit facility commitments under the Revolving Credit Facility is initially LIBOR plus 2.25% and such rate can additionally be reduced to LIBOR plus 2.00% in future periods based on a measure of Operating Company's total leverage ratio.  The maturity date for the Revolving Credit Facility is the earlier of (i) May 17, 2024 and (ii) the 91st day prior to the maturity of the Term B-3 Loans. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, pursuant to the Fifth Amendment, certain modifications were made to the Credit Agreement in order to, among other things, provide for determination of a benchmark replacement interest rate when LIBOR is no longer available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The availability of capacity under the Revolving Credit Facility is reduced by the aggregate value of all outstanding letters of credit under the Credit Agreement. As of June&#160;30, 2021, Operating Company had $719 million of unutilized capacity under the Revolving Credit Facility due to $6 million of outstanding letters of credit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;5.000% Senior Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, Operating Company completed a private offering of $500 million aggregate principal amount of 5.000% Senior Notes due 2027 (the &#x201c;2027 Notes&#x201d;). The 2027 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2027 Notes were offered in the U.S to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2027 Notes will mature on July 15, 2027 and bear interest at the rate of 5.000% per annum. Interest is payable semi-annually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The proceeds of the 2027 Notes after payment of the offering fees and expenses were used to repay in full the borrowings under Operating Company&#x2019;s then-outstanding term loans under its senior secured credit facilities that would otherwise have matured in May 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2.375% Euro-denominated Senior Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, Operating Company completed a private offering of &#x20ac;825 million aggregate principal amount of 2.375% Senior Notes due 2028 (the "2028 Notes"). The 2028 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The Euro 2028 Notes were offered in the U.S. to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S. only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2028 Notes will mature on March 1, 2028 and bear interest at the rate of 2.375% per annum. Interest is payable semi-annually in arrears on March 1 and September 1 of each year. The proceeds of the 2028 Notes after payment of the offering fees and expenses were used to repay in full the borrowings then outstanding under Operating Company's euro-denominated term loans under its senior secured credit facilities, which would have matured in May 2024, and repay in full Operating Company's euro-denominated 4.75% Senior Notes due 2024 (the &#x201c;2024 Notes&#x201d;), which would have matured in December 2024, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;3.125% Senior Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, Operating Company completed a private offering of $550 million aggregate principal amount of 3.125% Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes and the 2028 Notes, the "Senior Notes"). The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2029 Notes will mature on February 15, 2029 and bear interest at the rate of 3.125% per annum payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021. The proceeds of the 2029 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under Operating Company's 4.875% Senior Notes due 2026. which would have matured in January 2026 (the "2026 Notes") plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Purchase Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Cook Pharmica LLC (now Catalent Indiana, LLC) in October 2017, $200 million of the $950 million aggregate nominal purchase price is payable in $50 million installments, on each of the first four anniversaries of the closing date. The Company made installment payments in October 2018, 2019, and 2020. The balance of the deferred purchase consideration was recorded at fair value as of the acquisition date, with the difference between the remaining nominal amount and the fair value as of any relevant period end treated as imputed interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term and Other Obligations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other obligations consist primarily of finance leases for buildings and other loans for business and working capital needs. Maturities of long-term obligations, including finance leases of $193 million, and other short-term borrowings for future fiscal years are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturities of long-term and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Issuance Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt issuance costs associated with the Credit Agreement (other than its Revolving Credit Facility component) and the Senior Notes are presented as a reduction to the carrying value of the related debt, while debt issuance costs associated with the Revolving Credit Facility are capitalized within other long-term assets on the consolidated balance sheet. All debt issuance costs are amortized over the life of the related obligation through charges to interest expense in the consolidated statements of operations. The unamortized total debt issuance costs, including the costs associated with the Revolving Credit Facility capitalized within other long-term assets, were $38 million and $39&#160;million as of June&#160;30, 2021 and 2020, respectively. Amortization of debt issuance costs totaled $6 million and $6 million for the fiscal years ended June&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Security &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the following assets of Operating Company and each guarantor (Operating Company's parent entity, PTS Intermediate, and each of Operating Company's material domestic subsidiaries), subject to certain exceptions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;a pledge of 100% of the capital stock of Operating Company and 100% of the equity interests directly held by Operating Company and each guarantor in any wholly owned material subsidiary of Operating Company or any guarantor (which pledge, in the case of any non-U.S. subsidiary of a U.S. subsidiary, will not include more than 65% of the voting stock of such non-U.S. subsidiary); and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;a security interest in, and mortgages on, substantially all tangible and intangible assets of Operating Company and of each guarantor, subject to certain limited exceptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Senior Notes are general, unsecured, and subordinated to all existing and future secured indebtedness of the guarantors to the extent of the value of the assets securing such indebtedness. Each of the Senior Notes is separately guaranteed by all of Operating Company's wholly owned U.S. subsidiaries that guarantee the senior secured credit facilities. None of the Senior Notes is guaranteed by either PTS Intermediate or the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains a number of covenants that, among other things, restrict, subject to certain exceptions, Operating Company&#x2019;s (and Operating Company&#x2019;s restricted subsidiaries&#x2019;) ability to incur additional indebtedness or issue certain preferred shares; create liens on assets; engage in mergers and consolidations; sell assets; pay dividends and distributions or repurchase capital stock; repay subordinated indebtedness; engage in certain transactions with affiliates; make investments, loans or advances; make certain acquisitions; enter into sale and leaseback transactions; amend material agreements governing Operating Company's subordinated indebtedness and change Operating Company's lines of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement also contains change of control provisions and certain customary affirmative covenants and events of default. The Revolving Credit Facility requires compliance with a net leverage covenant when there is a 30% or more draw outstanding at a period end. As of June&#160;30, 2021, the Company was in compliance with all material covenants under the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to certain exceptions, the Credit Agreement permits Operating Company and its restricted subsidiaries to incur certain additional indebtedness, including secured indebtedness. None of Operating Company&#x2019;s non-U.S. subsidiaries nor its dormant Puerto Rico subsidiary is a guarantor of the loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Credit Agreement, Operating Company&#x2019;s ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consolidated EBITDA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the Credit Agreement). Adjusted EBITDA is based on the definitions in the Credit Agreement, is not defined under U.S. GAAP, and is subject to important limitations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The various indentures governing the Senior Notes (collectively, the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indentures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) contain covenants that, among other things, limit the ability of Operating Company and its restricted subsidiaries to incur or guarantee more debt or issue certain preferred shares; pay dividends on, repurchase, or make distributions in respect of their capital stock or make other restricted payments; make certain investments; sell certain assets; create liens; consolidate, merge, sell; or otherwise dispose of all or substantially all of their assets; enter into certain transactions with their affiliates, and designate their subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of exceptions, limitations, and qualifications as set forth in the Indentures. The Indentures also contain customary events of default, including, but not limited to, nonpayment, breach of covenants, and payment or acceleration defaults in certain other indebtedness of Operating Company or certain of its subsidiaries. Upon an event of default, either the holders of at least 30% in principal amount of each of the then-outstanding Senior Notes or the applicable Trustee under the Indentures may declare the applicable notes immediately due and payable; or in certain circumstances, the applicable notes will automatically become immediately due and payable. As of June&#160;30, 2021, Operating Company was in compliance with all material covenants under the Indentures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Estimated Fair Value of Debt Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The estimated fair values of the senior secured credit facilities and Senior Notes are classified as Level 2 (see Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; for a description of the method by which fair value classifications are determined) in the fair value hierarchy and are calculated by using a discounted cash flow model with market interest rate as a significant input. The carrying amounts and the estimated fair values of financial instruments as of June&#160;30, 2021 and June&#160;30, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% Senior Notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% Senior Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Euro-denominated Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% Senior Notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior secured credit facilities &amp;amp; other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDE3_125504bd-42af-4d94-9dc4-1ec4ade63e08">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term obligations and short-term borrowings consist of the following at June&#160;30, 2021 and June&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Maturity as of June 30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior secured credit facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility B-2 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan facility B-3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit facility &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Euro-denominated senior notes due 2028&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 to 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion of long-term obligations and other short-term&lt;br/&gt;&#160;&#160;&#160;&#160;&#160;borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term obligations, less current portion &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i533413c430064ec6b4c844cc3f1acfbe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzItMy0xLTEtMA_35c3d2bb-6c6c-4795-bf81-c1150da4acf7"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i15fceb629bb441a8a053f8395affd416_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzItNS0xLTEtMA_e909be16-3d6d-4130-87d6-98c4bac22bab"
      unitRef="usd">938000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="icad07736ec7541dcaa87a7b378aa1ebf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzMtMy0xLTEtNjMy_667a07ff-8562-4987-8c01-4fbd4feba9e1"
      unitRef="usd">997000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i684ac58b65d2462d9086fd8d03006003_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzMtNS0xLTEtNjM1_2fe4ad7b-b3f2-4b74-b7b0-09259a132b9d"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i776ba765031f4822ac7631755e4324e0_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzUtMy0xLTEtMA_2f6391cf-8f05-4b0b-b946-f8af1e6228cb"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="icf427a11407e441c9ae17c2a3bc8d22a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzUtNS0xLTEtMA_2eb6c6f8-6fa6-408e-98d1-6a110ddcd049"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzctMy0xLTEtMA_04b2316a-e856-4138-8cb2-8a52988099b8"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i93d7e2c8c43a47c0a933c613e1998a34_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzctNS0xLTEtMA_cc23af87-7f07-4fec-915b-8e5038fe2de8"
      unitRef="usd">450000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d8daa403fef413dba97b83235c8ea21_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzgtMy0xLTEtMA_d2e5fd77-4c9d-46c3-9a7c-515626699067"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i13a1e048ba7c4e9691ded7739ee1a189_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzgtNS0xLTEtMA_85db73c0-8f6a-4878-ac34-fd45a96daab5"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
      unitRef="usd">984000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i796cb7ff80c54ea8a86407355ff7fedb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
      unitRef="usd">926000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMjMyMA_9c81d95e-bf0c-4c0e-ad43-fd6199fca1d2"
      unitRef="usd">550000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib061337543284797b3b9d0ef58f9ec80_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMjMyMw_aaaa444f-4db6-4f39-bedb-a4fde9132053"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i4d27525d7cf54500bd9efcef6e00f2a5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEwLTMtMS0xLTA_32299aa3-4269-4a88-9a3f-9feec49a8605"
      unitRef="usd">50000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i0ac432fc632a4aa4b73cc9827f98414a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEwLTUtMS0xLTA_b7414073-00a0-471c-acb6-cbe144ff23fb"
      unitRef="usd">98000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i508875b781734fda88090125bce65502_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEyLTMtMS0xLTA_5af276e1-a426-417d-892f-eb957759d754"
      unitRef="usd">193000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2a9042a8cb274081acd357a646d69523_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEyLTUtMS0xLTA_1eedf086-5078-4d7f-b235-35aac525bd3b"
      unitRef="usd">142000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i9de35b0a15464306a00bc384ef0ae803_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEzLTMtMS0xLTA_b2f073b3-a216-4612-ab28-b4acebe9f0f2"
      unitRef="usd">3000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i8095367c62b3442fb4b4cbb5c6ceeaa6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzEzLTUtMS0xLTA_897c0edd-08db-47e3-9b90-7ca1bce4c605"
      unitRef="usd">1000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTYzOA_06d5b7b5-e0ac-47ef-b6b1-40886220bbb6"
      unitRef="usd">36000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTYzOA_b7e2dc6a-5e00-4abd-97f1-da63c7bf3c6a"
      unitRef="usd">36000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTY0MQ_67bc48b1-0174-4a39-9328-c791b43ebbb1"
      unitRef="usd">37000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTY0MQ_f53bae1e-bcd3-43d9-9796-2f87b0cfb09b"
      unitRef="usd">37000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE0LTMtMS0xLTA_773f8f9b-afa2-4794-9348-80d38e48e279"
      unitRef="usd">3241000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE0LTUtMS0xLTA_8ec984fa-f8df-4349-a3db-5e1f2fb68060"
      unitRef="usd">3018000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTMtMS0xLTA_0dbe6038-db0e-4942-80bd-e05d09450dd6"
      unitRef="usd">75000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE1LTUtMS0xLTA_17eb26c2-0656-4536-be47-320e2d7c530c"
      unitRef="usd">73000000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE2LTMtMS0xLTA_65b41302-461a-4c7b-b90f-c91f6467b1ae"
      unitRef="usd">3166000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzE2LTUtMS0xLTA_bddb4a06-6680-4292-9be2-89b4470fd70f"
      unitRef="usd">2945000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ie91ae3a1701e42c4bab269d3f3f05bb4_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjI2_7cf8aa7f-d3e6-43d4-9b98-289bf3f4a7c3"
      unitRef="usd">933000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet
      contextRef="i889429d7ce8e4d9998dd05977d62e04b_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjQ2_06037404-ce01-4133-a2ce-c648a2d75503"
      unitRef="usd">67000000</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:DebtInstrumentIncreaseDecreaseOtherNet
      contextRef="i8a70d7001a4d41889b95e3278d9d6e76_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEwOTk1MTE2NTUyMzc_2f3ce16b-2fbc-4d74-83fd-fc433399b122"
      unitRef="usd">175000000</us-gaap:DebtInstrumentIncreaseDecreaseOtherNet>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i82917b6fc7de420b9f04e1c84874f333_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjU5_b15bd8f1-5d2a-4dd6-8211-d256f0ab0fed"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0282c343e7634e19b53f822bfc4e477f_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjY4_7780d965-b005-4541-b7fb-f40c5c861a52"
      unitRef="number">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ctlt:DebtInstrumentQuarterlyAmortizationRate
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjc4_cb54d649-4587-4b56-8263-aacd6e952674"
      unitRef="number">0.0025</ctlt:DebtInstrumentQuarterlyAmortizationRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i076d5ed390e143ec905916749b2b91cd_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjg3_ca974445-21c5-4ec6-85e0-5d96b9f46ad8"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i51dabd2b047049b4a2d87b4d8f3f5b9c_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjk1_f1e52eff-da61-4209-aee1-19b6ede8ddef"
      unitRef="number">0.02</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzMwMzA_09707abe-7ca4-4411-b03b-76f777df017c"
      unitRef="usd">719000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzMxMTU_549913cb-e1e1-4fd4-b61e-034492006731"
      unitRef="usd">6000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQxNTU_fdebce41-2608-424a-8e7a-1f4dcd666d2d"
      unitRef="usd">500000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQxODg_a3bc2dbc-3121-4081-afce-f5e2004d92db"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic0408f495c5d4d949488007caa31f4ae_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ3NDY_a3bc2dbc-3121-4081-afce-f5e2004d92db"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i814e92c75da3452187f82acd0565e8db_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzMzk5Mzk_3c5c7c34-4906-4dd2-9743-dd71ea01c564"
      unitRef="eur">825000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i814e92c75da3452187f82acd0565e8db_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEwOTk1MTE2NDI3NzY_e1989fa5-8bc4-44c0-862a-5a2d96f7bd48"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i814e92c75da3452187f82acd0565e8db_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMDY_e1989fa5-8bc4-44c0-862a-5a2d96f7bd48"
      unitRef="number">0.02375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2277ff43db9c4df8b0dc6f627b3a499a_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMTQ_06e8200b-9675-412f-b4a4-68fb3ced285c"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzMzk5Nzc_ec97b755-7311-4696-aa48-8c457b696118"
      unitRef="usd">550000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwNDE_25a0e80d-17ca-47f0-a724-8745e1508492"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2eb1fd54009e499f99ec2c00ac274ea3_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMzI_25a0e80d-17ca-47f0-a724-8745e1508492"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic60365c610a94f2a911805e966520b33_I20171018"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzQ5NDc4MDIzNDAwMjM_fedc589d-5a97-44ab-ac8b-151a99593a6d"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibf405a2085fd40a8b0117b3a3432c514_D20171001-20171023"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzYzNjc_0823772c-9391-49b0-b30a-24710658b975"
      unitRef="usd">200000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8b827d728ed040f9aa9a77f9d945ef0d_D20171001-20171023"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzYzNzc_e84012ab-6da8-4d4a-b545-cfd53211583c"
      unitRef="usd">950000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <ctlt:InstallmentPaymentForAcquisition
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzY0Mjc_5b27bad1-640a-498e-b622-fe6592fd15e5"
      unitRef="usd">50000000</ctlt:InstallmentPaymentForAcquisition>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDEz_34504090-4dba-4c85-b39e-f4d1e92de4a8">Maturities of long-term obligations, including finance leases of $193 million, and other short-term borrowings for future fiscal years are:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturities of long-term and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i508875b781734fda88090125bce65502_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzcwMTE_5af276e1-a426-417d-892f-eb957759d754"
      unitRef="usd">193000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMS0xLTEtMA_442e5d9d-af27-47e9-861d-216c0838439f"
      unitRef="usd">75000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMi0xLTEtMA_56b46de6-1fbc-4bc7-9799-782e472a809b"
      unitRef="usd">23000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtMy0xLTEtMA_8f672537-974b-4139-93f1-c5d5f54d34ea"
      unitRef="usd">24000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNC0xLTEtMA_4156afe8-bed3-4a2f-a103-749196db0eba"
      unitRef="usd">22000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNS0xLTEtMA_68f86c88-f962-4cb8-afa6-e8cabdb47092"
      unitRef="usd">20000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNi0xLTEtMA_190f90fd-8f36-4b04-ba51-75b2ffb6b722"
      unitRef="usd">3113000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTo1YTc3YTAxZWMzODA0YmM4Yjc2NTU1NjY4ZDMzN2Y5Mi90YWJsZXJhbmdlOjVhNzdhMDFlYzM4MDRiYzhiNzY1NTU2NjhkMzM3ZjkyXzEtNy0xLTEtMA_4237c888-ddb2-4eb7-92fd-a1e535c4f5ee"
      unitRef="usd">3277000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc2NzQ_53019b6b-5d60-4662-bb4c-9a69968b93af"
      unitRef="usd">38000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc2ODE_a011a7a1-8215-493d-979c-1b8aa3a99e0b"
      unitRef="usd">39000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc3NjE_2eb13d64-f8e6-472b-8fa6-6c59f87931bd"
      unitRef="usd">6000000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzc3Njg_8e5e9caa-f876-46d2-9117-521ad6addd2f"
      unitRef="usd">6000000</us-gaap:AmortizationOfFinancingCosts>
    <ctlt:PledgePercentageOfCapitalStock
      contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzgyMjk_3958dd18-d261-4eac-8f45-5c074578ae97"
      unitRef="number">1</ctlt:PledgePercentageOfCapitalStock>
    <ctlt:PledgePercentageOfEquityInterest
      contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzgyNzg_d53c262d-14f6-4111-b7bc-2dd85aeaa4b3"
      unitRef="number">1</ctlt:PledgePercentageOfEquityInterest>
    <ctlt:MaximumPercentageOfVotingStock
      contextRef="i86d7538814354fbd8ebdb6c738423bb5_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzg1NDA_ec582c6f-d9d6-4ded-938e-4fe5e7e76c16"
      unitRef="number">0.65</ctlt:MaximumPercentageOfVotingStock>
    <ctlt:ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMDA5_b999c210-aae8-4184-9f7a-53c16a54ec2d">The carrying amounts and the estimated fair values of financial instruments as of June&#160;30, 2021 and June&#160;30, 2020 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.875% Senior Notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.000% Senior Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.375% Euro-denominated Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125% Senior Notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior secured credit facilities &amp;amp; other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ied10dab2368d4b34b3b1eb8a94e17bce_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtMi0xLTEtMA_04b2316a-e856-4138-8cb2-8a52988099b8"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibaffc390ab5942bea52a4be57e7dbde6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtNC0xLTEtMA_87f0ac38-d6e7-4890-8450-e735087f7a60"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i93d7e2c8c43a47c0a933c613e1998a34_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtNi0xLTEtMA_cc23af87-7f07-4fec-915b-8e5038fe2de8"
      unitRef="usd">450000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i05c37e0185644986bb65525bb1644ccd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzMtOC0xLTEtMA_ff1e9e67-320e-4c07-b049-9fd6e4ee9eb5"
      unitRef="usd">464000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d8daa403fef413dba97b83235c8ea21_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtMi0xLTEtMA_d2e5fd77-4c9d-46c3-9a7c-515626699067"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iabaebe4c2d684181a51203e58e9005fe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtNC0xLTEtMA_640494c5-495b-49c6-aa6f-db1f71555ca2"
      unitRef="usd">539000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i13a1e048ba7c4e9691ded7739ee1a189_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtNi0xLTEtMA_85db73c0-8f6a-4878-ac34-fd45a96daab5"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i86102d72c35440138d512f3c29d2305f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzQtOC0xLTEtMA_063fefc1-ef3b-4eb4-9890-c7750475d546"
      unitRef="usd">538000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
      unitRef="usd">984000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6671e05a3e2b467a944f21f20d4c3366_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNC0xLTEtMA_4f736a3d-3b80-429c-9eec-a141e9210ff6"
      unitRef="usd">993000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i796cb7ff80c54ea8a86407355ff7fedb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
      unitRef="usd">926000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie15380ce82624d0e9f2df108f51ffe4b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtOC0xLTEtMA_6daf31f9-dd15-483b-af59-e77c2fb8a08d"
      unitRef="usd">844000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id16b5a16fdc04b628d9ec759b80705ff_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtMy0xLTEtMjQ0OA_9c81d95e-bf0c-4c0e-ad43-fd6199fca1d2"
      unitRef="usd">550000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia3db9452ad5e47a1bb0e9ab578f325b3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNS0xLTEtMjQ1MQ_94c4e4e3-5430-4f2a-b2d0-a2664a66f136"
      unitRef="usd">524000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib061337543284797b3b9d0ef58f9ec80_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNy0xLTEtMjQzNA_24e4d6cb-d1c4-42a6-bb5e-9051cd54de1c"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5a6d816c6a3b45b4ac0a46bfbcb69988_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtOS0xLTEtMjQzNw_b0d59535-7068-49fe-abac-e27e96b21c7a"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i09171d0cebb6430a942aa7517fe61fe9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtMi0xLTEtMA_07dd6de1-c684-4c25-84a1-a841fa7e4d9b"
      unitRef="usd">1243000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ief6bc672a6674233a298d9a2b454a730_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNC0xLTEtMA_c5f709e1-734a-4008-acc6-44e67014d6ee"
      unitRef="usd">1209000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1a171a9b90a84e74bda5120a9f3baca5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtNi0xLTEtMA_c4bb7d70-ae5d-4a25-9000-69d36798b0c5"
      unitRef="usd">1179000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6faf7a0fe4914b9f87e7fa0c0d7bd9a2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzYtOC0xLTEtMA_5c3c9bef-11dc-48c3-a1e4-907a51c6be8a"
      unitRef="usd">1160000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctMi0xLTEtMA_86dfde31-3928-4b88-85c6-0394615f4fb8"
      unitRef="usd">3277000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2e1619d8d97442d2b05880b4bab402aa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctNC0xLTEtMA_8ce21a05-d64f-4c2b-8757-2508425ba23c"
      unitRef="usd">3265000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctNi0xLTEtMA_87652421-47f9-45a2-a834-5debb860ea96"
      unitRef="usd">3055000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzctOC0xLTEtMA_a33ce110-7584-4190-b380-80fe1eba1a0d"
      unitRef="usd">3006000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktMy0xLTEtNTcwNg_06d5b7b5-e0ac-47ef-b6b1-40886220bbb6"
      unitRef="usd">36000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i801d701548f94353a03e6bbafcc35c85_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktMy0xLTEtNTcwNg_b7e2dc6a-5e00-4abd-97f1-da63c7bf3c6a"
      unitRef="usd">36000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="if6dcbdcff43d44a9947d50294da0c59f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNS0xLTEtNTcwOA_f9f6377c-2869-459d-948a-8d56673d91f2"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNy0xLTEtNTA2MQ_67bc48b1-0174-4a39-9328-c791b43ebbb1"
      unitRef="usd">37000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2d2ad22ca2e9468182fd61677afb1c58_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktNy0xLTEtNTA2MQ_f53bae1e-bcd3-43d9-9796-2f87b0cfb09b"
      unitRef="usd">37000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i8856d25fb8b24759af14435f4b8ba6ca_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzktOS0xLTEtNTcxMA_3b9ab696-7380-429d-a27f-c86a62d7dd0c"
      unitRef="usd">0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i324f9e1797a44fa5a5ee426673cb92c8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTMtMS0xLTUwNjM_e3d6914b-a219-41d7-8cd2-ef6e714dfc25"
      unitRef="usd">3241000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2e1619d8d97442d2b05880b4bab402aa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTUtMS0xLTUwNjM_cc286f1a-58b0-4f53-9d46-5a2e125f3297"
      unitRef="usd">3265000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iafa628a205694eb380b875de3bbacbfa_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTctMS0xLTUwNjM_2e0d9d1b-3bb3-4930-bae2-31e78e3bbe16"
      unitRef="usd">3018000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="id02a5d73c1924ec5ad28ea1ec2436f7b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzEwLTktMS0xLTUwNjM_da7eda5f-6d4a-428b-8445-c03e9581420b"
      unitRef="usd">3006000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE4MTM_de5abb6a-bc3c-4d25-820f-e0dc0edcec49">EARNINGS PER SHARE &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company computes earnings per share (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EPS&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) of the Common Stock &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;using the two-class method required due to the participating nature of the Series A Preferred Stock (as noted in Note 13,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The weighted-average number of shares outstanding utilized in diluted earnings per share is computed using the weighted-average number of common shares outstanding plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation. The dilutive effect of the securities that are issuable under the Company&#x2019;s equity incentive plans (see Note 14, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) are reflected in diluted earnings per share by application of the treasury stock method. The Company applies the if-converted method to compute the potentially dilutive &lt;/span&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;effect of the Series A Preferred Stock. The reconciliations between basic and diluted earnings per share attributable to Catalent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; common shareholders for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;&#160; (In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net earnings attributable to preferred shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average dilutive securities issuable - stock plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Series A Preferred Stock is deemed a participating security, meaning that it has the right to participate in undistributed earnings with the Company's Common Stock. On November 23, 2020 (the &#x201c;Partial Conversion Date&#x201d;), holders of Series A Preferred Stock converted 265,223 shares and $2 million of unpaid accrued dividends into shares of Common Stock (the &#x201c;Partial Conversion&#x201d;). The holders received 20.33 shares of Common Stock for each converted preferred share, resulting in the issuance of 5,392,280 shares of Common Stock. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The diluted weighted average number of shares outstanding for the fiscal years ended June 30, 2021, 2020 and 2019 did not include the weighted average number of shares of Common Stock associated with the Series A Preferred Stock reported below or the weighted average number of shares of Common Stock associated with the following types of outstanding equity grants due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(share counts in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE4MTQ_3d91c71e-030f-451d-be7d-ff061d46eeae">The reconciliations between basic and diluted earnings per share attributable to Catalent common shareholders for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;&#160; (In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net earnings attributable to preferred shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average dilutive securities issuable - stock plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItMS0xLTEtMA_1a79d6e3-63d7-4ec4-8b76-5a9a898091e6"
      unitRef="usd">585000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItMy0xLTEtMA_6c208770-78e3-4aaa-9c2e-471a3e243ba9"
      unitRef="usd">221000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzItNS0xLTEtMA_3b8a0bc1-8060-44b7-b861-7fbf8740fc97"
      unitRef="usd">137000000</us-gaap:ProfitLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtMS0xLTEtMA_e1272089-1562-47ee-abf7-1685e018db63"
      unitRef="usd">56000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtMy0xLTEtMA_8286ef4e-7b65-49f0-a703-c2d1b94fc4ed"
      unitRef="usd">48000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzMtNS0xLTEtMA_ddc174b2-b976-49ea-9656-49e6ed404e3d"
      unitRef="usd">5000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtMS0xLTEtMA_4fbf0d88-bf5c-44b9-adcc-69ca0faa4ae6"
      unitRef="usd">529000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtMy0xLTEtMA_839422c6-e698-440a-a53d-5e2fa79e1e03"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzQtNS0xLTEtMA_c447dfd8-7abb-4e84-8747-482efd7a670e"
      unitRef="usd">132000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtMS0xLTEtMA_35837ed4-2a74-44f1-bc1a-7c970f611653"
      unitRef="shares">168000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtMy0xLTEtMA_8cb8b551-568a-40a8-93df-5f8a0ad609f7"
      unitRef="shares">150000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzYtNS0xLTEtMA_964393f6-6672-464c-ad69-9339ce13276d"
      unitRef="shares">144000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctMS0xLTEtMA_ad3bf1fd-59a2-4120-85f9-12dca801874b"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctMy0xLTEtMA_519cd6f2-a670-47d2-91c5-2fc9ab8ad2e0"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzctNS0xLTEtMA_2b3bb38a-b8d6-43e1-9a72-9c2bbf3a7866"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtMS0xLTEtMA_e03b5dab-ae88-4d59-ae51-bc6ff464fdcd"
      unitRef="shares">170000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtMy0xLTEtMA_c2a05cbc-9821-42ed-a751-830e5780088b"
      unitRef="shares">152000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzgtNS0xLTEtMA_b9af67ce-cbc9-4ac4-ba04-0cd9b1cc6eb9"
      unitRef="shares">146000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTEtMS0xLTA_96ea0cd2-22b7-41cd-87e9-3764e632c991"
      unitRef="usdPerShare">3.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTMtMS0xLTA_d1b51ef4-b6cb-4394-bab6-80432ac76835"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzExLTUtMS0xLTA_6469aa4a-869a-40ad-b2d8-6b0271844618"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTEtMS0xLTA_a2b5ad29-bec7-4fd4-a77e-08c00431fa8a"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTMtMS0xLTA_4c40499b-cc6e-4ebe-a06f-96a311b86035"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiYjUwZGE4OGI0OWM0NWEwOWI0ZTUyZGQ2ZmFkZmIwYy90YWJsZXJhbmdlOmJiNTBkYTg4YjQ5YzQ1YTA5YjRlNTJkZDZmYWRmYjBjXzEyLTUtMS0xLTA_fe87e090-ec55-4048-8abe-3673a2be2c1c"
      unitRef="usdPerShare">0.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg1NzM_c04e5d78-84ee-47b2-b240-b2fac6cb6740"
      unitRef="shares">265223</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg1ODg_36f5a079-2d5a-4621-a158-51b12b0fa54a"
      unitRef="usd">2000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg2NDg_a034ab87-5883-4462-9b41-6e23b526c72a"
      unitRef="shares">20.33</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzQ5NDc4MDIzMjg2NDA_e17c2197-3f56-4849-9d46-e67ba0b48575"
      unitRef="shares">5392280</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90ZXh0cmVnaW9uOmM1ZmIyZGZmMTc1MTQ1MWVhMDExZjI1ZDhhOGZhNTIwXzE2NDkyNjc0NDY3MzM_5552de93-df36-4c0a-8256-97070b30fa62">&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The diluted weighted average number of shares outstanding for the fiscal years ended June 30, 2021, 2020 and 2019 did not include the weighted average number of shares of Common Stock associated with the Series A Preferred Stock reported below or the weighted average number of shares of Common Stock associated with the following types of outstanding equity grants due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(share counts in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Time-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance-based restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i671c59d76d904023aea5037521cce6c5_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItMS0xLTEtNTA2NQ_ed5362fe-3d8f-49f4-a3bb-f21484e9588a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItMy0xLTEtNTA2Nw_6773d043-4bdd-4881-b8c2-82b4fb804f2a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3ae15435182f490c81d494a5e1ec3b32_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzItNS0xLTEtNTA2OQ_1fb46f70-06be-4794-8fb7-273582cce015"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtMS0xLTEtNTA2NQ_76b41dbb-69e4-446a-afff-97dca8219eb0"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtMy0xLTEtNTA2Nw_8631bf75-54af-46eb-ba42-1f3c15249c78"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzMtNS0xLTEtNTA2OQ_0f5ac427-6691-4963-b619-0f2add5e1de5"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtMS0xLTEtNTA2NQ_3cbe9e8e-fa04-42ff-93fc-be178922faa4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i170d00009dcc4cd1ba9ddacd15fdefc1_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtMy0xLTEtNTA2Nw_7c82b24d-f680-45bf-abdd-ce1a24b9adc3"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9bc1999796814b39a7ce2ada34826470_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzQtNS0xLTEtNTA2OQ_a03a0225-0cd8-472a-8aaa-9c76baad12d6"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i419473081c56497ab865784949c1efce_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtMS0xLTEtNTA2NQ_9cde9cb6-f48f-4d4e-a641-1a0416f0d72b"
      unitRef="shares">10000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1814fd669de945459192151f0faec56c_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtMy0xLTEtNTA2Nw_98e9dff8-1b48-45f9-8ff8-26d589051165"
      unitRef="shares">13000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i12b3309684564f31b7fd6fb52491e6be_D20180701-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTEvZnJhZzpjNWZiMmRmZjE3NTE0NTFlYTAxMWYyNWQ4YThmYTUyMC90YWJsZTpiZGIwNDJhZWIzMzE0OGViOTY3MTFmNjEwODJlNjQwNC90YWJsZXJhbmdlOmJkYjA0MmFlYjMzMTQ4ZWI5NjcxMWY2MTA4MmU2NDA0XzUtNS0xLTEtNTA2OQ_d639ca45-6f37-403f-95b9-7aa18c215b4e"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzU3NDM_0a2ddec7-501e-4263-8a11-bcfe230bfa56">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risk Management Objective of Using Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to fluctuations in the currency exchange rates applicable to its investments in foreign operations. While the Company does not actively hedge against changes in foreign currency, the Company has mitigated the exposure arising from its investments in its European operations by denominating a portion of its Senior Notes in euros. At June&#160;30, 2021, the Company had euro-denominated debt outstanding of $984 million (U.S. dollar equivalent), which qualifies as a hedge of a net investment in foreign operations. For non-derivatives designated and qualifying as net investment hedges, the effective portion of the translation gains or losses are reported in accumulated other comprehensive income (loss) as part of the cumulative translation adjustment. The unhedged portions of the translation gains or losses are reported in the consolidated statements of operations. The following table includes net investment hedge activity during the fiscal years ended June&#160;30, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange gain (loss) within Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange gain (loss) within the Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net accumulated gain of this net investment within accumulated other comprehensive loss was $6 million as of June&#160;30, 2021. Amounts are reclassified out of accumulated other comprehensive loss into earnings when the entity in which the gains and losses reside is either sold or substantially liquidated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock Derivative Liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 13, Equity, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Preferred Stock and Accumulated Other Comprehensive Loss, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in May 2019, the Company issued shares of Series A Preferred Stock in exchange for net proceeds of $646 million after taking into account the $4 million issuance cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dividend rate used to determine the amount of the quarterly dividend payable on shares of the Series A Preferred Stock is subject to adjustment so as to provide holders of shares of Series A Preferred Stock with certain protections against a decline in the trading price of shares of Common Stock. The Company determined that this feature should be accounted for as a derivative liability, since the feature fluctuates inversely to changes in the trading price and is also linked to the performance of the S&amp;amp;P 500 stock index. Accordingly, the Company bifurcated the adjustable dividend feature from the remainder of the Series A Preferred Stock and accounted for this feature as a derivative liability at fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a gain of $17 million on the change in the estimated fair value of the derivative liability for the fiscal year ended June 30, 2021, which is reflected as other expense, net in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the derivative liability was settled on the Partial Conversion Date due to the Partial Conversion. The fair value of the derivative liability as of the Partial Conversion Date was $9 million, of which $4 million was related to the converted portion of the outstanding shares of Series A Preferred Stock. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity, Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details of the Partial Conversion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest-Rate Swap &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to its interest rate and risk management strategy, in April 2020, the Company entered into an interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its U.S dollar-denominated term loans under its senior secured credit facilities, so that the interest payable on that portion of the debt becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, in connection with the Fifth Amendment to the Credit Agreement, the Company settled the interest-rate swap agreement with Bank of America N.A. The Company paid $2 million in cash to Bank of America N.A to settle the interest-rate swap agreement. This loss is deferred in stockholders&#x2019; equity, net of income taxes, as a component of accumulated other comprehensive loss, and amortized as an adjustment to interest expense, net over the original term of the Term B-2 Loans. The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into a new interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its Term B-3 Loans, so that the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest payable on that portion of the Term B-3 Loans becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense. As a result of entering into the interest-rate swap agreement, the floating portion of the applicable rate on $500 million of the Term B-3 Loans is now effectively fixed at 0.9985%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new interest-rate swap agreement qualifies for and is designated as a cash-flow hedge. The Company evaluates hedge effectiveness at the inception of the hedge and on an ongoing basis. The cash flows associated with the interest-rate swap are reported in net cash provided by operating activities in the consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6839464700d0468ba36b8a430fd5892f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzUxNg_009e287b-5966-4eca-a57b-f95754e12597"
      unitRef="usd">984000000</us-gaap:DebtInstrumentFairValue>
    <ctlt:ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzU3MzU_2547f6ea-2751-4723-8bfd-cdf42c176d59">The following table includes net investment hedge activity during the fiscal years ended June&#160;30, 2021 and 2020, respectively:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange gain (loss) within Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange gain (loss) within the Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzEtMS0xLTEtMA_9dd4fd36-4384-4b42-9456-376e63fe5fb9"
      unitRef="usd">-56000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzEtMy0xLTEtMA_e21e2eaf-5c8d-42b6-86e1-9fce390cfa91"
      unitRef="usd">3000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzItMS0xLTEtMA_d572997d-311d-4bd1-937d-a5a818b66265"
      unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTo3ODMwYWQ2ZThlYzU0MWEwOTFmMmE5ODI4ZTlkMGY4Ni90YWJsZXJhbmdlOjc4MzBhZDZlOGVjNTQxYTA5MWYyYTk4MjhlOWQwZjg2XzItMy0xLTEtMA_2222b4e7-7757-4958-bc49-c8d066aaefc9"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEwOTk1MTE2NDMwNDE_2795e08d-333c-4654-b7a5-4a4e608f9030"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzE1OTY_becddaad-feb8-4311-8692-6dedd63c11ad"
      unitRef="usd">646000000</us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzE2Mjk_ae2b1322-eb27-47f9-ad51-bcfe65c35d40"
      unitRef="usd">4000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzMxNDk_5af9799a-756c-4275-bba2-3fc0591ea46b"
      unitRef="usd">17000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwMDM_b1c6376e-373a-4675-ae72-7c941c688aad"
      unitRef="usd">9000000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwNDc_31b7f59c-063f-4ca5-902f-32fff0947f49"
      unitRef="usd">4000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements>
    <ctlt:CashPaidToSettleInterestRateSwapAgreement
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwNjQ_8eff8c7c-44be-46a6-be88-81f1d462f182"
      unitRef="usd">2000000</ctlt:CashPaidToSettleInterestRateSwapAgreement>
    <ctlt:TotalDebtUSDenominatedTermLoan
      contextRef="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwODM_d5ab8bbc-247a-4ede-86a6-188d66bc5420"
      unitRef="usd">500000000</ctlt:TotalDebtUSDenominatedTermLoan>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic45779cffaa54ad3aac3cf5dbf33119d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzQ5NDc4MDIzNDAwOTk_5ef099c4-ec9f-4f6b-9a4c-535c1f5e88e5"
      unitRef="number">0.009985</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_2ff40c16-7a1b-4c09-90ff-19c722f4e5bf">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_cf75d7dd-b4bb-4204-90f9-c72343dfc2d0">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90ZXh0cmVnaW9uOjY2NTlhNmU2OTRmYTQwZGRhYTNlMDkzN2RjMDc1ZGUxXzEyNjQ0MzgzNzM3NTUz_dde010e9-27b3-42ee-b30d-9259997fd1e2">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTplZGJlMjU1OThjM2Y0NDA5YTVlYWE1NTVjYjAyOTUxOC90YWJsZXJhbmdlOmVkYmUyNTU5OGMzZjQ0MDlhNWVhYTU1NWNiMDI5NTE4XzItNC0xLTEtNTA3NA_7daed9eb-87cb-44f1-8c8a-d278601eabb9"
      unitRef="usd">2000000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTQvZnJhZzo2NjU5YTZlNjk0ZmE0MGRkYWEzZTA5MzdkYzA3NWRlMS90YWJsZTplZGJlMjU1OThjM2Y0NDA5YTVlYWE1NTVjYjAyOTUxOC90YWJsZXJhbmdlOmVkYmUyNTU5OGMzZjQ0MDlhNWVhYTU1NWNiMDI5NTE4XzItOC0xLTEtNTA3Ng_2480659d-4e2c-4684-a74f-44ce2316a380"
      unitRef="usd">4000000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM1OTU4_eeb2238b-9e7e-497c-b400-3d7741585940">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, defines fair value as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. To measure fair value, the Company uses the following fair value hierarchy based on three levels of inputs, of which Level 1 and Level 2 are considered observable and Level 3 is considered unobservable:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Quoted prices in active markets for identical assets or liabilities.                      &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.                      &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Value is determined using pricing models, discounted cash flow methodologies, or similar techniques and also includes instruments for which the determination of fair value requires significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses of the Company approximate fair value based on the short maturities of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level of classification as of the end of each reporting period. The following table sets forth the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis and the fair value measurement for such assets and liabilities at June 30, 2021 and June 30, 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the interest-rate swap agreement is determined at the end of each reporting period based on valuation models that use interest-rate yield curves and discount rates as inputs. The discount rates are based on U.S. deposit or U.S. Treasury rates. The significant inputs used in the valuation models are readily available in public markets or can be derived from observable market transactions, and the valuation is therefore classified as Level 2 in the fair-value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Series A Preferred Stock derivative is determined using an option pricing methodology, specifically both a Monte Carlo simulation and a binomial lattice model. The methodology incorporates the terms and conditions of the preferred stock arrangement, historical stock price volatility, the risk-free interest rate, a credit spread based on the yield indexes of high-yield bonds, and the trading price of shares of the Common Stock. The calculation of the estimated fair value of the derivative liability is highly sensitive to changes in unobservable inputs, such as the expected volatility and the Company&#x2019;s credit spread. The estimated fair value of the Series A Preferred Stock derivative liability is classified as Level 3 in the fair-value hierarchy due to the significant management judgment required to make the assumptions underlying the calculation of value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of changes in the estimated fair value of the Series A Preferred Stock derivative liability from June 30, 2020 to June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement of&lt;br/&gt;Series A Preferred Stock&lt;br/&gt;Derivative Liability&lt;br/&gt;Using Significant&lt;br/&gt;Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value of Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of derivative liability upon Partial Conversion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets, goodwill, and other intangible assets are subject to non-recurring fair value measurement for the evaluation of potential impairment. Other than the fair value estimates disclosed in Note 3, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations and Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, there was no non-recurring fair value measurement during the fiscal years ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM2MDY3_c43fa72c-9cc9-4f7a-a7d8-30ebdbcb220f">The following table sets forth the Company&#x2019;s financial assets and liabilities that were measured at fair value on a recurring basis and the fair value measurement for such assets and liabilities at June 30, 2021 and June 30, 2020, respectively:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTItMS0xLTUwNzg_50cee40f-0927-469d-af8a-c37bfd020983"
      unitRef="usd">71000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTQtMS0xLTUwNzg_2524bf4a-5fc7-4c7e-b4d2-9c816734c0ce"
      unitRef="usd">71000000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTYtMS0xLTUwNzg_367b7a09-ae17-436e-b948-fd4612074491"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8zLTgtMS0xLTUwNzg_aad16228-a9bf-42b3-9e65-64e1de7384a4"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTItMS0xLTUwNzg_c3743952-1002-4d60-a08b-d34704ee396c"
      unitRef="usd">2000000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTQtMS0xLTUwNzg_8e4af942-035d-4140-810b-2478d2d2c4d3"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTYtMS0xLTUwNzg_e877522a-7546-46a0-9bdb-59aa5a394399"
      unitRef="usd">2000000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl81LTgtMS0xLTUwNzg_17e6375f-0fd2-402d-ad56-ab85b153383b"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTItMS0xLTUwNzg_a95ef7f9-b048-4d71-951e-945c898abca3"
      unitRef="usd">1000000</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTQtMS0xLTUwNzg_6dd2a584-0610-49f9-bae9-0db8446b9631"
      unitRef="usd">1000000</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTYtMS0xLTUwNzg_0fc0b684-7f8c-49f9-8068-483f5146b225"
      unitRef="usd">0</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl82LTgtMS0xLTUwNzg_87a72100-bedb-4922-b7e5-c7fedbc6b316"
      unitRef="usd">0</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTItMS0xLTUwODA_66fa85e0-5e3d-407b-b2bf-dc5115101f95"
      unitRef="usd">3000000</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTQtMS0xLTUwODA_9984747b-8f81-4182-a151-ebfd91bfe2aa"
      unitRef="usd">0</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTYtMS0xLTUwODA_e880f53d-c7ca-4a99-ad5d-dc51f6c4b6b4"
      unitRef="usd">0</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl85LTgtMS0xLTUwODA_1d29df7f-f05f-4140-ba87-c6f55ba0b4c3"
      unitRef="usd">3000000</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC0yLTEtMS01MDgy_863b9f7e-8566-42fa-91ec-979c29c32ddd"
      unitRef="usd">1000000</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC00LTEtMS01MDgy_e6fd1d9d-b54b-401f-b73d-8cd9dad9aed5"
      unitRef="usd">1000000</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC02LTEtMS01MDgy_64fc7c91-28d2-4e39-bfb0-d4afb8f7f53e"
      unitRef="usd">0</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:TradingSecuritiesAtFairValue
      contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNC04LTEtMS01MDgy_374ad867-f7a9-4f68-9364-ed886899cb4c"
      unitRef="usd">0</ctlt:TradingSecuritiesAtFairValue>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy0yLTEtMS01MDg0_bb440e7f-bd01-4a81-945a-5b7b8b58d09f"
      unitRef="usd">24000000</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy00LTEtMS01MDg0_c0e99d0f-f3d1-4690-aead-386620c03a0e"
      unitRef="usd">0</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy02LTEtMS01MDg0_2756d050-2955-4102-b920-6bd404d90eed"
      unitRef="usd">0</ctlt:SeriesAPreferredStockDerivativeLiability>
    <ctlt:SeriesAPreferredStockDerivativeLiability
      contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xNy04LTEtMS01MDg0_c768be15-ddcd-419c-8292-0b98fa5b77e4"
      unitRef="usd">24000000</ctlt:SeriesAPreferredStockDerivativeLiability>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC0yLTEtMS01MDg0_8d96161a-9072-4537-b797-0b9484e8660d"
      unitRef="usd">4000000</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC00LTEtMS01MDg0_c426fc42-2eb3-4b9d-aad3-34d6ef4c3902"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC02LTEtMS01MDg0_52800fcc-686d-48bd-a91c-645d9eeeac20"
      unitRef="usd">4000000</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue
      contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6ZTBlMDI5MGMxZTFjNDA0NDhiY2E2MTg4YWQ0NWY2NmIvdGFibGVyYW5nZTplMGUwMjkwYzFlMWM0MDQ0OGJjYTYxODhhZDQ1ZjY2Yl8xOC04LTEtMS01MDg0_80db4db9-1294-46ec-b378-b21d80c3933f"
      unitRef="usd">0</us-gaap:InterestRateCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGV4dHJlZ2lvbjo3ZjE0ZDUzZWZiYzg0M2ZmYjhjMGJiYTZmYzlkMDIxYV8xMDk5NTExNjM2MDY2_13840978-a833-4784-95f9-1c6f277f018b">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of changes in the estimated fair value of the Series A Preferred Stock derivative liability from June 30, 2020 to June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Dollars in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement of&lt;br/&gt;Series A Preferred Stock&lt;br/&gt;Derivative Liability&lt;br/&gt;Using Significant&lt;br/&gt;Unobservable Inputs (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in estimated fair value of Series A Preferred Stock derivative liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of derivative liability upon Partial Conversion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8xLTEtMS0xLTUwODY_76328e66-ceeb-4ad9-a165-376cfb0e042f"
      unitRef="usd">24000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8yLTEtMS0xLTUwODY_0f03689f-fb6d-4867-ae1b-49ece1b961b1"
      unitRef="usd">17000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF8zLTEtMS0xLTUwODY_026f7518-9656-44c9-a0dd-c388e9c1a45a"
      unitRef="usd">4000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNDE2L2ZyYWc6N2YxNGQ1M2VmYmM4NDNmZmI4YzBiYmE2ZmM5ZDAyMWEvdGFibGU6NWUyZWJlMDExZDM1NGY1MjgyZjRjYjdiZDc0ZjA1ODQvdGFibGVyYW5nZTo1ZTJlYmUwMTFkMzU0ZjUyODJmNGNiN2JkNzRmMDU4NF80LTEtMS0xLTUwODY_0c4069c6-e647-4984-b5a3-71f29939f89c"
      unitRef="usd">3000000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDI_01f0fee9-fa0a-4afd-838c-1018334a4d83">INCOME TAXES&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes are as follows for fiscal 2021, 2020, and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consists of the following for fiscal 2021, 2020, and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision starting from the tax computed at the federal statutory income tax rate to the tax computed at the Company&#x2019;s effective income tax rate is as follows for the fiscal years ended 2021, 2020, and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision at U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low tax income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Withholding tax and other foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for the fiscal year ended June 30, 2021 is not comparable to the provision in the prior year due to changes in the geographic mix of pretax income, changes in the tax impact of permanent differences and credits, and the tax impact of discrete items. The effective tax rate for the fiscal year ended June 30, 2021 reflects a tax expense for the sale of the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Blow-Fill-Seal Business and an increase to state taxes, offset by an increase to the U.S. foreign tax credits as a result of amended prior year returns, as well as a reduction to the foreign valuation allowance. The effective tax rate for the fiscal year ended June 30, 2020 reflects a reduction to the federal and foreign valuation allowance partially offset by permanent items, and an increase in state tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company intends to repatriate foreign earnings taxed in prior fiscal years as a result of the changes imposed by the 2017 U.S. Tax Cuts and Jobs Act. In addition to these foreign earnings previously taxed, as of June 30, 2021, for purposes of ASC 740-10-25-3, the Company had &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$142 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of undistributed earnings from non-U.S. subsidiaries that it intends to reinvest permanently in its non-U.S. operations. As these ASC 740-10-25-3 earnings are considered permanently reinvested, no tax provision has been accrued. It is not feasible to estimate the amount of tax that might be payable on the eventual remittance of such earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes arise from temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the Company's deferred income tax assets and liabilities are as follows at June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities in the preceding table are in the following captions in the consolidated balance sheets at June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021, the Company had federal net operating loss (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOL&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) carryforwards of $512 million, $229 million of which are subject to limitations under Section 382 of the Internal Revenue Code of 1986, as amended (the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal Revenue Code&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).  The majority of the $229 million federal NOL carryforwards subject to Section 382 of the Internal Revenue Code are attributed to the Company's acquisitions of Pharmatek Laboratories, Inc., Juniper Pharmaceuticals, Inc., Paragon Bioservices, Inc., and MaSTherCell. As of June 30, 2021, $432 million of the Company's federal NOL carryforwards have an indefinite life and the remaining NOL carryforwards will expire in fiscal years 2023 through 2037.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021, the Company had state tax NOL carryforwards of $441 million. Substantially all state NOL carryforwards have a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMxMTQ_40c2bc12-63e0-4386-a398-62f51315a07f"&gt;twenty&lt;/span&gt;-year carryforward period. At June&#160;30, 2021, the Company had non-U.S. tax NOL carryforwards of $161 million, a majority of which, are available for at least &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyNTI_21287ddd-d08b-44ee-ae2d-42c777ef2210"&gt;three&lt;/span&gt; years or have an indefinite carryforward period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had valuation allowances of $65 million and $53 million as of June&#160;30, 2021 and 2020, respectively, against its deferred tax assets. The Company considered all available evidence, both positive and negative, in assessing the need for a valuation allowance against tax assets. Four possible sources of taxable income were evaluated when assessing the realization of deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;carrybacks of existing NOLs (if and to the extent permitted under the tax law);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;future reversals of existing taxable temporary differences; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;tax planning strategies; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;future taxable income exclusive of reversing temporary differences and carryforwards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the valuation allowance related to certain U.S. combined states was released during the fiscal year ended June 30, 2019, there remained as of June 30, 2021 a valuation allowance for the NOLs and deductible temporary differences in the remaining combined and separate states of $39 million. The state valuation allowance as of June 30, 2021 is due to the Company&#x2019;s history of tax losses and anticipated loss utilization rates in separate filing status states as well as the difference in the rules related to allocated and apportioned income for separate filing status states versus combined filing status states.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considered the need to maintain a valuation allowance on deferred tax assets based on management&#x2019;s assessment of whether it is more likely than not that the Company would realize the value of its deferred tax assets based on future reversals of existing taxable temporary differences and the ability to generate sufficient taxable income within the carryforward period available under the applicable tax laws. During the fiscal year ended June 30, 2021, the Company released $17 million of its valuation allowances. The amount released is related to $17 million of NOLs and temporary differences for certain Italian operations. The $17 million release of the Company&#x2019;s valuation allowance was partially offset by establishing a $2 million valuation allowance on NOLs and temporary differences related to certain Canadian operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company's income taxes are subject to audits by federal, state, and foreign tax authorities, some of which are ongoing and may result in proposed assessments. Germany and the U.K. are among the jurisdictions where the Company has substantial tax positions. The Company is no longer subject to examinations by the relevant tax authorities for years prior to fiscal 2009. The Company&#x2019;s estimate for the potential outcome for any uncertain tax issue is highly judgmental. The Company assesses its income tax positions and records benefits for all years subject to examination based upon management&#x2019;s evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions for which it is more likely than not that a tax benefit will be sustained, the Company records the amount that has a greater than 50% likelihood of being realized upon resolution with the taxing authority that has full knowledge of all relevant information based on the technical merit. Interest and penalties are accrued, where applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company had a total of $5 million of unrecognized tax benefits.&#160;A reconciliation of unrecognized tax benefits, excluding accrued interest, as of June&#160;30, 2021, 2020, and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapse of the applicable statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapse of the applicable statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the unrecognized tax benefits as of June 30, 2021 and 2020 would, if subsequently recognized, favorably affect the effective income tax rate.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.&#160;As of June&#160;30, 2021, the Company has $1 million of accrued interest related to uncertain tax positions, consistent with the prior year, as a result of an increase to certain tax positions taken in the fiscal year ended June 30, 2021, offset by a reduction to prior-year positions due to lapses in the statute of limitations. The Company had $1 million of accrued interest related to uncertain tax positions as of both June 30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTQ_1d6227ef-828a-457a-ac40-4d2b20b3dde9">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings before income taxes are as follows for fiscal 2021, 2020, and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItMS0xLTEtMA_d1548fdb-5830-494f-be99-1cb3ee6b7cdd"
      unitRef="usd">457000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItMy0xLTEtMA_6b671b32-873a-4134-9207-e68da87f7b3d"
      unitRef="usd">121000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzItNS0xLTEtMA_3a405c8a-2cba-4a57-b8a2-09264984929e"
      unitRef="usd">36000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtMS0xLTEtMA_c5c9c791-daae-47be-8b81-0721f91ea57b"
      unitRef="usd">258000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtMy0xLTEtMA_08117b26-cbb0-478a-9de1-a48c6c57eb67"
      unitRef="usd">139000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzMtNS0xLTEtMA_b6be044a-cdeb-42ff-881a-4ea5f782fc68"
      unitRef="usd">124000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtMS0xLTEtMA_bd884e0c-5c64-4b62-bcb1-8224cf4c2803"
      unitRef="usd">715000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtMy0xLTEtMA_446ca5f3-9326-4c5b-b1fe-85c628ce03e9"
      unitRef="usd">260000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZToxODcxNTNmNmY4NWE0ZDZhODljNGRiMTc3Yjk4OTc2OC90YWJsZXJhbmdlOjE4NzE1M2Y2Zjg1YTRkNmE4OWM0ZGIxNzdiOTg5NzY4XzQtNS0xLTEtMA_8b30e64c-1f89-43cd-b26d-234772aab60f"
      unitRef="usd">160000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyODg_ed191553-3c7f-451d-8ac4-a6f738af4568">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consists of the following for fiscal 2021, 2020, and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtMS0xLTEtMA_43bdfee6-41a8-4d1f-a68c-ac315fb9c249"
      unitRef="usd">8000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtMy0xLTEtMA_f560701d-6b75-4a86-88b6-ac39d90260d9"
      unitRef="usd">1000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzMtNS0xLTEtMA_24a5ec3b-2d4e-40fb-9a07-105cab5a8a0c"
      unitRef="usd">2000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtMS0xLTEtMA_f124c0db-657e-4254-8cba-873c4f8241ab"
      unitRef="usd">20000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtMy0xLTEtMA_36723cc3-dc68-4bf7-9ae2-fc02e43be351"
      unitRef="usd">1000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzQtNS0xLTEtMA_3e96d1fe-ecb4-4387-ac6c-2cdefe1696e6"
      unitRef="usd">1000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtMS0xLTEtMA_1aceffe9-550f-48c0-b6b1-14f7f4215a9d"
      unitRef="usd">38000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtMy0xLTEtMA_182d0b4a-066a-474c-aad3-b6375a0d0a4a"
      unitRef="usd">33000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzUtNS0xLTEtMA_50d4309c-f26e-4cab-b758-39a9e6b71b20"
      unitRef="usd">26000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtMS0xLTEtMA_065344ae-3537-4be8-a993-77e6a831edf5"
      unitRef="usd">66000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtMy0xLTEtMA_2da45a20-6b15-479c-8084-1bd75be8bb42"
      unitRef="usd">35000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzYtNS0xLTEtMA_57b89138-53e9-4b96-a1c2-c394b209d7b7"
      unitRef="usd">29000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtMS0xLTEtMA_bdb78ac8-8652-407a-8a51-61057637d520"
      unitRef="usd">62000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtMy0xLTEtMA_142b2c01-9c82-439a-86f9-e407cff2882f"
      unitRef="usd">11000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzgtNS0xLTEtMA_2a0c4cf3-9126-4c26-90e4-a71e4a4b30ff"
      unitRef="usd">4000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktMS0xLTEtMA_d96cfc6e-0321-4cbe-b1c8-07e03cd7b082"
      unitRef="usd">7000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktMy0xLTEtMA_b4cf35a4-ff26-4286-8634-3f453c708eea"
      unitRef="usd">6000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzktNS0xLTEtMA_26db35f0-d5a5-4da2-8b5a-bfb3040d7131"
      unitRef="usd">-12000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTEtMS0xLTA_38f8c645-8ae6-43ef-aeb8-5bf812f32ba6"
      unitRef="usd">-5000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTMtMS0xLTA_68270f0e-c04a-418a-b22d-0a48a3746016"
      unitRef="usd">-13000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEwLTUtMS0xLTA_7d0efc6e-be9d-4f4c-bbca-b91e4c5b90cc"
      unitRef="usd">2000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTEtMS0xLTA_93e569d6-64cc-4946-98f0-8c47dadc4847"
      unitRef="usd">64000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTMtMS0xLTA_f2400096-47d0-44ce-9392-677faf91ca40"
      unitRef="usd">4000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzExLTUtMS0xLTA_f95a66ce-44c7-4dfd-b559-ddccfb362cec"
      unitRef="usd">-6000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTEtMS0xLTA_66e484d0-5658-4be6-9a79-c82e5fb190d5"
      unitRef="usd">130000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTMtMS0xLTA_bb844f8d-8426-49b5-9dd7-228ab517c2ca"
      unitRef="usd">39000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTphNWM2MTcxZTdmZDg0MTA5YmM3NjI3MTBlYWQwMDBlZC90YWJsZXJhbmdlOmE1YzYxNzFlN2ZkODQxMDliYzc2MjcxMGVhZDAwMGVkXzEzLTUtMS0xLTA_8405b9ec-ea9f-4097-9a72-d5c1120c8101"
      unitRef="usd">23000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDM_41328708-cfee-4333-ad7e-f6e0047ad516">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the provision starting from the tax computed at the federal statutory income tax rate to the tax computed at the Company&#x2019;s effective income tax rate is as follows for the fiscal years ended 2021, 2020, and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision at U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Global intangible low tax income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Withholding tax and other foreign taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItMS0xLTEtMA_3ca4cfb4-6e3d-4024-a94b-54f6f8ad1763"
      unitRef="usd">150000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItMy0xLTEtMA_645e44c1-fcc7-432f-8d83-a6db6f130922"
      unitRef="usd">55000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzItNS0xLTEtMA_9abd345b-97f3-4c66-9e2f-b456476c1028"
      unitRef="usd">34000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtMS0xLTEtMA_aec56c65-21bf-4a8b-a6fa-137102c95ab5"
      unitRef="usd">26000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtMy0xLTEtMA_a053e3e4-c27c-4d5f-9727-9fe45f23c3bd"
      unitRef="usd">6000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzMtNS0xLTEtMA_726bc59b-14ca-4d12-908e-2ce770d379ad"
      unitRef="usd">-1000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtMS0xLTEtMA_c92f2c07-4daf-4d96-ac42-041ac3faafa9"
      unitRef="usd">-14000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtMy0xLTEtMA_111379df-0eb3-4b15-a8f4-22b8f7baf50a"
      unitRef="usd">-6000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzQtNS0xLTEtMA_f3ad92cc-9aad-42f0-b9be-130990261fb4"
      unitRef="usd">-3000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtMS0xLTEtMA_9964b464-81ed-495a-8739-a5d53767ca80"
      unitRef="usd">3000000</ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome>
    <ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtMy0xLTEtMA_4b2fb0c3-dcab-46f9-bb81-cf82dfdfcb6b"
      unitRef="usd">3000000</ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome>
    <ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzUtNS0xLTEtMA_b4ad2514-166b-4b25-bb30-440263ba5e22"
      unitRef="usd">3000000</ctlt:EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtMS0xLTEtMA_17181542-af4d-4b91-8525-117b94204dca"
      unitRef="usd">-5000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtMy0xLTEtMA_d3bacc92-2b39-40cc-9df4-945a741f0c86"
      unitRef="usd">2000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzYtNS0xLTEtMA_560cf443-4ad6-4665-a625-ad4e97a58529"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctMS0xLTEtMA_cd091ede-8b97-40f9-91b9-9977797c4b71"
      unitRef="usd">3000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctMy0xLTEtMA_ab6558f5-1e4b-4bd9-9aa0-81397175e497"
      unitRef="usd">-1000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzctNS0xLTEtMA_c5893d26-a423-4140-be7f-28d263499f3c"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtMS0xLTEtMA_745eb40d-ca55-47df-b70c-4c81b54976a3"
      unitRef="usd">-7000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtMy0xLTEtMA_0d78d91a-e651-47c2-a438-838297b4a2d2"
      unitRef="usd">-21000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzgtNS0xLTEtMA_0cc86cac-ade6-44a9-ada5-189b94cf2050"
      unitRef="usd">-11000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktMS0xLTEtMA_4557d66e-ea45-457a-ad27-f09a7892ac8a"
      unitRef="usd">24000000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktMy0xLTEtMA_a708ddec-5c5f-4503-9eb8-4610789e1033"
      unitRef="usd">3000000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzktNS0xLTEtMA_cc791f73-55a7-4c64-8fbb-b3978790affd"
      unitRef="usd">4000000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTEtMS0xLTA_cac1f87c-dc11-43b0-9307-90d0ad4dc676"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTMtMS0xLTA_f20a3e3d-1fa1-40d1-8bb7-a42a0c8230c3"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEwLTUtMS0xLTA_4391c1bf-83f4-435c-a809-6d27a58cf09e"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTEtMS0xLTA_223ad6ae-9040-4f36-8836-1fe618157718"
      unitRef="usd">2000000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTMtMS0xLTA_d8a124c3-baeb-4ab3-b59b-42a0b2213199"
      unitRef="usd">4000000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzExLTUtMS0xLTA_3ca46f48-e540-4e51-9036-6879904104b9"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTEtMS0xLTA_a412cbbc-55a4-4056-95b9-6fbc3798035e"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTMtMS0xLTA_e4d4e5c1-a6cc-4ece-ae37-b8e1704b0539"
      unitRef="usd">2000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzEzLTUtMS0xLTA_94239aed-6f52-4884-92b0-4d688fa0d46a"
      unitRef="usd">2000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTEtMS0xLTA_25dc1b3d-ffcc-4600-8d97-55a9d19a464c"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTMtMS0xLTA_1ffa38e3-72bf-4544-a38a-0cf7bb1e4c9e"
      unitRef="usd">1000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE1LTUtMS0xLTA_57bff55f-e3ca-4b3a-a667-58349c0a59d4"
      unitRef="usd">-1000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTEtMS0xLTA_4f878f8b-bb0a-43d9-8fdc-81fcf888802b"
      unitRef="usd">130000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTMtMS0xLTA_0cd11be7-92fb-4fb7-88e1-946ec43c33d0"
      unitRef="usd">39000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpkZThlNzRjMjM0OGI0OTZiYTg2NGY4YTI2NGRhNWExMi90YWJsZXJhbmdlOmRlOGU3NGMyMzQ4YjQ5NmJhODY0ZjhhMjY0ZGE1YTEyXzE2LTUtMS0xLTA_a40fbb54-d76e-4eb0-91df-4c7bbfd2655c"
      unitRef="usd">23000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzE1MTE_4b1ba73c-8018-47db-ac75-9181989df2a0"
      unitRef="usd">142000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTk_4472fa42-4fd6-47bf-a511-a6fd28903b11">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes arise from temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the Company's deferred income tax assets and liabilities are as follows at June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMtMS0xLTEtMA_05ba7403-1e60-4a8c-98ad-fcd55bf78264"
      unitRef="usd">43000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMtMy0xLTEtMA_740fb93f-f91a-41f4-aa55-4f35515f2e86"
      unitRef="usd">30000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzQtMS0xLTEtMA_a99336f3-7f0a-44b2-918d-0a69eb0307ce"
      unitRef="usd">15000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzQtMy0xLTEtMA_d4084d70-76c7-4843-acfb-74190e6326d1"
      unitRef="usd">16000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzUtMS0xLTEtMA_17f58603-8540-4440-8e74-080ec38e9efa"
      unitRef="usd">187000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzUtMy0xLTEtMA_44157c75-f671-4a81-8235-37d6156cbc38"
      unitRef="usd">194000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzYtMS0xLTEtMA_09a9a268-09c4-4c73-8314-4cfd41a50158"
      unitRef="usd">12000000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzYtMy0xLTEtMA_c80d2e10-cf0e-4e9a-add6-7d2b9668ad11"
      unitRef="usd">15000000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzctMS0xLTEtMA_2d67d916-9ffd-4e89-a540-e3f4e8ed33c5"
      unitRef="usd">24000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzctMy0xLTEtMA_698d9408-dd64-4137-b728-fd9ee1ef5fef"
      unitRef="usd">28000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzgtMS0xLTEtMA_db3636b1-7c19-4ef8-a204-24c7796a5d14"
      unitRef="usd">14000000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzgtMy0xLTEtMA_b117c411-3c21-4dd1-8938-d6c598940d62"
      unitRef="usd">9000000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzktMS0xLTEtMA_022e32d6-4cf2-4755-bf14-5299084d5406"
      unitRef="usd">3000000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzktMy0xLTEtMA_ec420d69-bc0b-4868-8287-2bec48e2803b"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <ctlt:DeferredIncomeTaxOperatingLeaseLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzExLTEtMS0xLTA_867bcbe3-385b-4f57-a25b-bee0f0968dd5"
      unitRef="usd">-35000000</ctlt:DeferredIncomeTaxOperatingLeaseLiabilities>
    <ctlt:DeferredIncomeTaxOperatingLeaseLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzExLTMtMS0xLTA_9888761b-8a4b-4ae8-bcc9-f8ad5b4fd2ea"
      unitRef="usd">-34000000</ctlt:DeferredIncomeTaxOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEyLTEtMS0xLTA_db69f549-2ba5-4a5e-bdc6-bf81c88f61c6"
      unitRef="usd">23000000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsOtherComprehensiveLoss
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEyLTMtMS0xLTA_981cdf62-593f-4614-bf7b-898b9f690557"
      unitRef="usd">7000000</us-gaap:DeferredTaxAssetsOtherComprehensiveLoss>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEzLTEtMS0xLTA_22560352-827e-4cc1-90eb-3ac602801c84"
      unitRef="usd">356000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzEzLTMtMS0xLTA_c70f8d49-87c4-4a6b-8e19-2355b10f0bf8"
      unitRef="usd">333000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE0LTEtMS0xLTA_807a1c40-7a59-41c8-a854-a0706a0b2f49"
      unitRef="usd">65000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE0LTMtMS0xLTA_d6bd84a9-7ef3-4e31-9fff-55a1cacc95fd"
      unitRef="usd">53000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE1LTEtMS0xLTA_0fdc26eb-baee-4424-87ba-0c799841cc43"
      unitRef="usd">291000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzE1LTMtMS0xLTA_8a763e78-83db-4e62-adb9-19e9769ab86a"
      unitRef="usd">280000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzIzLTEtMS0xLTA_d4c00027-0cd2-45f1-aef6-7ffc411f5b8b"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzIzLTMtMS0xLTA_83bc0742-ac7e-44e8-8942-f4c178d92306"
      unitRef="usd">8000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI0LTEtMS0xLTA_e89201d7-e7cc-432d-90e6-735a2791ca7a"
      unitRef="usd">171000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI0LTMtMS0xLTA_9d084ef7-20b0-4ccd-8d3b-0d94b92d00f2"
      unitRef="usd">100000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI1LTEtMS0xLTA_15c07ad7-69c6-4682-931e-785c3d790aca"
      unitRef="usd">194000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI1LTMtMS0xLTA_2ca6b9e9-077f-4e60-b4b0-a5c075b637f6"
      unitRef="usd">192000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <ctlt:DeferredIncomeTaxRightOfUse
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI2LTEtMS0xLTA_9237e7cb-3b40-474d-bad3-3a69742f6bce"
      unitRef="usd">-18000000</ctlt:DeferredIncomeTaxRightOfUse>
    <ctlt:DeferredIncomeTaxRightOfUse
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI2LTMtMS0xLTA_3c0e3620-ecb7-41f2-b4ba-23e60be5b0b3"
      unitRef="usd">-22000000</ctlt:DeferredIncomeTaxRightOfUse>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI3LTEtMS0xLTA_c930687b-9301-4b63-9b87-06b115359d29"
      unitRef="usd">6000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI3LTMtMS0xLTA_87be0d39-2bea-4006-98d3-148e809d5267"
      unitRef="usd">3000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI5LTEtMS0xLTA_d15677c1-fc7e-465c-9027-06eb6728845a"
      unitRef="usd">389000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzI5LTMtMS0xLTA_1cf1a9ac-3633-46fc-a4fc-35eef980461a"
      unitRef="usd">325000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMxLTEtMS0xLTA_2d3ca1ac-72ef-4dbc-9b99-1de194a45e2f"
      unitRef="usd">98000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTo4MDE0M2Y4YWQzNmE0YTM0YmEyNWRjYzMxYjZjMjMwZi90YWJsZXJhbmdlOjgwMTQzZjhhZDM2YTRhMzRiYTI1ZGNjMzFiNmMyMzBmXzMxLTMtMS0xLTA_194e99cd-843d-4725-86d7-209052cf3024"
      unitRef="usd">45000000</us-gaap:DeferredTaxLiabilities>
    <ctlt:DeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcyOTE_2b5be1a3-75ad-46e2-bf04-922c7fce2e64">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities in the preceding table are in the following captions in the consolidated balance sheets at June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:DeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzItMS0xLTEtMA_597077c0-ad80-4827-bb3f-a6306a947723"
      unitRef="usd">66000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzItMy0xLTEtMA_bc157e23-2c18-46af-ac81-11e8e4f3eabb"
      unitRef="usd">49000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzMtMS0xLTEtMA_f03c2da6-298b-4699-b07e-13a39715b0e4"
      unitRef="usd">164000000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzMtMy0xLTEtMA_47922a0c-68db-4901-b017-19f7057c0a37"
      unitRef="usd">94000000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzQtMS0xLTEtMA_9031eb88-341d-4988-a26a-bf031114c887"
      unitRef="usd">98000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTowODU5YTQ5YjFiMjM0MWY5YTQ0YzdjODE1N2U5ODNmMi90YWJsZXJhbmdlOjA4NTlhNDliMWIyMzQxZjlhNDRjN2M4MTU3ZTk4M2YyXzQtMy0xLTEtMA_e3b17268-4f4c-4cd1-bc4b-fe40d2fdec2a"
      unitRef="usd">45000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzIzODU_854897dc-8b99-4b10-8dfc-9794cd66e57f"
      unitRef="usd">512000000</us-gaap:OperatingLossCarryforwards>
    <ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382
      contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzIzODk_f1fb795a-88d2-4762-ba4e-78e805f6e473"
      unitRef="usd">229000000</ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382>
    <ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382
      contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI1NDc_f1fb795a-88d2-4762-ba4e-78e805f6e473"
      unitRef="usd">229000000</ctlt:OperatingLossCarryforwardsSubjectToLimitationsSection382>
    <ctlt:OperatingLossCarryforwardsIndefiniteLife
      contextRef="i7afaad523b4d4aa097e6a26233712228_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI3NDM_c9f184eb-0a78-4bfe-8c69-9b9260858fa4"
      unitRef="usd">432000000</ctlt:OperatingLossCarryforwardsIndefiniteLife>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i33922380dc6b4abe8a22039a9468b7e1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzI5NTA_7a3c196e-308f-4ac2-b60f-00cecb4e99bb"
      unitRef="usd">441000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i125f9fdad01e48d9b2c4c0fac0f4bf10_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyMDA_4a512b1b-40a1-4828-be00-94de5a91becd"
      unitRef="usd">161000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMzNDQ_807a1c40-7a59-41c8-a854-a0706a0b2f49"
      unitRef="usd">65000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMzNTE_d6bd84a9-7ef3-4e31-9fff-55a1cacc95fd"
      unitRef="usd">53000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i33922380dc6b4abe8a22039a9468b7e1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzQyMTQ_3f8f6eea-7165-44b1-b0d9-27c9d5f3bc36"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUwMjg_b667b210-b65e-4346-b6e7-4937df5ed32f"
      unitRef="usd">-17000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i98daa63182c347e2b14fbd8135bcfe10_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUxMzI_932aec58-331c-42e8-a366-d24f5ba4c51b"
      unitRef="usd">-17000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUyMDU_b667b210-b65e-4346-b6e7-4937df5ed32f"
      unitRef="usd">-17000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i9d70d7b7223b4d6f862421f894246388_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzUyOTI_9d9b37fa-2d07-4c65-97b2-b5114b96dd2d"
      unitRef="usd">2000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzY1MTM_64acb880-6c0f-4b0c-b591-5e14f36dabce"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzczMDQ_b2bd2aa8-aa00-4538-8f6e-bad3c1e18935">A reconciliation of unrecognized tax benefits, excluding accrued interest, as of June&#160;30, 2021, 2020, and 2019 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapse of the applicable statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapse of the applicable statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEtMS0xLTEtMA_1d9d8236-007d-4df9-917b-f93645333467"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzMtMS0xLTEtMA_97668d15-041c-454b-8011-b1291fc4903b"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzYtMS0xLTEtMA_ca35cef1-d104-4752-bc4c-ce13bf8392b1"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzctMS0xLTEtMA_f5e2ae3a-68e8-4f89-9406-19ba99c4f8f4"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzktMS0xLTEtMA_ff23dd7d-c682-4410-829d-22fcb1be2f07"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEyLTEtMS0xLTA_2c5a4fa9-12f6-4985-bce6-d8103a0e9ecc"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzEzLTEtMS0xLTA_9aacdd8e-82ab-4f1b-a0d7-1f1d0c78cca0"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE0LTEtMS0xLTA_04fdcaf8-11d6-4150-b41a-9b4326f6f77d"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE1LTEtMS0xLTA_7d05f31a-bfff-4bf5-a6ff-0f3d6287b4ea"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE3LTEtMS0xLTA_ce6fc1ec-f654-479a-817c-3b37c756e528"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90YWJsZTpjOTcwYTZkYTFiMTI0Mzc1OTViMDUwYWU2MTM3ZDVkOC90YWJsZXJhbmdlOmM5NzBhNmRhMWIxMjQzNzU5NWIwNTBhZTYxMzdkNWQ4XzE5LTEtMS0xLTA_64acb880-6c0f-4b0c-b591-5e14f36dabce"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzY5NDI_bcad0957-8c71-4413-ab37-7234544a4cc0"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzcxODU_8ca6628c-9a13-4e0f-a65d-c9c353aae81a"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTk_7c18940f-60e0-4634-ab9a-61d335a3e315">EMPLOYEE RETIREMENT BENEFIT PLANS&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various retirement plans, including defined benefit pension plans and defined contribution plans. Substantially all of the Company&#x2019;s domestic non-union employees are&#160;eligible to participate in employer-sponsored retirement savings plans, which include plans created under Section&#160;401(k) of the Internal Revenue Code that provide for the Company to match a portion of contributions by participating U.S. employees. The Company&#x2019;s contributions to the plans are discretionary but are subject to certain minimum requirements as specified in the plans. The Company uses a measurement date of June&#160;30 for all of its retirement and postretirement benefit plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records obligations related to its withdrawal from one multi-employer pension plan that covered former employees at three former sites. This withdrawal was classified as a mass withdrawal under the Multiemployer Pension Plan Amendments Act of 1980, as amended, and the Pension Protection Act of 2006 and resulted in the recognition of liabilities associated with the Company&#x2019;s long-term obligations in prior years not presented, which were primarily recorded as an expense within discontinued operations. The estimated discounted value of the projected contributions related to these plans is $38 million and $39 million as of June&#160;30, 2021 and 2020, respectively. The annual cash impact associated with the Company&#x2019;s long-term obligation arising from this plan is $2 million per year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the change in projected benefit obligation and fair value of plan assets for the defined benefit retirement and other retirement plans, excluding the multi-employer pension plan liability:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the net amount recognized in the consolidated balance sheets: &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Statement of Financial Position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive loss (income) at the end of the fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Information for Plan with ABO or PBO in Excess of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (gain) loss arising during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increases (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increases (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Future Contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal year 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual Asset Allocation (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual Asset Allocation (Amount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Target Asset Allocation (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Investment Committee employs a building-block approach in determining the long-term rate of return for plan assets, with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed income are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long run. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data are reviewed to check for reasonability and appropriateness. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan assets are recognized and measured at fair value in accordance with the accounting standards regarding fair value measurements. The following are valuation techniques used to determine the fair value of each major category of assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Short-term investments, equity securities, fixed-income securities, and real estate are valued using quoted market prices or other valuation methods, and thus are classified within Level 1 or Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt"&gt;Insurance contracts and other types of investments include investments with some observable and unobservable prices that are adjusted by cash contributions and distributions, and thus are classified within Level 2 or Level 3. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a summary of plan assets that are measured at fair value as of June&#160;30, 2021 and 2020, aggregated by the level in the fair value hierarchy within which those measurements fall:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021 (dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="30" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Other as of June&#160;30, 2021, included $62 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2020 (dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="30" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Other as of June 30, 2020, included $31 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 other assets as of June 30, 2021 and 2020 consist of an insurance contract in the U.K. to fulfill the benefit obligations for a portion of the participant benefits. The value of this commitment is determined using the same assumptions and methods used to value the pension liability of the associated plan. Level 3 other assets for the same periods also include the partial funding of a pension liability relating to current and former employees of the Company&#x2019;s Eberbach, Germany facility through a Company promissory note with an annual rate of interest of 5%. The value of this commitment fluctuates due to contributions and benefit payments in addition to loan interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of Level 3 assets as well as the changes during the period attributable to assets held and those purchases, sales, settlements, contributions, and benefits that were paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Total (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Relating to assets still held at the reporting date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales, settlements, contributions and benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers in or out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investment policy reflects the long-term nature of the plans&#x2019; funding obligations. The assets are invested to provide the opportunity for both income and growth of principal. This objective is pursued as a long-term goal designed to provide required benefits for participants without undue risk. It is expected that this objective can be achieved through a well-diversified asset portfolio. All equity investments are made within the guidelines of quality, marketability, and diversification mandated by the Employee Retirement Income Security Act of 1974, as amended (for plans subject to the act) and other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;relevant legal requirements. Investment managers are directed to maintain equity portfolios at a risk level approximately equivalent to that of the specific benchmark established for that portfolio. Assets invested in fixed income securities and pooled fixed-income portfolios are managed actively to pursue opportunities presented by changes in interest rates, credit ratings, or maturity premiums. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assumed Healthcare Cost Trend Rates at the Balance Sheet Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare cost trend rate &#x2013; initial (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare cost trend rate &#x2013; ultimate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year in which ultimate rates are reached&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzEzMzY_dd7b8d30-36b4-4955-981e-2bc557a718ba"
      unitRef="usd">38000000</us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount>
    <us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzEzNDM_73759093-ebad-42ba-ae89-df6e8b014d9b"
      unitRef="usd">39000000</us-gaap:MultiemployerPlanPensionSignificantFutureEmployerContributionAmount>
    <ctlt:MultiemployerPlansEstimatedAnnualCashContribution
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzE0Nzk_818c9c34-7e7a-487b-802e-ce6c7dc056c4"
      unitRef="usd">2000000</ctlt:MultiemployerPlansEstimatedAnnualCashContribution>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NzI_e00982c7-1a51-4d4c-bd29-08629369b18c">The following table provides a reconciliation of the change in projected benefit obligation and fair value of plan assets for the defined benefit retirement and other retirement plans, excluding the multi-employer pension plan liability:&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net pension liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtMS0xLTEtMA_353314a5-4c5f-4733-a244-a86d6074fb21"
      unitRef="usd">364000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtMy0xLTEtMA_d537efbc-543b-4a2e-833a-f95eeb0fc613"
      unitRef="usd">351000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtNS0xLTEtMA_a46afc02-0481-4b5e-bdb4-27a583f0a4fa"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMtNy0xLTEtMA_44c214fc-8937-4676-a588-bdfd2952264e"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtMS0xLTEtMA_b2adc2dd-37d7-45c8-9eae-a4ae2b39126c"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ife004a47c4ec48ce97f593d352e32a55_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtMy0xLTEtMA_45b97a6e-e9a6-491f-839a-3f0388d099f6"
      unitRef="usd">350000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtNS0xLTEtMA_1a3a5909-690f-4435-a4da-7873b1ba5483"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iba420f2700c34ea3a4b4416c427c3200_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzYtNy0xLTEtMA_39520583-b635-41d9-a190-154cc4790eb9"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctMS0xLTEtMA_73fb7814-a660-47aa-9fc5-80ef6583d33a"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctMy0xLTEtMA_d9cf0617-fd44-41d2-a4d6-17286d4895a5"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctNS0xLTEtMA_6d3c4c7f-a105-4914-8f0d-a387ea940f42"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzctNy0xLTEtMA_6409ca32-a01e-4239-bdd0-bd1507fdcddc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtMS0xLTEtMA_0f6d2ea0-69c3-4b80-a19d-82ee67155960"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtMy0xLTEtMA_f3ff0888-da44-472c-a270-08dd69eb7f8d"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtNS0xLTEtMA_1e87c129-48ac-41d5-bfd8-4bd0c67c2aa0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzgtNy0xLTEtMA_c8dc2d0b-f407-469a-8a95-597a1b21a6f4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTEtMS0xLTA_1646606e-0024-457d-a778-a0d002c1117c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTMtMS0xLTA_aa53c693-0bd5-4a50-ab83-661da6c152c9"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTUtMS0xLTA_a52644e9-5023-4b5c-b3dd-d3b157f9364c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzExLTctMS0xLTA_ec6afff7-5a83-4172-80ce-ff46f6b53306"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTEtMS0xLTA_6f2111c1-e4c5-41eb-b43a-b791005195c5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTMtMS0xLTA_5e3fa859-3eeb-4936-9277-6d06e977000d"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTUtMS0xLTA_803f7755-15a0-4a5a-b4b6-cbeabf52374e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzEyLTctMS0xLTA_4fd8f404-07f0-46d0-a41f-e7f01156e0d5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTEtMS0xLTA_baf24f4c-e6cd-4ad3-b754-72df2e1f8b37"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTMtMS0xLTA_9b0d3c77-599c-4ad5-a6b7-c8e5a5dfb4f9"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTUtMS0xLTA_d35b2c9a-8412-449e-9515-5dbc869f9ee7"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE2LTctMS0xLTA_fe2768f7-bb63-476b-8f86-062f2244b1fa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTEtMS0xLTA_fb4055fb-602f-46f6-be76-ea031e518bdc"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTMtMS0xLTA_6333c9ad-3175-44d5-bfda-88cbd8251866"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTUtMS0xLTA_7984767f-a26f-4045-8922-c2c6072d6e89"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE4LTctMS0xLTA_71330c05-1f25-4c79-b54e-a1af5d0422f7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTEtMS0xLTA_90338dae-310c-45e2-b5d1-6ed34d8671df"
      unitRef="usd">28000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTMtMS0xLTA_1eb2c488-669a-4e40-a30b-97850c7b301a"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTUtMS0xLTA_b11bb95f-54aa-4f6e-a253-7ab1e322a8ac"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzE5LTctMS0xLTA_c8862b84-f970-4525-a8b9-9dc76c3e3ba9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTEtMS0xLTA_2c9797d5-4c2d-4011-84c9-acf4cc8f9a3d"
      unitRef="usd">372000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTMtMS0xLTA_32cf863c-6617-408b-a6e0-8a5f36b86c27"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTUtMS0xLTA_877de718-3190-4b6d-8d3b-64d4a16afa50"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIwLTctMS0xLTA_6c5e4802-6e88-459e-b13e-537ba01bc744"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTEtMS0xLTA_54e25a77-0dd1-432c-af64-b73e5f843037"
      unitRef="usd">295000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife004a47c4ec48ce97f593d352e32a55_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTMtMS0xLTA_56cf91de-1946-4d72-acc3-929b51d90ceb"
      unitRef="usd">272000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTUtMS0xLTA_74d5259f-8b17-4a58-9b84-4af94f6f2fd3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba420f2700c34ea3a4b4416c427c3200_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzIzLTctMS0xLTA_0d87fc3a-8e39-4216-b58c-522e6ab62eee"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTEtMS0xLTA_b850ecb6-0613-4838-a925-c2984df1c8ec"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTMtMS0xLTA_7034afa5-f7cb-4b6a-9e8f-4de625f1c5da"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTUtMS0xLTA_40cfe8a0-4618-4230-9020-f3b3eca7a762"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI0LTctMS0xLTA_12ed5398-702c-483e-a3f4-8895265201f7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTEtMS0xLTA_fea1d14b-f406-4a33-8eeb-62db699da382"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTMtMS0xLTA_9f01e52d-7604-4025-bf91-666ce26f7a15"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTUtMS0xLTA_0c3a4b6d-ef6f-484a-94fd-5183c61cdd88"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI1LTctMS0xLTA_a4d464b5-fe23-4c89-b741-a335ffbce5be"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTEtMS0xLTA_f264c785-3805-4560-96a8-16d708214793"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTMtMS0xLTA_b3fc7c53-c4f8-44cf-a4a6-d304f6a81cc2"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTUtMS0xLTA_ebe08cc9-61ba-4ef7-8db1-b2f501ec961e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzI3LTctMS0xLTA_7c165542-40e4-4687-a9ca-1ec680d03480"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTEtMS0xLTA_e5dca4ec-ab0f-449e-9584-845e2b0a1d59"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTMtMS0xLTA_95477984-5efc-4ae1-931f-1f8502bdccdd"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTUtMS0xLTA_d40b4968-a5db-41c4-ba7e-7533ad941873"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMxLTctMS0xLTA_303f6cbb-69e5-4da7-a884-2e9b886cb9b8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTEtMS0xLTA_8221664c-02f4-40d7-b7f0-e42e1d7e9127"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTMtMS0xLTA_206c8a07-a2c8-4ef8-a37b-9a3988f69c30"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTUtMS0xLTA_56e7a702-a14d-417a-888e-0712e09ceb47"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzMzLTctMS0xLTA_d069764d-aa69-4802-a661-b0c0271bfa77"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTEtMS0xLTA_0fc44fd9-1a96-478d-9cbe-7c14fa9c97ab"
      unitRef="usd">318000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTMtMS0xLTA_78057b72-e37e-4bdf-adf0-7b7a6bb005ce"
      unitRef="usd">295000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTUtMS0xLTA_dd137b86-4718-4925-9152-7833431423ef"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM0LTctMS0xLTA_4dcc7347-dc1b-4f07-8ac5-ef717eebb428"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTEtMS0xLTA_9d041fd6-e2fa-4bbd-8ad7-0c84a01ee1a0"
      unitRef="usd">-54000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTMtMS0xLTA_ab49c9f3-47d0-46d7-b6f8-a9bc77714b0a"
      unitRef="usd">-63000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTUtMS0xLTA_126bc802-0d33-41a2-b629-5e46b3c14f9f"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM3LTctMS0xLTA_a9ec1b40-1a9a-43f1-89cd-056c27c3e909"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTEtMS0xLTA_c84c889d-156a-474b-b095-8210a775bff0"
      unitRef="usd">-54000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTMtMS0xLTA_cf410428-5d3a-41f8-80ee-8960db137807"
      unitRef="usd">-63000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTUtMS0xLTA_9772968e-b213-4d34-9b79-a24cc0ea3fcb"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo4MDcyNzFlOTY5NTU0ZDEzYTFjMTJjMTQzZjY2ODY3Zi90YWJsZXJhbmdlOjgwNzI3MWU5Njk1NTRkMTNhMWMxMmMxNDNmNjY4NjdmXzM5LTctMS0xLTA_a70d8728-7943-4e72-8865-2f69868ad4be"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NjA_ec8c2411-eb19-43c5-9716-7f871d7dea7b">The following table provides a reconciliation of the net amount recognized in the consolidated balance sheets: &lt;span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Statement of Financial Position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive loss (income) at the end of the fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional Information for Plan with ABO or PBO in Excess of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (gain) loss arising during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in net periodic benefit cost and other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increases (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increases (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Future Contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal year 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.477%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financial year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual Asset Allocation (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual Asset Allocation (Amount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Target Asset Allocation (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtMS0xLTEtMA_3fbb4132-e197-448a-b3d5-e0dc6fddf9f2"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtMy0xLTEtMA_fc48c5d9-df29-4a80-a8ac-2c7f4a9ef99a"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtNS0xLTEtMA_f816577f-4c3e-4913-a86b-659ac1232765"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzQtNy0xLTEtMA_27c60929-9307-494f-810b-967b179781df"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtMS0xLTEtMA_53aac8fb-f2c2-410d-9fac-4a4ceff41a26"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtMy0xLTEtMA_e7608941-a1e4-4869-b7f9-65a81829cb9c"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtNS0xLTEtMA_a84307af-6e85-498e-bc2b-61fa2c1f4fbd"
      unitRef="usd">0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzUtNy0xLTEtMA_65142cf4-d69a-447c-93e2-624156a9ce91"
      unitRef="usd">0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtMS0xLTEtMA_efbbd69a-c356-41ba-8b62-2300cd007b09"
      unitRef="usd">96000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtMy0xLTEtMA_02a4bee9-fbe0-4c6c-b229-5a6b8159fd43"
      unitRef="usd">94000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtNS0xLTEtMA_a8ef54c0-342b-4722-856b-2f6847b7ec6c"
      unitRef="usd">2000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzYtNy0xLTEtMA_543e3948-1145-44b6-94a4-d3cad95fbafc"
      unitRef="usd">3000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctMS0xLTEtMA_2c493e38-462a-4a29-9d8e-2ecf9e53545d"
      unitRef="usd">-54000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctMy0xLTEtMA_bf77ad82-80ed-45f4-b65c-9a9f1c7b4436"
      unitRef="usd">-63000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctNS0xLTEtMA_305b61a5-7c42-4633-ab49-70cc0a71ed8f"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzctNy0xLTEtMA_a8c1232b-fb6b-4a45-b5ff-905848fdc9b9"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTEtMS0xLTA_013ccb55-3743-4265-834a-5fcdbd99cb2b"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTMtMS0xLTA_593cf810-e27b-43a5-82a8-b4da7b90fe8b"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTUtMS0xLTA_226cab9d-e745-4253-a347-e07ae376286d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzExLTctMS0xLTA_42f6cdce-61ab-4b6c-959b-753434bb1fdb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTEtMS0xLTA_165c88a6-c08c-4651-8f45-7f7b4d240c4b"
      unitRef="usd">-62000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTMtMS0xLTA_5d0cb46d-c6ea-4ee4-83eb-eeeb7834ab31"
      unitRef="usd">-62000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTUtMS0xLTA_8ffeaf88-c6c9-48a7-9c41-3d3337187cf7"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEyLTctMS0xLTA_731ec339-326e-455d-8167-e2b8e34fd3cd"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTEtMS0xLTA_e4dc0e4b-c88b-4538-a771-6751309b11b4"
      unitRef="usd">61000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTMtMS0xLTA_cb076a92-9f6c-45b4-aa4f-18a2da09c5e3"
      unitRef="usd">61000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTUtMS0xLTA_66ddb42e-610e-468d-bb9e-6d257d8a00e0"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzEzLTctMS0xLTA_2c9aa663-d3d7-46f5-a632-7d5f788f997c"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTEtMS0xLTA_58c5424f-d443-488f-97ca-afe62c4a6ece"
      unitRef="usd">130000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTMtMS0xLTA_02eb32f8-c81e-44f5-94da-a67a5d8030f5"
      unitRef="usd">165000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTUtMS0xLTA_5e4d33bc-5e90-4468-8376-0b4789efceec"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE2LTctMS0xLTA_c9a43e3f-cece-4d26-9b90-271971500855"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTEtMS0xLTA_5ef2ce9d-85ee-44d0-95c2-cdee096140be"
      unitRef="usd">124000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTMtMS0xLTA_ba2d22f2-d4d2-48b4-bd94-10a3d9f38c38"
      unitRef="usd">159000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTUtMS0xLTA_5d05515e-ef39-4b7f-981d-a78651f9f07f"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE3LTctMS0xLTA_2375f076-93f2-4696-97ca-fdde0e011e44"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTEtMS0xLTA_122875e0-7de5-40a0-97a5-c66d290db98d"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTMtMS0xLTA_720364b0-ee2b-4a8e-b886-6a65623860b1"
      unitRef="usd">70000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTUtMS0xLTA_3d6a53dd-6d1e-4a78-a584-6c94c8b80d4f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzE4LTctMS0xLTA_d377868f-603e-435c-a898-f87d7340a6d8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTEtMS0xLTA_cf2a0250-e094-4fc9-b646-643d477eb2bb"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTMtMS0xLTA_2d15d2af-ca73-4af3-8a13-2063160ea34b"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTUtMS0xLTA_37c46c0c-02a2-488d-8b89-be5ea0280e74"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI2LTctMS0xLTA_506e12a2-7bc4-4f71-be6f-8d85a869c7d8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTEtMS0xLTA_aac8c6c3-8818-4577-a752-bf8776e3a477"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTMtMS0xLTA_341793f1-3898-44fe-8121-341884084b05"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTUtMS0xLTA_24a9bf21-fa35-4b7f-89cf-f44fb9ec3160"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI3LTctMS0xLTA_6a72790a-e3e7-404a-a714-7a48e6a20fa6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTEtMS0xLTA_38f31982-d209-47e8-931a-b7f7e721e263"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTMtMS0xLTA_1fecd08a-dbb8-44d3-8e88-1577115e9c14"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTUtMS0xLTA_02322edc-98cf-4df4-9148-0dbc9848ec79"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzI4LTctMS0xLTA_ecd7465c-8c62-44db-8f30-6b11a833b065"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTEtMS0xLTA_46e64683-e458-4a44-a6b4-8a8467974cb2"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTMtMS0xLTA_b360b75c-59db-428d-b5e1-7661bfac8ac8"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTUtMS0xLTA_0d66df68-fd0d-461d-af2e-caa38f2fd9d7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzMyLTctMS0xLTA_e52765e3-3f02-4ecb-8188-d830b0579796"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTEtMS0xLTA_f676746d-62d0-4473-a5ee-f846247ba492"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTMtMS0xLTA_ad362033-c54a-47ef-ae64-a5843c6101da"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTUtMS0xLTA_21204f73-1199-4de2-b36d-14c6e22025b8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWQ1YWJjYjIzY2U0MjcxYWM5MmE3YTVkYjU4MTYwZS90YWJsZXJhbmdlOjFhZDVhYmNiMjNjZTQyNzFhYzkyYTdhNWRiNTgxNjBlXzM1LTctMS0xLTA_f0ba5021-cbdd-4c72-8a29-5a8f6f8cbc27"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtMS0xLTEtMA_200a42e7-b554-4ab5-b5d3-0931c9fd64ae"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtMy0xLTEtMA_76450a1d-1472-413d-80b8-367cd07bb108"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtNS0xLTEtMA_df106c1c-3361-44bb-887c-2557f30f3a37"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzQtNy0xLTEtMA_f131b023-eacc-427e-9437-54015b6d020f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtMS0xLTEtMA_2293450e-56de-484d-9840-086d5cbfc325"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtMy0xLTEtMA_34be9207-4085-4c2f-9d04-eed9f7354b78"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtNS0xLTEtMA_b0914fd3-1a50-4d72-be31-cd169108fbcb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzgtNy0xLTEtMA_75f7a1d5-5bc9-4c1f-a47a-0df43325325d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTEtMS0xLTA_03023b05-0bc6-4b9f-b2c1-8da14d2f64f2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTMtMS0xLTA_1a9bbd51-a3e6-48e0-8571-9f6cbbf61d05"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTUtMS0xLTA_e2011344-99cf-41a4-b287-e67c9069a6eb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEwLTctMS0xLTA_3280eada-1203-4fe4-b202-55cbe9363b4c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTEtMS0xLTA_14154d14-a73f-4cb9-abd5-648a62dd13aa"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTMtMS0xLTA_0632262f-58f0-45af-afc0-80aed5ee7d49"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTUtMS0xLTA_2d052201-6f90-489b-8bf3-424ef29c6126"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzEyLTctMS0xLTA_aa49ba29-0538-4288-b513-e0b58e4cb3fc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTEtMS0xLTA_fb20b43e-45f9-4b0c-a219-46adec953173"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTMtMS0xLTA_425a5ad2-c775-4d28-8fe0-54741e568816"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTUtMS0xLTA_b0f36f64-9f47-4b6b-8b6f-2a3df5300e7d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE3LTctMS0xLTA_038a5264-8b23-4b81-a688-ac183d774fa5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTEtMS0xLTA_ced30e1f-4142-44b4-82d1-aaa85736e2b1"
      unitRef="number">0.016</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTMtMS0xLTA_9a4872d5-0528-420c-a075-64dae39aba85"
      unitRef="number">0.014</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTUtMS0xLTA_3d094626-18eb-474a-8f40-d6f2e02e6530"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzE5LTctMS0xLTA_c9c63e12-3e51-4e7d-9829-fb7d1e0db1d9"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIwLTEtMS0xLTA_beb607bf-2a70-4f1d-9380-a52e4e5aaf5f"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIwLTMtMS0xLTA_03462529-7d01-4ba6-8204-9bd5bc9d1910"
      unitRef="number">0.016</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTEtMS0xLTA_d14f6976-a898-4731-8c8a-9758adce07ed"
      unitRef="number">0.014</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTMtMS0xLTA_7f8c4c43-fa77-4661-8e1f-ec54a99d94cc"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ia4449e3ff03b4159a65310d9fb7dce52_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTUtMS0xLTA_d4e633dd-315e-4596-a425-a9dc378a4e3f"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="iab053a6427c144d0967665353d78987e_D20190701-20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIyLTctMS0xLTUwODg_33a604cc-b071-4df9-8d07-05f516499f9e"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIzLTEtMS0xLTA_d67e8999-67f7-448e-9056-2ad3266e4f34"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzIzLTMtMS0xLTA_ad0a8c39-3732-40a6-b1fb-42f45c2f5944"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI0LTEtMS0xLTA_6042dc33-8664-47cd-8d77-7f16bd000c1a"
      unitRef="number">0.036</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if12f9ca2cdc94fdab5806af62694adcc_D20190701-20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI0LTMtMS0xLTA_04fe7de9-d369-4080-859b-acc1b2b066ee"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTEtMS0xLTA_4db9ebc7-722c-4970-a380-3aa85e6420f4"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTMtMS0xLTA_7aa08bad-e23d-4a2e-85b5-48fa375cfbc2"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTUtMS0xLTA_8a54a82a-2134-49cc-861a-fe94cadc6f08"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpiM2EyMTNkNmQzYzk0ODFhODNjZjU2OTAxOTQyYzcwZS90YWJsZXJhbmdlOmIzYTIxM2Q2ZDNjOTQ4MWE4M2NmNTY5MDE5NDJjNzBlXzI2LTctMS0xLTA_25c77b08-4c26-4fa0-a6a8-850206b05fc0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtMS0xLTEtMA_3b23bde6-9e69-4785-92c1-0b1ee5d35119"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtMy0xLTEtMA_13070bab-7194-408d-919d-fe346effdb6f"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtNS0xLTEtMA_509c044e-54e5-4ba1-b488-cea2b9c392eb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzUtNy0xLTEtMA_680abac7-ed73-4ab7-9693-f96a5f30cc62"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtMS0xLTEtMA_6e8de67e-3f1a-4894-83b1-438473f469c4"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtMy0xLTEtMA_0a5a04d3-5bab-4406-a9a0-100c2409b14c"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtNS0xLTEtMA_8e4538eb-c79d-4bfe-847a-6bcf625b85b7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzYtNy0xLTEtMA_c784f4ba-9822-4518-8da7-0f9edbff6eba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctMS0xLTEtMA_f4516a4c-5beb-4c5b-a0d6-a87978871123"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctMy0xLTEtMA_97764e43-f2ed-4f87-8f47-d8e2021f9c42"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctNS0xLTEtMA_00d23f20-371f-40ee-a270-174685e6073e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzctNy0xLTEtMA_e0fc0618-57be-4282-b8d8-cdd63ae9784e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtMS0xLTEtMA_b53bba15-4573-49a7-b754-f5d816956111"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtMy0xLTEtMA_3ace11bd-10e8-4e86-a008-26368f77909e"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtNS0xLTEtMA_c63aa7cb-98d1-409c-8486-c5ed5d0a49f3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzgtNy0xLTEtMA_f53c8657-2b0b-41ed-b89f-b52a3f151f58"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktMS0xLTEtMA_e5b222f1-a7cd-4f85-9f48-22ac387ec8fb"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktMy0xLTEtMA_62d6e9ef-b2a0-4c16-aa68-2a011ce9c480"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktNS0xLTEtMA_7af98ed5-123d-46c2-a8b8-34bf1169faca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzktNy0xLTEtMA_b6f3e954-2b88-459a-9b86-8c83f643952f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTEtMS0xLTA_dd3a671f-ed73-4818-8f9b-102e249a33fe"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTMtMS0xLTA_2799fb57-d721-4521-a436-d1f317552dec"
      unitRef="usd">75000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTUtMS0xLTA_29997273-dee2-411b-b3a2-e488ff9780b8"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEwLTctMS0xLTA_3b2ac667-e2e2-4233-a5c5-e2906dcfb61a"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTEtMS0xLTA_cc4334e7-1bbc-46cc-8cb2-9e9dadae49a0"
      unitRef="number">0.044</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTMtMS0xLTA_337c1570-7f88-493a-b2ea-6f2faaac9b24"
      unitRef="number">0.097</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTUtMS0xLTA_20dfec78-a6ed-4061-ab6b-ac8d1fcfe381"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzEzLTctMS0xLTA_6dfec4d7-7145-412c-92ad-b5b21882ce67"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTEtMS0xLTA_aec9a262-76f3-48ae-889f-5311be6b6c46"
      unitRef="number">0.306</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTMtMS0xLTA_cc7cc422-4a2e-4792-905d-6258ad805ecc"
      unitRef="number">0.268</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ice706a08834741238da74ea29809773c_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTUtMS0xLTA_de394db6-df40-4bb8-a9ec-34fabf956384"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE0LTctMS0xLTA_25676a5a-9cd4-418c-ab9c-70687c294af8"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTEtMS0xLTA_61675bd0-7269-4f00-9913-7d6c073b781c"
      unitRef="number">0.210</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTMtMS0xLTA_a14cdb3e-a2e2-41a8-bd70-2fad4a61b70c"
      unitRef="number">0.248</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTUtMS0xLTA_4f829068-af8f-436f-975d-0e1c609957bb"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE1LTctMS0xLTA_f9e883e3-d112-49d9-b284-d384aa92862c"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTEtMS0xLTA_ed5f05a2-5309-46bd-9f90-f688bc362e1a"
      unitRef="number">0.035</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTMtMS0xLTA_96412499-a958-4aa3-89f3-53bc7c452877"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTUtMS0xLTA_b740a394-c8b5-4aa0-af56-8aa1fdabf454"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE2LTctMS0xLTA_024399f4-9c76-41d5-98b7-be6d7dd82af9"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTEtMS0xLTA_acbff6d6-ed72-40a5-ba12-070ae567451c"
      unitRef="number">0.096</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTMtMS0xLTA_38354b67-0e05-4229-8524-6a840e6ff9a8"
      unitRef="number">0.095</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i67761642cec34a60aa24257023272899_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTUtMS0xLTA_e60d90dc-6c5c-4e41-b6fa-a9afecd886c4"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE3LTctMS0xLTA_19c74819-fcae-4ef8-95a6-0efd364c1a98"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTEtMS0xLTA_8c6d48d1-81e5-4c71-8aa1-3d0ec7322e70"
      unitRef="number">0.309</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTMtMS0xLTA_219cfaed-8ac1-4d82-a5c3-2019e7a04848"
      unitRef="number">0.261</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTUtMS0xLTA_3fe78aa5-dd5b-4890-a180-012e53863f17"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE4LTctMS0xLTA_992d0748-06bc-4b8e-ad11-e22e9ec98441"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTEtMS0xLTA_78e75b4a-7ecc-4e3a-8730-ed2759554ab2"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTMtMS0xLTA_1ef76915-f560-4bee-9ad9-96c2f5c941b7"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTUtMS0xLTA_f71d29d0-af4c-4b9e-9993-3bd7c1b029cb"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzE5LTctMS0xLTA_211a4d0c-793c-4eeb-8acb-aa23efba932a"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTEtMS0xLTA_6a21b6f4-b4b9-4c47-a3b0-d34351322325"
      unitRef="usd">14000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTMtMS0xLTA_ffd281cf-88d9-44e7-9815-1289d95d9a80"
      unitRef="usd">29000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTUtMS0xLTA_e4e3fc34-6ecc-41ff-b9ef-ddbd3adf0e71"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIyLTctMS0xLTA_898597f7-efc5-4d76-83bc-971c8ac4357c"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTEtMS0xLTA_f02b5bf4-c9e8-44f6-972f-e3366175507d"
      unitRef="usd">97000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTMtMS0xLTA_b4be7578-2d34-41e9-8b11-15114c242b74"
      unitRef="usd">79000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="ice706a08834741238da74ea29809773c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTUtMS0xLTA_efb169f3-fea1-4570-8f6f-da4c6ec49bff"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzIzLTctMS0xLTA_3690b653-7a8a-4ab2-90f0-a92d7e9e3ed2"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTEtMS0xLTA_c32d60b7-5573-494d-a4ef-15a2320c5635"
      unitRef="usd">67000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTMtMS0xLTA_61764979-4ab6-4245-877e-066257b49e4a"
      unitRef="usd">73000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTUtMS0xLTA_f303d72e-6c6c-41e4-9e9c-d7dbd41f3061"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI0LTctMS0xLTA_5b6e5d6c-7769-40cc-b120-85be131ef147"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTEtMS0xLTA_668ca035-e135-4458-ae86-bea52d936f68"
      unitRef="usd">11000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTMtMS0xLTA_b6521090-7b24-4a32-a516-c8672253a6f8"
      unitRef="usd">9000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTUtMS0xLTA_5c337001-6959-45c1-9786-2dc659a23412"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI1LTctMS0xLTA_9b6244e2-5545-4d28-9581-156768729bbe"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTEtMS0xLTA_4ccfcd78-0c81-43d9-83be-9f905d3ae772"
      unitRef="usd">31000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTMtMS0xLTA_01a10526-f1f5-4234-8e6f-7743bfdb4ebd"
      unitRef="usd">28000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i67761642cec34a60aa24257023272899_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTUtMS0xLTA_54a8f337-c717-43ed-ae04-a3bbdd9dc0ac"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI2LTctMS0xLTA_3794e17d-13c8-4bd9-b9b9-7e6cebe2c082"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTEtMS0xLTA_308e42e1-3005-49e1-900b-7882d502ad30"
      unitRef="usd">98000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTMtMS0xLTA_89a11efd-18d4-4b30-9cdd-3a85ab097575"
      unitRef="usd">77000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTUtMS0xLTA_6e9461e7-271d-4c19-9312-3af33a837382"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI3LTctMS0xLTA_a34f7cef-a9c2-46fa-a208-bfb86d5238ec"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTEtMS0xLTA_0143d76a-41f6-443f-8f3e-d4e0ee382ff3"
      unitRef="usd">318000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTMtMS0xLTA_ed6a64e3-7256-44ab-9edf-92d305fa5f3d"
      unitRef="usd">295000000</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTUtMS0xLTA_2c41e2e4-6e9b-4288-8086-0971add50f5c"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzI4LTctMS0xLTA_aa35a44d-1e75-4842-8d37-3364a41663b9"
      unitRef="usd">0</ctlt:DefinedBenefitPlanActualPlanAssetsAllocationAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i73585509ea444f569767074a3eb6f0e7_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTEtMS0xLTA_18abd976-dbc2-4836-b36d-55c37c996c29"
      unitRef="number">0.045</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i40e4763f489e4965b255dfd5a6e6227b_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTMtMS0xLTA_3a2a0220-d38b-40cb-b140-25e214fa767f"
      unitRef="number">0.101</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i784893fdb3a544208242b89ecd1ee2d1_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTUtMS0xLTA_5ba33554-72e4-41b4-8e1a-3dadbf3c50eb"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i467be289ec5c4e1ba164a9b6fac7c96b_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMxLTctMS0xLTA_27c8f6b0-8012-4fc6-b04c-efe0258a4e2c"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i34d5795b05e7417d8213bd2b3e1b6afe_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTEtMS0xLTA_99e4a501-f610-4677-8554-c8cfa0064ad1"
      unitRef="number">0.305</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i2cee44c9e63c4f489171f4645ccb62f1_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTMtMS0xLTA_d6866693-a5b7-4cc9-8bd2-d7a66bec4119"
      unitRef="number">0.271</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ice706a08834741238da74ea29809773c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTUtMS0xLTA_d9521326-dffa-4245-ac26-84a2b12ab2fe"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i3ba1dff49d0441b99a14d5a695a48485_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMyLTctMS0xLTA_4e20c9ca-e06d-4b1c-a694-057a0c02310e"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ib0eab50ed80743d8a5a2731fc313e888_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTEtMS0xLTA_351caa37-13d4-4956-b01a-45960dd8b22e"
      unitRef="number">0.211</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i0b5da2a933744c8e97cede443f401e52_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTMtMS0xLTA_99cada45-084b-462e-98ed-3799e3287fef"
      unitRef="number">0.245</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i0aa2721ff8ac4556af2c1db97433052f_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTUtMS0xLTA_293bf227-a7f9-438f-9fa7-8304fb205eff"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i7641feb3a40c4cc5a431e94405fc50bb_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzMzLTctMS0xLTA_5ee89c37-07f5-44d2-ac75-cbacd6973584"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i6aabee3dc2d143e9831360b8909d220d_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTEtMS0xLTA_79f232e8-30d0-4306-9969-6c504f33c62e"
      unitRef="number">0.035</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i3d7c5b1cbbf54ebca385d03882dc114e_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTMtMS0xLTA_9506744e-5b25-484c-95a2-afe34bcd9a97"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i55c888b0858a407ca4c6882470d3ba57_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTUtMS0xLTA_2bce002b-516e-4e2f-81fd-4dc7dbd7054e"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i4ec188c749a342bfa2dbee5cfd413b77_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM0LTctMS0xLTA_28d9d3d1-4c5a-4882-bc27-2f8219092380"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i28107f2cb01d42869fd11e36fce2be21_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTEtMS0xLTA_88772a0f-868b-465b-91e1-27c5e6ee49e5"
      unitRef="number">0.096</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i6731d24e56c6494285a36dd2320f028b_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTMtMS0xLTA_d3f1c4b0-cc71-4c1d-aa5d-d319dda4e498"
      unitRef="number">0.095</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i67761642cec34a60aa24257023272899_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTUtMS0xLTA_aa6383f2-3ae2-405d-a64e-169f41bed55f"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i615eba980ba44e7d91f0e6f353950a76_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM1LTctMS0xLTA_27a3e142-d876-42d4-955f-9bad5ebeaa14"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if84be19874184c0ebe7a692cffb1b662_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTEtMS0xLTA_d936553d-d49e-4da3-9c41-e78eb5b94b99"
      unitRef="number">0.308</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i4219029a0a0f4dbc95510d66f4e4944f_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTMtMS0xLTA_01948fc2-52a6-4bcc-96d8-e4278643e125"
      unitRef="number">0.257</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i14776c06fd314b2bbd995fa64ee43e49_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTUtMS0xLTA_0f74d287-a069-4508-8220-89224255d3de"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="icf5bb2f93d92431f9720216af1c29f16_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM2LTctMS0xLTA_e571eab7-8506-4052-8a0d-1b43a6cf3b14"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTEtMS0xLTA_3896537f-5733-4819-acff-6be267228cf1"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i1e02363e7a2c426689077f3463d3da3f_I20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTMtMS0xLTA_59da4ede-e6f2-45e8-9aef-eb91c95b1141"
      unitRef="number">1.000</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8e85d458dcaf42d481153310021f91c5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTUtMS0xLTA_d42b80d3-ed31-48c8-9ec2-272eef0aa0b8"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i5fc7eaa2dfaa4dbc9afbe159e01d599e_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTo2NWNkNzNhZGY5OTI0ZTQwOGI5NTNhZWM2MjQ2N2Y5My90YWJsZXJhbmdlOjY1Y2Q3M2FkZjk5MjRlNDA4Yjk1M2FlYzYyNDY3ZjkzXzM3LTctMS0xLTA_88f636df-76df-4b6f-80b2-f3adc1583cbc"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTM_1595a5b1-c9b3-49eb-bf96-48b873c01a29">&lt;div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a summary of plan assets that are measured at fair value as of June&#160;30, 2021 and 2020, aggregated by the level in the fair value hierarchy within which those measurements fall:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021 (dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="30" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Other as of June&#160;30, 2021, included $62 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.&lt;/span&gt;&lt;/div&gt;</ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i91e902584a964a56b042714cd96fd856_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItMS0xLTEtMA_b4a5968e-3dc2-467d-99da-40f94a00f84a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id59d87ec9da544189ca37e884e903023_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItMy0xLTEtMA_7a4f1c2e-a2ce-4a69-a142-a9813aed29b8"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic76b7a1a1c50447c8795cfee9b76b6f2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItNS0xLTEtMA_dec3ba10-4014-42bf-bf62-b22b69264ea9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i280d65c3f17f458683c59c0a78aeb3f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItNy0xLTEtMA_94b4574d-42cc-421c-869c-d030209f7919"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i17dbf7d5602747039f196cf8fed44904_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzItOS0xLTEtMA_aa256855-1652-4e53-9b22-8f2d025d7472"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i78e5e7182ff24cb9a7f0279131bb4942_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtMS0xLTEtMA_591b5d1d-92ae-4615-8386-812f518e6d8f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib6429ba70c044f03b798cd9e4de2be0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtMy0xLTEtMA_cdb2f4fb-648a-4d4e-97f8-7dc861503f2c"
      unitRef="usd">164000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87e0ac7b8ffd4432b71c123c4597bc5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtNS0xLTEtMA_0a06099d-9925-4891-a917-f55efe6e9762"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if39f484cfb594508ae46c19f5b6065b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtNy0xLTEtMA_d302ad70-8811-4121-88a9-0481fa115c2b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3dbac52f32be4ec29dce953d13e92d44_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzMtOS0xLTEtMA_c9a81c7c-644d-4071-bd4f-02b2d1295962"
      unitRef="usd">164000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d771ace0eb1449fb7f3c12ed9ed1b72_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtMS0xLTEtMA_09208a73-289d-4748-b33f-fa082dac9df0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib594f3bd14cb40f2af014369a711be04_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtMy0xLTEtMA_abac4d4f-09f1-4246-be21-6bd7b0723789"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f6ce956a9a84c788e025d461d2fa55e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtNS0xLTEtMA_43bfe666-204b-46b2-8218-7bf54ebee0a7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icb9a6629638d4bec8bbeca03f202300b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtNy0xLTEtMA_4acb686a-3b24-4f55-97df-c1835493d1bc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie042f30541ea42e3925b4408eb1b5efe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzQtOS0xLTEtMA_5ffac322-7b6e-4a6d-9ad8-200781d87fe8"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i616dc17846934bb29e3dfa999602105a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtMS0xLTEtMA_cd4a161d-39bc-4628-b4b0-7a765c2f36cb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba82bbc9c25342b3ad2b0f7fca13b545_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtMy0xLTEtMA_d6de63f3-fea5-4580-8184-a3c2c06de327"
      unitRef="usd">106000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2af23bf32de448b9b29a639e339e12ca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtNS0xLTEtMA_a5b61bda-058d-44d5-9730-25dcfaa8b7d1"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i42f7205774aa465d8c2c5c62294b0b82_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtNy0xLTEtMA_44fc0b90-ac3b-4138-a62e-99fbd6ac5c37"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i48b7425856b04051877a7f4af9acb089_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzUtOS0xLTEtMA_71de675f-8d61-48ef-9bf6-a4fed789be1f"
      unitRef="usd">129000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtMS0xLTEtMA_b5648112-0e1b-44db-8f31-c2c30b524353"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifbb10789bf7a49039027ed20f163c57d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtMy0xLTEtMA_b659079c-5fb4-45ae-89b4-350e5057c1fa"
      unitRef="usd">295000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtNS0xLTEtMA_7090ce52-08a5-4442-9c6a-7e16c8676862"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idefe473808f242cfb4d79b76bb4cd1b6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtNy0xLTEtMA_a0076e8d-cd94-41c5-b663-6c86ac0cd9b1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxODQwMDc1NGRmMmM0NTk5YTI5ZDE4ZWY2NjJkNmE1OC90YWJsZXJhbmdlOjE4NDAwNzU0ZGYyYzQ1OTlhMjlkMThlZjY2MmQ2YTU4XzYtOS0xLTEtMA_d40a96e4-c9ae-4b56-9f65-e21c1064e389"
      unitRef="usd">318000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id3d162800d3645f09f06e974c9c7b41f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzI3NDg3NzkwNzUzMTI_c9f145a6-3293-4bb0-ba66-fed5b687f5ed"
      unitRef="usd">62000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTU_32ce8404-64ef-47ed-a373-70c7d86e4109">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2020 (dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="30" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id478458e161c4187b43283019eb85566_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItMS0xLTEtMA_40262f4d-b1ec-4be5-8fcc-253be80a4e54"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3d7d5a90f3e04d0a8cda16af1947057e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItMy0xLTEtMA_723c693a-50d9-4f9a-93fb-3bde0db7f843"
      unitRef="usd">29000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f58afe0b33945a38eaa3dbef03f5e38_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItNS0xLTEtMA_32b83951-d5c1-428b-b621-be87c68b2dd1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9365ffbe0c824e079d7910fb709ae51b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItNy0xLTEtMA_5e7a767a-23bf-4ad1-8452-311932de2383"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f2ea0ebe25a4a58af6552214e53fb98_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzItOS0xLTEtMA_bbdbab5b-176e-468e-b357-06b26915f17b"
      unitRef="usd">29000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i674ba7cf27b546a4bb3070be9a749b6b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtMS0xLTEtMA_5b581752-d836-449f-8dc7-2aba0e34f8bf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if95647ade5004209956c4a57536f85cd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtMy0xLTEtMA_a9fd76ad-2bb0-4dbe-909e-2e631a4bef67"
      unitRef="usd">152000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ideb17a22b64641879d269be22be9f957_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtNS0xLTEtMA_ce8f6c11-685b-4252-983c-dbe6b46e40c4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2766d6e8cc8a4999992fa9459d493068_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtNy0xLTEtMA_47a948bf-14d5-4775-b7b3-17b6abb3949b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib8ddfd65a6674ab581ba4e4d8629a7c1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzMtOS0xLTEtMA_d71658a2-ddee-4986-9eb8-6e6c7eecae40"
      unitRef="usd">152000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i338530796387480ebed0b8318b633f47_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtMS0xLTEtMA_385f0d4f-0a18-49c8-b995-702680466bfd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6c88f034a63243369678cb546a00e1ac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtMy0xLTEtMA_51f669dd-8453-4192-8324-a7c6050aea5d"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i217e96b6a96a4d41b70da7c1176afaac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtNS0xLTEtMA_a7f194c8-3e8d-42f1-9ce1-40dcc06ffa6c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9862365c693c40c5a75f7d109361924b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtNy0xLTEtMA_9ebb18da-11ab-481a-822e-b5f14e4d987d"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i36fc4fd39be144599048465035ffbf4f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzQtOS0xLTEtMA_d195fe81-920c-40b5-8951-54ee8496f2c7"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i044c92e5d7764b238c02260877d1c6a3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtMS0xLTEtMA_69ef09ff-7b1f-4051-8dff-82fdf76c5bbe"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0933365c8e7843c381a38dda5c76730a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtMy0xLTEtMA_0d79ab29-29ae-4c92-8221-1031eec3485b"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i761a3f210f0d4571a49d8aba4bf24cd5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtNS0xLTEtMA_442d3969-0fa0-4472-ba2d-d4b72498b845"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3a004bc1607d43e183c8e77e4c139dc5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtNy0xLTEtMA_a001f3e8-a69c-4837-a723-3fa7f5238b85"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9ad7c55e85245b69bd849dbef9f6339_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzUtOS0xLTEtMA_5a1777eb-8fb2-4d72-b0fe-1ecd6957a5cf"
      unitRef="usd">105000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibe887898b5bf481ba802abbfae71dccc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtMS0xLTEtMA_1578b7c9-0ecb-4556-a801-ba65b1256a61"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibc4683879d2e4f8484fed5c0cf725bd2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtMy0xLTEtMA_b8c73733-8307-4875-8f81-7246f3663d26"
      unitRef="usd">272000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtNS0xLTEtMA_ba8d3452-e244-4dde-9b27-f2efbe181786"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i065b118e37ce4fd4b007a6f358dfd1f8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtNy0xLTEtMA_2c96cd52-0296-42ae-b6b0-b14df3dbdc78"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZToxYWMyOGRhNzZkNTQ0OGJmYWIxZmFmMjRmZmFjZDVlYi90YWJsZXJhbmdlOjFhYzI4ZGE3NmQ1NDQ4YmZhYjFmYWYyNGZmYWNkNWViXzYtOS0xLTEtMA_3a2e186c-be56-4010-bc7f-e8b5e495b73e"
      unitRef="usd">295000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie793845427de4931a83bcaeee475b50b_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzI3NDg3NzkwNzU0Nzk_6f0006bd-4bfc-42d4-a4af-71e5850348b9"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i925686e50afe4c2ebf90635e12f3836a_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzQwNTY_442ae9d6-436d-4f4c-9e7f-74d49f3f58f2"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTc_7a9b4960-dbeb-44b6-a80f-2a06505d5f3a">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of Level 3 assets as well as the changes during the period attributable to assets held and those purchases, sales, settlements, contributions, and benefits that were paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Total (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Insurance Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total (Level 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Relating to assets still held at the reporting date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales, settlements, contributions and benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers in or out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i94de709fd06649489f2953db5ca5be8f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtMS0xLTEtMA_c7b82690-c03b-4f3f-b42f-ee7aa5440b59"
      unitRef="usd">21000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib73f5a43231945369c1c0f4f80a2d43d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtMy0xLTEtMA_612cd9c1-bb22-43ed-abf9-d28aa5ea417a"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7f9023c3b6654d3882840dd7e57a6add_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzMtNS0xLTEtMA_d3cdb419-3cde-4b4e-a555-ea4e1f1725ce"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate
      contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtMS0xLTEtMA_dba784bd-4f46-48d4-b382-eb22cc94b198"
      unitRef="usd">3000000</ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate>
    <ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate
      contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtMy0xLTEtMA_ba580126-9b75-4a3e-91cf-e0f26f65a1f0"
      unitRef="usd">0</ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate>
    <ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate
      contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzUtNS0xLTEtMA_677514e5-69d7-4bcb-b8d3-be3edd0fe634"
      unitRef="usd">3000000</ctlt:FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
      contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctMS0xLTEtMA_54ed3828-af08-4405-a6b2-8abec94970d6"
      unitRef="usd">-2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
      contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctMy0xLTEtMA_e30353d6-628b-43ff-bcbe-fc2b5e08b923"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
      contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzctNS0xLTEtMA_7074f9a7-3947-462f-9690-c1fc56b9208c"
      unitRef="usd">-2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i0c85cca94eff47529cb6b5352b86ba30_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtMS0xLTEtMA_3cd13479-065f-4c80-9eb5-a13285140d1b"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ie446e8a6181e42b08fe2a40786161688_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtMy0xLTEtMA_41f3a180-8bed-440c-96d2-29c7084deb93"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i94cdca9bad3548428bb7e945fb55fa34_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzgtNS0xLTEtMA_6c6f3fc3-ac39-4c8b-a09c-9a2606b9779b"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if7abc05af1e54767abafd35e659d3d05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktMS0xLTEtMA_6bfdeaa5-07b2-4796-9e38-faaeec9e163d"
      unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i3b03fecf1a824b69b571ab998730a8de_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktMy0xLTEtMA_52a6d504-997d-4387-b31f-32fd73eb7aa9"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i15d51546be7e4dca88d0b88655adaa62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTpjMDQwODYwODMwOGU0NWYxYmE4N2IwZDIwNDg4ZGRkNS90YWJsZXJhbmdlOmMwNDA4NjA4MzA4ZTQ1ZjFiYTg3YjBkMjA0ODhkZGQ1XzktNS0xLTEtMA_90bd4686-ea84-4ca9-b309-fef3c28bb3e9"
      unitRef="usd">20000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90ZXh0cmVnaW9uOjg2Y2YxNWYzN2YxNTRiYWFhZGVhYjM3MjdkNWU4NjI1XzU0NTg_2fedab74-dfa3-4654-b2ee-15cc50bb9d7c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&#160;Post-Retirement&#160;Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assumed Healthcare Cost Trend Rates at the Balance Sheet Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare cost trend rate &#x2013; initial (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare cost trend rate &#x2013; ultimate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year in which ultimate rates are reached&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzYtMS0xLTEtMA_2dab37b1-a0ba-4d58-a213-2938d9dfe0bf"
      unitRef="number">0.073</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzYtMy0xLTEtMA_4f3a2082-61d9-4570-9ca5-8e4e91d29578"
      unitRef="number">-0.011</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i3b58bc5b3f9c4be98dfb87803c419d06_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzktMS0xLTEtMA_6621e662-7c81-42c7-a1a5-03a0dc23d343"
      unitRef="number">0.044</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i7a0f4e724ec64227b6ecf4e42e1927a0_I20200630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzktMy0xLTEtMA_24306a0e-d08d-4ed2-8f9e-81df533cab1a"
      unitRef="number">0.049</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate
      contextRef="ie7bbc3d33ba64564905716133264e5cf_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzEyLTEtMS0xLTA_6c04b61f-f5be-4c33-8886-22447a47bc12">2035</us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate>
    <us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate
      contextRef="i0c19f2e7fd444db984805e159c3087f7_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjAvZnJhZzo4NmNmMTVmMzdmMTU0YmFhYWRlYWIzNzI3ZDVlODYyNS90YWJsZTphYWQ4Yjg0MDk3ZDk0YmI0OGRkMmM5OWU3ZTIwMGNhNi90YWJsZXJhbmdlOmFhZDhiODQwOTdkOTRiYjQ4ZGQyYzk5ZTdlMjAwY2E2XzEyLTMtMS0xLTA_c81f4439-052a-4c98-8cc9-bd82db9ecf7c">2032</us-gaap:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ0NTg_2f59cdeb-0cda-46e7-b78b-b34c7a103892">EQUITY, REDEEMABLE PREFERRED STOCK AND ACCUMULATED OTHER COMPREHENSIVE LOSS &lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Capital Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue 1,000,000,000 shares of its Common Stock and 100,000,000 shares of preferred stock, par value $0.01 per share. In accordance with the Company&#x2019;s amended and restated certificate of incorporation, each share of Common Stock has one vote, and the Common Stock votes together as a single class. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Public Offerings of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2020, the Company completed a public offering of its Common Stock (the &#x201c;June 2020 Equity Offering&#x201d;), in which the Company sold 7.7 million shares of Common Stock at a price of $70.72 per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the June 2020 Equity Offering of $548 million after the payment of associated offering expenses. The net proceeds of the June 2020 Equity Offering were used to repay $200 million of prophylactic borrowings from the third quarter of fiscal 2020 under Operating Company's Revolving Credit Facility, with the remainder available for general corporate purposes. On July 10, 2020, the underwriter for the June 2020 Equity Offering exercised its over-allotment option on 1.2 million additional shares, resulting in net proceeds of $82 million from the June 2020 Equity Offering, which was recorded in the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 6, 2020, the Company completed the February 2020 Equity Offering, in which the Company sold 8.4 million shares of Common Stock at a price of $58.58 per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the February 2020 Equity Offering of $494 million. The net proceeds of the February 2020 Equity Offering were used to repay $100 million of borrowings earlier in the quarter under Operating Company's Revolving Credit Facility and the consideration for the MaSTherCell acquisition due at its closing, with the remainder available for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effect of Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares outstanding of Common Stock include shares of unvested restricted stock. Unvested restricted stock included in reportable shares outstanding as of June 30, 2021 was not material. Shares of unvested restricted stock are excluded from the calculation of basic weighted average shares outstanding, but their dilutive impact is added back in the calculation of diluted weighted average shares outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2019, the Company designated 1,000,000 shares of its preferred stock, par value $0.01, as its &#x201c;Series A Convertible Preferred Stock&#x201d; (the &#x201c;Series A Preferred Stock&#x201d;), pursuant to a certificate of designation of preferences, rights, and limitations (as amended, the &#x201c;Certificate of Designation&#x201d;) filed with the Delaware Secretary of State, and issued and sold 650,000 shares of the Series A Preferred Stock for an aggregate purchase price of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$650 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to affiliates of Leonard Green &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&amp;amp; Partners, L.P., each share having an initial stated value of $1,000 (as such value may be adjusted in accordance with the terms of the Certificate of Designation). The Series A Preferred Stock ranks senior to the Company&#x2019;s Common Stock with respect to dividend rights and rights upon the voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from the offering of the Series A Preferred Stock, net of stock issuance costs, were $646 million, of which $40 million was allocated to the dividend-adjustment feature at its issuance and separately accounted for as a derivative liability.  Any change in the fair value of derivative liability during a fiscal quarter is recorded as a non-operating expense in the consolidated statement of operations. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for detail concerning the change in fair value during the fiscal year ended June 30, 2021.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, on the Partial Conversion Date, holders of Series A Preferred Stock converted 265,223 shares (approximately 41% of their holdings) and $2 million of unpaid accrued dividends into shares of Common Stock. The holders received 20.33 shares of Common Stock for each converted preferred share, resulting in the issuance of 5,392,280 shares of Common Stock. There was no gain or loss recognized upon the Partial Conversion as it occurred in accordance with the terms of the Certificate of Designation. The Company has 384,777 shares of Series A Preferred Stock that remain outstanding at June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Partial Conversion, additional paid in capital increased $253 million, which includes $4 million related to the fair value of the portion of the derivative liability that was settled upon the Partial Conversion and $2 million related to an unpaid accrued dividend. See Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for detail concerning the change in fair value during the fiscal year ended June 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the changes in the cumulative translation adjustment, derivatives and hedges, minimum pension liability, and marketable securities for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consists of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term inter-company loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign currency translation adjustments, pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign currency translation adjustments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in derivatives and hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in derivatives and hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in minimum pension liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in minimum pension liability, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&#160;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Liability Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives and Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEzMQ_00e49571-3c4a-4177-b4bf-a833652af615"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEyNjQ0MzgzNzMyOTc4_afe83730-05c7-4a07-b40d-48a191a50df6"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzIwNQ_0b7e8939-8328-4121-8af9-7926ea4a5d5d"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzIwNQ_de854692-8dcd-40ab-8d48-c7e6c3ee8d40"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzU0MA_909013c5-1849-49ee-a2fb-87ba3b4312dd"
      unitRef="shares">7700000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ic1290537b263472c96221d671edce576_I20200615"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzU4MA_07b60c2a-60c2-4cc3-9f3a-ed08025439f1"
      unitRef="usdPerShare">70.72</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzcxOQ_76e0d94a-9695-4e07-b692-92a2bcf8228d"
      unitRef="usd">548000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues
      contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzg0Mg_f2e56138-7aa0-4661-968e-76aa2ad24486"
      unitRef="usd">200000000</ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues>
    <ctlt:StcokIssuedDuringPeriodSharesOverAllotmentOption
      contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzExMzE_aa810c8d-7931-4810-aff6-dd604d78f996"
      unitRef="number">1200000</ctlt:StcokIssuedDuringPeriodSharesOverAllotmentOption>
    <ctlt:StockIssuedDuringPeriodValueOverAllotmentOption
      contextRef="i9d1f082bc83040aea156051c060c4587_D20200615-20200615"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzExODI_888e8a6b-49b7-4fb6-aeef-f59977ac0d2b"
      unitRef="usd">82000000</ctlt:StockIssuedDuringPeriodValueOverAllotmentOption>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEzODU_019b6959-12e1-4ac9-8120-4251b74b381d"
      unitRef="shares">8400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ic61973bb2144417ab4cb0d8936b28d87_I20200206"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE0MjU_6892460e-ef66-4ef0-93f5-286637b654c9"
      unitRef="usdPerShare">58.58</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE1Njg_48d1844c-e716-49a2-b55f-e742a1d8c760"
      unitRef="usd">494000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues
      contextRef="i374456a5e8d7406f862d03f0bcaacc9d_D20200206-20200206"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzE2NDU_cc380c60-01dd-49f2-a02a-5baea2b27b72"
      unitRef="usd">100000000</ctlt:NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i47f799b0175d45b2b0f741e0b0d836f2_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4ODk3MTI_60670215-af81-4a2b-a693-0aa60e0fdbef"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4ODk3NTc_9e180431-23dc-40d3-99a6-b631e7ae80bf"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAwMzQ_99414299-7213-4e40-b41f-f2e11affb860"
      unitRef="shares">650000</us-gaap:PreferredStockSharesIssued>
    <ctlt:PreferredStockIssuanceValue
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAxMTI_007aff17-dca1-4739-a085-b16f770b9b20"
      unitRef="usd">650000000</ctlt:PreferredStockIssuanceValue>
    <us-gaap:PreferredStockValue
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTAyMzg_6db4bdf1-836b-480a-8abb-75be20bb89af"
      unitRef="usd">1000</us-gaap:PreferredStockValue>
    <ctlt:PreferredStockIssuanceValueNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTA2Nzk_c4ba2591-111d-41e1-ae4f-cf92f8d7c958"
      unitRef="usd">646000000</ctlt:PreferredStockIssuanceValueNet>
    <ctlt:EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability
      contextRef="i7867ffbd357d4690b08c9d4613c293e4_I20190517"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzMyOTg1MzQ4OTA4MjM_e37ddcd1-8f63-47c6-9ad8-68f157feffca"
      unitRef="usd">40000000</ctlt:EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4MTE_c04e5d78-84ee-47b2-b240-b2fac6cb6740"
      unitRef="shares">265223</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4MzA_36f5a079-2d5a-4621-a158-51b12b0fa54a"
      unitRef="usd">2000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i36da9517a14e4528a0349b2cb8978970_I20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NDI_a034ab87-5883-4462-9b41-6e23b526c72a"
      unitRef="shares">20.33</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NTQ_e17c2197-3f56-4849-9d46-e67ba0b48575"
      unitRef="shares">5392280</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4NjQ_5cb3f38f-3836-44a1-9cac-8de848da877c"
      unitRef="shares">384777</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i99b709ddabb8411e93196c3996cdf2d1_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4Nzk_27fc9003-6ea4-4142-8d19-264f214754e1"
      unitRef="usd">253000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc4OTY_50bacd1f-1cfc-4bd7-bbda-a21ecc18ac09"
      unitRef="usd">4000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i1f7f8a0927504804b92712b8810c121f_D20201123-20201123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ5NDc4MDIzMzc5MTc_eb817beb-4aee-4466-ac6e-245c14e64c01"
      unitRef="usd">2000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzQ0Njk_b365b05b-649e-43c7-94ed-06ede9f05c8f">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the changes in the cumulative translation adjustment, derivatives and hedges, minimum pension liability, and marketable securities for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consists of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.488%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term inter-company loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign currency translation adjustments, pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total foreign currency translation adjustments, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in derivatives and hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in derivatives and hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in minimum pension liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in minimum pension liability, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss recognized during the year, pretax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in marketable securities, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&#160;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Liability Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives and Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtMS0xLTEtMA_fd850335-8201-4d6c-b85c-88f13b7ee55a"
      unitRef="usd">-56000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtMy0xLTEtMA_3f28fdfc-9593-45c4-875a-6d77cb18c637"
      unitRef="usd">3000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMtNS0xLTEtMA_6111aef2-96b9-4f2e-bded-6a9bf10f323c"
      unitRef="usd">12000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtMS0xLTEtMA_9afe1f70-25dc-4683-9577-ce591c0c8a42"
      unitRef="usd">39000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtMy0xLTEtMA_9b9d45b2-2f3e-40a3-8e74-aa5c302443c9"
      unitRef="usd">-9000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzQtNS0xLTEtMA_a9a7c335-b3d3-4b5f-a1af-a12d20d8970b"
      unitRef="usd">-13000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtMS0xLTEtMA_0c2e356f-c363-4311-b947-a85642fd11d5"
      unitRef="usd">72000000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtMy0xLTEtMA_fa438ef4-3c06-45e9-8b5f-b1dc2d1d7e42"
      unitRef="usd">-25000000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzUtNS0xLTEtMA_cd4a6de2-fae2-4063-a614-dd6296242755"
      unitRef="usd">-16000000</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtMS0xLTEtMA_866cc24a-5d86-4502-9856-d841380246ed"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtMy0xLTEtMA_69061225-adc9-4818-b7e0-470362765fc8"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzYtNS0xLTEtMA_21284fbd-d316-4aa3-b9f4-3ec2abd194e9"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctMS0xLTEtMA_f441fc41-dbdc-4547-80f9-44494eee7cd5"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctMy0xLTEtMA_61011f03-ec04-40a6-83b9-b337aeaf34cc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzctNS0xLTEtMA_9ea0aa81-45da-495c-870a-4825d9b04347"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMS0xLTEtMA_6f4fa381-2601-4af7-a55e-d115313a0324"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMS0xLTEtMA_d650da5b-cc2c-4d2d-9210-4c997afe3e90"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtMy0xLTEtMA_8ffe0386-3303-4e56-8a7b-0a67a31207df"
      unitRef="usd">-31000000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzgtNS0xLTEtMA_5e59bc11-8f2f-4d6d-a71d-7a0305ee41f5"
      unitRef="usd">-19000000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTEtMS0xLTA_f3aa80cd-b2ed-4c2f-aa57-adc31ba5e5cf"
      unitRef="usd">4000000</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTMtMS0xLTA_4438e0ee-5981-4e30-a421-69be4816f3ad"
      unitRef="usd">-4000000</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzExLTUtMS0xLTA_3adf60da-271b-42b1-9b74-5d7296c24c66"
      unitRef="usd">0</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTEtMS0xLTA_d9b4d234-0e9a-4fe2-ab53-99107fc32778"
      unitRef="usd">1000000</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTMtMS0xLTA_aa0fcd51-73e4-4dbc-8de7-01630bc70122"
      unitRef="usd">-1000000</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax>
    <ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE1LTUtMS0xLTA_6013ff85-b96a-433d-8b18-fca263fa6af2"
      unitRef="usd">0</ctlt:OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTEtMS0xLTA_2e3cd357-055e-4143-bc6e-b2278f860096"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTEtMS0xLTA_90cc32bc-ec3a-4ce0-a044-f1967fe33019"
      unitRef="usd">3000000</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTMtMS0xLTA_9591aeb1-4789-4457-b392-cadd01bce960"
      unitRef="usd">-3000000</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE2LTUtMS0xLTA_b6e6139d-36f3-4009-a6bf-9b04b907be3d"
      unitRef="usd">0</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTEtMS0xLTA_a16eaf0a-f9ec-4254-a6b9-b47cafed2052"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTMtMS0xLTA_32cd0922-01ed-484f-978c-ed0382af711f"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzE5LTUtMS0xLTA_41b1baf8-38af-4cc9-840e-373117a4b692"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTEtMS0xLTA_5f055d4f-b67d-43cd-9209-1d9f2680b27f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTMtMS0xLTA_12689245-e134-407d-a5ef-c7ec00adb2ef"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI0LTUtMS0xLTA_d16c72ea-7817-4c10-955a-e702a9044db8"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTEtMS0xLTA_99685733-46fa-438f-af8c-bd67c25837a9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTEtMS0xLTA_9ba26b85-41ea-47af-8a92-c59194f542df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTMtMS0xLTA_1f5d240f-4b65-44ef-951a-e169021835af"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI1LTUtMS0xLTA_b8fbc437-bea8-418c-9047-ec0daa8dc3b3"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTEtMS0xLTA_6b481b86-fa99-46ab-bbaf-ca590630ea76"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTMtMS0xLTA_9b5ddd8c-1bdf-4a1a-a3e3-5d22090556c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzI4LTUtMS0xLTA_b3f85d1d-4e53-4941-b10a-d5fb22b9b3a2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTEtMS0xLTA_8ba473ec-dfdf-4e5f-8f61-9e5dd2dde15d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTMtMS0xLTA_e4cb6765-2364-447b-a77f-3739f9dc72bf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMyLTUtMS0xLTA_0101654d-6bfd-4600-97c6-d8e857060ffd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_81b099d4-7acc-4808-92ea-72fada505513"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_8622dedf-b416-4972-98c0-dec8e34dccbd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTEtMS0xLTA_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTMtMS0xLTA_761890dd-4fa3-4e6f-8ab1-759b3b28209c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTpmYTM0YjY0YjMzNTU0Nzc1ODViMzA0MmYxYTVmNmE1ZC90YWJsZXJhbmdlOmZhMzRiNjRiMzM1NTQ3NzU4NWIzMDQyZjFhNWY2YTVkXzMzLTUtMS0xLTA_9ae49af7-3e45-45fc-833f-e41cd3580791"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90ZXh0cmVnaW9uOmJkNTYxYTU2YWYzNzRhMmU4MDE3ZmI0YWMzOGRiMzBmXzEwOTk1MTE2NDExODU_e32b762c-5743-4ee0-8e59-f21b0729f671">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&#160;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension Liability Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives and Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ef4a2ddd640405884e26ccb88aec2cc_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMS0xLTEtNTA5MA_dda4ac51-14a2-4cff-8d03-8ae3dfc8e056"
      unitRef="usd">-285000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifec61b66a0ae41bb8d96d423f6b1d627_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMy0xLTEtNTA5MA_f00daa25-3bdf-498a-a821-6d809fbddd70"
      unitRef="usd">-40000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2a022f50ba3b4184aca687e31673f394_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctNS0xLTEtNTA5MA_7bc63b78-32f4-4437-8dcd-b277689dc59e"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i221440e603ee468f84a494f340ce58aa_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctNy0xLTEtNTA5MA_d5589bc2-c535-4bde-b2a1-e1f9fce8e657"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i50d58655fb4b4d95a56611db174ed7c0_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctOS0xLTEtNTA5MA_5386ad20-ad15-430c-8e8f-9d62f8d5abb1"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i95c6836230814e07a0db1966aafcc2e7_I20180630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzctMTEtMS0xLTUwOTA_b0e29b48-b7a1-4da7-b106-fc2bb794a831"
      unitRef="usd">-326000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMS0xLTEtNTA5MA_db38f36f-60db-4dc2-8f00-90f3b9b02787"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMy0xLTEtNTA5MA_3dbab112-7e81-4929-8321-bb8ef544e921"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5655f5c2bab84586add677e627a148ce_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtNS0xLTEtNTA5MA_70577b62-b3b6-4107-8d18-5968b04f47a3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtNy0xLTEtNTA5MA_826f6ad5-f553-4cdc-94fb-cce5189ea280"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtOS0xLTEtNTA5MA_0e00fa74-02ea-4ce1-9637-ea2705824371"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzgtMTEtMS0xLTUwOTA_78b79cf5-6ce8-4f4f-8602-f4ef32f8e55e"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i877c0103bbb0465bb1d84bbf70e7f612_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMS0xLTEtNTA5MA_83762249-c8be-4a73-a4f1-04a65fd6321e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i81fe6974f8334413b15c3acbfa8c65a5_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMy0xLTEtNTA5MA_3eb9d600-5840-4b50-8303-c6d06caebf8f"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5655f5c2bab84586add677e627a148ce_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktNS0xLTEtNTA5MA_4f2f6dc5-760c-4e52-b37f-78bf848b8049"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5769fa4b1d3b4a7894d37687450f3884_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktNy0xLTEtNTA5MA_09ec7f51-9e6e-48cf-9090-7b834a483836"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icc8cededb03c4e4b8dce6945b701ee1b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktOS0xLTEtNTA5MA_721f847f-8a2a-46b5-bc46-8d906dbacdc8"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzktMTEtMS0xLTUwOTA_e1a38828-0248-422e-9c01-b4304617fa4e"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i821917bb413b4a56aac98433b843532a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTEtMS0xLTUwOTI_cc83b973-1dea-4b78-8d89-6c2397f868ee"
      unitRef="usd">-304000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b5caf499e0a431a8879e0fccd6f9ece_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTMtMS0xLTUwOTI_657e4136-02ed-4ce0-82ce-b13afff90c7b"
      unitRef="usd">-49000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf2629dad7444ac6a087600fb4eeb17d_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTUtMS0xLTUwOTI_ec09edb4-37d4-49cc-9275-92e4f1527965"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9f53a97e9a3e45b0b0be1df8cb9a0cb5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTctMS0xLTUwOTI_d699d4c5-6097-4369-be2f-b127c7f597c6"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i240eab7869244315a4272887642c26a5_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTktMS0xLTUwOTI_1845d146-fee4-4d51-9d53-371ecec59d38"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEwLTExLTEtMS01MDky_58f69434-cae7-4712-a113-b38d6164a96b"
      unitRef="usd">-354000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTEtMS0xLTUwOTQ_93e36e68-0501-4c88-805c-1b267d6a2d35"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTMtMS0xLTUwOTQ_9564d480-3127-4bcb-b5be-e916fc7bf37d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTUtMS0xLTUwOTQ_80be04d7-bb83-4ce9-bfc3-c5120c7e3229"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTctMS0xLTUwOTQ_974c931d-89bd-40f8-92ad-7ffc0dbdda1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if39c138759b140dab2149dee8ac05f30_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTktMS0xLTUwOTQ_356c7bf2-89d4-4901-bc26-6db6bd2dda24"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzExLTExLTEtMS01MDk0_93581bd0-a95b-4834-b25d-5f772e9607a8"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib8443bd609194937ac3719bb10bf2f11_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTEtMS0xLTUwOTQ_c22a1ada-4aa8-4853-bf1c-c9ff9d3bff0e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaed4b69cfd14442e89f4612ebc72bd62_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTMtMS0xLTUwOTQ_d081f622-b3dc-4527-8713-0425a7668331"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia37c15be53ba4ec4b864ce2ce50b965f_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTUtMS0xLTUwOTQ_f0f49017-b66a-4f6d-94c7-f67ee62b0c62"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iae1d9d3042644ae4bd02d4e015fed934_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTctMS0xLTUwOTQ_353d5043-8de7-4149-ad6f-a50982315177"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if39c138759b140dab2149dee8ac05f30_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTktMS0xLTUwOTQ_630b3f7d-4cca-43fb-8087-ad66451081bf"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEyLTExLTEtMS01MDk0_ce9964f4-c35e-4fa6-bc54-4aef34549916"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib607491522bf4a9cbf1b0e51427ed504_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTEtMS0xLTUwOTY_ae79c586-5587-4200-8ad4-fd75b4166b64"
      unitRef="usd">-335000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ebe451150f641eba39d44e90165f2bc_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTMtMS0xLTUwOTY_a5b3418a-fcd2-4e85-8397-99301402f0a2"
      unitRef="usd">-47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i087ba84b22354e09b7931fd608163258_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTUtMS0xLTUwOTY_0ea8f2a1-9cb1-45b8-83f5-2ef1d3d4ccc2"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6065f8b36ce4420b00d99511de9eeb2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTctMS0xLTUwOTY_4b0f0a60-98f2-4d6e-9924-743a6b5eb434"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ieef7b19288854132b4c14e7c56376062_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTktMS0xLTUwOTY_aa8fb7e3-f23f-456c-b074-86f791255789"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzEzLTExLTEtMS01MDk2_8037ce50-054a-4c0a-bbbd-296a714f7723"
      unitRef="usd">-386000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2782505d17674bb49380b553158607bd_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTEtMS0xLTUwOTk_6f4fa381-2601-4af7-a55e-d115313a0324"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTEtMS0xLTUwOTk_d650da5b-cc2c-4d2d-9210-4c997afe3e90"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic1dbc59a20da4293a1cede7d4d62b235_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTMtMS0xLTUwOTk_aabf3331-c614-45ed-929a-4f5868df38c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i955f79dfe5cf4e95b9d974632a90d8b8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTUtMS0xLTUwOTk_2e3cd357-055e-4143-bc6e-b2278f860096"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTUtMS0xLTUwOTk_90cc32bc-ec3a-4ce0-a044-f1967fe33019"
      unitRef="usd">3000000</ctlt:OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_81b099d4-7acc-4808-92ea-72fada505513"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_8622dedf-b416-4972-98c0-dec8e34dccbd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie479863b69c34993af12d306ac0e1fd9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTctMS0xLTUwOTk_f9ad8a9e-03a5-4cf0-a872-51339e9d36a8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id21c601ca07c400c97c3e7ea14464b57_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTktMS0xLTUwOTk_9b627365-dac5-4558-b6fc-44a4d23759ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE0LTExLTEtMS01MDk5_a75c1eb8-1784-430c-9b4a-7faff266bc0c"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibf4b5715f5e247d7b165eac3e63b264b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTEtMS0xLTUwOTg_bf34b67f-893f-4f23-8f49-d84a7a02d2e0"
      unitRef="usd">-268000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie772514199484fb3aae9babd28777987_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTMtMS0xLTUwOTg_690b35f1-b443-4fb7-9a51-9ff810b5d0b2"
      unitRef="usd">-47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2b9e16ce3314fc2920a48d1f12d45fd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTUtMS0xLTUwOTg_3abf5338-6c2d-4466-afbe-1caf50c01cc0"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i16adf08f770b46c8aa99e285f1f5c1ac_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTctMS0xLTUwOTg_73f09cd7-bcd8-407c-b5c0-4bb5018810d8"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1fabe70416074ebda423b8e2c3b19f93_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTktMS0xLTUwOTg_ac05242d-5098-471e-8e92-a721c82c2795"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMjMvZnJhZzpiZDU2MWE1NmFmMzc0YTJlODAxN2ZiNGFjMzhkYjMwZi90YWJsZTo1NTk4NmZhYjg2Nzk0NjNjODMxNjIyZmJmMWMwY2JiOS90YWJsZXJhbmdlOjU1OTg2ZmFiODY3OTQ2M2M4MzE2MjJmYmYxYzBjYmI5XzE2LTExLTEtMS01MDk4_c4c03530-d4b0-4404-b78f-8490674f471f"
      unitRef="usd">-317000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDM2_c9b3ec5b-d5a4-428a-b8bf-7c03533e422c">STOCK-BASED COMPENSATION &lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stock-based compensation is comprised of stock options, restricted stock units, performance-based restricted stock units, and restricted stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2014 and 2018 Omnibus Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the IPO, the Company&#x2019;s board of directors adopted, and the holder of a majority of the shares approved, the 2014 Omnibus Incentive Plan effective July 31, 2014 (the &#x201c;2014 Plan&#x201d;). The 2014 Plan provided certain members of management, employees, and directors of the Company and its subsidiaries with the opportunity to obtain various incentives, including grants of stock options, restricted stock units (defined below), and restricted stock. In October 2018, the Company&#x2019;s shareholders approved the 2018 Omnibus Incentive Plan (the &#x201c;2018 Plan&#x201d;), and, as a result, new awards may no longer be issued under the 2014 Plan, although it remains in effect as to any previously granted award. The 2018 Plan is substantially similar to the 2014 Plan, except that (a) a total of 15,600,000 shares of Common Stock (subject to adjustment) may be issued under the 2018 Plan, (b) each share of Common Stock issuable under the 2018 Plan pursuant to a restricted stock or restricted stock unit award will reduce the number of reserved shares by 2.25 shares, and (c) the 2018 Plan imposes a limit on the aggregate value of awards that may be made in a single year to a non-employee director. Both the 2014 Plan and the 2018 Plan permit &#x201c;net settlement&#x201d; of vested awards, pursuant to which the award holder forfeits a portion of the vested award to satisfy the purchase price (in the case of options), the holder&#x2019;s withholding tax obligation, if any (in all cases), or both. Where the holder net-settles the tax obligation, the Company pays the amount of the withholding tax to the U.S. government in cash, which is accounted for as an adjustment to Additional Paid in Capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Compensation Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock compensation expense recognized in the consolidated statements of operations was $51 million, $48 million, and $33 million in fiscal 2021, 2020, and 2019, respectively. Stock compensation expense is classified in selling, general, and administrative expenses as well as cost of sales. The Company has elected to account for forfeitures as they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options granted under the 2014 Plan or 2018 Plan, as applicable, during fiscal 2021, 2020, and 2019 had an intrinsic value of $5 million, $6 million, and $24 million, respectively, which represents approximately 231,000, 329,000, and 1,179,000 shares of Common Stock, respectively. Each stock option granted under the 2014 Plan or 2018 Plan vests in equal annual installments over a four-year period from the date of grant, contingent upon the participant&#x2019;s continued employment with the Company, except for a small number of grants that vest based on the achievement of operating performance targets set forth in the award documents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Methodology and Assumptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All outstanding stock options have an exercise price per share equal to the fair market value of one share of Common Stock on the date of grant. All outstanding stock options have a contractual term of 10&#160;years, subject to forfeiture under certain conditions upon separation of employment. The grant-date fair value is recognized as expense on a graded-vesting basis over the vesting period. The fair value of stock options is determined using the Black-Scholes-Merton option pricing model for service and performance-based awards, and an adaptation of the Black-Scholes-Merton option valuation model, which takes into consideration the internal rate of return thresholds, for market-based awards. This model adaptation is essentially equivalent to the use of a path dependent-lattice model. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average of assumptions used in estimating the fair value of stock options granted during each year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Public trading of the Common Stock commenced only in July 2014, and, as a result, there is only available limited relevant historical volatility experience; therefore, the expected volatility assumption is based on the historical volatility of the closing share prices of a comparable peer group. The Company selected peer companies from the pharmaceutical industry with similar characteristics, including market capitalization, number of employees and product focus.&#160;In addition, since the Company does not have a pattern of exercise behavior of option holders, the Company used the simplified method to determine the expected life of each option, which is the mid-point between the vesting date and the end of the contractual term. The risk-free interest-rate for the expected life of the option is based on the comparable U.S.&#160;Treasury yield curve in effect at the time of grant. The weighted-average grant-date fair value of stock options in fiscal 2021, 2020, and 2019 was $24.36 per share, $15.22 per share, and $9.49 per share, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity and shares subject to outstanding options for the fiscal year ended June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,997,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.63&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,229,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.01&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,453,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;870,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,527,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expired / Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,280,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,696,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vest and expected to vest as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,280,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,696,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested and exercisable as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.69&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,607,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2021, participants exercised options to purchase approximately 726,000 net settled shares, resulting in $27 million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2021 was $64 million. The total fair value of options vested during the period was $7 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2020, participants exercised options to purchase approximately 166,000&#160;net settled shares, resulting in $7 million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2020 was $18 million. The total fair value of options vested during the period was $4 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, $2 million of unrecognized compensation cost related to granted and not forfeited stock options is expected to be recognized as expense over a weighted-average period of approximately 1.8 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock and Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may grant to employees and members of its board of directors under the 2018 Plan (and formerly granted under the 2014 Plan) shares of restricted stock and units each representing the right to one share of Common Stock (&#x201c;restricted stock units&#x201d;). Since the IPO, the Company has granted to employees and directors restricted stock units and restricted stock that vest over specified periods as well as restricted stock units and restricted stock that have certain performance-related vesting requirements (&#x201c;performance stock units&#x201d; and &#x201c;performance stock,&#x201d; respectively). The restricted stock and restricted stock units granted during fiscal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 2021 and 2020 had grant date fair values aggregating $47 million and $43 million, respectively, which represent approximately 502,000 and 748,000 shares of Common Stock, respectively. Under the 2014 Plan or 2018 Plan, as appropriate, the performance stock and performance stock units vest upon achieving Company financial performance metrics established at the outset of the three-year performance period associated with each grant. The metrics for the fiscal 2019, 2020, and 2021 performance stock and performance stock unit grants were based on performance against a mix of adjusted EPS targets and relative total shareholder return (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RTSR&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) targets. Note that adjusted EPS is calculated as a quotient of tax-effected Adjusted EBITDA by the weighted average number of fully diluted shares, a financial measure that is not defined under U.S. GAAP and is subject to important limitations. The performance stock and performance stock units vest following the end of their respective three-year performance periods upon a determination of achievement relative to the targets. Each quarter during the period in which the performance stock and performance stock units are outstanding, the Company estimates the likelihood of such achievement by the end of the performance period in order to determine the probability of vesting. The number of shares actually earned at the end of the three-year period for the fiscal 2019, 2020 and 2021 grants will vary, based only on actual performance, from 0% to 200%, or from 0% to 150%, of the target number of performance stock or performance stock units specified on the date of grant, in the case of adjusted EPS and RTSR grants, respectively. Time-based restricted stock units and restricted stock generally vest on the second or third anniversary of the date of grant, subject to the participant&#x2019;s continued employment with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Methodology and Assumptions - Expense Recognition and Grant Date Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of (a) time-based restricted stock units and restricted stock are recognized as expense on a cliff-vesting schedule over the applicable vesting period and (b) performance shares and performance share units are re-assessed quarterly as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant date fair values of both time-based and performance-based shares and units are determined based on the number of shares subject to the grants and the fair value of the Common Stock on the dates of the grants, as determined by the closing market prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-Based Restricted Stock Units and Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested time-based restricted stock units and restricted stock for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Based Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adjusted EPS and RTSR-Based Performance Share Units and Performance Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested performance share units and performance shares for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Performance-Based Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation of RTSR Performance Shares and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RTSR performance share unit and performance share is determined using the Monte Carlo pricing model because the number of shares to be awarded is subject to a market condition. The Monte Carlo simulation is a generally accepted statistical technique used to simulate a range of possible future outcomes. Because the valuation model considers a range of possible outcomes, compensation cost is recognized regardless of whether the market condition is actually satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in estimating the fair value of the RTSR performance share units and performance shares granted during each year were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested RTSR performance share units and performance shares for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;RTSR Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2021, participants vested and settled 671,000 net settled shares, resulting in $31 million of cash paid on behalf of participants for withholding taxes. In fiscal 2020, participants vested and settled 734,000 net settled shares, resulting in $24 million of cash paid on behalf of participants for withholding taxes.&lt;/span&gt;&lt;/div&gt;As of June&#160;30, 2021, $54 million of unrecognized compensation cost related to restricted stock and restricted stock units (including performance shares and performance share units, respectively) is expected to be recognized as expense over a weighted-average period of approximately 1.9&#160;years. The weighted-average grant-date fair value of restricted stock and restricted stock units in fiscal 2021, 2020, and 2019 was $94.19, $57.17, and $44.65, respectively. The fair value of restricted stock units vested in fiscal 2021, 2020, and 2019 was $39 million, $35 million, and $13 million, respectively.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNTY_ff6b888d-df18-4458-a7e8-5dda23079594"
      unitRef="shares">15600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDI4_ea316afe-ebf8-494a-ab61-5e34ad16cf84"
      unitRef="shares">2.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNTQ_b978c74d-cf4a-4dda-9f48-74d97fa3f7bf"
      unitRef="usd">51000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNTg_6e136a50-5685-48eb-87ab-8af66d11981f"
      unitRef="usd">48000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzIzNjY_35e176d1-f2d4-4251-bbbb-06d7dd323f33"
      unitRef="usd">33000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxMzM_4f6c99cf-b2af-47bd-a882-9906de465e41"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxMzc_24d17f3a-55f6-4dcc-889a-35d7de65932f"
      unitRef="usd">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i226e7ad29001479db3560c191da2d80c_D20180701-20190630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxNDU_5d3368ee-7eb4-456f-8376-23d09fcd68d2"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i9ceb06aa7e2d40eb9e3d7af741dfb1ae_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxOTQ_b76ba68e-f5cf-4c7b-89f5-e3df4d0f622d"
      unitRef="shares">231000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="ifa00c20c01bc41bca56102a5ab3a684c_D20190701-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQxOTg_a2d55259-f7d5-48d8-9e32-098df18932a8"
      unitRef="shares">329000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i226e7ad29001479db3560c191da2d80c_D20180701-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQyMDY_2550ab85-f51d-41c7-a404-0b80f140995b"
      unitRef="shares">1179000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <ctlt:StockOptionGrantedContractualTerm
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzQ4MzE_13988ff7-8a1e-4dbd-9328-723934a0f205">P10Y</ctlt:StockOptionGrantedContractualTerm>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQ0_0b006c4c-d8e6-4b82-95b2-46c57d22f19a">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average of assumptions used in estimating the fair value of stock options granted during each year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib2bd505327db495a8249c5115973c38f_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItMS0xLTEtMA_5907c3ab-1285-4227-89b0-443e9bd6bad6"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItNS0xLTEtMA_71caabe8-5b3e-47f6-a4f0-0efb2d76579f"
      unitRef="number">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItNy0xLTEtMA_a2d833f6-6f4e-4a15-8329-897c14bce21f"
      unitRef="number">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i4c12a76e607440788d887a6561e62949_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItOS0xLTEtMA_70628cf6-2d6b-41a5-8e05-c3bf04a495ea"
      unitRef="number">0.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzItMTEtMS0xLTA_4717feee-79cb-4836-96c0-2f0eaecbe1fe"
      unitRef="number">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtMS0xLTEtMA_b04b0daa-851a-4ff5-8c2f-c53888b3fb75">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtNS0xLTEtMA_35bd0e86-b3d4-4327-85b4-f1c0dac9cfe8">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzMtOS0xLTEtMA_090a39c9-aca7-4f6d-b282-c2001494f097">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib2bd505327db495a8249c5115973c38f_D20200701-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtMS0xLTEtMA_1d4984f5-ca32-477f-90b2-1702ba60a97e"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0eee85a8dbdd4673922fe45bc35c2a3a_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtNS0xLTEtMA_bf14cce4-fc97-4683-a806-aada038a6832"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtNy0xLTEtMA_6da4e320-5206-413b-a589-2347faedea82"
      unitRef="number">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i4c12a76e607440788d887a6561e62949_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtOS0xLTEtMA_b30da5c5-aef9-481f-9d15-89853b7ead87"
      unitRef="number">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzQtMTEtMS0xLTA_a9fe75cc-dbfa-4e69-83fa-34b86fdede91"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare
      contextRef="iba09a50b28ce4491b65fefe388f2b77c_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtMS0xLTEtMA_61b4fafb-3bce-4604-93f9-9931afe615f5"
      unitRef="usdPerShare">0</ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare>
    <ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare
      contextRef="ic5705a45b17e45b08f1812d9463c621f_D20190701-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtNS0xLTEtMA_c7fe7117-0be0-4d2e-8399-4a426f82d2de"
      unitRef="usdPerShare">0</ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare>
    <ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare
      contextRef="i3d22a60d3d1d4c46adaa8bac25766efc_D20180701-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTphMTVjZjY2ZDZjYTk0NTA1YjQxOGE0NDk2ZjlkM2Y1Ni90YWJsZXJhbmdlOmExNWNmNjZkNmNhOTQ1MDViNDE4YTQ0OTZmOWQzZjU2XzUtOS0xLTEtMA_7441a120-9036-4bfd-803e-3289c96a08b8"
      unitRef="usdPerShare">0</ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1MjU_a20fa09f-a745-4a8e-86cf-1a02d5fcf0e2"
      unitRef="usdPerShare">24.36</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1Mzk_efe944f0-feb2-40e3-9087-929b2ea57c3c"
      unitRef="usdPerShare">15.22</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib7738cb71ee1402fa2cb64c881b42e46_I20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY1NTc_5972be3a-999e-401e-936a-56c316bd3dfc"
      unitRef="usdPerShare">9.49</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDM5_b281ec97-4817-4d7a-bf17-5ba0112f71da">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity and shares subject to outstanding options for the fiscal year ended June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,997,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.63&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,229,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;85,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.01&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,453,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;870,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,527,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expired / Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,280,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,696,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vest and expected to vest as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,280,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,696,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested and exercisable as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.69&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,607,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMS0xLTEtMA_be29843a-75a1-4d20-9f0b-41d560309baa"
      unitRef="usdPerShare">35.53</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i696afeb709ea478c8ccf7a35b63793d5_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMi0xLTEtMA_beabe15a-c692-4876-b3bd-07f14fa049a7"
      unitRef="shares">1997888</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="id4760a1c73cc4e78b46d8250df062040_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktMy0xLTEtMA_546dafb0-f63b-4095-9464-50c2a3c3ead9">P8Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i696afeb709ea478c8ccf7a35b63793d5_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNC0xLTEtMA_992071b4-70e1-4bfd-b13c-802962c1940c"
      unitRef="usd">76229381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNS0xLTEtMA_7ab7a9c8-55a2-4345-8d3d-fa8b028f685c"
      unitRef="shares">85482</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i1910093577c14f8a935dd760ba3c5e1d_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNi0xLTEtMA_b2031bb6-f5c1-48ed-a433-b905b005b263">P5Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib3c0613db8ec469b9d21f2ffc58ce438_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzktNy0xLTEtMA_86e86620-7400-4b95-835e-bed570965b82"
      unitRef="usd">2453938</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTEtMS0xLTA_78b80bbf-a855-46a0-8a10-d67a066cdc5c"
      unitRef="usdPerShare">88.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTItMS0xLTA_21410c6b-6586-4ced-b53d-94d49d8b721b"
      unitRef="shares">231352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEwLTUtMS0xLTA_a174ca1b-9f55-47fb-8bdc-0f2746021d22"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTEtMS0xLTA_fe7856df-007d-422d-8216-40ae0a5d8818"
      unitRef="usdPerShare">26.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTItMS0xLTA_bca11769-d253-41b1-b1f1-ed47c438bf2a"
      unitRef="shares">870210</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTQtMS0xLTA_ad609b46-d613-42bb-aa6c-0eb634e8a82a"
      unitRef="usd">63527893</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTUtMS0xLTA_3c61aee7-9cd5-4bd7-a515-9904830fa5d6"
      unitRef="shares">2492</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzExLTctMS0xLTA_97bba896-ccd6-4f41-b7dd-2f5fc9898b81"
      unitRef="usd">222251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTEtMS0xLTA_7b0a9a24-bad9-461a-80dd-29c50309f6ac"
      unitRef="usdPerShare">48.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTItMS0xLTA_d42be68a-ec1e-41d5-9dd3-0a8c9ecab4ed"
      unitRef="shares">73855</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEyLTUtMS0xLTA_43e340ca-4436-480f-98e0-8356b5f21593"
      unitRef="shares">82990</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTEtMS0xLTA_4bfae6dd-1d10-485b-9af4-0f0d0d837ac0"
      unitRef="usdPerShare">41.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTItMS0xLTA_361abf2a-1b0e-4598-a325-cd6fba9cfacf"
      unitRef="shares">5001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzEzLTUtMS0xLTA_8e03a8cf-a51a-4822-9187-368ff3f5e255"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTEtMS0xLTA_9b9882bb-f0b0-437e-9ff1-b4ef5f7bf677"
      unitRef="usdPerShare">49.77</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTItMS0xLTA_3222cfa5-40d6-4019-96cb-372d749144f6"
      unitRef="shares">1280174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTItMS0xLTA_92fa9489-3a68-4d8c-a8de-5028790cb029"
      unitRef="shares">1280174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTMtMS0xLTA_5d3d963b-c4c1-4b29-b4c7-c09f40db047b">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTQtMS0xLTA_c952409e-e3a7-4b94-9de7-964988244ec8"
      unitRef="usd">74696700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTYtMS0xLTA_03ed959a-3dd3-4c95-86d9-dd7c331b9a68">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE0LTctMS0xLTA_0c1c7322-2892-472e-ba95-38b7e05ef754"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTEtMS0xLTA_d96b9c25-7be3-4182-b436-09ce5dcb1b92"
      unitRef="usdPerShare">49.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTItMS0xLTA_7d4caefb-3dfc-4316-9dca-7829254bd3aa"
      unitRef="shares">1280174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTMtMS0xLTA_591e83f5-c280-4a0f-99b4-4b0e4b9521bd">P4Y11M1D</ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTQtMS0xLTA_9967c788-1c26-4e7f-9789-edeb5ee22286"
      unitRef="usd">74696700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTUtMS0xLTA_1b7c1e77-5e3c-410d-aadf-ef392d610950"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTYtMS0xLTA_477ff6c6-377d-458b-824e-05a5ac312abc">P0Y</ctlt:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE1LTctMS0xLTA_17cd9477-12b3-4314-9260-dab40f9fcdba"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTEtMS0xLTA_8f112b03-c6fc-4d30-85c6-7da917a04751"
      unitRef="usdPerShare">38.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTItMS0xLTA_1d83ecd7-e929-4d55-aae3-61290eba6268"
      unitRef="shares">480235</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8537fc35e54b4f339023800b403c82ef_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTMtMS0xLTA_271ef1fb-c907-4e39-b694-f78e5b4886f8">P6Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="iaa2bbd50d0184ad8a2f50b0a84e17355_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTQtMS0xLTA_94a7285b-df78-4185-8252-ff95aabad1a5"
      unitRef="usd">33607419</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTUtMS0xLTA_9cc0502f-3650-4382-b351-33a7bb98545e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="iedbb1269e11a4079b292052a9060792f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTYtMS0xLTA_8b2d224d-bab1-4945-831f-89db55f550b8">P0Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i7c79c1d61c8b42c0802484894294b5ab_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTozNGZjMmUzNTdlYmQ0MGM4YjQwYmI3NzRhODExMTVhZS90YWJsZXJhbmdlOjM0ZmMyZTM1N2ViZDQwYzhiNDBiYjc3NGE4MTExNWFlXzE2LTctMS0xLTA_b04d5a59-98e1-429b-920b-472a14324e98"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY3ODQ_42ea0aba-27d0-4e4c-a08a-f6e04f0dbbfa"
      unitRef="shares">726000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i671c59d76d904023aea5037521cce6c5_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY4MjA_fee0e9c3-71f6-4e57-a645-7cfb7cea13bb"
      unitRef="usd">27000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzY5NDc_2c746d67-f5d1-49c4-a3fa-7af0aded36ea"
      unitRef="usd">64000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcwMTI_0446cc17-df4b-44b6-be27-b3a7ef20f744"
      unitRef="usd">7000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcwODg_f4e1d759-223b-42d2-b86e-5352848a0957"
      unitRef="shares">166000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib842829e3f92462f8939cf2f247eae49_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcxMjQ_c54cacf5-c321-4710-91b9-77bf6901c4d3"
      unitRef="usd">7000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzcyNTE_0f7adc66-4240-4dfa-af58-065cd5dfd381"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzczMTY_3b9e09fa-78be-4e6e-98c0-14d4e626e06b"
      unitRef="usd">4000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzc1NDU_96baf624-1c31-4fc7-891f-69b183a23f13"
      unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzc3MjE_f63a4b04-6f32-40c4-9ff5-631a33e16655">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg0NzI_2b10a08f-d39d-4cd4-8059-04e198358b87"
      unitRef="usd">47000000</ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit>
    <ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg0Nzk_d9237148-4185-43d2-a1e1-9eb334b524ce"
      unitRef="usd">43000000</ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg1Mjc_ee26b7ac-3ac7-4898-b707-0713cd97ff6c"
      unitRef="shares">502000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzg1MzQ_373a4cfc-0014-4503-90dd-e3c97a78fdda"
      unitRef="shares">748000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQw_8c647e43-6b46-4dba-8678-2ee5cc62afed">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested time-based restricted stock units and restricted stock for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Time-Based Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6be771f1b5b348f8986509afc9283597_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzUtMS0xLTEtMA_ea68eb0c-d30c-45c7-ad94-6045c9f220b1"
      unitRef="shares">1081648</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6be771f1b5b348f8986509afc9283597_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzUtMy0xLTEtMA_edba076d-3f7c-4c21-a5fc-75ab9067e674"
      unitRef="usdPerShare">47.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzYtMS0xLTEtMA_ea2369a5-7566-4962-9f34-3be1c4ddf024"
      unitRef="shares">283495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzYtMy0xLTEtMA_6d8a40a3-b568-4c86-b545-11bc7f5ecc95"
      unitRef="usdPerShare">93.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzctMS0xLTEtMA_dad9a4a0-ff8b-4f9f-9be7-06bb18e725af"
      unitRef="shares">492274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzctMy0xLTEtMA_546453d1-fd1c-437e-9dea-db5ac76af5c4"
      unitRef="usdPerShare">43.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzgtMS0xLTEtMA_006ad979-2b11-49f0-967f-4fe23d00d3fa"
      unitRef="shares">108513</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8a613e7e09e24004aeb5a892e1f37333_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzgtMy0xLTEtMA_71fec20d-6a74-445a-9669-b89c3c6be00a"
      unitRef="usdPerShare">57.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i549198ff2e8b45a69be9153279060162_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzktMS0xLTEtMA_f89404a4-ed36-437f-a893-e6182ad853f2"
      unitRef="shares">764356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i549198ff2e8b45a69be9153279060162_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo2Nzc1ZTllNWFhNjY0ZTJiOGZmYTIwNWZmMzg5ZGY0ZS90YWJsZXJhbmdlOjY3NzVlOWU1YWE2NjRlMmI4ZmZhMjA1ZmYzODlkZjRlXzktMy0xLTEtMA_15b04191-bc70-4e95-9d05-451efe5e1343"
      unitRef="usdPerShare">65.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDMw_3dec8c6c-2cfa-4da9-90c9-0aed2724abcf">&lt;div style="text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adjusted EPS and RTSR-Based Performance Share Units and Performance Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested performance share units and performance shares for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Performance-Based Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6fcb40d78880478bae00f3e6351a3717_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzUtMS0xLTEtMA_16219ba6-4f29-407b-b0a5-b4c6e89a65f7"
      unitRef="shares">516416</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6fcb40d78880478bae00f3e6351a3717_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzUtMy0xLTEtMA_3b61e632-792d-44e2-bb8e-9668c8bf24d7"
      unitRef="usdPerShare">43.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzYtMS0xLTEtMA_3af9ce61-b2b3-406b-8d5b-18653c2dcb9c"
      unitRef="shares">113376</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzYtMy0xLTEtMA_4cccc69c-7d5c-4930-be5d-e8cb959455d4"
      unitRef="usdPerShare">88.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzctMS0xLTEtMA_a1132cc9-82ba-440a-8fed-90672df3c0e7"
      unitRef="shares">259730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzctMy0xLTEtMA_298696ac-e962-4336-923c-31f07f9746c9"
      unitRef="usdPerShare">36.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzgtMS0xLTEtMA_37810197-d880-4d80-9ede-027da8c2222c"
      unitRef="shares">-22033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie50f8cde55134bbc87d2fac94dd8b9e2_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzgtMy0xLTEtMA_2289c37e-d296-4464-ba64-7c8a1b3785ea"
      unitRef="usdPerShare">47.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzktMS0xLTEtMA_d0b0be03-8c01-4518-85de-535b443b110e"
      unitRef="shares">392095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2e0a10934e7447ce9f8e595a31cc2fcc_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTplYTI5ZDc3MTU4NmQ0YjczYWY3YmFiOGY1OGI4YTUyNy90YWJsZXJhbmdlOmVhMjlkNzcxNTg2ZDRiNzNhZjdiYWI4ZjU4YjhhNTI3XzktMy0xLTEtMA_0b2d9803-72bd-452c-bef4-f78a88fc4f3c"
      unitRef="usdPerShare">58.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDQx_cadc6eac-5451-49c6-933f-1bb189db5cf0">&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Valuation of RTSR Performance Shares and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RTSR performance share unit and performance share is determined using the Monte Carlo pricing model because the number of shares to be awarded is subject to a market condition. The Monte Carlo simulation is a generally accepted statistical technique used to simulate a range of possible future outcomes. Because the valuation model considers a range of possible outcomes, compensation cost is recognized regardless of whether the market condition is actually satisfied.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used in estimating the fair value of the RTSR performance share units and performance shares granted during each year were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItMS0xLTEtMA_5175e919-5aad-493b-826e-f484f44a3a82"
      unitRef="number">0.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItMy0xLTEtMA_79de8c3d-c13c-4895-a385-029fb74660b8"
      unitRef="number">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItNS0xLTEtMA_e5352635-3c20-40fa-8835-7eabf80cb378"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzItNy0xLTEtMA_e76af2c5-b0b2-46c6-b11a-09ef5035a5a6"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtMS0xLTEtMA_f23515af-d17e-4923-9b15-f4307a08ae43">P2Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtMy0xLTEtMA_4a1fcda0-a2e4-4a70-adf5-898a44d5c701">P2Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtNS0xLTEtMA_6127874c-be1f-413d-a229-a41e46f9dcba">P2Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzMtNy0xLTEtMA_02583bff-721d-4c5e-91ce-24e7a52f0754">P2Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1730caa4211844d082b1dbd594fa0e1d_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtMS0xLTEtMA_cb7cf9f1-99b9-4cad-ad2e-81aceb128371"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtMy0xLTEtMA_041c5b25-bd3f-418b-8aac-6651eb7a761d"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id2e5e93d0895458081db1e626ca0934d_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtNS0xLTEtMA_037d2105-447c-455a-922e-15496a58f01d"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzQtNy0xLTEtMA_52f9768c-5ce4-40e0-a891-604e2f3bcb04"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare
      contextRef="ieddff663b86f4c73a856875b79ff000f_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzUtMS0xLTEtMA_7434bba8-184a-4851-b43b-d03c0b862ab4"
      unitRef="usdPerShare">0</ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare>
    <ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare
      contextRef="icb682c3fc0d94ed29620278d8c510b23_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTpkODgyZGYzOTU0MzE0YzgwODljMzkyN2NiNmNkZGNkNS90YWJsZXJhbmdlOmQ4ODJkZjM5NTQzMTRjODA4OWMzOTI3Y2I2Y2RkY2Q1XzUtNS0xLTEtMA_a37b58fb-72a5-47b1-8067-d6fa5cb20333"
      unitRef="usdPerShare">0</ctlt:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDMy_73d5dfc7-0dcd-4d49-8ade-1a4edadcd213">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in unvested RTSR performance share units and performance shares for the fiscal year ended June&#160;30, 2021: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;RTSR Units and Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Cancelled/forfeited/adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Target Number Unvested as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzUtMS0xLTEtMA_30646461-632e-43f7-94a7-f214fe2876e5"
      unitRef="shares">427903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0d64c8c37b1d467f8cf2bafd98c8b016_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzUtMy0xLTEtMA_260b125d-9d0a-44d3-b084-b098699988ca"
      unitRef="usdPerShare">49.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzYtMS0xLTEtMA_25319c5d-03d5-430a-81d2-6bfa1a837758"
      unitRef="shares">105449</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzYtMy0xLTEtMA_3f51576c-48ac-46cf-ba09-6ca075144e3f"
      unitRef="usdPerShare">101.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzctMS0xLTEtMA_d5bbfed3-9885-4d53-bac0-c29b0e6b8012"
      unitRef="shares">202805</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzctMy0xLTEtMA_8a8ae6c7-05aa-4372-9fc3-a9f58db8f388"
      unitRef="usdPerShare">38.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzgtMS0xLTEtMA_2324c384-b9dd-4ed8-b65d-8f277ddead7b"
      unitRef="shares">3519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie251f1278632490e90c1f8cd720d5e89_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzgtMy0xLTEtMA_6ffed89f-b766-4c70-a922-1e9e7820a8d7"
      unitRef="usdPerShare">56.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id9521aa39e6a402cbbdddd19532b77db_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzktMS0xLTEtMA_85e14841-f301-495c-86dc-ba431ecd013f"
      unitRef="shares">327028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id9521aa39e6a402cbbdddd19532b77db_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90YWJsZTo3NzI2Nzc3NThjYjc0MGJiOGU1ZGE4OTY2NDg4MDMwMi90YWJsZXJhbmdlOjc3MjY3Nzc1OGNiNzQwYmI4ZTVkYTg5NjY0ODgwMzAyXzktMy0xLTEtMA_0cca288c-f520-4798-9bc7-0ccd7a504bf4"
      unitRef="usdPerShare">68.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNjUx_b184a7ee-9f64-43ae-a86f-947a580d173a"
      unitRef="shares">671000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNjg3_3ac705d1-2d7a-484e-8e6a-97295fd2b9d7"
      unitRef="usd">31000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyNzk4_5d33c8c9-6ba9-482c-b020-1fa3584b37c0"
      unitRef="shares">734000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyODM0_cbf6294d-e0ef-4cd7-86f3-723dbe71cd7a"
      unitRef="usd">24000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="iab90ce5a26874c06bf75dc201cdc453b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEyOTA5_718397b9-fc89-4771-9d3b-0d19e29a2be9"
      unitRef="usd">54000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMTYy_467cab5f-a604-4e44-9d16-bc911577258b">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMjkx_d93ed318-12b0-4448-98c5-cbcbbe3744d0"
      unitRef="usd">94.19</ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit>
    <ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit
      contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMjk1_008110d6-6b91-4708-aed6-1664d929fd6c"
      unitRef="usd">57.17</ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit>
    <ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit
      contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMzAz_31ddffe8-c202-4c93-80c5-e0ddbf9a94b7"
      unitRef="usd">44.65</ctlt:WeightedAverageGrantDateFairValueOfRestrictedStockUnit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib3e6e040ff704eda9a36c1d267f4dbf9_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzMzk4_f6532229-ef39-4e6e-87cd-b868ae427ef3"
      unitRef="usd">39000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i1cd858ee19a644768ecb8846c410bdce_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDAy_08142995-b746-499b-b279-205a900c006e"
      unitRef="usd">35000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i933c6bf3776c461c86fa1432b3cd5d96_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzIvZnJhZzoyZWU4YzZmM2JkNzk0ZGYxOTFkMjZlMzZlOTUwYjlhMy90ZXh0cmVnaW9uOjJlZThjNmYzYmQ3OTRkZjE5MWQyNmUzNmU5NTBiOWEzXzEzNDEw_e77901c1-ee4e-4570-985b-e9a4ed6bd879"
      unitRef="usd">13000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMDk_a82c64c1-2acb-430b-ae5f-32ae44c4cde6">OTHER EXPENSE, NET&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of other expense, net for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt refinancing costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency (gains) and losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)    Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#x2019;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#x2019;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)    Foreign currency (gains) and losses include both cash and non-cash transactions. &lt;/span&gt;&lt;/div&gt;(3)    Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTU_b6ebc903-5311-4484-a284-e3c513b1fc38">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of other expense, net for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended &#160;&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt refinancing costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency (gains) and losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)    Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#x2019;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#x2019;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)    Foreign currency (gains) and losses include both cash and non-cash transactions. &lt;/span&gt;&lt;/div&gt;(3)    Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05"
      unitRef="usd">18000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8"
      unitRef="usd">-5000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f"
      unitRef="usd">3000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0"
      unitRef="usd">5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9"
      unitRef="usd">13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktNS0xLTEtMA_37239cc0-b91a-4ce1-bd42-e142869274d5"
      unitRef="usd">-3000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktNy0xLTEtMA_eaf0f4d6-98fb-444b-9cc1-9b8c35d7d3a7"
      unitRef="usd">-8000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzktOS0xLTEtMA_0597521b-8d28-4730-8d41-d4ecebce9976"
      unitRef="usd">-3000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwMTQ_d52b983c-45de-49dd-a568-48d210ac5936"
      unitRef="usd">4000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwMzE_7797d350-b302-484e-8944-f13339717cbc"
      unitRef="usd">3000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkwNDk_57af6860-9fbb-4402-9e0e-a5072c904a4d"
      unitRef="usd">11000000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzE4OA_e022dc83-cc22-4e48-b17e-e192c42861ff"
      unitRef="usd">6000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQwOA_94a4e93d-9f63-44b4-999d-0d711190abc5"
      unitRef="usd">10000000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzQ5NDc4MDIzMjkxOTE_0a9804f2-63fd-476b-826f-d02b029a0eeb"
      unitRef="usd">17000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEyNjQ0MzgzNzIzOTc3_a10106dc-5e99-4b08-96dc-5103e5404caa"
      unitRef="usd">3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NTc_eef74991-e5eb-410c-8b6a-c81f6bad090d">LEASES&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain manufacturing and office facilities, land, vehicles, and equipment. The terms of these leases vary widely, although most have terms between 3 and 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recognizes a &#x201c;right-of-use&#x201d; asset and related lease liability at the commencement date of each lease based on the present value of the fixed lease payments over the expected lease term. The lease term for this purpose will include any renewal period where the Company determines that it is reasonably certain that it will exercise the option to renew. While certain leases also permit the Company to terminate the lease in advance of the nominal term upon payment of an associated penalty, the Company generally does not take into account potential early termination dates in its determination of the lease term as it is reasonably certain not to exercise an early-termination option as of the lease commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses its incremental borrowing rate, which represents the interest rate the Company would expect to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms, in order to calculate the present value of a lease, when the implicit discount rate for its leases is not readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed lease payments are recognized on straight-line basis over the lease term, while variable payments are recognized in the period incurred. As permitted by ASC 842, the Company has elected not to separate those components of a lease agreement not related to the leasing of an asset from those components that are related.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not record leases with an initial lease term of 12 months or less on its consolidated balance sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information concerning the leases recorded in the Company's consolidated balance sheet as of June&#160;30, 2021 is detailed in the following table:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Line item in the consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance at &lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term obligations and other       short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net lease costs for the fiscal year ended June&#160;30, 2021 reflected in the Company's consolidated statement of operations were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term lease cost amounted to $4 million during the fiscal year ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate related to the Company's right-of-use assets and lease liabilities as of June&#160;30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information concerning the cash-flow impact arising from the Company's leases for the fiscal year ended June&#160;30, 2021 recorded in the Company's unaudited consolidated statement of cash flows is detailed in the following table (in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Non-cash transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company expects that its future minimum lease payments will become due and payable as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NTg_8eb9010a-5e01-46dc-85cf-b6b8d98690ac">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information concerning the leases recorded in the Company's consolidated balance sheet as of June&#160;30, 2021 is detailed in the following table:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Line item in the consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Balance at &lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term obligations and other       short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term obligations, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzItMi0xLTEtMA_cdfe5463-afed-42aa-b1e6-7073915cd062"
      unitRef="usd">139000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzMtMi0xLTEtMA_03645225-b73f-49e9-abb2-14b63d4a4f21"
      unitRef="usd">84000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzYtMi0xLTEtMA_8a658523-ba41-4082-be42-cd11f81e32ab"
      unitRef="usd">15000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzctMi0xLTEtMA_63c1f3de-5508-492e-a044-0fad99ade9c7"
      unitRef="usd">16000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzEwLTItMS0xLTA_4a157271-9ce5-48ba-aa05-a46c3fd1d0d7"
      unitRef="usd">178000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkMzYzNTQ0NjMzNjY0NTc2OGM3YjI2MzEzNTZmNzFhOC90YWJsZXJhbmdlOmQzNjM1NDQ2MzM2NjQ1NzY4YzdiMjYzMTM1NmY3MWE4XzExLTItMS0xLTA_b7758115-f97a-43d8-aa9e-a3ba58ae35bb"
      unitRef="usd">73000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjA_69d8f6ad-37e2-4f58-8c3e-e2cf0bc372ee">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net lease costs for the fiscal year ended June&#160;30, 2021 reflected in the Company's consolidated statement of operations were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term lease cost amounted to $4 million during the fiscal year ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate related to the Company's right-of-use assets and lease liabilities as of June&#160;30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzItMi0xLTEtMA_5b53c311-994c-49c7-a367-e4c285c5d47b"
      unitRef="usd">16000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzMtMi0xLTEtMA_fbd9f622-fabd-4d60-8c1e-c0a33f37198f"
      unitRef="usd">11000000</us-gaap:FinanceLeaseInterestExpense>
    <ctlt:FinanceLeaseExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzQtMi0xLTEtMA_3429538b-139a-42ab-b5a7-c71b8136a4ca"
      unitRef="usd">27000000</ctlt:FinanceLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzYtMi0xLTEtMA_41a1201c-7787-42d4-afe0-f108e0f3746b"
      unitRef="usd">29000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:VariableLeaseCost
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzctMi0xLTEtMA_489b6680-87c5-460d-ac2c-c2c626ec355c"
      unitRef="usd">10000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTo2NDc0ODdlODVlNjk0OGEwYjQzNjI2YWI5NGY1MzAyZi90YWJsZXJhbmdlOjY0NzQ4N2U4NWU2OTQ4YTBiNDM2MjZhYjk0ZjUzMDJmXzgtMi0xLTEtMA_59102bdd-cd64-462d-a6a8-764435f7094b"
      unitRef="usd">66000000</us-gaap:LeaseCost>
    <ctlt:ShortTermLeaseCosts
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzIxOTU_e01ceff5-89d6-462b-8695-547cf5943df8"
      unitRef="usd">4000000</ctlt:ShortTermLeaseCosts>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzEtMS0xLTEtMA_dfc69862-84b0-4d80-a797-95234f8b20c5">P12Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzItMS0xLTEtMA_6e3950ad-57dd-45d1-908f-fe4936522826">P11Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzQtMS0xLTEtMA_6da0bc3c-d540-422f-8a8a-75a9fcf5334c"
      unitRef="number">0.072</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpiYmU5ZDIxN2M0MjA0ZDVjYjg0NjY0ZmUwOTc2M2E4Yi90YWJsZXJhbmdlOmJiZTlkMjE3YzQyMDRkNWNiODQ2NjRmZTA5NzYzYThiXzUtMS0xLTEtMA_ed855a1e-a5ef-4cbc-ae67-03aa70a06f3d"
      unitRef="number">0.048</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjE_d8eb48d1-6496-426b-8010-157d87d893cc">Supplemental information concerning the cash-flow impact arising from the Company's leases for the fiscal year ended June&#160;30, 2021 recorded in the Company's unaudited consolidated statement of cash flows is detailed in the following table (in &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended&#160;&lt;br/&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"&gt;Non-cash transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzItMy0xLTEtMA_8b54654d-34d5-4a47-acd6-cbc1ce8ebc1b"
      unitRef="usd">15000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzMtMy0xLTEtMA_541dd33b-82b6-4278-97d9-db82bfdba1ed"
      unitRef="usd">10000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzQtMy0xLTEtMA_4bf3af44-b237-4551-88e4-8b08d6c6ce48"
      unitRef="usd">21000000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzctMy0xLTEtMA_22e7424c-ffcb-47b0-b2fd-10c0199833c8"
      unitRef="usd">57000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTozZjc4ODY3NjNhZTE0NGVmYjcyOGZmYjJhMmEzNDVjMS90YWJsZXJhbmdlOjNmNzg4Njc2M2FlMTQ0ZWZiNzI4ZmZiMmEyYTM0NWMxXzgtMy0xLTEtMA_e27e29be-a4e2-4c1c-a2e0-26339f4fab87"
      unitRef="usd">13000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90ZXh0cmVnaW9uOmNlNDQ1MmIwYzQyYzQ3OTQ5NjBkM2JjNzEyNzgzNmNkXzI3NjI_738d5932-bffa-44ae-8d7c-cab8af78a0d0">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company expects that its future minimum lease payments will become due and payable as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtMS0xLTEtMA_a52ad4da-f4b8-4766-8bab-ea904c8316c0"
      unitRef="usd">26000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtMy0xLTEtMA_e489498c-4d6a-4bc5-9cfe-6e766e560645"
      unitRef="usd">18000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <ctlt:TotalLeaseLiabilityPaymentsDueYearOne
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzEtNS0xLTEtMA_77c0bcd8-4346-4750-b313-b45df1a450de"
      unitRef="usd">44000000</ctlt:TotalLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItMS0xLTEtMA_d90c5f39-dedf-4452-a214-63b9f6f71416"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItMy0xLTEtMA_97a91670-b631-41e9-9986-964a9d9aceb8"
      unitRef="usd">17000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <ctlt:TotalLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzItNS0xLTEtMA_ef158506-9117-424d-84ee-bcbce8991cdd"
      unitRef="usd">42000000</ctlt:TotalLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtMS0xLTEtMA_8bad36be-3f8c-4abf-a91e-1391355ef277"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtMy0xLTEtMA_96571199-472d-44bb-8779-72f0a54c8cb9"
      unitRef="usd">14000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <ctlt:TotalLeaseLiabilityPaymentsDueYearThree
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzMtNS0xLTEtMA_35ddc456-81f9-4bd4-96d7-7045c8eba61f"
      unitRef="usd">38000000</ctlt:TotalLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtMS0xLTEtMA_523e22ee-1a09-4f9f-8d60-bf7a9e09f065"
      unitRef="usd">22000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtMy0xLTEtMA_c0aef192-8a88-4698-9b88-6d1eb146fa4a"
      unitRef="usd">11000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <ctlt:TotalLeaseLiabilityPaymentsDueYearFour
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzQtNS0xLTEtMA_d8809504-0b38-4797-88ad-6258c6838071"
      unitRef="usd">33000000</ctlt:TotalLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtMS0xLTEtMA_6743c23e-6899-4e95-af3e-9f69bddbebdd"
      unitRef="usd">18000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtMy0xLTEtMA_07c20d36-5be7-4bf4-b89d-f9bad6c4477d"
      unitRef="usd">9000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <ctlt:TotalLeaseLiabilityPaymentsDueYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzUtNS0xLTEtMA_91c5c8eb-922f-4d20-9200-af4ee28e2db6"
      unitRef="usd">27000000</ctlt:TotalLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtMS0xLTEtMA_cb33289a-b0f4-4f13-9d59-7c1a0c8f00a7"
      unitRef="usd">175000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtMy0xLTEtMA_a8918fcf-41d7-495c-97a7-c861877d0054"
      unitRef="usd">52000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <ctlt:TotalLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzYtNS0xLTEtMA_aa7a1cb1-38c8-4dd1-99cb-4c90276cb560"
      unitRef="usd">227000000</ctlt:TotalLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctMS0xLTEtMA_eedc73f9-6e4e-4bd1-8536-4174f201c9f6"
      unitRef="usd">290000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctMy0xLTEtMA_95cd3224-5d29-4ce4-bb56-f4588cd6e13e"
      unitRef="usd">121000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <ctlt:TotalLeaseLiabilityPaymentsDue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzctNS0xLTEtMA_e873a85c-a72a-4056-85ea-59a8a88c72fb"
      unitRef="usd">411000000</ctlt:TotalLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtMS0xLTEtMA_24e84c34-121d-4b6f-aa5f-89b7664074d6"
      unitRef="usd">97000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtMy0xLTEtMA_5981fe65-181a-4901-8cba-639ed29e591c"
      unitRef="usd">32000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <ctlt:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzgtNS0xLTEtMA_a81f623e-783d-46c1-a0f2-9c4feb8dfbec"
      unitRef="usd">129000000</ctlt:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktMS0xLTEtMA_f7462ace-07ed-43ef-a9be-c61e716d906b"
      unitRef="usd">193000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktMy0xLTEtMA_1e68e10a-be76-4064-a5ef-1adb8e4dd905"
      unitRef="usd">89000000</us-gaap:OperatingLeaseLiability>
    <ctlt:TotalLeaseLiability
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDEvZnJhZzpjZTQ0NTJiMGM0MmM0Nzk0OTYwZDNiYzcxMjc4MzZjZC90YWJsZTpkYzcxNDE2M2M1YjY0ZDhiYWU4YTYzZDFiOGMxNTc3Yi90YWJsZXJhbmdlOmRjNzE0MTYzYzViNjRkOGJhZThhNjNkMWI4YzE1NzdiXzktNS0xLTEtMA_93e4512b-ea5c-4b2a-a285-7540dbbbf069"
      unitRef="usd">282000000</ctlt:TotalLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNDcvZnJhZzoxZGQ0OWZiNTMwMjI0OTY3YmYyMTM3M2E2NmE0Yjg2Yy90ZXh0cmVnaW9uOjFkZDQ5ZmI1MzAyMjQ5NjdiZjIxMzczYTY2YTRiODZjXzE1ODg_0d43ccb4-474b-47c7-ab14-25c490e7256d">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may be involved in legal proceedings arising in the ordinary course of business, including, without limitation, inquiries and claims concerning environmental contamination as well as litigation and allegations in connection with acquisitions, product liability, manufacturing or packaging defects, and claims for reimbursement for the cost of lost or damaged active pharmaceutical ingredients, the cost of any of which could be significant. The Company intends to vigorously defend itself against any such litigation and does not currently believe that the outcome of any such litigation will have a material adverse effect on the Company&#x2019;s financial statements. In addition, the healthcare industry is highly regulated and government agencies continue to scrutinize certain practices affecting government programs and otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information relating to the business practices and activities of customers or suppliers from various governmental agencies or private parties, including from state attorneys general, the U.S. Department of Justice, and private parties engaged in patent infringement, antitrust, tort, and other litigation. The Company generally responds to such subpoenas and requests in a timely and thorough manner, which responses sometimes require considerable time and effort and can result in considerable costs being incurred. The Company expects to incur costs in future periods in connection with future requests.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40">SEGMENT AND GEOGRAPHIC INFORMATION&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company conducts its business within the following segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Company evaluates the performance of its segments based on segment revenue and segment earnings before non-controlling interest, other (income) expense, impairments, restructuring costs, interest expense, income tax (benefit) expense, and depreciation and amortization (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment EBITDA&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The Company considers its reporting segments results in the context of a similar Company-wide measure: EBITDA from operations, which the Company defines as consolidated earnings from operations before interest expense, income tax (benefit) expense, depreciation and amortization, adjusted for the income or loss attributable to non-controlling interest. Neither Segment EBITDA nor EBITDA from operations is defined under U.S. &lt;/span&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GAAP, and neither is a measure of operating income, operating performance, or liquidity presented in accordance with U.S. GAAP. Each of these non-GAAP measures is subject to important limitations. These consolidated financial statements include information concerning Segment EBITDA and EBITDA from operations (a) because Segment EBITDA and EBITDA from operations are operational measures used by management in the assessment of the operating segments, the allocation of resources to the segments, and the setting of strategic goals and annual goals for the segments, and (b) in order to provide supplemental information that the Company considers relevant for the readers of the consolidated financial statements, but such information is not meant to replace or supersede U.S. GAAP measures. The Company&#x2019;s presentation of Segment EBITDA and EBITDA from operations may not be comparable to similarly titled measures used by other companies. The most directly comparable U.S. GAAP measure to EBITDA from operations is net earnings. Included in this Note is a reconciliation of net earnings to EBITDA from operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables include net revenue and Segment EBITDA for each of the Company's current reporting segments during the fiscal years ended June&#160;30, 2021, 2020, and 2019:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment EBITDA reconciled to net earnings:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges and gain (loss) on sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other special items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sale of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-allocated corporate costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unallocated costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)    Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#x2019;s cell and gene therapy acquisitions and the disposal of a facility in Australia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)    Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)     Refer to Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes total assets for each segment, as well as reconciling items necessary to total the amounts reported in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Total Assets &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capital Expenditures &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; by geographic area: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Long-Lived Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Long-lived assets include property, plant, and equipment, net of accumulated depreciation.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables include net revenue and Segment EBITDA for each of the Company's current reporting segments during the fiscal years ended June&#160;30, 2021, 2020, and 2019:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inter-segment revenue elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment EBITDA reconciled to net earnings:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciling items to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges and gain (loss) on sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other special items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on sale of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-allocated corporate costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unallocated costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)    Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#x2019;s cell and gene therapy acquisitions and the disposal of a facility in Australia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)    Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)     Refer to Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.&lt;/span&gt;&lt;/div&gt;</ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock>
    <us-gaap:Revenues
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtMS0xLTEtMA_b78bdfaf-5c4c-48b8-a4d3-897704a0e901"
      unitRef="usd">1928000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtMy0xLTEtMA_628169c3-05a7-4781-a1c3-903412d7be4b"
      unitRef="usd">1021000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzMtNS0xLTEtMA_c82b9fab-a55f-4b2c-861f-400498b53325"
      unitRef="usd">573000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtMS0xLTEtMA_697a891b-3515-4764-8a13-9ee5771f9ef3"
      unitRef="usd">1012000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtMy0xLTEtMA_3f91e120-3954-4c02-b675-0e526b327c75"
      unitRef="usd">1062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzQtNS0xLTEtMA_fc1f300b-8ea2-4f1c-9cb4-6209e25d94a5"
      unitRef="usd">1039000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtMS0xLTEtMA_dee04950-925a-4af2-8269-d64d14da0267"
      unitRef="usd">686000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtMy0xLTEtMA_a3e80105-aaa8-4a80-836c-925d02b23410"
      unitRef="usd">676000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzUtNS0xLTEtMA_745a835d-ff9d-4294-929c-c4072f06798a"
      unitRef="usd">598000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtMS0xLTEtMA_73c35975-78d1-4d63-84f2-4257526dfc3e"
      unitRef="usd">391000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtMy0xLTEtMA_434b8e48-ee6c-428d-8726-4206a04b7e7a"
      unitRef="usd">345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzYtNS0xLTEtMA_56e0188d-7c80-401a-b171-f65e2e316f3f"
      unitRef="usd">322000000</us-gaap:Revenues>
    <ctlt:SegmentReportingInformationInterSegmentRevenueElimination
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctMS0xLTEtMA_8c368462-168e-4ba3-8cb0-152e30584671"
      unitRef="usd">-19000000</ctlt:SegmentReportingInformationInterSegmentRevenueElimination>
    <ctlt:SegmentReportingInformationInterSegmentRevenueElimination
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctMy0xLTEtMA_40fbf22e-1a7b-47c8-9784-eeb68754fb3e"
      unitRef="usd">-10000000</ctlt:SegmentReportingInformationInterSegmentRevenueElimination>
    <ctlt:SegmentReportingInformationInterSegmentRevenueElimination
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzctNS0xLTEtMA_2c05fb1b-0ee1-4b59-9fc6-a904b100f34c"
      unitRef="usd">-14000000</ctlt:SegmentReportingInformationInterSegmentRevenueElimination>
    <us-gaap:Revenues
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtMS0xLTEtMA_3f1ccd72-43dd-4019-b357-845871c7b151"
      unitRef="usd">3998000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtMy0xLTEtMA_bfdfaab8-2717-425c-a4d0-417ee05996fb"
      unitRef="usd">3094000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZToxNWM5YTg0NDFkZGI0ZDkxOWJmNmMyMDBhMzllODcxOC90YWJsZXJhbmdlOjE1YzlhODQ0MWRkYjRkOTE5YmY2YzIwMGEzOWU4NzE4XzgtNS0xLTEtMA_48ab64f7-70a3-4641-a8a5-4c31b5814d48"
      unitRef="usd">2518000000</us-gaap:Revenues>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtMS0xLTEtMA_6010e54a-aeae-4ad3-8154-6d97e32803cc"
      unitRef="usd">608000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtMy0xLTEtMA_de646374-64be-47b5-bc31-d92edfb6a314"
      unitRef="usd">237000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzMtNS0xLTEtMA_581a3042-6a4b-4b5d-8f07-49cda3758217"
      unitRef="usd">147000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtMS0xLTEtMA_234b16d6-a96f-4e1e-a864-51f20b37cd36"
      unitRef="usd">237000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtMy0xLTEtMA_2b945f9a-bfab-43f5-9c29-2cc64d2e05c3"
      unitRef="usd">257000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzQtNS0xLTEtMA_fe3a49db-21e6-4331-ab70-c1243a973c44"
      unitRef="usd">236000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtMS0xLTEtMA_2e39d7c4-1e06-4e03-bdfd-aa8259145015"
      unitRef="usd">160000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtMy0xLTEtMA_20154d36-37af-443a-9785-7a0f9f8b9dbf"
      unitRef="usd">201000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzUtNS0xLTEtMA_53ef3271-a87e-45b5-bb1b-6ed1cae5b0ce"
      unitRef="usd">175000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtMS0xLTEtMA_c6940e4e-89f5-4317-b2b8-984e30f115f8"
      unitRef="usd">108000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtMy0xLTEtMA_b824e9b3-3c8d-468a-a6c3-77c8c529f51c"
      unitRef="usd">91000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzYtNS0xLTEtMA_36689440-a7af-44cf-915b-b5cf667a8329"
      unitRef="usd">85000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i2bd515f3814a4c76bab0cb060aab91ef_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctMS0xLTEtMA_fb8118b2-9781-4165-b034-50f904aa4ce0"
      unitRef="usd">1113000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="i2d88dad07c8b4257bc335a79b87e5840_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctMy0xLTEtMA_c866367a-2dbe-4172-9f41-a55086dd5a8c"
      unitRef="usd">786000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization
      contextRef="ia9126ac8ef8946a0984ee537fe89c5a6_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzctNS0xLTEtMA_432e9b4a-b9fd-4264-959f-47b44488ad9e"
      unitRef="usd">643000000</ctlt:SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktMS0xLTEtMA_08be16a0-eb59-4ade-817c-e302bcc1f8b8"
      unitRef="usd">-1000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktMy0xLTEtMA_fc7016cd-4c5a-447c-9fdd-94d91beb3525"
      unitRef="usd">146000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzktNS0xLTEtMA_b044a391-528f-4f02-8218-432338e84444"
      unitRef="usd">143000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTEtMS0xLTA_480f62d4-6c81-4470-8ee1-59a359e90e83"
      unitRef="usd">289000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTMtMS0xLTA_61031c6b-c0ae-400c-94b1-e5eaa672cb01"
      unitRef="usd">254000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEwLTUtMS0xLTA_4429bb66-9c4f-4bee-8154-9fbb9e95c344"
      unitRef="usd">229000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTEtMS0xLTA_c0402fc3-a03d-49f8-b7a0-9a5530e3cf00"
      unitRef="usd">-110000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTMtMS0xLTA_a1d3017a-089b-4fac-9e3c-d3221cbdd3f8"
      unitRef="usd">-126000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzExLTUtMS0xLTA_1eee9496-4f6f-4a1a-a8b3-6e73fe347092"
      unitRef="usd">-111000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTEtMS0xLTA_8f1e5ced-5c3f-4201-be62-60256ba6b443"
      unitRef="usd">130000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTMtMS0xLTA_0458cdd8-27f6-4f1a-8b35-c427b850a1c2"
      unitRef="usd">39000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzEyLTUtMS0xLTA_5445cee7-8b68-447b-894b-9bc2768444f2"
      unitRef="usd">23000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTEtMS0xLTA_f9cd8cd8-2620-43f6-a7ca-d62638c2d27a"
      unitRef="usd">585000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTMtMS0xLTA_5d139d54-e786-44f6-94d5-fe13ca54f837"
      unitRef="usd">221000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTplNzFlMmJhYjYzOGU0ODRmOWNkMzY1OWQxMmRiNWQzNi90YWJsZXJhbmdlOmU3MWUyYmFiNjM4ZTQ4NGY5Y2QzNjU5ZDEyZGI1ZDM2XzE0LTUtMS0xLTA_d2059b2f-6c64-4ccc-9c48-989de01575ea"
      unitRef="usd">137000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItMS0xLTEtMA_94c9cf7e-8513-4535-9166-76877bfb41ea"
      unitRef="usd">9000000</ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets>
    <ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItMy0xLTEtMA_c026a663-f664-4426-b142-724a98a737c2"
      unitRef="usd">5000000</ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets>
    <ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzItNS0xLTEtMA_1195b58f-1666-47bc-88ec-ca3effa0aaf9"
      unitRef="usd">5000000</ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtMS0xLTEtMA_a050b05e-a6aa-4ff5-86ed-a5ddb3cce614"
      unitRef="usd">51000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtMy0xLTEtMA_feecf005-88a6-44a8-93db-48130ad4cb23"
      unitRef="usd">48000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzMtNS0xLTEtMA_dc2a4d5b-dde5-4114-9688-dea64c8fc0f7"
      unitRef="usd">33000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ctlt:RestructuringAndOtherSpecialItems
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621"
      unitRef="usd">31000000</ctlt:RestructuringAndOtherSpecialItems>
    <ctlt:RestructuringAndOtherSpecialItems
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163"
      unitRef="usd">42000000</ctlt:RestructuringAndOtherSpecialItems>
    <ctlt:RestructuringAndOtherSpecialItems
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb"
      unitRef="usd">58000000</ctlt:RestructuringAndOtherSpecialItems>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a"
      unitRef="usd">182000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a"
      unitRef="usd">-1000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa"
      unitRef="usd">3000000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed"
      unitRef="usd">8000000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d"
      unitRef="usd">3000000</us-gaap:OtherNonrecurringIncomeExpense>
    <ctlt:NonAllocatedCorporateCostsNet
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktMS0xLTEtMA_a9142283-5106-48a7-a28e-4442c5e85a63"
      unitRef="usd">87000000</ctlt:NonAllocatedCorporateCostsNet>
    <ctlt:NonAllocatedCorporateCostsNet
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktMy0xLTEtMA_ea2167c5-08b8-4b41-84a6-b23806ac65ea"
      unitRef="usd">42000000</ctlt:NonAllocatedCorporateCostsNet>
    <ctlt:NonAllocatedCorporateCostsNet
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzktNS0xLTEtMA_e9642bf5-8901-4e32-b38a-b0291212a088"
      unitRef="usd">44000000</ctlt:NonAllocatedCorporateCostsNet>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTEtMS0xLTA_8aa5bc24-dad0-486d-be85-e801e8eefdb9"
      unitRef="usd">-1000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTMtMS0xLTA_d9c355b1-0761-4e96-8435-09b4f4f06dd4"
      unitRef="usd">146000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <ctlt:SegmentReportingInformationUnallocatedExpense
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzEwLTUtMS0xLTA_ec2a859b-bfda-4c20-bad9-991224cd1f15"
      unitRef="usd">143000000</ctlt:SegmentReportingInformationUnallocatedExpense>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNjA_ec132e38-a88f-4aad-bc38-c3f17f2d422f">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes total assets for each segment, as well as reconciling items necessary to total the amounts reported in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Total Assets &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="ia0d420fead59462095697a3993d8f4e5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzEtMS0xLTEtMA_ee227c73-fca0-4938-b254-d683632ace4c"
      unitRef="usd">4973000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibe2726cb57c9441d90eb8e733906a808_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzEtMy0xLTEtMA_b72362e6-0ac4-4dc7-9a33-a687b97dced6"
      unitRef="usd">3775000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5ebdb26351324dc59f4adf268bf038a1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzItMS0xLTEtMA_a6ebb868-6abe-46e0-a019-9676caef86e5"
      unitRef="usd">1604000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id7061380698a4b9395a2f0cfba0d8aac_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzItMy0xLTEtMA_1218af07-1013-4137-80c2-06d7fdbe3e67"
      unitRef="usd">1502000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia7814e488a794292a9e3f5a1d348951e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzMtMS0xLTEtMA_ddfb0cab-68de-4c25-8955-193a5e3a45f4"
      unitRef="usd">1269000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i171b9881ff2c45b4a4ce33a84e36f3d2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzMtMy0xLTEtMA_1c9587ef-d0b7-42ac-8d46-938c5df40c58"
      unitRef="usd">1248000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i88402b35bd0c42118b8f0b1db0690925_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzQtMS0xLTEtMA_be1b240b-b89c-4ce7-82b5-5782ba5b906b"
      unitRef="usd">483000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iab98274d571d4d449f30491cdd65c962_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzQtMy0xLTEtMA_c92878ff-e72d-41d7-a2d8-e15d1758ef30"
      unitRef="usd">451000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i32780b0807f04e8886a1644091ccd209_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzUtMS0xLTEtMA_8885cc27-c277-451b-9e5f-fa90554fb963"
      unitRef="usd">783000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2efc8c22dd864f77bfa1a9eeb9bf0b27_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzUtMy0xLTEtMA_a6c521ff-d1e2-4700-b65b-ae9cfade2183"
      unitRef="usd">801000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzYtMS0xLTEtMA_98bcdeb5-a6b6-4ae3-84da-f63ab9aa0b14"
      unitRef="usd">9112000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTo5NTdiMTBmYzhlNTc0ZjFiODdhNDE2OGFkM2M3MTBjNy90YWJsZXJhbmdlOjk1N2IxMGZjOGU1NzRmMWI4N2E0MTY4YWQzYzcxMGM3XzYtMy0xLTEtMA_94b1a72b-8aea-41ee-b51a-592856962ec9"
      unitRef="usd">7777000000</us-gaap:Assets>
    <ctlt:ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTY_35e66337-7888-422a-a822-deb1f0071a57">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capital Expenditures &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biologics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Softgel and Oral Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral and Specialty Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical Supply Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if6cb136c77c04c04a63dc800213368c0_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMS0xLTEtNjMyMQ_7433332e-1525-4637-bb16-17f5148ed3fe"
      unitRef="usd">516000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i900c9ca5cf284816a171e02078943bb0_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMy0xLTEtNjMyMQ_ed1dd3e0-ae24-40a2-b130-ed784e38c4dc"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4758e061601246c28a5892fd160aa21b_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItNS0xLTEtNjMyMQ_9172a329-8e17-40a6-871c-31fdecc9a7dc"
      unitRef="usd">79000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMS0xLTEtMA_988d1dca-7f39-4353-b209-52783bd5c4c7"
      unitRef="usd">61000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id52260c3af8b48c8a97d934dd9d91d24_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItMy0xLTEtMA_c731a624-d178-4673-990a-f3b148a619a2"
      unitRef="usd">54000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4cf1fd86b75e452c8576e3a169416b6c_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzItNS0xLTEtMA_033e39da-cb0b-4719-8c91-41b88aabe3ea"
      unitRef="usd">83000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id4f020c2ef0243488ba1047d63cabd24_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtMS0xLTEtMA_65be1e50-0928-4f4a-b6fa-1fe82f1a36d9"
      unitRef="usd">64000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i35e6ed543fa4430dad3d3e31ba3a1c57_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtMy0xLTEtMA_6228c795-61ec-4c48-8844-9d9ec8fdeee8"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8255b75ca674484f85321eed13714758_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzQtNS0xLTEtMA_c99b15a9-1c60-4684-b844-d05024bc2ddd"
      unitRef="usd">29000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i63353789ae524a5b9930c1b94a9d75d8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtMS0xLTEtMA_965e76ee-6c15-4240-9652-b54d6deaaf9b"
      unitRef="usd">26000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5e66019cf9ea42369e485cb03141d0e3_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtMy0xLTEtMA_6b1b4ce9-faab-4704-b4a2-903674244bd6"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i65d78abb95eb435680e25eba4cbe4ba9_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzUtNS0xLTEtMA_e4b57264-aa33-4e86-b2b6-bacbae94e665"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i56d8aebfe31c4223803b5f24bc0f29f8_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtMS0xLTEtMA_6ca22022-720c-4463-a5f3-6c3e6315808a"
      unitRef="usd">19000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i733c8bb4e1014e9e8cfe80267a047ad9_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtMy0xLTEtMA_b7abf8ac-e0cc-44ba-a99d-21e434e49168"
      unitRef="usd">17000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i62be34a4b4e64451b2e516bfcb375e8a_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzYtNS0xLTEtMA_6d5b82bd-400f-4d66-879d-8641e212b481"
      unitRef="usd">24000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctMS0xLTEtMA_76f03209-bbf6-4aad-b678-c77a5d22799a"
      unitRef="usd">686000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctMy0xLTEtMA_e4dd79b8-efb4-46ba-a080-dc58aca21b4b"
      unitRef="usd">466000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib17a95384f7640ea92a2964cc8752c2f_D20180701-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTowMTAxOTM2ZDhjZTk0ZjhlYTI2ZGEzNjg2MDUzNmQ3OS90YWJsZXJhbmdlOjAxMDE5MzZkOGNlOTRmOGVhMjZkYTM2ODYwNTM2ZDc5XzctNS0xLTEtMA_cf7e49ea-d827-4fd9-8f75-504deb51e31c"
      unitRef="usd">218000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <ctlt:ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTE_41a46ef2-081b-41da-b1b7-da14c35f8554">&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; by geographic area: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Long-Lived Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;Long-lived assets include property, plant, and equipment, net of accumulated depreciation.&lt;/span&gt;&lt;/div&gt;</ctlt:ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie0b3a62ee7424499b7a078665cc2f930_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e"
      unitRef="usd">1867000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i651f15c7ca5a4375a12683f4493dd86d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff"
      unitRef="usd">1396000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7abb0547c47a44e190eab0c56374dc2b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07"
      unitRef="usd">541000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icb9b2c18f5a64a6084f50a6976406e31_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab"
      unitRef="usd">405000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic71b854cd3924d249f25376d9c0ad39a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1"
      unitRef="usd">116000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i971cccffdd7d479f8c71a1f66c16fc3a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812"
      unitRef="usd">100000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483"
      unitRef="usd">2524000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7"
      unitRef="usd">1901000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcxNQ_407c4400-6839-489e-8a08-de6db5930eef">SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information at June&#160;30, 2021 and June&#160;30, 2020 is detailed in the following tables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process and inventories include raw materials, labor, and overhead. Total inventories consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory cost adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. value-added tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment, net consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, buildings, and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate-owned life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Venture capital investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyNg_364b57d6-c25d-4e67-b8a9-f638d84447c4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process and inventories include raw materials, labor, and overhead. Total inventories consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory cost adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzEtMS0xLTEtMA_6732150d-d341-4c3e-a6ab-a1f93e72804c"
      unitRef="usd">469000000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzEtMy0xLTEtMA_d0510a30-75a7-4ecc-9c54-f7db32966208"
      unitRef="usd">223000000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzItMS0xLTEtMA_7baab436-5d1f-439f-ba30-779307d51c35"
      unitRef="usd">151000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzItMy0xLTEtMA_dc1a6c22-51a3-41ae-a47e-2406741afc1d"
      unitRef="usd">123000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzQtMS0xLTEtMA_bbb87577-3c87-4d34-b6d8-3426d8c4434c"
      unitRef="usd">620000000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzQtMy0xLTEtMA_c3e6c090-d96f-45bb-9edf-e63b72d6604d"
      unitRef="usd">346000000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzUtMS0xLTEtMA_3d3bbaf6-ae7e-411f-a46d-81e9cfe2ea8f"
      unitRef="usd">57000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzUtMy0xLTEtMA_aa8a9005-7184-4a0d-b268-5255a6d0284a"
      unitRef="usd">22000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzYtMS0xLTEtMA_f31e3532-f742-4cb4-9e0c-bcadfc633bd9"
      unitRef="usd">563000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo4M2FmYmE5ODY2MTU0NzczODM1M2ZlNzZjNjc5YzBjNy90YWJsZXJhbmdlOjgzYWZiYTk4NjYxNTQ3NzM4MzUzZmU3NmM2NzljMGM3XzYtMy0xLTEtMA_9445d7a9-0683-47cd-8da8-087a07314122"
      unitRef="usd">324000000</us-gaap:InventoryNet>
    <ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcxNw_abf363e9-2335-4965-8e0d-860b05376865">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. value-added tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEtMS0xLTEtMA_cd3950f1-4b76-494a-a0eb-b0ea24092def"
      unitRef="usd">46000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEtMy0xLTEtMA_5fbe6de3-df9f-4fab-8c07-63815caabb08"
      unitRef="usd">29000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzItMS0xLTEtMA_e3e183b5-22c0-4811-b379-b2e8275fe001"
      unitRef="usd">181000000</us-gaap:ContractWithCustomerAssetPurchase>
    <us-gaap:ContractWithCustomerAssetPurchase
      contextRef="iadf190b0c5114109b18e62d0a277885b_D20190701-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzItMy0xLTEtMA_5bf307c4-d45e-48fe-badb-28abe2a1de34"
      unitRef="usd">61000000</us-gaap:ContractWithCustomerAssetPurchase>
    <ctlt:SpareParts
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzMtMS0xLTEtMA_6208e15e-4aa0-4a3b-a473-17f2bf529920"
      unitRef="usd">30000000</ctlt:SpareParts>
    <ctlt:SpareParts
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzMtMy0xLTEtMA_92d8f760-7657-40df-8a5c-11802a4b5a6b"
      unitRef="usd">23000000</ctlt:SpareParts>
    <us-gaap:PrepaidTaxes
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzQtMS0xLTEtMA_c3593790-2d6e-439a-b5d1-0221b9d91f55"
      unitRef="usd">22000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzQtMy0xLTEtMA_73262589-4feb-44d0-a9c7-ce764d6929ed"
      unitRef="usd">15000000</us-gaap:PrepaidTaxes>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzUtMS0xLTEtMA_2ccdf257-c004-4f63-93fb-a41bb24b8aac"
      unitRef="usd">50000000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzUtMy0xLTEtMA_bf8a3ef2-fc69-4d6d-b98e-96eb65e44562"
      unitRef="usd">19000000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzktMS0xLTEtMA_a48352dc-3f84-421d-bfca-357d10ee8677"
      unitRef="usd">47000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzktMy0xLTEtMA_d6e3472e-f835-4084-a2f7-58baff8f3546"
      unitRef="usd">31000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEwLTEtMS0xLTA_fd08b1ef-c757-4b9b-8efd-200b33fd9ffd"
      unitRef="usd">376000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo3N2IyN2UwMTA3M2U0MTc4ODQ5ZWQyZTY1Yzk1NGE3NS90YWJsZXJhbmdlOjc3YjI3ZTAxMDczZTQxNzg4NDllZDJlNjVjOTU0YTc1XzEwLTMtMS0xLTA_618d9372-214f-4f3c-b097-5121c5b68234"
      unitRef="usd">178000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyMw_74dc7547-31f7-4e11-ac67-4d197bd02caf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment, net consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, buildings, and improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <ctlt:LandBuildingsAndImprovements
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzEtMS0xLTEtMA_379c34df-315f-4154-abd3-de13612c3b03"
      unitRef="usd">1571000000</ctlt:LandBuildingsAndImprovements>
    <ctlt:LandBuildingsAndImprovements
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzEtMy0xLTEtMA_9fb40c64-5375-4f69-9940-cb5f326456b4"
      unitRef="usd">1251000000</ctlt:LandBuildingsAndImprovements>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzItMS0xLTEtMA_a880765c-c814-42e8-b155-ba9d8e72a5ca"
      unitRef="usd">1558000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzItMy0xLTEtMA_0729a913-2fa5-4c25-803d-0152b9c86477"
      unitRef="usd">1233000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzMtMS0xLTEtMA_4b25e064-6975-4524-b139-d04452fdedea"
      unitRef="usd">31000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzMtMy0xLTEtMA_d73c03cf-2100-4714-a64c-6fb7af9607c8"
      unitRef="usd">21000000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzQtMS0xLTEtMA_9ee79cb4-46a3-4f8b-a4fb-953e30e3c9c5"
      unitRef="usd">543000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzQtMy0xLTEtMA_5fd33dbb-b9fd-4fb0-bbad-c51e60644ec4"
      unitRef="usd">440000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzUtMS0xLTEtMA_4108905e-6684-4527-b37d-e098cc02727d"
      unitRef="usd">3703000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzUtMy0xLTEtMA_963f2603-ec78-4b4f-bc69-5d12f98253a4"
      unitRef="usd">2945000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzYtMS0xLTEtMA_339b1afc-758a-4da4-95c9-7c75f2940d01"
      unitRef="usd">1179000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzYtMy0xLTEtMA_1e08c50b-f921-409e-9c1d-52ff1b822adf"
      unitRef="usd">1044000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzctMS0xLTEtMA_c2fb245a-e740-43c2-b6b9-4f9c5293eb5d"
      unitRef="usd">2524000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTozOTcyOTVhNTVmM2E0ZDUwOWRkZDkwMTdhMjNiZDMzZC90YWJsZXJhbmdlOjM5NzI5NWE1NWYzYTRkNTA5ZGRkOTAxN2EyM2JkMzNkXzctMy0xLTEtMA_39bf0a74-18a6-4699-bc52-55bda3a811ee"
      unitRef="usd">1901000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyNA_254eb1c6-3e27-4230-80ba-49f1adb25bfe">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate-owned life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Venture capital investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzEtMS0xLTEtMTgyNA_5541053e-3267-409c-9d70-1ad92172f3ff"
      unitRef="usd">84000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzEtMy0xLTEtNTEwNg_3c1c26e3-e98f-4b5b-ae69-8c3a4916881a"
      unitRef="usd">101000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LoansAndLeasesReceivableGrossCarryingAmount
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzItMS0xLTEtNTEwOA_cb3f7909-89b9-4f10-99d5-04b7d7b0343e"
      unitRef="usd">47000000</us-gaap:LoansAndLeasesReceivableGrossCarryingAmount>
    <us-gaap:LoansAndLeasesReceivableGrossCarryingAmount
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzItMy0xLTEtNTEwNg_29039eb3-177a-4e2a-bf96-6adcb79a418c"
      unitRef="usd">0</us-gaap:LoansAndLeasesReceivableGrossCarryingAmount>
    <ctlt:PensionAsset
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzMtMS0xLTEtMA_12f57e20-1be3-48ae-a4ff-45572821fb58"
      unitRef="usd">43000000</ctlt:PensionAsset>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzMtMy0xLTEtMA_e3ccdde0-3568-4153-9f36-1149ea837a38"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzUtMS0xLTEtNTExMA_18976838-446c-4817-bb83-3ba874367cf5"
      unitRef="usd">35000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzUtMy0xLTEtNTEwNg_7568d424-6a19-4433-b65b-af6426f543fb"
      unitRef="usd">23000000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:AlternativeInvestment
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMS0xLTEtNTEzNQ_c47bda3a-d0cd-40dc-8c3f-2fb827f44eb1"
      unitRef="usd">38000000</us-gaap:AlternativeInvestment>
    <us-gaap:AlternativeInvestment
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMy0xLTEtNTEzNw_a3882efd-b5aa-4ddc-b7b5-548f64eb3a11"
      unitRef="usd">5000000</us-gaap:AlternativeInvestment>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzgtMS0xLTEtNTExMg_110d859b-0ec0-4224-8d91-0605c7988f88"
      unitRef="usd">2000000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzgtMy0xLTEtNTExMg_701b5432-a2a3-49e3-b076-74480f96dd93"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzYtMS0xLTEtMA_c82039b7-28c3-48b3-bb20-44a8d59a5431"
      unitRef="usd">19000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzYtMy0xLTEtMA_c40cb797-026b-4ed4-837d-a8ad074a66af"
      unitRef="usd">13000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMS0xLTEtMA_4354b178-f05c-45e9-8d90-548537317be5"
      unitRef="usd">268000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTo5YTdjYTM0NzM5ZjY0YTg5YWVlN2U5MjI3NzY4YTM1MS90YWJsZXJhbmdlOjlhN2NhMzQ3MzlmNjRhODlhZWU3ZTkyMjc3NjhhMzUxXzctMy0xLTEtMA_2c9548c2-c9a6-49b3-84ec-5a378b798247"
      unitRef="usd">174000000</us-gaap:OtherAssetsNoncurrent>
    <ctlt:OtherAccruedLiabilitiesTableTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90ZXh0cmVnaW9uOjA2NDQ3ZWE5MzM1NTQ5MzI5YWU5NDNhMTcyNGYyMDYwXzcyOA_a20bbe53-aa03-4a66-8129-a79b9e136862">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee-related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ctlt:OtherAccruedLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMS0xLTEtMTg5Mg_68ffb821-428d-4be2-bd7f-ab930142f785"
      unitRef="usd">305000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMy0xLTEtMTg4OQ_7ec0e48c-8784-43da-97ba-189407218b28"
      unitRef="usd">191000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMS0xLTEtMA_179084f4-dd04-4aab-a39d-cf8ffad84872"
      unitRef="usd">184000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzEtMy0xLTEtMA_374cdd28-b1ca-4326-94b9-a1e5ddc4886f"
      unitRef="usd">141000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMS0xLTEtODEzMQ_a0c52042-052b-4716-b38a-e9644dba899a"
      unitRef="usd">170000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMy0xLTEtODEzNQ_830e52f0-58aa-470f-a9a0-9891f7fe857e"
      unitRef="usd">115000000</us-gaap:OtherLiabilitiesCurrent>
    <ctlt:AccruedOperatingLeaseLiabilities
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMS0xLTEtNTExNA_2fa7e00b-9b2f-4c7f-bf71-7a9a839fc7af"
      unitRef="usd">16000000</ctlt:AccruedOperatingLeaseLiabilities>
    <ctlt:AccruedOperatingLeaseLiabilities
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzMtMy0xLTEtNTExNA_06ba8009-f59b-4bf9-a8bd-ac257888224c"
      unitRef="usd">15000000</ctlt:AccruedOperatingLeaseLiabilities>
    <ctlt:AccruedRestructuringReserve
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzItMS0xLTEtMA_f59717af-2999-4aa1-8553-5a5d71c7b6df"
      unitRef="usd">4000000</ctlt:AccruedRestructuringReserve>
    <ctlt:AccruedRestructuringReserve
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzItMy0xLTEtMA_dfb9bc11-9907-4feb-86aa-2b46ecc9f7f6"
      unitRef="usd">3000000</ctlt:AccruedRestructuringReserve>
    <us-gaap:InterestPayableCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzQtMS0xLTEtMA_cf038c28-d830-40fa-9659-c25b75bc6954"
      unitRef="usd">27000000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzQtMy0xLTEtMA_a7e4eb9a-71c8-4c81-bcdf-c0c89010b563"
      unitRef="usd">29000000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzctMS0xLTEtMA_6a4ab9c5-ab23-4456-8ab7-6db8f6606eda"
      unitRef="usd">30000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzctMy0xLTEtMA_53a1ae05-b6ab-43b5-9955-073ae95ae18d"
      unitRef="usd">5000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ifc35871a5183468aaab7c718b6a42771_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzktMS0xLTEtMA_ef5ad15c-b176-4a42-a960-ec8261d93215"
      unitRef="usd">736000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i33e364a4c60a40d186dee61881303017_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTYvZnJhZzowNjQ0N2VhOTMzNTU0OTMyOWFlOTQzYTE3MjRmMjA2MC90YWJsZTpjYzcwZWU5ZGFmNzQ0M2Y1Yjk2ZWNmODI3NTVlOWVmMC90YWJsZXJhbmdlOmNjNzBlZTlkYWY3NDQzZjViOTZlY2Y4Mjc1NWU5ZWYwXzktMy0xLTEtMA_314396c9-a05b-4a24-8cf3-80906d7a33ba"
      unitRef="usd">499000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ida593e8c48d442df8c3c2d0272608660_D20200701-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTAyL2ZyYWc6ZWFjMzdhOWYzM2Y2NDZlY2E2ZmFjOGE3MDk3YzZkNDQvdGV4dHJlZ2lvbjplYWMzN2E5ZjMzZjY0NmVjYTZmYWM4YTcwOTdjNmQ0NF8xMDk5NTExNjMxNzgy_63ca1bad-3ea9-40d8-9f80-5208977af7e1">SUBSEQUENT EVENTS&lt;div style="margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bettera Holdings, LLC Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company entered into an agreement to acquire Bettera Holdings, LLC ("Bettera") for $1.00 billion, subject to customary adjustments. Bettera is a manufacturer of nutraceuticals and nutritional supplements in gummy, soft chew, and lozenge delivery formats.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing, Bettera&#x2019;s operations and facilities, will become part of the Company&#x2019;s Softgel and Oral Technologies segment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The agreement is subject to customary closing conditions and is expected to close before December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="iaa422029d99543199793d9ff01d7b6fa_I20210830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xNTAyL2ZyYWc6ZWFjMzdhOWYzM2Y2NDZlY2E2ZmFjOGE3MDk3YzZkNDQvdGV4dHJlZ2lvbjplYWMzN2E5ZjMzZjY0NmVjYTZmYWM4YTcwOTdjNmQ0NF8xMDk5NTExNjM0MjYx_627e3a16-c6f6-4060-a8d1-8c3159f33948"
      unitRef="usd">1000000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTk_f6ab7647-580c-4f54-a153-23d5978f4101" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTk_f6ab7647-580c-4f54-a153-23d5978f4101" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTk_f6ab7647-580c-4f54-a153-23d5978f4101"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. <xhtml:div style="margin-top:9pt;padding-left:48pt;text-align:justify"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#x2019;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</xhtml:span></xhtml:div><xhtml:div style="margin-top:9pt;padding-left:48pt;text-align:justify"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to Note 15, <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTg_5252681a-36e9-4538-8265-5b5ab32dcf5f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctNi0xLTEtMA_be2d22cd-77b7-45c3-8602-e321401e332b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMS0xLTEtMA_ee038661-744e-4632-8f90-79409b90ea09"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzctMTAtMS0xLTA_c3411374-f1c2-4cb0-9ad2-fe19e69db282"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUy_bf80e485-1cfa-45be-9d08-cea1a7dda18b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#x2019;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#x2019;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.<xhtml:div style="margin-top:9pt;padding-left:45pt;text-align:justify"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. </xhtml:span></xhtml:div><xhtml:div style="margin-top:9pt;padding-left:45pt;text-align:justify"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. </xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzUyMQ_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNy0xLTEtMA_febce6ac-6d75-4ade-bd98-3a9059a7397c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtNS0xLTEtMA_212172d1-b263-44cc-b7b5-a40fd5618e05"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzMtOS0xLTEtMA_e22ef0d4-6bec-4352-a43d-72fdca09ae1f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTc_c2bdb85c-2d50-4485-b1da-9d47d8710b03"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMTAtMS0xLTA_4c454024-11b3-45a4-8336-f03b4dd39a84"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzItMS0xLTEtMA_f2f0bd31-80a0-440e-b02a-2a483ed601ab"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEwOTk1MTE2Mjk3MDI_076486c5-7849-48cb-8b44-832f93832422"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Foreign currency (gains) and losses include both cash and non-cash transactions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNy0xLTEtMA_5945b0e0-e44a-403b-83ca-5563f711081f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctOS0xLTEtMA_c6cb5595-57a1-4f5b-89ba-1b9b084acf04"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzctNS0xLTEtMA_669a37d8-71c1-4afe-949d-a1607dbc59e8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzExMTg_1324a946-c657-45f9-8fde-1e2d46064b9f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktNS0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtMi0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZTozOWJmZmEwYTU0NzQ0OGRlYjA0MzU3MjEwMzQ1ZjkwMi90YWJsZXJhbmdlOjM5YmZmYTBhNTQ3NDQ4ZGViMDQzNTcyMTAzNDVmOTAyXzUtNi0xLTEtMA_90d55847-73f1-43a4-9588-f19369f0348c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90YWJsZToxMDAzZjhjYjY2MTE0OTA3YmEzYmZkYjhkYTY5N2UyZS90YWJsZXJhbmdlOjEwMDNmOGNiNjYxMTQ5MDdiYTNiZmRiOGRhNjk3ZTJlXzktMy0xLTEtMA_5828506b-7efa-46d3-b954-b416d68fc6ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMDUvZnJhZzo5Yjk4YzY3YjBkMDA0OGUyOTdmNzg1ZWYzMmY1YjBjZi90ZXh0cmVnaW9uOjliOThjNjdiMGQwMDQ4ZTI5N2Y3ODVlZjMyZjViMGNmXzEzMTk0MTM5NTYwNjEx_d675361b-40c8-4dce-a874-8e21974ea82d"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtNi0xLTEtMjczMw_dd700804-ade4-4bc0-b0c3-6a8364d8e11b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzgtMTAtMS0xLTUwNTI_93129c2a-dfd4-4336-a2d3-6bb69e6339fe"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUz_a6796041-1b5b-4c15-89a4-d55f21485cdb"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjU_06075297-4751-46c5-a27e-6f29d0b084c2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjU_06075297-4751-46c5-a27e-6f29d0b084c2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at June 30, 2021, which is the </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount less a </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discount determined using a discounted cash flow model with the market interest rate as a significant input.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzItMS0xLTEtNTA1MA_30088f55-41f1-4e25-b6af-5fa2aac9fe10"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjU_06075297-4751-46c5-a27e-6f29d0b084c2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtNS0xLTEtMA_23658ffa-02f2-42c6-a3b2-edce368efe5d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMS0xLTEtMA_b3a82705-0457-4623-8076-ac83f2648dfa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTI_ed759136-0580-4f2b-9e54-b17f60342a40"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzgtMy0xLTEtMA_39ca98dc-67bf-4d1c-9082-0ccc61bd22ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzU4NzU_3270cc70-0569-4059-8fc9-bc1f1cbc1e14"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNy0xLTEtMA_d9a7d0a3-1f73-4822-a49d-78efe84a1de0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtOS0xLTEtMA_af754935-cb48-40d7-a522-81687cd7a8f9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90YWJsZTo2Yjc3MTQ2Y2QxYzQ0ZWQxYThhOThkM2ZkY2Y5OTkxYy90YWJsZXJhbmdlOjZiNzcxNDZjZDFjNDRlZDFhOGE5OGQzZmRjZjk5OTFjXzgtNS0xLTEtMA_f579b50a-8d29-421f-9212-9c5e1ebdfa18"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMzgvZnJhZzpiYzhmMTQwOTU0ZjA0NjIyODc1MTcwNjYyZmU5MDJlMC90ZXh0cmVnaW9uOmJjOGYxNDA5NTRmMDQ2MjI4NzUxNzA2NjJmZTkwMmUwXzEwOTk1MTE2MzI1MjU_d53110d8-11bf-4db8-96d9-ecf1b0114593"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMy0xLTEtMzg4Mg_f754c007-70d7-4ee1-b9ff-3e5a772a332a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtNS0xLTEtMzg4Ng_d918445f-4070-44f9-a1f9-b7a0092a1645"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzUtMS0xLTEtMzg3OQ_99deefd6-62b9-4618-b829-524c1924a54a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTQ_98768c6d-7762-400c-a7a3-71852d3426c8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctOS0xLTEtMA_0e790a97-8a38-485f-bc17-51d16dfd64c7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzctNy0xLTEtMA_b3ecace8-f477-4e3a-9e4c-7984fa971483"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtOS0xLTEtMA_a1797bb7-d4b4-4edf-a452-c549ae96b812"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtOS0xLTEtMA_e6a92d0a-4abb-4d12-99af-b065f6ed7dff"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzUtNy0xLTEtMA_e8917f82-68cf-48aa-b402-3f8b71923da1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtNy0xLTEtMA_995dbc5e-f261-400e-af5a-500ee4a6ed07"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzMtNy0xLTEtMA_bac9e469-2305-4699-bab7-2b16fecc084e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTphZWFhYzlkNzYyMWQ0YWQ2OWFiOTZiMTk0NjM1MzM3Yy90YWJsZXJhbmdlOmFlYWFjOWQ3NjIxZDRhZDY5YWI5NmIxOTQ2MzUzMzdjXzQtOS0xLTEtMA_245242e6-8227-4498-83a2-1e8971ec51ab"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzEwOTk1MTE2MzY1MjQ_e98dded7-1c92-4f06-abad-c439bf3f9030"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjY_d5a34fbe-8aac-4050-91f7-0f104b2d6e4e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjY_d5a34fbe-8aac-4050-91f7-0f104b2d6e4e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, <xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzMtMS0xLTEtNTA1MA_6d97869c-da56-465d-94c5-149f2f1c525f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjY_d5a34fbe-8aac-4050-91f7-0f104b2d6e4e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtNS0xLTEtMA_fa5537c6-1f3a-4601-8143-e82d47c2e5cb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMS0xLTEtMA_986ea49b-bd31-4f9d-9a1d-d32466172621"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90YWJsZTpiNmFmNGE5NDQ1Y2Q0ZDFkODg5MWRmMjIzZGYzYmNlMi90YWJsZXJhbmdlOmI2YWY0YTk0NDVjZDRkMWQ4ODkxZGYyMjNkZjNiY2UyXzQtMy0xLTEtMA_8bc638f2-a1be-404b-8fd0-366d472ef163"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yNTMvZnJhZzo3OWMwMzUyZTJlNjg0MmI2OTcyZTAxYTUyMThmYjIwMC90ZXh0cmVnaW9uOjc5YzAzNTJlMmU2ODQyYjY5NzJlMDFhNTIxOGZiMjAwXzQyNTM_507a1ff0-21e7-495a-8981-8c359e20238b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The reallocation in fiscal 2020 relates to adjustments to the Company&#x2019;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNC0xLTEtMA_1ebe834f-9b74-4205-b449-c7dea5498359"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMTAtMS0xLTA_936a9a38-f385-450e-b8d8-19280caecff1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtNi0xLTEtMA_56523879-30d4-4dc7-97b7-6a6565ffbf77"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtOC0xLTEtMA_c8c97381-0eaf-4f78-8013-21374240e54f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90YWJsZTo1MzI4MTAwZjI0MGM0ZjM3YWIzNTI4NTI0Y2EyYzdhYi90YWJsZXJhbmdlOjUzMjgxMDBmMjQwYzRmMzdhYjM1Mjg1MjRjYTJjN2FiXzMtMS0xLTEtMA_bad6d484-db4b-4d50-be21-1472c1a85329"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xOTMvZnJhZzpiMDMzNjk4ZjA2ODc0OTI0YTZlZGE3ZmQ3ODU2OTM5My90ZXh0cmVnaW9uOmIwMzM2OThmMDY4NzQ5MjRhNmVkYTdmZDc4NTY5MzkzXzEyNjQ0MzgzNzIxMzUx_6c416c78-dae4-44df-bc9e-25ee8220585c"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjc_3f28e412-27b7-4462-b4ea-70aa0eee8b9f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjc_3f28e412-27b7-4462-b4ea-70aa0eee8b9f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other includes <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of transaction expenses, a working capital adjustment of </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million</xhtml:span><xhtml:span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assumption of liabilities resulting in net cash proceed of </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90YWJsZTo1ZTgwOTkxMGNhMDA0MWViYTQ2ZTdlYWYwNTMzMTljYy90YWJsZXJhbmdlOjVlODA5OTEwY2EwMDQxZWJhNDZlN2VhZjA1MzMxOWNjXzQtMS0xLTEtNTA1MA_f0abc108-0709-42c2-a5e5-c5532a655bc9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18xODcvZnJhZzozYWIxNjg3ZDU2MDk0MGYwOTQ3MzcwMTk3YTU4NjQ3OS90ZXh0cmVnaW9uOjNhYjE2ODdkNTYwOTQwZjA5NDczNzAxOTdhNTg2NDc5XzEwOTk1MTE2NzEwNjc_3f28e412-27b7-4462-b4ea-70aa0eee8b9f"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626677640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DocumentDocumentAndEntityInformationAbstract', window );"><strong>Document Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-8737688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">14 Schoolhouse Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Somerset,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(732)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">537-6200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTLT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CATALENT, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001596783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,787,238.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,710,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DocumentDocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DocumentDocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626294776">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,998,000,000<span></span>
</td>
<td class="nump">$ 3,094,000,000<span></span>
</td>
<td class="nump">$ 2,518,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,646,000,000<span></span>
</td>
<td class="nump">2,111,000,000<span></span>
</td>
<td class="nump">1,713,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,352,000,000<span></span>
</td>
<td class="nump">983,000,000<span></span>
</td>
<td class="nump">805,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">687,000,000<span></span>
</td>
<td class="nump">577,000,000<span></span>
</td>
<td class="nump">512,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(182,000,000)<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other Cost and Expense, Operating</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">828,000,000<span></span>
</td>
<td class="nump">394,000,000<span></span>
</td>
<td class="nump">274,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,000,000<span></span>
</td>
<td class="nump">126,000,000<span></span>
</td>
<td class="nump">111,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (Income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings from continuing operations before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">715,000,000<span></span>
</td>
<td class="nump">260,000,000<span></span>
</td>
<td class="nump">160,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">130,000,000<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Catalent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">585,000,000<span></span>
</td>
<td class="nump">221,000,000<span></span>
</td>
<td class="nump">137,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic', window );">Participating Securities, Distributed and Undistributed (Earnings) Loss, Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(56,000,000)<span></span>
</td>
<td class="num">(48,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Available to Common Stockholders, Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 529,000,000<span></span>
</td>
<td class="nump">$ 173,000,000<span></span>
</td>
<td class="nump">$ 132,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2740-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539281064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income / (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">67<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax', window );">Other Comprehensive Income, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income /(loss), net of tax</a></td>
<td class="nump">69<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income/(loss)</a></td>
<td class="nump">654<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember', window );">ACOI, Accumulated Gain (Loss), Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544844808">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 896<span></span>
</td>
<td class="nump">$ 953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">563<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid Expense and Other Assets, Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">376<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,524<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,519<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">817<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Non-current deferred tax asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,112<span></span>
</td>
<td class="nump">7,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">385<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">736<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Finance Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,166<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Pension liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">137<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome', window );">Non-current deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">164<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">175<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitment and contingencies (see Note 14)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,838<span></span>
</td>
<td class="nump">4,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common Stock, Value, Outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred Stock, Value, Outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">3,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25<span></span>
</td>
<td class="num">(535)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(317)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,915<span></span>
</td>
<td class="nump">2,899<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable preferred stock, and shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,112<span></span>
</td>
<td class="nump">$ 7,777<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542979192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">170,549,341<span></span>
</td>
<td class="nump">162,788,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Issued &amp; Outstanding</a></td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544866680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Shareholder's Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment [Member]</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss)/Income [Member]</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Jun. 30, 2018</a></td>
<td class="nump">1,086,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 2,283,000,000<span></span>
</td>
<td class="num">$ (872,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (326,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Stockholders' Equity, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">447,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">446,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_EquityIssuedInLieuOfCashConsideration', window );">Equity issued in lieu of cash consideration</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">137,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income /(loss), net of tax</a></td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">1,682,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,757,000,000<span></span>
</td>
<td class="num">(723,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(354,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Temporary Equity, Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">607,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="nump">607,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">1,042,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,042,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock</a></td>
<td class="num">(33,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">221,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income /(loss), net of tax</a></td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,000,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="nump">2,899,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">3,818,000,000<span></span>
</td>
<td class="num">(535,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(386,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="nump">607,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="nump">253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="num">(46,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</a></td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends, Preferred Stock</a></td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">585,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income /(loss), net of tax</a></td>
<td class="nump">69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2021</a></td>
<td class="nump">3,915,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 4,205,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (317,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Temporary Equity, Carrying Amount, Period Increase (Decrease)</a></td>
<td class="num">(248,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="nump">$ 359,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_EquityIssuedInLieuOfCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity issued in lieu of cash consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_EquityIssuedInLieuOfCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989648464664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock - shares<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance - Common Stock Outstanding (shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,424,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,431,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance - Common Stock Outstanding (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,738,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,196,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="nump">166,000<span></span>
</td>
<td class="nump">854,000,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance - Common Stock Outstanding (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,788,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="nump">726,000<span></span>
</td>
<td class="nump">1,206,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,392,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance - Common Stock Outstanding (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,549,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544654824">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 585,000,000<span></span>
</td>
<td class="nump">$ 221,000,000<span></span>
</td>
<td class="nump">$ 137,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile earnings from continued operations to net cash from operations:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">289,000,000<span></span>
</td>
<td class="nump">254,000,000<span></span>
</td>
<td class="nump">229,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_AmortizationAndWriteOffOfFinancingCosts', window );">Amortization and write-off of debt financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain (Loss) on Sale of Assets and Asset Impairment Charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(182,000,000)<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing fees paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(17,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51,000,000<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Provision/(benefit) for deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="num">(15,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProvisionForBadDebtsAndInventory', window );">Provision for bad debts and inventory</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">41,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase)/decrease in trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(186,000,000)<span></span>
</td>
<td class="num">(151,000,000)<span></span>
</td>
<td class="num">(119,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase)/decrease in inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(260,000,000)<span></span>
</td>
<td class="num">(76,000,000)<span></span>
</td>
<td class="num">(34,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">72,000,000<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets/accrued liabilities, net - current and non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities, Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">433,000,000<span></span>
</td>
<td class="nump">440,000,000<span></span>
</td>
<td class="nump">248,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(686,000,000)<span></span>
</td>
<td class="num">(466,000,000)<span></span>
</td>
<td class="num">(218,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Payments to Acquire Debt Securities, Available-for-sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(72,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries', window );">Proceeds from Divestiture of Interest in Consolidated Subsidiaries</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">287,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment for acquisitions, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(147,000,000)<span></span>
</td>
<td class="num">(379,000,000)<span></span>
</td>
<td class="num">(1,291,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to Acquire Investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(649,000,000)<span></span>
</td>
<td class="num">(827,000,000)<span></span>
</td>
<td class="num">(1,510,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in other borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowing, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">164,000,000<span></span>
</td>
<td class="nump">909,000,000<span></span>
</td>
<td class="nump">1,448,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(67,000,000)<span></span>
</td>
<td class="num">(811,000,000)<span></span>
</td>
<td class="num">(1,290,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAndInterestPaid', window );">Dividends and Interest Paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,000,000)<span></span>
</td>
<td class="num">(36,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">1,046,000,000<span></span>
</td>
<td class="nump">445,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock', window );">Proceeds from Issuance of Redeemable Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">646,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(46,000,000)<span></span>
</td>
<td class="num">(32,000,000)<span></span>
</td>
<td class="num">(15,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Proceeds from (Payments for) Other Financing Activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by/(used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">142,000,000<span></span>
</td>
<td class="nump">1,002,000,000<span></span>
</td>
<td class="nump">1,201,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of foreign currency on cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,000,000<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57,000,000)<span></span>
</td>
<td class="nump">608,000,000<span></span>
</td>
<td class="num">(65,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND EQUIVALENTS AT BEGINNING OF PERIOD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">953,000,000<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
<td class="nump">410,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND EQUIVALENTS AT END OF PERIOD</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">896,000,000<span></span>
</td>
<td class="nump">953,000,000<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTARY CASH FLOW INFORMATION:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,000,000<span></span>
</td>
<td class="nump">98,000,000<span></span>
</td>
<td class="nump">103,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING ACTIVITY:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Stock Issued During Period, Value, Conversion of Convertible Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">253,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (46,000,000)<span></span>
</td>
<td class="num">$ (32,000,000)<span></span>
</td>
<td class="num">$ (15,000,000)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_AmortizationAndWriteOffOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization And Write Off Of Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_AmortizationAndWriteOffOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ProvisionForBadDebtsAndInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for bad debts and inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ProvisionForBadDebtsAndInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAndInterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contractual amount of dividends (or interest on participating income bonds) that must be paid for the current period (for example, unpaid cumulative dividends).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAndInterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stock that is classified as callable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542460296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent, Inc. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Catalent</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) directly and wholly owns PTS Intermediate Holdings LLC (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intermediate Holdings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).&#160;Intermediate Holdings directly and wholly owns Catalent Pharma Solutions, Inc. (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The financial results of Catalent are primarily comprised of the financial results of Operating Company and its subsidiaries on a consolidated basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company commenced an initial public offering (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPO</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of its common stock, par value $0.01 (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in which it sold a total of 48.9 million shares at a price of $20.50 per share, before underwriting discounts and commissions. The Common Stock began trading on the New York Stock Exchange (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NYSE</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the symbol </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CTLT</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of the IPO. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides differentiated development and manufacturing solutions for drugs, protein-based biologics, cell, and gene therapies, and consumer health products at over fifty facilities across four continents under rigorous quality and operational standards. Its oral, injectable, and respiratory delivery technologies, along with its state-of-the-art protein and cell and gene therapy manufacturing capacity address a wide and growing range of modalities and therapeutic and other categories across the biopharmaceutical and consumer health industries. Through its extensive capabilities, growth-enabling capacity, and deep expertise in product development, regulatory compliance, and clinical trial supply, it can help its customers take products to market faster, including nearly half of new drug products approved by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) in the last decade. Its development and manufacturing platforms, which include those in its Biologics, Softgel and Oral Technologies, and Oral and Specialty Delivery segments, its proven formulation, supply, and regulatory expertise, and its broad and deep development manufacturing know-how enable its customers to advance and then bring to market more products and better treatments for patients and consumers. Its commitment to reliably supply its customers&#8217; and their patients&#8217; needs is the foundation for the value it provides; annually, it produces more than 70 billion doses for nearly 7,000 customer products, or approximately 1 in every 24 doses of such products taken each year by patients and consumers around the world. The Company believes that, through its investments in state-of-the-art facilities and capacity expansion, including investments in facilities focused on new treatment modalities and other attractive market segments, its continuous improvement activities devoted to operational and quality excellence, the sales of existing and introduction of new customer products, and, in some cases, its innovation activities and patents, it will continue to attract premium opportunities and realize the growth potential from these areas. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reporting Segments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the four reporting segments reports through a separate management team and ultimately reports to the Company's Chief Executive Officer, who is designated as the Chief Operating Decision Maker for segment reporting purposes. The Company's operating segments are the same as its reporting segments. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biologics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The segment has extensive expertise in development, scale up, and commercial manufacturing. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s growing biologic offering includes cell-line development based on its advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Its development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce current good manufacturing practices ("cGMP") quality biologics drug substance from 250L to 4,000L scale using single-use technology to provide maximum efficiency and flexibility. Its Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and the Anagni, Italy facility add substantial capacity for finished-dose drug product manufacturing and packaging. The segment has continued to expand production capacity, including the fourth and fifth drug substance manufacturing suites in its Madison, Wisconsin facility, expanded drug product manufacturing and packaging capacity in its Bloomington and Anagni facilities, and recently announced a planned expansion of its Anagni facility to permit drug substance </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and manufacturing. Its SMARTag next-generation antibody-drug conjugate (&#8220;ADC&#8221;) technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s cell and gene therapy centers in Belgium, Maryland, and Texas, it develops and manufactures complex biologics, including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through continued inorganic investment between November 2020 and June 2021, the Company acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#8220;Delphi&#8221;), a plasmid DNA business, to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production. Additionally, in August 2021, it acquired RheinCell Therapeutics GmbH (&#8220;RheinCell&#8221;), a company based in Lagenfeld, Germany that specializes in pluripotent stem cell (&#8220;iPSC&#8221;) production. This portfolio expansion strengthens Catalent&#8217;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances the Company&#8217;s ability to manufacture next generation cell therapies at scale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its gene therapy network across Maryland and Texas, the Company has further expanded its footprint with the construction of 5 additional commercial gene therapy suites at its Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed its Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Its specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with its expanded capabilities in plasmids, positions the Company to capitalize on strong and growing industry demand in the cell and gene therapy market.</span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment's range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within the segment's existing network. In addition to primary packaging, its network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. The Company's Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial supply of biotherapeutics and cell and gene therapies. Its fill and finish services are largely focused on complex pharmaceuticals and biologics. With its range of technologies, the Company is able to meet a wide range of specifications, timelines, and budgets. The Company believes that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide it with a meaningful competitive advantage in the market. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics segment also offers biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Its OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. The Biologics segment provides a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Softgel and Oral Technologies </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its Softgel and Oral Technologies segment, the Company provides formulation, development, and manufacturing services for soft capsules, or &#8220;softgels,&#8221; as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services. Catalent&#8217;s softgel technology was first commercialized by its predecessor in the 1930s, and it has continually enhanced the platform since then. The segment is the market leader in overall softgel development and manufacturing and holds the leading market position in innovator drug softgels. Its principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. The segment typically performs encapsulation for a product within one of its softgel facilities, with active ingredients provided by customers or sourced directly by the Company. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. The segment also participates in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of the Company&#8217;s plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, the segment extended this platform to pharmaceutical products via its OptiShell capsule offering. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Its Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies the Company has conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Its large-scale manufacturing under cGMP of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site or time-specific drug release, taste masking, or enhanced bioavailability. The Company has deep experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#8217;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Oral and Specialty Delivery</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including its proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms (including metered dose inhalers, dry powder inhalers and nasal delivery devices). </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment provides comprehensive pre-clinical screening, formulation and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. It has substantial, proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. It provides spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#8217;s bioavailability and clinical performance. It offers comprehensive analytical method development and scientific capabilities, including stability testing, and global regulatory services to support both fully integrated development programs and standalone fee-for-service work. In recent years, the segment has expanded its network of clinical development sites focused on earlier phase compounds (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for its offerings is driven by the need for strong scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of its supply performance across quality and operational parameters. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its orally dissolving tablet business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that dissolves in the mouth, without water, in typically less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). The Company can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#8217;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. It continues to invest in and develop Zydis orally dissolving tablets in different ways with its customers as it extends the application of the technology to new therapeutic categories, including immunotherapy, vaccines and biologic molecule delivery.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment&#8217;s respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Clinical Supply Services </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. It offers customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and reporting. It supports trials in all regions of the world through its facilities and distribution network. In recent years, the segment has continued to expand and extend its network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. The segment continues to develop new solutions for the evolving clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. The Clinical Supply Services segment is the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements include all of the Company&#8217;s subsidiaries, including those operating outside the United States (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). All significant transactions among the Company&#8217;s subsidiaries and reporting segments have been eliminated, other than as noted.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, allowance for credit losses, inventory and long-lived asset valuation, goodwill and other intangible asset valuation and impairment, equity-based compensation, income taxes, derivative valuation, and pension plan asset and liability valuation. Actual amounts may differ from these estimated amounts. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior-period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows, or notes to the consolidated financial statements. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s operations outside the U.S. are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of the foreign operations into U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Beginning on July 1, 2018, as a result of the three-year cumulative consumer price index exceeding 100%, the Company has accounted for its Argentine operations as highly inflationary, but this change has not had a material effect on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The currency fluctuation related to certain long-term inter-company loans where settlement is not planned or anticipated in the foreseeable future have been recorded within the cumulative translation adjustment, a component of other comprehensive income. In addition, the currency fluctuation associated with the portion of the Company&#8217;s euro-denominated debt designated as a net investment hedge is included as a component of other comprehensive income. Foreign currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other expense, net.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Such foreign currency transaction gains and losses include inter-company loans that are repayable in the foreseeable future.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All liquid investments purchased with original maturities of three months or less are considered cash equivalents. The carrying value of these cash equivalents approximates fair value.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables, contract assets, and other amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. The Company determines its allowance methodology by considering various factors, including the Company&#8217;s previous loss history, aging of customer receivable balances, significant aspects of a geographic location's economic conditions, the current and anticipated future condition of the general economy and the industries in which the Company's primary customers operate. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, trade receivables and contract assets are written off against the allowance when the related balances are no longer deemed collectible. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Major Customers </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers&#8217; financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company&#8217;s expectations. No single customer exceeded 10% of revenue during the fiscal years ended June 30, 2021, 2020, and 2019. As of June 30, 2021, the Company had one customer that represented 15% or $155 million of its net trade receivables balance. No customer exceeded 10% of trade receivables as of June 30, 2020.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value, using the first-in, first-out (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIFO</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) method. The Company provides for cost adjustments for excess, obsolete, or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory consists of costs associated with raw material, labor, and overhead. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. The Company performs an impairment evaluation of goodwill annually during the fourth quarter of its fiscal year or when circumstances otherwise indicate an evaluation should be performed. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. Factors considered in a qualitative assessment include, among other things, macroeconomic conditions, industry and market considerations, financial performance of the respective reporting unit and other relevant entity and reporting-unit specific considerations. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and macroeconomic, industry, and market conditions. In fiscal 2019 and 2021, the Company began its impairment evaluation with the qualitative assessment, but in fiscal 2020, the Company proceeded immediately to the quantitative assessment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its qualitative assessment conducted as of April 1, 2021, the Company determined for each reporting unit with goodwill that it was more likely than not that its respective fair value exceeded its carrying value, indicating there was no impairment. For more information regarding goodwill balances at June 30, 2021, see Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment and Other Definite-Lived Intangible Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including leasehold improvements and finance lease right-of-use assets that are amortized over the shorter of their useful lives or the terms of the respective leases. The Company generally uses the following range of useful lives for its property and equipment categories: buildings and improvements&#8212;5 to 50 years; machinery and equipment&#8212;3 to 10 years; and furniture and fixtures&#8212;3 to 7 years. Depreciation expense was $196 million for the fiscal year ended June&#160;30, 2021, $165 million for the fiscal year ended June&#160;30, 2020, and $141 million for the fiscal year ended June&#160;30, 2019. Depreciation expense includes amortization of assets related to financing leases. The Company charges repairs and maintenance costs to expense as incurred. The amount of capitalized interest for fiscal 2021 and 2020 was $17 million and $11 million, respectively, and was immaterial for fiscal 2019.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, including customer relationships, patents, and trademarks, are amortized over their useful lives. The Company also capitalizes certain computer software and development costs in other intangibles, net, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 5 years. The Company evaluates the recoverability of its other long-lived assets, including amortizing intangible assets, if circumstances indicate impairment may have occurred pursuant to ASC 360,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This analysis is performed by comparing the respective carrying values of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, the carrying value of such assets is reduced to fair value through a charge to the consolidated statements of operations. Fair value is determined based on assumptions the Company believes marketplace participants would utilize and comparable marketplace information in similar arm&#8217;s length transactions. The Company recorded impairment charges related to definite-lived intangible assets and property, </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plant, and equipment of $9 million, $5 million, and $5 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Retirement and Pension Plans</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement and pension plans, including defined benefit and defined contribution retirement plans.&#160;The measurement of the related benefit obligations and the net periodic benefit costs recorded each year are based upon actuarial computations, which require management&#8217;s judgment as to certain assumptions. These assumptions include the discount rates used in computing the present value of the benefit obligations and the net periodic benefit costs, the expected future rate of salary increases (for pay-related plans) and the expected long-term rate of return on plan assets (for funded plans). The Company uses the corridor approach to amortize actuarial gains and losses. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to utilize an approach to estimate the service and interest components of net periodic benefit cost for benefit plans that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. The expected long-term rate of return on plan assets is based on the target asset allocation and the average expected rate of growth for the asset classes invested. The average expected rate of growth is derived from a combination of historic returns, current market indicators, and the expected risk premium for each asset class. The Company uses a measurement date of June 30 for all its retirement and postretirement benefit plans.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments, Hedging Activities, and Fair Value </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest-rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments from time to time to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings. The Company does not net any of its derivative positions under master netting arrangements. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily, the Company is exposed to fluctuations in the euro-U.S. dollar exchange rate on its investments in foreign operations in Europe. While the Company does not actively hedge against changes in foreign currency, it has mitigated the exposure of investments in its European operations through a net-investment hedge by denominating a portion of its debt in euros. In addition, a portion of Operating Company's interest payment obligation on its U.S dollar-denominated term loans is exposed to interest rate variability. The Company has mitigated its exposure to this risk by entering into interest-rate swap agreements, which qualify for and are designated as cash-flow hedges. Also, as discussed in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has determined that an aspect of the dividend-rate adjustment feature of the Company&#8217;s convertible Series A Preferred Stock (as defined below, see Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) should be accounted for as a derivative liability.  </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. The Company uses fair value extensively, including in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. The Company estimates fair value using an exit price approach, which requires, among other things, that it determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the assets or liability, the Company may use one or all of the following approaches: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Income approach, which is based on the present value of the future stream of net cash flows. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain investments that are measured at fair value using the net asset value (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NAV</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%;padding-left:17.65pt">&#160;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its liquid debt investments with original maturities greater than ninety days as marketable securities. The Company invests in highly rated corporate debt securities, with the primary objective of minimizing the potential risk of principal loss. The Company&#8217;s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any single issuer. The Company regularly reviews its investments and utilizes quantitative and qualitative evidence to evaluate potential impairments. For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable securities as available-for-sale, because it may sell certain of its marketable securities prior to the stated maturity for various reasons, including management of liquidity, credit risk, duration, relative return, and asset allocation. The Company determines the fair value of each marketable security in its portfolio at each period end and recognizes gains and losses in the portfolio in other comprehensive income. As of June 30, 2021, the amortized cost basis of marketable securities approximates fair value and all outstanding marketable securities mature within one year.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is partially self-insured for certain employee health benefits and partially self-insured for property losses and casualty claims. The Company accrues for losses based upon experience and actuarial assumptions, including provisions for losses incurred but not reported. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, which is reported in the accompanying consolidated statements of changes in shareholders&#8217; equity, consists of foreign currency translation, net change in marketable securities, and defined benefit pension plan changes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses research and development costs as incurred.  Research and development costs amounted to $21 million, $21 million, and $19 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports net earnings per share in accordance with ASC 260,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company computes basic earnings per share for the Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the two-class method by d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Series A Preferred Stock, due to its convertible feature, is participating in nature; accordingly, the outstanding shares of Series A Preferred Stock are included in the two-class method. Diluted earnings per common share measures the performance of the Company over the reporting period while giving effect to all potential shares of Common Stock that were dilutive and outstanding during the period. The denominator includes the weighted average over the measurement period of the sum of the number of shares of Common Stock outstanding and the number of additional such shares that would have been outstanding if </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the shares of Common Stock that were both potentially issuable and dilutive had been issued, and is calculated using the more dilutive of the two-class, treasury stock, and if-converted methods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company&#8217;s assets and liabilities. The Company measures deferred tax assets and liabilities using enacted tax rates in the respective jurisdictions in which it operates. In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that the Company will be able to realize some or all of the deferred tax assets. The calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in each of its tax jurisdictions. The number of years with open tax audits varies by tax jurisdiction. A number of years may lapse before a particular matter is audited and finally resolved. The Company applies ASC 740 to determine the accounting for uncertain tax positions. This standard clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before the Company may recognize the position in its financial statements. The standard also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has elected not to reclassify the income tax effects stranded in accumulated other comprehensive income to retained earnings.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 718, companies recognize compensation expense using a fair-value-based method for costs related to share-based payments, including stock options and restricted stock units. The expense is measured based on the grant date fair value of the awards, and the expense is recorded over the applicable requisite service period. Forfeitures are recognized as and when they occur. In the absence of an observable market price for a share-based award, the fair value is based upon a valuation methodology that takes into consideration various factors, including the exercise price of the award, the expected term of the award, the current price of the underlying shares, the expected volatility of the underlying share price, the expected dividends on the underlying shares and the risk-free interest rate. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Company&#8217;s stock-based compensation plans permit an employee holding vested stock options or restricted stock units to elect to have the Company use a portion of the shares otherwise issuable upon the employee&#8217;s exercise of the option or grant, a so-called </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net settlement transaction,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a means of paying the exercise price, meeting tax withholding requirements, or both. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Financial Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2018, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirement for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changes the disclosure requirements on fair value measurements in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance eliminates certain disclosure requirements that are no longer considered cost beneficial and adds new disclosure requirements for Level 3 fair value measurements. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial statement disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which introduces a new accounting model known as Credit Expected Credit Losses (&#8220;CECL&#8221;). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for financial assets at the time they are originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaces the multiple existing impairment models in current U.S. GAAP, which generally require that a loss be incurred before it is recognized. The new standard applies to receivables arising from </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue transactions such as contract assets, accounts receivables, available for-sale debt securities and notes receivable arising from divestitures. The Company adopted the amended guidance using a modified retrospective approach on July 1, 2020. The amended guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Standards Not Adopted as of June 30, 2021</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance to ease the potential burden in accounting for the discontinuation of a reference rate such as LIBOR, formerly known as the London Interbank Offered Rate, because of reference rate reform. The expedients and exceptions provided by the guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the incremental approach for intra-period allocation, deferred tax recognition requirement for changes in equity method investments and foreign subsidiaries, and methodology for calculating income taxes in an interim period. The guidance also simplifies certain aspects of the accounting for franchise taxes, the accounting for step-up in the tax basis of goodwill, and accounting for the change in the enacted change in tax laws or rates. The ASU will be effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General (Subtopic 715-20): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Defined Benefit Plan</span>, which removes certain disclosures and added additional disclosures around weighted-average interest crediting rates for cash balance plans and explanation for significant gains and losses related to change in the benefit obligation for the period. The ASU will be effective for fiscal years beginning after December 15, 2020 with a retrospective application for all periods presented. The adoption of this guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538477064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company generally earns its revenue by supplying goods or providing services under contracts with its customers in three primary revenue streams: manufacturing and commercial product supply, development services, and clinical supply services. The Company measures the revenue from customers based on the consideration specified in its contracts, excluding any sales incentive or amount collected on behalf of a third party. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer contracts generally include provisions entitling the Company to a termination penalty when the customer invokes its contractual right to terminate prior to the contract&#8217;s nominal end date. The termination penalties in the customer contracts vary but are generally considered substantive for accounting purposes and create enforceable rights and obligations throughout the stated duration of the contract. The Company accounts for a contract cancellation as a contract modification in the period in which the customer invokes the termination provision. The determination of the contract termination penalty is based on the terms stated in the relevant customer agreement. As of the modification date, the Company updates its estimate of the transaction price using the expected value method, subject to constraints, and recognizes the amount over the remaining performance period</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally expenses sales commissions as incurred because either the amortization period is one year or less, or the balance with an amortization period greater than one year is not material.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects revenue by the location where the goods were made or the service performed:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of revenue attributable to multiple locations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing &amp; Commercial Product Supply Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing and commercial product supply revenue consists of revenue earned by manufacturing products supplied to customers under long-term commercial supply arrangements. In these arrangements, the customer typically owns and supplies the active pharmaceutical ingredient, or API, that is used in the manufacturing process. The contract generally includes the terms of the manufacturing services and related product quality assurance procedures to comply with regulatory requirements. Due to the regulated nature of the Company&#8217;s business, these contract terms are highly interdependent and, therefore, are considered to be a single combined performance obligation. The transaction price is generally stated in the agreement as a fixed price per unit, with no contractual provision for a refund or price concession. Control is transferred to the customer over time, creating a corresponding right to recognize the related revenue, because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. Progress is measured based on the units of product that have successfully completed the contractually required product quality assurance process, as the conclusion of that process generally defines the time when the applicable contract and the related regulatory requirements permit the customer to exercise control over the product&#8217;s disposition. The customer is typically responsible for arranging the shipping and handling of product following completion of the quality assurance process.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days after the goods are shipped as requested by the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development services contracts generally take the form of short-term, fee-for-service arrangements. Performance obligations vary, but frequently include biologic cell-line development, performing formulation, analytical stability, or other services related to product development, and providing manufacturing services for products that are under development or otherwise not intended for commercial sale. The transaction prices for these arrangements are fixed and include amounts stated </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the contracts for each promised service, and each service is generally considered to be a separate performance obligation. The Company recognizes revenue over time because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures progress toward the completion of its performance obligations satisfied over time based on the nature of the services to be performed. For certain types of arrangements, revenue is recognized over time and measured using an output method based on the completion of tasks and activities that are performed to satisfy a performance obligation. For all other types of arrangements, revenue is recognized over time and measured using an input method based on effort expended. Each of these methods provides an appropriate depiction of the Company&#8217;s progress toward fulfilling its performance obligations for its respective arrangement. In certain development services arrangements that require a portion of the contract consideration to be received in advance at the commencement of the contract, such advance payment is initially recorded as a contract liability. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates consideration to each performance obligation using the &#8220;relative standalone selling price&#8221; as defined under ASC 606. Generally, the Company utilizes observable standalone selling prices in its allocations of consideration. If observable standalone selling prices are not available, the Company estimates the applicable standalone selling price using an adjusted market assessment approach, representing the amount that the Company believes the market is willing to pay for the applicable service. Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreemen</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Supply Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical supply services contracts generally take the form of fee-for-service arrangements. Performance obligations for clinical supply services revenue typically include a combination of the following services: the manufacturing, packaging, storage, distribution, destruction, and inventory management of customer clinical trial material. Performance obligations can also include the sourcing of comparator drug products on behalf of customers to be used in clinical trials to compare performance with the drug under clinical investigation. In certain arrangements, the Company recognizes revenue over time when the Company satisfies performance obligations. Satisfaction of the performance obligations is measured using an input method measure of progress based on effort expended by the Company. In other arrangements, revenue is recognized at the point in time when control transfers, which occurs upon either the delivery of the related output of the service to the customer or the completion of quality testing with respect to the product, and the Company has an enforceable right to payment based on the terms of the arrangement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue for comparator sourcing arrangements on a net basis because it is acting as an agent that does not control the product or service before it is transferred to the customer. Payment for comparator sourcing activity is typically received in advance at the commencement of the contract and is initially recorded as a contract liability.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occasionally enters into arrangements with its customers that include licenses of functional intellectual property, including patents, or other intangible property (&#8220;out-licensing&#8221;). Revenue from such arrangements are within the scope of ASC 606. The Company does not have any material license arrangement that contains more than one performance obligation. The terms of such out-licensing arrangements include the license of functional intellectual or intangible property (primarily drug formulae) and typically provide for payment by the licensee of one or more of the following: non-refundable, up-front license fees or royalties on net sales of licensed products. The Company recognizes revenue from nonrefundable, up-front license fees when the licensed intellectual property is made available for the customer&#8217;s use and benefit, which is generally at the inception of the arrangement. Royalty payments from such arrangements are recognized when subsequent sale or usage of an item subject to the royalty occurs and the performance obligation to which royalty relates is satisfied</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to cash consideration that the Company receives in advance of satisfying the related performance obligations. The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:91.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities that will be recognized within 12 months of June 30, 2021 are accounted for in Other accrued liabilities and those that will be recognized longer than 12 months after June 30, 2021 are accounted for within Other liabilities.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily relate to the Company's conditional right to receive consideration for services that have been performed for the customer as of June&#160;30, 2021 relating to its development services but had not yet been invoiced as of June&#160;30, 2021. Contract assets are transferred to trade receivables, net when the Company&#8217;s right to receive the consideration becomes unconditional. Contract assets totaled $181 million and $61 million as of June&#160;30, 2021 and 2020, respectively. Contract assets are accounted for within prepaid expenses and other in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989651876200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text">BUSINESS COMBINATIONS AND DIVESTITURES<div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anagni Acquisition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company acquired an oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy. The Company paid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$55 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in cash as part of the purchase consideration and as consideration for the provision of certain services to facilitate the transition to Company ownership. At the closing of this acquisition, the seller of the facility also entered into a five-year agreement for continuing supply by the Company of certain products at the Anagni facility. Due to the variety of activities performed at Anagni, the results of the Anagni facility are allocated between the Oral and Specialty Delivery and Biologics segments.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cash consideration was allocated between the facility purchase and the transitional services arrangement, with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$52 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assigned to the purchase consideration and the balance to transitional services. The Company funded the entire amount with cash on hand and allocated the purchase price among the acquired assets, recognizing property, plant, and equipm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ent of $34 million, inventory of $6 million, and prepaid expenses and other of $12 million. The purchase price was also allocated to deferred tax assets and certain employee-related liabilities assumed in the a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cquisition. </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MaSTherCell Acquisition </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired 100% of the equity interest in Masthercell Global Inc. (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MaSTherCell</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for an aggregate purchase price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$323 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was funded with the net proceeds of the Company&#8217;s February 2020 equity offering (the &#8220;February 2020 Equity Offering&#8221;) of its Common Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  MaSTherCell is a contract development and manufacturing organization focused on the development and manufacture of autologous and allogeneic cell therapies for third parties, as well as a variety of related analytical services. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the MaSTherCell acquisition using the acquisition method in accordance with ASC 805, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The operating results of MaSTherCell have been included in the Company&#8217;s consolidated financial statements for the period following the acquisition date. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimated fair values at the date of acquisition for the allocation of consideration to the net tangible and intangible assets acquired and liabilities assumed as part of the MaSTherCell acquisition.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation to assets acquired and liabilities assumed in the transaction is (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant, and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Identifiable intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other net assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable net assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total assets acquired and liabilities assumed</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of trade receivables, raw materials inventory, and trade payables, as well as certain other current and non-current assets and liabilities generally represented their fair values at the date of acquisition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment was valued using the cost approach, which is based on the current replacement or reproduction cost of the asset as new, less depreciation attributable to physical, functional, and economic factors. The Company then determined the remaining useful life based on the anticipated life of the asset and Company policy for similar assets.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer-relationship intangible assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$46 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were valued using the multi-period, excess-earnings method, a method that values the intangible assets using the present value of the after-tax cash flows attributable to the intangible assets only. The assumptions used in developing the valuation included the estimated annual net cash flows (including application of an appropriate margin to forecasted revenue, selling and marketing costs, return on working capital, contributory asset charges, and other factors), the discount rate that appropriately reflects the risk inherent in each future cash flow stream, and an assessment of the assets&#8217; life cycles, as well as other factors. The assumptions used in the financial forecasts were based on historical data, supplemented by current and anticipated growth rates, management plans, and market-comparable information. The customer relationship intangible assets have a weighted average useful life of 13 years. Goodwill is mainly comprised of the growth from an expected increase in capacity utilization, potential new customers, and advanced cell therapy development and manufacturing capabilities. The goodwill arising from the MaSTherCell acquisition has been assigned to the Biologics segment. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Cell Therapy Support SA Acquisition</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the Company acquired 100% of the equity interest in Skeletal Cell Therapy Support SA (&#8220;Skeletal&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$15 million, subject to customary adjustments, as well as related supply agreements with the seller. Skeletal operates </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a cell therapy manufacturing facility in Gosselies, Belgium. The operations were assigned to the Company&#8217;s Biologics segment, expanding the Company&#8217;s cell therapy capacity for clinical and commercial supply. The acquisition, when combined with the Company's other European-based facilities and capabilities in cell therapy, has created an integrated European center of excellence in cell therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Skeletal acquisition using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price to trade receivables, property, plant, and equipment, deferred tax assets, and other current and non-current assets and liabilities assumed in the acquisition, which resulted in a recognition of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$9 million of goodwill</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Results for the fiscal year ended June 30, 2021 were not material to the Company&#8217;s statement of operations, financial position, or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and income taxes are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acorda Therapeutics, Inc. Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company acquired the manufacturing and packaging operations of Acorda Therapeutics, Inc.'s (&#8220;Acorda&#8221;) dry powder inhaler and spray dry manufacturing business, including its manufacturing facility located near Boston, Massachusetts, for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$83 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, subject to customary adjustments. In connection with the purchase, Acorda and the Company entered into a long-term supply agreement, under which the Company will continue the manufacture and packaging of an Acorda product at the facility. The facility and operations became part of the Company&#8217;s Oral and Specialty Delivery segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Acorda transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price among the acquired assets, recognizing property, plant, and equipment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$79 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, inventory of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purchase price was also preliminarily allocated to other current and non-current assets and liabilities assumed in the acquisition. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to goodwill and inventory are preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delphi Genetics SA Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company acquired 100% of the equity interest in Delphi for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, subject to customary adjustments. Delphi is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. The facility and operations acquired became part of the Company&#8217;s Biologics segment. Results of the business acquired were not material to the Company's statement of operations, financial position, or cash flows for the fiscal year ended June 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Delphi transaction using the acquisition method in accordance with ASC 805. The Company funded the entire purchase price with cash on hand and preliminarily allocated the purchase price recognizing property, plant, and equipment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, intangible assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, other current assets of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, assumed debt of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, other current liabilities of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$45 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not completed its analysis regarding the assets acquired and liabilities assumed. Therefore, the allocation to intangible assets, inventory, goodwill, and income taxes is preliminary and subject to finalization. The Company expects to finalize its allocation over the next several months, but, in any event, within one year from the acquisition date.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hepatic Cell Therapy Support SA Asset Acquisition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company acquired 100% of the equity interest in Hepatic Cell Therapy Support SA (&#8220;Hepatic&#8221;) for approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$15 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of cash acquired and debt assumed. Hepatic operates a manufacturing facility at the same location where Skeletal operates a cell therapy manufacturing facility in Gosselies, Belgium. The facility acquired will expand the C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany&#8217;s cell therapy capacity for clinical and commercial supply in its Biologics segment.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RheinCell Therapeutics GmbH Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into an agreement to acquire 100% of the equity interest in RheinCell for approximately $30 million and completed the acquisition in August 2021. RheinCell is a developer and manufacturer of cGMP-grade iPSCs.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations acquired became part of the Company&#8217;s Biologics segment and build upon Catalent&#8217;s existing custom cell therapy process development and manufacturing capabilities with proprietary GMP cell lines for iPSC-based therapies. Due to the date of the closing, a preliminary purchase price allocation has not yet been performed. However, a portion of the purchase price is expected to be allocated to intangible assets and goodwill.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blow</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">-Fill-Seal Divestitur</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company sold 100% of the shares of Catalent USA Woodstock, Inc. and certain related assets (collectively, the &#8220;Blow-Fill-Seal Business&#8221;) for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$300 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cash, a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> note receivable (estimated fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) as well as potential additional contingent consideration (up to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) dependent upon the performance of aspects of the Blow-Fill-Seal Business. The Blow-Fill-Seal Business was part of the Oral and Specialty Delivery segment. The carrying value of the net assets sold was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$149 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which included goodwill of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$54 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result of the sale, the Company realized a gain from divestiture of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$182 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, net of transaction costs, for the fiscal year ended June 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Blow-Fill-Seal Business was classified as held-for-sale. The Company determined that the sale of the business did not meet the criteria to be considered a discontinued operation as the disposal of the Blow-Fill-Seal Business did not represent a strategic shift that has (or will have) a major effect on the Company's financial results upon disposal.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All consideration received was measured at its divestiture date fair value. The Company valued the total consideration received from divestiture of the Blow-Fill-Seal Business as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fair value of consideration received</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at June 30, 2021, which is the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount less a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discount determined using a discounted cash flow model with the market interest rate as a significant input.</span></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;Other includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of transaction expenses, a working capital adjustment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assumption of liabilities resulting in net cash proceed of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989629271448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">GOODWILL<div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes from June&#160;30, 2019 to June&#160;30, 2020 and then to June&#160;30, 2021 in the carrying amount of goodwill in total and by reporting segment:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The reallocation in fiscal 2020 relates to adjustments to the Company&#8217;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. </span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>(4) Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.The Company recorded no impairment charge to goodwill in fiscal 2021, 2020, or 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542981672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Definite Lived Long-Lived Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract', window );"><strong>Finite lived intangible assets disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Definite Lived Long-Lived Assets</a></td>
<td class="text">OTHER INTANGIBLES, NET<div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of other intangible assets subject to amortization as of June&#160;30, 2021 and June&#160;30, 2020 are as follows (in millions):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $93 million, $89 million, and $88 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively. Future amortization expense for the next five fiscal years is estimated to be:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FinitelivedintangibleassetsdisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539204728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Other Costs</a></td>
<td class="text">RESTRUCTURING COSTS<div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has implemented plans to restructure certain operations, both domestically and internationally. The restructuring plans focused on various aspects of operations, including closing and consolidating certain manufacturing operations, rationalizing headcount and aligning operations in a strategic and more cost-efficient structure. In addition, the Company may incur restructuring charges in the future in cases where a material change in the scope of operation with its business occurs. Employee-related costs consist primarily of severance costs and also include outplacement services provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods. Facility exit and other costs consist of accelerated depreciation, equipment relocation costs, and costs associated with planned facility closures to streamline Company operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2021, the Company adopted a plan to reduce costs and optimize its infrastructure in Europe by closing its Clinical Supply Services facility in Bolton, U.K. In connection with this restructuring plan, the Company expects to reduce its headcount between 150 and 180 employees through December 31, 2021 and estimates that it will incur charges between $7 million and $8 million, primarily associated with employee severance benefits. For the fiscal year ended June 30, 2021, restructuring charges associated with the Bolton facility closure were $7 million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2020, no significant restructuring plan was adopted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal year ended June 30, 2019, the Company adopted a plan to restructure its workforce following a temporary suspension of operations at a Softgel and Oral Technology facility. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the costs recorded within restructuring costs: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee-related reorganization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facility exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543943240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text">LONG-TERM OBLIGATIONS AND SHORT-TERM BORROWINGS<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term obligations and short-term borrowings consist of the following at June&#160;30, 2021 and June&#160;30, 2020:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Maturity as of June 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-2 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% senior notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% senior notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated senior notes due 2028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% senior notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred purchase consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term<br/>&#160;&#160;&#160;&#160;&#160;borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities and Fifth Amendment to the Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Operating Company completed Amendment No. 5 (the "Fifth Amendment") to its Amended and Restated Credit Agreement, dated as of May 20, 2014 (as subsequently amended, the "Credit Agreement"). Pursuant to the Fifth Amendment, Operating Company refinanced the existing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$933 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount of U.S. dollar-denominated term loans (the "Term B-2 Loans") with the proceeds of an equivalent amount of new U.S. dollar-denominated term loans (the "Term B-3 Loans"), incurred an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$67 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount of Term B-3 Loans, and obtained an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$175 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revolving credit commitments (the "Incremental Revolving Credit Commitments") under the Credit Agreement's revolving credit facility (the "Revolving Credit Facility"). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term B-3 Loans constitute a new class of term loans under the Credit Agreement, with an interest rate of one-month LIBOR (subject to a floor of 0.50%) plus 2.00% per annum, a maturity date of February 2028 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly amortization of principal equal to 0.25% with payments on the last business day of March, June, September, and December. The proceeds of the Term B-3 Loans, after payment of the offering fees and expenses, were used to repay in full the existing Term B-2 Loans under the Credit Agreement, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Incremental Revolving Credit Commitments constitute revolving credit commitments under the Revolving Credit Facility.  The applicable rate for all revolving credit facility commitments under the Revolving Credit Facility is initially LIBOR plus 2.25% and such rate can additionally be reduced to LIBOR plus 2.00% in future periods based on a measure of Operating Company's total leverage ratio.  The maturity date for the Revolving Credit Facility is the earlier of (i) May 17, 2024 and (ii) the 91st day prior to the maturity of the Term B-3 Loans. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the Fifth Amendment, certain modifications were made to the Credit Agreement in order to, among other things, provide for determination of a benchmark replacement interest rate when LIBOR is no longer available.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of capacity under the Revolving Credit Facility is reduced by the aggregate value of all outstanding letters of credit under the Credit Agreement. As of June&#160;30, 2021, Operating Company had $719 million of unutilized capacity under the Revolving Credit Facility due to $6 million of outstanding letters of credit. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.000% Senior Notes due 2027</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Operating Company completed a private offering of $500 million aggregate principal amount of 5.000% Senior Notes due 2027 (the &#8220;2027 Notes&#8221;). The 2027 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2027 Notes were offered in the U.S to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2027 Notes will mature on July 15, 2027 and bear interest at the rate of 5.000% per annum. Interest is payable semi-annually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The proceeds of the 2027 Notes after payment of the offering fees and expenses were used to repay in full the borrowings under Operating Company&#8217;s then-outstanding term loans under its senior secured credit facilities that would otherwise have matured in May 2024.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2.375% Euro-denominated Senior Notes due 2028</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, Operating Company completed a private offering of &#8364;825 million aggregate principal amount of 2.375% Senior Notes due 2028 (the "2028 Notes"). The 2028 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The Euro 2028 Notes were offered in the U.S. to qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the U.S. only to non-U.S. investors pursuant to Regulation S under the Securities Act. The 2028 Notes will mature on March 1, 2028 and bear interest at the rate of 2.375% per annum. Interest is payable semi-annually in arrears on March 1 and September 1 of each year. The proceeds of the 2028 Notes after payment of the offering fees and expenses were used to repay in full the borrowings then outstanding under Operating Company's euro-denominated term loans under its senior secured credit facilities, which would have matured in May 2024, and repay in full Operating Company's euro-denominated 4.75% Senior Notes due 2024 (the &#8220;2024 Notes&#8221;), which would have matured in December 2024, plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">3.125% Senior Notes due 2029</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Operating Company completed a private offering of $550 million aggregate principal amount of 3.125% Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes and the 2028 Notes, the "Senior Notes"). The 2029 Notes are fully and unconditionally guaranteed, jointly and severally, by all of the wholly owned U.S. subsidiaries of Operating Company that guarantee its senior secured credit facilities. The 2029 Notes will mature on February 15, 2029 and bear interest at the rate of 3.125% per annum payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2021. The proceeds of the 2029 Notes after payment of the offering fees and expenses were used to repay in full the outstanding borrowings under Operating Company's 4.875% Senior Notes due 2026. which would have matured in January 2026 (the "2026 Notes") plus any accrued and unpaid interest thereon, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Purchase Consideration</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Cook Pharmica LLC (now Catalent Indiana, LLC) in October 2017, $200 million of the $950 million aggregate nominal purchase price is payable in $50 million installments, on each of the first four anniversaries of the closing date. The Company made installment payments in October 2018, 2019, and 2020. The balance of the deferred purchase consideration was recorded at fair value as of the acquisition date, with the difference between the remaining nominal amount and the fair value as of any relevant period end treated as imputed interest. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term and Other Obligations </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other obligations consist primarily of finance leases for buildings and other loans for business and working capital needs. Maturities of long-term obligations, including finance leases of $193 million, and other short-term borrowings for future fiscal years are:</span></div><div style="margin-top:9pt;text-indent:24pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:35.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of long-term and other obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs associated with the Credit Agreement (other than its Revolving Credit Facility component) and the Senior Notes are presented as a reduction to the carrying value of the related debt, while debt issuance costs associated with the Revolving Credit Facility are capitalized within other long-term assets on the consolidated balance sheet. All debt issuance costs are amortized over the life of the related obligation through charges to interest expense in the consolidated statements of operations. The unamortized total debt issuance costs, including the costs associated with the Revolving Credit Facility capitalized within other long-term assets, were $38 million and $39&#160;million as of June&#160;30, 2021 and 2020, respectively. Amortization of debt issuance costs totaled $6 million and $6 million for the fiscal years ended June&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Security </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the following assets of Operating Company and each guarantor (Operating Company's parent entity, PTS Intermediate, and each of Operating Company's material domestic subsidiaries), subject to certain exceptions: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">a pledge of 100% of the capital stock of Operating Company and 100% of the equity interests directly held by Operating Company and each guarantor in any wholly owned material subsidiary of Operating Company or any guarantor (which pledge, in the case of any non-U.S. subsidiary of a U.S. subsidiary, will not include more than 65% of the voting stock of such non-U.S. subsidiary); and </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">a security interest in, and mortgages on, substantially all tangible and intangible assets of Operating Company and of each guarantor, subject to certain limited exceptions. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Senior Notes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Senior Notes are general, unsecured, and subordinated to all existing and future secured indebtedness of the guarantors to the extent of the value of the assets securing such indebtedness. Each of the Senior Notes is separately guaranteed by all of Operating Company's wholly owned U.S. subsidiaries that guarantee the senior secured credit facilities. None of the Senior Notes is guaranteed by either PTS Intermediate or the Company. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains a number of covenants that, among other things, restrict, subject to certain exceptions, Operating Company&#8217;s (and Operating Company&#8217;s restricted subsidiaries&#8217;) ability to incur additional indebtedness or issue certain preferred shares; create liens on assets; engage in mergers and consolidations; sell assets; pay dividends and distributions or repurchase capital stock; repay subordinated indebtedness; engage in certain transactions with affiliates; make investments, loans or advances; make certain acquisitions; enter into sale and leaseback transactions; amend material agreements governing Operating Company's subordinated indebtedness and change Operating Company's lines of business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement also contains change of control provisions and certain customary affirmative covenants and events of default. The Revolving Credit Facility requires compliance with a net leverage covenant when there is a 30% or more draw outstanding at a period end. As of June&#160;30, 2021, the Company was in compliance with all material covenants under the Credit Agreement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, the Credit Agreement permits Operating Company and its restricted subsidiaries to incur certain additional indebtedness, including secured indebtedness. None of Operating Company&#8217;s non-U.S. subsidiaries nor its dormant Puerto Rico subsidiary is a guarantor of the loans.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Credit Agreement, Operating Company&#8217;s ability to engage in certain activities such as incurring certain additional indebtedness, making certain investments, and paying certain dividends is tied to ratios based on Adjusted EBITDA (which is defined as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Credit Agreement). Adjusted EBITDA is based on the definitions in the Credit Agreement, is not defined under U.S. GAAP, and is subject to important limitations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Senior Notes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various indentures governing the Senior Notes (collectively, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indentures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) contain covenants that, among other things, limit the ability of Operating Company and its restricted subsidiaries to incur or guarantee more debt or issue certain preferred shares; pay dividends on, repurchase, or make distributions in respect of their capital stock or make other restricted payments; make certain investments; sell certain assets; create liens; consolidate, merge, sell; or otherwise dispose of all or substantially all of their assets; enter into certain transactions with their affiliates, and designate their subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of exceptions, limitations, and qualifications as set forth in the Indentures. The Indentures also contain customary events of default, including, but not limited to, nonpayment, breach of covenants, and payment or acceleration defaults in certain other indebtedness of Operating Company or certain of its subsidiaries. Upon an event of default, either the holders of at least 30% in principal amount of each of the then-outstanding Senior Notes or the applicable Trustee under the Indentures may declare the applicable notes immediately due and payable; or in certain circumstances, the applicable notes will automatically become immediately due and payable. As of June&#160;30, 2021, Operating Company was in compliance with all material covenants under the Indentures. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimated Fair Value of Debt Measurements</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair values of the senior secured credit facilities and Senior Notes are classified as Level 2 (see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for a description of the method by which fair value classifications are determined) in the fair value hierarchy and are calculated by using a discounted cash flow model with market interest rate as a significant input. The carrying amounts and the estimated fair values of financial instruments as of June&#160;30, 2021 and June&#160;30, 2020 are as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% Senior Notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% Senior Notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated Senior Notes due 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Senior Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities &amp; other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538458568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes earnings per share (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPS</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of the Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the two-class method required due to the participating nature of the Series A Preferred Stock (as noted in Note 13,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The weighted-average number of shares outstanding utilized in diluted earnings per share is computed using the weighted-average number of common shares outstanding plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation. The dilutive effect of the securities that are issuable under the Company&#8217;s equity incentive plans (see Note 14, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) are reflected in diluted earnings per share by application of the treasury stock method. The Company applies the if-converted method to compute the potentially dilutive </span><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect of the Series A Preferred Stock. The reconciliations between basic and diluted earnings per share attributable to Catalent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> common shareholders for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows: </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160; (In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to preferred shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average dilutive securities issuable - stock plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Series A Preferred Stock is deemed a participating security, meaning that it has the right to participate in undistributed earnings with the Company's Common Stock. On November 23, 2020 (the &#8220;Partial Conversion Date&#8221;), holders of Series A Preferred Stock converted 265,223 shares and $2 million of unpaid accrued dividends into shares of Common Stock (the &#8220;Partial Conversion&#8221;). The holders received 20.33 shares of Common Stock for each converted preferred share, resulting in the issuance of 5,392,280 shares of Common Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock and Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The diluted weighted average number of shares outstanding for the fiscal years ended June 30, 2021, 2020 and 2019 did not include the weighted average number of shares of Common Stock associated with the Series A Preferred Stock reported below or the weighted average number of shares of Common Stock associated with the following types of outstanding equity grants due to their antidilutive effect:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(share counts in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542981672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to fluctuations in the currency exchange rates applicable to its investments in foreign operations. While the Company does not actively hedge against changes in foreign currency, the Company has mitigated the exposure arising from its investments in its European operations by denominating a portion of its Senior Notes in euros. At June&#160;30, 2021, the Company had euro-denominated debt outstanding of $984 million (U.S. dollar equivalent), which qualifies as a hedge of a net investment in foreign operations. For non-derivatives designated and qualifying as net investment hedges, the effective portion of the translation gains or losses are reported in accumulated other comprehensive income (loss) as part of the cumulative translation adjustment. The unhedged portions of the translation gains or losses are reported in the consolidated statements of operations. The following table includes net investment hedge activity during the fiscal years ended June&#160;30, 2021 and 2020, respectively:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within Other Comprehensive Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within the Consolidated Statements of Operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net accumulated gain of this net investment within accumulated other comprehensive loss was $6 million as of June&#160;30, 2021. Amounts are reclassified out of accumulated other comprehensive loss into earnings when the entity in which the gains and losses reside is either sold or substantially liquidated. </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock Derivative Liability </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 13, Equity, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Preferred Stock and Accumulated Other Comprehensive Loss, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in May 2019, the Company issued shares of Series A Preferred Stock in exchange for net proceeds of $646 million after taking into account the $4 million issuance cost.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dividend rate used to determine the amount of the quarterly dividend payable on shares of the Series A Preferred Stock is subject to adjustment so as to provide holders of shares of Series A Preferred Stock with certain protections against a decline in the trading price of shares of Common Stock. The Company determined that this feature should be accounted for as a derivative liability, since the feature fluctuates inversely to changes in the trading price and is also linked to the performance of the S&amp;P 500 stock index. Accordingly, the Company bifurcated the adjustable dividend feature from the remainder of the Series A Preferred Stock and accounted for this feature as a derivative liability at fair value. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a gain of $17 million on the change in the estimated fair value of the derivative liability for the fiscal year ended June 30, 2021, which is reflected as other expense, net in the consolidated statements of operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the derivative liability was settled on the Partial Conversion Date due to the Partial Conversion. The fair value of the derivative liability as of the Partial Conversion Date was $9 million, of which $4 million was related to the converted portion of the outstanding shares of Series A Preferred Stock. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity, Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details of the Partial Conversion.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest-Rate Swap </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its interest rate and risk management strategy, in April 2020, the Company entered into an interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its U.S dollar-denominated term loans under its senior secured credit facilities, so that the interest payable on that portion of the debt becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, in connection with the Fifth Amendment to the Credit Agreement, the Company settled the interest-rate swap agreement with Bank of America N.A. The Company paid $2 million in cash to Bank of America N.A to settle the interest-rate swap agreement. This loss is deferred in stockholders&#8217; equity, net of income taxes, as a component of accumulated other comprehensive loss, and amortized as an adjustment to interest expense, net over the original term of the Term B-2 Loans. The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is not material.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a new interest-rate swap agreement with Bank of America N.A. as a hedge against the economic effect of a portion of the variable interest obligation associated with its Term B-3 Loans, so that the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest payable on that portion of the Term B-3 Loans becomes fixed at a certain rate, thereby reducing the impact of future interest rate changes on future interest expense. As a result of entering into the interest-rate swap agreement, the floating portion of the applicable rate on $500 million of the Term B-3 Loans is now effectively fixed at 0.9985%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new interest-rate swap agreement qualifies for and is designated as a cash-flow hedge. The Company evaluates hedge effectiveness at the inception of the hedge and on an ongoing basis. The cash flows associated with the interest-rate swap are reported in net cash provided by operating activities in the consolidated statements of cash flows. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538640968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, defines fair value as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. To measure fair value, the Company uses the following fair value hierarchy based on three levels of inputs, of which Level 1 and Level 2 are considered observable and Level 3 is considered unobservable:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Quoted prices in active markets for identical assets or liabilities.                      </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.                      </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Value is determined using pricing models, discounted cash flow methodologies, or similar techniques and also includes instruments for which the determination of fair value requires significant judgment or estimation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses of the Company approximate fair value based on the short maturities of these instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level of classification as of the end of each reporting period. The following table sets forth the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis and the fair value measurement for such assets and liabilities at June 30, 2021 and June 30, 2020, respectively:</span></div><div style="padding-left:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Basis of Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the interest-rate swap agreement is determined at the end of each reporting period based on valuation models that use interest-rate yield curves and discount rates as inputs. The discount rates are based on U.S. deposit or U.S. Treasury rates. The significant inputs used in the valuation models are readily available in public markets or can be derived from observable market transactions, and the valuation is therefore classified as Level 2 in the fair-value hierarchy.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Series A Preferred Stock derivative is determined using an option pricing methodology, specifically both a Monte Carlo simulation and a binomial lattice model. The methodology incorporates the terms and conditions of the preferred stock arrangement, historical stock price volatility, the risk-free interest rate, a credit spread based on the yield indexes of high-yield bonds, and the trading price of shares of the Common Stock. The calculation of the estimated fair value of the derivative liability is highly sensitive to changes in unobservable inputs, such as the expected volatility and the Company&#8217;s credit spread. The estimated fair value of the Series A Preferred Stock derivative liability is classified as Level 3 in the fair-value hierarchy due to the significant management judgment required to make the assumptions underlying the calculation of value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of changes in the estimated fair value of the Series A Preferred Stock derivative liability from June 30, 2020 to June 30, 2021:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.877%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement of<br/>Series A Preferred Stock<br/>Derivative Liability<br/>Using Significant<br/>Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value of Series A Preferred Stock derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of derivative liability upon Partial Conversion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, goodwill, and other intangible assets are subject to non-recurring fair value measurement for the evaluation of potential impairment. Other than the fair value estimates disclosed in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there was no non-recurring fair value measurement during the fiscal years ended June 30, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539331192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes are as follows for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision starting from the tax computed at the federal statutory income tax rate to the tax computed at the Company&#8217;s effective income tax rate is as follows for the fiscal years ended 2021, 2020, and 2019:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision at U.S. federal statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low tax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax and other foreign taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for the fiscal year ended June 30, 2021 is not comparable to the provision in the prior year due to changes in the geographic mix of pretax income, changes in the tax impact of permanent differences and credits, and the tax impact of discrete items. The effective tax rate for the fiscal year ended June 30, 2021 reflects a tax expense for the sale of the </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blow-Fill-Seal Business and an increase to state taxes, offset by an increase to the U.S. foreign tax credits as a result of amended prior year returns, as well as a reduction to the foreign valuation allowance. The effective tax rate for the fiscal year ended June 30, 2020 reflects a reduction to the federal and foreign valuation allowance partially offset by permanent items, and an increase in state tax.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to repatriate foreign earnings taxed in prior fiscal years as a result of the changes imposed by the 2017 U.S. Tax Cuts and Jobs Act. In addition to these foreign earnings previously taxed, as of June 30, 2021, for purposes of ASC 740-10-25-3, the Company had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$142 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of undistributed earnings from non-U.S. subsidiaries that it intends to reinvest permanently in its non-U.S. operations. As these ASC 740-10-25-3 earnings are considered permanently reinvested, no tax provision has been accrued. It is not feasible to estimate the amount of tax that might be payable on the eventual remittance of such earnings.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the Company's deferred income tax assets and liabilities are as follows at June&#160;30, 2021 and 2020:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities in the preceding table are in the following captions in the consolidated balance sheets at June&#160;30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company had federal net operating loss (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOL</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) carryforwards of $512 million, $229 million of which are subject to limitations under Section 382 of the Internal Revenue Code of 1986, as amended (the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal Revenue Code</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  The majority of the $229 million federal NOL carryforwards subject to Section 382 of the Internal Revenue Code are attributed to the Company's acquisitions of Pharmatek Laboratories, Inc., Juniper Pharmaceuticals, Inc., Paragon Bioservices, Inc., and MaSTherCell. As of June 30, 2021, $432 million of the Company's federal NOL carryforwards have an indefinite life and the remaining NOL carryforwards will expire in fiscal years 2023 through 2037.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company had state tax NOL carryforwards of $441 million. Substantially all state NOL carryforwards have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMxMTQ_40c2bc12-63e0-4386-a398-62f51315a07f">twenty</span>-year carryforward period. At June&#160;30, 2021, the Company had non-U.S. tax NOL carryforwards of $161 million, a majority of which, are available for at least <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRkOWNmOTJiZjZhMzRjNzhhYzkzNmI0NzI2MjY0MGQ3L3NlYzpkZDljZjkyYmY2YTM0Yzc4YWM5MzZiNDcyNjI2NDBkN18yMTcvZnJhZzo4N2QxZjc2MzU4OTI0NTNmODg0N2U5ODM4ZDM1MDE5MC90ZXh0cmVnaW9uOjg3ZDFmNzYzNTg5MjQ1M2Y4ODQ3ZTk4MzhkMzUwMTkwXzMyNTI_21287ddd-d08b-44ee-ae2d-42c777ef2210">three</span> years or have an indefinite carryforward period.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had valuation allowances of $65 million and $53 million as of June&#160;30, 2021 and 2020, respectively, against its deferred tax assets. The Company considered all available evidence, both positive and negative, in assessing the need for a valuation allowance against tax assets. Four possible sources of taxable income were evaluated when assessing the realization of deferred tax assets:</span></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">carrybacks of existing NOLs (if and to the extent permitted under the tax law);</span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future reversals of existing taxable temporary differences; </span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">tax planning strategies; and </span></div><div style="margin-top:6pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">future taxable income exclusive of reversing temporary differences and carryforwards. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the valuation allowance related to certain U.S. combined states was released during the fiscal year ended June 30, 2019, there remained as of June 30, 2021 a valuation allowance for the NOLs and deductible temporary differences in the remaining combined and separate states of $39 million. The state valuation allowance as of June 30, 2021 is due to the Company&#8217;s history of tax losses and anticipated loss utilization rates in separate filing status states as well as the difference in the rules related to allocated and apportioned income for separate filing status states versus combined filing status states.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the need to maintain a valuation allowance on deferred tax assets based on management&#8217;s assessment of whether it is more likely than not that the Company would realize the value of its deferred tax assets based on future reversals of existing taxable temporary differences and the ability to generate sufficient taxable income within the carryforward period available under the applicable tax laws. During the fiscal year ended June 30, 2021, the Company released $17 million of its valuation allowances. The amount released is related to $17 million of NOLs and temporary differences for certain Italian operations. The $17 million release of the Company&#8217;s valuation allowance was partially offset by establishing a $2 million valuation allowance on NOLs and temporary differences related to certain Canadian operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company's income taxes are subject to audits by federal, state, and foreign tax authorities, some of which are ongoing and may result in proposed assessments. Germany and the U.K. are among the jurisdictions where the Company has substantial tax positions. The Company is no longer subject to examinations by the relevant tax authorities for years prior to fiscal 2009. The Company&#8217;s estimate for the potential outcome for any uncertain tax issue is highly judgmental. The Company assesses its income tax positions and records benefits for all years subject to examination based upon management&#8217;s evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions for which it is more likely than not that a tax benefit will be sustained, the Company records the amount that has a greater than 50% likelihood of being realized upon resolution with the taxing authority that has full knowledge of all relevant information based on the technical merit. Interest and penalties are accrued, where applicable.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company had a total of $5 million of unrecognized tax benefits.&#160;A reconciliation of unrecognized tax benefits, excluding accrued interest, as of June&#160;30, 2021, 2020, and 2019 is as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the unrecognized tax benefits as of June 30, 2021 and 2020 would, if subsequently recognized, favorably affect the effective income tax rate.  </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.&#160;As of June&#160;30, 2021, the Company has $1 million of accrued interest related to uncertain tax positions, consistent with the prior year, as a result of an increase to certain tax positions taken in the fiscal year ended June 30, 2021, offset by a reduction to prior-year positions due to lapses in the statute of limitations. The Company had $1 million of accrued interest related to uncertain tax positions as of both June 30, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539143928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Retirement Benefit Plans</a></td>
<td class="text">EMPLOYEE RETIREMENT BENEFIT PLANS<div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement plans, including defined benefit pension plans and defined contribution plans. Substantially all of the Company&#8217;s domestic non-union employees are&#160;eligible to participate in employer-sponsored retirement savings plans, which include plans created under Section&#160;401(k) of the Internal Revenue Code that provide for the Company to match a portion of contributions by participating U.S. employees. The Company&#8217;s contributions to the plans are discretionary but are subject to certain minimum requirements as specified in the plans. The Company uses a measurement date of June&#160;30 for all of its retirement and postretirement benefit plans. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records obligations related to its withdrawal from one multi-employer pension plan that covered former employees at three former sites. This withdrawal was classified as a mass withdrawal under the Multiemployer Pension Plan Amendments Act of 1980, as amended, and the Pension Protection Act of 2006 and resulted in the recognition of liabilities associated with the Company&#8217;s long-term obligations in prior years not presented, which were primarily recorded as an expense within discontinued operations. The estimated discounted value of the projected contributions related to these plans is $38 million and $39 million as of June&#160;30, 2021 and 2020, respectively. The annual cash impact associated with the Company&#8217;s long-term obligation arising from this plan is $2 million per year. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the change in projected benefit obligation and fair value of plan assets for the defined benefit retirement and other retirement plans, excluding the multi-employer pension plan liability:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the net amount recognized in the consolidated balance sheets: </span></div><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:46.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Statement of Financial Position</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive loss (income) at the end of the fiscal year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Information for Plan with ABO or PBO in Excess of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain) loss arising during the year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (Amount)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Investment Committee employs a building-block approach in determining the long-term rate of return for plan assets, with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed income are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long run. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data are reviewed to check for reasonability and appropriateness. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets are recognized and measured at fair value in accordance with the accounting standards regarding fair value measurements. The following are valuation techniques used to determine the fair value of each major category of assets: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Short-term investments, equity securities, fixed-income securities, and real estate are valued using quoted market prices or other valuation methods, and thus are classified within Level 1 or Level 2.</span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Insurance contracts and other types of investments include investments with some observable and unobservable prices that are adjusted by cash contributions and distributions, and thus are classified within Level 2 or Level 3. </span></div><div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of plan assets that are measured at fair value as of June&#160;30, 2021 and 2020, aggregated by the level in the fair value hierarchy within which those measurements fall:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:29.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.178%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></td></tr><tr style="height:15pt"><td colspan="30" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other as of June&#160;30, 2021, included $62 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:29.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.178%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></div></td></tr><tr style="height:14pt"><td colspan="30" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other as of June 30, 2020, included $31 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 other assets as of June 30, 2021 and 2020 consist of an insurance contract in the U.K. to fulfill the benefit obligations for a portion of the participant benefits. The value of this commitment is determined using the same assumptions and methods used to value the pension liability of the associated plan. Level 3 other assets for the same periods also include the partial funding of a pension liability relating to current and former employees of the Company&#8217;s Eberbach, Germany facility through a Company promissory note with an annual rate of interest of 5%. The value of this commitment fluctuates due to contributions and benefit payments in addition to loan interest. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of Level 3 assets as well as the changes during the period attributable to assets held and those purchases, sales, settlements, contributions, and benefits that were paid:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Insurance Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Other</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at the reporting date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales, settlements, contributions and benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in or out of Level 3, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment policy reflects the long-term nature of the plans&#8217; funding obligations. The assets are invested to provide the opportunity for both income and growth of principal. This objective is pursued as a long-term goal designed to provide required benefits for participants without undue risk. It is expected that this objective can be achieved through a well-diversified asset portfolio. All equity investments are made within the guidelines of quality, marketability, and diversification mandated by the Employee Retirement Income Security Act of 1974, as amended (for plans subject to the act) and other </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relevant legal requirements. Investment managers are directed to maintain equity portfolios at a risk level approximately equivalent to that of the specific benchmark established for that portfolio. Assets invested in fixed income securities and pooled fixed-income portfolios are managed actively to pursue opportunities presented by changes in interest rates, credit ratings, or maturity premiums. </span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumed Healthcare Cost Trend Rates at the Balance Sheet Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; initial (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; ultimate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year in which ultimate rates are reached</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989547786616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">EQUITY, REDEEMABLE PREFERRED STOCK AND ACCUMULATED OTHER COMPREHENSIVE LOSS <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Capital Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue 1,000,000,000 shares of its Common Stock and 100,000,000 shares of preferred stock, par value $0.01 per share. In accordance with the Company&#8217;s amended and restated certificate of incorporation, each share of Common Stock has one vote, and the Common Stock votes together as a single class. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offerings of Common Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2020, the Company completed a public offering of its Common Stock (the &#8220;June 2020 Equity Offering&#8221;), in which the Company sold 7.7 million shares of Common Stock at a price of $70.72 per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the June 2020 Equity Offering of $548 million after the payment of associated offering expenses. The net proceeds of the June 2020 Equity Offering were used to repay $200 million of prophylactic borrowings from the third quarter of fiscal 2020 under Operating Company's Revolving Credit Facility, with the remainder available for general corporate purposes. On July 10, 2020, the underwriter for the June 2020 Equity Offering exercised its over-allotment option on 1.2 million additional shares, resulting in net proceeds of $82 million from the June 2020 Equity Offering, which was recorded in the fiscal year ended June 30, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2020, the Company completed the February 2020 Equity Offering, in which the Company sold 8.4 million shares of Common Stock at a price of $58.58 per share, net of underwriting discounts and commissions. The Company obtained total net proceeds from the February 2020 Equity Offering of $494 million. The net proceeds of the February 2020 Equity Offering were used to repay $100 million of borrowings earlier in the quarter under Operating Company's Revolving Credit Facility and the consideration for the MaSTherCell acquisition due at its closing, with the remainder available for general corporate purposes.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Restricted Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares outstanding of Common Stock include shares of unvested restricted stock. Unvested restricted stock included in reportable shares outstanding as of June 30, 2021 was not material. Shares of unvested restricted stock are excluded from the calculation of basic weighted average shares outstanding, but their dilutive impact is added back in the calculation of diluted weighted average shares outstanding.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Preferred Stock</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Company designated 1,000,000 shares of its preferred stock, par value $0.01, as its &#8220;Series A Convertible Preferred Stock&#8221; (the &#8220;Series A Preferred Stock&#8221;), pursuant to a certificate of designation of preferences, rights, and limitations (as amended, the &#8220;Certificate of Designation&#8221;) filed with the Delaware Secretary of State, and issued and sold 650,000 shares of the Series A Preferred Stock for an aggregate purchase price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$650 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to affiliates of Leonard Green </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&amp; Partners, L.P., each share having an initial stated value of $1,000 (as such value may be adjusted in accordance with the terms of the Certificate of Designation). The Series A Preferred Stock ranks senior to the Company&#8217;s Common Stock with respect to dividend rights and rights upon the voluntary or involuntary liquidation, dissolution, or winding up of the affairs of the Company.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from the offering of the Series A Preferred Stock, net of stock issuance costs, were $646 million, of which $40 million was allocated to the dividend-adjustment feature at its issuance and separately accounted for as a derivative liability.  Any change in the fair value of derivative liability during a fiscal quarter is recorded as a non-operating expense in the consolidated statement of operations. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail concerning the change in fair value during the fiscal year ended June 30, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, on the Partial Conversion Date, holders of Series A Preferred Stock converted 265,223 shares (approximately 41% of their holdings) and $2 million of unpaid accrued dividends into shares of Common Stock. The holders received 20.33 shares of Common Stock for each converted preferred share, resulting in the issuance of 5,392,280 shares of Common Stock. There was no gain or loss recognized upon the Partial Conversion as it occurred in accordance with the terms of the Certificate of Designation. The Company has 384,777 shares of Series A Preferred Stock that remain outstanding at June 30, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Partial Conversion, additional paid in capital increased $253 million, which includes $4 million related to the fair value of the portion of the derivative liability that was settled upon the Partial Conversion and $2 million related to an unpaid accrued dividend. See Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail concerning the change in fair value during the fiscal year ended June 30, 2021. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the changes in the cumulative translation adjustment, derivatives and hedges, minimum pension liability, and marketable securities for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consists of:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term inter-company loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, pretax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges, net of tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign&#160;Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Liability Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives and Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989540782344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Shareholders' Equity and Share-based Payments</a></td>
<td class="text">STOCK-BASED COMPENSATION <div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock-based compensation is comprised of stock options, restricted stock units, performance-based restricted stock units, and restricted stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 and 2018 Omnibus Incentive Plans</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s board of directors adopted, and the holder of a majority of the shares approved, the 2014 Omnibus Incentive Plan effective July 31, 2014 (the &#8220;2014 Plan&#8221;). The 2014 Plan provided certain members of management, employees, and directors of the Company and its subsidiaries with the opportunity to obtain various incentives, including grants of stock options, restricted stock units (defined below), and restricted stock. In October 2018, the Company&#8217;s shareholders approved the 2018 Omnibus Incentive Plan (the &#8220;2018 Plan&#8221;), and, as a result, new awards may no longer be issued under the 2014 Plan, although it remains in effect as to any previously granted award. The 2018 Plan is substantially similar to the 2014 Plan, except that (a) a total of 15,600,000 shares of Common Stock (subject to adjustment) may be issued under the 2018 Plan, (b) each share of Common Stock issuable under the 2018 Plan pursuant to a restricted stock or restricted stock unit award will reduce the number of reserved shares by 2.25 shares, and (c) the 2018 Plan imposes a limit on the aggregate value of awards that may be made in a single year to a non-employee director. Both the 2014 Plan and the 2018 Plan permit &#8220;net settlement&#8221; of vested awards, pursuant to which the award holder forfeits a portion of the vested award to satisfy the purchase price (in the case of options), the holder&#8217;s withholding tax obligation, if any (in all cases), or both. Where the holder net-settles the tax obligation, the Company pays the amount of the withholding tax to the U.S. government in cash, which is accounted for as an adjustment to Additional Paid in Capital.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock compensation expense recognized in the consolidated statements of operations was $51 million, $48 million, and $33 million in fiscal 2021, 2020, and 2019, respectively. Stock compensation expense is classified in selling, general, and administrative expenses as well as cost of sales. The Company has elected to account for forfeitures as they occur. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted under the 2014 Plan or 2018 Plan, as applicable, during fiscal 2021, 2020, and 2019 had an intrinsic value of $5 million, $6 million, and $24 million, respectively, which represents approximately 231,000, 329,000, and 1,179,000 shares of Common Stock, respectively. Each stock option granted under the 2014 Plan or 2018 Plan vests in equal annual installments over a four-year period from the date of grant, contingent upon the participant&#8217;s continued employment with the Company, except for a small number of grants that vest based on the achievement of operating performance targets set forth in the award documents.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Methodology and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding stock options have an exercise price per share equal to the fair market value of one share of Common Stock on the date of grant. All outstanding stock options have a contractual term of 10&#160;years, subject to forfeiture under certain conditions upon separation of employment. The grant-date fair value is recognized as expense on a graded-vesting basis over the vesting period. The fair value of stock options is determined using the Black-Scholes-Merton option pricing model for service and performance-based awards, and an adaptation of the Black-Scholes-Merton option valuation model, which takes into consideration the internal rate of return thresholds, for market-based awards. This model adaptation is essentially equivalent to the use of a path dependent-lattice model. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average of assumptions used in estimating the fair value of stock options granted during each year were as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public trading of the Common Stock commenced only in July 2014, and, as a result, there is only available limited relevant historical volatility experience; therefore, the expected volatility assumption is based on the historical volatility of the closing share prices of a comparable peer group. The Company selected peer companies from the pharmaceutical industry with similar characteristics, including market capitalization, number of employees and product focus.&#160;In addition, since the Company does not have a pattern of exercise behavior of option holders, the Company used the simplified method to determine the expected life of each option, which is the mid-point between the vesting date and the end of the contractual term. The risk-free interest-rate for the expected life of the option is based on the comparable U.S.&#160;Treasury yield curve in effect at the time of grant. The weighted-average grant-date fair value of stock options in fiscal 2021, 2020, and 2019 was $24.36 per share, $15.22 per share, and $9.49 per share, respectively.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity and shares subject to outstanding options for the fiscal year ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.675%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance</span></td><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,997,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.63</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,229,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.01</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,453,938&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">870,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,527,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,251&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired / Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,280,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,696,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vest and expected to vest as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,280,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,696,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and exercisable as of June 30, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.69</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,607,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, participants exercised options to purchase approximately 726,000 net settled shares, resulting in $27 million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2021 was $64 million. The total fair value of options vested during the period was $7 million. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, participants exercised options to purchase approximately 166,000&#160;net settled shares, resulting in $7 million of cash paid on behalf of participants for withholding taxes. The intrinsic value of the options exercised in fiscal 2020 was $18 million. The total fair value of options vested during the period was $4 million. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, $2 million of unrecognized compensation cost related to granted and not forfeited stock options is expected to be recognized as expense over a weighted-average period of approximately 1.8 years. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may grant to employees and members of its board of directors under the 2018 Plan (and formerly granted under the 2014 Plan) shares of restricted stock and units each representing the right to one share of Common Stock (&#8220;restricted stock units&#8221;). Since the IPO, the Company has granted to employees and directors restricted stock units and restricted stock that vest over specified periods as well as restricted stock units and restricted stock that have certain performance-related vesting requirements (&#8220;performance stock units&#8221; and &#8220;performance stock,&#8221; respectively). The restricted stock and restricted stock units granted during fiscal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2021 and 2020 had grant date fair values aggregating $47 million and $43 million, respectively, which represent approximately 502,000 and 748,000 shares of Common Stock, respectively. Under the 2014 Plan or 2018 Plan, as appropriate, the performance stock and performance stock units vest upon achieving Company financial performance metrics established at the outset of the three-year performance period associated with each grant. The metrics for the fiscal 2019, 2020, and 2021 performance stock and performance stock unit grants were based on performance against a mix of adjusted EPS targets and relative total shareholder return (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RTSR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) targets. Note that adjusted EPS is calculated as a quotient of tax-effected Adjusted EBITDA by the weighted average number of fully diluted shares, a financial measure that is not defined under U.S. GAAP and is subject to important limitations. The performance stock and performance stock units vest following the end of their respective three-year performance periods upon a determination of achievement relative to the targets. Each quarter during the period in which the performance stock and performance stock units are outstanding, the Company estimates the likelihood of such achievement by the end of the performance period in order to determine the probability of vesting. The number of shares actually earned at the end of the three-year period for the fiscal 2019, 2020 and 2021 grants will vary, based only on actual performance, from 0% to 200%, or from 0% to 150%, of the target number of performance stock or performance stock units specified on the date of grant, in the case of adjusted EPS and RTSR grants, respectively. Time-based restricted stock units and restricted stock generally vest on the second or third anniversary of the date of grant, subject to the participant&#8217;s continued employment with the Company.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Methodology and Assumptions - Expense Recognition and Grant Date Fair Value</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of (a) time-based restricted stock units and restricted stock are recognized as expense on a cliff-vesting schedule over the applicable vesting period and (b) performance shares and performance share units are re-assessed quarterly as discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant date fair values of both time-based and performance-based shares and units are determined based on the number of shares subject to the grants and the fair value of the Common Stock on the dates of the grants, as determined by the closing market prices. </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-Based Restricted Stock Units and Restricted Stock</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested time-based restricted stock units and restricted stock for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24pt"><span><br/></span></div><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EPS and RTSR-Based Performance Share Units and Performance Shares</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Performance-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of RTSR Performance Shares and Performance Share Units</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RTSR performance share unit and performance share is determined using the Monte Carlo pricing model because the number of shares to be awarded is subject to a market condition. The Monte Carlo simulation is a generally accepted statistical technique used to simulate a range of possible future outcomes. Because the valuation model considers a range of possible outcomes, compensation cost is recognized regardless of whether the market condition is actually satisfied.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units and performance shares granted during each year were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested RTSR performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.176%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">RTSR Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, participants vested and settled 671,000 net settled shares, resulting in $31 million of cash paid on behalf of participants for withholding taxes. In fiscal 2020, participants vested and settled 734,000 net settled shares, resulting in $24 million of cash paid on behalf of participants for withholding taxes.</span></div>As of June&#160;30, 2021, $54 million of unrecognized compensation cost related to restricted stock and restricted stock units (including performance shares and performance share units, respectively) is expected to be recognized as expense over a weighted-average period of approximately 1.9&#160;years. The weighted-average grant-date fair value of restricted stock and restricted stock units in fiscal 2021, 2020, and 2019 was $94.19, $57.17, and $44.65, respectively. The fair value of restricted stock units vested in fiscal 2021, 2020, and 2019 was $39 million, $35 million, and $13 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989545068152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income / Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income and Other Expense Disclosure</a></td>
<td class="text">OTHER EXPENSE, NET<div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other expense, net for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt refinancing costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (gains) and losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)    Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#8217;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#8217;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.</span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)    Foreign currency (gains) and losses include both cash and non-cash transactions. </span></div>(3)    Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989540797672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Leases of Lessee Disclosure</a></td>
<td class="text">LEASES<div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain manufacturing and office facilities, land, vehicles, and equipment. The terms of these leases vary widely, although most have terms between 3 and 10 years. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes a &#8220;right-of-use&#8221; asset and related lease liability at the commencement date of each lease based on the present value of the fixed lease payments over the expected lease term. The lease term for this purpose will include any renewal period where the Company determines that it is reasonably certain that it will exercise the option to renew. While certain leases also permit the Company to terminate the lease in advance of the nominal term upon payment of an associated penalty, the Company generally does not take into account potential early termination dates in its determination of the lease term as it is reasonably certain not to exercise an early-termination option as of the lease commencement date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses its incremental borrowing rate, which represents the interest rate the Company would expect to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms, in order to calculate the present value of a lease, when the implicit discount rate for its leases is not readily determinable.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed lease payments are recognized on straight-line basis over the lease term, while variable payments are recognized in the period incurred. As permitted by ASC 842, the Company has elected not to separate those components of a lease agreement not related to the leasing of an asset from those components that are related.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not record leases with an initial lease term of 12 months or less on its consolidated balance sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information concerning the leases recorded in the Company's consolidated balance sheet as of June&#160;30, 2021 is detailed in the following table:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Line item in the consolidated balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance at <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other       short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net lease costs for the fiscal year ended June&#160;30, 2021 reflected in the Company's consolidated statement of operations were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term lease cost amounted to $4 million during the fiscal year ended June&#160;30, 2021.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate related to the Company's right-of-use assets and lease liabilities as of June&#160;30, 2021 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information concerning the cash-flow impact arising from the Company's leases for the fiscal year ended June&#160;30, 2021 recorded in the Company's unaudited consolidated statement of cash flows is detailed in the following table (in </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for amounts included in lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows used for finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-cash transactions:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company expects that its future minimum lease payments will become due and payable as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538603384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Losses</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal proceedings arising in the ordinary course of business, including, without limitation, inquiries and claims concerning environmental contamination as well as litigation and allegations in connection with acquisitions, product liability, manufacturing or packaging defects, and claims for reimbursement for the cost of lost or damaged active pharmaceutical ingredients, the cost of any of which could be significant. The Company intends to vigorously defend itself against any such litigation and does not currently believe that the outcome of any such litigation will have a material adverse effect on the Company&#8217;s financial statements. In addition, the healthcare industry is highly regulated and government agencies continue to scrutinize certain practices affecting government programs and otherwise.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information relating to the business practices and activities of customers or suppliers from various governmental agencies or private parties, including from state attorneys general, the U.S. Department of Justice, and private parties engaged in patent infringement, antitrust, tort, and other litigation. The Company generally responds to such subpoenas and requests in a timely and thorough manner, which responses sometimes require considerable time and effort and can result in considerable costs being incurred. The Company expects to incur costs in future periods in connection with future requests.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543248664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC INFORMATION<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company conducts its business within the following segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Company evaluates the performance of its segments based on segment revenue and segment earnings before non-controlling interest, other (income) expense, impairments, restructuring costs, interest expense, income tax (benefit) expense, and depreciation and amortization (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment EBITDA</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Company considers its reporting segments results in the context of a similar Company-wide measure: EBITDA from operations, which the Company defines as consolidated earnings from operations before interest expense, income tax (benefit) expense, depreciation and amortization, adjusted for the income or loss attributable to non-controlling interest. Neither Segment EBITDA nor EBITDA from operations is defined under U.S. </span><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP, and neither is a measure of operating income, operating performance, or liquidity presented in accordance with U.S. GAAP. Each of these non-GAAP measures is subject to important limitations. These consolidated financial statements include information concerning Segment EBITDA and EBITDA from operations (a) because Segment EBITDA and EBITDA from operations are operational measures used by management in the assessment of the operating segments, the allocation of resources to the segments, and the setting of strategic goals and annual goals for the segments, and (b) in order to provide supplemental information that the Company considers relevant for the readers of the consolidated financial statements, but such information is not meant to replace or supersede U.S. GAAP measures. The Company&#8217;s presentation of Segment EBITDA and EBITDA from operations may not be comparable to similarly titled measures used by other companies. The most directly comparable U.S. GAAP measure to EBITDA from operations is net earnings. Included in this Note is a reconciliation of net earnings to EBITDA from operations. </span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include net revenue and Segment EBITDA for each of the Company's current reporting segments during the fiscal years ended June&#160;30, 2021, 2020, and 2019:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA reconciled to net earnings:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and gain (loss) on sale of assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on sale of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-allocated corporate costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unallocated costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#8217;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)    Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)     Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes total assets for each segment, as well as reconciling items necessary to total the amounts reported in the consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Assets </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and eliminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,777&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Expenditures </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by geographic area: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.908%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Long-Lived Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</span></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 15, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538402024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text">SUPPLEMENTAL BALANCE SHEET INFORMATION<div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information at June&#160;30, 2021 and June&#160;30, 2020 is detailed in the following tables.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process and inventories include raw materials, labor, and overhead. Total inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory cost adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid expenses and other</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. value-added tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, plant, and equipment, net</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment, net consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings, and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, at cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other long-term assets</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate-owned life insurance policies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venture capital investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other accrued liabilities</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538361048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bettera Holdings, LLC Purchase Agreement</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company entered into an agreement to acquire Bettera Holdings, LLC ("Bettera") for $1.00 billion, subject to customary adjustments. Bettera is a manufacturer of nutraceuticals and nutritional supplements in gummy, soft chew, and lozenge delivery formats.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing, Bettera&#8217;s operations and facilities, will become part of the Company&#8217;s Softgel and Oral Technologies segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement is subject to customary closing conditions and is expected to close before December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626366280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting, Policy</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reporting Segments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the four reporting segments reports through a separate management team and ultimately reports to the Company's Chief Executive Officer, who is designated as the Chief Operating Decision Maker for segment reporting purposes. The Company's operating segments are the same as its reporting segments. </span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biologics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Biologics segment provides biologic cell-line, cell therapy and viral-based gene therapy development and manufacturing; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The segment has extensive expertise in development, scale up, and commercial manufacturing. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s growing biologic offering includes cell-line development based on its advanced and patented GPEx suite of technologies, which are used to develop stable, high-yielding mammalian cell lines for both innovator and biosimilar biologic compounds. GPEx technology can provide rapid cell-line development, high biologics production yields, flexibility, and versatility. Its development and manufacturing facility in Madison, Wisconsin has the capability and capacity to produce current good manufacturing practices ("cGMP") quality biologics drug substance from 250L to 4,000L scale using single-use technology to provide maximum efficiency and flexibility. Its Bloomington, Indiana facility brings additional biologics development, clinical, and commercial drug substance manufacturing, and formulation capabilities and capacity. Both Bloomington and the Anagni, Italy facility add substantial capacity for finished-dose drug product manufacturing and packaging. The segment has continued to expand production capacity, including the fourth and fifth drug substance manufacturing suites in its Madison, Wisconsin facility, expanded drug product manufacturing and packaging capacity in its Bloomington and Anagni facilities, and recently announced a planned expansion of its Anagni facility to permit drug substance </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and manufacturing. Its SMARTag next-generation antibody-drug conjugate (&#8220;ADC&#8221;) technology, based in Emeryville, California, is a clinical-stage technology that enables development of ADCs and other protein conjugates with improved efficacy, safety, and manufacturability.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s cell and gene therapy centers in Belgium, Maryland, and Texas, it develops and manufactures complex biologics, including CAR-T, AAV, lentivirus, oncolytic virus and other cell or virus modalities for cell- and viral-based therapies and next-generation vaccines.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through continued inorganic investment between November 2020 and June 2021, the Company acquired two additional cell and gene therapy manufacturing facilities and Delphi Genetics SA (&#8220;Delphi&#8221;), a plasmid DNA business, to create a European Center of Excellence in Belgium. This campus now includes clinical through commercial-scale cell therapy manufacturing and both small- and large-scale plasmid DNA production. Additionally, in August 2021, it acquired RheinCell Therapeutics GmbH (&#8220;RheinCell&#8221;), a company based in Lagenfeld, Germany that specializes in pluripotent stem cell (&#8220;iPSC&#8221;) production. This portfolio expansion strengthens Catalent&#8217;s cell therapy offering by adding proprietary cGMP iPSC cell lines and enhances the Company&#8217;s ability to manufacture next generation cell therapies at scale.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its gene therapy network across Maryland and Texas, the Company has further expanded its footprint with the construction of 5 additional commercial gene therapy suites at its Harmans commercial campus in Maryland, creating a total of 15 commercial suites, and repurposed its Rockville facility in Maryland for both small- and large-scale plasmid DNA production. Its specialized expertise in AAV vectors, the most commonly used delivery system for gene therapy, and both autologous and allogeneic cell therapy modalities, together with its expanded capabilities in plasmids, positions the Company to capitalize on strong and growing industry demand in the cell and gene therapy market.</span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment's range of injectable manufacturing offerings includes manufacturing drug substance and filling small molecules or biologics into vials, syringes, and cartridges, with flexibility to accommodate other formats within the segment's existing network. In addition to primary packaging, its network provides secondary packaging capabilities, including auto-injector and safety device assembly for commercial launch and life cycle management. The Company's Clinical Supply Services business provides a global network for clinical distribution, as well as labeling, packaging and cold chain for clinical trial supply of biotherapeutics and cell and gene therapies. Its fill and finish services are largely focused on complex pharmaceuticals and biologics. With its range of technologies, the Company is able to meet a wide range of specifications, timelines, and budgets. The Company believes that the complexity of the manufacturing process, the importance of experience and know-how, regulatory compliance, and substantial capital requirements provide it with a meaningful competitive advantage in the market. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biologics segment also offers biologics analytical development and testing services for large molecules, including bioassay, biophysical characterization, and cGMP release and stability testing. Its OneBio Suite provides customers the potential to seamlessly integrate drug substance, drug product, and clinical supply management for products in development, and for integrated commercial supply across both drug substance and drug product. The Biologics segment provides a broad range of technologies and services supporting the development and launch of new biologic entities, biosimilars, biobetters, and cell and gene therapies to bring a product from gene to commercialization, faster.</span></div><div style="margin-top:9pt;padding-left:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Softgel and Oral Technologies </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its Softgel and Oral Technologies segment, the Company provides formulation, development, and manufacturing services for soft capsules, or &#8220;softgels,&#8221; as well as large-scale manufacturing of oral solid dose forms for pharmaceutical and consumer health markets, along with supporting ancillary services. Catalent&#8217;s softgel technology was first commercialized by its predecessor in the 1930s, and it has continually enhanced the platform since then. The segment is the market leader in overall softgel development and manufacturing and holds the leading market position in innovator drug softgels. Its principal softgel technologies include traditional softgel capsules, in which the shell is made of animal-derived gelatin, and Vegicaps and OptiShell capsules, in which the shell is made from plant-derived materials. Softgel capsules are used in a broad range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. Softgel capsules encapsulate liquid, paste, or oil-based formulations of active compounds in solution or suspension within an outer shell. In the manufacturing process, the capsules are formed, filled, and sealed simultaneously. The segment typically performs encapsulation for a product within one of its softgel facilities, with active ingredients provided by customers or sourced directly by the Company. Softgels have historically been used to solve formulation challenges or technical issues for a specific drug, to help improve the clinical performance of compounds, to provide important market differentiation, particularly for over-the-counter medications, and to provide safe handling of hormonal, highly potent, and cytotoxic drugs. The segment also participates in the softgel vitamin, mineral, and supplement business in selected regions around the world. With the 2001 introduction of the Company&#8217;s plant-derived softgel shell, Vegicaps capsules, consumer health customers have been able to extend the softgel dose form to a broader range of active ingredients and serve patient/consumer populations that were previously inaccessible due to religious, dietary, or cultural preferences. In recent years, the segment extended this platform to pharmaceutical products via its OptiShell capsule offering. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Its Vegicaps and OptiShell capsules are protected by patents in most major global markets. Physician and patient studies the Company has conducted have demonstrated a preference for softgels versus traditional tablet and hard capsule dose forms in terms of ease of swallowing, real or perceived speed of delivery, ability to remove or eliminate unpleasant odor or taste, and, for physicians, perceived improved patient adherence with dosing regimens.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Its large-scale manufacturing under cGMP of oral solid dose forms typically includes late-stage clinical trial supplies, registration batches, and commercial production across a broad range of formats, and may also involve advanced processing of intermediates to achieve the desired clinical performance of the prescription or over-the-counter pharmaceutical product. Finished dose forms include traditional and advanced complex oral solid-doses, including coated and uncoated tablets, pellet/bead/powder-filled two-piece hard capsules, granulated powders, and other immediate and modified release forms. Advanced intermediate processing may include coating, extrusion, or spheronization to achieve specific functional outcomes, including site or time-specific drug release, taste masking, or enhanced bioavailability. The Company has deep experience at managing complex technical transfers of clinical or commercial programs, whether from Catalent&#8217;s early development network in the Oral and Specialty Delivery segment, other contract development sites, or from customers directly.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Oral and Specialty Delivery</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Oral and Specialty Delivery segment provides advanced analytical and formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The technologies cover a broad range of oral (including its proprietary fast-dissolve Zydis tablets and many bioavailability enhancement technologies for both immediate and controlled-release tablets and capsules), respiratory and inhaled dose forms (including metered dose inhalers, dry powder inhalers and nasal delivery devices). </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment provides comprehensive pre-clinical screening, formulation and analytical development, and cGMP manufacturing at both clinical and commercial scale for both traditional and advanced complex oral solid-dose formats. It has substantial, proven experience in developing and scaling up orphan and rare disease oral products, especially those requiring accelerated development timelines, solubility enhancement, specialized handling (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., potent or controlled substance materials), complex technology transfer and specialized manufacturing processes. It provides spray drying, hot melt extrusion, micronization, and lipid formulation capabilities, all of which are used to enhance a drug&#8217;s bioavailability and clinical performance. It offers comprehensive analytical method development and scientific capabilities, including stability testing, and global regulatory services to support both fully integrated development programs and standalone fee-for-service work. In recent years, the segment has expanded its network of clinical development sites focused on earlier phase compounds (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., pre-clinical and Phase I) to engage with more customer molecules earlier in their development, with the intent to also support these molecules downstream as they progress towards commercial approval and supply. Demand for its offerings is driven by the need for strong scientific expertise, the depth and breadth of integrated services offered, as well as the reliability of its supply performance across quality and operational parameters. </span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched its orally dissolving tablet business in 1986 with the introduction of Zydis, a unique proprietary freeze-dried tablet that dissolves in the mouth, without water, in typically less than three seconds. The platform is often used for drugs that benefit from rapid oral dissolution and buccal absorption and for drugs for specialized patient groups, including geriatric or pediatric populations, that have difficulty swallowing (dysphagia). The Company can adapt the Zydis technology to a wide range of molecules and indications, including prescription treatments for a variety of central nervous system-related conditions such as migraine, Parkinson&#8217;s disease, and schizophrenia, and also for a range of consumer healthcare products targeting broader indications such as pain or allergy relief. It continues to invest in and develop Zydis orally dissolving tablets in different ways with its customers as it extends the application of the technology to new therapeutic categories, including immunotherapy, vaccines and biologic molecule delivery.</span></div><div style="text-align:justify;text-indent:24pt"><span><br/></span></div><div style="text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The segment&#8217;s respiratory platform provides integrated molecule screening, formulation development, and commercial manufacturing services for inhaled products delivered via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. Delivery of these inhaled combination device products requires specialized capabilities to account for both the molecule and the device, to ensure accurate repeatable dose delivery.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Clinical Supply Services </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. It offers customers flexible solutions for clinical supplies production and provide distribution and inventory management support for both simple and complex clinical trials. This includes over-encapsulation where needed; supplying placebos, comparator drug procurement, and clinical packages and kits for physicians and patients; inventory management; investigator kit ordering and fulfillment; and return supply reconciliation </span></div>and reporting. It supports trials in all regions of the world through its facilities and distribution network. In recent years, the segment has continued to expand and extend its network, with significant expansions in Kansas City, Missouri and Singapore and new facilities in California, China, and Japan. The segment continues to develop new solutions for the evolving clinical trial environment, including FlexDirect direct-to-patient and CT Success and trial planning. The Clinical Supply Services segment is the leading provider of integrated development solutions and one of the leading providers of clinical trial supplies.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements include all of the Company&#8217;s subsidiaries, including those operating outside the United States (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). All significant transactions among the Company&#8217;s subsidiaries and reporting segments have been eliminated, other than as noted.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, allowance for credit losses, inventory and long-lived asset valuation, goodwill and other intangible asset valuation and impairment, equity-based compensation, income taxes, derivative valuation, and pension plan asset and liability valuation. Actual amounts may differ from these estimated amounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Reclassifications', window );">Reclassifications</a></td>
<td class="text">ReclassificationCertain prior-period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the consolidated statements of operations, consolidated balance sheets, consolidated statements of cash flows, or notes to the consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation and Transaction of Foreign Currencies</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s operations outside the U.S. are generally measured using the local currency as the functional currency. Adjustments to translate the assets and liabilities of the foreign operations into U.S. dollars are accumulated as a component of other comprehensive income utilizing period-end exchange rates. Beginning on July 1, 2018, as a result of the three-year cumulative consumer price index exceeding 100%, the Company has accounted for its Argentine operations as highly inflationary, but this change has not had a material effect on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The currency fluctuation related to certain long-term inter-company loans where settlement is not planned or anticipated in the foreseeable future have been recorded within the cumulative translation adjustment, a component of other comprehensive income. In addition, the currency fluctuation associated with the portion of the Company&#8217;s euro-denominated debt designated as a net investment hedge is included as a component of other comprehensive income. Foreign currency transaction gains and losses calculated by utilizing weighted average exchange rates for the period are included in the statements of operations in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other expense, net.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Such foreign currency transaction gains and losses include inter-company loans that are repayable in the foreseeable future.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All liquid investments purchased with original maturities of three months or less are considered cash equivalents. The carrying value of these cash equivalents approximates fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables and Allowance dor Doubtful Accounts</a></td>
<td class="text">Allowance for Credit Losses Trade receivables, contract assets, and other amounts owed to the Company are presented net of an allowance that includes an assessment of expected credit losses. The Company determines its allowance methodology by considering various factors, including the Company&#8217;s previous loss history, aging of customer receivable balances, significant aspects of a geographic location's economic conditions, the current and anticipated future condition of the general economy and the industries in which the Company's primary customers operate. To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, trade receivables and contract assets are written off against the allowance when the related balances are no longer deemed collectible.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Major Customers</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Major Customers </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk, with respect to accounts receivable, is limited due to the large number of customers and their dispersion across different geographic areas. The customers are primarily concentrated in the pharmaceutical and consumer products industries. The Company does not normally require collateral or any other security to support credit sales. The Company performs ongoing credit evaluations of its customers&#8217; financial conditions and maintains reserves for credit losses. Such losses historically have been within the Company&#8217;s expectations. No single customer exceeded 10% of revenue during the fiscal years ended June 30, 2021, 2020, and 2019. As of June 30, 2021, the Company had one customer that represented 15% or $155 million of its net trade receivables balance. No customer exceeded 10% of trade receivables as of June 30, 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value, using the first-in, first-out (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIFO</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span>) method. The Company provides for cost adjustments for excess, obsolete, or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory consists of costs associated with raw material, labor, and overhead.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for purchased goodwill and intangible assets with indefinite lives in accordance with ASC 350,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles - Goodwill and Other</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under ASC 350, goodwill and intangible assets with indefinite lives are not amortized, but instead are tested for impairment at least annually. The Company performs an impairment evaluation of goodwill annually during the fourth quarter of its fiscal year or when circumstances otherwise indicate an evaluation should be performed. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evaluation may begin with a qualitative assessment for each reporting unit to determine whether it is more-likely-than-not that the fair value of the reporting unit is less than its carrying value. Factors considered in a qualitative assessment include, among other things, macroeconomic conditions, industry and market considerations, financial performance of the respective reporting unit and other relevant entity and reporting-unit specific considerations. If the qualitative assessment does not generate a positive response, or if no qualitative assessment is performed, a quantitative assessment, based upon discounted cash flows, is performed and requires management to estimate future cash flows, growth rates, and macroeconomic, industry, and market conditions. In fiscal 2019 and 2021, the Company began its impairment evaluation with the qualitative assessment, but in fiscal 2020, the Company proceeded immediately to the quantitative assessment. </span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its qualitative assessment conducted as of April 1, 2021, the Company determined for each reporting unit with goodwill that it was more likely than not that its respective fair value exceeded its carrying value, indicating there was no impairment. For more information regarding goodwill balances at June 30, 2021, see Note 4, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and equipment are stated at cost. Depreciation expense is computed using the straight-line method over the estimated useful lives of the assets, including leasehold improvements and finance lease right-of-use assets that are amortized over the shorter of their useful lives or the terms of the respective leases. The Company generally uses the following range of useful lives for its property and equipment categories: buildings and improvements&#8212;5 to 50 years; machinery and equipment&#8212;3 to 10 years; and furniture and fixtures&#8212;3 to 7 years. Depreciation expense was $196 million for the fiscal year ended June&#160;30, 2021, $165 million for the fiscal year ended June&#160;30, 2020, and $141 million for the fiscal year ended June&#160;30, 2019. Depreciation expense includes amortization of assets related to financing leases. The Company charges repairs and maintenance costs to expense as incurred. The amount of capitalized interest for fiscal 2021 and 2020 was $17 million and $11 million, respectively, and was immaterial for fiscal 2019.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives, including customer relationships, patents, and trademarks, are amortized over their useful lives. The Company also capitalizes certain computer software and development costs in other intangibles, net, when incurred in connection with developing or obtaining computer software for internal use. Capitalized software costs are amortized over the estimated useful lives of the software, which generally range from 3 to 5 years. The Company evaluates the recoverability of its other long-lived assets, including amortizing intangible assets, if circumstances indicate impairment may have occurred pursuant to ASC 360,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This analysis is performed by comparing the respective carrying values of the assets to the current and expected future cash flows, on an un-discounted basis, to be generated from such assets. If such analysis indicates that the carrying value of these assets is not recoverable, the carrying value of such assets is reduced to fair value through a charge to the consolidated statements of operations. Fair value is determined based on assumptions the Company believes marketplace participants would utilize and comparable marketplace information in similar arm&#8217;s length transactions. The Company recorded impairment charges related to definite-lived intangible assets and property, </span>plant, and equipment of $9 million, $5 million, and $5 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Post-Retirement and Pension Plans</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Retirement and Pension Plans</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement and pension plans, including defined benefit and defined contribution retirement plans.&#160;The measurement of the related benefit obligations and the net periodic benefit costs recorded each year are based upon actuarial computations, which require management&#8217;s judgment as to certain assumptions. These assumptions include the discount rates used in computing the present value of the benefit obligations and the net periodic benefit costs, the expected future rate of salary increases (for pay-related plans) and the expected long-term rate of return on plan assets (for funded plans). The Company uses the corridor approach to amortize actuarial gains and losses. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to utilize an approach to estimate the service and interest components of net periodic benefit cost for benefit plans that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. The expected long-term rate of return on plan assets is based on the target asset allocation and the average expected rate of growth for the asset classes invested. The average expected rate of growth is derived from a combination of historic returns, current market indicators, and the expected risk premium for each asset class. The Company uses a measurement date of June 30 for all its retirement and postretirement benefit plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest-rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments from time to time to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the values of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings. The Company does not net any of its derivative positions under master netting arrangements. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily, the Company is exposed to fluctuations in the euro-U.S. dollar exchange rate on its investments in foreign operations in Europe. While the Company does not actively hedge against changes in foreign currency, it has mitigated the exposure of investments in its European operations through a net-investment hedge by denominating a portion of its debt in euros. In addition, a portion of Operating Company's interest payment obligation on its U.S dollar-denominated term loans is exposed to interest rate variability. The Company has mitigated its exposure to this risk by entering into interest-rate swap agreements, which qualify for and are designated as cash-flow hedges. Also, as discussed in Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has determined that an aspect of the dividend-rate adjustment feature of the Company&#8217;s convertible Series A Preferred Stock (as defined below, see Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Preferred Stock, and Accumulated Other Comprehensive Loss</span>) should be accounted for as a derivative liability.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. The Company uses fair value extensively, including in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. The Company estimates fair value using an exit price approach, which requires, among other things, that it determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the assets or liability, the Company may use one or all of the following approaches: </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. </span></div><div style="margin-top:6pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Income approach, which is based on the present value of the future stream of net cash flows. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain investments that are measured at fair value using the net asset value (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NAV</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its liquid debt investments with original maturities greater than ninety days as marketable securities. The Company invests in highly rated corporate debt securities, with the primary objective of minimizing the potential risk of principal loss. The Company&#8217;s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any single issuer. The Company regularly reviews its investments and utilizes quantitative and qualitative evidence to evaluate potential impairments. For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable securities as available-for-sale, because it may sell certain of its marketable securities prior to the stated maturity for various reasons, including management of liquidity, credit risk, duration, relative return, and asset allocation. The Company determines the fair value of each marketable security in its portfolio at each period end and recognizes gains and losses in the portfolio in other comprehensive income. As of June 30, 2021, the amortized cost basis of marketable securities approximates fair value and all outstanding marketable securities mature within one year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Self Insurance</a></td>
<td class="text">Self-Insurance The Company is partially self-insured for certain employee health benefits and partially self-insured for property losses and casualty claims. The Company accrues for losses based upon experience and actuarial assumptions, including provisions for losses incurred but not reported.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Accumulated Other Comprehensive Income/(Loss)</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss, which is reported in the accompanying consolidated statements of changes in shareholders&#8217; equity, consists of foreign currency translation, net change in marketable securities, and defined benefit pension plan changes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">Research and Development CostsThe Company expenses research and development costs as incurred.  Research and development costs amounted to $21 million, $21 million, and $19 million for the fiscal years ended June&#160;30, 2021, 2020, and 2019, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports net earnings per share in accordance with ASC 260,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company computes basic earnings per share for the Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the two-class method by d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ividing net income attributable to common stockholders by the weighted average number of common shares outstanding during the period. The Series A Preferred Stock, due to its convertible feature, is participating in nature; accordingly, the outstanding shares of Series A Preferred Stock are included in the two-class method. Diluted earnings per common share measures the performance of the Company over the reporting period while giving effect to all potential shares of Common Stock that were dilutive and outstanding during the period. The denominator includes the weighted average over the measurement period of the sum of the number of shares of Common Stock outstanding and the number of additional such shares that would have been outstanding if </span></div>the shares of Common Stock that were both potentially issuable and dilutive had been issued, and is calculated using the more dilutive of the two-class, treasury stock, and if-converted methods.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company&#8217;s assets and liabilities. The Company measures deferred tax assets and liabilities using enacted tax rates in the respective jurisdictions in which it operates. In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that the Company will be able to realize some or all of the deferred tax assets. The calculation of the Company&#8217;s tax liabilities involves dealing with uncertainties in the application of complex tax regulations in each of its tax jurisdictions. The number of years with open tax audits varies by tax jurisdiction. A number of years may lapse before a particular matter is audited and finally resolved. The Company applies ASC 740 to determine the accounting for uncertain tax positions. This standard clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before the Company may recognize the position in its financial statements. The standard also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has elected not to reclassify the income tax effects stranded in accumulated other comprehensive income to retained earnings.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Equity-Based Compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 718, companies recognize compensation expense using a fair-value-based method for costs related to share-based payments, including stock options and restricted stock units. The expense is measured based on the grant date fair value of the awards, and the expense is recorded over the applicable requisite service period. Forfeitures are recognized as and when they occur. In the absence of an observable market price for a share-based award, the fair value is based upon a valuation methodology that takes into consideration various factors, including the exercise price of the award, the expected term of the award, the current price of the underlying shares, the expected volatility of the underlying share price, the expected dividends on the underlying shares and the risk-free interest rate. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Company&#8217;s stock-based compensation plans permit an employee holding vested stock options or restricted stock units to elect to have the Company use a portion of the shares otherwise issuable upon the employee&#8217;s exercise of the option or grant, a so-called </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net settlement transaction,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span> as a means of paying the exercise price, meeting tax withholding requirements, or both.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Financial Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2018, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework&#8212;Changes to the Disclosure Requirement for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which changes the disclosure requirements on fair value measurements in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance eliminates certain disclosure requirements that are no longer considered cost beneficial and adds new disclosure requirements for Level 3 fair value measurements. The Company adopted the guidance on July 1, 2020. The guidance did not have a material impact on the Company&#8217;s financial statement disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which introduces a new accounting model known as Credit Expected Credit Losses (&#8220;CECL&#8221;). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk. The CECL model utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for financial assets at the time they are originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. This model replaces the multiple existing impairment models in current U.S. GAAP, which generally require that a loss be incurred before it is recognized. The new standard applies to receivables arising from </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue transactions such as contract assets, accounts receivables, available for-sale debt securities and notes receivable arising from divestitures. The Company adopted the amended guidance using a modified retrospective approach on July 1, 2020. The amended guidance did not have a material impact on the Company&#8217;s financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Standards Not Adopted as of June 30, 2021</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional guidance to ease the potential burden in accounting for the discontinuation of a reference rate such as LIBOR, formerly known as the London Interbank Offered Rate, because of reference rate reform. The expedients and exceptions provided by the guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022. The ASU is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the incremental approach for intra-period allocation, deferred tax recognition requirement for changes in equity method investments and foreign subsidiaries, and methodology for calculating income taxes in an interim period. The guidance also simplifies certain aspects of the accounting for franchise taxes, the accounting for step-up in the tax basis of goodwill, and accounting for the change in the enacted change in tax laws or rates. The ASU will be effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Retirement Benefits&#8212;Defined Benefit Plans&#8212;General (Subtopic 715-20): Disclosure Framework&#8212;Changes to the Disclosure Requirements for Defined Benefit Plan</span>, which removes certain disclosures and added additional disclosures around weighted-average interest crediting rates for cash balance plans and explanation for significant gains and losses related to change in the benefit obligation for the period. The ASU will be effective for fiscal years beginning after December 15, 2020 with a retrospective application for all periods presented. The adoption of this guidance is not expected to have a material impact on the Company&#8217;s consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EEEE<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109999725-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Reclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Reclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989537039688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contract with Customer (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company generally earns its revenue by supplying goods or providing services under contracts with its customers in three primary revenue streams: manufacturing and commercial product supply, development services, and clinical supply services. The Company measures the revenue from customers based on the consideration specified in its contracts, excluding any sales incentive or amount collected on behalf of a third party. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer contracts generally include provisions entitling the Company to a termination penalty when the customer invokes its contractual right to terminate prior to the contract&#8217;s nominal end date. The termination penalties in the customer contracts vary but are generally considered substantive for accounting purposes and create enforceable rights and obligations throughout the stated duration of the contract. The Company accounts for a contract cancellation as a contract modification in the period in which the customer invokes the termination provision. The determination of the contract termination penalty is based on the terms stated in the relevant customer agreement. As of the modification date, the Company updates its estimate of the transaction price using the expected value method, subject to constraints, and recognizes the amount over the remaining performance period</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally expenses sales commissions as incurred because either the amortization period is one year or less, or the balance with an amortization period greater than one year is not material.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects revenue by the location where the goods were made or the service performed:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of revenue attributable to multiple locations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing &amp; Commercial Product Supply Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing and commercial product supply revenue consists of revenue earned by manufacturing products supplied to customers under long-term commercial supply arrangements. In these arrangements, the customer typically owns and supplies the active pharmaceutical ingredient, or API, that is used in the manufacturing process. The contract generally includes the terms of the manufacturing services and related product quality assurance procedures to comply with regulatory requirements. Due to the regulated nature of the Company&#8217;s business, these contract terms are highly interdependent and, therefore, are considered to be a single combined performance obligation. The transaction price is generally stated in the agreement as a fixed price per unit, with no contractual provision for a refund or price concession. Control is transferred to the customer over time, creating a corresponding right to recognize the related revenue, because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. Progress is measured based on the units of product that have successfully completed the contractually required product quality assurance process, as the conclusion of that process generally defines the time when the applicable contract and the related regulatory requirements permit the customer to exercise control over the product&#8217;s disposition. The customer is typically responsible for arranging the shipping and handling of product following completion of the quality assurance process.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days after the goods are shipped as requested by the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development services contracts generally take the form of short-term, fee-for-service arrangements. Performance obligations vary, but frequently include biologic cell-line development, performing formulation, analytical stability, or other services related to product development, and providing manufacturing services for products that are under development or otherwise not intended for commercial sale. The transaction prices for these arrangements are fixed and include amounts stated </span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the contracts for each promised service, and each service is generally considered to be a separate performance obligation. The Company recognizes revenue over time because there is no alternative use to the Company for the asset created and the Company has an enforceable right to payment for performance completed as of that date. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures progress toward the completion of its performance obligations satisfied over time based on the nature of the services to be performed. For certain types of arrangements, revenue is recognized over time and measured using an output method based on the completion of tasks and activities that are performed to satisfy a performance obligation. For all other types of arrangements, revenue is recognized over time and measured using an input method based on effort expended. Each of these methods provides an appropriate depiction of the Company&#8217;s progress toward fulfilling its performance obligations for its respective arrangement. In certain development services arrangements that require a portion of the contract consideration to be received in advance at the commencement of the contract, such advance payment is initially recorded as a contract liability. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates consideration to each performance obligation using the &#8220;relative standalone selling price&#8221; as defined under ASC 606. Generally, the Company utilizes observable standalone selling prices in its allocations of consideration. If observable standalone selling prices are not available, the Company estimates the applicable standalone selling price using an adjusted market assessment approach, representing the amount that the Company believes the market is willing to pay for the applicable service. Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreemen</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Supply Services Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical supply services contracts generally take the form of fee-for-service arrangements. Performance obligations for clinical supply services revenue typically include a combination of the following services: the manufacturing, packaging, storage, distribution, destruction, and inventory management of customer clinical trial material. Performance obligations can also include the sourcing of comparator drug products on behalf of customers to be used in clinical trials to compare performance with the drug under clinical investigation. In certain arrangements, the Company recognizes revenue over time when the Company satisfies performance obligations. Satisfaction of the performance obligations is measured using an input method measure of progress based on effort expended by the Company. In other arrangements, revenue is recognized at the point in time when control transfers, which occurs upon either the delivery of the related output of the service to the customer or the completion of quality testing with respect to the product, and the Company has an enforceable right to payment based on the terms of the arrangement. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment is typically due 30 to 90 days following the completion of services provided to the customer, based on the payment terms set forth in the applicable customer agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue for comparator sourcing arrangements on a net basis because it is acting as an agent that does not control the product or service before it is transferred to the customer. Payment for comparator sourcing activity is typically received in advance at the commencement of the contract and is initially recorded as a contract liability.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Revenue</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occasionally enters into arrangements with its customers that include licenses of functional intellectual property, including patents, or other intangible property (&#8220;out-licensing&#8221;). Revenue from such arrangements are within the scope of ASC 606. The Company does not have any material license arrangement that contains more than one performance obligation. The terms of such out-licensing arrangements include the license of functional intellectual or intangible property (primarily drug formulae) and typically provide for payment by the licensee of one or more of the following: non-refundable, up-front license fees or royalties on net sales of licensed products. The Company recognizes revenue from nonrefundable, up-front license fees when the licensed intellectual property is made available for the customer&#8217;s use and benefit, which is generally at the inception of the arrangement. Royalty payments from such arrangements are recognized when subsequent sale or usage of an item subject to the royalty occurs and the performance obligation to which royalty relates is satisfied</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities relate to cash consideration that the Company receives in advance of satisfying the related performance obligations. The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:91.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities that will be recognized within 12 months of June 30, 2021 are accounted for in Other accrued liabilities and those that will be recognized longer than 12 months after June 30, 2021 are accounted for within Other liabilities.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily relate to the Company's conditional right to receive consideration for services that have been performed for the customer as of June&#160;30, 2021 relating to its development services but had not yet been invoiced as of June&#160;30, 2021. Contract assets are transferred to trade receivables, net when the Company&#8217;s right to receive the consideration becomes unconditional. Contract assets totaled $181 million and $61 million as of June&#160;30, 2021 and 2020, respectively. Contract assets are accounted for within prepaid expenses and other in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539343736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect revenue for the fiscal year ended June&#160;30, 2021 and 2020 by type of activity and reporting segment (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.939%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.227%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing &amp; commercial product supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical supply services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract', window );"><strong>Revenue Recognition and Deferred Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ContractualLiabilitiesTableTextBlock', window );">Contractual Liabilities</a></td>
<td class="text">The contract liabilities balances (current and non-current) as of June 30, 2021 and June 30, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:91.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized in the period from amounts included in contracts liability at the beginning of the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ctlt_geographicalMember', window );">geographical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects revenue by the location where the goods were made or the service performed:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of revenue attributable to multiple locations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ContractualLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Contractual Liabilities [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ContractualLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAndDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ctlt_geographicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ctlt_geographicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989537297704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text">The Company valued the total consideration received from divestiture of the Blow-Fill-Seal Business as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.327%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fair value of consideration received</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at June 30, 2021, which is the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount less a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discount determined using a discounted cash flow model with the market interest rate as a significant input.</span></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;Other includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of transaction expenses, a working capital adjustment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assumption of liabilities resulting in net cash proceed of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember', window );">MaSTherCell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation to assets acquired and liabilities assumed in the transaction is (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant, and equipment</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Identifiable intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other net assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total identifiable net assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total assets acquired and liabilities assumed</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538540568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes from June&#160;30, 2019 to June&#160;30, 2020 and then to June&#160;30, 2021 in the carrying amount of goodwill in total and by reporting segment:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Biologics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Supply Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The reallocation in fiscal 2020 relates to adjustments to the Company&#8217;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment. </span></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div>(4) Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542998136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Definite Lived Long-Lived Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract', window );"><strong>Finite lived intangible assets disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Other Intangible Assets Subject to Amortization</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of other intangible assets subject to amortization as of June&#160;30, 2021 and June&#160;30, 2020 are as follows (in millions):</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangibles:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(553)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense</a></td>
<td class="text">Future amortization expense for the next five fiscal years is estimated to be:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FinitelivedintangibleassetsdisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539120840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Other Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the costs recorded within restructuring costs: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee-related reorganization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facility exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989541908056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term obligations and short-term borrowings consist of the following at June&#160;30, 2021 and June&#160;30, 2020:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Maturity as of June 30, 2021</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-2 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility B-3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% senior notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% senior notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated senior notes due 2028</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% senior notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred purchase consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 to 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term obligations and other short-term<br/>&#160;&#160;&#160;&#160;&#160;borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Maturities of long-term obligations</a></td>
<td class="text">Maturities of long-term obligations, including finance leases of $193 million, and other short-term borrowings for future fiscal years are:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:35.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of long-term and other obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock', window );">Schedule Of Carrying And Fair Value Of Financial Instruments Table</a></td>
<td class="text">The carrying amounts and the estimated fair values of financial instruments as of June&#160;30, 2021 and June&#160;30, 2020 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875% Senior Notes due 2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.000% Senior Notes due 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.375% Euro-denominated Senior Notes due 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125% Senior Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior secured credit facilities &amp; other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of carrying and fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543632216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Calculation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text">The reconciliations between basic and diluted earnings per share attributable to Catalent common shareholders for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#160; (In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to preferred shareholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average dilutive securities issuable - stock plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The diluted weighted average number of shares outstanding for the fiscal years ended June 30, 2021, 2020 and 2019 did not include the weighted average number of shares of Common Stock associated with the Series A Preferred Stock reported below or the weighted average number of shares of Common Stock associated with the following types of outstanding equity grants due to their antidilutive effect:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal year ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(share counts in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Time-based restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989625892488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock', window );">Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]</a></td>
<td class="text">The following table includes net investment hedge activity during the fiscal years ended June&#160;30, 2021 and 2020, respectively:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within Other Comprehensive Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange gain (loss) within the Consolidated Statements of Operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">Schedule of Interest Rate Derivatives</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the estimated fair value of the interest-rate swap reported in the consolidated balance sheets is stated in the table below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543940312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">The following table sets forth the Company&#8217;s financial assets and liabilities that were measured at fair value on a recurring basis and the fair value measurement for such assets and liabilities at June 30, 2021 and June 30, 2020, respectively:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Basis of Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred Stock derivative liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of changes in the estimated fair value of the Series A Preferred Stock derivative liability from June 30, 2020 to June 30, 2021:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.877%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement of<br/>Series A Preferred Stock<br/>Derivative Liability<br/>Using Significant<br/>Unobservable Inputs (Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimated fair value of Series A Preferred Stock derivative liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of derivative liability upon Partial Conversion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542887496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Earnings/(loss) from continuing operations before income taxes and discontinued operations</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings before income taxes are as follows for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision/ (benefit) for income taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following for fiscal 2021, 2020, and 2019: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of the provision/(benefit) based on the federal statutory income tax rate</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the provision starting from the tax computed at the federal statutory income tax rate to the tax computed at the Company&#8217;s effective income tax rate is as follows for the fiscal years ended 2021, 2020, and 2019:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision at U.S. federal statutory tax rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low tax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding tax and other foreign taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of the deferred income tax assets and liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the Company's deferred income tax assets and liabilities are as follows at June&#160;30, 2021 and 2020:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred tax assets and liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities in the preceding table are in the following captions in the consolidated balance sheets at June&#160;30, 2021 and 2020:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock', window );">Reconciliation of Unrecognized tax benefit, excluding accrued interest</a></td>
<td class="text">A reconciliation of unrecognized tax benefits, excluding accrued interest, as of June&#160;30, 2021, 2020, and 2019 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.474%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of the applicable statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543768456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Benefit obligation and fair value of plan assets for the defined benefit retirement and postretirement plan</a></td>
<td class="text">The following table provides a reconciliation of the change in projected benefit obligation and fair value of plan assets for the defined benefit retirement and other retirement plans, excluding the multi-employer pension plan liability:<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Reconciliation of the net amount recognized in the Consolidated Balance Sheets</a></td>
<td class="text">The following table provides a reconciliation of the net amount recognized in the consolidated balance sheets: <span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:46.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.565%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Statement of Financial Position</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive loss (income) at the end of the fiscal year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Information for Plan with ABO or PBO in Excess of Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (gain) loss arising during the year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Recognized in Net Periodic Benefit Cost and Other Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit cost and other comprehensive income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increases (%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return (%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year 2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retirement&#160;Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Future Benefit Payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Asset Allocation (Amount)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Asset Allocation (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock', window );">Summary of plan assets that are measured in fair value</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:12pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a summary of plan assets that are measured at fair value as of June&#160;30, 2021 and 2020, aggregated by the level in the fair value hierarchy within which those measurements fall:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:29.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.178%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></td></tr><tr style="height:15pt"><td colspan="30" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other as of June&#160;30, 2021, included $62 million of investments in hedge funds related to the Company's U.K. pension plan, which were classified as Level 2.</span></div><span></span>
</td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:29.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.178%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2020 (dollars in millions)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments Measured at Net Asset Value</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Assets</span></div></td></tr><tr style="height:14pt"><td colspan="30" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of beginning and ending balances of level 3 assets</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of Level 3 assets as well as the changes during the period attributable to assets held and those purchases, sales, settlements, contributions, and benefits that were paid:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Insurance Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurement Using Significant Unobservable Inputs Other</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total (Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at the reporting date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales, settlements, contributions and benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in or out of Level 3, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock', window );">Assumed healthcare cost trend rates</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other&#160;Post-Retirement&#160;Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumed Healthcare Cost Trend Rates at the Balance Sheet Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; initial (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare cost trend rate &#8211; ultimate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year in which ultimate rates are reached</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-65</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-65</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of plan assets that are measured in fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538487176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated other comprehensive earnings/(loss)</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign&#160;Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Liability Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives and Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the changes in the cumulative translation adjustment, derivatives and hedges, minimum pension liability, and marketable securities for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consists of:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.488%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term inter-company loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, pretax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total foreign currency translation adjustments, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivatives and hedges, net of tax</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) recognized during the year, pretax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in minimum pension liability, net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized during the year, pretax</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in marketable securities, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss by component and changes for the fiscal years ended June&#160;30, 2021, 2020, and 2019 consist of:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign&#160;Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Liability Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives and Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543830296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average of assumptions used in estimating the fair value of stock options granted during each year were as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity and shares subject to outstanding options for the fiscal year ended June&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.675%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance</span></td><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted Average Contractual Term</span></td><td colspan="3" rowspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,997,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.63</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,229,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.01</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,453,938&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">870,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,527,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,251&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired / Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,280,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,696,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vest and expected to vest as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,280,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,696,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and exercisable as of June 30, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.69</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,607,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.00</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested time-based restricted stock units and restricted stock for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Time-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EPS and RTSR-Based Performance Share Units and Performance Shares</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Performance-Based Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock', window );">Fair Value Measurements, Nonrecurring</a></td>
<td class="text"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of RTSR Performance Shares and Performance Share Units</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RTSR performance share unit and performance share is determined using the Monte Carlo pricing model because the number of shares to be awarded is subject to a market condition. The Monte Carlo simulation is a generally accepted statistical technique used to simulate a range of possible future outcomes. Because the valuation model considers a range of possible outcomes, compensation cost is recognized regardless of whether the market condition is actually satisfied.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used in estimating the fair value of the RTSR performance share units and performance shares granted during each year were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.192%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in unvested RTSR performance share units and performance shares for the fiscal year ended June&#160;30, 2021: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.176%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">RTSR Units and Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Weighted Average Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Cancelled/forfeited/adjusted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Target Number Unvested as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,028&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.92&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538518392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income / Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Nonoperating Income (Expense)</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of other expense, net for the fiscal years ended June&#160;30, 2021, 2020, and 2019 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.057%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended &#160;<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt refinancing costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency (gains) and losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)    Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#8217;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#8217;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.</span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)    Foreign currency (gains) and losses include both cash and non-cash transactions. </span></div>(3)    Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543684232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock', window );">Schedule of Operating and Financing Leases Presented in Balance Sheet</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information concerning the leases recorded in the Company's consolidated balance sheet as of June&#160;30, 2021 is detailed in the following table:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Line item in the consolidated balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Balance at <br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term obligations and other       short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term obligations, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net lease costs for the fiscal year ended June&#160;30, 2021 reflected in the Company's consolidated statement of operations were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term lease cost amounted to $4 million during the fiscal year ended June&#160;30, 2021.</span></div><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate related to the Company's right-of-use assets and lease liabilities as of June&#160;30, 2021 are as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash Flow, Supplemental Disclosures</a></td>
<td class="text">Supplemental information concerning the cash-flow impact arising from the Company's leases for the fiscal year ended June&#160;30, 2021 recorded in the Company's unaudited consolidated statement of cash flows is detailed in the following table (in <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.771%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended&#160;<br/>June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for amounts included in lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows used for finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used for operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Non-cash transactions:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company expects that its future minimum lease payments will become due and payable as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Maturities of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Operating and Financing Leases Presented in Balance Sheet</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544908232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock', window );">Net Revenue and Segment EBITDA</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include net revenue and Segment EBITDA for each of the Company's current reporting segments during the fiscal years ended June&#160;30, 2021, 2020, and 2019:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment revenue elimination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment EBITDA reconciled to net earnings:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciling items to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges and gain (loss) on sale of assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on sale of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-allocated corporate costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unallocated costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#8217;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)    Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)     Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2],[3],[4]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Total Assets for Each Segment and Reconciling in Consolidated Financial Statements</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes total assets for each segment, as well as reconciling items necessary to total the amounts reported in the consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Assets </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and eliminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,777&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock', window );">Capital Expenditures by Segment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Expenditures </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Softgel and Oral Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral and Specialty Delivery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Supply Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock', window );">Presentation of revenue and long-lived assets by geographic area</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by geographic area: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.908%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.530%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Long-Lived Assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:48pt;text-indent:-24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</span></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 15, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. <div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#8217;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Unallocated costs include restructuring and special items, stock-based compensation, gain (loss) on sale of subsidiary, impairment charges, certain other corporate directed costs, and other costs that are not allocated to the segments as follows:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue and long-lived assets by geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Segment Reporting Information, Capital Expenditures by Segment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment reporting information net revenue and EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989537215272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process and inventories include raw materials, labor, and overhead. Total inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory cost adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock', window );">Prepaid and Other Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. value-added tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment, net consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings, and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, at cost</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,044)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Other Assets Non Current</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate-owned life insurance policies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Venture capital investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OtherAccruedLiabilitiesTableTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OtherAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OtherAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expense and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542897768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)<br> shares in Millions</strong></div></th>
<th class="th">
<div>Jun. 15, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 06, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>customer </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">48.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 70.72<span></span>
</td>
<td class="nump">$ 58.58<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NumberofCustomers', window );">Number of Customers | customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_NumberofCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Customers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_NumberofCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539349832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest Costs Capitalized</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain (Loss) on Sale of Assets and Asset Impairment Charges</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ctlt_BuildingAndImprovementsMember', window );">Building And Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ctlt_BuildingAndImprovementsMember', window );">Building And Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">50 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ctlt_BuildingAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ctlt_BuildingAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539122504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989548794120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989540079112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationInterSegmentRevenueElimination', window );">Inter-segment revenue elimination</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">3,998<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
<td class="nump">2,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member] | Manufacturing &amp; Commercial Product Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">877<span></span>
</td>
<td class="nump">955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member] | Development Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member] | Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,928<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="nump">573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member] | Manufacturing &amp; Commercial Product Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member] | Development Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member] | Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member] | Manufacturing &amp; Commercial Product Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">455<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member] | Development Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member] | Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member] | Manufacturing &amp; Commercial Product Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member] | Development Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member] | Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember', window );">Total Catalent before inter-segment revenue elimination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">4,017<span></span>
</td>
<td class="nump">3,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember', window );">Total Catalent before inter-segment revenue elimination [Member] | Manufacturing &amp; Commercial Product Supply [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">1,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember', window );">Total Catalent before inter-segment revenue elimination [Member] | Development Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,761<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember', window );">Total Catalent before inter-segment revenue elimination [Member] | Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationInterSegmentRevenueElimination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment reporting information inter segment revenue elimination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationInterSegmentRevenueElimination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ctlt_ManufacturingCommercialProductSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ctlt_ManufacturingCommercialProductSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ctlt_DevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ctlt_DevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989634990776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Disaggregation of Revenue by Geography (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_Eliminationofrevenueattributabletomultiplelocations', window );">Elimination of revenue attributable to multiple locations</a></td>
<td class="num">$ (95.0)<span></span>
</td>
<td class="num">$ (80.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">3,998.0<span></span>
</td>
<td class="nump">3,094.0<span></span>
</td>
<td class="nump">$ 2,518.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,343.0<span></span>
</td>
<td class="nump">976.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ctlt_InternationalOtherMember', window );">International Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">288.0<span></span>
</td>
<td class="nump">376.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">$ 2,462.0<span></span>
</td>
<td class="nump">$ 1,822.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_Eliminationofrevenueattributabletomultiplelocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Elimination of revenue attributable to multiple locations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_Eliminationofrevenueattributabletomultiplelocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ctlt_InternationalOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ctlt_InternationalOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626414152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Contractual Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract', window );"><strong>Revenue Recognition and Deferred Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAndDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAndDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989548794120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Contractual Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Contract with Customer, Asset</a></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543216568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations Purchase Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th"><div>Feb. 11, 2021</div></th>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Feb. 10, 2020</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (147,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (379,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1,291,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 264,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember', window );">Anagni [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember', window );">MaSTherCell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_SkeletalCellTherapySupportSAMember', window );">Skeletal Cell Therapy Support SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_HepaticCellTherapySupportSA', window );">Hepatic Cell Therapy Support SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment for acquisitions, net of cash acquired</a></td>
<td class="num">$ (15,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_KyotoMember', window );">Kyoto</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payment for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_AcordaTherapeuticsIncMember', window );">Acorda Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember', window );">Delphi Genetics SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_SkeletalCellTherapySupportSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_SkeletalCellTherapySupportSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_HepaticCellTherapySupportSA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_HepaticCellTherapySupportSA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_KyotoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_KyotoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_AcordaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_AcordaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989548448360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Net Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th"><div>Feb. 10, 2020</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember', window );">Anagni [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NetAssetsAcquiredLineItems', window );"><strong>Net Assets Acquired from Business Combinations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_BusinessCombinationTransitionalServiceAgreement', window );">Business Combination, Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember', window );">MaSTherCell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NetAssetsAcquiredLineItems', window );"><strong>Net Assets Acquired from Business Combinations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Net Assets</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Business Acquisition, Goodwill</a></td>
<td class="nump">253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember', window );">Delphi Genetics SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NetAssetsAcquiredLineItems', window );"><strong>Net Assets Acquired from Business Combinations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member] | MaSTherCell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NetAssetsAcquiredLineItems', window );"><strong>Net Assets Acquired from Business Combinations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_BusinessCombinationTransitionalServiceAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, transitional service agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_BusinessCombinationTransitionalServiceAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_NetAssetsAcquiredLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_NetAssetsAcquiredLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_AnagniMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_MaSTherCellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626405176">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Divestitures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 264<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_BlowFillSealBusinessWoodstockMember', window );">Blow-Fill-Seal Business, Woodstock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from Divestiture of Businesses and Interests in Affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount', window );">Business Combination, Acquired Receivables, Gross Contractual Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue', window );">Business Combination, Acquired Receivable, Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Disposal Group, Including Discontinued Operation, Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_BusinessCombinationLoanDiscount', window );">Business Combination, Loan Discount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business Acquisition, Transaction Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_BusinessCombinationWorkingCapitalAdjustments', window );">Business Combination, Working Capital Adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds', window );">Proceeds From Divestiture Of Businesses, Net Cash Proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Business Combination, Contingent Consideration, Asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Business Combination, Consideration Transferred, Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived', window );">Cash and Noncash Divestiture, Amount of Consideration Received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Accrued Liabilities, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember', window );">Delphi Genetics SA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Gain on sale of subsidiary for the fiscal year ended June 30, 2021 is affiliated with the sale of the Blow-Fill-Seal Business. Loss on sale of subsidiary for the fiscal year ended June 30, 2020 is affiliated with the disposal of the Australia facility.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The note receivable, which provides for interest at a rate of 5.0% paid in kind, had an estimated fair value of <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at June 30, 2021, which is the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal amount less a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discount determined using a discounted cash flow model with the market interest rate as a significant input.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The Company determined that the estimated fair value of the contingent consideration from the sale of the Blow-Fill-Seal Business at June 30, 2021 was zero, and therefore no contingent consideration was recorded at divestiture. If any contingent consideration is subsequently received, it will be recorded in the period in which it is received. The Company has elected an accounting policy to recognize increases in the carrying amount of the contingent consideration asset using the gain contingency guidance in ASC 450, <span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Other includes <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of transaction expenses, a working capital adjustment of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assumption of liabilities resulting in net cash proceed of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$287 million for the fiscal year ended June 30, 2021, with an additional $3&#160;million accrued at June 30, 2021 as a post-closing purchase price adjustment. The final post-closing purchase price adjustment was paid by the Company in August 2021.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_BusinessCombinationLoanDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Loan Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_BusinessCombinationLoanDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_BusinessCombinationWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Working Capital Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_BusinessCombinationWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Noncash Divestiture, Amount of Consideration Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Divestiture Of Businesses, Net Cash Proceeds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_BlowFillSealBusinessWoodstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_BlowFillSealBusinessWoodstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_DelphiGeneticsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626058424">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Carrying Amount of Goodwill (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,471,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,221,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">264,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Goodwill, Other Increase (Decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,519,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,471,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(54,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">505,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">409,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">108,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">516,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">505,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,463,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,320,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">264,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(124,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Goodwill, Other Increase (Decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,531,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,463,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">355,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">340,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Goodwill, Other Increase (Decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">316,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">355,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(54,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">148,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">152,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Goodwill, Other Increase (Decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">156,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 148,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The addition in the Biologics segment relates to the Skeletal and Delphi acquisitions. The addition in the Oral and Specialty Delivery segment relates to the Acorda transaction. For further details, see Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The increase in fiscal 2020 primarily relates to the MaSTherCell acquisition. See Note 3, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations and Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The reallocation in fiscal 2020 relates to adjustments to the Company&#8217;s reporting segments, as a result of which certain assets moved from the Biologics segment to the Oral and Specialty Delivery segment, and other assets moved from the Oral and Specialty Delivery segment to the Softgel and Oral Technologies segment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents goodwill associated with the divestiture of the Blow-Fill-Seal Business.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543546104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProductRightsLineItems', window );"><strong>Intangibles [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 1,462<span></span>
</td>
<td class="nump">$ 1,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(645)<span></span>
</td>
<td class="num">(553)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 817<span></span>
</td>
<td class="nump">$ 889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_CoreTechnologyMember', window );">Core technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProductRightsLineItems', window );"><strong>Intangibles [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">19 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProductRightsLineItems', window );"><strong>Intangibles [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 1,024<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(306)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_ProductRelationshipsMember', window );">Product relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProductRightsLineItems', window );"><strong>Intangibles [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(237)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ProductRightsLineItems', window );"><strong>Intangibles [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ProductRightsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Rights [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ProductRightsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_CoreTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_CoreTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_ProductRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ctlt_ProductRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543263768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Definite Lived Long-Lived Assets - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract', window );"><strong>Finite lived intangible assets disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FinitelivedintangibleassetsdisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543691768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract', window );"><strong>Finite lived intangible assets disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">$ 83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FinitelivedintangibleassetsdisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FinitelivedintangibleassetsdisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549462232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>employees</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related reorganization</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Facility exit and other costs</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, Settlement and Impairment Provisions</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ctlt_BoltonCSMember', window );">Bolton CS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, Settlement and Impairment Provisions</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ctlt_BoltonCSMember', window );">Bolton CS [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Expected Number of Positions Eliminated | employees</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ctlt_BoltonCSMember', window );">Bolton CS [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Expected Number of Positions Eliminated | employees</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected number of positions to be eliminated as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ctlt_BoltonCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ctlt_BoltonCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989548155064">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 23, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 18, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Finance Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,166.0<span></span>
</td>
<td class="nump">2,945.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_InstallmentPaymentForAcquisition', window );">Installment Payment for Acquisition, Next Twelve Months</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_InstallmentPaymentforAcquisitionYearTwo', window );">Installment Payment for Acquisition, Year Two</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_InstallmentPaymentforAcquisitionYearThree', window );">Installment Payment for Acquisition, Year Three</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_InstallmentPaymentforAcquisitionYearFour', window );">Installment Payment for Acquisition, Year Four</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of Debt Issuance Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DebtInstrumentQuarterlyAmortizationRate', window );">Debt Instrument Quarterly Amortization Rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ctlt_SeniorSecuredCreditFacilityMember', window );">Senior Secured Credit Facility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PledgePercentageOfCapitalStock', window );">Pledge Percentage Of Capital Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PledgePercentageOfEquityInterest', window );">Pledge Percentage Of Equity Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_MaximumPercentageOfVotingStock', window );">Maximum Percentage Of Voting Stock from non US subsidiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanFacilityIncrementalDollarTermB2Member', window );">Term Loan Facility Incremental Dollar Term B-2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">938.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember', window );">Revolving Credit Facility - Two [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditCommitmentsMember', window );">Revolving Credit Commitments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet', window );">Debt Instrument, Increase (Decrease), Other, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember', window );">Four Point Seven Five Percent Senior Euro Denominated Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember', window );">U.S. Dollar-denominated 4.875% Senior Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember', window );">U.S Dollar-denominated 5.00% Senior Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember', window );">2.375% Senior Euro Denominated Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations | &#8364;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember', window );">Senior Unsecured Term Loan Facility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="nump">98.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CapitalLeaseObligationsMember', window );">Capital Lease Obligations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193.0<span></span>
</td>
<td class="nump">142.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_OtherObligationsMember', window );">Other Obligations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember', window );">3.125% Senior US Denominated Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember', window );">Term Loan Three Facility Dollar Denominated [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 997.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet', window );">Debt Instrument, Increase (Decrease), Other, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember', window );">Term Loan Two Facility Dollar Denominated [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 933.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,241.0<span></span>
</td>
<td class="nump">3,018.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,277.0<span></span>
</td>
<td class="nump">3,055.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement [Member] | Debt Issuance Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Reported Value Measurement [Member] | U.S. Dollar-denominated 4.875% Senior Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">450.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Reported Value Measurement [Member] | U.S Dollar-denominated 5.00% Senior Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Reported Value Measurement [Member] | 2.375% Senior Euro Denominated Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">984.0<span></span>
</td>
<td class="nump">926.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Reported Value Measurement [Member] | 3.125% Senior US Denominated Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ScheduleOfDebtLineItems', window );"><strong>Schedule Of Debt [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DebtInstrumentQuarterlyAmortizationRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Quarterly Amortization Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DebtInstrumentQuarterlyAmortizationRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_InstallmentPaymentForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Installment Payment for Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_InstallmentPaymentForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_InstallmentPaymentforAcquisitionYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Installment Payment for Acquisition, Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_InstallmentPaymentforAcquisitionYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_InstallmentPaymentforAcquisitionYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Installment Payment for Acquisition, Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_InstallmentPaymentforAcquisitionYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_InstallmentPaymentforAcquisitionYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Installment Payment for Acquisition, Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_InstallmentPaymentforAcquisitionYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_MaximumPercentageOfVotingStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of voting stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_MaximumPercentageOfVotingStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PledgePercentageOfCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pledge percentage of capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PledgePercentageOfCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PledgePercentageOfEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pledge percentage of equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PledgePercentageOfEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ScheduleOfDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Debt [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ScheduleOfDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseDecreaseOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in debt instruments, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseDecreaseOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ctlt_SeniorSecuredCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ctlt_SeniorSecuredCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanFacilityIncrementalDollarTermB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_TermLoanFacilityIncrementalDollarTermB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditCommitmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditCommitmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_OtherObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_OtherObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543794232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_LongTermAndShortTermDebtAbstract', window );"><strong>Long-term and Short-term Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months</a></td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Two</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Three</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour', window );">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Four</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive', window );">Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Five</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Long Term Debt and Capital Lease Obligations Repayments of Principal After Year Five</a></td>
<td class="nump">3,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total</a></td>
<td class="nump">$ 3,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_LongTermAndShortTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term and Short-term Debt [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_LongTermAndShortTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544752152">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,277.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,055.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,241.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,265.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,006.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,265.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,006.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember', window );">U.S. Dollar-denominated 4.875% Senior Notes [Member] | Level 2 [Member] | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember', window );">U.S. Dollar-denominated 4.875% Senior Notes [Member] | Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember', window );">U.S Dollar-denominated 5.00% Senior Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember', window );">U.S Dollar-denominated 5.00% Senior Notes [Member] | Level 2 [Member] | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember', window );">U.S Dollar-denominated 5.00% Senior Notes [Member] | Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">539.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember', window );">2.375% Senior Euro Denominated Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations | &#8364;</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember', window );">2.375% Senior Euro Denominated Notes [Member] | Level 2 [Member] | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">984.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember', window );">2.375% Senior Euro Denominated Notes [Member] | Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">993.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">844.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember', window );">3.125% Senior US Denominated Notes | Level 2 [Member] | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">550.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember', window );">3.125% Senior US Denominated Notes | Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">524.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorSecuredCreditFacilitiesOtherMember', window );">Senior Secured Credit Facilities &amp; Other [Member] | Level 2 [Member] | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,243.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,179.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorSecuredCreditFacilitiesOtherMember', window );">Senior Secured Credit Facilities &amp; Other [Member] | Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,209.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,160.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember', window );">Debt Issuance Costs | Reported Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember', window );">Debt Issuance Costs | Estimate of Fair Value Measurement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Measurements Of Financial Instruments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The increase in euro-denominated debt at June 30, 2021 compared to the prior year is primarily due to fluctuations in foreign currency exchange rates.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurements Of Financial Instruments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_U.S.Dollardenominated4.875SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_USDollarDenominated500SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_A2375SeniorEuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_A3125SeniorUSDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorSecuredCreditFacilitiesOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_SeniorSecuredCreditFacilitiesOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_DebtIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543511032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember', window );">Term Loan Three Facility Dollar Denominated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="nump">$ 997.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember', window );">Term Loan Three Facility Dollar Denominated [Member] | London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember', window );">Term Loan Three Facility Dollar Denominated [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember', window );">Revolving Credit Facility - Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember', window );">Senior Unsecured Term Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember', window );">Term Loan Two Facility Dollar Denominated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 933.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_TermLoanThreeFacilityDollarDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_RevolvingCreditFacilityTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_SeniorUnsecuredTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_TermLoanTwoFacilityDollarDenominatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549708008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Calculations of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic', window );">Participating Securities, Distributed and Undistributed (Earnings) Loss, Basic</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income (Loss) Available to Common Stockholders, Basic</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">168.0<span></span>
</td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">144.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">170.0<span></span>
</td>
<td class="nump">152.0<span></span>
</td>
<td class="nump">146.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">$ 3.15<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings Per Share, Diluted</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2740-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539248392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Earnings Per Share - Additional Details (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549632504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 23, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>May 17, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (56.0)<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net accumulated gain related to investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock', window );">Proceeds from Issuance of Redeemable Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 646.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Fair Value of Embedded Derivative Liability</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Estimate of Embedded Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_CashPaidToSettleInterestRateSwapAgreement', window );">Cash Paid to Settle, Interest Rate Swap Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_USDenominatedTermLoanMember', window );">U.S. Denominated Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9985%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalDebtUSDenominatedTermLoan', window );">Total Debt, U.S Denominated Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_CashPaidToSettleInterestRateSwapAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid to Settle, Interest Rate Swap Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_CashPaidToSettleInterestRateSwapAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Embedded Derivative, Estimate of Embedded Derivative Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalDebtUSDenominatedTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Debt, U.S Denominated Term Loan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalDebtUSDenominatedTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stock that is classified as callable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_USDenominatedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_USDenominatedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549584616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TradingSecuritiesAtFairValue', window );">Trading Securities at Fair Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SeriesAPreferredStockDerivativeLiability', window );">Series A Preferred Stock derivative liability</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest Rate Cash Flow Hedge Liability at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TradingSecuritiesAtFairValue', window );">Trading Securities at Fair Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SeriesAPreferredStockDerivativeLiability', window );">Series A Preferred Stock derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest Rate Cash Flow Hedge Liability at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TradingSecuritiesAtFairValue', window );">Trading Securities at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SeriesAPreferredStockDerivativeLiability', window );">Series A Preferred Stock derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest Rate Cash Flow Hedge Liability at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TradingSecuritiesAtFairValue', window );">Trading Securities at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SeriesAPreferredStockDerivativeLiability', window );">Series A Preferred Stock derivative liability</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue', window );">Interest Rate Cash Flow Hedge Liability at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SeriesAPreferredStockDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series A Preferred Stock derivative liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SeriesAPreferredStockDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TradingSecuritiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>participant-directed stock and bond mutual funds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TradingSecuritiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544655032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed Earnings of Foreign Subsidiaries</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossMember', window );">Foreign, Net Operating Loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossEstablishedMember', window );">Foreign, Net Operating Loss Established [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382', window );">Operating Loss Carryforwards, Subject to Limitations, Section 382</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OperatingLossCarryforwardsIndefiniteLife', window );">Operating Loss Carryforwards, Indefinite Life</a></td>
<td class="nump">432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OperatingLossCarryforwardsCarryForwardPeriod', window );">Operating Loss Carryforwards, Carry Forward Period</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OperatingLossCarryforwardsCarryForwardPeriod', window );">Operating Loss Carryforwards, Carry Forward Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OperatingLossCarryforwardsCarryForwardPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Carry Forward Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OperatingLossCarryforwardsCarryForwardPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OperatingLossCarryforwardsIndefiniteLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Indefinite Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OperatingLossCarryforwardsIndefiniteLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject to Limitations, Section 382</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossEstablishedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ctlt_ForeignNetOperatingLossEstablishedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543413000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Schedule of Income before Tax Domestic and Foreign (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S. operations</a></td>
<td class="nump">$ 457<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S. operations</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings from continuing operations before income taxes</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549558984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes-Components of Income Tax Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989545205784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes-Income Tax Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Provision at U.S. federal statutory tax rate</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="num">(14,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome', window );">Effective Income Tax Rate Reconciliation, Global intangible low tax income</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent items</a></td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Unrecognized tax positions</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Tax valuation allowance</a></td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(21,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Withholding Tax and other foreign taxes</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in tax rate</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</a></td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision</a></td>
<td class="nump">$ 130,000,000<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>the income earned by foreign affiliates of US companies from intangible assets such as patents, trademarks, and copyrights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989651837464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes-Deferred Tax Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Loss and tax credit carryforwards</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Foreign currency</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions', window );">Pension</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property-related</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities', window );">Deferred Income Tax, Operating Lease, Liabilities</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss', window );">Euro Denominated Debt</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">356<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Foreign currency</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property-related</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Goodwill and other intangibles</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DeferredIncomeTaxRightOfUse', window );">Deferred Income Tax, Right-of-Use Asset</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(389)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DeferredIncomeTaxOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax, Operating Lease, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DeferredIncomeTaxOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DeferredIncomeTaxRightOfUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax, Right-of-Use</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DeferredIncomeTaxRightOfUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherComprehensiveLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherComprehensiveLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from pension benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543946056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes-Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Non-current deferred tax asset</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome', window );">Non-current deferred tax liability</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred Tax Liabilities, Net</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989636925736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes-Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning Balance</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending Balance</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989536991160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_MultiemployerPlansEstimatedAnnualCashContribution', window );">Multiemployer Plans, Estimated Annual Cash Contribution</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ctlt_EberbachPensionPromissoryNoteOrLoanMember', window );">Eberbach Pension Promissory Note or Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount', window );">Multiemployer Plan, Pension, Significant, Future Employer Contribution, Amount</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_MultiemployerPlansEstimatedAnnualCashContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Multiemployer Plans, Estimated Annual Cash Contribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_MultiemployerPlansEstimatedAnnualCashContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for employer contribution required to be made in future period to multiemployer pension plan determined to be individually significant. Includes, but is not limited to, employer contribution required by collective-bargaining arrangement (CBA), statutory obligation, and other contractual obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=35742348&amp;loc=SL14450788-114948<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450657-114947<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ctlt_EberbachPensionPromissoryNoteOrLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ctlt_EberbachPensionPromissoryNoteOrLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544601720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Defined Benefit Plan, Amortization of Gain (Loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Benefit Obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Company service cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Curtailments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Exchange rate gain/(loss)</a></td>
<td class="nump">28<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Company contributions</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Defined Benefit Plan, Plan Assets, Benefits Paid</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Exchange rate gain/(loss)</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Net Pension assets (liabilities)</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Defined Benefit Plan, Amortization of Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Benefit Obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Company service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Curtailments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain)/loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Exchange rate gain/(loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Company contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Defined Benefit Plan, Plan Assets, Benefits Paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Exchange rate gain/(loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Net Pension assets (liabilities)</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542962936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts Recognized in Statement of Financial Position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts Recognized in Statement of Financial Position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract', window );"><strong>Amounts Recognized in Accumulated Other Comprehensive Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax', window );">Prior service cost</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Net (gain)/loss</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Total accumulated other comprehensive income at the end of the year</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract', window );"><strong>Additional Information for Plan with ABO in Excess of Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net (gain)/loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts Recognized in Statement of Financial Position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract', window );"><strong>Amounts Recognized in Accumulated Other Comprehensive Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax', window );">Prior service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax', window );">Net (gain)/loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Total accumulated other comprehensive income at the end of the year</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract', window );"><strong>Additional Information for Plan with ABO in Excess of Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net (gain)/loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989548340968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net (gain)/loss arising during the year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net (gain)/loss arising during the year</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax', window );">Net gain/(loss) recognized during the year</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total minimum pension liability, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract', window );"><strong>Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Net (gain)/loss</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increases (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increases (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return (percent)</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract', window );"><strong>Expected Future Contributions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Fiscal Year 2020 Expected Future Contributions</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract', window );"><strong>Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net (gain)/loss arising during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax', window );">Net gain/(loss) recognized during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total minimum pension liability, pretax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract', window );"><strong>Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Net (gain)/loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract', window );"><strong>Expected Future Contributions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Fiscal Year 2020 Expected Future Contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of increase (decrease) in accumulated other comprehensive income from gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (s)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542400152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Fiscal Year Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 318<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">9.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | US Government Agencies Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">30.60%<span></span>
</td>
<td class="nump">26.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">30.50%<span></span>
</td>
<td class="nump">27.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | Corporate Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">24.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">21.10%<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | Real Estate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | Insurance Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">9.60%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">9.60%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Benefits [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">30.90%<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">30.80%<span></span>
</td>
<td class="nump">25.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | US Government Agencies Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | Corporate Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | Real Estate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | Insurance Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Post-Retirement Benefits [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Expected Future Benefit Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount', window );">Actual Asset Allocation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Asset Allocation (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actual Plan Assets Allocation, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=ctlt_InsuranceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=ctlt_InsuranceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542928024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 318.0<span></span>
</td>
<td class="nump">$ 295.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">295.0<span></span>
</td>
<td class="nump">272.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">29.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Fair Value Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">164.0<span></span>
</td>
<td class="nump">152.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">164.0<span></span>
</td>
<td class="nump">152.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Fair Value Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember', window );">Real Estate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember', window );">Real Estate [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember', window );">Real Estate [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember', window );">Real Estate [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember', window );">Real Estate [Member] | Fair Value Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">129.0<span></span>
</td>
<td class="nump">105.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">106.0<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Fair Value Measured at Net Asset Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_DefinedBenefitPlanOtherAssetsAxis=us-gaap_HedgeFundsMember', window );">Hedge Funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 62.0<span></span>
</td>
<td class="nump">$ 31.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_DefinedBenefitPlanOtherAssetsAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_DefinedBenefitPlanOtherAssetsAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989636630328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Level 3 (Details) - Level 3 [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate', window );">Relating to assets still held at the reporting date</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements', window );">Purchases, sales, settlements, contributions and benefits paid</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers in and/or out of Level 3</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ctlt_InsuranceContractsMember', window );">Insurance Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate', window );">Relating to assets still held at the reporting date</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements', window );">Purchases, sales, settlements, contributions and benefits paid</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers in and/or out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ctlt_OtherUnobservableAssetsMember', window );">Other Unobservable Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Employer contributions between measurement date and reporting date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate', window );">Relating to assets still held at the reporting date</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements', window );">Purchases, sales, settlements, contributions and benefits paid</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers in and/or out of Level 3</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement With Unobservable Inputs Reconcilation, Recurring Basis, Assets Held at Reporting Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ctlt_InsuranceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ctlt_InsuranceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ctlt_OtherUnobservableAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ctlt_OtherUnobservableAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538775368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details) - Other Post-Retirement Benefits [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract', window );"><strong>Effect of 1% Change in Healthcare Cost Trend Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Fiscal Year 2020 Expected Future Contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate (percent)</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PostretirementBenefitsByAgeGroupAxis=ctlt_Post65Member', window );">Post 65 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract', window );"><strong>Assumed Healthcare Cost Trend Rates at the Balance Sheet Date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Healthcare cost trend rate-initial (percent)</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Healthcare cost trend rate-ulitimate (percent)</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate', window );">Year in which ultimate rates are reached</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">2032<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Year ultimate health care cost trend rate is expected to be reached, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PostretirementBenefitsByAgeGroupAxis=ctlt_Post65Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PostretirementBenefitsByAgeGroupAxis=ctlt_Post65Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542373240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)<br> $ / shares in Units, number in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 23, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 15, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 06, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 17, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Issued &amp; Outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">8,400,000<span></span>
</td>
<td class="nump">48,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.72<span></span>
</td>
<td class="nump">$ 58.58<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,000,000<span></span>
</td>
<td class="nump">$ 494,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="nump">$ 1,042,000,000<span></span>
</td>
<td class="nump">$ 447,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues', window );">Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption', window );">Stcok Issued During Period, Shares, Over-allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption', window );">Stock Issued During Period, Value, Over-allotment Option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems', window );"><strong>Auction Market Preferred Securities, Stock Series [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PreferredStockIssuanceValue', window );">Preferred Stock, Issuance Value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PreferredStockIssuanceValueNet', window );">Preferred Stock, Issuance Value, Net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 646,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Estimate of Embedded Derivative Liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted | shares</a></td>
<td class="nump">265,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividends, Preferred Stock, Stock | $</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible Preferred Stock, Shares Issued upon Conversion | shares</a></td>
<td class="nump">20.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities | shares</a></td>
<td class="nump">5,392,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Issued &amp; Outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements | $</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">$ 1,042,000,000<span></span>
</td>
<td class="nump">$ 446,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems', window );"><strong>Auction Market Preferred Securities, Stock Series [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Stock Issued During Period, Value, Conversion of Convertible Securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember', window );">Designated shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems', window );"><strong>Auction Market Preferred Securities, Stock Series [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Embedded Derivative, Estimate of Embedded Derivative Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PreferredStockIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Issuance Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PreferredStockIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PreferredStockIssuanceValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Issuance Value, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PreferredStockIssuanceValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stcok Issued During Period, Shares, Over-allotment Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_StockIssuedDuringPeriodValueOverAllotmentOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Over-allotment Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_StockIssuedDuringPeriodValueOverAllotmentOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989542970280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (317)<span></span>
</td>
<td class="num">$ (386)<span></span>
</td>
<td class="num">$ (354)<span></span>
</td>
<td class="num">$ (326)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income /(loss), net of tax</a></td>
<td class="nump">69<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">67<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">69<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Translation Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">67<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember', window );">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember', window );">ACOI, Accumulated Gain (Loss), Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989625906840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease', window );">Net investment hedge</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax', window );">Long term inter-company loans</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease', window );">Translation adjustments</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Total foreign currency translation adjustments, pretax</a></td>
<td class="nump">55<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Total foreign currency translation adjustments, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax', window );">Net Derivative and Hedge (gain)/loss arising during the year</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax', window );">Derivative and Hedge, (Income) Loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax', window );">Other Comprehensive Income, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net gain/(loss) arising during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension liability tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in minimum pension liability, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Derivative and Hedge, after Reclassification Adjustment, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Derivative and Hedge, Gain (Loss) Arising During Period, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current period adjustment resulting from gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature because settlement is not planned or anticipated in the foreseeable future.  Resulting from the entities to the transaction being consolidated, combined, or accounted for by the equity method in the reporting entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cumulative translation adjustment from gain (loss), after tax, on foreign currency derivatives, that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543511912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 15, 2020</div></th>
<th class="th"><div>Feb. 06, 2020</div></th>
<th class="th"><div>May 17, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_RedeemablePreferredStockLineItems', window );"><strong>Redeemable Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">384,777<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PreferredStockIssuanceValue', window );">Preferred Stock, Issuance Value</a></td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.72<span></span>
</td>
<td class="nump">$ 58.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred Stock, Value, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PreferredStockIssuanceValueNet', window );">Preferred Stock, Issuance Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability', window );">Embedded Derivative, Estimate of Embedded Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable Preferred Stock Outstandings</a></td>
<td class="nump">$ 607,000,000<span></span>
</td>
<td class="nump">$ 359,000,000<span></span>
</td>
<td class="nump">$ 607,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember', window );">Designated shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_RedeemablePreferredStockLineItems', window );"><strong>Redeemable Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Embedded Derivative, Estimate of Embedded Derivative Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PreferredStockIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Issuance Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PreferredStockIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PreferredStockIssuanceValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Issuance Value, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PreferredStockIssuanceValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_RedeemablePreferredStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_RedeemablePreferredStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_DesignatedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549678568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Compensation (Additional) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="nump">15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)</a></td>
<td class="nump">2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="nump">726,000<span></span>
</td>
<td class="nump">166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</a></td>
<td class="nump">$ 24.36<span></span>
</td>
<td class="nump">$ 15.22<span></span>
</td>
<td class="nump">$ 9.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit', window );">Weighted Average Grant Date Fair Value of Restricted Stock Unit</a></td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_StockOptionGrantedContractualTerm', window );">Stock Option Granted Contractual Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</a></td>
<td class="nump">$ 51,000,000<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit', window );">Weighted Average Grant Date Fair Value of Restricted Stock Unit</a></td>
<td class="nump">$ 94.19<span></span>
</td>
<td class="nump">57.17<span></span>
</td>
<td class="nump">44.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</a></td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare', window );">Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare', window );">Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ctlt_StockCompensationPlanOmnibusMember', window );">Stock Compensation Plan - Omnibus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="nump">231,000<span></span>
</td>
<td class="nump">329,000<span></span>
</td>
<td class="nump">1,179,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated amount of dividends per share to be paid to holders of the underlying shares (expected dividends per share) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_StockOptionGrantedContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock option granted contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_StockOptionGrantedContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value of restricted stock unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of increase (decrease) of non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ctlt_StockCompensationPlanOmnibusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ctlt_StockCompensationPlanOmnibusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989545098312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Compensation (Option Activity) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 49.77<span></span>
</td>
<td class="nump">$ 35.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="nump">88.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="nump">26.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</a></td>
<td class="nump">48.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</a></td>
<td class="nump">41.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">49.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 38.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(726,000)<span></span>
</td>
<td class="num">(166,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="nump">46,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_TimeMember', window );">Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">1,280,174<span></span>
</td>
<td class="nump">1,997,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">231,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(870,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</a></td>
<td class="num">(73,855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</a></td>
<td class="num">(5,001)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">1,280,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</a></td>
<td class="nump">480,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">8 years 7 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration', window );">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="nump">$ 74,696,700<span></span>
</td>
<td class="nump">$ 76,229,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">63,527,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">74,696,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 33,607,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_PerformanceMember', window );">Performance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">1,280,174<span></span>
</td>
<td class="nump">85,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="num">(2,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</a></td>
<td class="num">(82,990)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">5 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration', window );">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,453,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="nump">222,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_TimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_TimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_PerformanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_PerformanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544222008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Compensation (RSU Activity) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">502,000<span></span>
</td>
<td class="nump">748,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="nump">$ 32,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit', window );">Weighted Average Grant Date Fair Value of Restricted Stock Unit</a></td>
<td class="nump">$ 47,000,000<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_TimeBasedRestrictedStockUnitsMember', window );">Time Based Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">764,356<span></span>
</td>
<td class="nump">1,081,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">283,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">492,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</a></td>
<td class="nump">108,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 65.54<span></span>
</td>
<td class="nump">$ 47.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">93.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">43.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 57.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">392,095<span></span>
</td>
<td class="nump">516,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">113,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">259,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</a></td>
<td class="num">(22,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 58.16<span></span>
</td>
<td class="nump">$ 43.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">88.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">36.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 47.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ctlt_RTSRPerformanceShareUnitsMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">327,028<span></span>
</td>
<td class="nump">427,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</a></td>
<td class="nump">105,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">202,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</a></td>
<td class="nump">3,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 68.92<span></span>
</td>
<td class="nump">$ 49.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">101.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">38.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 56.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</a></td>
<td class="nump">671,000<span></span>
</td>
<td class="nump">734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments Related to Tax Withholding for Share-based Compensation</a></td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="nump">$ 54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit', window );">Weighted Average Grant Date Fair Value of Restricted Stock Unit</a></td>
<td class="nump">$ 94.19<span></span>
</td>
<td class="nump">57.17<span></span>
</td>
<td class="nump">44.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</a></td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value of restricted stock unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_TimeBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_TimeBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ctlt_RTSRPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ctlt_RTSRPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549655304">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Income / Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other Nonoperating Expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign Currency Transaction Gain (Loss), Unrealized</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Nonoperating Income (Expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">20<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (Income)/expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write-off of Deferred Debt Issuance Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Early Repayment of Senior Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Debt refinancing costs for the fiscal year ended June 30, 2021 includes (a) a write-off of $4 million of previously capitalized financing charges related to the Company&#8217;s repaid Term B-2 Loans and the 2026 Notes, (b) $3 million of financing charges related to the Company&#8217;s Term B-3 Loans, and (c) an $11 million premium on early redemption of the 2026 Notes.<div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2020 includes (x) a write-off of $6 million of previously capitalized financing charges related to the Company's repaid euro-denominated term loans under its senior secured credit facilities and the Company's redeemed 2024 Notes, and (y) a $10 million premium on early redemption of the 2024 Notes. </span></div><div style="margin-top:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt financing costs for the fiscal year ended June 30, 2019 includes $16 million of financing charges related to the offering of the 2028 Notes. </span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Foreign currency (gains) and losses include both cash and non-cash transactions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Other, for the fiscal years ended June 30, 2021 and 2020 includes, in part, total realized and unrealized gain of $17 million and $3 million, respectively, related to the fair value of the derivative liability associated with the Series A Preferred Stock.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543459592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Assets and Liabilities, Lessee [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">$ 139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989626072296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_FinanceLeaseExpense', window );">Finance Lease Expense</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable Lease, Cost</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ShortTermLeaseCosts', window );">Short-Term Lease Costs</a></td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">12 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">11 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">7.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_FinanceLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_FinanceLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ShortTermLeaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-Term Lease Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ShortTermLeaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539385272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Amounts Included In Measurement Of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539393576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, Payments, Due Year One</a></td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due</a></td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Year One</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueYearOne', window );">Total Lease Liability Payments Due Year One</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo', window );">Total Lease Liability Payments Due Year Two</a></td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueYearThree', window );">Total Lease Liability Payments Due Year Three</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueYearFour', window );">Total Lease Liability Payments Due Year Four</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueYearFive', window );">Total Lease Liability Payments Due Year Five</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive', window );">Total Lease Liability Payments Due After Year Five</a></td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityPaymentsDue', window );">Total Lease Liability Payments Due</a></td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Total Lease Liability Undiscounted Excess Amount</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_TotalLeaseLiability', window );">Total Lease Liability</a></td>
<td class="nump">$ 282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989543515016">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Net Revenue and Segment Ebitda (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,998<span></span>
</td>
<td class="nump">$ 3,094<span></span>
</td>
<td class="nump">$ 2,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationInterSegmentRevenueElimination', window );">Inter-segment revenue elimination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets', window );">Impairment charges and gain/(loss) on sale of assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_RestructuringAndOtherSpecialItems', window );">Restructuring and other special items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_NonAllocatedCorporateCostsNet', window );">Non-allocated corporate costs, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationUnallocatedExpense', window );">Total unallocated costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization', window );">Segment EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">237<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,928<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="nump">573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization', window );">Segment EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">608<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">686<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization', window );">Segment EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">160<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">391<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization', window );">Segment EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentSubTotalOfSegmentReportingMember', window );">Total Catalent sub-total of Segment Reporting [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization', window );">Segment EBITDA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,113<span></span>
</td>
<td class="nump">$ 786<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Restructuring and other special items for the fiscal year ended June 30, 2021 include transaction and integration costs associated with the Anagni, MaSTherCell, Skeletal, Delphi, and Acorda acquisitions, and restructuring costs associated with the closure of the Company's Clinical Supply Services facility in Bolton, U.K. <div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during the fiscal year ended June 30, 2020 include transaction and integration costs associated with the Company&#8217;s cell and gene therapy acquisitions and the disposal of a facility in Australia.</span></div><div style="margin-top:9pt;padding-left:48pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and other special items during fiscal 2019 include transaction and integration costs associated with the acquisitions of Paragon Bioservices, Inc. and Juniper Pharmaceuticals, Inc., and the disposal of a facility in Australia. </span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 15, <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for details of financing charges and foreign currency translation adjustments recorded within other expense, net.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment charges and (gain)/loss on sale of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_NonAllocatedCorporateCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-allocated corporate costs, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_NonAllocatedCorporateCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_RestructuringAndOtherSpecialItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and other special items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_RestructuringAndOtherSpecialItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment reporting information earning before interest tax depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationInterSegmentRevenueElimination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment reporting information inter segment revenue elimination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationInterSegmentRevenueElimination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationUnallocatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Information Unallocated Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationUnallocatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentSubTotalOfSegmentReportingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_TotalCatalentSubTotalOfSegmentReportingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989537107496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Earnings/(loss) from continuing operations</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SegmentReportingInformationUnallocatedExpense', window );">Total unallocated costs</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SegmentReportingInformationUnallocatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Information Unallocated Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SegmentReportingInformationUnallocatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539315128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information Total Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 9,112<span></span>
</td>
<td class="nump">$ 7,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,973<span></span>
</td>
<td class="nump">3,775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,269<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">483<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_CorporateAndEliminationsMember', window );">Corporate and Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 783<span></span>
</td>
<td class="nump">$ 801<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAssetReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989634868280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Depreciation and Amortization (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">$ 289<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989549787016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Capital Expenditures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">$ 686<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember', window );">Softgel and Oral Technologies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember', window );">Biologics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember', window );">Oral and Specialty Drug Delivery [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember', window );">Clinical Supply Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_SoftgelAndOralTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_BiologicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_OralAndSpecialtyDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ctlt_ClinicalSupplyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989547231320">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Segment Information - Assets and Revenues (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,524<span></span>
</td>
<td class="nump">$ 1,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">541<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ctlt_RestofWorldMember', window );">International Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ctlt_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ctlt_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989547270312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Raw materials and supplies</a></td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total inventory, gross</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory cost adjustment</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989541184168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetPurchase', window );">Contract with Customer, Asset</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_SpareParts', window );">Spare Parts</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid Taxes</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivable', window );">Value Added Tax Receivable</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid Expense and Other Assets, Current</a></td>
<td class="nump">$ 376<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_SpareParts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spare parts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_SpareParts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989539241496">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Property and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_LandBuildingsAndImprovements', window );">Land, buildings, and improvements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,571<span></span>
</td>
<td class="nump">$ 1,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">543<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, at cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,703<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,179)<span></span>
</td>
<td class="num">(1,044)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,524<span></span>
</td>
<td class="nump">$ 1,901<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Long-lived assets include property, plant, and equipment, net of accumulated depreciation.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_LandBuildingsAndImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Land, buildings and improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_LandBuildingsAndImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538738776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Other Assets Non Current (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_PensionAsset', window );">Pension Asset</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AlternativeInvestment', window );">Alternative Investment</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other Assets, Miscellaneous, Noncurrent</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount', window );">Loans and Leases Receivable, Gross</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash Surrender Value of Life Insurance</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_PensionAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_PensionAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AlternativeInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL6742756-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI http://asc.fasb.org/extlink&amp;oid=117332851&amp;loc=SL7495116-110257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AlternativeInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableGrossCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allowance of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableGrossCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989544856040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee-related expenses</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_AccruedRestructuringReserve', window );">Restructuring accrual</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest Payable, Current</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue and fees</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income tax</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other accrued liabilities and expenses</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">736<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ctlt_AccruedOperatingLeaseLiabilities', window );">Accrued Operating Lease, Liabilities</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_AccruedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Operating Lease, Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_AccruedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ctlt_AccruedRestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ctlt_AccruedRestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ctlt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139989538470392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ctlt_ZenyattaMember', window );">Zenyatta | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ctlt_ZenyattaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ctlt_ZenyattaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>131
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1I 6F6]DYR=:;,W6[DIH+6)S&'#F<YD] /?70NC]2=9 ^>>$RW\ 4$L#!!0
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M&8 / MQ10P I \A! ,8- 4X9X!P$D$%#@%L&N(<]6 T!@S)@<! P]!H"AF7
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MWY><B\<3]3[/[J6UL_\!4$L#!!0    ( %)+'E-D]S4\?P,   4-   8
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MB?TG: 4Y@KE@ROVC?6L;>"BOE195"S8,*LJ;)WEL W$$P-$ (&P!X?\ 83@
MB%I Y(0VS)RL:Z+);"+%'DEK;;S9AHN-0QLUE-MM7&EI9JG!Z=E"<"48+8B&
M JVT>9@]TDALT*(D? L*48Y6)9%0"E: ?*/0S<^:ZB?TOAE6SE94E=F3E1;Y
MO9E0;F+B:T/0+N/G+9EY0R8<(/.WT(3UP!;G82]6__X%JC7('R_=^"8L76S"
M+C:A\QL/^)W#EG).^1;-"2,\!R/MQ5I?:ZTTX84U>=N(?H>(1I]K?HFBX *%
M <[Z]#3K)FY=>] >9CB*XC .@F#B/_10CCK*D8-& Y1O>6X.LP+T]AJ:UCNW
M@99NLX'JS?,&?K\3C"%S&/9$%N?B%7>+QV?CU03E5JG:Y-)U+6U8EB"I*"[:
M7+E ?YF#[2SZTF,1G\8%QQ$>#$O2,4O.,[.KO[?'O; [:-Z!BKBWR)64-LM=
MSJ^?T+'=DCRYX2L;G@OT=6<!1L'-(\B<JN9D-/+ZI"0G4K(L&A22=D+2LT)N
MFF1[13Z.^\BFIW&/DU&4#?(==7Q'OS\?LV[Q[!?G8W8:EQ2/T\#]^B,S[LB-
M_["4G(][U*3'0AK1IV99$I^3C(-#L0E^;?J&06]Y"'J4A:-L.'_Q47W$OS^#
M\:$$X?,UZ/4YC'N*#4Z'7T7X4&MP]*>E<,OH6,PH[,GA'CL<!NFPZ$.-PZ\O
M<N92]6#RPH;"78YL3],U [2"W$ T'=BJT_J71.-PF/6A_N'S!?#U!P_W$CZM
M<G@4)/'XE+)_=$>U'PA?B#2W*X48; PVN!P9)[*Y<S<=+7;NVKH6VER"7;,T
MWRD@K8&9WPBAGSOV)MQ]^<S^ U!+ P04    " !22QY34EE$6#D+  "*,@
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M^.)S&@&B7B?\ +#%V^FI"-BSKUA>;+*")N1[GFTWIV2:E02N*>=QMW,0I^3
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M-<EONR3X,"/R]QM\QR+L) Q"7@U+RK:AK8E/0PC);&3[?BI[?1.U2;HCIB_
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M#^HL@&+\BN\/F^*3-1E&&0RC2,B8!_5(CR-*(4XL<JDG*;H'F+^RV[+9IY/
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MNUQ,AMT6BH'$BP"(J(VX99_!CQI8U]JUQD<\/:.F<5-!&T(!6C4)NDT!":N
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M%_66%MI$(RIHU!!?2/+/"?,D+2T"AK=:N;= V_JP]O!9&2"P"L_&(:<8K<8
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M;BNK)9D@GCVJ/R1\6$AQ+U_DX.]QYO^>B@$BE/XCF3*FQN2A'&Q+)"LL@]4
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MPE2@KW:R""R!/XO618-6GQOVHSM9@1>OE5^9<H0V\)LJR#S1,F %7?L0)++
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M%';>S57P:G9Y*B:S4S&=3=*4R>C\;-)1N)7"TK#MS]GEA/XQ![COY?2"/L<
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M>V-RRR.G4\CLB%R14\LIP-5N:&7[SE49*C7VK]J%"(ZAN@SQ,QQ.ASJ5QY#
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MK!18=.,M#P5R+(#OA;5A\\ .NO]5)O\"4$L#!!0    ( %)+'E.+<[&1;!,
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MVY-I'K_HL07Z'!1Y+J6RR)Q<8R7(>H.30,[JV_)<3M(H*+MUP<]16[Y%AQB
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MY_K:XFG8:<EUR973IB++LY/>67)TOBO?AP]^T;QP*_<DGDR-^20/[_*3WD@
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M[][YOZ.GXK23]:B!Q[.H.D<'XGB,#KEQJFX!@5?L$QR=GP"'Z,A)-4Z,,&W
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MNDS3&IBQ%$/@_J7ES[Z8G$[I\R3!YYBNQ'7#VIX)5ST\)M^WT$5!G "'2:H
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M@/?S$KF=OZ$%FE_;O/Y?4$L#!!0    ( %)+'E/L>XSA+@L  /0@   9
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MA"R?_WD!B]RAT651$?0=B*#7)7FD:@C*LWO(4;X]%N*X_?;$Y[9;I1BN$N1
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MHI]K?>I)(2.&@VAS[/,W4N!L 3:*?LVYPN+F$1HUF59NM\?[R!-X:UR,S+Y
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MJ!7XAO=J5 RLV>VJ\@X7X45B=9I#)E8K0:C"_M'F#RST'?7X&2Y$M@+O&5W
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MV'"-Q\]HQ0?QPIF''@MG;C!^Y*@9G 50UX3A.5G7>.51JPC!UCPPP%,6)]A
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M? #NK\JR,5]P@^XW<B__ U!+ P04    " !22QY3\ZG@VN(#  "M"0  &0
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MQP%[MPZ[RU=P=T_J:BZ+X'[L7-=>)X+:O=1&5M:\:>CN0TKFF^4XVF36-T@
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M2UQ0A*4->#\WN)^F!S+0?5.]^0=02P,$%     @ 4DL>4\^#UY/D!   H0H
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M0%Q7R!_GZ[1&W5_Y?.4:PY4ZCLMEF4JFM1\K=K<\Z[_8_ZS_]V#?RXC!P<;
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MUQW0U515E]?JP\C"71CGTM#UT[W:@Q:5-:#YA:0"KS]L@.8?Q/A_4$L#!!0
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M[@2@&Q5L#*LJKSR)LE267Q;TXT#M'.A\J4AJ6L,EZ'Y%D[]02P,$%     @
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M+'6WVQP\CTJX"?\"P>EW=<,QZD%+Z%WC2.T1L Q!!9!I!0M_:1WMA,@*3J-
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MFU:C%,7!E>8LL>.5_;'4K'T4F\"E7#4(FBG9\$S91Y(B^ Y$JGU"K#!7XD
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M(*JJ.EFJ[SA<&XE'=)'$3W;"H0SZ&B0J*AZ_NQ*GRX@)5M1S&+V_0W:(I))
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MSD.1C8NU0\=P=?GOV *Q?]?ND;+=AW8W-?)R)*^AD+1K;K%A+?+XWTL1E&2
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M6I$3 -E81B_KGBQYR7WSPESOI=<%Q_,1I$LG]IMNWY T=[9(5\G:DV?@[EW
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M3II7!CJ9=K7]DV-FP&'C%!:^Q=7Z_,TTRRUC'0PN8(/6N0B[EN\X1&)9T,F
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M<'5R?'#D-TGKH]/&C&GVW$3K14/9]V=_CWXM5<DMX%(9>=!<I^)TJS190CW
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MY8R@4[</]W9A5>T?RTMEZ>GMIVOZKX/:$=#Y2BG;+9R"_M_3_$]02P,$%
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M:?#AX88EOO2HL@HH+R0&U$VL@_[M./\74$L#!!0    ( %)+'E/F"IC\I0,
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M.WQG^I]+?-AS0QMP?:ZU6P_H@/*O@NF_4$L#!!0    ( %)+'E-SWYQ">@@
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M=!"S4\?L7(_I2MCE;.GS0E)L<KJ,Y](XO5XS3>CWHJ,\IZBD[R?]HT0.]=!
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M[N!\.]='HI<<BC1)CQ^G5V)_[^ C2LPJK*5(UU*D ;:W _8GM]!F==9H7N?
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MJV";J%OQ\"NO%E0&&(HD+_^"A\K6&X%PFRN15LXZ@C3.=O^#[U4B]AP@ZW!
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M9[;FJII^JHV12S\/3*6QTX5?YG9B!.4,[/N%E&:]<0&:&73\%U!+ P04
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M+W-H965T-3<N>&ULU5A=;]LV%/TKA+&'%G BB?)7"MN 8R==BJ8SXG9[&/9
M6]<V48ET22I.AOWX7DJRI$&RYG1 C.8A)BF>RW-X21Z)P[U47_46P)"G*!1Z
MU-H:LWOG.'JUA8CI2[D#@4_64D7,8%5M'+U3P(($%(4.==V>$S$N6N-ATC97
MXZ&,3<@%S!71<10Q]7P-H=R/6E[KT/# -UMC&YSQ<,<VL #S93=76'/R* &/
M0&@N!5&P'K4FWKL;ZEM TN-W#GM=*A,K92GE5UNY"T8MUS*"$%;&AF#X\PA3
M"$,;"7E\RX*V\C$ML%P^1+]-Q*.8)=,PE>$?/##;46O0(@&L61R:![G_%3)!
M71MO)4.=_"?[K*_;(JM8&QEE8&00<9'^LJ=L(DH KW,$0#, /17@9P#_5$ G
M W1.!70S0"+=2;4G$S=CAHV'2NZ)LKTQFBTDLY^@<;ZXL ME810^Y8@SX^M8
M8XO69"JC)1?,9D^33[A")UJ#T62R^A9S!0%Y,P/#>*C?D@OR93$C;WYY.W0,
M4K"!G%4VW'4Z'#TRW(=87!+?;1/J4J\&/FV&W\+RDE#_*'QV MQ+1W=KX#?_
M09XA>=>K@SLX[?G<TWSN:1*O<R3>1+"-X.3/>XB6H/YJB.CG$?TDHG\D8EW>
MUDI&I#;-#0-V\@$[C1+JXK;) ZPD*OL;1[\+0!B^YFP90H4:$P'YB(]XR T'
M;9_'$01M,E=X$BKSC*60"=-.>MX@:H=GE*G+7$JSE]"TA^/CV.^XR=_0>:P1
MV,T%=G] X#Q6JRT>3]B*1V8 *FFOXY5&[Y9X=6D3KU[.JW>.B;\3CPB3ZKE.
M2Z^BI=<DI9]+Z9]#RC16"G$9P*XIV#&.R^@)31939X&_F2VHK$>=XGYE57F-
MV1ODD@>-DN_9XC..;/WQE.U_E8>]>IWM[[F%?;@_Q0%PG?$LYXHV+D^O9)'>
M.32FBZ_(6:TJK[+GO$91A?=XS>93)^K_:YK!&I3M\9D]E7O4:J,5;1>#1G&%
M#7K^.3*&N:H5XE>$]-U&(86]>B?Z:T).\U3(>RF#/0_#6C*="AG:]1O9%%[H
M_8@9GCBM!>WVRV>X:J,^;195&*EW%B>]Y8(;N/B(GT$80A@F-AP#U.^$7N7L
MZC9O\\);O69SG4&XVW+R'@08OM)D,6DZ]@O_\@:OY#2%MWE7/X733#.>O5/?
M@VAAIO0L9OJ"I3BE51OM-XHK7)0VN^@T^9@%=?$ (3/_8G*0<G@5(O^0%[XA
MT=(W%WV=E4L+-Z)G<:,7I'66,2RGM5._:)W278*]*KIG:L.%)B&L$>I>]O$0
M5NGM2UHQ<I=<+RREP?PFQ2TP_":R'?#Y6DISJ-@;B_P.;/P=4$L#!!0    (
M %)+'E-Z2T MRP@  +@@   9    >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM
M;+5::V_;-A?^*X21%^@ Q[8DWQ(D 7Q9+D.[!/6V?@CV@9%HFZLDJB05U_OU
M.X>2)3FF9+_9"A2M+/+<+\\AU:N-D%_5FC%-OD=AK*Y;:ZV3RVY7^6L64=41
M"8MA92ED1#7\E*NN2B2C@2&*PJ[;ZPV[$>5QZ^;*O'N2-U<BU2&/V9,D*HTB
M*K=3%HK-=<MI[5Y\YJNUQA?=FZN$KMB"Z=^3)PF_N@67@$<L5ES$1++E=6OB
M7-Y['A*8'7]PME&59X*FO CQ%7\\!->M'FK$0N9K9$'AGU<V8V&(G$"/;SG3
M5B$3":O/.^ZWQG@PYH4J-A/A%Q[H]75KW"(!6](TU)_%YI[E!@V0GR]"9?XF
MFWQOKT7\5&D1Y<2@0<3C[%_Z/7?$*01N3N"^(7#Z-01>3N"=2M#/"?IO";P:
M@D%.,#A5PC G&)XJ8903C$Z5,,X)QB:Z63A,+.=4TYLK*39$XF[@A@\F(0PU
MA)#'F+L++6&5 YV^F:8*WBA%9B)ZX3'%A%)M,H>$4IKK5#)%/LR9ICQ4/Y%S
M\OMB3CZ<_43."(_))QZ&N/^JJT$59-CU<[&S3*Q;(_:6O72(Z[6)VW,="_F\
MF?R7-.X0KU=+?GLZ><]"?G\RN7.Q3]X%]Q<Q<(L8N(:?=RP&$_];RA4W1?W\
M$=Z1!\TB]6>##*^0X1D9_1H9=T($&PA7.Q,B64#FJ>3QBCPQR45@BT'&<6@X
M8@]\O1D,K[JOE2T_-PM]=OZT!>>0KSOL[S.^.\+8;?))O_!)OY'+G*M$*!J2
M.RG2I$U^%1H27_DBUCQ.P4./"9.F(MKD#F" ?/@H%%0!1&=':C%OVBSTV;/Y
M9)X1#2H^<<;NOD]N^P=^.W?VM]P?;ND5._9\-"A\-&A4=PK@=GX+B7.^8."I
M7:JVR1=(*.A._M>&0 P+(<,?5@"C0L:HT9 G*7S& D664D35_D;$LC +FAV-
M _(0:P:-3RML<I/EDH><:F9K<_/10=R\7HW+QX6FXV:76UIRI6P_,Y_Q5_H2
M,H@"9*[9&&L)4T *$9I$(HVU3=7Q@:J#&DTO"DTO_AM-V^26<DG^H&'*;"73
M+.:Y;RV9BP-[^B.[/4ZO1,/>.RR:F8ZP8K'&1\6#O"V0B904WL,LIR$8G_$9
MT^DQU;Z(,#[&XC:YAPG*BG*]DV/B5!#=^;_:VD/LAVF K;ZNN4T@\[4UO7-1
M>WVI?U&C88EWCON?@U'.<L]5_1I%2E!TFG'DQR# /)=:U\WWE2W1RFE&#GMN
M?A0TSG2N*7OG$%J\&E5*4'".H(*E8;?);U ,BF9GDIE0-1DU.%!G7*-."1_.
M\!V>^0*')LRI&4VXQLX8_ 7SM*E5JV+# \6&-8J5F.,T@XY=,>B+8A7SOR&_
M'@)0AR\Y-LF\#,N:0"CZ"$L /YH#-,%Z&K&@77UIM>00E.J2K\0DIQF4"OB\
M?0N?CU7XA!*"\_:,JC7945@U/,0B=US7O$LT<MX#1W7-.V][-C@Z(N=Y8,4C
MYQ"0:GJY6^*1^TX\JH"0*;LEDQ)3XU&OF;39=$30\]!JDWL(4$Y-5;@E0+G-
M &72 Y/[5Q'[^%Q)IW8^P"",[IN931/,"@[N(4QYGE.C9^58U@Q3$]^7" *5
M<JL.,J;KAD*!UE:=W(-9O*;ONB5>N4?PBH7)FI,[%C/-?446DZ;C9XDL;O^'
MS=]N"1IN,VB\ _5G.<NJ$_N#&B^6<.&^!RY^<%>>Y4KM':=K+$%\V7]3]FFW
MN4_;C]S3(U2_K1FA09 %'L8<:")DRD4H5IAEBJT0-8ED(1Z#B!9FP^(K"QD"
M*WHDSTQ:)I#J$!O;1YE3+!+F<QKJ+=)"8<MMG:")+V1 B2['BPZY%9(L4XG=
MC@39]50;Z!F.<(QX;6*]V,I4K=YM=9I2NT0>]P@BO+V/R+W>2(77TI<JH3Z[
M;B6@"Y.OK&5"P6-?,JKP@2RAR8#'\*:*)))'5/)P^]9#G^@"Z"1> 5=#T"&+
M=WB$-%TWE<CE'0$4ZSW'] B5&;(A66"P-B<IE;X !' *R;&$B*.MN4.VC$K"
MX@ J\I<4&M7N-I!PL&EW9 _(ANNU(=MQ-*EMO]3H$)SN_Y7X7IWX8'?2R%68
MP"@*E< I65(?N\:V*1.]$EN]9FRUGY6G1Z@PZ6),$UDYLF_6W%]#SHE7 &%E
M',#SBQ%"X0\!8#9>&G1Z_R,)Y0'F*XS<T O7%!LEP:R*C".6")NO!C:!XJP_
M(E%V>8RL]@*X$PR.1$>=#7KEUM5*LA5*A4J(?9Y@*\G&A1 3FY(SK]@<Y&<B
M; ],1F!Q0##0*]BV6X-79@!90D*02 0L+",&E?859MG"9&,M12&* TXLN4]C
M7$Y2W1BZ<MSPFL<-^U@Y/4*%H8."3FB\K5JJU^!7-*,N!+CFEZ.QOS=KF3NR
M$ZOF((!D U[ZFTG1-LT%6S2#Y,$,JY>(-)!\T.@18B%H94OJD(<E0?-JB2%5
ML%+9MQ363'?,1L4VX9K@R$%>6,D]!Z+$#!WX*\\WC7QVI!EX[1R[!NW,YS:#
M_]!B3?9@+B4BY/X6^[#<S0]%^U8[43Z5<FLRKYAM&]U/<>3(DQ4WKK K%KM!
MW"KE 8U] Q"3Q8ST![W*0<?G1X#-JWPU.'+1;CT63(]0F4,(NB%,L7.<C8NB
M1,LKMP3L>\)B<VRDYALG&NSGQW5:'-=-QQ@6/+*T.G/+MH 36*)S_F%E-H/"
M34,3)W 4S,Q9M2?9R=2PA6-GP>=$A&EG/0+S()]M8'.E\=#\V'!0%Z9Y  KH
M<SPVF.Q)I;]&H(=^YK.*R5GZ+3FR/HW"5)!IPB];8\4N=S%%TA7L,DI8TZ);
M^7X8,;DRWY(5,4F>WYX6KXL/UE/S7??-^[ES^;/M_:US>6=[/W%'EW?NR+("
M(RNLC*TK%[!R85OQ>I=W,&'85D !SZ8!]%=8<:TK'JR8;\O=TBO9-_U/5*XX
M3$\A6X*'>IT1G%-D]ID\^Z%%8CZZO@BM160>UXQ"A>,&6%\*@-O\!PHH_K/"
MS3]02P,$%     @ 4DL>4X#)X?&@!P  0"8  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3DN>&ULK9I=<^,F%(;_"N-V.NU,' N0'"=-,A-_I!\SV^[$N^U%
MIA=$PC9=27@!Q\V_+\BRL2R$E$URX=C2.8<#.KP/DKC><O%%KBA5X+\LS>5-
M;Z74^FHPD/&*9D2>\S7-]9D%%QE1^J=8#N1:4)(43EDZ0$$P'&2$Y;W;Z^+8
M1W%[S3<J93G]*(#<9!D1+V.:\NU-#_;V!Q[8<J7,@<'M]9HLZ9RJS^N/0O\:
M'*(D+*.Y9#P'@BYN>G?PZCX*C$-A\1>C6WGT'9BN/''^Q?SX+;GI!28CFM)8
MF1!$_WNF$YJF)I+.XVL9M'=HTS@>?]]'OR\ZKSOS1"2=\/1OEJC536_4 PE=
MD$VJ'OCV5UIV*#+Q8I[*XA-L=[:1-HXW4O&L=-899"S?_2?_E0-QY# *&AQ0
MZ8!.'."PP0&7#OC4 3<XA*5#>.H0-3A$I4/4M85AZ3 LQGXW6,5(3XDBM]>"
M;X$PUCJ:^5)<KL);#S#+367-E=!GF?93M[]PGFQ9FH(^F! A7EB^!'<9W^0*
M\ 4XG/UQ2A5AZ4_:[/-\"G[\_J?K@=+-FR"#N&QJLFL*-30%$?C <[628)8G
M-*D&&.B\#\FC??(3Y(WX^R8_!S@X RA T)'0K+M[X$D''\82%_%PVU@^/G#]
MJ2M_2T3RCR=R>(@<%I'#ALACNF1Y;J[-$TE)'E/7Z.]"#(L01E">;U%X 8/B
M[WKP?#PN#E.$3DTKF4:'3"-OIOLQ. -W\=<-$S0!TXTPF7^D@O'$E?@N8G24
M331TI3WU-_T(_W'50#TZ&H:N\/<MX9'O2@X/XS/L.#Z?!,GE@@KI2'KL#_*(
MG3T=UGK:<#$O#LE>=$SV3[6B OR6QYI>DAHYV'USR<#LHI8']I76Z)#-R)N-
MGD^:$[E612%H'K\ 948P)3M")?]JL=3(4Z[QG(QJ*87.$IO5#?OPPI?]Y2'[
M2V_V6O-:YN]EO5 C>.G,TF%:G^J5-&%@@1!TO.A_"Z84S34(%N"!ZH'6DUEQ
M,"<I-7 8;Z1VE1)\SIER%7%+0X^AJXHGI5?E$D2G$[;:MR/806^3<[Y02YH"
MDB?@3T%2\(G&JYRG?,FH!(\?:/9$A6^:0V2;0N\, V@Y _';<5#&J,AJ$#G+
MR6$:!J>55\W5D@OZT?4M0"A#NI6L3-EG4DW5H@MV99=7FUNB-(@SK',(!B/O
M&%NF0#\/WJ*,L$X-Z%XT."S[I653#RQHH)\T[>H(ZU2)H%O#7::URJ\F:AD$
M_1!Z-W6<P#IJFK*SC(%^R(Q9H65Q)RU#%@DH>&<M0U:2D5^2.VE9&:-2I.'P
M=%51KOD=MAAYZQ1954?HW=6L#%DI1^<"=-K2>,,"UQ&_:87;UH!WB8LLGY"?
M3QV%M"5*@Y"B.JSZ$'D7",C2"G6EU:M6O*A.HS[R9F2AA/PX>8NV(P=SG(4Q
M<U@V96ZIA/Q4:M=TY&!/A-WT<=G6):":JL4/ZGJC\U951W7VU'KRROLC9.&$
M_' JEK1F;3M?TYB15+V J=@LP92F[)F*ETY4L+!!E^],!6R)@_WW!IVH@.MW
M"CARKW!=IJ&7"=@2#/L)]BU,P'5(G>K%#@DM;3<@P1&^J9L6?;@K^KRBWA*E
M0=1QG6&UQ5TU[Z.'<EUA]"I)QW7,>!4=6\9@/V/>HNBX#AKH7@8Y+/M>F<$6
M2=B/I'9AQW6<X(;%NLNT-HFKB5H"X:X/V][Z**.EH89'&=AQQ^1_E($MLK ?
M61-]@,5:[^>;]3I] 7,JGEG<[2D&MD3!H_?6>,L/W'*STDGCZX^Z8'AZVUQ6
MDL,T\L[9T/(H[/I0K+O&AW7FU)[#^TRJJ5H<A5UQY-7IEB@-.AUV!DMHP1)V
M!<NK!#JL(Z,I%<N*T,^*MTAS6 >&NTX=AGVO*(1'KXG\:&E7YM !$/?;EEE8
M?TM4GWK51"U"PJZ/VMZZX"X;&G8H \.-ZA&KMJ%?;=WKK'&+UZ<5U563L*)\
M6 YT>0/[B$;2I2DF((I>2]-K8S#_0E.JRH6\7KFO5PP0(SJRB"//@2NL:^F_
M7_4W-'07<Y&078F3XCW_N1%XL-B(8AXFQ2M?>:;]*?B#*PKPF;T>$YX]L;R8
M&7*7JFY,*J8V0C=Q[GOI:>D3^N]G:L\CRE'W>IF]&%=R36)ZTUOK7#07::^X
M%&PO+'K,%DP:>)HWOV M6$8$TQ ]&:$/9*[]A-GW<'P)SC5L7S\BP#<D%IJA
M'YIN71ZW>)G>ZZZG*8_)OFJ.1^"HWT<JMQ\&W;$UR5]^^&Z$X,7/4ENON5!&
M:,K*TC5"=)?U";E)BXT#VQ6+5R"F0I>05DXIJ0Z7\6<]N1>"9PTSH6RO0RV?
M%>=Y4:?NZ%TFQ'[&>=\*E<:^BH[L.B+ZEG=>XQ:O!UH4LKDDR_V"3/>:ZWX9
MN=PRM2HZDMB",Q>A&.24;_OWVJ$_U]?_4*S.W@R.MI%D5"R+#3\2Q&8WR.Y%
MY^'H85/1N-A*<W)\ J_NH>LXNIJZ[&?HZMYU_"X<7LW"H>.,5EY]YL)Y9J3/
MC)QG+O692]>9*+B:[79'#6S'=WNK/A"AEZD2I'2A!R$XO]"\$;OM2KL?BJ^+
M[35/7"F>%5]7E"14& -]?L&U4)0_3 .'36.W_P-02P,$%     @ 4DL>4R:&
M(6.$!   'A4  !D   !X;"]W;W)K<VAE971S+W-H965T-C N>&ULM5C1<MLH
M%/T5QM.'=J:)!))E.>-X)G&VN]E)MIEFTCYT^H!M;+-%P@44-_OUBY B; G)
M3L9YL25Q[^5<X)P+C#9<_)0K0A3XG;!4GO=62JW//$_.5B3!\I2O2:I;%EPD
M6.E7L?3D6A \-TX)\Y#O1UZ":=H;C\RW.S$>\4PQFI([ 626)%@\71+&-^<]
MV'O^\(4N5RK_X(U':[PD]T0]K.^$?O.J*'.:D%12G@)!%N>]"W@V"?S<P5A\
MI60CMYY!GLJ4\Y_YR_7\O.?GB @C,Y6'P/KOD4P(8WDDC>-7&;17]9D[;C\_
M1_]DDM?)3+$D$\Z^T;E:G??B'IB3!<Z8^L(W?Y$RH7X>;\:9-+]@4]KZ/3#+
MI.))Z:P1)#0M_O'O<B"V'&#4XH!*!U1W"%L<@M(A,(D6R$Q:5UCA\4CP#1"Y
MM8Z6/YBQ,=XZ&YKFTWBOA&ZEVD^-K\B"IE01<*-'<PYN>+H\*1XOI"1*@A/P
M6:V( ->IPNF23AEY;KG/IO_JR0"*@XN$"T7_PV9FWE\1A2G[H%T?[J_ ^W<?
MP#M 4W!+&=/M<N0I#3SOWIN5("\+D*@%)$3@EJ=J)<$?Z9S,=P-X.N,J;?2<
M]B7JC/AWEIZ"P/\(D(^@ ]#D<'>_ TY0S4)@X@4M\>S@2O#]1C>":T42^:,C
M=%B%#DWHL"7TGX)+"298B">:+L%7S#+BFH$B2F2BY-Q_',,P0B/O<7M47$:A
M-=H!V*\ ]CL!7LQF69(QK/(UM[6.7""+2/VM_D^BL%\#Z3#J]P,WR*@"&76"
M_$<+ZOXQC!K#$\-!#9W#)AZZP0TJ<(-.<!,N"%!DMDHYX\LG\/V6)%,BNE9/
M7(6.C[TPAU7HX9YY_Y51H2?]DQ&@$V94IR$S'\$W(\7YZG@D0I<6\"#)(F-:
ML1;.6>CN%@[!$\'"I4*3UWCNY Y]*[O^46A9AMFEG%];4RZCH.]>5'"K,L"C
M$;,,M4.Z85B'Z3"*6X@)D86)CD#-,LCV$(51'5_3IM\B;M J.PRZR6EJN"Z@
M@C S?')%U_(0CD(K\3 \-DNAE6>X3Y_?B*=[^H5A.U%?Y;J;OU5^V"W]!S.U
MJ>S01PT..*U@RRJS%0!VEX 7<770I&'@-\C@L$)AW +4UA,8'X.M<6.4!C"N
M(W08#=KDQ%8EV*WR=X+/,[VK?3%=D=5^Y!^;KLBJ-MJGVF]$USW]0MA.UU>Y
M[N9ORP'J+@>'TA4UQ1[%L+;$7$8#W[W$D"T)J+LDO(2L9:A=&@;U3:73:FOK
MN0O4UA74?78XC*RH>2H(Z[+GL&G;DB-;F5"WS+<=3 \AJY5_%!V=K%:VT3[9
M?BNR=O?;[^#J*SQWL[>U '77@H.IVA3ZQK'*91.U+#!;"]"^(\H+B#IT;&[K
M(!TV+=OTP%:3H/LD<1A)@^8185A#YS"!]8V)MW73I#>U2W,!)\&,9ZDJ;E^J
MK]4EWX6YVJI]OX1GD^*JSH8I;@YOL5C25 )&%CJD?SK0PR6*R[CB1?&UN<^:
M<J5WUN9Q1?"<B-Q MR\X5\\O>0?5E>CX?U!+ P04    " !22QY3""(8"FL"
M  #3!0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6R-5&U/VS 0_BNG
MB \@#9PFA0%*([5D:""0$(CMP[0/;G)-+!R[LQW*]NOGES0KK$5\2>[.]SSW
M9E^VDNI)-X@&7EHN]"1JC%F>$Z++!ENJC^02A3U92-528U55$[U42"L/:CE)
MXOB$M)2)*,^\[4[EF>P,9P+O%.BN;:GZ/4,N5Y-H%*T-]ZQNC#.0/%O2&A_0
M/"[OE-7(P%*Q%H5F4H#"Q22:CLZ+L?/W#M\8KO2&#*Z2N91/3KFJ)E'L$D*.
MI7$,U/Z>\0(Y=T0VC5\]9S2$=,!-><U^Z6NWM<RIQ@O)O[/*-)/H-((*%[3C
MYEZNOF)?S['C*R77_@NKWC>.H.RTD6T/MAFT3(0_?>G[L $8G>P )#T@>0L8
M[P"D/2#]*&#< WRK22C%]Z&@AN:9DBM0SMNR.<$WTZ-M^4RXL3\894^9Q9F\
MP 43S"#<V/97<"-%?1C$J=9H-!S"M*J8FQ'E<"7"17,3VR_04,8/K,?C0P'[
M>P>P!TS +>/<GNN,&)N?BT+*/I=9R"79D<LH@5LI3*/ABZBP>DU ;&%#=<FZ
MNEGR+N-U)XX@C3]!$B>C+0E=?!P>;X$7'X:/SMZI)AUFE7J^= ??99@4]^-A
MPE!1LSE'H&%2%=,EE[I3"#^F<VV4?5,_WPD['L*.?=CQCK#35BK#_H2IXXM=
M.!JW#3>PG'@6MVV>\[,T(\^;[?[?Y?3LM4NQQ>5T< GYDXWKWJ*J_=K04,I.
MF' W!NNPF:;^0;ZQS^S&"@OF'TU8=[=4U4QHX+BPE/'1Y^,(5%@A03%RZ1_5
M7!K[1+W8V*V+RCG8\X649JVX ,,>S_\"4$L#!!0    ( %)+'E-<-?=T:P(
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M7+)2T+VJ/F#C9^#R+90P_A>JYFP4P*(TI(HFV!(47-9/MFWJL!,0]UX)B)N
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M; _TP]Q^=%"[ W9_J10]3UPC;#]CZ1]02P,$%     @ 4DL>4_$[1]I_ P
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M83$7$OPI%$N*H07^U=VZ82% Y4?/JW&PQ)ZPE5$);3&'S=7\Z>,R-UP&T:_
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M8X^_[G)MQQ"JQ,"^7TIIGFZ2 /E'DOZ_4$L#!!0    ( %)+'E,O YDAMP,
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M$QG75:]D3J#E"-BK\JD7&JN?]E^2BI#&ZY#1VY"HC'BE_*I4?E6K?,Q2*EX
M<H?1S]2I>Y@ 6X"LV]KK<H'KC^1XNZ35?F_'VV^\.C3\9,3H;<01OV]*W3>U
MNF>@M"2QWIYI=,^)-C?M;'YOKMDS? ^#W;T??"3GP[T/4OC>WA<,ZLP_'3*J
M" FK[0^CG?BH5KRA[VHY'D,N0YWE^N[;$38^E.N[+T_8?'?7FZ==/QDRJ@@Y
M=-W?*\<8R)4K:Q6*+;&\:BE'R]*Y[PK&@_&!+:E=F;>#R>OQ"98KPA6BL#20
MP>6UX2/S$C?O:)&ZHF\AM"DA77-M_A: M %F?BF$WG;L N4?C=X_4$L#!!0
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MY_,8_[S';V2F()9_-<S<*6;NF)F[G\XL22HAU"%_Q'(X2_"-TJEDL@BN\$V
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MJ96JLNVYF'9AX !6G9C9#FS?_K&3-"\$3#J8>@-Q<L[QWX?\?S$9;(5\4BL
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M->Z"N5,UNHW6L4[[82_2Y,;["K-5Q'[%IC$_[DP==*LA5#\=*EJYBE:BHGU
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MG#,S',YDLN?BNRP!%'JI*)/3H%1J\R$,95Y"A66/;X#I+RLN*JST4JQ#N1&
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M/!%14#F3]:[K?^?IFG>!B9-*%W>I[XS*N*4R]E)Y9D+';<W(WU#8X&RX)":
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MVM]5G=>=F5/)9GGR%U^JS>7@?("6;$6+1'W*=[^QND-Q6=\B3V3U%^WJV-$
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MB?U')OL#E6^K[S3FN5)Y6OW<,+IDH@S0UU=YKAX/R@::3WVF_P%02P,$%
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M7'.VX,H:P/]+*<W3@;U M=4U_@M02P,$%     @ 4DL>4RO7J%4P!P  /SH
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M,>;,S)GW,,_P&J:[*/Z9K*54Z'?@A\GY:*W4YH-E)8NU#-SD+-K(,#VSBN+
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M0'I^%47JY2![<;!\473V'U!+ P04    " !22QY3,!H5LY@#   D#@  &0
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M1.TVT/>U4O9YX@RTS>?T?U!+ P04    " !22QY3/!@.5<H&  "'(   &0
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MD8(RY_Q)7<S"HX&E/*(174AE@L#'FI[1*%*6P(^_2J.#S9I*L?[]Q?I%#A[
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MSP7ZJ6<R*JD?EDBAV53P(Q &K;69F]29J;2F3YB)^Y,2^E^BY=3LP_>$J%>
M6 3FZW42)Q0I'(%?U0X+L."Q3J:=B?(!@\]LS6,,VO=<RH[W0!B)DQ@\YCEP
M3]"*4*.KO<0*$2H[P //3TO0?M<![P!AX(%0JJ%RZBMMN?F^O\ZMO,NL#&NL
MA"%XX$SM)/C (AQ=*O UY8)W>.)]%S9J_#EA-Z 7=$$8A-!AT.+MXH%#?/EF
M<3AI8-,KHMA+]?6:H_C'?"65T*7T9X/.?J&SG^KLU^C\13<=P@Y8*EWF"NQP
MM,6NR&5:AJD6TV4.,V\PG/J'LC-M3.\2L;01,"P@%_8/"OL'C?;?<[8%"HM8
ML] 73R?O'K%70#ERIV"F;E V<E+A84.\"F3I@,">F\FP8#)L9/)5:(MU7:9]
M,OHKR2+BY#"TOCX**QQLB!<.*B0<&#ATDQ@5)$;-)+A"%.B%2G=BICN;$)BM
M7X%R<^L"W7@4>G%Q'%G&#2KV+VR(UX,5C@X,'+DYC@N.XT:.5[MF%WS,'; X
M.: <W'GA@"[XZB8_=EA=C;"-"2K<;41-L4T*YI/_-;I,-Q>^ >X(+R9O")\#
M R=N$C X+X;!U9ZWQ((<D)E&TE7QD^E[H+W5(U3'ISJ(  DBB>XM42+,1<<<
MO&(DG*M:8%G9KP3+ ?$JF*4#$]10+:W[L)&JBV87M+-T[0"3KDY&T#(%5AG9
M$*\:/0>FCE%X9A3^Q^KKZJ"N%'C".C&)(EAVG5'N@I]TE(M211N];)1J,@76
ME&5NVJ!^A5LX(%YU%71@ZMQR'@U@[VI.F^SUVR9[._\J?7O7.LG" ;&RUX;4
M+HGP/)W YO'D-'?28NZL62YR/8TD;$A8)6%#2F5ZR>$\H<#F$<6$9KU#3#<8
MG7=Q/E'OJ\RNM,L[:,\<%D,;8C%L'&XN&9XG%]@\NKQA12Q7Y?R@-PYH1;&G
MEQ+O"5%=D\],[V<I^5OO2CYQ&IF<+94IF.?IO,S2^5'7-8^Z8(7-8E1;KJX!
MI^HR&U-=1ALAEQX[CTFP>4[Z(8_)U&-UI.V)QTJ3JY!E(^22\WEL@C\\-UWC
M7!Z=LL9=YX6QO5^Q0F]C+#<T03(W^*5=>8S%-CW=D&#-$Z:RC6KQMCA!F:?G
M!I7W=^9D)=WMG]5DQS(/2&P)DX#BC589W(QT6$1VTI$]*+Y/]_XKKA2/T]L=
M1A$6!J#_WW"N3@_F \5YT^P?4$L#!!0    ( %)+'E-OF#S<#@0  !D0   9
M    >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;+58VV[C-A#]%4+HPRZ06J*N
M]L(V$%_2N-BT1HS=/BSZ0%MCFX@D>DDJWO3K2UTB7T0IRA;-0RQ2<P[/#,><
MH8='QI_$'D"B'W&4B)&QE_+PR33%9@\Q$3UV@$2]V3(>$ZF&?&>* P<2YJ X
M,FW+\LV8T,08#_.Y)1\/62HCFL"2(Y'&,>$O$XC8<61@XW7BD>[V,ILPQ\,#
MV<$*Y)?#DJN16;&$-(9$4)8@#MN1<8L_+7"0 7*+KQ2.XNP99:ZL&7O*!HMP
M9%B9(HA@(S,*HCZ>80I1E#$I'=]+4J-:,P.>/[^RW^7.*V?61,"417_14.Y'
M1M] (6Q)&LE'=KR'TB$OX]NP2.3_T;&P]1T#;5(A65R"E8*8)L4G^5$&X@R
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M5_I:+&B/(T]UFZLZ[K'=Y5VQ@(1ML6>I\)I4>+VIJ,,2X):FL51Q2@8^QM_
MYT0N%BR=)?D<J'48V%)F"JAJT6]Y2GRW_&V%U!7$R"0X[@I";TOP6?1^$[W?
M&_W;;)FR#:5@0OEC,J76,$_!GRQ_I*+(4#D"5-\^&SE73$@E(\%&[6JW=,KF
M>?(/50.EZO<RA_5E6]KZ787*<LQ!!+)JJ8$AF,4;T3,;@B8)0:_ES^4N4@3V
M2+G:%:M!"]3"2\&[..'@4YRN*& /*@ UVI-I(3N1;/H5W*EH3*$$W1$0&$>
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MDNZ*I$-"-^7F-<F97"'078)WYK7[-/@$VAOL!QTVH,/_!OK!TW;4X>=#UOV
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MZML=7*MG'E"5Y=R#.6G*L+*AD/:&DJ\MIQ1^+0V=/1P9]P@VLK6\V"OMRE9
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MI7O2R[U 4*"1P,Z,. V71  V>>@>YC$,:AX:,%&]'DTZ8;.'7NFA]XZ'1&9
MD.[V+IH,]!JZN6[@$!/7ZC0YA$3U=O(K<R(#M73S5IM.WPC,7YCE;CG2;]TD
MJ^V/S*C/)_.K3/Z=\$#5DID9P&%A)(.KKDFHRF=OOD"Y=M-H+M',-G>Y,I\K
MH"S W%](B?N%/:#\ !K^!U!+ P04    " !22QY38B.3P"0#  #D"P  &@
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MU/G0#Y#TT\,;6M3N/:V$-J_3+2LS<$': +._%D+O#9N@'>'I/U!+ P04
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M0:!L +Y?2&FV&SM=ZX_I\#]02P,$%     @ 4DL>4PRF(8P9 P  #@D  !H
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MP1_X-<RF3<]OQ^Q5F+V+F*L,"T!++%1K4?<: 4.OQM0T"<)VIG[%U/_0WO[
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MX_T)E#7 [TLIS=O GM#5C6S\#U!+ P04    " !22QY327KL @P#   N"0
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MS7?O9U76ZFBV;=O=F_E<Y5M>,?5/L^.UOK)N9,5:?2@W<[63G!5JRWE;E?/
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M PJWA?K$#AH#/64[8>I4]_0.*-P8ZA-;:/P=[1^[&8!U0.'F4)_80W@A5^B
MPNVA/O6J. @:.:!PMZ@_Z=*XV &%^T5]\CT_"#1Q0.&.49_:2Q!TZ8#";:0^
MM9E>[J(:B9@6^'<(AA\BF/?%U;NWA9F@Y\5G_0%*G\]9F5]+S_S3WRN(8K-U
M=MV5I9G-NZHO&U;L?T1G_P- [_X%4$L#!!0    ( %)+'E,ZFT U& ,  )E
M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VTM.W$ 4A>&MH%X
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M>&T*M@'$-B7; &:;HFT M4W9-H#;IG ;0&Y3N@U@MRG>!M#;J]X>H+=7O3U
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M=ZSOX[C_Q_'+/>ZK=GC-3Y;_PV]^ E!+ 0(4 Q0    ( %)+'E,'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ 4DL>4\QX[\SN    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ 4DL>4YE<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !2
M2QY3:5G&Q<<%  !:&   &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ 4DL>4T-?:EN0!0  *Q4  !@
M         ("!"@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( %)+'E/=[PW&Y ,  , -   8              " @= 3  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !22QY3I?NA!5X&  !4&@
M&               @('J%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ 4DL>4]:H42_@ @  W0@  !@              ("!?AX  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( %)+'E/5KK"*.@<
M , F   8              " @90A  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " !22QY39/<U/'\#   %#0  &               @($$
M*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 4DL>4U)9
M1%@Y"P  BC(  !@              ("!N2P  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( %)+'E,V, !*2BT  %>&   8
M  " @2@X  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !2
M2QY3VRYS$L(/   5,0  &0              @(&H90  >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %)+'E,QP-]90A$  +LX   9
M          " @:%U  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#
M%     @ 4DL>4^^E"OQ*!   - H  !D              ("!&H<  'AL+W=O
M<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !22QY352QW-+\#  #M
M"   &0              @(&;BP  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+ 0(4 Q0    ( %)+'E-GI*HZ8 4  +<,   9              " @9&/
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 4DL>4XMS
ML9%L$P  Z3\  !D              ("!*)4  'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6Q02P$"% ,4    " !22QY3J5I<PD4&  !C$   &0
M    @('+J   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M %)+'E.==&ZXQPD  ,<;   9              " @4>O  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ 4DL>4Q(ND?B3"   #!@  !D
M             ("!1;D  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " !22QY3 %HD-D\.  !#*@  &0              @($/P@  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( %)+'E,9>PR%G1
M 'DS   9              " @970  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ 4DL>4^Q[C.$N"P  ]"   !D              ("!
M:>$  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !22QY3
MOU24Y^T1   O-P  &0              @('.[   >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( %)+'E/SJ>#:X@,  *T)   9
M      " @?+^  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ 4DL>4QDSH1P""   7Q4  !D              ("!"P,! 'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !22QY3SX/7D^0$  "A"@
M&0              @(%$"P$ >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( %)+'E-HT<,&C H  /L=   9              " @5\0 0!X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 4DL>4ZOF;!X6
M!0  30P  !D              ("!(AL! 'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " !22QY3NF@YR1P#  "6!@  &0
M@(%O( $ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( %)+
M'E,N(=C@UC8  *.P   9              " @<(C 0!X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ 4DL>4SJB8C'&#P  ,#$  !D
M         ("!SUH! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " !22QY3$+Z<XM\$  !)#0  &0              @(',:@$ >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( %)+'E.XVB;UD@4  'H-
M   9              " @>)O 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ 4DL>4^"J9H-1!   1PH  !D              ("!JW4!
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !22QY3Y@J8
M_*4#   ("0  &0              @($S>@$ >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( %)+'E,3P;;SH (  +T%   9
M  " @0]^ 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M4DL>4YIK?V6'!0  H X  !D              ("!YH ! 'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " !22QY3=N+- "L$  "W"@  &0
M            @(&DA@$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( %)+'E,3$Z(JC0,  (\(   9              " @0:+ 0!X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 4DL>4X]LYN"] P
M. H  !D              ("!RHX! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " !22QY30DK@-  '  !_%0  &0              @(&^
MD@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( %)+'E,L
MS#-XA H  -TD   9              " @?69 0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ 4DL>4^N!?4+(!    A(  !D
M     ("!L*0! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %)+'E/SV5M^1P4  /T-   9              "
M@>[# 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ 4DL>
M4_-[-W_K @  -0@  !D              ("!;,D! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " !22QY3:P7;@\$#  #W#0  &0
M        @(&.S $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( %)+'E-ZTM4430(  )4%   9              " @8;0 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 4DL>4S>N;!AL @  +P4
M !D              ("!"M,! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " !22QY3)0#K<!(&  !T)@  &0              @(&MU0$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( %)+'E,&*<$W
M)@,  (\*   9              " @?;; 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ 4DL>4_>%&FA9 @  Q04  !D
M ("!4]\! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !2
M2QY3:J!I=S\"   9!0  &0              @('CX0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( %)+'E,"X]@$E 8  'TA   9
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M970V,"YX;6Q02P$"% ,4    " !22QY3""(8"FL"  #3!0  &0
M    @('E! ( >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    (
M %)+'E-<-?=T:P(  -(&   9              " @8<' @!X;"]W;W)K<VAE
M971S+W-H965T-C(N>&UL4$L! A0#%     @ 4DL>4_$[1]I_ P  ) T  !D
M             ("!*0H" 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"
M% ,4    " !22QY3!N6VUVH)  "_-   &0              @('?#0( >&PO
M=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( %)+'E.<;</HJP(
M $X(   9              " @8 7 @!X;"]W;W)K<VAE971S+W-H965T-C4N
M>&UL4$L! A0#%     @ 4DL>4Q,J)8 I!@  H"0  !D              ("!
M8AH" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " !22QY3
M_X(@'.D#   P$0  &0              @('"( ( >&PO=V]R:W-H965T<R]S
M:&5E=#8W+GAM;%!+ 0(4 Q0    ( %)+'E,O YDAMP,  "P,   9
M      " @>(D @!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%
M  @ 4DL>4PD(A?,? P  = P  !D              ("!T"@" 'AL+W=O<FMS
M:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " !22QY31UM.ZID$   \#P
M&0              @($F+ ( >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+
M 0(4 Q0    ( %)+'E,*T%_CW@,  !L3   9              " @?8P @!X
M;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ 4DL>4]CLC *!
M!   %1,  !D              ("!"S4" 'AL+W=O<FMS:&5E=',O<VAE970W
M,BYX;6Q02P$"% ,4    " !22QY3HW"Y#[L"  !K!P  &0
M@('#.0( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( %)+
M'E.+4XEB8 ,  .8+   9              " @;4\ @!X;"]W;W)K<VAE971S
M+W-H965T-S0N>&UL4$L! A0#%     @ 4DL>4R]-$4\N!   71   !D
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M=#<Y+GAM;%!+ 0(4 Q0    ( %)+'E.ZN'BCB 8  /8C   9
M  " @692 @!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @
M4DL>4W8UD;*Z!0  +!T  !D              ("!)5D" 'AL+W=O<FMS:&5E
M=',O<VAE970X,2YX;6Q02P$"% ,4    " !22QY3ZG4\6XT%  #V&@  &0
M            @($67P( >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4
M Q0    ( %)+'E,KUZA5, <  #\Z   9              " @=ID @!X;"]W
M;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ 4DL>4P)I2YBZ!0
M-"H  !D              ("!06P" 'AL+W=O<FMS:&5E=',O<VAE970X-"YX
M;6Q02P$"% ,4    " !22QY3,!H5LY@#   D#@  &0              @($R
M<@( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( %)+'E-=
M*)OD7 ,  (@*   9              " @0%V @!X;"]W;W)K<VAE971S+W-H
M965T.#8N>&UL4$L! A0#%     @ 4DL>4SP8#E7*!@  AR   !D
M     ("!E'D" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %)+'E,HC)2*/P<  % P   9              "
M@="6 @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%     @ 4DL>
M4][:;<-7!@  <BL  !D              ("!1IX" 'AL+W=O<FMS:&5E=',O
M<VAE970Y,RYX;6Q02P$"% ,4    " !22QY3:#,A0HL%   ]$@  &0
M        @('4I ( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0
M   ( %)+'E.9[S ,K0(  (<'   9              " @9:J @!X;"]W;W)K
M<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ 4DL>4\2@4:T; P  /PH
M !D              ("!>JT" 'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6Q0
M2P$"% ,4    " !22QY3D;%_A\T"   <!P  &0              @(',L (
M>&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( %)+'E,I_.L
M/00  #D5   9              " @="S @!X;"]W;W)K<VAE971S+W-H965T
M.3@N>&UL4$L! A0#%     @ 4DL>4WQ<VQ+K!@  BQP  !D
M ("!1+@" 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q02P$"% ,4    " !2
M2QY3O$=_^!8#   ,"0  &@              @(%FOP( >&PO=V]R:W-H965T
M<R]S:&5E=#$P,"YX;6Q02P$"% ,4    " !22QY38B.3P"0#  #D"P  &@
M            @(&TP@( >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"
M% ,4    " !22QY3#N!@24X"  #.!0  &@              @($0Q@( >&PO
M=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " !22QY3$V>42',#
M  "B#0  &@              @(&6R ( >&PO=V]R:W-H965T<R]S:&5E=#$P
M,RYX;6Q02P$"% ,4    " !22QY34O:!N3D#  !)"P  &@
M@(%!S ( >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4    " !2
M2QY3Z LC&\H"  !8!P  &@              @(&RSP( >&PO=V]R:W-H965T
M<R]S:&5E=#$P-2YX;6Q02P$"% ,4    " !22QY3#*8AC!D#   ."0  &@
M            @(&TT@( >&PO=V]R:W-H965T<R]S:&5E=#$P-BYX;6Q02P$"
M% ,4    " !22QY3N77AL6(#  !0"@  &@              @($%U@( >&PO
M=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    " !22QY3T<OYTCX#
M  "="0  &@              @(&?V0( >&PO=V]R:W-H965T<R]S:&5E=#$P
M."YX;6Q02P$"% ,4    " !22QY327KL @P#   N"0  &@
M@($5W0( >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6Q02P$"% ,4    " !2
M2QY3X#ZQ01<"  !>!   &@              @(%9X ( >&PO=V]R:W-H965T
M<R]S:&5E=#$Q,"YX;6Q02P$"% ,4    " !22QY3J7KQ"#0#   ($P  #0
M            @ &HX@( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( %)+'E.7
MBKL<P    !,"   +              "  0?F @!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( %)+'E.7!:94C@<  (1(   /              "  ?#F @!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !22QY3.IM -1@#  "90   &@
M        @ &K[@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !22QY3QX65K'H"   G/@  $P              @ '[\0( 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     =@!V 'P@  "F] (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>405</ContextCount>
  <ElementCount>677</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>102</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Statements of Comprehensive Income / (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income / (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statement of Changes in Shareholder's Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity</Role>
      <ShortName>Consolidated Statement of Changes in Shareholder's Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock</Role>
      <ShortName>Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210081002 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210151003 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210211004 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210241005 - Disclosure - Definite Lived Long-Lived Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DefiniteLivedLongLivedAssets</Role>
      <ShortName>Definite Lived Long-Lived Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210291006 - Disclosure - Restructuring and Other Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RestructuringandOtherCosts</Role>
      <ShortName>Restructuring and Other Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210321007 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210381008 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210421009 - Disclosure - Derivative Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DerivativeInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210451010 - Disclosure - Fair Value Measures and Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/FairValueMeasuresandDisclosures</Role>
      <ShortName>Fair Value Measures and Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210481011 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210571012 - Disclosure - Employee Retirement Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlans</Role>
      <ShortName>Employee Retirement Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210671013 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Equity and Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210751015 - Disclosure - Equity Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityBasedCompensation</Role>
      <ShortName>Equity Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210801016 - Disclosure - Other Income / Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/OtherIncomeExpense</Role>
      <ShortName>Other Income / Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210831017 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210891018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210941019 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>211021020 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>211101021 - Disclosure - Subsequent Events (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://catalent.com/role/SubsequentEventsNotes</Role>
      <ShortName>Subsequent Events (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>220092002 - Disclosure - Revenue from Contract with Customer (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenuefromContractwithCustomerPolicies</Role>
      <ShortName>Revenue from Contract with Customer (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230103001 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/RevenueRecognition</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230163002 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/BusinessCombinations</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230223003 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/Goodwill</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230253004 - Disclosure - Definite Lived Long-Lived Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DefiniteLivedLongLivedAssetsTables</Role>
      <ShortName>Definite Lived Long-Lived Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/DefiniteLivedLongLivedAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230303005 - Disclosure - Restructuring and Other Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RestructuringandOtherCostsTables</Role>
      <ShortName>Restructuring and Other Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/RestructuringandOtherCosts</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230333006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230393007 - Disclosure - Earnings Per Share Calculation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EarningsPerShareCalculationTables</Role>
      <ShortName>Earnings Per Share Calculation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230433008 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/DerivativeInstrumentsandHedgingActivities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230463009 - Disclosure - Fair Value Measures and Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/FairValueMeasuresandDisclosuresTables</Role>
      <ShortName>Fair Value Measures and Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/FairValueMeasuresandDisclosures</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230493010 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230583011 - Disclosure - Employee Retirement Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansTables</Role>
      <ShortName>Employee Retirement Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/EmployeeRetirementBenefitPlans</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230683012 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Equity and Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230763014 - Disclosure - Equity Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityBasedCompensationTables</Role>
      <ShortName>Equity Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityBasedCompensation</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230813015 - Disclosure - Other Income / Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/OtherIncomeExpenseTables</Role>
      <ShortName>Other Income / Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/OtherIncomeExpense</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230843016 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/Leases</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230953018 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/SegmentInformation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>231033019 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://catalent.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240034001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240054003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240064004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240074005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240114006 - Disclosure - Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails</Role>
      <ShortName>Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240124007 - Disclosure - Revenue Recognition Disaggregation of Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails</Role>
      <ShortName>Revenue Recognition Disaggregation of Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240134008 - Disclosure - Revenue Recognition Contractual Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails</Role>
      <ShortName>Revenue Recognition Contractual Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240144009 - Disclosure - Revenue Recognition Contractual Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RevenueRecognitionContractualAssetsDetails</Role>
      <ShortName>Revenue Recognition Contractual Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240174010 - Disclosure - Business Combinations Purchase Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails</Role>
      <ShortName>Business Combinations Purchase Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240184011 - Disclosure - Business Combinations Net Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails</Role>
      <ShortName>Business Combinations Net Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240204013 - Disclosure - Business Combinations, Divestitures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/BusinessCombinationsDivestituresDetails</Role>
      <ShortName>Business Combinations, Divestitures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240234014 - Disclosure - Goodwill - Carrying Amount of Goodwill (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail</Role>
      <ShortName>Goodwill - Carrying Amount of Goodwill (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240264015 - Disclosure - Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail</Role>
      <ShortName>Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240274016 - Disclosure - Definite Lived Long-Lived Assets - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail</Role>
      <ShortName>Definite Lived Long-Lived Assets - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240284017 - Disclosure - Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail</Role>
      <ShortName>Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240314018 - Disclosure - Restructuring and Other Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/RestructuringandOtherCostsDetails</Role>
      <ShortName>Restructuring and Other Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/RestructuringandOtherCostsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240344019 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240354020 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240364021 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240374022 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240404023 - Disclosure - Earnings Per Share Calculations of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share Calculations of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240414024 - Disclosure - Earnings Per Share Earnings Per Share - Additional Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails</Role>
      <ShortName>Earnings Per Share Earnings Per Share - Additional Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240444025 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail</Role>
      <ShortName>Derivative Instruments and Hedging Activities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240474026 - Disclosure - Fair Value Measures and Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/FairValueMeasuresandDisclosuresDetails</Role>
      <ShortName>Fair Value Measures and Disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/FairValueMeasuresandDisclosuresTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240504027 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240514028 - Disclosure - Income Taxes Schedule of Income before Tax Domestic and Foreign (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails</Role>
      <ShortName>Income Taxes Schedule of Income before Tax Domestic and Foreign (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240524029 - Disclosure - Income Taxes-Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>Income Taxes-Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240534030 - Disclosure - Income Taxes-Income Tax Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails</Role>
      <ShortName>Income Taxes-Income Tax Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240544031 - Disclosure - Income Taxes-Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes-Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240554032 - Disclosure - Income Taxes-Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesBalanceSheetDetails</Role>
      <ShortName>Income Taxes-Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240564033 - Disclosure - Income Taxes-Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes-Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240594034 - Disclosure - Employee Retirement Benefit Plans-Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240604035 - Disclosure - Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240614036 - Disclosure - Employee Retirement Benefit Plans-Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240624037 - Disclosure - Employee Retirement Benefit Plans-AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EmployeeRetirementBenefitPlansTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240634038 - Disclosure - Employee Retirement Benefit Plans-Fiscal Year Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Fiscal Year Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240644039 - Disclosure - Employee Retirement Benefit Plans-Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240654040 - Disclosure - Employee Retirement Benefit Plans-Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details</Role>
      <ShortName>Employee Retirement Benefit Plans-Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EmployeeRetirementBenefitPlansTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240664041 - Disclosure - Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails</Role>
      <ShortName>Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240694042 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails</Role>
      <ShortName>Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240704043 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails</Role>
      <ShortName>Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240714044 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails</Role>
      <ShortName>Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240744045 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240774046 - Disclosure - Equity Based Compensation (Additional) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityBasedCompensationAdditionalDetails</Role>
      <ShortName>Equity Based Compensation (Additional) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityBasedCompensationTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240784047 - Disclosure - Equity Based Compensation (Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityBasedCompensationOptionActivityDetails</Role>
      <ShortName>Equity Based Compensation (Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityBasedCompensationTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240794048 - Disclosure - Equity Based Compensation (RSU Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/EquityBasedCompensationRSUActivityDetails</Role>
      <ShortName>Equity Based Compensation (RSU Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/EquityBasedCompensationTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240824049 - Disclosure - Other Income / Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/OtherIncomeExpenseDetails</Role>
      <ShortName>Other Income / Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/OtherIncomeExpenseTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240854050 - Disclosure - Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails</Role>
      <ShortName>Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240864051 - Disclosure - Leases - Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LeasesCostDetails</Role>
      <ShortName>Leases - Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240874052 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240884053 - Disclosure - Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240964057 - Disclosure - Segment Information - Net Revenue and Segment Ebitda (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail</Role>
      <ShortName>Segment Information - Net Revenue and Segment Ebitda (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240974058 - Disclosure - Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail</Role>
      <ShortName>Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240984059 - Disclosure - Segment Information Total Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationTotalAssetsDetails</Role>
      <ShortName>Segment Information Total Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240994060 - Disclosure - Segment Information Depreciation and Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails</Role>
      <ShortName>Segment Information Depreciation and Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>241004061 - Disclosure - Segment Information Capital Expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationCapitalExpendituresDetails</Role>
      <ShortName>Segment Information Capital Expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>241014062 - Disclosure - Segment Information - Assets and Revenues (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail</Role>
      <ShortName>Segment Information - Assets and Revenues (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>241044063 - Disclosure - Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>241054064 - Disclosure - Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>241064065 - Disclosure - Supplemental Balance Sheet Information - Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Property and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>241074066 - Disclosure - Supplemental Balance Sheet Information - Other Assets Non Current (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Other Assets Non Current (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>241084067 - Disclosure - Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail</Role>
      <ShortName>Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="ctlt-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>241114069 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://catalent.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://catalent.com/role/SubsequentEventsNotes</ParentRole>
      <Position>110</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="ctlt-20210630.htm">ctlt-20210630.htm</File>
    <File>catalent-20210630xex311.htm</File>
    <File>catalent-20210630xex312.htm</File>
    <File>catalent-20210630xex321.htm</File>
    <File>catalent-20210630xex322.htm</File>
    <File>catalent-2021630xex211.htm</File>
    <File>catalent-2021630xex231.htm</File>
    <File>ctlt-20210630.xsd</File>
    <File>ctlt-20210630_cal.xml</File>
    <File>ctlt-20210630_def.xml</File>
    <File>ctlt-20210630_lab.xml</File>
    <File>ctlt-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ctlt-20210630_g1.jpg</File>
    <File>ctlt-20210630_g2.jpg</File>
    <File>ctlt-20210630_g3.jpg</File>
    <File>ctlt-20210630_g4.jpg</File>
    <File>ctlt-20210630_g5.jpg</File>
    <File>ctlt-20210630_g6.jpg</File>
    <File>ctlt-20210630_g7.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>137
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ctlt-20210630.htm": {
   "axisCustom": 2,
   "axisStandard": 25,
   "contextCount": 405,
   "dts": {
    "calculationLink": {
     "local": [
      "ctlt-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ctlt-20210630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "ctlt-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ctlt-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctlt-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ctlt-20210630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 1001,
   "entityCount": 1,
   "hidden": {
    "http://catalent.com/20210630": 6,
    "http://fasb.org/us-gaap/2020-01-31": 16,
    "http://xbrl.sec.gov/dei/2020-01-31": 7,
    "total": 29
   },
   "keyCustom": 78,
   "keyStandard": 599,
   "memberCustom": 54,
   "memberStandard": 46,
   "nsprefix": "ctlt",
   "nsuri": "http://catalent.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Document and Entity Information",
     "role": "http://catalent.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210081002 - Disclosure - Revenue Recognition",
     "role": "http://catalent.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974058 - Disclosure - Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail)",
     "role": "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail",
     "shortName": "Segment Information - Reconciliation of Earnings/ (loss) from Continuing Operations to Ebitda (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984059 - Disclosure - Segment Information Total Assets (Details)",
     "role": "http://catalent.com/role/SegmentInformationTotalAssetsDetails",
     "shortName": "Segment Information Total Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i5ebdb26351324dc59f4adf268bf038a1_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994060 - Disclosure - Segment Information Depreciation and Amortization (Details)",
     "role": "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
     "shortName": "Segment Information Depreciation and Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004061 - Disclosure - Segment Information Capital Expenditures (Details)",
     "role": "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
     "shortName": "Segment Information Capital Expenditures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i0b1686ddf30c477ba6a9d3f65800f533_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014062 - Disclosure - Segment Information - Assets and Revenues (Detail)",
     "role": "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail",
     "shortName": "Segment Information - Assets and Revenues (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ie0b3a62ee7424499b7a078665cc2f930_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044063 - Disclosure - Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail",
     "shortName": "Supplemental Balance Sheet Information - Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054064 - Disclosure - Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail",
     "shortName": "Supplemental Balance Sheet Information - Prepaid and Other Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:LandBuildingsAndImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064065 - Disclosure - Supplemental Balance Sheet Information - Property and Equipment (Detail)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail",
     "shortName": "Supplemental Balance Sheet Information - Property and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:LandBuildingsAndImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:PensionAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074066 - Disclosure - Supplemental Balance Sheet Information - Other Assets Non Current (Detail)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail",
     "shortName": "Supplemental Balance Sheet Information - Other Assets Non Current (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:PensionAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:OtherAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084067 - Disclosure - Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail",
     "shortName": "Supplemental Balance Sheet Information - Other Accrued Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:OtherAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210151003 - Disclosure - Business Combinations",
     "role": "http://catalent.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "iaa422029d99543199793d9ff01d7b6fa_I20210830",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241114069 - Disclosure - Subsequent Events (Details)",
     "role": "http://catalent.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "iaa422029d99543199793d9ff01d7b6fa_I20210830",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210211004 - Disclosure - Goodwill",
     "role": "http://catalent.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210241005 - Disclosure - Definite Lived Long-Lived Assets",
     "role": "http://catalent.com/role/DefiniteLivedLongLivedAssets",
     "shortName": "Definite Lived Long-Lived Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210291006 - Disclosure - Restructuring and Other Costs",
     "role": "http://catalent.com/role/RestructuringandOtherCosts",
     "shortName": "Restructuring and Other Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210321007 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381008 - Disclosure - Earnings Per Share",
     "role": "http://catalent.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421009 - Disclosure - Derivative Instruments and Hedging Activities",
     "role": "http://catalent.com/role/DerivativeInstrumentsandHedgingActivities",
     "shortName": "Derivative Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210451010 - Disclosure - Fair Value Measures and Disclosures",
     "role": "http://catalent.com/role/FairValueMeasuresandDisclosures",
     "shortName": "Fair Value Measures and Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210481011 - Disclosure - Income Taxes",
     "role": "http://catalent.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Statements of Operations",
     "role": "http://catalent.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210571012 - Disclosure - Employee Retirement Benefit Plans",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlans",
     "shortName": "Employee Retirement Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210671013 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)",
     "role": "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Equity and Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210751015 - Disclosure - Equity Based Compensation",
     "role": "http://catalent.com/role/EquityBasedCompensation",
     "shortName": "Equity Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801016 - Disclosure - Other Income / Expense",
     "role": "http://catalent.com/role/OtherIncomeExpense",
     "shortName": "Other Income / Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210831017 - Disclosure - Leases",
     "role": "http://catalent.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210891018 - Disclosure - Commitments and Contingencies",
     "role": "http://catalent.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210941019 - Disclosure - Segment Information",
     "role": "http://catalent.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211021020 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211101021 - Disclosure - Subsequent Events (Notes)",
     "role": "http://catalent.com/role/SubsequentEventsNotes",
     "shortName": "Subsequent Events (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income / (Loss)",
     "role": "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income / (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220092002 - Disclosure - Revenue from Contract with Customer (Policies)",
     "role": "http://catalent.com/role/RevenuefromContractwithCustomerPolicies",
     "shortName": "Revenue from Contract with Customer (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230103001 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://catalent.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230163002 - Disclosure - Business Combinations (Tables)",
     "role": "http://catalent.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230223003 - Disclosure - Goodwill (Tables)",
     "role": "http://catalent.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230253004 - Disclosure - Definite Lived Long-Lived Assets (Tables)",
     "role": "http://catalent.com/role/DefiniteLivedLongLivedAssetsTables",
     "shortName": "Definite Lived Long-Lived Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230303005 - Disclosure - Restructuring and Other Costs (Tables)",
     "role": "http://catalent.com/role/RestructuringandOtherCostsTables",
     "shortName": "Restructuring and Other Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230333006 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393007 - Disclosure - Earnings Per Share Calculation (Tables)",
     "role": "http://catalent.com/role/EarningsPerShareCalculationTables",
     "shortName": "Earnings Per Share Calculation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230433008 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "role": "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230463009 - Disclosure - Fair Value Measures and Disclosures (Tables)",
     "role": "http://catalent.com/role/FairValueMeasuresandDisclosuresTables",
     "shortName": "Fair Value Measures and Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Balance Sheets",
     "role": "http://catalent.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230493010 - Disclosure - Income Taxes (Tables)",
     "role": "http://catalent.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230583011 - Disclosure - Employee Retirement Benefit Plans (Tables)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansTables",
     "shortName": "Employee Retirement Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230683012 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) (Tables)",
     "role": "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Equity and Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230763014 - Disclosure - Equity Based Compensation (Tables)",
     "role": "http://catalent.com/role/EquityBasedCompensationTables",
     "shortName": "Equity Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813015 - Disclosure - Other Income / Expense (Tables)",
     "role": "http://catalent.com/role/OtherIncomeExpenseTables",
     "shortName": "Other Income / Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230843016 - Disclosure - Leases (Tables)",
     "role": "http://catalent.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230953018 - Disclosure - Segment Information (Tables)",
     "role": "http://catalent.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231033019 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://catalent.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i9d1f082bc83040aea156051c060c4587_D20200615-20200615",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240034001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "0",
      "lang": "en-US",
      "name": "ctlt:NumberofCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "customer",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054003 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details)",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Property and Equipment and Other Definite Lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064004 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details)",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Research and Development Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074005 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Recent Financial Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:SegmentReportingInformationInterSegmentRevenueElimination",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114006 - Disclosure - Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details)",
     "role": "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
     "shortName": "Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "iada4b587fca14301a3db1cee71bb807f_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:Eliminationofrevenueattributabletomultiplelocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124007 - Disclosure - Revenue Recognition Disaggregation of Revenue by Geography (Details)",
     "role": "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
     "shortName": "Revenue Recognition Disaggregation of Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:Eliminationofrevenueattributabletomultiplelocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134008 - Disclosure - Revenue Recognition Contractual Liabilities (Details)",
     "role": "http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails",
     "shortName": "Revenue Recognition Contractual Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:PrepaidExpenseAndOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetPurchase",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144009 - Disclosure - Revenue Recognition Contractual Assets (Details)",
     "role": "http://catalent.com/role/RevenueRecognitionContractualAssetsDetails",
     "shortName": "Revenue Recognition Contractual Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174010 - Disclosure - Business Combinations Purchase Agreement (Details)",
     "role": "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
     "shortName": "Business Combinations Purchase Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i4fb7193cbe7d43bca3a20da21b84f54d_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i1ea3ee19783347fcbcdad64f27aae413_I20200101",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184011 - Disclosure - Business Combinations Net Assets Acquired (Details)",
     "role": "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
     "shortName": "Business Combinations Net Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i1ea3ee19783347fcbcdad64f27aae413_I20200101",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ctlt:BusinessCombinationTransitionalServiceAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204013 - Disclosure - Business Combinations, Divestitures (Details)",
     "role": "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
     "shortName": "Business Combinations, Divestitures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i68464b9bc71941688262bd571d7a7c49_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i33e364a4c60a40d186dee61881303017_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234014 - Disclosure - Goodwill - Carrying Amount of Goodwill (Detail)",
     "role": "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
     "shortName": "Goodwill - Carrying Amount of Goodwill (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ib7738cb71ee1402fa2cb64c881b42e46_I20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i95c6836230814e07a0db1966aafcc2e7_I20180630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statement of Changes in Shareholder's Equity",
     "role": "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
     "shortName": "Consolidated Statement of Changes in Shareholder's Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i95c6836230814e07a0db1966aafcc2e7_I20180630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264015 - Disclosure - Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail)",
     "role": "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail",
     "shortName": "Definite Lived Long-Lived Assets - Other Intangible Assets Subject to Amortization (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274016 - Disclosure - Definite Lived Long-Lived Assets - Additional Information (Detail)",
     "role": "http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail",
     "shortName": "Definite Lived Long-Lived Assets - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284017 - Disclosure - Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)",
     "role": "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail",
     "shortName": "Definite Lived Long-Lived Assets - Future Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314018 - Disclosure - Restructuring and Other Costs (Details)",
     "role": "http://catalent.com/role/RestructuringandOtherCostsDetails",
     "shortName": "Restructuring and Other Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344019 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354020 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings- Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i324f9e1797a44fa5a5ee426673cb92c8_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364021 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Fair Value Measurements of Financial Instruments - Carrying Amounts and Estimated Fair Value of FInancial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i2e1619d8d97442d2b05880b4bab402aa_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "icad07736ec7541dcaa87a7b378aa1ebf_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374022 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details)",
     "role": "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Interest Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i0282c343e7634e19b53f822bfc4e477f_D20200701-20210630",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404023 - Disclosure - Earnings Per Share Calculations of Earnings Per Share (Details)",
     "role": "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails",
     "shortName": "Earnings Per Share Calculations of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i419473081c56497ab865784949c1efce_D20200701-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414024 - Disclosure - Earnings Per Share Earnings Per Share - Additional Details (Details)",
     "role": "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
     "shortName": "Earnings Per Share Earnings Per Share - Additional Details (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i419473081c56497ab865784949c1efce_D20200701-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i86567583f6c54f90bd46551acae65b63_I20180630",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock",
     "role": "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
     "shortName": "Consolidated Statement of Changes in Shareholder's Equity - Shares of Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i86567583f6c54f90bd46551acae65b63_I20180630",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444025 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "role": "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
     "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474026 - Disclosure - Fair Value Measures and Disclosures (Details)",
     "role": "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
     "shortName": "Fair Value Measures and Disclosures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504027 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514028 - Disclosure - Income Taxes Schedule of Income before Tax Domestic and Foreign (Details)",
     "role": "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails",
     "shortName": "Income Taxes Schedule of Income before Tax Domestic and Foreign (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524029 - Disclosure - Income Taxes-Components of Income Tax Expense (Details)",
     "role": "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
     "shortName": "Income Taxes-Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534030 - Disclosure - Income Taxes-Income Tax Reconciliation (Details)",
     "role": "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails",
     "shortName": "Income Taxes-Income Tax Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544031 - Disclosure - Income Taxes-Deferred Tax Assets (Details)",
     "role": "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails",
     "shortName": "Income Taxes-Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:DeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsDeferredIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554032 - Disclosure - Income Taxes-Balance Sheet (Details)",
     "role": "http://catalent.com/role/IncomeTaxesBalanceSheetDetails",
     "shortName": "Income Taxes-Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i33e364a4c60a40d186dee61881303017_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564033 - Disclosure - Income Taxes-Unrecognized Tax Benefits (Details)",
     "role": "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes-Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:MultiemployerPlansEstimatedAnnualCashContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594034 - Disclosure - Employee Retirement Benefit Plans-Additional Information (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
     "shortName": "Employee Retirement Benefit Plans-Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "ctlt:MultiemployerPlansEstimatedAnnualCashContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i33e364a4c60a40d186dee61881303017_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604035 - Disclosure - Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
     "shortName": "Employee Retirement Benefit Plans-Accumulated Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i33e364a4c60a40d186dee61881303017_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614036 - Disclosure - Employee Retirement Benefit Plans-Balance Sheet (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
     "shortName": "Employee Retirement Benefit Plans-Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624037 - Disclosure - Employee Retirement Benefit Plans-AOCI (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
     "shortName": "Employee Retirement Benefit Plans-AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i45a8aa065a6a4d85abde1cc2147fe900_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634038 - Disclosure - Employee Retirement Benefit Plans-Fiscal Year Maturity (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails",
     "shortName": "Employee Retirement Benefit Plans-Fiscal Year Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i4ec90f996dad4ae093ad7d6ab39d0ec3_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644039 - Disclosure - Employee Retirement Benefit Plans-Fair Value (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
     "shortName": "Employee Retirement Benefit Plans-Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "idc84ec4b5d724e5bb27a66a8b3b1c749_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i94de709fd06649489f2953db5ca5be8f_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654040 - Disclosure - Employee Retirement Benefit Plans-Level 3 (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details",
     "shortName": "Employee Retirement Benefit Plans-Level 3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i94de709fd06649489f2953db5ca5be8f_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i8e85d458dcaf42d481153310021f91c5_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664041 - Disclosure - Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details)",
     "role": "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
     "shortName": "Employee Retirement Benefit Plans-Assumed Healthcare Trend Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfHealthCareCostTrendRatesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i3b58bc5b3f9c4be98dfb87803c419d06_I20210630",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694042 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)",
     "role": "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails",
     "shortName": "Equity and Accumulated Other Comprehensive Income (Loss) Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "i9d1f082bc83040aea156051c060c4587_D20200615-20200615",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704043 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details)",
     "role": "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails",
     "shortName": "Equity and Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Earnings/(Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ib7738cb71ee1402fa2cb64c881b42e46_I20190630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714044 - Disclosure - Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details)",
     "role": "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails",
     "shortName": "Equity and Accumulated Other Comprehensive Income (Loss)-Minimum Pension Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ib7738cb71ee1402fa2cb64c881b42e46_I20190630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744045 - Disclosure - Equity (Details)",
     "role": "http://catalent.com/role/EquityDetails",
     "shortName": "Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774046 - Disclosure - Equity Based Compensation (Additional) (Details)",
     "role": "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
     "shortName": "Equity Based Compensation (Additional) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784047 - Disclosure - Equity Based Compensation (Option Activity) (Details)",
     "role": "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
     "shortName": "Equity Based Compensation (Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794048 - Disclosure - Equity Based Compensation (RSU Activity) (Details)",
     "role": "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
     "shortName": "Equity Based Compensation (RSU Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824049 - Disclosure - Other Income / Expense (Details)",
     "role": "http://catalent.com/role/OtherIncomeExpenseDetails",
     "shortName": "Other Income / Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854050 - Disclosure - Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details)",
     "role": "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails",
     "shortName": "Leases - Schedule of Operating and Finance Leases Presented in the Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ctlt:ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864051 - Disclosure - Leases - Cost (Details)",
     "role": "http://catalent.com/role/LeasesCostDetails",
     "shortName": "Leases - Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeasePrincipalPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874052 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information (Details)",
     "role": "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeasePrincipalPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884053 - Disclosure - Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)",
     "role": "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Schedule of Maturities of Operating And Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ctlt:ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ifc35871a5183468aaab7c718b6a42771_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964057 - Disclosure - Segment Information - Net Revenue and Segment Ebitda (Detail)",
     "role": "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
     "shortName": "Segment Information - Net Revenue and Segment Ebitda (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ctlt-20210630.htm",
      "contextRef": "ida593e8c48d442df8c3c2d0272608660_D20200701-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "ctlt:ImpairmentChargesAndGainLossOnSaleOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 102,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_A2375SeniorEuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.375% Senior Euro Denominated Notes",
        "label": "2.375% Senior Euro Denominated Notes [Member]",
        "terseLabel": "2.375% Senior Euro Denominated Notes [Member]"
       }
      }
     },
     "localname": "A2375SeniorEuroDenominatedNotesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_A3125SeniorUSDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Senior US Denominated Notes",
        "label": "3.125% Senior US Denominated Notes [Member]",
        "terseLabel": "3.125% Senior US Denominated Notes"
       }
      }
     },
     "localname": "A3125SeniorUSDenominatedNotesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ACOIAccumulatedGainLossMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ACOI, Accumulated Gain (Loss), Marketable Securities",
        "label": "ACOI, Accumulated Gain (Loss), Marketable Securities [Member]",
        "terseLabel": "ACOI, Accumulated Gain (Loss), Marketable Securities"
       }
      }
     },
     "localname": "ACOIAccumulatedGainLossMarketableSecuritiesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_AcceleratedAmortizationOfIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Amortization Of Intangible Assets",
        "label": "Accelerated Amortization Of Intangible Assets",
        "terseLabel": "Accelerated Amortization Of Intangible Assets"
       }
      }
     },
     "localname": "AcceleratedAmortizationOfIntangibleAssets",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AccruedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Operating Lease, Liabilities",
        "label": "Accrued Operating Lease, Liabilities",
        "terseLabel": "Accrued Operating Lease, Liabilities"
       }
      }
     },
     "localname": "AccruedOperatingLeaseLiabilities",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AccruedRestructuringReserve": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued restructuring reserve.",
        "label": "Accrued Restructuring Reserve",
        "terseLabel": "Restructuring accrual"
       }
      }
     },
     "localname": "AccruedRestructuringReserve",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AccumulatedDeferredCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Deferred Compensation [Member]",
        "label": "Accumulated Deferred Compensation [Member]",
        "terseLabel": "Accumulated Cash Flow Hedge [Member]"
       }
      }
     },
     "localname": "AccumulatedDeferredCompensationMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_AcordaTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acorda Therapeutics, Inc",
        "label": "Acorda Therapeutics, Inc [Member]",
        "terseLabel": "Acorda Therapeutics, Inc"
       }
      }
     },
     "localname": "AcordaTherapeuticsIncMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_AdditionalInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Information [Abstract]",
        "label": "Additional Information [Abstract]"
       }
      }
     },
     "localname": "AdditionalInformationAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for doubtful accounts receivable impact of foreign exchange.",
        "label": "Allowance For Doubtful Accounts Receivable, Impact Of Foreign Exchange",
        "terseLabel": "Impact of foreign exchange"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableImpactOfForeignExchange",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net",
        "label": "Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net",
        "negatedTerseLabel": "Allowance for Doubtful Accounts Receivable, Write-offs and Recoveries, net"
       }
      }
     },
     "localname": "AllowanceforDoubtfulAccountsReceivableWriteoffsandRecoveriesnet",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AmortizationAndWriteOffOfFinancingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization And Write Off Of Financing Costs",
        "label": "Amortization And Write Off Of Financing Costs",
        "terseLabel": "Amortization and write-off of debt financing costs"
       }
      }
     },
     "localname": "AmortizationAndWriteOffOfFinancingCosts",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_AnagniMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anagni",
        "label": "Anagni [Member]",
        "terseLabel": "Anagni [Member]"
       }
      }
     },
     "localname": "AnagniMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_BiologicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biologics [Member]",
        "label": "Biologics [Member]",
        "terseLabel": "Biologics [Member]"
       }
      }
     },
     "localname": "BiologicsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_BlowFillSealBusinessWoodstockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blow-Fill-Seal Business, Woodstock",
        "label": "Blow-Fill-Seal Business, Woodstock [Member]",
        "terseLabel": "Blow-Fill-Seal Business, Woodstock"
       }
      }
     },
     "localname": "BlowFillSealBusinessWoodstockMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_BoltonCSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bolton CS",
        "label": "Bolton CS [Member]",
        "terseLabel": "Bolton CS [Member]"
       }
      }
     },
     "localname": "BoltonCSMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_BuildingAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building And Improvements [Member]",
        "label": "Building And Improvements [Member]",
        "terseLabel": "Building And Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndImprovementsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_BusinessCombinationLoanDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Loan Discount",
        "label": "Business Combination, Loan Discount",
        "terseLabel": "Business Combination, Loan Discount"
       }
      }
     },
     "localname": "BusinessCombinationLoanDiscount",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_BusinessCombinationTransitionalServiceAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, transitional service agreement",
        "label": "Business Combination, transitional service agreement",
        "terseLabel": "Business Combination, Purchase Consideration"
       }
      }
     },
     "localname": "BusinessCombinationTransitionalServiceAgreement",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_BusinessCombinationWorkingCapitalAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Working Capital Adjustments",
        "label": "Business Combination, Working Capital Adjustments",
        "terseLabel": "Business Combination, Working Capital Adjustments"
       }
      }
     },
     "localname": "BusinessCombinationWorkingCapitalAdjustments",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_CashAndNoncashDivestitureAmountOfConsiderationReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Noncash Divestiture, Amount of Consideration Received",
        "label": "Cash and Noncash Divestiture, Amount of Consideration Received",
        "terseLabel": "Cash and Noncash Divestiture, Amount of Consideration Received"
       }
      }
     },
     "localname": "CashAndNoncashDivestitureAmountOfConsiderationReceived",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_CashPaidToSettleInterestRateSwapAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid to Settle, Interest Rate Swap Agreement",
        "label": "Cash Paid to Settle, Interest Rate Swap Agreement",
        "terseLabel": "Cash Paid to Settle, Interest Rate Swap Agreement"
       }
      }
     },
     "localname": "CashPaidToSettleInterestRateSwapAgreement",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ClinicalSupplyServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Supply Services [Member]",
        "label": "Clinical Supply Services [Member]",
        "terseLabel": "Clinical Supply Services [Member]"
       }
      }
     },
     "localname": "ClinicalSupplyServicesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ConcentrationRiskNumberofCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration Risk, Number of Customers",
        "label": "Concentration Risk, Number of Customers",
        "terseLabel": "Concentration Risk, Number of Customers"
       }
      }
     },
     "localname": "ConcentrationRiskNumberofCustomers",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ctlt_ConcentrationsofCreditRiskandMajorCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentrations of Credit Risk and Major Customers [Abstract]",
        "label": "Concentrations of Credit Risk and Major Customers [Abstract]"
       }
      }
     },
     "localname": "ConcentrationsofCreditRiskandMajorCustomersAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_ContractualLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Contractual Liabilities [Table]",
        "label": "Contractual Liabilities [Table Text Block]",
        "terseLabel": "Contractual Liabilities"
       }
      }
     },
     "localname": "ContractualLiabilitiesTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_CoreTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core technology.",
        "label": "Core Technology [Member]",
        "terseLabel": "Core technology [Member]"
       }
      }
     },
     "localname": "CoreTechnologyMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate and eliminations.",
        "label": "Corporate And Eliminations [Member]",
        "terseLabel": "Corporate and Eliminations [Member]"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DebtInstrumentQuarterlyAmortizationRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Quarterly Amortization Rate",
        "label": "Debt Instrument Quarterly Amortization Rate",
        "terseLabel": "Debt Instrument Quarterly Amortization Rate"
       }
      }
     },
     "localname": "DebtInstrumentQuarterlyAmortizationRate",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ctlt_DebtIssuanceCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Issuance Costs",
        "label": "Debt Issuance Costs [Member]",
        "terseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DebtIssuanceCostsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DebtRefinancingCostsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Refinancing Costs [Axis]",
        "label": "Debt Refinancing Costs [Axis]",
        "terseLabel": "Debt Refinancing Costs [Axis]"
       }
      }
     },
     "localname": "DebtRefinancingCostsAxis",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_DebtRefinancingCostsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Debt Refinancing Costs [Axis]",
        "label": "Debt Refinancing Costs [Domain]",
        "terseLabel": "Debt Refinancing Costs [Domain]"
       }
      }
     },
     "localname": "DebtRefinancingCostsDomain",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DeferredIncomeTaxOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax, Operating Lease, Liabilities",
        "label": "Deferred Income Tax, Operating Lease, Liabilities",
        "terseLabel": "Deferred Income Tax, Operating Lease, Liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxOperatingLeaseLiabilities",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_DeferredIncomeTaxRightOfUse": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax, Right-of-Use",
        "label": "Deferred Income Tax, Right-of-Use",
        "terseLabel": "Deferred Income Tax, Right-of-Use Asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxRightOfUse",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_DeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets and liabilities.",
        "label": "Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Deferred tax assets and liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_DefinedBenefitPlanActualPlanAssetsAllocationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Actual Plan Assets Allocation, Amount",
        "label": "Defined Benefit Plan, Actual Plan Assets Allocation, Amount",
        "terseLabel": "Actual Asset Allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualPlanAssetsAllocationAmount",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_DefinedBenefitPlanOtherAssetsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Other Assets",
        "label": "Defined Benefit Plan, Other Assets [Axis]",
        "terseLabel": "Defined Benefit Plan, Other Assets [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherAssetsAxis",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_DefinedBenefitPlanOtherAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Other Assets",
        "label": "Defined Benefit Plan, Other Assets [Domain]",
        "terseLabel": "Defined Benefit Plan, Other Assets [Domain]"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherAssetsDomain",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DelphiGeneticsSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delphi Genetics SA",
        "label": "Delphi Genetics SA [Member]",
        "terseLabel": "Delphi Genetics SA"
       }
      }
     },
     "localname": "DelphiGeneticsSAMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DesignatedSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated shares",
        "label": "Designated shares [Member]",
        "terseLabel": "Designated shares [Member]"
       }
      }
     },
     "localname": "DesignatedSharesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DevelopmentServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Services [Member]",
        "label": "Development Services [Member]",
        "terseLabel": "Development Services [Member]"
       }
      }
     },
     "localname": "DevelopmentServicesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_DocumentDocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document Document and Entity Information [Abstract]",
        "label": "Document Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentDocumentAndEntityInformationAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_EberbachPensionPromissoryNoteOrLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eberbach Pension Promissory Note or Loan [Member]",
        "label": "Eberbach Pension Promissory Note or Loan [Member]",
        "terseLabel": "Eberbach Pension Promissory Note or Loan [Member]"
       }
      }
     },
     "localname": "EberbachPensionPromissoryNoteOrLoanMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the income earned by foreign affiliates of US companies from intangible assets such as patents, trademarks, and copyrights",
        "label": "Effective Income Tax Rate Reconciliation, Global intangible low tax income",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Global intangible low tax income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncome",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_Eliminationofrevenueattributabletomultiplelocations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Elimination of revenue attributable to multiple locations",
        "label": "Elimination of revenue attributable to multiple locations",
        "terseLabel": "Elimination of revenue attributable to multiple locations"
       }
      }
     },
     "localname": "Eliminationofrevenueattributabletomultiplelocations",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Embedded Derivative, Estimate of Embedded Derivative Liability",
        "label": "Embedded Derivative, Estimate of Embedded Derivative Liability",
        "terseLabel": "Embedded Derivative, Estimate of Embedded Derivative Liability"
       }
      }
     },
     "localname": "EmbeddedDerivativeEstimateOfEmbeddedDerivativeLiability",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_EmployeeStockOptionsandRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Options and RSUs [Member]",
        "label": "Employee Stock Options and RSUs [Member]",
        "terseLabel": "Employee Stock Options and RSUs [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionsandRSUsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_EquityIssuedInLieuOfCashConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity issued in lieu of cash consideration",
        "label": "Equity issued in lieu of cash consideration",
        "negatedTerseLabel": "Equity issued in lieu of cash consideration"
       }
      }
     },
     "localname": "EquityIssuedInLieuOfCashConsideration",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ExcludingSharesGrantedInConsiderationForAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excluding shares granted in consideration for acquisition",
        "label": "Excluding shares granted in consideration for acquisition [Member]",
        "terseLabel": "Excluding shares granted in consideration for acquisition [Member]"
       }
      }
     },
     "localname": "ExcludingSharesGrantedInConsiderationForAcquisitionMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement With Unobservable Inputs Reconcilation, Recurring Basis, Assets Held at Reporting Date",
        "label": "Fair Value Measurement With Unobservable Inputs Reconcilation, Recurring Basis, Assets Held at Reporting Date",
        "terseLabel": "Relating to assets still held at the reporting date"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconcilationRecurringBasisAssetsHeldatReportingDate",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_FairValueMeasurementsOfFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurements Of Financial Instruments [Line Items]",
        "label": "Fair Value Measurements Of Financial Instruments [Line Items]",
        "terseLabel": "Fair Value Measurements Of Financial Instruments [Line Items]"
       }
      }
     },
     "localname": "FairValueMeasurementsOfFinancialInstrumentsLineItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_FairValueMeasurementsOfFinancialInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurements Of Financial Instruments [Table]",
        "label": "Fair Value Measurements Of Financial Instruments [Table]",
        "terseLabel": "Fair Value Measurements Of Financial Instruments [Table]"
       }
      }
     },
     "localname": "FairValueMeasurementsOfFinancialInstrumentsTable",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_FinanceLeaseExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Expense",
        "label": "Finance Lease Expense",
        "terseLabel": "Finance Lease Expense"
       }
      }
     },
     "localname": "FinanceLeaseExpense",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_FinitelivedintangibleassetsdisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite lived intangible assets disclosure [Abstract]",
        "label": "Finite lived intangible assets disclosure [Abstract]"
       }
      }
     },
     "localname": "FinitelivedintangibleassetsdisclosureAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_ForeignNetOperatingLossEstablishedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign, Net Operating Loss Established",
        "label": "Foreign, Net Operating Loss Established [Member]",
        "terseLabel": "Foreign, Net Operating Loss Established [Member]"
       }
      }
     },
     "localname": "ForeignNetOperatingLossEstablishedMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ForeignNetOperatingLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign, Net Operating Loss",
        "label": "Foreign, Net Operating Loss [Member]",
        "terseLabel": "Foreign, Net Operating Loss [Member]"
       }
      }
     },
     "localname": "ForeignNetOperatingLossMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_FourPointSevenFivePercentSeniorEuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Five Percent Senior Euro Denominated Notes [Member]",
        "label": "Four Point Seven Five Percent Senior Euro Denominated Notes [Member]",
        "terseLabel": "Four Point Seven Five Percent Senior Euro Denominated Notes [Member]"
       }
      }
     },
     "localname": "FourPointSevenFivePercentSeniorEuroDenominatedNotesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_HepaticCellTherapySupportSA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hepatic Cell Therapy Support SA",
        "label": "Hepatic Cell Therapy Support SA",
        "terseLabel": "Hepatic Cell Therapy Support SA"
       }
      }
     },
     "localname": "HepaticCellTherapySupportSA",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ImpairmentChargesAndGainLossOnSaleOfAssets": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 1.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment charges and (gain)/loss on sale of assets.",
        "label": "Impairment Charges And Gain Loss On Sale Of Assets",
        "negatedLabel": "Impairment charges and gain/(loss) on sale of assets"
       }
      }
     },
     "localname": "ImpairmentChargesAndGainLossOnSaleOfAssets",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_InstallmentPaymentForAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment Payment for Acquisition",
        "label": "Installment Payment for Acquisition",
        "terseLabel": "Installment Payment for Acquisition, Next Twelve Months"
       }
      }
     },
     "localname": "InstallmentPaymentForAcquisition",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_InstallmentPaymentforAcquisitionYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment Payment for Acquisition, Year Four",
        "label": "Installment Payment for Acquisition, Year Four",
        "terseLabel": "Installment Payment for Acquisition, Year Four"
       }
      }
     },
     "localname": "InstallmentPaymentforAcquisitionYearFour",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_InstallmentPaymentforAcquisitionYearThree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment Payment for Acquisition, Year Three",
        "label": "Installment Payment for Acquisition, Year Three",
        "terseLabel": "Installment Payment for Acquisition, Year Three"
       }
      }
     },
     "localname": "InstallmentPaymentforAcquisitionYearThree",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_InstallmentPaymentforAcquisitionYearTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Installment Payment for Acquisition, Year Two",
        "label": "Installment Payment for Acquisition, Year Two",
        "terseLabel": "Installment Payment for Acquisition, Year Two"
       }
      }
     },
     "localname": "InstallmentPaymentforAcquisitionYearTwo",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_InsuranceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Contracts [Member]",
        "label": "Insurance Contracts [Member]",
        "terseLabel": "Insurance Contracts [Member]"
       }
      }
     },
     "localname": "InsuranceContractsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_InternationalOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Other [Member]",
        "label": "International Other [Member]",
        "terseLabel": "International Other"
       }
      }
     },
     "localname": "InternationalOtherMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_KyotoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyoto",
        "label": "Kyoto [Member]",
        "terseLabel": "Kyoto"
       }
      }
     },
     "localname": "KyotoMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_LandBuildingsAndImprovements": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land, buildings and improvements.",
        "label": "Land Buildings And Improvements",
        "terseLabel": "Land, buildings, and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovements",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_LongTermAndShortTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term and Short-term Debt [Abstract]",
        "label": "Long-term and Short-term Debt [Abstract]"
       }
      }
     },
     "localname": "LongTermAndShortTermDebtAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_MaSTherCellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MaSTherCell",
        "label": "MaSTherCell [Member]",
        "terseLabel": "MaSTherCell [Member]"
       }
      }
     },
     "localname": "MaSTherCellMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ManufacturingCommercialProductSupplyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing &amp; Commercial Product Supply [Member]",
        "label": "Manufacturing &amp; Commercial Product Supply [Member]",
        "terseLabel": "Manufacturing &amp; Commercial Product Supply [Member]"
       }
      }
     },
     "localname": "ManufacturingCommercialProductSupplyMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_MarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market.",
        "label": "Market [Member]",
        "terseLabel": "Market [Member]"
       }
      }
     },
     "localname": "MarketMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_MaximumPercentageOfVotingStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of voting stock.",
        "label": "Maximum Percentage Of Voting Stock",
        "terseLabel": "Maximum Percentage Of Voting Stock from non US subsidiary"
       }
      }
     },
     "localname": "MaximumPercentageOfVotingStock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ctlt_MultiemployerPlansEstimatedAnnualCashContribution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multiemployer Plans, Estimated Annual Cash Contribution",
        "label": "Multiemployer Plans, Estimated Annual Cash Contribution",
        "terseLabel": "Multiemployer Plans, Estimated Annual Cash Contribution"
       }
      }
     },
     "localname": "MultiemployerPlansEstimatedAnnualCashContribution",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_NetAssetsAcquiredLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Assets Acquired",
        "label": "Net Assets Acquired [Line Items]",
        "terseLabel": "Net Assets Acquired from Business Combinations"
       }
      }
     },
     "localname": "NetAssetsAcquiredLineItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues",
        "label": "Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues",
        "terseLabel": "Net Proceeds used to Repay Debt, Stock Issued During Period, New Issues"
       }
      }
     },
     "localname": "NetProceedsUsedToRepayDebtStockIssuedDuringPeriodNewIssues",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_NonAllocatedCorporateCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 6.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-allocated corporate costs, net.",
        "label": "Non Allocated Corporate Costs Net",
        "negatedTerseLabel": "Non-allocated corporate costs, net"
       }
      }
     },
     "localname": "NonAllocatedCorporateCostsNet",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_NumberofCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Customers",
        "label": "Number of Customers",
        "terseLabel": "Number of Customers"
       }
      }
     },
     "localname": "NumberofCustomers",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "ctlt_NumberofDoses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Doses",
        "label": "Number of Doses",
        "terseLabel": "Number of Doses"
       }
      }
     },
     "localname": "NumberofDoses",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "ctlt_OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax",
        "label": "OCI, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Other Comprehensive Income, Debt Securities, Derivative and Hedge, Gain (Loss), after Adjustment and Tax"
       }
      }
     },
     "localname": "OCIDebtSecuritiesDerivativeAndHedgeGainLossAfterAdjustmentAndTax",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OperatingLossCarryforwardsCarryForwardPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Carry Forward Period",
        "label": "Operating Loss Carryforwards, Carry Forward Period",
        "terseLabel": "Operating Loss Carryforwards, Carry Forward Period"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsCarryForwardPeriod",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "ctlt_OperatingLossCarryforwardsIndefiniteLife": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Indefinite Life",
        "label": "Operating Loss Carryforwards, Indefinite Life",
        "terseLabel": "Operating Loss Carryforwards, Indefinite Life"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsIndefiniteLife",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OperatingLossCarryforwardsSubjectToLimitationsSection382": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject to Limitations, Section 382",
        "label": "Operating Loss Carryforwards, Subject to Limitations, Section 382",
        "terseLabel": "Operating Loss Carryforwards, Subject to Limitations, Section 382"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToLimitationsSection382",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OralAndSpecialtyDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral and Specialty Delivery [Member]",
        "label": "Oral and Specialty Delivery [Member]",
        "terseLabel": "Oral and Specialty Drug Delivery [Member]"
       }
      }
     },
     "localname": "OralAndSpecialtyDeliveryMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_OralDrugDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Drug Delivery [Member]",
        "label": "Oral Drug Delivery [Member]",
        "terseLabel": "Oral Drug Delivery"
       }
      }
     },
     "localname": "OralDrugDeliveryMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_OtherAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accrued liabilities.",
        "label": "Other Accrued Liabilities Table [Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Derivative and Hedge, after Reclassification Adjustment, Tax",
        "label": "Other Comprehensive (Income) Loss, Derivative and Hedge, after Reclassification Adjustment, Tax",
        "terseLabel": "Derivative and Hedge, (Income) Loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeAndHedgeAfterReclassificationAdjustmentTax",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Derivative and Hedge, Gain (Loss) Arising During Period, before Tax",
        "label": "Other Comprehensive Income (Loss), Derivative and Hedge, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Net Derivative and Hedge (gain)/loss arising during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeAndHedgeGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Derivative and Hedge,Total, before Tax",
        "label": "Other Comprehensive Income (Loss), Derivative and Hedge,Total, before Tax",
        "terseLabel": "Derivative and Hedge,Total, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeAndHedgeTotalBeforeTax",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During the Year, before Tax",
        "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit) Arising During the Year, before Tax",
        "negatedTerseLabel": "Prior service cost (credit) during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostCreditArisingDuringYearBeforeTax",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_OtherObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Obligations [Member]",
        "label": "Other Obligations [Member]",
        "terseLabel": "Other Obligations [Member]"
       }
      }
     },
     "localname": "OtherObligationsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_OtherUnobservableAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Unobservable Assets [Member]",
        "label": "Other Unobservable Assets [Member]",
        "terseLabel": "Other Unobservable Assets [Member]"
       }
      }
     },
     "localname": "OtherUnobservableAssetsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ParagonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paragon",
        "label": "Paragon [Member]",
        "terseLabel": "Paragon [Member]"
       }
      }
     },
     "localname": "ParagonMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_PensionAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension Asset",
        "label": "Pension Asset",
        "terseLabel": "Pension Asset"
       }
      }
     },
     "localname": "PensionAsset",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_PerformanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance.",
        "label": "Performance [Member]",
        "terseLabel": "Performance [Member]"
       }
      }
     },
     "localname": "PerformanceMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_PledgePercentageOfCapitalStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledge percentage of capital stock.",
        "label": "Pledge Percentage Of Capital Stock",
        "terseLabel": "Pledge Percentage Of Capital Stock"
       }
      }
     },
     "localname": "PledgePercentageOfCapitalStock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ctlt_PledgePercentageOfEquityInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledge percentage of equity interest.",
        "label": "Pledge Percentage Of Equity Interest",
        "terseLabel": "Pledge Percentage Of Equity Interest"
       }
      }
     },
     "localname": "PledgePercentageOfEquityInterest",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ctlt_Post65Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post 65 [Member]",
        "label": "Post 65 [Member]",
        "terseLabel": "Post 65 [Member]"
       }
      }
     },
     "localname": "Post65Member",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_PostretirementBenefitsByAgeGroupAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Postretirement Benefits, by Age Group [Axis]",
        "label": "Postretirement Benefits, by Age Group [Axis]",
        "terseLabel": "Postretirement Benefits, by Age Group [Axis]"
       }
      }
     },
     "localname": "PostretirementBenefitsByAgeGroupAxis",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_PostretirementBenefitsByAgeGroupDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Postretirement Benefits, by Age Group [Axis]",
        "label": "Postretirement Benefits, by Age Group [Domain]",
        "terseLabel": "Postretirement Benefits, by Age Group [Domain]"
       }
      }
     },
     "localname": "PostretirementBenefitsByAgeGroupDomain",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_PreferredStockIssuanceValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Issuance Value",
        "label": "Preferred Stock, Issuance Value",
        "terseLabel": "Preferred Stock, Issuance Value"
       }
      }
     },
     "localname": "PreferredStockIssuanceValue",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_PreferredStockIssuanceValueNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Issuance Value, Net",
        "label": "Preferred Stock, Issuance Value, Net",
        "terseLabel": "Preferred Stock, Issuance Value, Net"
       }
      }
     },
     "localname": "PreferredStockIssuanceValueNet",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_PrepaidExpenseAndOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expense and other assets.",
        "label": "Prepaid Expense And Other Assets Table [Text Block]",
        "terseLabel": "Prepaid and Other Assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ProFormaResultsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Results [Abstract]",
        "label": "Pro Forma Results [Abstract]"
       }
      }
     },
     "localname": "ProFormaResultsAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_ProceedsFromDivestitureOfBusinessesNetCashProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Divestiture Of Businesses, Net Cash Proceeds",
        "label": "Proceeds From Divestiture Of Businesses, Net Cash Proceeds",
        "terseLabel": "Proceeds From Divestiture Of Businesses, Net Cash Proceeds"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetCashProceeds",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ProductRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product relationships.",
        "label": "Product Relationships [Member]",
        "terseLabel": "Product relationships [Member]"
       }
      }
     },
     "localname": "ProductRelationshipsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ProductRightsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Rights [Line Items]",
        "label": "Product Rights [Line Items]",
        "terseLabel": "Intangibles [Line Items]"
       }
      }
     },
     "localname": "ProductRightsLineItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_PropertyandEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and Equipment [Abstract]",
        "label": "Property and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyandEquipmentAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_ProvisionForBadDebtsAndInventory": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for bad debts and inventory.",
        "label": "Provision For Bad Debts And Inventory",
        "terseLabel": "Provision for bad debts and inventory"
       }
      }
     },
     "localname": "ProvisionForBadDebtsAndInventory",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_RTSRPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RTSR Performance Share Units [Member]",
        "label": "RTSR Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RTSRPerformanceShareUnitsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_RecentFinancialAccountingStandardsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recent Financial Accounting Standards",
        "label": "Recent Financial Accounting Standards [Abstract]"
       }
      }
     },
     "localname": "RecentFinancialAccountingStandardsAbstract",
     "nsuri": "http://catalent.com/20210630",
     "xbrltype": "stringItemType"
    },
    "ctlt_RedeemablePreferredStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Preferred Stock",
        "label": "Redeemable Preferred Stock [Line Items]",
        "terseLabel": "Redeemable Preferred Stock [Line Items]"
       }
      }
     },
     "localname": "RedeemablePreferredStockLineItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Representation Of Depreciation And Amortization Expense And Capital Expenditure In Consolidated Financial Statements.",
        "label": "Representation Of Depreciation And Amortization Expense And Capital Expenditure In Consolidated Financial Statements Table [Text Block]",
        "terseLabel": "Representation of depreciation and amortization expense and capital expenditure by segment"
       }
      }
     },
     "localname": "RepresentationOfDepreciationAndAmortizationExpenseAndCapitalExpenditureInConsolidatedFinancialStatementsTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "International Other [Member]"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_RestructuringAndOtherSpecialItems": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 3.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and other special items.",
        "label": "Restructuring And Other Special Items",
        "negatedTerseLabel": "Restructuring and other special items"
       }
      }
     },
     "localname": "RestructuringAndOtherSpecialItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_RevolvingCreditCommitmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Commitments",
        "label": "Revolving Credit Commitments [Member]",
        "terseLabel": "Revolving Credit Commitments [Member]"
       }
      }
     },
     "localname": "RevolvingCreditCommitmentsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_RevolvingCreditFacilityTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility Two [Member]",
        "label": "Revolving Credit Facility - Two [Member]",
        "terseLabel": "Revolving Credit Facility - Two [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityTwoMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of carrying and fair value of financial instruments.",
        "label": "Schedule Of Carrying And Fair Value Of Financial Instruments Table [Table Text Block]",
        "terseLabel": "Schedule Of Carrying And Fair Value Of Financial Instruments Table"
       }
      }
     },
     "localname": "ScheduleOfCarryingAndFairValueOfFinancialInstrumentsTableTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ScheduleOfDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Debt [Line Items]",
        "label": "Schedule Of Debt [Line Items]",
        "terseLabel": "Schedule Of Debt [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfDebtLineItems",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_ScheduleOfDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Debt [Table]",
        "label": "Schedule Of Debt [Table]",
        "terseLabel": "Schedule Of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfDebtTable",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Maturities of Lease Liabilities",
        "label": "Schedule of Maturities of Lease Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLeaseLiabilitiesTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Operating and Financing Leases Presented in Balance Sheet",
        "label": "Schedule of Operating and Financing Leases Presented in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Operating and Financing Leases Presented in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfOperatingAndFinancingLeasesPresentedInBalanceSheetTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ScheduleOfRedeemablePreferredStockTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Redeemable Preferred Stock",
        "label": "Schedule of Redeemable Preferred Stock [Table]",
        "terseLabel": "Schedule of Redeemable Preferred Stock [Table]"
       }
      }
     },
     "localname": "ScheduleOfRedeemablePreferredStockTable",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ctlt_ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue and long-lived assets by geographic area.",
        "label": "Schedule Of Revenue And Long Lived Assets By Geographic Area Table [Text Block]",
        "terseLabel": "Presentation of revenue and long-lived assets by geographic area"
       }
      }
     },
     "localname": "ScheduleOfRevenueAndLongLivedAssetsByGeographicAreaTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Segment Reporting Information, Capital Expenditures by Segment [Table Text Block]",
        "label": "Schedule of Segment Reporting Information, Capital Expenditures by Segment [Table Text Block]",
        "terseLabel": "Capital Expenditures by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationCapitalExpendituresBySegmentTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]",
        "label": "Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedge in Accumulated Other Comprehensive Income (Loss) and Statement of Financial Performance [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofNetInvestmentHedgeinAccumulatedOtherComprehensiveIncomeLossandStatementofFinancialPerformanceTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment reporting information earning before interest tax depreciation and amortization.",
        "label": "Segment Reporting Information Earning Before Interest Tax Depreciation And Amortization",
        "terseLabel": "Segment EBITDA",
        "verboseLabel": "EBITDA from continuing operations"
       }
      }
     },
     "localname": "SegmentReportingInformationEarningBeforeInterestTaxDepreciationAndAmortization",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_SegmentReportingInformationInterSegmentRevenueElimination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment reporting information inter segment revenue elimination.",
        "label": "Segment Reporting Information Inter Segment Revenue Elimination",
        "terseLabel": "Inter-segment revenue elimination"
       }
      }
     },
     "localname": "SegmentReportingInformationInterSegmentRevenueElimination",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment reporting information net revenue and EBITDA.",
        "label": "Segment Reporting Information Net Revenue And Ebitda Table [Text Block]",
        "terseLabel": "Net Revenue and Segment EBITDA"
       }
      }
     },
     "localname": "SegmentReportingInformationNetRevenueAndEbitdaTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_SegmentReportingInformationUnallocatedExpense": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Information Unallocated Expense",
        "label": "Segment Reporting Information Unallocated Expense",
        "negatedTotalLabel": "Total unallocated costs",
        "terseLabel": "Total unallocated costs"
       }
      }
     },
     "localname": "SegmentReportingInformationUnallocatedExpense",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_SeniorSecuredCreditFacilitiesOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Credit Facilities &amp; Other [Member]",
        "label": "Senior Secured Credit Facilities &amp; Other [Member]",
        "terseLabel": "Senior Secured Credit Facilities &amp; Other [Member]"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesOtherMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SeniorSecuredCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Credit Facility [Member]",
        "label": "Senior Secured Credit Facility [Member]",
        "terseLabel": "Senior Secured Credit Facility [Member]"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilityMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SeniorUnsecuredTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Term Loan Facility [Member]",
        "label": "Senior Unsecured Term Loan Facility [Member]",
        "terseLabel": "Senior Unsecured Term Loan Facility [Member]"
       }
      }
     },
     "localname": "SeniorUnsecuredTermLoanFacilityMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SeriesAPreferredStockDerivativeLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Preferred Stock derivative liability",
        "label": "Series A Preferred Stock derivative liability",
        "terseLabel": "Series A Preferred Stock derivative liability"
       }
      }
     },
     "localname": "SeriesAPreferredStockDerivativeLiability",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated amount of dividends per share to be paid to holders of the underlying shares (expected dividends per share) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share",
        "terseLabel": "Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions, Expected Dividend Payments, Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPaymentsPerShare",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ctlt_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)",
        "terseLabel": "Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Expected to Vest Exercisable Exercised Weighted Average Remaining Contractual Term (duration)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsVestedandExpectedtoVestExercisableExercisedWeightedAverageRemainingContractualTermduration",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ctlt_ShortTermLeaseCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term Lease Costs",
        "label": "Short-Term Lease Costs",
        "terseLabel": "Short-Term Lease Costs"
       }
      }
     },
     "localname": "ShortTermLeaseCosts",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_SkeletalCellTherapySupportSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal Cell Therapy Support SA",
        "label": "Skeletal Cell Therapy Support SA [Member]",
        "terseLabel": "Skeletal Cell Therapy Support SA"
       }
      }
     },
     "localname": "SkeletalCellTherapySupportSAMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SoftgelAndOralTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Softgel and Oral Technologies [Member]",
        "label": "Softgel and Oral Technologies [Member]",
        "terseLabel": "Softgel and Oral Technologies [Member]"
       }
      }
     },
     "localname": "SoftgelAndOralTechnologiesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SoftgelTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Softgel [Member]",
        "label": "Softgel Technologies [Member]",
        "terseLabel": "Softgel Technologies"
       }
      }
     },
     "localname": "SoftgelTechnologiesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_SpareParts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spare parts.",
        "label": "Spare Parts",
        "terseLabel": "Spare Parts"
       }
      }
     },
     "localname": "SpareParts",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_StcokIssuedDuringPeriodSharesOverAllotmentOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stcok Issued During Period, Shares, Over-allotment Option",
        "label": "Stcok Issued During Period, Shares, Over-allotment Option",
        "terseLabel": "Stcok Issued During Period, Shares, Over-allotment Option"
       }
      }
     },
     "localname": "StcokIssuedDuringPeriodSharesOverAllotmentOption",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ctlt_StockCompensationPlanOmnibusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Compensation Plan - Omnibus [Member]",
        "label": "Stock Compensation Plan - Omnibus [Member]",
        "terseLabel": "Stock Compensation Plan - Omnibus [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanOmnibusMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_StockIssuedDuringPeriodValueOverAllotmentOption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Over-allotment Option",
        "label": "Stock Issued During Period, Value, Over-allotment Option",
        "terseLabel": "Stock Issued During Period, Value, Over-allotment Option"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOverAllotmentOption",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_StockOptionGrantedContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock option granted contractual term.",
        "label": "Stock Option Granted Contractual Term",
        "terseLabel": "Stock Option Granted Contractual Term"
       }
      }
     },
     "localname": "StockOptionGrantedContractualTerm",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ctlt_SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of plan assets that are measured in fair value.",
        "label": "Summary Of Plan Assets Measured In Fair Value Table [Text Block]",
        "terseLabel": "Summary of plan assets that are measured in fair value"
       }
      }
     },
     "localname": "SummaryOfPlanAssetsMeasuredInFairValueTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_TaxCutsandJobsActTaxEffect": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Cuts and Jobs Act, Tax Effect",
        "label": "Tax Cuts and Jobs Act, Tax Effect",
        "negatedTerseLabel": "Tax Cuts and Jobs Act, Tax Effect"
       }
      }
     },
     "localname": "TaxCutsandJobsActTaxEffect",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TermLoanFacilityIncrementalDollarTermB2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility Incremental Dollar Term B-2",
        "label": "Term Loan Facility Incremental Dollar Term B-2 [Member]",
        "terseLabel": "Term Loan Facility Incremental Dollar Term B-2 [Member]"
       }
      }
     },
     "localname": "TermLoanFacilityIncrementalDollarTermB2Member",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TermLoanThreeFacilityDollarDenominatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Three Facility Dollar Denominated [Member]",
        "label": "Term Loan Three Facility Dollar Denominated [Member]",
        "terseLabel": "Term Loan Three Facility Dollar Denominated [Member]"
       }
      }
     },
     "localname": "TermLoanThreeFacilityDollarDenominatedMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TermLoanTwoFacilityDollarDenominatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Two Facility Dollar Denominated",
        "label": "Term Loan Two Facility Dollar Denominated [Member]",
        "terseLabel": "Term Loan Two Facility Dollar Denominated [Member]"
       }
      }
     },
     "localname": "TermLoanTwoFacilityDollarDenominatedMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TimeBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time Based Restricted Stock Units [Member]",
        "label": "Time Based Restricted Stock Units [Member]",
        "terseLabel": "Time Based Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "TimeBasedRestrictedStockUnitsMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time.",
        "label": "Time [Member]",
        "terseLabel": "Time [Member]"
       }
      }
     },
     "localname": "TimeMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TotalCatalentSubTotalOfSegmentReportingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Catalent sub-total of Segment Reporting",
        "label": "Total Catalent sub-total of Segment Reporting [Member]",
        "terseLabel": "Total Catalent sub-total of Segment Reporting [Member]"
       }
      }
     },
     "localname": "TotalCatalentSubTotalOfSegmentReportingMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TotalCatalentbeforeintersegmentrevenueeliminationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Catalent before inter-segment revenue elimination [Member]",
        "label": "Total Catalent before inter-segment revenue elimination [Member]",
        "terseLabel": "Total Catalent before inter-segment revenue elimination [Member]"
       }
      }
     },
     "localname": "TotalCatalentbeforeintersegmentrevenueeliminationMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_TotalDebtUSDenominatedTermLoan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Debt, U.S Denominated Term Loan",
        "label": "Total Debt, U.S Denominated Term Loan",
        "terseLabel": "Total Debt, U.S Denominated Term Loan"
       }
      }
     },
     "localname": "TotalDebtUSDenominatedTermLoan",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalFixedRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Fixed Rate",
        "label": "Total Fixed Rate",
        "terseLabel": "Total Fixed Rate"
       }
      }
     },
     "localname": "TotalFixedRate",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "ctlt_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total Lease Liability"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total Lease Liability Payments Due"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due After Year Five",
        "label": "Total Lease Liability Payments Due After Year Five",
        "terseLabel": "Total Lease Liability Payments Due After Year Five"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due Year Five",
        "label": "Total Lease Liability Payments Due Year Five",
        "terseLabel": "Total Lease Liability Payments Due Year Five"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due Year Four",
        "label": "Total Lease Liability Payments Due Year Four",
        "terseLabel": "Total Lease Liability Payments Due Year Four"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due Year One",
        "label": "Total Lease Liability Payments Due Year One",
        "terseLabel": "Total Lease Liability Payments Due Year One"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due Year Three",
        "label": "Total Lease Liability Payments Due Year Three",
        "terseLabel": "Total Lease Liability Payments Due Year Three"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Payments Due Year Two",
        "label": "Total Lease Liability Payments Due Year Two",
        "terseLabel": "Total Lease Liability Payments Due Year Two"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Total Lease Liability Undiscounted Excess Amount"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade receivables allowance for doubtful accounts.",
        "label": "Trade Receivables Allowance For Doubtful Accounts Table [Text Block]",
        "terseLabel": "Trade receivables allowance for doubtful accounts"
       }
      }
     },
     "localname": "TradeReceivablesAllowanceForDoubtfulAccountsTableTextBlock",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ctlt_TradingSecuritiesAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "participant-directed stock and bond mutual funds",
        "label": "Trading Securities at Fair Value",
        "terseLabel": "Trading Securities at Fair Value"
       }
      }
     },
     "localname": "TradingSecuritiesAtFairValue",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_U.S.Dollardenominated4.875SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Dollar-denominated 4.875% Senior Notes [Member]",
        "label": "U.S. Dollar-denominated 4.875% Senior Notes [Member]",
        "terseLabel": "U.S. Dollar-denominated 4.875% Senior Notes [Member]"
       }
      }
     },
     "localname": "U.S.Dollardenominated4.875SeniorNotesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_USDenominatedTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Denominated Term Loan",
        "label": "U.S. Denominated Term Loan [Member]",
        "terseLabel": "U.S. Denominated Term Loan [Member]"
       }
      }
     },
     "localname": "USDenominatedTermLoanMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_USDollarDenominated500SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S Dollar-denominated 5.00% Senior Notes",
        "label": "U.S Dollar-denominated 5.00% Senior Notes [Member]",
        "terseLabel": "U.S Dollar-denominated 5.00% Senior Notes [Member]"
       }
      }
     },
     "localname": "USDollarDenominated500SeniorNotesMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_WeightedAverageGrantDateFairValueOfRestrictedStockUnit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value of restricted stock unit.",
        "label": "Weighted Average Grant Date Fair Value of Restricted Stock Unit",
        "terseLabel": "Weighted Average Grant Date Fair Value of Restricted Stock Unit"
       }
      }
     },
     "localname": "WeightedAverageGrantDateFairValueOfRestrictedStockUnit",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ctlt_ZenyattaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zenyatta",
        "label": "Zenyatta [Member]",
        "terseLabel": "Zenyatta"
       }
      }
     },
     "localname": "ZenyattaMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ctlt_geographicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "geographical",
        "label": "geographical [Member]",
        "terseLabel": "geographical [Member]"
       }
      }
     },
     "localname": "geographicalMember",
     "nsuri": "http://catalent.com/20210630",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r824",
      "r825",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Eliminations [Member]",
        "terseLabel": "Consolidation, Eliminations [Member]"
       }
      }
     },
     "localname": "ConsolidationEliminationsMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r172",
      "r180",
      "r281",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r172",
      "r180",
      "r281",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r172",
      "r180",
      "r281",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r479",
      "r485",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r786",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r479",
      "r485",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r786",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails",
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "Untied States"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r260",
      "r376",
      "r379",
      "r726",
      "r785",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r260",
      "r376",
      "r379",
      "r726",
      "r785",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r414",
      "r479",
      "r485",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r786",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails",
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r414",
      "r479",
      "r485",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r786",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails",
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r171",
      "r173",
      "r174",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r205",
      "r282",
      "r283",
      "r526",
      "r571",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r171",
      "r173",
      "r174",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r205",
      "r282",
      "r283",
      "r526",
      "r571",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r168",
      "r170",
      "r171",
      "r173",
      "r174",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r185",
      "r186",
      "r205",
      "r282",
      "r283",
      "r526",
      "r571",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r261",
      "r262",
      "r376",
      "r380",
      "r788",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/RevenueRecognitionTables",
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r261",
      "r262",
      "r376",
      "r380",
      "r788",
      "r808",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/RevenueRecognitionTables",
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r345",
      "r480",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r47",
      "r266",
      "r267"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r39",
      "r748",
      "r772"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income tax"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of accrued expenses.",
        "label": "Accrued Liabilities, Fair Value Disclosure",
        "terseLabel": "Accrued Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "AccruedLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r94",
      "r101",
      "r104",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r63",
      "r322"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r89",
      "r101",
      "r104",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Available for Sale Investments"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r101",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r95",
      "r101",
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "terseLabel": "Total accumulated other comprehensive income at the end of the year"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r50",
      "r98",
      "r100",
      "r101",
      "r773",
      "r797",
      "r801"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r97",
      "r101",
      "r104",
      "r168",
      "r169",
      "r171",
      "r617",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss)/Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r88",
      "r101",
      "r104",
      "r617",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Translation Adjustment [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r168",
      "r169",
      "r171",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax": {
     "auth_ref": [
      "r666",
      "r673"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current period adjustment resulting from gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature because settlement is not planned or anticipated in the foreseeable future.  Resulting from the entities to the transaction being consolidated, combined, or accounted for by the equity method in the reporting entity's financial statements.",
        "label": "Adjustment for Long-term Intercompany Transactions, Net of Tax",
        "terseLabel": "Long term inter-company loans"
       }
      }
     },
     "localname": "AdjustmentForLongTermIntercompanyTransactionsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r568",
      "r569",
      "r570",
      "r571",
      "r728",
      "r729",
      "r730",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r487",
      "r489",
      "r529",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile earnings from continued operations to net cash from operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r489",
      "r515",
      "r528"
     ],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 2.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "negatedLabel": "Equity compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r269",
      "r284",
      "r286",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Trade receivables allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AlternativeInvestment": {
     "auth_ref": [
      "r645",
      "r654"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.",
        "label": "Alternative Investment",
        "terseLabel": "Alternative Investment"
       }
      }
     },
     "localname": "AlternativeInvestment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r118",
      "r147",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of Debt Issuance Costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r147",
      "r306",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": {
     "auth_ref": [
      "r101",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.",
        "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]",
        "terseLabel": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent"
       }
      }
     },
     "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r159",
      "r236",
      "r249",
      "r256",
      "r277",
      "r611",
      "r618",
      "r662",
      "r746",
      "r771"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]",
        "terseLabel": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r82",
      "r159",
      "r277",
      "r611",
      "r618",
      "r662"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r11",
      "r14",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Auction Market Preferred Securities, Stock Series [Line Items]",
        "terseLabel": "Auction Market Preferred Securities, Stock Series [Line Items]"
       }
      }
     },
     "localname": "AuctionMarketPreferredSecuritiesStockSeriesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTable": {
     "auth_ref": [
      "r45",
      "r354",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information pertaining to auction market preferred securities, including liquidation preference, liquidation value, par value, rate setting interval, redemption requirements, dividend distributions, roll forward of shares outstanding, shares authorized, aggregate value of auction market preferred securities, variable interest rate earned, and other information necessary to a fair presentation. If redeemable, the auction market preferred securities are redeemable solely at the option of the issuer.",
        "label": "Auction Market Preferred Securities, Stock Series [Table]",
        "terseLabel": "Auction Market Preferred Securities, Stock Series [Axis]"
       }
      }
     },
     "localname": "AuctionMarketPreferredSecuritiesStockSeriesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r490",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r490",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r628",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r474",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r474",
      "r481",
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business Acquisition, Transaction Costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r606"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Business Acquisition, Goodwill"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r584",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r584",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesFairValue": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of acquired receivable from business combination, excluding certain loans and debt securities acquired in transfer.",
        "label": "Business Combination, Acquired Receivable, Fair Value",
        "terseLabel": "Business Combination, Acquired Receivable, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.",
        "label": "Business Combination, Acquired Receivables, Gross Contractual Amount",
        "terseLabel": "Business Combination, Acquired Receivables, Gross Contractual Amount"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesGrossContractualAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r597",
      "r598",
      "r601"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Business Combination, Consideration Transferred, Other"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r596",
      "r599",
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Asset",
        "terseLabel": "Business Combination, Contingent Consideration, Asset"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r595",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "negatedTerseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Net Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r588",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r588",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r588",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r588",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r147",
      "r330",
      "r335",
      "r338"
     ],
     "calculation": {
      "http://catalent.com/role/RestructuringandOtherCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Facility exit and other costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Capital Lease Obligations [Member]"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement [Member]"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r60",
      "r149"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "CASH AND EQUIVALENTS AT END OF PERIOD",
        "periodStartLabel": "CASH AND EQUIVALENTS AT BEGINNING OF PERIOD",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r32",
      "r150",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r143",
      "r670"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING ACTIVITY:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash Surrender Value, Fair Value Disclosure"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r24",
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Cash Surrender Value of Life Insurance"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r157",
      "r159",
      "r190",
      "r191",
      "r194",
      "r198",
      "r201",
      "r210",
      "r211",
      "r212",
      "r277",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r74",
      "r344",
      "r753",
      "r777"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitment and contingencies (see Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r168",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r46",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance - Common Stock Outstanding (shares)",
        "periodStartLabel": "Beginning Balance - Common Stock Outstanding (shares)",
        "terseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common Stock, Value, Outstanding"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r107",
      "r109",
      "r115",
      "r610",
      "r622",
      "r757",
      "r782"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r264",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r264",
      "r660",
      "r661",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r264",
      "r660",
      "r661",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r215",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Major Customers"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r264",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetPurchase": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase from purchase of right to consideration in exchange for good or service transferred to customer when right is conditioned on passage of time.",
        "label": "Contract with Customer, Asset, Purchase",
        "terseLabel": "Contract with Customer, Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetPurchase",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionContractualAssetsDetails",
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r365",
      "r366",
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionContractualLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r152",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of Stock, Shares Converted"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r44",
      "r45",
      "r356",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r415",
      "r465",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate [Member]"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r120",
      "r726"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r673"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.",
        "label": "Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)",
        "totalLabel": "Total foreign currency translation adjustments, net of tax"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r564",
      "r574"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r164",
      "r564"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r564",
      "r574",
      "r576"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r564",
      "r574"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r218",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r752",
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Debt and Capital Lease Obligations"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r37",
      "r39",
      "r40",
      "r747",
      "r750",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseDecreaseOtherNet": {
     "auth_ref": [
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in debt instruments, classified as other.",
        "label": "Debt Instrument, Increase (Decrease), Other, Net",
        "terseLabel": "Debt Instrument, Increase (Decrease), Other, Net"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseDecreaseOtherNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r70",
      "r349",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r72",
      "r161",
      "r356",
      "r360",
      "r361",
      "r362",
      "r682",
      "r683",
      "r685",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Debt Instrument, Unused Borrowing Capacity, Amount"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityFee": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment fees for the unused borrowing capacity under the long-term financing arrangement that is available to the entity.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Fee",
        "terseLabel": "Debt Instrument, Unused Borrowing Capacity, Fee"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityFee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "terseLabel": "Financing fees paid"
       }
      }
     },
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities [Member]"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.",
        "label": "Deferred Compensation Plan Assets",
        "terseLabel": "Deferred Compensation Plan Assets"
       }
      }
     },
     "localname": "DeferredCompensationPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r565",
      "r574"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r64",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred long term debt financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r565",
      "r574"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r147",
      "r160",
      "r565",
      "r574",
      "r575",
      "r576"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r42",
      "r43",
      "r555",
      "r749",
      "r767"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r539",
      "r540"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue and fees"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r565",
      "r574"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetDomain": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.",
        "label": "Deferred Tax Asset [Domain]",
        "terseLabel": "Deferred Tax Asset [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Non-current deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/IncomeTaxesBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred Tax Assets, Net of Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Loss and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOtherComprehensiveLoss": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses in other comprehensive income.",
        "label": "Deferred Tax Assets, Other Comprehensive Loss",
        "terseLabel": "Euro Denominated Debt"
       }
      }
     },
     "localname": "DeferredTaxAssetsOtherComprehensiveLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property-related"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from pension benefits.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions",
        "terseLabel": "Pension"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r540",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesBalanceSheetDetails",
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedTerseLabel": "Goodwill and other intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Property-related"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.",
        "label": "Deferred Tax Liabilities, Tax Deferred Income",
        "terseLabel": "Non-current deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesTaxDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/IncomeTaxesBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "negatedTerseLabel": "Foreign currency"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41",
      "r390",
      "r391",
      "r413"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Pension liability"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]",
        "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": {
     "auth_ref": [
      "r101",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax",
        "negatedTerseLabel": "Net (gain)/loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": {
     "auth_ref": [
      "r101",
      "r435"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax": {
     "auth_ref": [
      "r101",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), after Tax",
        "terseLabel": "Transition (asset)/obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r405",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gain)/loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r392",
      "r430",
      "r459",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Net (gain)/loss",
        "negatedTerseLabel": "Defined Benefit Plan, Amortization of Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r392",
      "r431",
      "r460",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation": {
     "auth_ref": [
      "r392",
      "r432",
      "r461"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transition asset (obligation) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Transition Asset (Obligation)",
        "terseLabel": "Transition (asset)/obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfTransitionAssetObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Amounts Recognized in Statement of Financial Position"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax": {
     "auth_ref": [
      "r93",
      "r98",
      "r434"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      },
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of increase (decrease) in accumulated other comprehensive income from gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax",
        "terseLabel": "Net gain/(loss) recognized during the year"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year [Abstract]",
        "terseLabel": "Estimated Amounts to be Amortized from Accumulated Other Comprehensive Income into Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsThatWillBeAmortizedFromAccumulatedOtherComprehensiveIncomeLossInNextFiscalYearAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r36",
      "r390",
      "r391",
      "r413",
      "r465",
      "r745",
      "r770"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumed Health Care Cost Trend Rates [Abstract]",
        "terseLabel": "Assumed Healthcare Cost Trend Rates at the Balance Sheet Date"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumedHealthCareCostTrendRatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increases (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r438",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increases (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of year",
        "periodStartLabel": "Benefit obligation at beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r400",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in plan assets of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Plan Assets, Business Combination",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r442",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Employer contributions between measurement date and reporting date"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r407",
      "r415",
      "r417",
      "r463",
      "r465",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Company contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "negatedTerseLabel": "Curtailments"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "terseLabel": "Divestitures"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresPlanAssets": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Plan Assets, Divestiture",
        "terseLabel": "Divestitures"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Effect of One-Percentage Point Change in Assumed Health Care Cost Trend Rate [Abstract]",
        "terseLabel": "Effect of 1% Change in Healthcare Cost Trend Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in accumulated postretirement benefit obligation from one-percentage-point decrease in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation",
        "negatedTerseLabel": "Effect of 1% decrease on APBO at balance sheet date"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in service and interest cost components of net periodic postretirement benefit cost from one-percentage-point decrease in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components",
        "negatedTerseLabel": "Effect of 1% decrease on total service and interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in accumulated postretirement benefit obligation from one-percentage-point increase in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation",
        "terseLabel": "Effect of 1% increase on APBO at balance sheet date"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in service and interest cost components of net periodic postretirement benefit cost from one-percentage-point increase in assumed health care cost trend rate.",
        "label": "Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components",
        "terseLabel": "Effect of 1% increase on total service and interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "terseLabel": "Expected Future Benefit Payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Employer Contributions [Abstract]",
        "terseLabel": "Expected Future Contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureEmployerContributionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "terseLabel": "Net (gain)/loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "terseLabel": "Prior service cost/(credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for transition asset (obligation) expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Transition Asset (Obligation), Next Fiscal Year",
        "negatedTerseLabel": "Transition (asset)/obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r425",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Fiscal Year 2020 Expected Future Contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r392",
      "r429",
      "r458",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r404",
      "r415",
      "r417",
      "r418",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Exchange rate gain/(loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r390",
      "r413",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "netLabel": "Net Pension assets (liabilities)",
        "periodEndLabel": "Funded status at end of year",
        "terseLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "terseLabel": "Healthcare cost trend rate-initial (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r392",
      "r396",
      "r428",
      "r457",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r426",
      "r455",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]",
        "terseLabel": "Additional Information for Plan with ABO in Excess of Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r451",
      "r452",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r451",
      "r452",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "terseLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r409",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Plan Assets, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Exchange rate gain/(loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r414",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target Asset Allocation (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r394",
      "r427",
      "r456",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Company service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSpecialTerminationBenefits": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation for benefits provided to employees payable from defined benefit plan or payable upon retirement.",
        "label": "Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits",
        "terseLabel": "Special termination benefits",
        "verboseLabel": "Special company contributions to fund termination benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanSpecialTerminationBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Healthcare cost trend rate-ulitimate (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Actual Asset Allocation (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Financial Assumptions Used to Determine Benefit Obligations at the Balance Sheet Date"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Financial Assumptions Used to Determine Net Periodic Benefit Cost for Financial Year"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year ultimate health care cost trend rate is expected to be reached, in CCYY format.",
        "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate",
        "terseLabel": "Year in which ultimate rates are reached"
       }
      }
     },
     "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r449",
      "r450",
      "r453",
      "r454",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r147",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r147",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r147",
      "r231"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r629"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedTerseLabel": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r634",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r83",
      "r84",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r633",
      "r635",
      "r639",
      "r640",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.",
        "label": "Derivatives, Methods of Accounting, Hedging Derivatives [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingHedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r490",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r147",
      "r319",
      "r324"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsAndInterestPaid": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contractual amount of dividends (or interest on participating income bonds) that must be paid for the current period (for example, unpaid cumulative dividends).",
        "label": "Dividends and Interest Paid",
        "negatedTerseLabel": "Dividends and Interest Paid"
       }
      }
     },
     "localname": "DividendsAndInterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r363",
      "r762"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Preferred Stock",
        "negatedTerseLabel": "Dividends, Preferred Stock"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r363",
      "r762"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "terseLabel": "Dividends, Preferred Stock, Stock"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment of Senior Debt",
        "terseLabel": "Early Repayment of Senior Debt"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r116",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r187",
      "r190",
      "r198",
      "r200",
      "r201",
      "r205",
      "r206",
      "r758",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r116",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r190",
      "r198",
      "r200",
      "r201",
      "r205",
      "r206",
      "r758",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of foreign currency on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r630"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "terseLabel": "Embedded Derivative, Fair Value of Embedded Derivative Liability"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee-related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r171",
      "r174",
      "r183",
      "r186",
      "r209",
      "r281",
      "r355",
      "r363",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678",
      "r792",
      "r793",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r33",
      "r38",
      "r276",
      "r769",
      "r805",
      "r806",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": {
     "auth_ref": [
      "r646",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).",
        "label": "Fair Value Measurements, Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r649",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of beginning and ending balances of level 3 assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r646",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r465",
      "r647",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r646",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r415",
      "r417",
      "r422",
      "r465",
      "r647",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r415",
      "r417",
      "r422",
      "r465",
      "r647",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r465",
      "r647",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r417",
      "r645",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)",
        "terseLabel": "Purchases, sales, settlements, contributions and benefits paid"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "terseLabel": "Relating to assets sold during the period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers in and/or out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r649"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r465",
      "r713",
      "r714",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Purchases, Sales, Issues, Settlements"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchasesSalesIssuesSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r692",
      "r697",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r695",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r690",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Finance Lease, Liability, Payment, Due"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year One"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r694",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r692",
      "r697",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r702",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r701",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r312"
     ],
     "calculation": {
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsFutureAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r307",
      "r309",
      "r312",
      "r316",
      "r727",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r312",
      "r731"
     ],
     "calculation": {
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r307",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r312",
      "r727"
     ],
     "calculation": {
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r663",
      "r664",
      "r667",
      "r669"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r148",
      "r667",
      "r669"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), Unrealized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Translation and Transaction of Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "terseLabel": "Gain (Loss) on Sale of Assets and Asset Impairment Charges"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Gain (Loss) Related to Litigation Settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r147",
      "r350",
      "r351"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r296",
      "r297",
      "r744"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r155",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "terseLabel": "Goodwill, Other Increase (Decrease)"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Goodwill, Written off Related to Sale of Business Unit"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r119",
      "r159",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258",
      "r277",
      "r662"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedge Funds [Member]",
        "verboseLabel": "Hedge Funds [Member]"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r147",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of Intangible Assets, Finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r163",
      "r577"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r163",
      "r577"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non-U.S. operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r163",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/IncomeTaxesScheduleofIncomebeforeTaxDomesticandForeignDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r159",
      "r173",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258",
      "r277",
      "r610",
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Earnings/(loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails",
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails",
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r546",
      "r552",
      "r554",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r543",
      "r553",
      "r560",
      "r572",
      "r578",
      "r580",
      "r581",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r185",
      "r186",
      "r234",
      "r541",
      "r573",
      "r579",
      "r784"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total provision",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails",
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails",
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r155",
      "r537",
      "r538",
      "r553",
      "r554",
      "r559",
      "r566",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Tax valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r536",
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Change in tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign tax rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Provision at U.S. federal statutory tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Withholding Tax and other foreign taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and local income taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Unrecognized tax positions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "(Increase)/decrease in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Provision/(benefit) for deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "(Increase)/decrease in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets/accrued liabilities, net - current and non-current"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r192",
      "r193",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Definite Lived Long-Lived Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r155",
      "r311",
      "r723",
      "r724",
      "r725",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets, Finite-Lived"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r305",
      "r310"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r681"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Interest Costs Capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsIncurred": {
     "auth_ref": [
      "r681"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings.",
        "label": "Interest Costs Incurred",
        "terseLabel": "Interest Costs Incurred"
       }
      }
     },
     "localname": "InterestCostsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r759"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/SegmentInformationReconciliationofEarningslossfromContinuingOperationstoEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r141",
      "r144",
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r68"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Interest Payable, Current"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Interest Rate Cash Flow Hedge Asset at Fair Value"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Interest Rate Cash Flow Hedge Liability at Fair Value"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.",
        "label": "Interest Rate Derivative Assets, at Fair Value",
        "terseLabel": "Interest Rate Derivative Assets, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "totalLabel": "Total inventory, gross"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r79"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r30",
      "r80",
      "r155",
      "r208",
      "r289",
      "r290",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.",
        "label": "Inventory, Raw Materials and Supplies, Gross",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSupplies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r79",
      "r166",
      "r291"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Inventory cost adjustment"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationWorkinProcessandFinishedGoodsInventoriesIncludeRawMaterialsLaborandOverheadDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r703",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases of Lessee Disclosure [Text Block]",
        "terseLabel": "Leases of Lessee Disclosure"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year One"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r67",
      "r159",
      "r250",
      "r277",
      "r612",
      "r618",
      "r619",
      "r662"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r53",
      "r159",
      "r277",
      "r662",
      "r751",
      "r775"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable preferred stock, and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r69",
      "r159",
      "r277",
      "r612",
      "r618",
      "r619",
      "r662"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansAndLeasesReceivableGrossCarryingAmount": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allowance of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.",
        "label": "Loans and Leases Receivable, Gross",
        "terseLabel": "Loans and Leases Receivable, Gross"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableGrossCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Finance Lease Obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five",
        "terseLabel": "Long Term Debt and Capital Lease Obligations Repayments of Principal After Year Five"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Five"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Four"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Three"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "Long Term Debt and Capital Lease Obligations Repayments of Principal in Year Two"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r72",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r25",
      "r321"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r754"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://catalent.com/role/IncomeTaxesBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities [Table Text Block]"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MultiemployerPlanPensionSignificantFutureEmployerContributionAmount": {
     "auth_ref": [
      "r480",
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for employer contribution required to be made in future period to multiemployer pension plan determined to be individually significant. Includes, but is not limited to, employer contribution required by collective-bargaining arrangement (CBA), statutory obligation, and other contractual obligation.",
        "label": "Multiemployer Plan, Pension, Significant, Future Employer Contribution, Amount",
        "terseLabel": "Multiemployer Plan, Pension, Significant, Future Employer Contribution, Amount"
       }
      }
     },
     "localname": "MultiemployerPlanPensionSignificantFutureEmployerContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by/(used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r143",
      "r145",
      "r148"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by (Used in) Operating Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r105",
      "r108",
      "r113",
      "r148",
      "r159",
      "r173",
      "r178",
      "r179",
      "r180",
      "r181",
      "r185",
      "r186",
      "r196",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258",
      "r277",
      "r662",
      "r755",
      "r780"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Catalent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r108",
      "r185",
      "r186",
      "r614",
      "r621"
     ],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 4.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r187",
      "r188",
      "r197",
      "r201",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r205",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r568",
      "r569",
      "r570",
      "r571",
      "r728",
      "r729",
      "r730",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "auth_ref": [
      "r152",
      "r153",
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed",
        "terseLabel": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other (Income)/expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Nonvested Restricted Stock Shares Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r236",
      "r248",
      "r252",
      "r255",
      "r258"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating earnings"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/LeasesScheduleofMaturitiesofOperatingAndFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r696",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofOperatingandFinanceLeasesPresentedintheBalanceSheetDetails",
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r702",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r701",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r68"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "Other assets:"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r628",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other Assets, Miscellaneous, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAssetsNonCurrentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r96",
      "r98",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r434"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      },
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Net (gain)/loss recognized during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r90",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r90",
      "r91",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r90",
      "r91",
      "r98"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r90",
      "r91",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r101",
      "r111",
      "r671",
      "r673",
      "r678"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r87",
      "r98"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "totalLabel": "Total foreign currency translation adjustments, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r87",
      "r99",
      "r668",
      "r677"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r106",
      "r109",
      "r111",
      "r114",
      "r355",
      "r671",
      "r676",
      "r678",
      "r756",
      "r781"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income /(loss), net of tax",
        "totalLabel": "Other comprehensive income /(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r95",
      "r98",
      "r434",
      "r465"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTotalLabel": "Total minimum pension liability, pretax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r95",
      "r98"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      },
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTotalLabel": "Net change in minimum pension liability, net of tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r93",
      "r98",
      "r434"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      },
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net gain/(loss) arising during the year",
        "terseLabel": "Net (gain)/loss arising during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r95",
      "r99",
      "r610"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Pension liability tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r434"
     ],
     "calculation": {
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Transition asset/(obligation) recognized during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r90",
      "r98",
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r90",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net accumulated gain related to investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other Cost and Expense, Operating"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r387",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income and Other Expense Disclosure"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r26",
      "r27",
      "r68"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities and expenses"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationOtherAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "terseLabel": "Other Nonoperating Expense"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail": {
       "order": 5.0,
       "parentTag": "ctlt_SegmentReportingInformationUnallocatedExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring (Income) Expense",
        "negatedTerseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonrecurringIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r445",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Post-Retirement Benefits [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": {
     "auth_ref": [
      "r195",
      "r197"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic",
        "negatedTerseLabel": "Participating Securities, Distributed and Undistributed (Earnings) Loss, Basic"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests."
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of Debt Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Payments of Stock Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail",
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments Related to Tax Withholding for Share-based Compensation",
        "terseLabel": "Payments Related to Tax Withholding for Share-based Compensation"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r127",
      "r130",
      "r274"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Payments to Acquire Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r131",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payment for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "terseLabel": "Payments to Acquire Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r414",
      "r416",
      "r422",
      "r440",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r465",
      "r467",
      "r470",
      "r472",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Retirement Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r39",
      "r390",
      "r391",
      "r413",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41",
      "r390",
      "r391",
      "r413",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r155",
      "r449",
      "r468",
      "r469",
      "r472",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Post-Retirement and Pension Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r388",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r445",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Retirement Benefits [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r442",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r490",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail",
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsFairValueMeasurementsofFinancialInstrumentsCarryingAmountsandEstimatedFairValueofFInancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred Stock, Shares Issued &amp; Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Preferred Stock [Text Block]"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RedeemablePreferredStockSeriesAPreferred"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred Stock, Value, Outstanding"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableFairValueDisclosure": {
     "auth_ref": [
      "r778"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of amount receivable on insurance policies.",
        "label": "Premiums Receivable, Fair Value Disclosure",
        "terseLabel": "Premiums Receivable, Fair Value Disclosure"
       }
      }
     },
     "localname": "PremiumsReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21",
      "r58",
      "r59"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid Expense and Other Assets, Current"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r22",
      "r294",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid Expense, Current"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r20",
      "r22",
      "r293",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid Taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from Divestiture of Businesses and Interests in Affiliates"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).",
        "label": "Proceeds from Divestiture of Interest in Consolidated Subsidiaries",
        "terseLabel": "Proceeds from Divestiture of Interest in Consolidated Subsidiaries"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowing, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemablePreferredStock": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stock that is classified as callable.",
        "label": "Proceeds from Issuance of Redeemable Preferred Stock",
        "terseLabel": "Proceeds from Issuance of Redeemable Preferred Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemablePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r136",
      "r140",
      "r165"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Proceeds from (Payments for) Other Financing Activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net change in other borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r134",
      "r518"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from Stock Options Exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Product and Service[Member]"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r105",
      "r108",
      "r142",
      "r159",
      "r173",
      "r185",
      "r186",
      "r236",
      "r248",
      "r252",
      "r255",
      "r258",
      "r277",
      "r610",
      "r613",
      "r615",
      "r621",
      "r622",
      "r662",
      "r760"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r63",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r62",
      "r321"
     ],
     "calculation": {
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r34",
      "r35",
      "r323",
      "r776"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant, and equipment, net",
        "verboseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail",
      "http://catalent.com/role/SupplementalBalanceSheetInformationPropertyandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r155",
      "r323",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r34",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r34",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r117",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for Doubtful Accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateMember": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property consisting of land, land improvement and buildings.",
        "label": "Real Estate [Member]",
        "terseLabel": "Real Estate [Member]"
       }
      }
     },
     "localname": "RealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r268",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables and Allowance dor Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r101",
      "r104",
      "r111",
      "r671",
      "r675",
      "r678"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Reclassifications": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.",
        "label": "Reclassifications [Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "Reclassifications",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": {
     "auth_ref": [
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r249",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Total Assets for Each Segment and Reconciling in Consolidated Financial Statements"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r247",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r31",
      "r159",
      "r277",
      "r353",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable Preferred Stock [Member]"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r442",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r442",
      "r706",
      "r708",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r533",
      "r821"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r155",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Other Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r331",
      "r332",
      "r337",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated",
        "terseLabel": "Restructuring and Related Cost, Expected Number of Positions Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r147",
      "r330",
      "r335",
      "r338"
     ],
     "calculation": {
      "http://catalent.com/role/RestructuringandOtherCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "totalLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, Settlement and Impairment Provisions"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r49",
      "r363",
      "r526",
      "r774",
      "r796",
      "r801"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r168",
      "r169",
      "r171",
      "r174",
      "r183",
      "r186",
      "r281",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571",
      "r792",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r445",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r445",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r481",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAdditionalInformationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r156",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RevenueRecognition",
      "http://catalent.com/role/RevenuefromContractwithCustomerPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition and Deferred Revenue [Abstract]",
        "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAndDeferredRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r112",
      "r159",
      "r227",
      "r228",
      "r247",
      "r253",
      "r254",
      "r260",
      "r261",
      "r264",
      "r277",
      "r662",
      "r760"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebyGeographyDetails",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r700",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r700",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesScheduleofSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r101",
      "r676",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Accumulated other comprehensive earnings/(loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Other Intangible Assets Subject to Amortization"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Reconciliation of the net amount recognized in the Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareCalculationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/BusinessCombinationsNetAssetsAcquiredDetails",
      "http://catalent.com/role/BusinessCombinationsPurchaseAgreementDetails",
      "http://catalent.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision/ (benefit) for income taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r72",
      "r161",
      "r356",
      "r360",
      "r361",
      "r362",
      "r682",
      "r683",
      "r685",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of the deferred income tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r449",
      "r450",
      "r453",
      "r454",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAOCIDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAccumulatedBenefitObligationDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansAssumedHealthcareTrendRatesDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansBalanceSheetDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFairValueDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails",
      "http://catalent.com/role/EmployeeRetirementBenefitPlansLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r12",
      "r13",
      "r14",
      "r328",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareCalculationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of the provision/(benefit) based on the federal statutory income tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r307",
      "r311",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsOtherIntangibleAssetsSubjecttoAmortizationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Statement of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.",
        "label": "Schedule of Health Care Cost Trend Rates [Table Text Block]",
        "terseLabel": "Assumed healthcare cost trend rates"
       }
      }
     },
     "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Earnings/(loss) from continuing operations before income taxes and discontinued operations"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.",
        "label": "Schedule of Interest Rate Derivatives [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Derivatives"
       }
      }
     },
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r30",
      "r55",
      "r56",
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Work-in-Process and Finished Goods Inventories Include Raw Materials, Labor and Overhead"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Maturities of long-term obligations"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Benefit obligation and fair value of plan assets for the defined benefit retirement and postretirement plan"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Other Assets Non Current"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r333",
      "r334",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Other Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r236",
      "r239",
      "r251",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r490",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.",
        "label": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Unrecognized tax benefit, excluding accrued interest"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in restricted stock units (RSUs).",
        "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unvested Restricted Stock Units Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DefiniteLivedLongLivedAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAssetReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Asset Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Asset Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingAssetReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r236",
      "r240",
      "r252",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure [Text Block]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationAssetsandRevenuesDetail",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting, Policy"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "terseLabel": "Self Insurance"
       }
      }
     },
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r147",
      "r330",
      "r335",
      "r338"
     ],
     "calculation": {
      "http://catalent.com/role/RestructuringandOtherCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee-related reorganization"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/RestructuringandOtherCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r494",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r488",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r155",
      "r490",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Equity-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r510",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of increase (decrease) of non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r364",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Shareholders' Equity and Share-based Payments"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://catalent.com/role/EquityDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r264",
      "r302",
      "r327",
      "r332",
      "r339",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/GoodwillCarryingAmountofGoodwillDetail",
      "http://catalent.com/role/RevenueRecognitionDisaggregationofRevenuebytypeofactivityandreportingsegmentDetails",
      "http://catalent.com/role/SegmentInformationCapitalExpendituresDetails",
      "http://catalent.com/role/SegmentInformationDepreciationandAmortizationDetails",
      "http://catalent.com/role/SegmentInformationNetRevenueandSegmentEbitdaDetail",
      "http://catalent.com/role/SegmentInformationTotalAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r157",
      "r159",
      "r190",
      "r191",
      "r194",
      "r198",
      "r201",
      "r210",
      "r211",
      "r212",
      "r277",
      "r355",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BusinessCombinationsDivestituresDetails",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r76",
      "r168",
      "r169",
      "r171",
      "r174",
      "r183",
      "r186",
      "r209",
      "r281",
      "r355",
      "r363",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678",
      "r792",
      "r793",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveEarningsLossDetails",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r168",
      "r169",
      "r171",
      "r209",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesConcentrationsofCreditRiskandMajorCustomersDetails",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPropertyandEquipmentandOtherDefiniteLivedIntangibleAssetsDetails",
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesResearchandDevelopmentExpenseDetails",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows",
      "http://catalent.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Stock Compensation Plan [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareEarningsPerShareAdditionalDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r75",
      "r355",
      "r356",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r45",
      "r46",
      "r355",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r45",
      "r46",
      "r355",
      "r363",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquitySharesofCommonStock",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r76",
      "r355",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments",
        "terseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r45",
      "r46",
      "r355",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r76",
      "r355",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock Issued During Period, Value, Stock Options Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r46",
      "r51",
      "r52",
      "r159",
      "r270",
      "r277",
      "r662"
     ],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r159",
      "r168",
      "r169",
      "r171",
      "r174",
      "r183",
      "r277",
      "r281",
      "r363",
      "r523",
      "r524",
      "r525",
      "r570",
      "r571",
      "r608",
      "r609",
      "r620",
      "r662",
      "r671",
      "r672",
      "r678",
      "r793",
      "r794"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r158",
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Stockholders' Equity, Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r679",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r679",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r679",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r679",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r709",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events [Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SubsequentEventsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTARY CASH FLOW INFORMATION:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://catalent.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Redeemable Preferred Stock Outstandings"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedBalanceSheets",
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity",
      "http://catalent.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": {
     "auth_ref": [
      "r31",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.",
        "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)",
        "terseLabel": "Temporary Equity, Carrying Amount, Period Increase (Decrease)"
       }
      }
     },
     "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Temporary Equity, Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/ConsolidatedStatementofChangesinShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r665",
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/DerivativeInstrumentsandHedgingActivitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r676"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cumulative translation adjustment from gain (loss), after tax, on foreign currency derivatives, that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Net of Tax, Period Increase (Decrease)",
        "terseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r98",
      "r676"
     ],
     "calculation": {
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.",
        "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)",
        "terseLabel": "Translation adjustments"
       }
      }
     },
     "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityandAccumulatedOtherComprehensiveIncomeLossMinimumPensionLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r568",
      "r569",
      "r570",
      "r571",
      "r728",
      "r729",
      "r730",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRecentFinancialAccountingStandardsDetails",
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r415",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "US Government Agencies Debt Securities [Member]"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EmployeeRetirementBenefitPlansFiscalYearMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized Debt Issuance Expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r534",
      "r582",
      "r765",
      "r802"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r535",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r213",
      "r214",
      "r216",
      "r217",
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.",
        "label": "Valuation Allowance by Deferred Tax Asset [Axis]",
        "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]"
       }
      }
     },
     "localname": "ValuationAllowanceByDeferredTaxAssetAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValueAddedTaxReceivable": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.",
        "label": "Value Added Tax Receivable",
        "terseLabel": "Value Added Tax Receivable"
       }
      }
     },
     "localname": "ValueAddedTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/SupplementalBalanceSheetInformationPrepaidandOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r698",
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable Lease, Cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LeasesCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/LongTermObligationsandOtherShortTermBorrowingsInterestRateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EquityBasedCompensationAdditionalDetails",
      "http://catalent.com/role/EquityBasedCompensationOptionActivityDetails",
      "http://catalent.com/role/EquityBasedCompensationRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r189",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r187",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/EarningsPerShareCalculationsofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write-off of Deferred Debt Issuance Costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://catalent.com/role/OtherIncomeExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1930-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2029-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21564-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(m)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(s)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EEEE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999725-113959"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80784-113994"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30755-110894"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4),(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r822": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r823": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r824": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r825": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r826": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r827": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r828": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r829": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0001596783-21-000110-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001596783-21-000110-xbrl.zip
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M5OUGH*!08AU(N!9()2PKF7$3HX,Z@] 9N ;R4$ZQ&R/C^?HT? /T+D WOQQ
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M@*>/!O"-DVK]R,[#.6B<*5Q[5[L_#,RRI14AS?7^76Q]'P."K!C),P:9*U2
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MF\D<MH&Y%._FHTB_<R+X#8CB".6.?/FCI^C!>/[?;![;CX8U?-SFT1T(LT7
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M.R^MHVKSV;&]]F)P^@Q;#%S<B*FZ&S$UP[;;3HZK)_7[F^O58-E6<[J]?O1
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MR[;_P6#,UNX=+FC#L7M]T84.P!VY6>_RD:N*Q:>_..FN<)[^#5!+ P04
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M&#Y,(5-4=VY7I_S!M;=ZEI=P]^^ _=\!4$L#!!0    ( %)+'E.3G20'@ 0
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M8$?%4G0@B3VY;W_P&?Z64MJ(5S%[(EP<$=ZZC!JEU!QY9*QK(["J5[$&&>4
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M$^76-"!X1\FR=9XAE$0<!E TOF/$&<K)3DVE!&3@1J% ,"I.(;(M+5 T,=
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M:*]/-/UGG-P_?OY\<G)?YB_&O)LVV[<8VM!\MJ!@IDA(ALGTT$K%#JHFZE.
M?3!;XN0ZZE_ZPOUC6CV_V\ZNO"?/9_/E>/IX%W,.5W.N6$U:U8&$1.Q]P%0H
M)_G_V7OWKK:59'WXJV@Q9\Y)UK+8NE^RY^1]2;@,.;%)P$D&_F&UI)8MD"5O
M20;,I_]5=;<N-N:Z =M$L]9D)[8LM:JKJYZZF\Y:I?ZNS4XOJ7NQJVH6\1T:
M.JYA$<5U#$HQ]Y$ZKF\2ZXT)Z]78Z>5496FV@R.'%3M4#.HXC@50VC 45_7]
M0%/<U;=8'Z2-TPSV$*X#M+431Z,H8=7_Z^)6T&CH.[ZF!6#W&*%M>R%1"3;+
M=+U0\;0U2'I8V4UZ/N^J:04.H5Y(==4W-,P+USTSU S/5T+-#9VW@X/*RZH-
M>XM@Q]9U@#F>055%-:A+'1^4GZ)9-E$,FP3NVP$[K[R=RT$TEN91'0P4V%!0
M;Z;J:=14+2_T/=TVJ4/>#J)Y[>U<"FRA"G:7TBBU#<TP7->#8VD[EF5BTIFK
M*ZL+6S#R6^W@'DT'&1D/T5,@-&$Z28IL^N''T<JC$@NCB:9O^\0D!IPB C:#
MHX>P'3H"E6!U4<FR]^#Y0(=-/$\Q#=L'G62 KG)Q!IC">G(;@:^M<,#IGCW
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M,)Y,%"$PM.,S7X??:,?:]ZOCZ^_*R2_X;W\X!*8][VHGY[ "$Z#RU?%T7F#
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MSX[/CC5 ;H ,M_3CT<XU$.O\^&P(*._8[&D_IB='\P0%8F_#>^WU(A!"(#P
M&6X'T7&_%X&PCF!CAH X=8RK_>?ZO.A.?P\.?36"-B#%0SAT_33@$_=A-D@;
M1X \SGIG003K /K"J>_O _V/P>3Y&8-I.3TY RFPUQN!!KSN]L^5+IA!8-*
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M(H]6N^%O[F0?<9.5G^K*;N7_G#,YWL2N+V.J#0<HC-*?)CDL*5_/(/ZK A0
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MX:_RUS0]9YWJ2]L@_]<?Y/$Y"L\P!Y:E(=U^SMM]?]R^Z[?LXUN0.\N;"OA
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MH2VW6B2Y;.'HML)QQ4\*_&7CXV?6A!V[>#.1"-"1##(JA.0O; *_Q3MK$_P
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M:F&@P,2RF@^3>$X#BM8\ N%W\RG\>U":&25,H\&E9Z!QF7C$LE F+Q&1Q;0
M81KE_B0OT1LNI%(1ETQ;T!F^IP4*<+@)W'B#MPG<VISAF\V-9^(<W7I)OF%W
M_! 5\'S_@6(S%[,*@,J@^0Y@9SZ5.E' ,YQ+ &^2(==)OQC5?E'I " ;Z+B'
MDD7TV9*QJ=8'P[F?4+*F;[K.T@X9XW]KB0)[EF*:LFDP8N &E:"E(X55V]@*
M%PO@RW:'X1F$0XAT [1G*& 9 N#&%^!E$*<>_'I(20SL3\=P^D:1GS>%"G(
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MV;SYE%8VOS(+SNWX;?S#W>2Y&-&>\?I+%,)7-/,CU@4 I"OKM8!%,I(HQF+
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M3O\=1QF?V1> >H9U3*6BD; -E\78$X-W=6(]9H%L<AK*\'HR=D 2U.#ON(
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MCC!;AH\DG3]G.>MQ7M!2 3%IT+B5UC'A5C-6+!L(5<Q+Z4[Y;MA67<I]M'>
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MP4,HR-;P*^Z0N*4T@3=1R[&I:YV)RY:]H&BA4ZVT*GQIUB\T:FE0E9 I\'C
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MH *O0D3887UQ"6A(/#9A"AS0])=\4=+Z_BTXG>#\KFD?$K9&$;3;%#_K**+
MQVZ4RKOXHCA^/WQP[Y_X:E@EX0?9PY3WPG]5!4BL_'@YTI)5_K9<;586$,_Y
M@=PP\%L_J1IBZ^SQ/L_K19A'AZH]$;FNB&IW#^PG0)G"1O9E\%H3#:D>\;<3
M@"SR@>YI#4*>P'[CHZ.=V0,"$^ QAX"*2A],@@:, _8GVC_S-_EI(F.<,,8(
M<G_PSCN@]K:*:)"Y%Y^7-CQ-XB%&B+,$=7G*?(9]&Y9T6N-[UT=/GF$XGCJ6
M^-E4A/.PA3=L0TBD 2'6J-N OQF''TNQ:%=E/QR-2[<9KTGM5ADV!PR;8MC0
MA==X%E;;]ARG+X#851FFN"[SC"N/NC2#OT4I*[==$#87!#_KAJW"X5X>*:9*
MV6&Z?]^<1JU.0^[1/LOGT% 179GTY;3:_''1'>_@VF).BVD59X9*$-#C25&=
MEIM5AH;/;<7.SR*$)6]S+HI[OJ$X4E' _63@<&#U/CUZM?>:U,BS&7KBR^ '
M;I"7J,/;PZ^:T2_<U-%CACW/OW?"1-IZMS?R)U-]H^$R/,_GI%$0Q8JB$8CY
MH]BP&**2_@+ WG\!:G,2'HE[&<*EB;?#FMQ92PKWOVB23J+)@9X\G_290Q2U
M/BMG/X4O]!C XZ/95U*VXS^IDD+&F]I2:+$'$TX7(9.B,_$3",T))3X/CMZ&
M08H$WPE7,1&'IYQ(#IO("=W$Y8!A*^T*=7/A_!GCF[2!U8-$J)Z3,&!LY<CE
M(']Q3UBL@O,L7YU.%.[/9D<VTA6)S,^.-J<;(+I'\_(J;(/Z*1[A=222[F8_
MK4Y^MN&US^@(PP0)@YH9K'_"S:V7P37)PARUU+=(UBAVY- .DFN6+X^?*IHB
M>70:R5@8B%8Y^-Q%,.MG(3 P"=_(V.@'T;Q*I@"1)*SU>9"W@OM[[XYRFXP-
M8S$REX'W&QD[9^9VSE \K&>?)KS(<UY@R0+_C %S&+"#SQBP:PV8R:QQ.\N.
M$XA<* ?QB'UJRZ;I@37JG28W%9W$DPO6[4%BHZ/+FRQB=M:PU'&)GQ&RU@EG
MJMA!<@CY&3.VJ=SBV3?H(0UW.WB0EB?9!V1';;UIPY*6)W_5S-^0+S2(660
M+#*[IIDDF0'7+YCD&ESS>Q:A+WC>IJZV'$A:RT:W[?IB-6R2%X^)'BW?]#CY
M-<\/;E]\4C)"T?Z[>D4?/D&S:-,U31?%10>\(7(VC99B-@JXIW3<'T !:E%5
M"8TX\A:= ^D'D$+SK@,:]9&/!%A_93["96:L5W/(%Z#RSG:@IQ\81 )*74 Q
M34J]G>HR>4Z#7<FUC"=^H)L(X. *RP2)#EH>RC0Y57L3FY'0\'!,S<3$%D-E
MTKO,)L;REMS&GWPR67Q)\W98XGL\E)(;X;@!3G$Y)VZ?X"LJ082C6!9>3NQ:
M*' PX_K*X%"\47>R %GBT!XZ'T+3$^+O!8BDT*S#-=58C*QR*$11?XF]*X?^
MU0)-664]P2 ^#;(0HHG>NU3TP<NHL(?,YY8S1>**[%E:SM:8(LT:=FD_HP/-
MVW(?),>$& 2K'\X.Y)!%R<>^H62XVIX%]6<AJ*"[;<)Z'6F(Y[WT9M%C8OD*
MV=-0[U#8[HFZ.V&*<=I'N$ULGIR4>AMW3"I?@5>_FX":K(*+'YYDN:FF!<U3
M\,V?9_UN%"XA7?-DX1+"]@_*Y7M[ "Z5K@/W#%'T;#M.:H?5&N8^//4?KLF6
M?'(E<J!I[,T!Y]OR'GE1%T]"5'!,>5[;\#&G3^QC35_P_%,+7;X*S]4E8)G4
M:F=)HDF>1S>Y[.=HC12T/D4G%COTG6;/V#B( T=^P<0!XI^&MI2NV%%%820T
M8%,C#=A*Q32<2C&YTM=K>6OMZ\U<5IO_$>)]I$ NE8D@BB6.6R-"A0@Q"^X+
MF!!76.8@YK@C]8UQ_:_5VE-8!]]\]V4VNW__2QJYP_M?:IHQ/ST-Y@S+TK/^
MG13+IF6$3FNTX\&TKDI%;'/2UW$*(@7#$W1X[^ 1C"3,-B/%[B:+PZ7X@#O@
MI/JFO,O?559(HE9RG;)P8M/1QH^SLV.+'GYS*[$6MP"SKTPKV>T=H)OM.TG]
MZQB2CVC9'+53Q"3P63N6NARVTD=P;RR_NQ,0B+JJ0A"CR_R.'#C*MS&0P(GE
MH M BJ L."3E1@L<,6H7BP+>-[DLY"H</+I_;UI"@D")DB,5\0KE2S0!B9KE
M>MO".<R.9K A/J5(97*%.@U D@B^B)%$1$ODFIKGP%53X1FC/V*/4;KK'']*
MXC4I[L-S)N@'HPD,-XDZ$]T9%C1ZI?(%TX77(9BN]L([EN<$W8'1%<?V?X&1
M#=>1QO*^/*9OO].ER7DB#7F[-N#Z)%RU;P>"7BKB&XB+9> JCIAP4XBR$R$1
M;HZ1_L>* ; < "XDEQXYX4$#7)<]EY_G3;>B*DTF "$,D.U65L2FQFLT2:J
MT>B%0N!'/\(WJB @LT!H'AQ&.I.:4FM;GCK$T;<;"H.5K[@K M_L-FATH**"
MY$QRI$U(Y.2,I$&>UU<%JLFHXP&*139CM)3$H>%E@9PJH0B2UP6AT6EW1*FH
M$-W2]HDO:F2?YD%K5J<V$3ICV;'ZF&2*Y+W#LX9M7?I@ES:\0SZU,^L<T5X^
MX>(Y5NXPVOEG9?A**T]+3#X*H %K39$"'2)M32.T(62PRZ[;B&.11U4=UBH/
M%R("%:DY\\AJZ"6CH\D F\[,@T(T8= ;W;XC=R7/AU'ZX2E;23U=OK+S.E'*
M00HKC$6]J.2@.@N/!"O!"!U,(H6;$AEM^Z9OWLK[.>WRV"H0FZ]E&L^#N[N"
MN0C_!>NH:0P36[ $%]$NBK8-I."IQV<DYOZ;MA@?WKMW8"3TFN$7$4%G4O0Y
M:.EGT6!%$S4\;N-"B@Q/FCXRA;7X@G:>4_J2#5/ATE$3RU9CV4+5E_YNS[!N
MUK;7*<=$V@_!DIR7W/ 1+ MIS9=XH@43Z4"%]Q1_-\M%)H39&=@0T:*!:X#-
M[UM ?*</WHW.OM*1!?<CX-Z(\&]D^"VSS(?4%:>$B+.!FUXXU900+2P)JDNL
M\M\;8^0PN:&7E'0!CDV@<BQDU0>K[_BAD.'=T(4G6I'<T%ALP-R"8?Y18G#G
MIG!:<F]#N[!W=0X=UGZ!'Y#=$[6-[B(7%::,^(=(."_X*@4OSW6!=.?2L;:Y
MTFP;'O:<I/8T-@YG8+U&'@DVH5D0)6-X,CHUJ!+%/J4,#"HF=BM#ONA(Y8LS
M>746'FP(J(:M%S;FQ\(O=*47Z?URRL.]HW,>SS$KCN"H%E#23I%/#!\M+UBD
MD[P'.>L(8^< 9LK>-_1HI.RAT>S66(CY9!(X'#]P3.@W#C\J![J\)*5:<!2H
MED"4S\:FZ @NL>MP&DFY39TSTU9B'[W<[EEUHXS]4G*EC$9:LO]Q;LCU2IG&
M&^DG7(1-(?\093ZL^W!<]W\_"7[UW]?-13#)RJS=7S1[ZS*8P&0;AZ^<AL%7
MFD+Z1N>YM\J5C![/2+/@;D_-ZJJ$C;Z 'V\_%9A*?7L\L_0Y]>VFH_,<1F@=
M[M?4JEWCYLK\"T>8$CR[,%CIR( ;?8\L0]A->XE7H@^<L=4(S].]X0)9&Z,?
MY+;/\[(RQA4%3Q+9Y6>8AX-Y''Z&>5QKP'S1J^?" ^]EWN_1L:9^R:5T,IAA
M2FNKCGE+B!DIJ!SAI\9,R%H[%6_U,DD82SX*.K%AX:2T*YW!'8T\0'0A-0"Y
M RF9RSI-+D_?JKU[N0RW:S/ *A$PA %[DF_QBY^J_&USO I>R#^X>0C7>1F,
M)LX5;E'Y*5\%RWX'AO'%NV:[D_+*X0.45[[YDH?FFX._N+[R_@UZMZ::<LD6
MOQN+ZAULF .1Q"XCIP>2]G9<):XMCNN.>FW,5;MJ\:*Y0/"%9O*(6-FIWJ<5
M9>/\X%ZZY#YSXCH;N<_D-WZ5,CIZE"PJLWN+LN-$#]/N>U5G O@.W"#/KI@^
M1&R>2IS$J.*PIVZBOX=ZGE_S9BM;8;TFF-H9Y=>F&QA%H6&6*#2@SK\5Q]7]
MDO#P(5RL(IR/ 4MA,.](A$=S'<&*1A!C*8R(I A>1EN<2?,EU'8B$F+>%D5-
MGO"((WT:->*@'8.=T?-BL&L/5S7%HK9FKAL#:6@8O7(/"J(8O_;8HO(R*9RF
M79]) J5%&B;L TY<M"[1$P(4 9)6I 78%8(Y8CLP#VM;MK=GC(@@*DS)%$&I
M1Z=:$O(_K1FR\]C8X:_NG^Y/UC__LAHC9V#9\S55&-^@)S63K[/4BY:6*7&C
M>>)W2D=)A"JR1Y8>7K<A7 UVA?;%61,<]J+J?;BZ*N<Q5,T$Y8B^SUU-@IGJ
M(HZ[5F5M@(TD!*KFO ^M< )@<HD*>G(&?*7[W&W?8#G/FL7HR''R#;O@GR/$
M%D.$."7I 'M>BE.E&FF;0^QUFYR%4_J[#2G1UPL<GV&G%\5>>+T]N>C,P*Z[
M,K@.#^^(B\?A#\4K'FV)CY2<Q.E\;>F6[<9RO[C)O;B?I8<&A2DT8L^_YA5\
MBN0@>3U$BF5UR0B4UI'FR+-LTR/%&%2)O(@H\RGQITM)2,#L:LZAXH;F;=06
MZYN+O%TDO0NFJ&%%F.#;_Q"I\HED):+"NT0#%B$&UR-WZ)UP*G$MG;#(=RSZ
M,TT^RJJW_4&W*5+E:-9*K4K=:EH29#?0)R7%^]2N;$K3.0I>U%W)2[H+6(C?
M"D$TRLY^\</KI&IV\.B[;Y.%DY3$R+=%T^"F+O^]*5(O./@\?Q2@TK+4*5>=
MG)P7MV!PB\B&N,1*R 'WLXN<1,=\GGQ6T;HCJ8ZS<&T!V(O?'O4G,?N]EEN7
M@FR0@M=)41?+4K"5S"' #AXYZQNC CW9S&D+GG3!AXG*BG8Q6J;NO-.J!S!+
MZ\2TG^+\)(IC*LTLY!^N%)?QHW$*M$3C\ ;A52SMS+Y:;+M@.T_+_&LZAT"$
MD"_R-8/$);Y(^OZ'(/2XISD <$7;'5 &XP'3\O-YCHFE;8/CH:4>@?8<73G<
MPK.G3&!S957MA$BK"R=YF&U*OKS,H33?-;4=P>(52NUV?E;^T:S#_%++-O?[
M!!/%SQ A&6E9=2Y%/JX<]BC*,'V:U$O="]LCK7-2V8/'4+2G6S(-Q9+'MXDZ
M(MRX2[B0VHY5&?.P5QC&K'7S&1*OKD7,LEADAGR!UTDP:0TDG4& BUT/Q R=
MMZ=-.W <0DBXJ1MKF=)>Y"QI9+#9MSCFKI3??&0[#LC<P6 C,!V)341>N]0,
M$[2G1M*V]&2 H=U3YM<.I6%=\ST.J,D[[O9CEH57B5V('O%$,F[:)F3/(5T;
M76*DDLXW:8?:""J?@\6S>/HSF(/Q[R6 _N2!,+_U?+ZA7H"V6!<Y]W[1*\;E
M-;L+X?]E.>G+\F&:D=Y!@Z2):DE/'YV<_&\IUN])V> 8J!,T)F6+4M:CCGLN
ME;/19)REM9S3XE3,C4V)4QFQ,*H(;3[^J7K7%*7/>A\\_#*;'1Y*UOOCZ2JX
M-4GOG6V%=V,][7R]4;Y[0&/D&D,! 0Q!6S;LG"1C']85G5R#!BGV, EU)#0S
MNQJ'MDE7[  VTOF41=3:IHY8'(26R4P:,Q5KDJ!(^%$H:>/?8_=K:$ 9N\M+
MY([T9*4TTNAIB;W"X#"$ $G!G4R^C3"Q6#R6N(W\5M#&GC1=IJ(*!F=VZD2#
MWC2>(_&'WY1]-\ V>=17]WCR+1\K2?4IW3!<A$6;-7VSW%0 A?!'N3,_K)!:
M TYHR0-<7T;E=J,3I:FSJ)S&ASS0JC+PHCB-HI7NFET&U"_)A/F6YNDLSQ2!
M%?XCKJO+_4@Z85)TFI[V'Z D[F9/B6/M%P1887^P@0ZOF*\;D<J IYO*Z'K2
MIJ=G92V!P'\'_Z6.N%#OI:M?CFNE*QN#5)R+3N1G<(D#E]S_#"ZYUH -4'E%
M?5ZV3<VV)49D/P;;]@/A,@2>$5YDST"1814_?1T.%$+9LHM-%R,B-=WXV@*B
M;1MB>]M!LFNW<($ WJ>ND0)>4GSAY7R?.X]#H_\,\=*;V3]^RH^RV?/_^=_G
MX7^>5>7LGR41*7DW]WD]WP;OZJF0@8-0Y!-Q&1+_\UYP/0\.Q/\\^*O]S_=F
M-+]_<&L9S9_'W?'#H HCPN(Z,T^)D^+8MLW'O_X&+"5#3$(J0$>L%3A$?<M'
M#!:E'T0ZW1QFG'O4C5VG&1"EIF:HZP%I;I8$Y,U;DX <]MPID\(.VR;N)WUS
MB-G@U"GRH2>%)$20QP9JO0S#SF]$ 31EYBB'0?F*-#T'A2Z24>":"7=Q.;F)
MJ<9)R[50+KG*3QI)1!'K&<;/6O1G+[CRJ&]1DO!F'&B:$L]NFY08,S\PZ4!D
M?'/N&-FT<T%I1R*5GMBAJS?C1A$A%7"5S$M80C/5,-/RI.27."5NH%_I_P'I
MRQZ3OB"_&B:%,2TKJJ%LVC2*X/2]SL6>G^X(+HX3[HDBT3XF\0QS6C,A,<T6
M<69A\+K&^%2VS-""%Y%Z!8().MTH2F%"#G)WQZF5J340TRWD)[<%U\#6+:%T
M$K8+-.N@>Q-<?F.RE^%&NFS-9Y;"1K?+CTAYJAT3<@]"_CFV#[CJ:(EQ#K.3
MW19CL=S0U*B0Y'N?#M_<VM/A.-<"R"^T[2Z-"#X:NP^_@RL>SJ"I3\8K>J(-
M' Q+CEE;UW%FZ<7,]D#FT1WA&+C.U2[=-$F6TV<N!0QM#7NNR#-0F;&MD+;)
M4IZ4.A,K!:196C_>)5_\GE,,+#QN]$AZ06O#C4@H/"SA)[2M0@QGJA-/;V-N
M]Y5C93SUB,D3[PV6KES$8BQ=^+N'5BX*%O  *JQM'AF?>7BHH'!XWW_R\ $S
M;R)5Y#_TS>!#,:'D/D7^Z</!)Z>)!+#X5.@LJ;Y'V )5< ^RL"L4]!['X,<<
MV#3IR.6.X6!,Y[8*VZ)<G6S:KI $7/@$ZV7&&_$U99W$QMKLVGM!1:U(M@H$
MZ[#!F[#QJ".U%K]!<45)CMU18='4\<B5/K?G::,621-O(I1MWT38D+?"]98<
M%?Q1)>NOL![#]X6^J$1(\+80K6/T?(=1_@4.T9^[T?G.2.,(;5*7KPJ=.P&]
M,OF SIDPEL^!^*M)]Q?^):D2YH1GF@VU\,)I-0L.!*:W;W02I-HJW1,Z=9H0
MJTP:,@^.C["8.?T_\3]YK?$<MB6_;O<FG)DHSB>,;]I=2U&=>4'1,Z81CY5H
M=07W(36ZPW60JS <(4*I@%YQLA>NOVT I:;;O$'OU&8=D1J$05[3=KJD:7N*
MC8!?,OAJ'5.91K/+4(MN;(4YG*A<1[DX%2H11U,G[[D@?L5Y[SV:E1W(-,!\
M4,.5RF.+H]Y4--INB4;?C3/5_(9E49% \.QL&Y;A0NA(/4DYTY!+S]^J6125
MIF^=%AU7@R'&YM1%:"UA-SK$U:@%RLTDQ0#69Z7EYTZORQ&.7C@X6 SIBM\
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M5!4\34Y59I)MC?P!E*/V%E>UCDP^$]#8*S*N[S&"P2U 4Y$D7,RIV9_]VDF
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M26*C.OI5GIP$.%?V< RY8F(W!%-I-RL"2$4("WM4#L62'G4'W]%1YV&''A=
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M;%]G64,8X@2;LMGIIEQP:8&QKF?;TQ+JD"'DZ&B6:"^WX:03\I0!2 FCH>-
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M)O8H=E3)WN4M&#;V*GA,^[,CZ9B >P6?'78F*0-R!TNW.?D=?X%1J4_)*(0
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MIV(61_R!3XSS2SZ4B6VBNI@X>;.^Z)CN(ZF;*3_:_ UCE9QAWM.#T0)&//H
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M+28&-N6M4I?9J:#J.&4\2EE\V8A[UW?B%**\UG]"&S5)9(;SB=TAN;V-Z,2
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M6R=T9N5YG%<.K8UK^&17/1PC>K4J+!JIAX\2M#@@N$]+35&RD?:),90DQ.T
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MUCW]@]W]@S6]2L_Z+_$L>@GVF;MZ*HH8JA<3WM:#CNQSFTO:F^K(["9 "E$
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M$>4/(AF##:^W1R_WPX4^.C 2[)I<I['XN7#WF1;C]@Z/P5$]Z:9Y"0?F'?5
M?,S')Q7&)?_KQF7C+ODK@_V+#1H&BD;LB,LGSEG])2^IAW(YJ)#PU8_U:/?<
M4'B/JA KB19R&G<.J!RQ,KQIF],%?OB_]P[N][(!=V\;O'"_0N1XY&) %Q$=
MY<TI14UWV#*\4#&KK148'J"/-35:W<#]OC^TW\]Q<59QVN-QGD\FSR7>0Z9P
MWE&[49$E].K/+SG3[@K?>AZ?G1?'[G$JF[($A[.<%*$NL-C7#L4E=L&W'<YA
MXW%E [I_L!W%KQ_%A]M!_/I!?+P=Q*\?Q ?;0?P&1G$[B%\_B ?Q?KZTSR*]
M93?%,SFJ%U_IF?1>^(O6S_F#=LU6"9!2!\^W _9]#?R='*KMVMH.V'5T%.[D
M4#W\.F^@YUQ==V_@Y:*IYQ?)QGU7-_+FK(XGVZ&Z,;F&[5#=PJ&Z\KS!S1FJ
M*\\.W*"A>G:G<@"';9'NO$_'U!VV]0RW4<>U,D!W<JBV:^N2 _9H.U3;;?B=
MP[O;'OP#;'+53J*4D 2M_V#>)5F](.P_RDBWH<#4<RZW8WR;X2&W>8SWMF/\
MW<?XRH/VVS_&5YYMN_U#_&@ 4_'?Z,Y;WYTXR,;P\&F_*?P*NY+O[=]/Z#]'
M1:<$M2GX59@AU?<"2P,GMRE+:RHI< B!5YX24[<T>:H0*P9G/?G!-1Z4 QX4
M-,QJ)[)[JZ'VZP3=MJVT,5?)IIZ'RW0UKQ^W3407!RSI=R6C=A@H:JVV-9K
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M<?Y-32C6//A_X+C@QRCP"DM+1KGYH<Y0!Q9^2&IU[U).[ 1J2"0'M:X1&!^
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MN,QUV%9T5IE/8__"HJKDF4EWM$UVH06 ;OSO129IIT -P%3]ZH#X=G7VGHG
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MAV0WJ>51&(C:PBWTM+$/VNIIUX8#_0;IAUW<G.P_<IORC5LZ5<OMC'<@$@D
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M>^%\S:R0V,OV!PO[:GQWD]7WQ<Q:72_"/K+T7A8Z-J#)<MP669'"Q?<4")-
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M-3+;1M-ZE(9II!FQ_>7VFB94=K3UIEO."0#G;B)^OBY&%U("Z29/*,I(\K5
M&URFE[@FWB-<5$GH)G:ET)N[\\ M@:)<:HW4%/&<W9%67'=%(YR@O;L2V(YT
M7BQ%-*+GO&(2%)D;ZG#R)LJ-,'L1_M0F3X3/V)8/$.52B5CJ8[XB;C4M"$C+
M\O;+Y'B13?.. MI62=.S?(R*(8E21<(UZB:[V1N?R)%AJ$Q$C8!Y5K8@,0L2
M>W)+0&)_U8"%O412&EX[*'5G\XD<[:7SZUA7#802+%L'YJYC+ELNRM+#;]UN
M%V+WD;#Z$)<3M;21T!DBXI%N8H\[@.]KN?OZ6]G0/3%+K9A#$2OZ\J/R.I/$
M'8Y=@-$&G1#EAGX-\3[V*U].G+MP&[AHZ2B4-C_AIG>>GV;Y0*UD>,#A7(?1
M :<RAYI=,-O.RC+\WD<)A0R<IBJC2X 0HK92C+7W5N9NX,DMZS464J^=N7,6
M7Y"[]G.*2W>@5A[;\"+D$W[?_2>'P:D5&EH:_KK*'$3\.B%3Y-\J"^_PKI$S
MY(A0U.CU_T645O'K%1TG:!$K#JE<#C90AO?LC3]>-8@CXAU2E4_2EY$8M!_Y
M_YR7TV(QN]AK#<A/_2%,^QL?CG[%JD*18I((#.F=VV\YGKT19)D]5JR29_2Z
M5:F(6/FX7(S@RD43I2Z< !]@%MMNDKPBUPXX@:-\WN6S8V<>0^^K[_Q/HQ$8
M$J:2[#Z1ET'A!3EQ%M%%>ZOGU)*69C7D:<]<%=A37GU4E/A62&/M!O%.T$2[
MVZF%G;*&8S3+ G^W.N. ,9@%V-O7R:^U6WLELJ&RW'Y"6PT]_5N2%=.Q\N-$
M[W/T*7>7=Y=[0<OXHRSC(WF-HT,/Z]$/!HR8T2NE#FZ[#8;UNYYS%P_6J?-\
M><E$3_-W0K85XW,?1CX7GD5$9"%7I<PEZ46>R0WP#O.ZB8?K!P1)8Y+DPBN2
MH@VL\I'SA__K?QT\>/"\X_]+,CF^BVK2I-0D!<I[DG', ^6>\QKT<_PU%R]
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M*+A"1S8>4Q[H$?26147,)Y]5@H_7@KRFV5 &%8;?%O]9D.L.G(7PQ7)*#NY
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M(AO67/ V^><W$6-I\H$P]RYIGSSU6NV> [(O*\F]X.TE*<:,A?QD+,KP4Y:
MGW7PYST=U8"=DH./H!D"I'E4;<+OB[*J_,Q&%;%V]6LYP(1/#TL\GKI%RDF1
MSW.X-,[21&>I8>WX8'VDRRX%<W::%H6KMI#V$RIB,(%*#D'9[W6!ZT":+I K
M66A.>(NUR(D:/TX=3IZE7_A:E:%S#5!X89M<-C9N,(LPX!=/PT2P+-T-BPIC
M=%]Q5W)@;:-HHRG/\=$6TMJ.EX&F]I11E*<-HJ13BVA[=/<F<U[P4Y1+_%Y
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MSWTN>B^G;%+/7+E%7FA'0.1?S#6>6NR$]:?:7#SU%GAJAY@KDV[*?1 $F5%
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M<RFRIIE+D;6>-D/V;>Z7/"%Z_O*-]J^&HVOT8Q\[[,)/;T-_-F'8EW3FH[?
M\U7Q%_A-D-@19I8[V(L7%\9LV5LOG,7^O>';L\ 9\YZWF!,KH88]3KW(3D*$
M4@JX*7@H<(()WT\*-+5S+[5;#<*@_M>]Z\'N(DK/=CG$&8JMR81%N)Z2M@[?
M%.9R9VU;E5?@N03BJ#M%[U7!:_C;BUZ&RS!,9:]/QYA0K.;S/MSXMS*<L(KL
M5R:(=_(-I*W.TY+_W%ZP@B&<):NI7]FQU?ZI5I@R7L ?N,P"0V1[VP%?8#=@
M.'@,F\ 5X8S1#:,M/&]9$JRR8[!]<Q.Q&SN!O\5Q""MAICF>G[[EVVL8ET_$
M B/[%I[ '&Y8=38"&,RP738*(,_Q6.!X^>[+#PB$!>Y-E,1_W0I?8<Q.1[?"
M?Z1H2]N($R6?.V"9V3R"!F1,$F/;?M\U*AS!>Y!Z>@^2M@#O\1;@O2U;@*_J
M &[\R82$PZ^QJ[H?WM7?@<"H7S%8\S7(E(#%>##C@QTY8]%4G'=+S\3A#D\K
M&I[WG^"TE:^3N8"/T(XWKF;3J8\*-;KU'-WG7!?)Z"*9QQ3)K ^P(\CA?Z)B
MDU)$7I^BX.@8ZSAT'4SIZF"V!4[IKC5TD<SB?453W_'IN^.G("R=E' "#<\K
MM^&*7<_KS-1M862F[M8AN/[4^B?JU-C]$'5+$_6A<:!3<W5JKD[-U>Z53LTM
M 1AT:JY.S7VRB(1.@]2YN7LAS+XFS /GYS[QY/A-,W0?RJ90LGDP0;'5V7L'
M6[D!:E";Y1BF'6%E/UH\33Z=#K^ M;_9-_)?<1)&]@T328TQ[XF,OD4X&C%\
MAI)\<BV<CR ==2F.YS*4\J@VK3RJ6X=!=99?FB']Q@^'\-I=X[X U9[[?\\\
MUQTXHX$U''7M5MOI]6UGT.H.VSVK:W7;3;?W']/L/WN00/8?1# [@/SWWG]G
MGNLE]W3P"WN*B5;&9Q8#S!REM\JA-K\T^VOA.*+[-FV;#C.+*=/WPH['NV+2
M0TIG3*T$:@\<;PH8XOC!\_DI!L? %D,&3.' D8V1'][-]\D.I_BO-'$[$0W<
MIU$(7IE+V=".( '1UQZS-F^]Q&,QY\%L!P!>\0"\#+@>F7XTPY;S_"6"K^1Z
M[/L41( LD1C*I$D0'78<LWQ6.28R)@Q^"%NS[U$&Q1C7<=DPX=45XE/J!,2
M/5'F3 $@5#6 B9.>*PZ:U5M<V+ -?.@2MF$'MOK&A57QG_^=V1'L A.W 01
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M(#6,WV=1/+.S7\P]*"P=+D_$VFE=^?-!YB0K#32R?AY9OX<_&E<-PZ7<_CK
M-9Q@'3NNAST:_!" P;M:'*B)LL4+*ZBC1M$6#H[R:X33Z[IEO$=8'1Q*9CFA
M]"(K7E0[^, .46W=\GKUC"BQB8$FS)T09DL3YDK"I X,,^IF@$U/LLX=S[N]
M-45H'M+<-PJ'B0TO6UC4['54+RA*&TZ(WA\X:-=+N(>MR7NEJ@6((9RH!]Q<
MVXZ+#(H'AU]9"5]IX+2\V]$3!CP.#@'TU?*LRP?9>LD,FXV1$G)\FP__5K1.
M!K>"'EZHY2BX+)K"84<[BBK!VZGEB_'^\O6GS\99/!M^%6U/;+Q["*D;4K/1
M:?[TPICZL]BPP!/]R9A23Y-@-JE1\R31J\05RZK69I]+GD,2?-9$!J0CN)P_
MTI9(F=S$,+V/QVXV:"H\@4SMG4<SU[%E3MIYS[6I.PN-+*Z1WUT#5V2:4/<F
M?FK9RTFV_LMLC&0!S? $]B:9;[ C/6=CQ(1#0XT 8VS#1$%-"E#"QB,&3](5
MR\SW\X9WWAI<22J$8^Q68SM.-&.NN&X0C70$^<"C$:-(1S;1'=L 4:>;M)<1
MAM%X^T0?2#B:AD1UTQG\+6:KHI:GV,>F5XD^-B4.[2&#K:M]58FZTM992QD1
M;]O3J>\Y1/=$YG0/ 7SXV.6Q59P7>").QJ6TD,,@IWCCW1FVG<27.CFS#EOZ
MLK2E(DB(W-,HQ4E8T T#R',O!,DTI( EVI;&A-FQN'S(<@&HGTYP_[\QK(=0
M]MDMHZZ_U+1+P"*O#V0T?>4125S9D>_Q]GMGW@MJ%VGV*(39IG.>>? I_G!@
M@@Q"Z<LC>B(2H7;,6I2NC5*:.W@O(1%60]&X.K;BL CM=V,2NM1GC,<Y20M,
M\)YW2=2&[O,C(K6PACH0V_2A#,<N@A23%;%@PI7+T*I0^P8"&07.&+OZH9+Q
M;4>NJEH3=V,6" H#? 8AF"7!C:H/"C&P-T!7_^Z"I P')F<;WFN8-U%=4Y+,
M]U=-'<BT/>[#C5:76P]J ]N"?J@],W?5-@MF"6SL!W,W.X9(PMB@O6J5<AT6
MFXQ;:!Z N 9Y+>+=U :0X(!= :M/V2 $B62LICFH+2H;)51MH\B_Y5Z&,(N%
MM%?Z(Y(.ROY-K;71)KX7MFS:EY14Y TX!R!SP2ZO&5]#D&GB=S%I-OA%C:ZE
MD"WXF^[&(5U9W6$<A<*!N42%(G7).X*F;S*\)'ZPR>K",4C,T[%Y0@+NA5X/
MS(#."V@$^H(;-J+/Z^R>\>8X8#Q[&))'W?YY!E:*V6Z?*_Q&=RC\TN3<X9=&
MR%.H%-(7A0&<&]X6A$&=/N#Y'R&\055=GZE3)VF/JZ5O6#P>MC+EW:)QC]0)
MT^S4^$]P.T.\XTQUCLU[ETI'5C!(ZI;BC;_XI8<7C?>\F1R;>'7\GC /4+$C
M,*8C\N]^LP-R6<T.O4V\/VWKC=>&0 D,."H0;6ZS)]1[UGDG3R7$S?R[A]R[
MPF[1TJ@L--E 1=?5IQ;"!^L0)B?FNW#FN]R*N,/;5^J!RM'GJLV^MTR%>.(Y
M 1O>,UJ-5@^,[;>S*,P%_8OD<?\HY#$%-42NS-8"N3\GD/O'(9#[QRV0^\4"
MF5,$;TG>?U@@"Y9YA$ 6+Z17I6$U^/<*B:S\[ &1W"^)2&;S(F4KD5S;3";S
MV.3B[LG3)KBD63H/K)CVJN?+[B]X^)3S:/81%=A0 ;4:)D9[BO3-$WO5&VYT
ML("8Y;'&XC!LZ<8&+6;/;*T0!W,*<7 <"G%0K#%2J D#>?"PUA!TGFJ-M12%
M\AZ>ILO'B*PVWM,?U91:E )%,3B HA"O[DI97%*Q>MA+U(U3(<5PB-_EM(D+
M==I$]8WV3YPDGP^4,1Q9?(\;&'XV:P.DE)/%YA>&<Y0R6JXDWA\REES#BI$,
MR#R3F8LI9'&LU."2:ME(%#XUA"+VZJ"4]+895OGD)"&WJ\Q^C0)CQ/2933NT
M?>X]<+0_-,3-X_9";F6*S4IAX7KDR."20Y;<X1"\_'@724$BP4C.4AG97B2B
MQW)+$<,*#!1329H1D!M0!)*;5&6,97:SA&523,\V4>^$^Q6Z$RY9U#Q+?[\(
M;UE@5RO;O9@>'LIVK[X.NRZZO 1!AI>>>&DO,$G&:O%%)@H1T&SPK9+))*]-
MV7>'3479UH(%C%EQ9N]5;)RA:%O^M7P##E)1K&KQ_0M#WL[!>RF%4\VS1 @/
MX4DYN)-F%J;;FZ8#K.(Q> 3Q*S2Y47[Z'MB4="F/@S[A<Q;<X)T[W@2SZ 8#
M2C0H-!WR@D=\!38SUJV)1]  E:.SXH49O;0;L%)3Y2&*I:F@YI6P7^&X(-=%
MG$(]BKHA>1AEVETL\L]&(X ,/ R_G]C?F A6D<JK\9 '#4*VW5M4(_)7<D&U
MZNX5'PO(AP)2N2B-W\-*(312<B]_!72"X\)DE78V03 V;H"BJ)I\!;Y7G)J
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M%\Q^?HMAYMQDBC6!<M"1(NN=\^PRD Y$O#!]HV@(RSI3NBN!X5S5^ZY.OLX
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M7!>_%6E&($Y%!R>1X)F,[<2@X3KRY6(Y8!XO= U!)LP%MH4-$]Z%18]S?NS
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MG+^5VG%E3(=O M.$++< C;<H!!6._YQXWW'S(^\[<^NXU B\M83Z@=*ON7&
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ME;G)@AN)!9= ) W *!8Y"&V!9N5-).<ZN!R)UGA>T:#2C6%-X/XD!U$%[G.
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MZ&E_VKDD@NG N( D+P')Y'*@N4& \G!V:5W0P61Z$NQF15YIS;$V4'Y:MZE
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M6CBL9X'EZC=P?M#Y^LV2Z0<TD5_AT//,S[^Z<>F%]Z:N!K%;MZQS_KMQ#'I
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MO>'P+/B79UE@K],C#ORH$BX]?O/2L-3!S:J6)LD7*&C%B [@/,/ (@M@:$3
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M)!)0B%A(GFP@3A#BM-C:$8].D6\Q:$OBQPI$1 H1++;ER9?W7#E-><00;8C
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M4T:$8!FA95B0/%<!B9B,LIB#[QB#M,8[U6]DE-;;E=8BX6D>PTX'>4AED+$
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MDX"6>1 G&MBP<2ZBFQT+/5AS+M[B8,=[YLN_P^.+4Z622*B,DRS-4[AGXHB
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MI_ 6-:=#V:RWB=Q5RTX)X\/FH+;LR39S >G5,UN".3S) I!?XY()V'LS(7N
MK_3&W)!O)?P7?),KQI?3Y<^O5[-2-K4Z=$OVA/VOHXLW[U^>QF5<\CC-B<Q3
M;"0G%#A@(=P7/!)1SC/! [[W/-N'^W_3 7/;V)WQ?81/:.7T&=9^*>$,A*@-
MI);BB-HC CJM77'O8D75")]B\+M+.#JHUK;+Q(1IVT\?UHNZF8K.E].V0PGB
M >_"\\V6F SIKXEJ#K^W,E?--R]'_S;'-[J[#S0(&#9:Q_0*>NUAWG=5#8N"
M.:NY5MN=H*_?C^8^9,NE7DRXO*S*&&HZ"SE#XZ&::;5G%#)^Q3P+U%>-UA'H
M!M^DP%<X<T-^QLM>ZHM+>QYPX/4>R,]P/^!TM&J<+\UN6#(R'/V6_86/ZNA<
MB_SK'.PJ.])J/J\_&67BC0X?#!OI)@3FPW3:X>BT"C4+@'QGLVHU@SDLZF:)
M>L)]'19P"I:D'KFYTB>+>JFMPJDI!3> =08?W,CGW2V"],3LU3N)8W8PT4OS
MWR<.%8U.0Q5D2<$SPA-6$,I53$JN B+C+(W"*%94YNN8RC0(LU@%3.1Q1C.:
M%EF<9;R02L5AFK)X'2IZ(U_G@5#@W>F8V./R","6+U%1NZP\^CQ--TFGO^RO
MVDX',_C3@C4(2('WLS.CR9:2S;28KZ9+=V-TWZS];/;_;B>'YY54DY>?)5]I
ME?E&J8JCY7QQ7J-1 _8*+)9V%IDQ<<PW>HS "[ )--OB,5PXC395[("]*2Q6
MS0*OJ<'5 J^ON\=TDV2-M"H5M"&\L^HF[G_LVSWT(52?WO,YOA(\O/T4=.;]
MCW^@O8VVIK+GO71'I(M,N$B"]J()/LZ$%#H_&D_T)_#6IS;T,'"RO^I:_6/H
MU@R<T4T_S#@/C:YR@>L0K:N)]<MZ8P6Y1.'>12[12_P67MF?X/9TT0ZP?II*
MG!EC'STC-KTT;OCZ2)>RM0>[^51Q:^M/89-!INLIB.7428U;LG/F.^@#?WLP
M-6V%3U8+%X"9P8VMH3Z#^3Z&4-=DVUEST93N8'7P'.M8M_U1&^R*.5ZU\;>M
M/RH\LPO^\>O;EY_!W*Z6.DPSC!@9YQVUF#9:0>/:AZ-]K$-/YS!T<EE)#2&$
MW9B!2U7!JNGCCL,QAZ"L=81&VX#H LQUN*VM8 '1G._D!>:-]CN<$CVL;C27
M.FAB!6R"P3BQ?<9F1'TLSYFFJ-3U,&%6:@J6K0X$V8  4FJ!0.$OOB6Z8<WY
M2SREQTQ4+4KBOW0I<@N_.K>72Q=NNAQZ#+"*UD\& [I!X9R<86AF+82B#7\4
MHK_M\5^/W^[]U!GL_>1TU >!;$L=:-#F;I0$O^$[*/IDOSG):;5<PG^FDL!>
M^BMKQJ,7=L; +P,S6^+-">X5-T/W%LRL#UBN]0P>ML29'\T%[#CKET6'.?"X
MB<JZ&]Z(_:UR(;(-J5Z;UV!ES(<]+3B(ZPV6^MGD%SQWWFA=[&-R ";&O(+!
MPVUVV0\=QNS>:PB8W:;A(588,#N7@F@]ZD?<UO;.R!?_R,ZT4EI7>)U1BTNO
M_4?A'],^$-GK:&=)P6ST["L%/WUME8Q$MR[4MN68NCGOVR%@"/T;I]0OBXOD
MK:VP65W/[W6!-RRXU #C.8BY5D48*YS/X:?.D7; L>%#S#F5S0S<Q+6)KU6K
MKI=VK95S/?E:Y/CJ6N3[KRK>6FMW;>W<>@DA4DW(C,4R"6E*(Y:6299P$:M(
MI%D8[5WQGNO]R>%[ IYQ7B:,EV%"XY+FJ0C#. LRR1.98G?1W?(XMQ^ KUYN
M1K^?'!^\>\\PT0!C1N/49@E0*Y:UN"1: F%Q_ER=H<?V-YLY.'AQV&4.^AMF
MWYHAH"Q>@E!>?D)K<W]R"(L!:G5>L7WTSEAW'8"C :=O<$6=LZ4-LP\O9U 5
M\$X_9.:26-W@6IOQFMF4B+[;&(=1M4Q)9P+TBV#O[&^J'[_&=OQV H@=,T(/
MEKYKW9FAVY."1IOIJ^87.3VK5K-]N&^:RZF.!>+'W\O/S 3X[-ZU:VLN6Y,^
MDY_]+&Q__1T>O"/O]R<'!W_L3[ 4H +G:871Y#FL"#HC$_T+/Y.(0X4[V_S>
M"Z[B1:XMQPTGK,ORZK^L'_U/C',T9Y_=369_O1C^"N=@*Q[D_KQ@$ZKI[9=J
M7C=G#(36BWAC#NM"ROGD-8:C2]@+#)3J-?WO%1P;C)8.ZQ 8_\^JPEX6RXO:
MMQJ_)0>]%I9_(:>+\VKR*WQAB>;FR4&GF\R?G'K:-Y9'.P-'XL7K@TEI*YWW
MT<S@&)67\(F7JZ9>2%CI0WW&4=V\[*+EWH%'&P]4&&>S!9RV>7WA^65=&KA;
M/6?F$F.;#R(#FU:7=IU:<*OLD=7^M/VJ/X/>@GPV.>@642?FYI.#U1EH&+OV
MU;)?\G>PP_-#','[/B/?3GZ=E?_L5J[[C+]XW*54G&K_#73V7(&'M0_+W\SP
M;UIMMR9="^=,JXC%%*9F(O1P?N7,3-^]JGI[TM\@_HST^F+@3-73JO:,Q78)
M'M09IE?[.K6APG)+V_G,I;;SC9-5+YI*+AGF[\')FN#[?=\5%US.S]',;+>J
M1.?AZ:1NI\ZT]IAXVL,;2&50J7H#'U:9/&S9IK;Q!Y(-,GN!<$H+_7!WB'^%
M^&H#72F%+A$(9N?"5#IE7B]A6^=+<_-K7QQ\GF739Z^2@9[I'<_!>*P+!9N%
M3_TG(E#FK?]I*^\Z#.#N.ZT[M.SVB/0P\;]E'NL\(AM--B-_5_./VCI:BS'8
MA>@B*3=4!VC2]6(HAG$VN%0GGR1?UHU=WUD-FL)4[8"KI@,_':"HO=0RBP/Q
MEVJ_UU1LM<0+O+:W,8RSQD_:8&BOY[H;&37NF=2[V$&3NNT<N/9:>^@9(G;+
M.EX#L=3*&T1L:7*"1CW45I&Z()H%"F&@=68RF^:(7'';8-KU-HS!>P\D_H!C
M]B(E_[OML6,]UFWM?G0JO>WOV^$'UB(%)G8RU7@O+4-]7!J-Q3Y,!<JC=D'P
M/BH^#(?OF_/J!<=TQIIKT<$B4FN*&O")<4/L6>OGV.78K?(#89UWNLF$YK#@
M];(/OIA\NM.57<ZAE:#CQ."3:X"WWIQ&&25F46TPUKA":)YCI01K6[#<IB;J
MY6FN*5O-N8E @>L&(G/)IWZZ;CTC=NALGQ.#1CIQ>0%G;?7#9Y.S:5W"1]W$
M]*O=]P4"U:IR99(>H/<OM+"V,"*$=."B]+,VL<0I_.><5?/A@WPL'IXLV/&E
M;_=<!7W4J$)4HWAZ[#'"8&"?ZL @N=;%>MDZD(=S:X8 QM9%P,UQ>S;YE]-\
MW9D?!N)]'8>^,HH"FAQ2+AWJLONFUO3HX]H2_25(J+9FK)9>P>%=ME\!QM@;
M4P\<3[7-Y*['IVMN[&7X$SC78)JY?G;Z>JFD$SB'D_LJ6G(MZ(H:'#ZNC523
M2G4AZLK>Z@PF#Y['_$RM] V^ (-?9WUUED,'$*RP616^J0]OQ4G_&C?:?:C+
MS30D'*_::,;6TVC?F;;SU0<\%#0$P[@.(G,O6_U4D#9,6<!,OMCDI!8FM*H;
M.96L-:<!$T=669K7&KEZ,Y<P$U 4F(?JM(('IX2I]K@>./JM9#,85XL@1T-1
MN91KZGY_$-!>0^5:'>!A#72RU"'.UA.0SOSJWB6&)IU^F#5<M1VTY>;Q1V/$
M[RLY9&:!J%L5@EE)MUWX=@LIP&5:WUZKM2UFJ\NUX5*:BZ'/Q)E_&!"JN^^V
M:T/< @-G95W&0*>?S,=J;W6Z\V" S%?;4C\RV.&K .;;,,5^V%BBC\7_^BI9
M&1C>=IU W 3W,-!D+;P4[Y36Z#'XC0TVM&8T[;Z-. P-B]ZM6K<Y=07&1%.%
M>) *HS^NKU,PU]&P',.38*0PF4Z9!K6;23S;C&O8D?LA\@OTAJO&NFY.\DP)
M@ '%2R'QQM9*3"]Q6,1!ZX#O?F82PT8N[&'2I0[0CREDKM7 ?)C7M)AQBU(%
M=8^5+? >K(=!.]N-^.N9=?S-.9ANYF'X%(,JT ]U'I]..G90 J-G[4Z:NP1]
M?UXMV'1SG8P;:6L1L)K3E=C8#_;'I*LPU_;Z.1Z+"KT+H94Q6![@/A"89/5)
MXW?P8-HK[P\)ZI79&/>;Q;(ZT=_^ID>;[K_@["^[9R/J#:U6F-S)VBA[9 96
M[:Q?&%O0N0/03\N;:J$7U)9#X5YIO+,NBX4O(D-49T8*&R?3=YVT(&1$XIIT
M.*_;F8ZY[EN4$"Y0=^;Q014N-+Q7H_Q,G>W&A,!HU#_B93ZMP/P3:-G#M:'E
MMJY<K-Y3!AJJ;$'2'7[$0)!-R1=^LUV!56P"AM8- T58KY:Z0A@V0+M=UQBY
M@U7' 4@8G$%.61L6)HLHJ@J&!K>^K%=@G0S%9'FY0,4 X@4FLE$;_91=I45_
MH]JQUG/IDN+NH/JI=6,/FQ6 48.@5[[)K%5 ;TEIC;AJ4+([PB];)F1U;K<O
M+2@%>.8Y>%]U8\==8FC?H8%@B3_)(1;CG&%T_,PXU%KNM":L-+&!G9[S4/3!
MTQ%W4PYE4G1FL9V=9M?)^1;=#N_[N!7G?RR=KO!K _6%H3MJ@R6KZTYP%%\_
M[-HL[I^/[C&LQ5Q,[0UP#D-"Q6'@1KB=VC:U)M/ELE[6G^W\UA!OVCHWHZD6
MS$(TM"*P._L);(X9ZA+XCVP<.*:7NMYYQC,.EC5'8Q1<*RT+F_4/_W(QT"@(
MP@T8_[:8]E#_N'%I.=GOM5NOS]9ON/ZLZ>.C3XSS6#783PPFW%VA.GQBM!B6
M13H]MN5D._-7NC*0OW=C6-2+3C%H9_9"ZB(K^:G2\@C/81R%&OLF3H0I,\"R
MJ3/\>Z?FM+Z!\X()X:EMMXX>;:LUA0&RZ%H4JQS<]IKYZ5NS:OMK$\_2T#3H
M/(U/%=.2O7%3=-&M===U$]$R8ES6,"YTYS$NUV)6UK G(LM$+&(6EP6EH:(E
M#50>Q1S^?Q;13%R%<;D6L[)>8Z$8E8%*LR(4- HC)D,1Q%$.'RTCH>25&_ZP
MH!:T^ZXQO"Q_("AJK3%-#9DKT=))CQG[$Q,;)A!I[?1GD[<ZPH&@5HN;K4SN
M$@RI85+0F= HU_ "K?R$G.G4DZDZ\!1)YYKH>Q81J*MV8)+J>+<QDD%SB$XK
M>!X'WAP2?\"@&P98,/IW@2F7"QT3Q=HHU&-PAV+W&U3F"VD($UU&9]_/8#8P
M6!@S? /^"N<>K;#5?('!&[Q;:X'W)MSJQB#3Z2[C]-@%PK1,]ZH.<.-6C(ES
M.W5ML, \=($X;!IHSJ_T"WD"/K)V6ZYV.0U/@ ZE7>E]]I9EEPI!*]IBJ;8%
MP+7MB,O?%8&7;,G/>Y:#+KSE@5-MB&O#V;!)#N>,7QH[IYI_TA9BASRW!K6U
MHBJ/AM943/-S#$/;,%:K$0I768+:+?6]F&U&W?9+]QEVV=!0WJ$T;?J%VI5Q
M@W>Q_'X#M.LS\*MX;20=2Y;F]A]&DK5P@&V\_'L)?NW?%_4%;"JQE1?+BYHL
M*K J!K*N60K@)$SU8\PW[!*;U%(U<R2^>MEK,'LK;0R:>*N>%Z)![ 3\]?:W
M O?+S1['K)4'2$:S,H6MJ*D6\+YZ;F-Y_EYUQKR""=ME \\*%FNX,JVN,&AT
M.H(,/  WWGVC66 X[4<]!%1$+@J!0>=/K)HZ>-X@?8&*MV=LL*F'I0GNFETQ
M.]?[([#)\U:'R-&I<$=LF.Z"%8+E-R0&)D&MW?.-:(PI9O<C&RZ)94W[;Z N
MV'>X-= 5NN+5?UQK  .U'4!O7SL'[IMCJ@^J K\]I!I&2)Y\]:H]Y;MB6WW0
M-QPP+[/0EP%U*:'UDHIKPG3N$K@B.>'QS/3I$H%4XECO/O/RNFNOV4RI=+P]
M1N '[^&:;&?C*M+J^6]>,;X)A71 +TQ#$%&U)GCQ/Y<"8Y=&1;NY7JZK&Z>'
M;%&J-XB^NFF@B[4<UZC;B=/&_CN<@O]I?T#<8^ HYSJ,Y-U,WF1F$E2X^ZOY
M*%X) O/^^G[H?FE0K&"Y37OXCLGOMS]]I5#NB4C0AE1H.G%Y;BL1X4?2IPIY
M(^5<WTB^C%Q=#.FE/M<$9VG.2O?H]4.OC;_N2-W4$G%6&(;!]9WH9=7W'2V.
M=T7V24X7?,<!:(MS <]>G%N?IT'/"<3$^!B-%[T ,\$"RZ:7EMS'9.V-FN!P
M])L-=BX/D(#BO2EA^P.T6A=WV]IFX.%2?O+9V4,B*)_MVZ"CL5J<NAD4A-G,
MP4_[0PO(%E58$\ALO+?@6V/@!@#CX8T6#5B-H'>T7)S78&W)Z=*W&F<5[RW&
M?8L:PL+-JVKW,"6F\9*;9:?V<("R1X.QN_?6M?0@P^_Y"WKH%A(Q%'1/@$&U
MGM>;/'(M%D(NM;%Z%9YJ ]-@N>-,(,%#O71Y28R=FYR?D72UFOI AN$HG!WJ
M\!-S@3<L2+N4!&9([%,G'7[LZO"DJ;?VL++.4O6MX W3TP<TH;%;&<^J]1,N
M.R:<U3/YT,+I7R&X<V_UBAW]9,[S&;KEVD;27%E=LJX')+J5-DY$U0QOF [:
MC(?&D']IE]L=*\-ZTS_-,[],??*E.5>82%C6%T@OZ-]$AD'.CMS88L_ IIQU
M.!C=7J-#7V(I<H6WB\TD(9&8B7 9_*TG1![EFG'S%[:H%2.Q8GGN @-6$#J1
MT6_3J;8^2X\/,)1G1OQ<DLS8CG[ P)JL5U$L8DY2FU9?(^-X J;1CPH:=H$
M@W6RN@TM%73,C:FOX5$FINIGT,(B3P?"-$B/:>\ RUU6\^H_*SGT(\ J_"()
M'/PNQF,R3LZWZ%)[LWJU/#<B"S]-+ICE<_2"=E,MAVAP+<_AN1;.:[V>+HU4
MH1@L70*V8S(UKRWE7*K*PK ,18*VU<QP5IW-6JZX5DEE"R9>]]O^85IL/7/
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M]CM25G,U8C9:%S-XAU0CP<V+J[EIX& @_6>L,2R[;J!]5GJY'E1NI9R\KD$
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MA8>G]]9US87&<@B]$W#P;*['?K5G3G,'&DG0OE5M+M![Q$H.J4!_Y=<K4O*
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MU&IT>65=O-34+4XWJ5RL,'*I(T$YLO:2SK4)RYC<E[^O.Q'-W)]A[P?GT[C
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ML78.3\*?_MF 9_SQ>?/U?.+H&OOT]N/9]@X\=^?-^?;..[&]OL%W=V FZW_
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M!?FVW&-1.A$P]RC("*0K)4$6:!85%DR5PC./0\@8E?2^,"J7 9'C*7C NK:
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MV9-7/7'*#XQ/AP76 $[3YS#)TG(\+MULB<)AZ1.K.0$2#,>3>JU+I;@DJ?9
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M")@)IH73C*Z\8I=[R-2\8[6%.O2C'Z.->J;/^MALK:_M<18)5C+7VP4X-J9
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M;;8L3S*KZ.4RSOYQ7<)9OSR]M"HTJ:O/,@I$4S!ECH]/P8A-(9/62'XJK\Y
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ML9].@+N7E<Z@G@TG213DLW[63**:MO'_II)9WRYD/K^AD#J]IND%E%=FOYZ
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M%LGCAT-J+:6+A2Q#+&0]#$X.^KVWX3@D%_U-R94_+I'<,@AR0P)EM9Q/*8Y
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MOY+Z[C:,^RNK;WTXP$IR+;U 2N=:I-H[I!WG2#.:#(.?G-(2K5J=80QO,]:
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MM^#6NY<_J4:XBB-<4IV,@J'82I>K?=?MQ=I@'-]Q=B=.NKE(R,K&4L]T%=K
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MK75\TH['^5 YU$[:\*Y\:>^"*V+- [K95J?6/8F]L@C_>@T@KED+W>,<!@C
MUSXK8DU;^62Z4UR3/]NH[<*[>M,,-GI#ZOIA']X'^_7-]EK=8;]FBP#5?JV;
M+KVHU?'M80:N6F;"_&]^$>Q>@=)P5?YF-$!8K6&RXS=-/Z4W&E/K/'_3!/+U
M( <&Q;.*G;M\0X[4L;!5\&<\!,S)EX&DAZ7H]@<(1$;+MV#!:A=KM%'[ '<
MP Z*4.WI)3ZV9WD2P]Z5A?!-H*)8O*J(ZRVC,>$O;_OP\6DSYN#,6HZQ[+5L
M.U_?.8SCR_L>1GMIK6JG+=B2%JR@&\(ZQ3XLI8?7]C=JV[##W;,84:_$MF(:
M_6(16_U![:0'JD\/:"\_KQ]S!<..CZ.+RA7J=T<; >\<#F /?4$Q<'7O6\O#
M<$]ZW6^M4$:#QM'K\B2Z0&+?8LW%")S9^=9MPZJ7[X)I';<ZQ7#R.\+PI V4
M-(BU$WO6Z[;;H_>'<K5@*V"PQ3QAPJUN@&F]M[[5;@W.:O%[J]S*LOK'Y=G!
MG"S(^79>)GA7B"<]T/5LN5'QO\/623$36)JN+Q>RN']]1&?%&O3[W7P+W%XL
M<J;A#OR1Q@,8R8>"<V"/HSW.G'A! A/"VI@;%GL=1$:(L?E_KO?+_'#:50:?
MK='>70Y;GXI:KTT"UJ=9QH;N24$7Q4J7<!2&ET@2+F@=PU *@F]U4L].\ I8
M9'O8R_SASBY0(U_W#H:8T:KV>7AR B3X>4R]%QL)M_[6;0\R:7S9^/\*K@8Z
MZD0_X;!!L]6?@6F79Y!#0C*838:>WS_!'1<'IYDEYEHS%SQT-=%2:4T(J(,1
M)YY2="HYP_()=**@";D;TKENJ_V\@X7>+N80 XA=%WL[Z:]NR8#][79KQ+D7
M-@Y^=1K11P%CX/#>\SK84?6C#P?8>*948,C2W(<W$(.L2Q@Q:YF324G,Q=HF
M$=<=,@5%+TP*/BELHL$1; ).00$#DC!):DD5"R2:BA2>B!0.#PASG%O*0560
M%'&2.-("C%@J>.!*&TN#!U+0,TAA(CP'3;!5#YNUK0C"%I:]QLJ\'E*0RSC_
M(E]G!P O@$X@-$M-8ZQ;C&%FD;0QH!X"BC##)ADP-YU6"1/JF=$B\.3I?*_)
M MEBMZ"U_#M9%2?*DU-58VO[P#N)H[$>!;!O$3<<(\,T1\[J$))*GCFSMGF]
M4\)%#MFB&80Z)>HI\Q+4!!Z2==KD#O"66$RY4*(BA2<AA=W# ZI=3-Y19##U
MB(/=BHPT B5,I9&P:=+0M<WYZ83K4TK_5>UVC$!3IH"+G9A @P&=^WH:XFQ]
M;K:Q<_5=^5&EPG5-F:Z=9@-H(7*-&FS^A'-7-"Z$=X0H+ PE0@N'/;\IU5W<
MG6X_Q\&@-**!@C^ #MCJY3_^RE91/PO*5TR]VZ<[NU^SYYG6S_?@_P!DV*C$
M4D26*8(X%Z I69OKW$KM2!(XY4/Y^4"VB!4UWQJZC6'UQ%84H8M84?"S _9G
M]F8D,',*H_:JF5+4CQC95S<LXUW7;/6,T866,6=+WV2,3MF:8-:==GM? 3A\
M3IMMM[NGA9.J-@ <[?9L[ZS6'_;SR5!&KTO.K1KH;;;VN9L&A[%=".>='@QK
M-_IF!Q;E\.P"$S=JEY=\]FG!:$&;XU4H7/PG(U7]3=E!\UN<Y+/^Y[)7<Y0-
MBR>W6-?OMH>#^;=<RTIY(D=#3IR_M#Y3/YN]24[-842N%^U79!,,]HUMG]JS
M_MHOEYV[K0ZZO(179S^?%6XZ@YE16&:F^_H6[NC'R>#?23]0S_JO^SSDRT%2
M'BM*!5(R.L1UC,@8[1%8^MP*'33U^.KYQI/P1W;#3[!IE#@_/,X*X'EA08Y=
M:[WH\UEHJ9VU.E>UN'S-FPLL>MP$?&,VA"1WR;\79H,9\Q"YS(+>+I=YT<1K
M_NH'*Y5:9I;XW(Q+(IYGRN7[4H7)P2:U[4LJS"*)F'=-HK\0@JN42?^@XYD=
MC'0EW*34 7X0SG;;.)/5IKVL--RFK/Z-L[U-7?T7LV2X6K(%EXR8IT@J?]+H
MQD\S]*W[M+2;2PLWD,/C+0R_"] ^1/^A%[&:MR2S:CD?F#B7U';G&1#1;7Y>
MBS_JQ6[OT'9&@=/W:1'\TD+U9TWQQ03D+Z$6\14WU?B$JG!'/?\CPG%]\/KN
M;^TZW6\WX%WYGCU:AW=^:N[G\6Y].*L?>;)_]/:L\?E:??#O]=^_G.\??\EU
MQ&'<GX[VSO>;C=_?M^O'?WRM'WTX:YS_?0SC(U>Z[N9N@R8XB@CQ"G%E)3+"
M1R0D?,ZCH#'-/%%\NB[?C]0)H4*;59K;XY:_KM!FJ6@SR5V,$I#?"H)4H"9W
MNR+(6$F1$ Y;(KC$N1+ZO7L45VA3H<TCH<T2JJU7:+-,M)DN B$U-]@:Y(7U
MB'MGD96!(J^\2A*VR%JYMDGX"L'-:W!VW=Z _&&FQUPWQJOO*+UT>^NW46;1
M-FQ#!4MW@*6]:9/+8TF%IA$920"6(F=(6\D0%X%B%G-+:;VVN:RR6RM4I:'B
MT =JT9-:WV- Y['7K3AW^9P[,5\8V"C8,8$4%1',%RMSLUZ!B),Z]^I-/H8L
MWS0E]->*?U\N_RZYQU+%OP_(OU,& 5-4268\2C$'[@7!D286(^N43@:+R+E?
M1?Y]#<=*N]V!;<\*/'RJ)JTOTPM3M;!]:&/IE24(/2Z<^TN&5&0"2TF0H03,
M)\TT,L3K')9-1/!!>.G6-LF]*^&M1FO;J@-X!9^K!Y]+/VVKX/-AX7-BS1KA
M$F-.(L9S(5'M(W+<2)08*,/$)^I-6-YA7(6>%7I6Z/G0IX<5>CXH>D[Y$G34
MS.=>SH(QCGCT"1G.&"*:,Z*,,2PM\W#QB>'S6C'32W49YQ0W72@A]D=IYK>M
MARIFU4.]7 "57RM_RI^L^*G:>*+:IUO1#5:QO.F7<<%B 2# ]\[WV-[1;U_K
M6V\!!+Z<[>R&X\;Y(=G_9^^\?KQ'X+NC_=;5GMOMULYN\ZB1"Q#__O&TOO61
M[^]^$ VZQW:V_F[O']7/]H_^AN\:QSF=M[ZU30\PDY[:H%'DP2)N<YQ 5 P)
M(2/%WE@NU=7*H3I1L#XU&)E!<@[W6>&"LE$H+8SWXFK^[Y\[C=_1[O:G>FWG
MMS\__/YV]\-.XW/M;6.K]OG_[7S:+;_Z;>?3IYU_/C1^OTOMTYM'='D&S":/
MA08JBA& BSMOA&)44R4D31P_8K)YIL</G2RYLGQ:H?SR)R%(=D"H$)B[7-W?
MIMQSCB,3/$<D>FY#E"QB?2W!_)9H^Y2%(?_L @[G J"UK@,A,RZ'T0'QU^SV
M!N57(,AZ1<+ZI5J>@TNI['90Y+V68#DN/E0\Z-K'^,UU>3)SF=8>.[/]'JWE
MA=Z@0BX_ 9MN&":>4T_Q9]4 _78;]BP:H!<%4NZ9N'VW-L@W):@_6HV:VZY!
MW69K;) +KF4@NU0O[=8IY,^PA?0MEV?V>KSVE<!/D0+]='VU/\=.J]NK]:,'
M>P3F"#]:@W$9K%:<'^NYK'33^^2S/EI.[/,;Y)("%TIOJ%EQ=^ANUE[;73M5
MT_(W1&MWHMV; SA6S^]9MV<9NN0R)ESES[R2_)GL/27,<X:QY-%+Q[WFW'N6
MB/7)Q=O5&IX?0)=="V\[X9T]:0UL^\]H^W%G8GNND /\;JZ&D0/\.UQWOG_4
M/-H[VJ/UW6V\L_N6[1UOG^\=[W_=.VI^W=O=$PWZY6S_F@-\^[2^!?/ZO=%J
M'.U]K^]^%/6MT-K;;;3VCS^U=G[_U&P<?67[NW^T_SW_<"D85OC<ILLAZ:5'
M7!F!7-*YQ2H1..0&TDDM+9BNRNBK$.F1$(F(Y'/C*.,<Y\1JBP5+FAEA4PJ<
MR *1;A'(4"'/4I%GZN@M&FQ<)!*Q( ,"\8&15D$BHST'8J746;>V:=@J52U8
MD@GWC#5AMHRZ0\]"$7X?76^8*T #4.AES+I*Q)@'UMX&K!23T2O!2?#6:F65
M8TI;2Z)+M^WU6H'U$L&Z?J$F-H[J9P=2*HM52DB+W!7':(6TQP3QY )/T5D3
M"<"UN5[XO\J8>C&,*C48!$([*0+ED@:#M4Q!!YP-/XS9?*VJLO.>@(''VA8P
M,#F@*7(;E$..)6!@ISARRF&$#17&$D:=6<FTQQMTKO$Y+@PV_ICOG_.5K\H%
M^RE^Z[:_%:ECEXX0SEZ=%Y8_A!?V5N+LMOZ/U5NZ!<294M)9)05F)'%-J?5*
M,J*$B)Q1'O$<O5-4XNP)Q-FE$F0T29:S&Y!.6( PPR#6#)<H:9M(E)1J[UZP
MV[)BX4D?54Z5)81C%3DGWMA(E*>6.:\#</0<C;1BX:=AX2G_'XU.>IDTDKD"
M!\<Z(J,#01)V$X?@ ^9F%5GX-13WXAM:B?_4^F5 1Z>;.]6&8;S[P?!S= #^
M83MC_]]2)EVY%>:!> S \=91)G7@CL%_CD2GK>$ YLXOY?AX$IG^WK9Z?]OV
M,%;HO1!Z7TH[Q1RVBTB+HA8RG]YHI'-+6VT%-5IC8YQ>16]"Q;M+YEW#@HK4
M:\^9Y<IC:QCSDK!(C-&6\44.6BL>O3^/3FE8WE-FDU9():P03]$C0X1#.H+%
MJU.D(0*/<G'OTAK/KTC2TP7)BB);9*9JI5Z->^N/8?ML:3.NC..YQS5!!VLY
M9BDF$-'!6:.<9I0)KZ.E9)%SU0J;[XO-A]/Z4Z!1I*  EKT)B$O/D+'*(T&$
MI%(:@Z4"L,#+*GM4.:]6D#\)LR1BKAWL/(]&&A(BT 0S,1)+M*ETI\?ES^G"
M$"(XQ3Q&.H&1P[72R'K&40I<6",!5IU8-?Y\U 2CY7>1O25_T0V6?5/;PUX7
MA=CI'K<Z15NR61K51=S64@<JKZ6"S1KIKR?=?BM3Q)NB<5KK6_PUY]P@MC$C
MK]C9?LP/6-O\B?Q\ZWS"E^%GJ]N>;U91=H\0O,,,EUQA'#"7('28=-IRAE,0
MVM"%HNPJ:7-?:?-U6AL4FFJ!I4,J)I V,C#DC.#(<2*#U,G+7)+<Z'O7(:H\
M::O+G\I([U1*&GO!H]562XX5$R(EE6)PE3;XN/PYI0T:'(307"'%$D'9TXF,
MT!HE8I@T"3.N/? GO7>9Q>?G27M2[F(;A,XYIS2OQIDVG:BPE%E7!OO<,N-$
M.F&)3,%C[B35P>2<!>-R=4? Z4J%>B(5ZJA^EF'::Q*,B,@EG%O%X8ALX R,
M=DF,2=Z20,%HO_^!1^546UT>=5@2QI3@C(+$-LHQ9P*.2>@$S*KQ,G(4*MY=
MHGJ5>??TP,+_..>Y4)Z3B"=FD .E%UF>0C2$42S8*PX'>[H#RZV88B_7\SD9
M]GS3]F-9T"_$7A$#^6K"P7;\H.MB[[85KBI#^,X(S@-5@HJ@?!)<8.Q RTH^
M)ADQ3M2**AWT"0![^_3/W?JH;\O; T:I,=8RQ*DTB%NPA8UE"9D4H^?&:HF+
MXY$5LH<K-ETRFV+K0<=*7C)J.0CO?%[FC:8J&<T)GQ=Z7['I0[/IEPLV=8KG
MS B&,+88<44\LA[4*^\B 5TK499RC8U[E]BHTCU7,MUS=97*]ZV.[?B<XMG.
M_#Y=2?K5^.V*:M>#+BB4[&XGGY5+X+;EZ;#62CBEB6)@3MH<GXX)%<Y'*02F
ME4+Y%)+J;%JA%#;1W/$/['V:\PE40/E,&D5GA%+"!"7XVB8Q;(5,_XI/E\RG
MU!K,J<V))(IC3:P/3"@KN0S2"/J#\B(5GSXHGTXT2A)C2%A+)+#2B >5D*-,
M(":L]6"TN\!RMTY.5XA/7[R+;F?0C+U[ZU#/T2DWT:&JZ+$'SO,*D0F'+1%<
M<H:EQ=AYIGE,V$8]*OU4Z5"/C,WGTSJ4HPEL?<>0I01T*$DHLHYJY+CUT463
M<*)KF_?6H"J?W.IR*1@V@DGE)76,<YH<=]P[)[R$V5M;E;U]*BZ=:%#:*(]C
M" CKX!!7D2'C#$;*6P(&*?>%ZYRL$)>^ADBR3/"U5K\_M!V?3SC[@Z4XHN[4
MJ.-UVXL_+01W)"@,*HE.AC/!+&91.F>3]SG'L3HI?!*X(Q.E9.]\Y^T!ED$X
MY02*V.8> Q%L1NE(KOFC):78.2<7E'+5MJ_^MCL5:?#2(A$QS@U9 S(J$12L
M9%ZYQ. [4$>OQTQ?^^!:L[G*N_<<T9H&:@.EWM)HN-1$TQR8*96RR1$O=*6<
M/A';CI53F.O' ZF<YQK@&1/%@6V908:!%>F5(8ZS"&A-%O/J5MO^#+8]">9L
M)!$Y'QCB+,"V*R,135HY[)/#Q@%:7R_OOAIH_=B=.9[.V;O;!>H'1G&#!W5X
M5NZ8);AC&.7)1**,LIPG*ZR(D5,I%?/.4*]O5V"X,SQ&H3M HRLJ7'Q(7,33
M'E6E6 (;PR&;+,W=T3C(0JZ1QH'IR'6DR@ HKE.^2OZ:BHV7S,:P^Y)J2[&0
MAD?'-'9:B1 9V)S>I5L6&:[8^''9>,KE&KW1@+\HZ9! M^$&618<&*8DT>2D
MQA)G-L;D&45"/O\@P#]CO_^FYH>]7NP,:B?=7L&'W51K=SN':)#;CTV=:==L
M)]2ZQ4EWOPG7%A?\G^O],MJB>3]=M]?KGL*"O B'[MSNS2\<@I-G0BMB!=$,
MC$AKK5->$>VDY52IA4K9O2LIKH+4._OWWA[@X*+$3*/@<$3<< I*D0LH8A&P
MX0*'(-<VE5A2&-#MR/X9N?I>*Q\S%IGD-I]R6HX#T3+$*(G6A&&&B5K$&53Q
M\7T]/V\/B(J.2D\1EKF.MV 2N<@58A1'&I07#'O@XV6%W3XL'[\>)]"?LS2D
M]5H;-*IK"M6JNHENNF]$*^46OV&P+Z$[=.U8TLL] '3E@@]NW[-[F4OS8F3*
MW77#!<SSS'&Y(W)EIB]3%M%IG5(*E]N TQRZ:!'WN5>EP0EY0Y+D4CEB8S;3
MB5Q6G:UE\-$3>^DJ%*U0](DU\PI%GQY%IW*^0W#<8HFDU!AQ:B@R+H)Y;ASG
M"J< _U_;I.M@I+\ %"U4_E\&%EXW+I@,/\9#/K:]PU:G>'=6YT<O1!FZWE":
M"S$_/E_2(FR&_%S+O)FZW4$N6_@\R7S_WR;VQW]W[#]FN'/4;NWL-H\:1Z$%
MXP#R_<CW=S\ >>^QG:V_V_M'];/]H[_AN\9Q#HFN[W[%]=VZ:.SNG3:.MK\?
M!*G ^B0.<>QS9IF/R&K%D8Z4&)4+HM*0L:9<L$_=O%W-P>#DS2^_G)Z>;GQW
MO?9&MW?X"V 4^Z4'7_\ROG9M<[<)*]SQO2+7O-6IQ:O%P_-Q>LT.:G\,.['&
M\'I1Y0?P\?C$YM)'@VYM (\XZ>4RDV?1]FJM?OX+Z MHHR@Y"9>D]M /AB-O
M-;P%<!'VO#,RR/Q9+7[W3=LYC+4>O+2_4;#?>)";5ZI^EYS9&!X#@?D?$/7#
M$7#QQ#<9GUO^$DFKF23]N2S"^3G"=&')WI6MF]^7K9M;L?3?OV^E0;/V]CAV
M0JZ>-E[8T<5O#WLQYL\OK\5\AI["BJ-A?]!*9^5'K0YL+K XO[8^<ST3C\7Y
M'SJUZ8*=9+VV<U*4TNH<UMYE>NN<%737CIDN)RO5Z&[41.VGO%IK5U9Q[>>\
MCJU!O_P(;LM+_2GV!P5M7UW<]5HH/K?]?-92=IK.!$]X[2?XK#]T_?C?(5P(
ME&W+!ZX7N[1V]4EK/V_4_AKV<M#\Q59>&=NLZ?5B*LH_9,:".^+W5K_X_D&*
M]=]R6_YGD7:%!@P19HG")'+JN;..2A-88@D+Y_C(WJ145\?!#R\Z/M #Y1-8
M_2JAP*+,L6L\I]1H1$'G@4WA5GFVMFG8=2]F#4BI/57%;J6@HF8/@=-@QPO)
MT_&M$]L&CH01#3+G?MGXO &:5KMM>Y=D6>$6;'?AQ2.XR IW[3=$:W_F#P$M
M3EO HJ5 ZX(*%PH@@(D#V[>^ 5G!\R>OZ<!D%GT5&[]J/8O=85$^$)Z?U:^\
M[#"-Y\+K6AM0H8/R44<>C#$Z!"R,4D'2B+D[V"JL(H "M*10KDEMT0\CC64K
MEO\6:=Z-^/P//);'_!_I 9:8*8XY\A$V@1.6\U]!>?22:TN#$@(#\\OK@:O/
MF?<O\]EZ&1OA!A:>\VPYS2H,MBDFE@=.@.^<$9%1I8,),BI9<=KC<MKISNY7
M4M_=IHW=+V?U<W] $_.12(=H<CZ7_@#;C*6 DN>,,6,<H71MD\PX\U]M3@-V
MZL5OW?:WK(/Z4L4%#?RX-<BD,99L!8GD#X"E/EU</M*(WTTN!_$*<XF]F7;-
M__:OORJ5%M+9Z#W7GCVRH,ZRLOV"[:)LHE]&M:+.\* U& (&VD(-\6W;+W25
M*;UC_F*OEWH.S+$%,-,#<ZBPN_/]77C[,0RI6?OSPV\[GVH_@=%S%'UAQ%BP
MX[M@R,)E<]$+P,7%WE4 HX8H)Y-7 <P"[$S"/!*ON58\ 8?< &#\'OCUF^VW
M^I]/ +O"3N=OVVME?]@GF"RY0#!$7Q^$75$6OH@#1X0+.A$D K6 84$B30E!
M@0J9L'4XY49+>&-&Y=K__%P[:0_["Q(%IIIZQAD(, ;48)Q@25/J #0C5RI5
M1/'$1+''#Y32.!@ID,-8("XX04XEAQ+'7G@MB14T]QV<T>SQ/[430!_;@8T!
M):P&&S7L92P/(Z"9=O7H0DM[2G7LOS 40,+"KY.#0\[M..)VHF."#0@_ 0<7
MH_.[G<%_:+R_%8'[07MPA;H_CN?R=FHJF;HKXIX0M^<'W@D>)#= UUHA[D1&
M/ DVDO6@5AM!I>(9\>AUM>T_I0 ]L6>E(@1$D.4L".%!S0W[0%X@C8,]*]V(
M/=]<+_SGZ[7/\600,Y&4A@EHU<5?&[7=*SZ'P36A#W<DV-;Q2\<7=5,"D@>E
M*,61)SE^/XF=?H0;3D&VUX;]TDW?BW!GX7P?MMN7W8N7W2 _5!P*H,^N2NM]
M;SARJ X[)[85)LI$MA%BM[,^<:> @FA;Q6/M-]MJ9[S-U%T[C)W8 Z[RW=Y)
MM]!!3H;P&XS^JDJ7MR#S5:M3GB-<4O*:8]XN.HA>;R]ZV@J#YOC@=^J^T<$<
MGMQB7;_;!KUJ[BU3"J2/><)/=$ZFS97UF?K9[(U'<V(/(W(@Z+ZB@GK>V/:I
M/>NO_7)91P8%^?(27IU].<?-(JE@UGNO;$Z)+LPFCX76@<<(AA!WW@C%0.PK
M(2F(D!(HX9X8WF:4L]YH&0)+0EBNM+>@<EB:B"38*FKHVG(5^\?4WV]K(TUK
M]C\TO28\.M<LVJ@5J&)/3MHM7W!<P6"9[2P@P'QS:\'WY!._%HC %CSU;&0V
MW$4?5#*(&)C!D8!6Z T6A@ $&T>=(3Y4^N 3B\Q#=N"M49QS@2CQH ]&#R)3
M1 PV@Y%@U7%I@\[ZX$R1F25%?^B;)1GZ2[XX(!R7*3X,?2FM[DQ&@@3K G68
M*PRTPRT-6CD.I@W@BC.^(J,G)J.OY""1*&A,*1>\(8A3;)"-D2 P F4,48<0
MTURSHM!@P)B(V<!H=4%=RBW"0];!P,R(MI^_ N7HVNGJ__:!L#( M^,W^*H,
M-FAU1S!YV4#)('DCZ!4ZE.VU6['PB?S4^KDX,R:J")+@!<'_U()/\X6&@&*4
M5<(R5&)T)GSQUIDJW\9,F^C)'5(?)IR[GO6U'Y]R^]C+WO?:<3>T$@BB,@BD
M4$V/;8CS AWR/A?Q47#!>K;*8 _*',=!,Z<LKF=U^5LKE'L58G9\Y;.WD=EF
M 4\ZO@E*PM>L^;:M'S]UVN%UVHR=$=3 ?G:Z17[EM)*Z\7!^Q<=4/T;S*2D7
M5L?;$Z!C^/V6XGT,S.ZLN'9R O,M-_@KUALTBNYPT!\ T9?-*P:PT(4I,U(O
MYEL5&[6WQ8791"KC[,9Q1K-B))HVU!8Y/7F4&/C+@N!+)QM=OXW3:]^-5OMM
M<4CUBD].ZJ?U\[<'V"BLK(NYKB='G!."'&8.*9F44B%AHG)B%3%S3TLRL0P[
MPP'0YSE0Y4+4/(I(6SD*^K-DF)U4#GAGPDL5V7RO[WXY$-P8PKQ#D8"JP%/@
MR$D2$6:<FQQ^K1A9V[R>_S!--#]$J/L<(JU,K*$ I0G_IS8*.6Q,]_U6RY)E
M3QD>#+I'$8E*,3$_#A"T6=/Z5GJ;1RXRV.I%^-YCCG7B1G@1>##<<*W!<O#6
M,I*XC4N3'%4TVPRN__B] 5R?0LREG\%8DUB#J< MTE%9!!L0?)!2!AIR.\7K
MEL(%W_\X7F0QZ_)N)'%;9_Z\$(Q29<V6Y.<B</6OV,N^1S!A7K-A^?'[SM;A
M@67.T^ \8H06A7,)LLE'E$0$H0![!%^.8'&&,3D3)\MX@]Q0F>)?BP^*[XL/
MR*\_E\[ZR><U"Z9,=JJ?C9SA0#%3?HW#H>V!?11SK/!1MU4&#V=72&&%PA7K
M6:TN].?2!CQM=O-]W=,<L53$%^; XU9HV5X.%I]EVL)]=C!Y4Q'QW"^GUA]%
MG5]V\K6R@_W*- J3K,#*F'WYQ5C@]5E;RB=?8+P5GY?NR3*"R@W/L@B%BWNQ
MW2H*A ,+?1JV8XUP_G9*(2N"W\MH][=^4$9E@3#.]MOX/=T.S!I>!CN$BFFW
M.M^ [+OP@FDC\U,\'+9+.^_SW!=<GQR 06EM%T/\8PCO(F*]O"2/QA6Y"V/K
MT [*8XO1864%$L\6)%AC:^^>('%QD+U1&R]SD>5BSPJO>C\>MU#^OF!WX 7;
MZP$Q%:>"?]A.<<A-1$%D([++)!6M;Q8),\#^$;2O3J&@3-]1$">>?30XC3Z+
MG0K>="@X*0HU8JYK8%-TFE>_%OZO#II6J:\%']T&ATKL.NT.VZ,B5J>M?@0K
M_]O(.U:"49F,0?EM'3(KHY#3#:;$?VK;5_.J9DD>_?R]31\ZY8%W0;MW4="!
MNICDO\Y%W#B\%EU&>#34*Q$LXX(2K9*FU@<LI(@ZN$I-?U" %3 &7M_Z<%X_
M_PIC^GK O/#*,XZXP3)'DE%D%&<H!$6BQ<0+R=<V]8PSH@=1V>]&'I4T?N#0
MZ:T/K'&^=Q")T299@;3SV1GH,=*26B0L#48FY0+7(Q"]I?JN1^'"Q:_%-VL3
ME5V_ )4]BY+IN<S1VS<>2W'?>!C-7<_6W$OI0M8G<8-+U-PKK%@=K)@(EL;6
M6[CVOEAQ#RU^1',%M5U$\,'?TVK\7#U=/[B>GO7P2Z[M.8K[__:OI_??265?
M!\!KP;Q+I7V>JEZ&.%X>^:W&M!C/4JI42IP%9SP/23L<O$R2*L<L-\96//MD
M/+O[\0#+J,'$=LA()1 G-.6FFQQ)G1SS,5 M_-HFW[BU>.=7O7/\LG?NQ[0Y
M#K@=$>CC1;.^@*,EMD&HF+TIYMKTY@>,SHZE7<6#I@6J4=S_L"D0Z80E,@6/
MN9-4!Q-!$3%.8X5%2@\0IO#>MGI_YP".RGP=F:^-<W\0O5%."8$4(P1Q:22R
M-G>V\%PH!W\2 EJ&F)$']2#F*XV.I"" 2$T$<98,D 7U&%M/<^F?.=VE*_'V
M\.*ML;5]0(7%4>. B/(6<94PLHIRI!47D0BL>0Y;+Y#SEO+-3,Q7,S)?LU1:
M!RWP,!;Q;Q=B:-H)W E7],U189KI5TS9P>8%V,%3T[AB(UX ]\B);I9M)U9,
MN:I,63__<$^FO+ 3;V4:3I%:061OAX>@R=QPQG-Q41GE.-=T- ]C.DZ;BC<?
M]_SOHA'X7F(FA<]9.X8G:@T(3"RBD5)0[%C!'$013'3%'(_,'$?U@Q2#%]H$
M)*Q1B'/KD/7:(2*(-4889F7(!IF^M44F-WYH<HT/-/.5$]DFQR)I]6RPE3&X
MMB)P>%[%OX8]W\P%&M]U.]GS6N0M=%[$82$@1R>6J'*QM=;_=]@J\S$SV+WK
M=K_6_FK:WG'+V]J??[ZK_=3IGM;>V4%9D.L#()GMV/7\U<^9XG;\H%O:^#D5
M8Q$CS"6.A:58BQ0XMMIA0K(?B7%&O2 \)P]EZ"J2A_(OE-W#&OMKE#Z\VWV;
M9]R+OXU2AV/_]UZW_YI/%??.&T?^ &O*E*(>&6; %#,.(\>P193#TDNAG5%B
M;9/^*/AO)"P7*K?D-%5!41T#YC@9:XU5*IE@0'U(.%1$\'A$D.UQS3&A(*9D
ML+GZ+;?("2Z0!P6<44*$9GYMT]S.'B^=S.TL$TI$!0/=Q^ES ,"/E<D-*(H[
M9"4'%,],)"-:>=_MO9U Y&LF$%P'E!".*F<#01(@&U!"1^0DI2A%*0Q-@8@H
M<HCP?/IH3988[&;XH%#<1]"16CU00%)W6)@%+;!\^Q?6;/[>M[O]K"[GO,%2
MDQ];MD5ZV]2S)_4B+@LIO3X*9\^:SR3FR]EV>3!;OB>,M8$+VO73VD#MU.8\
M+9]SYD*V;I-M]4;Y6?9BL-.B-0]X2J$*K>((.;_1Q<%IC)TI/2M/<,P[(T_6
MV.5P[3UE(=MV_):/?<L<S5K,%X/1-*JNVSH^&0[B1+^KBCW\6%$R>.6+/=Q8
MO.%*L0>EM74T!A>#X,PQXW'R8 )D;[>*N=;4,]#0BV931<YNYH:B-F)M*BQL
ML82BI]?'RPE,=Q8M( ;@;U+1'1A\5*.ZULY1</W"ZG+#5CL47H1)+]+R5+G\
M=E02)W]YVNU]+:I.E*%TM4YV>FR,?0RCLNY7SD8LV*51>ZX#YS0D[9FG 5.5
MDT*DQ#-S^B^K69]],X9A.^ZD>IER#0B^DZ:;;NQF\;\+[_RMW?5?7YTLW3ZO
M;VV?'S N0.DU&!0MESL-:0$JMXDH\4"BH2%RJZ^R,N'&.YM ]V&6>_A+:Q>)
M  C@<+WT:[4(*LI)QE,P\-<V)SLPMZ5M41VY/2Q<5%?(;<%S-8&U5L(I313C
M"51(#;,C5#@/ZH' M(H.?4BJ\J?UW>T#81-5,A($.K%$G*B -&AF*#HCE!(F
M*,'7-HF97X5\?6:/XVGO9<:945V(U,KK73A>BQ..-]=Z1MP/EF\XU;XFJV;*
MRQN9YFE$P(7(&I2N[['J5'2J\;G.^4D_OAG_\FMH]4_:]NQ-JU,\JKCIU]$"
MC/2MK&%<[0Z9U[7\>J1\&+5A!,OZQZA)Y>C%(]5DHU!-KG3=*;]C8D-),?=K
MO$'F?O>CQZH-CM6=GOKC[YBYVU.KL59CK<;Z)&,EMQO/#2UVK[3T>II^@?J*
M#+AFU10VX$];13^+PDTQDK_]GV_1*_<'4RRMYU6:)&A]=($YW:+-[W.;/GO=
MT^>O>_KB=4]?ON+I[^;#],)#^)H7(9<"O#3_&P3XC?V'GT,GX'FNEXEU/>6$
MN6.WTU?=,OG5-$6^^\'G7?H>?XKCL[.=]-<XIOI#IP'#V3V-[6^QGGN6/']/
MVZ@],MG;]6QO]^WW_7_JYSMPS]YQG>\=^=QQB.3.#/M;]?,&W1/UUM7VR'\W
M&^>A6=]Z#V.N\_K6I];>>;/5.-\C<"]M'#6_UL_K+,_CW_/M46MD^/?M ><T
MBF "RLXZQ%4T2$L2$"728\TT9R:M;<Z("KM7:^07T4*^0KP*\9:->!-)/0?[
M]J+M[9YV*\A;%/):%Y GI.,R1(E(T;?->86,,@8I32-7U&IL'%@+UX\E*LBK
M(*^"O*>!O&8O/O^$Q4<'O;,+T--)*BI8ACKN<E=8@PQ+!'D11!(\,!XM@!ZO
M0*\"O0KT5@/TWG=SU;,*\Q;"O,:[B6U+A+0I:N1B8(A;FI EF"'%#3$R.!Q=
MQCQ:85Z%>17FK0CFM;Y5>M["F#?QYTF=M/1:HV0D1=P[C6RR$D7MK0N.*YRS
MH.GUM(@*\RK,JS!O66U=E@&(;_-9;86)=\7$B<./&)S@OX!T8A)QASERL/](
M"4=3<M(IFBM#K!-2^?PJ6*Q@\8EA\<,X!^3=L-<#3)S 9 6"BX+@Q '(*5.@
M%VH4@@/%,#J%<IHL6,11,.%Y$C%F$(3-?A8@6,3M_%*D'LS*''T^U3[<H/:A
MGZLE^YQ#W!\LF#^XDB4^BEFUQK/RQ:QLO]_UK2(7^"+[^%K[SY_&S3YAS+DF
MV/R.?KD*8[<#]_Q\D9-\J4Q-KG%VTHO]'()69!_;LI]E 82C[J/>]GIG^>$7
M#2W+W.=V,<H DRCJBK9C\?MM)C1_O'D\H^3'HGUAOB4W.QTE35Z$9/7[<5#4
MF"H&"'"8V:9XR3@SO-^,,7?/;+=G#PM>9(^[P#KY-=UOHWK;[5:Z-L-)U!=\
M#"Q\V*SY)M!8;L_1G93A&568&E<9OS2H?BZ[5*:WYTY[)Z.\]%&QMF%G,I*R
M"^^,$4]G_97/7WQU;[VRZV69K)4I]C 6C5\F*U74N!JMT':Y],]>\-TCEY V
MSC\>"(9SFVB'1) 8<2DI<HY[9*PT1FIGF$T@O?0/JH%T%FL@RUADDEON);8<
M!Z)EB%$2K0G#,!A5[#JN=OVA=GUG:_O 8D*LL@1I2@3BAH4<J>$1<3HG4!H3
ML8-=O]XRME18+K9^3I_AB\H;ZX"(_9-<D.I;;)\!M):;<M%6>A;,%G 6%Z.I
M.V6TWYFXIF>QD]X7^=19J\[#?\VDQ1I'VP>YEB<+DJ.DHT1<48=T]I-*+TS2
MRC#BP@_[RBZ*)S8D8K##7A#""3:.P(MA\RV($*V%*^I+F?'>WQ=8JKV?N_>'
M!SJ*:+RUL/<*]E[F5D6$*"0HL4&";1)H^N'>YZSSLDC05,IY[.02/ N@S',K
M3/C[N%IO?]02HVC@<K:"Y4[F3FRVM3*R&SZ/"@]?UBU;L?_\[;%L*TP7>)FT
MX;EJ@:U?6%.'D^TNS(8N6 "7:G5D0V-<K-F=%36?!W!#JZB7.U4>.G7;[:)<
MPX5Q,ZL@=%'*-A?@&KT7-N2G655I3VSV"0&W#8#VUFM_[7XN&[L<PSR*TE87
M#YKU&G@ 0"@L8C9%NK#"@Y:_5*WZY_7\YQ%P:3:!?.P-+-@2\;N/)\6TW]R:
MW$=.#I1]H6^XOID^T!,22-%'0UZX>!Y_")>7B^*R!X2MG8".=7B7GDXR*,%
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M_,KG4>.;QN^;*?9>?"\WD0+-I%OKVY&>4I34S6$[<]\&Q;.="[9/["0[)C+
MS1Q&4)2#OPC%+YUNN=A@V\",+WHPTW@AJ\:EHN_0,'6EN11,KNZ454<K4C!J
M9]#KMG(7L%^P9YD"BB4;;:6'J<&(P)C,))$/?YJ_X@QW%Y;OKW'P18C)#ENC
M5NJ7ATKT8M%PI%_V,2V[P)=D5^O$ 1!'[O+W8_H9$-)E4X!>T3'#UAC^GTQ^
MA>$:>O9XKK,8"&P[4_Y_K;9^R>'KZUD96[0QR!,^.Z2RP5])C]-Y7^Z^KEH*
M7--2@*Q\2X&[M A885SX<K64O3 :#OBHG:/@+K8A\Y5+9.Q4IDZDPL6R=3;V
MZB)#8JI.7R[GSWLQ\@@ZW;*K?,B'UC"7?X8PDF[M<]-W9[UD!:),76TCO;V0
M<9<+@P=0M&_HT)B+BWVR,NOK%<>!E^_[C/YV7JO)2L6OLN1<84<6^ [T55B6
MUQ(E*#2S]\WI/YGT0<F:O3Y5UX"<X)ME!\R,*?V:L[DC9FZ_&?*JP\^;?V[M
M;*R/O;KP! C.9J<,$KW(-W4^P#D5_[U]4+\9?D2_V:MW[V=C/LL%7-VE(H^Z
M5./S@;.L]*^U<R38G"'/4;.G9J?4W"][R^O\4#X_&!-MJ0L5^/MQ??V?DC^:
M_5FKKMD^ZO:RW[)T*-K*D[A:<[QV1K] I':'_5HYFF%6WJ<6V3D_UQ^Y3\,X
MS*C4+%:75Q\7UK8F"[JZ*_2X:/:OL=EZ(Z=2@2^E,WFD'%QZ G(C[35W]IVX
M?TN#,SLR;^ 0FO?BY,.;J=/F=6&^9I_)O&<'7C2*T!OIH<W>V;B$T7/EK&>&
M/T[?/>.+F5%<1EZFB>HS\C;-.J[>SJ96O"X]5J^+Q][F+Q<?/6[VBV$?=4>G
MS]FYWKLT^ IF,'6%33Q!E[N>1H],'%"E. FQ#\B8QUE>G]LLF^WQ2W:R\$7T
MYUP6^<1B*IIFO9:SYM",H"J'\-\AH'-J^M%YBLWG#;D_8V]P,!:54V8N72#3
M?\_Y7V:\*N=\)S/FT.L:D$4A:<>G<(/NZVSKC+8:KO?&86:3Z4VTT[)E>R]W
MMXZM<:_&T4?ZLWIR24EGSVXN#$J8/)(*YIE?YZ]'14QR.:6Y&8U..?(*'71;
M(?M ,]T,"C?@H/#F%!PTRCH?-WH<GU".+#+X?P?-.GKF1,[HQ,0>'8&8+EH(
M[?2RIA-G7#4SV]'.S!E]R_;BV><ZY5%->W06 \2<^XV/5K7H,U0KXSLF/K)F
MSP_;>5@^CNSH<Z\K@B[L,.]ZD5 (;W71=]OQJ@]=Y;HZOS^W=6#-$NU3"PC>
M!$6I75@$'W(WT&_CP\3BL*D.U 73*K!O 4/^EMVW5E)_(W2DO\7)0DW;ID[.
M:*\[T1P%6Y\Y-0;FZ?<!$$NS]6]@^U:-UO[H \OEFVH$:/6>]8:;J^;%0LS0
MR$6T\1A[4P3RVRS>?*]Y-,[VR9O2CH.#;G%(7'H)9MK=CE=^(HH*K20?'V=[
M[%]C:33SQ$$3T )4CU+Q*1-!6WY8YF#")X9%)V&;Q;K/V)NIP/;AHZWN,6@]
M ;:V !. @9]Q, U2R:?M969K%L_%D#KY\M%P<&^=-8MPL6E;S?>C#-KU3LC[
M6VSO)-\DUW0"M6!8=CHO&FU6W3;7Q;XSQGA85F1MU(@3S9%)RB+!/)%6\ B;
M<;;;)I5)49Q83!1S9XDQ$G.2B$XTA2#HV6Z;.[/IS:5([T]"^R_%HS3>N**!
M]6CGKLZ?._=K7&8@]T=Q__V[]6$\Z^6]\,C@VL5YZ,:&!.,U7!Z#+-K9D.,U
M58#3<CN:F37"V#UT7Q/L\F_>=JP$'A3WT2JN&NQ3&ZSDR^S"MT WHV7<:IYF
MCZ2,Z+4QQB^C5]0S6 >\2,^HE6@-535]G$SR8LMCN5W0+BUVA,_7.[HQ03QD
M ,G-EG*L[]_$$'_,<1:[?2;DY(Z;5Q'!>'$G?I]2[\_L];SHH=KRBN\KOG_.
M?'^-!C?V W2ZG7CUUE=WWO^=#]2B%=CWD>JT\C6MQ/_,._GS:=0-.Q;?O0+G
M8^GO-UR?T?'&79:B*H)<%4&^MD97# 0'ZRB3.G#'X'^.1*>MX9$HY^/-*CVF
MYN\8T&GL=<]6Y2IJ_$T<ZY,#DR=?D&M4UOAT^_M?[;WVYO'NSE<8RR=XYG-K
M]W =UT^_LOKAYG']]!.!L1R?+VM<%[OPY.[.GP>-G4^LD4]1/GYKUC<^G39V
M_$E]9_VTL?$-YKU^\I_3^FPS1\QANXBT*&J1:TXPC;1W%&DKJ-$:&^-T&4A%
MZ-LG4=BX K8*V)8-;,ZFY)G!U@G#J8O '):[*%14P84H*V!;#6";:5ZF5<+6
M YP%&17BVF"DN< H*B8P7%16X@K8*F![V<!F6%"1>NTYLUQY; UC7A(6B3':
M,GYYE>8*P.X%P*::F?>4V:05 B!3N5*21X8(AW04F.D4:8B@F0&D5>!5@=>+
M!"\L/%,1$[!<.#=:.B>%H,(Y O_V/E3@];#@M3W5OE(BT42I$*,X(NX!P1SF
M!ID$ZAB/<,T) "_Y-/IE+^Q '>4Y/1D'JBBB[2YTH*I;>0VO7X!GYB8],^%+
M#[WH8HMVH:1ZTJ M@P[6<LQ23)RPX*Q13C/*A-?1TAOWS*U >QF@_6G6%QAH
M%"DH4#:]"8A+SY"QRB-!A*12&H.E JRXH/[L@J!],3K<JUY9\>=-^VPX&UWD
MG@:I.=&Y;1/%+ H=#<8B7>'#K_CS/OASQJ4E.:A0W.=./F '<N,ELC87U74D
M*2*$\)8"?U[:SZ?BSV? GX19$C'7#I"91R,-"1$PFYD8B27:5$;/ _/G5'YJ
M$9QB'B.=I$5<*XVL9QREP(4U$M2>;/14\O-9\Z>6!-.@J&>"<TR8#B! $_/4
M!,I @%;\^;#\.>.4@$4'H\,3%!-SN84O1R:?"WFE!.9*!,%EEI_GNR ^'G\^
M^]@MNL9R[-;FL-=%(7:Z[5$=U(M\$7H9$4S/WQ=QC0_]1EA]P:(]/ZR6FADN
MN<(X8"Y!I6+2:<L93D%H0U-EZSPD5G^=]44(3;7 TB$5D\T]!AER1G#D.)%@
MF28O<R53HY?E0%ZA,ZZ*/R?\*178.L*R2!V7RAK.$R6)XL ]8_**L)N*/^^#
M/V=\$3PI)BT+B#F-$:?&([! /;*$DVA@4U("7<H85O'G\^5/9:1W*B6-O>#1
M:JLEQXH)D9)*,;C*UGE@_IS*3X.#$)HKI%@B*$?W(".T1HD8)DW"C&L/_$G/
M=^FM^//9\&<D8,QB'S65E <<3:(A$:R3("E%7O'G _/GC"]"!IL820:%0 3B
MFCEDDS H*N5I BL$:]!O-5\E_?;9AT&P-4(OR2,S51A$Y29>(C0'(IVP1*;@
M,7>2ZF"B5\* -JTPZ$^5:?.0T+P[J)^,H/D0O@'JD]<D&!&12]CG^+6(;. ,
MI2"),<E;$O)1Z]V#;ZNCG-7E43!OG>&"VB B5Y8X!RJ4=4+IQ*APK.+1A^71
MQI<)CY+ZIWW#/8\\,B0XPX@G:I&C 2-+I>16RD18/LZA=U:A*AY=71YU6!+&
M%)  !6O7*,>< 4LG"9U H&I\N8E39>8]*.].Y>MI8WV? N<&Z1T*Q'/$J97(
M.1"W!@OB@^ A$K^T[+R*?U>7?X6501/II66."\>MQY9+EYQWTABM*_Y=#?[=
M_C+#O\?[#@=A!!-(8:D1-PGT8Z!@%*F*1CI*O+*KR+_//ISBRW75\/^?;1^]
M+=MF5-$4E;=YF>EXAB@2L(_.2=#(K0&Q;I4@*D5)4C0W*Y+0&;91Z [0Z(X*
MS^_)WS%3 D:%($'A0EYJT,4\%4AS2Y#5G"2K0%$S[M4[\IKRZC#W&;-O3-)Y
MJ4 5EXI3QBPU.AA+02WC5C%<L>\*L>],)(8726$#[*L8MPC(($>=>XDXCU)A
M F96C 7[XCOGA53LN[KL2RQ(7VN<P8#;47$7BLPM:Q*#%;'B9H94Q;X/P[XS
M93ZX<RHHC&P4 7$+TM< 42%I I/*:(>]R.Q+5,6^SYA]9;))69PB-X0[D[2*
M*EGL<5 N2^&*?5>(?6?B.(1GWKB8$"'!(ZX]0Y9$#CRL '^]=%';@GWELNKT
MK% D1\F%9J7](4,WZ YLZUZC&>[PCNN>NW%I].=6TVCA^3\;4< H3Z#/*Z,L
MY\D**V+D%*PRYIVA7E>&V,J( C_K1]$RI! 90<Q0C;C3&FD!AAC.249$))YR
M*5WVFBJU)(_X(GT3'O.XJP*Y"N3.@!R-1!(3=# JMU"E#@NML>/..HZIM17(
MK1#(S9;5]9$2BP4*DJ?L+'9(*Z$0%5AS*IRES!<@)T4%<A7(O6R0L\E*JBW%
M0AH>'0.  V8!'<'!*KED*Z-^E4!N1I-34E!.">(J&<2%I<AJQA%LG7-:XFB-
MS""'105R%<B]<) +H*Z) ,8I,91'+VR@.EH2/>5,)G5%DED%<@\.<C.>2\N8
MCX1@I$0^]B<&HRRAD,8IDN@L:'FA #E\YQS1AP*Y9Q_=E=F@UNSWA[;C(TRQ
M/^C?:TQ3=;1SV4[\L4A),$R"PD1PG0QG@EG,H@05,'F?J]Z*1?)(UCOAO3UJ
M#FSK[VC[<=O!4M@\@'Z%A0MAX<])RA=<.V[\V,<R"*><0!%;#YI?3,A)!SH@
MUEI2BIUS<K%*<-6V/X%M=RK2X*5%(F*,N'4!&94("E8RKUQB< W$X'D9>.X7
MY_J^5P?QJX+6"W!MDL&[X%/B+'!NC>$J"$P-#Q9[8:Y(S+UY0D+%S4OCYG%.
M8.;F[?7]9))D2GE$M<R6NP%NYMHB'40^0 N&)+KLKE\5&Z^BTD4#!4N4>DNC
MX5(337/NME3*)D>\N"*QJ.+7^^37B?1=I_5/^U(YSS5H69@H,$(M,\@PJI%7
MACC.(BA=9+%SI6K;G\"V)\&<C20BYP-#(&EAVY61B":M'/;)X9QRP,Z?DU=*
MU]-!ZT5,)2UDH"(Y[2A7PMA$.)A,B<,OK/0W/"BIE*X'XN;MJ=+UN[Z^SYRQ
M3@+[*E;6@@S(4I60U])*&E0(>'G)W%44Y"U8<2>'0 +GN,$3CX,L-_ -@U4/
MW:%KQ1=XN'3#-7@VPN'!XB$K";$D";%Y_/=.?5 OI,37X\9A?3^R('-B P@&
M G8Y"0II'RB*249%>$B>BB)LB)/E'C;=C%F>QJEZ!7XO#_P>+$ZR K\E@M_7
M.?#SGFJ9B$5"NURH3#!D I=(6-A=L'H8->I>8B8K\*O [RF#WX/%3U;@MT3P
M\W/@1R,.)A"'8-,8XH9AY&RDB)&H=-Y)$'!%F!%95MNM"OPJ\'L&X/=@<945
M^"T1_'[.@5^P*@8K$I(AUV:AVB'-N4 >LVB$)IQB=R\QEO<+?H7C]-\#"^\M
M3V0RX38[0SLZHPG-7Q?]'GX]'G_;]GXT.T4HZ,1QVNR$V!F\H;Q R'+:KO?O
M=Y,E*%Z;7U+28C ^&>J2M(Q[I:TW3#JNJ*22XZ#V*<E'A].G1I\>+0#*P%A\
M;';RA\/^H)E.Y@:$9D9T%B^(=-;<"B_H&;Q09_&"9KS0:R49G/]SA"2-81O>
M[,] AQ6&1>VY#MEH3-HS3P%/8&VPEA+O;Q30H3!!4^MQ'A@V;:\#J]3_)_:^
M'-A>W(&7_]GJ^I^/C00[FR,D.#IL?-]KUMN?VWN'FZRQLXD;.Q]:NSOKO^O?
M=T\:WS_QW9T#X-RO)_7W!N_]YP#[]K>._6Z&V^TZV6MOG>Q]W&O7=SRI[WPB
M]>_?#NH;F[_W#K?(WL;!P?;'/>#XK6/@:E[? 4Z.PCHG+7*PEHB'7"2-XH1
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M61L1*>'<8@M_X<BC(]%+ILU9KT &PEZ$=^06#J5?%G2!P7&,G9K+>U)H:E?
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M1J^])C![P7(-]W/@IPO-YOH3OXN/<2:S(N(FTWK(ECKG)W;.'UQ,[,,4+6?
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M@J^%X,O/FA V,)=("D@8"_!%*$9:)(,(#=YJD#F*NU?O[NSZJL+$5IJ3'\:
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M"CD'&9D8<0KX,[E\LD.B=+%2R9\$1YY1R8-DQELND$Q,(8Y90D8X@Y2U1'N
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M6;WS/M@%"SG"(*=2XH-M]K[9%J#5ZIB3#RX0?C=^[&-L(M7*(6&D1#QZBZR
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M6SE? M0O]#G+U2_']N@9Z#: @=G3,9AFEY>3+)T$F3)[.9._/<WD[P_RI1]
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MEHGW>C+9T=%]=[2HJ=4]'E58*"&XK,Q2>CM@-.Y,:$'AW+QY8,'%DYD);>X
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M<5.M[BC(J0&OJ;'7M7LYS+D!W5V\OG_FD)S8[^>P"]?LV#(J(2_L!BPZS&0
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MTUQ+L$G)=X6%"@L]:""DL-"]L-#L,3^+/?>YKC2IZDK#/P9'CJPBD5ON&$[
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MXZ7IY^XI Y]GH=?-I8OA:Q=K\4X4V%&[VSX:'<&4_>]H/&>5'LN]&=NI72G
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M^O(77+!>U9GQ<C!@6H4ZW^1'7LC$$C_]29GITO3A0A04XPL3U+RN#S\-C%V
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MU73*S I0R@A1DP)&[TL)SHOHMW9DIZ=.3_>$GJXNI'5Z&@@]+;J*ZZ@H6>N
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M$Q- 3*\2BMJ)R(UPBL5<]O7><:Z% <X2)?MGZ2K]^D+G\RI?>W;_<PEL4@\
M9=QZ16G) Y]X_9?18-A.)X_/H:5/^D_DYU:5,V\O-JA=;;6[OC,*,;3^YQ:L
M')5AF@M.50!R8,1JYKR-,7(EG,"7G3L3TU&0[N@(A=X0U5>\5#Z_>]/UMVQ[
M8Y]M_SC\MIT;L/\XW),)B$FZ@+A+'O2=P)'E-B%%HM ",ZZ=67G-+MJ)X^[$
MF4+:$[U"V]W600S[L96 :P>M<N(!B&78:P%)M=[TCH"B3_[_0>OCVO^MM8YC
M=Y"?<0R;L]KZ=M#V!ZUOL1];OF,'@W9JYYZC@U;=!'=M^CC$;/8R,UFI^JC=
M#3#&5[3JH?D4O%7-A+5Z-7]E>IS!9J1ENZ%J" UL-&@/AOD*&&Z[.QCU;=?'
MPEYY+_*"YY4MZPFKG$:=!#M3/G,5)[1Z#M;"YFT;9'YJV=9QKS^L-R]?>&PS
MTK5A08;CFP9KK5WXYFOFGNJR]@!>>G34+AO=@K]"',;^46:YUF@ <%8>-0"6
MS!,;'1U7+\PS.8K#@QY0PVA0D4+UU/+FF@(Z;>O:G=S$LQX2/*+GVX5V,G6L
MM68N79[-Z5N/84_R6P [>F.8.IN>[122S./,:SGCS=7IG#R/7LN/^OT\S3SZ
M#$'PRGATW.F=Q#@8#[$FYA+X4[\,6ILN]D%B':RV?H=U@6]:R?KJT<,#D&+[
M!_#:^J;6<;]WU(8Y]D]:W=XPMKZUAP=YAVVW.X*A]F'F%6O!&L=J_R_%6\!%
M>/5Y9QT54LLHL$V1>QI=,H"O(A*:F&:RRJ<GYR'W[?9O%V'5#=]V!\/^*&_\
MVWI ?\( /^221>%=[.=>NG8_GB(KHB\.6M]_V][]E%-M;30!5" F 5,3]\A$
MT(,4#]PDEH1.=.7U12WH']=P6^J,_' $JPU<ESFG5_%_VXW.F&S,[<?VY!2*
MLYY1: 7NZ/0*@%3;M]::!M,I!>9<Y54K#(O:<QUR)G'2GGD:,%7YI)64>&^C
MR&Z%"3JCJ&D2.I7#E00>]Y/>Z?Z9J\[W@>=^M8!R'[L]!\#Z-2M5;[O'(Q@
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MB2>-+0V<W;BG78-^3XU^9PEIDE ?8".1<Y0BSF) UB6# M6 ?M%RHNS*:]:
M7P-^+QO\5#*8,L^<E(('IC75'(>@HE!6PHP;\%L2\)LXQ1"8#XX3@^#?B+CC
M$5DA! +8BR01186/*Z^)7A;T>PG=Q-=SH+K3ZL?AJ-]MU<D]==#LU0U\)7<O
M#-,\XV5XBOZ<R-.I@[&#8<YYJD*RPQ*\[<>2XP17A::OUE5G4[P6WEO#8:I<
M"6J\DTXP09V6SK+9V1VSY*<?=H9W$)Z7R<[!OV S+0RRWL8-V,5&E-Y*E$[5
MV0W.*LU=24J2*.?R(,<T11',"N\-=\3H^=D1"V0J-*Q^FH3-N8S:2J))Y-1A
MG2*U'"LM"?Q/ZQNP^M4U:1H(6$ (F"BF8(7&A$IDG!*(6Q:1(3ZAB!.520I+
M$FZZ +T (##<!Q#YS@8FN.94.Z>BX2(Y(9)EO)'Y2\SP$^:S5$H0'@62)B@P
MG[U#3@>&7&0Q!)RB9'RQ9/XUYLLX=1 &&Z]&AV6^\B5X"=[=(EUV.ELVY\C>
MR9Q;WMJP/SVN/3> "<-O#^@8/=W]#WGOWPX&HY*E_>&,!!K8OQ7L^TE33_ 8
MP+33R":L$>=8("L=1=JZ"):>43C(634,+F0R/4:UV:8Z]+)9>0T>+ 4>G-E]
MD6$F6)!(@J:/.$L)@2H84?+4B8BU,Y0UA>.7%1INHQS,P?!KE(,E!(,)FU!A
MQ9.Q"C'#P2:4-"%3DNM(\D("%&#M%T8Y> G1K-T^W)QBE53>Z[=ZH^'$:<75
M5C<.F^C5@T>O'@#'3C=V.PX;Q+H58NU/FC/,!\*X,@A+D1#W&B,3'=@TA%$M
M2*X,Y59>SRO]MW%8+R";+Z--T[#_?=C_S'KA)#%+@.FU@TWC''M06 )%@/4*
M:QZB,_.S7AH06%P0F%O4JF'VQ6+VR8B5EXDESY#US&19[Y#%!CC>4HG!.E'*
M+)BL?PG!FLVJF,HEYS+);2W#IACLXRW0LT'_I*SS6-A$HN!*PE\V@2"(4IC
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M@8'"9L#=9U@(+X+%[E>\%^ 27V/7D6UWA_#?F$]/N7>07<6VX 0\/.>SV&-
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M59[P7>R779H+K="[@L<[V]_I?QCFXENE&N'9J%XLP;S]M@T@XE34AAFD&=4
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M@^^CSJD4E18R) 3+&Q"G-"  3;!DL8W8BJ UT6"_RBTJ5J,/WI*3#5Z1?J^
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MG96M1CQ==5:V<KZ=A]6_.OQXI*(/#S]4X-[&Y,!J21YQ1B0RP5ND-!BP@KO
MK/W1X<=J*/MB9&:]/ U/<=;ANXWNP_KJ9M%7.]37;J&O_4W9NL;M_GPW4>L^
M-P2,LAA#I=<SZO7(>8@A4;,DD ?-1=SFS&[C..(.Q]RYEQ(7EG@>\BK9\:O<
M,]^=GK;CJ>W&RF6QH+(-STN,D6 ?:8V(IQ+QJ$#9E#8HANA$C)12+9=Y7K(:
ME/DUG)>\0&S0T_DC*\+\9+H^3$<A3GD2E4(B,B#,! =D;4@H)F8HB 8V J]Z
M.LI;HLM/<3!7T>77H=7#PSNN5$K22\14;F8EM$.:\HBPL,)Z1JAU?HF'=V^!
M+J_]9EDQY67IV?!PCR@?#"@;(M2Q[&[BR%")4;".XV22#\XN>_>L#O?6/!&N
M5-7^\=[M[CC+R=["T1.K-A7_L] 3KNW6LI;GE"-,KCJG7-Y^0D?/*74BL)-@
MAKS,QQ>!8:0%T#@5K"'*8JX$V=AF>HLL?'3QXD&JY3WN[F#5(>8Z.F1'L*'R
MR3P2!8:'F"1H%GU0*!IJ  6$0-9&AB2A!D=G)<VAEUSC3<J656S]ATKY I'4
M\XQG?;TYJYSH-3<-N,^/0RH(F!$"AN>=5)&82'+(&ZP0C\P@)PU'2>DH'-=:
M)H  N27-0PZ<I2G:ZS0H9G_\]60:K^K<=P1[*F_6LD!GY-R76T5S,=P ,).C
M) 725%"4DA%@B]H IBE8'VQ38K7)B5E'ZK%,^Z0Z,5X/)WAEG2R.$L,38^,]
M%I@FQ*3(=8=R+#43!#%FE7-&"R[B$R6T5-;)VI\U5];)VD+ \'A9.QHHY0$Y
MZPCBA@-18"0A;8(3(@G@DS/FAE;6266=O"Z&41DFR\*;X3&[PSP(*TSNY@5X
M0XU#L!.YG$UK"6>41Z.?E7*\@3/X7[I9FN'?4/^V/0'C\.+@#A>V?5IOHF[K
M\E<S#K_GO4ZWGJ[+E^K- +KT*^67W66#$,$/H1#-*+37K*5ZUL+B;'VS=FGS
M"M1A)-W.X"0^AEJKU/2<<7O9:_LS0(*:O;QLM[X#V'1CX[HVG\VT8*>A.1TO
MN63K7J?3BV&G!_!S6E9L+\N[CM1SO:WENO[%W+_\YPS[B[^;]A_3.SS_=^/+
MT=GYP<7Q#8 3.SSZ]/7+^:[8_^?C]4$&K8O/XN#H7_7#?W9O_G-SS YW/IYP
M&BVVSB*J M@SD7MDL;8HR8AYPL"!D]W8AM7:Q%-"W6O-"-H?N]T&B$ZY_ILU
M^-%K='.AXWJS]C]S['Y2$2],4#(8S#%E-EJ!F1*4>!^E%P_("I)S"4M_?^M\
MB@U;;&5']OL_]>[96:N1$>Q]JSU]N[P5&?GV1(;OG[\[23'B:#Q#BJ2<("$4
MLA)(L/+)*1\M8<YM;-/)7.(:P%HCRT KU;SMG $&P;8!?[MX9ALIOSR&2K"8
MM:OABM2Z]GOL;-6.SB)(5I]>U+YE?I$_VH67!^@UQ+/Z&.S5KFQG+I%<$+[F
M%,G%NU64CWW;J^*HU;6->ZC8&Q1? 6,XH5YQ&:1"281LOGF.+$L6*9NP#3$P
M&0'QY&2(R4!\2PGLYJFM)5MO#T5P('[?RABW4.Q!A6!>%LNQ#N*WL%=B('OO
M86H*B2-O6.3\U?[1W@GF7'I/% J) V_G3B(7J4*.6143Q4EQ#IOL#R3NEK_?
M\M$L)_5FSY95:T<8Z=F !6X)((:7K4X]7_)K.V]S]6_QMZMZZ)X-3-.1S_6Y
M/AY^Q#H@]KWN_1^9\.V]$+<EV-R9H)&?9^W!<"[M:42N'>U79!.,]E?;N++7
MG8U?QAD]T/GQ.;S[^.5#;O\?U_YE>]KWWEF=4N:U%<D'P2DCDA,J=(B"!NN5
M%C$Z34K-A\^ @9W5-4;. (ZHE$#*.&.:.DZ"!Y9&96",;[P",P0_FQEB0R(&
M.^P%(1S$Q1$=)2"II4II+5P&4KB@#Z2X,D.>$2$/=TY/$H\D*&$0I0P0D@:*
MG)81"2:HYMIB(Q3HN9QNAI0^CJ7:(DYSJJF)+!G*)4W:,.,3392K:",W#PA,
M98L\N=Q\WS__>.(%]];GR@B, IE3!"-#G$$J=P QF'@>V(]VUA<S1?#<7'!!
M"$.B,D562'JO#XYV3X#XV> E&-&48\0#6"$V"8VP%$ 50@H,>,$VT:M@BBPJ
M?I4I\M(B=[-_='S"G(G89'-7NXAXA#W6:(\1X0'^H#)BF4OKSVR*K",'?7>;
M:U82AT'"V>9<"O&X?*4Y]6#WXK+1NH[QK]C^5O=Q.BH?M)JEFA<:T"F0=O3]
MWUN=[D&K>QQAY+YUVLPMSMZR(I"#G<\G1CJ;).6(> ;,(7F%M"$)R8QLS%*6
M"# '^D/FT&NV;R<4A&,XX_!'IUMKEVPN&S&G %R#M,=FJYM%(,5Z?J63[8%;
MN*YWQHJ>NE@;^09;OMD$6ZCU+;9KMG;5C_) M@SS&( [C&VJM30UT.513J89
M UV>3'[[P-YJ]U_*UZUK,,L"HLSVSW=/DF26.\R13(PBCCW/O? $DHQ8QB)8
M3;FI+MG2=P\R:WG).C-#^M/!=7''7^NP[G4_!N!J*H!_ FF!\6<E*<SI0JTF
M7OP,4M%YNMWJWK/SY]K&,O7+:F*;U[4+>UUB3$:-V%>Z3C$O%S$'?19;'LQ'
MS;5 Q_(?H0[0TFW!.[W<[K+@AD#A="UWNZS]E#^:E3RV&]>W\#5V)2^N_+EO
M:^=;MH=+T+E=E[R% G!9?P;O7\(EL=D=<-$B&" /N=6,Y7WR;>"A+@!#RU7\
M*0<V4/S;Q+V+^Q9ODM]^WJK]56_Z6-QT[\_#S>*7P>2< 7 .GF!B>H;3,/T;
MBHLFWNJ>V6Y9DKI X@Y =CW5X>T2@#L9JZ]BHY'_G?N^9X#F-1_;70LF(]RP
MP%IX.C384/(7YRELQ__V8/B%Z^!VHD8^,&6FBJ^][\K-P44PKKP)U;_!WO%S
M:61,7=M['FTPV7VKH[1Z!YKX$HRO//S+(RY,[S,;^MH28#Y'+"=8E7X 4Q[W
MZIW4%+6*[H1V?L@/L@//<6OE'*8A%A9*E)'P#1.^TSSF$^H(ME@G%)@)B/O
MD<;"(,PC,1JXO-.Y8^P/?$59?E;/9*YDXK$R\?4D&,H4X?UT'\X"199$@DQT
MC'$G*/<19(+=*Q.;8U"Y6;LZJX_N<VL4.O58?]\N;$'=Z[TF"%>OV(@.8>MM
M'YW99M\54\CBK1OP#9]TG)+]<W\2(Y5.68^8!9.3:Z.14U@AK CSP125RS:V
M!:;3 ZXR!JWRT5<E1L\@1C<?3Y@"F\\GCS 0<<0%9LC@$%!DWBBK= HAQ^UQ
M/5V,AIQ]E&R/H]D66% 3=+_6:@^MA,U,;PN(NVS7 >(V!P[F.P0T"^T]M+0D
MT;W+O+WZLWK\EHG7@+BG>A.NK]O&V*<O8M['P*3HY"#=>N<LNT:ZY:%+K]N)
MW<$13/>L'2/*-N[8Y_L^$MOIM'R]X-/Y9*>T4 I66!+>P=?DHY]\M]NS&V(V
M^X?7?4))YGKD\CNR>0#63N&_SN=.H]?:4R#^N=L-[#+?"U].R#8I7+C[YU^U
M+ABN\=9^*(,Z^D< Q:KF(RI8M7;L]MI@QTVCW2]NNO8-D)<T"3X=_?5I=>>&
MO.C<_#P0LJW:0:L;2ZMT3 CKG1HH@^^5]FA&@=I_>ZUN/7.>K'WV.XHIE7[,
M=[<?_-?>T<Z[FKLN]&G@NZP-?)?-(CLU?SSU&L"60CT''PW/\NT('EQ$V^FU
M^R.#P62?:HCP_JV3XO/67UNU#^_>_5DH"ES2Z;ES&%#V -0O+EM@7<-8&_6+
M>K?8H_JGN8\ K]1J-%I7 Y=&;(8^_M3;(W#Z8S#J]!$0GJ$;VQ?PF-V^B[D$
MQ6+K'-7V$M\&B[2;H>N_/=N&#T\YZJLW^[QT?G0N/#+#*IKC?I7LA<C,ME.\
MVJA_C8WZ6:MT/W=Z\'VC@^^O^G!ZIF%R/>\OQ9[3NIV*TJD#>XRSKMX DI _
MW_> E&LV%)S^ME;F-X((P6PWA[O#R'>/KT;^ZGMA?HCR ^ &ZE_[9MM ]P?P
M#5]5;&#Y:T>?:[.6VJV+&O[?_$# K?YW,^^?(Z\14;R61M9SY'$F5Z75OG>I
MACXH&$J^7>';@+L4P][,<YM?]3F4ZNZ>4OA/ 1#[CWB7!V1P0>6SSN/,.HU-
MT.R\#J6GK!Q )P(]#;5BNNOM?"32A*]I=V!"!Q-Q9^0CFEN(PC PHTAZ4K]U
MAK%S?>]>(7+%MCXBL%MS.8.?Y9SR7L?W=&#>C]VS5H"O/[TNIOQ=I].[Z!\=
MH=IN_W!HY$BDN*J@SK7L#JAE?T"M< BL_S%N5OU1UQT(S$\6MJ['"6M&NGO.
MVC(P^T8])31PO'8\D,Y>HW\.ET4,6# L85'*='#1@&?"M_WD?A[7VSY.W47>
MP@,^1-YV1,!28R<_2Q_>09E@: % JE>\;!T,X34<RN?5O,<G"POK6EF5ARM[
M9^;ZKXY,ZW 2;_>1,&3;W6F[QAV8Z:-]OEEW3-(&*#5V3#&"N9W!!0,PS0LV
M,HAR(_2-5B=+"2S05P#]RUP]=.(HK@KTOA/H3?#*!WH_&+A])]!;T80]$2$8
M3'DBSD@35!*4$ZH2%OKA0.]5W*D*RE!X>>XYF)UZ9KO !KWL (<[?JT^X!^F
MVV"%*?[TSKM,F8"B'N6-X @&\*\&O/7F7%2[-P<['Z].M)=<@38@Z;A$/#B+
MM%0:T1B%]Y+:E..0(O#MRXPQ[5Y\228QM.**71R(%0@=W*0P)XI5S12ZUU_]
MQ]*,.V9&88& 70+O3\:C_5I[$B> F=$-,5HWH#\G@PVDR/^'@33L92?^.OCE
MMT$Z?;U9W*_XT&]]U>WO.AEF[R3_%\I<OCU$X"U<HG"_&'[_F_MO;Q5OW:EE
M4+XGR98DYMZW\1:Y][T?W9:H+:+XHV[[X_<$N_]+%QJLFNFV#S0<&%1SP+F6
MPX]+*:QHW:>) ")\9W<:;D9E?LZ]+6!>_ZP,#I%K_5/DTG!$]QF.,\C/<]7L
M6%J'C6K U8"7T%7M^4IO/<QP"M7^/* MDWU6\+V(-WL+R<S+R4K7 YUQGN8[
M6I<N*D7 9A..<9VTT5)@8Y,W5#-A5)$"L+(GZK>6S.LJ"TH/;CSY<M1H'/SS
M_NP QO$%QGGXX<O%\='>U<$_<*^;4P'WP9,UNH[9P<W?C<-_/I/C?W;IP?FG
MQO[%'O]R <]X_H[ '6X.=QI@]WQJ_.=F4!)TM[O_[B1:J:/#'@4&/[CP"ME@
M.)(8?C>)4NQR(M<FUF13\LE\KH5Z83VL?,_<9O(N+WI:$%DYK)V]SN'<S[^F
MX'E_TZ?'(>CRFC[-#I(/1EA6^#DO?EX/\3,XBY4,B"4%^.DI0;E<!E+".H.E
MBE+Q')N[Q1?N^/)<V+G6K?QF5/@/99S_HPCDK$W[U@CFIG)$;25A445L(H7[
M<1N=L-K02!)3C+$JBO?U8]WQ.%>D3!HK -QRYK^1%)G$.&(NYG(5(6$*6 ?;
MWR8WR^IO]0)%XA]TDKTQ<+B? RV($,](AL9!H&)$2T>)(2.205N.+4-.2 V,
M2$OXC0M$B/,JB>B]$1O;AFV)A:W))6+$6W"EE:5%7DNG^(KSW ]WXT5D*C2;
M"\W\*.<)-AC++48I:8=X,@D9L/P1EBZG(RDJ; +[SM!-JA;N[3L=4U[2 ?96
MP>$U<)YQ$*@XS])18LAY!)=<L$!0"L0CSE1$)D2+ LB&5](FX;,7B&W)R;(\
M+X<1;\'1\WL.LFTT8OCEMG#1+X,$@LK[\_J94 E^>TW?CO#9G5C^6V'=7%AW
M.LJ(,); B91!U)%<A3YA9*1*P(TB90'CP'+?#8+UIB"3Y0<J+]":@L1K8$3O
MRRV@!VA7T:&E0\20#BF2HJ<X(&D51YP+"Q A#7+:>.:EBQ@#1 BUI5?)3?P6
M7$ _B*8B2XBFZH=*,UB!T.KEP.O!([WM<"O!#3$Z)1JU VV0QD5#!*,JMV0E
MDKYH[_8JW.I)D?'K*'E*VG#8(3G*W7JRH9@0;)4,14DTM4$+ENC&MI)\DPFY
MW("!)>CF&CFC*D!ZF+@]#I6J$*97@4E#MD:$PYP8@IQ7N9&B$<@$+! 7)*8H
M(F&<;6Q+L266Y>!^>40:;Y5ZM]?UW1S.>W)5IZ77/GLRYY_#7/)"P:ILSO%L
MSOVK$P;@I;WTB/ID$0_6((.]0=C& +//K?-I(IOSX>5_^53E=],JH?2SPT;D
MHLP/&\D7FWAOOF+3JU%R8=ZTUWO+54PK93%1/*U*=ZW27:MTUV4F=A9U*QY.
M[1S!JC>5]SKC]%29K]6 JP&_2E_M45E4KW2ZU:H\V"?)@TW><1R4UAISI9V-
M&"<6)1/$,D6J/-@7<()<-HZ/]L27'<_VCS[S@XN/^/C<WQS_<\R.+][7#S\<
MD\,/>_SXZ//UP?4=)\C%WV?[YPWX'O_]X.B4?MGY5#^X.3C[<A[JQ__L\2_G
M,);SL[.#HSUV)P^62$J,LQ+Q1 WB6#GDL!7(<2^C-E:*I#:V!9&;G"S9,;OR
M?M<J"[;*@KTO"_91^%FYD%\%>@Y=R,Q) HM.D3(T(,XC1<[IF$_]M=<N41Y4
M$?_()IO4K"AVOH7@R'&&6>7$/LP7H\!)^Q"%((P[Y[4*-%EO> C:F4C7)"KR
M5>;$/A?RC>7$,IN,CY(@1QT#WB@=TD$X1+04^7C'.^-S]5>VR=3"O+&*AEP5
M<+B?$2V($%5.[.M!B2$_XA[^D\8C%81'W#",7!0!10WX( P7(O"-;:VWQ,+\
MJ J(7( "51FR;X4!O<H,V>?"MK$,60ODAGIOD*;.@NV'+=(I!I2K']&0F,<1
M;#\JS*9BD_W<J@S9-06'U\" WF:&[#.BQ) !4:.ED=:CF,L&<<8D,I1YQ$C"
M*AG%I3<;VTQNT65YB"HGT&,84)4O>SLQ/STW,>K (_^_&VA%&-*KSIQ]+@P<
MRYQE2A-,C$)!:XQX@!\FAH@P5<%J3^$_#TR);F(VF3C[<^4E6E6@>-4<Z0WF
MS#XC.(P0))J38U5$@1H)9I3DR%GXH;RVQ %TB&C+0K*5BVA%X["J#-JG<SO1
MB"W!AO&H.%<^FJ2C,,(RXCU-WE<9M*\7)\<R: -VV$7,D/:P.7)!--("2)1@
MPG'.'"$X@B%I@$4M7H1V9?+5GC>2ZZE :.6@_;&A7LN8H#5%Y_LY[>,@NHH%
M>Q4 /22RV-%@- "THBX 0%./7$P<):6MULGSQ,#*%7IKV7&T*Y-.?-L >32I
M>(:>Q,^?3WPK\.\ZG=CM[$?; 4,O'#9!5=K1]]IMF!E0M'KG;2<1?_Q^XFWP
M,EJ/!' .Q(V7R#"6$,EU8$UPPB=\MT&R(QQS3:2F3'(1DU4L26Z=MMQ2[=CL
M2<=;2JQ0WG$6F;)O-%A .>=X2D;Q]$3C,GGO=?1\'^^K#J)Q5L[%]$3CZ7G&
MM?I8A_5>T5@]IQWO9TVO_6[;C5;18;UHN-X*L5%ST=M>)T[O!-]MP?LUF[=#
MN%U]K#6\'71L!R$-1?OTK=K1G:_JU"]ZC7Y+<%C"VFELPA;9:%S7+(#M9=D-
M&-[O%%A8ZT9_UJS_%V:@ES,SN[<W@#'4B@T[C^VRU>G4,QZG7O8CU5J]KF]=
MY)[Q_QIYEF^W0E4^)XRR4P?8[DR]U> >FW#=D"7 'YUN'CF 5^NT"0N:&QF?
MPFPT8J>PUZ_.8F8%Q3?>G8[BD7VW5SQOOF$GU6/8FFQL/U8LHFIT?Z?1/;DS
M8:O7Z/[!QO5W<!P3AHGD! B,Y$QI(Y/R4I-HL8U&^XWY.[Y/#NK!S>+ED,YV
M.KV+DD.7BEYOPL[5!0;?'>#5.!CF5WZ A?<673@M0]!KH9>)1XFI1>6%J]C.
MP^@7?>C\NG;E#A39$G+Y%03$%M%R3:H=5&-]LK$:^BQ%)"C9N*-K?>T9MZI^
MY-U?O=[A[\L"+\<99G8G"[S,4SKAP0DT=^=OTB1=K\G[X:D'>_AI1Q_X3<T:
MGD>N7L4QVN[W2S!$0+V^M3+[;=2[UT]2M^!5G84U^^=%8XX?HACVUG)*B.8\
M8$T="2X(PY/%D80'@@?V#MXOS><ZZD :4,3!0O]]N\Z?P""\=:DBNJ8NI+Y/
M]>OASNDU7'<#[^']FUWXKM.K0_C^_9NOUP?TH'YP<?#URX>#KP=W2S1>?.2'
M.__^^N5\7QP<?;S9/_IT?KCSCA_^LP_WVF/'=(\>TT]?C^E'\I^;O=%#+T&4
MB(88)*P-.7_$(4UE1(EKGCBWS&J:#[V>.KEV46?I2^C6_\ZR/RT\$R^UX<PX
M">C9)V'E]I_Y,#:&D)*4S&F9N%>@8$)J)9PR*<$X4X6QKP-C1YH6F!"U9R#\
MA'G$M1'(,BT0IB8YQ:7$3F]L\\D&3@L!S!)K7;]%*A1HA(V1 0<R@@N--1 A
M$B65WN:3Z((*$3-0TXE"))6:KH>:'HPTH19,4,D$8IYBQ'&R2&OX4T7KDL8^
MATH"%5I6IEE%A2HJ],:ID'=24\^2Q\'PF,.3 4J5#MH+@AUE%<:^#HP=4J&8
M6U92+Y"#]45<>HD<(19A$Y/ 3%AA)6 L>8 *O87LN5NO5J.>8NVG>K,XK^I,
M9.LLZ?E7;T_Y4832HQQ5(P';,";_:^BU\Y1.Q1#W,(:X>3#D*+8O2(47,^#%
M_EA7(\H$$3:A0%1$W%"&C",")<ZPLEC;F#N(T"T^&3WQ)%KR:EC'&@+BC_#@
M44Z5"@_6! ]&RAU9DGRP&%D:.>)6P6\A":2-MK /" \KG/' / 4>S%#C__7O
MO(_RBU2:MAZ:-N(-D00L,<5SB#U)B!,60.>H09:3R&4RP3M;[;S5SOLH&[["
M@S7!@Y'D&RHT<RDA14E W(N(#/$141Z5%31A)?C#.^];"$?Y5.]\1:D=8ZV>
M(2MVNK6V[?Z@F] ;J^^UCI$G>4W?PY+N]5>T<@3.#R<?1PU[[Y1/)A%DC#,
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MN433A$"=%D5*0BY2DG*1DF_9\Y;E:Q[UJ-]Q491D/G\@4Z':%0CV,UJ/=";
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MW3"=K0O3Y.<>[.V3,[+>/&[!_;_"/7?I_LT>V3__?!)R^R0<-"+$)<2#T\C
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M2J9$(G!!JZ,VWGM'$WPBY6.8A]H\WD^?7[CS8]_W6VL4<ESSL=W-1 CNW4L
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MQ*.H]_+':*R@^@4UECU(:E@7J>'7*#5,B]1P4<PM4L-%:OCARCRS-1W.:IT
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MB'8T!WD)XD0*!%2;(X&3P=S"1(@XU_LEA,TI)E0/9:8'GLDOP/B:@#%H'6S
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M,C+U1WXXZF<1F)S(-A@7HQL+PBS#%.GY;RA+7>2O'N:X<X6!RXT]V^XV?NL
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M:JV#YDGSPU?%&?R/1D0$%8A+\*^<(Q(1E03A.@:6P(\2Y&J=DCEGSM9I_[J
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MW(@A(0M4"'G!C8U&.DUH%AV;5VG&)^ ]]5ZV7]LG7U\&>F&K);VII#<](J<
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M$G+8IZ=TPXWG=&.0)S7@VIBOY?ZQPT9.8QE;V5D>4 5P5U[&C?8 @&UHVQU
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MIB#X?1#\VS3%BDG80(1'CBB)8)VER!J)4?2:2A(,HT0LK2HVK_,VSR]S5=0
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M; Q9!Y ,Z02S?<$W!H[PTR /A.472(>GG' \&!)Z0()H/<GJR)]H[M]P[M>
MI20P\S/G\ZDI@$3#Y6@+H/\-@9?[C_9X$2@WQL48\X=7<7LTEA(CDJU:]E@R
M-!_=>(@JCT;$;U<\U)@ UH"%8LS)64RC25&$]XP]/_B$?Z:1O@))W^M+WTQ3
M@T3ACKH0*']F3XVY&0G9Q(UF&N42M^0DM&38!#2-Y\?A9AYMI*"9WL2QP+@
MSHO[*J#14& E$6:>-%97"?(9Z/!K;AIBD ;,%BMSR'%[CSDV+&:Y;C(;*/E'
MXQELU'$T9V+LQ4RQ1SN(#1RK.($GO G_X>9T=8KMUJG%A-_,FW> ,H,)(L#4
MIX! $-L0$*3.#GY$TQJ:.=BJ<"<&VARQTG[8=6Z+(/W8UD'H_/#\T)K$[0=L
MC;2%9OB"<I3$8_"=V'5H)^K&,Q"5!6L ;7%<1.@,6FV*>QOQ0V&X2C<E6J_R
M4V3"9L'L@I?_D,S=CMXL_1"Q1DVBQ@Q\XY$_>?X/!LL<3168+F&SBPTXD.VQ
MG-(NFC.>R-?5\A\,-ZXL\.(>@)/U!',I[@K0A<,NJJUNZP-T;3ZF\*U#.))"
M&>;-TTO\XD$XA=CM=% N-$7-?3CDOE[HHY8.$X&Q"[.ZH*KG_1P;RM83^HVF
M?HWUDG;Z"[6WI\7(ED='K/H^Y\"U)H"6TA%6\]U@S/YD/(X^L3^\"=S>: @>
MQW LD+;A!()"MP,92C.:]$&8!5V;B&@3:(/_*'Q70D<(#S&J(]F@#'L:VN@$
M#B(C4EQ0!V7"2MF8ZZ4[HYB(QMUIR -2U!MC;$C/\Y+;[KCW/ZI"&PG6O.1[
M\L[6]]1#(B(6KNM%"CG<KT@OQA<H4;A_ #<\2D\17";%IX,[#E*ZU9QQJ>8O
M!A^$V*AY*_QK]8;(AQ"!T.H5WGN9[E'@E1=(LP7D?6!CA!0#KN&/Q5,,J3,C
M?HG6LEBDZ*T'JB&\:R$1?@;^]0-I[MA;OCZSV2"\ J EQ?FEW6DMK=II/8FM
MU>O$K=56[Z[68?7F;:MS7^G56\U3W#VG0/YXO(NZCW@7-:_K%/"R[7JK)JZW
M6)Q*I_:YTKG!4!98?+7ZYR;[\JU3[][4J[@.NZQW5^FQ=D=$A<,*[;9K\H=M
M5N@!@Y2;8%<;P&AL$UTE*]9J2O@MJBD"7=Y^%:Z6A7:E W-6KV\8<9YV*/33
MTT1,33[C<E/O@&RW.MT,J_VS5OW6JW^OL=;M;;U:Z\B@GVJKTVYU*KT:^]SZ
M7NM@U%?M],EB/18>@H8B,*.(DMU$[EW![99VWH/,RNC6Q .!;^JR?77?PMHF
M=$,'JUJX,#ZP:[ D8<1$Z,&3"P,WM$<S>T-$-4O76.9XQU,]Z'A*X\,6TA<,
M#9\//<<2CL<H>$DXGJ:>Q;YG^"+\9+I#D0F#G?R1\"FR!^3\<JM.NCC9 (<X
MLI/:OO?K>6841V9T&)@.MH(SB]:")C(+" @3;&2%Y2\/Q<@(ZM"=$%HXS]SP
M7XJ+Z:X(XL+\:&%/Q'T^EI[FT)ED&CH/-]EB?E\F2;%X)L&?JIJH'&8:H=JZ
M;]>:W<W-E%,"?SZ%>G3;<S>05RPN%)3J4UHHZ!:!9FR^7F+,=<?%4E+.9;%H
MB8NE"VNE4^_]P5K_: )WNJNW@4<QH%&]2KW)KFO-&I JC)>7OPMN=5]I5CZ+
MF'OQ9Z?6 )YUP[J]5O7K7:MQ4^O );T>7'Y>BVZV51O DO-%--64(N"V61AA
MTI]1"/E[&#$V]?'3VMQ];>9.T:+))9]8"%><6$QHM,-*[,XMKUZG JI,6O29
M\/2+M(+ UK^I@:*[J<6,G(,>H#NW]1ZM;.D'!/8**SX(3P.(Z/Q+# U_7A7_
M)2EM;(=H!8D]S_6?=B47SD7+ZHFKN]VI-ZOU-JC1V?$T=ENKR17>K76^UZNI
MCR>=W.H1<0H<WC(R;!&[C"L#2^/8&*H\XC[>),51[OC,-E/#K5,#MSK?QZIY
MSQL1VEX.WI;*Q[$/<5RNY>_+RGDO1*RLG0M\Y]=X%.[JU_7>P@GB;@]XF;""
MNM6[VLVWQBH$3SN*ZP[EAFL:Q3$VKJO3[AQH[5X8'R[4#TGCMRIR)<LP?&=E
M3(N#\3-3B*^#D/Q"K;$Z_L6/4%X&,43!,L<5K+9!Z,Y!/;<B&#!%V%!:J5X9
M /'&P4;) JMM)+"L:PZY-7&XE-Q9^*XX_RJ<TWA2S 2*8(\9D(@ 8YD"$28\
MC;4.8W?#W"A_#N8/5_4-1SPG&'*.*V2[S 3%PYU@1UZ#%*EG_&(5&7A^R;Y/
M1ZH2C534+Y'N<49=1(I):*QCC +^,?KP*:JN8KOBE>*F3\O8N)@2'<=$_AQJ
M\7(YFR^HJ,C#S.SABT,=GQ4Z?B%CIOP-R$!.*2?^K&35Q-_6/5;5LN5R8:O'
MKO\MG].IL:?3V%Q64=(UZ(6Z AO6#GJ=?,6EE[!"D.F+&US>O@CW?)2IP8)I
MH/::#-IKNBA9]C%U\IH#1HE=FFL)[1MT,+%6RXF.19A0C[5E@H&+ZA 0G$<;
M[LE5.<]_9&Z 5L1\AB*K]CL>CIIK):V8-ZJI=M \[K<QEQ-ZP:QXDHM8TN4M
MRD E)O%^N4#4/HI,40N/L85O5/_YH&L*[9$5!MLNA3?/M%S&"16\N"@5E@CC
MAD)[S)5=2-B.J6^J>O*5M$G@3DG@+E0"MV.:C[.6M>)A-&E(/1?VO%49[7P
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MW"QN:?E98M)KIQ.,O!3":2M,VIMNI=S#5W:]V*=\HCX<4Y@9_.H*_@CQH93
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M/(MQ30< Z\V:9P$(Q.F)(<ULI4WS).,[H=0+;P2?7\&.*'L0]'Z2WN6A>--
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M+ESW5ODF-'T>+)MNB[\HO2=--;7$?#@.2*<I2Y*(C)"DL9E8+101!@0PYEB
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MTL<<2KN+;(N;*1RQ2E.BC15.)*>UYS7(O0'/>9.O#R6L(<?>URB_P>Q+@>&
M"1TDEXE(AAAD=D"LQ;6JQ+)5T04=JAB']U"<-Q%V%_@:]5?M.7-;FZPL6&Z\
M($E(!"D#)YYKW,4$M51ZRU.H$M8^S6KR0Y*E=_6LX5 _]R3[WR=+XX1.,1)6
M6OI*C\NPD4:B@Z;H?TOO0Y6H8(V4@>V%^!$NKYJ)G]S,(72[()-.AF2C)-R6
M),S(@#B*]CF7%%7/5,:=I8;(=@%[WB]J=?6M>7'W#O2O@&Y1W>\M\':R%-Z
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M^M<[';:1>(TV <WEY>*&=%%P!F@^@TV1N& \D4(KXI251#KPPBGALJMR2CQ
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M5RXD1.)2*2YQ6W!2)N. "F6=!LBA7$WL=2&Q-_+>KR>"<9)1,*2LDTB#3D0
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M+NU1PZN62S7U5*DFGL[>YKLE1T$QD36S)$ON"*Z<(K3,2.:"9<076:R2\OD
MR3EQ8C\QGWI@J-3"_3+$?Q&'2/C;/_A02G?\)!VKA*L[L*.&B':2WDJ<B*MD
M(D\YZQ"D]M)S+K+--*&'%9E/>\:)ND+<;R_Z#?Z\\_!),\8OXSRIY.WDY:<2
MFWT]OOL70\2#'/KB<*+?D"WP0(Q(Z'!R$XAUN*,* 'P_F70@7(V]:V_D^V[C
M;]'?\N6CWX"?XL?Z,!P-9S<#G22U8&29-<++S'%'G!"1>!9P.PL<K*OB9F[
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MELD!^?"$:7)H.FPC\0HT>%\N%\:0?O:3,>Z*T]O<^&1Y,(XP$TK[;^U+B^=
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MB!JN,=[F=CEK)#;]Z>;.=XN6ZQ[::R0""4'+9*'TXB_=+@TW,6>+?U"7D=V
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M/Q:U%58S$3DN5QM7VOH'2JS.CF@1,KJ!&7?5CM<@3S_L)$S???335!1NW]6
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M]H],./\GE$>B2/'%]!?P^Q3R]>C-,,/ >Q^"TV6N.;5$IH0;K,J.H$T+6:C
M-%TYE?IJ8[0[Z,-MD7VQXF%3HP.IK$+&U2.8VP%/ X6"$<(QDFRI3V,JDZ"B
M(X*Z' R@<5:G@.\I8,^?-KV*OD*,\!%\+V*\OKQNK\CN[MEHJW,MC;"$<T#_
M2PM/ C4&K05P/'EJ)'2I">J3+!N@GC5]^E!/A=RO1Q#_!K.!%#2XP!11.21T
MWI'SGEM'$#/-S";-ZE0=/0[KK(FRK=@KI(A]N7I[!.?\-LY(';(*Q?\O;7>"
ME,2727 R:IF<$@9,%>NF.\3:E]ZU*%))":=R$_[(HGZZ^=7_JYFT]3;MG0_3
MTF;ID0<FL9(Q&8EECI/D0#.NT FP50H,ML!X_%OR?EG2?;_:2UN'-9&^ /W-
M7R[["G6!6_.B?4N\Q[F*KZ;_[CSK37DGP#D=HTTV* )>9R(SL-),EQ-E?:1.
M9D;KU&>>!->>N/X_5:IMH[.^;RA?-A.XC=TOX[XR:R>"1RQ4T1*E0$#.(R!A
M?&"!4IH[]E!?\^F'#Y)7U4?3IS KA'Q>7D]GS25,VAS7TL?@T_!J>4-CH[>(
M+I'L2N?M%%F9&I_1DHS<Y !4UNG_^0BF\V1'W\KH>Q=8.AEK8#'O-<U<(8Y0
M1AR#0(?11))S,A;]#D3=+4=A\S/.4^=]"K9">&;MW<PRL0(L@XQ4#*'T;)?6
MH&6/^U;TJ4R8E5JS*OO"(YC.DR-]*V-CQ*:W2]CW,$4?/L[:(E,_GD^*:2<[
MSJ_PIKO<K#[]H7M>EVZ)>N4.5$0G(D/],D51C\(IFJWR7 <F4J(P>/KC]WM7
M[WU^^=P7XX0_@\EG^!(14KB7,*4885(4BQ696(9"$:&4T)"%5W5N [N VW>S
MNO>,]O/;<'=YVL]_74'$KW^[+F_+V_RN6?1K^GDTO"QCCB -I%,,M>5(E%*B
M'2;+Q&R>"=KR' Q5PM6YU=H/]N&WO-YYMKK/'5"/%4SI#NC+UVR@(/B8DB$0
MI"9EYA'QB=F24XY6GC/9I"KG9U> 7R>SMM=-E5*,DA,PCM >#VQ  VBG\4Q/
MBJK2%9 1J\$0+BQ/,F29?)4[U!4<9\B(?21=P=Y>EIS\_-=PMD#$G03#(!(!
MI4]\1"I:GQ71R63IF-5*IQJZ?PCE#-6_I[PKW'W>7_(G/[F Z4!D[G4 61*"
M<JDYU"2HY(BEP?)(2R^?*M?@Z\"<(0OVEGF-IAB+'@NW5>=O4,H7;7S@ \QF
M\]O0@3+)IU*(%F(V1'J&7^D<B07EJ:8J2E[%G.^$[@R9TK]6*K3%N">%+[!0
M%J\OK_QP4KYY-VD^#\M]"!(=;1E.$5ZD0$L[>$]"B23$P%#[ A3U]3>7)V&>
M(9DJZNDAJ_2NK$HP'/P\GK6#.1<-C:G1(+TFM+0QE@RW1V<$E.0Q 9:CEY76
MI$-,ERJ90OSAHOG\(W[PG"SXQ2I''CST4*TCJBE]/S$>.VNFH'\#%W[4+N%F
MWLM6!"8]E40(C;M<RIZXTCI*:0@V."WYNM&36]-@Y;&'3G394V]-/_+KT<>\
M7=#-LHUT!QR;$U!V>ZUOCI%,LK<25E_E?2184Z/<)",Y'@TJF4"D!;1:\9 @
M.J=H=:9!F#63JT]0DQM2-:HI<AO!]3YFL1G-FO'+#\L+'>Z@'8HNJ2]#_]"&
MM )5(*(P-H? G%HY9#=5[-_[W,.94?L)M^E',CW&=\NTCO=^? $MW32 I084
ML<QP(DUTI1\06@0\0O A>1>[1&4Z33JY?>KS//MV%UR/ ;9;$,NBU0XP^IY#
M=.?YAY]!M*,&5G6XA_AZGCUT%TY*0D0;#'$^EO9N41%'E25>\@22)IMMEXZ(
MIZ'%1V8.]:O$;:36L_)^14E=7E\N@&0\&2P$2K1BN*T#BR2DZ$D.0E$9L\0M
MO2_UW7ORX4[#O63?]"&XGH_"7_U?=X#88%665A":2UEBQ(5Y**WE&3#G+*"S
MW)\&[S[Y&6IP9\'5G^!2*O,_PN3R;1@MHIK39:+*AT_-9%9^]U,SF31_#L<7
MTQ<IM4_SH]?CW$PN]^R<T-_#]\P#JB2%U7PA"-I)PQ5H(VW2EFJN%%6))YVE
M,H/^8.S3[>:VON<5A-F7$)A4@&8\\M;3TH$G:E8:JFK"BR&8>701NG5,V/"
M?6/@Y<->C--+?S5$];XI;<[OR'$0DV8@F";)QG)\<DLL@"!M*:S$ETZG*KD^
MC\,Z<%UI'[I=C6GW*/<*N3D%W>MQB?"68.@O?CCY+S^ZAH%-I8%-<882^!(\
M"&A7X5XN(^CL\3T5ODJSRPUXSH0'^TJZ0F)-@35O:#]#XTD" $<NBC)J$Z0L
M%[RQS$+.RJ!KRT.5;L=W,)R)HG>1:(7DF>6!^<0>!(@D*5HH:(K)Y1/!<]@0
M(TL+=X>H4Y5DJF[PSH 2%?10(='F]7@&$YC.TWY>CV/A<!JHI'WV0A$.910*
M,Y1X 90P:E3*3";I7 URK$5S!ES87\H5<FON'TZ_CZ^GD&XM::2KC^56H9W,
M./!.)XH'$T$ZEC2@:$C@(A#MDZ!9<UQ'E2S=+3"> 4UJ::1"=LT;F"&EIV_S
M2V3R</;V>C:=H5]V.\MSP*-AWFI'(J6XKX%(:.)XA?B"]5J*TGZQROGR!+ S
MH$FOLN\Q1V8]C9=[WWL_@[:I?'H'DXB_\!<PD(X%;2T0@"#1$X+28L=)HG(.
M^"-P4JVYH^U[7WD,XAGPI9(^'C+'[,N<=_ZFG3'PL5ET#EQF)L.B\5O4(6DI
M'6&Y+?RUY=:SM%!A3&?GC%3KDJ[VY\M3P,Z );W*_B$W[%YI 86^?C1J<P'G
M.']I)BW.>>73(#C'T)DN)<%2$"G0H I4(GN%-DZ!3%&:3I&XIY[TC#7=OR0?
MJMGUK.9\#]S_ 3_Y^&<SR,DE+S(G(:I )$=XUGOTLXV,V:(EC8S<4=MK'WA^
M2M]?KFOB4OM-Z^@$$K4) ZU9M-1D(E)" ]C&0$("0[(/AMI$8TJ\/_671WX5
M!-A:MFLHL%_V5Q>8OS37DP'R,YK(/8G1NN("46*U!L)$-@$H6,F[Y85U?>+7
M0("M);M&_WN'+W\?^WEC5DBMW3J=7I?"Q%*8.I["@.FH71EA**1E2$^*IQ.S
MEC"7'>4R.LJJC+Y]'-8S9D<%N:^AQ=YQRKO=>MLNBPAN49LP'3#.M$;3A&CE
M<-W(U))_$$@VB@+"!INJU.X\!NH,*-&;S-<08K^1)>]&D"[@B]_Z-B_"ZQ]F
M3?QCH+2B 3(0&K)"+Y8E4B[5B!-!4^:HCSEU.AT>?\XS5G'?4ERCX9U#C!NP
M_8QGU>QF&;T8,$\Y3S$287'IZ(UF-%H9$% 9DE=,ZMS-!7CJ2>>GY3TDN4;/
M.X<+6W2+/+"[\/ZKF95*P):#UOH<3)0$(GJD4LOBFJ!'ZG3(3%'!/._64>WQ
MYSQW'?<HQ34:WCFLUV*['WW\7]=^@KP;W=P]7$HH<F#!<J71KD!/$PU/;XK;
MJ2GQ (QRKV):3438H.J.#WSN.J\AUS7*WSENMRGZ'"?E"OP5S/^W3>0KS?:%
M14VB&4&\+BDQP99^12X2Y8*2+@=0K%H>RM/PGC%9*NIA#5WVB__=7_>\V,8A
M2YE NT.[%,KF18F+I9D_ Z-SQ(-KM:JA4X[EX:82]/[F[RNE8Y=1WW:-7.;#
M_71S^^5_#F&"R#[=O('/,&J+/%QT3JG$"><EGZH=]B,@$1:"BTJG1%6=T3F=
MX!VZ&JT?!JQVX>Y?$S7ZNR^A_8H[UO6D)>/T(=Y%H647L%4G"FR#]DCS!"JH
M?1.SJNGLZ$3+2@DGO2)@7?&?M" ![6U\#[46TOF04Y5DN1,@V%-#!$Z-7]NH
MJB:O7H^OKF?35@)L60+E>$#C"KUP;MIIAX[XP#0!,&6L AH#4&>:X&9,1^@C
M74^;FWBSIRIJ#)Y< XTO!R0$B:\*X))92O.8G+4YXYOC$Y,T>F:KM$%\!-/7
MQI)=5%%S+_GIYHX8?O+3X6(H2S1<YT2)5+049HJ('ITQ!&),*2MI0%2Y*'L"
MU[F9RWO+OD(%R+L2 4*1?BDXNOWBU7!:/#Q$O)RLT %J32MY"ZQ'MY'WU_5J
MREUE1=7<=KX +-&,>>+Q=-D)RA@3#&ZYW C<&D,&XG 3Q@.4LS**,>M4)9;7
M!=RQ#>'>2=2[1BJP9ANB"^MM\!Q*#IHDT@,O4U^ ")&S4"Q9NYK:\ZQWHBU-
MGMZ4O,=6M(V&:DSI\I/)S7!\\1ZN$'0[R/GZ3G'M [@ R=&@' F&NO*&&3SI
M'2,64M8FV\1"E1J#+7&>(:EJ:JK"+O63'Y64IP^? &9ORE\7Z9?MV;@,TGA<
MM"@-9C@@+LX8<5H9?!%DY+'*>;8)T%D8T;U(NT)%[#I<BW>A"[*:QO)F:,>Q
MC?M180=>["'_ ^T3R\%F.6L(*9$L2[!!^DR\RIQ09Z7)3NLDJA@OAV;&$_;N
MH8FQC=@K$.)%C)-K2&^&/@Q';9_(Q8&FRIF5H'3W=++,N:/$4NN)\D%F)QR3
MG?IC;I^8N@'0X6V,OI2VFIK:A\1[M$UO,W+>%YG>R9-M60\\&LA&$QTH^G@V
M"#28=0DHBY3!<!KTRJ#I1U*;UCWA61L$_<FNQR8)&T$MR-L%UGI38 O5'N-L
M[U$;3^EW#U'VW7;Z$7B!"9DSE22[TJ#%\DB<SY;$J'"C"C8);T]2PQO.Z,,K
M>!L)5NIV]27Q;6Z&H'(,1QP^),!30GC<H?"KD&3&7P&UNHJ9]A#*L]ZY>Y)P
MA?8D]Q'=F3S<!5=-%VX3L.,X</LJ[E$>["GUZCO!'7S"1Y>#=,3F$M$LIJA3
M)0W%^\B<5=(?HO-A;38\X;0=B@S;"+OO<[XT9'O3^/$O/A:_X:9-@R[X_.A5
M,QKY2=M.=GG%+Q@3EIF$*^><R"!P3V2Q=$8PX*3$'5%VJS+>ZK&'=]+Z455S
M$#GW[;2]A\_-Z'.Q6-IF2DO '_]L;L&E2).-)(*P1')J\6!4C"1JHU<^:N]T
M)Q(\]:1ST'NOTNS[Y5\!][*YO!S.VN2A!3A$HKA,CD13VE]H9T@HW>1=ICXX
MZ[2-W?STIYYTAJK>3YH]9L&TX$HK@W<-RJI,-A[_,OR\+(#\ .-A,_GY>M*\
M@G&S&);^6S.[#2 )(90'='NH5(I(KR**PDKB'(CL)<2T:@ILX,#.$,Z!'(>1
M?X^W/RWJWW_X\,/\>$I?P,D?K%%SV'=Q)AV-25D2876IJ43CSD?$J2G/+&DA
MN[9^W^*AY\",6C+N._;W^X<YRCLT590^Q*AB63<7Q*62NJ.X(8ZB!^VSTEXJ
MR@&ZF0<='W@6'*@@VQZ#""W&%UPL*?G(;F4]ZK$T2&31:31?921E@@5QFN<B
M !M2M^+$3H\[!]WW+]<>.YC.HV,MN-_'4XC7:-JLNC(+A%QH,-D;4N81X]YD
M& E9%R<_1F6U-X%W:SC8Z7'GH/G^Y5JA ^F&-NT+<-1#=HQ9/(%\*8[.F?C$
M2K\,9"@OG9ACE2*=1U$]<V[T+_F^FX^VM?$/(0F@C&9FVJD=1.(91JR-F221
MJ?144;\Z/6?##K#^\Y^Y6ON27-\M1E\(QA?G#YHAZT\?[XUU$7<>X8OGJB00
M;RTC6KCHG8_HU+)NI_K3#SL'-?<MT]Y;BR[/FK;%Y?+ >6"#+I &)H4.P1,>
M(J '*CRQ@">0L9 %>ATA6-%)^]L\]1QH4$W*O?<9O=OAL+VI7A;99&YS4HD@
M*='XD$R0X*PAGJN()W/I==C-G-_P@'/0<A^RZ[-QZ'WJ_=D\1;R4$*=1GCA#
MR]0514G0:%A \-PFJU+TW3;W[L\\![57DG"-7J'W[Q[:BTP:M;'(04*C:2-)
MBN!Z&4&'0G*GK5?25C'<'T YBX2//25<8>;(?43+VI4.F&HF>ZP#=9Q$CWT5
M]JC^]Y!VA22/M=APR^,"MV^B/$>R@W'H/DI&E$+ PAO*=94>+8=CP!/)'8<@
MP#9"[OMN=^Y]?)B'ENZC6YQ*VHD<@05BLM<E@H#[G7",<.VI]M9IR9\<SMSM
M48<_[O=7Q\- 75^RW)BP<:1YW6N[AS3+]M9E</32;)HNZQ<7%9'XH3]/9\/+
M8NK<?@K^R]</_^5\Y/3TO@QJ#  _Z&H..E'\>'I:&5'N?<I,12Y<BC(KYZBS
MD0?GG1))0=YR1/E!U[5/"L4ZG&_7XGQSV],R1 LB6TM$BK@QL!1)L*7MK-!*
M9V>BI]TRYG9Y>JVYV*A^/!)M(!8]&")S,,0YRTFFPD8 YZ*L8CR<QESLZCSH
M.C1[&S54FIK^R!Q?E@*"\[A.X7&=-'&"J#CAR45CN51>52/)R<Q1/@I7>E)*
MWQ;I%K*8.^1,4.62!!)U"<WH+$B(8 C57 9*A=:YVU2K;9]\D"[(!Z-&?>&?
M2O_D-0G[ ;?%D)@GW$>+8L+](B0T_*4#&1G:Z,:;^D?5T>)<==7^=-73-N(_
M9'U+%UQ?==735HKK6NBRB]0/6O7$/7?&X)D8\ V0SBGB HLD1LF]]FA/Y0/8
MM:=7]52%#-L(NW=39.=L;$XM;I"X=I=* 5@LM[2< F&9"Z5Y-@\FJYUS-OPV
M*NPG&WX;^?==&;5-IG:(:*%%F0@-C!%ILB)6&TV859 @@$RYF]__3+/A=V5&
M+1GWO8-TS=CVS#@E8B0J!L08(R-6*$KD_\_>OS:WF>/HX_ G0A7/AY?I=&<F
M_^KIY.FD=^OWR@628*(=1\I*<J:SG_X!)9]BR[9DW;PEVYG=2L=.8ET +I(
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M,:((88)."5QL_?VCEQ"-TZW,IG@.DXB\>^I,>. J>BPB[*+J<>;NI62<\:6
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M.TVN3R.]FT">RPW!7@KND!I]'<]%I>46B'K>#-R&=)@[@?U,=8_=]]!SA[N
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M?4C7OK$/2G6S3ZQ(064798C2:-+1L)W:]:;65+72#_2)W?1Q8_2%M2ZX:$P
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MG')HSG-*!M 4!<%9'P-2<'JD08N'ZE=U5VW"Y45(*44$5WEQ"52MZD9 H%P
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M:^%=>Z]^<6_#^YA\/Q5WJ >_%2,;+8M5*H-7'"B;T!HCL$!05-(A:F^]ZI)
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M,%7OA*2KR1*"REFTUA2,4EG-\6QV46AM*7;)%-@.WHMCT2!VZN#Q;>)ZFW#
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M5;''N_G_[PQ/)_7[9/KI-2X^OSF=_>>?5#Y=%H#P2L' "XB-77@1>><A1@Q
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M?\,/2-%Q+\0ZENDB1H]YO[L?#!^$OCS)'X# )H8'F*_%6+X3)SINO"&#6\=
M19I7O)066$XF"6VR5EVF[G&@N&.>;@!B#ZLU6((?DM9GR7V2,D ]?:8U(=$2
M8W+M)JMC5,HP8YO00SV0X3(GYT/!:,#PLA9E'2UT$:9E@/Y(FM/$YGMCLQWC
M PS;;A:XWQU8F7A)-!$9!:K*4YNI0XI.19NB=*Q)#'X$E%\(O]N W,>>#<#]
MX78^N<GS^8-<TFI'P6P0R02:FFC-4MD70"\(E1"U%T*BD4UZ6>V0Y[*G_B%
M:L"%M$VL^NTLWZ5 NPC8<FEX4<+3+!>#X-G!1PX'XT@SSF-!@Y'9QAPA<<-!
M)>GJY,K!8>+*:FM2;-*OXD3>\L*R<QIGZ8/!X ?4.,-/]V<:TG&E!$I AHDD
M00Z>>P[:(OT3E'%*/_:&78?3#Q][_#.F@6T^'<1@.PM(_N^?-@SS-_IQ^8OE
MYU7Q][G\H?[[R_N?[HU$N.(U+7S_$:>?_[2TSCM2<?'UR<+Y_L,O;^)B\AO]
M[B]Y@9/K^6.1YI//7Z[S2[AV?_B?OLG^6*?U&QY!/9@6^?=%ODDY_?$/D_3G
M/TZ0%1<];?^%#\KEZ$/@PI:")6#@15YU?\V)&G3][?Z:;.!<:\,04&</*N@(
M7H<$.=B@6.#1N''11=^+?K+N9BMT?[J9+V:WRXCQY\6O>?;Q5[Q9-SVYO_J^
MYEYP(9?H:\MXZ6EO8)D#'YD AKFDZ'.,V(96[U@:CO"D?UC/'ZQ[65/?&;",
ML+VBCQDSK[0)0?I0@+EB07F;:;T4""):+[01M)2.J^=L3P5?A\@8/.<4=PSV
MUO-Q[ZRKR'0V*M?"(\M(3T%@\%@@9^Y<]CX%-JY.LST5?!TA8_"<!G>(V^FY
MTN^GFSC+]+=_R:M_KRQWC&M>:-MERJI\SGF>0,N:M&.HC&V2>#BVHJ\C9DR>
M=(I+F(>'F1M\'\NUM=Y1OF_5>,5%+JB\!]KPUL-KK#329(@<>-9*!HGFS-:=
M[LJ_CK"Q>UR+\N<C1:XO&\)SEZ2J7:I#K)WO:/5&5!(LHVV?R25S.RZZSZ$M
M\#K^SL+W!BP?/'9P_+(A'(7)7JA8:[_H"TL"D M)T;/-1GHOL9SFOO>Q+/ Z
M",_"]QH4B+4SQ(_36<F3Q>TLSU^V@D81@A8!,M8C4B4*H+$">$S<N""E*6>6
M&^RC_NOP&[_7-:C*V=L*%&BOU'UBCO4-Q"M1> S"TX(NT( R7H(WPH T46NF
MBXFE29._=BJ]CI'3>,=3OS^8RFUO$A5M0HDH!<C":KV$C.!"-+4E9W N<V&*
M;N'5%T6/<XC/'@79IQYY, U:LW;WWYZT^J/-Y>J*M,0H)4(J2.&?+YJ6H!@A
M&QTM9TYEUJ1Z]V0:7]R8. _?VG)L>G!EP9%))#SCVC-D$$+6]6HM!Y\U@C8E
M. R1J] DYGFE(CG/\7.X%VT9-(?5T[ZX9?FYO"<U9Y-*A[B\!_X+R7T5#<^9
MR0),)$?FM95S2&7((GG.F ML\P+VCL+;_=Y_,2YY+(RV^-6(C^@?9[R60^_;
M%CN*6 )M*LBNRM3"! G.& LY"J^35RJ8<6U$#U+W8D;"&7G5EL%T^*G]8)?-
M:@?!R,CXR3C2I-#<$'0E272"9@<94\(VX^,"^:(.<O23(#Y*OJ@<LN$B)?"\
M=L3$I,%I(X"QK%0L++#4Y,CZ^^*+ZN4&S_%%]8&C/7M0%VDNBB^J%SS/TPCM
M8]OVB!>?K!.* ?+:T4KK#)A8 %[;("=AE=ML/WP^2/?ABQH0Z#XF;<X7A3HE
MHZ*"LF0NQQ* -BL6F#$LIB+0QR;3_7?&%W7(?+\_($?@B^HBSH7Q1?5"Z 4*
MH7W,>P2^J%1S8;'VQ\BT[U)1<P@QUXZ&J$+!H'-NTB9V?'Q10X+=QZK-^:)2
M5$DQGD!H784I IQC&DK&P#T3TIG<#.+OAR_JX(E_+T#.A2^JBTZO?%']^:)Z
M^<HQ.'?V ?I<^**J^"PX!XA2@C+&0]T,@-4BTEJ@; FGN3\S&N?MQ1<U.M_M
M@^_0+78J%<U2UBV'2O-U'QF*/"RWF("%>K:$%(RX[#0M,5Q8[KABN3L#T LO
M&^$11W-(-ZF!AL2C04>'!U0V2[O<B65=M$DG!<DK&E?!6W#")0A&,:.C*PJ;
MQ.P[Y+E@3QH2J:$GG/<?/[S?E.NA<R<ADXO2 )<Y@A(T16.FG8\3E@FKN?+1
M=YIL7GC1!;O'X#@T2 -MF_[>?_CECAJ/)2V-3F"]RJ"<8>!K2\UBDS#!YJQE
MDYY3STIUP1XU/&HM-I@[63,86B&,-V!R%*!X*1!0TD9>Z:)RS%S)5U*BXZ4E
MA@'J.*1$722Z;%*B7IB]3$FSC\&/0TK$N>442TFPV09066=PR0K0P6NG0W")
M-5F41D]*-+ ']+%S,U(BR910U@L(R;-:;TEKF961% N>%1M3$%T*JRZ-E&B?
M96%_PS<D)>HBQG=*2M0+@1U\-ON8KRDID<+ 38(D.*<IA<1Q&1,8GBA =5;Q
MV*7(9!PH=B(E&@+$/E8;&+R_DZ4^WWY>"Y)#9,47#BD9VEC05W"&?D1GHY>T
MG1'8Y99;)_@>O?EX6[Z#;#\=PG #9A*7@N#O#P21N3:QEQX<(M9>%06<(&D\
ML\D;;>FW7:J NB'X\,UGB.#>AFM,#,;1(C-"@<5*8",L@O>9EOKLBG"%E=R4
M$.AR Z1#P6A.#-9%F LB!NN%S;.<4?L8MCDQ6% B!,,"&"D2*!D5K2<J BM*
M(N."R4YS^1A1[D$,-AS(?>RY$]S!:#P^K*Y\_'2S/#E87HZMMUY_RS>W&6_2
M^M?OPF21<,51\5BV;GP>>[SE0&*/0_7:8/@(S%<BCU083\I:AY&@<DDX3VC*
MG*[V>-^!Z>_5$]_G+]-9]:[UN^KMY)LXH;_Z5*\Q_>W^.I/7O!CE HC !#DP
M!2F(-D#4I&4IG+1KT@VEIYR''S0M'S^_RDY+E44]]UC2M-83$*-(7P*,;.'1
MA287#>X$.,'Q44./>'HRM(>9!]QR+,\\-Q5^,/C>X>R&/ODATR?YIYM%GM$<
M_!%__TO^,LMQLHKB;M*;S_4O_V?558:)&'PF!6*AB%LQ5.!8EA $TYKQ("SC
M+TUT#>3Z/AWIU  .70?QC"I+Z>]_OS3EN^O)Y\G-2NH@979(H4"A):8V5Z7-
M7Z&@0"JGLZHUW*Y;.X:]1;A,#QL0E@$+)I92__3Y"TYFR\,7VEM^RG/R]+^2
M7?\VG<]_OOF =6?Z9C[/B_E53+[H&,C3M?.U> P!$Q;@**4P1C$FNTU:W=_Y
M';M+(\,WJ'YX<[W\/P_[.CW,4+S[O7Z;KQ@S!C&2)=!HLH3CX(5*P+SQG#,G
M=6G"?-%-O._3DQI"-& 1Q*IJK!;XW,;%[:SN<V_2LJW&AR]U@;U>&2!F9#K0
M-*A#J5V'*;1#R3/-A=E&3PNNS=AI?GGQ5=^G,S0P<X/FZK17_>F&]LZY3G1O
M%HO9)-PN:@+SX_0?9(OIS8+LNC3(.A*[2K'X%+(%C+E2,B1& L<,H;BB:/IS
M+C3)#O>6]/MTJ^, UR"3O'1]$HV"^-O9;"E8%?]N,K2!2VLJM8?P- Z2E^#0
M1BC<,6E$TL4U<:OGQ?J^?6A 2 9L>[V<.$FJ^U7T[71&QJ#O:G>^.3G^%9H<
M9506A*PW?[@UX(),8()BRDBC1$R=UJ9G7_-]@C^P>0?L^_S2ONV7&[R3^<Y%
M511**J2]6L@)E/::#. #^* ]S79%.-WM1E.OUW['CM'._ W:,=^KOY2O]E-<
M6N5',M]:C_G'Z=OIS7QZ/4G+1M/+H]FH@S.<W#LK5>_,TT+H;/)02.@HA%&V
M30/8_<0]6N.THR:1FP,WEI9H]]6T/]S.R7;S^9V"R\-%RS2MIA;!6OJB;+'@
MN*"83#H1-7*?1-L+"]ND.E7QQ3&\8M<-A8/1:7$'?27+^O2XBS!-.R \E.;$
M=Q,.1VO3#PXV=7/\<XF%F9#J'??:^,73=Y*K6C+O%1.&:]&&?*P][ETO)#2&
MO8^%!S]%FI;%IWQ=4T0SO/Z8XZ\WT^OII\G]5=_LHW89#;!4BT<,(^&8*1"\
M=TKD7*1SW2+=%]YTLN!V'Q2FK4PX](GU#Y.E+/%.EHCT?D.C#2TI2%X;J\-:
M\)&IK$A,R40G.#<>?+;H'6*@H0=C]1]RHW6>=O'U+_EZ\EN>?5V+YB3#[(H!
MA>@J%;2!P(T'9I*F2"3:)$,G[)Y_S]E".:#YACY??4N?3B)>?[C]\N7ZZYHJ
MXKZ;0J1=K+0%9*R"87&U@$""4,8RY7,RY<5ZMQ??<K:H#F:Z <]$5YU6EB0>
MZSK #[=A^?//97,_>S>OA$+3A]50,'A0+M=SW"(@QV *8O).=BNZZ/7:LT6]
MG7%WGF@VK'!=2K\ZQE^58LZ'J6G=\MS!JUA?DGVC;M5C*"EC<MD&%5#XB#%S
M77*,2 &SW%*WNN4-PU:J+I^],Z&D'$7Q)3!(Y*3UN$& E]+3%^1&>XTHVG1'
MZR/EP=4;ZQH2*9@+ B$69/7.D(7@& -9(B8M<I2Y"9W;6.IXAO.$)[47_0W<
MH+769BIK)=6#3-:V1!9F(0-F"=%HFJ0%[4^\\!Y$LLY8G85@31JI[B/LJ;+2
M[1RG.63GD9%FWN>H2",4JH#2(H*KX4()+HJL:3G736:FL\A(#^\3O?+1?;!I
MGH_L(LQ%YZ-[H?5L8G(?4S?'/WH;O BTPCI-6SZ1!="V#\$'Y:)" JU-@>G8
M\]'#P=['PD?/1]MDLK"6KV^]%X. W)*N47DMF7%V\U;9F>:C>Z'0*Q_=QX2M
M\]%6:6VBBK1*^;IH107>>PV2=I2N\! 8/\M\]-[H'6*@(^>C13"<UXM/I?9X
M5*Y>?)*N@'$"9:4XY+E;-=RX\]%[0SF@^8Z:CRZ&A2)C59BV- IK^LYH#EDP
M+J-2)JENYPQCSD?OC>I@IALZ'WU?3TD^]^!>V9UH+B4G,^T'(B<G4[9.^%DF
MT)DV!UY(H4NWDL7GWW.^N YGOE.DF!]>4\7'UU0'33EW>,_@*>B^NFVDI(US
M(B8;BTU<Y8A8 A:*B)7-IFBT6U+2'=XX;(KZP;N_I96L3])*M.!5[:1,'@P>
ME2'7YCXRH8,/&Q-QF\ST-N$.W=0]M#!]?YVWW:\F1[3"%P&\( VZ.HYI3^,@
M:@S:8(XF-KF<T46XTR>S#_:9S6W@X)@TR' _Z)2UVQP_?+W+DRTS8USDE$7Q
M%&DI!763 \'F2H&FA5"Z2*?:G/#TE_54^>W!?:DU3N>1U?:*H_<L0H@N@JH]
MC"D>E)!YSLQCBF@O)ZO=W"5Z);7[0-,\J=E%F(M.:O="Z]GLYCZF;I_4YK3;
M+SD A:BTJ&94X$6]G*^#\$X$I;%)R[NQ)[6'@[V/A8^>U [>2RM" ;<\/]91
MTD*;++@DN9&H3=Z\VWZN2>T^*/1*:O<Q8>ND-E<\14EB>"$J XX+]5"&E+99
M9@Q*%,,ZP3FVI/:^Z!UBH",GM7WT3+(D07OC0#F:<4(M)50J:RYS46PS8CO/
MI/:^4 YHOJ,FM84(UF'6M54]B9-=K8ZP 9@(.A?A+=\D%SS'I/:^J YFN@:-
MI^X3LVMQ,#(9)!,@#+.@K%& 3&20.7"% K7530H -N0X1ZR',.DIDMMO\<N$
M_M?R^G^:+&YG>=@ZZF>>/W@RNZLN&TEL:;U3A@=1>3=IWQLD>N$Y)AZBM$%M
M26(_\Z8C)*]U(@&5%Q2!.5%7 @1OI*]!/$HN#'E::C%,CY&\7K?=GW^<OHG_
MOIW,\C]GTR]YMOA:J1 7]0")/OU2_\N5*5[;X!085OOQRV@JTX*'X&E%C()%
MY$U(O;J+.-)$=A__><);VP:?D:2SK?1.ER!!E$(S/ZLD/*Q82":B]"1X:'0C
M^\S3V8=X5&N<SB.=G3GWQ2H&)M0&34(K"%E3"!*,B[&4I'63FP+?33J[ETOT
M2F?W@:9]SX@.PEQT.KL76L\WC]C#U.UK])52VJH(M%<L]:IUAL ]AQ"LY2:'
M8D2;8Z^1I[.'@[V/A8^>SH[:6(-<4Q"5*:;R/M-V4F>(Q6KEBRA"="L,'7LZ
MNQ<*O=+9?4S8.IWMLC?690UE6=08"TF5I08AC"M%EH"L6^IL9.GLO=$[Q$!'
M3F=;#%K;RNSG:B]5$0LX+CD%OLE4JHJ8-TM?SC*=O3>4 YKOJ.GL&*)*M=.%
M+*9F[*2C74T,P*+5:"MUE#[_&NV]41W,=$=(9QN)MCAA( GD]2S,@:\\;4;[
MJ(,V//LF19XC2V?O@_40)CU%.GMUG1=OTAVIU9 \=[L>/G@BNY,6&UGL9*17
M-A$ 12J7N(\8BM:29R,Y3:A;LMB[7G.$%#:2:$K2DFY,/<Q,5M5PC$.6B5EA
M=3'G6W^],R.Z;,3-8]8Y:J (U-<F:+3LV4B#,;O(M8L211/JON>$&FF:NH^/
M/$E3#X7!6#J)D&32>5D H]>@T-=R'.O!I,232$C&:G+8<4Z=1 ;WHN9(G3HW
M74G+[_,J?\W33S/\\FL-[]8\N2)FJP7)'RI/+HT3"AEJ*Y:(*AB3]28GP_[,
M[SNE.*M&(;VPGPZ-P8 ;X*50*ST?BG3/;?VR4#V2T-T<9)<TQTU"#XC6M)6I
MC^8'QG/)@A.@726+X-8"*LT!@].Z9.>R[G+[9XSX[TA&'QO^/A8>,O\UO;U9
MS+Y>_?+ABG:.R+G+H*3$FH$S$$2.X*.D($IF9$D]Q7A^9^9YCO_Q:?K;G]9/
M7.&\_F$3YF]O/5Y$.J#YIP?9;L! L^KT[K9&P'<5W#I24!O(+S%%4$X'\,HD
M\"YYZ:513'4)'CN-TX<O/F<8#S+BT*GH2CHX+?^:4@QXGXCQHM@B@=<6VDHA
M J+@])WS)>7LL^_6<^#)H\\9M &,-6"NN>KW+48D$VYI?F =SU8(#PEK<JX4
M!>BTA,*3$\4GH6V7ZTF=AN8+LIPS\$.;>F=V>KC<Y6V8YW_?TF?O?JNGV(=4
MW>YXU*%YR2X2;F0A>8A,2V\))J6*YQA*%D;1TA>U-BBO=CWTP)SCXZ=^V_W'
MHHPJ&:$HBL.4YPY\$0)D"EEDKF@5;L/&M$.@0W-'=[4/;Z>?P]J]R>UK\H/>
M4@? A)QUG0'!0+O7Q=>WM[/9LAQ3"L;02PI&$@4CTF9PV5@0GM:OR# DUB2#
MM+_()\A+#N%'FUFD(V'6HH3VL3E6.8YDF/?USHIUDN*@*&EZMHZ!]H$S6F<Q
M^S8M'[8(<[1,8PN_.-BZI\X>;CKXLB)\O@*@;H=EBH;3(@5*5QJW;"4$]!9T
ML,9@3"JF)CUF=LASLFK6@W'>,:$<8N\&A8K;Q%K=$<CKR*Z+@"V+5U^4\#0%
MK8/@V<%'#@?C)%ZCE7 J2YI4F3!UJ-">F]&:*#-MPEDNVL0FES).Y"TOE,&>
MQEGZ8#!T\N._\\U77"SP+@\CHN2!=N^^H*S-V!V$E"70QP%-2<SY;AT='C_W
M^,'FP%:?#F.R(X21]&=+EU766$T[1,C2"%*/D\NJ6J<D8C9"HTFIS9V7[?)\
M-_'!$/8>, WVC%AK/^\B6--++;LD.]$%ER'P>]DG#C!^BVLN.P4TRA6F2B*)
M])+XAX/CQ8'3,AAET(32)'%Q9*]XZ?K+49VBC\W;.\-=&C]J[R0G597SI*HI
M-8V?0&3&8@DFL7B,9-[)JGJ'0>MY']C#U#LCAAVY\O7']4O >?ZO__._4$L#
M!!0    ( %)+'E/JOHQW]:0  -.P   4    8W1L="TR,#(Q,#8S,%]G,2YJ
M<&?LNF54'<H2)KKQ  &"N[N[NTMPM^#N[I+@[A""!G=W#^[N[A#</<!L<D[.
MO7-G[IKY\=Z_:>C%IKNZJKKJ*VD6KPNO&X /4F*28@ 04 # "/@%>#T&((HX
M&UJZ T  X # [Z53 )F@D:V!,<#H!W %! R "@X&"0,' ) 3 P#ZPP! \"P
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M>WP5PIU&([R\:2*+[DMSX>F^QTE:7ZQSULN;08)<1>V6R1RP.;8/]?WZH:W
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MBP7^! 6P8X'E1WPES5+8 N-#2Z-_/ .)=-9?-S7#J;3][,MN+/!38_73(@$
M*N+.<3/@$D2:O1>$XV@9Z\SQ)00@SQ<[4J5C"/LG'/ZS?!"0QFHHSMYDYL^
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MAP*K 3AT"Q=S0FERU(%&3\V9L+JA:]T'?H9*N\5K$9J\OHSOQL?X(=E@-#3
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MC+,/OYO9AL]PXA\DBGI"H(&UVV/7YQB1IY?X\9UZKNR>2F:&89HIY@-DO>M
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MM>GGW+L89Y'@2<OAL:X7BG<H P?9SR]VU@]JZ]G?Y%X\RP]DOVQ*@]=D2Q)
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MSGG<'.V,:78#W_*DKBO8!)((3N7(^FY]A ,.J&PXOFL6@A?")7^-#7*#J]C
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MX,F%[^,8C)HBH2ON+4HX-,^V?Q7>*!9<>;"HI/8<,U>RJ-;.ME*M%)^9-/3
MU2B*ZS"+%R-/B_D''UAW7A/QX?DT5H08OQ_)B9J!6!J'W\K/Y1!M(.=KJ=\:
M2V@@6<\*6(4A';7:LX:T(YOA8JVOFD:%"LJV=3401F*?VM;!7W#/59 A@W2
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M5'9=J(ZVF#D9IY,23_Z DUTK'%F9T$-\X\I95GQ&K"-+%_.34'T&5<([L(V
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MG@2>\KI=_-V^MNONP&&R6J9;@'XP@,W:>JUXBAM>L+V&3Y>;]\],S?)MI-M
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M#,NTGW^%/WRK1P[?=E-Q#)T\WPKAMC-JZET\RE%PN]SW=KAH;2^04S5%T$\
M(J#66IZ&=.X:<C_TR2LS1/(\.L6KQ4>MQV'TEO?;?G_=V*\RJ"K=(R19L%QU
M]EQ5^!E2G3'DTQ>&4=;JP6.W3KGR#UN.?_O_C. G(#]EQ_E;W1G.3392VNT'
MGJ;YS0R6G1%6IPYF)BXF6B@_%U4;UR>@]I4HPXYQ'(XUD[W=".'4A-J+[()(
MAB@J:&.H_GB.FPW_C[OJSB@_B 9_PU9JYTFY0((8^K>8*_N];>4\J188 338
M'A>%+X6HHCQR#4AZ8PX4TG90KSQWM[Q^?:<RA)HA5[4W,FLZTQ(:\630=U:A
MG%!U)HM3Z#*K]H0'Y>#-!?)0>B?;I_2)7DZ-R3Q84T%I-5SC"GB:/&L^C?)Y
M6"XD)XRGD"^EJ#LI\%CTDP,-+A$DQDD::A5/[)F./)^ VUQG 9Z+MGC-1)O0
MMCR8R$,IDA-IER"_/DBCKJ>[2+8"?^^B>;^_30-#Y38_-*.Z/=VBK\VJAM!^
M(Y,$ %8I8T,(QI#<^F#>*6IU-4.',:*9VRW*?3WL6T@7F3#[&02 )C+)+J2?
M'=KZ:D3>-7R'@!EO*'KVY>Y=6106I3E:.!^,_.OZ^E/'[RR%# 9'*G5G^U=+
M1!ZH.2MH;JH']?DBD%%!00\!ZTL43^)B/F["\'M%0 !_%ARIL7DJYLV]2/99
MB^8/CU@1B=NQV(]$V.%RUW0V@2$H>!NVCBXH5/R<O0=1'1909]KPN )71*-M
M!I6"24.I*>,(K0B;U&?]&],X7,A]V%I82/+V&/6&]10:78?< 5F3G-?M!Y8_
M*#H)'*%;+*^3=>/AF]->9Q0OW/DT6,PKX($'43!^S("(?;M7>_9W."-?;SB4
M*]%%Z 4)4>)3A9H*;\9V@:T"H;J5?T+F5MN?"-\^E8$\UEI&.^)905<4_T$V
MG$02>\B[Q5 Y!WCZSLZ %A<J\4X.BKH3'+]R/(H;!F&AO40>1H_M7OB@\:S^
MC/5NLI 0Z)7\TC$J$^[\"<#T1(_HY@,?&QR:@+E+SN)*XG'U)'P91 \$FYKU
M(%[0%8-KOQ$?O0LUX&GA3)Y#OYSX=4=UO&:6O.]++UG;@:(E9OEL]2Q=RB3N
MA4L,HT),_PG0V_8DF1 F6*)9[@S\D59SEPH9PM^PS('O.%&OD'2<W>OEZ$)7
M9K'YGOF'TXC-FM^IBUZ$!D4/:\9_<6*1B@U!3-JOV<<7WUH>JT06WN+D$SI&
M.%XL3UG$*LRRQ,A;GE>G3'S4O[?@SR*J?X=]*.#PK*SQH9LX('A:3.Y*RERO
ME;CWI6[=%6]8:6]ZRR. W\TTQXA'Z665M(YTURO <S<97H\LJB<[.WX7!9@+
M)V!@(0Y $^^0.F7"X,I\25B4L8@7HH"U#=DS%.8!(N;4[;%QX.ZI@3U@/-CZ
M#E;#W<O9O[7*$%,V:-AW;;8M9-[<JW,3)H9#7;3GO%7$&.J)-ES]E.!)E]W]
M^@GPO=14&E/1OPX(X"0R3)1JF!R-2WKA*[B+.9ORO?.YHB82_:'] .KUC<%K
M8G>)[Y7A#R"$!P,!@** H0  R/_O;E3Y_^4#Q.#4_W^F8#".#_O71?=?@^'?
MU$C_;'X-J$W(@?SK#$/\UXBB_Y_;H,3_4*#: \S^.H/'_C5"_[.=ZW\95N(_
M?$'%_T6G_O?]L'\HC/^BF)%4)6#*E;"@!Z5%>* %4==VJ0"O_YO"Z:\50E@/
M[\7+[UU*&V R403E@GM_@8^7^D?:OY9$SR_<+0&0][?VCT3^S< (ZHL1B_+/
M+,'_DO+/ H!_I@-5%PE= D,&J00)@_Y;;@#B7_NK@^"7TZ+R@Q4YTI(>3_R4
M \0"@.#\?U. T?[%0<H&$X88[G< )HKYC00Y0!R ^E\*^9?@7)V 2/!83GY
M)'3G7_(" 3#_I1"0LC_LCG(!(H'B^%, D6"M=G\ /RH W/^_% )>XK]XP(_#
M/, (;4X@V$NKY [@AP& \A<#F/]F$GYCZ!1CK&&$F300MVR 24R]Q _N#T(L
M*(/V]T2)\9:EZ!;=V^-\V)+>6^)@*W*5COQ@F424PXS_B ,- -/^HXQ>0.%?
M/R'E_JT*M:!_!/[_C_]'#ZA_W@1#_NM-,"1S6S/), %X!#G2@.\(RZ#X0)G=
M]VE1"6U@QAFMJ@+15_Q:"; OI"^8..CY2O"5Q>&3<MACH1K8UGUV3WD?)DP!
M(:TQ5/[N!(&V(LBT:1;[\OU+!H30?R*X_S+A:U0^$ 55DF!+:'ISYT*_,3M+
M1;!H/\"5(1PP#Z(1R]A'["^O'DPEH>T2-YH5W]E\VL*.H1Q'[%X7FR'":,9X
MQ"PMDTA^%>Q" HFNRG44,8.WE_<5]-VAFQR28^:BC@3BM_Q31B607AMDQL72
M988[FA&7J'$DT_8[,=ATX(T$^-Y=V%O_]\+!(@EJ[')/?PB+':DCY"F5_1_^
MN4HC,% :X>C"$L0HJJQB&$6(3U2%G8F!K 35_L-H:WH2OT%G-F(Y)4XCBZ=Y
M)R@9D)ZB'J73JHW,I17QRC.(A5DH=:< D$O;EM[L+@XE!N<41:1AOB [6]H.
M7R%:H%G\D/-V:6I[0#!B?@,371.Z23X!80RMQA-.T'81D@,WN8,K4NY5-;1@
M>_IM"LF1*4YDE7Z[\-L^LQ16:8A<8>*WI,$.S.;@"?,^A;&INC!FP1NS=/-'
MMDTC$,2>IC(H3YJ(*(FZ1FR=C.SY./ 3(!J@4K ($+11&#>F]HWAX,+Q88FP
M/M;ZP53JK(6=^3/^_C71!>:JIAB4GP"QQ)$Y\R'6>3LGP#"*#*Q' -(:P83-
M"5PI-7$Z!G9X(HH(UR3H,X(B'".N&*DJ'T$"S+8(,&^%A&$>E&8X24D 6"2@
MDBLM>+.17ZE/+U_(%JR@1V$&)QXK+$&%^[63--[($E,'@H(B  "!+^>N3+V8
MHD\K='08X'@W$ISM -EESX!.I]4(&9WDK=&,F8#/]D":Y3\(9UQ?3:[9\Y5*
M :B8[[D3S_,Q5@ZMHQ8>*K)E_%UP(1(!FU=VAC-160U5!O:'\"AT?H2RQ75[
MB558G0S"',L9M(D?-+I/_()LNP1[W9$_%--PO?UH*9 L]O>$2"&_# 0YPFQR
M!1)J*H(('#!JM'8'V-V/_> (72+"GFDN7Z"\K84E+IX(D@MM_:/A/,\8B$ME
M1?6;6G>>S-E/FYP.(EB05+O AL2,-(4()HE@&];=_)0ZP$3<[@D0-DT'F^@/
M3Q511T[>M&D3Y&$2;-"[,R0" H=-L,385^ HX_\=0R"\ %,+V\G+;(TYS:X2
M<2@QGCRANYE2NYLV5F IP8DQ'5PC;D%='$7UR$X\,D+57XBI !([)*!>PAXS
MZKM*N'F=2C4_=CIJJG.\ (3"-*=4.\HFA1F>L#C5CYQXXV[4D?A;#']00&=(
M.0C);HRL6&4NMU!H,'$<O$ 1$R"DA7[9NDJ&F53*,5W)]K*1,_.[)PS5LM!]
MP_;;YE<K#?X?O@1[ ;T1]N*P$J 1FXP&(.Z_\#RIHJ\267.@-2$7(FB%0-27
MTVULWLW%/Z0=BNYU7<7$Y2A(<MHI#D,2=;V-H4'L(/W1<0.CJ/J"2/S=W7MI
MW,;64AN0E6 [>5K,M^E,P8D#EGCZP7:;)575U+('X%Q]UHIZA(2#US7G8;T#
M-6:<3VMCD3U((+>W]!P;2!LTL#2D(:A2&]P1E1_Q[B#*AP88)4"MI14W+AH2
M5-JQ9$]9/*RRX/39MPPT%IQ9FZ\8%RRF0$CYT$=J&$_ (XTJ:082 6'^"EPH
M\J22G4:/F3F/(]  ! 2Q62HE<G[H+$3[-G-B7.;!%4(Z9_69)5?SY92K2RAT
M+^2%>&A_,\5K5\T!BB]L^J)A-N&UQR#XQ+4]N$HL>XF+H.:'*JZ<M]AQ(4./
MN >F095;J<@80.T$L3D;55=\Y&!L9;@7<&X22-SF2D7I>)K==9\SM0"IS!1<
M\C"ZY[4TEI5[X636H5@;F1%O+7)[F_A2CLKO%'"_0=_BXU:_#!X8=Z@H,6QM
MPM4*;Z,FFDY-CY!A),*PIB: #K]QK76C(3*I^TT2_!79P@" P!-,F>Z(9CII
MMTG798!5VNMX:9J2G'HDI RB4Y0<4CTCG (OD!@C'TLNY4N;V-<T25-?+*#!
M#!QU3[_PCJB&R#'8$B6T+K)T16-Y_M2FD+'2#P%B  3/C:E#DW!^^=CVNL]2
MB5^C"JL EB:9F+5U'R.'!'J\B^=9*O2TT)=\(9.5!E? +$R@,ODXX+LX''*B
M/YV<=UJFC0)5>?V'&X5TNV.>YQ2SAFZ8LWB/F1<$)0C>K]W)'%YS98I"^&_!
MZD(H!11=QV=N5/$@I)\ I(WN *M4!1[)#0]4=7M,ZI[4:W<UT1$Z@#?)5]GB
MQ2V1MB-Y(JK?B8[V+!09E3&0"1MC_(UP8JFR"6MIRH"\/-PC. 2Y8VQ_?F7D
M$:0B"-KH-T# UKK/W.!:F;/C/-ATB//>H/%>+LX?@I&?[<?0(82B-*A2 1R(
MT&S\+-SBB0ZH3!3_JVDOCX?Z^_Y_S<;,V&;&V+*-L3/69(EJC+$OV;.'$&4/
M2:K!8 9IR%:VL6:KD&2ML94L$2I;MNQ)I4C:?KT_R^_[^?,^'O?>\SCG><ZY
MS^?CWENE G7WE\@4-T,ZB^Z#(*Q6=>^4):4V>$4\?_,)51PQ#@PK3ID>8\42
MFD_T7JS'N:P&0G=-C+K"S$W(ZZGY+@JKBX1ZJUC44>%L3M8#0R+6]=&@;X1L
M@2HV]D3^:M 9.>#V:<DX6ME0'+*JY&!H44<6R6(9)T>^>1MV2R/-D8\7[P@B
M>V76QUE,9OT]+1-+<3!'9!JPCR.XTU.PUZ=>C0Y$$:%5>HKW+&[;(GQN=RLR
MB!3;<O5L[=GIP/V=S[]/=,:!WZC7Q7GBD.Z/PF+8;R@C^$)3X3()A[[LB=E,
M]ZM[P&AL5AS]8AZ3?9K),I*H^KH'FNEFY[=.*$G8,<1BO2+?S%E8)RH$IV)+
M6BU1N#UJ$0EDOF37J_PW%"XZGIQ9PKIR4ED__^4-0+Y=F-2D#2=T;1BH!QKX
M]-C%A\;M/UQVO(RGG2&:_@'0_T":?W8O5-'_"NWAAL8S1XW^2=X-FRX[JPXO
M<P-^QF NP/;-3;4);'3?8,/=U@H'Y$QXW'(OH[R*M>\:0#*-NOAF)2IM;0ZA
M[,(3X A"&6<"OYJ^48J\-AG:=+BJK=[->))ZM).G(M)4FP)VM6&X(2F,;U?"
M/KSUDRJP UD 3CS=[X*'7"%>8:_R#0J5(:S Z32ESH=G?*1Z#'II%AZ4L=F%
M4CE]/5+:[>0#2I 'V*P9:<T9WBZX:ZV$_\IR4%Y+_LN0?FY;W&JHH3 QF>@C
MH)>8:<P6 X6U.1GVX\7)'\M9^/1[_R(4^S!KN:SM>>KV>BMI131/;Z_)INK.
M_OW+8)BN1 6^Q].E+B]M@D?$Y_B&+_=\5Y58,!3>@R:GU=_M<'IW^_-Q:=#!
M_;4_P&.2_+DX;%E_RTQ$LG2&Q%WQ%Y3"<P*LAYT*!UE/WPXM'"\M8@ZE]R96
M.I&<O"<DRY>[P[KC3*DUZQT6&C/-)F>-,OCUKVEC-:VA#/ZTJU]N_OXN@4?H
M3UDW]]1X,_2KUFX=@Z?;_W9AN&A9ZM==U$-58<&UG'G:=B9& '#./K,DY4X5
MX)C 20[A75+=/H&($KKXY8'IYB>M!_^WQV9#.^-73'C-A)T^_I27I ]*#F9/
MR,,MZ.Q21=0S'<SHLG"\3;6M69+"8X!L1N'>,VF^EJ/E65!JVGD);.V(KU&%
M%0BH]A]OCXZ''Q4W6V>$PBP$JH,'S?@+52_]Y/[;(N^7O<]H?:1WQ+)KF;I6
M3F0?HSMYY4RS\LND>\X"$&A#XR/'@8FA,N'^I$ CJKVJV^%[4_43\>%?<S[,
M6"^'FY_N,_];!R<\F>4838P41N/T+X^,AO#I'GW<&)3PNA]9BQ9-_P-<V36'
M#X_R;@-(EP*,S)$HNM0?(/SXE[.G IJ.W@D3-_3\ S@" !&+2O"QR"[F?GR1
MYGVTOYQ;^;-@P'N)#//Q3NYG]-LXZ(4:@ @NH7#4+%0+,\L%+L4.@Y<FQBSF
M'%Y BGVKJIY*J\7((X?-B;/F@^'DM,6:^Y[YSI/<6/;&K@  ![)FP5Z%VA/L
MYU@N^DD^\>7:PI$ZQ^G?CK@<BG]SM2!<OM>066S<.;,R]QB!/ZK]:TWVUXX9
MV:BXNS,X "_X/=?EW 20+;]@HGA;]&\1F&A32LU'B[I*2$ZI"@8H[Z3&KD-Y
MI7AN8<<?_9JZ[T@W.&!C0<=@:=JJ>:;27?1M_\[0I)]8M.%5+?IWK(1W#/B*
MV+>0W)A]*=KZC^2'K,Y1ZDV2;\=E=X,"(9/(!#:.]<R/T1%ZS/5F"[K/S4!C
M&X/:<;< -],Z^X'LICY>7+/%1$?)^N,A<ZE>0\,!PA@C LZ1;SW&30\YRVW1
M1>XI.:'ITI4\BI7]%+R_$)_HK=JR;E'[+@7)5\JBCHVQW7O5D.]',*ITW+MQ
M!<76#QM+ 2^,F1-*V0\YEYSZB(Z,!CW4,6D4YO/JW]8([/SQ#+4_(&#^%L)1
MG\0J;3ZR,]L0D-"/Z3K8R(UM8@@!\5:?SO]R#/G]XDR$ICVCBI@?1W!?,9=>
M3N'FT+AE'!'R73,1291!=3GE%(SNQ,6OQODZM1\?/7HR0,/HXW$>X@W%QC9A
MJB[VR2;/N<]2M9$E>2MRD/=Y]'-S!RPI]9JWT;T-&K/5][5M&Q534IJ2XRM6
M_:CPU'?\ND@S*:%)"&',3$,_K>\+D(]W>5*AZ;YLUM>VPA#?!-5'(P"G$X;$
MR/4Q2 M(M>"0;^#CZ,O43"*J\;9<KQF#0LOG,9([U,1?K@:K^BO'GOS_QVG_
MB+/U(_.!,GSI+27FOKF_G#HMB2$/CL^Z1_9&EG)\\4Y?>_G>JBY:](3:UGOC
M$D[3P;XOX[_EJ&I\QL1)Y;L4!U  R36H36!$@9LM(2EH;AUQR=E]O@] 2HA(
MLP_A)&\U*&\<W^TPF9+M"&0TSNH9*=4/_Y#,@O8[DUU^>'\3%S4V99)0*$.^
ME1;I_/VNYDI)"PLTWB1> 8Q>>18>W%+LZC!Q-INIC3T=&G.U8_VOE,HZ _7R
M0Z=F0]OGUR@Q V\KK<_9Z)L.W5X,%]AC_)1K&+A.D:OG,(+;]PWGD$R5,A'6
M&L>(R%I P"$0E%/87C*M6SZM(C+V/H!^9-KD2O S;OGNX\Y?Y]YKIPVF(-\&
M%%V-CP3FD/C6$1$%+RU!RV'<GO&6XRYUZV]MMV0<%S98>>+VG6=VG [ I%^S
M:Q&\GA-<GG53583CO$;!%#NIU7A)GY+NX:0O\[W.; N,R9@2RP''#$C2^FIK
MD06UJ7^ B)EP)F2^L/B]1-X/XLGY=6'Y1,A)P$&8RKN5;G?L&*_S%, G2N&+
M4C IO2/C-YI?::^R3Z9_FA97.ECKOSI7](-5B#6^U*[6HU^8,?E4=T!XW_.!
M3F*<C%^D%H=^-)N?+@G,7V^%50ZMTY&]0,9I2.+4O?(GIISEO?VI9\Q4+$U.
M![[MS'>8E!;9S[Q\_]&IW3K56K8F/W1_%1R^'F%C)=6*GVUMIK=_8 9]D/23
M"4G0/QU$.Z+X/"FLF7Y?AG!86\$R?%QZ&.^Y4.^WLY,XVM!]+Y#\K!$< NH1
MXB2'S^VJ>O$)2-U$SE4.#!,L46D!ADK/>3D_1.T%64<-Q47)N"EE"#S0ZBC1
MFN'_F-&(@P;\XUHUA20R$\$:?MF21<]2C[*ZV UM\$AWZLC4VY[+K5EVNW(H
MDCZFDZT9XJU[G7O9^9E_ZM* 7_D1WVYG@!PNM:GRH8'-;,>KP#\OPF!07O=(
MVX#5![-1-K>-QKYWMDL*^+T5CM&HPE'.%%S=[)3AM(6\PJ/:H.@#^J-\KTYC
M=/_S(D80/:N+(F;YM0F',5K( <E/Y9"S"' 9]:,R=):I7(42/[\2$XGDY,5=
M[^V=T]2P<!LO&8BWN7IFMTL*TD+;N'4^,!)2_DQ4]AJWKPLD_OC'WS/8R3*<
M^RA/3/3"+1Z1@E_JS8A#J8]\GI"^-^]F)^ILI7R-B*8M.4L7H]4\<R_H"_M\
MTD,LWE@W>+=RVYXW@SV2?5B#9*K6JG/@%Y1O']8FL7R+V>+S9<IA?>-!-@RD
M%99;1U#_V^J]1-*+N4IVIOE9\O6^KD*6">#I5%H\%;O9BE8+'S"S1GEN]5T,
M$+@]^"QC]]JD?,DA0T.Z(&^ R6($["8\X?V%XX(!U]T.51GUW^+U^8DW,UVM
M*S9_KM5*#;%PYB3J"M]]E:U0<U="U:P*--"LP+E#%YC<9Y9GXLHRI*RFN7)T
MO$RVXX)5JC_-9ZQU//& O%-C\=R5<5W\>?/5DZ2/^]WK7P#,KQD^[21/S1;N
MF$*9V/?)CFT,+*^*%M([<#!R<+_QJA=H48;7QQ)*Q'JI'06+<LRS3.+O,-_H
M>[)Q=CDE)ME+4U"1<F)\(F]J6\=KG3:J$?KJ7\*$+>G!7-***LN(9#HND%[B
MZX,'2-P V\O4?V532>&&C/M-*M]@DH"%8F@T9%):G6K'VYCMZ!!<\]9Q<TU?
ML,^+NT/;B&R#-DLGP;S(J6>PFL@N_ROQ,OSLJ[,]#?N]PA.FRKL8Y8VL]3+C
M5M/1C-+>[E*;QPGKI0K3;LQ3\,:E.U)"G'B30LP!.U-KK.$I_\RAV.0/ 9,(
MYUG!F^%>Z9_V)K)6BO#]$NOZNKT?#Q0";UBXCO+47J4@T/4,L00QBCA%_"]N
M$Q<CDYZM8K$&5^$>7>81B8NFZUR2->/1_,]\7$'[&I3;0>CK[6=[F]C!B+FN
M#QA1W>1%7AVL4M&XOY<.'L.,XU._=^J3YPKR2T1,@XJ[WIN<8HD?,1?<)84]
M=%S>%-Y]FHH0#2T*_QQIF- ;?0&P84E[Q!E#QRE[7!MS+Y\N%W8>YBXORA8\
M(21R8=/Z;$Q2MNJ=;<+N, ! 091/+)/TM 6D"&!V'W2J48K6!NJ 72JYOK&U
MDC$A?HX>6)=^XBOSQ5X*3L)[PS42V>D8,_J7UPCRL'B21K^?@TJU-DN=Y#<8
M",@407"#&DUUCZS=7[GT_KM'S.]314^R<B5R)!#XY5PM)::\PLB&KO@(&_[2
M?:[_>!"J.$%-+;K[IDVR8P,BW3#HNUFP_(@GJ35O3^9[]\/\[M2<N$&3Y!$&
MX\*,4;)5!2!2"UP,B+LW-6O"$U'=><OPU_D@AW<8-MLW=H&<T40ITVI!7$*>
MDGQTYH8,)53)>,T)%[W_E<,V"PBO [VZPSYS5MB4)^QU\263;Y([!].U3Z4X
M*^Y53@K^!/[IT!,6*WH 'U"+84:>'SX]_>747L>K7_>/7/O/()]OBDG,KZ$$
M[ZOQ#D<'K'8T?>>9&4^D$%=0+VX<N_*0X(5R9SOVBN;W6T]1CS?ZA66/73AL
M/1;==LERHF;]7D!/?'8@*#L*R8ZCM'>\AM"Q6FR;RJ:G$PYX[]  !#HL]8C,
M62TN*S[AL/BQ=J;T*M_8&!0P:T$&KB8##QZQ8SHG*[KLXSLA">M6Q7E K&;R
MH/5R5WZKX??4A5&#F\UY@K'/O*Z1_B>X%[^S;E)=?)NTZJY@V<A2Y$;IWN>5
M0=B<5FNO"FO)Y#BB0X\T9S.!@1NB^6,%ZJTZ[QA<*GXJ! ZYYF:L]9D(PB/'
MM9BIGV/6_!+C",[ A>FDWSS OT _I'^4]?*;<9F1")8>)B+9\F:$*;OD(,SL
M=#'=%J;E7)-@4+""6&LW),Z73?5_PC4[_G3#3C5E,-VND^EK C:@.6/(,>,"
M1\N$JT:YLJ 811STZ%<V[= /59*.+ $'%I82OV,XD#ND4)#V4E'. )CSE P;
M;NNQ*LUS^NB]>_;,=XUI9[Q]HY^^FQ3N(?3<)'BS!4S)H^YZJN?7\953U/I#
M!<' 3T"WGKO_A*3)BKPL/HP019Y>9<@#\Y[-\^RZ7M,,.W7,0+K'ETD+ VL%
MCKL(F3C+WYC^MR0U**Y2E@('-/^=&Z-J[_@_>5TTV/2HVDB_#.*";)J:<ARR
M:\S H FT6:/^=W9,)B#M^ \=MQ8/[CI/[>O%-7+IGV[)XA]7RK$V3.R TU<[
M-+YXN, R+UQL=GMWOG-_-+63L[* 7:T>(A-ISLKU7L&UW;PK(R1AT2(8W"T;
M\HI'RED?1\*;Y!Z";PKP ]KRP_&/8\:_7-LDQ]K">&##\4493^7E-<]^!]+S
M:O\ 1\Q;!&K>:P^+#5 >(>E"X),O[\U+9CC/37-WHX70+70?<_KM""1 9-"F
M,/U3\H6W&V#KI"AH/9YBDI>M%+!M+O8RW*;P]56?'^P5_T>DRC3HO)*R<OQT
M]?@)L"&> .V+*2OW7\<"<1+H1NF,1KNOKU2:I;B3*E=T/I52 0*ZY:L[0^]N
MOO>'!8YJE12@5Q^-(9OCW<RECP%P.EZ3'$C/S/*JQ;BSH%N(<QC$'OK;;^R$
MH*SL+?RJ8A\^5*K6D[/6;-_E:;6K.J=U8_S$/PD7!-83##XK03*O"Q[+2)H>
MDWS0(BP% O$:U73V?8 VC@,R?=7XG"$5)U?Z$T7GV2B.NJOU>U7HSIYM&SW4
M!O/LS,6LHS8T+V6TWG]1,)NR[4',%ML+W]8MX[;#H45[4^Q'L[XRV8E<*9E>
MNTXF[ &A2>$(F\35O2B2,0>9FEBA_F;_* 26=:CE_6U]RUFT5G[%R&::V[#:
M K%7UXP4J@S 2S]\-7!/-!^C3V SA'@S#M?TS=I(MDTM%A1YKR@$->6=DE6L
M>>!KT>C+'ND0Z*2*0@4\),F>T_P@S\7@0W;PJQ921G"@1NY4@3!#JJ.7!]IT
MHC.,K#"\)C99/@>T4R#L;RQPI9\I"X_A3'Y&A"G0+=<M&4LOC;*F=4OWFM-F
M+>P/]0O6.U$Z6Z6&APR\$T9\C>?)1@1JL&2&8KA>342MORK[*&X3.TH[LM E
MZWEX")@]@KNE0LO/M'IS5VW0SS,"[^BM684X+D]U EM;Z/K)*!T%FA)*3=C0
M1FCA94LHGBS!HAD_IJ#D;*#J",F-6M*0SA3! ^#&0;$6_+#GG?A\S%6-:$L\
MO(!^=MR^)MY+O.H.^9S6.0B[J^C]"QQU]IYZ@AMQ2E,AS!A4<(.425[F&:)8
MNT6MGX6%FD[RC=YC,E2:CQ$I=!UT109':R$WZMV6:#J*05U"F8F-<JWT8(=@
M*TPC;40[_OB!#"X[D)2Y96"2 D%,5'W1"GVCF2-8U5V;JG9)Z/GM'(YL#;6,
M)/QJ/ZCUQ36OZOY=D=W\+];A]^C+!7-^XVK^7236![&HF+6[V/(/5P-QW''B
M&=YIH"C]8QMQ%K0BB,")^,)*5-QEX:[WYR:_&1"9N!HD>/6]?T>^:W,EI9ZY
M%7]Y?+0 'ZU;S!I[U8TJ7Q)_ZI/V]OSU&K9MS,?2IJ]FV8YD#H$FI7L_.L9J
M7.^OWR$/?&P3E8B/J]L.U,U/6/<_#:6UXXJN$WF6ML>-[_P!?/_G7>F_;M+&
M'OL,F?&.:S18AHJ30APK-;5O7 UL\XNQY;@06C0RO5=ZBK.2N^7&1;,(*QDV
M,:?Q)S_M^"ARHJ<B*1SE(&LF,=SC /A$\ V8%SZZ8,<. C7L4\B<](P[6@44
M-:1J!D1LXB':E*?)\IL ]@:ZV/M!\,8B!*7%BP//=N:.&+^6S^34Z$$'7#4(
MGSM\#E[T68U 4DW,5(B*7ACQ.W[KAOFK EEB"@.;,R5ZS4-*'>_M]H)DBL $
M3K!D@\LX/!BML;UA.P\-(2B)[%L\TT(["A\! 1)X,_%(I%JS -S)ZS',BX^Y
M+P<@'.I!D:X@\FQC</X4]Y=S7OZ1$Q9R(9Q5T[T[?C=\<&F]\XU/?9N$[JSE
MTLHV;Y +*\I;"T7"@8Q)DV5W:5N8LGZGE&R&YA] 85(O>E]\=JH=1A(6(CNW
MYL):%''<.P@"UQL'G)R(.D2HXFGFIN'2RY&^G:M=B?-C9L(:&LPRB3>T)(DX
M! R4A*:P@K7 B&3Q%5?V&^*0'Y=U5*:&XI+#- 4WUX6LGA.!M_:0J%) XI-3
M^\"'%L/BM?],TP6I1LE\X+U073I/?)AYF:@;*28,W@!9AR9)UF,/LUD87<RV
M&1Y3Y_ ABJ=$15A6T1B9(GGZL_ 22A*YP#^0Z?,MY./VW-W-GA=PR8:#R//M
MSW&E=@0SU7CK&L$*??;^P&[^P(_,DTT/C3L*IVC-[N)96GBR$MZ)/D_,R5D]
MGXCF?A"=].*F0S@R\U,RDB&AES(,I:7OU.A(7\H1@3=73U?:Y%CF>?7S)[2@
M#4"<=.W1*<;0Y;6_-BMT3'#!O3KFS4%XI74_@EOS"+6%5O[S9_1S5I'TI')+
M8Q0;_5:FV$+>OO7UZ8F!C>)0JQ?#5=I/4>.-ITJ)#:.>AO=X?2KYXY ?(V+I
MRDC->)&'O2@9=/*I/M'^'/X, ODCT\C'CLKI0^J""_-7/=/O^16.:%J>XK)\
M.Y6JDFUAF)1GW\+1J&-)DTH ^!469<[.XW^K9+Y2 !"0F/''?K+XTV5)281*
MQ!1IG>M0[B2 RD*_X"7>)-2@_>.U3H64?H-C"G.@\+RFE0CXPNTRJKWFK.4?
MP)TUX'HKG;'=,4(\VOOEM>:GQ<2I2V>VKFVT&\U_ZIODVV,^DTM63+YQ#_P>
M8>>[G;-#^N&(7#K;DC Q*B35'AFO?2L%D]133G"+A00K^L4\_O[=.Y[@95ZO
MTL<M!@]OB3Y84E&+*0Z)V+%PC*HZ/*N_&?#X%:<K2B?_%,DI @3#R/#N?%[Z
M"E&OX[@(:I/F&)>RA2A=%N3%U.DC.3>7MU^=C3Z<TG?RYOH?@&E3.2&GJUIN
MN ABO PR9CLUP]63:29O5P4G^Q@MR1B?_=0%51G.>.>/C\)D5V<7"1I?]*S'
M 0"(*&@-U'R"O2YW1L0;3'XO5V! Q=#4F*-2>!-?TI;<2<VIJU?UVI/?OR#L
M79![_#7M8]:7$=*<D+0TATRO@N"@%E+;>^!^>%J$"TY_S(IZQ$D>QW'Y++EO
M,E#TANJ-SQ*RDAA=VGJ/@JQ$QBO%5P\[V+JD=4[[-.A+NPF8/!=4YK-(QMDQ
M>/@V".7KI)C-6ENR2&SWYW!A! EEO.^8,80)EBQ]'B7CX.CAH/SE\+7!9VE2
MZVKIEU BHE(!:2K<3F[EW)A1EL5?1\  !^#$P7;=T[O_F(ZZE!P:=2ZZYLJH
MZH>WL+>US/(WY%;DDU0UY8_OXO(C/!M&2?G*Z$JJT2*/[8M;'28R0 (YRAZ0
M"L34TMM8\I,$K@Q!XZJIE[:.C_)'=$[';GPZ\?"!?!J^.Y-[R/18>5'DWRJX
MU5)ZT/AT7/@JO8SCM>:N\?9?$&8\N254:G@<3I\>?B*FZWRFW3W[9-X?@! 2
M62H&V2'MVB839^BDCQ$S9?O\ABXJ&H4-D0,:QAF7'O;,><?LG>YAT](83-S;
MR5$=+2," (Z3?2% /W2IUZBW:_PD?O$.Z_?<,)(4OU<DD/2R56^=E[?-!MHU
M/$IR^HPD# #AY9":\7ZHSY4W1_>P[?6_YF@C1NPN-T\7*$=_K0YHLM^R8XC[
M0IB&.$.+VNQ/,X'LW X 9PV%ZU5* X,IW%1;4*-=,;^EXEZ(_5:1N=:]]@=
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M]YA7RY8VP^9I3OXE_._,<XPV).E\&9:V7JEP;E9"QX990*B151.K=_@!.*6
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M;>B)9JJUW_TR6?L ?S#.-YYZ5ZG/?&8_D9;T 9-5[2J3[PKZ8N3;3_EMLPA
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M_5W.OKL>FC);668TA!Z+H<"1C7T(U0X=GKA 7K][MC552>ES_-P93MOL1I5
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MJAU.\4F FKJP6$IJU*Z$:6SO=% BRVXWK.Y>+R.++^:2;OI^X)D>/+"8#@$
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M*ZV:LJ'B\I9+BM<4U55TS*1=0AA>H![V[) 1FOG%R*V^PG36/?YXMO>8JCN
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M?:B)/M54?UZ4.!1OCHZ?^O[Q2OAIJ=*?X+.D?%:8*'8;M[?"OP?&"GG[_Q_
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MPE="%\[ BW,/9MLJ[M0*9N>V2HS%ZFTZ#JV>\Y31/;>@5+AKP=$0,8<RZ&E
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M,P+QETFN&=!)A2[X S[8!A*HSIZ.+L-HE>',D0KV]BVP@%G9++UST$0[M$I
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MOC&M8"O-D.6]Z6 M6]TV:HIO#38A3^$#IJ2B8=)6@@IW1*+C#AI2[%]X/BV
M^"K0AN3-#$PUCL-8LNYGR.A]>1]MML9P;+Q3=&_53 @M"3@]G?B6=YSWS4-
MC']L39E7C/G]?;X2[,\D8B\_B*^49VI,?"N^-FY7/:@TI%CK3E14FX"+PT<H
MIZ+MEX+JN&/3>7R[SHC:<%.MYWJ3XXJ$Y 56Y>4TEQKI''MDCH!TM#P-'F\:
MI'AAAFJS"$:=\2A&E@1JR\ 94Z817EW=%L1T0CFTI$$V,$("YJ@LW*<+J>+2
M_;@^]&BB:GLVNZDYI=76+48X?*Y':E=-:8328_.(0'>KY(YQ]8M!5WZ'CB9#
M&9S, X$CH78Q&[0#]IMB]PXX-5ML1K,CF6OC+-P<GEKJHT77/25X3]0G=%HX
MO73FP:#X1;&H>N##JJ*C=:Q<B^RK2H(/DQJZ1"]F4L;AEF1XZH6*2H1N/F''
M@D-A+M.1<W?UMXIG=PCY\Z"[N9_IPM2\2SO<TP]V<V; /=#($ZA ]U5E5!0L
M1(.ZS?V0;AZ2H,HXK/\6B57ELB1Q(N_#8Y]S=9>FC A"#RX^CB48;>\+KN?!
MA]80 'KEG2A'^H]URV(YZA-B%GIR"$#@Z@L<I#K+'? M!#9E/K)<M\<W$,4'
M_3 5#TJ5(O>M>J]=Y7:R%*5>8P@]Y-)7QM.C_Q T$"7C-WO>1)X+&_JJ<$PP
MCP#8+Q?.;U!WS#P*+^Z7 VV^YF:!^^<4MH3S=UYFK+7,^W8C@'>[^>3M-7E.
M-;HJDBW&E C@4T$;.(C[&&R<_G4:&418Y%_U?=78E@SQFKTBBO>RL5!BJ&5"
M -7N=J#[MT#9++#;SKWPC(^?$4"3TQ<$<"^DT$$:DHDK44;KC\P[<&G@;OFR
MO "'(0TGN:P ]QH,NHA1Z&Z$1#ZKX=R[<VK*=:1@^&[$6$O).*EW@VXL7%<1
M 3QSJ4B_H FJ=3."#G6V7)W9P^]$)"P<'=@C !]J!!"6F89KA0",')S&G_=Z
M(<V@E]_SK*V:B]N=13%9"KFM5XG\/L8\\=@5.KAHX8PK::UT$\T9-]PK ,,%
MK5>TNWD9EO SZW8$$,BS9,_:?>+16/-1_5+F$E,"<BGK-6ENFCN4"SXYT8Q]
M4',RS,G#(?/U01Z .GB+Q6\L1M%6K9%*OWRS& FE!L"C'?.&([D&7+:-7\-+
M=T*H]\#$O<A^4565PGK?6DDA+<8+2QF6RY&/VO!RJL_3W@@ = ,!G"ZUG-4+
M_MO0RD^:C=+/D__50@^&=IW0'5,91F->AB\,8^C@%J=%Y>;"4&8O0BLK+N$^
M7 A@KQUZX/*L&0&DAT$O]Q=@!MS@U<"=TL;T!;BT/8L>Z/#2N.5D'3D=UJ&2
M_87I3?FS4:><2(=M_;%_[_RL%@&TX". SN$?6VO*:FQ>I6V36$"JS4#QR4VY
MJUV#X,OX#5":%7RP"?1<KY'N:R<6W#'I3_M .V)HY(0 Z$\(OR* ?1:XN?U.
M8M3\A, UF"E=+P;=U(>K72D5^TL(X_G3HIT?ZE'_J"'5;Y[C>&LM#_&>(2TP
ML3555Z)]!I@J/C]'+U/_T8I*%('DHXRX>(W+PO??Q"N.#L<7@B2IQSF_]5\2
MD&YHW5!I=US7OLK8$N&C7JVPC91%LS$+7PD&7 0V?F0B\Z,0)M)U\GM[H2"^
MV_Z9NP9Z+M7UWAVX;\%8TU0&:7M[%*3I Z'59*E5H"W;Y:BK#M3$/QN]V1<1
MNX\O1W+I@MB\PO@U;'^GKN:G,)@>$IL'(8#E+7S<?^_QQO<%\=]E_$YMON]U
M_YD>?5\MK_F3-^;M+Z;_=::_/Y.G&?\[/>(.C]F'D!@NB&- *^UXT=&)Q7/V
MF@OHB)F-<$5%?SPF]X>-X_I':S#!40)B2'_?0Y.K2CK.U>]'"*8^_9W?V*K<
M,[\5='\Q8#Z4%57L.<26*Z.V.N26/RDVC6J>AC0:RCT: ),B_Y_\(X?_PD&Z
MO[4*W-.+A'08@:MTLSR'V= -.O"6-"#__[]/>WX^OZ#G^O."T5DT[]EO'V7\
M]8#(_\ 7WIJ:I<O>!/?J*FHGCO7T*$M7#XMC/!XDZLU*U.-]ZT7+IQPOQ3[;
MMW4I);>Z&,_N+/Y84M-%DK&E&7&[YAW6$1:PCQMD8> ;HY!SCZ('LTJY>%.S
MOI%*XV.NY?5,IX;%RIBE&V"M- WL7CJV#3&Z1TV&N,M\3O.LDSLW)0>+MCQK
M@IVS=8G1<YBPWW>!&BAUW(G:ED*Z/$[_QIF^MC-GE0,%;4,$8+91+]&9L343
M*LOUL9235Y";&9.UYB,F,G8@6KDIJED[VX@T'P].@Y&>S!N$ &Z-R\\KAHHR
MN;S6$CK90UJ53TU+" !&IXP >ER\&[J0ZL,-0>H#YBCRU;XI]S$F=!T^MP*]
M(&]$5@[81 #GUZ-J(0OPP#T"!+!X 85+O;W^CRVS8GY %VXRN<L?M#\?9'>G
MV+)>AFIG%K5CF /5IS=EW;S[9I02W_/=>:2#?/<<B8W.)-.1FK^!EI51U_+[
MUC+_MQ1Z/V?3X</SJ0I?2JL1.>B3"^^B!+4BW9W.:54%PK<S*"G7>:4-+]TC
MD.&<X3Y20PB0X?FJ*+#)6F+_A^;^]Q?;B@A^"3/-F]]R*X/82VF-VL5//+W8
M^<!'89K,$:8D,_W$.?+^Q:OK??]TFON?*I/7OPRB:"^= >,O->%]-M =<@D7
MF*[!",G01+^*%1GHCQ2C33%#J_BGU-N_I]!/:Q\%"W8'+5>X\W0(H/4;TC %
M(SW#6*,)@6_U.3<_/C[7Z.,ZL"Z7G:7K?1*S@F05[.Y[<D-YVQKD8&8VZ\2%
M86DRQG]WA<2YG3Q$W*RB[R6TQE38 @UN<O(:A>6G#52.Y#_^VN=??8[NY8ZJ
MWE6I&B&GH,?[HUPTPEWUA-[+]VJ?+T@T;9+.PK(,MQ$ _O$N]R.#TP1--2:V
M!KN3[KG>1<M<<>=!0"'W;+M])B<YWTAW0;0U6_J+85B8CC&$D6T=DXVAT):M
MA]YX)7PX%[+=7E_2=!5EFD?>-/".K'CM85P&O5P^(ZNL^6<A]AA9Q]92T#!7
M]>PVEY9RT(*>[;63/45_] EBJ*@D42ET$G]9(L >Q+SL=OHQOJP6SGP6G%L3
MG66MJ:XWNZ"S16+M%E[63:187L5+DZ/3E]+A3D8'P@& +9>]FV>:AR-P&_S[
MFO-MF$VI@XW1A5()7+PW5-=S-. NG['W!JV4EVUI9SLT=?$FATL*H22*]N"
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MKIVDTD#6%]&*>XV1Q@EIG,WY[8DV021W(I.2VN:,(&EB77%X.6V* F\[&A#
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MY_4*KV&:1?9XNM\D,!V\$[A_I/#IVYN=S*;Q]5N)\ZH%RM=/+#B5>N94/20
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MDD@A-\Z8JC$ KI;Z\-#1JA_B$Q:D#[_KWQP;.+*8&JD%LT+UGH:V#M 4/1B
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MUT@#7=A8C RTGFI4R@"\4-Z^6&*:;YZ<W?,*5SOE7>66<&GMBX1?6OW;S!A
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M7CHWXCKM)36"^.,:"6&@B9/.$'-UC2RZZJ/P2S$ALKD7?:T;^MQC==)(%:)
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MEU=;L]?,D%M(HU*<Y_K.XUZDS;-!F-@1XVTN"8J2KE^Z=Y[J0PHE6BXS87?
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M"99TX9N75X=^W<[BAH:='NF?3W>"Y5\VN'LKRA)M;_YPMO>.ELY:K8%R\V+
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M36WJP.3RFSUIGU(\LC*<+%8^5^]+49W11=B#XY0 -R@+?>_2".IM[F/2!08
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M/>7A"^O#Z/][1OA?)$W#;DSN%+SU;H$GR..KGD#G1YO*Q! =VW\?H-_0/S/
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M^&K#+#F;?A!"BT)],P#3F-:D/(1N\OL23-L]IG:_LNXY0&FAW?Q(P533\AG
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M'GHH>19GW;?4O]IH:26:*'J.Y>K9SWQ?\Q$2PSK"/U]\KL#$P]Z9Q4.=83M
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MG)N8V^!)RA'Z)VC9=$%0,4( 5'\).JU="KOVOGI X8&9VO6JG4ZG0H->\B?
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MR\N.#LMG)DZM;KFQKGB%S@A$M</"Z+O 6L4D5D("C_MVF:YX9W2)XNR3EPS
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MFS$#@)6AOEFPE/Y!JB_[Z31J_";VQQ?1#?72JV38NM8TDQ1/8!]'VOZ^WYW
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MPX2T,]UW[WW6^O__/F>OLY_GGG7O79/G"V1FS(RO?^\WQH#VB88%#ID8&!L
M= ?H@"O0#T#[ 7#J>02X>0*> '31T>:!\\ !NM_7[]<#OR\&^M^OC P,] Q,
MC$Q,_T;,!UD@8F9B8F%C.<CZ^X+^8F=C9?_]YO>7_%^/'F"DIV=D969B9OV'
M+UH7P,U"MW/@$3V=)'" FXZ>FX[6!\ @'AG_C3TZX-\ON@/T#(Q,S! ;;-"
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M#?L3<CGMK'3>!SH_XU6ZV53B4:+M?@2GWEQN0]^5-G]=?]=>7_;\E%<ZLKC
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MG.#A-%M=LU,<OWP]RB\D^'[LP%TEX879OLZDM9#5B'9([B08=X2P<\1[.-X
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M0 2Y)#VY]EYCZ>+[%^)":YF'=!Z,8]8.G.EW5AD2=*6C 7'G(%$/FZX8^=^
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M-=WH ;)1+[@(4KLU,/M'_1S_Y$PG_BZR%6!=-&";)9>*]J(!'RO<_MO#_\Z
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M%:^ YQ>DAY[0>\"\H^1Y6B%:%*8$C% 4AJFRI,("@F>H<IM61F398(K(4XU
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M=%('KZFKVB(<W',,PN%V 2Y,['K@E?L5>RL_8%!0_<8]?&4D_V'#V'<<><]
M;" .4.4WMFX2O1]5JE$_B2VUZ-?A).FN?.YWZ)/Q.M>D51CY)OT$U.2^P(6J
MB@=PEWU8[O./]A\]FF>$A'=)Z +;(*(1&5]'B]:5IGJGX^%AD#L\,?Z.(=9E
M"6I>PHKO[RX,/30(.W(ID%W,^^"C9\>+]&@UB"O=N^!#"$YEK^M42$X;H8-+
MR[96"!\R6A-WK>^E;Y6/^NBL7(/V+A?9O/7"&G(H[1$<1._ AHX7-2"C ZK/
M=^6^G=O*ZE3LG%D]--7!T,+"OVBA]-3N'C8D?1R\$@0N&:(AL47T]/FOG><N
M]OJK>&,'BSVO*15:80?&+RK _;LSBE_B-30;&A/-Y9NHK@S)==+BZ?N#T%")
MH#9<5V7(&]-7W7"E4;Q@=:99\T=[HQBK-05-A:#X0RQW0/@W,"@M<12O$4OG
M@:GT>0EVXY!-)_R#,K]ZK[L7+GNORY]MO^PA$1 L<N1:FK'X>-P.:W%?D*;/
M"/<<%PN=0Y5R%E"V=8FV'%"J57TS+(5*F_OX=2'J-_I*5I+5[9TPFX_0BI</
M0DF"W>19TL9=Q1U+*9[!4Z;[9*(_FZ:N$5B@AB8;$3RH?J_06=(L69Z6B7!;
MYAL.6L8;113Q-8NX9-G; 7?U!Y?*1C]57C$.RRE_L(_0+BU_E;E-N+U;C]A&
M]@7V$P-QUBA6N 3L>'\^3/&F6'M(]OLH_[K5E.LO QZ7FG?5JIZV?5LORU /
M(@8XO U*A*GB?0 99.PM16::\KG6@#0#3)14V%WU+,7.Q=+&8A#<]YQR&"K)
M>-$.4N*$TFCJ!N0P;1!FX 6%+B,R%*8C'IJ='9V>[FG*4V)QP'7Y4'JXD9_3
M(^(HG;V((@&3([U,): XJ&HU(1D[I\> @([S)/'UQ>0'*IJKB@6%,D$O+@7O
M%CI\4C[>QH)$(1\'F"BFGB(VL;J' ).9\CI>#:3)T)K7E5ES=&7,:O7^$V7W
M%J)EIZ^<5#@->NC&T@YQC8IK01&MEY&9RCT737/=T(+$I9A0O[T?O6!7W.V/
MC#1<M2R_0\F]>W=HKIJ 9H,Q 084#4 :I@NH3@W[>ZD49L[A+KC+I,WA2&CW
METEIQMG7=Y<6'P?Y@[A;[QP'8U6G4AJ4L9!ZMJG*-E'.D!IQ^RGCW'H?>+=O
MI27SO%KI:^Z#>N]F_%:66 44>+K@X@-P'7HSI@+2!!XI@6)E;8'T*9^8FQYG
M[;_J'MG;7?!E9Q_/L8N<V4RS$<3<CR!00=B#M"T^<@8ME2X$'X!PS1)MFI$[
M;#U6[;,K15B'2CO9B]$K(\ZI+G=BI!JD#EI(%7^]&+W@2F&'': EZ4AES9OB
M.#DQ]WQPHYX6 D##TI*R;&W5WB+4C*EO"R$RFS7BY)T[59;Q(&YM.L?0-DA:
MM1Y%MM=AQ(@<,ZBYI]9$ JY3W=&U6:NN(/+I\=7"927!0UGM'!JJ>W8:LSP:
MB"5M@^(A1 N+$57";+P2-9#DBJ,7O/'0J%2Y:#Y)?.HI2(RY8G!Z7#)J\4!\
M7M[4"^[@.6.=H44>"O=7NB; E UOP[#GS_3#V N 0NQR6^!MU#WOY4)\_[,D
M;ZQ\L%)V\CF%TB9F9H?KGK6$8M 2Q),'FW62EDH5OS9HST^7)J7$*)E%A\&$
M7CX=][1IOO&,IXKCZK&'J"2AL5<,.%H,7N@HA'<YL0[!H"2?9O6MHF9EB?FC
M#$2P1^T>]_"._NF",LVOK!PF2J&VQ%V6.:0F,A\M&>/6+>CNI G4$"<(9S^5
MF:E2M$UJ2T@R69<&R:.IM>6"*7MWNZ0_9&]HO0%ZK2M ;\*4*C<$E=<@HNDL
MZ"CEO5^57WJ>]8 ?'EC?M>0%W9\E%^AWN%!/,@DT13C&M!JX:$D!!SF3>6B/
MUE'QC"Q]49$DWS"$9BUU*. QJR75#MF;=:0.T7A-Y4HY\^.G=X!@"^QL]P/]
M>00\-J#$\^!(!*^NY C784(;HE2SK*SD@4G>G/MM96^O_IM=,PF;XB<MT]:Z
MN1$-RML@9S"W)Q9> 1>=T\K6.M'8G?6%+DFZEO7*G7Q4>=QMT5LVZ-W"/EON
M3U^@93P+#413,JHG_Q@X'LU#[Z6WUU*<D*&>(6HY$R@(N#8*SV8L)<LBJ<[=
M>__&$28\7,&MUH$!R>.)22_#\:[$E(802L+MTXF_,7\F&NTVUVNLHN L#IK?
M]H.>'\JD,M&2X;O@'ROL,S"-RKOJ,KHJ;Y3.WRZG/S^Q2'Y^()R_\^:-9:E(
MUD7'41M9T-79GE<LJ4##5%'D)"]=P@/"I7O4UM8I**19)4&7W&;YU#!%QI!I
MKX-DC ;H[.O=PLSO)$4V.?$64;I*C&!YM-:%V$O?0^_5V@;%Z8*!HK8*"<$4
M7'1"CNE\NENA\?E'%E7U21?VO-L+?NSB:Q8:0@J9&FK<!B'AK#6 *^EN0W(:
M.?+V^R&1T*E+.8^7;"Y8[1.6."7'>GOH'KT5033;!D5 2B/+48FUKE.+JK8,
M"(IXI59T[^I D7)+9';*.5$W+_1@VP>YZ[V&77GYIV&EKC=!-8R!NKP->ASX
M[0CMM\R(KV?4%A!<1=?7)B/L=V:]&F_Q\?'!U=C)9@8S2[M5S-FE(D$@=FDB
MJ%">,+F@1U&#]Z?U#J'5 >5S@S*>K"5!5TCP-Z[>1*G2O#+!(97F-K_B,>MB
M@FQ8H@4>L>"<&Z1-=B1%+U H,E\Z<SH(P^>,/RG5GL)[TO2U1>7:1I9R]0*/
M%3RN<-<WC-3SK?J:!EK<!KGQC+3A>!;=GP'>0ZUI2WG%7ZKS/#,E!FJ5B^J>
MXBWY# \FNIDOUERC?# Z+[D%*#<)ZTK2NZ#$LQ3HB';#-D@<YDB [ K*Q95/
M5")R@(Z+H5;S32DJ'YT3_=\A)J2M;H2KRW[V#=Z\N9 I2[N+N+8-$J$J$XT:
M,?Q!KF>31W$3#],0$>NFX@%SK5L?5/@M-?E&C47Y)*..3DVKG+UY7]YGBF<A
M@<A&=DFQ&M#="XAAY^Q[S^7/IR4^/[%.(T]62[^K"KS_:N%9Y')\#UL<HD%"
MQ_(9$$AGQ^#&M:'HNQ8I#1II,RFQ@L',";INY:*OIWFGJ1%&!S2[CHB>D)_9
M!HV<.X,F7LB@",)L2!;ISB\\('M@-^ZGYPP7HW/1V@*:4_MV7[<9T#4(K23Q
M_%O@,B=-O"&Q-6^#N+S[YJ%50A)2)?TZ1J$N+F\^<L,ZTMUD3N=<";YB\UDZ
MN5U6-XQD2O8!P"04[BB,"X@C$BS0Q'P5_>3;9TQZ#CZ)\(JH[Q5PVR<4J9(D
M>=5?^BQ;)'U442@6XJT\$HVCQ^(=K49;M-"5?F*NBC[./E<UW@.0PZ6P9YGY
MN\1W%>7-?Z"SP%NV0:63"SB\_+((3)V8-.J)3<K#C@-W+PX6ELL/5EKM"KM6
M_0![?(5I^ GK'?,;*G./_WRO5_N37'\V?L&?Y/K_ONOVAS>R_4FN/R.G]$]R
M_3\N)4 .PA6#YELG=M*>ZX0$3J&$YZIU2H%**^.9OG)V+ZR!D.\>X=;Z!YFM
M)1C<<UU=1.\-4C2=OQ)*]8V5'\LU?_JZI:S"*%6SW2Q[*YIZ3+:M>TM)XL@V
MJ#%YGH%G&++A8B>MTN.B&:EK3O4VB/#8TF;A->(P)686%0 F]J# D"_O@IJV
M01P.171-HQ\K,)#XD+)2]$YS=OR/U6Y4DD-]L\0=O''YQQ\13?HPV#;H!8[
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MPI.,@:OCAT XU*I\.?*O YSP3*T0DV; _U.DUY.H!)\)_,O2:R2Q&*,4,RX
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M(%J$1UD!Q/0 )H#+."?(R#"@HI?Q\9E8Z@W2;LQE<Z.ZX-R&K7YCQ\J-H-;
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MXBT5 YSD\DJB\P(V6Q>V4B+W4:2GZJ<9,XX.9 BF^XIB_.-=];B8TV-S0ZA
M6\OV^FVS?E1QW6O>5(DSC3._>A0!V/%<:90/T4K4>JSV(*XK;K<EPF%;W31U
M5!/1*0!ZXR$\C-0&415S-@2*0(6F9:X0Y,]<<?TW9H_^.7%E?BGIZ/I1[DX4
MB9\QR 3P:V]8PJ8J=U1,LKS$O(UM/Q9%/K]&5['PNV)%"K**VKYNSC!\IJF
M*\O&+HW47SIP)& ^K]C9F)C_[_;"_0= <C%8)@"%36,"'ATK;T/38;HJH3_D
M'XK]CYKJ_.V[#?&^7W[%:Y9UVBFXQA8A_ ]G,$; V:^X*'^\,,8G6:>Y<:2_
MN^6A:/CC<NU;+9Y/1=A.2MV^?FA'<GD;:2!''^'RLRAJ^EK7:ET (SR(^2,1
M\5K2HH4,>K$KH/-VV'7&][#K;[KIT]?NYQ'04S_/*K-4IZ2[ ==]: '4A+UW
M%/ZTT/_!V'M&-=EU^]ZQ(D@1!)$:E=ZEB701Z3<@(+T)2(WT3B 1E")50$!
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MOJP_XU4,00)AVU$OV]/7SM&8>)$A#O^'7:MOM12$7_T=+!N$VFF>,19"=YB
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M[PDU0,H-^YSO/+_O._?>?WB>K+5(UEQSS/&.,>=\W^4NSO *.6*20Q?+OVB
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M^%5>X6,8:= SJA.AW?^,FXJ&QP?D_)5(LMQ3;#8LD&RLBAUS//NTZ0TY<^Q
M>GPT\8U">.M'_BZZ4L[K_#_+!TU$F;0#8VV'H)L:H^/(X_V25Z_5YO09<F82
M3E8MJ5PXA'^ZO;K" -9<*+)(2%N9;<;E JM>P=>/$7FQA^<.K[LP'";\I@%
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M8$5G5+.[Q)XTCU\VF)35OH05U^KJL51SQ^O:]\I#(.)\?U^9N^DD88?]BG5
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M_%? [7EK<('OPPNA7A:VZ5Z<,1\,*)HR(<*2_8P/<HU,,9..N*!BV>X]+O3
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MI173I7D+Q-9PRJQZBQQ@%BEITI<3<5),<ZSO88 #BUZI?2VO?$T]6C/#G :
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M#1"+%1\ZZIJEFI)I@--YP354HCSR'_2.,0B('&ND.]S5O]SVMC<C\&#2"QH
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M@2ZOQB1Q5H;YBR[6Z(O?_!$,4(NQ>&KBOW0/Z*E?Y+DVCSLH)VK,9?J1-?#
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M*#8+/R;G>2>R'6'GT3?@NI0?FPB0D0V414%S'G)UC ;XL#KA@,&W-V\N)>9
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MX=)5\[R13GY,)W]&F,WH6'31/FU,J='/#^O ].@\ZX??V(>9'5VC1;N;G\F
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MQ.;_1S\G)J1CH PMF=WPHY&GXNP]T'ZW]FR1A>FZ:K@(7.29QJ=,JOQ' #8
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M4M3.+Z-;04$ZC0)SBKFYO)Y#,VQ6(PX;DZ\I,C3O*QG 87 SSG7XU^^N*N.
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M0D(.&=!:5F+R7%))3+V3<F7Z<W$2THD\-6F>%CQ]?C<VRXQ2GI#VY4N*!:A
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M AL6A!M!R0-O KJO5G^]F7&'Q>8\<F]9MS%^[D56E\5L]#K\=O;D0OM9?XJ
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M$%PT'Z.NY.+?+!.E<W<6&YL.?3*G-BF]IRA"@2QT">F)P6EN\I>!CZ<7Y>A
M7)VV(\^HVS?^&K%5K5\[.0_EJQ*"H@%2)_4#VIEUY,N[[#I$^Y(GS*-1^D3M
M3GN0ST_5C(UF#6(%CC>6 D$@(9W#1$V],:2&Q-F6C\6>]P?<.>K'I3T/-FNR
M9G$CPZ"&$< 1@N;B']#UA*0UG)]M0UR-.T*^4IC3EW^C([)!8ENE*,OX-G]U
MJX_=24X?]Z&@@^US-+GL"#3!?' ROTM\L#WXM)*F":$HN=337N.E%5N:O]J
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MR(!^2QA!BCBU@()82M:-.=+C5T[1#[Y_0BY:S)'K4A5?XT)R_!61X>9G-([
M<@H+H7LKDWS*:Z%VJR5"Y6F.KCIMUOR@1VG@;7^/\5+>= &9".I>C,]U7&B6
M:N(Z@HEV@M:FJP/>6EI@1W4D!2BK>N>:^Y6MT;@(^[;'W$(OQ1L+'8[5EBJ\
ML$R,IE#(,DL57'.MN&U07CB,; GZDP@@QHL8ZJBJK#[ 33MJ]D:Y]$UFC>1C
MM\OI!3^?Q7)G7M$E]H;RCF;7_>XPCQ&_1 >JJ0,_:MX$H*\363N#A7F%UZ9=
M?R48JB8-&V2-7XW5^=S<'Q>7\#AZ#[:(B$<OIHBG402*C0CR&*0B[IP>OB;
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M)ZI?K3!^603BSE<8I15[6P[3!K%\*&E4)Y8!OO@BP[K.RPV_'1E4V^"D^#X
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M[(;^O0W;YC32#PBRZQ%7J4]Y:;$FNV]W$#---#/>[FP2$WQ?58%QKQ4RV'V
M<O=_YJ3!OR5K+1P!SUKG#X(].!4AY*5A>*T.O"@@HVW;L7*GG5KT13MRWKT^
M2^+AK336<J]=+*ET&.XSB'$ZAICNH[''D>_8@I@V"X_Z;[R,[ONO3$EN1H3>
M0RF7U=3X^BV#DXYI'WB=P_LY.TP>]QY,ST&WX<43"<6DC^^),-(91!VGRLG
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M?=8 6$[V@9 ]&,^$[#'N!\UU)$B\)L$Z9AX_?A'$_NN[BYF06B(3$IW)$#X
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M'ZPY\:__Z%ZP4+ _[AK4*F<Z,.J/U"X%M6?";-^U7C\>R,,6MF>#YZ/$3G%
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MNF?2/1A+5J(!JK_LTP"&T3PD!:8GF^['[%K6,KH#38Y[1779=A(P5LRCJ[9
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M6H!NO$JM_C7:B_&>P4$3R"IXIDX-<(J60 6FU$MP#,%.R( S:\I#5F_A^YH
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MS^LPP[[/GT<_Y7B#9M:ZS1IQOSE>@8.H:M08LT0L[+WVM<_VI[=5OL'$LH3
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M-K*Y9EZ[9%,%W]3ZG&-@.J+6+*G5F'2;'MP=[3+X]9X6V=Y#,X#G\$:> (Z
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M<>X#U0T/[*DE)$\HWP(HJ16Z8,S8,JX,9=ZTF5(IUVT="&&O3+OSRB^$:[-
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M;O-__7)&]D2U"WU\Q?-DD 8P\MA#QH/V;,</8JEODRVIS*HT@%07G@:@3M$
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M5CS2]%SUO0^+EVHXYGR?'=],&H;>X@L\BU2D;R/R2VC R#)3!R)V/P* E]
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M2T75;2Z)5%;RAW/:6>W9;&/I.%(AJN,9"!@0S@P>"SI+MBR:_BO*:WN0!+=
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M&+$_95-AS7WLL/ )A;YJW59GT^QDW;0RW-<D/5(B,Y]I:F;V9LNW3>AX@EQ
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MVCHY%IZW*YG,*] -G#^/&K!T&BYI&O5M'3=.*I_F\;L9-<%A]]<GT^_9VM+
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M"FHH]*1J>3T53*<C0(JSH)W\Y,]QZG,6)1#+FDCQ'/Z03GVMH9:328_'VW7
MU*<(62.S#^I L>FUSJ@+E=[3S9G:J_:]Z^)RN^ICQ![5(A4.!),2 L'LRWW7
M*(%3*>QEC L/]F-_NK_,LO*HX.7,^J1+.E\VT=89+Z$?N&4'!@*&0O,O,;A-
M#;6[*)+.G+<T#(V2 5;GK=L2B34*CB+N8K:>8AI_NR_AQ].XA!!MC'X\(@::
M26?>,6VH%OK4E;1V<V5O1<7#T97MMUT&\4J?O\K",1NK#%NN:T _Q *>2(/:
M82_ K%A91)*.?_LND>*ZFW:BN+M4JYB)16EIHC+E]2TYU4:]>C5,!KNDVF6F
M-.4P]A0UH]0$C*XH^*.N*(_-/(OWC+1)"<8O?R$@HRV F9P14<V]=35._70[
M*:1).3\HW0%9TK#I]<!S[P&#A(&+]^SZ2GIV<<6<E! XG;C[W$N.MGWNF+EH
M(>"+4Q43 V%'SX6=5._NF>J3<"MG( $PA\(52.$$97)$ T\+2$0J6 CT2T;.
M,3EGGO<3_EQ]V^[2<>^AXD7DZ<?C3,[W^9?F:Z5+J<[>  5_2/[Z^#?HD#5X
M P2HJ.,V:D->2(<56FV)=%VE@N"42HC.8M[SFQ(>[2H*LZM](Q%<KK/=JUYG
M3A#)7-]O]711 I+.*+KJIK7!<H^K5B4W1T.\-&,\F1!1:N7BAXP>$2\L3#;Y
M;OL!XW=]*D)[AYW6,>'+*9DG<^(>2(SA(GU-GP0H [65UBS@,%EE#!=1BN)P
M5+1IJZ@@ZW7GO[,GGQO\N6;6,=#F]F9#Z_+&!5LW]*T!H%894@>W[FYPG"8\
M()0%$0*K!6A7R,8=3[":HU3T[D:%O(P1J_$%7/_ZDK14U7 :VRT;'F:6T8KA
M(EBK-QPZ8/!9C0:/CY23;YG9!/=JEI#]\Y\*.]CSISF=U*5X2-P62=Z?V";0
M8Q$_W/2=7"&H?L(THK?TQ)<6E<QT:<R,2Z7$T%=O2RNG?<]>K3X>SS%Q=U']
MA"VW9Z?ZS*H?IS\$;)=VT01! ;+VF.<PH8&!"/]X/]!K#--^:ZZ!'\(Y>O I
MHOH7SGB=XEUXI,FYZF.5R.9AV5R;=WZ,IUYF8&DT-J!-?0_]W20IN-+'\QW-
ML!N2F3%OV'2O<6ZUF#VA!HVZRK7A9<^]_AY4L[1T2(T>JBX-=:**C="[\4[L
M ^I"^DV;VN'.6$TB 0GJU[6\*WOH[Y!%,;LVG!YC9WOSU!D[J[K19W<&<I79
M X&=#(3+ D_SIDDE>9Q21^K%C]*ECEGDL=;CV,:[)WKY7M_3KJB(_6ESL,\V
M\8[XB]N(E ^&C]V\O6\>XQ'[8KTNO_%I+H]_W;-<=Z =K==N&YPG>2XVW&#=
M&>-7YEL0KJ]B/:<O/-71OS**C@*(;W <D!SM/AA*U:/IDNJ\+<;>Y1 9B!!S
MQ8<T,^EDS!N+F1'SO,$:W+&&Y<I%S^<G#SL?SMKF2P"/I*?F94!-YJ7!GW(B
MSVVRAP6(1%%H9X]2+^=XGV\M]-9KV^,LR#96)HW:>DBF1+0^.CQ5C8R<?TV]
M&;W-6WLL&'_\PU@!^Q H+:3UL][PQ=F/E=U3/L8W?=[O6A&^&[%MVWLN7_WY
M8]0C&E1.[(&/H(PCF66IX5O+6)ZN2?GWI06*I8^7(=_!,U<H*[>-:QR51OI5
M3)72(QM'IQZ]/'*Z^^YDF)[[VY3N3BF"UE(%J<+I6T.3>Z#>":MAIT&3N4V)
M.WYJ7 9H=;__U73F_[XIS_\G/P$.OP)$%'$2OP$#0C@XSV.J8)1X4Q/0 KU@
M,>8AS6#?>ADR)FM#NLK04_B[_5^ 6AB:3X !* 9B$$T_TXK.,=YZ7/HW>1H3
M6+B18W!8JM??2N98&(&KM$BQD[_#[6QE-F'=UA_^5I/<4S"&036WHRC6=!Q-
MC[QD3)H8^(0/GH\=TU,8(5Y868P7WBWXB">154E-C.F;6"XZY-"I<C"2M*(!
M!CG>HG1B!J3RT[A+HOC>F(V:G>-4$F%I\L]Q^B=WT[*?SA:VY^JE/7E^6E8R
M:*66M11A\4\OX>7,?GSD:'YO("(F\;JAF[%J4L*N"R01X@UE%@3E\RO6SG^6
M#V-\I,<F^7JR]OZ3#K?,]DP]8G<J_R?9*,;^IE?U)*XD&\3*S>UV$<^(.WM0
M[)V&6.J.EVRL9VL.]7-M_E>E ]5;^TWEP!=E]1/ CX/L=,E'U1$%+[>>NB,L
M1T6'H2G,@0R$[N%7L"'V3T&[V:D<H >1_6&56C[T?61W2?5[4L +5Q^,>B5G
ME5QZKM-T3>K.&QJ'WE0B01_6>7B*VLY$?1JR$9*GS1B@TQF(+%[D!E6FGA8=
MQ$"8DX&5150H_2!LC9]1-SHV55RW T1(AIP&'=*@L@"=@]X'& A6,A )*!L9
M0&]O %/S>/9E]K4"'@9"?1S$=;K25 ,I\-#2RDBB$/L8 \&/&IU OK>G"Y4_
M1)$ 'K!O)5T3.:O%"@6TDO[V:OA_ESZ_E,!Z"X/JLL;F*IOH.;1]1_TN]MQ6
M7KTN<B"F%Y_J*\9 7#N)6J&@0S98-_M@_H%SH^E/E_^Y0R1IF?W'*2@*CFD@
M*IR&V>AZ$[TF#$,XE"T(/ 7RO/$;Z\@&*!SXQRG";(G],#T0-;U0M0LV<1#?
MA$\1__]SEUZ-*))!] ^=I?J^^[V$TNB'J=J/@S3[WHC@ON;]@#&P-G!C>OYU
M) .!T=_^J%#L\!SYKMM:P91U&.I[!#N-GC@*:4"EL%ZGAH #FU(PY'@:4(M;
MO3^R _XM#3VN_8O^H7N9:?2+-0Q$1W\ <@(Y9RT#^3>346\(?UIWIX%_-+F"
M*9W_0)\Y(S18I#N6P:5Q5+]B [KTLOH!\@Z%3?4TS+X7KPN"7-XFFI8GLNA^
M?LF^)AL8.VKFC3K9:&/Q6*Y*^4JZCT1)PN GGO,ZEKK/39S/Q=XWG2O:P)6A
M_U$Y#K\,!-VQ7N?Z$,6OKC*[/(UB43^(&1&K++_:)^N09%E^Z%PJT\6K^WE%
M;AP\;(3F#MB#M00%QHZ1<$VHX(&^8$^>\/:P;O/NM^6.-E\5WY&8\C4$$H4/
MKQA#[R93N_NI7NV#P_@AF34<LJ5C/KYRSK4*>HC_]ZW PL\OO/)Q:>G#R033
M78)N67;W11&(,R*I/=,CZO0HO%-'4.I.="AR/P-A#_ Z).W?C3;Z7K)K+(RC
M@7EEC\QBT46F +F+0M,XELF2B33Q!<72#<_5G61U=<>*+CVI]6_TB;^B#9\J
M'F(T'U:;K)GQ* #I;6C0)Q^I\>7ZC+E>\I"EY<EK#2(.>Q2XS:)8$0>^&>-#
MD;NKCV.%R$@:'%@.JB,QZOP] 5^+(U6LNFU+GS?T#XR*7-5YR<%^A3T=M28C
M/35!Z<([2\NLI0FTML.2F07.X?8P$'<(_=IC'4W;B-'!0 E/D&<[VK!D,&-F
MP"5/L-B2MW/RZ=' N-+]SS>9CW]*P#,!Q##\<APJ&+?.MY6MN1:P8=HRM6$L
MF<;'?WIBP$T?;8(_/UV$K7MG&^1I%^LXJ'^!@;CZ)DRB7NW&GX-\+H&7@?A<
MZ,= 6.YU-'&- ":N?V(@\ED>2#L2EMD#H8J"96[Y\QG 9W7VS3'\9Z/O_V73
M7__V*(L+ _'L'O8: _%>$KEIQNS/ASX#VX$%?E((R86?W\,*)6B<17:DP*C]
M&^OXS?\(/-<C&38<VD=*;-+?Y9TS=CR&_GJ4?JJAE\=W(20!N:#@-J2UHEE"
M&DQCJU#S0.?!&- ZAGH?ZTO6@7K1I,NN@W+-#0&<X7KE)[T%M+^/H8N5M8,-
M=F3??/$\^%;<?,RE'UP+B( +M!.HO<T-[4P0#\?WZ"!4Z4+S$UC67^B99CZ!
M7V5=Q@/:QM7F5J.)B4$P04*3= >7]D%#RNP+BN,=G#.0_#=/;A(J*(U$U9#.
MX91K%!^2-3JWOU_VI\_9]_M>/^IKF_IF/9!R450\P4GV[E1$04[X_.JGU2XZ
MNY]H',7C<<KK>X/7)I\YI]-Z*[W4T?1 9\!97\#2NYBH.+]!U7%$[ZFJ?-NC
M>LZSW7NZJ^-NY(0/1M+M]."SN(^RI?Y:=R6FHT%IZ/6XU![B4BWJ,9[CWK N
MNN^TVHED,S#R.*ZHXUJEPC>1+#9\P^)G6]OQ!R%Q*7AEK R),*]+M<9 BF ,
M51?J6F<@=M$P8^Q":*?>]P4AN*M=D\4?W!03JLVS+G&:/K--T;!Z?LW#.@/6
M/1M]Z\*8/X:B [I1F:&OU<H]6,=T;VV#THJ>*@QP@WSS<)A#P]W<[-PV[+HJ
MXLF33+[EBV'?9_7/I"EU>^FM2&O%5MTAJ'?-)V[PZ-P--C7A3(UT7+*FQ"^T
M4+#]#4 M>X @Z#7&0^,2J(\#8YM4GM/4TM%.E/=M#Y\-:?->Q+%^//U&4^T%
M%Z4@"T5,!DK9FY #Y919<)2*HOF0\U^/L;-B!O:5V)#6:#\M+'C'\6']-X/8
M]XO&W)T^R^1F+!77[@VO2+6 .MQ[?1J7<"V2&W\;$,",2("^6 7G*ANUH6M\
MH['C7R-IA9)7$\3P]L_>#=V6"XP+6D/M"?@&D*[H_]!M9""X41AD?Q\ELHI,
MB,#ZOQNI'47NJAV="_?LTFL;&TTPL]5DD7]Q](QS/J<JL[N'Y8NWXC;B5YR>
M)6?MS+26)CM=68>LHQ8'!(C'V$X?X;EVXIR[QWI"3KPYH;W'T5]?B1YZ+Q)%
MV45/7I,9]&A,("M&J?IDE3^&.,R&&A0U=ST[]C/K_500(ONEIUZ&A)*\!;0/
M=G]Q)!AV%;+"U*ESW;B5=@S&8(U8+(GUH:H0*=P8-",UFW:JBCJRX&S\"KQ-
M,#F9>=\S[8<I$:Y'-(X9W7[@9@&08/8VB!M-7+ G&UX@$6KH^A=Z:1)ICIU#
MHD_R5L\L%*17 K*W'TZD&"0=,^ SWHFP<]%WR5:Z@_7XT9NC'^#7HI*.](IW
M3L\K-QD\F8-FE7QCE-7A8B65M_;3;VZN4R1*!=J9PT"<.+7U?R]N./HIM.E2
M? #,#FNY@<GCP%[4(NSEWF%FZ<L%+\9=-_CK:?"T=&(6206T\$E(<>/"%E=8
MF7GT9YY0C+5A((XV+M'ORJ>;5<LR$#&WUJ$*?L2'O[O<GGTI,-P%47-A#,01
MP__;-P-,0P,Z"67W\$RJKNSU[#N@=B0G=,P[:/79]\4\[(%7D@F]"@4B,6EZ
MGJ=C&O(7N))MKGV]SWF6]WC'? OU'FT//1/:B4$)8>6],KT#ZNO*31.J3W>K
MFCI(+JFJN3FEVC9X7?KPZ([^\_>W9%//2XC->*OJO,E>IGX,4''\B+_R<\\!
MC1X*%N9N<.3Q,NP7*XC9>F*NAB9;WG6/$)9Z@IZL+CX-[)9/.2=@I3C6F_-*
MX] S$S/5BOS)B"LN1TKO"]]I1ZHD3O(5&-'?HNX8DD0;>@\A2.CY!?*!,=,G
MGGM/SDK<)#KOM7W4V^=WM,7-\]1; Q?;N]E\*67TH1N]L:V%3Y,"@_/IIGJ+
M2[8NY8-9^YM&TWF.2?$46)7,!20,47PE/J-@A0\:CJ(77A#;[1L"6#K7VEF-
M2-7%Q^/&"+O!_!KS667Y><#W1!I;S;Y]O+)(":9@$X,6F@P\C]2 =H( X(1!
M]7N,<O26;KB6Y,RUNO+U_]CVQE(^32Q)3%KHX0?Q*WL:\GB5MD5=$9Y5*CW3
M'#/"W]KB2O>:-NU]/U28*%=2MJ(>#H.!9].[-SJ@W<,,A-@T"#/(&]=1JT6[
M-^5^9:X/U"]'0SO-J&*/M\/@BZ/UAHM$UH\'^MWS]EQXTABA7Q$*4VS0I_'_
M ):Y_=,U_1,I37!\1YFMH/J?LV]0HF'\WX@O<J5SN3[!@?+O84P@COJEA KC
MY[)3J(W->NJI;3 ]ZR2[TI3**7H,Q)M(,@R.6<J0M"#M7XO0C@;:_]+?=<#N
M!FIJ0'T+<A^$6O"K!M5' 6)O/0/Q-//7HIP%<3'H1QL,T^?8Y]M8:53MQE\F
M@_S-[)"#?#@:_2;]Q0.8HCB Y9"@!?4X[+>TP% 8\%BP0^?2?BTJ*,E,H]K
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MXW,+!B=G[]]PNCFJU\RV(+"ZZ#L55.JSML"RUV1,1#OQ_N1EXLTG2ZMYNQM
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M&7K^ZIF"@G$2_5/WK"G_O<2#"_</M#YG#9?"N\=Z-_%=P:PRP2HC:1T@XOC
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MBR%5 H]1_3 JN+VNICILMO[-4YQ3PGD7QQ  Q\@SVDXZ4D>"\6E2;E!;;IK
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M]9H'0;N:0^NAUXHOO"XVMC'S %GD:LH-1KJ[>XV6(O58)-;%ZJ\1"9,B0;N
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M\6PKM,@S 6VQ<TQ 7$[L-E;U=N_#@SDOJA:^P8SO;R[@I7.E4R8_;O%0')B
M@Z#Y*@J2">"4SV8H/?[EFUAYTU(<$Y 4TMVS9(6<@P?_?QG);K< OXN,1_PV
M^6WRV^2WR6^3WR:_3?Y[3$YI&Y-XNABJX?(04<J<U5!.6 _F4&%QCV9G^XT4
M[J[=$AV"9C9Z*N$U%DE/YS0139E3SYFC_P=02P,$%     @ 4DL>4SSS7-EJ
MSP$ "AD4 !4   !C=&QT+3(P,C$P-C,P7VQA8BYX;6SDO7F3XSB6)_C_? IL
MC<U:IIFCD@=X]4[WFL>5[6.1X;$1GE73EK8FP^G!+KGH15)Q]*=?@*0D2BY1
M  123-NQZ<IP=Y)X[P?RAX>'=_S/__O[TQ)\Y665%ZM__8O_5^\O@*]HP?+5
MX[_^Y?>'=S#]R__];__MO_W/_P/"__WJTWOPIJ#K)[ZJP>N2XYHS\"VOOX"_
M,U[] XBR> )_+\I_Y%\QA/_6W/2Z>/Y1YH]?:A!X@7_XU_)?PL2+!"<A9$)D
M$(F80\*X!Y,PR;*,,8_[XN;Q7T(AXC3T(Y@E'$,4^!XDF#!((NQ[/*;<\UGS
MT&6^^L>_J/\AN.) *K>JFA__]2]?ZOKY7W[YY=NW;W_]3LKE7XOR\9? \\)?
M-E?_I;O\^XOKOX7-U;Z4Z)?FK]M+J_S8A?*Q_B__^[?WG^D7_H1AOJIJO*)J
M@"K_EZKYY?N"XKK!_*Q<X.05ZB>XN0RJ7T$_@*'_U^\5^\N__3< 6CC*8LD_
M<0'4?W__='=RR.P7=<4O*_ZH9O8C+_."?:YQ6;_'A"^E],W3ZA_/_%__4N5/
MSTN^^=V7DHOCCUV6Y=Y3E929DM*/E93__=1@OUP@OB-YZY>R.A"N4?>#*QF'
M,/W@3-P'R0]\?(%[PUPL<OM"O5VQJ=[=[5 7BSZ^Q*Y>BZ+&RPE>B]TP/9&7
MZA?OY;^Z8=2#!LBT&:>C[IZH_'O-5XRW;+GW:)"S?_V+_-=B7<%'C)\7G[_@
MDK^21,M>%T_/?%4U_'U;EGCUR-62^.K'[I*/^(?ZU>TW7+*W_USG]8\[N0B4
MS=)9W==?>/GP!:_NG]4CJE_E(^KJ;M6^2(L 88^$.(0B9C%$:4P@\1*U."8H
M2W 6AP%;U-MO9<%7\/?/&[4:V:\C^%\,9J(^P2@EKXIU27=K\=/RV (KUU:U
M&J>_K/ 3KYYQ=X/47IDM+2#_UB@%U=+(0%]ST%,=D!^@?UVG/FCTOP$M J '
M 6@P +4$ 70HW( 6!Y"O0(O$__QE-Q<S>K&6?]K79?G_NS>EH'O:+I6Y6)2'
MTU;0JTW;'JTW4R9P11K,.Y'D_ 7>+WQ95YO?0/4;Z/F=B?K?)Y?]EQ=?XVVY
M 1J7],RKV%WQ"RVD,?]<P[VW4FU^KCLC=7'=#[E]4R5(?P%%R7@IMY-' ']!
M?W=RN_G$'_#W3UP!FR_S1LX/A5J7U[3.R9*__:[DYXL@"KR$\Q1F(180D2R"
M.&0$IDF0"@^3!,>^R=)H,/;<5C>)_1->*0;*:_Y4F2TY)ICKK1HC(3DR\;\5
M@DO9OG+0R@^D N"3-#K!OAHW8$\1T&ER VZ?BO6J=L?B%C"Z)&*3X2?E4@M<
M#NG0YA%FC$;K9;UX*+%RGGWF=%WF=<ZKV_H=SLN_X>6:+P1/)/ LA5C0$"+J
M,4@8R6 DHH"') RXH#K\=7:DN;%5)RO8"0MP#92XH)%7C[[. SQ,5DYA&YF:
MID*,=0[=YF.8!KF](<=#\!F7=4[S9VFK0):7DNBEV5[5!?T'P"L&B/SPP=.Z
M7N,E$.L5.[V$:K.X-DHM9ZO+%1/[7AQZ#0^??\ DK*NMQX9C]6\P8]2JK!>?
M>"7?E,9@O?V>5PO.B!=S7\ PH1Y$61C#U,L0C% 8H,SS6(0\'0X]\NRYL69/
M//"'$O#_U?OJC\$VS(P7@C$R%W[B7W-U0 4* 3[*+4?9[9[/@:+]X0ZH/V!>
MR;MZII7\Z="L.O;823[@ 7TVG^S0)78;N3=<Y"O.7O&5_$?]4<Z@^K_;JN)U
M]8#+1U[?+I?=L9></ZI6@$>^((BPE(<(HDCX$.$X@AGV./3#+*!^P/R0<),]
MG9T8<_OT6TE!(S;8"0Q^>FY%_MELPV<Y-WI[O_$1'YE?.@5 IP%0XM\T_]M.
M0'4#-O.Q5>0&[%1QM_^[#$J76T%+22;=%5Z&UN$&\<*GV9&FM9.N<\7=KVL5
M7* ,K[M57>:K*J>M89_1!*<DB*'O9]).2D,*,Q'[, GB)$A]CR41F>08Z9RD
M<Z->!Z<!6W]_3^D;L%7;9 <W_HLR\K&0R^F?_SG093,_W:F/[JS,XICGK+!_
MCG,=7<R='>1H#^C*X%?^4^5F>;>NUR5_^_2\+'[P\G6A1B7K1I@/_'O]+J\H
M7OX'Q^4B$C0.B-R^)R*4JQ3FTOH/,(%1S&+/XTG"4GR9]6\LT]S6HU8RH$13
M090>V&@$6I7 GBZ7[@O,I]!VDS#JQ%QEQW X,1N=]F?H!BBU0&]:Q]P_6*,\
M[F;"7*PK[RRL<3R_S;!_M"O>?OU%+25WJ^Y7]V29/S:+S*=BN7Q7E&HQ63 O
MH")% 40(4[FAR$+EJ F@CWB899PGA*:74;6.&'-CYU9F%=&SX8*=V)=RL=:T
MV-*O:["OPKA#Z(,_E":@4\6!E]@-EN/RJI8D5Z92$[3.LZ?1T^P(4YK=3WG=
MA$+=KI@B9FE*\Q7->?5&DO*RJ"1O/TB*?B45_\>"A)[/6!)#&L=8$F6009RQ
M$++ BZ(T8SSA1@&\9L//CB!WTC?GKGORFS&DX3SH,>-XZ([,B(/ @IWLX \E
M/6C$=\B"=KBY9#]#"29E/3MT#MG.\BF6KFA>JD/[CW*&>%ER]EF%2OS&GP@O
M%[&@*$U2"E,D]^HHH"G$@9=!CP>$12&A069T2#<PUMSXJQ45W(*ML*"1UM!]
M.P"NI@/6#61CNU!/H 7^:$5U2$ :@#CU7@X,-ZW_\;S>+SR(&K=8Q#I*UOGV
M+E\N/W.\?+6NI&%657\O"E;U7FZ.4(03DD#A!0E$?AQ!0B,&??G_ I;B(/"$
M=LBCQH!SHP\E,E0R0R4TV$A] [9R&T3RZ0 ^S"9CP#@RI9Q'\#RYV$%I$!OI
M&-*)0B0O>#G-@B(-X!F,C=1YSG0AD@9:[45*FMQG9\M]XLLF-1F7]8^'$J\J
M3!L_XJL?_;\T@8&"QTGD^Q@R3Z32M,,!3 /N0R_AB2\RSB*1F9AV^D//C:H[
M^4 CH%' I07L>D;?.&".3-A&.!J;?>:0N+0"#4:?U"@T1^701K1X@NOCAVVX
M^+W8A5[U?=TDDV]<Q#G$2!"(1)9"0K@'@XBC+,4\PP%R<P1Q3I2Y<=?VJ)'V
MCXT X?4WSE?@B6/E*F@B59C*;U,.HY(_%Z7R*#2_<G58<782+SVP<#DU5SZT
MV*7S-*'MNX#3*YQ=Z,(ZS?G%66EF<H:ABYK^.8;V$VW3K24=\:I66:ZO<?7E
MG;1%_YVS1]X,U,\,XRF*4Q0F,$B]#**8R)U[A#AD(O$]' 48>T8^/^V1Y\:M
M&\';S& E.E"R@T;X+D3?(C?/?$;TF',4G$<F2G<06Z1<&\+E-N%:=_")TZT-
M,7F9;&WZ #LVV^R>7Q=/)%^UQ[Z<%H^K_+\XNV/2W,E%CLFR';>ZI?]<YR5G
MMROV7OXZ7[9YBE6U?N+L3><<?<#?>W]<^"RB/D?2TD1J?\P3!#/N$\BS"*,P
MPCQ(0A,:'%_DN?'G1F/04_D&[)0&?:TW!M!&[\92[2D'.M5OP$;YIFA#[PHS
M]IW@#=*C[7F]%V/[=&?R2ABO%M/-DLME9@*I)UV?IIN%PX5MPI'M5L3;=>.V
M^0V7_^#U[L!OFY3?'/VUYX$/2LY%'".2I@C!A/M<5>!-81IE'*;<DXM;FJ3,
M+/_65("YK5:=_*!5H'^.O57AICO3[@Z[;3S%QM.DMXB,"?[(2X(%[HT*#ITC
MMNBYI&IC&28E7EN$#FG4^CG6+N=F@'>2LJ6>KXNJKCY(C=?REZOZ Z\7D? $
M9X$/8XJPLO()S!*!(/)BC_G$\V-F= IV=L2YT=[6=%H6JT<@1WP"C),:B$8!
MY22F2@=C+_$9W+6=P>[0'-WG*U&[DRN\DA0THC;EXSIA5?:/PX)QVL@X=MN>
M&71J[ZP>!D><L)HW3IS<_V&M8@#NQ2UCN;H%+YOKJMMU_:4HE:FYD(1$:!:%
M4"#D0>03!(FO7+1!E*8LB5 LIJD2?5[6N5&=@S3O5FEU:+-3N[U>[D:WBD^4
MX:_QMNC1[$S>@9$)^OK3/UV:O_[$S"+17T/</T>JOS[NSI+]#8:T-:))O2L*
M?;>B)9<RO.'M?YL:T<JB\P).68@0]"CS(2(DAD2:UI!%02+\(&;",[2D=8:=
MVQK36H%;L54)D%9@\--&])]OVA+QPQ;A)5.A:UR[!G@2"]L!MA;6M@E4;DUN
MK9$GMKM-T'AI?!O=;9O3M!1RD'6I[/M/O.+E5_ZQ6.;TQRY-,& HR;BRI+U$
M6M(>81"G+((ASV+L>3P-?#-+^OR8<V,K)3+8RFR:V70>8DWSTRUP8YN1>YB!
M3E[P1RLQ&"7GT@ AMZE/YX>=. 5*&X>7J5#ZM]IQSEMIAS&FCG?*_"M6W05Z
M(5TO_[@Y^OFQB),X]6**( U\#%$61S 5ZDR&Q0@G89ARH94J=:D@<V.GC:A@
M)^O-0>CDD4NVY[\_S/C,>OKT2&Z*21F9^4:;#V,^O!1,ER1I+<NDS'DI8H=T
M>O'SG#8-VL30OEUA55!)_1W7?,&PY%4A4B@B=;CC)QE,/3F#W$,1(6&$$ D<
MM TZ/OK<V'07?5[C[Z TCOPW@UZ/%$<#=&PFU.X?M$.]4V9[Z61-A(;1G*"-
MT D!YM!(:!@;S59"9Q[B*EOJEM+UT[I)R6IVR<I/6/(O?%7)%[$536Z<?\7Y
MJGI?5!6O;H7D%2F--# YSQ+BPX#C&"*N&FB'001%(H>.!&4B$(L7S7@M4G6L
M1=3ZMO6:$[O\SJ6PX*='*>[/ORREO)>F2MG/H/9Q^:03,E& T$Z'KK?FGA8;
M"OY)*?!S$PMZ)/=*J;B]!"LE%1&/F5]U,?3C)ES9BW?E#*R+<3V?DG7Y$#8-
MY)IVU\H'NC66NV.>ZLV:J_*?#_*-X(O BXCOL1@R%D80X=2'&,M_T<S#(L4X
M(%FLWTM.;]"YV;*-V*"1>[>]W!S65D"*WI9-;H0WZ9BF.0?#=#P6LB/S[+5!
M->E(YQ[<B2JON '9L#.=&5K#3>HTGS5AOSHS[?9;UQG>:]'%3FT--F6%&(I2
MX:<P2D@&4<)CF!$L8.+[2>#A*$M8I-W!;O?<N9%S(QKXXTWQ)!=(D\YU/:B&
M"?8" ,8^'%+\4=6YJO#^6Z_VPEDTS%K6O=3]XG9UO4=.UZKNI1Y[;>J._-EN
M,]W/P5FU5?"^%$MY?]7V/+\E55W*S?N"$1&D$4<P$Y$'D: )Q#0-(1-1Y(5I
MB'!BU)9"=^"Y?</O[VY?W;V_>[A[^QG<?G@#/O_[[:>W_W[__LW;3Y__S_^>
M!G[R?X&W_\_O=P__8;8GUIX(O0WO&/".S!#]_$65S]@*"O[8B.KPU-@4'9<;
M3NVQ)]U-FB)RN%4TOM]B'WAL.ZJ:%>^*@NS:T;4>Y 5E"4U8[$/Y8:;2L/ D
M?[$HA8)$5/Z4A"+62N6S'']NY-7*^Z*'IL&6Q6(.-+:$XR([,F\==ZMU4/<K
M&/5;99XYX7 "O,&V<=P)F&@'.<9$F.TG[6$<W%I:/':Z7::]SGL;S@L>,W$J
MTGLIYUW-GZJ%B$D619F @1\+N;H@#V)I",,(^P&/,4Y9D$R2<;05:6X+SL69
M)> /I1MHE#-,*'<PP7JV]K33-O8^?9H9FR[AYP7(L\CKV4GUYTC?>8&BLRR=
MET^VX_,N9;7Q67[*'[_4]^+WJJNN]:2J>OY7:P>E8<I\CBBDH8HI%0F#Q$M4
M$;\8)43^[&,CTM8<=V[,W(G=.MQO0",Y+ 24LK=F4F,:;<4WHU[=N=#CUQ$0
M'IE$78%KS)*&4+FD0MVA)^4[0SP.2<WT=@NGQMOO=+E6C8C;W,1?)5_6G-VM
M7A>K*I?/: 9X5Y1-W:2JR6/<="#RA.^+"$./!BE$+$$P99Q#CI5CUF<H]/7[
MB%B+,3=>VRH"JC;[^+%5104:TKXR0!0EP#MU;%IFV$^>AE-DDBD9F0C_)+-A
MX"F99%8F<IA8SXXC=\G%6 YZ3>R?/IWSY&($]GPHES_-; %C/%]T%:I^R+&;
M8-\/\GU;B C%/F$)3$7 (.*,P33("!2)AWC&$\]/M=(+3@TPMT5G(R/8" F4
ME'K4=1+$X27"!31CNQ+,4-'FCG.J[ZS::F/65IS^];'X^HN\M;5HY3\.#=F3
MCYV$#LXIM?G0SUYG88/^ME[6.>_Z92B':_6VJO,G%>5YNUJM\5(5K.YW7U]0
M%OB,>!%$*4$093B&*6<1%&E"*8YY1+"O;7L:#S^WSW]/@>:DH;H!6QU JT1;
MP[VOAH%I8SY#&@;FJ+B/S"USA-S BAP5^HFL1]=38&8[6B,X:#.:/W4Z6]%:
MXST;T?XIKK*UCK9S6638%TGB8<CB4$B34:[+J<=2R F-D$!IY!&\>.9E7K#/
M-2YK/>>LYN@F7]>A#"-Z$54"^==- OFS.L#&[0$VK@'AC_EJI?9N\F\_."XO
M3<$Z,2TD]GF4A3 .HU"N]C&"6>S%$%/B">$3+@3MIN7MBEUY4C827&E*^(J-
M.QG81X@RPF$8)*HQI< P$PA!G-(D\6-*,T\KP67$B9CDZ.+4)(R#NMXAQ0A8
MCFQ"'0^7Z<7)N,_#-@1IW#R_XT-?.8=O$(_S^7G#M[NH<OC[:EW)(8NR++[)
MU><UEF^7BN]L0\[B1-)3''DP]B(.$?4SF.$L@ $7'J*IEP7,L!VE]MAS8ZD7
M-?E:Z<%6?+"1WRP:T&9:="EL%+!'IS%G.%]8_5 +L?%*( X/?\4ZB%JX#!=#
MU'N$A>OK55XLB\><5MU)D$]\A+,PDR96&D&4B11F+..0)0E.64;C*-%W;!T\
M?&X,M17/YK#M$#@-?],%<(S,(4Z1,' #78#(1$X> V3,_#<G5!_TSAS>,YWO
MY82T>YZ54]=<G)CWNNV^L @D&R$<8$B#1!6K"2*8(HH@]SR1T3#Q(S]9U$WB
MKM9Z_W(((X;:#C3>V]?FA'?=)\#2MJ/A$2SU+*++$!J9M'K"W8!.O%%2Y Y4
M'RD9;C/*M=+>#K0<2' [O-*58U0^M\;YLDFR7V1^$$190B%'+(7(]Q@D(DD@
M#V.!B-QGX3AT4IFJ/ZK6VSU]L:F^B)?Z>/9 MG7M&&-V38_.YJ=[LLP?NZRG
MGS;5Q7\&F_KB38Q/3[$QO3['\!O7V;,WXI5]/,>T/^_:.7J7*^KYS.MZV83I
M5SW/IQ<*C'@40X^$JDIHX,-4>!&D?HBBP$<TC&,G''1T^)F244_62[GH..JV
MI&0/XFS\S9M$(D5%.W7&9*)!T,:EI.-#7YF;!O$X3U+#M]NQU4=>RO?A207B
MMW&-W3Z;I *SV$]@$+$$(DHRF'DI@SP5F8BRE$2$F/B:3XPS-Z]-3\Q-@RTS
MI\4Y7/7XQP%:(_.-#5#&C'(&!I<,<FJH21GCC+Z'#''N<DM&*/DSSMG;[RK/
MD-^NVEJ4+=EL-OB4,F6U)#!*8@81I@DDE'-)$;$7B]@/6>P9L</Y,6?'%*W(
MH).Y*:K3EHG=K+?GO ;6Z&MRB%M,Q^:3B^$T9Q=]@)PRC<:PT[*./@XO&,C@
MUHD+2;25D7:'7%4CVL,7O+I_5H]0G7>_\DKN:_[.5?(A9[=?>8D?>9/8\49N
M>+;'_8LD2Q*140P9SQ!$@G&(XS2%C$4^YV$<8!Q.4HK"H5)SXU,';5*[FF8]
M>#H*J25 H$.H:8[=8G0#-BB!#B;0X 044+T.,Q-5QG#YQNHM$7,0=49KT)_Q
M%9RNU,<(<SZ+8B$N]?ISE!L982:=%2P90S8[R^-ON,PQ67+55*4MH[M@6818
M$%+H8RP@\@6"V!-"OI*A0(2$*8F, O!>#C&W57DC8=MER*RX\@"0>LO39?",
MO%@8(F/,TZ>5=\F:1T:9E,-.:WG(* -7NCJG4=L8U4GIW;I>2VKJ_M 59E=5
MV=_E7_E"X(3[G*H21ZKA>! G,$M2 B,D:)8Q3B-DM!FPE&-N3''\ &*C"FAU
MV?VUU>:F[3J@]+GTN$=O\FR/?YQ/R56.@QS,AH-3(2,LQSTETA/ERJ=&1GB=
M/T4R>]SEY>*.M;A8>"3S*(TI#!(60D2B"*:4QS!.DC"(/!*2V.AXZ=R <V/+
M@QIF6Y%O=M_B&U/'PUG0]<C/)90CL]R%*%Y4 &X(FK$JOQT=\VHEWX80&*KU
M-GB?30<S_/WUNJ[PBOVO@E2WM):_:#NE+@@+& L]HA(.5 WA+(,D5-Y;&I"(
MIA[C*3:(L3DSW$QC:E3G5R5Q<Z:B9%95NV^:AK"MW"9-M4YC/<PN+J";J!_9
M-'"9M!US MM4G<:LX3/L+G86E.&&8J=OG["'V%D=]MN&G;_<SESK2L!OFN (
MSR=,;F5ADGD>1"CAD"2<02^.@RS.4C_#1IGP^X^?FREV^_GSVX?/9J;6 6!Z
MAI4]#",S7M>X88Q>0,=U=FD?'8PPJ35T7+M#V^?$51:6SCLYY1^+?%5_YE_Y
M2NW3/G+Y#JB?5WE1OEV7Q1N^*IZDL25MBP]%O0T[\U*2)L1G$/E8[K<\^:^4
M>!Q&./$B@KE@J=9^ZS(QYO;I*T5 HPEH5&E<'Z!3!K3: *4.Z.D#&H5L<AGM
MIT_#MIID4L;>S_U9YL/ >)MD7B:R[4:='S/S[V)8!ZU#^Z=/9SQ>C,">;7GY
MTRQ-3TI5E8%\]?BQ6.94=;@SM*I./F!&Q+83$FRD',?<.@N&4]/K]&C3FF%G
MM7YADIV_P^YUOG]N"D&O'AM/U\;!M0AC/XBSC$*/9;$J])9"'"8^E-NL.(R$
MAX@P:HMR?)BYF5=;*3<.VHV@9INM$YCJT</E2(U,#>8@&;/", 8N&>'$2).R
MP;"VATQPYFJ+3=IG^H6S]9+?B\_\43WM$W]6W4Q6CW>K)EU#V6BO\7->XV43
M.,UR=1!7O?K17?^@PAP>^/?ZE53K'PN>AIF(< PI3YH^>"'$"4.0I"P+4M5_
M-=!JWSZ&<'-CG$YRT!>]B=ALA3?8&[B>18T=W!7G9F2.VVBF*DIVLH*M<J"G
MW0TX,X/@CT9)H+0$C9HF&S[7DVJP#;SBY$ZT.;S.))OM&D>:A<&]I.LQI]MA
MCH36WKYSK#$LZT(5J\<'7CZI^GBW*]:-VY@&NP(?E12QLQ/NQ<<R7]'\&2_O
M5A^D$ _?^/(K_ZU8U5^J191PCU(OAB*B"**88TB"6$ OB @61(1)8I0EZ52Z
MN2W=2CDH!WH"3<U)=7JXH8E&PUZ%E>H&[)14=+-54_564HJ"5E/0JFI8S\KI
M.Z"W2[G:S(Z\\%]C4LV+<8T!OM,Z7DX%G+8$V!C8OJ@>-LH@%EN_VU#NQ5J'
MZ>^?3QP=!''&6< 9E,N!4.'C&<PR%LLY#XB71F'BI_J-)34&G!O/AW^5(O^/
MS6'![Y]?'A48&/0Z@&OLO!S#.#*IGD?0YC!,!TJ#_8YC2"?:PUSP<IIM1 S@
M&=Q<Z#QGN@V#@59[FP"3^RQH6:T+GU0</):DOWI\751U=?L]KQ9!R C),D6^
M.(#(0\JK%D8P8C&/LT!0&NE'19P:96X$W%AB/4%!(RGX0\EJ0A@G4=4@7!=8
MC<RRH\-D0*8NX)J(0>U@,R//<W ,,N;)FZ>CR7/R[W'CV8LM"+')J5:)V27_
MPE=5_I7?K6CQQ-\75?51_:)8;6JY?)3CE;S.RS9K>Y=&5'W@M32CB_(S+[_F
ME"O!7I><Y?5MF5=2TC=K:60_JH2B5UP4)7_ WQ=!EI(XP'$3@ \13BE,18QA
M&*.(QH3X&0I,X_&OI8S6QS=]M'^C!JA:/0"5BH"?:*/*SX U6@ )A4$?K>N^
M,1J+R:Q?@(D.D9L:(WL8@!8$\)."X><;T"'1*ZRU#P;HIXJJ$B6\!NV[U$'2
M,#GXZ77W+G6X@#>[=TJA<P-(@X\*^/\SO%\&J_"?X3V;:)7_D[UO9N;%M>=Y
MT'RYFG#3F4?7QG_/_+JZ,".VE7O'^2*D$8O"E$ :8ZS:G@BY!?;E9C@(!0^R
M+!/"?4\Y.? L=\6:C<ZD^"-TDU.SH7=:- ;&4^RF'< [3A.Y'E:3=Y!38\^O
M?5P/$:O><?W[K<OS\%*2I.3"7G>87XN"?<N72\FY=]+*63WF9,F[TOZ1SSU,
M,Q]Z*8[:!K[$"PDD81QY4818&%*[A@IF@LQT8[B1N+'(BL8BR[>2FW=;,)P<
M768; ^O)2NXTLC>ISGOMH_:0WVG0539V6FK'#CW'178,A9BZO(X=1D<*ZU@^
MR#91YI]K:5JR=_DJK_E[:8B^&.&@(N+O%1?KY?M<\$6"_"1)0@&C@'FJW(X/
M4TY3&/E9E/F<^3SF1AG=%P@S-\MOHPMHE8%+I<W+S_1(I=96)Z"4,DP?OV0N
M]9ATJAD:F53'G1R+_*K+476;@76!/!/G:%V.W,LL+@?/M&EKO):;=EY5KXLG
MH@ZJ\V+U4,IM?J[^A9?=+O_VL>2-)V 1^M(BQ3Z'2>I1B) (8>IQ'S(>8)ZD
M@8A3K>POF\'GQK8;\4%/_AOP43[^BXH'?%U(35B3DE.L3-H$&TZ)QK'"B$"/
M3)K',:Y[PF_/A_!&_!&Q-FG9/![F4[5T=HF]8=-G._"&FT(;/G/"IM%VVNXW
ME;9\ADU68"'J1[Y\X/3+JNEDO0VJXW%"&8D3J,)"(0H3#C&*F4H03A'B\C4C
M6O6$AX>9VSK0"0KZDIID<IV$4X/9G8 T,H<?P\<FK/,T4";):RX FRH-K0/.
M<;V1LQ ,YX"=O'O";*YS&NSG99V]VC+#2M(MY_M9U\<*@KY(I%$YSXSX$933
MSB B7@)QY*40"Y;@,$LRBK7BYB\59&Y$VNIQ U[4$7A9#;=JRN&V1;[O5X8^
M"^N)T_-73#$=(U.VSDS4!2!<SD?.;L[/@WDFTX4@.DU:LI5EVORD"Q%[D8IT
MZ?,F[I+7-=6Y7]=5C5=,BOQAW5@':1!G?IAET$N36%JE40;3F#(8BT3P4(B$
M(CI)R[M3$LZ-AQTT#]NV!^LI>P-:=2?J07?R?=!C\:O.\M@6^94F>+H.;^<F
M81;MVDX*^>?HO78.8V>-U,X.-*[]WC02D=_>0H0DB'V40$]$""+N$YA% L$,
M,98P3Y D,2I]9BK W-8)2WM=J3*.P;Z=*;>&N@W^<S30!X$?S4(_1.\:EOE6
MAEE:Y(<(V5KB+YYC:8%OZ]AL^T]V=;]7K!<?\IL48UUR=K_ZQ.FZ5&&_DKGS
MZJ"P%(E3#Z,T@X2HQ-2$RG\%.(,A#FC* I&FW,SZ=BG=W!BU7WAJUS'WI@L-
M:(*N>CJ"C9) FFY;-4&CIZ&1[73*-0WL:TWDV,:ULSD<I7C8J/ [-:N="CBM
M23T&MB_,Z5$&L5LRWCX]+XL?G'?'C,<M_6V[X\:HKQZ*&B_[?U>Y)!^*^C]X
M+24M'E?Y?W&V2#@C<1@@F/J80I0%(<QB^://A @CZE$19";+QVB2SFTIV2BZ
MS4$[M>GOM7!O-_?25M]S"C3):U)=\(.K?/B-PF8KS'AOB-YJ,XMYG]"MLW77
M[+;7+R;ZYM34RL7J2145=[?:C Z_RY5G/&$G785&Q_QP11I_P#%+82Y2E@8T
MB@@DD>H5Q@,?9I1BF/D)1BB,/8:Q^QJ7<ULWCM0YW.M-VJ]S.$8U2J=E)F=$
MSD=P/<1SZCJ0HWAD]$:>8>7&D]X7L[OM*.H#_]9KY%$6*_E/RML2C^7K+VH)
MOUOUKVB*/B[Y^WS%[VK^5"UXPGT<HA@&-";24.849B0*8>QY2>JG,?(BK=KZ
MSB2:&[%)A4"_><V>2G*R0*N4*M&Z=UFG%_A#:08:U32CUMQ-KAXG3CIE(]/E
M)+-ES*O.$'9)N9<+-2D;.\/PD*C=/=B.PU^ORU(.]KG&-5<^&/DV+55;6U7J
MO>)=$8V%8)&7Q-+*#/PPA<B/,FEOIAXD*>5!G(;$B[1BI(U&G1L7-](V-I#Z
MYI9F=*J'LQYE.D=O9%KLY 4[ !N1VY[4K=#@IT[LG]WQGA%,+KE-;^!)^<L(
MBT..,KO9CH<^EET^]^>ZH/]H',,+EF0)#@(,PRA@$(D$0<Q"!#WF(R%00D+?
MJ#;.D3'FQC%;$4$CX\WF'.:NJM:FWLMCD.H1S(5 C4PGEA@9\\< "B[9XM@P
MDW+#@)Z'3#!TJ67#QH'Z7A]X?2\DT7SD95XP^?M2[5_?\/:_VSZEG/M)QE $
M(\\/)4T0(3>1@0\C3I$G_%#U?#1J[GBQ2'-C%6D_KI_6RZ:*ND;I0%4*L!#-
M\JS1)'6L:=6CJFDG:V1F<SXWYJTJG<'IM*WEY5)-VP+3&8HOVF6Z>[+E?K%X
M>BI6#?U_Q.5]V1B%K%D)Y+C-Z<DBII)V8\8@D?^!*/(0))032#/"XC3SP@09
MI8IIC#DWQFU%!E5KH#SC$GQ5XH*?UA4#S_(CKY34IS<[UMAK[B#=(CKV_K$%
ML[/VI,#*E=:*W-I^0 K=A@HXW#WJ0^1T[Z@Q[+0[1WT<7NP;#6ZU8Z/?</D/
M7JN@H,\J3JB)'5K$:9 )=9Z0)5X&428MPXRHL'>:!4&:D2Q@1L6VC@TR-[[9
MR0AV0IJQRU$L]>CD4H1&Y@\S<(R98DA[E]1P=)Q)N6!(T\./?_!:ZY*D^8JS
M7F5GY8*BDE/>K553TLT?NN!R%5G^("> +\(,$YPA!%DJR0#);2'$ J<PR#P?
MAT+N$D.C':*M('-CC4X/T"\%?P,VNH!6F=U?6W6ZO(Q&(>.JI7;SI\="4\S*
MR$PUWH38%#.]"$W'-4WM9)FZM.E%B!VI<'K9\R[PR/5BL3]([=L#@ 7S,Y]D
MV(,A0T(5TO,A1KX'&6=!(!+*8F'N:3LZU-R8LO7,+'>B6KC#CF-JX.:Z&*E)
MW%=[I9=W<CKV40UBX=SW='RTZ7U*@UH?]14-WV''$%UH91--MNWDNZ&A1<*Q
MH%Z00(8I@2A.,)1;L!"R*(J$EQ F.#,AB<'1YL83>U&G-[T>VAN!S7AC&&D]
MZG"&W\CL80^=,8-H0>*21(8'G)1'M'0_I!*]FRZHG4/.5U@@)RHL_*T)S+];
MM6[O;5J9OQ!9Z$<!BZ%': 91D'%(,L9A' 78(P'#G!D%EXXEZ-PXS&6AE59G
M%?#8:GW3RRZU**DSQFNBQZ)SF/R1"?CJ\VY7:6?$27%><&<,6:>ONS,BXD?+
M[XPYGF4SD*4D8E6P6)V_JLRPIM V#3),TX!"^1\$$0T3B -U!,']+.9IQF,2
M&'7Y.#;*W%:+GI!@)Z5A/XZC<.H1\\4@C<RJAOB8M\08TM]IKXNC TW;Q&)(
MUQ?=*08OMOON'_C3<U'B\L?;?Z[S^D<3<;@?;G%?;@(N%AAE?LH2).W/E$.$
MY;^('WHP1AX3.,L(3XW"5TT&GQM+;&4'K? WX#4NRQ\J_:7-VK[I# 6PT07\
MM-'%,$K":([T.&8LY$>FGG% -V8H&_1<$I?1^)/RF0TRAS1G]0P[]E,TNI)S
M_>,#KQ<AXBCQ4 QI& B($C^":<(S&"8L%"F)$>)&N^O^P^?&7AO9C/W^^XC1
M@# :"YAEH30/LR2$64)3F&)5V3<BH1>DBUJ5%A@9L>T0<T=,CYUM<1B9?;=B
M-4&[[NCTF+HNZ7+O^9/2X3'-#NGNZ#6V=+:)G'TG17E=J 3+M5P<NYJ%<O<H
MKUBN5>G6CT79[#OKNLS)NHEJ>2C4>8J\26HH!WF\6TDFDE;F(LO\$/O,AQE2
M64M^AB$)P@B&@;(# QQJ=AL;5\RY4>Q;7*ZD>-4O/RU5H#M0;P>@6V5!L=76
ME$]&F61=9KKVU(W.<;WDA';.=EJ"G9K]O(4;L%4:=%J#OMJJ!.R^XF"CN4L2
M'7-FW-+Q*)).3.QCHOURB1AU-%>QB[VDK%-9'?*CV?5#:^LD]JJWW HIF?R@
M%IA33S"4PI!P#!&7*PYF7+6."*,@9%%$,J-\BQ%EG=NRLQ,9_(25T#__4IPO
M;33Y#.LM-S.9M[$=JF;)C,=#*GOSWN@,?MHI+6_"2FVU6(T93^E\<L8-N70G
M[I6C,IWC?CYPT_V0%BTP/W$JMTYM*$>.E[NB,I]5@PI5UU S]];P:3/BCE9H
ML)6Z7X9I*[=QTK,IN@:='\=!>:)6D%IH.^H/:0[48,-(@\=-UT'27,>]EI(6
MM[NR=3\JIBM6ZI_5W_/Z2X\/NZMZ7'>W>ON=\JJZ%PUUMN7!'Q]++O_.MT?X
M_;\NL@SYF3IJXS'G$*D0=4Q%! 7'298F<2A?U<LLX)$UF)M=W$3KM"G+<M?^
M+/\&&O/8T/LR_9M@:RG/:'Y'7@./&\3J?\$WJ3CHV]>;:W:ZJY"N5GGU8C1W
MM1K>]'\8TVR>:*;&-:;'5N+*)O9$<W3>\)Y*$-<)K;=/RC/U7XU<]^)7G*_:
M"A_?Y?I=4;Q4R5X++XU(3#&'*?-]56=#KGH,<2C"C$5)PE#L&26Z7R;.W)8P
MY7'^Z5&*^O,OZDC!5:JJULS8KD)CX7V5)66;MMK71JT:2I]>0:/O:HN@M&KR
M6*?(8#6!=YH\5BV)9I+-:H*>?DZKT5,MO!\?RX*M:?TI?_Q25^^W1:I#[J=1
ME@J8)$D $>((D@0E,.74\P(4!C34RE8;&&-NQ'@G-_ZKQYPL>651'WP(3 VW
MT>40C<QEG8"@E= Q0 :>G\N!FLC+8P.8F6]G&(I!/\Z)6Z?SV0S+ON>?.7.I
M97:=JKFDWH+=2X@ERU'NQS -$84H2'Q(1);!V&,\"X.,ILBH.]G+(>;&>%L)
M+^B'< 1(/2OO,GA&9CM#9,PSM$XJ[S2WZN4HTV9%G=3R13[3Z2LO[7M[NZIS
MEB_7*N%A5W))[FB7:\99&PKQ]+RN.PMK$W"UJ<2VZX2*PRSB7L0@24.B\A8\
MF*9)#)F7>E&68$ZP4=Z">Q%GQR^][JE]'7OEQL!&RTV4U%9/==-&4XU"AE.]
M!9KD=M6Y'9L<W4_K1-UQ74_&."URG4EYI3ZYKE$^W2S7^4B6Q7^76'E'FXJ>
M;XHGN4=?9)2'@?!B&/N)@"C&6'DC$^@)'F8A0HE(C7R0+X>8&]DW$JJONY$1
M_-%*:6A-'D%2CW OPV=DPC2%QKPH[TGMG=;@?3G*M"5W3VKYHL+NZ2NO68SE
MP_J)\%+*I2ZM%AE1-:$B"A-*4XA2$D.,"((H(A&-,HY\[D]?B&5?R+FQC/MB
M'#>@U;CY/AN=KU& Y>#5T+0RKSSA8]N9UYSK*Q5=.3X9\RNX<B#GG[#8RG&D
MQRFT<F*L"UV7S99ID7@!#I(@A"SA"43("R%!(8%I$'O($T3^V<YMV3Q^=OR_
M<\PU\MEZ*UOL##V5QHA,YZ4\ X:]@W)/YU&<D^T(UW%,[FEWTBFY?Y6KF);J
M=M5&O7\LJKKD=5ZVA-*[XDU>T651K>5+T[ZP#-& 4IK -!,A1)ADTF1$TF[$
M@@6$,N8%1@U'G4@U-XXX%G91-?TUV[R8?<T.+NLI9T<Q;B9:CYDFG[Z1"6VR
MF7,0-',!TN/&SM@(=N40F@NP/!])<\G#77'])EOVM11AX8L,JQA%Z'%?0.1E
M#&98&G!^$/B$\,#WR(5M-_K#S8V=-[(!6@QDKMO@ROS8#W@8PMB//(@"N4P2
M1#',>,I(%F;,][S%5UZ28GID^\/^&;&U78]L\;K"0G.SK:< 7@_!YV#M.(;*
MN(O"WHA79OMCVI^G\:-WF?%S5=:+3VKC?OL]KQ8BX,R+40 #$B"(>(0A%GX(
M$X03%@0<I7KM&/>>.C>V;00#?RC1-.W8?9"&OWMKU2?8&.=5G:O@Z=\X5@M[
MNTT>QD'[RSZJ]\ '+*_O?;SRI\,/=_^!DWR?1W78?(;'_^BLQ$=39;%Z^(+K
MO^?+Y2O>!3FW1[8:2>$J!/INM1\$O4TC#K/0RX@J(,>Y_*Y12F"&.(4BY0''
M'L<B-(K3F5C^N3'(6_D=/>$N7T&IK0H1$0ZV.K<A'IKE)_*5*F/$ZZ["9DZW
M2_#@FCN+%\O6!IK-ZW(5H^IHNLO+_)91VG9?:2Y&+C@RJ@K7+D(RQ?QH%":9
M1 R+=)U7Q;(N5J\__\;5B=(B#(4(([GE33!+(8IC!--0[8!Y$(01CAA+M5P)
M1YX]MW6HE0Z\_@S^: 4TR3LY@&V8R2\$8V26=8F#0=Z-/1X3Y=ML<7&477-<
MX<&LFH-;ILNF.2[K7A;-B4MLZ_UW@9.&MM&+^V;T7>U"CT<Q14ZJ[K:D^^$@
M$]=M/Z'CR^+LIRZT#8F0SVI*O+,WZU(5L&QV%TU=@M?%ZJM<GIH X/;?=;[7
M?5ON1N[%+?O/==L*HUHD-!(AX1GD!*FJ.2R#),,Q%!Y!?HPP\YAA1(5#Z>:V
M++<AK:UVH%5OV]NJT? &['14<5<]+77:SD\PWWK<=;59'-U7YF0"MZ6,>UJZ
M#$<9 7RWT2PN!9PX&&8$;%_&THPQB,4&ZC-_5,_XQ)_5AD[5,19%^=38IG*8
M3_PK7ZWY[8J])7G-<',:O$O^2D+?S[B?P"S-Y,I 8^5:C!(8!H)'F)*$"2W7
MXL62S&T54-]^)W$3KM'I!MZ^NGMX<VNP0;EH>C2V=5.!/C9I=_AN]0 ]14!_
M-J0NH%4&M"EV?^CDV#F>&(-]YE03--&N=#-1Y7:B\MY$K;CZR^ZS:3^7OSK:
MP;J <G"_>]$ T^V.7>"PMY=V\D#KPS1>EIP]X.^]%O:_KUA>M;7Z.7M7E#Q_
M7&V2'1<)DQL603CT19I"Q!*YG0E3#KF?^4F0"80BL5@UQ=S8@]&QF*$D6I]G
MUGZ>+^09[Q/MI 32VBCYBOXP/H0RG1#M<Z0Q\)WL**@17M6*!SWQ;\"> F"#
M_48%IT<_EO Y/KTQE6+J QA+E(Z<H=@^R8P)&<\7;U=U7O_X_(27RU?K*E_Q
M2M4Z)H+%-(")\ 1$/F.0X-B'F<"!_'^81GK9E">>/S>+NQ41-#*"C9!ZU'4*
MP6%><H#+R*1C!HDVHYQ1?$<7U88O*D[_^EA\_47>V5*%_,<A0YQZZB2?_QF5
M-M_VN<LLFX1O-_*2$-X7JT>YR#\UT7VT>'K&JQ]-OP=,F_RY9NNO6KU$A 8"
ML11Z:>I#%'@JO@=Y, @#EO'(CX0P*JA@)<7<2$#)#>1 3RJNAI>P$QTL"VS:
M$,YN5O1,F=&Q'IE8=O(#:>@#I0%L4._K /I*]!N[.>QI?@F.3GN>6PDR;4_T
M2[!ZT3/]HH=9>"G?<%(K;RF6NJK N*H[L*>$4):(""8!PA!YE$,<9AP*/X@3
MP46&8JW\OZ%!YD9R2DRPD;,)$]2DMD$D-7R%#O 9?9OU AJ;J)!3&!FX[1Q@
M-9%'SN1U,O.WG<%@T)5VZM[IO&1GI-]S@)V[ULXPW+82Z(7L5]M?_GO.2_G(
M+S^ZNE!,A-P/TPBB4*"V7&N:<@P3G_F(IR3(F)%!:#3ZW#BRZ4O3G=;VY;\!
MN[^ K0Z6Q;G,YD?/-!P-]9&9]RBLRH7_X?9O(Q3XLH+)I<5G)L"DEIX5-H<6
MGMU#;'WXI-YE'.].R7C*2>1C#$,4RRTN3@.844] @C%"4<H(#@*SQ)6CX\R-
MNYKME#*H>^V4^DG_G[\49=U>\*HHR^+;H*/8"'%=3_S%.$YA!^Y$U#OCM7"I
M#^+@UF]^?*B)G>.#^K[T@ ]?;D<6'TO^C'.FLFA6%7_=G%'5B\A#:>*'$C?B
MJ=*!"8(XD_M *AA&<80#*CP3JC@ZRMR(HA,2=%+>@$Y.,RXX#J@>$UP,T\@\
M8(R0,0<,(N"2 8X/-.GW/ZCKX=<_?+'CS-E/G!:/*Y6.=+<:RD#ZP.M-QZ!7
M7!22E?#W19R1U/?"!&9$)!#Y20Q3P@C,PBA$H0H-"+3RWD>5<F[<H]RYJFG:
M+S^IIFD_@W*K&V!MS*Q4$/P8:M0UX13KVC57GKB1V7 @#7G39>UXRNI>([:V
MY[V$1-44SD5.NQJD6Y?P#2"-\FY]_:-.SB0)JA<).H\T5!=8:R>;.AG,/);B
M5K[#K#G:6.+'19;XGHBY!U.<8(BB.(-9%#&84C\0411AP8EN%,7>D^=&Z%OA
M@))./W!B'ZYAHKT(A+'/-/7T-XJ2.*KK!?$1^\^;+#+BJ!K]F(CC%UC:>-L=
M8U<>^-5 L>&JJS;\ZK#:<*]+$4]9&HL8LBCT((I3#+. ,9@EH<=%DH;R_XRL
M.[?RS8T&>DZ334WP,Q7'J\&2XR:-;"9Y'S1-P>O-\MBNL2M.L+G1-\XT.#7W
M'(LXK:$W#KXO3+R1AK$\5LU7><W?2QN2[5K<MGW:?\/_691-LY0/\A/J#NX0
M"SW*/ %]K%K_XC"$J2 !C!&G41I[02B,CB$,QY_;"M&*#QOYP4X!T&IP QH=
M0-OB1VEA>[AJ.$N:QZOC83_V :MSV,T/7>W <WKL:BC"M >O=OB\.'JU?(Q%
M6)TZ1'Q?X-7#M^(=IBI'X<>;8KG$Y1N^*I[RE4HYZF*?@HQP+T81#+CJ]AD&
M/L3"PS!!29@*CGE,]2LKZ8\[-_9KCEV5Z$#*#C;"@U9ZT!/?)N[,8#J&Z6Y$
MD$>FN;G@:Q#J-P[.$T7_:>/M*";0'*S!,$&#QTT7.6BNXUXPH<7M5A'5;7Y:
MZT=]P-_OGWF)5?;N>RXM[U[.V@+3+(ZCD$G6CQ*(* LA$5X&A1<A3L)$^'%B
M$&2M.^[<J'^;P]F=F4C954.U3GK0B'_33^XTBCC6G@T-YA\'X[$=$_. URC&
M>PR8)PO[=@6W:5"X*6AGXL2U'S=EZ+BIC@?1Y,:WVWE"?BT*]BU?+IML'3EF
MM>"(9DE**,0XDU:^+TW]+,E2*%%'#'O4I]@H%N+%"',C]8V -V KHIF?XB6&
M>IZ(BY 9F8I-0#'V(IQ4W*6?X.4@DWH"3NIXN-<_?>'$?9G[EZL,%G]!&&8I
MYPQ22J35ES $B8=3&&-?)#%71]]F51^=B38W#G'0EW?O-O/*_PZG78^]KC.9
M(]/>T?G9J72S"2-E33#^:_R<UWBIXE-NNE80,VB>?!+?6;1,?BG=GZ-1\DE4
MG;5'/CV"B[W]I_SQ2WTO?J_X@G@D85F0PH"25'5YHG(S'V'Y(T>QR&@FC3[[
MS?QNH+F1]-']3B,N+ 24 K<G*9=L*GLHVVS2[;"[QJZ\#YLCP"[9=ML!=\U]
MMA: %^ZK7Z)BMI'NW7_%G?-++8:WRD>NO[BP8'OV]FM95-6VOK^?4>0+WX,^
MSX1*. IA%@<<\C0-$I9X'M*K?*LWW&S)-&]?ZAI_![@1^U^LJP4>0UG/&'6'
MW51DJJH ;@[N&V''ZO:D@<M(Y?V.C7BM4GX#V@^4[1NZRXY3FBCV6TK+-6<]
M+]XFYRX,HC!AH0<3RC!$A*<0>RR&81:Q+(LQX]PH5'5XN+EQ2IN=@EMQP=+4
MSZ^),4)1QD,)+X\D6R/,$RBA54X.',2"TY2J8*Y";NPFQW@[Z)\=8SW6=H?<
MR*S=@M9)NE^\U7DZJ1XH+BG[S(B34K:>]H>4K7F7Q3[Z[3)OSMOE!J$075UR
M7+?E6U70<UT\K9=U_KSDS<RJ.@T++V!44HQD%):H,CP^@9F',R@R1D*:IA[S
MM*)%;068&ZWW5% !Y]OJ[CTM5 /5C1Y@JXC!QM)FGC1VZ".C/S)MS15X@YW^
MR!,PD0? _428>08N0''08V#SW.D\"1=HO>=AN.0Y=KN$3UQN-M:T;M+H;U?L
M$V\ZJ][2.O_:K&S'*O?(/4)$D8>4(<L@$L2')&/J'#].LBSC<O&G)GL'&R'F
MMO3LZ= KH&10,O.B.=&S@\=&>N1EYB7(G0)@I\'XI9@N =&E-6TEQZ0V]B5(
M'5K>%SW+50F8MT)NV^M[<;_B'[E\J>5Z_L@_%OFJOEO14@5,W:\^\_)K3E4+
MFJ9(L11;<8 Z<RM6*N5L0446H4@(&/@LAHC*F<T2K'P#0898Q 1-M-+\QQ5S
M;@3;ZJ2,&O]_*%=PHP:09D[CRP!5JTY#"GFG$*#&P0TC3;FV;_G*$SF^3_I(
MQ9?=S$HUP4Y/T"@*[GIS_;DWRQMMFR46[/0=LPR,R_D8MPZ,$TFO7 C&)=KG
M*\$X'<W5@E/)H1I#\J,<I^1UWE9'[5^QW^+LO7S 7<V?JD6:B2 ,2:SB:0.(
M.$L@]I4?VO=#)A!&L6E%4W?"S6UQ.49,_3*H^PH>7'98DP#\H?0$C:*F!2A<
MO@"VB\XTTWJ%I6;D&76POEP._;BKR@7R77DMN1S9\RN(@S&<;52^/\O%C,M=
MDMPPK>Y73:FSYHQY$6<XH$$4PP2I\K41BB'V0@%Q&HB81X@)'-FUI-2608LG
MIF]&N1$8E(W$RN!\EA=TT287;R1.3XGU]N RA*]J]&^P;F7O*CXJR-7?NX"5
M44WYL]B-;*"?'O_:9O=99#2,Z?//L*6Z,O^*Z_PKW]1AO%_M?O>!UPOL>1PA
M(5G-Q]+N%51%RZ4,1AA%288YC7QLQ6]G!IXIJ>UDW*NMJKZT_I\^Z(8CZT^$
M2%C$?:&BOU63&%4GG60"0T9%F 64J,:@9AL0%S,PZ:[B6M#K+B@. 1U]%;D8
M2XM%0Q,?MRO%N4$G7AXT,7BY)NC>>&'#JIW?7YG273W?39\J'"(A,@83/V J
M0,:'68 %3'"0QH20-(N-(J=U!IT;"_6Z)?7ZZUS:AFH(=3WV<8WER 1D"Z-]
MNRD-7$;I,C4T[G6:2VD@<;*GE,Z]=@RT:<G\NG@B7=3&ZV)5Y:PIH%"L-GG6
M)6^] OXBCB*1QED&>:;J _/(AX32%$8J%4ZP./2Y4=L\8PGFQDT;!4!/ Y6@
MW-,!])2X:9UW9I1E/DUZ_#4J^".3F6/<C3G.&CN7A&<NQ*3L9XW1(17:/^B2
MS)-FL[]-KF(H#2FC$4P%8JK6"X4X\2F,XS3AJ6!93(UJO1P98V[<UN4_V&2J
M'4-0CY0NQ&5DVNFR&QKQ1LE"&U#??1[#_C!72%XXJN?QC(7CEUJD*;R6?\@I
M7GY>/S\O?W3GX9N>U8+Z280YA=3'!"*,/9BI.-' 3QCS.,;"C[3S$89&FMNW
MOI$5M,)NXE2L&H(/(CS, DYQ&YD+)H/,( ? %703!?O;0V@6U*\#RV#T_N #
MI@O3U]%C+QY?ZP;+XEEK4O%_KN5+\O:KBAS:17)31G"*(@HC)O\')93#U.,Q
M)#@.:.9'8<BTBE^?'6EN)+H3%+22ZL5O&\*K9T<Y 6UD!K7$R[P^U#DLG)9[
M.CG8M-6;SNG\HAC3V1LLC*WW>,5>K?,E4UVW5=#ATW-9?&T[ERP\$D610#Y,
M>"9Y@DN+*PVQ@'X<99QPRE&FY=L^.]+<>$+)>@/(1MJ;-N:[)["!Y3"(L(:Q
MY0JWD:E"B0FV<H);%3X] F &II8KX"8RM0[>N1>OW%\=F5HZL R:6H,/F,[4
MTM%CS]32NL'.U'J+R^6/3_RYK8!W+S[S55Z4JF/\ D<X]'B40IPQ 1'U4TAH
M[$'Y?YX799&JM61B:YT>:FXDVD@*MJ(V_=D:88&2ULS8&@!8S]IR ]O('&J)
MF+&Y=1X,E_;6P&B3&ESGM3ZTN#3NL"G#(;=V!-,O'U7GWV+U40J:5U51_OA0
MU/R^5+TR.K\""D(4)"R0NS.,(0JYM+]X'$*4$1X&2< IT4KC,QMV=CS2"0XZ
MR<%.=*!DE\BW+5\LW#KZ<Z%AJ8V"\-B4,PMP38IHC 'R5*4SG(%M6#+#%+/A
M0AG:3YNP/(:IAOM%,8SOMC,3_\Y5.4_.;K_R$C_R#VOUS#?Y<BU_U]11KN[7
M=55+.U4EH+/_7%>U>BL7J> $I4$"O2#.I U)$211(B"+(D2#E!/,C((Z+.68
MV\+02)Q_Y=)(HNNRJV&V2?5=@5>XRBF0:_BJV4]]Y&5;LOX&;&]\7:PD!'73
M>7+W$#/3U'92]>S6":9JY!5FHP'H5 "M#J!3HIV3"O34 #L]W-F\%P+ITB"V
M%652:_E"O Y-Z4L?9T>XDLF?Y??]0^6&U'++__:?Z_RYK5O_()]X^SVO%E$B
M]^$T2B#+,%*U,BC$L<B@GZ$T33Q"4:!UHFPPYMR(="/R39,953>NIZW8-T")
M#?Y0@AL>D>C KT>#CD$=VQ=:K!Z[UL8/>XV-SZ%HS&H&N+AD,)UA)V4K QP.
MF<GD5CL6:J+?EFWKC"VSO2O*#[R^D_9'^_._<_:H<A;NQ0/^+FV5O&";HA!O
M>/O?112GDI*R!.(4JV877@33F 20>B&C@B,>>D;GMJX$FQN?26E!OE4 ?%$:
MF#&7LRG3H[=K3,3('+A+Q*G NFIJZZO4*;#3!S0*-0E5RM/9=))HU=H5Y/EI
MH]G/[CC3-=@NB=69;).RKVM$#RG:^?,MO+8?E^KYN[(]]T(M%/6/396>1>P)
M+XYB 6,_BR%".("93V,H& \(\7G A7Y'^7.CS8UQ6WG[E;7N!6A%WE;1,O <
MG@5;PQOK$L*1N7)J] S<K2Y1G,C+VJ'YO$-3KBZ\17-3M\_58;HN/(,.U;,/
MF<Z/JJO/GOM4^R8[\[EMAO19OC;-6?W[KBYQEPD:$8$CW_>@"#(.$4&>*A),
M8(RRE% 2^2S0ZN:N-=K<:+=KPK65%FS$M<R]'89:SY9U!N#(I'L!=L8FIQ8F
M+NW(X0$G-0ZU=#^T^/1NLN.3G0E9/12WC.7JR7CY$>?28.S:H#8NR5>'C2\_
MUP7]Q_US4Q7]DUI1JKSF7<QV:W%^XK1X7#5/7+!4> '),D@"A"#" D,<D BB
MD"9Q1&,>IT:.Q8GDGAO'W7Z\>WUSO-EPOYEMJ][-;NLHBK8T.NCI9L:&4[TH
M>KPZP^D?F:$GF7EC+I]X'ERN"E.)/NGZ,O%\'*Y44P]_B0VM&HIR!6N^S-N\
M;/S]=<FES%* BLNG?EDPD@C"< A3F@JY5D4)S'PO@XP%W,\20C.16-0VTQ9
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MTX/:YQDHS6OWRRP$YF];^Y^A*Z^-NC,Y>?T6+1?:Y5H%U[UK,BN:P]BN+)C
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MS"'"<GV9JSK(5'"&DSPOXL*HLH1)XW-CS]92L#N:"DAKZUAJ'.@"%!%,41Q
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MF/X<0SL-VSTGG ;:"<YAG4@\P06\9HH)1D@-2B;HW6DZS00CSTY$$\RNM)L
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MVM39>G*FS\N'-=@ILRUW"37ZPG#CT"W"G@GMM1!<K8ZZDD@UPA_E; "<NK$
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MY*["KSO)] &J]QGF)6DY]2]H;%VH]?*68U72X15O?OJE#MMKNZ)Q#]RHZ^Q
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MM/M(CT]\(.^99?R";LQ*I@BZY"KMMB=E,%-$GO*:\?5CDURZ0X]C\D029Z%
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M6"(HC%(6R)&#9+!(HQRF812G!8NS6&A5Q'9MV-P&C]9"L#J:.+)*BVV/Z>[
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MS%-6P**(&$N+@M$H,H\FTVAYKI%ES2'(YF GP#M #O%F\C7X*0>^L>=3Y_U
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M!:*X"'B<\G%I+)J6S&V(/AH*7F!EZB^_;F[OG#KN'=O=:0^8/\N>]4D$T$:
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MNI%UL!R7%WV]6[-7_#M?;1[5[5OYMCLBVY.CGWYTUNU[S8C".GOKJ*R>Q9V
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M?S:&FQQ*ZP _S" ^X/3,),^&I,%IOF-$)SJ\=X"LV4F] 4R#!_,Z]YGN'-[
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MDSB+(\93*/) KM1$RF&ATKNP"$E* U&01.L$Q*S9N3%DK^S,P=A:XN']W3_
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MID%&$<M08%2-U[#]N9%M9[XZ5.\<:%.GCRX8:A$9]H@>K7K$V3./:D'<1BL
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M40@)9@@20=,@%*@HB)'NS.5FYD9!RCA8KN%C8YX9QUQ!4H]5QN/CF4<.!BZ
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M/3+V3?"MKGS[^WKU)*J-Z)46JEWN/U;%IFJCKIZ/;/HD9T$2D! *073=!IE
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M"9'(.&1$NRJ,13R7)!,$.37%ND:9L3&0=;2O7A.5%H&629=RZ?T/I1VW#35
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M8(5ED<824I2E$(D,0Y8BI><PG N<YIPG3JW< ^DYMIGK5(OR5Y6EOY2]RN_
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M02:80BQ.)'.+&#@I96P\6JL':*FL:U>LDSC:.;=7HQ/:-ZTC(AJ @G22ZL+
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MM, Y$-1R2.SX. C0@;GV/,;K!6"RS+R^LT&X3WRG&UJ>0SHMA0\=Q>F&R8G
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M?3E]NX!\-+O8'Z>4:4GKETD<9PIE.(*"2 (1)A%DC&,H$,(1Q4(P9%_KZ(2
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M)$)(E&("!4H51#A/(,YS A.>"19%DDEJE78P<CO'-B.4,(#71R>E[2,PP%Y
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MWSY\^ANX?_/MPS\^?/OP[NO_<0[A=!T7NUDH+-J!9Q*S="]+1S7JFUGCE;%
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M*T )[HM9X]$C$/JDU7[CG?=%#!S6?-*^X^CETY?U/:742S[C23ZHXU,'Q[@
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M,$4$8(Q*0 1')8>\$,SI)-JRW:EQY'/1S)<"V>L;4R=IMS/B1J2V76%'FA$
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M."<I*)C 3%#*%;7:<[=M<&ILL;,Y:8W>:H$L5=(;[G3:9@W]:1*) 6CTO?
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M]]P_?99%\4]9/WPQ@:#?]&\?Y"=IXK_Z?VR/:THN<4ZER7--A5X#E! PE"J
MF2A*:E8(=G(;O@9,;2=@+^NG=R'I?$BV3K17>)R^.7>2Y:9H1.AC[X6&1=U]
MU],3NJ";G:XVC+O'Z8G0WM:F[W-"Z:\-#JY^,W-J.N=-XN_BX;"\D2F'=:>&
M4^]W"[XR]LU2)3"7A004801@)BG )2X!*PN9Y0@SB)PJ4,4T=FH\V]2*6ZJ$
M#]?3=6?L.OE)OR9<#X<_7RK>%K"[[5AX*IT8F;$/SW\'KB:_-=LE.V>/*\;=
M)/W;\&QWI?<ZIGA<^+Z)*S07T-XKB]*%1_Z\@%V$-CW"J.^7&SI_EN7\H]NV
M6;]^DK?F?/??)5V]K;_)&8-EE18\!ZFD1@T/04!I08%2L,AD114MK?(J7!N>
MVG#1F-Y-_;;&]YNLZ^2UB8]J#L:- XGQP"$PV*5#3@\",6&.3.B30=@A!CL2
MTB,%8P=$W"THVP.VD]'9+L\;+TS;P\MG\=H^]WN>[?(O4CS-]5#SFRD*M'Q8
MU/\EQ3W]W@U%ZS??^?S)9.W>/BZ?=/MZJ-JT"Z7[Y9OO]-$,<_KR3W+SM%JL
M/RWG\[?+E3D":(I)[<IL28X** L$2E4I %.3G5-4.5"<JU3A*BN(4XS<6(9/
M;33Z),T+J%^)=J*J)ZY#_Y,-_9ZP%H&;1/80)+03EJF[0LN.A[MCO226)[X3
M[/K8Q\"=RWO];8J;]&Z;$]Z^PSO/DYWK1E"B=[ZYK7,_,?XG'0!1:\"-W6]!
M3XW'LGW<H^21>V3O?'GL]GWKMSP^+A=-$E43@#[0LICEN,"89Q!DN?X#LDJ/
M:P@ID!6<RE2Q2I;4K7++T;:F-A2UIO951KH:N -[7<NU' ?9;EP(!%UD*O=&
MS:,ZRUD\PM9E.=[<R!59SOJ]7XOE_"V73K!?U^NORS6=_[I:/GU=OUMTS*9_
MS=O24ULANB9<Q@1=?];KP#;.ANIWB,O/7Z3<W"[$K1"UN8S.S=WSI2GL.2AI
MR[+,;-#DH$I-T7*I$""X,M$NA.4YYVE*G&1PKN##U+BN=SQI/3>UOONIUM#Y
M02DYWRGV>*^)ZVQ[DIT?^ZS!N=]'FD*/WAEQ9M/CN7&EB?7H_71\CCV^*7Y#
MYB[!;'V_W+7TD=;BW>(5_5IOZ/QP9.J;QZ_SY0\IFX'\H^: +_J*CZOEPXH^
M?I+_^52OZXW\+%??:B[;,Y=/[:JCV>_-,X5I!@G(TC(#4&$,2)E20)@J.$09
M2;%3_;,K^3&UH?/VX[M7-X<#U'>!Q#?)F\\?/]YL#UX3M5RU);T&GKD-J==Z
MC>R&U3_!RQ%Y:!WAO7 >7Z_<*R''V&NY,NHX>^7^>CG67ML<O_'VW<*4MUFN
M?IBE;V/-)[G63<GU3%%!,(,E2$MJ"E;A###))1!8,04+@I%@?:*$W:!XO#&/
MQ(?((]?6UH0;QJ';WG4;B$[@:S=67(C9.'2^ VMK9=*;&8Z@ST,1DD-/M#8J
MS9WW^B436=PQJ9H&;[[+%:_79N5\^_"P:C[O=XO-JEZL:]YLR<U8*E4N$08B
M@P6 &5* "8D!KDJ2IHA(7K@5S[N6)U.;H(^F9#^ YB;9@I-LT6EWPR=1",'B
M?;3</OLSO&6Q3Z__)"_85*HGV'?NE!*C_9WY4Z5/7]QG(Q5<<##(<YMNWGP@
M4AQ9T7PW/\I949 2PKP (L4,P()A0(LR R7+48DJCE2)W)80=@U/;SGQ1B_C
M-C^>I9TX[FC9(6ZY 14.Q?%'D<,[1:W) 7>#G" *NGECU_*X>RU.:.QMC;C=
M[2,1_V6YVIC$O29PUNP1KF<*,2(8A"!7E0"0ZS\HQ@K(E#&!"U8A!>TUX?<;
MF-Y47IL(C(U=<'=CI8M0^0$03_-)"&BB,T<$5%STVB]#9RR!=C>4',78CT-P
M6GW]P'TCRJT?M_JYOOJ)ZSPG5YRW58&E^" W)CJ2SDULI-G7:?<@C3*G$67L
MR@>H*I.JJ#! 7)G#RQ(!5I4*,,PQ+B"LI,!.AY>.!DR-"6\;C=.!%\^E3,^(
MG[;:LQ_I23F5,!UG.5N+V!VQS_F"]43 "A&7XAITLN=JP[C3/D^$]B: OL_Q
M(]!AP,I[\QK4;2'U6494(2A.09;ETA!E!3#D&4"IA%E.I<H*JS)!YQJ:&B%V
M=B:-H4EO:?*[L=6Q6.!1;.VX+ 1BD3G+#RQG]CF'1$B6.=K6J&QRSN.7K''V
M>C]V^'6Y%'_4\_GM0O//1O=\;;;)UFNY6>\"VF[9>K.BW%9QSNF9$WK7>[N;
M/?6=Y4EK>K*S7;_^G?4!/P$OU$)^%VX&C/JQ>&'S\@OR>XAG),GC5UJOS%A^
MIUXV]K9>U!LYK[]),<.F3J](*<"I*@#DA.G%2B5 27..L$HKFCN-P9;M3FU(
MWIEM\CKW/KV;I+4=-,8[QIQ8]H1E $IX?&-'HP2!UCT\Q0VHH+$JEDV/&[CB
MAL=>%(OC[>ZE)UYW>VNWB\43G7^27Y>KS8Q#AEF9%0#E6-,3I0@PPU8\%[R"
M%14(6^T:'VM@:CS4VYBT1B:ME?9E* Z">)I90D 3F4(<47$J27'*]0O*4AQ\
M[&BE*4XY-2Q/<?(Z;ZU%N5H]/U+J5+<T5<RH]J3 >H*!!28 LJP$1$@&L@QC
MF16"I=0I=.QT<Y/[O#MK#Q1?;0UV%CH\A;7=C"(<@K%9P!L\'XE "TP"B_R=
M:G%LF3X+[P\([=G<Y<<J>HIA-A^."C$U&DSZ39O!%*.R0A!44G'-+RP#E,H2
M0(A1"E7!B\(I<\RVX:DQ36=WKZ0\T*SOC;]IM,5:53'=K!OS6/>''0?%0#DR
M&QT'>+-,F$Q,ILF-!;S.W.2*54B6LFY[5+YR1>0E<SG?[Q$2\VZQWM#YW#RR
M>[):KFYYFTZDF=*T<:^[2LZJ@NJ94$9!A2$%FK)*0*LL!2I7HF 8EK*0UH$R
MULU.C;\&AF]#S$S"X<#V[NMJS'>((+'OB=/<%0_?V!LR$X#6(60G"L0C!?*$
M@MHMPL<9L9-Q/_9/&R\:R-G#9S%"[G=[$/ZKY4JOINE&FG#P>?VHQY@F1KR+
M-2$*LPQ+ 9@D>G9:\AS0 E9 X))7>5I)[,#RI]N:&K5OK6U31P;VGH\J<<;9
M@L/#H1>9N'? W<8'SH&APP$X$BT_?P/EP.2_!*)@.TA.\NZ91XQ'MG:^/&-8
MRUN\-2!WN3D+\6E77<LW7L#AB1.B@YV922_2&24NP .=P&*&ULV/+6[HBLL!
ML4/G1W@FBS^QM?S/)_WH-R8=O1%&FR&(4)X1"#+$)("2*T AI4 2R#'B*1?(
M+8_[0"-3FWWL;$P:(SN1.,>XNX-PVI'-I2!%9A5G?-Q3=4\ $#2+]E [XR:X
MGO!T+_?TU+6^1W%L8]8ZJV9.U;ZCG.%,B:("2ID<T(SK%4@A.2A5D>*L+'%A
M5TKF1!N3^^('BNWOEXL'L#&)-4VP^\[RM1\/'(+8]MCM(N!BLT 8S#P.WHZB
M$O:T;;^9D8_8COJY?ZYV_%+/@/RG=;V0Z[6>?;!N9OYI*_G^3NA6:E73;7A/
MLS.R:O+:!\5JFRI:30+!+*M411C.@:R@GD; - =8F+SRM"0E+@7B;F=N@>V;
M&A_U[B4#_VZ2G8?)T,4^]K=WLEFQ#MQ,.C]O3&$]Q]R!P*^!'>]=L7,C<^85
M^M4]S2$.^D&S(P*;.&Y211Q\]W(Q(C4SLA!9*\,QF% T)=/OO]!%)ZCRJW[$
M9OUNT>HLOJ@3W/SC:[J1;VF]:H6@H"IHR:I<KV7U%!>F>FG+*"X!37-:0H7+
M3#F-1)/Q;&IC6  =J4Z#93B=;$!*-AJEG<I4"U12+[JJL0>J@C>7) :OQ  V
MJG99\%?8<A-A*O9.:/S]$[^3X\F=Q>K_2<B?!7?NSR&'%JM/@\FC13/0;[ZB
M9SROZ/K+Q]7R6RVD^.6'*0/];M&FOYL*9WQ3?VNG2/TY$BN$8"DQP>JYGEW
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M5UI!"*!D A!8I8#(HB"XY*2HG(1 G5J?&@,>"T:[V2K%W23:!^NPB0#]8\>
MT5"/S'_' =\L$R8U[+6XB1>EX@5;])#!HP9</Y3P'#96(89G'^+'>Y^?OGZ=
M-XJ"=/Z*KK^\U4O==PN]T'ULJ;57@ZBJ0C&D<J!* DWB00X(*B% F> EX6D*
M9>[">);M3HWK/O_V\>/[-W]_\^'^]M._)Z]N/_\M>?O^[I_)NP]O[S[]_?;^
MW=T'1T4.VPZPH[0(L$8FLZ'%B3$Y,38G Z.CJ' X A62OFR;'I6X'/%X25FN
MMU^V5!VDGW?'^[(K$(ZYI)G(*E!P5 #85,:4I  %SA0MLQ*BW*K8@W6+4R.H
M[=IH8/%-'^8C/8NQG\?=;<D9!,VQ%IF>0'HO*\^"$V,A>;S1JRP=SV)P;+%X
M_L; Y=?N]?.Z;X"D'+,JS4&6D4I/D;(44$$(*(@0+&=IE;LI4UBT.37V.5-Z
MR1CN24$V'6!'0H%AC4Q#3?;">SW/-Q7.AW&8$1C( 9E1:EH-FIU&::M]'*PK
M7!VX-9CZV,NB"]TOUF8?8)8+GN=ID0)9R53/B"H](\*Y"3!,TSQ7)$655<:X
M9_M38RC[TBB]%\UVRL5Z9"?[R(ZX(B(?F<1"@QY";\P&NLCZ8B=-N+:>F T^
M%OIA5H_Q""+L:M%\D)NMRJ,)4.Q%PM)24,P8$&5.]%3,A%%#I5>%J&*:]"@1
MR(KTSC<U-7[KC&W*7 X$38W!/NHUIV$^S5MAP8N]ISXF;@X!=,'P&RD\[@2.
M@>+=K! Y&<UV^@GCQ:I9>?(L$LWNCM!+W&T-)FD6M5G% *\P!3#-D)Y+5CE
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MZ6^2@<FN>P$GT;;=#0B%863*O 0^C_6_#2IA=P!.MCCR'H"-]_N[ %9W>9X
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M^>>/0@76;O:L8'^#M_8NUY_[^JTVT3S0)+^9$CQ"RD=SN/Y<FF-6E9@Q*7,
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M0YX[I@Y9-3PU+N[M;BN"]D8[IP79@6Y'KC&@C,R?O<DW#7-NGH,YSI+<%;7
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MH]>?Y-JHQ2P>C%4?]01QU4T3Z?>/RW7=S"%GM!(*,\B!GL<5 %9$ 2H% YQ
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M=-D+:#=^3O^UBCRT3OR-&D_I*$B'3D+[Z#)/_AQJ2$%Z*Y@^4AAK/,^?'XU
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M_]Y.0#$O%RA'R;D)C+R;AMD<G?25/#ZA;M+KV=5T.?_^>A;3*!J&OKE'^I5
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M*8WL1\?I^'Z]_'$";P RUW)9'SX6[VXV+3')2C;&BI05QV"445Q5%*5D!>%
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M]9!D9$(('FRHXO!WI*^9';<J#GO75 , 7+FENY<2+B1*K',0LD1I48:<L)B
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MU 'J?@PY1\N^ 2#=X^'-[,*-IR//B70F,HC$R#(>Q0$&&@9LUB&*X#Q-K :
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M3Z+G!G#\9KRXG"W<Y-?Y[.KR]]D2OR\-H,;3JQ0W,KW9+,ZFVX^/J,<EJ84
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MPC3NR$"5V0Z3V>)JGFZ:I:KLI:;H5BJO2^J+@N>X?E0,V@07A555IBH>2_C
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M[([T<5$]*?3/*.>?)Z6T,-(@$_,"0M88CN@0P7 O<>-1%C<=E(:LXH$<0_3
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MM3]!52,.^($JWV?TX5[R_^OEOLH%PK=C_(LPQCW]^@.?RMTM-X]#W87K3MC
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M" D%>,^#X(Y)H=N,@GJ<IFXQ=SP6[J97C*28J0M3/JR6^3QM'F*#T0EADC>
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M_W$?(J=]X#X5*INI;>JP\![^];NK1C$Q.93%.9 YU=M<3D ^#^T^:;0IWJ;
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MZRV=Y;G&[%).$.K@"V9%,CHT\: >)&=:%ZJ-ZN\-*CI:#SV@Z6''T/ <LM"
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M Y1F@E*^:"$X);54(J)K&Y(.7V;U0+;_6"W7MZ6Q.?LH96(@M"*.C3?$K-'
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M#]$)'NJN#=5T&<43=/7;(78(1EZ\N#]!&=W&WG<J+Z_8XAF%<;& CB0M94,
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M%T4)4;M2\D@N\S@_.>+Q/3Q$7D3E:?KJ9CW"0\;>X^KK/&W[9&=,T+\PA@Z
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MKB086T1.M7T_CG3 [TMR;T'H1-!MHN$NL7RG"N+.V6$SBAB3 XV)XOPL!;A
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M-[N=LY(]B<O3"9LH4W YILR;@&@_\LZIL?*4++^!LCKP6#>L_(ZA"FI7M?:
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MY\P,Z&<\W*'PF:CBL+KV =;.)V;)HS ;P1;K.)=HC1LI@QF8L]ZRF_,SJ_:
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MS>)B;HT(T5I*L0IE7-)3QI4]R56:E$72*9@F9VH+9B8>HG\\MN[O )Y:T1V
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M(FH8&70 IA\QKFZ"N7_,+I>8?Y@O%O-_T\K>AF\A35=__8RTKD)LL4* P&A
M)4O[(RL/FC,=35HGV5M@:U<"Q[TXUA!J3234!?(6T^\DH.]X==R_G]U\]ANN
M)DFZ5'R.X+(OH'S6$!1WP)T.7#@,V.9&\HN4C7O1J2G6AI1)!R#[QV*ZPO>E
MO"\_;@E8;Z?E\K+./:A%#1-?ZG2UK"#F:$$Q@;6G35T;CSRJ8FV;L<(ODS;N
M=9R&,!M8*AW@[*>PN/CK W[;)$K?EX\XF\X7=543M,DD# +0UHZA)3#R7.@[
M+WP0.C):49.N=$^3-.Y=D8:X&D@*'>"IJM]EU;](&OBG/ZN9>3E=?MDL:[V@
M4)PE9M0AMUZ LJ22:0D!LM;<**]9RDWF+;Y(V;@W)1JB:UB9]!B0_Z6V[#@H
M^K[]RZ-#[8]1,%!<??/H&R2X4&PT&DIQ6 46(9J2H,0H4W J,MO$G[E+QK%Z
M8O.T]^47)%@^GN&N\^@2.@A<U8;5,D.LG<4X>G))>4RF35>"%RD;-Y)^!!KN
MZX5A9="O7CB\LN#.WP^D(QI6$-S#AG<Y1"XM2%$;*3/Z+M01S\58PS&DZ'43
M VX83;$NF[V58+Z*6M'I^/-T1O8V?;]YT^\;:=3:O1_"Q68N'.+J7M+9ZAQR
M"<0-6X@;GO9,%((3M+ET+')7T+V$AX%IZDJ3[(.6.Z7-(\FH V-WO;3J]=U;
MAL])".D9.,X-*66%$)@)X%(2B@?M@VO2C^,)>L9-Q T LR'YW0%L;C;,V[#\
M\O/%_-\?+[_1:50-\G!Q<PXO[RW3Y*R\]0E228R6F6G!AM.17% %%M$8;-,F
M_C!ZQ\W*#0B[4\AK[ M%-VO\-:PN%]/5=&,9$A-_F88XO5A_<F^!00==@JPS
M8+ 04Z,C=1T+6.FM1&M2%F+/(W7WMX^;HAO^\&S$]W[-\JNESV_LAG!E-^ ]
MJV$Z6WW!VX;#$05W [Y]()=@>$X,Y%"\(<=PM21K[A86-][B-?(=#S[5E!U3
M66^13W8:I(!"B6)*44TJD5XF[>B"K%O\_U!O[[TO?RQQ_=Y),,6Z6'>@+IX,
MU4!:'3%"D":0(RZ8Q29!F&=H&M>9&!@I#TJN!I)%!];?]19_=#'>>.:=-"1X
M.CY4O?H?30WO9&G)ELTJB28#3YZE:EP'HC&TAI/'P>#ZCHLX'ZJ,]-9.N6+8
M7YM2Q=4D&JY]5 HBCPC*2$DN4U# K.0HM+,IMRD;?8:H<=V$$^JMHZ31G>)Z
ML!JK@K%<>K)",ZU&>PU1Y0RD@!./.2<O=IFJ>Z3F.@A=S;R$DZJNHR32 ;X>
MW2N_S6=INYR@I//DV8"AE]-R-((7M;]W*J9Z6"GR)O4N+] U;OW>&/KK0)ET
M +$G-LRM!8G(//<VD_58RW>\3N"2=6!-X%SG8&(Y@?UU*,R:E>Z-H\@.E$N_
M(8\:NSXZ<G'[(0,%()ZD:\C$9'W)-5I$*!@"J[,VZU"CXLAIDTY#+LQ$%GBP
MN<D%W@>4-(P2O/DZ7ZRF_W?38-%:DV7BBKQ4H>N,-#+[I';D3="R;4)31).R
MIQWIZR 5>3 ^]@@6'"R2#@ZOV\MZ-Z/GXG)U=7G#\)0"XPF"K^QB2H"+M@:(
M QKF/?&KR>2=9VCJ(.O8!%''L'[L+,_M=5Q?DTTZ(AEMD+((H)!+"%$J\-8Z
MYD0JVOF7#J:G'MY!"O!H# S"N [4QUT;ZVH1"8L1/&K0AM,B0B*[BHL(0059
M=)+!FC9]CQZCIH.4WF JXWAV=X"9OX?%M*8>KUE36W?8VOD<R-:/H'+0$!,A
M7^N"VM86F6UN:CZ@9%RW>UBL',?F#G!R0S@Z;J/%#,S41'A&#]$J"8X,JXQ&
MQY*:Z)/]<-',3QX6%X>Q=6PCX^,7LK$_X>+K-?G+B4I>^I 5,*'J+0.>2>\5
M#\Z2"1&U\3'O6'SY\.'CWC8;T,@XEG$=*(+;=M*]EK<?\&N8SJX.Q+I,/F&"
M@"V9 A-4'?L6:76,=)U5*:%V5C'>W"E^F<QQKYVU\V0&%E '\+MK=.VP/B\4
M9Y$),+G>?I(L0TADCT7MC*6SE]9Z@J350!!L=C>MI64\L) Z .$S6ZS6BLXO
M9ZL/886_XR+5R'8JGB=6=U<(JC9Q00CH$VCEH]&AMO)L$@G=C\R1Q^J<3 D>
M*Z$.\/?L_GIL?1*9D\)D2+7KAJH5RR'79E7*>)=%"3HTN:ZP+Z$C3Z(YH18\
M5DK]9L!N2EUOU]!?U=6_FY7YXNOZ-0,6^.[XIL&+>0]9X9$)M[4?4=_U>YC6
M 2=OOE88+=_-TL5EKI>O?B4:+Q>XN?M]O\S\&MA*A1R*8Q 5UH&0P8#SFH!M
M0^:$MXQ\MSDA1Y,RY&'\^V(Z2]-OX>)J2MH$H[0823E%64.XG-<92T+60GK/
M.49T;;*0SU(U3BIN!.0\=RP?)ZL.3N''4D;;M;R?75<X3+((CF&PP!W'VI:(
M@7>2@RM&&Z8*T[&) [(;>>/D\#J#XD#2ZP"3=VV.ZYW%F)+"8LV#N]I&4BOP
M:#SX2/X]N?QD[#:)PCQ.SC@YPPXP-X!T.L#8O8*+]Y&,G%EEX$]_IB]U1@\Q
M]]&JP@D*7Y(COYY;VD?*,@]!F'IG4G,RM*..NDGIW<$4CY.N[ "IIY'QF8#Y
MB=K%22S"27064&;R$(G-$+-(@-$(1:]BV3>YK7T$S>/D5,\$T$/(^1S\\IM[
MR/-'&GK@??X/Z*<?^.;!_?8A.-"FHP^3R@KNQ*;,3#&^'E'J@!D3>> ZFC;5
MZ<-T]'GV4L&5O?/C)?Y&S/OT;[SXCK_.9ZLORTF.D:,L 9!S!4H;,H8R640I
M2>.R95F%)K,T]B6T@R+:P["RT[6/H234P;G^TOK^&\/BT[_GDQ!,D<4[2"AC
MO5ILB8<N@[3:.2](V>OFU[R?H:^#$MO3X.T0>9P+S @W.&&T/R1M%N"2_#O%
M+(?H)-DR@4Y+CF@3:UZ__2R%'53RGA!J>\OD3,#V\_QR,4G:R>@C>5ZT9VA=
M.H!714!F7);LA4[8)-VW*X$=5 &?#FI[2^1<D#;]CA/O5"XL*(BLU.GETD!
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M?TZ79$_HPITE9]':VGFN6'!<($1)IK .W&?1I _1LU2-B[53P.)^"'PP&?4
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MXE!$#,;&#DS*ZS#ZEOR0F(R2"1"&65#6* A,($B,7 41M-5-:ESNT=%5BN(
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MZV\VQ%1+WO?L9-XR 6@])L4 +'LR 4ITX+0-M**@A,^(R3>Y:/8R:>.6@)]
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M,S$Q+FAT;5!+ 0(4 Q0    ( %)+'E,$UOQ=;0@  !TJ   ;
M  "  8P(  !C871A;&5N="TR,#(Q,#8S,'AE>#,Q,BYH=&U02P$"% ,4
M" !22QY39G\?"'D$  !I$   &P              @ $R$0  8V%T86QE;G0M
M,C R,3 V,S!X97@S,C$N:'1M4$L! A0#%     @ 4DL>4Y.=) > !   [!
M !L              ( !Y!4  &-A=&%L96YT+3(P,C$P-C,P>&5X,S(R+FAT
M;5!+ 0(4 Q0    ( %)+'E-KGA;31@D  !W    :              "  9T:
M  !C871A;&5N="TR,#(Q-C,P>&5X,C$Q+FAT;5!+ 0(4 Q0    ( %)+'E,U
M#3$^F@,  ( ,   :              "  1LD  !C871A;&5N="TR,#(Q-C,P
M>&5X,C,Q+FAT;5!+ 0(4 Q0    ( %)+'E.:W43Z5E<% 'L9.@ 1
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M &-T;'0M,C R,3 V,S!?9S$N:G!G4$L! A0#%     @ 4DL>4RJ;(7D^30
M-X\  !0              ( !/S@' &-T;'0M,C R,3 V,S!?9S(N:G!G4$L!
M A0#%     @ 4DL>4PL*>DKVAP  =<@  !0              ( !KX4' &-T
M;'0M,C R,3 V,S!?9S,N:G!G4$L! A0#%     @ 4DL>4[UNFFEE<P  >+8
M !0              ( !UPT( &-T;'0M,C R,3 V,S!?9S0N:G!G4$L! A0#
M%     @ 4DL>4T;J7+08^P  @@8! !0              ( !;H$( &-T;'0M
M,C R,3 V,S!?9S4N:G!G4$L! A0#%     @ 4DL>4U/&[L_S>@  )+@  !0
M             ( !N'P) &-T;'0M,C R,3 V,S!?9S8N:G!G4$L! A0#%
M  @ 4DL>4QOIUG[NH0  .ML  !0              ( !W?<) &-T;'0M,C R
M,3 V,S!?9S<N:G!G4$L! A0#%     @ 4DL>4SSS7-EJSP$ "AD4 !4
M         ( !_9D* &-T;'0M,C R,3 V,S!?;&%B+GAM;%!+ 0(4 Q0    (
M %-+'E-.HW3O1#4! +)/#@ 5              "  9II# !C=&QT+3(P,C$P
A-C,P7W!R92YX;6Q02P4&     !, $P ,!0  $9\-

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
